-- MySQL dump 10.13  Distrib 5.7.9, for Win64 (x86_64)
--
-- Host: 146.169.32.152    Database: eHS_METADATA
-- ------------------------------------------------------
-- Server version	5.5.46-0ubuntu0.14.04.2

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;


--
-- Dumping data for table `Dbs`
--

LOCK TABLES `Dbs` WRITE;
/*!40000 ALTER TABLE `Dbs` DISABLE KEYS */;
INSERT INTO `Dbs` VALUES ('DB-NCIT','NCI thesaurus','14.08d','http://ncit.nci.nih.gov/','http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=');
/*!40000 ALTER TABLE `Dbs` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping data for table `DBxreferences`
--

LOCK TABLES `DBxreferences` WRITE;
/*!40000 ALTER TABLE `DBxreferences` DISABLE KEYS */;
INSERT INTO `DBxreferences` VALUES ('DBX-NCIT-C100000','C100000','Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable-Over 12 Hours From Symptom Onset','DB-NCIT'),('DBX-NCIT-C100001','C100001','Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable After Successful Full-Dose Thrombolytic Therapy','DB-NCIT'),('DBX-NCIT-C100002','C100002','Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset','DB-NCIT'),('DBX-NCIT-C100003','C100003','Percutaneous Mitral Valve Repair','DB-NCIT'),('DBX-NCIT-C100004','C100004','Pericardial Stripping','DB-NCIT'),('DBX-NCIT-C100005','C100005','Post-Cardiac Transplant Evaluation','DB-NCIT'),('DBX-NCIT-C100006','C100006','Pre-Operative Evaluation for Non-Cardiovascular Surgery','DB-NCIT'),('DBX-NCIT-C100007','C100007','Previously Implanted Cardiac Lead','DB-NCIT'),('DBX-NCIT-C100008','C100008','Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy','DB-NCIT'),('DBX-NCIT-C100010','C100010','Right Cardiac Ventricle Assist Device Procedure','DB-NCIT'),('DBX-NCIT-C100011','C100011','Right Cardiac Ventricle Pacing Malfunction','DB-NCIT'),('DBX-NCIT-C100012','C100012','Severe Cardiac Valve Regurgitation','DB-NCIT'),('DBX-NCIT-C100013','C100013','Severe Cardiac Valve Stenosis','DB-NCIT'),('DBX-NCIT-C100014','C100014','Spontaneous Sustained Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C100015','C100015','Staged Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C100016','C100016','Subject Delay in Providing Consent','DB-NCIT'),('DBX-NCIT-C100017','C100017','Surgical Maze Procedure','DB-NCIT'),('DBX-NCIT-C100018','C100018','Syncope with High Risk Cardiac Characteristics','DB-NCIT'),('DBX-NCIT-C100019','C100019','Syncope with Inducible Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C100020','C100020','Three Vessel Coronary Disease','DB-NCIT'),('DBX-NCIT-C100021','C100021','Thrombolysis in Myocardial Infarction Flow','DB-NCIT'),('DBX-NCIT-C100022','C100022','Transcatheter Aortic Valve Implantation','DB-NCIT'),('DBX-NCIT-C100023','C100023','Two Vessel Coronary Disease','DB-NCIT'),('DBX-NCIT-C100024','C100024','Typical Coronary Artery Disease Symptom','DB-NCIT'),('DBX-NCIT-C100025','C100025','Unable to Obtain Acceptable Pacing Thresholds','DB-NCIT'),('DBX-NCIT-C100026','C100026','Unable to Obtain Satisfactory Coronary Sinus Access','DB-NCIT'),('DBX-NCIT-C100027','C100027','Unable to Obtain Satisfactory Vascular Access','DB-NCIT'),('DBX-NCIT-C100028','C100028','Unable to Position Lead Due to Coronary Sinus Dissection','DB-NCIT'),('DBX-NCIT-C100029','C100029','Unable to Position Lead In tributary Vein of Coronary Sinus','DB-NCIT'),('DBX-NCIT-C100030','C100030','Upgrade to Cardiac Device with Additional Pacing Capabilities','DB-NCIT'),('DBX-NCIT-C100031','C100031','Urgent Procedure','DB-NCIT'),('DBX-NCIT-C100032','C100032','American College of Cardiology/American Heart Association Lesion Complexity Class','DB-NCIT'),('DBX-NCIT-C100033','C100033','Cardiac Arrest/Arrhythmia Etiology Unknown','DB-NCIT'),('DBX-NCIT-C100034','C100034','Cardiac Lead Dislodgement Requiring Reposition/Reoperation','DB-NCIT'),('DBX-NCIT-C100035','C100035','Faulty Device Connector/Header','DB-NCIT'),('DBX-NCIT-C100036','C100036','Idiopathic Primary Ventricular Tachycardia/Ventricular Flutter by ECG Finding','DB-NCIT'),('DBX-NCIT-C100037','C100037','American College of Cardiology/American Heart Association Lesion Complexity Score A','DB-NCIT'),('DBX-NCIT-C100038','C100038','American College of Cardiology/American Heart Association Lesion Complexity Score B','DB-NCIT'),('DBX-NCIT-C100039','C100039','American College of Cardiology/American Heart Association Lesion Complexity Score C','DB-NCIT'),('DBX-NCIT-C100040','C100040','Thrombolysis in Myocardial Infarction Flow-0','DB-NCIT'),('DBX-NCIT-C100041','C100041','Thrombolysis in Myocardial Infarction Flow-1','DB-NCIT'),('DBX-NCIT-C100042','C100042','Thrombolysis in Myocardial Infarction Flow-2','DB-NCIT'),('DBX-NCIT-C100043','C100043','Thrombolysis in Myocardial Infarction Flow-3','DB-NCIT'),('DBX-NCIT-C100044','C100044','Pulmonic Valvuloplasty','DB-NCIT'),('DBX-NCIT-C100045','C100045','Manufacturer Recall','DB-NCIT'),('DBX-NCIT-C100076','C100076','Sinus Rhythm','DB-NCIT'),('DBX-NCIT-C100080','C100080','Cardiac Stent Placement','DB-NCIT'),('DBX-NCIT-C100085','C100085','Coronary Angiography','DB-NCIT'),('DBX-NCIT-C100086','C100086','Coronary Artery Dominance','DB-NCIT'),('DBX-NCIT-C100104','C100104','Sign or Symptom','DB-NCIT'),('DBX-NCIT-C100122','C100122','Pepsinogen Measurement','DB-NCIT'),('DBX-NCIT-C100130','C100130','CDISC SDTM Relationship to Subject Terminology','DB-NCIT'),('DBX-NCIT-C100390','C100390','Mean QRS Duration Ventricular Paced','DB-NCIT'),('DBX-NCIT-C100391','C100391','Corrected QT Interval','DB-NCIT'),('DBX-NCIT-C100418','C100418','Sideroblast Measurement','DB-NCIT'),('DBX-NCIT-C100419','C100419','Ringed Sideroblast Measurement','DB-NCIT'),('DBX-NCIT-C100420','C100420','Tricyclic Antidepressant Measurement','DB-NCIT'),('DBX-NCIT-C100422','C100422','Ecarin Clotting Time Measurement','DB-NCIT'),('DBX-NCIT-C100423','C100423','CH50 Measurement','DB-NCIT'),('DBX-NCIT-C100424','C100424','Platelet Hematocrit Measurement','DB-NCIT'),('DBX-NCIT-C100425','C100425','HDL Cholesterol to LDL Cholesterol Ratio Measurement','DB-NCIT'),('DBX-NCIT-C100426','C100426','Beta-Trace Protein Measurement','DB-NCIT'),('DBX-NCIT-C100427','C100427','Apolipoprotein C2 Measurement','DB-NCIT'),('DBX-NCIT-C100428','C100428','Apolipoprotein J Measurement','DB-NCIT'),('DBX-NCIT-C100429','C100429','Alpha-1 Acid Glycoprotein Measurement','DB-NCIT'),('DBX-NCIT-C100430','C100430','Alanine Aminopeptidase Measurement','DB-NCIT'),('DBX-NCIT-C100431','C100431','Chemokine Receptor CXCR3 Measurement','DB-NCIT'),('DBX-NCIT-C100432','C100432','Ceruloplasmin Measurement','DB-NCIT'),('DBX-NCIT-C100433','C100433','Kidney Injury Molecule-1 Measurement','DB-NCIT'),('DBX-NCIT-C100434','C100434','Non-Prostatic Acid Phosphatase Measurement','DB-NCIT'),('DBX-NCIT-C100435','C100435','Prealbumin Measurement','DB-NCIT'),('DBX-NCIT-C100436','C100436','Protein S Measurement','DB-NCIT'),('DBX-NCIT-C100437','C100437','Retinol Binding Protein Measurement','DB-NCIT'),('DBX-NCIT-C100438','C100438','Soluble Transferrin Receptor Measurement','DB-NCIT'),('DBX-NCIT-C100439','C100439','Iohexol Clearance','DB-NCIT'),('DBX-NCIT-C100440','C100440','EDTA Clearance','DB-NCIT'),('DBX-NCIT-C100441','C100441','Diethylene Triamine Pentaacetic Acid Clearance','DB-NCIT'),('DBX-NCIT-C100442','C100442','Immature Neutrophils to Leukocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C100443','C100443','Immature Lymphocytes to Leukocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C100444','C100444','Immature Lymphocytes Measurement','DB-NCIT'),('DBX-NCIT-C100445','C100445','Immature Granulocytes to Leukocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C100446','C100446','Proerythroblast Measurement','DB-NCIT'),('DBX-NCIT-C100447','C100447','Homeostatic Model Assessment of Insulin Resistance','DB-NCIT'),('DBX-NCIT-C100448','C100448','Free Glycerol Measurement','DB-NCIT'),('DBX-NCIT-C100449','C100449','Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement','DB-NCIT'),('DBX-NCIT-C100450','C100450','Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement','DB-NCIT'),('DBX-NCIT-C100452','C100452','Ova and Parasite Measurement','DB-NCIT'),('DBX-NCIT-C100453','C100453','Plasmodium Measurement','DB-NCIT'),('DBX-NCIT-C100454','C100454','Liver Kidney Microsomal Type 1 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100455','C100455','Liver Kidney Microsomal Type 1 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100456','C100456','Liver Kidney Microsomal Type 1 IgA Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100457','C100457','Ribonucleoprotein Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100458','C100458','Scl-70 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100459','C100459','Jo-1 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100460','C100460','HLA-B27 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C100461','C100461','Alpha-1 Microglobulin Measurement','DB-NCIT'),('DBX-NCIT-C100462','C100462','Alpha-1 Microglobulin to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C100463','C100463','DNase-B Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100464','C100464','Chlamydia trachomatis IgA Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100465','C100465','Chlamydia trachomatis IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100466','C100466','Chlamydia trachomatis IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C100467','C100467','Pepsinogen I Measurement','DB-NCIT'),('DBX-NCIT-C100468','C100468','Pepsinogen II Measurement','DB-NCIT'),('DBX-NCIT-C100469','C100469','Pepsinogen A Measurement','DB-NCIT'),('DBX-NCIT-C100470','C100470','Pepsinogen C Measurement','DB-NCIT'),('DBX-NCIT-C100471','C100471','Activated Protein C Resistance Measurement','DB-NCIT'),('DBX-NCIT-C100472','C100472','Beta Carotene Measurement','DB-NCIT'),('DBX-NCIT-C100758','C100758','Lateral Decubitus Position','DB-NCIT'),('DBX-NCIT-C100805','C100805','Biological Grandchild','DB-NCIT'),('DBX-NCIT-C100806','C100806','Biological Grandparent','DB-NCIT'),('DBX-NCIT-C100807','C100807','Biological Child','DB-NCIT'),('DBX-NCIT-C100808','C100808','Third Degree Relative','DB-NCIT'),('DBX-NCIT-C100809','C100809','Biological Sibling','DB-NCIT'),('DBX-NCIT-C100810','C100810','Organ Donor','DB-NCIT'),('DBX-NCIT-C100811','C100811','Pregnancy Partner','DB-NCIT'),('DBX-NCIT-C100812','C100812','Sexual Partner','DB-NCIT'),('DBX-NCIT-C100896','C100896','Prostatic Fluid','DB-NCIT'),('DBX-NCIT-C100897','C100897','Thousand Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C100898','C100898','Million Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C100899','C100899','Diopter','DB-NCIT'),('DBX-NCIT-C100900','C100900','Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C100945','C100945','Pulse Pressure','DB-NCIT'),('DBX-NCIT-C100946','C100946','Forearm Circumference','DB-NCIT'),('DBX-NCIT-C100947','C100947','Hip Circumference','DB-NCIT'),('DBX-NCIT-C100948','C100948','Waist Circumference','DB-NCIT'),('DBX-NCIT-C101016','C101016','Carbohydrate-Deficient Transferrin Measurement','DB-NCIT'),('DBX-NCIT-C101017','C101017','3,4-Dihydroxyphenylglycol Measurement','DB-NCIT'),('DBX-NCIT-C101224','C101224','Bonaire, Sint Eustatius and Saba','DB-NCIT'),('DBX-NCIT-C101225','C101225','Curacao','DB-NCIT'),('DBX-NCIT-C101226','C101226','Sint Maarten (Dutch Part)','DB-NCIT'),('DBX-NCIT-C101231','C101231','Medical Device Deployment','DB-NCIT'),('DBX-NCIT-C101293','C101293','Next Generation Sequencing','DB-NCIT'),('DBX-NCIT-C101526','C101526','Treatment Epoch','DB-NCIT'),('DBX-NCIT-C101589','C101589','Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C101596','C101596','Acute Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C101597','C101597','Old Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C101687','C101687','Needle Gauge','DB-NCIT'),('DBX-NCIT-C101832','C101832','CDISC SDTM Findings About Test Code Terminology','DB-NCIT'),('DBX-NCIT-C101833','C101833','CDISC SDTM Findings About Test Name Terminology','DB-NCIT'),('DBX-NCIT-C101834','C101834','CDISC SDTM Normal Abnormal Response Terminology','DB-NCIT'),('DBX-NCIT-C101837','C101837','CDISC SDTM Consensus Cardiac Classification Systems Test Name Terminology','DB-NCIT'),('DBX-NCIT-C101838','C101838','CDISC SDTM Consensus Cardiac Classification Systems Test Code Terminology','DB-NCIT'),('DBX-NCIT-C101839','C101839','CDISC SDTM New York Heart Association Class Responses Terminology','DB-NCIT'),('DBX-NCIT-C101840','C101840','CDISC SDTM Killip Class Responses Terminology','DB-NCIT'),('DBX-NCIT-C101841','C101841','CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology','DB-NCIT'),('DBX-NCIT-C101842','C101842','CDISC SDTM Canadian Cardiovascular Society Classification Terminology','DB-NCIT'),('DBX-NCIT-C101843','C101843','CDISC SDTM Coronary Artery Disease Presentation Terminology','DB-NCIT'),('DBX-NCIT-C101844','C101844','CDISC SDTM Coronary Artery Disease Symptoms Terminology','DB-NCIT'),('DBX-NCIT-C101845','C101845','CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology','DB-NCIT'),('DBX-NCIT-C101846','C101846','CDISC SDTM Cardiovascular Test Name Terminology','DB-NCIT'),('DBX-NCIT-C101847','C101847','CDISC SDTM Cardiovascular Test Code Terminology','DB-NCIT'),('DBX-NCIT-C101848','C101848','CDISC SDTM Risk Assessment Terminology','DB-NCIT'),('DBX-NCIT-C101849','C101849','CDISC SDTM Coronary Artery Disease Risk Terminology','DB-NCIT'),('DBX-NCIT-C101850','C101850','CDISC SDTM Coronary Vessel Disease Extent Terminology','DB-NCIT'),('DBX-NCIT-C101851','C101851','CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology','DB-NCIT'),('DBX-NCIT-C101852','C101852','CDISC SDTM Sudden Death Syndrome Type Terminology','DB-NCIT'),('DBX-NCIT-C101853','C101853','CDISC SDTM Cardiac Valvular Regurgitation Severity Terminology','DB-NCIT'),('DBX-NCIT-C101854','C101854','CDISC SDTM Cardiac Valvular Stenosis Severity Terminology','DB-NCIT'),('DBX-NCIT-C101855','C101855','CDISC SDTM Non-system Reason for PCI Delay Terminology','DB-NCIT'),('DBX-NCIT-C101856','C101856','CDISC SDTM Procedure Urgency Status Terminology','DB-NCIT'),('DBX-NCIT-C101857','C101857','CDISC SDTM Diabetes Therapy Terminology','DB-NCIT'),('DBX-NCIT-C101858','C101858','CDISC SDTM Procedure Terminology','DB-NCIT'),('DBX-NCIT-C101859','C101859','CDISC SDTM Cardiac Procedure Indication Terminology','DB-NCIT'),('DBX-NCIT-C101860','C101860','CDISC SDTM Coronary Artery Dominance Terminology','DB-NCIT'),('DBX-NCIT-C101861','C101861','CDISC SDTM Lesion Complexity Terminology','DB-NCIT'),('DBX-NCIT-C101862','C101862','CDISC SDTM Lead Abnormality Terminology','DB-NCIT'),('DBX-NCIT-C101863','C101863','CDISC SDTM Discharge Disposition Terminology','DB-NCIT'),('DBX-NCIT-C101864','C101864','CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology','DB-NCIT'),('DBX-NCIT-C101865','C101865','CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology','DB-NCIT'),('DBX-NCIT-C101866','C101866','CDISC SDTM Cardiac Rhythm Device Failure Manifestation Terminology','DB-NCIT'),('DBX-NCIT-C101867','C101867','CDISC SDTM Lead Status Terminology','DB-NCIT'),('DBX-NCIT-C101868','C101868','CDISC SDTM Left Ventricular Ejection Fraction Measurement Result Terminology','DB-NCIT'),('DBX-NCIT-C101888','C101888','ST Elevation Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102244','C102244','Cardiac Valvular Regurgitation Severity','DB-NCIT'),('DBX-NCIT-C102245','C102245','Cardiac Valvular Stenosis Severity','DB-NCIT'),('DBX-NCIT-C102246','C102246','Oral Medication','DB-NCIT'),('DBX-NCIT-C102247','C102247','Institution Not Defined','DB-NCIT'),('DBX-NCIT-C102248','C102248','Short Term General Hospital','DB-NCIT'),('DBX-NCIT-C102249','C102249','Median Heart Rate','DB-NCIT'),('DBX-NCIT-C102250','C102250','Median PR Duration','DB-NCIT'),('DBX-NCIT-C102251','C102251','Median QRS Duration','DB-NCIT'),('DBX-NCIT-C102252','C102252','Median QT Duration','DB-NCIT'),('DBX-NCIT-C102253','C102253','Median QTcF','DB-NCIT'),('DBX-NCIT-C102254','C102254','Median RR Duration','DB-NCIT'),('DBX-NCIT-C102255','C102255','Blinded Treatment Epoch','DB-NCIT'),('DBX-NCIT-C102256','C102256','Open Label Treatment Epoch','DB-NCIT'),('DBX-NCIT-C102257','C102257','Adenosine Diphosphate Measurement','DB-NCIT'),('DBX-NCIT-C102258','C102258','Antiphospholipid Antibody Measurement','DB-NCIT'),('DBX-NCIT-C102259','C102259','Arachidonic Acid Measurement','DB-NCIT'),('DBX-NCIT-C102260','C102260','CD34 Measurement','DB-NCIT'),('DBX-NCIT-C102261','C102261','Clue Cell Count','DB-NCIT'),('DBX-NCIT-C102262','C102262','Dextroamphetamine Measurement','DB-NCIT'),('DBX-NCIT-C102263','C102263','Endogenous Thrombin Potential Area Under Curve Measurement','DB-NCIT'),('DBX-NCIT-C102264','C102264','Endogenous Thrombin Potential Lag Time Measurement','DB-NCIT'),('DBX-NCIT-C102265','C102265','Endogenous Thrombin Potential Lag Time Relative Measurement','DB-NCIT'),('DBX-NCIT-C102266','C102266','Endogenous Thrombin Potential Measurement','DB-NCIT'),('DBX-NCIT-C102267','C102267','Endogenous Thrombin Potential Peak Height Measurement','DB-NCIT'),('DBX-NCIT-C102268','C102268','Endogenous Thrombin Potential Peak Height Relative Measurement','DB-NCIT'),('DBX-NCIT-C102269','C102269','Endogenous Thrombin Potential Time to Peak Measurement','DB-NCIT'),('DBX-NCIT-C102270','C102270','Endogenous Thrombin Potential Time to Peak Relative Measurement','DB-NCIT'),('DBX-NCIT-C102271','C102271','Factor V Leiden Measurement','DB-NCIT'),('DBX-NCIT-C102272','C102272','Factor XIV Measurement','DB-NCIT'),('DBX-NCIT-C102273','C102273','Hematocrit Corrected Reticulocyte Count','DB-NCIT'),('DBX-NCIT-C102274','C102274','Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C102275','C102275','Hydrogen Measurement','DB-NCIT'),('DBX-NCIT-C102276','C102276','Immature Reticulocyte Fraction Measurement','DB-NCIT'),('DBX-NCIT-C102277','C102277','Lupus Anticoagulant Sensitive APTT Measurement','DB-NCIT'),('DBX-NCIT-C102278','C102278','Lymphoblast Count','DB-NCIT'),('DBX-NCIT-C102279','C102279','P50 Oxygen Measurement','DB-NCIT'),('DBX-NCIT-C102280','C102280','Soluble Interleukin 2 Receptor Activity Measurement','DB-NCIT'),('DBX-NCIT-C102281','C102281','Sperm Motility Measurement','DB-NCIT'),('DBX-NCIT-C102282','C102282','Urine Conductivity','DB-NCIT'),('DBX-NCIT-C102283','C102283','Extracted Lead','DB-NCIT'),('DBX-NCIT-C102284','C102284','Reused Lead','DB-NCIT'),('DBX-NCIT-C102285','C102285','Acute Marginal Artery','DB-NCIT'),('DBX-NCIT-C102286','C102286','Circumflex Artery and its Branches','DB-NCIT'),('DBX-NCIT-C102287','C102287','Circumflex Artery AV Groove Continuation Artery','DB-NCIT'),('DBX-NCIT-C102288','C102288','Costochondral Joint 1','DB-NCIT'),('DBX-NCIT-C102289','C102289','Costochondral Joint 7','DB-NCIT'),('DBX-NCIT-C102290','C102290','Distal Circumflex Artery','DB-NCIT'),('DBX-NCIT-C102291','C102291','Distal Interphalangeal Joint 2','DB-NCIT'),('DBX-NCIT-C102292','C102292','Distal Interphalangeal Joint 3','DB-NCIT'),('DBX-NCIT-C102293','C102293','Distal Interphalangeal Joint 4','DB-NCIT'),('DBX-NCIT-C102294','C102294','Distal Interphalangeal Joint 5','DB-NCIT'),('DBX-NCIT-C102295','C102295','Distal Left Anterior Descending Artery','DB-NCIT'),('DBX-NCIT-C102296','C102296','Distal Right Coronary Artery Conduit','DB-NCIT'),('DBX-NCIT-C102297','C102297','First Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102298','C102298','First Left Posterolateral Branch Artery','DB-NCIT'),('DBX-NCIT-C102299','C102299','First Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102300','C102300','First Right Posterolateral Artery','DB-NCIT'),('DBX-NCIT-C102301','C102301','Interphalangeal Joint 1','DB-NCIT'),('DBX-NCIT-C102302','C102302','Interphalangeal Joint 2','DB-NCIT'),('DBX-NCIT-C102303','C102303','Interphalangeal Joint 3','DB-NCIT'),('DBX-NCIT-C102304','C102304','Interphalangeal Joint 4','DB-NCIT'),('DBX-NCIT-C102305','C102305','Interphalangeal Joint 5','DB-NCIT'),('DBX-NCIT-C102306','C102306','Interphalangeal Thumb Joint','DB-NCIT'),('DBX-NCIT-C102307','C102307','Lateral First Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102308','C102308','Lateral First Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102309','C102309','Lateral Ramus Intermedius Artery','DB-NCIT'),('DBX-NCIT-C102310','C102310','Lateral Second Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102311','C102311','Lateral Second Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102312','C102312','Lateral Third Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102313','C102313','Left Anterior Descending Septal Perforator Artery','DB-NCIT'),('DBX-NCIT-C102314','C102314','Left Posterolateral Descending Artery','DB-NCIT'),('DBX-NCIT-C102315','C102315','Left Ventricular Epicardium','DB-NCIT'),('DBX-NCIT-C102316','C102316','Metacarpophalangeal Joint 1','DB-NCIT'),('DBX-NCIT-C102317','C102317','Metacarpophalangeal Joint 2','DB-NCIT'),('DBX-NCIT-C102318','C102318','Metacarpophalangeal Joint 3','DB-NCIT'),('DBX-NCIT-C102319','C102319','Metacarpophalangeal Joint 4','DB-NCIT'),('DBX-NCIT-C102320','C102320','Metacarpophalangeal Joint 5','DB-NCIT'),('DBX-NCIT-C102321','C102321','Metatarsophalangeal Joint 1','DB-NCIT'),('DBX-NCIT-C102322','C102322','Metatarsophalangeal Joint 2','DB-NCIT'),('DBX-NCIT-C102323','C102323','Metatarsophalangeal Joint 3','DB-NCIT'),('DBX-NCIT-C102324','C102324','Metatarsophalangeal Joint 4','DB-NCIT'),('DBX-NCIT-C102325','C102325','Metatarsophalangeal Joint 5','DB-NCIT'),('DBX-NCIT-C102326','C102326','Mid-Circumflex Artery','DB-NCIT'),('DBX-NCIT-C102327','C102327','Mid-Distal Left Anterior Descending Coronary Artery and All Diagonal Coronary Branches','DB-NCIT'),('DBX-NCIT-C102328','C102328','Mid-Left Anterior Descending Artery','DB-NCIT'),('DBX-NCIT-C102329','C102329','Mid-Right Coronary Artery Conduit','DB-NCIT'),('DBX-NCIT-C102330','C102330','Perihilar Lymph Node','DB-NCIT'),('DBX-NCIT-C102331','C102331','Proximal Circumflex Artery','DB-NCIT'),('DBX-NCIT-C102332','C102332','Proximal Interphalangeal Joint 2','DB-NCIT'),('DBX-NCIT-C102333','C102333','Proximal Interphalangeal Joint 3','DB-NCIT'),('DBX-NCIT-C102334','C102334','Proximal Interphalangeal Joint 4','DB-NCIT'),('DBX-NCIT-C102335','C102335','Proximal Interphalangeal Joint 5','DB-NCIT'),('DBX-NCIT-C102336','C102336','Proximal Left Anterior Descending Artery','DB-NCIT'),('DBX-NCIT-C102337','C102337','Proximal Right Coronary Artery Conduit','DB-NCIT'),('DBX-NCIT-C102338','C102338','Ramus Intermedius Artery','DB-NCIT'),('DBX-NCIT-C102339','C102339','Right Atrial Endocardium','DB-NCIT'),('DBX-NCIT-C102340','C102340','Right Coronary Artery and its Branches','DB-NCIT'),('DBX-NCIT-C102341','C102341','Right Posterior Atrioventricular Artery','DB-NCIT'),('DBX-NCIT-C102342','C102342','Right Posterior Descending Artery','DB-NCIT'),('DBX-NCIT-C102343','C102343','Right Ventricular Endocardium','DB-NCIT'),('DBX-NCIT-C102344','C102344','Second Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102345','C102345','Second Left Posterolateral Branch Artery','DB-NCIT'),('DBX-NCIT-C102346','C102346','Second Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102347','C102347','Second Right Posterolateral Artery','DB-NCIT'),('DBX-NCIT-C102348','C102348','Septal Perforator Artery','DB-NCIT'),('DBX-NCIT-C102349','C102349','Sublingual Region','DB-NCIT'),('DBX-NCIT-C102350','C102350','Third Diagonal Branch Artery','DB-NCIT'),('DBX-NCIT-C102351','C102351','Third Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102352','C102352','Third Posterolateral Descending Artery','DB-NCIT'),('DBX-NCIT-C102353','C102353','Third Right Posterolateral Artery','DB-NCIT'),('DBX-NCIT-C102354','C102354','Transverse Tarsal Joint','DB-NCIT'),('DBX-NCIT-C102355','C102355','Study Subject Withdrawal by Parent or Guardian','DB-NCIT'),('DBX-NCIT-C102356','C102356','Accumulation Ratio Area Under the Curve','DB-NCIT'),('DBX-NCIT-C102357','C102357','Accumulation Ratio Cmax','DB-NCIT'),('DBX-NCIT-C102358','C102358','Accumulation Ratio Cmin','DB-NCIT'),('DBX-NCIT-C102359','C102359','Amount Recovered from T1 to T2','DB-NCIT'),('DBX-NCIT-C102360','C102360','Amount Recovered from T1 to T2 Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102361','C102361','Amount Recovered from T1 to T2 Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102362','C102362','Amount Recovered from T1 to T2 Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102363','C102363','Amount Recovered Over Dosing Interval','DB-NCIT'),('DBX-NCIT-C102364','C102364','Amount Recovered Over Dosing Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102365','C102365','Amount Recovered Over Dosing Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102366','C102366','Amount Recovered Over Dosing Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102367','C102367','Concentration Divided by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102368','C102368','Concentration Divided by Dose','DB-NCIT'),('DBX-NCIT-C102369','C102369','Concentration Divided by Surface Area','DB-NCIT'),('DBX-NCIT-C102370','C102370','Concentration Divided by Weight','DB-NCIT'),('DBX-NCIT-C102371','C102371','Initial Volume of Distribution','DB-NCIT'),('DBX-NCIT-C102372','C102372','Initial Volume of Distribution Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102373','C102373','Initial Volume of Distribution Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102374','C102374','Initial Volume of Distribution Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102375','C102375','Initial Volume of Distribution Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102376','C102376','Nonrenal Clearance','DB-NCIT'),('DBX-NCIT-C102377','C102377','Observed Steady State Volume of Distribution Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102378','C102378','Observed Steady State Volume of Distribution Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102379','C102379','Observed Steady State Volume of Distribution Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102380','C102380','Observed Steady State Volume of Distribution Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102381','C102381','Peak Trough Ratio','DB-NCIT'),('DBX-NCIT-C102382','C102382','Percent Recovered from T1 to T2','DB-NCIT'),('DBX-NCIT-C102383','C102383','Percent Recovered from T1 to T2 Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102384','C102384','Percent Recovered from T1 to T2 Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102385','C102385','Percent Recovered from T1 to T2 Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102386','C102386','Percent Recovered Over Dosing Interval','DB-NCIT'),('DBX-NCIT-C102387','C102387','Percent Recovered Over Dosing Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102388','C102388','Percent Recovered Over Dosing Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102389','C102389','Percent Recovered Over Dosing Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102390','C102390','Predicted Steady State Volume of Distribution Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102391','C102391','Predicted Steady State Volume of Distribution Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102392','C102392','Predicted Steady State Volume of Distribution Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C102393','C102393','Predicted Steady State Volume of Distribution Normalized by Weight','DB-NCIT'),('DBX-NCIT-C102394','C102394','Trough Concentration','DB-NCIT'),('DBX-NCIT-C102395','C102395','Trough Concentration Divided by Body Mass Index','DB-NCIT'),('DBX-NCIT-C102396','C102396','Trough Concentration Divided by Dose','DB-NCIT'),('DBX-NCIT-C102397','C102397','Trough Concentration Divided by Surface Area','DB-NCIT'),('DBX-NCIT-C102398','C102398','Trough Concentration Divided by Weight','DB-NCIT'),('DBX-NCIT-C102399','C102399','Intrajejunal Route of Administration','DB-NCIT'),('DBX-NCIT-C102400','C102400','Intrapalatal Route of Administration','DB-NCIT'),('DBX-NCIT-C102401','C102401','High Risk','DB-NCIT'),('DBX-NCIT-C102402','C102402','Intermediate Risk','DB-NCIT'),('DBX-NCIT-C102403','C102403','Low Risk','DB-NCIT'),('DBX-NCIT-C102405','C102405','Capful Dosing Unit','DB-NCIT'),('DBX-NCIT-C102406','C102406','Centimeter per Second','DB-NCIT'),('DBX-NCIT-C102407','C102407','Decibel','DB-NCIT'),('DBX-NCIT-C102425','C102425','Lateral Third Obtuse Marginal Branch Artery','DB-NCIT'),('DBX-NCIT-C102426','C102426','Accumulation Ratio Ctrough','DB-NCIT'),('DBX-NCIT-C102516','C102516','Image Plane','DB-NCIT'),('DBX-NCIT-C102574','C102574','Ventricular Repolarization Abnormality','DB-NCIT'),('DBX-NCIT-C102575','C102575','CDISC SDTM Contact Case Investigation Contact Type Terminology','DB-NCIT'),('DBX-NCIT-C102576','C102576','CDISC SDTM Directly Observed Therapy Location Terminology','DB-NCIT'),('DBX-NCIT-C102577','C102577','CDISC SDTM Drug Resistance Status Terminology','DB-NCIT'),('DBX-NCIT-C102578','C102578','CDISC SDTM Disease Outcome Terminology','DB-NCIT'),('DBX-NCIT-C102579','C102579','CDISC SDTM Supporting Evidence for Re-Treatment Terminology','DB-NCIT'),('DBX-NCIT-C102580','C102580','CDISC SDTM Laboratory Test Standard Character Result Terminology','DB-NCIT'),('DBX-NCIT-C102581','C102581','CDISC SDTM Microbial Identification Certainty Terminology','DB-NCIT'),('DBX-NCIT-C102582','C102582','CDISC SDTM Priority of Tuberculosis Contact Terminology','DB-NCIT'),('DBX-NCIT-C102583','C102583','CDISC SDTM Reason for Treatment Interruption Terminology','DB-NCIT'),('DBX-NCIT-C102584','C102584','CDISC SDTM Reason For Treatment Terminology','DB-NCIT'),('DBX-NCIT-C102585','C102585','CDISC SDTM Treatment Failure Reason Terminology','DB-NCIT'),('DBX-NCIT-C102586','C102586','CDISC SDTM Reason Treatment Not Administered Terminology','DB-NCIT'),('DBX-NCIT-C102587','C102587','CDISC SDTM Social Risk Factor Terminology','DB-NCIT'),('DBX-NCIT-C102588','C102588','CDISC SDTM Contact Setting Terminology','DB-NCIT'),('DBX-NCIT-C102589','C102589','CDISC SDTM Treatment Episode Terminology','DB-NCIT'),('DBX-NCIT-C102590','C102590','CDISC SDTM Vaccination Evidence Source Terminology','DB-NCIT'),('DBX-NCIT-C102591','C102591','Acute Anterolateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102592','C102592','Acute Anteroseptal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102593','C102593','Acute High Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102594','C102594','Acute Right Ventricular Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102595','C102595','Acute Septal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102596','C102596','Atrial Bigeminy by ECG Finding','DB-NCIT'),('DBX-NCIT-C102597','C102597','Atrial Couplet by ECG Finding','DB-NCIT'),('DBX-NCIT-C102598','C102598','Atrial Trigeminy by ECG Finding','DB-NCIT'),('DBX-NCIT-C102599','C102599','Auramine Staining Method','DB-NCIT'),('DBX-NCIT-C102600','C102600','Bacteriological Cure','DB-NCIT'),('DBX-NCIT-C102601','C102601','Bacteriological Failure','DB-NCIT'),('DBX-NCIT-C102602','C102602','Bacteriological Finding','DB-NCIT'),('DBX-NCIT-C102603','C102603','Blocked Atrial Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102605','C102605','Cardiovascular System Findings Domain','DB-NCIT'),('DBX-NCIT-C102606','C102606','Casual Contact','DB-NCIT'),('DBX-NCIT-C102607','C102607','Clinical Cure','DB-NCIT'),('DBX-NCIT-C102608','C102608','Clinical Failure','DB-NCIT'),('DBX-NCIT-C102609','C102609','Contact With Exposure During Medical Procedure','DB-NCIT'),('DBX-NCIT-C102610','C102610','Contact With Exposure In Crowd Setting','DB-NCIT'),('DBX-NCIT-C102611','C102611','Contact With Medical Risk Factor','DB-NCIT'),('DBX-NCIT-C102612','C102612','Country of Potential Disease Exposure','DB-NCIT'),('DBX-NCIT-C102613','C102613','Current or Recent Employee or Volunteer in Homeless Shelter','DB-NCIT'),('DBX-NCIT-C102614','C102614','Current or Recent Employee or Volunteer in Jail or Prison','DB-NCIT'),('DBX-NCIT-C102615','C102615','Current or Recent Employee or Volunteer in Nursing Home','DB-NCIT'),('DBX-NCIT-C102616','C102616','Device Events Domain','DB-NCIT'),('DBX-NCIT-C102617','C102617','Device Exposure Domain','DB-NCIT'),('DBX-NCIT-C102618','C102618','Device Identifiers Domain','DB-NCIT'),('DBX-NCIT-C102619','C102619','Device Properties Domain','DB-NCIT'),('DBX-NCIT-C102620','C102620','Device to Subject Relationship Domain','DB-NCIT'),('DBX-NCIT-C102621','C102621','Device Tracking and Disposition Domain','DB-NCIT'),('DBX-NCIT-C102622','C102622','Device-In-Use Domain','DB-NCIT'),('DBX-NCIT-C102623','C102623','Dextrocardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C102625','C102625','Disease Contact Investigation','DB-NCIT'),('DBX-NCIT-C102626','C102626','Drug Resistance Status','DB-NCIT'),('DBX-NCIT-C102627','C102627','Dural Venous Sinus','DB-NCIT'),('DBX-NCIT-C102628','C102628','Early R Wave Transition by ECG Finding','DB-NCIT'),('DBX-NCIT-C102629','C102629','Early Repolarization','DB-NCIT'),('DBX-NCIT-C102630','C102630','Endocrine System Findings Domain','DB-NCIT'),('DBX-NCIT-C102631','C102631','Entry Date from Country of Potential Disease Exposure','DB-NCIT'),('DBX-NCIT-C102632','C102632','Enzyme-linked Immunosorbent Spot Assay','DB-NCIT'),('DBX-NCIT-C102633','C102633','Extensively Drug Resistance Process','DB-NCIT'),('DBX-NCIT-C102634','C102634','Extreme Right Axis Deviation','DB-NCIT'),('DBX-NCIT-C102635','C102635','Failure After First Treatment','DB-NCIT'),('DBX-NCIT-C102636','C102636','Failure After Multiple Treatments','DB-NCIT'),('DBX-NCIT-C102638','C102638','Forgot to Take Medication Dose','DB-NCIT'),('DBX-NCIT-C102639','C102639','Fusion Complex','DB-NCIT'),('DBX-NCIT-C102640','C102640','Gastrointestinal System Findings Domain','DB-NCIT'),('DBX-NCIT-C102641','C102641','Hematopoietic System Findings Domain','DB-NCIT'),('DBX-NCIT-C102642','C102642','High Grade Atrioventricular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C102643','C102643','High Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102644','C102644','High-priority Tuberculosis Subject','DB-NCIT'),('DBX-NCIT-C102645','C102645','Homeless During Past Year','DB-NCIT'),('DBX-NCIT-C102646','C102646','Household Contact','DB-NCIT'),('DBX-NCIT-C102647','C102647','Household Environment','DB-NCIT'),('DBX-NCIT-C102648','C102648','Immigrant From High Tuberculosis Prevalent Area','DB-NCIT'),('DBX-NCIT-C102649','C102649','Immune System Findings Domain','DB-NCIT'),('DBX-NCIT-C102650','C102650','In the Field','DB-NCIT'),('DBX-NCIT-C102651','C102651','Integumentary System Findings Domain','DB-NCIT'),('DBX-NCIT-C102652','C102652','Junctional Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102653','C102653','Late R Wave Transition by ECG Finding','DB-NCIT'),('DBX-NCIT-C102655','C102655','Left Ventricular Hypertrophy with Strain by ECG Finding','DB-NCIT'),('DBX-NCIT-C102656','C102656','Line Probe Assay','DB-NCIT'),('DBX-NCIT-C102657','C102657','Lived in Refugee Camp','DB-NCIT'),('DBX-NCIT-C102658','C102658','Log10 Colony Forming Units per Gram','DB-NCIT'),('DBX-NCIT-C102659','C102659','Log10 Colony Forming Units per Milliliter','DB-NCIT'),('DBX-NCIT-C102660','C102660','Long-term Facility Resident','DB-NCIT'),('DBX-NCIT-C102661','C102661','Loop-mediated Isothermal Amplification','DB-NCIT'),('DBX-NCIT-C102662','C102662','Low-priority Tuberculosis Subject','DB-NCIT'),('DBX-NCIT-C102663','C102663','Medication Lost','DB-NCIT'),('DBX-NCIT-C102664','C102664','Medication Misplaced','DB-NCIT'),('DBX-NCIT-C102665','C102665','Medium-priority Tuberculosis Subject','DB-NCIT'),('DBX-NCIT-C102666','C102666','Member Of High Risk Population','DB-NCIT'),('DBX-NCIT-C102668','C102668','Microbial Liquid Culture','DB-NCIT'),('DBX-NCIT-C102669','C102669','Microbial Solid Culture','DB-NCIT'),('DBX-NCIT-C102670','C102670','Migratory Worker','DB-NCIT'),('DBX-NCIT-C102671','C102671','Morphology Findings Domain','DB-NCIT'),('DBX-NCIT-C102672','C102672','Multifocal Atrial Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102673','C102673','Multifocal Ventricular Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102674','C102674','Musculoskeletal Findings, Connective and Soft Tissue Findings Domain','DB-NCIT'),('DBX-NCIT-C102677','C102677','Nervous System Findings Domain','DB-NCIT'),('DBX-NCIT-C102679','C102679','Non-household Environment','DB-NCIT'),('DBX-NCIT-C102680','C102680','Non-Sustained Atrial Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C102681','C102681','Normal Sinus Rhythm','DB-NCIT'),('DBX-NCIT-C102682','C102682','Not Offered','DB-NCIT'),('DBX-NCIT-C102683','C102683','Observed Volume of Distribution Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102684','C102684','Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102685','C102685','Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102686','C102686','Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102687','C102687','Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102688','C102688','Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102689','C102689','Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102690','C102690','Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102691','C102691','Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102692','C102692','Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102693','C102693','Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102695','C102695','Per 100 High Powered Fields','DB-NCIT'),('DBX-NCIT-C102696','C102696','Predicted Volume of Distribution Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102697','C102697','Presumptive','DB-NCIT'),('DBX-NCIT-C102698','C102698','Previous Patient Noncompliance','DB-NCIT'),('DBX-NCIT-C102699','C102699','Priority of Disease Contact','DB-NCIT'),('DBX-NCIT-C102700','C102700','Procedure Domain','DB-NCIT'),('DBX-NCIT-C102701','C102701','QRS Axis Indeterminate','DB-NCIT'),('DBX-NCIT-C102705','C102705','Refugee From High Tuberculosis Prevalent Area','DB-NCIT'),('DBX-NCIT-C102706','C102706','Repolarization Abnormality Secondary To Ventricular Hypertrophy','DB-NCIT'),('DBX-NCIT-C102707','C102707','Reproductive System Findings Domain','DB-NCIT'),('DBX-NCIT-C102708','C102708','Setting of Disease Contact','DB-NCIT'),('DBX-NCIT-C102709','C102709','Short QTc Interval','DB-NCIT'),('DBX-NCIT-C102711','C102711','Social Risk Factor','DB-NCIT'),('DBX-NCIT-C102712','C102712','Social Setting','DB-NCIT'),('DBX-NCIT-C102713','C102713','Source Case Investigation','DB-NCIT'),('DBX-NCIT-C102714','C102714','Subject in Contact With Tuberculosis Source','DB-NCIT'),('DBX-NCIT-C102715','C102715','Sub-therapeutic Drug Level','DB-NCIT'),('DBX-NCIT-C102716','C102716','Superficial Lymph Node','DB-NCIT'),('DBX-NCIT-C102718','C102718','T Wave Alternans by ECG Finding','DB-NCIT'),('DBX-NCIT-C102719','C102719','Travel To High Burden Tuberculosis Country','DB-NCIT'),('DBX-NCIT-C102723','C102723','Type of Contagion Contact','DB-NCIT'),('DBX-NCIT-C102724','C102724','Unifocal Atrial Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102725','C102725','Unifocal Ventricular Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C102726','C102726','Urinary System Findings Domain','DB-NCIT'),('DBX-NCIT-C102728','C102728','Ventricular Parasystole by ECG Finding','DB-NCIT'),('DBX-NCIT-C102729','C102729','Volume of Distribution of Fraction Dose Observed Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102730','C102730','Volume of Distribution of Fraction Dose Predicted Normalized by Dose','DB-NCIT'),('DBX-NCIT-C102731','C102731','New Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102732','C102732','New Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102733','C102733','New Anterolateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102734','C102734','New Anteroseptal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102735','C102735','New Extensive Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102736','C102736','New High Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102737','C102737','New Inferior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102738','C102738','New Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C102739','C102739','New Septal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C103329','C103329','CDISC SDTM General Observation Class Terminology','DB-NCIT'),('DBX-NCIT-C103330','C103330','CDISC SDTM Subject Characteristic Test Name Terminology','DB-NCIT'),('DBX-NCIT-C103343','C103343','Prostaglandin Measurement','DB-NCIT'),('DBX-NCIT-C103344','C103344','11-Dehydro-Thromboxane B2 Measurement','DB-NCIT'),('DBX-NCIT-C103345','C103345','3,4-Dihydroxyphenylacetic Acid Measurement','DB-NCIT'),('DBX-NCIT-C103346','C103346','Abdominal Skinfold Thickness','DB-NCIT'),('DBX-NCIT-C103347','C103347','Absolute Change From Nadir','DB-NCIT'),('DBX-NCIT-C103348','C103348','Activated Coagulation Time','DB-NCIT'),('DBX-NCIT-C103349','C103349','Alpha Tocopherol Measurement','DB-NCIT'),('DBX-NCIT-C103350','C103350','Alpha Tocopherol to Vitamin E Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103351','C103351','Alpha-2 Antiplasmin Measurement','DB-NCIT'),('DBX-NCIT-C103352','C103352','Amyloid Beta 1-38 Measurement','DB-NCIT'),('DBX-NCIT-C103353','C103353','Amyloid Beta 1-40 Measurement','DB-NCIT'),('DBX-NCIT-C103354','C103354','Apolipoprotein A4 Measurement','DB-NCIT'),('DBX-NCIT-C103355','C103355','Apolipoprotein A5 Measurement','DB-NCIT'),('DBX-NCIT-C103356','C103356','Apolipoprotein B to Apolipoprotein A1 Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103357','C103357','Beta Catenin Measurement','DB-NCIT'),('DBX-NCIT-C103358','C103358','Beta-2 Glycoprotein 1 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103359','C103359','Beta-2 Glycoprotein 1 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103360','C103360','Calcium and Phosphorus Product Measurement','DB-NCIT'),('DBX-NCIT-C103361','C103361','Cancer Antigen 1 Measurement','DB-NCIT'),('DBX-NCIT-C103362','C103362','Cancer Antigen 15-3 Measurement','DB-NCIT'),('DBX-NCIT-C103363','C103363','Cardiolipin IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103364','C103364','CD1 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103365','C103365','CD14 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103366','C103366','CD2 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103367','C103367','CD2 Expressing Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103368','C103368','CD20 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103369','C103369','CD5 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103370','C103370','CD56 Expressing Cell Measurement','DB-NCIT'),('DBX-NCIT-C103371','C103371','CDISC Basic Data Structure Dataset','DB-NCIT'),('DBX-NCIT-C103372','C103372','CDISC Events Class','DB-NCIT'),('DBX-NCIT-C103373','C103373','CDISC Findings Class','DB-NCIT'),('DBX-NCIT-C103374','C103374','CDISC Interventions Class','DB-NCIT'),('DBX-NCIT-C103375','C103375','CDISC Other ADaM Dataset','DB-NCIT'),('DBX-NCIT-C103376','C103376','CDISC Relationship Class','DB-NCIT'),('DBX-NCIT-C103377','C103377','CDISC Special Purpose Class','DB-NCIT'),('DBX-NCIT-C103378','C103378','CDISC Subject Level Analysis Dataset','DB-NCIT'),('DBX-NCIT-C103379','C103379','CDISC Trial Design Class','DB-NCIT'),('DBX-NCIT-C103380','C103380','Cholesteryl Ester Transfer Protein Activity Measurement','DB-NCIT'),('DBX-NCIT-C103381','C103381','Clostridium difficile Toxin Measurement','DB-NCIT'),('DBX-NCIT-C103382','C103382','Clostridium tetani IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103383','C103383','Collagen Type IV Measurement','DB-NCIT'),('DBX-NCIT-C103384','C103384','Common Iliac Lymph Node','DB-NCIT'),('DBX-NCIT-C103385','C103385','Complete Response with Incomplete Bone Marrow Recovery','DB-NCIT'),('DBX-NCIT-C103386','C103386','Dilute Russell\'s Viper Venom Time to Control Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103387','C103387','Dipeptidyl Peptidase-4 Activity Measurement','DB-NCIT'),('DBX-NCIT-C103388','C103388','Diphtheria IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103389','C103389','Every Eight Weeks','DB-NCIT'),('DBX-NCIT-C103390','C103390','Every Five Weeks','DB-NCIT'),('DBX-NCIT-C103391','C103391','Experimental Organism Benign Basalioma','DB-NCIT'),('DBX-NCIT-C103392','C103392','Experimental Organism Benign Bone Osteofibroma','DB-NCIT'),('DBX-NCIT-C103393','C103393','Experimental Organism Malignant Hepatocholangiocellular Carcinoma','DB-NCIT'),('DBX-NCIT-C103394','C103394','Experimental Organism Malignant Hibernoma','DB-NCIT'),('DBX-NCIT-C103395','C103395','Factor IX Activity Measurement','DB-NCIT'),('DBX-NCIT-C103396','C103396','Factor V Activity Measurement','DB-NCIT'),('DBX-NCIT-C103397','C103397','Factor VII Activity Measurement','DB-NCIT'),('DBX-NCIT-C103398','C103398','Factor VIIa Activity Measurement','DB-NCIT'),('DBX-NCIT-C103399','C103399','Factor VIII Activity Measurement','DB-NCIT'),('DBX-NCIT-C103400','C103400','FDG-Positron Emission Tomography','DB-NCIT'),('DBX-NCIT-C103401','C103401','FLT-Positron Emission Tomography','DB-NCIT'),('DBX-NCIT-C103402','C103402','HDL Particle Size Measurement','DB-NCIT'),('DBX-NCIT-C103403','C103403','Helicobacter pylori IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103404','C103404','Hepatitis B DNA Measurement','DB-NCIT'),('DBX-NCIT-C103405','C103405','Human Albumin Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103406','C103406','Human Anti-Mouse Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103407','C103407','Immunoblast Count','DB-NCIT'),('DBX-NCIT-C103408','C103408','Influenza A IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103409','C103409','Influenza B IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103410','C103410','Isoleucine Measurement','DB-NCIT'),('DBX-NCIT-C103411','C103411','Lavage Fluid','DB-NCIT'),('DBX-NCIT-C103412','C103412','LDL Particle Size Measurement','DB-NCIT'),('DBX-NCIT-C103413','C103413','Leukotriene B4 Measurement','DB-NCIT'),('DBX-NCIT-C103414','C103414','Leukotriene D4 Measurement','DB-NCIT'),('DBX-NCIT-C103415','C103415','Leukotriene E4 Measurement','DB-NCIT'),('DBX-NCIT-C103416','C103416','Measured Tumor Identification','DB-NCIT'),('DBX-NCIT-C103417','C103417','Median Or Lower Cervical Lymph Node','DB-NCIT'),('DBX-NCIT-C103418','C103418','Myelin Antibodies Measurement','DB-NCIT'),('DBX-NCIT-C103419','C103419','N-acetyl-beta-D-glucosaminidase Measurement','DB-NCIT'),('DBX-NCIT-C103420','C103420','New Lesion Progression','DB-NCIT'),('DBX-NCIT-C103421','C103421','New Tumor Confirmation','DB-NCIT'),('DBX-NCIT-C103422','C103422','Nodular Partial Response','DB-NCIT'),('DBX-NCIT-C103423','C103423','Non-Measurable Tumor Identification','DB-NCIT'),('DBX-NCIT-C103424','C103424','Not All Tumors Evaluated','DB-NCIT'),('DBX-NCIT-C103425','C103425','Not Measured Tumor Identification','DB-NCIT'),('DBX-NCIT-C103426','C103426','Paratracheal Lymph Node','DB-NCIT'),('DBX-NCIT-C103427','C103427','Platelet Aggregation Measurement','DB-NCIT'),('DBX-NCIT-C103428','C103428','Posterior Cervical Lymph Node','DB-NCIT'),('DBX-NCIT-C103429','C103429','Preauricular Lymph Node','DB-NCIT'),('DBX-NCIT-C103430','C103430','Procalcitonin Measurement','DB-NCIT'),('DBX-NCIT-C103431','C103431','Prostaglandin D2 Measurement','DB-NCIT'),('DBX-NCIT-C103432','C103432','Prostaglandin D2 Synthase Measurement','DB-NCIT'),('DBX-NCIT-C103433','C103433','Prostaglandin E Synthase Measurement','DB-NCIT'),('DBX-NCIT-C103434','C103434','Prostaglandin E1 Measurement','DB-NCIT'),('DBX-NCIT-C103435','C103435','Prostaglandin E2 Measurement','DB-NCIT'),('DBX-NCIT-C103436','C103436','Prostaglandin F1 Alpha Measurement','DB-NCIT'),('DBX-NCIT-C103437','C103437','Prostaglandin F2 Alpha Measurement','DB-NCIT'),('DBX-NCIT-C103438','C103438','Rectosigmoid Colon','DB-NCIT'),('DBX-NCIT-C103439','C103439','Retrocrural Lymph Node','DB-NCIT'),('DBX-NCIT-C103440','C103440','Rubella IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C103441','C103441','Sum of Diameters of Non Lymph Node Tumors','DB-NCIT'),('DBX-NCIT-C103442','C103442','Target Extra Nodal Tumor Identification','DB-NCIT'),('DBX-NCIT-C103443','C103443','Target Nodal Tumor Identification','DB-NCIT'),('DBX-NCIT-C103444','C103444','Target Nodule Tumor Identification','DB-NCIT'),('DBX-NCIT-C103445','C103445','Thromboxane B2 Measurement','DB-NCIT'),('DBX-NCIT-C103446','C103446','Thyroglobulin Measurement','DB-NCIT'),('DBX-NCIT-C103447','C103447','Upper Cervical Lymph Node','DB-NCIT'),('DBX-NCIT-C103448','C103448','Vitamin E to Cholesterol Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103449','C103449','Vitamin K1 Measurement','DB-NCIT'),('DBX-NCIT-C103450','C103450','VLDL Particle Size Measurement','DB-NCIT'),('DBX-NCIT-C103451','C103451','Whole Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C103452','C103452','Per Milliliter','DB-NCIT'),('DBX-NCIT-C103453','C103453','Albumin to Total Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103454','C103454','Iliac Fossa','DB-NCIT'),('DBX-NCIT-C103455','C103455','Ischiorectal Fossa','DB-NCIT'),('DBX-NCIT-C103456','C103456','Occipital Scalp','DB-NCIT'),('DBX-NCIT-C103512','C103512','Positron Emission Tomography and Computed Tomography Scan','DB-NCIT'),('DBX-NCIT-C103513','C103513','High Performance Liquid Chromatography Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C103514','C103514','Positron Emission Tomography and Magnetic Resonance Imaging','DB-NCIT'),('DBX-NCIT-C103808','C103808','CD19 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C103809','C103809','CD3 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C103810','C103810','CD4 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C103811','C103811','CD8 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C103812','C103812','CD19 Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103813','C103813','CD3 Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103814','C103814','CD4 Cell to CD8 Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103815','C103815','CD4 Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103816','C103816','CD8 Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C103818','C103818','Iliac Crest','DB-NCIT'),('DBX-NCIT-C103912','C103912','Carpometacarpal Joint 1','DB-NCIT'),('DBX-NCIT-C103913','C103913','Carpometacarpal Joint 2','DB-NCIT'),('DBX-NCIT-C103914','C103914','Carpometacarpal Joint 3','DB-NCIT'),('DBX-NCIT-C103915','C103915','Carpometacarpal Joint 4','DB-NCIT'),('DBX-NCIT-C103916','C103916','Carpometacarpal Joint 5','DB-NCIT'),('DBX-NCIT-C104504','C104504','Batch Number','DB-NCIT'),('DBX-NCIT-C104622','C104622','Total Body Water Measurement','DB-NCIT'),('DBX-NCIT-C105438','C105438','Amyloid Beta Precursor Protein Measurement','DB-NCIT'),('DBX-NCIT-C105439','C105439','CD11A Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C105440','C105440','CD11B Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C105441','C105441','Cystine Measurement','DB-NCIT'),('DBX-NCIT-C105442','C105442','Factor XIV Activity Measurement','DB-NCIT'),('DBX-NCIT-C105443','C105443','FibroTest Score Measurement','DB-NCIT'),('DBX-NCIT-C105444','C105444','Lymphoblast to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C105445','C105445','Theophylline Measurement','DB-NCIT'),('DBX-NCIT-C105446','C105446','Ischial Tuberosity','DB-NCIT'),('DBX-NCIT-C105447','C105447','Sacral Tuberosity','DB-NCIT'),('DBX-NCIT-C105448','C105448','Failure to Meet Randomization Criteria','DB-NCIT'),('DBX-NCIT-C105449','C105449','Excretion Rate From T1 to T2','DB-NCIT'),('DBX-NCIT-C105450','C105450','Excretion Rate From T1 to T2 Normalized by BMI','DB-NCIT'),('DBX-NCIT-C105451','C105451','Excretion Rate From T1 to T2 Normalized by Dose','DB-NCIT'),('DBX-NCIT-C105452','C105452','Excretion Rate From T1 to T2 Normalized by SA','DB-NCIT'),('DBX-NCIT-C105453','C105453','Excretion Rate From T1 to T2 Normalized by WT','DB-NCIT'),('DBX-NCIT-C105454','C105454','Nonrenal Clearance Normalized by BMI','DB-NCIT'),('DBX-NCIT-C105455','C105455','Nonrenal Clearance Normalized by Dose','DB-NCIT'),('DBX-NCIT-C105456','C105456','Nonrenal Clearance Normalized by SA','DB-NCIT'),('DBX-NCIT-C105457','C105457','Nonrenal Clearance Normalized by WT','DB-NCIT'),('DBX-NCIT-C105458','C105458','Renal Clearance Normalized by BMI','DB-NCIT'),('DBX-NCIT-C105459','C105459','Renal Clearance Normalized by Dose','DB-NCIT'),('DBX-NCIT-C105460','C105460','Renal Clearance Normalized by SA','DB-NCIT'),('DBX-NCIT-C105461','C105461','Renal Clearance Normalized by WT','DB-NCIT'),('DBX-NCIT-C105462','C105462','Gram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105463','C105463','Gram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105464','C105464','Hour Times Gram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105465','C105465','Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105466','C105466','Hour Times Microgram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105467','C105467','Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105468','C105468','Hour Times Milligram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105469','C105469','Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105470','C105470','Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105471','C105471','Hour Times Picogram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105472','C105472','Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105473','C105473','Microgram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105474','C105474','Microgram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105475','C105475','Milligram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105476','C105476','Milligram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105477','C105477','Nanogram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105478','C105478','Nanogram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105479','C105479','Picogram Per Milliliter Per Milligram Per Kilogram','DB-NCIT'),('DBX-NCIT-C105480','C105480','Picogram Per Milliliter Per Milligram Per Kilogram Per Day','DB-NCIT'),('DBX-NCIT-C105481','C105481','Centimeter Per Minute','DB-NCIT'),('DBX-NCIT-C105482','C105482','Centisecond','DB-NCIT'),('DBX-NCIT-C105483','C105483','Decamole Per Liter','DB-NCIT'),('DBX-NCIT-C105484','C105484','Fraction of 1','DB-NCIT'),('DBX-NCIT-C105485','C105485','Gram Per Gram of Creatinine','DB-NCIT'),('DBX-NCIT-C105486','C105486','Gram Per Mole of Creatinine','DB-NCIT'),('DBX-NCIT-C105487','C105487','Hectopascal','DB-NCIT'),('DBX-NCIT-C105488','C105488','Hundred Billion Per Liter','DB-NCIT'),('DBX-NCIT-C105489','C105489','Hundred Million Per Liter','DB-NCIT'),('DBX-NCIT-C105490','C105490','Hundred Thousand Per Liter','DB-NCIT'),('DBX-NCIT-C105491','C105491','Kilodalton','DB-NCIT'),('DBX-NCIT-C105492','C105492','Kilopascal Per Liter Per Second','DB-NCIT'),('DBX-NCIT-C105493','C105493','Kilosecond','DB-NCIT'),('DBX-NCIT-C105494','C105494','Liter Per Hour Per Square Meter','DB-NCIT'),('DBX-NCIT-C105495','C105495','Liter Per Liter','DB-NCIT'),('DBX-NCIT-C105496','C105496','Liter Per Minute Per Square Meter','DB-NCIT'),('DBX-NCIT-C105497','C105497','Microgram Equivalent','DB-NCIT'),('DBX-NCIT-C105498','C105498','Micromole Per Liter Per Second','DB-NCIT'),('DBX-NCIT-C105499','C105499','Microvolt Second','DB-NCIT'),('DBX-NCIT-C105500','C105500','Mile Per Hour','DB-NCIT'),('DBX-NCIT-C105501','C105501','Milliequivalent Per Gram of Creatinine','DB-NCIT'),('DBX-NCIT-C105502','C105502','Milligram Per Gram of Creatinine','DB-NCIT'),('DBX-NCIT-C105503','C105503','Milliliter per Centimeter','DB-NCIT'),('DBX-NCIT-C105504','C105504','Milliliter per Deciliter','DB-NCIT'),('DBX-NCIT-C105505','C105505','Milliliter Per Second Per 1.73 Meter Squared','DB-NCIT'),('DBX-NCIT-C105506','C105506','Millimeter Mercury Per Liter Per Minute','DB-NCIT'),('DBX-NCIT-C105507','C105507','Millimeter Per Minute','DB-NCIT'),('DBX-NCIT-C105508','C105508','Millimeter Per Second','DB-NCIT'),('DBX-NCIT-C105509','C105509','Millimeter per Two Hours','DB-NCIT'),('DBX-NCIT-C105510','C105510','Millimole Per Gram of Creatinine','DB-NCIT'),('DBX-NCIT-C105511','C105511','Millimole Per Mole of Creatinine','DB-NCIT'),('DBX-NCIT-C105512','C105512','Millivolt Minute','DB-NCIT'),('DBX-NCIT-C105513','C105513','Nanounit Per Centiliter','DB-NCIT'),('DBX-NCIT-C105514','C105514','Per Deciliter','DB-NCIT'),('DBX-NCIT-C105515','C105515','Per Liter','DB-NCIT'),('DBX-NCIT-C105516','C105516','Per Visual Field','DB-NCIT'),('DBX-NCIT-C105517','C105517','Ten Billion Per Liter','DB-NCIT'),('DBX-NCIT-C105518','C105518','Tera International Unit Per Liter','DB-NCIT'),('DBX-NCIT-C105519','C105519','Thousand Per Liter','DB-NCIT'),('DBX-NCIT-C105520','C105520','Unit Per Centiliter','DB-NCIT'),('DBX-NCIT-C105521','C105521','Unit Per Deciliter','DB-NCIT'),('DBX-NCIT-C105522','C105522','Unit Per Gram Hemoglobin','DB-NCIT'),('DBX-NCIT-C105523','C105523','Unit Per Gram of Creatinine','DB-NCIT'),('DBX-NCIT-C105524','C105524','Volt Per Second','DB-NCIT'),('DBX-NCIT-C105585','C105585','Glucose Measurement','DB-NCIT'),('DBX-NCIT-C105586','C105586','Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C105587','C105587','High Density Lipoprotein Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C105588','C105588','Low Density Lipoprotein Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C105589','C105589','Very Low Density Lipoprotein Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C105590','C105590','Ammonium Biurate Crystals Measurement','DB-NCIT'),('DBX-NCIT-C105744','C105744','Sediment Analysis','DB-NCIT'),('DBX-NCIT-C106478','C106478','CDISC SDTM Reproductive System Findings Test Name Terminology','DB-NCIT'),('DBX-NCIT-C106479','C106479','CDISC SDTM Reproductive System Findings Test Code Terminology','DB-NCIT'),('DBX-NCIT-C106480','C106480','CDISC SDTM Device Identifier Long Name Terminology','DB-NCIT'),('DBX-NCIT-C106481','C106481','CDISC SDTM Device Identifier Short Name Terminology','DB-NCIT'),('DBX-NCIT-C106482','C106482','CDISC SDTM Device-In-Use Test Name Terminology','DB-NCIT'),('DBX-NCIT-C106483','C106483','CDISC SDTM Device-In-Use Test Code Terminology','DB-NCIT'),('DBX-NCIT-C106496','C106496','Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C106497','C106497','Age at Menopause','DB-NCIT'),('DBX-NCIT-C106498','C106498','Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106499','C106499','Alpha Fetoprotein Activity Measurement','DB-NCIT'),('DBX-NCIT-C106501','C106501','Birth Control Method','DB-NCIT'),('DBX-NCIT-C106502','C106502','Biventricular Hypertrophy by ECG Finding','DB-NCIT'),('DBX-NCIT-C106503','C106503','Brugada Syndrome Pattern by ECG Finding','DB-NCIT'),('DBX-NCIT-C106504','C106504','Budding Yeast Measurement','DB-NCIT'),('DBX-NCIT-C106505','C106505','Cancer Antigen 72-4 Measurement','DB-NCIT'),('DBX-NCIT-C106508','C106508','Childbearing Potential','DB-NCIT'),('DBX-NCIT-C106509','C106509','Chloride Clearance Measurement','DB-NCIT'),('DBX-NCIT-C106510','C106510','Coil Strength','DB-NCIT'),('DBX-NCIT-C106511','C106511','Corticosterone to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106512','C106512','Cortisol to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106513','C106513','Cystatin C to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106514','C106514','Cytokeratin Fragment 21-1 Measurement','DB-NCIT'),('DBX-NCIT-C106515','C106515','Dialysis Fluid','DB-NCIT'),('DBX-NCIT-C106516','C106516','Dipstick','DB-NCIT'),('DBX-NCIT-C106517','C106517','Elastography','DB-NCIT'),('DBX-NCIT-C106518','C106518','Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement','DB-NCIT'),('DBX-NCIT-C106519','C106519','Epstein-Barr Virus Profile Interpretation','DB-NCIT'),('DBX-NCIT-C106520','C106520','Extensive Anterior Wall Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C106521','C106521','Fatty Acid Binding Protein 3 Measurement','DB-NCIT'),('DBX-NCIT-C106523','C106523','Flame Photometry','DB-NCIT'),('DBX-NCIT-C106524','C106524','Frames Per Second','DB-NCIT'),('DBX-NCIT-C106525','C106525','Hemoglobin Distribution Width Measurement','DB-NCIT'),('DBX-NCIT-C106526','C106526','Hepatitis E Virus IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C106527','C106527','HIV Antibody Measurement','DB-NCIT'),('DBX-NCIT-C106528','C106528','Hour Squared Times Micromole Per Liter','DB-NCIT'),('DBX-NCIT-C106529','C106529','Hour Squared Times Picomole Per Liter','DB-NCIT'),('DBX-NCIT-C106530','C106530','Hour times Millimole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C106531','C106531','Hour times Mole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C106532','C106532','Hour times Picomole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C106533','C106533','Image Acquisition Matrix Size','DB-NCIT'),('DBX-NCIT-C106534','C106534','Image Slice Thickness','DB-NCIT'),('DBX-NCIT-C106535','C106535','Immunoblasts to Lymphocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106536','C106536','Immunoturbidimetry','DB-NCIT'),('DBX-NCIT-C106537','C106537','Intact Glucose-dependent Insulinotropic Peptide Measurement','DB-NCIT'),('DBX-NCIT-C106539','C106539','Lipocalin-2 Measurement','DB-NCIT'),('DBX-NCIT-C106540','C106540','Lipocalin-2 to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106541','C106541','Menopause Status','DB-NCIT'),('DBX-NCIT-C106542','C106542','Milliliters Per Millimeter of Mercury','DB-NCIT'),('DBX-NCIT-C106543','C106543','Minute Times Picomole Per Liter','DB-NCIT'),('DBX-NCIT-C106544','C106544','Monocytes to Macrocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106545','C106545','Multi-slice Spiral Computed Tomography','DB-NCIT'),('DBX-NCIT-C106546','C106546','Myoglobin to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106547','C106547','Myosin Light Chain 3 Measurement','DB-NCIT'),('DBX-NCIT-C106548','C106548','New Posterior Wall Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C106550','C106550','Number of Abortions','DB-NCIT'),('DBX-NCIT-C106551','C106551','Number of Pregnancies','DB-NCIT'),('DBX-NCIT-C106552','C106552','Pharmacogenomics Biomarker Domain','DB-NCIT'),('DBX-NCIT-C106553','C106553','Phosphate Clearance Measurement','DB-NCIT'),('DBX-NCIT-C106554','C106554','Plasma Infranatant','DB-NCIT'),('DBX-NCIT-C106555','C106555','Plasma Supernatant','DB-NCIT'),('DBX-NCIT-C106556','C106556','Platelet-poor Plasma','DB-NCIT'),('DBX-NCIT-C106557','C106557','Platelet-rich Plasma','DB-NCIT'),('DBX-NCIT-C106558','C106558','Pleural Fluid Infranatant','DB-NCIT'),('DBX-NCIT-C106559','C106559','Pleural Fluid Supernatant','DB-NCIT'),('DBX-NCIT-C106560','C106560','Potassium Clearance Measurement','DB-NCIT'),('DBX-NCIT-C106561','C106561','Pregnant During the Study','DB-NCIT'),('DBX-NCIT-C106562','C106562','Pulse Sequence','DB-NCIT'),('DBX-NCIT-C106563','C106563','Receiver Bandwidth','DB-NCIT'),('DBX-NCIT-C106564','C106564','Reconstruction Filter Type','DB-NCIT'),('DBX-NCIT-C106565','C106565','Serum Infranatant','DB-NCIT'),('DBX-NCIT-C106566','C106566','Serum Supernatant','DB-NCIT'),('DBX-NCIT-C106567','C106567','Single-slice Spiral Computed Tomography','DB-NCIT'),('DBX-NCIT-C106568','C106568','Sodium Clearance Measurement','DB-NCIT'),('DBX-NCIT-C106569','C106569','Specimen Weight Measurement','DB-NCIT'),('DBX-NCIT-C106570','C106570','Stereotactic Surgery Frame Type','DB-NCIT'),('DBX-NCIT-C106571','C106571','Subject Biomarker Domain','DB-NCIT'),('DBX-NCIT-C106574','C106574','Thrombin to Antithrombin Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106575','C106575','Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C106576','C106576','Trial Site Terminated by Sponsor','DB-NCIT'),('DBX-NCIT-C106577','C106577','Tumor Identifier Domain','DB-NCIT'),('DBX-NCIT-C106578','C106578','Tumor Results Domain','DB-NCIT'),('DBX-NCIT-C106579','C106579','U Wave Abnormality by ECG Finding','DB-NCIT'),('DBX-NCIT-C106581','C106581','Viral Resistance Domain','DB-NCIT'),('DBX-NCIT-C107097','C107097','Disease Response Domain','DB-NCIT'),('DBX-NCIT-C107098','C107098','QTcB Prolongation','DB-NCIT'),('DBX-NCIT-C107099','C107099','QTcF Prolongation','DB-NCIT'),('DBX-NCIT-C107100','C107100','Interpolated Premature Ventricular Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C107435','C107435','Fractional Excretion of Sodium','DB-NCIT'),('DBX-NCIT-C111088','C111088','AV Block First Degree by ECG Finding','DB-NCIT'),('DBX-NCIT-C111089','C111089','AV Block Second Degree Mobitz Type I by ECG Finding','DB-NCIT'),('DBX-NCIT-C111090','C111090','AV Block Second Degree Mobitz Type II by ECG Finding','DB-NCIT'),('DBX-NCIT-C111091','C111091','AV Block Third Degree by ECG Finding','DB-NCIT'),('DBX-NCIT-C111092','C111092','Atrial Fibrillation by ECG Finding','DB-NCIT'),('DBX-NCIT-C111093','C111093','Software Version','DB-NCIT'),('DBX-NCIT-C111094','C111094','Atrial Flutter by ECG Finding','DB-NCIT'),('DBX-NCIT-C111095','C111095','Clot Detection','DB-NCIT'),('DBX-NCIT-C111096','C111096','Colorimetry','DB-NCIT'),('DBX-NCIT-C111097','C111097','Sinus Bradycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111100','C111100','Supraventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111102','C111102','Ventricular Fibrillation by ECG Finding','DB-NCIT'),('DBX-NCIT-C111103','C111103','Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111104','C111104','Sinus Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111105','C111105','Atrial Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111106','C111106','CDISC SDTM Respiratory Test Code Terminology','DB-NCIT'),('DBX-NCIT-C111107','C111107','CDISC SDTM Respiratory Test Name Terminology','DB-NCIT'),('DBX-NCIT-C111108','C111108','CDISC SDTM Employment Status Terminology','DB-NCIT'),('DBX-NCIT-C111109','C111109','CDISC SDTM Device Events Category Terminology','DB-NCIT'),('DBX-NCIT-C111110','C111110','CDISC SDTM Device Events Action Taken with Device Terminology','DB-NCIT'),('DBX-NCIT-C111111','C111111','CDISC SDTM Device Properties Test Code Terminology','DB-NCIT'),('DBX-NCIT-C111112','C111112','CDISC SDTM Device Properties Test Name Terminology','DB-NCIT'),('DBX-NCIT-C111114','C111114','CDISC Genetic Sample Type Terminology','DB-NCIT'),('DBX-NCIT-C111115','C111115','Ventricular Flutter by ECG Finding','DB-NCIT'),('DBX-NCIT-C111120','C111120','Bradycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111121','C111121','Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C111123','C111123','A Proliferation-Inducing Ligand Measurement','DB-NCIT'),('DBX-NCIT-C111124','C111124','Abnormal Cell Count','DB-NCIT'),('DBX-NCIT-C111125','C111125','Adenovirus Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111126','C111126','Alpha Hydroxybutyrate Dehydrogenase Measurement','DB-NCIT'),('DBX-NCIT-C111127','C111127','Aluminum Measurement','DB-NCIT'),('DBX-NCIT-C111128','C111128','Angiopoietin 1 Measurement','DB-NCIT'),('DBX-NCIT-C111129','C111129','Antibody Unit','DB-NCIT'),('DBX-NCIT-C111130','C111130','Apolipoprotein J to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111131','C111131','Atrioventricular Conduction ECG Assessment','DB-NCIT'),('DBX-NCIT-C111132','C111132','Axis and Voltage ECG Assessment','DB-NCIT'),('DBX-NCIT-C111133','C111133','Bacteroides dorei','DB-NCIT'),('DBX-NCIT-C111134','C111134','Bacteroides faecis','DB-NCIT'),('DBX-NCIT-C111135','C111135','B-Cell Activating Factor Measurement','DB-NCIT'),('DBX-NCIT-C111136','C111136','Bence-Jones Protein Measurement','DB-NCIT'),('DBX-NCIT-C111137','C111137','Biospecimen Domain','DB-NCIT'),('DBX-NCIT-C111138','C111138','Biospecimen Events Domain','DB-NCIT'),('DBX-NCIT-C111139','C111139','Biscuit Dosing Unit','DB-NCIT'),('DBX-NCIT-C111140','C111140','Block Unit of Distance','DB-NCIT'),('DBX-NCIT-C111142','C111142','Butyrylcholinesterase Measurement','DB-NCIT'),('DBX-NCIT-C111143','C111143','Cancer Antigen 27-29 Measurement','DB-NCIT'),('DBX-NCIT-C111144','C111144','Cardiolipin IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111145','C111145','Cartilage Oligomeric Matrix Protein Measurement','DB-NCIT'),('DBX-NCIT-C111146','C111146','CD10 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111147','C111147','CD13 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111148','C111148','CD22 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111149','C111149','CD23 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111150','C111150','CD33 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111151','C111151','CD38 Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111152','C111152','CD79A Expressing Cell Count','DB-NCIT'),('DBX-NCIT-C111153','C111153','Cellularity Measurement','DB-NCIT'),('DBX-NCIT-C111154','C111154','Centromere B Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111155','C111155','Chamber Hypertrophy or Enlargement ECG Assessment','DB-NCIT'),('DBX-NCIT-C111157','C111157','Chemical Ablation','DB-NCIT'),('DBX-NCIT-C111158','C111158','Chloroplast DNA','DB-NCIT'),('DBX-NCIT-C111159','C111159','Chymotrypsin Measurement','DB-NCIT'),('DBX-NCIT-C111160','C111160','Coccidioides Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111161','C111161','Copper Measurement','DB-NCIT'),('DBX-NCIT-C111163','C111163','Cross-Linking and Immunoprecipitation','DB-NCIT'),('DBX-NCIT-C111164','C111164','Cryoglobulin Measurement','DB-NCIT'),('DBX-NCIT-C111165','C111165','Cyclic Guanosine Monophosphate Measurement','DB-NCIT'),('DBX-NCIT-C111166','C111166','Cytoplasmic Basophilia Neutrophil Count','DB-NCIT'),('DBX-NCIT-C111167','C111167','Day Times Femtogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111168','C111168','Day Times Femtogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111169','C111169','Day Times Gram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111170','C111170','Day Times Gram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111171','C111171','Day Times Microgram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111172','C111172','Day Times Microgram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111173','C111173','Day Times Micromole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111174','C111174','Day Times Micromole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111175','C111175','Day Times Milligram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111176','C111176','Day Times Milligram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111177','C111177','Day Times Millimole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111178','C111178','Day Times Millimole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111179','C111179','Day Times Mole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111180','C111180','Day Times Mole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111181','C111181','Day Times Nanogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111182','C111182','Day Times Nanogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111183','C111183','Day Times Nanomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111184','C111184','Day Times Nanomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111185','C111185','Day Times Picogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111186','C111186','Day Times Picogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111187','C111187','Day Times Picomole per Liter','DB-NCIT'),('DBX-NCIT-C111188','C111188','Day Times Picomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111189','C111189','Day Times Picomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111190','C111190','Degenerated Leukocyte Count','DB-NCIT'),('DBX-NCIT-C111191','C111191','Electrical Lead Locking Type','DB-NCIT'),('DBX-NCIT-C111192','C111192','Electrocauterization','DB-NCIT'),('DBX-NCIT-C111193','C111193','Electrochemiluminescence','DB-NCIT'),('DBX-NCIT-C111194','C111194','Electrochemiluminescence Immunoassay','DB-NCIT'),('DBX-NCIT-C111195','C111195','Enzymatic Colorimetry','DB-NCIT'),('DBX-NCIT-C111196','C111196','Enzyme Multiplied Immunoassay Technique','DB-NCIT'),('DBX-NCIT-C111197','C111197','Erythrocyte Agglutination Measurement','DB-NCIT'),('DBX-NCIT-C111198','C111198','Experimental Organism Basal Cell Adenoma','DB-NCIT'),('DBX-NCIT-C111199','C111199','Experimental Organism Basal Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C111200','C111200','Expiratory Reserve Volume','DB-NCIT'),('DBX-NCIT-C111201','C111201','Full Brother','DB-NCIT'),('DBX-NCIT-C111202','C111202','Full Sister','DB-NCIT'),('DBX-NCIT-C111203','C111203','Gas Chromatography Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C111204','C111204','Granulicatella elegans','DB-NCIT'),('DBX-NCIT-C111205','C111205','Hansel Staining Method','DB-NCIT'),('DBX-NCIT-C111206','C111206','Heinz Body to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111207','C111207','Hemoglobin A1C to Hemoglobin Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111208','C111208','Hemolytic Index','DB-NCIT'),('DBX-NCIT-C111209','C111209','Histone Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111210','C111210','Hour Times Femtogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111211','C111211','Hour Times Femtogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111212','C111212','Hour Times Gram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111213','C111213','Hour Times Gram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111214','C111214','Hour Times Microgram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111215','C111215','Hour Times Microgram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111216','C111216','Hour Times Micromole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111217','C111217','Hour Times Micromole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111218','C111218','Hour Times Milligram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111219','C111219','Hour Times Milligram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111220','C111220','Hour Times Millimole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111221','C111221','Hour Times Millimole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111222','C111222','Hour Times Mole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111223','C111223','Hour Times Mole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111224','C111224','Hour Times Nanogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111225','C111225','Hour Times Nanogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111226','C111226','Hour Times Nanomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111227','C111227','Hour Times Nanomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111228','C111228','Hour Times Picogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111229','C111229','Hour Times Picogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111230','C111230','Hour Times Picomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111231','C111231','Hour Times Picomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111232','C111232','Icteric Index','DB-NCIT'),('DBX-NCIT-C111233','C111233','IgG IgM IgA Total Measurement','DB-NCIT'),('DBX-NCIT-C111234','C111234','Immature Cell to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111235','C111235','Immunochemiluminometric Assay','DB-NCIT'),('DBX-NCIT-C111236','C111236','Immunoradiometric Assay','DB-NCIT'),('DBX-NCIT-C111237','C111237','Inspiratory Reserve Volume','DB-NCIT'),('DBX-NCIT-C111238','C111238','Intraventricular and Intraatrial Conduction ECG Assessment','DB-NCIT'),('DBX-NCIT-C111239','C111239','Ketone Body Measurement','DB-NCIT'),('DBX-NCIT-C111240','C111240','Kinetic Microparticle Immunoassay','DB-NCIT'),('DBX-NCIT-C111241','C111241','Laser Ablation','DB-NCIT'),('DBX-NCIT-C111242','C111242','Lipemic Index','DB-NCIT'),('DBX-NCIT-C111243','C111243','Macroamylase Measurement','DB-NCIT'),('DBX-NCIT-C111244','C111244','Macrophage to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111245','C111245','Manual Clot Detection','DB-NCIT'),('DBX-NCIT-C111246','C111246','Mast Cell Count','DB-NCIT'),('DBX-NCIT-C111247','C111247','Mast Cell to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111248','C111248','Maternal Biological Grandparent','DB-NCIT'),('DBX-NCIT-C111249','C111249','Mechanical Clot Detection','DB-NCIT'),('DBX-NCIT-C111250','C111250','Meningeal Cell Count','DB-NCIT'),('DBX-NCIT-C111251','C111251','Meningeal Cell to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111252','C111252','Microparticle Enzyme Immunoassay','DB-NCIT'),('DBX-NCIT-C111253','C111253','Millimole per Mole','DB-NCIT'),('DBX-NCIT-C111254','C111254','Minute Times Femtogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111255','C111255','Minute Times Femtogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111256','C111256','Minute Times Gram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111257','C111257','Minute Times Gram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111258','C111258','Minute Times Microgram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111259','C111259','Minute Times Microgram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111260','C111260','Minute Times Micromole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111261','C111261','Minute Times Micromole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111262','C111262','Minute Times Milligram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111263','C111263','Minute Times Milligram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111264','C111264','Minute Times Millimole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111265','C111265','Minute Times Millimole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111266','C111266','Minute Times Mole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111267','C111267','Minute Times Mole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111268','C111268','Minute Times Nanogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111269','C111269','Minute Times Nanogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111270','C111270','Minute Times Nanomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111271','C111271','Minute Times Nanomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111272','C111272','Minute Times Picogram per Milliliter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111273','C111273','Minute Times Picogram per Milliliter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111274','C111274','Minute Times Picomole per Liter per Kilogram per Meter Squared','DB-NCIT'),('DBX-NCIT-C111275','C111275','Minute Times Picomole per Liter per Meter Squared','DB-NCIT'),('DBX-NCIT-C111276','C111276','Monocytoid Cell Count','DB-NCIT'),('DBX-NCIT-C111277','C111277','Monocytoid Cell to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111278','C111278','msdRNA','DB-NCIT'),('DBX-NCIT-C111279','C111279','Multicopy Single-stranded DNA','DB-NCIT'),('DBX-NCIT-C111280','C111280','Myocardial Infarction ECG Assessment','DB-NCIT'),('DBX-NCIT-C111281','C111281','Nephelometry','DB-NCIT'),('DBX-NCIT-C111282','C111282','Non-Compliant ADaM Datasets Domain','DB-NCIT'),('DBX-NCIT-C111283','C111283','Nucleated Thrombocyte Count','DB-NCIT'),('DBX-NCIT-C111284','C111284','Oxygen Measurement','DB-NCIT'),('DBX-NCIT-C111285','C111285','Pacemaker ECG Assessment','DB-NCIT'),('DBX-NCIT-C111286','C111286','Paternal Biological Grandparent','DB-NCIT'),('DBX-NCIT-C111287','C111287','Periurethral Region','DB-NCIT'),('DBX-NCIT-C111289','C111289','Pharmacogenomics Findings Domain','DB-NCIT'),('DBX-NCIT-C111290','C111290','Pharmacogenomics Trial Characteristics Domain','DB-NCIT'),('DBX-NCIT-C111291','C111291','Photometric Clot Detection','DB-NCIT'),('DBX-NCIT-C111292','C111292','Platelet Activating Factor Measurement','DB-NCIT'),('DBX-NCIT-C111293','C111293','Platelet Aggregation Amplitude Measurement','DB-NCIT'),('DBX-NCIT-C111294','C111294','Platelet Component Distribution Width Measurement','DB-NCIT'),('DBX-NCIT-C111295','C111295','Platelet Function Closure Time Measurement','DB-NCIT'),('DBX-NCIT-C111296','C111296','Platelet Morphology Measurement','DB-NCIT'),('DBX-NCIT-C111297','C111297','Positron Emission Tomography and Single Photon Emission Computed Tomography Scan','DB-NCIT'),('DBX-NCIT-C111298','C111298','Precursor mRNA','DB-NCIT'),('DBX-NCIT-C111299','C111299','Proinsulin to Insulin Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111300','C111300','Protocol Summary for Pharmacogenomic Assessments Domain','DB-NCIT'),('DBX-NCIT-C111302','C111302','Ralstonia mannitolilytica','DB-NCIT'),('DBX-NCIT-C111303','C111303','Reconstruction of Raw Data Type','DB-NCIT'),('DBX-NCIT-C111304','C111304','Refractometry','DB-NCIT'),('DBX-NCIT-C111305','C111305','Renin Activity Measurement','DB-NCIT'),('DBX-NCIT-C111306','C111306','Reprogram','DB-NCIT'),('DBX-NCIT-C111307','C111307','Rhythm Not Otherwise Specified ECG Assessment','DB-NCIT'),('DBX-NCIT-C111309','C111309','Scheduled Maintenance','DB-NCIT'),('DBX-NCIT-C111310','C111310','Semi-Recumbent','DB-NCIT'),('DBX-NCIT-C111311','C111311','Single-stranded DNA','DB-NCIT'),('DBX-NCIT-C111312','C111312','Sinus Node Rhythm and Arrhythmia ECG Assessment','DB-NCIT'),('DBX-NCIT-C111313','C111313','Slackia exigua','DB-NCIT'),('DBX-NCIT-C111314','C111314','Slice Number','DB-NCIT'),('DBX-NCIT-C111315','C111315','Slow Vital Capacity','DB-NCIT'),('DBX-NCIT-C111316','C111316','Small Nucleolar RNA','DB-NCIT'),('DBX-NCIT-C111317','C111317','Smooth Muscle Antibody Measurement','DB-NCIT'),('DBX-NCIT-C111318','C111318','Step Unit of Distance','DB-NCIT'),('DBX-NCIT-C111320','C111320','Supraventricular Arrhythmia ECG Assessment','DB-NCIT'),('DBX-NCIT-C111321','C111321','Supraventricular Tachyarrhythmia ECG Assessment','DB-NCIT'),('DBX-NCIT-C111322','C111322','Surfactant Protein D Measurement','DB-NCIT'),('DBX-NCIT-C111324','C111324','Tidal Volume','DB-NCIT'),('DBX-NCIT-C111325','C111325','Total Lung Capacity','DB-NCIT'),('DBX-NCIT-C111326','C111326','Transmammary Route of Administration','DB-NCIT'),('DBX-NCIT-C111327','C111327','Troponin Measurement','DB-NCIT'),('DBX-NCIT-C111328','C111328','Turbidimetry','DB-NCIT'),('DBX-NCIT-C111329','C111329','Vacuolated Lymphocyte Count','DB-NCIT'),('DBX-NCIT-C111330','C111330','Ventricular Arrhythmia ECG Assessment','DB-NCIT'),('DBX-NCIT-C111331','C111331','Ventricular Tachyarrhythmia ECG Assessment','DB-NCIT'),('DBX-NCIT-C111333','C111333','Volume of Distribution for Dosing Interval','DB-NCIT'),('DBX-NCIT-C111334','C111334','Wautersiella falsenii','DB-NCIT'),('DBX-NCIT-C111359','C111359','Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement','DB-NCIT'),('DBX-NCIT-C111360','C111360','Forced Inspiratory Volume in 1 Second','DB-NCIT'),('DBX-NCIT-C111361','C111361','Forced Vital Capacity','DB-NCIT'),('DBX-NCIT-C111362','C111362','Inspiratory Capacity','DB-NCIT'),('DBX-NCIT-C111363','C111363','ST Segment, T wave, and U wave ECG Assessment','DB-NCIT'),('DBX-NCIT-C111364','C111364','Volume of Distribution for Dosing Interval by Fraction','DB-NCIT'),('DBX-NCIT-C111365','C111365','Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C111366','C111366','Volume of Distribution for Dosing Interval by Fraction Normalized by Dose','DB-NCIT'),('DBX-NCIT-C111367','C111367','Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C111368','C111368','Volume of Distribution for Dosing Interval by Fraction Normalized by Weight','DB-NCIT'),('DBX-NCIT-C111369','C111369','Volume of Distribution for Dosing Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C111370','C111370','Volume of Distribution for Dosing Interval Normalized by Dose','DB-NCIT'),('DBX-NCIT-C111371','C111371','Volume of Distribution for Dosing Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C111372','C111372','Volume of Distribution for Dosing Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C112023','C112023','CDISC SDTM Skin Response Test Name Terminology','DB-NCIT'),('DBX-NCIT-C112024','C112024','CDISC SDTM Skin Response Test Code Terminology','DB-NCIT'),('DBX-NCIT-C112029','C112029','Sapovirus','DB-NCIT'),('DBX-NCIT-C112030','C112030','Alphavirus','DB-NCIT'),('DBX-NCIT-C112031','C112031','Filoviridae','DB-NCIT'),('DBX-NCIT-C112032','C112032','Amount Recovered Infinity Observed','DB-NCIT'),('DBX-NCIT-C112033','C112033','Amount Recovered Infinity Predicted','DB-NCIT'),('DBX-NCIT-C112034','C112034','Percent Recovered Infinity Observed','DB-NCIT'),('DBX-NCIT-C112035','C112035','Percent Recovered Infinity Predicted','DB-NCIT'),('DBX-NCIT-C112036','C112036','Dengue Virus','DB-NCIT'),('DBX-NCIT-C112037','C112037','CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology','DB-NCIT'),('DBX-NCIT-C112038','C112038','Trial Indication','DB-NCIT'),('DBX-NCIT-C112217','C112217','5-Hydroxyindoleacetic Acid Measurement','DB-NCIT'),('DBX-NCIT-C112218','C112218','Absolute Change From Nadir in Sum of Diameter','DB-NCIT'),('DBX-NCIT-C112219','C112219','Active Ghrelin Measurement','DB-NCIT'),('DBX-NCIT-C112220','C112220','Aggrecan Chondroitin Sulfate Epitope 846 Measurement','DB-NCIT'),('DBX-NCIT-C112221','C112221','Allergen Skin Response Index','DB-NCIT'),('DBX-NCIT-C112222','C112222','Allergen Skin Response Intensity','DB-NCIT'),('DBX-NCIT-C112223','C112223','Amount Recovered Infinity Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C112224','C112224','Amount Recovered Infinity Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C112225','C112225','Amount Recovered Infinity Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C112226','C112226','Amount Recovered Infinity Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C112227','C112227','Amount Recovered Infinity Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C112228','C112228','Amount Recovered Infinity Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C112229','C112229','Aphthovirus','DB-NCIT'),('DBX-NCIT-C112230','C112230','Arbovirus','DB-NCIT'),('DBX-NCIT-C112231','C112231','Astroviridae','DB-NCIT'),('DBX-NCIT-C112232','C112232','Barmah Forest Virus','DB-NCIT'),('DBX-NCIT-C112233','C112233','Breast Fed Indicator','DB-NCIT'),('DBX-NCIT-C112235','C112235','Capillary Blood','DB-NCIT'),('DBX-NCIT-C112236','C112236','Chemokine (C-C Motif) Ligand 17 Measurement','DB-NCIT'),('DBX-NCIT-C112237','C112237','Chemokine (C-C Motif) Ligand 18 Measurement','DB-NCIT'),('DBX-NCIT-C112238','C112238','Chemokine (C-X-C Motif) Ligand 10 Measurement','DB-NCIT'),('DBX-NCIT-C112239','C112239','Coagulation Index Measurement','DB-NCIT'),('DBX-NCIT-C112240','C112240','Colorado Tick Fever Virus','DB-NCIT'),('DBX-NCIT-C112241','C112241','Count of Unspecified Cells','DB-NCIT'),('DBX-NCIT-C112242','C112242','Coxsackie A Virus','DB-NCIT'),('DBX-NCIT-C112243','C112243','Coxsackie B Virus','DB-NCIT'),('DBX-NCIT-C112244','C112244','Day Times Femtogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112245','C112245','Day Times Femtogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112246','C112246','Day Times Gram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112247','C112247','Day Times Gram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112248','C112248','Day Times Microgram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112249','C112249','Day Times Microgram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112250','C112250','Day Times Micromole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112251','C112251','Day Times Micromole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112252','C112252','Day Times Milligram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112253','C112253','Day Times Milligram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112254','C112254','Day Times Millimole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112255','C112255','Day Times Millimole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112256','C112256','Day Times Mole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112257','C112257','Day Times Mole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112258','C112258','Day Times Nanogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112259','C112259','Day Times Nanogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112260','C112260','Day Times Nanomole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112261','C112261','Day Times Nanomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112262','C112262','Day Times Picogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112263','C112263','Day Times Picogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112264','C112264','Day Times Picomole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112265','C112265','Day Times Picomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112266','C112266','Dengue Virus 1','DB-NCIT'),('DBX-NCIT-C112267','C112267','Dengue Virus 2','DB-NCIT'),('DBX-NCIT-C112268','C112268','Dengue Virus 3','DB-NCIT'),('DBX-NCIT-C112269','C112269','Dengue Virus 4','DB-NCIT'),('DBX-NCIT-C112270','C112270','Destroyed Medical Device','DB-NCIT'),('DBX-NCIT-C112271','C112271','Ebola Virus','DB-NCIT'),('DBX-NCIT-C112272','C112272','Echovirus','DB-NCIT'),('DBX-NCIT-C112273','C112273','Epidermal Growth Factor Receptor Measurement','DB-NCIT'),('DBX-NCIT-C112274','C112274','Estrogen Receptor Measurement','DB-NCIT'),('DBX-NCIT-C112275','C112275','Experimental Organism Benign Polyp','DB-NCIT'),('DBX-NCIT-C112276','C112276','Experimental Organism Benign Seminoma','DB-NCIT'),('DBX-NCIT-C112277','C112277','Factor XIII Measurement','DB-NCIT'),('DBX-NCIT-C112278','C112278','FDA Device Classification','DB-NCIT'),('DBX-NCIT-C112279','C112279','FDA Unique Device Identifier','DB-NCIT'),('DBX-NCIT-C112280','C112280','Fibroblast Growth Factor 21 Measurement','DB-NCIT'),('DBX-NCIT-C112281','C112281','Flare Longest Diameter','DB-NCIT'),('DBX-NCIT-C112282','C112282','Flare Mean Diameter','DB-NCIT'),('DBX-NCIT-C112283','C112283','Flare Size','DB-NCIT'),('DBX-NCIT-C112284','C112284','Flow Microscopy','DB-NCIT'),('DBX-NCIT-C112285','C112285','Forced Expiratory Volume in 1 Second Reversibility','DB-NCIT'),('DBX-NCIT-C112286','C112286','Ghrelin Measurement','DB-NCIT'),('DBX-NCIT-C112287','C112287','Hemodialysis Clearance','DB-NCIT'),('DBX-NCIT-C112288','C112288','Hemoglobin C Crystals Measurement','DB-NCIT'),('DBX-NCIT-C112289','C112289','Hendra Virus','DB-NCIT'),('DBX-NCIT-C112290','C112290','Henipavirus','DB-NCIT'),('DBX-NCIT-C112291','C112291','HER2 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C112292','C112292','Herpes Simplex Virus 6 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112293','C112293','Histone 1 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112294','C112294','Histone 2A Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112295','C112295','Histone 2B Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112296','C112296','Histone 3 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112297','C112297','Histone 4 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112298','C112298','Hour Times Femtogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112299','C112299','Hour Times Femtogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112300','C112300','Hour Times Gram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112301','C112301','Hour Times Gram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112302','C112302','Hour Times Microgram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112303','C112303','Hour Times Microgram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112304','C112304','Hour Times Micromole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112305','C112305','Hour Times Milligram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112306','C112306','Hour Times Milligram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112307','C112307','Hour Times Millimole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112308','C112308','Hour Times Mole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112309','C112309','Hour Times Nanomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112310','C112310','Hour Times Picogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112311','C112311','Hour Times Picomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112312','C112312','Human Epidermal Growth Factor Receptor 2 Measurement','DB-NCIT'),('DBX-NCIT-C112313','C112313','Human Herpesvirus 2','DB-NCIT'),('DBX-NCIT-C112314','C112314','Human Herpesvirus 5','DB-NCIT'),('DBX-NCIT-C112315','C112315','Human Herpesvirus 7','DB-NCIT'),('DBX-NCIT-C112316','C112316','Human Parainfluenza Virus 2','DB-NCIT'),('DBX-NCIT-C112317','C112317','Human Parainfluenza Virus 3','DB-NCIT'),('DBX-NCIT-C112318','C112318','Human Parainfluenza Virus 4','DB-NCIT'),('DBX-NCIT-C112319','C112319','Hyaluronic Acid Measurement','DB-NCIT'),('DBX-NCIT-C112320','C112320','Immunogenicity Specimen Assessments Domain','DB-NCIT'),('DBX-NCIT-C112321','C112321','Inspiratory Capacity Reversibility','DB-NCIT'),('DBX-NCIT-C112322','C112322','Insulin-Like Growth Factor Binding Protein 3 Measurement','DB-NCIT'),('DBX-NCIT-C112323','C112323','Interleukin 1 Beta Measurement','DB-NCIT'),('DBX-NCIT-C112324','C112324','Interleukin 1 Receptor Antagonist Measurement','DB-NCIT'),('DBX-NCIT-C112325','C112325','Intermediate Density Lipoprotein Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C112326','C112326','JC Virus Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112327','C112327','L2-L3 Intervertebral Space','DB-NCIT'),('DBX-NCIT-C112328','C112328','L3-L4 Intervertebral Space','DB-NCIT'),('DBX-NCIT-C112329','C112329','Lost Medical Device','DB-NCIT'),('DBX-NCIT-C112330','C112330','Lyssavirus','DB-NCIT'),('DBX-NCIT-C112331','C112331','Marburgvirus','DB-NCIT'),('DBX-NCIT-C112332','C112332','Material Pore Size','DB-NCIT'),('DBX-NCIT-C112333','C112333','Maximum Forced Inspiratory Flow','DB-NCIT'),('DBX-NCIT-C112334','C112334','Minute Times Femtogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112335','C112335','Minute Times Femtogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112336','C112336','Minute Times Gram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112337','C112337','Minute Times Gram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112338','C112338','Minute Times Microgram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112339','C112339','Minute Times Microgram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112340','C112340','Minute Times Micromole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112341','C112341','Minute Times Micromole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112342','C112342','Minute Times Milligram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112343','C112343','Minute Times Milligram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112344','C112344','Minute Times Millimole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112345','C112345','Minute Times Millimole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112346','C112346','Minute Times Mole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112347','C112347','Minute Times Mole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112348','C112348','Minute Times Nanogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112349','C112349','Minute Times Nanogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112350','C112350','Minute Times Nanomole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112351','C112351','Minute Times Nanomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112352','C112352','Minute Times Picogram Per Milliliter Per Gram','DB-NCIT'),('DBX-NCIT-C112353','C112353','Minute Times Picogram Per Milliliter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112354','C112354','Minute Times Picomole Per Liter Per Gram','DB-NCIT'),('DBX-NCIT-C112355','C112355','Minute Times Picomole Per Liter Per Kilogram','DB-NCIT'),('DBX-NCIT-C112356','C112356','Molluscipoxvirus','DB-NCIT'),('DBX-NCIT-C112357','C112357','Molluscum Contagiosum Virus','DB-NCIT'),('DBX-NCIT-C112358','C112358','Nairovirus','DB-NCIT'),('DBX-NCIT-C112359','C112359','Nipah Virus','DB-NCIT'),('DBX-NCIT-C112360','C112360','Nitric Oxide Measurement','DB-NCIT'),('DBX-NCIT-C112361','C112361','Non-Study Device Issue','DB-NCIT'),('DBX-NCIT-C112362','C112362','Norovirus','DB-NCIT'),('DBX-NCIT-C112363','C112363','Norwalk Virus','DB-NCIT'),('DBX-NCIT-C112364','C112364','Number of Coil Channels','DB-NCIT'),('DBX-NCIT-C112365','C112365','Orbivirus','DB-NCIT'),('DBX-NCIT-C112366','C112366','Orthobunyavirus','DB-NCIT'),('DBX-NCIT-C112367','C112367','Parapoxvirus','DB-NCIT'),('DBX-NCIT-C112368','C112368','Peak Expiratory Flow Reversibility','DB-NCIT'),('DBX-NCIT-C112369','C112369','Percent Change From Baseline in Sum of Area','DB-NCIT'),('DBX-NCIT-C112370','C112370','Percent Change From Baseline in Sum of Diameter','DB-NCIT'),('DBX-NCIT-C112371','C112371','Percent Change From Baseline in Sum of Longest Diameter','DB-NCIT'),('DBX-NCIT-C112372','C112372','Percent Change From Baseline in Sum of Volume','DB-NCIT'),('DBX-NCIT-C112373','C112373','Percent Change From Nadir in Sum of Diameter','DB-NCIT'),('DBX-NCIT-C112374','C112374','Percent Change From Nadir in Sum of Longest Diameter','DB-NCIT'),('DBX-NCIT-C112375','C112375','Percent Predicted Expiratory Reserve Volume','DB-NCIT'),('DBX-NCIT-C112376','C112376','Percent Predicted Forced Expiratory Volume in 1 Second','DB-NCIT'),('DBX-NCIT-C112377','C112377','Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity','DB-NCIT'),('DBX-NCIT-C112378','C112378','Percent Predicted Forced Expiratory Volume in 6 Seconds','DB-NCIT'),('DBX-NCIT-C112379','C112379','Percent Predicted Forced Inspiratory Flow Maximum','DB-NCIT'),('DBX-NCIT-C112380','C112380','Percent Predicted Forced Inspiratory Volume in 1 Second','DB-NCIT'),('DBX-NCIT-C112381','C112381','Percent Predicted Forced Vital Capacity','DB-NCIT'),('DBX-NCIT-C112382','C112382','Percent Predicted Inspiratory Capacity','DB-NCIT'),('DBX-NCIT-C112383','C112383','Percent Predicted Inspiratory Reserve Volume','DB-NCIT'),('DBX-NCIT-C112384','C112384','Percent Predicted Peak Expiratory Flow','DB-NCIT'),('DBX-NCIT-C112385','C112385','Percent Predicted Residual Volume','DB-NCIT'),('DBX-NCIT-C112386','C112386','Percent Predicted Slow Vital Capacity','DB-NCIT'),('DBX-NCIT-C112387','C112387','Percent Predicted Tidal Volume','DB-NCIT'),('DBX-NCIT-C112388','C112388','Percent Predicted Total Lung Capacity','DB-NCIT'),('DBX-NCIT-C112389','C112389','Percent Recovered Infinity Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C112390','C112390','Percent Recovered Infinity Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C112391','C112391','Percent Recovered Infinity Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C112392','C112392','Percent Recovered Infinity Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C112393','C112393','Percent Recovered Infinity Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C112394','C112394','Percent Recovered Infinity Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C112395','C112395','Periostin Measurement','DB-NCIT'),('DBX-NCIT-C112396','C112396','Perivenous Route of Administration','DB-NCIT'),('DBX-NCIT-C112397','C112397','Phlebovirus','DB-NCIT'),('DBX-NCIT-C112398','C112398','Pneumovirus','DB-NCIT'),('DBX-NCIT-C112399','C112399','Precuneus','DB-NCIT'),('DBX-NCIT-C112400','C112400','Premature Birth Indicator','DB-NCIT'),('DBX-NCIT-C112401','C112401','Pseudocowpox Virus','DB-NCIT'),('DBX-NCIT-C112402','C112402','QTcB Shortened','DB-NCIT'),('DBX-NCIT-C112403','C112403','QTcF Shortened','DB-NCIT'),('DBX-NCIT-C112404','C112404','Quadrate Lobe of Liver','DB-NCIT'),('DBX-NCIT-C112405','C112405','Rabies Virus','DB-NCIT'),('DBX-NCIT-C112406','C112406','Reagent Lot Number','DB-NCIT'),('DBX-NCIT-C112407','C112407','Rhinovirus A','DB-NCIT'),('DBX-NCIT-C112408','C112408','Rhinovirus B','DB-NCIT'),('DBX-NCIT-C112409','C112409','Rhinovirus C','DB-NCIT'),('DBX-NCIT-C112410','C112410','Roseolovirus','DB-NCIT'),('DBX-NCIT-C112411','C112411','Ross River Virus','DB-NCIT'),('DBX-NCIT-C112412','C112412','Rubeola IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112413','C112413','Rubeola IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C112414','C112414','Rubivirus','DB-NCIT'),('DBX-NCIT-C112415','C112415','Sapporo Virus','DB-NCIT'),('DBX-NCIT-C112416','C112416','Signal Amplitude','DB-NCIT'),('DBX-NCIT-C112417','C112417','Signal Frequency','DB-NCIT'),('DBX-NCIT-C112418','C112418','Signal Width','DB-NCIT'),('DBX-NCIT-C112419','C112419','Simplexvirus','DB-NCIT'),('DBX-NCIT-C112420','C112420','Skin Response Domain','DB-NCIT'),('DBX-NCIT-C112421','C112421','Surgical Mesh Open Area','DB-NCIT'),('DBX-NCIT-C112422','C112422','Tick-Borne Encephalitis Virus','DB-NCIT'),('DBX-NCIT-C112423','C112423','Torr','DB-NCIT'),('DBX-NCIT-C112424','C112424','Twin Type','DB-NCIT'),('DBX-NCIT-C112426','C112426','Varicellovirus','DB-NCIT'),('DBX-NCIT-C112427','C112427','Wheal Longest Diameter','DB-NCIT'),('DBX-NCIT-C112428','C112428','Wheal Mean Diameter','DB-NCIT'),('DBX-NCIT-C112429','C112429','Wheal Size','DB-NCIT'),('DBX-NCIT-C112432','C112432','SARS Coronavirus','DB-NCIT'),('DBX-NCIT-C112433','C112433','Shockwave Dosing Unit','DB-NCIT'),('DBX-NCIT-C113205','C113205','Coronaviridae','DB-NCIT'),('DBX-NCIT-C114108','C114108','Experimental Organism Islet Cell Adenoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114109','C114109','Experimental Organism Acidophil Carcinoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114110','C114110','Experimental Organism Histiocytic Lymphoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114111','C114111','Experimental Organism Mixed Lymphoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114112','C114112','Experimental Organism Lymphosarcoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114113','C114113','Experimental Organism Benign Stromal Tumor Neoplasm','DB-NCIT'),('DBX-NCIT-C114114','C114114','Experimental Organism Benign Teratoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114115','C114115','Experimental Organism Benign Thymoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114116','C114116','CDISC SDTM Morphology Test Name Terminology','DB-NCIT'),('DBX-NCIT-C114117','C114117','CDISC SDTM Morphology Test Code Terminology','DB-NCIT'),('DBX-NCIT-C114118','C114118','CDISC SDTM Protocol Milestone Terminology','DB-NCIT'),('DBX-NCIT-C114119','C114119','CDISC SDTM Pharmacogenomics Biomarker Medical Statement Terminology','DB-NCIT'),('DBX-NCIT-C114121','C114121','Total Body Clearance by Fraction of Dose for Dose Interval','DB-NCIT'),('DBX-NCIT-C114122','C114122','Total Body Clearance for Dose Interval','DB-NCIT'),('DBX-NCIT-C114145','C114145','Electrical Stimulation Electrode Type','DB-NCIT'),('DBX-NCIT-C114146','C114146','Explanted Medical Device','DB-NCIT'),('DBX-NCIT-C114147','C114147','Baseline Wander by ECG Finding','DB-NCIT'),('DBX-NCIT-C114148','C114148','Muscle Tremor Artifact','DB-NCIT'),('DBX-NCIT-C114149','C114149','Alternating Current Noise by ECG Finding','DB-NCIT'),('DBX-NCIT-C114150','C114150','Interchanged Limb Electrodes by ECG Finding','DB-NCIT'),('DBX-NCIT-C114151','C114151','Disconnected Limb Electrodes by ECG Finding','DB-NCIT'),('DBX-NCIT-C114152','C114152','Interchanged Precordial Electrodes by ECG Finding','DB-NCIT'),('DBX-NCIT-C114153','C114153','Disconnected Precordial Electrode V1 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114154','C114154','Disconnected Precordial Electrode V2 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114155','C114155','Disconnected Precordial Electrode V3 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114156','C114156','Disconnected Precordial Electrode V4 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114157','C114157','Disconnected Precordial Electrode V5 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114158','C114158','Disconnected Precordial Electrode V6 by ECG Finding','DB-NCIT'),('DBX-NCIT-C114159','C114159','All Precordial Electrodes Are Disconnected by ECG Finding','DB-NCIT'),('DBX-NCIT-C114160','C114160','Incorrectly Positioned Precordial Electrodes by ECG Finding','DB-NCIT'),('DBX-NCIT-C114161','C114161','Quality Problem Not Otherwise Specified by ECG Finding','DB-NCIT'),('DBX-NCIT-C114162','C114162','Artifact Lead Signal by ECG Finding','DB-NCIT'),('DBX-NCIT-C114163','C114163','ECG Waveforms Not Present','DB-NCIT'),('DBX-NCIT-C114164','C114164','60 Hertz Noise by ECG Finding','DB-NCIT'),('DBX-NCIT-C114165','C114165','50 Hertz Noise by ECG Finding','DB-NCIT'),('DBX-NCIT-C114166','C114166','Low Amplitude QRS Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C114167','C114167','Incomplete ECG','DB-NCIT'),('DBX-NCIT-C114168','C114168','Incorrectly Scaled ECG','DB-NCIT'),('DBX-NCIT-C114169','C114169','Incompletely Digitized ECG Leads','DB-NCIT'),('DBX-NCIT-C114170','C114170','Inability to Digitize ECG Leads','DB-NCIT'),('DBX-NCIT-C114171','C114171','Invalid ECG Waveforms','DB-NCIT'),('DBX-NCIT-C114172','C114172','Poor Quality ECG','DB-NCIT'),('DBX-NCIT-C114173','C114173','Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding','DB-NCIT'),('DBX-NCIT-C114174','C114174','Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding','DB-NCIT'),('DBX-NCIT-C114175','C114175','ECG Acquired with Precordial Electrodes Placed on the Right Chest','DB-NCIT'),('DBX-NCIT-C114176','C114176','Other Incorrect Electrode Placement','DB-NCIT'),('DBX-NCIT-C114177','C114177','Insufficient Number of Beats for Complete ECG Evaluation','DB-NCIT'),('DBX-NCIT-C114178','C114178','ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed','DB-NCIT'),('DBX-NCIT-C114179','C114179','Incomplete ECG Measurements Due to Truncation of QRS Complexes','DB-NCIT'),('DBX-NCIT-C114180','C114180','ECG Evaluation Not Performed Due to Poor Quality of Printed ECG','DB-NCIT'),('DBX-NCIT-C114181','C114181','ECG Evaluation Not Performed Due to Corrupted Digital ECG File','DB-NCIT'),('DBX-NCIT-C114182','C114182','Dominant Hand','DB-NCIT'),('DBX-NCIT-C114183','C114183','Boundary Shift Integral','DB-NCIT'),('DBX-NCIT-C114184','C114184','MRI Without Contrast','DB-NCIT'),('DBX-NCIT-C114185','C114185','Polysomnography','DB-NCIT'),('DBX-NCIT-C114186','C114186','Femoral Condyle','DB-NCIT'),('DBX-NCIT-C114187','C114187','Humeral Epicondyle','DB-NCIT'),('DBX-NCIT-C114188','C114188','Distal Interphalangeal Joint 2 of the Hand','DB-NCIT'),('DBX-NCIT-C114189','C114189','Distal Interphalangeal Joint 3 of the Hand','DB-NCIT'),('DBX-NCIT-C114190','C114190','Interphalangeal Joint 2 of the Hand','DB-NCIT'),('DBX-NCIT-C114191','C114191','Interphalangeal Joint 3 of the Hand','DB-NCIT'),('DBX-NCIT-C114192','C114192','Interphalangeal Joint 4 of the Hand','DB-NCIT'),('DBX-NCIT-C114193','C114193','Interphalangeal Joint 5 of the Hand','DB-NCIT'),('DBX-NCIT-C114194','C114194','Proximal Interphalangeal Joint 2 of the Hand','DB-NCIT'),('DBX-NCIT-C114195','C114195','Proximal Interphalangeal Joint 3 of the Hand','DB-NCIT'),('DBX-NCIT-C114196','C114196','Proximal Interphalangeal Joint 4 of the Hand','DB-NCIT'),('DBX-NCIT-C114197','C114197','Proximal Interphalangeal Joint 5 of the Hand','DB-NCIT'),('DBX-NCIT-C114198','C114198','Distal Interphalangeal Joint 2 of the Foot','DB-NCIT'),('DBX-NCIT-C114199','C114199','Distal Interphalangeal Joint 3 of the Foot','DB-NCIT'),('DBX-NCIT-C114200','C114200','Interphalangeal Joint 1 of the Foot','DB-NCIT'),('DBX-NCIT-C114201','C114201','Interphalangeal Joint 2 of the Foot','DB-NCIT'),('DBX-NCIT-C114202','C114202','Interphalangeal Joint 3 of the Foot','DB-NCIT'),('DBX-NCIT-C114203','C114203','Interphalangeal Joint 4 of the Foot','DB-NCIT'),('DBX-NCIT-C114204','C114204','Interphalangeal Joint 5 of the Foot','DB-NCIT'),('DBX-NCIT-C114205','C114205','Proximal Interphalangeal Joint 2 of the Foot','DB-NCIT'),('DBX-NCIT-C114206','C114206','Proximal Interphalangeal Joint 3 of the Foot','DB-NCIT'),('DBX-NCIT-C114207','C114207','Proximal Interphalangeal Joint 4 of the Foot','DB-NCIT'),('DBX-NCIT-C114208','C114208','Proximal Interphalangeal Joint 5 of the Foot','DB-NCIT'),('DBX-NCIT-C114209','C114209','Subject is Randomized','DB-NCIT'),('DBX-NCIT-C114210','C114210','Platelet Aggregometry Curve Type','DB-NCIT'),('DBX-NCIT-C114211','C114211','Platelet Aggregometry Mean Amplitude','DB-NCIT'),('DBX-NCIT-C114212','C114212','Platelet Aggregometry Mean Curve Type','DB-NCIT'),('DBX-NCIT-C114213','C114213','Nuclear Swelling Measurement','DB-NCIT'),('DBX-NCIT-C114214','C114214','Mean Platelet Dry Mass','DB-NCIT'),('DBX-NCIT-C114215','C114215','Reticulocyte Mean Corpuscular Volume','DB-NCIT'),('DBX-NCIT-C114216','C114216','Eosinophil Band Form Count','DB-NCIT'),('DBX-NCIT-C114217','C114217','Eosinophil Band Form to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C114218','C114218','Reticulocyte Distribution Width','DB-NCIT'),('DBX-NCIT-C114219','C114219','Fractional Excretion of Calcium','DB-NCIT'),('DBX-NCIT-C114220','C114220','Fractional Excretion of Chloride','DB-NCIT'),('DBX-NCIT-C114221','C114221','Fractional Excretion of Phosphate','DB-NCIT'),('DBX-NCIT-C114222','C114222','Fractional Excretion of Potassium','DB-NCIT'),('DBX-NCIT-C114223','C114223','Sialyl SSEA-1 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C114224','C114224','Sulfur Dioxide Measurement','DB-NCIT'),('DBX-NCIT-C114225','C114225','Unspecified Cells to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C114226','C114226','Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose','DB-NCIT'),('DBX-NCIT-C114227','C114227','Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C114228','C114228','Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C114229','C114229','Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C114230','C114230','Total Body Clearance for Dose Interval Normalized by Dose','DB-NCIT'),('DBX-NCIT-C114231','C114231','Total Body Clearance for Dose Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C114232','C114232','Total Body Clearance for Dose Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C114233','C114233','Total Body Clearance for Dose Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C114234','C114234','Accumulation Index using Lambda z','DB-NCIT'),('DBX-NCIT-C114235','C114235','Experimental Organism Benign Nephroblastoma Neoplasm','DB-NCIT'),('DBX-NCIT-C114237','C114237','Virtual Pixel','DB-NCIT'),('DBX-NCIT-C114238','C114238','Pixels per Centimeter','DB-NCIT'),('DBX-NCIT-C114239','C114239','Pixels per Inch','DB-NCIT'),('DBX-NCIT-C114240','C114240','Percent per Minute','DB-NCIT'),('DBX-NCIT-C114241','C114241','Millivolt Squared per Hertz','DB-NCIT'),('DBX-NCIT-C114242','C114242','Grating Cycles per Centimeter','DB-NCIT'),('DBX-NCIT-C114243','C114243','Enterococcus thailandicus','DB-NCIT'),('DBX-NCIT-C114244','C114244','Atopobium rimae','DB-NCIT'),('DBX-NCIT-C114245','C114245','Peptoniphilus harei','DB-NCIT'),('DBX-NCIT-C114246','C114246','Alistipes shahii','DB-NCIT'),('DBX-NCIT-C114247','C114247','Megamonas funiformis','DB-NCIT'),('DBX-NCIT-C114248','C114248','Arthrobacter cumminsii','DB-NCIT'),('DBX-NCIT-C114249','C114249','Corynebacterium tuberculostearicum','DB-NCIT'),('DBX-NCIT-C114250','C114250','Clostridium bolteae','DB-NCIT'),('DBX-NCIT-C114251','C114251','Clostridium hathewayi','DB-NCIT'),('DBX-NCIT-C114252','C114252','Fusobacterium naviforme','DB-NCIT'),('DBX-NCIT-C114253','C114253','Tsukamurella pulmonis','DB-NCIT'),('DBX-NCIT-C114254','C114254','Candida rugosa','DB-NCIT'),('DBX-NCIT-C114255','C114255','Candida dubliniensis','DB-NCIT'),('DBX-NCIT-C114256','C114256','Kluyveromyces marxianus','DB-NCIT'),('DBX-NCIT-C114257','C114257','Yarrowia lipolytica','DB-NCIT'),('DBX-NCIT-C114258','C114258','Candida pararugosa','DB-NCIT'),('DBX-NCIT-C114259','C114259','Pichia norvegensis','DB-NCIT'),('DBX-NCIT-C114260','C114260','Candida orthopsilosis','DB-NCIT'),('DBX-NCIT-C114261','C114261','Candida zeylanoides','DB-NCIT'),('DBX-NCIT-C114262','C114262','Wickerhamomyces anomalus','DB-NCIT'),('DBX-NCIT-C114263','C114263','Magnusiomyces capitatus','DB-NCIT'),('DBX-NCIT-C114264','C114264','Rhodotorula glutinis','DB-NCIT'),('DBX-NCIT-C114265','C114265','Filobasidium uniguttulatum','DB-NCIT'),('DBX-NCIT-C114266','C114266','Cryptococcus randhawii','DB-NCIT'),('DBX-NCIT-C114267','C114267','Cryptococcus albidus','DB-NCIT'),('DBX-NCIT-C114268','C114268','Cryptococcus gattii','DB-NCIT'),('DBX-NCIT-C114269','C114269','Cryptococcus laurentii','DB-NCIT'),('DBX-NCIT-C114270','C114270','Pichia kluyveri','DB-NCIT'),('DBX-NCIT-C114271','C114271','Prototheca wickerhamii','DB-NCIT'),('DBX-NCIT-C114272','C114272','Trichosporon asahii','DB-NCIT'),('DBX-NCIT-C114273','C114273','Distal Interphalangeal Joint 4 of the Hand','DB-NCIT'),('DBX-NCIT-C114274','C114274','Distal Interphalangeal Joint 5 of the Hand','DB-NCIT'),('DBX-NCIT-C114275','C114275','Distal Interphalangeal Joint 4 of the Foot','DB-NCIT'),('DBX-NCIT-C114276','C114276','Distal Interphalangeal Joint 5 of the Foot','DB-NCIT'),('DBX-NCIT-C116062','C116062','Hour Times Nanomole per Liter per Gram','DB-NCIT'),('DBX-NCIT-C116063','C116063','Hour Times Micromole per liter per Gram','DB-NCIT'),('DBX-NCIT-C116103','C116103','CDISC SDTM Nervous System Physiology Test Name Terminology','DB-NCIT'),('DBX-NCIT-C116104','C116104','CDISC SDTM Nervous System Physiology Test Code Terminology','DB-NCIT'),('DBX-NCIT-C116105','C116105','CDISC SDTM Pharmacogenomics Findings Test Name Terminology','DB-NCIT'),('DBX-NCIT-C116106','C116106','CDISC SDTM Pharmacogenomics Findings Test Code Terminology','DB-NCIT'),('DBX-NCIT-C116107','C116107','CDISC SDTM Death Details Test Name Terminology','DB-NCIT'),('DBX-NCIT-C116108','C116108','CDISC SDTM Death Details Test Code Terminology','DB-NCIT'),('DBX-NCIT-C116109','C116109','CDISC SDTM Viral Resistance Findings Test Name Terminology','DB-NCIT'),('DBX-NCIT-C116110','C116110','CDISC SDTM Viral Resistance Findings Test Code Terminology','DB-NCIT'),('DBX-NCIT-C116111','C116111','CDISC SDTM Species Terminology','DB-NCIT'),('DBX-NCIT-C116112','C116112','Spinous Process','DB-NCIT'),('DBX-NCIT-C116118','C116118','Multiplex Probe Parameter','DB-NCIT'),('DBX-NCIT-C116119','C116119','MRI Coil Type','DB-NCIT'),('DBX-NCIT-C116120','C116120','Scintillation Crystal Type','DB-NCIT'),('DBX-NCIT-C116121','C116121','Data Storage Failure','DB-NCIT'),('DBX-NCIT-C116122','C116122','Image Weighting Type','DB-NCIT'),('DBX-NCIT-C116123','C116123','Interslice Distance Measurement','DB-NCIT'),('DBX-NCIT-C116124','C116124','Inversion Time','DB-NCIT'),('DBX-NCIT-C116125','C116125','Number of Slices','DB-NCIT'),('DBX-NCIT-C116126','C116126','Image Acquisition Dimensionality','DB-NCIT'),('DBX-NCIT-C116127','C116127','Decay Correction Indicator','DB-NCIT'),('DBX-NCIT-C116128','C116128','Randoms Correction Indicator','DB-NCIT'),('DBX-NCIT-C116129','C116129','Junctional Escape Complexes by ECG Finding','DB-NCIT'),('DBX-NCIT-C116130','C116130','Asystole by ECG Finding','DB-NCIT'),('DBX-NCIT-C116131','C116131','Undetermined Rhythm by ECG Finding','DB-NCIT'),('DBX-NCIT-C116132','C116132','Aberrantly Conducted Complexes by ECG Finding','DB-NCIT'),('DBX-NCIT-C116133','C116133','Low Voltage in Limb Leads Only by ECG Finding','DB-NCIT'),('DBX-NCIT-C116134','C116134','Non-Diagnostic Q Waves by ECG Finding','DB-NCIT'),('DBX-NCIT-C116135','C116135','PR Segment Depression by ECG Finding','DB-NCIT'),('DBX-NCIT-C116136','C116136','Short ST Segment by ECG Finding','DB-NCIT'),('DBX-NCIT-C116137','C116137','Prolonged ST Segment by ECG Finding','DB-NCIT'),('DBX-NCIT-C116138','C116138','ACC/AHA Ischemic ECG Changes','DB-NCIT'),('DBX-NCIT-C116139','C116139','12 Lead Placement Right-sided Precordial Leads','DB-NCIT'),('DBX-NCIT-C116140','C116140','Acute Myocardial Ischemia by ECG Assessment','DB-NCIT'),('DBX-NCIT-C116141','C116141','Standard Uptake Value Ratio','DB-NCIT'),('DBX-NCIT-C116142','C116142','Secondary Cause of Death','DB-NCIT'),('DBX-NCIT-C116143','C116143','Mean Vessel Diameter','DB-NCIT'),('DBX-NCIT-C116144','C116144','Minimum Vessel Lumen Diameter','DB-NCIT'),('DBX-NCIT-C116145','C116145','Percent Diameter Stenosis Measurement','DB-NCIT'),('DBX-NCIT-C116146','C116146','Late Lumen Loss Measurement','DB-NCIT'),('DBX-NCIT-C116147','C116147','Lesion Restenosis Indicator','DB-NCIT'),('DBX-NCIT-C116148','C116148','In-Stent Restenosis Indicator','DB-NCIT'),('DBX-NCIT-C116149','C116149','Every Seven Weeks','DB-NCIT'),('DBX-NCIT-C116150','C116150','Peripheral Vascular Intervention','DB-NCIT'),('DBX-NCIT-C116151','C116151','Single Nucleotide Polymorphism Array','DB-NCIT'),('DBX-NCIT-C116152','C116152','Cross-linking Immunoprecipitation High-throughput Sequencing','DB-NCIT'),('DBX-NCIT-C116153','C116153','Two Color Microarray','DB-NCIT'),('DBX-NCIT-C116154','C116154','Direct Sequencing','DB-NCIT'),('DBX-NCIT-C116155','C116155','Biopolymer Sequencing','DB-NCIT'),('DBX-NCIT-C116156','C116156','Oligonucleotide Array-based Comparative Genomic Hybridization','DB-NCIT'),('DBX-NCIT-C116157','C116157','Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization','DB-NCIT'),('DBX-NCIT-C116158','C116158','Digital Array','DB-NCIT'),('DBX-NCIT-C116159','C116159','Multiplex Amplifiable Probe Hybridization','DB-NCIT'),('DBX-NCIT-C116160','C116160','Multiple Complete Digest Restriction Fragment Mapping','DB-NCIT'),('DBX-NCIT-C116161','C116161','Multiplex Ligation-dependent Probe Amplification','DB-NCIT'),('DBX-NCIT-C116162','C116162','Optical Mapping','DB-NCIT'),('DBX-NCIT-C116163','C116163','Fifth Lumbar Spinous Process','DB-NCIT'),('DBX-NCIT-C116164','C116164','Skin Of The Axilla','DB-NCIT'),('DBX-NCIT-C116165','C116165','Aortopulmonary Window Lymph Node','DB-NCIT'),('DBX-NCIT-C116166','C116166','Aortoiliac Artery Segment','DB-NCIT'),('DBX-NCIT-C116167','C116167','Femoropopliteal Artery Segment','DB-NCIT'),('DBX-NCIT-C116168','C116168','Tibialcrural Artery','DB-NCIT'),('DBX-NCIT-C116169','C116169','Right Coronary Artery Ostium','DB-NCIT'),('DBX-NCIT-C116170','C116170','Posterolateral Coronary Artery','DB-NCIT'),('DBX-NCIT-C116171','C116171','Right Ventricular Branch of Right Coronary Artery','DB-NCIT'),('DBX-NCIT-C116172','C116172','Left Main Coronary Artery Ostium','DB-NCIT'),('DBX-NCIT-C116173','C116173','Left Main Coronary Artery Body','DB-NCIT'),('DBX-NCIT-C116174','C116174','Left Main Coronary Artery Bifurcation','DB-NCIT'),('DBX-NCIT-C116175','C116175','Left Anterior Descending Artery Ostium','DB-NCIT'),('DBX-NCIT-C116176','C116176','Left Circumflex Artery Ostium','DB-NCIT'),('DBX-NCIT-C116177','C116177','Left Atrioventricular Artery','DB-NCIT'),('DBX-NCIT-C116178','C116178','Left Posterior Descending Artery','DB-NCIT'),('DBX-NCIT-C116179','C116179','Infrarenal Aortic Segment','DB-NCIT'),('DBX-NCIT-C116180','C116180','Popliteal Artery Above the Knee','DB-NCIT'),('DBX-NCIT-C116181','C116181','Popliteal Artery Below the Knee','DB-NCIT'),('DBX-NCIT-C116182','C116182','Tibioperoneal Arterial Trunk','DB-NCIT'),('DBX-NCIT-C116183','C116183','Accessory Renal Artery','DB-NCIT'),('DBX-NCIT-C116184','C116184','Inclusion Body Measurement','DB-NCIT'),('DBX-NCIT-C116185','C116185','Azurophilic Granule Measurement','DB-NCIT'),('DBX-NCIT-C116186','C116186','Heterophil Measurement','DB-NCIT'),('DBX-NCIT-C116187','C116187','Heterophils to Leukocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C116188','C116188','High Absorption Reticulocyte Measurement','DB-NCIT'),('DBX-NCIT-C116189','C116189','High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C116190','C116190','Low Absorption Reticulocyte Measurement','DB-NCIT'),('DBX-NCIT-C116191','C116191','Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C116192','C116192','Medium Absorption Reticulocyte Measurement','DB-NCIT'),('DBX-NCIT-C116193','C116193','Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C116194','C116194','Cholera Toxin B Subunit IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C116195','C116195','Leukemic Cells Measurement','DB-NCIT'),('DBX-NCIT-C116196','C116196','Hepatitis C Virus Antigen Measurement','DB-NCIT'),('DBX-NCIT-C116197','C116197','IDL Particles Measurement','DB-NCIT'),('DBX-NCIT-C116198','C116198','Metanephrine Measurement','DB-NCIT'),('DBX-NCIT-C116199','C116199','Mid Cell Fraction Measurement','DB-NCIT'),('DBX-NCIT-C116200','C116200','Agranular Neutrophils Measurement','DB-NCIT'),('DBX-NCIT-C116201','C116201','Hypogranular Neutrophil Measurement','DB-NCIT'),('DBX-NCIT-C116202','C116202','Left Shift Neutrophil Measurement','DB-NCIT'),('DBX-NCIT-C116203','C116203','Natural Killer Cell Activity Measurement','DB-NCIT'),('DBX-NCIT-C116204','C116204','Non-High Density Lipoprotein Cholesterol Measurement','DB-NCIT'),('DBX-NCIT-C116205','C116205','Neuron Specific Enolase Measurement','DB-NCIT'),('DBX-NCIT-C116206','C116206','Osteoprotegerin Measurement','DB-NCIT'),('DBX-NCIT-C116207','C116207','Parietal Cell Antibody Measurement','DB-NCIT'),('DBX-NCIT-C116208','C116208','Platelet Derived Growth Factor Isoform AB Measurement','DB-NCIT'),('DBX-NCIT-C116209','C116209','Platelet Satellitism Assessment','DB-NCIT'),('DBX-NCIT-C116210','C116210','Panel Reactive Antibody Test','DB-NCIT'),('DBX-NCIT-C116211','C116211','Gamma Tocopherol Measurement','DB-NCIT'),('DBX-NCIT-C116212','C116212','Erythrocyte Fragment Measurement','DB-NCIT'),('DBX-NCIT-C116213','C116213','Hemodialysis Extraction Ratio','DB-NCIT'),('DBX-NCIT-C116214','C116214','Experimental Organism Malignant Neuromyoblastoma','DB-NCIT'),('DBX-NCIT-C116215','C116215','Experimental Organism Benign Acinar-islet Cell Tumor','DB-NCIT'),('DBX-NCIT-C116231','C116231','Biological Allergy Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C116232','C116232','Histamine Equivalent Prick Unit','DB-NCIT'),('DBX-NCIT-C116233','C116233','Standardized Allergy Biological Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C116234','C116234','Standardized Allergy Quality Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C116235','C116235','Bioequivalent Allergy Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C116236','C116236','Allergenic Protein Nitrogen Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C116237','C116237','Copies per Microliter','DB-NCIT'),('DBX-NCIT-C116238','C116238','Log10 International Units per Milliliter','DB-NCIT'),('DBX-NCIT-C116239','C116239','Cells per Kilogram','DB-NCIT'),('DBX-NCIT-C116240','C116240','Per Thousand Cells','DB-NCIT'),('DBX-NCIT-C116241','C116241','Millijoules per Square Centimeter','DB-NCIT'),('DBX-NCIT-C116242','C116242','Millimoles per Minute per Kilopascal','DB-NCIT'),('DBX-NCIT-C116243','C116243','Per Nanoliter','DB-NCIT'),('DBX-NCIT-C116244','C116244','Cigar Dosing Unit','DB-NCIT'),('DBX-NCIT-C116245','C116245','Cigarette Dosing Unit','DB-NCIT'),('DBX-NCIT-C116246','C116246','Pipe Dosing Unit','DB-NCIT'),('DBX-NCIT-C116247','C116247','Half Maximal Inhibitory Concentration Treatment Result Measurement','DB-NCIT'),('DBX-NCIT-C116248','C116248','Half Maximal Inhibitory Concentration Reference Control Result Measurement','DB-NCIT'),('DBX-NCIT-C116249','C116249','Half Maximal Inhibitory Concentration Fold Change from Reference Measurement','DB-NCIT'),('DBX-NCIT-C116250','C116250','Half Maximal Inhibitory Concentration Fold Change from Baseline Measurement','DB-NCIT'),('DBX-NCIT-C116251','C116251','95 Percent Maximal Inhibitory Concentration Treatment Result Measurement','DB-NCIT'),('DBX-NCIT-C116252','C116252','95 Percent Maximal Inhibitory Concentration Reference Control Result Measurement','DB-NCIT'),('DBX-NCIT-C116253','C116253','95 Percent Maximal Inhibitory Concentration Fold Change from Reference Measurement','DB-NCIT'),('DBX-NCIT-C116254','C116254','95 Percent Maximal Inhibitory Concentration Fold Change from Baseline Measurement','DB-NCIT'),('DBX-NCIT-C116255','C116255','Inhibitory Concentration Net Assessment Measurement','DB-NCIT'),('DBX-NCIT-C117736','C117736','Vastus Medialis Muscle','DB-NCIT'),('DBX-NCIT-C117737','C117737','CDISC SDTM Graft Type Terminology','DB-NCIT'),('DBX-NCIT-C117738','C117738','CDISC SDTM Hepatic Findings About Test Name Terminology','DB-NCIT'),('DBX-NCIT-C117739','C117739','CDISC SDTM Hepatic Findings About Test Code Terminology','DB-NCIT'),('DBX-NCIT-C117740','C117740','CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology','DB-NCIT'),('DBX-NCIT-C117741','C117741','CDISC SDTM Multiple Sclerosis Findings About Test Code Terminology','DB-NCIT'),('DBX-NCIT-C117742','C117742','CDISC SDTM Ophthalmic Exam Test Name Terminology','DB-NCIT'),('DBX-NCIT-C117743','C117743','CDISC SDTM Ophthalmic Exam Test Code Terminology','DB-NCIT'),('DBX-NCIT-C117746','C117746','CDISC SDTM West Haven Hepatic Encephalopathy Grade Terminology','DB-NCIT'),('DBX-NCIT-C117747','C117747','West Haven Hepatic Encephalopathy Grade','DB-NCIT'),('DBX-NCIT-C117748','C117748','Lipase Measurement','DB-NCIT'),('DBX-NCIT-C117749','C117749','Soluble Tumor Necrosis Factor Receptor Measurement','DB-NCIT'),('DBX-NCIT-C117754','C117754','Temporal Anatomic Qualifier','DB-NCIT'),('DBX-NCIT-C117755','C117755','Procedure Agents Domain','DB-NCIT'),('DBX-NCIT-C117756','C117756','Functional Tests Domain','DB-NCIT'),('DBX-NCIT-C117757','C117757','Healthcare Encounters Domain','DB-NCIT'),('DBX-NCIT-C117758','C117758','Device Intended But Not Used','DB-NCIT'),('DBX-NCIT-C117759','C117759','Checkerboard Square Size','DB-NCIT'),('DBX-NCIT-C117760','C117760','Superimposition of Multiple Leads','DB-NCIT'),('DBX-NCIT-C117761','C117761','Comparison to a Prior ECG','DB-NCIT'),('DBX-NCIT-C117762','C117762','Aggregate JT Interval','DB-NCIT'),('DBX-NCIT-C117763','C117763','Aggregate JTCB Interval','DB-NCIT'),('DBX-NCIT-C117764','C117764','Single Beat JTCB Interval','DB-NCIT'),('DBX-NCIT-C117765','C117765','Aggregate JTCF Interval','DB-NCIT'),('DBX-NCIT-C117766','C117766','Single Beat JTCF Interval','DB-NCIT'),('DBX-NCIT-C117767','C117767','Aggregate J-T Peak Interval','DB-NCIT'),('DBX-NCIT-C117768','C117768','Single Beat J-T Peak Interval','DB-NCIT'),('DBX-NCIT-C117769','C117769','Single Beat JT Interval','DB-NCIT'),('DBX-NCIT-C117770','C117770','New Q Wave','DB-NCIT'),('DBX-NCIT-C117771','C117771','Aggregate PP Interval','DB-NCIT'),('DBX-NCIT-C117772','C117772','Single Measurement PP Interval','DB-NCIT'),('DBX-NCIT-C117773','C117773','Aggregate PR Interval','DB-NCIT'),('DBX-NCIT-C117774','C117774','Single Beat PR Interval','DB-NCIT'),('DBX-NCIT-C117775','C117775','Aggregate P Wave Duration','DB-NCIT'),('DBX-NCIT-C117776','C117776','Single Beat P Wave Duration','DB-NCIT'),('DBX-NCIT-C117777','C117777','Aggregate P Wave Amplitude','DB-NCIT'),('DBX-NCIT-C117778','C117778','Single Beat P Wave Amplitude','DB-NCIT'),('DBX-NCIT-C117779','C117779','Aggregate QRS Duration','DB-NCIT'),('DBX-NCIT-C117780','C117780','Single Beat QRS Duration','DB-NCIT'),('DBX-NCIT-C117781','C117781','Paced Ventricular Aggregate QRS Duration','DB-NCIT'),('DBX-NCIT-C117782','C117782','Paced Ventricular Single Beat QRS Duration','DB-NCIT'),('DBX-NCIT-C117783','C117783','Aggregate QT Interval','DB-NCIT'),('DBX-NCIT-C117784','C117784','Aggregate QTCB Interval','DB-NCIT'),('DBX-NCIT-C117785','C117785','Single Beat QTCB Interval','DB-NCIT'),('DBX-NCIT-C117786','C117786','Aggregate QTCF Interval','DB-NCIT'),('DBX-NCIT-C117787','C117787','Single Beat QTCF Interval','DB-NCIT'),('DBX-NCIT-C117788','C117788','Single Beat QT Interval','DB-NCIT'),('DBX-NCIT-C117789','C117789','Aggregate Q Wave Amplitude','DB-NCIT'),('DBX-NCIT-C117790','C117790','Single Beat Q Wave Amplitude','DB-NCIT'),('DBX-NCIT-C117791','C117791','Aggregate RR Interval','DB-NCIT'),('DBX-NCIT-C117792','C117792','RR Interval Single Measurement','DB-NCIT'),('DBX-NCIT-C117793','C117793','RS Wave Amplitude Aggregate','DB-NCIT'),('DBX-NCIT-C117794','C117794','RS Wave Amplitude Single Beat','DB-NCIT'),('DBX-NCIT-C117795','C117795','R Wave Amplitude Aggregate','DB-NCIT'),('DBX-NCIT-C117796','C117796','R Wave Amplitude Single Beat','DB-NCIT'),('DBX-NCIT-C117797','C117797','ST Segment Depression Aggregate','DB-NCIT'),('DBX-NCIT-C117798','C117798','ST Segment Depression Single Beat','DB-NCIT'),('DBX-NCIT-C117799','C117799','ST Segment Deviation Aggregate','DB-NCIT'),('DBX-NCIT-C117800','C117800','ST Segment Deviation Single Beat','DB-NCIT'),('DBX-NCIT-C117801','C117801','ST Segment Elevation Aggregate','DB-NCIT'),('DBX-NCIT-C117802','C117802','ST Segment Elevation Single Beat','DB-NCIT'),('DBX-NCIT-C117803','C117803','ST Segment Duration Aggregate','DB-NCIT'),('DBX-NCIT-C117804','C117804','ST Segment Duration Single Beat','DB-NCIT'),('DBX-NCIT-C117805','C117805','S Wave Amplitude Aggregate','DB-NCIT'),('DBX-NCIT-C117806','C117806','S Wave Amplitude Single Beat','DB-NCIT'),('DBX-NCIT-C117807','C117807','ECG Technical Quality','DB-NCIT'),('DBX-NCIT-C117808','C117808','T Peak-T End Interval Aggregate','DB-NCIT'),('DBX-NCIT-C117809','C117809','T Peak-T End Interval Single Beat','DB-NCIT'),('DBX-NCIT-C117810','C117810','T Wave Area Aggregate','DB-NCIT'),('DBX-NCIT-C117811','C117811','T Wave Area Single Beat','DB-NCIT'),('DBX-NCIT-C117812','C117812','T Wave Duration Aggregate','DB-NCIT'),('DBX-NCIT-C117813','C117813','T Wave Duration Single Beat','DB-NCIT'),('DBX-NCIT-C117814','C117814','T Wave Amplitude Aggregate','DB-NCIT'),('DBX-NCIT-C117815','C117815','T Wave Amplitude Single Beat','DB-NCIT'),('DBX-NCIT-C117816','C117816','Free Arterial Graft','DB-NCIT'),('DBX-NCIT-C117817','C117817','In Situ Arterial Graft','DB-NCIT'),('DBX-NCIT-C117818','C117818','Autologous Vein Graft','DB-NCIT'),('DBX-NCIT-C117819','C117819','Cadaveric Arterial Graft','DB-NCIT'),('DBX-NCIT-C117820','C117820','Cadaveric Venous Graft','DB-NCIT'),('DBX-NCIT-C117821','C117821','Composite Vessel Graft','DB-NCIT'),('DBX-NCIT-C117822','C117822','Saphenous Vein Graft','DB-NCIT'),('DBX-NCIT-C117823','C117823','Synthetic Vessel Graft','DB-NCIT'),('DBX-NCIT-C117824','C117824','West Haven Hepatic Encephalopathy Grade 0','DB-NCIT'),('DBX-NCIT-C117825','C117825','West Haven Hepatic Encephalopathy Grade 1','DB-NCIT'),('DBX-NCIT-C117826','C117826','West Haven Hepatic Encephalopathy Grade 2','DB-NCIT'),('DBX-NCIT-C117827','C117827','West Haven Hepatic Encephalopathy Grade 3','DB-NCIT'),('DBX-NCIT-C117828','C117828','West Haven Hepatic Encephalopathy Grade 4','DB-NCIT'),('DBX-NCIT-C117829','C117829','Albumin Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117830','C117830','Aspartate Aminotransferase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C117831','C117831','Calcium Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117832','C117832','Chloride Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117833','C117833','Creatinine Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117834','C117834','Glucose Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117835','C117835','Soluble Immunoglobulin Measurement','DB-NCIT'),('DBX-NCIT-C117836','C117836','Soluble Interleukin-1 Receptor Type I Measurement','DB-NCIT'),('DBX-NCIT-C117837','C117837','Soluble Interleukin 6 Receptor Measurement','DB-NCIT'),('DBX-NCIT-C117838','C117838','Iron Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117839','C117839','Potassium Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117840','C117840','Gastric Lipase Measurement','DB-NCIT'),('DBX-NCIT-C117841','C117841','Pancreatic Lipase Measurement','DB-NCIT'),('DBX-NCIT-C117842','C117842','Lysosomal Acid Lipase Measurement','DB-NCIT'),('DBX-NCIT-C117843','C117843','Microfilaria Measurement','DB-NCIT'),('DBX-NCIT-C117844','C117844','Monoclonal Protein Spike Measurement','DB-NCIT'),('DBX-NCIT-C117845','C117845','Phosphorus Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117846','C117846','Progesterone Receptor Measurement','DB-NCIT'),('DBX-NCIT-C117847','C117847','Promyeloblasts Measurement','DB-NCIT'),('DBX-NCIT-C117848','C117848','Total Protein Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117849','C117849','Protozoa Measurement','DB-NCIT'),('DBX-NCIT-C117850','C117850','P-Selectin Measurement','DB-NCIT'),('DBX-NCIT-C117851','C117851','Parathyroid Hormone-related Protein Measurement','DB-NCIT'),('DBX-NCIT-C117852','C117852','Receptor Activator Nuclear KappaB Ligand Measurement','DB-NCIT'),('DBX-NCIT-C117853','C117853','Dimorphic Erythrocyte Population','DB-NCIT'),('DBX-NCIT-C117854','C117854','Total Reticulocyte Corpuscular Hemoglobin Content Measurement','DB-NCIT'),('DBX-NCIT-C117855','C117855','Reticulocyte Mean Corpuscular Hemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C117856','C117856','Sodium Urine Excretion Rate','DB-NCIT'),('DBX-NCIT-C117857','C117857','Sclerostin Measurement','DB-NCIT'),('DBX-NCIT-C117858','C117858','Strongyloides IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C117859','C117859','Terminal Deoxynucleotidyl Transferase Antigen Measurement','DB-NCIT'),('DBX-NCIT-C117860','C117860','Bioavailable Testosterone Measurement','DB-NCIT'),('DBX-NCIT-C117861','C117861','Transforming Growth Factor Beta 1 Measurement','DB-NCIT'),('DBX-NCIT-C117862','C117862','TNF-a Production Inhibitory Activity Measurement','DB-NCIT'),('DBX-NCIT-C117863','C117863','Soluble Tumor Necrosis Factor Receptor Type I Measurement','DB-NCIT'),('DBX-NCIT-C117864','C117864','Soluble Tumor Necrosis Factor Receptor Type II Measurement','DB-NCIT'),('DBX-NCIT-C117865','C117865','Tartrate-Resistant Acid Phosphatase 5b Measurement','DB-NCIT'),('DBX-NCIT-C117866','C117866','Urate to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C117867','C117867','Varicella Zoster Virus Antibody Measurement','DB-NCIT'),('DBX-NCIT-C117868','C117868','Ankle Mortise','DB-NCIT'),('DBX-NCIT-C117869','C117869','Paracaval Lymph Node','DB-NCIT'),('DBX-NCIT-C117870','C117870','Pericardial Lymph Node','DB-NCIT'),('DBX-NCIT-C117871','C117871','Porta Hepatis Lymph Node','DB-NCIT'),('DBX-NCIT-C117872','C117872','Portacaval Lymph Node','DB-NCIT'),('DBX-NCIT-C117873','C117873','Subcarinal Lymph Node','DB-NCIT'),('DBX-NCIT-C117874','C117874','Tibialis Anterior Muscle','DB-NCIT'),('DBX-NCIT-C117875','C117875','Tracheobronchial Tree','DB-NCIT'),('DBX-NCIT-C117876','C117876','Vastus Intermedius Muscle','DB-NCIT'),('DBX-NCIT-C117877','C117877','Early Treatment of Diabetic Retinopathy Study Eye Chart','DB-NCIT'),('DBX-NCIT-C117878','C117878','Pelli-Robson Contrast Sensitivity Eye Chart','DB-NCIT'),('DBX-NCIT-C117879','C117879','Peripheral Angiography','DB-NCIT'),('DBX-NCIT-C117880','C117880','Sloan Letter Eye Chart 1.25 Percent','DB-NCIT'),('DBX-NCIT-C117881','C117881','Sloan Letter Eye Chart 2.5 Percent','DB-NCIT'),('DBX-NCIT-C117883','C117883','Which Diagnostic Criteria Met','DB-NCIT'),('DBX-NCIT-C117884','C117884','Location of Disease Onset','DB-NCIT'),('DBX-NCIT-C117885','C117885','Focality of Disease Onset','DB-NCIT'),('DBX-NCIT-C117886','C117886','N145 Latency','DB-NCIT'),('DBX-NCIT-C117887','C117887','N75 to P100 Peak to Peak Amplitude','DB-NCIT'),('DBX-NCIT-C117888','C117888','P100 Latency','DB-NCIT'),('DBX-NCIT-C117889','C117889','Astigmatism Axis','DB-NCIT'),('DBX-NCIT-C117890','C117890','Log Score','DB-NCIT'),('DBX-NCIT-C117891','C117891','Number of Correct Eye Chart Letters','DB-NCIT'),('DBX-NCIT-C117892','C117892','Cylindrical Refractive Error','DB-NCIT'),('DBX-NCIT-C117893','C117893','Spherical Refractive Error','DB-NCIT'),('DBX-NCIT-C117894','C117894','Day Times Femtogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117895','C117895','Day Times Femtogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117896','C117896','Day Times gram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117897','C117897','Day Times gram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117898','C117898','Day Times Milligram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117899','C117899','Day Times Milligram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117900','C117900','Day Times Millimole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117901','C117901','Day Times Millimole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117902','C117902','Day Times mole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117903','C117903','Day Times mole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117904','C117904','Day Times Nanogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117905','C117905','Day Times Nanogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117906','C117906','Day Times Nanomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117907','C117907','Day Times Nanomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117908','C117908','Day Times Picogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117909','C117909','Day Times Picogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117910','C117910','Day Times Picomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117911','C117911','Day Times Picomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117912','C117912','Day Times Microgram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117913','C117913','Day Times Microgram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117914','C117914','Day Times Micromole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117915','C117915','Day Times Micromole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117916','C117916','Hour Times Femtogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117917','C117917','Hour Times Femtogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117918','C117918','Hour Times gram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117919','C117919','Hour Times gram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117920','C117920','Hour Times Milligram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117921','C117921','Hour Times Milligram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117922','C117922','Hour Times Millimole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117923','C117923','Hour Times Millimole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117924','C117924','Hour Times mole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117925','C117925','Hour Times mole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117926','C117926','Hour Times Nanogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117927','C117927','Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117928','C117928','Hour Times Nanomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117929','C117929','Hour Times Nanomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117930','C117930','Hour Times Picogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117931','C117931','Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117932','C117932','Hour Times Picomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117933','C117933','Hour Times Picomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117934','C117934','Hour Times Microgram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117935','C117935','Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117936','C117936','Hour Times Micromole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117937','C117937','Hour Times Micromole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117938','C117938','Minute Times Femtogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117939','C117939','Minute Times Femtogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117940','C117940','Minute Times gram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117941','C117941','Minute Times gram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117942','C117942','Minute Times Milligram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117943','C117943','Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117944','C117944','Minute Times Millimole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117945','C117945','Minute Times Millimole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117946','C117946','Minute Times mole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117947','C117947','Minute Times mole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117948','C117948','Minute Times Nanogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117949','C117949','Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117950','C117950','Minute Times Nanomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117951','C117951','Minute Times Nanomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117952','C117952','Minute Times Picogram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117953','C117953','Minute Times Picogram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117954','C117954','Minute Times Picomole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117955','C117955','Minute Times Picomole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117956','C117956','Minute Times Microgram Per Milliliter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117957','C117957','Minute Times Microgram Per Milliliter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117958','C117958','Minute Times Micromole Per Liter Per Milligram Per Gram','DB-NCIT'),('DBX-NCIT-C117959','C117959','Minute Times Micromole Per Liter Per Milligram Per Gram Per Day','DB-NCIT'),('DBX-NCIT-C117960','C117960','Diagnostic Criteria','DB-NCIT'),('DBX-NCIT-C117961','C117961','Relapse Criteria','DB-NCIT'),('DBX-NCIT-C117962','C117962','Severity Criteria','DB-NCIT'),('DBX-NCIT-C117963','C117963','Percent Inhibition','DB-NCIT'),('DBX-NCIT-C117964','C117964','Per Picoliter','DB-NCIT'),('DBX-NCIT-C117965','C117965','Immunoglobin A Phospholipid Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C117966','C117966','Bethesda Unit','DB-NCIT'),('DBX-NCIT-C117967','C117967','Bethesda Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C117968','C117968','Disintegration per Minute per 100 milligrams','DB-NCIT'),('DBX-NCIT-C117969','C117969','Disintegration per Minute per Milligram','DB-NCIT'),('DBX-NCIT-C117970','C117970','Disintegration per Minute per Milliliter','DB-NCIT'),('DBX-NCIT-C117971','C117971','Immunoglobin G Phospholipid Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C117972','C117972','Log10 Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C117973','C117973','Immunoglobin M Phospholipid Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C117974','C117974','Nanomole Bone Collagen Equivalent per Liter','DB-NCIT'),('DBX-NCIT-C117975','C117975','Microequivalent per Liter','DB-NCIT'),('DBX-NCIT-C117976','C117976','Ideal Body Weight','DB-NCIT'),('DBX-NCIT-C117977','C117977','Experimental Organism Benign Keratoacanthoma','DB-NCIT'),('DBX-NCIT-C117983','C117983','Oxalate to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C118137','C118137','Nanomole Bone Collagen Equivalent per Millimole','DB-NCIT'),('DBX-NCIT-C118164','C118164','P Wave Axis','DB-NCIT'),('DBX-NCIT-C118165','C118165','QRS Axis','DB-NCIT'),('DBX-NCIT-C118166','C118166','T Wave Axis','DB-NCIT'),('DBX-NCIT-C12220','C12220','Lip','DB-NCIT'),('DBX-NCIT-C12221','C12221','External Upper Lip','DB-NCIT'),('DBX-NCIT-C12222','C12222','External Lower Lip','DB-NCIT'),('DBX-NCIT-C12226','C12226','Mucosa of the Lip','DB-NCIT'),('DBX-NCIT-C12230','C12230','Hard Palate','DB-NCIT'),('DBX-NCIT-C12231','C12231','Soft Palate','DB-NCIT'),('DBX-NCIT-C12246','C12246','Hypopharynx','DB-NCIT'),('DBX-NCIT-C12250','C12250','Cervical Esophagus','DB-NCIT'),('DBX-NCIT-C12251','C12251','Thoracic Esophagus','DB-NCIT'),('DBX-NCIT-C12252','C12252','Abdominal Esophagus','DB-NCIT'),('DBX-NCIT-C12253','C12253','Upper Third of the Esophagus','DB-NCIT'),('DBX-NCIT-C12254','C12254','Middle Third of the Esophagus','DB-NCIT'),('DBX-NCIT-C12255','C12255','Lower Third of the Esophagus','DB-NCIT'),('DBX-NCIT-C12256','C12256','Gastric Cardia','DB-NCIT'),('DBX-NCIT-C12257','C12257','Fundus of the Stomach','DB-NCIT'),('DBX-NCIT-C12258','C12258','Body of Stomach','DB-NCIT'),('DBX-NCIT-C12259','C12259','Antrum Pylori','DB-NCIT'),('DBX-NCIT-C12262','C12262','Greater Curvature of the Stomach','DB-NCIT'),('DBX-NCIT-C12263','C12263','Duodenum','DB-NCIT'),('DBX-NCIT-C12265','C12265','Ascending Colon','DB-NCIT'),('DBX-NCIT-C12268','C12268','Descending Colon','DB-NCIT'),('DBX-NCIT-C12269','C12269','Head of the Pancreas','DB-NCIT'),('DBX-NCIT-C12270','C12270','Body of the Pancreas','DB-NCIT'),('DBX-NCIT-C12271','C12271','Tail of the Pancreas','DB-NCIT'),('DBX-NCIT-C12274','C12274','Middle Ear','DB-NCIT'),('DBX-NCIT-C12275','C12275','Maxillary Sinus','DB-NCIT'),('DBX-NCIT-C12276','C12276','Ethmoid Sinus','DB-NCIT'),('DBX-NCIT-C12277','C12277','Frontal Sinus','DB-NCIT'),('DBX-NCIT-C12280','C12280','Subglottis','DB-NCIT'),('DBX-NCIT-C12286','C12286','Middle Lobe of the Right Lung','DB-NCIT'),('DBX-NCIT-C12290','C12290','Mandible','DB-NCIT'),('DBX-NCIT-C12291','C12291','Skin of the Lip','DB-NCIT'),('DBX-NCIT-C12292','C12292','External Ear','DB-NCIT'),('DBX-NCIT-C12295','C12295','Skin of the Trunk','DB-NCIT'),('DBX-NCIT-C12298','C12298','Retroperitoneum','DB-NCIT'),('DBX-NCIT-C12299','C12299','Nipple','DB-NCIT'),('DBX-NCIT-C12308','C12308','Clitoris','DB-NCIT'),('DBX-NCIT-C12309','C12309','Endocervix','DB-NCIT'),('DBX-NCIT-C12311','C12311','Cervix Uteri','DB-NCIT'),('DBX-NCIT-C12314','C12314','Myometrium','DB-NCIT'),('DBX-NCIT-C12320','C12320','Parametrium','DB-NCIT'),('DBX-NCIT-C12328','C12328','Epididymis','DB-NCIT'),('DBX-NCIT-C12331','C12331','Bladder Trigone','DB-NCIT'),('DBX-NCIT-C12332','C12332','Dome of the Bladder','DB-NCIT'),('DBX-NCIT-C12336','C12336','Bladder Neck','DB-NCIT'),('DBX-NCIT-C12341','C12341','Conjunctiva','DB-NCIT'),('DBX-NCIT-C12342','C12342','Cornea','DB-NCIT'),('DBX-NCIT-C12343','C12343','Retina','DB-NCIT'),('DBX-NCIT-C12346','C12346','Lacrimal Gland','DB-NCIT'),('DBX-NCIT-C12347','C12347','Orbit','DB-NCIT'),('DBX-NCIT-C12351','C12351','Cerebral Hemisphere','DB-NCIT'),('DBX-NCIT-C12352','C12352','Frontal Lobe','DB-NCIT'),('DBX-NCIT-C12353','C12353','Temporal Lobe','DB-NCIT'),('DBX-NCIT-C12354','C12354','Parietal Lobe','DB-NCIT'),('DBX-NCIT-C12355','C12355','Occipital Lobe','DB-NCIT'),('DBX-NCIT-C12356','C12356','Brain Ventricle','DB-NCIT'),('DBX-NCIT-C12359','C12359','Intrathoracic Lymph Node','DB-NCIT'),('DBX-NCIT-C12360','C12360','Intra-Abdominal Lymph Node','DB-NCIT'),('DBX-NCIT-C12363','C12363','Pelvic Lymph Node','DB-NCIT'),('DBX-NCIT-C12366','C12366','Bone','DB-NCIT'),('DBX-NCIT-C12367','C12367','Mammary Gland','DB-NCIT'),('DBX-NCIT-C12371','C12371','Myocardium','DB-NCIT'),('DBX-NCIT-C12372','C12372','Artery','DB-NCIT'),('DBX-NCIT-C12376','C12376','Bile Duct','DB-NCIT'),('DBX-NCIT-C12377','C12377','Gallbladder','DB-NCIT'),('DBX-NCIT-C12378','C12378','Gastrointestinal System','DB-NCIT'),('DBX-NCIT-C12379','C12379','Large Intestine','DB-NCIT'),('DBX-NCIT-C12380','C12380','Appendix','DB-NCIT'),('DBX-NCIT-C12381','C12381','Cecum','DB-NCIT'),('DBX-NCIT-C12382','C12382','Colon','DB-NCIT'),('DBX-NCIT-C12383','C12383','Right Colon','DB-NCIT'),('DBX-NCIT-C12384','C12384','Sigmoid Colon','DB-NCIT'),('DBX-NCIT-C12385','C12385','Transverse Colon','DB-NCIT'),('DBX-NCIT-C12386','C12386','Small Intestine','DB-NCIT'),('DBX-NCIT-C12387','C12387','Ileum','DB-NCIT'),('DBX-NCIT-C12388','C12388','Jejunum','DB-NCIT'),('DBX-NCIT-C12389','C12389','Esophagus','DB-NCIT'),('DBX-NCIT-C12390','C12390','Rectum','DB-NCIT'),('DBX-NCIT-C12391','C12391','Stomach','DB-NCIT'),('DBX-NCIT-C12392','C12392','Liver','DB-NCIT'),('DBX-NCIT-C12393','C12393','Pancreas','DB-NCIT'),('DBX-NCIT-C12394','C12394','Ear','DB-NCIT'),('DBX-NCIT-C12398','C12398','Pineal Gland','DB-NCIT'),('DBX-NCIT-C12399','C12399','Pituitary Gland','DB-NCIT'),('DBX-NCIT-C12400','C12400','Thyroid Gland','DB-NCIT'),('DBX-NCIT-C12401','C12401','Eye','DB-NCIT'),('DBX-NCIT-C12402','C12402','Female Reproductive System','DB-NCIT'),('DBX-NCIT-C12403','C12403','Fallopian Tube','DB-NCIT'),('DBX-NCIT-C12404','C12404','Ovary','DB-NCIT'),('DBX-NCIT-C12405','C12405','Uterus','DB-NCIT'),('DBX-NCIT-C12407','C12407','Vagina','DB-NCIT'),('DBX-NCIT-C12408','C12408','Vulva','DB-NCIT'),('DBX-NCIT-C12409','C12409','Penis','DB-NCIT'),('DBX-NCIT-C12410','C12410','Prostate Gland','DB-NCIT'),('DBX-NCIT-C12412','C12412','Testis','DB-NCIT'),('DBX-NCIT-C12413','C12413','Urinary System','DB-NCIT'),('DBX-NCIT-C12414','C12414','Bladder','DB-NCIT'),('DBX-NCIT-C12415','C12415','Kidney','DB-NCIT'),('DBX-NCIT-C12416','C12416','Ureter','DB-NCIT'),('DBX-NCIT-C12417','C12417','Urethra','DB-NCIT'),('DBX-NCIT-C12418','C12418','Head and Neck','DB-NCIT'),('DBX-NCIT-C12419','C12419','Head','DB-NCIT'),('DBX-NCIT-C12420','C12420','Larynx','DB-NCIT'),('DBX-NCIT-C12421','C12421','Oral Cavity','DB-NCIT'),('DBX-NCIT-C12422','C12422','Tongue','DB-NCIT'),('DBX-NCIT-C12423','C12423','Nasopharynx','DB-NCIT'),('DBX-NCIT-C12424','C12424','Nasal Cavity','DB-NCIT'),('DBX-NCIT-C12425','C12425','Pharynx','DB-NCIT'),('DBX-NCIT-C12426','C12426','Salivary Gland','DB-NCIT'),('DBX-NCIT-C12427','C12427','Parotid Gland','DB-NCIT'),('DBX-NCIT-C12428','C12428','Trachea','DB-NCIT'),('DBX-NCIT-C12429','C12429','Limb','DB-NCIT'),('DBX-NCIT-C12431','C12431','Bone Marrow','DB-NCIT'),('DBX-NCIT-C12432','C12432','Spleen','DB-NCIT'),('DBX-NCIT-C12433','C12433','Thymus Gland','DB-NCIT'),('DBX-NCIT-C12434','C12434','Blood','DB-NCIT'),('DBX-NCIT-C12436','C12436','Striated Muscle Tissue','DB-NCIT'),('DBX-NCIT-C12437','C12437','Smooth Muscle Tissue','DB-NCIT'),('DBX-NCIT-C12438','C12438','Central Nervous System','DB-NCIT'),('DBX-NCIT-C12439','C12439','Brain','DB-NCIT'),('DBX-NCIT-C12440','C12440','Amygdala','DB-NCIT'),('DBX-NCIT-C12441','C12441','Brain Stem','DB-NCIT'),('DBX-NCIT-C12442','C12442','Medulla Oblongata','DB-NCIT'),('DBX-NCIT-C12443','C12443','Cerebral Cortex','DB-NCIT'),('DBX-NCIT-C12444','C12444','Hippocampus','DB-NCIT'),('DBX-NCIT-C12445','C12445','Cerebellum','DB-NCIT'),('DBX-NCIT-C12446','C12446','Corpus Callosum','DB-NCIT'),('DBX-NCIT-C12447','C12447','Basal Ganglia','DB-NCIT'),('DBX-NCIT-C12448','C12448','Corpus Striatum','DB-NCIT'),('DBX-NCIT-C12451','C12451','Caudate Nucleus','DB-NCIT'),('DBX-NCIT-C12452','C12452','Putamen','DB-NCIT'),('DBX-NCIT-C12453','C12453','Substantia Nigra','DB-NCIT'),('DBX-NCIT-C12458','C12458','Hypothalamus','DB-NCIT'),('DBX-NCIT-C12459','C12459','Thalamus','DB-NCIT'),('DBX-NCIT-C12464','C12464','Spinal Cord','DB-NCIT'),('DBX-NCIT-C12466','C12466','Nerve','DB-NCIT'),('DBX-NCIT-C12467','C12467','Sympathetic Ganglion','DB-NCIT'),('DBX-NCIT-C12468','C12468','Lung','DB-NCIT'),('DBX-NCIT-C12469','C12469','Pleura','DB-NCIT'),('DBX-NCIT-C12470','C12470','Skin','DB-NCIT'),('DBX-NCIT-C12471','C12471','Soft Tissue','DB-NCIT'),('DBX-NCIT-C12472','C12472','Adipose Tissue','DB-NCIT'),('DBX-NCIT-C12499','C12499','Inner Ear','DB-NCIT'),('DBX-NCIT-C12502','C12502','Tympanic Membrane','DB-NCIT'),('DBX-NCIT-C12503','C12503','Mastoid Process','DB-NCIT'),('DBX-NCIT-C12510','C12510','Mesencephalon','DB-NCIT'),('DBX-NCIT-C12511','C12511','Pons Varolii','DB-NCIT'),('DBX-NCIT-C12520','C12520','Platelet','DB-NCIT'),('DBX-NCIT-C12521','C12521','Erythrocyte','DB-NCIT'),('DBX-NCIT-C12608','C12608','Islet of Langerhans','DB-NCIT'),('DBX-NCIT-C12664','C12664','Abdomen','DB-NCIT'),('DBX-NCIT-C12665','C12665','Abducens Nerve','DB-NCIT'),('DBX-NCIT-C12666','C12666','Adrenal Gland','DB-NCIT'),('DBX-NCIT-C12667','C12667','Anterior Chamber of the Eye','DB-NCIT'),('DBX-NCIT-C12669','C12669','Aorta','DB-NCIT'),('DBX-NCIT-C12670','C12670','Aortic Valve','DB-NCIT'),('DBX-NCIT-C12671','C12671','Upper Extremity','DB-NCIT'),('DBX-NCIT-C12674','C12674','Axilla','DB-NCIT'),('DBX-NCIT-C12677','C12677','Intrahepatic Bile Duct','DB-NCIT'),('DBX-NCIT-C12678','C12678','Biliary Tract','DB-NCIT'),('DBX-NCIT-C12679','C12679','Blood Vessel','DB-NCIT'),('DBX-NCIT-C12681','C12681','Brachial Artery','DB-NCIT'),('DBX-NCIT-C12682','C12682','Brachial Plexus','DB-NCIT'),('DBX-NCIT-C12683','C12683','Bronchus','DB-NCIT'),('DBX-NCIT-C12687','C12687','Carotid Artery','DB-NCIT'),('DBX-NCIT-C12692','C12692','Cerebrospinal Fluid','DB-NCIT'),('DBX-NCIT-C12693','C12693','Cervical Vertebra','DB-NCIT'),('DBX-NCIT-C12694','C12694','Choroid Plexus','DB-NCIT'),('DBX-NCIT-C12695','C12695','Clavicle','DB-NCIT'),('DBX-NCIT-C12696','C12696','Coccyx','DB-NCIT'),('DBX-NCIT-C12700','C12700','Cranial Nerve','DB-NCIT'),('DBX-NCIT-C12702','C12702','Diaphragm','DB-NCIT'),('DBX-NCIT-C12709','C12709','Epiglottis','DB-NCIT'),('DBX-NCIT-C12711','C12711','Ethmoid Bone','DB-NCIT'),('DBX-NCIT-C12713','C12713','Eyelid','DB-NCIT'),('DBX-NCIT-C12714','C12714','Facial Nerve','DB-NCIT'),('DBX-NCIT-C12715','C12715','Femoral Artery','DB-NCIT'),('DBX-NCIT-C12716','C12716','Femoral Vein','DB-NCIT'),('DBX-NCIT-C12717','C12717','Femur','DB-NCIT'),('DBX-NCIT-C12718','C12718','Fibula','DB-NCIT'),('DBX-NCIT-C12719','C12719','Ganglion','DB-NCIT'),('DBX-NCIT-C12722','C12722','Male Reproductive System','DB-NCIT'),('DBX-NCIT-C12723','C12723','Glossopharyngeal Nerve','DB-NCIT'),('DBX-NCIT-C12724','C12724','Glottis','DB-NCIT'),('DBX-NCIT-C12726','C12726','Inguinal Region','DB-NCIT'),('DBX-NCIT-C12727','C12727','Heart','DB-NCIT'),('DBX-NCIT-C12728','C12728','Cardiac Atrium','DB-NCIT'),('DBX-NCIT-C12730','C12730','Cardiac Ventricle','DB-NCIT'),('DBX-NCIT-C12731','C12731','Humerus','DB-NCIT'),('DBX-NCIT-C12732','C12732','Hypoglossal Nerve','DB-NCIT'),('DBX-NCIT-C12736','C12736','Intestine','DB-NCIT'),('DBX-NCIT-C12738','C12738','Jugular Vein','DB-NCIT'),('DBX-NCIT-C12739','C12739','Renal Cortex','DB-NCIT'),('DBX-NCIT-C12740','C12740','Renal Medulla','DB-NCIT'),('DBX-NCIT-C12742','C12742','Lower Extremity','DB-NCIT'),('DBX-NCIT-C12743','C12743','Lens','DB-NCIT'),('DBX-NCIT-C12744','C12744','Lumbar Vertebra','DB-NCIT'),('DBX-NCIT-C12745','C12745','Lymph Node','DB-NCIT'),('DBX-NCIT-C12748','C12748','Mediastinum','DB-NCIT'),('DBX-NCIT-C12752','C12752','Metatarsal Bone','DB-NCIT'),('DBX-NCIT-C12756','C12756','Nose','DB-NCIT'),('DBX-NCIT-C12758','C12758','Oculomotor Nerve','DB-NCIT'),('DBX-NCIT-C12759','C12759','Olfactory Nerve','DB-NCIT'),('DBX-NCIT-C12760','C12760','Optic Disc','DB-NCIT'),('DBX-NCIT-C12761','C12761','Optic Nerve','DB-NCIT'),('DBX-NCIT-C12762','C12762','Oropharynx','DB-NCIT'),('DBX-NCIT-C12763','C12763','Paranasal Sinus','DB-NCIT'),('DBX-NCIT-C12765','C12765','Parathyroid Gland','DB-NCIT'),('DBX-NCIT-C12767','C12767','Pelvis','DB-NCIT'),('DBX-NCIT-C12768','C12768','Peripheral Nerve','DB-NCIT'),('DBX-NCIT-C12769','C12769','Peritoneal Cavity','DB-NCIT'),('DBX-NCIT-C12770','C12770','Peritoneum','DB-NCIT'),('DBX-NCIT-C12777','C12777','Radius Bone','DB-NCIT'),('DBX-NCIT-C12778','C12778','Renal Artery','DB-NCIT'),('DBX-NCIT-C12782','C12782','Rib','DB-NCIT'),('DBX-NCIT-C12783','C12783','Scapula','DB-NCIT'),('DBX-NCIT-C12784','C12784','Sclera','DB-NCIT'),('DBX-NCIT-C12785','C12785','Scrotum','DB-NCIT'),('DBX-NCIT-C12786','C12786','Lunate Bone','DB-NCIT'),('DBX-NCIT-C12787','C12787','Seminal Vesicle','DB-NCIT'),('DBX-NCIT-C12789','C12789','Skull','DB-NCIT'),('DBX-NCIT-C12793','C12793','Sternum','DB-NCIT'),('DBX-NCIT-C12794','C12794','Subclavian Vein','DB-NCIT'),('DBX-NCIT-C12796','C12796','Tarsal Bone','DB-NCIT'),('DBX-NCIT-C12797','C12797','Temporal Bone','DB-NCIT'),('DBX-NCIT-C12798','C12798','Thoracic Vertebra','DB-NCIT'),('DBX-NCIT-C12799','C12799','Thorax','DB-NCIT'),('DBX-NCIT-C12800','C12800','Tibia','DB-NCIT'),('DBX-NCIT-C12801','C12801','Tissue','DB-NCIT'),('DBX-NCIT-C12802','C12802','Tonsil','DB-NCIT'),('DBX-NCIT-C12806','C12806','Trigeminal Nerve','DB-NCIT'),('DBX-NCIT-C12808','C12808','Trochlear Nerve','DB-NCIT'),('DBX-NCIT-C12809','C12809','Ulna','DB-NCIT'),('DBX-NCIT-C12811','C12811','Uvea','DB-NCIT'),('DBX-NCIT-C12812','C12812','Vagus Nerve','DB-NCIT'),('DBX-NCIT-C12813','C12813','Vas Deferens','DB-NCIT'),('DBX-NCIT-C12814','C12814','Vein','DB-NCIT'),('DBX-NCIT-C12816','C12816','Superior Vena Cava','DB-NCIT'),('DBX-NCIT-C12817','C12817','Vena Cava','DB-NCIT'),('DBX-NCIT-C12822','C12822','Vocal Cord','DB-NCIT'),('DBX-NCIT-C12825','C12825','Anterior Tibial Artery','DB-NCIT'),('DBX-NCIT-C12826','C12826','Posterior Tibial Artery','DB-NCIT'),('DBX-NCIT-C12838','C12838','Radial Artery','DB-NCIT'),('DBX-NCIT-C12840','C12840','Pleural Cavity','DB-NCIT'),('DBX-NCIT-C12843','C12843','Coronary Artery','DB-NCIT'),('DBX-NCIT-C12853','C12853','Sacral Vertebra','DB-NCIT'),('DBX-NCIT-C12854','C12854','Scaphoid Bone','DB-NCIT'),('DBX-NCIT-C12855','C12855','Pisiform Bone','DB-NCIT'),('DBX-NCIT-C12856','C12856','Capitate Bone','DB-NCIT'),('DBX-NCIT-C12857','C12857','Trapezial Bone','DB-NCIT'),('DBX-NCIT-C12858','C12858','Triangular Bone','DB-NCIT'),('DBX-NCIT-C12859','C12859','Trapezoid Bone','DB-NCIT'),('DBX-NCIT-C12860','C12860','Hamate Bone','DB-NCIT'),('DBX-NCIT-C12870','C12870','Right Ventricle','DB-NCIT'),('DBX-NCIT-C12871','C12871','Left Ventricle','DB-NCIT'),('DBX-NCIT-C12872','C12872','Left Coronary Artery','DB-NCIT'),('DBX-NCIT-C12874','C12874','Circumflex Branch of the Left Coronary Artery','DB-NCIT'),('DBX-NCIT-C12875','C12875','Right Coronary Artery','DB-NCIT'),('DBX-NCIT-C12882','C12882','Coronary Vein','DB-NCIT'),('DBX-NCIT-C12903','C12903','Supraclavicular Lymph Node','DB-NCIT'),('DBX-NCIT-C12904','C12904','Axillary Lymph Node','DB-NCIT'),('DBX-NCIT-C12905','C12905','Thoracic Cavity','DB-NCIT'),('DBX-NCIT-C1292','C1292','Ribozyme','DB-NCIT'),('DBX-NCIT-C12934','C12934','Dorsal Motor Nucleus','DB-NCIT'),('DBX-NCIT-C12954','C12954','Peripheral Blood Mononuclear Cell','DB-NCIT'),('DBX-NCIT-C12971','C12971','Breast','DB-NCIT'),('DBX-NCIT-C12996','C12996','Vestibulocochlear Nerve','DB-NCIT'),('DBX-NCIT-C12998','C12998','Vertebral Column','DB-NCIT'),('DBX-NCIT-C13004','C13004','Endocardium','DB-NCIT'),('DBX-NCIT-C13005','C13005','Pericardium','DB-NCIT'),('DBX-NCIT-C13041','C13041','Body','DB-NCIT'),('DBX-NCIT-C13044','C13044','Joint','DB-NCIT'),('DBX-NCIT-C13046','C13046','Ligament','DB-NCIT'),('DBX-NCIT-C13050','C13050','Skeletal Muscle Tissue','DB-NCIT'),('DBX-NCIT-C13056','C13056','Muscle','DB-NCIT'),('DBX-NCIT-C13062','C13062','Back','DB-NCIT'),('DBX-NCIT-C13063','C13063','Neck','DB-NCIT'),('DBX-NCIT-C13070','C13070','Cheek','DB-NCIT'),('DBX-NCIT-C13071','C13071','Face','DB-NCIT'),('DBX-NCIT-C13092','C13092','Lateral Lobe of the Prostate','DB-NCIT'),('DBX-NCIT-C13093','C13093','Posterior Lobe of the Prostate','DB-NCIT'),('DBX-NCIT-C13094','C13094','Middle Lobe of the Prostate','DB-NCIT'),('DBX-NCIT-C13101','C13101','Prostatic Urethra','DB-NCIT'),('DBX-NCIT-C13108','C13108','Fascia','DB-NCIT'),('DBX-NCIT-C13164','C13164','Epicardium','DB-NCIT'),('DBX-NCIT-C13166','C13166','Mucosa','DB-NCIT'),('DBX-NCIT-C13188','C13188','Amniotic Fluid','DB-NCIT'),('DBX-NCIT-C13190','C13190','Aqueous Humor','DB-NCIT'),('DBX-NCIT-C13192','C13192','Bile','DB-NCIT'),('DBX-NCIT-C13233','C13233','Exudate','DB-NCIT'),('DBX-NCIT-C13234','C13234','Feces','DB-NCIT'),('DBX-NCIT-C13236','C13236','Body Fluid or Substance','DB-NCIT'),('DBX-NCIT-C13252','C13252','Lymph','DB-NCIT'),('DBX-NCIT-C13257','C13257','Breast Milk','DB-NCIT'),('DBX-NCIT-C13259','C13259','Mucus','DB-NCIT'),('DBX-NCIT-C13273','C13273','Lung Surfactant','DB-NCIT'),('DBX-NCIT-C13275','C13275','Saliva','DB-NCIT'),('DBX-NCIT-C13276','C13276','Sebum','DB-NCIT'),('DBX-NCIT-C13277','C13277','Semen','DB-NCIT'),('DBX-NCIT-C13278','C13278','Sputum','DB-NCIT'),('DBX-NCIT-C13280','C13280','Sweat','DB-NCIT'),('DBX-NCIT-C13283','C13283','Urine','DB-NCIT'),('DBX-NCIT-C13317','C13317','Hair Follicle','DB-NCIT'),('DBX-NCIT-C13323','C13323','Vitreous Humor','DB-NCIT'),('DBX-NCIT-C13325','C13325','Serum','DB-NCIT'),('DBX-NCIT-C13332','C13332','Bilateral','DB-NCIT'),('DBX-NCIT-C13356','C13356','Plasma','DB-NCIT'),('DBX-NCIT-C14157','C14157','Borderline','DB-NCIT'),('DBX-NCIT-C14165','C14165','Normal','DB-NCIT'),('DBX-NCIT-C14172','C14172','Benign','DB-NCIT'),('DBX-NCIT-C14179','C14179','Adenovirus','DB-NCIT'),('DBX-NCIT-C14187','C14187','Bacteria','DB-NCIT'),('DBX-NCIT-C14195','C14195','Cryptococcus neoformans','DB-NCIT'),('DBX-NCIT-C14196','C14196','Cytomegalovirus','DB-NCIT'),('DBX-NCIT-C14203','C14203','Enterovirus','DB-NCIT'),('DBX-NCIT-C14204','C14204','Epstein-Barr Virus','DB-NCIT'),('DBX-NCIT-C14206','C14206','Escherichia coli','DB-NCIT'),('DBX-NCIT-C14208','C14208','Flavivirus','DB-NCIT'),('DBX-NCIT-C14213','C14213','Hantavirus','DB-NCIT'),('DBX-NCIT-C14215','C14215','Hepatitis B Virus','DB-NCIT'),('DBX-NCIT-C14218','C14218','Human Herpesvirus 6','DB-NCIT'),('DBX-NCIT-C14220','C14220','Human Immunodeficiency Virus 1','DB-NCIT'),('DBX-NCIT-C14221','C14221','Human Immunodeficiency Virus 2','DB-NCIT'),('DBX-NCIT-C14223','C14223','HTLV-1','DB-NCIT'),('DBX-NCIT-C14224','C14224','HTLV-2','DB-NCIT'),('DBX-NCIT-C14226','C14226','Human Papillomavirus','DB-NCIT'),('DBX-NCIT-C14229','C14229','JC Virus','DB-NCIT'),('DBX-NCIT-C14237','C14237','Measles Virus','DB-NCIT'),('DBX-NCIT-C14254','C14254','Human Parainfluenza Virus 1','DB-NCIT'),('DBX-NCIT-C14259','C14259','Poliovirus','DB-NCIT'),('DBX-NCIT-C14260','C14260','Polyomavirus','DB-NCIT'),('DBX-NCIT-C14267','C14267','Human Respiratory Syncytial Virus','DB-NCIT'),('DBX-NCIT-C14271','C14271','Saccharomyces cerevisiae','DB-NCIT'),('DBX-NCIT-C14272','C14272','Serratia marcescens','DB-NCIT'),('DBX-NCIT-C14278','C14278','Streptomyces','DB-NCIT'),('DBX-NCIT-C14281','C14281','Vaccinia Virus','DB-NCIT'),('DBX-NCIT-C14289','C14289','Helicobacter pylori','DB-NCIT'),('DBX-NCIT-C14290','C14290','Lentivirus','DB-NCIT'),('DBX-NCIT-C14295','C14295','Hepatitis E Virus','DB-NCIT'),('DBX-NCIT-C14296','C14296','Helicobacter','DB-NCIT'),('DBX-NCIT-C14304','C14304','Calicivirus','DB-NCIT'),('DBX-NCIT-C14306','C14306','Arenavirus','DB-NCIT'),('DBX-NCIT-C14309','C14309','Morbillivirus','DB-NCIT'),('DBX-NCIT-C14310','C14310','Paramyxovirus','DB-NCIT'),('DBX-NCIT-C14311','C14311','Human Herpesvirus 1','DB-NCIT'),('DBX-NCIT-C14312','C14312','Hepatitis C Virus','DB-NCIT'),('DBX-NCIT-C14325','C14325','Hepatitis A Virus','DB-NCIT'),('DBX-NCIT-C14326','C14326','Rubulavirus','DB-NCIT'),('DBX-NCIT-C14327','C14327','Human Herpesvirus 8','DB-NCIT'),('DBX-NCIT-C14330','C14330','Helicobacter felis','DB-NCIT'),('DBX-NCIT-C14347','C14347','Deltaretrovirus','DB-NCIT'),('DBX-NCIT-C14378','C14378','Propionibacterium acnes','DB-NCIT'),('DBX-NCIT-C1505','C1505','Dietary Supplement','DB-NCIT'),('DBX-NCIT-C15184','C15184','Behavioral Intervention','DB-NCIT'),('DBX-NCIT-C15189','C15189','Biopsy','DB-NCIT'),('DBX-NCIT-C15215','C15215','Cryosurgery','DB-NCIT'),('DBX-NCIT-C15228','C15228','Double Blind Study','DB-NCIT'),('DBX-NCIT-C15232','C15232','Excision','DB-NCIT'),('DBX-NCIT-C15238','C15238','Gene Therapy','DB-NCIT'),('DBX-NCIT-C15246','C15246','Heart Transplantation','DB-NCIT'),('DBX-NCIT-C15262','C15262','Immunotherapy','DB-NCIT'),('DBX-NCIT-C15306','C15306','Primary Prevention','DB-NCIT'),('DBX-NCIT-C15313','C15313','Radiation Therapy','DB-NCIT'),('DBX-NCIT-C15320','C15320','Study Design','DB-NCIT'),('DBX-NCIT-C15350','C15350','Total-Body Irradiation','DB-NCIT'),('DBX-NCIT-C15359','C15359','Salvage Therapy','DB-NCIT'),('DBX-NCIT-C15383','C15383','Special Diet Therapy','DB-NCIT'),('DBX-NCIT-C15600','C15600','Phase I Trial','DB-NCIT'),('DBX-NCIT-C15601','C15601','Phase II Trial','DB-NCIT'),('DBX-NCIT-C15602','C15602','Phase III Trial','DB-NCIT'),('DBX-NCIT-C15603','C15603','Phase IV Trial','DB-NCIT'),('DBX-NCIT-C15609','C15609','Anastomosis','DB-NCIT'),('DBX-NCIT-C15693','C15693','Phase I/II Trial','DB-NCIT'),('DBX-NCIT-C15694','C15694','Phase II/III Trial','DB-NCIT'),('DBX-NCIT-C15712','C15712','Secondary Prevention','DB-NCIT'),('DBX-NCIT-C16032','C16032','Long-term Follow-up','DB-NCIT'),('DBX-NCIT-C16084','C16084','Observational Study','DB-NCIT'),('DBX-NCIT-C16153','C16153','Stratification Factors','DB-NCIT'),('DBX-NCIT-C16267','C16267','Afghanistan','DB-NCIT'),('DBX-NCIT-C16271','C16271','Albania','DB-NCIT'),('DBX-NCIT-C16274','C16274','Algeria','DB-NCIT'),('DBX-NCIT-C16277','C16277','Allele','DB-NCIT'),('DBX-NCIT-C16289','C16289','Andorra','DB-NCIT'),('DBX-NCIT-C16290','C16290','Angiogram','DB-NCIT'),('DBX-NCIT-C16292','C16292','Angola','DB-NCIT'),('DBX-NCIT-C16303','C16303','Antigua and Barbuda','DB-NCIT'),('DBX-NCIT-C16305','C16305','Argentina','DB-NCIT'),('DBX-NCIT-C16306','C16306','Armenia','DB-NCIT'),('DBX-NCIT-C16311','C16311','Australia','DB-NCIT'),('DBX-NCIT-C16312','C16312','Austria','DB-NCIT'),('DBX-NCIT-C16316','C16316','Azerbaijan','DB-NCIT'),('DBX-NCIT-C16321','C16321','Bahamas','DB-NCIT'),('DBX-NCIT-C16322','C16322','Bahrain','DB-NCIT'),('DBX-NCIT-C16323','C16323','Bangladesh','DB-NCIT'),('DBX-NCIT-C16324','C16324','Barbados','DB-NCIT'),('DBX-NCIT-C16329','C16329','Belgium','DB-NCIT'),('DBX-NCIT-C16331','C16331','Belize','DB-NCIT'),('DBX-NCIT-C16333','C16333','Benin','DB-NCIT'),('DBX-NCIT-C16334','C16334','Bermuda','DB-NCIT'),('DBX-NCIT-C16336','C16336','Bhutan','DB-NCIT'),('DBX-NCIT-C16352','C16352','African American','DB-NCIT'),('DBX-NCIT-C16357','C16357','Western Blotting','DB-NCIT'),('DBX-NCIT-C16358','C16358','Body Mass Index','DB-NCIT'),('DBX-NCIT-C16359','C16359','Bolivia, Plurinational State of','DB-NCIT'),('DBX-NCIT-C16361','C16361','Bosnia and Herzegovina','DB-NCIT'),('DBX-NCIT-C16363','C16363','Botswana','DB-NCIT'),('DBX-NCIT-C16364','C16364','Brazil','DB-NCIT'),('DBX-NCIT-C16365','C16365','British Indian Ocean Territory','DB-NCIT'),('DBX-NCIT-C16367','C16367','Brunei Darussalam','DB-NCIT'),('DBX-NCIT-C16368','C16368','Bulgaria','DB-NCIT'),('DBX-NCIT-C16369','C16369','Burkina Faso','DB-NCIT'),('DBX-NCIT-C16370','C16370','Myanmar','DB-NCIT'),('DBX-NCIT-C16371','C16371','Burundi','DB-NCIT'),('DBX-NCIT-C16372','C16372','Belarus','DB-NCIT'),('DBX-NCIT-C16378','C16378','Cambodia','DB-NCIT'),('DBX-NCIT-C16379','C16379','Cameroon','DB-NCIT'),('DBX-NCIT-C16380','C16380','Canada','DB-NCIT'),('DBX-NCIT-C16382','C16382','Cape Verde','DB-NCIT'),('DBX-NCIT-C16391','C16391','Cayman Islands','DB-NCIT'),('DBX-NCIT-C16409','C16409','Central African Republic','DB-NCIT'),('DBX-NCIT-C16412','C16412','Chad','DB-NCIT'),('DBX-NCIT-C16427','C16427','Chile','DB-NCIT'),('DBX-NCIT-C16428','C16428','China','DB-NCIT'),('DBX-NCIT-C16431','C16431','Chromatography','DB-NCIT'),('DBX-NCIT-C16434','C16434','High Performance Liquid Chromatography','DB-NCIT'),('DBX-NCIT-C16445','C16445','Cocos (Keeling) Islands','DB-NCIT'),('DBX-NCIT-C16449','C16449','Colombia','DB-NCIT'),('DBX-NCIT-C16458','C16458','Comoros','DB-NCIT'),('DBX-NCIT-C16467','C16467','Congo','DB-NCIT'),('DBX-NCIT-C16469','C16469','Cook Islands','DB-NCIT'),('DBX-NCIT-C16470','C16470','Costa Rica','DB-NCIT'),('DBX-NCIT-C16474','C16474','Croatia','DB-NCIT'),('DBX-NCIT-C16477','C16477','Cuba','DB-NCIT'),('DBX-NCIT-C16480','C16480','Cyprus','DB-NCIT'),('DBX-NCIT-C16496','C16496','Denmark','DB-NCIT'),('DBX-NCIT-C16506','C16506','Djibouti','DB-NCIT'),('DBX-NCIT-C16519','C16519','Dominica','DB-NCIT'),('DBX-NCIT-C16520','C16520','Dominican Republic','DB-NCIT'),('DBX-NCIT-C16525','C16525','Echocardiography','DB-NCIT'),('DBX-NCIT-C16528','C16528','Ecuador','DB-NCIT'),('DBX-NCIT-C16530','C16530','Egypt','DB-NCIT'),('DBX-NCIT-C16532','C16532','El Salvador','DB-NCIT'),('DBX-NCIT-C16536','C16536','Electrophoresis','DB-NCIT'),('DBX-NCIT-C16546','C16546','Endoscopic Procedure','DB-NCIT'),('DBX-NCIT-C16553','C16553','ELISA','DB-NCIT'),('DBX-NCIT-C16557','C16557','Equatorial Guinea','DB-NCIT'),('DBX-NCIT-C16558','C16558','Eritrea','DB-NCIT'),('DBX-NCIT-C16562','C16562','Estonia','DB-NCIT'),('DBX-NCIT-C16563','C16563','Ethiopia','DB-NCIT'),('DBX-NCIT-C16573','C16573','Faroe Islands','DB-NCIT'),('DBX-NCIT-C16576','C16576','Female','DB-NCIT'),('DBX-NCIT-C16582','C16582','Fiji','DB-NCIT'),('DBX-NCIT-C16584','C16584','Finland','DB-NCIT'),('DBX-NCIT-C16585','C16585','Flow Cytometry','DB-NCIT'),('DBX-NCIT-C16592','C16592','France','DB-NCIT'),('DBX-NCIT-C16593','C16593','French Guiana','DB-NCIT'),('DBX-NCIT-C16594','C16594','French Polynesia','DB-NCIT'),('DBX-NCIT-C16596','C16596','Gabon','DB-NCIT'),('DBX-NCIT-C16598','C16598','The Gambia','DB-NCIT'),('DBX-NCIT-C16634','C16634','Georgia (Republic)','DB-NCIT'),('DBX-NCIT-C16636','C16636','Germany','DB-NCIT'),('DBX-NCIT-C16638','C16638','Gibraltar','DB-NCIT'),('DBX-NCIT-C16639','C16639','Kiribati','DB-NCIT'),('DBX-NCIT-C16645','C16645','Greece','DB-NCIT'),('DBX-NCIT-C16646','C16646','Greenland','DB-NCIT'),('DBX-NCIT-C16647','C16647','Grenada','DB-NCIT'),('DBX-NCIT-C16651','C16651','Guadeloupe','DB-NCIT'),('DBX-NCIT-C16652','C16652','Guam','DB-NCIT'),('DBX-NCIT-C16654','C16654','Guatemala','DB-NCIT'),('DBX-NCIT-C16655','C16655','Guinea','DB-NCIT'),('DBX-NCIT-C16656','C16656','Guinea-Bissau','DB-NCIT'),('DBX-NCIT-C16657','C16657','Guyana','DB-NCIT'),('DBX-NCIT-C16660','C16660','Haiti','DB-NCIT'),('DBX-NCIT-C16694','C16694','Honduras','DB-NCIT'),('DBX-NCIT-C16695','C16695','Hong Kong','DB-NCIT'),('DBX-NCIT-C16699','C16699','Hungary','DB-NCIT'),('DBX-NCIT-C16704','C16704','Iceland','DB-NCIT'),('DBX-NCIT-C16714','C16714','Immunoenzyme Procedure','DB-NCIT'),('DBX-NCIT-C16724','C16724','Immunoprecipitation','DB-NCIT'),('DBX-NCIT-C16727','C16727','India','DB-NCIT'),('DBX-NCIT-C16728','C16728','Indonesia','DB-NCIT'),('DBX-NCIT-C16735','C16735','Informed Consent','DB-NCIT'),('DBX-NCIT-C16755','C16755','Iran, Islamic Republic of','DB-NCIT'),('DBX-NCIT-C16756','C16756','Iraq','DB-NCIT'),('DBX-NCIT-C16757','C16757','Ireland','DB-NCIT'),('DBX-NCIT-C16760','C16760','Israel','DB-NCIT'),('DBX-NCIT-C16761','C16761','Italy','DB-NCIT'),('DBX-NCIT-C16762','C16762','Cote d\'Ivoire','DB-NCIT'),('DBX-NCIT-C16763','C16763','Jamaica','DB-NCIT'),('DBX-NCIT-C16764','C16764','Japan','DB-NCIT'),('DBX-NCIT-C16765','C16765','Jordan','DB-NCIT'),('DBX-NCIT-C16768','C16768','Karyotyping','DB-NCIT'),('DBX-NCIT-C16769','C16769','Kenya','DB-NCIT'),('DBX-NCIT-C16771','C16771','Kyrgyzstan','DB-NCIT'),('DBX-NCIT-C16773','C16773','Korea, Democratic People\'s Republic of','DB-NCIT'),('DBX-NCIT-C16774','C16774','Korea, Republic of','DB-NCIT'),('DBX-NCIT-C16775','C16775','Kuwait','DB-NCIT'),('DBX-NCIT-C16780','C16780','Lao People\'s Democratic Republic','DB-NCIT'),('DBX-NCIT-C16783','C16783','Latvia','DB-NCIT'),('DBX-NCIT-C16784','C16784','Lebanon','DB-NCIT'),('DBX-NCIT-C16787','C16787','Lesotho','DB-NCIT'),('DBX-NCIT-C16790','C16790','Mixed Lymphocyte Reaction Test','DB-NCIT'),('DBX-NCIT-C16791','C16791','Liberia','DB-NCIT'),('DBX-NCIT-C16793','C16793','Libya','DB-NCIT'),('DBX-NCIT-C16794','C16794','Liechtenstein','DB-NCIT'),('DBX-NCIT-C16799','C16799','Lithuania','DB-NCIT'),('DBX-NCIT-C16803','C16803','Luxembourg','DB-NCIT'),('DBX-NCIT-C16807','C16807','Macau','DB-NCIT'),('DBX-NCIT-C16808','C16808','Madagascar','DB-NCIT'),('DBX-NCIT-C16809','C16809','Magnetic Resonance Imaging','DB-NCIT'),('DBX-NCIT-C16813','C16813','Malawi','DB-NCIT'),('DBX-NCIT-C16814','C16814','Malaysia','DB-NCIT'),('DBX-NCIT-C16815','C16815','Maldives','DB-NCIT'),('DBX-NCIT-C16816','C16816','Mali','DB-NCIT'),('DBX-NCIT-C16817','C16817','Malta','DB-NCIT'),('DBX-NCIT-C16818','C16818','Mammography','DB-NCIT'),('DBX-NCIT-C16822','C16822','Marshall Islands','DB-NCIT'),('DBX-NCIT-C16823','C16823','Martinique','DB-NCIT'),('DBX-NCIT-C16826','C16826','Mauritania','DB-NCIT'),('DBX-NCIT-C16827','C16827','Mauritius','DB-NCIT'),('DBX-NCIT-C16828','C16828','Mayotte','DB-NCIT'),('DBX-NCIT-C16830','C16830','Medical Device','DB-NCIT'),('DBX-NCIT-C16850','C16850','Mexico','DB-NCIT'),('DBX-NCIT-C16853','C16853','Microscopy','DB-NCIT'),('DBX-NCIT-C16855','C16855','Scanning Electron Microscopy','DB-NCIT'),('DBX-NCIT-C16856','C16856','Fluorescence Microscopy','DB-NCIT'),('DBX-NCIT-C16857','C16857','Phase-Contrast Microscopy','DB-NCIT'),('DBX-NCIT-C16871','C16871','Moldova, Republic of','DB-NCIT'),('DBX-NCIT-C16874','C16874','Monaco','DB-NCIT'),('DBX-NCIT-C16875','C16875','Mongolia','DB-NCIT'),('DBX-NCIT-C16876','C16876','Montserrat','DB-NCIT'),('DBX-NCIT-C16878','C16878','Morocco','DB-NCIT'),('DBX-NCIT-C16882','C16882','Mozambique','DB-NCIT'),('DBX-NCIT-C16891','C16891','Namibia','DB-NCIT'),('DBX-NCIT-C16896','C16896','Nauru','DB-NCIT'),('DBX-NCIT-C16901','C16901','Nepal','DB-NCIT'),('DBX-NCIT-C16903','C16903','Netherlands','DB-NCIT'),('DBX-NCIT-C16913','C16913','New Caledonia','DB-NCIT'),('DBX-NCIT-C16914','C16914','New Zealand','DB-NCIT'),('DBX-NCIT-C16915','C16915','Nicaragua','DB-NCIT'),('DBX-NCIT-C16916','C16916','Niger','DB-NCIT'),('DBX-NCIT-C16917','C16917','Nigeria','DB-NCIT'),('DBX-NCIT-C16918','C16918','Niue','DB-NCIT'),('DBX-NCIT-C16919','C16919','Norfolk Island','DB-NCIT'),('DBX-NCIT-C16920','C16920','Norway','DB-NCIT'),('DBX-NCIT-C16924','C16924','Nucleic Acid Hybridization','DB-NCIT'),('DBX-NCIT-C16933','C16933','Oman','DB-NCIT'),('DBX-NCIT-C16949','C16949','Pakistan','DB-NCIT'),('DBX-NCIT-C16950','C16950','Palpation','DB-NCIT'),('DBX-NCIT-C16951','C16951','Panama','DB-NCIT'),('DBX-NCIT-C16952','C16952','Papua New Guinea','DB-NCIT'),('DBX-NCIT-C16953','C16953','Paraguay','DB-NCIT'),('DBX-NCIT-C16955','C16955','Parity','DB-NCIT'),('DBX-NCIT-C16972','C16972','Peru','DB-NCIT'),('DBX-NCIT-C16978','C16978','Philippines','DB-NCIT'),('DBX-NCIT-C16993','C16993','Pitcairn','DB-NCIT'),('DBX-NCIT-C17002','C17002','Poland','DB-NCIT'),('DBX-NCIT-C17003','C17003','Polymerase Chain Reaction','DB-NCIT'),('DBX-NCIT-C17006','C17006','Portugal','DB-NCIT'),('DBX-NCIT-C17007','C17007','Positron Emission Tomography','DB-NCIT'),('DBX-NCIT-C17043','C17043','Puerto Rico','DB-NCIT'),('DBX-NCIT-C17045','C17045','Qatar','DB-NCIT'),('DBX-NCIT-C17057','C17057','Radioimmunoassay','DB-NCIT'),('DBX-NCIT-C17095','C17095','Reunion','DB-NCIT'),('DBX-NCIT-C17108','C17108','Romania','DB-NCIT'),('DBX-NCIT-C17111','C17111','Russian Federation','DB-NCIT'),('DBX-NCIT-C17112','C17112','Rwanda','DB-NCIT'),('DBX-NCIT-C17113','C17113','Saint Lucia','DB-NCIT'),('DBX-NCIT-C17114','C17114','Saint Vincent and the Grenadines','DB-NCIT'),('DBX-NCIT-C17115','C17115','San Marino','DB-NCIT'),('DBX-NCIT-C17116','C17116','Sao Tome and Principe','DB-NCIT'),('DBX-NCIT-C17117','C17117','Saudi Arabia','DB-NCIT'),('DBX-NCIT-C17118','C17118','School','DB-NCIT'),('DBX-NCIT-C17121','C17121','Senegal','DB-NCIT'),('DBX-NCIT-C17129','C17129','Seychelles','DB-NCIT'),('DBX-NCIT-C17130','C17130','Sierra Leone','DB-NCIT'),('DBX-NCIT-C17134','C17134','Singapore','DB-NCIT'),('DBX-NCIT-C17138','C17138','Slovenia','DB-NCIT'),('DBX-NCIT-C17148','C17148','Solomon Islands','DB-NCIT'),('DBX-NCIT-C17149','C17149','Somalia','DB-NCIT'),('DBX-NCIT-C17151','C17151','South Africa','DB-NCIT'),('DBX-NCIT-C17152','C17152','Spain','DB-NCIT'),('DBX-NCIT-C17156','C17156','Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C17163','C17163','Sri Lanka','DB-NCIT'),('DBX-NCIT-C17164','C17164','Saint Helena, Ascension and Tristan da Cunha','DB-NCIT'),('DBX-NCIT-C17165','C17165','Saint Pierre and Miquelon','DB-NCIT'),('DBX-NCIT-C17170','C17170','Sudan','DB-NCIT'),('DBX-NCIT-C17175','C17175','Suriname','DB-NCIT'),('DBX-NCIT-C17178','C17178','Svalbard and Jan Mayen','DB-NCIT'),('DBX-NCIT-C17179','C17179','Swaziland','DB-NCIT'),('DBX-NCIT-C17180','C17180','Sweden','DB-NCIT'),('DBX-NCIT-C17181','C17181','Switzerland','DB-NCIT'),('DBX-NCIT-C17182','C17182','Syrian Arab Republic','DB-NCIT'),('DBX-NCIT-C17183','C17183','Tajikistan','DB-NCIT'),('DBX-NCIT-C17184','C17184','Taiwan, Province of China','DB-NCIT'),('DBX-NCIT-C17185','C17185','Tanzania, United Republic of','DB-NCIT'),('DBX-NCIT-C17192','C17192','Thailand','DB-NCIT'),('DBX-NCIT-C17200','C17200','Timor-Leste','DB-NCIT'),('DBX-NCIT-C17202','C17202','Togo','DB-NCIT'),('DBX-NCIT-C17204','C17204','Computed Tomography','DB-NCIT'),('DBX-NCIT-C17205','C17205','Tonga','DB-NCIT'),('DBX-NCIT-C17217','C17217','Trinidad and Tobago','DB-NCIT'),('DBX-NCIT-C17221','C17221','Tunisia','DB-NCIT'),('DBX-NCIT-C17222','C17222','Turkey','DB-NCIT'),('DBX-NCIT-C17223','C17223','Turkmenistan','DB-NCIT'),('DBX-NCIT-C17224','C17224','Turks and Caicos Islands','DB-NCIT'),('DBX-NCIT-C17225','C17225','Tuvalu','DB-NCIT'),('DBX-NCIT-C17228','C17228','Uganda','DB-NCIT'),('DBX-NCIT-C17229','C17229','Ukraine','DB-NCIT'),('DBX-NCIT-C17230','C17230','Ultrasonography','DB-NCIT'),('DBX-NCIT-C17232','C17232','United Arab Emirates','DB-NCIT'),('DBX-NCIT-C17233','C17233','United Kingdom','DB-NCIT'),('DBX-NCIT-C17234','C17234','United States','DB-NCIT'),('DBX-NCIT-C17244','C17244','Uruguay','DB-NCIT'),('DBX-NCIT-C17246','C17246','Uzbekistan','DB-NCIT'),('DBX-NCIT-C17247','C17247','Vanuatu','DB-NCIT'),('DBX-NCIT-C17249','C17249','Holy See (Vatican City State)','DB-NCIT'),('DBX-NCIT-C17250','C17250','Venezuela, Bolivian Republic of','DB-NCIT'),('DBX-NCIT-C17252','C17252','Viet Nam','DB-NCIT'),('DBX-NCIT-C17255','C17255','Virgin Islands, U.S.','DB-NCIT'),('DBX-NCIT-C17259','C17259','Wallis and Futuna','DB-NCIT'),('DBX-NCIT-C17264','C17264','Yemen','DB-NCIT'),('DBX-NCIT-C17266','C17266','Congo, the Democratic Republic of the','DB-NCIT'),('DBX-NCIT-C17267','C17267','Zambia','DB-NCIT'),('DBX-NCIT-C17268','C17268','Zimbabwe','DB-NCIT'),('DBX-NCIT-C17370','C17370','Fluorescent Antibody Procedure','DB-NCIT'),('DBX-NCIT-C17423','C17423','Drug Delivery System','DB-NCIT'),('DBX-NCIT-C17445','C17445','Caregiver','DB-NCIT'),('DBX-NCIT-C17449','C17449','Antibiotic Resistance','DB-NCIT'),('DBX-NCIT-C17455','C17455','Enzyme Immunoassay','DB-NCIT'),('DBX-NCIT-C17459','C17459','Hispanic or Latino','DB-NCIT'),('DBX-NCIT-C17556','C17556','Worksite','DB-NCIT'),('DBX-NCIT-C17562','C17562','In Situ Hybridization','DB-NCIT'),('DBX-NCIT-C17563','C17563','Fluorescence In Situ Hybridization','DB-NCIT'),('DBX-NCIT-C17634','C17634','Prostate Specific Antigen Measurement','DB-NCIT'),('DBX-NCIT-C17638','C17638','Immunoblot Analysis','DB-NCIT'),('DBX-NCIT-C17649','C17649','Other','DB-NCIT'),('DBX-NCIT-C17653','C17653','Virgin Islands, British','DB-NCIT'),('DBX-NCIT-C17654','C17654','Macedonia, the Former Yugoslav Republic of','DB-NCIT'),('DBX-NCIT-C17668','C17668','Czech Republic','DB-NCIT'),('DBX-NCIT-C17669','C17669','Slovakia','DB-NCIT'),('DBX-NCIT-C17704','C17704','Tokelau','DB-NCIT'),('DBX-NCIT-C17721','C17721','Neurologist','DB-NCIT'),('DBX-NCIT-C17733','C17733','Palau','DB-NCIT'),('DBX-NCIT-C17739','C17739','American Samoa','DB-NCIT'),('DBX-NCIT-C17740','C17740','Samoa','DB-NCIT'),('DBX-NCIT-C17745','C17745','Multidrug Resistance Process','DB-NCIT'),('DBX-NCIT-C17821','C17821','Oncologist','DB-NCIT'),('DBX-NCIT-C17824','C17824','Radiologist','DB-NCIT'),('DBX-NCIT-C17881','C17881','Micronesia, Federated States of','DB-NCIT'),('DBX-NCIT-C17882','C17882','Northern Mariana Islands','DB-NCIT'),('DBX-NCIT-C17884','C17884','Aruba','DB-NCIT'),('DBX-NCIT-C17885','C17885','Saint Kitts and Nevis','DB-NCIT'),('DBX-NCIT-C17953','C17953','Education Level','DB-NCIT'),('DBX-NCIT-C17954','C17954','Falkland Islands (Malvinas)','DB-NCIT'),('DBX-NCIT-C17958','C17958','Functional Magnetic Resonance Imaging','DB-NCIT'),('DBX-NCIT-C17995','C17995','Light Microscopy','DB-NCIT'),('DBX-NCIT-C17998','C17998','Unknown','DB-NCIT'),('DBX-NCIT-C18007','C18007','Antarctica','DB-NCIT'),('DBX-NCIT-C18009','C18009','Tumor Tissue','DB-NCIT'),('DBX-NCIT-C18058','C18058','Partial Remission','DB-NCIT'),('DBX-NCIT-C18063','C18063','Gray','DB-NCIT'),('DBX-NCIT-C18064','C18064','Rad','DB-NCIT'),('DBX-NCIT-C18091','C18091','Gel Electrophoresis','DB-NCIT'),('DBX-NCIT-C18136','C18136','Reverse Transcriptase-Polymerase Chain Reaction','DB-NCIT'),('DBX-NCIT-C18158','C18158','DNA Microarray Chip','DB-NCIT'),('DBX-NCIT-C18213','C18213','Stable Disease','DB-NCIT'),('DBX-NCIT-C18216','C18216','Transmission Electron Microscopy','DB-NCIT'),('DBX-NCIT-C18475','C18475','Liquid Chromatography Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C18881','C18881','Nucleic Acid Sequencing','DB-NCIT'),('DBX-NCIT-C1909','C1909','Pharmacologic Substance','DB-NCIT'),('DBX-NCIT-C19263','C19263','Laser Capture Microdissection','DB-NCIT'),('DBX-NCIT-C19340','C19340','Reflectance or Transmission Spectroscopy','DB-NCIT'),('DBX-NCIT-C19597','C19597','Paraffin Embedded Tissue','DB-NCIT'),('DBX-NCIT-C19666','C19666','Age at Menarche','DB-NCIT'),('DBX-NCIT-C19811','C19811','Second Degree Relative','DB-NCIT'),('DBX-NCIT-C19935','C19935','Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C20055','C20055','Nucleic Acid Amplification Test','DB-NCIT'),('DBX-NCIT-C20059','C20059','Light-Scattering Spectroscopy','DB-NCIT'),('DBX-NCIT-C20080','C20080','Angiography','DB-NCIT'),('DBX-NCIT-C20104','C20104','Bouvet Island','DB-NCIT'),('DBX-NCIT-C20105','C20105','French Southern and Antarctic Lands','DB-NCIT'),('DBX-NCIT-C20106','C20106','Heard Island and McDonald Islands','DB-NCIT'),('DBX-NCIT-C20107','C20107','Kazakhstan','DB-NCIT'),('DBX-NCIT-C20110','C20110','Palestinian Territory, Occupied','DB-NCIT'),('DBX-NCIT-C20111','C20111','South Georgia and the South Sandwich Islands','DB-NCIT'),('DBX-NCIT-C20112','C20112','United States Minor Outlying Islands','DB-NCIT'),('DBX-NCIT-C20113','C20113','Western Sahara','DB-NCIT'),('DBX-NCIT-C20133','C20133','Anguilla','DB-NCIT'),('DBX-NCIT-C20197','C20197','Male','DB-NCIT'),('DBX-NCIT-C20645','C20645','Spiral CT','DB-NCIT'),('DBX-NCIT-C20821','C20821','Nurse','DB-NCIT'),('DBX-NCIT-C20828','C20828','Optical Coherence Tomography','DB-NCIT'),('DBX-NCIT-C20985','C20985','Ablation Therapy','DB-NCIT'),('DBX-NCIT-C20989','C20989','Physical Examination','DB-NCIT'),('DBX-NCIT-C21481','C21481','First Degree Relative','DB-NCIT'),('DBX-NCIT-C21541','C21541','Healthcare Facility','DB-NCIT'),('DBX-NCIT-C2191','C2191','Small Interfering RNA','DB-NCIT'),('DBX-NCIT-C23011','C23011','Hematoxylin and Eosin Staining Method','DB-NCIT'),('DBX-NCIT-C23012','C23012','Trichrome Staining Method','DB-NCIT'),('DBX-NCIT-C23014','C23014','Gram Staining Method','DB-NCIT'),('DBX-NCIT-C23015','C23015','Acid Fast Bacillae Staining Method','DB-NCIT'),('DBX-NCIT-C23019','C23019','Periodic Acid Schiff Staining Method','DB-NCIT'),('DBX-NCIT-C23020','C23020','Immunohistochemistry Staining Method','DB-NCIT'),('DBX-NCIT-C23041','C23041','Wright-Giemsa Staining Method','DB-NCIT'),('DBX-NCIT-C25157','C25157','Body Surface Area','DB-NCIT'),('DBX-NCIT-C25158','C25158','Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C25168','C25168','Tissue Donor','DB-NCIT'),('DBX-NCIT-C25177','C25177','Genitalia','DB-NCIT'),('DBX-NCIT-C25188','C25188','Marital Status','DB-NCIT'),('DBX-NCIT-C25193','C25193','Occupation','DB-NCIT'),('DBX-NCIT-C25196','C25196','Randomization','DB-NCIT'),('DBX-NCIT-C25203','C25203','Shoulder','DB-NCIT'),('DBX-NCIT-C25206','C25206','Temperature','DB-NCIT'),('DBX-NCIT-C25208','C25208','Weight','DB-NCIT'),('DBX-NCIT-C25228','C25228','Right','DB-NCIT'),('DBX-NCIT-C25229','C25229','Left','DB-NCIT'),('DBX-NCIT-C25230','C25230','Lateral','DB-NCIT'),('DBX-NCIT-C25231','C25231','Anterior','DB-NCIT'),('DBX-NCIT-C25232','C25232','Medial','DB-NCIT'),('DBX-NCIT-C25233','C25233','Peripheral','DB-NCIT'),('DBX-NCIT-C25235','C25235','Superior','DB-NCIT'),('DBX-NCIT-C25236','C25236','Proximal','DB-NCIT'),('DBX-NCIT-C25237','C25237','Distal','DB-NCIT'),('DBX-NCIT-C25239','C25239','Superficial','DB-NCIT'),('DBX-NCIT-C25240','C25240','Deep','DB-NCIT'),('DBX-NCIT-C25244','C25244','Area','DB-NCIT'),('DBX-NCIT-C25245','C25245','Surface','DB-NCIT'),('DBX-NCIT-C25250','C25250','Complete','DB-NCIT'),('DBX-NCIT-C25285','C25285','Diameter','DB-NCIT'),('DBX-NCIT-C25298','C25298','Systolic Blood Pressure','DB-NCIT'),('DBX-NCIT-C25299','C25299','Diastolic Blood Pressure','DB-NCIT'),('DBX-NCIT-C25300','C25300','Microbial Culture Procedure','DB-NCIT'),('DBX-NCIT-C25301','C25301','Day','DB-NCIT'),('DBX-NCIT-C25307','C25307','Contralateral','DB-NCIT'),('DBX-NCIT-C25308','C25308','Ipsilateral','DB-NCIT'),('DBX-NCIT-C25309','C25309','Lower','DB-NCIT'),('DBX-NCIT-C25326','C25326','Whole','DB-NCIT'),('DBX-NCIT-C25333','C25333','Depth','DB-NCIT'),('DBX-NCIT-C25334','C25334','Length','DB-NCIT'),('DBX-NCIT-C25335','C25335','Volume','DB-NCIT'),('DBX-NCIT-C25345','C25345','Width','DB-NCIT'),('DBX-NCIT-C25347','C25347','Height','DB-NCIT'),('DBX-NCIT-C25353','C25353','Inferior','DB-NCIT'),('DBX-NCIT-C25355','C25355','Upper','DB-NCIT'),('DBX-NCIT-C25365','C25365','Description','DB-NCIT'),('DBX-NCIT-C25370','C25370','Exclusion Criteria','DB-NCIT'),('DBX-NCIT-C25376','C25376','Small','DB-NCIT'),('DBX-NCIT-C25377','C25377','Appearance','DB-NCIT'),('DBX-NCIT-C25378','C25378','Partial','DB-NCIT'),('DBX-NCIT-C25389','C25389','Chest','DB-NCIT'),('DBX-NCIT-C25392','C25392','Manufacturer','DB-NCIT'),('DBX-NCIT-C25394','C25394','Pill Dosage Form','DB-NCIT'),('DBX-NCIT-C25397','C25397','Application Unit','DB-NCIT'),('DBX-NCIT-C25401','C25401','Abnormal','DB-NCIT'),('DBX-NCIT-C25423','C25423','Apical','DB-NCIT'),('DBX-NCIT-C25445','C25445','Center','DB-NCIT'),('DBX-NCIT-C25456','C25456','Concurrent','DB-NCIT'),('DBX-NCIT-C25465','C25465','Clinical Research Associate','DB-NCIT'),('DBX-NCIT-C25471','C25471','Current','DB-NCIT'),('DBX-NCIT-C25473','C25473','Daily','DB-NCIT'),('DBX-NCIT-C25488','C25488','Dose','DB-NCIT'),('DBX-NCIT-C25490','C25490','During','DB-NCIT'),('DBX-NCIT-C25529','C25529','Hour','DB-NCIT'),('DBX-NCIT-C25532','C25532','Inclusion Criteria','DB-NCIT'),('DBX-NCIT-C25586','C25586','New','DB-NCIT'),('DBX-NCIT-C25598','C25598','Observation','DB-NCIT'),('DBX-NCIT-C25613','C25613','Percentage','DB-NCIT'),('DBX-NCIT-C25622','C25622','Posterior','DB-NCIT'),('DBX-NCIT-C25627','C25627','Previous','DB-NCIT'),('DBX-NCIT-C25629','C25629','Prior','DB-NCIT'),('DBX-NCIT-C25639','C25639','Receive','DB-NCIT'),('DBX-NCIT-C25677','C25677','Shape','DB-NCIT'),('DBX-NCIT-C25681','C25681','Size','DB-NCIT'),('DBX-NCIT-C25724','C25724','Hilar','DB-NCIT'),('DBX-NCIT-C25742','C25742','Pregnancy','DB-NCIT'),('DBX-NCIT-C25746','C25746','Recovery','DB-NCIT'),('DBX-NCIT-C25747','C25747','Creatinine Clearance','DB-NCIT'),('DBX-NCIT-C25757','C25757','Ulceration','DB-NCIT'),('DBX-NCIT-C25936','C25936','Investigator','DB-NCIT'),('DBX-NCIT-C25966','C25966','MicroRNA','DB-NCIT'),('DBX-NCIT-C25967','C25967','Pri-miRNA','DB-NCIT'),('DBX-NCIT-C26330','C26330','Ghana','DB-NCIT'),('DBX-NCIT-C26465','C26465','Corpus Luteum','DB-NCIT'),('DBX-NCIT-C26470','C26470','Maxilla','DB-NCIT'),('DBX-NCIT-C26712','C26712','Mucinous Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C26726','C26726','Infectious Disorder','DB-NCIT'),('DBX-NCIT-C27004','C27004','Sarcomatoid Carcinoma','DB-NCIT'),('DBX-NCIT-C27093','C27093','Stage 0 Squamous Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C27096','C27096','Undifferentiated (Embryonal) Sarcoma','DB-NCIT'),('DBX-NCIT-C27132','C27132','Trichoblastoma','DB-NCIT'),('DBX-NCIT-C27349','C27349','Histiocytic Sarcoma','DB-NCIT'),('DBX-NCIT-C27477','C27477','Benign Giant Cell Tumor of Bone','DB-NCIT'),('DBX-NCIT-C27520','C27520','Benign Hair Follicle Neoplasm','DB-NCIT'),('DBX-NCIT-C27958','C27958','Nasal','DB-NCIT'),('DBX-NCIT-C28161','C28161','Intramuscular Route of Administration','DB-NCIT'),('DBX-NCIT-C28165','C28165','Klebsiella','DB-NCIT'),('DBX-NCIT-C28233','C28233','Single Blind Study','DB-NCIT'),('DBX-NCIT-C28251','C28251','Millimeter','DB-NCIT'),('DBX-NCIT-C28252','C28252','Kilogram','DB-NCIT'),('DBX-NCIT-C28253','C28253','Milligram','DB-NCIT'),('DBX-NCIT-C28254','C28254','Milliliter','DB-NCIT'),('DBX-NCIT-C28401','C28401','Olfactory Bulb','DB-NCIT'),('DBX-NCIT-C28407','C28407','National Origin','DB-NCIT'),('DBX-NCIT-C28408','C28408','Quantitative Reverse Transcriptase PCR','DB-NCIT'),('DBX-NCIT-C28454','C28454','hnRNA','DB-NCIT'),('DBX-NCIT-C28512','C28512','Mitochondrial DNA','DB-NCIT'),('DBX-NCIT-C2852','C2852','Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C2853','C2853','Papillary Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C2855','C2855','Adenoma','DB-NCIT'),('DBX-NCIT-C28554','C28554','Death','DB-NCIT'),('DBX-NCIT-C2858','C2858','Adrenal Cortex Neoplasm','DB-NCIT'),('DBX-NCIT-C28747','C28747','Reader','DB-NCIT'),('DBX-NCIT-C28944','C28944','Cream Dosage Form','DB-NCIT'),('DBX-NCIT-C2915','C2915','Carcinoid Tumor','DB-NCIT'),('DBX-NCIT-C2916','C2916','Carcinoma','DB-NCIT'),('DBX-NCIT-C29167','C29167','Lotion Dosage Form','DB-NCIT'),('DBX-NCIT-C2917','C2917','Carcinoma In Situ','DB-NCIT'),('DBX-NCIT-C2922','C2922','Skin Basosquamous Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C2923','C2923','Bronchioloalveolar Carcinoma','DB-NCIT'),('DBX-NCIT-C29269','C29269','Mouthwash Dosage Form','DB-NCIT'),('DBX-NCIT-C2928','C2928','Scirrhous Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C2929','C2929','Squamous Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C2930','C2930','Transitional Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C2932','C2932','Carotid Body Paraganglioma','DB-NCIT'),('DBX-NCIT-C2942','C2942','Bile Duct Adenoma','DB-NCIT'),('DBX-NCIT-C2946','C2946','Chondrosarcoma','DB-NCIT'),('DBX-NCIT-C2947','C2947','Chordoma','DB-NCIT'),('DBX-NCIT-C2948','C2948','Choriocarcinoma','DB-NCIT'),('DBX-NCIT-C2964','C2964','Craniopharyngioma','DB-NCIT'),('DBX-NCIT-C2971','C2971','Cystadenocarcinoma','DB-NCIT'),('DBX-NCIT-C2972','C2972','Cystadenoma','DB-NCIT'),('DBX-NCIT-C2973','C2973','Mucinous Cystadenoma','DB-NCIT'),('DBX-NCIT-C2974','C2974','Papillary Cystadenoma','DB-NCIT'),('DBX-NCIT-C29844','C29844','Week','DB-NCIT'),('DBX-NCIT-C29846','C29846','Month','DB-NCIT'),('DBX-NCIT-C29848','C29848','Year','DB-NCIT'),('DBX-NCIT-C29934','C29934','Magnetic Resonance Spectroscopic Imaging','DB-NCIT'),('DBX-NCIT-C2996','C2996','Dysgerminoma','DB-NCIT'),('DBX-NCIT-C3011','C3011','Yolk Sac Tumor','DB-NCIT'),('DBX-NCIT-C3017','C3017','Ependymoma','DB-NCIT'),('DBX-NCIT-C3041','C3041','Fibroma','DB-NCIT'),('DBX-NCIT-C3043','C3043','Fibrosarcoma','DB-NCIT'),('DBX-NCIT-C3049','C3049','Ganglioneuroma','DB-NCIT'),('DBX-NCIT-C3055','C3055','Giant Cell Tumor','DB-NCIT'),('DBX-NCIT-C3059','C3059','Glioma','DB-NCIT'),('DBX-NCIT-C307','C307','Biological Agent','DB-NCIT'),('DBX-NCIT-C3070','C3070','Granulosa Cell Tumor','DB-NCIT'),('DBX-NCIT-C3085','C3085','Hemangioma','DB-NCIT'),('DBX-NCIT-C3087','C3087','Hemangiopericytoma','DB-NCIT'),('DBX-NCIT-C3088','C3088','Angiosarcoma','DB-NCIT'),('DBX-NCIT-C3099','C3099','Hepatocellular Carcinoma','DB-NCIT'),('DBX-NCIT-C3146','C3146','Keratoacanthoma','DB-NCIT'),('DBX-NCIT-C3157','C3157','Leiomyoma','DB-NCIT'),('DBX-NCIT-C3158','C3158','Leiomyosarcoma','DB-NCIT'),('DBX-NCIT-C3161','C3161','Leukemia','DB-NCIT'),('DBX-NCIT-C3167','C3167','Acute Lymphoblastic Leukemia','DB-NCIT'),('DBX-NCIT-C3170','C3170','Acute Megakaryoblastic Leukemia','DB-NCIT'),('DBX-NCIT-C3172','C3172','Myeloid Leukemia','DB-NCIT'),('DBX-NCIT-C3188','C3188','Leydig Cell Tumor','DB-NCIT'),('DBX-NCIT-C3192','C3192','Lipoma','DB-NCIT'),('DBX-NCIT-C3194','C3194','Liposarcoma','DB-NCIT'),('DBX-NCIT-C3202','C3202','Ovarian Stromal Luteoma','DB-NCIT'),('DBX-NCIT-C32041','C32041','Accessory Nerve','DB-NCIT'),('DBX-NCIT-C32042','C32042','Acetabulum','DB-NCIT'),('DBX-NCIT-C32043','C32043','Achilles Tendon','DB-NCIT'),('DBX-NCIT-C32047','C32047','Acromioclavicular Joint','DB-NCIT'),('DBX-NCIT-C32048','C32048','Acromion','DB-NCIT'),('DBX-NCIT-C3205','C3205','Lymphangiosarcoma','DB-NCIT'),('DBX-NCIT-C32078','C32078','Ankle Joint','DB-NCIT'),('DBX-NCIT-C3208','C3208','Lymphoma','DB-NCIT'),('DBX-NCIT-C32089','C32089','Anterior Descending Coronary Artery','DB-NCIT'),('DBX-NCIT-C3209','C3209','Follicular Lymphoma','DB-NCIT'),('DBX-NCIT-C32098','C32098','Anterior Mediastinum','DB-NCIT'),('DBX-NCIT-C3212','C3212','Lymphoplasmacytic Lymphoma','DB-NCIT'),('DBX-NCIT-C32123','C32123','Aortic Arch','DB-NCIT'),('DBX-NCIT-C32126','C32126','Apex of the Heart','DB-NCIT'),('DBX-NCIT-C32141','C32141','Arm','DB-NCIT'),('DBX-NCIT-C32169','C32169','Axillary Artery','DB-NCIT'),('DBX-NCIT-C3217','C3217','Benign Mastocytoma','DB-NCIT'),('DBX-NCIT-C32171','C32171','Axillary Vein','DB-NCIT'),('DBX-NCIT-C32172','C32172','Axial Skeleton','DB-NCIT'),('DBX-NCIT-C32197','C32197','Basilic Vein','DB-NCIT'),('DBX-NCIT-C3222','C3222','Medulloblastoma','DB-NCIT'),('DBX-NCIT-C32239','C32239','C1 Vertebra','DB-NCIT'),('DBX-NCIT-C3224','C3224','Melanoma','DB-NCIT'),('DBX-NCIT-C32240','C32240','C2 Vertebra','DB-NCIT'),('DBX-NCIT-C32241','C32241','C3 Vertebra','DB-NCIT'),('DBX-NCIT-C32242','C32242','C4 Vertebra','DB-NCIT'),('DBX-NCIT-C32243','C32243','C5 Vertebra','DB-NCIT'),('DBX-NCIT-C32244','C32244','C6 Vertebra','DB-NCIT'),('DBX-NCIT-C32245','C32245','C7 Vertebra','DB-NCIT'),('DBX-NCIT-C32252','C32252','Calcarine Sulcus','DB-NCIT'),('DBX-NCIT-C32258','C32258','Canine Tooth','DB-NCIT'),('DBX-NCIT-C32286','C32286','Cephalic Vein','DB-NCIT'),('DBX-NCIT-C32293','C32293','Cerumen','DB-NCIT'),('DBX-NCIT-C32298','C32298','Cervical Lymph Node','DB-NCIT'),('DBX-NCIT-C3230','C3230','Meningioma','DB-NCIT'),('DBX-NCIT-C32334','C32334','Coccygeal Vertebra','DB-NCIT'),('DBX-NCIT-C3234','C3234','Mesothelioma','DB-NCIT'),('DBX-NCIT-C32348','C32348','Human Colostrum','DB-NCIT'),('DBX-NCIT-C32354','C32354','Common Femoral Artery','DB-NCIT'),('DBX-NCIT-C32357','C32357','Common Iliac Artery','DB-NCIT'),('DBX-NCIT-C32378','C32378','Coronary Sinus','DB-NCIT'),('DBX-NCIT-C32391','C32391','Costal Cartilage','DB-NCIT'),('DBX-NCIT-C324','C324','cDNA','DB-NCIT'),('DBX-NCIT-C32414','C32414','Cuboid Bone','DB-NCIT'),('DBX-NCIT-C3242','C3242','Plasma Cell Myeloma','DB-NCIT'),('DBX-NCIT-C32436','C32436','Deep Femoral Artery','DB-NCIT'),('DBX-NCIT-C32478','C32478','Dorsalis Pedis Artery','DB-NCIT'),('DBX-NCIT-C32497','C32497','Elbow Joint','DB-NCIT'),('DBX-NCIT-C32514','C32514','Endometrial Cavity','DB-NCIT'),('DBX-NCIT-C3252','C3252','Benign Granular Cell Tumor','DB-NCIT'),('DBX-NCIT-C32546','C32546','Exocrine Pancreas','DB-NCIT'),('DBX-NCIT-C3255','C3255','Myxosarcoma','DB-NCIT'),('DBX-NCIT-C32558','C32558','External Iliac Artery','DB-NCIT'),('DBX-NCIT-C32573','C32573','Extrahepatic Bile Duct','DB-NCIT'),('DBX-NCIT-C32576','C32576','Eyelash','DB-NCIT'),('DBX-NCIT-C32577','C32577','Facet Joint','DB-NCIT'),('DBX-NCIT-C32608','C32608','Finger','DB-NCIT'),('DBX-NCIT-C32609','C32609','Fingernail','DB-NCIT'),('DBX-NCIT-C3262','C3262','Neoplasm','DB-NCIT'),('DBX-NCIT-C32622','C32622','Foot','DB-NCIT'),('DBX-NCIT-C32628','C32628','Forearm','DB-NCIT'),('DBX-NCIT-C32668','C32668','Gastroesophageal Junction','DB-NCIT'),('DBX-NCIT-C32677','C32677','Gingiva','DB-NCIT'),('DBX-NCIT-C32682','C32682','Glenoid Fossa','DB-NCIT'),('DBX-NCIT-C3269','C3269','Schwannoma','DB-NCIT'),('DBX-NCIT-C32698','C32698','Great Trochanter','DB-NCIT'),('DBX-NCIT-C3270','C3270','Neuroblastoma','DB-NCIT'),('DBX-NCIT-C32705','C32705','Hair','DB-NCIT'),('DBX-NCIT-C32706','C32706','Hair Bulb','DB-NCIT'),('DBX-NCIT-C32711','C32711','Hair Root','DB-NCIT'),('DBX-NCIT-C32712','C32712','Hand','DB-NCIT'),('DBX-NCIT-C32718','C32718','Head of the Femur','DB-NCIT'),('DBX-NCIT-C3272','C3272','Neurofibroma','DB-NCIT'),('DBX-NCIT-C32720','C32720','Head of the Humerus','DB-NCIT'),('DBX-NCIT-C32740','C32740','Hilar Area of the Kidney','DB-NCIT'),('DBX-NCIT-C32742','C32742','Hip Joint','DB-NCIT'),('DBX-NCIT-C32752','C32752','Hyoid Bone','DB-NCIT'),('DBX-NCIT-C32761','C32761','Iliac Lymph Node','DB-NCIT'),('DBX-NCIT-C32765','C32765','Ilium','DB-NCIT'),('DBX-NCIT-C32769','C32769','Incisor','DB-NCIT'),('DBX-NCIT-C32770','C32770','Incus','DB-NCIT'),('DBX-NCIT-C32801','C32801','Inguinal Lymph Node','DB-NCIT'),('DBX-NCIT-C32845','C32845','Internal Iliac Artery','DB-NCIT'),('DBX-NCIT-C32853','C32853','Internal Mammary Lymph Node','DB-NCIT'),('DBX-NCIT-C3286','C3286','Odontogenic Neoplasm','DB-NCIT'),('DBX-NCIT-C32867','C32867','Interphalangeal Joint of the Foot','DB-NCIT'),('DBX-NCIT-C32868','C32868','Interphalangeal Joint of the Hand','DB-NCIT'),('DBX-NCIT-C3287','C3287','Odontoma','DB-NCIT'),('DBX-NCIT-C32874','C32874','Interventricular Septum','DB-NCIT'),('DBX-NCIT-C3288','C3288','Oligodendroglioma','DB-NCIT'),('DBX-NCIT-C32884','C32884','Ischium','DB-NCIT'),('DBX-NCIT-C32887','C32887','Thyroid Gland Isthmus','DB-NCIT'),('DBX-NCIT-C32888','C32888','Jaw Joint','DB-NCIT'),('DBX-NCIT-C32898','C32898','Knee Joint','DB-NCIT'),('DBX-NCIT-C32899','C32899','L1 Vertebra','DB-NCIT'),('DBX-NCIT-C32900','C32900','L2 Vertebra','DB-NCIT'),('DBX-NCIT-C32901','C32901','L3 Vertebra','DB-NCIT'),('DBX-NCIT-C32902','C32902','L4 Vertebra','DB-NCIT'),('DBX-NCIT-C32903','C32903','L5 Vertebra','DB-NCIT'),('DBX-NCIT-C32906','C32906','Lacrimal Bone','DB-NCIT'),('DBX-NCIT-C3294','C3294','Osteoblastoma','DB-NCIT'),('DBX-NCIT-C3295','C3295','Osteochondroma','DB-NCIT'),('DBX-NCIT-C32955','C32955','Left Cerebral Hemisphere','DB-NCIT'),('DBX-NCIT-C3296','C3296','Osteoma','DB-NCIT'),('DBX-NCIT-C32965','C32965','Left Lobe of the Liver','DB-NCIT'),('DBX-NCIT-C32967','C32967','Left Lung','DB-NCIT'),('DBX-NCIT-C32968','C32968','Left Main Bronchus','DB-NCIT'),('DBX-NCIT-C32973','C32973','Left Thyroid Gland Lobe','DB-NCIT'),('DBX-NCIT-C32974','C32974','Leg','DB-NCIT'),('DBX-NCIT-C32982','C32982','Lesser Trochanter','DB-NCIT'),('DBX-NCIT-C32996','C32996','Liver Fissure','DB-NCIT'),('DBX-NCIT-C33000','C33000','Caudate Lobe','DB-NCIT'),('DBX-NCIT-C33010','C33010','Lower Gastrointestinal Tract','DB-NCIT'),('DBX-NCIT-C33020','C33020','Lower Lobe of the Left Lung','DB-NCIT'),('DBX-NCIT-C33021','C33021','Upper Lobe of the Left Lung','DB-NCIT'),('DBX-NCIT-C33022','C33022','Lower Lobe of the Right Lung','DB-NCIT'),('DBX-NCIT-C33023','C33023','Upper Lobe of the Right Lung','DB-NCIT'),('DBX-NCIT-C33031','C33031','Lymph Node Hilum','DB-NCIT'),('DBX-NCIT-C33051','C33051','Malleus','DB-NCIT'),('DBX-NCIT-C33073','C33073','Mediastinal Lymph Node','DB-NCIT'),('DBX-NCIT-C3308','C3308','Paraganglioma','DB-NCIT'),('DBX-NCIT-C33103','C33103','Mesentery','DB-NCIT'),('DBX-NCIT-C33108','C33108','Metatarsophalangeal Joint','DB-NCIT'),('DBX-NCIT-C33123','C33123','Middle Mediastinum','DB-NCIT'),('DBX-NCIT-C33156','C33156','Nail','DB-NCIT'),('DBX-NCIT-C33157','C33157','Nasal Bone','DB-NCIT'),('DBX-NCIT-C33160','C33160','Nasal Septum','DB-NCIT'),('DBX-NCIT-C33162','C33162','Navicular Bone','DB-NCIT'),('DBX-NCIT-C33178','C33178','Nostril','DB-NCIT'),('DBX-NCIT-C33200','C33200','Olecranon','DB-NCIT'),('DBX-NCIT-C33205','C33205','Olfactory Mucosa','DB-NCIT'),('DBX-NCIT-C33209','C33209','Omentum','DB-NCIT'),('DBX-NCIT-C33252','C33252','Palmar Region','DB-NCIT'),('DBX-NCIT-C3326','C3326','Adrenal Gland Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C33278','C33278','Parotid Gland Lymph Node','DB-NCIT'),('DBX-NCIT-C33282','C33282','Patella','DB-NCIT'),('DBX-NCIT-C33287','C33287','Pelvic Bone','DB-NCIT'),('DBX-NCIT-C3329','C3329','Pituitary Gland Adenoma','DB-NCIT'),('DBX-NCIT-C33301','C33301','Perineum','DB-NCIT'),('DBX-NCIT-C33314','C33314','Peroneal Artery','DB-NCIT'),('DBX-NCIT-C33318','C33318','Pharyngeal Tonsil','DB-NCIT'),('DBX-NCIT-C33326','C33326','Plantar Region','DB-NCIT'),('DBX-NCIT-C33343','C33343','Portal Vein','DB-NCIT'),('DBX-NCIT-C33368','C33368','Posterior Mediastinum','DB-NCIT'),('DBX-NCIT-C3337','C3337','Fibroepithelial Polyp','DB-NCIT'),('DBX-NCIT-C3340','C3340','Polyp','DB-NCIT'),('DBX-NCIT-C33433','C33433','Pyloric Sphincter','DB-NCIT'),('DBX-NCIT-C33441','C33441','Quadriceps Muscle of the Thigh','DB-NCIT'),('DBX-NCIT-C33472','C33472','Right Cerebral Hemisphere','DB-NCIT'),('DBX-NCIT-C33481','C33481','Right Lobe of the Liver','DB-NCIT'),('DBX-NCIT-C33483','C33483','Right Lung','DB-NCIT'),('DBX-NCIT-C33486','C33486','Right Main Bronchus','DB-NCIT'),('DBX-NCIT-C33491','C33491','Right Thyroid Gland Lobe','DB-NCIT'),('DBX-NCIT-C33507','C33507','Sacroiliac Joint','DB-NCIT'),('DBX-NCIT-C33508','C33508','Sacrum','DB-NCIT'),('DBX-NCIT-C33511','C33511','Saphenous Vein','DB-NCIT'),('DBX-NCIT-C33519','C33519','Sebaceous Gland','DB-NCIT'),('DBX-NCIT-C33529','C33529','Seminal Fluid','DB-NCIT'),('DBX-NCIT-C33543','C33543','Shaft of the Hair','DB-NCIT'),('DBX-NCIT-C33548','C33548','Shoulder Joint','DB-NCIT'),('DBX-NCIT-C33556','C33556','Sinus','DB-NCIT'),('DBX-NCIT-C33574','C33574','Smegma','DB-NCIT'),('DBX-NCIT-C3358','C3358','Rhabdomyoma','DB-NCIT'),('DBX-NCIT-C3359','C3359','Rhabdomyosarcoma','DB-NCIT'),('DBX-NCIT-C33600','C33600','Splenic Hilar Lymph Node','DB-NCIT'),('DBX-NCIT-C33601','C33601','Splenic Hilum','DB-NCIT'),('DBX-NCIT-C33615','C33615','Sternoclavicular Joint','DB-NCIT'),('DBX-NCIT-C33645','C33645','Subcutis','DB-NCIT'),('DBX-NCIT-C33653','C33653','Subtalar Joint','DB-NCIT'),('DBX-NCIT-C33661','C33661','Superficial Femoral Artery','DB-NCIT'),('DBX-NCIT-C33684','C33684','Superior Mediastinum','DB-NCIT'),('DBX-NCIT-C33712','C33712','Sweat Gland','DB-NCIT'),('DBX-NCIT-C33718','C33718','Synovial Fluid','DB-NCIT'),('DBX-NCIT-C33720','C33720','T1 Vertebra','DB-NCIT'),('DBX-NCIT-C33721','C33721','T10 Vertebra','DB-NCIT'),('DBX-NCIT-C33722','C33722','T11 Vertebra','DB-NCIT'),('DBX-NCIT-C33723','C33723','T12 Vertebra','DB-NCIT'),('DBX-NCIT-C33724','C33724','T2 Vertebra','DB-NCIT'),('DBX-NCIT-C33725','C33725','T3 Vertebra','DB-NCIT'),('DBX-NCIT-C33726','C33726','T4 Vertebra','DB-NCIT'),('DBX-NCIT-C33727','C33727','T5 Vertebra','DB-NCIT'),('DBX-NCIT-C33728','C33728','T6 Vertebra','DB-NCIT'),('DBX-NCIT-C33729','C33729','T7 Vertebra','DB-NCIT'),('DBX-NCIT-C33730','C33730','T8 Vertebra','DB-NCIT'),('DBX-NCIT-C33731','C33731','T9 Vertebra','DB-NCIT'),('DBX-NCIT-C33757','C33757','Terminal Ileum','DB-NCIT'),('DBX-NCIT-C33763','C33763','Thigh','DB-NCIT'),('DBX-NCIT-C33769','C33769','Thoracic Lymph Node','DB-NCIT'),('DBX-NCIT-C33788','C33788','Toe','DB-NCIT'),('DBX-NCIT-C33790','C33790','Toenail','DB-NCIT'),('DBX-NCIT-C33794','C33794','Odontogenic Tissue','DB-NCIT'),('DBX-NCIT-C33809','C33809','Trapezius Muscle','DB-NCIT'),('DBX-NCIT-C33814','C33814','Trochanter','DB-NCIT'),('DBX-NCIT-C33816','C33816','Trunk','DB-NCIT'),('DBX-NCIT-C33820','C33820','Tunica Intima','DB-NCIT'),('DBX-NCIT-C33837','C33837','Upper Gastrointestinal Tract','DB-NCIT'),('DBX-NCIT-C33839','C33839','Upper Respiratory System','DB-NCIT'),('DBX-NCIT-C33885','C33885','Vitreous Chamber','DB-NCIT'),('DBX-NCIT-C33888','C33888','Vomer','DB-NCIT'),('DBX-NCIT-C33894','C33894','Wrist Joint','DB-NCIT'),('DBX-NCIT-C33895','C33895','Xiphoid Process','DB-NCIT'),('DBX-NCIT-C33929','C33929','Left Colon','DB-NCIT'),('DBX-NCIT-C3400','C3400','Synovial Sarcoma','DB-NCIT'),('DBX-NCIT-C34004','C34004','Lumbar Region','DB-NCIT'),('DBX-NCIT-C3403','C3403','Teratoma','DB-NCIT'),('DBX-NCIT-C34082','C34082','Gastrointestinal Tract','DB-NCIT'),('DBX-NCIT-C3411','C3411','Thymoma','DB-NCIT'),('DBX-NCIT-C34448','C34448','Carcinosarcoma','DB-NCIT'),('DBX-NCIT-C34483','C34483','Scar','DB-NCIT'),('DBX-NCIT-C3461','C3461','Immunoblastic Lymphoma','DB-NCIT'),('DBX-NCIT-C34786','C34786','Long QT Syndrome','DB-NCIT'),('DBX-NCIT-C34830','C34830','Cardiomyopathy','DB-NCIT'),('DBX-NCIT-C3486','C3486','Epithelioid Cell Type Gastrointestinal Stromal Tumor','DB-NCIT'),('DBX-NCIT-C34902','C34902','Paroxysmal Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C3494','C3494','Lung Papillary Adenoma','DB-NCIT'),('DBX-NCIT-C34940','C34940','Pre-Excitation Syndrome','DB-NCIT'),('DBX-NCIT-C3502','C3502','Thyroid Gland Follicular Adenoma','DB-NCIT'),('DBX-NCIT-C35058','C35058','Atrioventricular Nodal Reentry Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C35059','C35059','Junctional Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C35132','C35132','Wolff-Parkinson-White Syndrome','DB-NCIT'),('DBX-NCIT-C3520','C3520','Myeloid Sarcoma','DB-NCIT'),('DBX-NCIT-C35303','C35303','Anterolateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C35304','C35304','Anteroseptal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C35398','C35398','Inferior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C35399','C35399','Posterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C35417','C35417','Intrahepatic Cholangiocarcinoma','DB-NCIT'),('DBX-NCIT-C35519','C35519','Septal Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C3555','C3555','Malignant Placental Neoplasm','DB-NCIT'),('DBX-NCIT-C35571','C35571','Progressive Disease','DB-NCIT'),('DBX-NCIT-C35586','C35586','Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C35708','C35708','Stone','DB-NCIT'),('DBX-NCIT-C3574','C3574','Malignant Carotid Body Paraganglioma','DB-NCIT'),('DBX-NCIT-C35765','C35765','Histiocytoma','DB-NCIT'),('DBX-NCIT-C35815','C35815','Granulocytic Sarcoma','DB-NCIT'),('DBX-NCIT-C35869','C35869','Radiologic Finding','DB-NCIT'),('DBX-NCIT-C35875','C35875','Bronchogenic Carcinoma','DB-NCIT'),('DBX-NCIT-C3664','C3664','Vaginal Polyp','DB-NCIT'),('DBX-NCIT-C3677','C3677','Benign Neoplasm','DB-NCIT'),('DBX-NCIT-C3679','C3679','Oxyphilic Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C3692','C3692','Undifferentiated Carcinoma','DB-NCIT'),('DBX-NCIT-C3697','C3697','Myxopapillary Ependymoma','DB-NCIT'),('DBX-NCIT-C3698','C3698','Choroid Plexus Papilloma','DB-NCIT'),('DBX-NCIT-C3702','C3702','Hibernoma','DB-NCIT'),('DBX-NCIT-C3710','C3710','Ameloblastic Fibro-Odontoma','DB-NCIT'),('DBX-NCIT-C3712','C3712','Squamous Papilloma','DB-NCIT'),('DBX-NCIT-C3726','C3726','Adenomyoma','DB-NCIT'),('DBX-NCIT-C3727','C3727','Adenosquamous Carcinoma','DB-NCIT'),('DBX-NCIT-C3728','C3728','Hepatoblastoma','DB-NCIT'),('DBX-NCIT-C3729','C3729','Malignant Mixed Neoplasm','DB-NCIT'),('DBX-NCIT-C3733','C3733','Angiolipoma','DB-NCIT'),('DBX-NCIT-C3736','C3736','Adrenal Gland Myelolipoma','DB-NCIT'),('DBX-NCIT-C3738','C3738','Giant Cell Tumor of Bone','DB-NCIT'),('DBX-NCIT-C3739','C3739','Benign Fibrous Histiocytoma','DB-NCIT'),('DBX-NCIT-C3740','C3740','Bone Desmoplastic Fibroma','DB-NCIT'),('DBX-NCIT-C3744','C3744','Fibroadenoma','DB-NCIT'),('DBX-NCIT-C3752','C3752','Embryonal Carcinoma','DB-NCIT'),('DBX-NCIT-C3758','C3758','Hepatocellular Adenoma','DB-NCIT'),('DBX-NCIT-C3762','C3762','Adenomatoid Tumor','DB-NCIT'),('DBX-NCIT-C3764','C3764','Adenomatous Polyp','DB-NCIT'),('DBX-NCIT-C3766','C3766','Clear Cell Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C3768','C3768','Acinar Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C3770','C3770','Pancreatic Neuroendocrine Carcinoma','DB-NCIT'),('DBX-NCIT-C3773','C3773','Neuroendocrine Carcinoma','DB-NCIT'),('DBX-NCIT-C3775','C3775','Adnexal Carcinoma','DB-NCIT'),('DBX-NCIT-C3777','C3777','Papillary Cystadenocarcinoma','DB-NCIT'),('DBX-NCIT-C3788','C3788','Ganglioglioma','DB-NCIT'),('DBX-NCIT-C3789','C3789','Olfactory Neuroblastoma','DB-NCIT'),('DBX-NCIT-C3790','C3790','Ganglioneuroblastoma','DB-NCIT'),('DBX-NCIT-C37927','C37927','Color','DB-NCIT'),('DBX-NCIT-C37936','C37936','Cranial','DB-NCIT'),('DBX-NCIT-C3794','C3794','Sex Cord-Stromal Tumor','DB-NCIT'),('DBX-NCIT-C3795','C3795','Subependymoma','DB-NCIT'),('DBX-NCIT-C3798','C3798','Malignant Peripheral Nerve Sheath Tumor','DB-NCIT'),('DBX-NCIT-C37980','C37980','Inner','DB-NCIT'),('DBX-NCIT-C3799','C3799','Angiofibroma','DB-NCIT'),('DBX-NCIT-C38008','C38008','Post','DB-NCIT'),('DBX-NCIT-C3802','C3802','Amelanotic Melanoma','DB-NCIT'),('DBX-NCIT-C38036','C38036','Audiometric Test','DB-NCIT'),('DBX-NCIT-C38037','C38037','Total Bilirubin Measurement','DB-NCIT'),('DBX-NCIT-C38054','C38054','Electroencephalography','DB-NCIT'),('DBX-NCIT-C38073','C38073','Radionuclide Ventriculogram Scan','DB-NCIT'),('DBX-NCIT-C38084','C38084','Forced Expiratory Volume in 1 Second','DB-NCIT'),('DBX-NCIT-C38101','C38101','Radiography','DB-NCIT'),('DBX-NCIT-C38114','C38114','Route of Administration','DB-NCIT'),('DBX-NCIT-C38155','C38155','Recurrent Disease','DB-NCIT'),('DBX-NCIT-C38166','C38166','Outer','DB-NCIT'),('DBX-NCIT-C38192','C38192','Auricular Route of Administration','DB-NCIT'),('DBX-NCIT-C38193','C38193','Buccal Route of Administration','DB-NCIT'),('DBX-NCIT-C38194','C38194','Conjunctival Route of Administration','DB-NCIT'),('DBX-NCIT-C38197','C38197','Dental Route of Administration','DB-NCIT'),('DBX-NCIT-C38198','C38198','Soft Tissue Route of Administration','DB-NCIT'),('DBX-NCIT-C38200','C38200','Administration via Hemodialysis','DB-NCIT'),('DBX-NCIT-C38203','C38203','Iontophoresis Route of Administration','DB-NCIT'),('DBX-NCIT-C38205','C38205','Endocervical Route of Administration','DB-NCIT'),('DBX-NCIT-C38206','C38206','Endosinusial Route of Administration','DB-NCIT'),('DBX-NCIT-C38207','C38207','Endothoracic Route of Administration','DB-NCIT'),('DBX-NCIT-C38208','C38208','Endotracheal Route of Administration','DB-NCIT'),('DBX-NCIT-C38209','C38209','Enteral Route of Administration','DB-NCIT'),('DBX-NCIT-C38210','C38210','Epidural Route of Administration','DB-NCIT'),('DBX-NCIT-C38211','C38211','Extraamniotic Route of Administration','DB-NCIT'),('DBX-NCIT-C38212','C38212','Extracorporeal Circulation Route of Administration','DB-NCIT'),('DBX-NCIT-C38215','C38215','Infiltration Route of Administration','DB-NCIT'),('DBX-NCIT-C38216','C38216','Inhalation Route of Administration','DB-NCIT'),('DBX-NCIT-C38217','C38217','Intracoronal Dental Route of Administration','DB-NCIT'),('DBX-NCIT-C38218','C38218','Intracoronary Route of Administration','DB-NCIT'),('DBX-NCIT-C38219','C38219','Interstitial Route of Administration','DB-NCIT'),('DBX-NCIT-C38220','C38220','Intraabdominal Route of Administration','DB-NCIT'),('DBX-NCIT-C38221','C38221','Intraamniotic Route of Administration','DB-NCIT'),('DBX-NCIT-C38222','C38222','Intraarterial Route of Administration','DB-NCIT'),('DBX-NCIT-C38223','C38223','Intraarticular Route of Administration','DB-NCIT'),('DBX-NCIT-C38224','C38224','Intrabiliary Route of Administration','DB-NCIT'),('DBX-NCIT-C38225','C38225','Intrabronchial Route of Administration','DB-NCIT'),('DBX-NCIT-C38226','C38226','Intrabursal Route of Administration','DB-NCIT'),('DBX-NCIT-C38227','C38227','Intracardiac Route of Administration','DB-NCIT'),('DBX-NCIT-C38228','C38228','Intracartilaginous Route of Administration','DB-NCIT'),('DBX-NCIT-C38229','C38229','Intracaudal Route of Administration','DB-NCIT'),('DBX-NCIT-C38230','C38230','Intracavernous Route of Administration','DB-NCIT'),('DBX-NCIT-C38231','C38231','Intracavitary Route of Administration','DB-NCIT'),('DBX-NCIT-C38232','C38232','Intracerebral Route of Administration','DB-NCIT'),('DBX-NCIT-C38233','C38233','Intracisternal Route of Administration','DB-NCIT'),('DBX-NCIT-C38234','C38234','Intracorneal Route of Administration','DB-NCIT'),('DBX-NCIT-C38235','C38235','Intracorporus Cavernosum Route of Administration','DB-NCIT'),('DBX-NCIT-C38238','C38238','Intradermal Route of Administration','DB-NCIT'),('DBX-NCIT-C38239','C38239','Intradiscal Route of Administration','DB-NCIT'),('DBX-NCIT-C38240','C38240','Intraductal Route of Administration','DB-NCIT'),('DBX-NCIT-C38241','C38241','Intraduodenal Route of Administration','DB-NCIT'),('DBX-NCIT-C38242','C38242','Intradural Route of Administration','DB-NCIT'),('DBX-NCIT-C38243','C38243','Intraepidermal Route of Administration','DB-NCIT'),('DBX-NCIT-C38245','C38245','Intraesophageal Route of Administration','DB-NCIT'),('DBX-NCIT-C38246','C38246','Intragastric Route of Administration','DB-NCIT'),('DBX-NCIT-C38247','C38247','Intragingival Route of Administration','DB-NCIT'),('DBX-NCIT-C38248','C38248','Intrahepatic Route of Administration','DB-NCIT'),('DBX-NCIT-C38249','C38249','Intraileal Route of Administration','DB-NCIT'),('DBX-NCIT-C38250','C38250','Intralesional Route of Administration','DB-NCIT'),('DBX-NCIT-C38251','C38251','Intraluminal Route of Administration','DB-NCIT'),('DBX-NCIT-C38252','C38252','Intralymphatic Route of Administration','DB-NCIT'),('DBX-NCIT-C38253','C38253','Intramedullary Route of Administration','DB-NCIT'),('DBX-NCIT-C38254','C38254','Intrameningeal Route of Administration','DB-NCIT'),('DBX-NCIT-C38255','C38255','Intraocular Route of Administration','DB-NCIT'),('DBX-NCIT-C38256','C38256','Intraovarian Route of Administration','DB-NCIT'),('DBX-NCIT-C38257','C38257','Intrapericardial Route of Administration','DB-NCIT'),('DBX-NCIT-C38258','C38258','Intraperitoneal Route of Administration','DB-NCIT'),('DBX-NCIT-C38259','C38259','Intrapleural Route of Administration','DB-NCIT'),('DBX-NCIT-C38260','C38260','Intraprostatic Route of Administration','DB-NCIT'),('DBX-NCIT-C38261','C38261','Intrapulmonary Route of Administration','DB-NCIT'),('DBX-NCIT-C38262','C38262','Intrasinal Route of Administration','DB-NCIT'),('DBX-NCIT-C38263','C38263','Intraspinal Route of Administration','DB-NCIT'),('DBX-NCIT-C38264','C38264','Intrasynovial Route of Administration','DB-NCIT'),('DBX-NCIT-C38265','C38265','Intratendinous Route of Administration','DB-NCIT'),('DBX-NCIT-C38266','C38266','Intratesticular Route of Administration','DB-NCIT'),('DBX-NCIT-C38267','C38267','Intrathecal Route of Administration','DB-NCIT'),('DBX-NCIT-C38268','C38268','Intratubular Route of Administration','DB-NCIT'),('DBX-NCIT-C38269','C38269','Intratumoral Route of Administration','DB-NCIT'),('DBX-NCIT-C38270','C38270','Intratympanic Route of Administration','DB-NCIT'),('DBX-NCIT-C38271','C38271','Intraurethral Route of Administration','DB-NCIT'),('DBX-NCIT-C38272','C38272','Intrauterine Route of Administration','DB-NCIT'),('DBX-NCIT-C38273','C38273','Intravascular Route of Administration','DB-NCIT'),('DBX-NCIT-C38274','C38274','Intravenous Bolus','DB-NCIT'),('DBX-NCIT-C38276','C38276','Intravenous Route of Administration','DB-NCIT'),('DBX-NCIT-C38277','C38277','Intraventricular Route of Administration','DB-NCIT'),('DBX-NCIT-C38278','C38278','Intravesical Route of Administration','DB-NCIT'),('DBX-NCIT-C38279','C38279','Intravenous Drip','DB-NCIT'),('DBX-NCIT-C38280','C38280','Intravitreal Route of Administration','DB-NCIT'),('DBX-NCIT-C38281','C38281','Irrigation-Route of Administration','DB-NCIT'),('DBX-NCIT-C38282','C38282','Laryngeal Route of Administration','DB-NCIT'),('DBX-NCIT-C38283','C38283','Mucosal Route of Administration','DB-NCIT'),('DBX-NCIT-C38284','C38284','Nasal Route of Administration','DB-NCIT'),('DBX-NCIT-C38285','C38285','Nasogastric Route of Administration','DB-NCIT'),('DBX-NCIT-C38286','C38286','Occlusive Dressing Technique','DB-NCIT'),('DBX-NCIT-C38287','C38287','Ophthalmic Route of Administration','DB-NCIT'),('DBX-NCIT-C38288','C38288','Oral Route of Administration','DB-NCIT'),('DBX-NCIT-C38289','C38289','Oropharyngeal Route of Administration','DB-NCIT'),('DBX-NCIT-C3829','C3829','Benign Synovial Neoplasm','DB-NCIT'),('DBX-NCIT-C38291','C38291','Parenteral Route of Administration','DB-NCIT'),('DBX-NCIT-C38292','C38292','Periarticular Route of Administration','DB-NCIT'),('DBX-NCIT-C38293','C38293','Perineural Route of Administration','DB-NCIT'),('DBX-NCIT-C38294','C38294','Periodontal Route of Administration','DB-NCIT'),('DBX-NCIT-C38295','C38295','Rectal Route of Administration','DB-NCIT'),('DBX-NCIT-C38296','C38296','Retrobulbar Route of Administration','DB-NCIT'),('DBX-NCIT-C38297','C38297','Subarachnoid Route of Administration','DB-NCIT'),('DBX-NCIT-C38298','C38298','Subconjunctival Route of Administration','DB-NCIT'),('DBX-NCIT-C38299','C38299','Subcutaneous Route of Administration','DB-NCIT'),('DBX-NCIT-C38300','C38300','Sublingual Route of Administration','DB-NCIT'),('DBX-NCIT-C38301','C38301','Submucosal Route of Administration','DB-NCIT'),('DBX-NCIT-C38304','C38304','Topical Route of Administration','DB-NCIT'),('DBX-NCIT-C38305','C38305','Transdermal Route of Administration','DB-NCIT'),('DBX-NCIT-C38307','C38307','Transplacental Route of Administration','DB-NCIT'),('DBX-NCIT-C38308','C38308','Transtracheal Route of Administration','DB-NCIT'),('DBX-NCIT-C38309','C38309','Transtympanic Route of Administration','DB-NCIT'),('DBX-NCIT-C38310','C38310','Unassigned Route of Administration','DB-NCIT'),('DBX-NCIT-C38311','C38311','Unknown Route of Administration','DB-NCIT'),('DBX-NCIT-C38312','C38312','Ureteral Route of Administration','DB-NCIT'),('DBX-NCIT-C38313','C38313','Vaginal Route of Administration','DB-NCIT'),('DBX-NCIT-C3833','C3833','Asymptomatic','DB-NCIT'),('DBX-NCIT-C38462','C38462','Partial Thromboplastin Time','DB-NCIT'),('DBX-NCIT-C38633','C38633','Electro-osmosis Route of Administration','DB-NCIT'),('DBX-NCIT-C38662','C38662','Pericardial Cavity','DB-NCIT'),('DBX-NCIT-C38675','C38675','Cutaneous Route of Administration','DB-NCIT'),('DBX-NCIT-C38676','C38676','Percutaneous Route of Administration','DB-NCIT'),('DBX-NCIT-C38677','C38677','Peridural Route of Administration','DB-NCIT'),('DBX-NCIT-C38757','C38757','Negative Finding','DB-NCIT'),('DBX-NCIT-C38758','C38758','Positive Finding','DB-NCIT'),('DBX-NCIT-C3879','C3879','Thyroid Gland Medullary Carcinoma','DB-NCIT'),('DBX-NCIT-C38938','C38938','Grade III Meningioma','DB-NCIT'),('DBX-NCIT-C3903','C3903','Mixed Glioma','DB-NCIT'),('DBX-NCIT-C39493','C39493','Pharmacoeconomic Study','DB-NCIT'),('DBX-NCIT-C39779','C39779','Maximum Heart Rate','DB-NCIT'),('DBX-NCIT-C39807','C39807','Mucinous Tubular and Spindle Cell Carcinoma of the Kidney','DB-NCIT'),('DBX-NCIT-C39956','C39956','Rete Testis Adenoma','DB-NCIT'),('DBX-NCIT-C40030','C40030','Cryotherapy','DB-NCIT'),('DBX-NCIT-C40185','C40185','Forebrain','DB-NCIT'),('DBX-NCIT-C40211','C40211','Representational Oligonucleotide Microarray Analysis','DB-NCIT'),('DBX-NCIT-C40310','C40310','Sebaceous Carcinoma','DB-NCIT'),('DBX-NCIT-C40353','C40353','Shipping','DB-NCIT'),('DBX-NCIT-C40373','C40373','Lingula of the Lung','DB-NCIT'),('DBX-NCIT-C40407','C40407','Nephroblastoma','DB-NCIT'),('DBX-NCIT-C4047','C4047','Pilocytic Astrocytoma','DB-NCIT'),('DBX-NCIT-C4049','C4049','Anaplastic Ependymoma','DB-NCIT'),('DBX-NCIT-C4050','C4050','Oligoastrocytoma','DB-NCIT'),('DBX-NCIT-C4051','C4051','Anaplastic (Malignant) Meningioma','DB-NCIT'),('DBX-NCIT-C4055','C4055','Benign Meningioma','DB-NCIT'),('DBX-NCIT-C4090','C4090','Malignant Giant Cell Neoplasm','DB-NCIT'),('DBX-NCIT-C4092','C4092','Benign Epithelial Neoplasm','DB-NCIT'),('DBX-NCIT-C40960','C40960','Chromogenic In Situ Hybridization','DB-NCIT'),('DBX-NCIT-C41132','C41132','None','DB-NCIT'),('DBX-NCIT-C41139','C41139','Meter','DB-NCIT'),('DBX-NCIT-C41140','C41140','Millisecond','DB-NCIT'),('DBX-NCIT-C41145','C41145','Thickness','DB-NCIT'),('DBX-NCIT-C4115','C4115','Transitional Cell Papilloma','DB-NCIT'),('DBX-NCIT-C41161','C41161','Protocol Agent','DB-NCIT'),('DBX-NCIT-C41184','C41184','Indication','DB-NCIT'),('DBX-NCIT-C41185','C41185','Concentration','DB-NCIT'),('DBX-NCIT-C41189','C41189','Study Subject','DB-NCIT'),('DBX-NCIT-C41219','C41219','Native Hawaiian or Other Pacific Islander','DB-NCIT'),('DBX-NCIT-C41222','C41222','Not Hispanic or Latino','DB-NCIT'),('DBX-NCIT-C41255','C41255','Interpretation','DB-NCIT'),('DBX-NCIT-C41256','C41256','Family Member','DB-NCIT'),('DBX-NCIT-C41259','C41259','American Indian or Alaska Native','DB-NCIT'),('DBX-NCIT-C41260','C41260','Asian','DB-NCIT'),('DBX-NCIT-C41261','C41261','White','DB-NCIT'),('DBX-NCIT-C4133','C4133','Tubular Adenoma','DB-NCIT'),('DBX-NCIT-C41330','C41330','ST Segment Depression by ECG Finding','DB-NCIT'),('DBX-NCIT-C41331','C41331','Adverse Event','DB-NCIT'),('DBX-NCIT-C41337','C41337','Life Threatening or Disabling Adverse Event','DB-NCIT'),('DBX-NCIT-C41338','C41338','Mild Adverse Event','DB-NCIT'),('DBX-NCIT-C41339','C41339','Moderate Adverse Event','DB-NCIT'),('DBX-NCIT-C41340','C41340','Severe Adverse Event','DB-NCIT'),('DBX-NCIT-C41372','C41372','Peak Expiratory Flow','DB-NCIT'),('DBX-NCIT-C4140','C4140','Alveolar Adenoma','DB-NCIT'),('DBX-NCIT-C4151','C4151','Clear Cell Adenoma','DB-NCIT'),('DBX-NCIT-C4159','C4159','Lipoadenoma','DB-NCIT'),('DBX-NCIT-C4174','C4174','Sebaceous Adenoma','DB-NCIT'),('DBX-NCIT-C4176','C4176','Ceruminous Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C4196','C4196','Acinar Cell Adenoma','DB-NCIT'),('DBX-NCIT-C4200','C4200','Adenocarcinoma with Squamous Metaplasia','DB-NCIT'),('DBX-NCIT-C4205','C4205','Malignant Granulosa Cell Tumor','DB-NCIT'),('DBX-NCIT-C4209','C4209','Well Differentiated Ovarian Sertoli-Leydig Cell Tumor','DB-NCIT'),('DBX-NCIT-C4210','C4210','Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor','DB-NCIT'),('DBX-NCIT-C4212','C4212','Benign Leydig Cell Tumor','DB-NCIT'),('DBX-NCIT-C4213','C4213','Malignant Leydig Cell Tumor','DB-NCIT'),('DBX-NCIT-C4220','C4220','Malignant Adrenal Gland Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C4247','C4247','Unclassified Pleomorphic Sarcoma','DB-NCIT'),('DBX-NCIT-C4249','C4249','Fibrolipoma','DB-NCIT'),('DBX-NCIT-C42535','C42535','Second','DB-NCIT'),('DBX-NCIT-C42536','C42536','Ampere','DB-NCIT'),('DBX-NCIT-C42538','C42538','Candela','DB-NCIT'),('DBX-NCIT-C42539','C42539','Mole','DB-NCIT'),('DBX-NCIT-C42545','C42545','Hertz','DB-NCIT'),('DBX-NCIT-C42546','C42546','Newton','DB-NCIT'),('DBX-NCIT-C42547','C42547','Pascal','DB-NCIT'),('DBX-NCIT-C42548','C42548','Joule','DB-NCIT'),('DBX-NCIT-C42549','C42549','Watt','DB-NCIT'),('DBX-NCIT-C42550','C42550','Coulomb','DB-NCIT'),('DBX-NCIT-C42551','C42551','Volt','DB-NCIT'),('DBX-NCIT-C42552','C42552','Farad','DB-NCIT'),('DBX-NCIT-C42553','C42553','Sievert','DB-NCIT'),('DBX-NCIT-C42554','C42554','Ohm','DB-NCIT'),('DBX-NCIT-C42555','C42555','Siemens','DB-NCIT'),('DBX-NCIT-C42556','C42556','Weber','DB-NCIT'),('DBX-NCIT-C42557','C42557','Tesla','DB-NCIT'),('DBX-NCIT-C42558','C42558','Henry','DB-NCIT'),('DBX-NCIT-C42559','C42559','Degree Celsius','DB-NCIT'),('DBX-NCIT-C42560','C42560','Lumen','DB-NCIT'),('DBX-NCIT-C42561','C42561','Lux','DB-NCIT'),('DBX-NCIT-C42562','C42562','Becquerel','DB-NCIT'),('DBX-NCIT-C42566','C42566','Katal','DB-NCIT'),('DBX-NCIT-C42569','C42569','Square Meter','DB-NCIT'),('DBX-NCIT-C42570','C42570','Cubic Meter','DB-NCIT'),('DBX-NCIT-C42571','C42571','Meter per Second','DB-NCIT'),('DBX-NCIT-C42576','C42576','Kilogram per Cubic Meter','DB-NCIT'),('DBX-NCIT-C4267','C4267','Benign Mesenchymoma','DB-NCIT'),('DBX-NCIT-C42678','C42678','Cigarette Dosage Form','DB-NCIT'),('DBX-NCIT-C42679','C42679','Douche Dosage Form','DB-NCIT'),('DBX-NCIT-C42708','C42708','Offspring','DB-NCIT'),('DBX-NCIT-C42709','C42709','Parent','DB-NCIT'),('DBX-NCIT-C42763','C42763','Dressing Dosage Form','DB-NCIT'),('DBX-NCIT-C4286','C4286','Immature Teratoma','DB-NCIT'),('DBX-NCIT-C42872','C42872','Washout Period','DB-NCIT'),('DBX-NCIT-C42887','C42887','Aerosol Dosage Form','DB-NCIT'),('DBX-NCIT-C42888','C42888','Aerosol Foam Dosage Form','DB-NCIT'),('DBX-NCIT-C42889','C42889','Aerosol Spray Dosage Form','DB-NCIT'),('DBX-NCIT-C42890','C42890','Bead Dosage Form','DB-NCIT'),('DBX-NCIT-C42891','C42891','Block Dosage Form','DB-NCIT'),('DBX-NCIT-C42892','C42892','Chewable Bar Dosage Form','DB-NCIT'),('DBX-NCIT-C42893','C42893','Chewable Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42894','C42894','Chewing Gum Dosage Form','DB-NCIT'),('DBX-NCIT-C42895','C42895','Coated Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42896','C42896','Coated Pellet in Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42897','C42897','Coated Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42898','C42898','Concentrated Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42899','C42899','Concentrated Injectable Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42900','C42900','Cone Dosage Form','DB-NCIT'),('DBX-NCIT-C42901','C42901','Crystal Dosage Form','DB-NCIT'),('DBX-NCIT-C42902','C42902','Delayed Release Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42903','C42903','Delayed Release Granule Dosage Form','DB-NCIT'),('DBX-NCIT-C42904','C42904','Delayed Release Pellet in Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42905','C42905','Delayed Release Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42906','C42906','Dentifrice Gel Dosage Form','DB-NCIT'),('DBX-NCIT-C42907','C42907','Dentifrice Paste Dosage Form','DB-NCIT'),('DBX-NCIT-C42908','C42908','Dentifrice Powder Dosage Form','DB-NCIT'),('DBX-NCIT-C42909','C42909','Effervescent Granule Dosage Form','DB-NCIT'),('DBX-NCIT-C42910','C42910','Effervescent Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42911','C42911','Electrically Controlled Extended Release Patch Dosage Form','DB-NCIT'),('DBX-NCIT-C42912','C42912','Elixir Dosage Form','DB-NCIT'),('DBX-NCIT-C42913','C42913','Emulsion Dosage Form','DB-NCIT'),('DBX-NCIT-C42914','C42914','Emulsion for Injection Dosage Form','DB-NCIT'),('DBX-NCIT-C42915','C42915','Enema Dosage Form','DB-NCIT'),('DBX-NCIT-C42916','C42916','Extended Release Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42917','C42917','Extended Release Coated Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42918','C42918','Extended Release Coated Pellet Dosage Form','DB-NCIT'),('DBX-NCIT-C42919','C42919','Extended Release Core Dosage Form','DB-NCIT'),('DBX-NCIT-C42920','C42920','Extended Release Film Dosage Form','DB-NCIT'),('DBX-NCIT-C42921','C42921','Extended Release Granule for Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42922','C42922','Extended Release Insert Dosage Form','DB-NCIT'),('DBX-NCIT-C42923','C42923','Extended Release Patch Dosage Form','DB-NCIT'),('DBX-NCIT-C42924','C42924','Extended Release Suppository Dosage Form','DB-NCIT'),('DBX-NCIT-C42925','C42925','Extended Release Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42926','C42926','Injectable Extended Release Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42927','C42927','Extended Release Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42928','C42928','Extended Release Film Coated Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42929','C42929','Extract Dosage Form','DB-NCIT'),('DBX-NCIT-C42930','C42930','Film Coated Extended Release Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42931','C42931','Film Coated Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42932','C42932','Film Dosage Form','DB-NCIT'),('DBX-NCIT-C42933','C42933','Gas Dosage Form','DB-NCIT'),('DBX-NCIT-C42934','C42934','Gel Dosage Form','DB-NCIT'),('DBX-NCIT-C42935','C42935','Extended Release Gel Forming Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42936','C42936','Gelatin Coated Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42937','C42937','Globule Dosage Form','DB-NCIT'),('DBX-NCIT-C42938','C42938','Granule Dosage Form','DB-NCIT'),('DBX-NCIT-C42939','C42939','Granule for Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42940','C42940','Granule for Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42941','C42941','Gum Dosage Form','DB-NCIT'),('DBX-NCIT-C42942','C42942','Implant Dosage Form','DB-NCIT'),('DBX-NCIT-C42943','C42943','Implantable Pellet Dosage Form','DB-NCIT'),('DBX-NCIT-C42944','C42944','Inhalant Dosage Form','DB-NCIT'),('DBX-NCIT-C42945','C42945','Injectable Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42946','C42946','Injectable Dosage Form','DB-NCIT'),('DBX-NCIT-C42947','C42947','Irrigant Dosage Form','DB-NCIT'),('DBX-NCIT-C42948','C42948','Jelly Dosage Form','DB-NCIT'),('DBX-NCIT-C42949','C42949','Liniment Dosage Form','DB-NCIT'),('DBX-NCIT-C42950','C42950','Injectable Lipid Complex Dosage Form','DB-NCIT'),('DBX-NCIT-C42951','C42951','Injectable Liposomal Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42952','C42952','Lipstick Dosage Form','DB-NCIT'),('DBX-NCIT-C42953','C42953','Liquid Dosage Form','DB-NCIT'),('DBX-NCIT-C42954','C42954','Liquid Filled Capsule Dosage Form','DB-NCIT'),('DBX-NCIT-C42955','C42955','Lozenge Dosage Form','DB-NCIT'),('DBX-NCIT-C42956','C42956','Lyophilized Powder for Extended Release Injectable Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42957','C42957','Lyophilized Powder for Injectable Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42958','C42958','Lyophilized Powder for Injectable Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42959','C42959','Lyophilized Powder for Injectable Liposomal Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42960','C42960','Metered Aerosol Dosage Form','DB-NCIT'),('DBX-NCIT-C42961','C42961','Metered Powder Dosage Form','DB-NCIT'),('DBX-NCIT-C42962','C42962','Metered Spray Dosage Form','DB-NCIT'),('DBX-NCIT-C42963','C42963','Multilayered Extended Release Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42964','C42964','Multilayered Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42965','C42965','Oil Dosage Form','DB-NCIT'),('DBX-NCIT-C42966','C42966','Ointment Dosage Form','DB-NCIT'),('DBX-NCIT-C42967','C42967','Paste Dosage Form','DB-NCIT'),('DBX-NCIT-C42968','C42968','Patch Dosage Form','DB-NCIT'),('DBX-NCIT-C42969','C42969','Pellet Dosage Form','DB-NCIT'),('DBX-NCIT-C42970','C42970','Plaster Dosage Form','DB-NCIT'),('DBX-NCIT-C42971','C42971','Powder Aerosol Dosage Form','DB-NCIT'),('DBX-NCIT-C42972','C42972','Powder Dosage Form','DB-NCIT'),('DBX-NCIT-C42973','C42973','Powder for Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42974','C42974','Powder for Injectable Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42975','C42975','Powder for Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42976','C42976','Powder for Injectable Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42977','C42977','Powder for Injectable Extended Release Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42978','C42978','Resin Gum Dosage Form','DB-NCIT'),('DBX-NCIT-C42979','C42979','Rinse Dosage Form','DB-NCIT'),('DBX-NCIT-C42980','C42980','Salve Dosage Form','DB-NCIT'),('DBX-NCIT-C42981','C42981','Shampoo Dosage Form','DB-NCIT'),('DBX-NCIT-C42982','C42982','Shampoo Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42983','C42983','Soap Dosage Form','DB-NCIT'),('DBX-NCIT-C42984','C42984','Soluble Film Dosage Form','DB-NCIT'),('DBX-NCIT-C42985','C42985','Soluble Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42986','C42986','Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C42987','C42987','Solution for Slush Dosage Form','DB-NCIT'),('DBX-NCIT-C42988','C42988','Injectable Sonicated Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42989','C42989','Spray Dosage Form','DB-NCIT'),('DBX-NCIT-C42990','C42990','Spray Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42991','C42991','Stick Dosage Form','DB-NCIT'),('DBX-NCIT-C42992','C42992','Sugar Coated Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42993','C42993','Suppository Dosage Form','DB-NCIT'),('DBX-NCIT-C42994','C42994','Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42995','C42995','Injectable Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C42996','C42996','Syrup Dosage Form','DB-NCIT'),('DBX-NCIT-C42997','C42997','Delayed Release Particle Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42998','C42998','Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C42999','C42999','Orally Disintegrating Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C4300','C4300','Benign Hemangiopericytoma','DB-NCIT'),('DBX-NCIT-C43000','C43000','Tincture Dosage Form','DB-NCIT'),('DBX-NCIT-C43001','C43001','Troche Dosage Form','DB-NCIT'),('DBX-NCIT-C43002','C43002','Unassigned Dosage Form','DB-NCIT'),('DBX-NCIT-C43003','C43003','Wafer Dosage Form','DB-NCIT'),('DBX-NCIT-C4301','C4301','Malignant Hemangiopericytoma','DB-NCIT'),('DBX-NCIT-C4304','C4304','Malignant Giant Cell Tumor of Bone','DB-NCIT'),('DBX-NCIT-C4306','C4306','Benign Odontogenic Neoplasm','DB-NCIT'),('DBX-NCIT-C4313','C4313','Ameloblastoma','DB-NCIT'),('DBX-NCIT-C4314','C4314','Odontogenic Fibroma','DB-NCIT'),('DBX-NCIT-C43234','C43234','Not Stated','DB-NCIT'),('DBX-NCIT-C43246','C43246','Mass','DB-NCIT'),('DBX-NCIT-C4326','C4326','Anaplastic Oligodendroglioma','DB-NCIT'),('DBX-NCIT-C43310','C43310','Malignant Hair Follicle Neoplasm','DB-NCIT'),('DBX-NCIT-C4336','C4336','Malignant Granular Cell Tumor','DB-NCIT'),('DBX-NCIT-C43362','C43362','Anus','DB-NCIT'),('DBX-NCIT-C43451','C43451','Extended Release Bead Implant Dosage Form','DB-NCIT'),('DBX-NCIT-C43525','C43525','Disc Dosage Form','DB-NCIT'),('DBX-NCIT-C43820','C43820','MedDRA','DB-NCIT'),('DBX-NCIT-C44256','C44256','Ratio','DB-NCIT'),('DBX-NCIT-C44277','C44277','Degree Fahrenheit','DB-NCIT'),('DBX-NCIT-C44278','C44278','Unit','DB-NCIT'),('DBX-NCIT-C44282','C44282','Microarray','DB-NCIT'),('DBX-NCIT-C4436','C4436','Cholangiocarcinoma','DB-NCIT'),('DBX-NCIT-C44480','C44480','Isle of Man','DB-NCIT'),('DBX-NCIT-C44481','C44481','Aland Islands','DB-NCIT'),('DBX-NCIT-C44482','C44482','Christmas Island','DB-NCIT'),('DBX-NCIT-C4456','C4456','Malignant Mesothelioma','DB-NCIT'),('DBX-NCIT-C449','C449','DNA','DB-NCIT'),('DBX-NCIT-C45312','C45312','Segment','DB-NCIT'),('DBX-NCIT-C45413','C45413','Dental Liner Dosage Form','DB-NCIT'),('DBX-NCIT-C45414','C45414','Cement Dosage Form','DB-NCIT'),('DBX-NCIT-C45415','C45415','Culture Dosage Form','DB-NCIT'),('DBX-NCIT-C45416','C45416','Graft Dosage Form','DB-NCIT'),('DBX-NCIT-C45874','C45874','Dorsal','DB-NCIT'),('DBX-NCIT-C45875','C45875','Ventral','DB-NCIT'),('DBX-NCIT-C45908','C45908','Intersex','DB-NCIT'),('DBX-NCIT-C45997','C45997','pH','DB-NCIT'),('DBX-NCIT-C46087','C46087','Contrast-enhanced Magnetic Resonance Imaging','DB-NCIT'),('DBX-NCIT-C46101','C46101','Neoplastic C-Cell Hyperplasia','DB-NCIT'),('DBX-NCIT-C46119','C46119','Thyroid Gland Clear Cell Follicular Adenoma','DB-NCIT'),('DBX-NCIT-C4614','C4614','Skin Papilloma','DB-NCIT'),('DBX-NCIT-C4664','C4664','T-Cell Large Granular Lymphocyte Leukemia','DB-NCIT'),('DBX-NCIT-C4665','C4665','Plasma Cell Neoplasm','DB-NCIT'),('DBX-NCIT-C4684','C4684','Nasal Type Extranodal NK/T-Cell Lymphoma','DB-NCIT'),('DBX-NCIT-C4715','C4715','Choroid Plexus Carcinoma','DB-NCIT'),('DBX-NCIT-C47843','C47843','Forced Expiratory Volume in 6 Seconds','DB-NCIT'),('DBX-NCIT-C47865','C47865','Phase V Trial','DB-NCIT'),('DBX-NCIT-C47887','C47887','Packing Dosage Form','DB-NCIT'),('DBX-NCIT-C47889','C47889','Suture Dosage Form','DB-NCIT'),('DBX-NCIT-C47890','C47890','Vaginal Diaphragm Dosage Form','DB-NCIT'),('DBX-NCIT-C47892','C47892','Tampon Dosage Form','DB-NCIT'),('DBX-NCIT-C47897','C47897','Tape Dosage Form','DB-NCIT'),('DBX-NCIT-C47898','C47898','Swab Dosage Form','DB-NCIT'),('DBX-NCIT-C47912','C47912','Sponge Dosage Form','DB-NCIT'),('DBX-NCIT-C47913','C47913','Poultice Dosage Form','DB-NCIT'),('DBX-NCIT-C47914','C47914','Strip Dosage Form','DB-NCIT'),('DBX-NCIT-C47915','C47915','Intrauterine Device Dosage Form','DB-NCIT'),('DBX-NCIT-C47916','C47916','Kit Dosage Form','DB-NCIT'),('DBX-NCIT-C48040','C48040','Matrix-Assisted Laser Desorption Ionization Mass Spectrometry','DB-NCIT'),('DBX-NCIT-C4812','C4812','Malignant Odontogenic Neoplasm','DB-NCIT'),('DBX-NCIT-C48152','C48152','Microgram','DB-NCIT'),('DBX-NCIT-C48153','C48153','Microliter','DB-NCIT'),('DBX-NCIT-C48154','C48154','Minute','DB-NCIT'),('DBX-NCIT-C48155','C48155','Gram','DB-NCIT'),('DBX-NCIT-C48193','C48193','Generator Dosage Form','DB-NCIT'),('DBX-NCIT-C4822','C4822','Malignant Glioma','DB-NCIT'),('DBX-NCIT-C48226','C48226','Lack of Efficacy','DB-NCIT'),('DBX-NCIT-C48227','C48227','Lost To Follow-up','DB-NCIT'),('DBX-NCIT-C48250','C48250','Physician Decision','DB-NCIT'),('DBX-NCIT-C48251','C48251','Protocol Violation','DB-NCIT'),('DBX-NCIT-C48262','C48262','Trial Screening','DB-NCIT'),('DBX-NCIT-C48275','C48275','Death Related to Adverse Event','DB-NCIT'),('DBX-NCIT-C48281','C48281','Trial Phase','DB-NCIT'),('DBX-NCIT-C48284','C48284','Donor','DB-NCIT'),('DBX-NCIT-C48305','C48305','Benign Adrenal Gland Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C48306','C48306','Adrenal Gland Composite Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C48314','C48314','Benign Paraganglioma','DB-NCIT'),('DBX-NCIT-C48367','C48367','Pixel','DB-NCIT'),('DBX-NCIT-C48440','C48440','Single','DB-NCIT'),('DBX-NCIT-C48460','C48460','Square Centimeter','DB-NCIT'),('DBX-NCIT-C48461','C48461','Square Foot','DB-NCIT'),('DBX-NCIT-C48466','C48466','Curie','DB-NCIT'),('DBX-NCIT-C48473','C48473','Ampule Dosing Unit','DB-NCIT'),('DBX-NCIT-C48474','C48474','Bag Dosing Unit','DB-NCIT'),('DBX-NCIT-C48475','C48475','Bar Dosing Unit','DB-NCIT'),('DBX-NCIT-C48476','C48476','Bolus Dosing Unit','DB-NCIT'),('DBX-NCIT-C48477','C48477','Bottle Dosing Unit','DB-NCIT'),('DBX-NCIT-C48478','C48478','Box Dosing Unit','DB-NCIT'),('DBX-NCIT-C48479','C48479','Can Dosing Unit','DB-NCIT'),('DBX-NCIT-C48480','C48480','Capsule Dosing Unit','DB-NCIT'),('DBX-NCIT-C48481','C48481','Cartridge Dosing Unit','DB-NCIT'),('DBX-NCIT-C48483','C48483','Coat Dosing Unit','DB-NCIT'),('DBX-NCIT-C48484','C48484','Container Dosing Unit','DB-NCIT'),('DBX-NCIT-C48489','C48489','Cylinder Dosing Unit','DB-NCIT'),('DBX-NCIT-C48490','C48490','Disk Dosing Unit','DB-NCIT'),('DBX-NCIT-C48492','C48492','Drum Dosing Unit','DB-NCIT'),('DBX-NCIT-C48494','C48494','Fluid Ounce US','DB-NCIT'),('DBX-NCIT-C48497','C48497','Grain','DB-NCIT'),('DBX-NCIT-C48498','C48498','Homeopathic Dilution Unit','DB-NCIT'),('DBX-NCIT-C48499','C48499','Implant Dosing Unit','DB-NCIT'),('DBX-NCIT-C48500','C48500','Inch','DB-NCIT'),('DBX-NCIT-C48501','C48501','Inhalation Dosing Unit','DB-NCIT'),('DBX-NCIT-C48502','C48502','Jar Dosing Unit','DB-NCIT'),('DBX-NCIT-C48503','C48503','Kallikrein Inhibitor Unit','DB-NCIT'),('DBX-NCIT-C48504','C48504','Kit Dosing Unit','DB-NCIT'),('DBX-NCIT-C48505','C48505','Liter','DB-NCIT'),('DBX-NCIT-C48506','C48506','Lozenge Dosing Unit','DB-NCIT'),('DBX-NCIT-C48507','C48507','Microcurie','DB-NCIT'),('DBX-NCIT-C48508','C48508','Micromole per Liter','DB-NCIT'),('DBX-NCIT-C48509','C48509','Micromole','DB-NCIT'),('DBX-NCIT-C48510','C48510','Micron','DB-NCIT'),('DBX-NCIT-C48511','C48511','Millicurie','DB-NCIT'),('DBX-NCIT-C48512','C48512','Milliequivalent','DB-NCIT'),('DBX-NCIT-C48513','C48513','Millimole','DB-NCIT'),('DBX-NCIT-C48516','C48516','Nanogram','DB-NCIT'),('DBX-NCIT-C48517','C48517','Nanomole','DB-NCIT'),('DBX-NCIT-C48519','C48519','Ounce','DB-NCIT'),('DBX-NCIT-C48520','C48520','Package Dosing Unit','DB-NCIT'),('DBX-NCIT-C48521','C48521','Packet Dosing Unit','DB-NCIT'),('DBX-NCIT-C48523','C48523','Part Per Million','DB-NCIT'),('DBX-NCIT-C48524','C48524','Patch Dosing Unit','DB-NCIT'),('DBX-NCIT-C48525','C48525','Pellet Dosing Unit','DB-NCIT'),('DBX-NCIT-C48527','C48527','Percent Mass per Volume','DB-NCIT'),('DBX-NCIT-C48528','C48528','Percent Mass per Mass','DB-NCIT'),('DBX-NCIT-C48529','C48529','Pint','DB-NCIT'),('DBX-NCIT-C48530','C48530','Pouch Dosing Unit','DB-NCIT'),('DBX-NCIT-C48531','C48531','Pound','DB-NCIT'),('DBX-NCIT-C48532','C48532','Pressor Unit','DB-NCIT'),('DBX-NCIT-C48536','C48536','Scoopful Dosing Unit','DB-NCIT'),('DBX-NCIT-C48537','C48537','Spray Dosing Unit','DB-NCIT'),('DBX-NCIT-C48538','C48538','Strip Dosing Unit','DB-NCIT'),('DBX-NCIT-C48539','C48539','Suppository Dosing Unit','DB-NCIT'),('DBX-NCIT-C48540','C48540','Syringe Dosing Unit','DB-NCIT'),('DBX-NCIT-C48541','C48541','Tablespoon Dosing Unit','DB-NCIT'),('DBX-NCIT-C48542','C48542','Tablet Dosing Unit','DB-NCIT'),('DBX-NCIT-C48543','C48543','Tampon Dosing Unit','DB-NCIT'),('DBX-NCIT-C48544','C48544','Teaspoon Dosing Unit','DB-NCIT'),('DBX-NCIT-C48547','C48547','Trace Dosing Unit','DB-NCIT'),('DBX-NCIT-C48548','C48548','Troche Dosing Unit','DB-NCIT'),('DBX-NCIT-C48549','C48549','Tube Dosing Unit','DB-NCIT'),('DBX-NCIT-C48551','C48551','Vial Dosing Unit','DB-NCIT'),('DBX-NCIT-C48552','C48552','Wafer Dosing Unit','DB-NCIT'),('DBX-NCIT-C48553','C48553','Yard','DB-NCIT'),('DBX-NCIT-C48555','C48555','Mole per Liter','DB-NCIT'),('DBX-NCIT-C48571','C48571','Percent Volume per Volume','DB-NCIT'),('DBX-NCIT-C48577','C48577','Fluid Ounce British','DB-NCIT'),('DBX-NCIT-C48579','C48579','International Unit','DB-NCIT'),('DBX-NCIT-C4858','C4858','Placental Neoplasm','DB-NCIT'),('DBX-NCIT-C48589','C48589','Base of the Heart','DB-NCIT'),('DBX-NCIT-C48590','C48590','Quantity Sufficient','DB-NCIT'),('DBX-NCIT-C4861','C4861','Acute Monocytic Leukemia','DB-NCIT'),('DBX-NCIT-C48623','C48623','Route of Administration Not Applicable','DB-NCIT'),('DBX-NCIT-C48624','C48624','Dosage Form Not Applicable','DB-NCIT'),('DBX-NCIT-C48658','C48658','Indeterminate','DB-NCIT'),('DBX-NCIT-C48660','C48660','Not Applicable','DB-NCIT'),('DBX-NCIT-C4870','C4870','Complete Remission','DB-NCIT'),('DBX-NCIT-C4876','C4876','Symptom','DB-NCIT'),('DBX-NCIT-C48789','C48789','Dual X-ray Absorptiometry','DB-NCIT'),('DBX-NCIT-C48939','C48939','Bladder Fundus','DB-NCIT'),('DBX-NCIT-C48953','C48953','Farm','DB-NCIT'),('DBX-NCIT-C49018','C49018','Regional Lymph Node','DB-NCIT'),('DBX-NCIT-C49161','C49161','Refuse','DB-NCIT'),('DBX-NCIT-C49282','C49282','Hilar Area of the Lung','DB-NCIT'),('DBX-NCIT-C49468','C49468','World Health Organization Adverse Reaction Terminology','DB-NCIT'),('DBX-NCIT-C49471','C49471','Thesaurus of Adverse Reaction Term Coding Symbols','DB-NCIT'),('DBX-NCIT-C49474','C49474','International Classification of Diseases','DB-NCIT'),('DBX-NCIT-C49475','C49475','World Health Organization Drug Dictionary','DB-NCIT'),('DBX-NCIT-C49476','C49476','Logical Observation Identifiers Names and Codes','DB-NCIT'),('DBX-NCIT-C49477','C49477','Appendicular Skeleton','DB-NCIT'),('DBX-NCIT-C49484','C49484','Not Done','DB-NCIT'),('DBX-NCIT-C49485','C49485','Heart Septum','DB-NCIT'),('DBX-NCIT-C49487','C49487','No','DB-NCIT'),('DBX-NCIT-C49488','C49488','Yes','DB-NCIT'),('DBX-NCIT-C49494','C49494','Not Recovered or Not Resolved','DB-NCIT'),('DBX-NCIT-C49495','C49495','Recovered or Resolved with Sequelae','DB-NCIT'),('DBX-NCIT-C49496','C49496','Recovering or Resolving','DB-NCIT'),('DBX-NCIT-C49498','C49498','Recovered or Resolved','DB-NCIT'),('DBX-NCIT-C49501','C49501','Drug Interrupted','DB-NCIT'),('DBX-NCIT-C49502','C49502','Drug Withdrawn','DB-NCIT'),('DBX-NCIT-C49503','C49503','Dose Increased','DB-NCIT'),('DBX-NCIT-C49504','C49504','Dose Not Changed','DB-NCIT'),('DBX-NCIT-C49505','C49505','Dose Reduced','DB-NCIT'),('DBX-NCIT-C49507','C49507','Medium','DB-NCIT'),('DBX-NCIT-C49508','C49508','Large','DB-NCIT'),('DBX-NCIT-C49562','C49562','Adverse Event Domain','DB-NCIT'),('DBX-NCIT-C49563','C49563','Analysis Dataset Domain','DB-NCIT'),('DBX-NCIT-C49565','C49565','Autopsy Domain','DB-NCIT'),('DBX-NCIT-C49566','C49566','Bone Measurements Domain','DB-NCIT'),('DBX-NCIT-C49567','C49567','Biopsy Domain','DB-NCIT'),('DBX-NCIT-C49568','C49568','Concomitant Medication Domain','DB-NCIT'),('DBX-NCIT-C49569','C49569','Comment Domain','DB-NCIT'),('DBX-NCIT-C49572','C49572','Demographics Domain','DB-NCIT'),('DBX-NCIT-C49576','C49576','Disposition Domain','DB-NCIT'),('DBX-NCIT-C49578','C49578','Drug Accountability Domain','DB-NCIT'),('DBX-NCIT-C49585','C49585','Protocol Deviations Domain','DB-NCIT'),('DBX-NCIT-C49587','C49587','Exposure Domain','DB-NCIT'),('DBX-NCIT-C49588','C49588','Family History Domain','DB-NCIT'),('DBX-NCIT-C49589','C49589','Healthcare Resource Utilization Domain','DB-NCIT'),('DBX-NCIT-C49592','C49592','Laboratory Data Domain','DB-NCIT'),('DBX-NCIT-C49602','C49602','Microbiology Specimen Domain','DB-NCIT'),('DBX-NCIT-C49603','C49603','Medical History Domain','DB-NCIT'),('DBX-NCIT-C49604','C49604','Meal Data Domain','DB-NCIT'),('DBX-NCIT-C49606','C49606','Pharmacokinetic Concentration Domain','DB-NCIT'),('DBX-NCIT-C49607','C49607','Pharmacokinetic Parameters Domain','DB-NCIT'),('DBX-NCIT-C49608','C49608','Physical Exam Domain','DB-NCIT'),('DBX-NCIT-C49609','C49609','Questionnaire Domain','DB-NCIT'),('DBX-NCIT-C49610','C49610','Subject Characteristics Domain','DB-NCIT'),('DBX-NCIT-C49611','C49611','Surgery Domain','DB-NCIT'),('DBX-NCIT-C49612','C49612','Skin Test Domain','DB-NCIT'),('DBX-NCIT-C49613','C49613','Sleep Polysomnography Domain','DB-NCIT'),('DBX-NCIT-C49615','C49615','Substance Use Domain','DB-NCIT'),('DBX-NCIT-C49616','C49616','Subject Element Domain','DB-NCIT'),('DBX-NCIT-C49617','C49617','Subject Visits Domain','DB-NCIT'),('DBX-NCIT-C49618','C49618','Trial Arms Domain','DB-NCIT'),('DBX-NCIT-C49619','C49619','Trial Elements Domain','DB-NCIT'),('DBX-NCIT-C49620','C49620','Trial Inclusion and Exclusion Criteria Domain','DB-NCIT'),('DBX-NCIT-C49621','C49621','Trial Visits Domain','DB-NCIT'),('DBX-NCIT-C49622','C49622','Vital Signs Domain','DB-NCIT'),('DBX-NCIT-C49626','C49626','Electrocardiogram Domain','DB-NCIT'),('DBX-NCIT-C49628','C49628','Trial Screen Failure','DB-NCIT'),('DBX-NCIT-C49631','C49631','Non-Compliance With Study Drug','DB-NCIT'),('DBX-NCIT-C49632','C49632','Study Terminated By Sponsor','DB-NCIT'),('DBX-NCIT-C49633','C49633','Technical Problem','DB-NCIT'),('DBX-NCIT-C49634','C49634','Withdrawal by Subject','DB-NCIT'),('DBX-NCIT-C49636','C49636','Both','DB-NCIT'),('DBX-NCIT-C49640','C49640','During or After','DB-NCIT'),('DBX-NCIT-C49647','C49647','Control Type','DB-NCIT'),('DBX-NCIT-C49648','C49648','Placebo Control','DB-NCIT'),('DBX-NCIT-C49649','C49649','Active Control','DB-NCIT'),('DBX-NCIT-C49650','C49650','Diagnosis Group','DB-NCIT'),('DBX-NCIT-C49651','C49651','Healthy Subject','DB-NCIT'),('DBX-NCIT-C49652','C49652','Clinical Study by Intent','DB-NCIT'),('DBX-NCIT-C49653','C49653','Diagnosis Study','DB-NCIT'),('DBX-NCIT-C49654','C49654','Cure Study','DB-NCIT'),('DBX-NCIT-C49655','C49655','Adverse Effect Mitigation Study','DB-NCIT'),('DBX-NCIT-C49656','C49656','Treatment Study','DB-NCIT'),('DBX-NCIT-C49657','C49657','Prevention Study','DB-NCIT'),('DBX-NCIT-C49658','C49658','Trial Blinding Schema','DB-NCIT'),('DBX-NCIT-C49659','C49659','Open Label Study','DB-NCIT'),('DBX-NCIT-C49660','C49660','Trial Type','DB-NCIT'),('DBX-NCIT-C49661','C49661','Pharmacogenomic Study','DB-NCIT'),('DBX-NCIT-C49662','C49662','Pharmacodynamic Study','DB-NCIT'),('DBX-NCIT-C49663','C49663','Pharmacokinetic Study','DB-NCIT'),('DBX-NCIT-C49664','C49664','Bioavailability Study','DB-NCIT'),('DBX-NCIT-C49665','C49665','Therapeutic Equivalency Study','DB-NCIT'),('DBX-NCIT-C49666','C49666','Efficacy Study','DB-NCIT'),('DBX-NCIT-C49667','C49667','Safety Study','DB-NCIT'),('DBX-NCIT-C49668','C49668','Centimeter','DB-NCIT'),('DBX-NCIT-C49670','C49670','Millimeter of Mercury','DB-NCIT'),('DBX-NCIT-C49671','C49671','Kilogram per Square Meter','DB-NCIT'),('DBX-NCIT-C49673','C49673','Beats per Minute','DB-NCIT'),('DBX-NCIT-C49674','C49674','Breaths per Minute','DB-NCIT'),('DBX-NCIT-C49676','C49676','Pulse Rate','DB-NCIT'),('DBX-NCIT-C49677','C49677','Heart Rate','DB-NCIT'),('DBX-NCIT-C49678','C49678','Respiratory Rate','DB-NCIT'),('DBX-NCIT-C49679','C49679','Mean Arterial Pressure','DB-NCIT'),('DBX-NCIT-C49680','C49680','Body Frame Size','DB-NCIT'),('DBX-NCIT-C49686','C49686','Phase IIa Trial','DB-NCIT'),('DBX-NCIT-C49687','C49687','Phase IIIa Trial','DB-NCIT'),('DBX-NCIT-C49688','C49688','Phase IIb Trial','DB-NCIT'),('DBX-NCIT-C49689','C49689','Phase IIIb Trial','DB-NCIT'),('DBX-NCIT-C49692','C49692','Planned Subject Number','DB-NCIT'),('DBX-NCIT-C49693','C49693','Planned Minimum Age of Subjects','DB-NCIT'),('DBX-NCIT-C49694','C49694','Planned Maximum Age of Subjects','DB-NCIT'),('DBX-NCIT-C49696','C49696','Sex of Study Group','DB-NCIT'),('DBX-NCIT-C49697','C49697','Trial Length','DB-NCIT'),('DBX-NCIT-C49698','C49698','Study Stop Rule','DB-NCIT'),('DBX-NCIT-C49703','C49703','Test Product Added to Existing Treatment','DB-NCIT'),('DBX-NCIT-C49802','C49802','Trial Title','DB-NCIT'),('DBX-NCIT-C50322','C50322','Test Strip Device Component','DB-NCIT'),('DBX-NCIT-C50540','C50540','ST Segment Elevation by ECG Finding','DB-NCIT'),('DBX-NCIT-C50553','C50553','Exit Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C50599','C50599','Idioventricular Rhythm','DB-NCIT'),('DBX-NCIT-C50718','C50718','Pus','DB-NCIT'),('DBX-NCIT-C50779','C50779','Torsades De Pointes by ECG Finding','DB-NCIT'),('DBX-NCIT-C50799','C50799','Ventricular Fibrillation','DB-NCIT'),('DBX-NCIT-C50815','C50815','Aortic Valve Replacement','DB-NCIT'),('DBX-NCIT-C50816','C50816','Tricuspid Valve Replacement','DB-NCIT'),('DBX-NCIT-C50817','C50817','Pulmonary Valve Replacement','DB-NCIT'),('DBX-NCIT-C50825','C50825','Mitral Valve Replacement','DB-NCIT'),('DBX-NCIT-C50913','C50913','Invalid Data','DB-NCIT'),('DBX-NCIT-C50921','C50921','Staphylococcus aureus','DB-NCIT'),('DBX-NCIT-C51618','C51618','Pericardial Window Procedure','DB-NCIT'),('DBX-NCIT-C51773','C51773','Married','DB-NCIT'),('DBX-NCIT-C51774','C51774','Never Married','DB-NCIT'),('DBX-NCIT-C51775','C51775','Widowed','DB-NCIT'),('DBX-NCIT-C51776','C51776','Divorced','DB-NCIT'),('DBX-NCIT-C51777','C51777','Separated','DB-NCIT'),('DBX-NCIT-C51811','C51811','Clinical Coordinator','DB-NCIT'),('DBX-NCIT-C51828','C51828','Guardian','DB-NCIT'),('DBX-NCIT-C51946','C51946','Erythrocyte Count','DB-NCIT'),('DBX-NCIT-C51947','C51947','Reticulocyte Count','DB-NCIT'),('DBX-NCIT-C51948','C51948','Leukocyte Count','DB-NCIT'),('DBX-NCIT-C51949','C51949','Lymphocyte Count','DB-NCIT'),('DBX-NCIT-C51951','C51951','Platelet Count','DB-NCIT'),('DBX-NCIT-C51955','C51955','Bacterial Typing Procedure','DB-NCIT'),('DBX-NCIT-C51962','C51962','Real Time PCR','DB-NCIT'),('DBX-NCIT-C51996','C51996','Elective Surgical Procedure','DB-NCIT'),('DBX-NCIT-C51998','C51998','Coronary Artery Bypass Surgery','DB-NCIT'),('DBX-NCIT-C52002','C52002','Endarterectomy','DB-NCIT'),('DBX-NCIT-C52010','C52010','Pericardiocentesis','DB-NCIT'),('DBX-NCIT-C5219','C5219','Benign Ovarian Thecoma','DB-NCIT'),('DBX-NCIT-C52557','C52557','Parasympathetic Ganglion','DB-NCIT'),('DBX-NCIT-C52560','C52560','Gluteus Maximus','DB-NCIT'),('DBX-NCIT-C52658','C52658','Full Time Employment','DB-NCIT'),('DBX-NCIT-C52713','C52713','Cingulate Cortex','DB-NCIT'),('DBX-NCIT-C52730','C52730','Sternal Manubrium','DB-NCIT'),('DBX-NCIT-C52745','C52745','Palatine Bone','DB-NCIT'),('DBX-NCIT-C52749','C52749','Leg Skin','DB-NCIT'),('DBX-NCIT-C52754','C52754','Arm Skin','DB-NCIT'),('DBX-NCIT-C52756','C52756','Neck Skin','DB-NCIT'),('DBX-NCIT-C52757','C52757','Head Skin','DB-NCIT'),('DBX-NCIT-C52758','C52758','Abdominal Skin','DB-NCIT'),('DBX-NCIT-C52759','C52759','Rib 9','DB-NCIT'),('DBX-NCIT-C52760','C52760','Rib 8','DB-NCIT'),('DBX-NCIT-C52761','C52761','Rib 7','DB-NCIT'),('DBX-NCIT-C52762','C52762','Rib 6','DB-NCIT'),('DBX-NCIT-C52763','C52763','Rib 5','DB-NCIT'),('DBX-NCIT-C52764','C52764','Rib 4','DB-NCIT'),('DBX-NCIT-C52765','C52765','Rib 3','DB-NCIT'),('DBX-NCIT-C52766','C52766','Rib 2','DB-NCIT'),('DBX-NCIT-C52767','C52767','Rib 12','DB-NCIT'),('DBX-NCIT-C52768','C52768','Rib 11','DB-NCIT'),('DBX-NCIT-C52769','C52769','Rib 10','DB-NCIT'),('DBX-NCIT-C52770','C52770','Rib 1','DB-NCIT'),('DBX-NCIT-C52771','C52771','Hand Phalanx','DB-NCIT'),('DBX-NCIT-C52772','C52772','Foot Phalanx','DB-NCIT'),('DBX-NCIT-C52799','C52799','Talus','DB-NCIT'),('DBX-NCIT-C52810','C52810','Sciatic Nerve','DB-NCIT'),('DBX-NCIT-C52834','C52834','Hand Digit 1','DB-NCIT'),('DBX-NCIT-C52835','C52835','Hand Digit 2','DB-NCIT'),('DBX-NCIT-C52836','C52836','Hand Digit 3','DB-NCIT'),('DBX-NCIT-C52837','C52837','Hand Digit 4','DB-NCIT'),('DBX-NCIT-C52838','C52838','Hand Digit 5','DB-NCIT'),('DBX-NCIT-C52839','C52839','Foot Digit 1','DB-NCIT'),('DBX-NCIT-C52840','C52840','Foot Digit 2','DB-NCIT'),('DBX-NCIT-C52841','C52841','Foot Digit 3','DB-NCIT'),('DBX-NCIT-C52842','C52842','Foot Digit 4','DB-NCIT'),('DBX-NCIT-C52843','C52843','Foot Digit 5','DB-NCIT'),('DBX-NCIT-C52941','C52941','Internal Mammary Artery','DB-NCIT'),('DBX-NCIT-C53073','C53073','Vastus Lateralis','DB-NCIT'),('DBX-NCIT-C53146','C53146','Popliteal Lymph Node','DB-NCIT'),('DBX-NCIT-C53147','C53147','Biceps Femoris','DB-NCIT'),('DBX-NCIT-C53175','C53175','Rectus Femoris','DB-NCIT'),('DBX-NCIT-C53176','C53176','Semitendinosus','DB-NCIT'),('DBX-NCIT-C53262','C53262','Domestic Partnership','DB-NCIT'),('DBX-NCIT-C53265','C53265','Type of Device','DB-NCIT'),('DBX-NCIT-C53279','C53279','Continue','DB-NCIT'),('DBX-NCIT-C53287','C53287','Health Care Professional','DB-NCIT'),('DBX-NCIT-C53414','C53414','Composition','DB-NCIT'),('DBX-NCIT-C53454','C53454','Influenza A Virus','DB-NCIT'),('DBX-NCIT-C53459','C53459','Chondroma','DB-NCIT'),('DBX-NCIT-C53468','C53468','Influenza B Virus','DB-NCIT'),('DBX-NCIT-C53471','C53471','Isolate','DB-NCIT'),('DBX-NCIT-C53483','C53483','Trial Summary Domain','DB-NCIT'),('DBX-NCIT-C53489','C53489','Systematized Nomenclature of Medicine','DB-NCIT'),('DBX-NCIT-C53536','C53536','Psychiatric Facility','DB-NCIT'),('DBX-NCIT-C5358','C5358','Benign Cardiac Schwannoma','DB-NCIT'),('DBX-NCIT-C53684','C53684','Benign Connective and Soft Tissue Neoplasm','DB-NCIT'),('DBX-NCIT-C54055','C54055','Retreatment','DB-NCIT'),('DBX-NCIT-C54125','C54125','Calculation','DB-NCIT'),('DBX-NCIT-C54187','C54187','Floor of Mouth','DB-NCIT'),('DBX-NCIT-C54188','C54188','Rectosigmoid Region','DB-NCIT'),('DBX-NCIT-C54272','C54272','Throat','DB-NCIT'),('DBX-NCIT-C54297','C54297','Metastasizing Ameloblastoma','DB-NCIT'),('DBX-NCIT-C54703','C54703','Cup Dosing Unit','DB-NCIT'),('DBX-NCIT-C54711','C54711','Atmosphere','DB-NCIT'),('DBX-NCIT-C581','C581','Therapeutic Insulin','DB-NCIT'),('DBX-NCIT-C60334','C60334','Rat Benign Chordoma','DB-NCIT'),('DBX-NCIT-C60340','C60340','Rat Benign Granulosa Cell Tumor','DB-NCIT'),('DBX-NCIT-C60490','C60490','Rat Pars Distalis Adenoma','DB-NCIT'),('DBX-NCIT-C60491','C60491','Rat Pars Distalis Carcinoma','DB-NCIT'),('DBX-NCIT-C60493','C60493','Rat Pars Intermedia Adenoma','DB-NCIT'),('DBX-NCIT-C60781','C60781','Astrocytoma','DB-NCIT'),('DBX-NCIT-C60832','C60832','Oxygen Saturation Measurement','DB-NCIT'),('DBX-NCIT-C6088','C6088','External Auditory Canal Ceruminous Adenoma','DB-NCIT'),('DBX-NCIT-C60884','C60884','Cloth Dosage Form','DB-NCIT'),('DBX-NCIT-C60891','C60891','Concentrated Dosage Form','DB-NCIT'),('DBX-NCIT-C60897','C60897','Augmented Cream Dosage Form','DB-NCIT'),('DBX-NCIT-C60926','C60926','Extended Release Fiber Dosage Form','DB-NCIT'),('DBX-NCIT-C60927','C60927','Dosage Form for Solution','DB-NCIT'),('DBX-NCIT-C60928','C60928','Dosage Form for Suspension','DB-NCIT'),('DBX-NCIT-C60929','C60929','Extended Release Dosage Form for Suspension','DB-NCIT'),('DBX-NCIT-C60930','C60930','Metered Gel Dosage Form','DB-NCIT'),('DBX-NCIT-C60931','C60931','Liposomal Injection Dosage Form','DB-NCIT'),('DBX-NCIT-C60933','C60933','Insert Dosage Form','DB-NCIT'),('DBX-NCIT-C60934','C60934','Extended Release Liquid Dosage Form','DB-NCIT'),('DBX-NCIT-C60957','C60957','Augmented Lotion Dosage Form','DB-NCIT'),('DBX-NCIT-C60958','C60958','Lotion Shampoo Dosage Form','DB-NCIT'),('DBX-NCIT-C60984','C60984','Augmented Ointment Dosage Form','DB-NCIT'),('DBX-NCIT-C60985','C60985','Pastille Dosage Form','DB-NCIT'),('DBX-NCIT-C60988','C60988','Ring Dosage Form','DB-NCIT'),('DBX-NCIT-C60992','C60992','Drop Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C60994','C60994','Gel Forming Drop Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C60995','C60995','Drop Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C60997','C60997','Tablet Coated Particle Dosage Form','DB-NCIT'),('DBX-NCIT-C61004','C61004','Tablet for Solution Dosage Form','DB-NCIT'),('DBX-NCIT-C61005','C61005','Tablet for Suspension Dosage Form','DB-NCIT'),('DBX-NCIT-C61006','C61006','Orally Disintegrating Delayed Release Tablet Dosage Form','DB-NCIT'),('DBX-NCIT-C61019','C61019','Blood Urea Nitrogen Measurement','DB-NCIT'),('DBX-NCIT-C61123','C61123','Penile Portion of the Urethra','DB-NCIT'),('DBX-NCIT-C61125','C61125','Anterior Portion of the Urethra','DB-NCIT'),('DBX-NCIT-C61126','C61126','Posterior Portion of the Urethra','DB-NCIT'),('DBX-NCIT-C61395','C61395','R On T Phenomenon by ECG Finding','DB-NCIT'),('DBX-NCIT-C61529','C61529','Pharmacogenomics Domain','DB-NCIT'),('DBX-NCIT-C61531','C61531','Microbiology Susceptibility Domain','DB-NCIT'),('DBX-NCIT-C61536','C61536','Inclusion Exclusion Domain','DB-NCIT'),('DBX-NCIT-C61563','C61563','Femoral Neck','DB-NCIT'),('DBX-NCIT-C61575','C61575','Extraction','DB-NCIT'),('DBX-NCIT-C61599','C61599','Male Genitalia','DB-NCIT'),('DBX-NCIT-C61600','C61600','Female Genitalia','DB-NCIT'),('DBX-NCIT-C62004','C62004','Lysate','DB-NCIT'),('DBX-NCIT-C62016','C62016','AV Block Second Degree by ECG Finding','DB-NCIT'),('DBX-NCIT-C62086','C62086','Mean PR Duration','DB-NCIT'),('DBX-NCIT-C62087','C62087','Mean QRS Duration','DB-NCIT'),('DBX-NCIT-C62089','C62089','Mean QT Duration','DB-NCIT'),('DBX-NCIT-C62090','C62090','Mean RR Duration','DB-NCIT'),('DBX-NCIT-C62093','C62093','Minimum RR Duration','DB-NCIT'),('DBX-NCIT-C62094','C62094','Maximum RR Duration','DB-NCIT'),('DBX-NCIT-C62095','C62095','Mean Heart Rate','DB-NCIT'),('DBX-NCIT-C62096','C62096','Minimum Heart Rate','DB-NCIT'),('DBX-NCIT-C62112','C62112','QTcB - Bazett\'s Correction Formula','DB-NCIT'),('DBX-NCIT-C62113','C62113','QTcF - Fridericia\'s Correction Formula','DB-NCIT'),('DBX-NCIT-C62114','C62114','QTcLC - Linear Correction Formula','DB-NCIT'),('DBX-NCIT-C62115','C62115','Mean JT Duration','DB-NCIT'),('DBX-NCIT-C62116','C62116','Minimum JT Duration','DB-NCIT'),('DBX-NCIT-C62117','C62117','Maximum JT Duration','DB-NCIT'),('DBX-NCIT-C62118','C62118','JTcB - Bazett\'s Correction Formula','DB-NCIT'),('DBX-NCIT-C62119','C62119','JTcF - Fridericia\'s Correction Formula','DB-NCIT'),('DBX-NCIT-C62120','C62120','JTcLC - Linear Correction Formula','DB-NCIT'),('DBX-NCIT-C62122','C62122','Sitting','DB-NCIT'),('DBX-NCIT-C62123','C62123','Mean P Wave Duration','DB-NCIT'),('DBX-NCIT-C62124','C62124','Mean P Wave Height','DB-NCIT'),('DBX-NCIT-C62125','C62125','Minimum PR Duration','DB-NCIT'),('DBX-NCIT-C62131','C62131','Maximum PR Duration','DB-NCIT'),('DBX-NCIT-C62133','C62133','Minimum QT Duration','DB-NCIT'),('DBX-NCIT-C62135','C62135','Maximum QT Duration','DB-NCIT'),('DBX-NCIT-C62136','C62136','Mean R Wave Amplitude','DB-NCIT'),('DBX-NCIT-C62137','C62137','Mean S Wave Amplitude','DB-NCIT'),('DBX-NCIT-C62144','C62144','Mean R+S Amplitude','DB-NCIT'),('DBX-NCIT-C62145','C62145','Mean ST Segment Duration','DB-NCIT'),('DBX-NCIT-C62147','C62147','Mean T Wave Duration','DB-NCIT'),('DBX-NCIT-C62148','C62148','Mean T Wave Area','DB-NCIT'),('DBX-NCIT-C62149','C62149','Mean T Wave Height','DB-NCIT'),('DBX-NCIT-C62152','C62152','Mean Ventricular Heart Rate','DB-NCIT'),('DBX-NCIT-C62153','C62153','Minimum Ventricular Heart Rate','DB-NCIT'),('DBX-NCIT-C62154','C62154','Maximum Ventricular Heart Rate','DB-NCIT'),('DBX-NCIT-C62155','C62155','Mean ST Deviation','DB-NCIT'),('DBX-NCIT-C62156','C62156','Minimum ST Deviation','DB-NCIT'),('DBX-NCIT-C62157','C62157','Maximum ST Deviation','DB-NCIT'),('DBX-NCIT-C62158','C62158','Mean ST Segment Elevation','DB-NCIT'),('DBX-NCIT-C62159','C62159','Minimum ST Segment Elevation','DB-NCIT'),('DBX-NCIT-C62160','C62160','Maximum ST Segment Elevation','DB-NCIT'),('DBX-NCIT-C62161','C62161','Mean ST Segment Depression by ECG Finding','DB-NCIT'),('DBX-NCIT-C62162','C62162','Minimum ST Segment Depression by ECG Finding','DB-NCIT'),('DBX-NCIT-C62163','C62163','Maximum ST Segment Depression by ECG Finding','DB-NCIT'),('DBX-NCIT-C62165','C62165','Prone Position','DB-NCIT'),('DBX-NCIT-C62166','C62166','Standing','DB-NCIT'),('DBX-NCIT-C62167','C62167','Supine Position','DB-NCIT'),('DBX-NCIT-C62168','C62168','Trendelenburg','DB-NCIT'),('DBX-NCIT-C62169','C62169','Reverse Trendelenburg','DB-NCIT'),('DBX-NCIT-C62171','C62171','Right Lateral Decubitus Position','DB-NCIT'),('DBX-NCIT-C62172','C62172','Left Lateral Decubitus Position','DB-NCIT'),('DBX-NCIT-C62173','C62173','Fowler\'s Position','DB-NCIT'),('DBX-NCIT-C62174','C62174','Semi-Fowler\'s Position','DB-NCIT'),('DBX-NCIT-C62222','C62222','Unevaluable','DB-NCIT'),('DBX-NCIT-C62234','C62234','Monomorphic Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C62236','C62236','Polymorphic Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C62239','C62239','Sinus Arrhythmia by ECG Finding','DB-NCIT'),('DBX-NCIT-C62240','C62240','Wandering Atrial Pacemaker by ECG Finding','DB-NCIT'),('DBX-NCIT-C62242','C62242','Sinus Arrest by ECG Finding','DB-NCIT'),('DBX-NCIT-C62245','C62245','Ectopic Atrial Rhythm by ECG Finding','DB-NCIT'),('DBX-NCIT-C62246','C62246','Short PR Interval by ECG Finding','DB-NCIT'),('DBX-NCIT-C62248','C62248','Isorhythmic Atrioventricular Dissociation','DB-NCIT'),('DBX-NCIT-C62250','C62250','Paroxysmal Atrioventricular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C62256','C62256','Ventricular Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C62257','C62257','Atrial Premature Complex by ECG Finding','DB-NCIT'),('DBX-NCIT-C62258','C62258','Delta Wave by ECG Finding','DB-NCIT'),('DBX-NCIT-C62259','C62259','Ventricular Couplet by ECG Finding','DB-NCIT'),('DBX-NCIT-C62261','C62261','Atrioventricular Reentrant Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C62266','C62266','Accelerated Idioventricular Rhythm by ECG Finding','DB-NCIT'),('DBX-NCIT-C62267','C62267','Left Anterior Fascicular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C62268','C62268','Left Posterior Fascicular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C62269','C62269','Left Bundle Branch Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C62270','C62270','Right Bundle Branch Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C62271','C62271','Nonspecific Intraventricular Conduction Delay by ECG Finding','DB-NCIT'),('DBX-NCIT-C62298','C62298','Dental Percussion','DB-NCIT'),('DBX-NCIT-C62322','C62322','Fluorimetry','DB-NCIT'),('DBX-NCIT-C62329','C62329','Photon Correlation Spectroscopy','DB-NCIT'),('DBX-NCIT-C62432','C62432','Uncinate Process of Pancreas','DB-NCIT'),('DBX-NCIT-C62484','C62484','Chest Wall','DB-NCIT'),('DBX-NCIT-C62583','C62583','Staphylococcus','DB-NCIT'),('DBX-NCIT-C62584','C62584','Coagulase-Negative Staphylococcus','DB-NCIT'),('DBX-NCIT-C62585','C62585','Coagulase-Positive Staphylococcus','DB-NCIT'),('DBX-NCIT-C62589','C62589','Gram-Positive Rod','DB-NCIT'),('DBX-NCIT-C62607','C62607','Definitive','DB-NCIT'),('DBX-NCIT-C62609','C62609','Ring Dosing Unit','DB-NCIT'),('DBX-NCIT-C62648','C62648','Emergency','DB-NCIT'),('DBX-NCIT-C62649','C62649','Spouse','DB-NCIT'),('DBX-NCIT-C62653','C62653','Pack','DB-NCIT'),('DBX-NCIT-C62656','C62656','Prothrombin Time','DB-NCIT'),('DBX-NCIT-C62665','C62665','Dynamic Contrast-Enhanced Magnetic Resonance Imaging','DB-NCIT'),('DBX-NCIT-C62667','C62667','Radionuclide Imaging','DB-NCIT'),('DBX-NCIT-C62730','C62730','Infrared Photocoagulation Therapy','DB-NCIT'),('DBX-NCIT-C62954','C62954','Medical Device Operational Issue','DB-NCIT'),('DBX-NCIT-C62994','C62994','Medical Device Failure to Calibrate','DB-NCIT'),('DBX-NCIT-C63269','C63269','Computer Software Problem Associated with Medical Device','DB-NCIT'),('DBX-NCIT-C63321','C63321','Absolute Neutrophil Count','DB-NCIT'),('DBX-NCIT-C63705','C63705','Infraclavicular Lymph Node','DB-NCIT'),('DBX-NCIT-C63706','C63706','Facial Bone','DB-NCIT'),('DBX-NCIT-C63797','C63797','Circulating Tumor Cell','DB-NCIT'),('DBX-NCIT-C63861','C63861','Technician','DB-NCIT'),('DBX-NCIT-C64118','C64118','Malignant Mesenchymal Tumor of the Rat Kidney','DB-NCIT'),('DBX-NCIT-C64192','C64192','Waist','DB-NCIT'),('DBX-NCIT-C64193','C64193','Hip','DB-NCIT'),('DBX-NCIT-C64251','C64251','Left Ventricular Systolic Dysfunction','DB-NCIT'),('DBX-NCIT-C6433','C6433','Endometrial Polyp','DB-NCIT'),('DBX-NCIT-C64374','C64374','Jersey','DB-NCIT'),('DBX-NCIT-C64375','C64375','Guernsey','DB-NCIT'),('DBX-NCIT-C64377','C64377','Serbia','DB-NCIT'),('DBX-NCIT-C64378','C64378','Montenegro','DB-NCIT'),('DBX-NCIT-C64387','C64387','Millimole per Liter','DB-NCIT'),('DBX-NCIT-C64431','C64431','Albumin Measurement','DB-NCIT'),('DBX-NCIT-C64432','C64432','Alkaline Phosphatase Measurement','DB-NCIT'),('DBX-NCIT-C64433','C64433','Alanine Aminotransferase Measurement','DB-NCIT'),('DBX-NCIT-C64434','C64434','Amylase Measurement','DB-NCIT'),('DBX-NCIT-C64467','C64467','Aspartate Aminotransferase Measurement','DB-NCIT'),('DBX-NCIT-C64469','C64469','Bacterial Count','DB-NCIT'),('DBX-NCIT-C64470','C64470','Total Basophil Count','DB-NCIT'),('DBX-NCIT-C64471','C64471','Basophil to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64481','C64481','Direct Bilirubin Measurement','DB-NCIT'),('DBX-NCIT-C64483','C64483','Indirect Bilirubin Measurement','DB-NCIT'),('DBX-NCIT-C64487','C64487','Blast to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64488','C64488','Calcium Measurement','DB-NCIT'),('DBX-NCIT-C64489','C64489','Creatine Kinase Measurement','DB-NCIT'),('DBX-NCIT-C64490','C64490','Creatine Kinase BB Measurement','DB-NCIT'),('DBX-NCIT-C64491','C64491','Creatine Kinase MB Measurement','DB-NCIT'),('DBX-NCIT-C64494','C64494','Creatine Kinase MM Measurement','DB-NCIT'),('DBX-NCIT-C64495','C64495','Chloride Measurement','DB-NCIT'),('DBX-NCIT-C64496','C64496','Twice Daily','DB-NCIT'),('DBX-NCIT-C64497','C64497','Twice Weekly','DB-NCIT'),('DBX-NCIT-C64498','C64498','Monthly','DB-NCIT'),('DBX-NCIT-C64499','C64499','As Necessary','DB-NCIT'),('DBX-NCIT-C64500','C64500','Every Ten Hours','DB-NCIT'),('DBX-NCIT-C64501','C64501','Every Eleven Hours','DB-NCIT'),('DBX-NCIT-C64502','C64502','Every Twelve Hours','DB-NCIT'),('DBX-NCIT-C64503','C64503','Every Thirteen Hours','DB-NCIT'),('DBX-NCIT-C64504','C64504','Every Fourteen Hours','DB-NCIT'),('DBX-NCIT-C64505','C64505','Every Fifteen Hours','DB-NCIT'),('DBX-NCIT-C64506','C64506','Every Sixteen Hours','DB-NCIT'),('DBX-NCIT-C64507','C64507','Every Seventeen Hours','DB-NCIT'),('DBX-NCIT-C64508','C64508','Every Eighteen Hours','DB-NCIT'),('DBX-NCIT-C64509','C64509','Every Nineteen Hours','DB-NCIT'),('DBX-NCIT-C64510','C64510','Every Hour','DB-NCIT'),('DBX-NCIT-C64511','C64511','Every Twenty Hours','DB-NCIT'),('DBX-NCIT-C64512','C64512','Every Twenty-One Hours','DB-NCIT'),('DBX-NCIT-C64513','C64513','Every Twenty-Two Hours','DB-NCIT'),('DBX-NCIT-C64514','C64514','Every Twenty-Three Hours','DB-NCIT'),('DBX-NCIT-C64515','C64515','Every Twenty-Four Hours','DB-NCIT'),('DBX-NCIT-C64516','C64516','Every Two Hours','DB-NCIT'),('DBX-NCIT-C64517','C64517','Every Three Hours','DB-NCIT'),('DBX-NCIT-C64518','C64518','Every Four Hours','DB-NCIT'),('DBX-NCIT-C64519','C64519','Every Five Hours','DB-NCIT'),('DBX-NCIT-C64520','C64520','Every Six Hours','DB-NCIT'),('DBX-NCIT-C64521','C64521','Every Seven Hours','DB-NCIT'),('DBX-NCIT-C64523','C64523','Every Eight Hours','DB-NCIT'),('DBX-NCIT-C64524','C64524','Every Nine Hours','DB-NCIT'),('DBX-NCIT-C64525','C64525','Every Other Day','DB-NCIT'),('DBX-NCIT-C64526','C64526','Once Weekly','DB-NCIT'),('DBX-NCIT-C64527','C64527','Three Times Daily','DB-NCIT'),('DBX-NCIT-C64528','C64528','Three Times Weekly','DB-NCIT'),('DBX-NCIT-C64529','C64529','Every Four Weeks','DB-NCIT'),('DBX-NCIT-C64530','C64530','Four Times Daily','DB-NCIT'),('DBX-NCIT-C64531','C64531','Four Times Weekly','DB-NCIT'),('DBX-NCIT-C64533','C64533','Every Three Days','DB-NCIT'),('DBX-NCIT-C64534','C64534','Every Four Days','DB-NCIT'),('DBX-NCIT-C64535','C64535','Every Three Weeks','DB-NCIT'),('DBX-NCIT-C64536','C64536','Every Two Months','DB-NCIT'),('DBX-NCIT-C64537','C64537','Every Three Months','DB-NCIT'),('DBX-NCIT-C64538','C64538','Every Four Months','DB-NCIT'),('DBX-NCIT-C64545','C64545','Carbon Dioxide Measurement','DB-NCIT'),('DBX-NCIT-C64546','C64546','Color Assessment','DB-NCIT'),('DBX-NCIT-C64547','C64547','Creatinine Measurement','DB-NCIT'),('DBX-NCIT-C64548','C64548','C-Reactive Protein Measurement','DB-NCIT'),('DBX-NCIT-C64549','C64549','Elliptocyte Count','DB-NCIT'),('DBX-NCIT-C64550','C64550','Eosinophil Count','DB-NCIT'),('DBX-NCIT-C64551','C64551','Picogram','DB-NCIT'),('DBX-NCIT-C64552','C64552','Femtogram','DB-NCIT'),('DBX-NCIT-C64553','C64553','Attogram','DB-NCIT'),('DBX-NCIT-C64554','C64554','Centigram','DB-NCIT'),('DBX-NCIT-C64559','C64559','Atomic Mass Unit','DB-NCIT'),('DBX-NCIT-C64564','C64564','Dram Mass Unit','DB-NCIT'),('DBX-NCIT-C64566','C64566','Kilogram per Liter','DB-NCIT'),('DBX-NCIT-C64572','C64572','Microgram per Milliliter','DB-NCIT'),('DBX-NCIT-C64576','C64576','Once','DB-NCIT'),('DBX-NCIT-C64604','C64604','Eosinophil to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64605','C64605','Epithelial Cell Count','DB-NCIT'),('DBX-NCIT-C64606','C64606','Fibrinogen Measurement','DB-NCIT'),('DBX-NCIT-C64636','C64636','As Much as Desired','DB-NCIT'),('DBX-NCIT-C64693','C64693','Centigray','DB-NCIT'),('DBX-NCIT-C64696','C64696','Caplet Dosing Unit','DB-NCIT'),('DBX-NCIT-C64697','C64697','Deciliter','DB-NCIT'),('DBX-NCIT-C64777','C64777','Milliliter per Minute','DB-NCIT'),('DBX-NCIT-C64778','C64778','Enzyme Unit','DB-NCIT'),('DBX-NCIT-C64780','C64780','Femtoliter','DB-NCIT'),('DBX-NCIT-C64783','C64783','Gram per Deciliter','DB-NCIT'),('DBX-NCIT-C64796','C64796','Hematocrit Measurement','DB-NCIT'),('DBX-NCIT-C64797','C64797','Erythrocyte Mean Corpuscular Hemoglobin','DB-NCIT'),('DBX-NCIT-C64798','C64798','Erythrocyte Mean Corpuscular Hemoglobin Concentration','DB-NCIT'),('DBX-NCIT-C64799','C64799','Erythrocyte Mean Corpuscular Volume','DB-NCIT'),('DBX-NCIT-C64800','C64800','Erythrocyte Distribution Width Measurement','DB-NCIT'),('DBX-NCIT-C64801','C64801','Dacryocyte Analysis','DB-NCIT'),('DBX-NCIT-C64802','C64802','Hypochromia','DB-NCIT'),('DBX-NCIT-C64803','C64803','Polychromasia','DB-NCIT'),('DBX-NCIT-C64805','C64805','International Normalized Ratio of Prothrombin Time','DB-NCIT'),('DBX-NCIT-C64809','C64809','Sodium Measurement','DB-NCIT'),('DBX-NCIT-C64810','C64810','Nitrite Measurement','DB-NCIT'),('DBX-NCIT-C64812','C64812','Triglyceride Measurement','DB-NCIT'),('DBX-NCIT-C64813','C64813','Thyrotropin Measurement','DB-NCIT'),('DBX-NCIT-C64814','C64814','Urate Measurement','DB-NCIT'),('DBX-NCIT-C64815','C64815','Urea Measurement','DB-NCIT'),('DBX-NCIT-C64816','C64816','Urobilinogen Measurement','DB-NCIT'),('DBX-NCIT-C64817','C64817','Vitamin B12 Measurement','DB-NCIT'),('DBX-NCIT-C64818','C64818','Atypical Lymphocyte Count','DB-NCIT'),('DBX-NCIT-C64819','C64819','Atypical Lymphocyte to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64820','C64820','Lymphocyte to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64821','C64821','Macrocyte Count','DB-NCIT'),('DBX-NCIT-C64822','C64822','Microcyte Count','DB-NCIT'),('DBX-NCIT-C64823','C64823','Monocyte Count','DB-NCIT'),('DBX-NCIT-C64824','C64824','Monocyte to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64825','C64825','Myeloblast to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64826','C64826','Myelocyte to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64827','C64827','Neutrophil to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64828','C64828','Reticulocyte to Erythrocyte Ratio','DB-NCIT'),('DBX-NCIT-C64829','C64829','Prolymphocyte to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64830','C64830','Neutrophil Band Form Count','DB-NCIT'),('DBX-NCIT-C64831','C64831','Neutrophil Band Form to Leukocyte Ratio','DB-NCIT'),('DBX-NCIT-C64832','C64832','Specific Gravity','DB-NCIT'),('DBX-NCIT-C64840','C64840','Magnesium Measurement','DB-NCIT'),('DBX-NCIT-C64847','C64847','Gamma Glutamyl Transpeptidase Measurement','DB-NCIT'),('DBX-NCIT-C64848','C64848','Hemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C64849','C64849','Glycosylated Hemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C64850','C64850','Hepatitis B Virus Surface Antigen Measurement','DB-NCIT'),('DBX-NCIT-C64851','C64851','Choriogonadotropin Beta Measurement','DB-NCIT'),('DBX-NCIT-C64853','C64853','Potassium Measurement','DB-NCIT'),('DBX-NCIT-C64854','C64854','Ketone Measurement','DB-NCIT'),('DBX-NCIT-C64855','C64855','Lactate Dehydrogenase Measurement','DB-NCIT'),('DBX-NCIT-C64856','C64856','Leukocyte Esterase Measurement','DB-NCIT'),('DBX-NCIT-C64857','C64857','Phosphate Measurement','DB-NCIT'),('DBX-NCIT-C64858','C64858','Total Protein Measurement','DB-NCIT'),('DBX-NCIT-C64906','C64906','Oromucosal Route of Administration','DB-NCIT'),('DBX-NCIT-C64916','C64916','All','DB-NCIT'),('DBX-NCIT-C64954','C64954','Infrequent','DB-NCIT'),('DBX-NCIT-C64984','C64984','Intracameral Route of Administration','DB-NCIT'),('DBX-NCIT-C65045','C65045','Picomole','DB-NCIT'),('DBX-NCIT-C65047','C65047','CDISC SDTM Laboratory Test Terminology by Code','DB-NCIT'),('DBX-NCIT-C65060','C65060','Puff Dosing Unit','DB-NCIT'),('DBX-NCIT-C65104','C65104','Square Millimeter','DB-NCIT'),('DBX-NCIT-C65109','C65109','Photometry','DB-NCIT'),('DBX-NCIT-C65126','C65126','Smear','DB-NCIT'),('DBX-NCIT-C65132','C65132','Tuberculin Unit','DB-NCIT'),('DBX-NCIT-C65138','C65138','Administration via Stoma','DB-NCIT'),('DBX-NCIT-C65166','C65166','Celiac Lymph Node','DB-NCIT'),('DBX-NCIT-C65192','C65192','Tubular Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C6569','C6569','Congenital Mesoblastic Nephroma','DB-NCIT'),('DBX-NCIT-C6577','C6577','Myxoma','DB-NCIT'),('DBX-NCIT-C66726','C66726','CDISC SDTM Pharmaceutical Dosage Form Terminology','DB-NCIT'),('DBX-NCIT-C66727','C66727','CDISC SDTM Reason for Non-Completion Terminology','DB-NCIT'),('DBX-NCIT-C66728','C66728','CDISC SDTM Relation to Reference Period Terminology','DB-NCIT'),('DBX-NCIT-C66729','C66729','CDISC SDTM Route of Administration Terminology','DB-NCIT'),('DBX-NCIT-C66731','C66731','CDISC SDTM Sex of Individual Terminology','DB-NCIT'),('DBX-NCIT-C66732','C66732','CDISC SDTM Sex of Study Group Terminology','DB-NCIT'),('DBX-NCIT-C66733','C66733','CDISC SDTM Size Terminology','DB-NCIT'),('DBX-NCIT-C66734','C66734','CDISC SDTM Submission Domain Abbreviation Terminology','DB-NCIT'),('DBX-NCIT-C66735','C66735','CDISC SDTM Trial Blinding Schema Terminology','DB-NCIT'),('DBX-NCIT-C66736','C66736','CDISC SDTM Trial Indication Type Terminology','DB-NCIT'),('DBX-NCIT-C66737','C66737','CDISC SDTM Trial Phase Terminology','DB-NCIT'),('DBX-NCIT-C66738','C66738','CDISC SDTM Trial Summary Parameter Terminology by Code','DB-NCIT'),('DBX-NCIT-C66739','C66739','CDISC SDTM Trial Type Terminology','DB-NCIT'),('DBX-NCIT-C66741','C66741','CDISC SDTM Vital Sign Terminology by Code','DB-NCIT'),('DBX-NCIT-C66742','C66742','CDISC SDTM Yes No Unknown or Not Applicable Response Terminology','DB-NCIT'),('DBX-NCIT-C66760','C66760','Fibromyxoid Neoplasm','DB-NCIT'),('DBX-NCIT-C66767','C66767','CDISC SDTM Action Taken with Study Treatment Terminology','DB-NCIT'),('DBX-NCIT-C66768','C66768','CDISC SDTM Adverse Event Outcome Terminology','DB-NCIT'),('DBX-NCIT-C66769','C66769','CDISC SDTM Severity Intensity Scale for Adverse Event Terminology','DB-NCIT'),('DBX-NCIT-C66770','C66770','CDISC SDTM Unit for Vital Sign Result Terminology','DB-NCIT'),('DBX-NCIT-C66781','C66781','CDISC SDTM Age Unit Terminology','DB-NCIT'),('DBX-NCIT-C66784','C66784','CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology V3.0','DB-NCIT'),('DBX-NCIT-C66785','C66785','CDISC SDTM Control Type Terminology','DB-NCIT'),('DBX-NCIT-C66786','C66786','CDISC SDTM Country Terminology','DB-NCIT'),('DBX-NCIT-C66787','C66787','CDISC SDTM Diagnosis Group Terminology','DB-NCIT'),('DBX-NCIT-C66788','C66788','CDISC SDTM Dictionary Name Terminology','DB-NCIT'),('DBX-NCIT-C66789','C66789','CDISC SDTM Not Done Terminology','DB-NCIT'),('DBX-NCIT-C66790','C66790','CDISC SDTM Ethnic Group Terminology','DB-NCIT'),('DBX-NCIT-C66797','C66797','CDISC SDTM Category for Inclusion And Or Exclusion Terminology','DB-NCIT'),('DBX-NCIT-C66832','C66832','One','DB-NCIT'),('DBX-NCIT-C66864','C66864','Tooth Canal','DB-NCIT'),('DBX-NCIT-C66904','C66904','New York Heart Association Class I','DB-NCIT'),('DBX-NCIT-C66905','C66905','New York Heart Association Class II','DB-NCIT'),('DBX-NCIT-C66907','C66907','New York Heart Association Class III','DB-NCIT'),('DBX-NCIT-C66908','C66908','New York Heart Association Class IV','DB-NCIT'),('DBX-NCIT-C66909','C66909','New York Heart Association Class','DB-NCIT'),('DBX-NCIT-C66910','C66910','Canadian Cardiovascular Society Grading Scale Class','DB-NCIT'),('DBX-NCIT-C66911','C66911','Unstable Angina','DB-NCIT'),('DBX-NCIT-C66914','C66914','Stable Angina','DB-NCIT'),('DBX-NCIT-C66915','C66915','Variant Angina','DB-NCIT'),('DBX-NCIT-C66916','C66916','Killip Class','DB-NCIT'),('DBX-NCIT-C66962','C66962','Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C66965','C66965','Per Second','DB-NCIT'),('DBX-NCIT-C66966','C66966','Per Hour','DB-NCIT'),('DBX-NCIT-C66967','C66967','Per Minute','DB-NCIT'),('DBX-NCIT-C66969','C66969','Milligram per Hour','DB-NCIT'),('DBX-NCIT-C66974','C66974','Milligram per Square Meter per Day','DB-NCIT'),('DBX-NCIT-C66975','C66975','Gram per Kilogram per Day','DB-NCIT'),('DBX-NCIT-C66976','C66976','Milligram per Kilogram per Day','DB-NCIT'),('DBX-NCIT-C66977','C66977','Milliliter per Square Meter per Day','DB-NCIT'),('DBX-NCIT-C67006','C67006','Malignant Sertoli Cell Tumor','DB-NCIT'),('DBX-NCIT-C67012','C67012','Benign Sertoli Cell Tumor','DB-NCIT'),('DBX-NCIT-C67015','C67015','Milligram per Deciliter','DB-NCIT'),('DBX-NCIT-C67069','C67069','Weekly','DB-NCIT'),('DBX-NCIT-C67152','C67152','CDISC SDTM Trial Summary Parameter Terminology by Name','DB-NCIT'),('DBX-NCIT-C67153','C67153','CDISC SDTM Vital Sign Terminology by Name','DB-NCIT'),('DBX-NCIT-C67154','C67154','CDISC SDTM Laboratory Test Terminology by Name','DB-NCIT'),('DBX-NCIT-C67193','C67193','calorie','DB-NCIT'),('DBX-NCIT-C67194','C67194','Calorie','DB-NCIT'),('DBX-NCIT-C67219','C67219','Per 100 White Blood Cells','DB-NCIT'),('DBX-NCIT-C67227','C67227','Software Maintenance','DB-NCIT'),('DBX-NCIT-C67242','C67242','Cells per Microliter','DB-NCIT'),('DBX-NCIT-C67254','C67254','Per Microliter','DB-NCIT'),('DBX-NCIT-C67255','C67255','Billion per Liter','DB-NCIT'),('DBX-NCIT-C67264','C67264','Plaque Forming Unit','DB-NCIT'),('DBX-NCIT-C67273','C67273','Equivalent Weight','DB-NCIT'),('DBX-NCIT-C67274','C67274','High Power Field','DB-NCIT'),('DBX-NCIT-C67279','C67279','Kilohertz','DB-NCIT'),('DBX-NCIT-C67282','C67282','Gram per Square Meter','DB-NCIT'),('DBX-NCIT-C67284','C67284','Kilopascal','DB-NCIT'),('DBX-NCIT-C67305','C67305','Microgram per Deciliter','DB-NCIT'),('DBX-NCIT-C67306','C67306','Microgram per Liter','DB-NCIT'),('DBX-NCIT-C67307','C67307','Low Power Field','DB-NCIT'),('DBX-NCIT-C67308','C67308','Million per Microliter','DB-NCIT'),('DBX-NCIT-C67312','C67312','Microgram per Square Meter','DB-NCIT'),('DBX-NCIT-C67314','C67314','Megahertz','DB-NCIT'),('DBX-NCIT-C67318','C67318','Milliosmole','DB-NCIT'),('DBX-NCIT-C67324','C67324','Millivolt','DB-NCIT'),('DBX-NCIT-C67326','C67326','Nanogram per Deciliter','DB-NCIT'),('DBX-NCIT-C67327','C67327','Nanogram per Liter','DB-NCIT'),('DBX-NCIT-C67328','C67328','Nanometer','DB-NCIT'),('DBX-NCIT-C67330','C67330','Osmole','DB-NCIT'),('DBX-NCIT-C67331','C67331','Picogram per Deciliter','DB-NCIT'),('DBX-NCIT-C67334','C67334','Pound per Square Inch','DB-NCIT'),('DBX-NCIT-C67335','C67335','Million International Units','DB-NCIT'),('DBX-NCIT-C67352','C67352','Nanocurie','DB-NCIT'),('DBX-NCIT-C67372','C67372','Gram per 24 Hours','DB-NCIT'),('DBX-NCIT-C67376','C67376','International Unit per Liter','DB-NCIT'),('DBX-NCIT-C67377','C67377','International Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C67379','C67379','International Unit per Kilogram','DB-NCIT'),('DBX-NCIT-C67380','C67380','International Unit per Milligram','DB-NCIT'),('DBX-NCIT-C67388','C67388','Liter per Minute','DB-NCIT'),('DBX-NCIT-C67390','C67390','Liter per Second','DB-NCIT'),('DBX-NCIT-C67394','C67394','Microgram per Hour','DB-NCIT'),('DBX-NCIT-C67396','C67396','Microgram per Kilogram','DB-NCIT'),('DBX-NCIT-C67397','C67397','Microkatal per Liter','DB-NCIT'),('DBX-NCIT-C67399','C67399','Milligram per 24 Hours','DB-NCIT'),('DBX-NCIT-C67401','C67401','Milligram per Kilogram','DB-NCIT'),('DBX-NCIT-C67402','C67402','Milligram per Square Meter','DB-NCIT'),('DBX-NCIT-C67403','C67403','Milligram per Milliliter per Minute','DB-NCIT'),('DBX-NCIT-C67405','C67405','Microinternational Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C67406','C67406','Micromole per 24 Hours','DB-NCIT'),('DBX-NCIT-C67408','C67408','Microunit per Milliliter','DB-NCIT'),('DBX-NCIT-C67410','C67410','Milliliter per 24 Hours','DB-NCIT'),('DBX-NCIT-C67411','C67411','Milliliter per Kilogram','DB-NCIT'),('DBX-NCIT-C67412','C67412','Milliliter per Minute per 1.73 m2 of Body Surface Area','DB-NCIT'),('DBX-NCIT-C67417','C67417','Milliliter per Minute per Millimeters of Mercury','DB-NCIT'),('DBX-NCIT-C67418','C67418','Milliliter per Minute per Millimeters of Mercury per Liter','DB-NCIT'),('DBX-NCIT-C67419','C67419','Millimeter per Hour','DB-NCIT'),('DBX-NCIT-C67420','C67420','Millimole per 24 Hours','DB-NCIT'),('DBX-NCIT-C67423','C67423','Millimole per Minute per Thousand Pascal per Liter','DB-NCIT'),('DBX-NCIT-C67427','C67427','Milliosmole per Kilogram','DB-NCIT'),('DBX-NCIT-C67430','C67430','Nanogram per Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C67432','C67432','Nanomole per Liter','DB-NCIT'),('DBX-NCIT-C67434','C67434','Picomole per Liter','DB-NCIT'),('DBX-NCIT-C67441','C67441','RNA Copy per Milliliter','DB-NCIT'),('DBX-NCIT-C67452','C67452','Thousand per Milliliter','DB-NCIT'),('DBX-NCIT-C67454','C67454','Titer','DB-NCIT'),('DBX-NCIT-C67456','C67456','Unit per Liter','DB-NCIT'),('DBX-NCIT-C67465','C67465','Unit per Kilogram','DB-NCIT'),('DBX-NCIT-C67467','C67467','Unit per Square Meter','DB-NCIT'),('DBX-NCIT-C67469','C67469','Volume Fraction','DB-NCIT'),('DBX-NCIT-C67471','C67471','Milliequivalent per 24 Hours','DB-NCIT'),('DBX-NCIT-C67473','C67473','Milliequivalent per Deciliter','DB-NCIT'),('DBX-NCIT-C67474','C67474','Milliequivalent per Liter','DB-NCIT'),('DBX-NCIT-C67475','C67475','Milliequivalent per Kilogram','DB-NCIT'),('DBX-NCIT-C67561','C67561','Malignant Sex Cord-Stromal Tumor','DB-NCIT'),('DBX-NCIT-C6803','C6803','Benign Ovarian Sex Cord-Stromal Tumor','DB-NCIT'),('DBX-NCIT-C68598','C68598','Unilateral','DB-NCIT'),('DBX-NCIT-C68608','C68608','Vendor','DB-NCIT'),('DBX-NCIT-C68612','C68612','Active Comparator Drug','DB-NCIT'),('DBX-NCIT-C68667','C68667','Degree Unit of Plane Angle','DB-NCIT'),('DBX-NCIT-C68685','C68685','Decimole','DB-NCIT'),('DBX-NCIT-C68687','C68687','Centimole','DB-NCIT'),('DBX-NCIT-C68740','C68740','Mole per Kilogram','DB-NCIT'),('DBX-NCIT-C68768','C68768','Contamination','DB-NCIT'),('DBX-NCIT-C6878','C6878','Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas','DB-NCIT'),('DBX-NCIT-C68854','C68854','Femtomole','DB-NCIT'),('DBX-NCIT-C68855','C68855','Attomole','DB-NCIT'),('DBX-NCIT-C68858','C68858','Standard Cubic Meter','DB-NCIT'),('DBX-NCIT-C68859','C68859','Standard Cubic Foot','DB-NCIT'),('DBX-NCIT-C68871','C68871','Square Inch','DB-NCIT'),('DBX-NCIT-C68875','C68875','Enzyme-Linked Immunosorbent Assay Unit','DB-NCIT'),('DBX-NCIT-C68876','C68876','Enzyme-Linked Immunosorbent Assay Unit per Dose','DB-NCIT'),('DBX-NCIT-C68877','C68877','Enzyme-Linked Immunosorbent Assay Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C68878','C68878','Log10 Enzyme-Linked Immunosorbent Assay Unit','DB-NCIT'),('DBX-NCIT-C68879','C68879','Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose','DB-NCIT'),('DBX-NCIT-C68886','C68886','Centimole per Liter','DB-NCIT'),('DBX-NCIT-C68887','C68887','Femtomole per Liter','DB-NCIT'),('DBX-NCIT-C68891','C68891','Mole per Milliliter','DB-NCIT'),('DBX-NCIT-C68892','C68892','Millimole per Kilogram','DB-NCIT'),('DBX-NCIT-C68893','C68893','Mole per Gram','DB-NCIT'),('DBX-NCIT-C68894','C68894','Mole per Milligram','DB-NCIT'),('DBX-NCIT-C68895','C68895','Thousand Colony Forming Units','DB-NCIT'),('DBX-NCIT-C68896','C68896','Million Colony Forming Units','DB-NCIT'),('DBX-NCIT-C68897','C68897','Billion Colony Forming Units','DB-NCIT'),('DBX-NCIT-C68898','C68898','Colony Forming Unit per Gram','DB-NCIT'),('DBX-NCIT-C68899','C68899','Thousand Colony Forming Units per Gram','DB-NCIT'),('DBX-NCIT-C68900','C68900','Million Colony Forming Units per Gram','DB-NCIT'),('DBX-NCIT-C68901','C68901','Billion Colony Forming Units per Gram','DB-NCIT'),('DBX-NCIT-C68902','C68902','Colony Forming Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C68903','C68903','Thousand Colony Forming Units per Milliliter','DB-NCIT'),('DBX-NCIT-C68904','C68904','Million Colony Forming Units per Milliliter','DB-NCIT'),('DBX-NCIT-C68905','C68905','Billion Colony Forming Units per Milliliter','DB-NCIT'),('DBX-NCIT-C68915','C68915','Gauss','DB-NCIT'),('DBX-NCIT-C69073','C69073','Milliliter per Second','DB-NCIT'),('DBX-NCIT-C69087','C69087','Centiliter','DB-NCIT'),('DBX-NCIT-C69094','C69094','Kilogram per Square Centimeter','DB-NCIT'),('DBX-NCIT-C69104','C69104','Gram per Kilogram','DB-NCIT'),('DBX-NCIT-C69110','C69110','Liter per Day','DB-NCIT'),('DBX-NCIT-C69112','C69112','Part per Thousand','DB-NCIT'),('DBX-NCIT-C69114','C69114','Pint British','DB-NCIT'),('DBX-NCIT-C69148','C69148','Picometer','DB-NCIT'),('DBX-NCIT-C69149','C69149','Microsecond','DB-NCIT'),('DBX-NCIT-C69160','C69160','Liter per Hour','DB-NCIT'),('DBX-NCIT-C69175','C69175','Microliter per Milliliter','DB-NCIT'),('DBX-NCIT-C69187','C69187','Calibration','DB-NCIT'),('DBX-NCIT-C69188','C69188','Nanoliter','DB-NCIT'),('DBX-NCIT-C69189','C69189','Picoliter','DB-NCIT'),('DBX-NCIT-C69201','C69201','Horizontal Pixel Spacing','DB-NCIT'),('DBX-NCIT-C69208','C69208','Study Start Date','DB-NCIT'),('DBX-NCIT-C69210','C69210','Vertical Pixel Spacing','DB-NCIT'),('DBX-NCIT-C6926','C6926','Stromal Sarcoma','DB-NCIT'),('DBX-NCIT-C6929','C6929','Malignant Ovarian Thecoma','DB-NCIT'),('DBX-NCIT-C6930','C6930','Mixed Neoplasm','DB-NCIT'),('DBX-NCIT-C69300','C69300','Epicondyle','DB-NCIT'),('DBX-NCIT-C69314','C69314','Lumbar Spine','DB-NCIT'),('DBX-NCIT-C6938','C6938','Sweat Gland Carcinoma','DB-NCIT'),('DBX-NCIT-C69442','C69442','Medical Drop','DB-NCIT'),('DBX-NCIT-C6963','C6963','Neuroblastic Tumor','DB-NCIT'),('DBX-NCIT-C6966','C6966','Pineocytoma','DB-NCIT'),('DBX-NCIT-C70453','C70453','Gram per Gram','DB-NCIT'),('DBX-NCIT-C70455','C70455','Mole per Mole','DB-NCIT'),('DBX-NCIT-C70469','C70469','Revolution per Minute','DB-NCIT'),('DBX-NCIT-C70470','C70470','Dyne','DB-NCIT'),('DBX-NCIT-C70479','C70479','Log10 50 Percent Embryo Infective Dose','DB-NCIT'),('DBX-NCIT-C70480','C70480','Log10 50 Percent Embryo Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70484','C70484','Log10 50 Percent Cell Culture Infective Dose','DB-NCIT'),('DBX-NCIT-C70485','C70485','Log10 50 Percent Cell Culture Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70488','C70488','Log10 50 Percent Tissue Culture Infective Dose','DB-NCIT'),('DBX-NCIT-C70489','C70489','Log10 50 Percent Tissue Culture Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70492','C70492','Kilointernational Unit','DB-NCIT'),('DBX-NCIT-C70493','C70493','International Unit per Gram','DB-NCIT'),('DBX-NCIT-C70497','C70497','Anti-Xa Activity International Unit','DB-NCIT'),('DBX-NCIT-C70498','C70498','Anti-Xa Activity International Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C70500','C70500','Antigen Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C70501','C70501','D Antigen Unit','DB-NCIT'),('DBX-NCIT-C70502','C70502','D Antigen Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C70504','C70504','Allergy Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C70505','C70505','Bioequivalent Allergy Unit','DB-NCIT'),('DBX-NCIT-C70506','C70506','Tuberculin Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C70507','C70507','Millikatal','DB-NCIT'),('DBX-NCIT-C70508','C70508','Nanokatal','DB-NCIT'),('DBX-NCIT-C70509','C70509','Picokatal','DB-NCIT'),('DBX-NCIT-C70510','C70510','Nanokatal per Liter','DB-NCIT'),('DBX-NCIT-C70511','C70511','Kilobecquerel','DB-NCIT'),('DBX-NCIT-C70512','C70512','Megabecquerel','DB-NCIT'),('DBX-NCIT-C70513','C70513','Gigabecquerel','DB-NCIT'),('DBX-NCIT-C70521','C70521','Becquerel per Kilogram','DB-NCIT'),('DBX-NCIT-C70522','C70522','Becquerel per Gram','DB-NCIT'),('DBX-NCIT-C70523','C70523','Becquerel per Microgram','DB-NCIT'),('DBX-NCIT-C70524','C70524','Becquerel per Milligram','DB-NCIT'),('DBX-NCIT-C70525','C70525','Gigabecquerel per Gram','DB-NCIT'),('DBX-NCIT-C70526','C70526','Gigabecquerel per Microgram','DB-NCIT'),('DBX-NCIT-C70527','C70527','Gigabecquerel per Milligram','DB-NCIT'),('DBX-NCIT-C70528','C70528','Curie per Gram','DB-NCIT'),('DBX-NCIT-C70529','C70529','Curie per Kilogram','DB-NCIT'),('DBX-NCIT-C70530','C70530','Curie per Microgram','DB-NCIT'),('DBX-NCIT-C70531','C70531','Curie per Milligram','DB-NCIT'),('DBX-NCIT-C70532','C70532','50 Percent Embryo Infective Dose','DB-NCIT'),('DBX-NCIT-C70533','C70533','50 Percent Embryo Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70534','C70534','50 Percent Cell Culture Infective Dose','DB-NCIT'),('DBX-NCIT-C70535','C70535','50 Percent Cell Culture Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70537','C70537','50 Percent Tissue Culture Infective Dose per Dose','DB-NCIT'),('DBX-NCIT-C70543','C70543','Never','DB-NCIT'),('DBX-NCIT-C70562','C70562','Microkatal','DB-NCIT'),('DBX-NCIT-C70565','C70565','Part Per Billion','DB-NCIT'),('DBX-NCIT-C70566','C70566','Part Per Trillion','DB-NCIT'),('DBX-NCIT-C70570','C70570','Millicurie per Kilogram','DB-NCIT'),('DBX-NCIT-C70571','C70571','Microcurie per Kilogram','DB-NCIT'),('DBX-NCIT-C70575','C70575','Roentgen','DB-NCIT'),('DBX-NCIT-C70578','C70578','Milliequivalent per Microliter','DB-NCIT'),('DBX-NCIT-C70580','C70580','Milliequivalent per Gram','DB-NCIT'),('DBX-NCIT-C70581','C70581','Milliequivalent per Microgram','DB-NCIT'),('DBX-NCIT-C70715','C70715','Lipemic Specimen','DB-NCIT'),('DBX-NCIT-C70717','C70717','Frozen Specimen','DB-NCIT'),('DBX-NCIT-C70718','C70718','Refrigerated Specimen','DB-NCIT'),('DBX-NCIT-C70719','C70719','Specimen at Room Temperature','DB-NCIT'),('DBX-NCIT-C7072','C7072','Oncocytic Neoplasm','DB-NCIT'),('DBX-NCIT-C70720','C70720','Hemolysis in Specimen','DB-NCIT'),('DBX-NCIT-C70793','C70793','Clinical Study Sponsor','DB-NCIT'),('DBX-NCIT-C70848','C70848','Lot Number','DB-NCIT'),('DBX-NCIT-C70855','C70855','Medical Product Shelf Life','DB-NCIT'),('DBX-NCIT-C70918','C70918','Cmax','DB-NCIT'),('DBX-NCIT-C70919','C70919','Tmax','DB-NCIT'),('DBX-NCIT-C71029','C71029','ST Elevation Pericarditis by ECG Finding','DB-NCIT'),('DBX-NCIT-C71030','C71030','J Point Elevation','DB-NCIT'),('DBX-NCIT-C71031','C71031','Non-Specific ST-T Changes by ECG Finding','DB-NCIT'),('DBX-NCIT-C71032','C71032','T Wave Notched by ECG Finding','DB-NCIT'),('DBX-NCIT-C71033','C71033','Poor R Wave Progression by ECG Finding','DB-NCIT'),('DBX-NCIT-C71034','C71034','Prolonged QT Interval by ECG Finding','DB-NCIT'),('DBX-NCIT-C71035','C71035','Electrical Alternans by ECG Finding','DB-NCIT'),('DBX-NCIT-C71039','C71039','Atrial Enlargement by ECG Finding','DB-NCIT'),('DBX-NCIT-C71040','C71040','P-mitrale by ECG Finding','DB-NCIT'),('DBX-NCIT-C71041','C71041','P-pulmonale by ECG Finding','DB-NCIT'),('DBX-NCIT-C71042','C71042','Ectopic Ventricular Rhythm by ECG Finding','DB-NCIT'),('DBX-NCIT-C71044','C71044','2:1 Atrioventricular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C71045','C71045','Atrioventricular Dissociation by ECG Finding','DB-NCIT'),('DBX-NCIT-C71046','C71046','Bifascicular Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C71047','C71047','Incomplete Left Bundle Branch Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C71048','C71048','Incomplete Right Bundle Branch Block by ECG Finding','DB-NCIT'),('DBX-NCIT-C71050','C71050','Multifocal Atrial Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71051','C71051','Junctional Rhythm by ECG Finding','DB-NCIT'),('DBX-NCIT-C71052','C71052','Sustained Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71053','C71053','Non-Sustained Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71054','C71054','Ventricular Bigeminy by ECG Finding','DB-NCIT'),('DBX-NCIT-C71055','C71055','Ventricular Trigeminy by ECG Finding','DB-NCIT'),('DBX-NCIT-C71059','C71059','Brugada Syndrome Ventricular Arrhythmia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71060','C71060','Short QT Syndrome','DB-NCIT'),('DBX-NCIT-C71065','C71065','Acute Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71066','C71066','Acute Inferior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71067','C71067','Acute Lateral Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71068','C71068','Acute Posterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71069','C71069','Anterior Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71073','C71073','Intra-Atrial Conduction Delay by ECG Finding','DB-NCIT'),('DBX-NCIT-C71074','C71074','Junctional Bradycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71076','C71076','Left Ventricular Hypertrophy by ECG Finding','DB-NCIT'),('DBX-NCIT-C71077','C71077','Right Ventricular Hypertrophy by ECG Finding','DB-NCIT'),('DBX-NCIT-C71078','C71078','Low QRS Voltage by ECG Finding','DB-NCIT'),('DBX-NCIT-C71080','C71080','Non Q Wave Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C71085','C71085','T Wave Inversion by ECG Finding','DB-NCIT'),('DBX-NCIT-C71086','C71086','T Wave Peaked by ECG Finding','DB-NCIT'),('DBX-NCIT-C71087','C71087','T Waves Biphasic by ECG Finding','DB-NCIT'),('DBX-NCIT-C71088','C71088','T Waves Flat by ECG Finding','DB-NCIT'),('DBX-NCIT-C71090','C71090','Wide QRS Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C71091','C71091','Varicella Zoster Virus','DB-NCIT'),('DBX-NCIT-C71092','C71092','Vectorcardiograph Corrected','DB-NCIT'),('DBX-NCIT-C71093','C71093','Vectorcardiograph Uncorrected','DB-NCIT'),('DBX-NCIT-C71094','C71094','Q Axis Left Axis Deviation','DB-NCIT'),('DBX-NCIT-C71095','C71095','Q Axis Right Axis Deviation','DB-NCIT'),('DBX-NCIT-C71101','C71101','12 Lead Placement Unspecified','DB-NCIT'),('DBX-NCIT-C71102','C71102','12 Lead Placement Standard','DB-NCIT'),('DBX-NCIT-C71103','C71103','12 Lead Placement Mason Likar','DB-NCIT'),('DBX-NCIT-C7111','C7111','Benign Ameloblastoma','DB-NCIT'),('DBX-NCIT-C71110','C71110','12 Lead Placement Mason Likar Modified','DB-NCIT'),('DBX-NCIT-C71112','C71112','12 Lead Placement Chest','DB-NCIT'),('DBX-NCIT-C71113','C71113','CDISC SDTM Frequency Terminology','DB-NCIT'),('DBX-NCIT-C71114','C71114','12 Lead Placement Non-Standard','DB-NCIT'),('DBX-NCIT-C71115','C71115','Lead Placement Bicycle','DB-NCIT'),('DBX-NCIT-C71116','C71116','12 Lead Placement Cabrera','DB-NCIT'),('DBX-NCIT-C71117','C71117','Lead Placement Standard Intercostal Space Higher','DB-NCIT'),('DBX-NCIT-C71118','C71118','Lead Placement Frank','DB-NCIT'),('DBX-NCIT-C71119','C71119','Lead Placement McFee-Parungao','DB-NCIT'),('DBX-NCIT-C71120','C71120','Lead Placement Cube','DB-NCIT'),('DBX-NCIT-C71121','C71121','Lead Placement Bipolar Uncorrected XYZ','DB-NCIT'),('DBX-NCIT-C71122','C71122','Lead Placement Pseudo Orthogonal XYZ','DB-NCIT'),('DBX-NCIT-C71123','C71123','Lead Placement EASI Dower Transformation','DB-NCIT'),('DBX-NCIT-C71124','C71124','Every Five Days','DB-NCIT'),('DBX-NCIT-C71125','C71125','12 Lead Placement 1 Lead Missing','DB-NCIT'),('DBX-NCIT-C71126','C71126','12 Lead Placement Standard And CC5-CM5-CH5','DB-NCIT'),('DBX-NCIT-C71127','C71127','Every Two Weeks','DB-NCIT'),('DBX-NCIT-C71128','C71128','12 Lead Placement Standard And CC5-CM5-ML','DB-NCIT'),('DBX-NCIT-C71129','C71129','Twice Per Month','DB-NCIT'),('DBX-NCIT-C71130','C71130','12 Lead Placement Standard Extended Right','DB-NCIT'),('DBX-NCIT-C71131','C71131','12 Lead Placement Standard Extended Left','DB-NCIT'),('DBX-NCIT-C71148','C71148','CDISC SDTM Body Position Terminology','DB-NCIT'),('DBX-NCIT-C71150','C71150','CDISC SDTM ECG Finding Terminology','DB-NCIT'),('DBX-NCIT-C71151','C71151','CDISC SDTM ECG Test Method Terminology','DB-NCIT'),('DBX-NCIT-C71152','C71152','CDISC SDTM ECG Test Name Terminology','DB-NCIT'),('DBX-NCIT-C71153','C71153','CDISC SDTM ECG Test Terminology by Code','DB-NCIT'),('DBX-NCIT-C71165','C71165','Becquerel per Liter','DB-NCIT'),('DBX-NCIT-C71166','C71166','Becquerel per Microliter','DB-NCIT'),('DBX-NCIT-C71167','C71167','Becquerel per Milliliter','DB-NCIT'),('DBX-NCIT-C71168','C71168','Kilobecquerel per Microliter','DB-NCIT'),('DBX-NCIT-C71169','C71169','Megabecquerel per Microliter','DB-NCIT'),('DBX-NCIT-C71170','C71170','Curie per Liter','DB-NCIT'),('DBX-NCIT-C71171','C71171','Curie per Microliter','DB-NCIT'),('DBX-NCIT-C71172','C71172','Curie per Milliliter','DB-NCIT'),('DBX-NCIT-C71173','C71173','Microcurie per Liter','DB-NCIT'),('DBX-NCIT-C71174','C71174','Millicurie per Liter','DB-NCIT'),('DBX-NCIT-C71175','C71175','Microvolt','DB-NCIT'),('DBX-NCIT-C71176','C71176','Cycle per Minute','DB-NCIT'),('DBX-NCIT-C71177','C71177','Kilometer','DB-NCIT'),('DBX-NCIT-C71183','C71183','Mile','DB-NCIT'),('DBX-NCIT-C71185','C71185','100 International Units per Milliliter','DB-NCIT'),('DBX-NCIT-C71187','C71187','Thousand Organisms','DB-NCIT'),('DBX-NCIT-C71188','C71188','Million Organisms','DB-NCIT'),('DBX-NCIT-C71189','C71189','Billion Organisms','DB-NCIT'),('DBX-NCIT-C71190','C71190','Thousand Organisms per Gram','DB-NCIT'),('DBX-NCIT-C71191','C71191','Million Organisms per Gram','DB-NCIT'),('DBX-NCIT-C71192','C71192','Billion Organisms per Gram','DB-NCIT'),('DBX-NCIT-C71193','C71193','Million Organisms per Milligram','DB-NCIT'),('DBX-NCIT-C71194','C71194','Billion Organisms per Milligram','DB-NCIT'),('DBX-NCIT-C71195','C71195','Thousand Organisms per Milliliter','DB-NCIT'),('DBX-NCIT-C71196','C71196','Million Organisms per Milliliter','DB-NCIT'),('DBX-NCIT-C71197','C71197','Billion Organisms per Milliliter','DB-NCIT'),('DBX-NCIT-C71198','C71198','Plaque Forming Unit per Dose','DB-NCIT'),('DBX-NCIT-C71199','C71199','Plaque Forming Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C71200','C71200','Bel','DB-NCIT'),('DBX-NCIT-C71201','C71201','Gram per Square Centimeter','DB-NCIT'),('DBX-NCIT-C71202','C71202','Kilo United States Pharmacopeia Unit','DB-NCIT'),('DBX-NCIT-C71203','C71203','Kilometer per Hour','DB-NCIT'),('DBX-NCIT-C71204','C71204','Nebule Dosing Unit','DB-NCIT'),('DBX-NCIT-C71205','C71205','Microgram per Day','DB-NCIT'),('DBX-NCIT-C71207','C71207','Milligram per Kilogram per Minute','DB-NCIT'),('DBX-NCIT-C71209','C71209','International Unit per Kilogram per Hour','DB-NCIT'),('DBX-NCIT-C71210','C71210','Microgram per Kilogram per Minute','DB-NCIT'),('DBX-NCIT-C71211','C71211','Microgram per Minute','DB-NCIT'),('DBX-NCIT-C71251','C71251','Partial Pressure of Oxygen Measurement','DB-NCIT'),('DBX-NCIT-C71253','C71253','International Foot','DB-NCIT'),('DBX-NCIT-C71258','C71258','Lean Body Mass','DB-NCIT'),('DBX-NCIT-C7126','C7126','Intrahepatic Bile Duct Adenoma','DB-NCIT'),('DBX-NCIT-C71321','C71321','Fingertip Dosing Unit','DB-NCIT'),('DBX-NCIT-C71324','C71324','Sachet Dosing Unit','DB-NCIT'),('DBX-NCIT-C71325','C71325','Intermittent','DB-NCIT'),('DBX-NCIT-C71362','C71362','Milligram per Kilogram per Hour','DB-NCIT'),('DBX-NCIT-C71390','C71390','Full Sibling','DB-NCIT'),('DBX-NCIT-C71391','C71391','Half Sibling','DB-NCIT'),('DBX-NCIT-C71402','C71402','Half Brother','DB-NCIT'),('DBX-NCIT-C71403','C71403','Half Sister','DB-NCIT'),('DBX-NCIT-C71437','C71437','Intolerance','DB-NCIT'),('DBX-NCIT-C71480','C71480','Cycle per Second','DB-NCIT'),('DBX-NCIT-C7155','C7155','Conventional Chondrosarcoma','DB-NCIT'),('DBX-NCIT-C7157','C7157','Posterior Pituitary Gland Neoplasm','DB-NCIT'),('DBX-NCIT-C71620','C71620','CDISC SDTM Unit of Measure Terminology','DB-NCIT'),('DBX-NCIT-C7173','C7173','Diffuse Astrocytoma','DB-NCIT'),('DBX-NCIT-C71877','C71877','West Nile Virus','DB-NCIT'),('DBX-NCIT-C72074','C72074','Atypical Carcinoid Tumor','DB-NCIT'),('DBX-NCIT-C72884','C72884','Friend','DB-NCIT'),('DBX-NCIT-C73427','C73427','Twin','DB-NCIT'),('DBX-NCIT-C73428','C73428','Fraternal Twin','DB-NCIT'),('DBX-NCIT-C73429','C73429','Identical Twin','DB-NCIT'),('DBX-NCIT-C73468','C73468','Waldeyer\'s Tonsillar Ring','DB-NCIT'),('DBX-NCIT-C73518','C73518','Serial Number','DB-NCIT'),('DBX-NCIT-C73540','C73540','Mycoplasma','DB-NCIT'),('DBX-NCIT-C73558','C73558','Dosage Form Unit','DB-NCIT'),('DBX-NCIT-C7359','C7359','Endometrial Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C7367','C7367','Hair Follicle Neoplasm','DB-NCIT'),('DBX-NCIT-C7368','C7368','Pilomatricoma','DB-NCIT'),('DBX-NCIT-C73686','C73686','Absorbance Unit','DB-NCIT'),('DBX-NCIT-C73687','C73687','Absorbance Unit per Minute','DB-NCIT'),('DBX-NCIT-C73688','C73688','Count per Minute','DB-NCIT'),('DBX-NCIT-C73705','C73705','Intermediate','DB-NCIT'),('DBX-NCIT-C73710','C73710','Disintegration per Minute','DB-NCIT'),('DBX-NCIT-C73711','C73711','Femtomole per Gram','DB-NCIT'),('DBX-NCIT-C73713','C73713','Gram per Animal','DB-NCIT'),('DBX-NCIT-C73714','C73714','Gram per Animal per Day','DB-NCIT'),('DBX-NCIT-C73715','C73715','Gram per Animal per Week','DB-NCIT'),('DBX-NCIT-C73716','C73716','Gram per Cage','DB-NCIT'),('DBX-NCIT-C73717','C73717','Gram per Cage per Day','DB-NCIT'),('DBX-NCIT-C73718','C73718','Gram per Cage per Week','DB-NCIT'),('DBX-NCIT-C73720','C73720','Gram per Gram per Day','DB-NCIT'),('DBX-NCIT-C73721','C73721','Gram per Mole','DB-NCIT'),('DBX-NCIT-C73722','C73722','Gram per Square Meter per Day','DB-NCIT'),('DBX-NCIT-C73725','C73725','Liter per Kilogram','DB-NCIT'),('DBX-NCIT-C73726','C73726','Microequivalent','DB-NCIT'),('DBX-NCIT-C73727','C73727','Microgram per Square Meter per Hour','DB-NCIT'),('DBX-NCIT-C73728','C73728','Microgram per Animal','DB-NCIT'),('DBX-NCIT-C73729','C73729','Microgram per Kilogram per Day','DB-NCIT'),('DBX-NCIT-C73730','C73730','Microgram per Kilogram per Hour','DB-NCIT'),('DBX-NCIT-C73733','C73733','Microgram per Square Meter per Minute','DB-NCIT'),('DBX-NCIT-C73735','C73735','Micromole per Milligram per Minute','DB-NCIT'),('DBX-NCIT-C73736','C73736','Microosmole','DB-NCIT'),('DBX-NCIT-C73737','C73737','Milliequivalent per Milliliter','DB-NCIT'),('DBX-NCIT-C73738','C73738','Milligram per Animal','DB-NCIT'),('DBX-NCIT-C73740','C73740','Milligram per Gram per Hour','DB-NCIT'),('DBX-NCIT-C73741','C73741','Milligram per Gram per Minute','DB-NCIT'),('DBX-NCIT-C73742','C73742','Milligram per Minute','DB-NCIT'),('DBX-NCIT-C73743','C73743','Milligram per Square Meter per Hour','DB-NCIT'),('DBX-NCIT-C73744','C73744','Milligram per Square Meter per Minute','DB-NCIT'),('DBX-NCIT-C73746','C73746','Milliliter per Animal','DB-NCIT'),('DBX-NCIT-C73747','C73747','Milliliter per Animal per Day','DB-NCIT'),('DBX-NCIT-C73748','C73748','Milliliter per Animal per Week','DB-NCIT'),('DBX-NCIT-C73749','C73749','Milliliter per Breath','DB-NCIT'),('DBX-NCIT-C73750','C73750','Milliliter per Cage','DB-NCIT'),('DBX-NCIT-C73751','C73751','Milliliter per Cage per Day','DB-NCIT'),('DBX-NCIT-C73752','C73752','Milliliter per Cage per Week','DB-NCIT'),('DBX-NCIT-C73754','C73754','Milliliter per Gram','DB-NCIT'),('DBX-NCIT-C73755','C73755','Milliliter per Gram per Day','DB-NCIT'),('DBX-NCIT-C73756','C73756','Milliliter per Gram per Hour','DB-NCIT'),('DBX-NCIT-C73757','C73757','Milliliter per Gram per Minute','DB-NCIT'),('DBX-NCIT-C73758','C73758','Milliliter per Kilogram per Day','DB-NCIT'),('DBX-NCIT-C73759','C73759','Milliliter per Kilogram per Hour','DB-NCIT'),('DBX-NCIT-C73760','C73760','Milliliter per Kilogram per Minute','DB-NCIT'),('DBX-NCIT-C73761','C73761','Milliliter per Square Meter','DB-NCIT'),('DBX-NCIT-C73762','C73762','Milliliter per Square Meter per Hour','DB-NCIT'),('DBX-NCIT-C73763','C73763','Milliliter per Square Meter per Minute','DB-NCIT'),('DBX-NCIT-C73764','C73764','Millimeter of Mercury per Second','DB-NCIT'),('DBX-NCIT-C73765','C73765','Millipascal','DB-NCIT'),('DBX-NCIT-C73767','C73767','Nanosecond','DB-NCIT'),('DBX-NCIT-C73768','C73768','Picosecond','DB-NCIT'),('DBX-NCIT-C73770','C73770','Square Micrometer','DB-NCIT'),('DBX-NCIT-C73771','C73771','Thousand per Deciliter','DB-NCIT'),('DBX-NCIT-C73773','C73773','Unit per Animal','DB-NCIT'),('DBX-NCIT-C73774','C73774','Unit per Gram per Day','DB-NCIT'),('DBX-NCIT-C73775','C73775','Unit per Gram per Hour','DB-NCIT'),('DBX-NCIT-C73776','C73776','Unit per Gram per Minute','DB-NCIT'),('DBX-NCIT-C73777','C73777','Unit per Kilogram per Day','DB-NCIT'),('DBX-NCIT-C73778','C73778','Unit per Kilogram per Hour','DB-NCIT'),('DBX-NCIT-C73779','C73779','Unit per Kilogram per Minute','DB-NCIT'),('DBX-NCIT-C73780','C73780','Unit per Milligram','DB-NCIT'),('DBX-NCIT-C73783','C73783','Unit per Square Meter per Day','DB-NCIT'),('DBX-NCIT-C73784','C73784','Unit per Square Meter per Hour','DB-NCIT'),('DBX-NCIT-C73785','C73785','Unit per Square Meter per Minute','DB-NCIT'),('DBX-NCIT-C73787','C73787','Microgram per Square Meter per Day','DB-NCIT'),('DBX-NCIT-C73792','C73792','Flip Angle','DB-NCIT'),('DBX-NCIT-C73851','C73851','Caudal','DB-NCIT'),('DBX-NCIT-C73993','C73993','Pack Year','DB-NCIT'),('DBX-NCIT-C74298','C74298','Field of View','DB-NCIT'),('DBX-NCIT-C7440','C7440','Papilloma','DB-NCIT'),('DBX-NCIT-C7442','C7442','Benign Myoepithelioma','DB-NCIT'),('DBX-NCIT-C74456','C74456','CDISC SDTM Anatomical Location Terminology','DB-NCIT'),('DBX-NCIT-C74457','C74457','CDISC SDTM Race Terminology','DB-NCIT'),('DBX-NCIT-C74528','C74528','Self-Report','DB-NCIT'),('DBX-NCIT-C74558','C74558','CDISC SDTM Category For Disposition Event Terminology','DB-NCIT'),('DBX-NCIT-C74559','C74559','CDISC SDTM Subject Characteristic Test Code Terminology','DB-NCIT'),('DBX-NCIT-C74561','C74561','CDISC SDTM Skin Type Terminology','DB-NCIT'),('DBX-NCIT-C74563','C74563','Fitzpatrick Classification Scale','DB-NCIT'),('DBX-NCIT-C74565','C74565','Employee Job Class','DB-NCIT'),('DBX-NCIT-C74566','C74566','Employee Salary Type','DB-NCIT'),('DBX-NCIT-C74569','C74569','Fitzpatrick Skin Type I','DB-NCIT'),('DBX-NCIT-C74570','C74570','Fitzpatrick Skin Type II','DB-NCIT'),('DBX-NCIT-C74571','C74571','Fitzpatrick Skin Type III','DB-NCIT'),('DBX-NCIT-C74572','C74572','Fitzpatrick Skin Type IV','DB-NCIT'),('DBX-NCIT-C74573','C74573','Fitzpatrick Skin Type V','DB-NCIT'),('DBX-NCIT-C74574','C74574','Fitzpatrick Skin Type VI','DB-NCIT'),('DBX-NCIT-C74580','C74580','Skin Type','DB-NCIT'),('DBX-NCIT-C74588','C74588','Protocol Milestone','DB-NCIT'),('DBX-NCIT-C74589','C74589','Protocol Event','DB-NCIT'),('DBX-NCIT-C74590','C74590','Protocol Disposition Event','DB-NCIT'),('DBX-NCIT-C74591','C74591','Oily Skin','DB-NCIT'),('DBX-NCIT-C74592','C74592','Dry Skin','DB-NCIT'),('DBX-NCIT-C74593','C74593','Normal Skin','DB-NCIT'),('DBX-NCIT-C74604','C74604','Hairy Cell Count','DB-NCIT'),('DBX-NCIT-C74605','C74605','Blast Count','DB-NCIT'),('DBX-NCIT-C74610','C74610','Dohle Body Measurement','DB-NCIT'),('DBX-NCIT-C74611','C74611','Erythrocyte Sedimentation Rate Measurement','DB-NCIT'),('DBX-NCIT-C74612','C74612','Hypersegmented Neutrophil Measurement','DB-NCIT'),('DBX-NCIT-C74613','C74613','Lymphoma Cell Count','DB-NCIT'),('DBX-NCIT-C74614','C74614','May-Hegglin Anomaly Measurement','DB-NCIT'),('DBX-NCIT-C74615','C74615','Metamyelocyte Count','DB-NCIT'),('DBX-NCIT-C74616','C74616','Pappenheimer Body Count','DB-NCIT'),('DBX-NCIT-C74617','C74617','Pelger Huet Anomaly Measurement','DB-NCIT'),('DBX-NCIT-C74618','C74618','Plasmacytoid Lymphocyte Count','DB-NCIT'),('DBX-NCIT-C74619','C74619','Precursor Plasma Cell Count','DB-NCIT'),('DBX-NCIT-C74620','C74620','Prolymphocyte Count','DB-NCIT'),('DBX-NCIT-C74621','C74621','Promonocyte Count','DB-NCIT'),('DBX-NCIT-C74622','C74622','Promyelocyte Count','DB-NCIT'),('DBX-NCIT-C74624','C74624','Rouleaux Formation Count','DB-NCIT'),('DBX-NCIT-C74625','C74625','Sezary Cell Count','DB-NCIT'),('DBX-NCIT-C74626','C74626','Sickle Cell Count','DB-NCIT'),('DBX-NCIT-C74627','C74627','Smudge Cell Count','DB-NCIT'),('DBX-NCIT-C74628','C74628','Vacuolated Neutrophil Count','DB-NCIT'),('DBX-NCIT-C74629','C74629','Reactive Lymphocyte Count Measurement','DB-NCIT'),('DBX-NCIT-C74630','C74630','Leukemic Blast Count','DB-NCIT'),('DBX-NCIT-C74631','C74631','Monoblast Count','DB-NCIT'),('DBX-NCIT-C74632','C74632','Myeloblast Count','DB-NCIT'),('DBX-NCIT-C74633','C74633','Acanthocyte to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74634','C74634','Bite Cell to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74640','C74640','Hairy Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74641','C74641','Leukemic Blast to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74643','C74643','Malignant Cell to Blood Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74645','C74645','Metamyelocyte to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74646','C74646','Monoblast to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74647','C74647','Nucleated Red Blood Cell to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74648','C74648','Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74649','C74649','Poikilocyte to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74650','C74650','Precursor Plasma Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74651','C74651','Prolymphocyte to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74652','C74652','Promonocyte to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74653','C74653','Promyelocyte to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74654','C74654','Reactive Lymphocyte to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74655','C74655','Sezary Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74656','C74656','Sickle Cell to Erythrocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74657','C74657','Auer Rod Measurement','DB-NCIT'),('DBX-NCIT-C74658','C74658','Helmet Cell Count','DB-NCIT'),('DBX-NCIT-C74659','C74659','Large Unstained Cell Count','DB-NCIT'),('DBX-NCIT-C74660','C74660','Malignant Cell Count','DB-NCIT'),('DBX-NCIT-C74661','C74661','Mature Plasma Cell Count','DB-NCIT'),('DBX-NCIT-C74662','C74662','Myelocyte Count','DB-NCIT'),('DBX-NCIT-C74663','C74663','Spermatozoa Cell Count','DB-NCIT'),('DBX-NCIT-C74664','C74664','Yeast Cell Measurement','DB-NCIT'),('DBX-NCIT-C74665','C74665','Amorphous Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74666','C74666','Amorphous Sediment Measurement','DB-NCIT'),('DBX-NCIT-C74667','C74667','Bicarbonate Measurement','DB-NCIT'),('DBX-NCIT-C74668','C74668','Bilirubin Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74669','C74669','Calcium Carbonate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74670','C74670','Calcium Oxalate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74671','C74671','Calcium Phosphate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74672','C74672','Cholesterol Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74673','C74673','Crystal Present Or Absent','DB-NCIT'),('DBX-NCIT-C74674','C74674','Cystine Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74676','C74676','Folic Acid Measurement','DB-NCIT'),('DBX-NCIT-C74677','C74677','Free Carnitine Measurement','DB-NCIT'),('DBX-NCIT-C74678','C74678','Fructosamine Measurement','DB-NCIT'),('DBX-NCIT-C74679','C74679','Iron Measurement','DB-NCIT'),('DBX-NCIT-C74680','C74680','Leucine Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74681','C74681','Monosodium Urate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74682','C74682','Total Carnitine Measurement','DB-NCIT'),('DBX-NCIT-C74683','C74683','Tyrosine Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74684','C74684','Uric Acid Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74685','C74685','Anion Gap Measurement','DB-NCIT'),('DBX-NCIT-C74686','C74686','Occult Blood Measurement','DB-NCIT'),('DBX-NCIT-C74687','C74687','Amphetamine Drug Class Measurement','DB-NCIT'),('DBX-NCIT-C74688','C74688','Barbiturate Drug Class Measurement','DB-NCIT'),('DBX-NCIT-C74689','C74689','Cannabinoid Drug Class Measurement','DB-NCIT'),('DBX-NCIT-C74690','C74690','Cocaine Measurement','DB-NCIT'),('DBX-NCIT-C74691','C74691','Antidepressant Measurement','DB-NCIT'),('DBX-NCIT-C74692','C74692','Benzodiazepine Measurement','DB-NCIT'),('DBX-NCIT-C74693','C74693','Ethanol Measurement','DB-NCIT'),('DBX-NCIT-C74694','C74694','Phencyclidine Measurement','DB-NCIT'),('DBX-NCIT-C74695','C74695','Phenothiazine Measurement','DB-NCIT'),('DBX-NCIT-C74696','C74696','Pseudoephedrine Measurement','DB-NCIT'),('DBX-NCIT-C74698','C74698','Round Epithelial Cell Count','DB-NCIT'),('DBX-NCIT-C74699','C74699','Acanthocyte Count','DB-NCIT'),('DBX-NCIT-C74700','C74700','Bite Cell Count','DB-NCIT'),('DBX-NCIT-C74701','C74701','Burr Cell Count','DB-NCIT'),('DBX-NCIT-C74702','C74702','Cabot Ring Count','DB-NCIT'),('DBX-NCIT-C74703','C74703','Crenated Cell Measurement','DB-NCIT'),('DBX-NCIT-C74704','C74704','Howell-Jolly Body Measurement','DB-NCIT'),('DBX-NCIT-C74705','C74705','Nucleated Red Blood Cell Count','DB-NCIT'),('DBX-NCIT-C74706','C74706','Schistocyte Count','DB-NCIT'),('DBX-NCIT-C74707','C74707','Spherocyte Count','DB-NCIT'),('DBX-NCIT-C74708','C74708','Stomatocyte Count','DB-NCIT'),('DBX-NCIT-C74709','C74709','Heinz-Ehrlich Body Measurement','DB-NCIT'),('DBX-NCIT-C74711','C74711','Hepatitis B Surface Antibody Measurement','DB-NCIT'),('DBX-NCIT-C74713','C74713','HIV-1 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C74714','C74714','HIV-1 HIV-2 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C74715','C74715','HIV-2 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C74716','C74716','Rapid Plasma Reagin Measurement','DB-NCIT'),('DBX-NCIT-C74717','C74717','Rheumatoid Factor Measurement','DB-NCIT'),('DBX-NCIT-C74718','C74718','Total Iron Binding Capacity','DB-NCIT'),('DBX-NCIT-C74719','C74719','Unsaturated Iron Binding Capacity Measurement','DB-NCIT'),('DBX-NCIT-C74720','C74720','Volume Measurement','DB-NCIT'),('DBX-NCIT-C74721','C74721','Mucous Thread Measurement','DB-NCIT'),('DBX-NCIT-C74723','C74723','Turbidity Measurement','DB-NCIT'),('DBX-NCIT-C74728','C74728','Giant Platelet Count','DB-NCIT'),('DBX-NCIT-C74729','C74729','Large Platelet Count','DB-NCIT'),('DBX-NCIT-C74730','C74730','Mean Platelet Volume Measurement','DB-NCIT'),('DBX-NCIT-C74731','C74731','Aldolase Measurement','DB-NCIT'),('DBX-NCIT-C74732','C74732','Alpha-fetoprotein Measurement','DB-NCIT'),('DBX-NCIT-C74733','C74733','Apolipoprotein A1 Measurement','DB-NCIT'),('DBX-NCIT-C74734','C74734','Apolipoprotein B Measurement','DB-NCIT'),('DBX-NCIT-C74735','C74735','Brain Natriuretic Peptide Measurement','DB-NCIT'),('DBX-NCIT-C74736','C74736','C-peptide Measurement','DB-NCIT'),('DBX-NCIT-C74737','C74737','Ferritin Measurement','DB-NCIT'),('DBX-NCIT-C74738','C74738','Globulin Protein Measurement','DB-NCIT'),('DBX-NCIT-C74739','C74739','Glutamate Measurement','DB-NCIT'),('DBX-NCIT-C74740','C74740','Haptoglobin Protein Measurement','DB-NCIT'),('DBX-NCIT-C74741','C74741','Homocysteine Acid Measurement','DB-NCIT'),('DBX-NCIT-C74743','C74743','N-Telopeptide Measurement','DB-NCIT'),('DBX-NCIT-C74744','C74744','Osteocalcin Measurement','DB-NCIT'),('DBX-NCIT-C74745','C74745','Sex Hormone Binding Protein Measurement','DB-NCIT'),('DBX-NCIT-C74746','C74746','Thyroxine Binding Globulin Protein Measurement','DB-NCIT'),('DBX-NCIT-C74747','C74747','Triiodothyronine Measurement','DB-NCIT'),('DBX-NCIT-C74748','C74748','Triiodothyronine Uptake Measurement','DB-NCIT'),('DBX-NCIT-C74749','C74749','Troponin I Measurement','DB-NCIT'),('DBX-NCIT-C74750','C74750','Troponin T Measurement','DB-NCIT'),('DBX-NCIT-C74751','C74751','Tumor Necrosis Factor Measurement','DB-NCIT'),('DBX-NCIT-C74753','C74753','Blood Urea Nitrogen To Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74754','C74754','Hippuric Acid Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74755','C74755','Sulfa Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74756','C74756','Triple Phosphate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74757','C74757','Unclassified Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74759','C74759','Urine Ammonium Oxalate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74761','C74761','Albumin To Creatinine Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74762','C74762','Bacterial Cast Measurement','DB-NCIT'),('DBX-NCIT-C74763','C74763','Cast Present Or Absent','DB-NCIT'),('DBX-NCIT-C74764','C74764','Cellular Cast Measurement','DB-NCIT'),('DBX-NCIT-C74765','C74765','Coarse Granular Cast Measurement','DB-NCIT'),('DBX-NCIT-C74766','C74766','Fatty Cast Measurement','DB-NCIT'),('DBX-NCIT-C74768','C74768','Granular Cast Measurement','DB-NCIT'),('DBX-NCIT-C74769','C74769','Granular Fine Cast Measurement','DB-NCIT'),('DBX-NCIT-C74770','C74770','Hyaline Cast Measurement','DB-NCIT'),('DBX-NCIT-C74771','C74771','Mixed Cast Count','DB-NCIT'),('DBX-NCIT-C74772','C74772','Red Blood Cell Cast Measurement','DB-NCIT'),('DBX-NCIT-C74773','C74773','Squamous Epithelial Cell Count','DB-NCIT'),('DBX-NCIT-C74774','C74774','Squamous Transitional Epithelial Cell Count','DB-NCIT'),('DBX-NCIT-C74775','C74775','Tubular Epithelial Cell Count','DB-NCIT'),('DBX-NCIT-C74776','C74776','Unclassified Cast Measurement','DB-NCIT'),('DBX-NCIT-C74777','C74777','Waxy Cell Cast Measurement','DB-NCIT'),('DBX-NCIT-C74778','C74778','White Blood Cell Cast Measurement','DB-NCIT'),('DBX-NCIT-C74779','C74779','Epithelial-Cast Measurement','DB-NCIT'),('DBX-NCIT-C74780','C74780','Adrenocorticotropic Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74781','C74781','Cortisol Measurement','DB-NCIT'),('DBX-NCIT-C74782','C74782','Estradiol Measurement','DB-NCIT'),('DBX-NCIT-C74783','C74783','Follicle Stimulating Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74784','C74784','Fragmented Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74785','C74785','Free Testosterone Measurement','DB-NCIT'),('DBX-NCIT-C74786','C74786','Free Thyroxine Measurement','DB-NCIT'),('DBX-NCIT-C74787','C74787','Free Triiodothyronine Measurement','DB-NCIT'),('DBX-NCIT-C74788','C74788','Insulin Measurement','DB-NCIT'),('DBX-NCIT-C74789','C74789','Intact Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74790','C74790','Luteinizing Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74791','C74791','Progesterone Measurement','DB-NCIT'),('DBX-NCIT-C74793','C74793','Total Testosterone Measurement','DB-NCIT'),('DBX-NCIT-C74794','C74794','Total Thyroxine Measurement','DB-NCIT'),('DBX-NCIT-C74796','C74796','Opiate Measurement','DB-NCIT'),('DBX-NCIT-C74797','C74797','Anisocyte Measurement','DB-NCIT'),('DBX-NCIT-C74798','C74798','Macrophage Count','DB-NCIT'),('DBX-NCIT-C74799','C74799','Ammonia Measurement','DB-NCIT'),('DBX-NCIT-C74800','C74800','Bile Acid Measurement','DB-NCIT'),('DBX-NCIT-C74801','C74801','Osmolality Measurement','DB-NCIT'),('DBX-NCIT-C74802','C74802','Osmolarity Measurement','DB-NCIT'),('DBX-NCIT-C74805','C74805','Interleukin 1 Measurement','DB-NCIT'),('DBX-NCIT-C74806','C74806','Interleukin 10 Measurement','DB-NCIT'),('DBX-NCIT-C74807','C74807','Interleukin 11 Measurement','DB-NCIT'),('DBX-NCIT-C74808','C74808','Interleukin 12 Measurement','DB-NCIT'),('DBX-NCIT-C74809','C74809','Interleukin 13 Measurement','DB-NCIT'),('DBX-NCIT-C74810','C74810','Interleukin 14 Measurement','DB-NCIT'),('DBX-NCIT-C74811','C74811','Interleukin 15 Measurement','DB-NCIT'),('DBX-NCIT-C74812','C74812','Interleukin 16 Measurement','DB-NCIT'),('DBX-NCIT-C74813','C74813','Interleukin 17 Measurement','DB-NCIT'),('DBX-NCIT-C74814','C74814','Interleukin 18 Measurement','DB-NCIT'),('DBX-NCIT-C74815','C74815','Interleukin 19 Measurement','DB-NCIT'),('DBX-NCIT-C74816','C74816','Interleukin 2 Measurement','DB-NCIT'),('DBX-NCIT-C74817','C74817','Interleukin 20 Measurement','DB-NCIT'),('DBX-NCIT-C74818','C74818','Interleukin 21 Measurement','DB-NCIT'),('DBX-NCIT-C74819','C74819','Interleukin 22 Measurement','DB-NCIT'),('DBX-NCIT-C74820','C74820','Interleukin 23 Measurement','DB-NCIT'),('DBX-NCIT-C74821','C74821','Interleukin 24 Measurement','DB-NCIT'),('DBX-NCIT-C74822','C74822','Interleukin 25 Measurement','DB-NCIT'),('DBX-NCIT-C74823','C74823','Interleukin 26 Measurement','DB-NCIT'),('DBX-NCIT-C74824','C74824','Interleukin 27 Measurement','DB-NCIT'),('DBX-NCIT-C74825','C74825','Interleukin 28 Measurement','DB-NCIT'),('DBX-NCIT-C74826','C74826','Interleukin 29 Measurement','DB-NCIT'),('DBX-NCIT-C74827','C74827','Interleukin 3 Measurement','DB-NCIT'),('DBX-NCIT-C74828','C74828','Interleukin 30 Measurement','DB-NCIT'),('DBX-NCIT-C74829','C74829','Interleukin 31 Measurement','DB-NCIT'),('DBX-NCIT-C74830','C74830','Interleukin 32 Measurement','DB-NCIT'),('DBX-NCIT-C74831','C74831','Interleukin 33 Measurement','DB-NCIT'),('DBX-NCIT-C74832','C74832','Interleukin 4 Measurement','DB-NCIT'),('DBX-NCIT-C74833','C74833','Interleukin 5 Measurement','DB-NCIT'),('DBX-NCIT-C74834','C74834','Interleukin 6 Measurement','DB-NCIT'),('DBX-NCIT-C74835','C74835','Interleukin 7 Measurement','DB-NCIT'),('DBX-NCIT-C74836','C74836','Interleukin 8 Measurement','DB-NCIT'),('DBX-NCIT-C74837','C74837','Interleukin 9 Measurement','DB-NCIT'),('DBX-NCIT-C74838','C74838','Acetylcholine Measurement','DB-NCIT'),('DBX-NCIT-C74839','C74839','Adiponectin Measurement','DB-NCIT'),('DBX-NCIT-C74841','C74841','Aldosterone Measurement','DB-NCIT'),('DBX-NCIT-C74842','C74842','Androstenediol Metabolite Measurement','DB-NCIT'),('DBX-NCIT-C74843','C74843','Androstenedione Measurement','DB-NCIT'),('DBX-NCIT-C74844','C74844','Angiotensin I Measurement','DB-NCIT'),('DBX-NCIT-C74845','C74845','Angiotensin II Measurement','DB-NCIT'),('DBX-NCIT-C74846','C74846','Angiotensinogen Measurement','DB-NCIT'),('DBX-NCIT-C74847','C74847','Antidiuretic Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74848','C74848','Calcitonin Measurement','DB-NCIT'),('DBX-NCIT-C74849','C74849','Calcitriol Measurement','DB-NCIT'),('DBX-NCIT-C74850','C74850','Cholecystokinin Measurement','DB-NCIT'),('DBX-NCIT-C74851','C74851','Corticotropin Releasing Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74852','C74852','Dehydroepiandrosterone Measurement','DB-NCIT'),('DBX-NCIT-C74853','C74853','Dihydrotestosterone Measurement','DB-NCIT'),('DBX-NCIT-C74854','C74854','Dopamine Measurement','DB-NCIT'),('DBX-NCIT-C74855','C74855','Erythropoietin Measurement','DB-NCIT'),('DBX-NCIT-C74856','C74856','Estriol Measurement','DB-NCIT'),('DBX-NCIT-C74857','C74857','Estrone Measurement','DB-NCIT'),('DBX-NCIT-C74858','C74858','Gastrin Measurement','DB-NCIT'),('DBX-NCIT-C74859','C74859','Glucagon Measurement','DB-NCIT'),('DBX-NCIT-C74860','C74860','Gonadotropin Releasing Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74861','C74861','Growth Hormone Inhibiting Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74862','C74862','Growth Hormone Releasing Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74863','C74863','Homovanillic Acid Measurement','DB-NCIT'),('DBX-NCIT-C74864','C74864','Insulin Like Growth Factor-1 Measurement','DB-NCIT'),('DBX-NCIT-C74865','C74865','Insulin Like Growth Factor-2 Measurement','DB-NCIT'),('DBX-NCIT-C74866','C74866','Leptin Measurement','DB-NCIT'),('DBX-NCIT-C74867','C74867','Melatonin Measurement','DB-NCIT'),('DBX-NCIT-C74868','C74868','Noradrenaline Measurement','DB-NCIT'),('DBX-NCIT-C74869','C74869','Oxytocin Measurement','DB-NCIT'),('DBX-NCIT-C74870','C74870','Prolactin Measurement','DB-NCIT'),('DBX-NCIT-C74871','C74871','Secretin Measurement','DB-NCIT'),('DBX-NCIT-C74872','C74872','Serotonin Measurement','DB-NCIT'),('DBX-NCIT-C74873','C74873','Thrombopoietin Measurement','DB-NCIT'),('DBX-NCIT-C74874','C74874','Thyrotropin Releasing Hormone Measurement','DB-NCIT'),('DBX-NCIT-C74875','C74875','Vanillyl Mandelic Acid Measurement','DB-NCIT'),('DBX-NCIT-C74876','C74876','6-Monoacetylmorphine Measurement','DB-NCIT'),('DBX-NCIT-C74877','C74877','Codeine Measurement','DB-NCIT'),('DBX-NCIT-C74878','C74878','Dihydrocodeine Measurement','DB-NCIT'),('DBX-NCIT-C74879','C74879','Hydrocodone Measurement','DB-NCIT'),('DBX-NCIT-C74880','C74880','Hydromorphone Measurement','DB-NCIT'),('DBX-NCIT-C74881','C74881','Methadone Measurement','DB-NCIT'),('DBX-NCIT-C74882','C74882','Methaqualone Measurement','DB-NCIT'),('DBX-NCIT-C74883','C74883','Morphine Measurement','DB-NCIT'),('DBX-NCIT-C74884','C74884','Oxycodone Measurement','DB-NCIT'),('DBX-NCIT-C74885','C74885','Propoxyphene Measurement','DB-NCIT'),('DBX-NCIT-C74886','C74886','Atrial Natriuretic Peptide Measurement','DB-NCIT'),('DBX-NCIT-C74887','C74887','Lactate Dehydrogenase Isoenzyme 1 Measurement','DB-NCIT'),('DBX-NCIT-C74888','C74888','Lactate Dehydrogenase Isoenzyme 2 Measurement','DB-NCIT'),('DBX-NCIT-C74889','C74889','Lactate Dehydrogenase Isoenzyme 3 Measurement','DB-NCIT'),('DBX-NCIT-C74890','C74890','Lactate Dehydrogenase Isoenzyme 4 Measurement','DB-NCIT'),('DBX-NCIT-C74891','C74891','Lactate Dehydrogenase Isoenzyme 5 Measurement','DB-NCIT'),('DBX-NCIT-C74892','C74892','Neuropeptide Y Measurement','DB-NCIT'),('DBX-NCIT-C74893','C74893','Renin Measurement','DB-NCIT'),('DBX-NCIT-C74894','C74894','Albumin to Globulin Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74895','C74895','Vitamin A Measurement','DB-NCIT'),('DBX-NCIT-C74896','C74896','Vitamin B1 Measurement','DB-NCIT'),('DBX-NCIT-C74897','C74897','Vitamin B17 Measurement','DB-NCIT'),('DBX-NCIT-C74898','C74898','Vitamin B2 Measurement','DB-NCIT'),('DBX-NCIT-C74899','C74899','Vitamin B3 Measurement','DB-NCIT'),('DBX-NCIT-C74900','C74900','Vitamin B5 Measurement','DB-NCIT'),('DBX-NCIT-C74901','C74901','Vitamin B6 Measurement','DB-NCIT'),('DBX-NCIT-C74902','C74902','Vitamin B7 Measurement','DB-NCIT'),('DBX-NCIT-C74903','C74903','Vitamin C Measurement','DB-NCIT'),('DBX-NCIT-C74904','C74904','Vitamin D2 Measurement','DB-NCIT'),('DBX-NCIT-C74905','C74905','Vitamin D3 Measurement','DB-NCIT'),('DBX-NCIT-C74906','C74906','Vitamin E Measurement','DB-NCIT'),('DBX-NCIT-C74907','C74907','Vitamin K Measurement','DB-NCIT'),('DBX-NCIT-C74910','C74910','Lymphoma Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74911','C74911','Mature Plasma Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C74912','C74912','Acid Urate Crystal Measurement','DB-NCIT'),('DBX-NCIT-C74913','C74913','Anti-Double Stranded DNA Measurement','DB-NCIT'),('DBX-NCIT-C74916','C74916','Antinuclear Antibody Measurement','DB-NCIT'),('DBX-NCIT-C7492','C7492','Ameloblastic Carcinoma','DB-NCIT'),('DBX-NCIT-C74921','C74921','Microgram per Gram per Day','DB-NCIT'),('DBX-NCIT-C74922','C74922','Microgram per Gram per Hour','DB-NCIT'),('DBX-NCIT-C74923','C74923','Microgram per Gram per Minute','DB-NCIT'),('DBX-NCIT-C74924','C74924','Per Year','DB-NCIT'),('DBX-NCIT-C75346','C75346','Caffeine Measurement','DB-NCIT'),('DBX-NCIT-C75348','C75348','Methamphetamine Measurement','DB-NCIT'),('DBX-NCIT-C75350','C75350','Benzoylecgonine Measurement','DB-NCIT'),('DBX-NCIT-C75354','C75354','Lysergide Measurement','DB-NCIT'),('DBX-NCIT-C75359','C75359','3,4-Methylenedioxymethamphetamine Measurement','DB-NCIT'),('DBX-NCIT-C7539','C7539','Lymphoid Leukemia','DB-NCIT'),('DBX-NCIT-C754','C754','Plasmid','DB-NCIT'),('DBX-NCIT-C7540','C7540','Small Lymphocytic Lymphoma','DB-NCIT'),('DBX-NCIT-C7541','C7541','Retinoblastoma','DB-NCIT'),('DBX-NCIT-C75533','C75533','Absent Adverse Event','DB-NCIT'),('DBX-NCIT-C75562','C75562','Part Time Employment','DB-NCIT'),('DBX-NCIT-C75563','C75563','Unemployment','DB-NCIT'),('DBX-NCIT-C7558','C7558','Endometrial Carcinoma','DB-NCIT'),('DBX-NCIT-C75583','C75583','Slit-lamp Examination','DB-NCIT'),('DBX-NCIT-C7560','C7560','Sweat Gland Adenoma','DB-NCIT'),('DBX-NCIT-C7580','C7580','Skin Appendage Adenoma','DB-NCIT'),('DBX-NCIT-C75905','C75905','Microgram per Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C75912','C75912','Viscosity','DB-NCIT'),('DBX-NCIT-C75913','C75913','Renal Clearance','DB-NCIT'),('DBX-NCIT-C7596','C7596','Malignant Myoepithelioma','DB-NCIT'),('DBX-NCIT-C7612','C7612','Malignant Thymoma','DB-NCIT'),('DBX-NCIT-C76200','C76200','Acinetobacter','DB-NCIT'),('DBX-NCIT-C76201','C76201','Actinomyces','DB-NCIT'),('DBX-NCIT-C76202','C76202','Bacillus','DB-NCIT'),('DBX-NCIT-C76204','C76204','Bacteroides','DB-NCIT'),('DBX-NCIT-C76205','C76205','Bordetella pertussis','DB-NCIT'),('DBX-NCIT-C76208','C76208','Borrelia burgdorferi','DB-NCIT'),('DBX-NCIT-C76210','C76210','Moraxella catarrhalis','DB-NCIT'),('DBX-NCIT-C76211','C76211','Campylobacter','DB-NCIT'),('DBX-NCIT-C76240','C76240','Annulled','DB-NCIT'),('DBX-NCIT-C76241','C76241','Interlocutory Marital Status','DB-NCIT'),('DBX-NCIT-C76242','C76242','Polygamous','DB-NCIT'),('DBX-NCIT-C76269','C76269','Capnocytophaga','DB-NCIT'),('DBX-NCIT-C76271','C76271','Chlamydia','DB-NCIT'),('DBX-NCIT-C76272','C76272','Chlamydophila pneumoniae','DB-NCIT'),('DBX-NCIT-C76273','C76273','Citrobacter','DB-NCIT'),('DBX-NCIT-C76275','C76275','Clostridium','DB-NCIT'),('DBX-NCIT-C76276','C76276','Clostridium difficile','DB-NCIT'),('DBX-NCIT-C76307','C76307','Corynebacterium jeikeium','DB-NCIT'),('DBX-NCIT-C76308','C76308','Corynebacterium','DB-NCIT'),('DBX-NCIT-C76309','C76309','Coxiella','DB-NCIT'),('DBX-NCIT-C76310','C76310','Enterobacter','DB-NCIT'),('DBX-NCIT-C76311','C76311','Enterococcus','DB-NCIT'),('DBX-NCIT-C76319','C76319','Pseudomonas oryzihabitans','DB-NCIT'),('DBX-NCIT-C76320','C76320','Flavobacterium','DB-NCIT'),('DBX-NCIT-C76323','C76323','Fusobacterium','DB-NCIT'),('DBX-NCIT-C76324','C76324','Haemophilus','DB-NCIT'),('DBX-NCIT-C76348','C76348','CDISC SDTM Marital Status Terminology','DB-NCIT'),('DBX-NCIT-C76351','C76351','CDISC Skin Classification Terminology','DB-NCIT'),('DBX-NCIT-C76352','C76352','Lactobacillus','DB-NCIT'),('DBX-NCIT-C76353','C76353','Legionella','DB-NCIT'),('DBX-NCIT-C76355','C76355','Leptospira','DB-NCIT'),('DBX-NCIT-C76357','C76357','Leuconostoc','DB-NCIT'),('DBX-NCIT-C76359','C76359','Listeria','DB-NCIT'),('DBX-NCIT-C76361','C76361','Methylobacterium','DB-NCIT'),('DBX-NCIT-C76368','C76368','Mycobacterium avium complex','DB-NCIT'),('DBX-NCIT-C76369','C76369','Mycobacterium','DB-NCIT'),('DBX-NCIT-C76370','C76370','Mycobacterium tuberculosis','DB-NCIT'),('DBX-NCIT-C76371','C76371','Neisseria','DB-NCIT'),('DBX-NCIT-C76372','C76372','Nocardia','DB-NCIT'),('DBX-NCIT-C76373','C76373','Pasteurella multocida','DB-NCIT'),('DBX-NCIT-C76374','C76374','Proteus','DB-NCIT'),('DBX-NCIT-C76375','C76375','Pseudomonas','DB-NCIT'),('DBX-NCIT-C76376','C76376','Burkholderia cepacia','DB-NCIT'),('DBX-NCIT-C76377','C76377','Stenotrophomonas maltophilia','DB-NCIT'),('DBX-NCIT-C76378','C76378','Rhodococcus','DB-NCIT'),('DBX-NCIT-C76379','C76379','Rickettsia','DB-NCIT'),('DBX-NCIT-C76380','C76380','Salmonella','DB-NCIT'),('DBX-NCIT-C76381','C76381','Shigella','DB-NCIT'),('DBX-NCIT-C76382','C76382','Rothia mucilaginosa','DB-NCIT'),('DBX-NCIT-C76383','C76383','Streptococcus','DB-NCIT'),('DBX-NCIT-C76384','C76384','Streptococcus pneumoniae','DB-NCIT'),('DBX-NCIT-C76385','C76385','Treponema','DB-NCIT'),('DBX-NCIT-C76386','C76386','Vibrio','DB-NCIT'),('DBX-NCIT-C7644','C7644','Adamantinoma','DB-NCIT'),('DBX-NCIT-C77086','C77086','Micrococcus','DB-NCIT'),('DBX-NCIT-C7712','C7712','Uveal Melanoma','DB-NCIT'),('DBX-NCIT-C77170','C77170','Candida albicans','DB-NCIT'),('DBX-NCIT-C77172','C77172','Pichia guilliermondii','DB-NCIT'),('DBX-NCIT-C77173','C77173','Candida krusei','DB-NCIT'),('DBX-NCIT-C77174','C77174','Clavispora lusitaniae','DB-NCIT'),('DBX-NCIT-C77176','C77176','Candida parapsilosis','DB-NCIT'),('DBX-NCIT-C77177','C77177','Candida tropicalis','DB-NCIT'),('DBX-NCIT-C77179','C77179','Candida glabrata','DB-NCIT'),('DBX-NCIT-C77198','C77198','Rubella Virus','DB-NCIT'),('DBX-NCIT-C77199','C77199','Rotavirus','DB-NCIT'),('DBX-NCIT-C77208','C77208','Escherichia','DB-NCIT'),('DBX-NCIT-C77265','C77265','Canadian Cardiovascular Society Grading Scale Class I','DB-NCIT'),('DBX-NCIT-C77266','C77266','Canadian Cardiovascular Society Grading Scale Class II','DB-NCIT'),('DBX-NCIT-C77267','C77267','Canadian Cardiovascular Society Grading Scale Class III','DB-NCIT'),('DBX-NCIT-C77268','C77268','Canadian Cardiovascular Society Grading Scale Class IV','DB-NCIT'),('DBX-NCIT-C77269','C77269','Killip Class I','DB-NCIT'),('DBX-NCIT-C77270','C77270','Killip Class II','DB-NCIT'),('DBX-NCIT-C77271','C77271','Killip Class III','DB-NCIT'),('DBX-NCIT-C77272','C77272','Killip Class IV','DB-NCIT'),('DBX-NCIT-C77532','C77532','Recumbent Position','DB-NCIT'),('DBX-NCIT-C77533','C77533','Umbilicus','DB-NCIT'),('DBX-NCIT-C77534','C77534','Arbitrary Fluorescence Units','DB-NCIT'),('DBX-NCIT-C77535','C77535','Relative Fluorescence Unit','DB-NCIT'),('DBX-NCIT-C77606','C77606','Unit per Gram','DB-NCIT'),('DBX-NCIT-C77607','C77607','Unit per Milliliter','DB-NCIT'),('DBX-NCIT-C77608','C77608','Abdominal Wall','DB-NCIT'),('DBX-NCIT-C77613','C77613','Pleural Fluid','DB-NCIT'),('DBX-NCIT-C77637','C77637','Oral Mucosa','DB-NCIT'),('DBX-NCIT-C77640','C77640','Hepatic Lymph Node','DB-NCIT'),('DBX-NCIT-C77641','C77641','Mesenteric Lymph Node','DB-NCIT'),('DBX-NCIT-C77642','C77642','Pancreatic Lymph Node','DB-NCIT'),('DBX-NCIT-C77643','C77643','Paraaortic Lymph Node','DB-NCIT'),('DBX-NCIT-C77645','C77645','Portal Lymph Node','DB-NCIT'),('DBX-NCIT-C77650','C77650','Submandibular Lymph Node','DB-NCIT'),('DBX-NCIT-C77666','C77666','Vomitus','DB-NCIT'),('DBX-NCIT-C77951','C77951','Relocation','DB-NCIT'),('DBX-NCIT-C78139','C78139','Drug Test','DB-NCIT'),('DBX-NCIT-C78373','C78373','Dietary Route of Administration','DB-NCIT'),('DBX-NCIT-C78374','C78374','Oral Gavage Route of Administration','DB-NCIT'),('DBX-NCIT-C78504','C78504','Non-Cardiac Chest Pain','DB-NCIT'),('DBX-NCIT-C78720','C78720','Independent Rater','DB-NCIT'),('DBX-NCIT-C78721','C78721','Dispensed Amount','DB-NCIT'),('DBX-NCIT-C78722','C78722','Returned Amount','DB-NCIT'),('DBX-NCIT-C78723','C78723','Calcified Specimen','DB-NCIT'),('DBX-NCIT-C78724','C78724','Clotted Specimen','DB-NCIT'),('DBX-NCIT-C78725','C78725','Autolized Specimen','DB-NCIT'),('DBX-NCIT-C78726','C78726','Adjudication Committee','DB-NCIT'),('DBX-NCIT-C78727','C78727','Normal Reference Range','DB-NCIT'),('DBX-NCIT-C78728','C78728','Many','DB-NCIT'),('DBX-NCIT-C78729','C78729','Arterial Blood','DB-NCIT'),('DBX-NCIT-C78730','C78730','Venous Blood','DB-NCIT'),('DBX-NCIT-C78731','C78731','CDISC SDTM Drug Accountability Test Terminology by Name','DB-NCIT'),('DBX-NCIT-C78732','C78732','CDISC SDTM Drug Accountability Test Terminology by Code','DB-NCIT'),('DBX-NCIT-C78733','C78733','CDISC SDTM Specimen Condition Terminology','DB-NCIT'),('DBX-NCIT-C78734','C78734','CDISC SDTM Specimen Type Terminology','DB-NCIT'),('DBX-NCIT-C78735','C78735','CDISC SDTM Evaluator Terminology','DB-NCIT'),('DBX-NCIT-C78736','C78736','CDISC SDTM Reference Range Indicator','DB-NCIT'),('DBX-NCIT-C78737','C78737','CDISC SDTM Relationship Type Terminology','DB-NCIT'),('DBX-NCIT-C78738','C78738','CDISC SDTM Never/Current/Former Classification Terminology','DB-NCIT'),('DBX-NCIT-C78739','C78739','Atherosclerotic Plaque','DB-NCIT'),('DBX-NCIT-C78740','C78740','Menstrual Blood','DB-NCIT'),('DBX-NCIT-C78741','C78741','Expired Air','DB-NCIT'),('DBX-NCIT-C78742','C78742','Lochia','DB-NCIT'),('DBX-NCIT-C78743','C78743','Meconium','DB-NCIT'),('DBX-NCIT-C78744','C78744','Transudate','DB-NCIT'),('DBX-NCIT-C78800','C78800','Value Above Reference Range','DB-NCIT'),('DBX-NCIT-C78801','C78801','Value Below Reference Range','DB-NCIT'),('DBX-NCIT-C78802','C78802','Abnormal Reference Range','DB-NCIT'),('DBX-NCIT-C79089','C79089','CA-125 Measurement','DB-NCIT'),('DBX-NCIT-C79432','C79432','Preputial Gland','DB-NCIT'),('DBX-NCIT-C79433','C79433','Alpha Glutathione-S-Transferase Measurement','DB-NCIT'),('DBX-NCIT-C79434','C79434','Corticosterone Measurement','DB-NCIT'),('DBX-NCIT-C79435','C79435','Glutathione-S-Transferase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79436','C79436','Myoglobin Measurement','DB-NCIT'),('DBX-NCIT-C79437','C79437','5 Prime Nucleotidase Measurement','DB-NCIT'),('DBX-NCIT-C79438','C79438','Alkaline Phosphatase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79439','C79439','Calcium to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79440','C79440','Chloride to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79441','C79441','Creatine Kinase MB to Total Creatine Kinase Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79442','C79442','Creatine Kinase MM to Total Creatine Kinase Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79443','C79443','Deoxypyridinoline Measurement','DB-NCIT'),('DBX-NCIT-C79444','C79444','Deoxypyridinoline to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79445','C79445','Epinephrine Measurement','DB-NCIT'),('DBX-NCIT-C79446','C79446','Gamma Glutamyl Transferase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79447','C79447','Glucose to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79448','C79448','Glutamate Dehydrogenase Measurement','DB-NCIT'),('DBX-NCIT-C79449','C79449','Lactate Dehydrogenase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79450','C79450','Lactic Acid Measurement','DB-NCIT'),('DBX-NCIT-C79451','C79451','LDH Isoenzyme 1 to LDH Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79452','C79452','LDH Isoenzyme 2 to LDH Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79453','C79453','LDH Isoenzyme 3 to LDH Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79454','C79454','LDH Isoenzyme 4 to LDH Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79455','C79455','LDH Isoenzyme 5 to LDH Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79456','C79456','Magnesium to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79457','C79457','Mu Glutathione-S-Transferase Measurement','DB-NCIT'),('DBX-NCIT-C79458','C79458','Mu Glutathione-S-Transferase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79459','C79459','N-Acetyl Glucosamide Measurement','DB-NCIT'),('DBX-NCIT-C79460','C79460','N-Acetyl Glucosamide to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79461','C79461','Phosphate to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79462','C79462','Potassium to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79463','C79463','Protein to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79464','C79464','Sodium to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79465','C79465','Sorbitol Dehydrogenase Measurement','DB-NCIT'),('DBX-NCIT-C79466','C79466','Creatine Kinase BB to Total Creatine Kinase Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79467','C79467','Large Unstained Cells to Leukocytes Ratio Measurement','DB-NCIT'),('DBX-NCIT-C79602','C79602','Poikilocyte Measurement','DB-NCIT'),('DBX-NCIT-C79949','C79949','Carcinoma Arising from Craniopharyngioma','DB-NCIT'),('DBX-NCIT-C79950','C79950','Benign Carotid Body Paraganglioma','DB-NCIT'),('DBX-NCIT-C79951','C79951','Papillary Adenoma','DB-NCIT'),('DBX-NCIT-C79953','C79953','Tubulostromal Adenoma','DB-NCIT'),('DBX-NCIT-C80160','C80160','Complement Measurement','DB-NCIT'),('DBX-NCIT-C80163','C80163','Acid Phosphatase Measurement','DB-NCIT'),('DBX-NCIT-C80164','C80164','Active Glucagon-like Peptide-1 Measurement','DB-NCIT'),('DBX-NCIT-C80165','C80165','Alpha Glucuronidase Measurement','DB-NCIT'),('DBX-NCIT-C80166','C80166','Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C80167','C80167','Alpha-1 Antitrypsin Measurement','DB-NCIT'),('DBX-NCIT-C80168','C80168','Alpha-2 Macroglobulin Measurement','DB-NCIT'),('DBX-NCIT-C80169','C80169','Angiotensin Converting Enzyme Measurement','DB-NCIT'),('DBX-NCIT-C80170','C80170','Beta Glucuronidase Measurement','DB-NCIT'),('DBX-NCIT-C80171','C80171','Cholesterol to HDL-Cholesterol Ratio Measurement','DB-NCIT'),('DBX-NCIT-C80172','C80172','Complement Bb Measurement','DB-NCIT'),('DBX-NCIT-C80173','C80173','Complement C1q Antibody Measurement','DB-NCIT'),('DBX-NCIT-C80174','C80174','Complement C3 Measurement','DB-NCIT'),('DBX-NCIT-C80175','C80175','Complement C3a Measurement','DB-NCIT'),('DBX-NCIT-C80176','C80176','Complement C3b Measurement','DB-NCIT'),('DBX-NCIT-C80177','C80177','Complement C4 Measurement','DB-NCIT'),('DBX-NCIT-C80178','C80178','Complement C4a Measurement','DB-NCIT'),('DBX-NCIT-C80179','C80179','Complement C5a Measurement','DB-NCIT'),('DBX-NCIT-C80180','C80180','F2 Isoprostane Measurement','DB-NCIT'),('DBX-NCIT-C80182','C80182','Galanin Measurement','DB-NCIT'),('DBX-NCIT-C80183','C80183','Glucagon-like Peptide-1 Measurement','DB-NCIT'),('DBX-NCIT-C80184','C80184','Glucose-6-Phosphate Dehydrogenase Measurement','DB-NCIT'),('DBX-NCIT-C80185','C80185','Glutathione-S-Transferase Measurement','DB-NCIT'),('DBX-NCIT-C80186','C80186','Gold Measurement','DB-NCIT'),('DBX-NCIT-C80187','C80187','HDL-Cholesterol Subclass 2 Measurement','DB-NCIT'),('DBX-NCIT-C80188','C80188','HDL-Cholesterol Subclass 3 Measurement','DB-NCIT'),('DBX-NCIT-C80189','C80189','Histamine Measurement','DB-NCIT'),('DBX-NCIT-C80190','C80190','Hydroxyproline Measurement','DB-NCIT'),('DBX-NCIT-C80191','C80191','Macrophage Colony Stimulating Factor Measurement','DB-NCIT'),('DBX-NCIT-C80192','C80192','Matrix Metalloproteinase 1 Measurement','DB-NCIT'),('DBX-NCIT-C80193','C80193','Matrix Metalloproteinase 2 Measurement','DB-NCIT'),('DBX-NCIT-C80194','C80194','Matrix Metalloproteinase 3 Measurement','DB-NCIT'),('DBX-NCIT-C80195','C80195','Matrix Metalloproteinase 7 Measurement','DB-NCIT'),('DBX-NCIT-C80196','C80196','Matrix Metalloproteinase 8 Measurement','DB-NCIT'),('DBX-NCIT-C80197','C80197','Matrix Metalloproteinase 9 Measurement','DB-NCIT'),('DBX-NCIT-C80198','C80198','Myeloperoxidase Measurement','DB-NCIT'),('DBX-NCIT-C80199','C80199','Neopterin Measurement','DB-NCIT'),('DBX-NCIT-C80200','C80200','Non-esterified Fatty Acids Measurement','DB-NCIT'),('DBX-NCIT-C80201','C80201','Pancreatic Polypeptide Measurement','DB-NCIT'),('DBX-NCIT-C80202','C80202','Peptide YY Measurement','DB-NCIT'),('DBX-NCIT-C80203','C80203','Pi Glutathione S-Transferase Measurement','DB-NCIT'),('DBX-NCIT-C80204','C80204','Prostatic Acid Phosphatase Measurement','DB-NCIT'),('DBX-NCIT-C80205','C80205','Resistin Measurement','DB-NCIT'),('DBX-NCIT-C80206','C80206','Saturated Non-esterified Fatty Acids Measurement','DB-NCIT'),('DBX-NCIT-C80207','C80207','Theta Glutathione S-Transferase Measurement','DB-NCIT'),('DBX-NCIT-C80208','C80208','Total Radical-Trap Antioxidant Potential Measurement','DB-NCIT'),('DBX-NCIT-C80209','C80209','Unsaturated Non-esterified Fatty Acids Measurement','DB-NCIT'),('DBX-NCIT-C80210','C80210','Zinc Measurement','DB-NCIT'),('DBX-NCIT-C80211','C80211','Pyridinoline Measurement','DB-NCIT'),('DBX-NCIT-C80227','C80227','Vacation','DB-NCIT'),('DBX-NCIT-C80349','C80349','Cystic Keratinizing Epithelioma','DB-NCIT'),('DBX-NCIT-C80351','C80351','Benign Ito Cell Tumor','DB-NCIT'),('DBX-NCIT-C80352','C80352','Malignant Ito Cell Tumor','DB-NCIT'),('DBX-NCIT-C80356','C80356','Tubulostromal Adenocarcinoma','DB-NCIT'),('DBX-NCIT-C80360','C80360','Somatotrophin Measurement','DB-NCIT'),('DBX-NCIT-C80365','C80365','Thrombin Time','DB-NCIT'),('DBX-NCIT-C80383','C80383','Non-ST Elevation Myocardial Infarction by ECG Finding','DB-NCIT'),('DBX-NCIT-C80432','C80432','Atrial Ablation','DB-NCIT'),('DBX-NCIT-C80433','C80433','Ventricular Ablation','DB-NCIT'),('DBX-NCIT-C80435','C80435','Implantable Cardioverter-Defibrillator Placement','DB-NCIT'),('DBX-NCIT-C80436','C80436','Cardiac Resynchronization Therapy','DB-NCIT'),('DBX-NCIT-C80439','C80439','Septal Ablation','DB-NCIT'),('DBX-NCIT-C80449','C80449','Mitral Valve Repair','DB-NCIT'),('DBX-NCIT-C80451','C80451','Ventricular Aneurysm Resection','DB-NCIT'),('DBX-NCIT-C80457','C80457','Implanted Medical Device','DB-NCIT'),('DBX-NCIT-C80473','C80473','Left Ventricular Assist Device','DB-NCIT'),('DBX-NCIT-C80476','C80476','Coronary Graft Anastomoses','DB-NCIT'),('DBX-NCIT-C80494','C80494','Ischemic Myocardium Percentage','DB-NCIT'),('DBX-NCIT-C8054','C8054','Thyroid Gland Follicular Carcinoma','DB-NCIT'),('DBX-NCIT-C81170','C81170','Midline','DB-NCIT'),('DBX-NCIT-C812','C812','Ribonucleic Acid','DB-NCIT'),('DBX-NCIT-C81255','C81255','Head Circumference','DB-NCIT'),('DBX-NCIT-C81298','C81298','Total Body Length','DB-NCIT'),('DBX-NCIT-C813','C813','Messenger RNA','DB-NCIT'),('DBX-NCIT-C814','C814','Ribosomal RNA','DB-NCIT'),('DBX-NCIT-C815','C815','Small Nuclear RNA','DB-NCIT'),('DBX-NCIT-C816','C816','Transfer RNA','DB-NCIT'),('DBX-NCIT-C81854','C81854','Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor','DB-NCIT'),('DBX-NCIT-C81855','C81855','Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor','DB-NCIT'),('DBX-NCIT-C81947','C81947','Oval Fat Body Measurement','DB-NCIT'),('DBX-NCIT-C81948','C81948','Ionized Calcium Measurement','DB-NCIT'),('DBX-NCIT-C81951','C81951','Starch Crystal Measurement','DB-NCIT'),('DBX-NCIT-C81952','C81952','Eotaxin-1 Measurement','DB-NCIT'),('DBX-NCIT-C81953','C81953','Eotaxin-2 Measurement','DB-NCIT'),('DBX-NCIT-C81954','C81954','Eotaxin-3 Measurement','DB-NCIT'),('DBX-NCIT-C81955','C81955','Lymphotactin Measurement','DB-NCIT'),('DBX-NCIT-C81956','C81956','Macrophage-Derived Chemokine Measurement','DB-NCIT'),('DBX-NCIT-C81957','C81957','Reg upon Act Normal T-cell Exprd Secrtd Measurement','DB-NCIT'),('DBX-NCIT-C81958','C81958','Antithrombin Activity Measurement','DB-NCIT'),('DBX-NCIT-C81959','C81959','Factor III Measurement','DB-NCIT'),('DBX-NCIT-C81960','C81960','Factor VII Measurement','DB-NCIT'),('DBX-NCIT-C81961','C81961','Factor VIII Measurement','DB-NCIT'),('DBX-NCIT-C81962','C81962','Platelet Distribution Width','DB-NCIT'),('DBX-NCIT-C81963','C81963','Free Estriol Measurement','DB-NCIT'),('DBX-NCIT-C81964','C81964','C-Terminal Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C81965','C81965','Mid-Molecule Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C81966','C81966','N-Terminal Parathyroid Hormone Measurement','DB-NCIT'),('DBX-NCIT-C81967','C81967','Proinsulin Measurement','DB-NCIT'),('DBX-NCIT-C81968','C81968','Reverse Triiodothyronine Measurement','DB-NCIT'),('DBX-NCIT-C81969','C81969','Immunoglobulin A Measurement','DB-NCIT'),('DBX-NCIT-C81970','C81970','Immunoglobulin E Measurement','DB-NCIT'),('DBX-NCIT-C81971','C81971','Immunoglobulin G Measurement','DB-NCIT'),('DBX-NCIT-C81972','C81972','Immunoglobulin M Measurement','DB-NCIT'),('DBX-NCIT-C81973','C81973','Anti-DNA Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81974','C81974','Direct Antiglobulin Test','DB-NCIT'),('DBX-NCIT-C81975','C81975','Antimitochondrial Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81976','C81976','Anti-Saccharomyces cerevisiae Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81977','C81977','Antithrombin Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81978','C81978','Aspartate Aminotransferase Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81979','C81979','Beta-2 Glycoprotein Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81980','C81980','Beta-2 Microglobulin Measurement','DB-NCIT'),('DBX-NCIT-C81982','C81982','Cancer Antigen 19-9 Measurement','DB-NCIT'),('DBX-NCIT-C81983','C81983','Carcinoembryonic Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81984','C81984','Heterophile Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81985','C81985','Islet Cell 512 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81986','C81986','Islet Cell 512 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81987','C81987','Islet Neogenesis Associated Protein Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81988','C81988','Pemphigoid Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81989','C81989','Plasminogen Activator Inhibitor-1 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81990','C81990','Thyroid Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81991','C81991','Thyroid Antimicrosomal Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81992','C81992','Thyroid Antithyroglobulin Antibody Measurement','DB-NCIT'),('DBX-NCIT-C81993','C81993','Tissue Plasminogen Activator Antigen Measurement','DB-NCIT'),('DBX-NCIT-C81994','C81994','Interferon Alpha Measurement','DB-NCIT'),('DBX-NCIT-C81995','C81995','Interferon Beta Measurement','DB-NCIT'),('DBX-NCIT-C81996','C81996','Interferon Gamma Measurement','DB-NCIT'),('DBX-NCIT-C81997','C81997','Segmented Neutrophil Count','DB-NCIT'),('DBX-NCIT-C81998','C81998','Amyloid P Measurement','DB-NCIT'),('DBX-NCIT-C81999','C81999','Beta Amyloid Measurement','DB-NCIT'),('DBX-NCIT-C82000','C82000','Apolipoprotein AII Measurement','DB-NCIT'),('DBX-NCIT-C82001','C82001','Apolipoprotein CIII Measurement','DB-NCIT'),('DBX-NCIT-C82002','C82002','Apolipoprotein E Measurement','DB-NCIT'),('DBX-NCIT-C82003','C82003','Apolipoprotein H Measurement','DB-NCIT'),('DBX-NCIT-C82004','C82004','Brain-Derived Neurotrophic Factor Measurement','DB-NCIT'),('DBX-NCIT-C82005','C82005','Calprotectin Measurement','DB-NCIT'),('DBX-NCIT-C82006','C82006','CD40 Measurement','DB-NCIT'),('DBX-NCIT-C82007','C82007','CD40 Ligand Measurement','DB-NCIT'),('DBX-NCIT-C82008','C82008','Endothelin-1 Measurement','DB-NCIT'),('DBX-NCIT-C82009','C82009','Epidermal Growth Factor Measurement','DB-NCIT'),('DBX-NCIT-C82010','C82010','Epithelial Neutrophil-Activating Peptide 78 Measurement','DB-NCIT'),('DBX-NCIT-C82011','C82011','Extracell Newly Ident RAGE Bind Protein Measurement','DB-NCIT'),('DBX-NCIT-C82012','C82012','Fatty Acid Binding Protein 1 Measurement','DB-NCIT'),('DBX-NCIT-C82013','C82013','Fibrin Degradation Products Measurement','DB-NCIT'),('DBX-NCIT-C82014','C82014','Fibroblast Growth Factor Basic Form Measurement','DB-NCIT'),('DBX-NCIT-C82015','C82015','Glutamic Acid Decarboxylase 1 Measurement','DB-NCIT'),('DBX-NCIT-C82016','C82016','Glutamic Acid Decarboxylase 2 Measurement','DB-NCIT'),('DBX-NCIT-C82017','C82017','Glutamic Acid Decarboxylase 2 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C82018','C82018','Granulocyte Colony Stimulating Factor Measurement','DB-NCIT'),('DBX-NCIT-C82019','C82019','Granulocyte Macrophage Colony Stm Factor Measurement','DB-NCIT'),('DBX-NCIT-C82020','C82020','Inhibin A Measurement','DB-NCIT'),('DBX-NCIT-C82021','C82021','Lactoferrin Measurement','DB-NCIT'),('DBX-NCIT-C82022','C82022','Lipoprotein a Measurement','DB-NCIT'),('DBX-NCIT-C82023','C82023','Macrophage Inflammatory Protein 1 Alpha Measurement','DB-NCIT'),('DBX-NCIT-C82024','C82024','Macrophage Inflammatory Protein 1 Beta Measurement','DB-NCIT'),('DBX-NCIT-C82025','C82025','Monocyte Chemotactic Protein 1 Measurement','DB-NCIT'),('DBX-NCIT-C82026','C82026','Neutrophil Elastase Measurement','DB-NCIT'),('DBX-NCIT-C82027','C82027','Polymorphonuclear Neutrophil Elastase Measurement','DB-NCIT'),('DBX-NCIT-C82028','C82028','Pancreatic Elastase Measurement','DB-NCIT'),('DBX-NCIT-C82029','C82029','Polymorphonuclear Pancreatic Elastase Measurement','DB-NCIT'),('DBX-NCIT-C82030','C82030','Plasminogen Activator Inhibitor-1 Measurement','DB-NCIT'),('DBX-NCIT-C82031','C82031','Pregnancy-Associated Plasma Protein-A Measurement','DB-NCIT'),('DBX-NCIT-C82032','C82032','ProB-Type Natriuretic Peptide Measurement','DB-NCIT'),('DBX-NCIT-C82033','C82033','Procollagen Type I Carboxy Terminal Peptide Measurement','DB-NCIT'),('DBX-NCIT-C82034','C82034','Prothrombin Fragments 1 and 2 Measurement','DB-NCIT'),('DBX-NCIT-C82035','C82035','Stem Cell Factor Measurement','DB-NCIT'),('DBX-NCIT-C82036','C82036','Tissue Inhibitor of Metalloproteinase 1 Measurement','DB-NCIT'),('DBX-NCIT-C82037','C82037','Transferrin Measurement','DB-NCIT'),('DBX-NCIT-C82038','C82038','Type I Collagen C-Telopeptide Measurement','DB-NCIT'),('DBX-NCIT-C82039','C82039','Type I Collagen N-Telopeptide Measurement','DB-NCIT'),('DBX-NCIT-C82040','C82040','Type II Collagen C-Telopeptide Measurement','DB-NCIT'),('DBX-NCIT-C82041','C82041','Type II Collagen N-Telopeptide Measurement','DB-NCIT'),('DBX-NCIT-C82042','C82042','Vascular Cell Adhesion Molecule 1 Measurement','DB-NCIT'),('DBX-NCIT-C82044','C82044','Indican Measurement','DB-NCIT'),('DBX-NCIT-C82045','C82045','Segmented Neutrophil to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C82046','C82046','Nucleated Erythrocyte to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C82330','C82330','Repetition Time','DB-NCIT'),('DBX-NCIT-C82331','C82331','Echo Time','DB-NCIT'),('DBX-NCIT-C82621','C82621','D-Dimer Measurement','DB-NCIT'),('DBX-NCIT-C82625','C82625','Partial Pressure of Carbon Dioxide Measurement','DB-NCIT'),('DBX-NCIT-C82637','C82637','Crossover Study','DB-NCIT'),('DBX-NCIT-C82638','C82638','Factorial Study','DB-NCIT'),('DBX-NCIT-C82639','C82639','Parallel Study','DB-NCIT'),('DBX-NCIT-C82640','C82640','Single Group Study','DB-NCIT'),('DBX-NCIT-C82973','C82973','Subcapsular Adrenal Tumor','DB-NCIT'),('DBX-NCIT-C8312','C8312','Leptomeningeal Sarcoma','DB-NCIT'),('DBX-NCIT-C83470','C83470','Appendiceal Tip','DB-NCIT'),('DBX-NCIT-C83488','C83488','Benign Subcapsular Adrenal Tumor','DB-NCIT'),('DBX-NCIT-C83489','C83489','Malignant Subcapsular Adrenal Tumor','DB-NCIT'),('DBX-NCIT-C83609','C83609','Saint Barthelemy','DB-NCIT'),('DBX-NCIT-C83610','C83610','Saint Martin (French Part)','DB-NCIT'),('DBX-NCIT-C83817','C83817','Corrected Prolonged QT Interval by ECG Finding','DB-NCIT'),('DBX-NCIT-C8383','C8383','Renal Adenoma','DB-NCIT'),('DBX-NCIT-C8402','C8402','Fibrohistiocytic Neoplasm','DB-NCIT'),('DBX-NCIT-C8422','C8422','Ossifying Fibroma','DB-NCIT'),('DBX-NCIT-C84263','C84263','Mild Adverse Event','DB-NCIT'),('DBX-NCIT-C84264','C84264','Moderate Adverse Event','DB-NCIT'),('DBX-NCIT-C84265','C84265','Severe Adverse Event','DB-NCIT'),('DBX-NCIT-C84266','C84266','Life Threatening Adverse Event','DB-NCIT'),('DBX-NCIT-C84356','C84356','Non-Keratinizing Epithelioma','DB-NCIT'),('DBX-NCIT-C84357','C84357','Yolk Sac Adenoma','DB-NCIT'),('DBX-NCIT-C84372','C84372','Knee to Heel Length Measurement','DB-NCIT'),('DBX-NCIT-C84507','C84507','Buffy Coat','DB-NCIT'),('DBX-NCIT-C84516','C84516','Dried Specimen','DB-NCIT'),('DBX-NCIT-C84517','C84517','Fresh Specimen','DB-NCIT'),('DBX-NCIT-C84582','C84582','Proteus inconstans','DB-NCIT'),('DBX-NCIT-C84809','C84809','Beta Amyloid 42 Measurement','DB-NCIT'),('DBX-NCIT-C84810','C84810','Tau Protein Measurement','DB-NCIT'),('DBX-NCIT-C84811','C84811','Nonphosphorylated Tau Protein Measurement','DB-NCIT'),('DBX-NCIT-C84812','C84812','Phosphorylated Tau Protein Measurement','DB-NCIT'),('DBX-NCIT-C84818','C84818','Vitamin D Measurement','DB-NCIT'),('DBX-NCIT-C84819','C84819','Eosinophilic Metamyelocyte Count','DB-NCIT'),('DBX-NCIT-C84821','C84821','Eosinophilic Myelocyte Count','DB-NCIT'),('DBX-NCIT-C84822','C84822','Neutrophilic Metamyelocyte Count','DB-NCIT'),('DBX-NCIT-C84823','C84823','Neutrophilic Myelocyte Count','DB-NCIT'),('DBX-NCIT-C85250','C85250','Proteus vulgaris','DB-NCIT'),('DBX-NCIT-C85441','C85441','Clinical Events Domain','DB-NCIT'),('DBX-NCIT-C85442','C85442','Findings About Events or Interventions Domain','DB-NCIT'),('DBX-NCIT-C85491','C85491','CDISC SDTM Microorganism Terminology','DB-NCIT'),('DBX-NCIT-C85492','C85492','CDISC SDTM Method Terminology','DB-NCIT'),('DBX-NCIT-C85493','C85493','CDISC SDTM Pharmacokinetic Parameter Terminology','DB-NCIT'),('DBX-NCIT-C85494','C85494','CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology','DB-NCIT'),('DBX-NCIT-C85495','C85495','CDISC SDTM Microbiology Susceptibility Testing Result Category Terminology','DB-NCIT'),('DBX-NCIT-C85499','C85499','Clinician','DB-NCIT'),('DBX-NCIT-C85511','C85511','Microbacterium','DB-NCIT'),('DBX-NCIT-C85521','C85521','Incarceration','DB-NCIT'),('DBX-NCIT-C85542','C85542','R Squared','DB-NCIT'),('DBX-NCIT-C85543','C85543','Mycobacterium kansasii','DB-NCIT'),('DBX-NCIT-C85544','C85544','Mycobacterium africanum','DB-NCIT'),('DBX-NCIT-C85545','C85545','Mycobacterium bovis','DB-NCIT'),('DBX-NCIT-C85546','C85546','Mycobacterium bovis BCG','DB-NCIT'),('DBX-NCIT-C85547','C85547','Mycobacterium canetti','DB-NCIT'),('DBX-NCIT-C85548','C85548','Mycobacterium microti','DB-NCIT'),('DBX-NCIT-C85552','C85552','Five Times Weekly','DB-NCIT'),('DBX-NCIT-C85553','C85553','Adjusted R Squared','DB-NCIT'),('DBX-NCIT-C85554','C85554','Acridine Orange Staining Method','DB-NCIT'),('DBX-NCIT-C85555','C85555','Agar Dilution Method','DB-NCIT'),('DBX-NCIT-C85556','C85556','Aminoglycoside Screening Method','DB-NCIT'),('DBX-NCIT-C85557','C85557','Antibiotic Agar Screening Method','DB-NCIT'),('DBX-NCIT-C85558','C85558','Antimicrobial Combination Testing Method','DB-NCIT'),('DBX-NCIT-C85559','C85559','Antimicrobial Dose Dependent Susceptibility Result','DB-NCIT'),('DBX-NCIT-C85560','C85560','Antimicrobial Intermediate Susceptibility Result','DB-NCIT'),('DBX-NCIT-C85561','C85561','Antimicrobial Nonsusceptibility Result','DB-NCIT'),('DBX-NCIT-C85562','C85562','Antimicrobial Resistance Result','DB-NCIT'),('DBX-NCIT-C85563','C85563','Antimicrobial Susceptibility Result','DB-NCIT'),('DBX-NCIT-C85564','C85564','Area Under the Curve All','DB-NCIT'),('DBX-NCIT-C85565','C85565','Area Under the Curve From Dosing to Last Concentration','DB-NCIT'),('DBX-NCIT-C85566','C85566','Area Under the Curve from T1 to T2','DB-NCIT'),('DBX-NCIT-C85567','C85567','Area Under the Curve Over Dosing Interval','DB-NCIT'),('DBX-NCIT-C85569','C85569','Area Under the First Moment Curve From Dosing to Last Concentration','DB-NCIT'),('DBX-NCIT-C85570','C85570','Area Under the First Moment Curve Over Dosing Interval','DB-NCIT'),('DBX-NCIT-C85571','C85571','Area Under the Urinary Excretion Rate Curve From Dosing to Last Concentration','DB-NCIT'),('DBX-NCIT-C85572','C85572','Area Under the Urinary Excretion Rate Curve from T1 to T2','DB-NCIT'),('DBX-NCIT-C85573','C85573','Auscultation','DB-NCIT'),('DBX-NCIT-C85574','C85574','Atomic Absorption Spectroscopy','DB-NCIT'),('DBX-NCIT-C85575','C85575','Average Concentration','DB-NCIT'),('DBX-NCIT-C85576','C85576','Beta Lactamase Screening Method','DB-NCIT'),('DBX-NCIT-C85577','C85577','Calcofluor White Staining Method','DB-NCIT'),('DBX-NCIT-C85578','C85578','Cellulose Tape Method','DB-NCIT'),('DBX-NCIT-C85579','C85579','Cmin','DB-NCIT'),('DBX-NCIT-C85580','C85580','Collection Interval Midpoint','DB-NCIT'),('DBX-NCIT-C85581','C85581','Concentration Variability Between Dose Time and Tau','DB-NCIT'),('DBX-NCIT-C85582','C85582','Current Therapy','DB-NCIT'),('DBX-NCIT-C85583','C85583','Day Times Femtogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85584','C85584','Day Times Gram per Milliliter','DB-NCIT'),('DBX-NCIT-C85586','C85586','Day Times Microgram per Milliliter','DB-NCIT'),('DBX-NCIT-C85587','C85587','Day Times Micromole per Milliliter','DB-NCIT'),('DBX-NCIT-C85588','C85588','Day Times Milligram per Milliliter','DB-NCIT'),('DBX-NCIT-C85589','C85589','Day Times Millimole per Milliliter','DB-NCIT'),('DBX-NCIT-C8559','C8559','Malignant Paraganglioma','DB-NCIT'),('DBX-NCIT-C85591','C85591','Day Times Nanogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85592','C85592','Day Times Nanomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85593','C85593','Day Times Picogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85594','C85594','Day Times Picomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85595','C85595','Disk Diffusion Method','DB-NCIT'),('DBX-NCIT-C85596','C85596','Epsilometry','DB-NCIT'),('DBX-NCIT-C85597','C85597','Femtogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85598','C85598','Giemsa Staining Method','DB-NCIT'),('DBX-NCIT-C85599','C85599','Gradient Diffusion Method','DB-NCIT'),('DBX-NCIT-C85601','C85601','Gram per Hour','DB-NCIT'),('DBX-NCIT-C85602','C85602','Gram per Minute','DB-NCIT'),('DBX-NCIT-C85604','C85604','Hour Squared Times Microgram per Milliliter','DB-NCIT'),('DBX-NCIT-C85605','C85605','Hour Squared Times Micromole per Milliliter','DB-NCIT'),('DBX-NCIT-C85606','C85606','Hour Squared Times Milligram per Milliliter','DB-NCIT'),('DBX-NCIT-C85607','C85607','Hour Squared Times Millimole per Milliliter','DB-NCIT'),('DBX-NCIT-C85608','C85608','Hour Squared Times Nanogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85609','C85609','Hour Squared Times Picogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85610','C85610','Hour Squared Times Picomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85611','C85611','Hour Times Femtogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85612','C85612','Hour Times Femtomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85613','C85613','Hour Times Gram per Milliliter','DB-NCIT'),('DBX-NCIT-C85615','C85615','Hour Times Microgram per Milliliter','DB-NCIT'),('DBX-NCIT-C85617','C85617','Hour Times Microgram per Milliliter per Milligram','DB-NCIT'),('DBX-NCIT-C85618','C85618','Hour Times Micromole per Milliliter','DB-NCIT'),('DBX-NCIT-C85621','C85621','Hour Times Milligram per Milliliter','DB-NCIT'),('DBX-NCIT-C85622','C85622','Hour Times Millimole per Milliliter','DB-NCIT'),('DBX-NCIT-C85624','C85624','Hour Times Nanogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85625','C85625','Hour Times Nanogram per Milliliter per Gram','DB-NCIT'),('DBX-NCIT-C85626','C85626','Hour Times Nanogram per Milliliter per Kilogram','DB-NCIT'),('DBX-NCIT-C85627','C85627','Hour Times Nanogram per Milliliter per Milligram','DB-NCIT'),('DBX-NCIT-C85628','C85628','Hour Times Nanogram per Milliliter per Milligram per Kilogram','DB-NCIT'),('DBX-NCIT-C85629','C85629','Hour Times Nanogram per Milliliter per Milligram per Meter Squared','DB-NCIT'),('DBX-NCIT-C85631','C85631','Hour Times Nanomole per Liter per Micromole','DB-NCIT'),('DBX-NCIT-C85632','C85632','Hour Times Nanomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85635','C85635','Hour Times Picogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85636','C85636','Hour Times Picogram per Milliliter per Kilogram','DB-NCIT'),('DBX-NCIT-C85638','C85638','Hour Times Picogram per Milliliter per Milligram','DB-NCIT'),('DBX-NCIT-C85640','C85640','Hour Times Picomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85642','C85642','India Ink Staining Method','DB-NCIT'),('DBX-NCIT-C85643','C85643','Infrared Spectrometry','DB-NCIT'),('DBX-NCIT-C85644','C85644','Initial Concentration','DB-NCIT'),('DBX-NCIT-C85645','C85645','International Unit per Day','DB-NCIT'),('DBX-NCIT-C85646','C85646','International Unit per Hour','DB-NCIT'),('DBX-NCIT-C85647','C85647','International Unit per Minute','DB-NCIT'),('DBX-NCIT-C85649','C85649','Iodine Staining Method','DB-NCIT'),('DBX-NCIT-C85650','C85650','Iron Hematoxylin Staining Method','DB-NCIT'),('DBX-NCIT-C85651','C85651','Kinyoun Staining Method','DB-NCIT'),('DBX-NCIT-C85652','C85652','Lambda Z','DB-NCIT'),('DBX-NCIT-C85653','C85653','Lambda Z Time Lower Limit','DB-NCIT'),('DBX-NCIT-C85654','C85654','Lambda Z Time Upper Limit','DB-NCIT'),('DBX-NCIT-C85655','C85655','Last Concentration','DB-NCIT'),('DBX-NCIT-C85656','C85656','Last Measurable Observed Excretion Rate','DB-NCIT'),('DBX-NCIT-C85657','C85657','Liter per Gram per Day','DB-NCIT'),('DBX-NCIT-C85658','C85658','Liter per Gram per Hour','DB-NCIT'),('DBX-NCIT-C85659','C85659','Liter per Gram per Minute','DB-NCIT'),('DBX-NCIT-C85662','C85662','Liter per Microgram per Hour','DB-NCIT'),('DBX-NCIT-C85665','C85665','Liter per Microgram per Day','DB-NCIT'),('DBX-NCIT-C85666','C85666','Liter per Microgram per Minute','DB-NCIT'),('DBX-NCIT-C85668','C85668','Liter per Micromole per Day','DB-NCIT'),('DBX-NCIT-C85669','C85669','Liter per Micromole per Hour','DB-NCIT'),('DBX-NCIT-C85670','C85670','Liter per Micromole per Minute','DB-NCIT'),('DBX-NCIT-C85672','C85672','Liter per Milligram per Day','DB-NCIT'),('DBX-NCIT-C85673','C85673','Liter per Milligram per Hour','DB-NCIT'),('DBX-NCIT-C85674','C85674','Liter per Milligram per Minute','DB-NCIT'),('DBX-NCIT-C85676','C85676','Liter per Millimole per Day','DB-NCIT'),('DBX-NCIT-C85677','C85677','Liter per Millimole per Hour','DB-NCIT'),('DBX-NCIT-C85678','C85678','Liter per Millimole per Minute','DB-NCIT'),('DBX-NCIT-C85680','C85680','Liter per Mole','DB-NCIT'),('DBX-NCIT-C85681','C85681','Liter per Mole per Day','DB-NCIT'),('DBX-NCIT-C85682','C85682','Liter per Mole per Hour','DB-NCIT'),('DBX-NCIT-C85683','C85683','Liter per Mole per Minute','DB-NCIT'),('DBX-NCIT-C85685','C85685','Liter per Nanogram per Day','DB-NCIT'),('DBX-NCIT-C85686','C85686','Liter per Nanogram per Hour','DB-NCIT'),('DBX-NCIT-C85687','C85687','Liter per Nanogram per Minute','DB-NCIT'),('DBX-NCIT-C85689','C85689','Liter per Nanomole per Day','DB-NCIT'),('DBX-NCIT-C85690','C85690','Liter per Nanomole per Hour','DB-NCIT'),('DBX-NCIT-C85691','C85691','Liter per Nanomole per Minute','DB-NCIT'),('DBX-NCIT-C85693','C85693','Liter per Picogram per Day','DB-NCIT'),('DBX-NCIT-C85694','C85694','Liter per Picogram per Hour','DB-NCIT'),('DBX-NCIT-C85695','C85695','Liter per Picogram per Minute','DB-NCIT'),('DBX-NCIT-C85697','C85697','Macro Broth Dilution Method','DB-NCIT'),('DBX-NCIT-C85698','C85698','Maximum Concentration Dose Normalized','DB-NCIT'),('DBX-NCIT-C85699','C85699','Maximum Observed Excretion Rate','DB-NCIT'),('DBX-NCIT-C85700','C85700','Mean Residence Time Last','DB-NCIT'),('DBX-NCIT-C85701','C85701','Micro Broth Dilution Method','DB-NCIT'),('DBX-NCIT-C85702','C85702','Microbial Concentration Method','DB-NCIT'),('DBX-NCIT-C85703','C85703','Microgram per Inhalation','DB-NCIT'),('DBX-NCIT-C85704','C85704','Microgram per Puff','DB-NCIT'),('DBX-NCIT-C85707','C85707','Micromole per Hour','DB-NCIT'),('DBX-NCIT-C85708','C85708','Micromole per Minute','DB-NCIT'),('DBX-NCIT-C85710','C85710','Milligram per Liter per Milligram','DB-NCIT'),('DBX-NCIT-C85711','C85711','Milligram per Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C85716','C85716','Milliliter per Mole per Day','DB-NCIT'),('DBX-NCIT-C85717','C85717','Milliliter per Mole per Hour','DB-NCIT'),('DBX-NCIT-C85718','C85718','Milliliter per Mole per Minute','DB-NCIT'),('DBX-NCIT-C85720','C85720','Millimole per Hour','DB-NCIT'),('DBX-NCIT-C85721','C85721','Millimole per Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C85722','C85722','Millimole per Minute','DB-NCIT'),('DBX-NCIT-C85724','C85724','Minute Times Femtogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85725','C85725','Minute Times Gram per Milliliter','DB-NCIT'),('DBX-NCIT-C85727','C85727','Minute Times Microgram per Milliliter','DB-NCIT'),('DBX-NCIT-C85728','C85728','Minute Times Micromole per Milliliter','DB-NCIT'),('DBX-NCIT-C85729','C85729','Minute Times Milligram per Milliliter','DB-NCIT'),('DBX-NCIT-C85730','C85730','Minute Times Millimole per Milliliter','DB-NCIT'),('DBX-NCIT-C85732','C85732','Minute Times Nanogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85733','C85733','Minute Times Nanomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85734','C85734','Minute Times Picogram per Milliliter','DB-NCIT'),('DBX-NCIT-C85735','C85735','Minute Times Picomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85736','C85736','Modified Acid Fast Staining Method','DB-NCIT'),('DBX-NCIT-C85737','C85737','Mole per Day','DB-NCIT'),('DBX-NCIT-C85738','C85738','Mole per Hour','DB-NCIT'),('DBX-NCIT-C85739','C85739','Mole per Minute','DB-NCIT'),('DBX-NCIT-C85741','C85741','Nanogram per Day','DB-NCIT'),('DBX-NCIT-C85742','C85742','Nanogram per Hour','DB-NCIT'),('DBX-NCIT-C85743','C85743','Nanogram per Kilogram per Minute','DB-NCIT'),('DBX-NCIT-C85744','C85744','Nanogram per Milligram of Creatinine','DB-NCIT'),('DBX-NCIT-C85746','C85746','Nanogram per Milliliter per Kilogram','DB-NCIT'),('DBX-NCIT-C85747','C85747','Nanogram per Milliliter per Milligram','DB-NCIT'),('DBX-NCIT-C85749','C85749','Nanogram per Minute','DB-NCIT'),('DBX-NCIT-C85751','C85751','Nanomole per Day','DB-NCIT'),('DBX-NCIT-C85752','C85752','Nanomole per Gram','DB-NCIT'),('DBX-NCIT-C85753','C85753','Nanomole per Hour','DB-NCIT'),('DBX-NCIT-C85754','C85754','Nanomole per Kilogram','DB-NCIT'),('DBX-NCIT-C85755','C85755','Nanomole per Liter per Micromole','DB-NCIT'),('DBX-NCIT-C85756','C85756','Nanomole per Milliliter','DB-NCIT'),('DBX-NCIT-C85757','C85757','Nanomole per Milliliter per Hour','DB-NCIT'),('DBX-NCIT-C85758','C85758','Nanomole per Minute','DB-NCIT'),('DBX-NCIT-C85760','C85760','Nanounit per Milliliter','DB-NCIT'),('DBX-NCIT-C85761','C85761','Observed Area Under the Curve Infinity','DB-NCIT'),('DBX-NCIT-C85763','C85763','Observed Area Under the Curve Percent Back Extrapolation','DB-NCIT'),('DBX-NCIT-C85764','C85764','Observed Area Under the Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85765','C85765','Observed Area Under the First Moment Curve Infinity','DB-NCIT'),('DBX-NCIT-C85766','C85766','Observed Area Under the First Moment Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85767','C85767','Observed Area Under the Urinary Excretion Rate Curve infinity','DB-NCIT'),('DBX-NCIT-C85768','C85768','Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85769','C85769','Observed Mean Residence Time Infinity','DB-NCIT'),('DBX-NCIT-C85770','C85770','Observed Steady State Volume of Distribution','DB-NCIT'),('DBX-NCIT-C85772','C85772','Observed Total Body Clearance by Fraction of Dose Absorbed','DB-NCIT'),('DBX-NCIT-C85773','C85773','Observed Total Body Clearance Rate','DB-NCIT'),('DBX-NCIT-C85774','C85774','Observed Volume of Distribution','DB-NCIT'),('DBX-NCIT-C85775','C85775','Observed Volume of Distribution of Absorbed Fraction','DB-NCIT'),('DBX-NCIT-C85776','C85776','Optical Density Measurement','DB-NCIT'),('DBX-NCIT-C85778','C85778','Picogram per Day','DB-NCIT'),('DBX-NCIT-C85779','C85779','Picogram per Hour','DB-NCIT'),('DBX-NCIT-C85780','C85780','Picogram per Milligram of Creatinine','DB-NCIT'),('DBX-NCIT-C85781','C85781','Picogram per Milliliter per Microgram','DB-NCIT'),('DBX-NCIT-C85782','C85782','Picogram per Minute','DB-NCIT'),('DBX-NCIT-C85784','C85784','Picomole per Liter per Microgram','DB-NCIT'),('DBX-NCIT-C85785','C85785','Predicted Area Under the Curve Infinity','DB-NCIT'),('DBX-NCIT-C85786','C85786','Predicted Area Under the Curve Infinity by Dose','DB-NCIT'),('DBX-NCIT-C85787','C85787','Predicted Area Under the Curve Percent Back Extrapolation','DB-NCIT'),('DBX-NCIT-C85788','C85788','Predicted Area Under the Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85789','C85789','Predicted Area Under the First Moment Curve Infinity','DB-NCIT'),('DBX-NCIT-C85790','C85790','Predicted Area Under the First Moment Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85791','C85791','Predicted Area Under the Urinary Excretion Rate Curve Infinity','DB-NCIT'),('DBX-NCIT-C85792','C85792','Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation','DB-NCIT'),('DBX-NCIT-C85793','C85793','Predicted Mean Residence Time Infinity','DB-NCIT'),('DBX-NCIT-C85794','C85794','Predicted Steady State Volume of Distribution','DB-NCIT'),('DBX-NCIT-C85796','C85796','Predicted Total Body Clearance by Fraction of Dose Absorbed','DB-NCIT'),('DBX-NCIT-C85797','C85797','Predicted Total Body Clearance Rate','DB-NCIT'),('DBX-NCIT-C85798','C85798','Predicted Volume of Distribution','DB-NCIT'),('DBX-NCIT-C85799','C85799','Predicted Volume of Distribution of Absorbed Fraction','DB-NCIT'),('DBX-NCIT-C85801','C85801','Ryan Blue Staining Method','DB-NCIT'),('DBX-NCIT-C85816','C85816','Sum of Lambda Z Timepoints','DB-NCIT'),('DBX-NCIT-C85817','C85817','Sum Urine Volume','DB-NCIT'),('DBX-NCIT-C85818','C85818','Terminal Half Life','DB-NCIT'),('DBX-NCIT-C85819','C85819','Thick Smear Technique','DB-NCIT'),('DBX-NCIT-C85820','C85820','Thin Smear Technique','DB-NCIT'),('DBX-NCIT-C85821','C85821','Time and Log Concentration Correlation','DB-NCIT'),('DBX-NCIT-C85822','C85822','Time of Last Nonzero Concentration','DB-NCIT'),('DBX-NCIT-C85823','C85823','Time of Maximum Observed Excretion Rate','DB-NCIT'),('DBX-NCIT-C85824','C85824','Time until First Nonzero Concentration','DB-NCIT'),('DBX-NCIT-C85825','C85825','Tmin','DB-NCIT'),('DBX-NCIT-C85826','C85826','Trial Primary Objective','DB-NCIT'),('DBX-NCIT-C85827','C85827','Trial Secondary Objective','DB-NCIT'),('DBX-NCIT-C85828','C85828','Weber Green Staining Method','DB-NCIT'),('DBX-NCIT-C85829','C85829','Wright Staining Method','DB-NCIT'),('DBX-NCIT-C85830','C85830','X-Ray Fluorescence Spectrometry','DB-NCIT'),('DBX-NCIT-C85831','C85831','Ziehl Neelsen Acid Fast Staining Method','DB-NCIT'),('DBX-NCIT-C85837','C85837','Dark Field Microscopy','DB-NCIT'),('DBX-NCIT-C85839','C85839','CDISC SDTM Pharmacokinetic Parameter Terminology by Code','DB-NCIT'),('DBX-NCIT-C85841','C85841','Area Under Urinary Excretion Rate Curve All','DB-NCIT'),('DBX-NCIT-C85862','C85862','Correctional Institution','DB-NCIT'),('DBX-NCIT-C86009','C86009','Moraxella','DB-NCIT'),('DBX-NCIT-C86010','C86010','Serratia','DB-NCIT'),('DBX-NCIT-C86011','C86011','Agrobacterium','DB-NCIT'),('DBX-NCIT-C86012','C86012','Alcaligenes','DB-NCIT'),('DBX-NCIT-C86013','C86013','Propionibacterium','DB-NCIT'),('DBX-NCIT-C86015','C86015','Morganella morganii','DB-NCIT'),('DBX-NCIT-C86019','C86019','Proteus mirabilis','DB-NCIT'),('DBX-NCIT-C8602','C8602','Pleomorphic Adenoma','DB-NCIT'),('DBX-NCIT-C86027','C86027','Rhodotorula mucilaginosa','DB-NCIT'),('DBX-NCIT-C86042','C86042','Written Documentation','DB-NCIT'),('DBX-NCIT-C86071','C86071','Equivocal','DB-NCIT'),('DBX-NCIT-C86077','C86077','Abiotrophia','DB-NCIT'),('DBX-NCIT-C86078','C86078','Abiotrophia defectiva','DB-NCIT'),('DBX-NCIT-C86079','C86079','Achromobacter','DB-NCIT'),('DBX-NCIT-C86080','C86080','Achromobacter denitrificans','DB-NCIT'),('DBX-NCIT-C86081','C86081','Achromobacter piechaudii','DB-NCIT'),('DBX-NCIT-C86082','C86082','Achromobacter xylosoxidans','DB-NCIT'),('DBX-NCIT-C86083','C86083','Acidaminococcus','DB-NCIT'),('DBX-NCIT-C86084','C86084','Acidaminococcus fermentans','DB-NCIT'),('DBX-NCIT-C86085','C86085','Acidovorax','DB-NCIT'),('DBX-NCIT-C86086','C86086','Acidovorax delafieldii','DB-NCIT'),('DBX-NCIT-C86087','C86087','Acidovorax facilis','DB-NCIT'),('DBX-NCIT-C86088','C86088','Acidovorax temperans','DB-NCIT'),('DBX-NCIT-C86089','C86089','Acinetobacter anitratus','DB-NCIT'),('DBX-NCIT-C86090','C86090','Acinetobacter calcoaceticus','DB-NCIT'),('DBX-NCIT-C86091','C86091','Acinetobacter calcoaceticus/baumannii Complex','DB-NCIT'),('DBX-NCIT-C86092','C86092','Acinetobacter haemolyticus','DB-NCIT'),('DBX-NCIT-C86093','C86093','Acinetobacter johnsonii','DB-NCIT'),('DBX-NCIT-C86094','C86094','Acinetobacter junii','DB-NCIT'),('DBX-NCIT-C86095','C86095','Acinetobacter lwoffii','DB-NCIT'),('DBX-NCIT-C86096','C86096','Acinetobacter radioresistens','DB-NCIT'),('DBX-NCIT-C86097','C86097','Actinobacillus','DB-NCIT'),('DBX-NCIT-C86098','C86098','Actinobacillus actinomycetemcomitans','DB-NCIT'),('DBX-NCIT-C86099','C86099','Actinobacillus equuli','DB-NCIT'),('DBX-NCIT-C86100','C86100','Actinobacillus lignieresii','DB-NCIT'),('DBX-NCIT-C86101','C86101','Actinobacillus pleuropneumoniae','DB-NCIT'),('DBX-NCIT-C86102','C86102','Actinobacillus suis','DB-NCIT'),('DBX-NCIT-C86103','C86103','Actinobacillus ureae','DB-NCIT'),('DBX-NCIT-C86104','C86104','Actinomadura','DB-NCIT'),('DBX-NCIT-C86105','C86105','Actinomadura madurae','DB-NCIT'),('DBX-NCIT-C86106','C86106','Actinomadura pelletieri','DB-NCIT'),('DBX-NCIT-C86107','C86107','Actinomyces bovis','DB-NCIT'),('DBX-NCIT-C86108','C86108','Actinomyces israelii','DB-NCIT'),('DBX-NCIT-C86109','C86109','Actinomyces meyerii','DB-NCIT'),('DBX-NCIT-C86110','C86110','Actinomyces naeslundii','DB-NCIT'),('DBX-NCIT-C86111','C86111','Actinomyces neuii','DB-NCIT'),('DBX-NCIT-C86112','C86112','Actinomyces odontolyticus','DB-NCIT'),('DBX-NCIT-C86113','C86113','Actinomyces radingae','DB-NCIT'),('DBX-NCIT-C86114','C86114','Actinomyces turicensis','DB-NCIT'),('DBX-NCIT-C86115','C86115','Actinomyces viscosus','DB-NCIT'),('DBX-NCIT-C86116','C86116','Aerobic Gram Negative Bacillus','DB-NCIT'),('DBX-NCIT-C86117','C86117','Aerobic Gram Negative Coccus','DB-NCIT'),('DBX-NCIT-C86118','C86118','Aerobic Gram Positive Bacillus','DB-NCIT'),('DBX-NCIT-C86119','C86119','Aerobic Gram Positive Coccus','DB-NCIT'),('DBX-NCIT-C86120','C86120','Aerobic Streptococcus','DB-NCIT'),('DBX-NCIT-C86121','C86121','Aerococcus','DB-NCIT'),('DBX-NCIT-C86122','C86122','Aerococcus urinae','DB-NCIT'),('DBX-NCIT-C86123','C86123','Aerococcus viridans','DB-NCIT'),('DBX-NCIT-C86124','C86124','Aeromonas','DB-NCIT'),('DBX-NCIT-C86125','C86125','Aeromonas hydrophila','DB-NCIT'),('DBX-NCIT-C86126','C86126','Aeromonas jandaei','DB-NCIT'),('DBX-NCIT-C86127','C86127','Aeromonas punctata','DB-NCIT'),('DBX-NCIT-C86128','C86128','Aeromonas salmonicida','DB-NCIT'),('DBX-NCIT-C86129','C86129','Aeromonas schubertii','DB-NCIT'),('DBX-NCIT-C86130','C86130','Aeromonas sobria','DB-NCIT'),('DBX-NCIT-C86131','C86131','Aeromonas veronii','DB-NCIT'),('DBX-NCIT-C86132','C86132','Aggregatibacter','DB-NCIT'),('DBX-NCIT-C86133','C86133','Aggregatibacter actinomycetemcomitans','DB-NCIT'),('DBX-NCIT-C86134','C86134','Aggregatibacter aphrophilus','DB-NCIT'),('DBX-NCIT-C86135','C86135','Aggregatibacter segnis','DB-NCIT'),('DBX-NCIT-C86137','C86137','Agrobacterium radiobacter','DB-NCIT'),('DBX-NCIT-C86138','C86138','Agrobacterium tumefaciens','DB-NCIT'),('DBX-NCIT-C86140','C86140','Alcaligenes faecalis','DB-NCIT'),('DBX-NCIT-C86141','C86141','Alpha-Hemolytic Streptococcus','DB-NCIT'),('DBX-NCIT-C86142','C86142','Anaerobic Gram Negative Bacillus','DB-NCIT'),('DBX-NCIT-C86143','C86143','Anaerobic Gram Negative Coccus','DB-NCIT'),('DBX-NCIT-C86144','C86144','Anaerobic Gram Positive Bacillus','DB-NCIT'),('DBX-NCIT-C86145','C86145','Anaerobic Gram Positive Coccus','DB-NCIT'),('DBX-NCIT-C86146','C86146','Anaerobic Streptococcus','DB-NCIT'),('DBX-NCIT-C86147','C86147','Arcanobacterium','DB-NCIT'),('DBX-NCIT-C86148','C86148','Arcanobacterium bernardiae','DB-NCIT'),('DBX-NCIT-C86149','C86149','Arcanobacterium haemolyticum','DB-NCIT'),('DBX-NCIT-C86150','C86150','Arcanobacterium pyogenes','DB-NCIT'),('DBX-NCIT-C86152','C86152','Arcobacter','DB-NCIT'),('DBX-NCIT-C86153','C86153','Arcobacter butzleri','DB-NCIT'),('DBX-NCIT-C86154','C86154','Arcobacter cryaerophilus','DB-NCIT'),('DBX-NCIT-C86155','C86155','Arthrobacter','DB-NCIT'),('DBX-NCIT-C86156','C86156','Atopobium minutum','DB-NCIT'),('DBX-NCIT-C86157','C86157','Atopobium parvulum','DB-NCIT'),('DBX-NCIT-C86158','C86158','Avibacterium paragallinarum','DB-NCIT'),('DBX-NCIT-C86159','C86159','Bacillus alvei','DB-NCIT'),('DBX-NCIT-C86160','C86160','Bacillus anthracis','DB-NCIT'),('DBX-NCIT-C86161','C86161','Bacillus cereus','DB-NCIT'),('DBX-NCIT-C86162','C86162','Bacillus lentus','DB-NCIT'),('DBX-NCIT-C86163','C86163','Bacillus licheniformis','DB-NCIT'),('DBX-NCIT-C86164','C86164','Bacillus megaterium','DB-NCIT'),('DBX-NCIT-C86165','C86165','Bacillus mycoides','DB-NCIT'),('DBX-NCIT-C86166','C86166','Bacillus polymyxa','DB-NCIT'),('DBX-NCIT-C86167','C86167','Bacillus subtilis','DB-NCIT'),('DBX-NCIT-C86168','C86168','Bacteroides caccae','DB-NCIT'),('DBX-NCIT-C86169','C86169','Bacteroides capillosus','DB-NCIT'),('DBX-NCIT-C86170','C86170','Bacteroides cellulosolvens','DB-NCIT'),('DBX-NCIT-C86171','C86171','Bacteroides eggerthii','DB-NCIT'),('DBX-NCIT-C86172','C86172','Bacteroides fragilis','DB-NCIT'),('DBX-NCIT-C86173','C86173','Bacteroides fragilis Group','DB-NCIT'),('DBX-NCIT-C86174','C86174','Bacteroides nordii','DB-NCIT'),('DBX-NCIT-C86175','C86175','Bacteroides ovatus','DB-NCIT'),('DBX-NCIT-C86176','C86176','Bacteroides splanchnicus','DB-NCIT'),('DBX-NCIT-C86177','C86177','Bacteroides stercoris','DB-NCIT'),('DBX-NCIT-C86178','C86178','Bacteroides tectus','DB-NCIT'),('DBX-NCIT-C86179','C86179','Bacteroides thetaiotaomicron','DB-NCIT'),('DBX-NCIT-C86180','C86180','Bacteroides uniformis','DB-NCIT'),('DBX-NCIT-C86181','C86181','Bacteroides ureolyticus','DB-NCIT'),('DBX-NCIT-C86182','C86182','Bacteroides vulgatus','DB-NCIT'),('DBX-NCIT-C86184','C86184','Bartonella','DB-NCIT'),('DBX-NCIT-C86185','C86185','Bartonella elizabethae','DB-NCIT'),('DBX-NCIT-C86186','C86186','Bartonella henselae','DB-NCIT'),('DBX-NCIT-C86187','C86187','Bartonella quintana','DB-NCIT'),('DBX-NCIT-C86188','C86188','Bergeyella','DB-NCIT'),('DBX-NCIT-C86189','C86189','Bergeyella zoohelcum','DB-NCIT'),('DBX-NCIT-C86190','C86190','Beta-Hemolytic Streptococcus','DB-NCIT'),('DBX-NCIT-C86191','C86191','Beta Streptococcus Group C','DB-NCIT'),('DBX-NCIT-C86192','C86192','Beta Streptococcus Group F','DB-NCIT'),('DBX-NCIT-C86193','C86193','Beta Streptococcus Group G','DB-NCIT'),('DBX-NCIT-C86194','C86194','Bifidobacterium','DB-NCIT'),('DBX-NCIT-C86195','C86195','Bifidobacterium adolescentis','DB-NCIT'),('DBX-NCIT-C86196','C86196','Bifidobacterium angulatum','DB-NCIT'),('DBX-NCIT-C86197','C86197','Bifidobacterium bifidum','DB-NCIT'),('DBX-NCIT-C86198','C86198','Bifidobacterium dentium','DB-NCIT'),('DBX-NCIT-C86199','C86199','Bifidobacterium longum','DB-NCIT'),('DBX-NCIT-C86200','C86200','Bilophila','DB-NCIT'),('DBX-NCIT-C86201','C86201','Bilophila wadsworthia','DB-NCIT'),('DBX-NCIT-C86202','C86202','Bordetella','DB-NCIT'),('DBX-NCIT-C86203','C86203','Bordetella avium','DB-NCIT'),('DBX-NCIT-C86204','C86204','Bordetella bronchiseptica','DB-NCIT'),('DBX-NCIT-C86205','C86205','Bordetella parapertussis','DB-NCIT'),('DBX-NCIT-C86206','C86206','Borrelia','DB-NCIT'),('DBX-NCIT-C86207','C86207','Brevibacillus','DB-NCIT'),('DBX-NCIT-C86208','C86208','Brevibacillus laterosporus','DB-NCIT'),('DBX-NCIT-C86209','C86209','Brevibacterium','DB-NCIT'),('DBX-NCIT-C86210','C86210','Brevibacterium casei','DB-NCIT'),('DBX-NCIT-C86211','C86211','Brevibacterium epidermidis','DB-NCIT'),('DBX-NCIT-C86212','C86212','Brevundimonas','DB-NCIT'),('DBX-NCIT-C86213','C86213','Brevundimonas diminuta','DB-NCIT'),('DBX-NCIT-C86214','C86214','Brevundimonas vesicularis','DB-NCIT'),('DBX-NCIT-C86215','C86215','Brucella','DB-NCIT'),('DBX-NCIT-C86216','C86216','Brucella abortus','DB-NCIT'),('DBX-NCIT-C86217','C86217','Brucella canis','DB-NCIT'),('DBX-NCIT-C86218','C86218','Brucella melitensis','DB-NCIT'),('DBX-NCIT-C86219','C86219','Brucella suis','DB-NCIT'),('DBX-NCIT-C86220','C86220','Budvicia','DB-NCIT'),('DBX-NCIT-C86221','C86221','Budvicia aquatica','DB-NCIT'),('DBX-NCIT-C86222','C86222','Burkholderia','DB-NCIT'),('DBX-NCIT-C86223','C86223','Burkholderia cenocepacia','DB-NCIT'),('DBX-NCIT-C86224','C86224','Burkholderia cepacia Complex','DB-NCIT'),('DBX-NCIT-C86225','C86225','Burkholderia gladioli','DB-NCIT'),('DBX-NCIT-C86226','C86226','Burkholderia mallei','DB-NCIT'),('DBX-NCIT-C86227','C86227','Burkholderia pseudomallei','DB-NCIT'),('DBX-NCIT-C86228','C86228','Buttiauxella','DB-NCIT'),('DBX-NCIT-C86229','C86229','Buttiauxella agrestis','DB-NCIT'),('DBX-NCIT-C86230','C86230','Campylobacter coli','DB-NCIT'),('DBX-NCIT-C86231','C86231','Campylobacter concisus','DB-NCIT'),('DBX-NCIT-C86232','C86232','Campylobacter curvus','DB-NCIT'),('DBX-NCIT-C86233','C86233','Campylobacter fetus','DB-NCIT'),('DBX-NCIT-C86234','C86234','Campylobacter gracilis','DB-NCIT'),('DBX-NCIT-C86235','C86235','Campylobacter jejuni','DB-NCIT'),('DBX-NCIT-C86236','C86236','Campylobacter lari','DB-NCIT'),('DBX-NCIT-C86237','C86237','Campylobacter rectus','DB-NCIT'),('DBX-NCIT-C86238','C86238','Campylobacter upsaliensis','DB-NCIT'),('DBX-NCIT-C86239','C86239','Capnocytophaga canimorsus','DB-NCIT'),('DBX-NCIT-C86240','C86240','Capnocytophaga gingivalis','DB-NCIT'),('DBX-NCIT-C86241','C86241','Capnocytophaga ochracea','DB-NCIT'),('DBX-NCIT-C86242','C86242','Capnocytophaga sputigena','DB-NCIT'),('DBX-NCIT-C86243','C86243','Cardiobacterium','DB-NCIT'),('DBX-NCIT-C86244','C86244','Cardiobacterium hominis','DB-NCIT'),('DBX-NCIT-C86245','C86245','Cedecea','DB-NCIT'),('DBX-NCIT-C86246','C86246','Cedecea davisae','DB-NCIT'),('DBX-NCIT-C86247','C86247','Cedecea lapagei','DB-NCIT'),('DBX-NCIT-C86248','C86248','Cedecea neteri','DB-NCIT'),('DBX-NCIT-C86249','C86249','Cellulomonas','DB-NCIT'),('DBX-NCIT-C86250','C86250','Cellulomonas hominis','DB-NCIT'),('DBX-NCIT-C86251','C86251','Cellulosimicrobium','DB-NCIT'),('DBX-NCIT-C86252','C86252','Cellulosimicrobium cellulans','DB-NCIT'),('DBX-NCIT-C86253','C86253','Chlamydia trachomatis','DB-NCIT'),('DBX-NCIT-C86254','C86254','Chlamydophila','DB-NCIT'),('DBX-NCIT-C86255','C86255','Chlamydophila psittaci','DB-NCIT'),('DBX-NCIT-C86256','C86256','Chromobacterium','DB-NCIT'),('DBX-NCIT-C86257','C86257','Chromobacterium violaceum','DB-NCIT'),('DBX-NCIT-C86258','C86258','Chryseobacterium','DB-NCIT'),('DBX-NCIT-C86259','C86259','Chryseobacterium gleum','DB-NCIT'),('DBX-NCIT-C86260','C86260','Chryseobacterium indologenes','DB-NCIT'),('DBX-NCIT-C86261','C86261','Chryseomonas','DB-NCIT'),('DBX-NCIT-C86262','C86262','Citrobacter amalonaticus','DB-NCIT'),('DBX-NCIT-C86263','C86263','Citrobacter braakii','DB-NCIT'),('DBX-NCIT-C86264','C86264','Citrobacter farmeri','DB-NCIT'),('DBX-NCIT-C86265','C86265','Citrobacter freundii','DB-NCIT'),('DBX-NCIT-C86266','C86266','Citrobacter freundii Complex','DB-NCIT'),('DBX-NCIT-C86267','C86267','Citrobacter koseri','DB-NCIT'),('DBX-NCIT-C86268','C86268','Citrobacter youngae','DB-NCIT'),('DBX-NCIT-C86269','C86269','Clostridium acetobutylicum','DB-NCIT'),('DBX-NCIT-C86270','C86270','Clostridium baratii','DB-NCIT'),('DBX-NCIT-C86271','C86271','Clostridium beijerinckii','DB-NCIT'),('DBX-NCIT-C86272','C86272','Clostridium bifermentans','DB-NCIT'),('DBX-NCIT-C86273','C86273','Clostridium butyricum','DB-NCIT'),('DBX-NCIT-C86274','C86274','Clostridium cadaveris','DB-NCIT'),('DBX-NCIT-C86275','C86275','Clostridium celatum','DB-NCIT'),('DBX-NCIT-C86276','C86276','Clostridium clostridioforme','DB-NCIT'),('DBX-NCIT-C86277','C86277','Clostridium cochlearium','DB-NCIT'),('DBX-NCIT-C86278','C86278','Clostridium cocleatum','DB-NCIT'),('DBX-NCIT-C86279','C86279','Clostridium fallax','DB-NCIT'),('DBX-NCIT-C86280','C86280','Clostridium glycolicum','DB-NCIT'),('DBX-NCIT-C86281','C86281','Clostridium haemolyticum','DB-NCIT'),('DBX-NCIT-C86282','C86282','Clostridium histolyticum','DB-NCIT'),('DBX-NCIT-C86283','C86283','Clostridium innocuum','DB-NCIT'),('DBX-NCIT-C86284','C86284','Clostridium limosum','DB-NCIT'),('DBX-NCIT-C86285','C86285','Clostridium novyi','DB-NCIT'),('DBX-NCIT-C86286','C86286','Clostridium oceanicum','DB-NCIT'),('DBX-NCIT-C86287','C86287','Clostridium paraputrificum','DB-NCIT'),('DBX-NCIT-C86288','C86288','Clostridium perfringens','DB-NCIT'),('DBX-NCIT-C86289','C86289','Clostridium putrificum','DB-NCIT'),('DBX-NCIT-C86290','C86290','Clostridium ramosum','DB-NCIT'),('DBX-NCIT-C86291','C86291','Clostridium rectum','DB-NCIT'),('DBX-NCIT-C86292','C86292','Clostridium septicum','DB-NCIT'),('DBX-NCIT-C86293','C86293','Clostridium sordellii','DB-NCIT'),('DBX-NCIT-C86294','C86294','Clostridium sporogenes','DB-NCIT'),('DBX-NCIT-C86295','C86295','Clostridium subterminale','DB-NCIT'),('DBX-NCIT-C86296','C86296','Clostridium symbiosum','DB-NCIT'),('DBX-NCIT-C86297','C86297','Clostridium tertium','DB-NCIT'),('DBX-NCIT-C86298','C86298','Clostridium tetani','DB-NCIT'),('DBX-NCIT-C86299','C86299','Clostridium tyrobutyricum','DB-NCIT'),('DBX-NCIT-C86300','C86300','Collinsella','DB-NCIT'),('DBX-NCIT-C86301','C86301','Collinsella aerofaciens','DB-NCIT'),('DBX-NCIT-C86302','C86302','Collinsella intestinalis','DB-NCIT'),('DBX-NCIT-C86303','C86303','Comamonas','DB-NCIT'),('DBX-NCIT-C86304','C86304','Comamonas terrigena','DB-NCIT'),('DBX-NCIT-C86305','C86305','Comamonas testosteroni','DB-NCIT'),('DBX-NCIT-C86306','C86306','Corynebacterium accolens','DB-NCIT'),('DBX-NCIT-C86307','C86307','Corynebacterium afermentans','DB-NCIT'),('DBX-NCIT-C86308','C86308','Corynebacterium amycolatum','DB-NCIT'),('DBX-NCIT-C86309','C86309','Corynebacterium argentoratense','DB-NCIT'),('DBX-NCIT-C86310','C86310','Corynebacterium auris','DB-NCIT'),('DBX-NCIT-C86311','C86311','Corynebacterium bovis','DB-NCIT'),('DBX-NCIT-C86312','C86312','Corynebacterium diphtheriae','DB-NCIT'),('DBX-NCIT-C86313','C86313','Corynebacterium genitalium','DB-NCIT'),('DBX-NCIT-C86314','C86314','Corynebacterium kutscheri','DB-NCIT'),('DBX-NCIT-C86315','C86315','Corynebacterium macginleyi','DB-NCIT'),('DBX-NCIT-C86316','C86316','Corynebacterium matruchotii','DB-NCIT'),('DBX-NCIT-C86317','C86317','Corynebacterium minutissimum','DB-NCIT'),('DBX-NCIT-C86318','C86318','Corynebacterium pilosum','DB-NCIT'),('DBX-NCIT-C86319','C86319','Corynebacterium propinquum','DB-NCIT'),('DBX-NCIT-C86320','C86320','Corynebacterium pseudodiphtheriticum','DB-NCIT'),('DBX-NCIT-C86321','C86321','Corynebacterium pseudotuberculosis','DB-NCIT'),('DBX-NCIT-C86322','C86322','Corynebacterium renale','DB-NCIT'),('DBX-NCIT-C86323','C86323','Corynebacterium striatum','DB-NCIT'),('DBX-NCIT-C86324','C86324','Corynebacterium ulcerans','DB-NCIT'),('DBX-NCIT-C86325','C86325','Corynebacterium urealyticum','DB-NCIT'),('DBX-NCIT-C86326','C86326','Corynebacterium xerosis','DB-NCIT'),('DBX-NCIT-C86327','C86327','Coryneform Gram Positive Bacillus','DB-NCIT'),('DBX-NCIT-C86328','C86328','Coxiella burnetii','DB-NCIT'),('DBX-NCIT-C86329','C86329','Cronobacter sakazakii','DB-NCIT'),('DBX-NCIT-C86330','C86330','Cupriavidus','DB-NCIT'),('DBX-NCIT-C86331','C86331','Cupriavidus pauculus','DB-NCIT'),('DBX-NCIT-C86332','C86332','Delftia','DB-NCIT'),('DBX-NCIT-C86333','C86333','Delftia acidovorans','DB-NCIT'),('DBX-NCIT-C86334','C86334','Dermabacter','DB-NCIT'),('DBX-NCIT-C86335','C86335','Dermabacter hominis','DB-NCIT'),('DBX-NCIT-C86336','C86336','Dermacoccus nishinomiyaensis','DB-NCIT'),('DBX-NCIT-C86337','C86337','Dermatophilus','DB-NCIT'),('DBX-NCIT-C86338','C86338','Dermatophilus congolensis','DB-NCIT'),('DBX-NCIT-C86339','C86339','Desulfovibrio','DB-NCIT'),('DBX-NCIT-C86340','C86340','Desulfovibrio desulfuricans','DB-NCIT'),('DBX-NCIT-C86341','C86341','Desulfovibrio fairfieldensis','DB-NCIT'),('DBX-NCIT-C86342','C86342','Desulfovibrio piger','DB-NCIT'),('DBX-NCIT-C86343','C86343','Diptheroid Bacillus','DB-NCIT'),('DBX-NCIT-C86344','C86344','Edwardsiella','DB-NCIT'),('DBX-NCIT-C86345','C86345','Edwardsiella hoshinae','DB-NCIT'),('DBX-NCIT-C86346','C86346','Edwardsiella ictaluri','DB-NCIT'),('DBX-NCIT-C86347','C86347','Edwardsiella tarda','DB-NCIT'),('DBX-NCIT-C86348','C86348','Eggerthella','DB-NCIT'),('DBX-NCIT-C86349','C86349','Eggerthella lenta','DB-NCIT'),('DBX-NCIT-C86350','C86350','Eikenella','DB-NCIT'),('DBX-NCIT-C86351','C86351','Eikenella corrodens','DB-NCIT'),('DBX-NCIT-C86352','C86352','Elizabethkingia','DB-NCIT'),('DBX-NCIT-C86353','C86353','Elizabethkingia meningoceptica','DB-NCIT'),('DBX-NCIT-C86354','C86354','Empedobacter','DB-NCIT'),('DBX-NCIT-C86355','C86355','Empedobacter brevis','DB-NCIT'),('DBX-NCIT-C86356','C86356','Enterobacter aerogenes','DB-NCIT'),('DBX-NCIT-C86357','C86357','Enterobacter amnigenus','DB-NCIT'),('DBX-NCIT-C86358','C86358','Enterobacter asburiae','DB-NCIT'),('DBX-NCIT-C86359','C86359','Enterobacter cancerogenus','DB-NCIT'),('DBX-NCIT-C86360','C86360','Enterobacter cloacae','DB-NCIT'),('DBX-NCIT-C86361','C86361','Enterobacter gergoviae','DB-NCIT'),('DBX-NCIT-C86362','C86362','Enterobacter hormaechei','DB-NCIT'),('DBX-NCIT-C86363','C86363','Enterobacter taylorae','DB-NCIT'),('DBX-NCIT-C86364','C86364','Enterococcus avium','DB-NCIT'),('DBX-NCIT-C86365','C86365','Enterococcus casseliflavus','DB-NCIT'),('DBX-NCIT-C86366','C86366','Enterococcus dispar','DB-NCIT'),('DBX-NCIT-C86367','C86367','Enterococcus durans','DB-NCIT'),('DBX-NCIT-C86368','C86368','Enterococcus faecalis','DB-NCIT'),('DBX-NCIT-C86369','C86369','Enterococcus faecium','DB-NCIT'),('DBX-NCIT-C86370','C86370','Enterococcus gallinarum','DB-NCIT'),('DBX-NCIT-C86371','C86371','Enterococcus hirae','DB-NCIT'),('DBX-NCIT-C86372','C86372','Enterococcus malodoratus','DB-NCIT'),('DBX-NCIT-C86373','C86373','Enterococcus mundtii','DB-NCIT'),('DBX-NCIT-C86374','C86374','Enterococcus pseudoavium','DB-NCIT'),('DBX-NCIT-C86375','C86375','Enterococcus raffinosus','DB-NCIT'),('DBX-NCIT-C86376','C86376','Erysipelothrix','DB-NCIT'),('DBX-NCIT-C86377','C86377','Erysipelothrix rhusiopathiae','DB-NCIT'),('DBX-NCIT-C86378','C86378','Escherichia albertii','DB-NCIT'),('DBX-NCIT-C86379','C86379','Escherichia blattae','DB-NCIT'),('DBX-NCIT-C86380','C86380','Escherichia fergusonii','DB-NCIT'),('DBX-NCIT-C86381','C86381','Escherichia hermannii','DB-NCIT'),('DBX-NCIT-C86382','C86382','Escherichia vulneris','DB-NCIT'),('DBX-NCIT-C86383','C86383','Eubacterium','DB-NCIT'),('DBX-NCIT-C86384','C86384','Eubacterium alactolyticum','DB-NCIT'),('DBX-NCIT-C86385','C86385','Eubacterium contortum','DB-NCIT'),('DBX-NCIT-C86386','C86386','Eubacterium limosum','DB-NCIT'),('DBX-NCIT-C86387','C86387','Eubacterium nodatum','DB-NCIT'),('DBX-NCIT-C86388','C86388','Eubacterium rectale','DB-NCIT'),('DBX-NCIT-C86389','C86389','Eubacterium ventriosum','DB-NCIT'),('DBX-NCIT-C86390','C86390','Ewingella','DB-NCIT'),('DBX-NCIT-C86391','C86391','Ewingella americana','DB-NCIT'),('DBX-NCIT-C86392','C86392','Facklamia','DB-NCIT'),('DBX-NCIT-C86393','C86393','Faecalibacterium','DB-NCIT'),('DBX-NCIT-C86394','C86394','Faecalibacterium prausnitzii','DB-NCIT'),('DBX-NCIT-C86395','C86395','Fermentative Gram Negative Bacillus','DB-NCIT'),('DBX-NCIT-C86396','C86396','Francisella','DB-NCIT'),('DBX-NCIT-C86397','C86397','Francisella tularensis','DB-NCIT'),('DBX-NCIT-C86398','C86398','Fusobacterium gonidiaformans','DB-NCIT'),('DBX-NCIT-C86399','C86399','Fusobacterium mortiferum','DB-NCIT'),('DBX-NCIT-C86400','C86400','Fusobacterium necrogenes','DB-NCIT'),('DBX-NCIT-C86401','C86401','Fusobacterium necrophorum','DB-NCIT'),('DBX-NCIT-C86404','C86404','Fusobacterium nucleatum','DB-NCIT'),('DBX-NCIT-C86405','C86405','Fusobacterium russii','DB-NCIT'),('DBX-NCIT-C86406','C86406','Fusobacterium ulcerans','DB-NCIT'),('DBX-NCIT-C86407','C86407','Fusobacterium varium','DB-NCIT'),('DBX-NCIT-C86408','C86408','Gamma-Hemolytic Streptococcus','DB-NCIT'),('DBX-NCIT-C86409','C86409','Gardnerella','DB-NCIT'),('DBX-NCIT-C86410','C86410','Gardnerella vaginalis','DB-NCIT'),('DBX-NCIT-C86411','C86411','Globicatella','DB-NCIT'),('DBX-NCIT-C86412','C86412','Globicatella sanguinis','DB-NCIT'),('DBX-NCIT-C86413','C86413','Globicatella sulfidifaciens','DB-NCIT'),('DBX-NCIT-C86414','C86414','Gordonia','DB-NCIT'),('DBX-NCIT-C86415','C86415','Gordonia aichiensis','DB-NCIT'),('DBX-NCIT-C86416','C86416','Gordonia bronchialis','DB-NCIT'),('DBX-NCIT-C86417','C86417','Gordonia rubripertincta','DB-NCIT'),('DBX-NCIT-C86418','C86418','Gordonia sputi','DB-NCIT'),('DBX-NCIT-C86419','C86419','Gordonia terrae','DB-NCIT'),('DBX-NCIT-C86420','C86420','Gracilibacillus','DB-NCIT'),('DBX-NCIT-C86421','C86421','Gram Negative Bacillus','DB-NCIT'),('DBX-NCIT-C86422','C86422','Gram Negative Coccus','DB-NCIT'),('DBX-NCIT-C86424','C86424','Gram Positive Coccus','DB-NCIT'),('DBX-NCIT-C86425','C86425','Granulicatella','DB-NCIT'),('DBX-NCIT-C86426','C86426','Granulicatella adiacens','DB-NCIT'),('DBX-NCIT-C86427','C86427','Grimontia hollisae','DB-NCIT'),('DBX-NCIT-C86428','C86428','Haemophilus aegyptius','DB-NCIT'),('DBX-NCIT-C86429','C86429','Haemophilus haemoglobinophilus','DB-NCIT'),('DBX-NCIT-C86430','C86430','Haemophilus haemolyticus','DB-NCIT'),('DBX-NCIT-C86431','C86431','Haemophilus influenzae','DB-NCIT'),('DBX-NCIT-C86432','C86432','Haemophilus parahaemolyticus','DB-NCIT'),('DBX-NCIT-C86433','C86433','Haemophilus parainfluenzae','DB-NCIT'),('DBX-NCIT-C86434','C86434','Hafnia','DB-NCIT'),('DBX-NCIT-C86435','C86435','Hafnia alvei','DB-NCIT'),('DBX-NCIT-C86436','C86436','Halobacillus','DB-NCIT'),('DBX-NCIT-C86437','C86437','Helicobacter cinaedi','DB-NCIT'),('DBX-NCIT-C86438','C86438','Helicobacter fennelliae','DB-NCIT'),('DBX-NCIT-C86439','C86439','Helicobacter mustelae','DB-NCIT'),('DBX-NCIT-C86440','C86440','Helicobacter rappini','DB-NCIT'),('DBX-NCIT-C86441','C86441','Histophilus somni','DB-NCIT'),('DBX-NCIT-C86442','C86442','Holdemania','DB-NCIT'),('DBX-NCIT-C86443','C86443','Holdemania filiformis','DB-NCIT'),('DBX-NCIT-C86444','C86444','Inquilinus','DB-NCIT'),('DBX-NCIT-C86445','C86445','Inquilinus limosus','DB-NCIT'),('DBX-NCIT-C86446','C86446','Jeotgalibacillus','DB-NCIT'),('DBX-NCIT-C86447','C86447','Johnsonella','DB-NCIT'),('DBX-NCIT-C86448','C86448','Johnsonella ignava','DB-NCIT'),('DBX-NCIT-C86449','C86449','Kingella','DB-NCIT'),('DBX-NCIT-C86450','C86450','Kingella denitrificans','DB-NCIT'),('DBX-NCIT-C86451','C86451','Kingella kingae','DB-NCIT'),('DBX-NCIT-C86452','C86452','Kingella oralis','DB-NCIT'),('DBX-NCIT-C86453','C86453','Kingella potus','DB-NCIT'),('DBX-NCIT-C86454','C86454','Klebsiella granulomatis','DB-NCIT'),('DBX-NCIT-C86455','C86455','Klebsiella oxytoca','DB-NCIT'),('DBX-NCIT-C86456','C86456','Klebsiella ozaenae','DB-NCIT'),('DBX-NCIT-C86457','C86457','Klebsiella pneumoniae','DB-NCIT'),('DBX-NCIT-C86458','C86458','Klebsiella rhinoscleromatis','DB-NCIT'),('DBX-NCIT-C86459','C86459','Klebsiella singaporensis','DB-NCIT'),('DBX-NCIT-C86460','C86460','Klebsiella variicola','DB-NCIT'),('DBX-NCIT-C86461','C86461','Kluyvera','DB-NCIT'),('DBX-NCIT-C86462','C86462','Kluyvera ascorbata','DB-NCIT'),('DBX-NCIT-C86463','C86463','Kluyvera cryocrescens','DB-NCIT'),('DBX-NCIT-C86464','C86464','Kluyvera georgiana','DB-NCIT'),('DBX-NCIT-C86465','C86465','Kluyvera intermedia','DB-NCIT'),('DBX-NCIT-C86466','C86466','Knoellia','DB-NCIT'),('DBX-NCIT-C86467','C86467','Kocuria','DB-NCIT'),('DBX-NCIT-C86468','C86468','Kocuria kristinae','DB-NCIT'),('DBX-NCIT-C86469','C86469','Kocuria rosea','DB-NCIT'),('DBX-NCIT-C86470','C86470','Kocuria varians','DB-NCIT'),('DBX-NCIT-C86471','C86471','Kurthia','DB-NCIT'),('DBX-NCIT-C86472','C86472','Kytococcus','DB-NCIT'),('DBX-NCIT-C86473','C86473','Kytococcus sedentarius','DB-NCIT'),('DBX-NCIT-C86474','C86474','Lactobacillus acidophilus','DB-NCIT'),('DBX-NCIT-C86475','C86475','Lactobacillus brevis','DB-NCIT'),('DBX-NCIT-C86476','C86476','Lactobacillus casei','DB-NCIT'),('DBX-NCIT-C86477','C86477','Lactobacillus catenaformis','DB-NCIT'),('DBX-NCIT-C86478','C86478','Lactobacillus fermentum','DB-NCIT'),('DBX-NCIT-C86479','C86479','Lactobacillus gallinarum','DB-NCIT'),('DBX-NCIT-C86480','C86480','Lactobacillus jensenii','DB-NCIT'),('DBX-NCIT-C86481','C86481','Lactobacillus johnsonii','DB-NCIT'),('DBX-NCIT-C86482','C86482','Lactobacillus salivarius','DB-NCIT'),('DBX-NCIT-C86483','C86483','Lactococcus','DB-NCIT'),('DBX-NCIT-C86484','C86484','Lactococcus garvieae','DB-NCIT'),('DBX-NCIT-C86485','C86485','Lactococcus lactis','DB-NCIT'),('DBX-NCIT-C86486','C86486','Leclercia','DB-NCIT'),('DBX-NCIT-C86487','C86487','Leclercia adecarboxylata','DB-NCIT'),('DBX-NCIT-C86488','C86488','Legionella longbeachae','DB-NCIT'),('DBX-NCIT-C86489','C86489','Legionella pneumophila','DB-NCIT'),('DBX-NCIT-C86490','C86490','Leifsonia','DB-NCIT'),('DBX-NCIT-C86491','C86491','Leifsonia aquatica','DB-NCIT'),('DBX-NCIT-C86492','C86492','Leminorella','DB-NCIT'),('DBX-NCIT-C86493','C86493','Leminorella grimontii','DB-NCIT'),('DBX-NCIT-C86494','C86494','Leminorella richardii','DB-NCIT'),('DBX-NCIT-C86495','C86495','Leuconostoc citreum','DB-NCIT'),('DBX-NCIT-C86496','C86496','Leuconostoc lactis','DB-NCIT'),('DBX-NCIT-C86497','C86497','Leuconostoc mesenteroides','DB-NCIT'),('DBX-NCIT-C86498','C86498','Leuconostoc pseudomesenteroides','DB-NCIT'),('DBX-NCIT-C86499','C86499','Listeria grayi','DB-NCIT'),('DBX-NCIT-C86500','C86500','Listeria innocua','DB-NCIT'),('DBX-NCIT-C86501','C86501','Listeria ivanovii','DB-NCIT'),('DBX-NCIT-C86502','C86502','Listeria monocytogenes','DB-NCIT'),('DBX-NCIT-C86503','C86503','Listeria seeligeri','DB-NCIT'),('DBX-NCIT-C86504','C86504','Listeria welshimeri','DB-NCIT'),('DBX-NCIT-C86505','C86505','Macrococcus','DB-NCIT'),('DBX-NCIT-C86506','C86506','Macrococcus caseolyticus','DB-NCIT'),('DBX-NCIT-C86507','C86507','Mannheimia','DB-NCIT'),('DBX-NCIT-C86508','C86508','Mannheimia haemolytica','DB-NCIT'),('DBX-NCIT-C86510','C86510','Methylobacterium mesophilicum','DB-NCIT'),('DBX-NCIT-C86512','C86512','Microbacterium paraoxydans','DB-NCIT'),('DBX-NCIT-C86513','C86513','Micrococcus luteus','DB-NCIT'),('DBX-NCIT-C86514','C86514','Micrococcus lylae','DB-NCIT'),('DBX-NCIT-C86515','C86515','Mitsuokella','DB-NCIT'),('DBX-NCIT-C86516','C86516','Mitsuokella multacida','DB-NCIT'),('DBX-NCIT-C86517','C86517','Mobiluncus','DB-NCIT'),('DBX-NCIT-C86518','C86518','Mobiluncus curtisii','DB-NCIT'),('DBX-NCIT-C86519','C86519','Mobiluncus mulieris','DB-NCIT'),('DBX-NCIT-C86520','C86520','Moellerella','DB-NCIT'),('DBX-NCIT-C86521','C86521','Moellerella wisconsensis','DB-NCIT'),('DBX-NCIT-C86523','C86523','Moraxella atlantae','DB-NCIT'),('DBX-NCIT-C86524','C86524','Moraxella bovis','DB-NCIT'),('DBX-NCIT-C86525','C86525','Moraxella canis','DB-NCIT'),('DBX-NCIT-C86526','C86526','Moraxella lacunata','DB-NCIT'),('DBX-NCIT-C86527','C86527','Moraxella lincolnii','DB-NCIT'),('DBX-NCIT-C86528','C86528','Moraxella nonliquefaciens','DB-NCIT'),('DBX-NCIT-C86529','C86529','Moraxella oblonga','DB-NCIT'),('DBX-NCIT-C86530','C86530','Moraxella osloensis','DB-NCIT'),('DBX-NCIT-C86531','C86531','Morganella','DB-NCIT'),('DBX-NCIT-C86533','C86533','Mycobacterium abscessus','DB-NCIT'),('DBX-NCIT-C86535','C86535','Mycobacterium avium','DB-NCIT'),('DBX-NCIT-C86536','C86536','Mycobacterium chelonae','DB-NCIT'),('DBX-NCIT-C86537','C86537','Mycobacterium flavescens','DB-NCIT'),('DBX-NCIT-C86538','C86538','Mycobacterium fortuitum','DB-NCIT'),('DBX-NCIT-C86539','C86539','Mycobacterium fortuitum Complex','DB-NCIT'),('DBX-NCIT-C86540','C86540','Mycobacterium gastri','DB-NCIT'),('DBX-NCIT-C86541','C86541','Mycobacterium gordonae','DB-NCIT'),('DBX-NCIT-C86542','C86542','Mycobacterium haemophilum','DB-NCIT'),('DBX-NCIT-C86544','C86544','Mycobacterium leprae','DB-NCIT'),('DBX-NCIT-C86545','C86545','Mycobacterium marinum','DB-NCIT'),('DBX-NCIT-C86546','C86546','Mycobacterium peregrinum','DB-NCIT'),('DBX-NCIT-C86547','C86547','Mycobacterium scrofulaceum','DB-NCIT'),('DBX-NCIT-C86548','C86548','Mycobacterium simiae','DB-NCIT'),('DBX-NCIT-C86590','C86590','Mycobacterium smegmatis','DB-NCIT'),('DBX-NCIT-C86591','C86591','Mycobacterium szulgai','DB-NCIT'),('DBX-NCIT-C86592','C86592','Mycobacterium terrae','DB-NCIT'),('DBX-NCIT-C86593','C86593','Mycobacterium thermoresistibile','DB-NCIT'),('DBX-NCIT-C86594','C86594','Mycobacterium tuberculosis Complex','DB-NCIT'),('DBX-NCIT-C86595','C86595','Mycobacterium ulcerans','DB-NCIT'),('DBX-NCIT-C86597','C86597','Mycoplasma hominis','DB-NCIT'),('DBX-NCIT-C86598','C86598','Mycoplasma orale','DB-NCIT'),('DBX-NCIT-C86599','C86599','Mycoplasma pneumoniae','DB-NCIT'),('DBX-NCIT-C86600','C86600','Neisseria canis','DB-NCIT'),('DBX-NCIT-C86601','C86601','Neisseria cinerea','DB-NCIT'),('DBX-NCIT-C86602','C86602','Neisseria flavescens','DB-NCIT'),('DBX-NCIT-C86603','C86603','Neisseria gonorrhoeae','DB-NCIT'),('DBX-NCIT-C86604','C86604','Neisseria lactamica','DB-NCIT'),('DBX-NCIT-C86605','C86605','Neisseria meningitidis','DB-NCIT'),('DBX-NCIT-C86606','C86606','Neisseria mucosa','DB-NCIT'),('DBX-NCIT-C86607','C86607','Neisseria polysaccharea','DB-NCIT'),('DBX-NCIT-C86608','C86608','Neisseria sicca','DB-NCIT'),('DBX-NCIT-C86609','C86609','Neisseria subflava','DB-NCIT'),('DBX-NCIT-C86610','C86610','Neisseria weaverii','DB-NCIT'),('DBX-NCIT-C86611','C86611','Nocardia asteroides','DB-NCIT'),('DBX-NCIT-C86612','C86612','Nocardia asteroides Complex','DB-NCIT'),('DBX-NCIT-C86613','C86613','Nocardia brasiliensis','DB-NCIT'),('DBX-NCIT-C86614','C86614','Nocardia dassonvillei','DB-NCIT'),('DBX-NCIT-C86615','C86615','Nocardia farcinica','DB-NCIT'),('DBX-NCIT-C86616','C86616','Nocardia nova','DB-NCIT'),('DBX-NCIT-C86617','C86617','Nocardia otitidiscaviarum','DB-NCIT'),('DBX-NCIT-C86618','C86618','Non-Fermentative Gram Negative Bacillus','DB-NCIT'),('DBX-NCIT-C86619','C86619','Ochrobactrum','DB-NCIT'),('DBX-NCIT-C86620','C86620','Ochrobactrum anthropi','DB-NCIT'),('DBX-NCIT-C86621','C86621','Ochrobactrum intermedium','DB-NCIT'),('DBX-NCIT-C86622','C86622','Oerskovia','DB-NCIT'),('DBX-NCIT-C86623','C86623','Oerskovia turbata','DB-NCIT'),('DBX-NCIT-C86624','C86624','Oligella','DB-NCIT'),('DBX-NCIT-C86625','C86625','Oligella ureolytica','DB-NCIT'),('DBX-NCIT-C86626','C86626','Oligella urethralis','DB-NCIT'),('DBX-NCIT-C86627','C86627','Olsenella','DB-NCIT'),('DBX-NCIT-C86628','C86628','Olsenella uli','DB-NCIT'),('DBX-NCIT-C86629','C86629','Pandoraea','DB-NCIT'),('DBX-NCIT-C86630','C86630','Pandoraea pnomenusa','DB-NCIT'),('DBX-NCIT-C86631','C86631','Pantoea','DB-NCIT'),('DBX-NCIT-C86632','C86632','Pantoea agglomerans','DB-NCIT'),('DBX-NCIT-C86633','C86633','Parabacteroides','DB-NCIT'),('DBX-NCIT-C86634','C86634','Parabacteroides distasonis','DB-NCIT'),('DBX-NCIT-C86635','C86635','Parabacteroides merdae','DB-NCIT'),('DBX-NCIT-C86636','C86636','Pasteurella','DB-NCIT'),('DBX-NCIT-C86637','C86637','Pasteurella aerogenes','DB-NCIT'),('DBX-NCIT-C86638','C86638','Pasteurella bettyae','DB-NCIT'),('DBX-NCIT-C86639','C86639','Pasteurella canis','DB-NCIT'),('DBX-NCIT-C86640','C86640','Pasteurella pneumotropica','DB-NCIT'),('DBX-NCIT-C86641','C86641','Pediococcus','DB-NCIT'),('DBX-NCIT-C86642','C86642','Peptococcus','DB-NCIT'),('DBX-NCIT-C86643','C86643','Peptococcus niger','DB-NCIT'),('DBX-NCIT-C86644','C86644','Peptostreptococcus','DB-NCIT'),('DBX-NCIT-C86645','C86645','Peptostreptococcus anaerobius','DB-NCIT'),('DBX-NCIT-C86646','C86646','Photobacterium','DB-NCIT'),('DBX-NCIT-C86647','C86647','Photobacterium damselae','DB-NCIT'),('DBX-NCIT-C86648','C86648','Photorhabdus','DB-NCIT'),('DBX-NCIT-C86649','C86649','Photorhabdus luminescens','DB-NCIT'),('DBX-NCIT-C86650','C86650','Planococcus','DB-NCIT'),('DBX-NCIT-C86651','C86651','Plesiomonas','DB-NCIT'),('DBX-NCIT-C86652','C86652','Plesiomonas shigelloides','DB-NCIT'),('DBX-NCIT-C86653','C86653','Porphyromonas','DB-NCIT'),('DBX-NCIT-C86654','C86654','Porphyromonas asaccharolytica','DB-NCIT'),('DBX-NCIT-C86655','C86655','Porphyromonas catoniae','DB-NCIT'),('DBX-NCIT-C86656','C86656','Porphyromonas endodontalis','DB-NCIT'),('DBX-NCIT-C86657','C86657','Porphyromonas gingivalis','DB-NCIT'),('DBX-NCIT-C86658','C86658','Porphyromonas levii','DB-NCIT'),('DBX-NCIT-C86659','C86659','Porphyromonas somerae','DB-NCIT'),('DBX-NCIT-C86660','C86660','Prevotella','DB-NCIT'),('DBX-NCIT-C86661','C86661','Prevotella bivia','DB-NCIT'),('DBX-NCIT-C86662','C86662','Prevotella brevis','DB-NCIT'),('DBX-NCIT-C86663','C86663','Prevotella buccae','DB-NCIT'),('DBX-NCIT-C86664','C86664','Prevotella buccalis','DB-NCIT'),('DBX-NCIT-C86665','C86665','Prevotella corporis','DB-NCIT'),('DBX-NCIT-C86666','C86666','Prevotella dentalis','DB-NCIT'),('DBX-NCIT-C86667','C86667','Prevotella denticola','DB-NCIT'),('DBX-NCIT-C86668','C86668','Prevotella disiens','DB-NCIT'),('DBX-NCIT-C86669','C86669','Prevotella heparinolytica','DB-NCIT'),('DBX-NCIT-C86670','C86670','Prevotella intermedia','DB-NCIT'),('DBX-NCIT-C86671','C86671','Prevotella intermedia/nigrescens Group','DB-NCIT'),('DBX-NCIT-C86672','C86672','Prevotella loescheii','DB-NCIT'),('DBX-NCIT-C86673','C86673','Prevotella melaninogenica','DB-NCIT'),('DBX-NCIT-C86674','C86674','Prevotella nigrescens','DB-NCIT'),('DBX-NCIT-C86675','C86675','Prevotella oralis','DB-NCIT'),('DBX-NCIT-C86676','C86676','Prevotella oris','DB-NCIT'),('DBX-NCIT-C86677','C86677','Prevotella ruminicola','DB-NCIT'),('DBX-NCIT-C86678','C86678','Prevotella tannerae','DB-NCIT'),('DBX-NCIT-C86679','C86679','Prevotella veroralis','DB-NCIT'),('DBX-NCIT-C86681','C86681','Propionibacterium avidum','DB-NCIT'),('DBX-NCIT-C86682','C86682','Propionibacterium granulosum','DB-NCIT'),('DBX-NCIT-C86683','C86683','Propionibacterium propionicum','DB-NCIT'),('DBX-NCIT-C86684','C86684','Proteus hauseri','DB-NCIT'),('DBX-NCIT-C86687','C86687','Proteus myxofaciens','DB-NCIT'),('DBX-NCIT-C86688','C86688','Proteus penneri','DB-NCIT'),('DBX-NCIT-C86690','C86690','Providencia','DB-NCIT'),('DBX-NCIT-C86691','C86691','Providencia alcalifaciens','DB-NCIT'),('DBX-NCIT-C86692','C86692','Providencia heimbachae','DB-NCIT'),('DBX-NCIT-C86693','C86693','Proteus rettgeri','DB-NCIT'),('DBX-NCIT-C86694','C86694','Providencia rustigianii','DB-NCIT'),('DBX-NCIT-C86695','C86695','Providencia stuartii','DB-NCIT'),('DBX-NCIT-C86696','C86696','Pseudomonas aeruginosa','DB-NCIT'),('DBX-NCIT-C86697','C86697','Pseudomonas alcaligenes','DB-NCIT'),('DBX-NCIT-C86699','C86699','Pseudomonas chlororaphis','DB-NCIT'),('DBX-NCIT-C86701','C86701','Pseudomonas luteola','DB-NCIT'),('DBX-NCIT-C86702','C86702','Pseudomonas mendocina','DB-NCIT'),('DBX-NCIT-C86703','C86703','Pseudomonas mosselii','DB-NCIT'),('DBX-NCIT-C86704','C86704','Pseudomonas pseudoalcaligenes','DB-NCIT'),('DBX-NCIT-C86705','C86705','Pseudomonas putida','DB-NCIT'),('DBX-NCIT-C86706','C86706','Pseudomonas stutzeri','DB-NCIT'),('DBX-NCIT-C86707','C86707','Psychrobacter','DB-NCIT'),('DBX-NCIT-C86708','C86708','Psychrobacter immobilis','DB-NCIT'),('DBX-NCIT-C86709','C86709','Psychrobacter phenylpyruvicus','DB-NCIT'),('DBX-NCIT-C86710','C86710','Rahnella','DB-NCIT'),('DBX-NCIT-C86711','C86711','Rahnella aquatilis','DB-NCIT'),('DBX-NCIT-C86712','C86712','Ralstonia','DB-NCIT'),('DBX-NCIT-C86713','C86713','Ralstonia pickettii','DB-NCIT'),('DBX-NCIT-C86714','C86714','Raoultella','DB-NCIT'),('DBX-NCIT-C86715','C86715','Raoultella ornithinolytica','DB-NCIT'),('DBX-NCIT-C86716','C86716','Raoultella planticola','DB-NCIT'),('DBX-NCIT-C86717','C86717','Raoultella terrigena','DB-NCIT'),('DBX-NCIT-C86718','C86718','Rhizobium','DB-NCIT'),('DBX-NCIT-C86719','C86719','Rhodococcus equi','DB-NCIT'),('DBX-NCIT-C86720','C86720','Rickettsia africae','DB-NCIT'),('DBX-NCIT-C86721','C86721','Rickettsia felis','DB-NCIT'),('DBX-NCIT-C86722','C86722','Rickettsia japonica','DB-NCIT'),('DBX-NCIT-C86723','C86723','Rickettsia prowazekii','DB-NCIT'),('DBX-NCIT-C86724','C86724','Rickettsia rickettsii','DB-NCIT'),('DBX-NCIT-C86725','C86725','Rickettsia typhi','DB-NCIT'),('DBX-NCIT-C86726','C86726','Roseomonas','DB-NCIT'),('DBX-NCIT-C86727','C86727','Rothia','DB-NCIT'),('DBX-NCIT-C86728','C86728','Rothia dentocariosa','DB-NCIT'),('DBX-NCIT-C86729','C86729','Ruminococcus','DB-NCIT'),('DBX-NCIT-C86730','C86730','Ruminococcus productus','DB-NCIT'),('DBX-NCIT-C86731','C86731','Salmonella enterica','DB-NCIT'),('DBX-NCIT-C86732','C86732','Selenomonas','DB-NCIT'),('DBX-NCIT-C86733','C86733','Selenomonas noxia','DB-NCIT'),('DBX-NCIT-C86734','C86734','Selenomonas sputigena','DB-NCIT'),('DBX-NCIT-C86736','C86736','Serratia ficaria','DB-NCIT'),('DBX-NCIT-C86737','C86737','Serratia fonticola','DB-NCIT'),('DBX-NCIT-C86738','C86738','Serratia liquefaciens','DB-NCIT'),('DBX-NCIT-C86739','C86739','Serratia odorifera','DB-NCIT'),('DBX-NCIT-C86740','C86740','Serratia plymuthica','DB-NCIT'),('DBX-NCIT-C86741','C86741','Serratia rubidaea','DB-NCIT'),('DBX-NCIT-C86742','C86742','Shewanella','DB-NCIT'),('DBX-NCIT-C86743','C86743','Shewanella putrefaciens','DB-NCIT'),('DBX-NCIT-C86744','C86744','Shigella boydii','DB-NCIT'),('DBX-NCIT-C86745','C86745','Shigella dysenteriae','DB-NCIT'),('DBX-NCIT-C86746','C86746','Shigella flexneri','DB-NCIT'),('DBX-NCIT-C86747','C86747','Shigella sonnei','DB-NCIT'),('DBX-NCIT-C86748','C86748','Sphingomonas','DB-NCIT'),('DBX-NCIT-C86749','C86749','Sphingomonas paucimobilis','DB-NCIT'),('DBX-NCIT-C86750','C86750','Staphylococcus arlettae','DB-NCIT'),('DBX-NCIT-C86751','C86751','Staphylococcus auricularis','DB-NCIT'),('DBX-NCIT-C86752','C86752','Staphylococcus capitis','DB-NCIT'),('DBX-NCIT-C86753','C86753','Staphylococcus caprae','DB-NCIT'),('DBX-NCIT-C86754','C86754','Staphylococcus carnosus','DB-NCIT'),('DBX-NCIT-C86755','C86755','Staphylococcus chromogenes','DB-NCIT'),('DBX-NCIT-C86756','C86756','Staphylococcus cohnii','DB-NCIT'),('DBX-NCIT-C86757','C86757','Staphylococcus epidermidis','DB-NCIT'),('DBX-NCIT-C86758','C86758','Staphylococcus equorum','DB-NCIT'),('DBX-NCIT-C86759','C86759','Staphylococcus felis','DB-NCIT'),('DBX-NCIT-C86760','C86760','Staphylococcus gallinarum','DB-NCIT'),('DBX-NCIT-C86761','C86761','Staphylococcus haemolyticus','DB-NCIT'),('DBX-NCIT-C86762','C86762','Staphylococcus hominis','DB-NCIT'),('DBX-NCIT-C86763','C86763','Staphylococcus hyicus','DB-NCIT'),('DBX-NCIT-C86764','C86764','Staphylococcus intermedius','DB-NCIT'),('DBX-NCIT-C86765','C86765','Staphylococcus kloosii','DB-NCIT'),('DBX-NCIT-C86766','C86766','Staphylococcus lentus','DB-NCIT'),('DBX-NCIT-C86767','C86767','Staphylococcus lugdunensis','DB-NCIT'),('DBX-NCIT-C86768','C86768','Staphylococcus pasteuri','DB-NCIT'),('DBX-NCIT-C86769','C86769','Staphylococcus saccharolyticus','DB-NCIT'),('DBX-NCIT-C86770','C86770','Staphylococcus saprophyticus','DB-NCIT'),('DBX-NCIT-C86771','C86771','Staphylococcus schleiferi','DB-NCIT'),('DBX-NCIT-C86772','C86772','Staphylococcus sciuri','DB-NCIT'),('DBX-NCIT-C86773','C86773','Staphylococcus simulans','DB-NCIT'),('DBX-NCIT-C86774','C86774','Staphylococcus warneri','DB-NCIT'),('DBX-NCIT-C86775','C86775','Staphylococcus xylosus','DB-NCIT'),('DBX-NCIT-C86776','C86776','Stenotrophomonas','DB-NCIT'),('DBX-NCIT-C86777','C86777','Streptobacillus','DB-NCIT'),('DBX-NCIT-C86778','C86778','Streptobacillus moniliformis','DB-NCIT'),('DBX-NCIT-C86779','C86779','Streptococcus acidominimus','DB-NCIT'),('DBX-NCIT-C86780','C86780','Streptococcus agalactiae','DB-NCIT'),('DBX-NCIT-C86781','C86781','Streptococcus alactolyticus','DB-NCIT'),('DBX-NCIT-C86782','C86782','Streptococcus anginosis','DB-NCIT'),('DBX-NCIT-C86783','C86783','Streptococcus anginosus Group','DB-NCIT'),('DBX-NCIT-C86784','C86784','Streptococcus bovis','DB-NCIT'),('DBX-NCIT-C86785','C86785','Streptococcus bovis Group','DB-NCIT'),('DBX-NCIT-C86786','C86786','Streptococcus canis','DB-NCIT'),('DBX-NCIT-C86787','C86787','Streptococcus constellatus','DB-NCIT'),('DBX-NCIT-C86788','C86788','Streptococcus cristatus','DB-NCIT'),('DBX-NCIT-C86789','C86789','Streptococcus equi','DB-NCIT'),('DBX-NCIT-C86790','C86790','Streptococcus equinus','DB-NCIT'),('DBX-NCIT-C86791','C86791','Streptococcus gallolyticus','DB-NCIT'),('DBX-NCIT-C86792','C86792','Streptococcus gordonii','DB-NCIT'),('DBX-NCIT-C86793','C86793','Streptococcus infantarius','DB-NCIT'),('DBX-NCIT-C86794','C86794','Streptococcus intermedius','DB-NCIT'),('DBX-NCIT-C86795','C86795','Streptococcus milleri','DB-NCIT'),('DBX-NCIT-C86796','C86796','Streptococcus milleri Group','DB-NCIT'),('DBX-NCIT-C86797','C86797','Streptococcus mitis Group','DB-NCIT'),('DBX-NCIT-C86798','C86798','Streptococcus mutans Group','DB-NCIT'),('DBX-NCIT-C86799','C86799','Streptococcus oralis','DB-NCIT'),('DBX-NCIT-C86800','C86800','Streptococcus parasanguinis','DB-NCIT'),('DBX-NCIT-C86802','C86802','Streptococcus porcinus','DB-NCIT'),('DBX-NCIT-C86803','C86803','Streptococcus pyogenes','DB-NCIT'),('DBX-NCIT-C86804','C86804','Streptococcus salivarius','DB-NCIT'),('DBX-NCIT-C86805','C86805','Streptococcus salivarius Group','DB-NCIT'),('DBX-NCIT-C86806','C86806','Streptococcus sanguinis','DB-NCIT'),('DBX-NCIT-C86807','C86807','Streptococcus suis','DB-NCIT'),('DBX-NCIT-C86808','C86808','Streptococcus thermophilus','DB-NCIT'),('DBX-NCIT-C86809','C86809','Streptococcus uberis','DB-NCIT'),('DBX-NCIT-C86810','C86810','Streptococcus vestibularis','DB-NCIT'),('DBX-NCIT-C86811','C86811','Streptococcus viridans Group','DB-NCIT'),('DBX-NCIT-C86812','C86812','Streptomyces albus','DB-NCIT'),('DBX-NCIT-C86813','C86813','Streptomyces griseus','DB-NCIT'),('DBX-NCIT-C86814','C86814','Streptomyces somaliensis','DB-NCIT'),('DBX-NCIT-C86815','C86815','Suttonella','DB-NCIT'),('DBX-NCIT-C86816','C86816','Suttonella indologenes','DB-NCIT'),('DBX-NCIT-C86817','C86817','Tatlockia micdadei','DB-NCIT'),('DBX-NCIT-C86818','C86818','Tatumella','DB-NCIT'),('DBX-NCIT-C86819','C86819','Tatumella ptyseos','DB-NCIT'),('DBX-NCIT-C86820','C86820','Tetragenococcus','DB-NCIT'),('DBX-NCIT-C86821','C86821','Tetragenococcus solitarius','DB-NCIT'),('DBX-NCIT-C86822','C86822','Trabulsiella','DB-NCIT'),('DBX-NCIT-C86823','C86823','Trabulsiella guamensis','DB-NCIT'),('DBX-NCIT-C86825','C86825','Treponema pallidum','DB-NCIT'),('DBX-NCIT-C86826','C86826','Tropheryma','DB-NCIT'),('DBX-NCIT-C86827','C86827','Tropheryma whipplei','DB-NCIT'),('DBX-NCIT-C86828','C86828','Tsukamurella','DB-NCIT'),('DBX-NCIT-C86829','C86829','Tsukamurella paurometabolum','DB-NCIT'),('DBX-NCIT-C86830','C86830','Turicella','DB-NCIT'),('DBX-NCIT-C86831','C86831','Turicella otitidis','DB-NCIT'),('DBX-NCIT-C86832','C86832','Ureaplasma','DB-NCIT'),('DBX-NCIT-C86833','C86833','Ureaplasma urealyticum','DB-NCIT'),('DBX-NCIT-C86834','C86834','Vagococcus','DB-NCIT'),('DBX-NCIT-C86835','C86835','Varibaculum','DB-NCIT'),('DBX-NCIT-C86836','C86836','Varibaculum cambriense','DB-NCIT'),('DBX-NCIT-C86837','C86837','Veillonella','DB-NCIT'),('DBX-NCIT-C86838','C86838','Veillonella dispar','DB-NCIT'),('DBX-NCIT-C86839','C86839','Veillonella parvula','DB-NCIT'),('DBX-NCIT-C86840','C86840','Vibrio alginolyticus','DB-NCIT'),('DBX-NCIT-C86841','C86841','Vibrio cholerae','DB-NCIT'),('DBX-NCIT-C86842','C86842','Vibrio fluvialis','DB-NCIT'),('DBX-NCIT-C86843','C86843','Vibrio furnissii','DB-NCIT'),('DBX-NCIT-C86844','C86844','Vibrio metschnikovii','DB-NCIT'),('DBX-NCIT-C86845','C86845','Vibrio mimicus','DB-NCIT'),('DBX-NCIT-C86846','C86846','Vibrio parahaemolyticus','DB-NCIT'),('DBX-NCIT-C86847','C86847','Vibrio vulnificus','DB-NCIT'),('DBX-NCIT-C86848','C86848','Weeksella','DB-NCIT'),('DBX-NCIT-C86849','C86849','Weeksella virosa','DB-NCIT'),('DBX-NCIT-C86850','C86850','Wolinella','DB-NCIT'),('DBX-NCIT-C86851','C86851','Wolinella succinogenes','DB-NCIT'),('DBX-NCIT-C86852','C86852','Yersinia','DB-NCIT'),('DBX-NCIT-C86853','C86853','Yersinia aldovae','DB-NCIT'),('DBX-NCIT-C86854','C86854','Yersinia bercovieri','DB-NCIT'),('DBX-NCIT-C86855','C86855','Yersinia enterocolitica','DB-NCIT'),('DBX-NCIT-C86856','C86856','Yersinia frederiksenii','DB-NCIT'),('DBX-NCIT-C86857','C86857','Yersinia intermedia','DB-NCIT'),('DBX-NCIT-C86858','C86858','Yersinia kristensenii','DB-NCIT'),('DBX-NCIT-C86859','C86859','Yersinia mollaretii','DB-NCIT'),('DBX-NCIT-C86860','C86860','Yersinia pestis','DB-NCIT'),('DBX-NCIT-C86861','C86861','Yersinia pseudotuberculosis','DB-NCIT'),('DBX-NCIT-C86862','C86862','Yersinia rohdei','DB-NCIT'),('DBX-NCIT-C86863','C86863','Yersinia ruckeri','DB-NCIT'),('DBX-NCIT-C86864','C86864','Yokenella','DB-NCIT'),('DBX-NCIT-C86865','C86865','Yokenella regensburgei','DB-NCIT'),('DBX-NCIT-C86866','C86866','Zimmermannella','DB-NCIT'),('DBX-NCIT-C86867','C86867','Zimmermannella alba','DB-NCIT'),('DBX-NCIT-C86868','C86868','Zimmermannella bifida','DB-NCIT'),('DBX-NCIT-C86871','C86871','Alistipes putredinis','DB-NCIT'),('DBX-NCIT-C86872','C86872','Anaerococcus','DB-NCIT'),('DBX-NCIT-C86873','C86873','Helcococcus','DB-NCIT'),('DBX-NCIT-C86874','C86874','Anaerococcus hydrogenalis','DB-NCIT'),('DBX-NCIT-C86875','C86875','Anaerococcus prevotii','DB-NCIT'),('DBX-NCIT-C86876','C86876','Anaerococcus tetradius','DB-NCIT'),('DBX-NCIT-C86877','C86877','Anaerococcus vaginalis','DB-NCIT'),('DBX-NCIT-C86878','C86878','Helcococcus kunzii','DB-NCIT'),('DBX-NCIT-C86879','C86879','Helcococcus pyogenes','DB-NCIT'),('DBX-NCIT-C86880','C86880','Helcococcus sueciensis','DB-NCIT'),('DBX-NCIT-C86881','C86881','Escherichia coli strain O111','DB-NCIT'),('DBX-NCIT-C86882','C86882','Escherichia coli strain O157','DB-NCIT'),('DBX-NCIT-C86883','C86883','Escherichia coli strain O157:H7','DB-NCIT'),('DBX-NCIT-C86884','C86884','Escherichia coli strain O26','DB-NCIT'),('DBX-NCIT-C86885','C86885','Exiguobacterium','DB-NCIT'),('DBX-NCIT-C86886','C86886','Exiguobacterium acetylicum','DB-NCIT'),('DBX-NCIT-C86887','C86887','Finegoldia','DB-NCIT'),('DBX-NCIT-C86888','C86888','Finegoldia magna','DB-NCIT'),('DBX-NCIT-C86889','C86889','Gemella','DB-NCIT'),('DBX-NCIT-C86890','C86890','Gemella bergeri','DB-NCIT'),('DBX-NCIT-C86891','C86891','Gemella haemolysans','DB-NCIT'),('DBX-NCIT-C86892','C86892','Gemella morbillorum','DB-NCIT'),('DBX-NCIT-C86893','C86893','Gemella sanguinis','DB-NCIT'),('DBX-NCIT-C86895','C86895','Megasphaera','DB-NCIT'),('DBX-NCIT-C86896','C86896','Megasphaera elsdenii','DB-NCIT'),('DBX-NCIT-C86898','C86898','Mogibacterium','DB-NCIT'),('DBX-NCIT-C86899','C86899','Mogibacterium timidum','DB-NCIT'),('DBX-NCIT-C86900','C86900','Parvimonas','DB-NCIT'),('DBX-NCIT-C86901','C86901','Parvimonas micra','DB-NCIT'),('DBX-NCIT-C86902','C86902','Peptoniphilus','DB-NCIT'),('DBX-NCIT-C86903','C86903','Peptoniphilus asaccharolyticus','DB-NCIT'),('DBX-NCIT-C86904','C86904','Peptoniphilus indolicus','DB-NCIT'),('DBX-NCIT-C86906','C86906','Streptococcus dysgalactiae subsp equisimilis','DB-NCIT'),('DBX-NCIT-C86907','C86907','Tissierella','DB-NCIT'),('DBX-NCIT-C86908','C86908','Tissierella praeacuta','DB-NCIT'),('DBX-NCIT-C86909','C86909','Treponema pallidum subsp pertenue','DB-NCIT'),('DBX-NCIT-C86910','C86910','Salmonella enterica subsp arizonae','DB-NCIT'),('DBX-NCIT-C86913','C86913','Salmonella enterica subsp enterica','DB-NCIT'),('DBX-NCIT-C86915','C86915','Salmonella Serotype Choleraesuis','DB-NCIT'),('DBX-NCIT-C86918','C86918','Salmonella Serotype Dublin','DB-NCIT'),('DBX-NCIT-C86919','C86919','Salmonella Serotype Enteritidis','DB-NCIT'),('DBX-NCIT-C86921','C86921','Salmonella Serotype Newport','DB-NCIT'),('DBX-NCIT-C86922','C86922','Salmonella Serotype Paratyphi A','DB-NCIT'),('DBX-NCIT-C86924','C86924','Salmonella Serotype Paratyphi B','DB-NCIT'),('DBX-NCIT-C86925','C86925','Salmonella Serotype Paratyphi C','DB-NCIT'),('DBX-NCIT-C86926','C86926','Salmonella Serotype Typhi','DB-NCIT'),('DBX-NCIT-C86927','C86927','Salmonella Serotype Typhimurium','DB-NCIT'),('DBX-NCIT-C86953','C86953','Myroides','DB-NCIT'),('DBX-NCIT-C86954','C86954','Myroides odoratus','DB-NCIT'),('DBX-NCIT-C86955','C86955','Corynebacterium glucuronolyticum','DB-NCIT'),('DBX-NCIT-C86956','C86956','Sutterella','DB-NCIT'),('DBX-NCIT-C86957','C86957','Sphingobacterium','DB-NCIT'),('DBX-NCIT-C86958','C86958','Sphingobacterium mizutaii','DB-NCIT'),('DBX-NCIT-C86959','C86959','Sphingobacterium multivorum','DB-NCIT'),('DBX-NCIT-C86960','C86960','Sphingobacterium spiritivorum','DB-NCIT'),('DBX-NCIT-C86961','C86961','Sphingobacterium thalpophilum','DB-NCIT'),('DBX-NCIT-C86962','C86962','Pseudomonas fluorescens/putida Group','DB-NCIT'),('DBX-NCIT-C87054','C87054','Sagittal Abdominal Diameter','DB-NCIT'),('DBX-NCIT-C87162','C87162','CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology Version 4.0','DB-NCIT'),('DBX-NCIT-C88025','C88025','CDISC SEND Tumor Findings Results Terminology','DB-NCIT'),('DBX-NCIT-C8810','C8810','Extraskeletal Osteosarcoma','DB-NCIT'),('DBX-NCIT-C88113','C88113','Free Cortisol Measurement','DB-NCIT'),('DBX-NCIT-C88140','C88140','Paced Rhythm','DB-NCIT'),('DBX-NCIT-C88143','C88143','External Iliac Lymph Node','DB-NCIT'),('DBX-NCIT-C89081','C89081','Dose Frequency','DB-NCIT'),('DBX-NCIT-C8923','C8923','Acute Erythroid Leukemia','DB-NCIT'),('DBX-NCIT-C8965','C8965','Lymphangioma','DB-NCIT'),('DBX-NCIT-C8973','C8973','Endometrioid Stromal Sarcoma','DB-NCIT'),('DBX-NCIT-C8975','C8975','Malignant Mixed Mesodermal (Mullerian) Tumor','DB-NCIT'),('DBX-NCIT-C89772','C89772','Parvovirus B19','DB-NCIT'),('DBX-NCIT-C89788','C89788','Every Six Weeks','DB-NCIT'),('DBX-NCIT-C89789','C89789','Every Six Months','DB-NCIT'),('DBX-NCIT-C89803','C89803','Forehead','DB-NCIT'),('DBX-NCIT-C89806','C89806','Buttock','DB-NCIT'),('DBX-NCIT-C89807','C89807','Scalp','DB-NCIT'),('DBX-NCIT-C89820','C89820','BK Virus','DB-NCIT'),('DBX-NCIT-C89836','C89836','Residual Volume','DB-NCIT'),('DBX-NCIT-C8984','C8984','Adenofibroma','DB-NCIT'),('DBX-NCIT-C8991','C8991','Malignant Mastocytosis','DB-NCIT'),('DBX-NCIT-C90013','C90013','CDISC SDTM Electrocardiogram Lead Terminology','DB-NCIT'),('DBX-NCIT-C9003','C9003','Adrenal Cortex Adenoma','DB-NCIT'),('DBX-NCIT-C90067','C90067','Basal','DB-NCIT'),('DBX-NCIT-C90069','C90069','Tip','DB-NCIT'),('DBX-NCIT-C9011','C9011','Dermoid Cyst','DB-NCIT'),('DBX-NCIT-C90349','C90349','10 Lead Standard','DB-NCIT'),('DBX-NCIT-C90350','C90350','6 Lead Standard','DB-NCIT'),('DBX-NCIT-C90360','C90360','Augmented Vector Foot','DB-NCIT'),('DBX-NCIT-C90361','C90361','Augmented Vector Left','DB-NCIT'),('DBX-NCIT-C90362','C90362','Augmented Vector Right','DB-NCIT'),('DBX-NCIT-C90376','C90376','Dorsolateral','DB-NCIT'),('DBX-NCIT-C90386','C90386','Fore','DB-NCIT'),('DBX-NCIT-C90393','C90393','Hind','DB-NCIT'),('DBX-NCIT-C90403','C90403','Lead Site aV6','DB-NCIT'),('DBX-NCIT-C90404','C90404','Lead Site CM5','DB-NCIT'),('DBX-NCIT-C90405','C90405','Lead Site CV5RL','DB-NCIT'),('DBX-NCIT-C90406','C90406','Lead Site CV6LL','DB-NCIT'),('DBX-NCIT-C90407','C90407','Lead Site CV6LU','DB-NCIT'),('DBX-NCIT-C90408','C90408','Lead Site I','DB-NCIT'),('DBX-NCIT-C90409','C90409','Lead Site II','DB-NCIT'),('DBX-NCIT-C90410','C90410','Lead Site III','DB-NCIT'),('DBX-NCIT-C90411','C90411','Lead Site rV2','DB-NCIT'),('DBX-NCIT-C90412','C90412','Lead Site V1','DB-NCIT'),('DBX-NCIT-C90413','C90413','Lead Site V10','DB-NCIT'),('DBX-NCIT-C90414','C90414','Lead Site V2','DB-NCIT'),('DBX-NCIT-C90415','C90415','Lead Site V3','DB-NCIT'),('DBX-NCIT-C90416','C90416','Lead Site V4','DB-NCIT'),('DBX-NCIT-C90417','C90417','Lead Site V5','DB-NCIT'),('DBX-NCIT-C90418','C90418','Lead Site V6','DB-NCIT'),('DBX-NCIT-C90430','C90430','P Wave Abnormality by ECG Finding','DB-NCIT'),('DBX-NCIT-C90431','C90431','P Wave Notched by ECG Finding','DB-NCIT'),('DBX-NCIT-C90440','C90440','QRS Complex Abnormality by ECG Finding','DB-NCIT'),('DBX-NCIT-C90442','C90442','QTcV - Van de Water\'s Correction Formula','DB-NCIT'),('DBX-NCIT-C90444','C90444','R Wave Notched by ECG Finding','DB-NCIT'),('DBX-NCIT-C90462','C90462','Study End Date','DB-NCIT'),('DBX-NCIT-C90480','C90480','Unconstrained Body Movement','DB-NCIT'),('DBX-NCIT-C90483','C90483','Ventricular Escape Beat by ECG Finding','DB-NCIT'),('DBX-NCIT-C90505','C90505','Glomerular Filtration Rate','DB-NCIT'),('DBX-NCIT-C91060','C91060','Centimeters of Water','DB-NCIT'),('DBX-NCIT-C9118','C9118','Sarcoma','DB-NCIT'),('DBX-NCIT-C91372','C91372','Indirect Antiglobulin Test','DB-NCIT'),('DBX-NCIT-C9145','C9145','Osteosarcoma','DB-NCIT'),('DBX-NCIT-C91752','C91752','Patient Noncompliance','DB-NCIT'),('DBX-NCIT-C91842','C91842','Salmonella bongori','DB-NCIT'),('DBX-NCIT-C91843','C91843','Mycobacterium intracellulare','DB-NCIT'),('DBX-NCIT-C91844','C91844','Salmonella enterica subsp diarizonae','DB-NCIT'),('DBX-NCIT-C91845','C91845','Salmonella enterica subsp houtenae','DB-NCIT'),('DBX-NCIT-C91846','C91846','Salmonella enterica subsp indica','DB-NCIT'),('DBX-NCIT-C91847','C91847','Salmonella enterica subsp salamae','DB-NCIT'),('DBX-NCIT-C91848','C91848','Streptococcus dysgalactiae subsp dysgalactiae','DB-NCIT'),('DBX-NCIT-C91849','C91849','Treponema pallidum subsp pallidum','DB-NCIT'),('DBX-NCIT-C91850','C91850','Treponema pallidum subsp endemicum','DB-NCIT'),('DBX-NCIT-C92180','C92180','Rat Sertoliform Tubular Adenoma','DB-NCIT'),('DBX-NCIT-C92181','C92181','Benign Adrenal Gland Composite Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C92183','C92183','Rat Pars Intermedia Carcinoma','DB-NCIT'),('DBX-NCIT-C92184','C92184','Malignant Adrenal Gland Composite Pheochromocytoma','DB-NCIT'),('DBX-NCIT-C92221','C92221','Brachial Lymph Node','DB-NCIT'),('DBX-NCIT-C92227','C92227','RSR\' by ECG Finding','DB-NCIT'),('DBX-NCIT-C92228','C92228','Borderline QTcB','DB-NCIT'),('DBX-NCIT-C92229','C92229','Borderline QTcF','DB-NCIT'),('DBX-NCIT-C92231','C92231','Left Ventricular Conduction Delay by ECG Finding','DB-NCIT'),('DBX-NCIT-C92232','C92232','Paced Atrial And Ventricular Rhythm','DB-NCIT'),('DBX-NCIT-C92233','C92233','Paced Atrial Rhythm','DB-NCIT'),('DBX-NCIT-C92234','C92234','Paced Ventricular Rhythm','DB-NCIT'),('DBX-NCIT-C92235','C92235','Right Ventricular Conduction Delay by ECG Finding','DB-NCIT'),('DBX-NCIT-C92236','C92236','Sjogren\'s SS-A Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92237','C92237','Sjogren\'s SS-B Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92238','C92238','Trichomonas Screening','DB-NCIT'),('DBX-NCIT-C92239','C92239','Yeast Hyphae Screening','DB-NCIT'),('DBX-NCIT-C92240','C92240','Protein to Osmolality Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92241','C92241','Mycobacterium tuberculosis Interferon Gamma Response','DB-NCIT'),('DBX-NCIT-C92242','C92242','Myeloid to Erythroid Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92243','C92243','Amorphous Phosphate Crystals Measurement','DB-NCIT'),('DBX-NCIT-C92244','C92244','Amorphous Urate Crystals Measurement','DB-NCIT'),('DBX-NCIT-C92245','C92245','Erythrocyte Cell Clumps Measurement','DB-NCIT'),('DBX-NCIT-C92246','C92246','Leukocyte Cell Clumps Measurement','DB-NCIT'),('DBX-NCIT-C92247','C92247','Acetoacetic Acid Measurement','DB-NCIT'),('DBX-NCIT-C92248','C92248','Citrate Measurement','DB-NCIT'),('DBX-NCIT-C92249','C92249','Cotinine Measurement','DB-NCIT'),('DBX-NCIT-C92250','C92250','Oxalate Measurement','DB-NCIT'),('DBX-NCIT-C92251','C92251','Transitional Epithelial Cells Measurement','DB-NCIT'),('DBX-NCIT-C92252','C92252','Alpha-1 Globulin Measurement','DB-NCIT'),('DBX-NCIT-C92253','C92253','Alpha-1 Globulin to Total Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92254','C92254','Alpha-2 Globulin Measurement','DB-NCIT'),('DBX-NCIT-C92255','C92255','Alpha-2 Globulin to Total Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92256','C92256','Beta Globulin Measurement','DB-NCIT'),('DBX-NCIT-C92257','C92257','Gamma Globulin Measurement','DB-NCIT'),('DBX-NCIT-C92258','C92258','Hemoglobin A Measurement','DB-NCIT'),('DBX-NCIT-C92259','C92259','Hemoglobin A2 Measurement','DB-NCIT'),('DBX-NCIT-C92260','C92260','Hemoglobin B Measurement','DB-NCIT'),('DBX-NCIT-C92261','C92261','Hemoglobin C Measurement','DB-NCIT'),('DBX-NCIT-C92262','C92262','Hemoglobin F Measurement','DB-NCIT'),('DBX-NCIT-C92263','C92263','HIV-1 Group M and O Nucleic Acid Measurement','DB-NCIT'),('DBX-NCIT-C92264','C92264','HIV-1 Group O Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92265','C92265','HIV-1 p24 Antigen Measurement','DB-NCIT'),('DBX-NCIT-C92266','C92266','HIV-2 Nucleic Acid Measurement','DB-NCIT'),('DBX-NCIT-C92267','C92267','1, 25-Dihydroxyvitamin D Measurement','DB-NCIT'),('DBX-NCIT-C92268','C92268','25-Hydroxyvitamin D Measurement','DB-NCIT'),('DBX-NCIT-C92269','C92269','Anti-Single Stranded DNA IgG Measurement','DB-NCIT'),('DBX-NCIT-C92270','C92270','Extractable Nuclear Antigen Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92271','C92271','Hepatitis A Virus Antibody IgM Measurement','DB-NCIT'),('DBX-NCIT-C92272','C92272','Hepatitis G RNA Measurement','DB-NCIT'),('DBX-NCIT-C92273','C92273','Influenza A H1N1 Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92274','C92274','Influenza A Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92275','C92275','Legionella pneumophila Antigen Measurement','DB-NCIT'),('DBX-NCIT-C92276','C92276','Legionella pneumophila IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92277','C92277','Legionella pneumophila IgG IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92278','C92278','Legionella pneumophila IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92279','C92279','Mycobacterium tuberculosis Nucleic Acid Measurement','DB-NCIT'),('DBX-NCIT-C92280','C92280','Myeloperoxidase Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92281','C92281','Smith Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92282','C92282','Streptolysin O Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92283','C92283','Type I Myeloblasts Measurement','DB-NCIT'),('DBX-NCIT-C92284','C92284','Type II Myeloblasts Measurement','DB-NCIT'),('DBX-NCIT-C92285','C92285','Type III Myeloblasts Measurement','DB-NCIT'),('DBX-NCIT-C92286','C92286','Acyl Coenzyme A Oxidase Measurement','DB-NCIT'),('DBX-NCIT-C92287','C92287','Bone Specific Alkaline Phosphatase Measurement','DB-NCIT'),('DBX-NCIT-C92288','C92288','Carnitine Acetyl Transferase Measurement','DB-NCIT'),('DBX-NCIT-C92289','C92289','Cholinesterase Measurement','DB-NCIT'),('DBX-NCIT-C92290','C92290','Cystatin C Measurement','DB-NCIT'),('DBX-NCIT-C92291','C92291','Monoclonal Protein Measurement','DB-NCIT'),('DBX-NCIT-C92292','C92292','Tryptase Measurement','DB-NCIT'),('DBX-NCIT-C92293','C92293','Apolipoprotein E4 Measurement','DB-NCIT'),('DBX-NCIT-C92294','C92294','Beta Globulin to Total Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92295','C92295','Gamma Globulin to Total Protein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C92296','C92296','Erythrocyte Cell Morphology','DB-NCIT'),('DBX-NCIT-C92297','C92297','Leukocyte Cell Morphology','DB-NCIT'),('DBX-NCIT-C92298','C92298','Neisseria gonorrhoeae Screening','DB-NCIT'),('DBX-NCIT-C92299','C92299','Alcian Blue Staining Method','DB-NCIT'),('DBX-NCIT-C92300','C92300','Luxol Fast Blue and Cresyl Violet Staining Method','DB-NCIT'),('DBX-NCIT-C92301','C92301','Lead Citrate Staining Method','DB-NCIT'),('DBX-NCIT-C92302','C92302','Toluidine Blue Staining Method','DB-NCIT'),('DBX-NCIT-C92303','C92303','Uranyl Acetate Staining Method','DB-NCIT'),('DBX-NCIT-C92304','C92304','Alcian Blue and Periodic Acid Schiff Staining Method','DB-NCIT'),('DBX-NCIT-C92305','C92305','AUC Dosing to Last Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92306','C92306','AUC All Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92307','C92307','AUC All Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92308','C92308','AUC All Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92309','C92309','AUC Dosing to Last Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92310','C92310','AUC Dosing to Last Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92311','C92311','AUC Dosing to Last Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92312','C92312','AUC from T1 to T2 Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92313','C92313','AUC from T1 to T2 Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92314','C92314','AUC from T1 to T2 Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92315','C92315','AUC from T1 to T2 Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92316','C92316','AUC Infinity Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92317','C92317','AUC Infinity Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92318','C92318','AUC Infinity Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92319','C92319','AUC Infinity Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92320','C92320','AUC Infinity Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92321','C92321','AUC Infinity Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92322','C92322','AUC Over Dosing Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92323','C92323','AUC Over Dosing Interval Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92324','C92324','AUC Over Dosing Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92325','C92325','AUC Over Dosing Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92326','C92326','AUMC Dosing to Last Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92327','C92327','AUMC Dosing to Last Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92328','C92328','AUMC Dosing to Last Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92329','C92329','AUMC Dosing to Last Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92330','C92330','AUMC Infinity Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92331','C92331','AUMC Infinity Observed Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92332','C92332','AUMC Infinity Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92333','C92333','AUMC Infinity Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92334','C92334','AUMC Infinity Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92335','C92335','AUMC Infinity Predicted Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92336','C92336','AUMC Infinity Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92337','C92337','AUMC Infinity Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92338','C92338','AUMC Over Dosing Interval Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92339','C92339','AUMC Over Dosing Interval Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92340','C92340','AUMC Over Dosing Interval Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92341','C92341','AUMC Over Dosing Interval Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92342','C92342','AURC All Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92343','C92343','AURC All Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92344','C92344','AURC All Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92345','C92345','AURC All Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92346','C92346','AURC Dosing to Last Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92347','C92347','AURC Dosing to Last Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92348','C92348','AURC Dosing to Last Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92349','C92349','AURC Dosing to Last Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92350','C92350','AURC from T1 to T2 Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92351','C92351','AURC from T1 to T2 Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92352','C92352','AURC from T1 to T2 Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92353','C92353','AURC from T1 to T2 Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92354','C92354','AURC Infinity Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92355','C92355','AURC Infinity Observed Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92356','C92356','AURC Infinity Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92357','C92357','AURC Infinity Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92358','C92358','AURC Infinity Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92359','C92359','AURC Infinity Predicted Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92360','C92360','AURC Infinity Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92361','C92361','AURC Infinity Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92362','C92362','AUC All Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92367','C92367','Average Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92368','C92368','Average Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92369','C92369','Average Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92370','C92370','Average Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92371','C92371','Maximum Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92372','C92372','Maximum Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92373','C92373','Maximum Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92374','C92374','Minimum Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92375','C92375','Minimum Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92376','C92376','Minimum Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92377','C92377','Minimum Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92383','C92383','Initial Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92384','C92384','Initial Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92385','C92385','Initial Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92386','C92386','Initial Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92387','C92387','Last Concentration Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92388','C92388','Last Concentration Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92389','C92389','Last Concentration Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92390','C92390','Last Concentration Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92391','C92391','Last Measurable Excretion Rate Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92392','C92392','Last Measurable Excretion Rate Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92393','C92393','Last Measurable Excretion Rate Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92394','C92394','Last Measurable Excretion Rate Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92395','C92395','Maximum Observed Excretion Rate Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92396','C92396','Maximum Observed Excretion Rate Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92397','C92397','Maximum Observed Excretion Rate Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92398','C92398','Maximum Observed Excretion Rate Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92399','C92399','Total Clearance Observed by Fraction Dose Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92400','C92400','Total Clearance Observed by Fraction Dose Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92401','C92401','Total Clearance Observed by Fraction Dose Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92402','C92402','Total Clearance Observed by Fraction Dose Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92403','C92403','Total Clearance Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92404','C92404','Total Clearance Observed Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92405','C92405','Total Clearance Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92406','C92406','Total Clearance Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92407','C92407','Volume of Distribution Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92408','C92408','Volume of Distribution Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92409','C92409','Volume of Distribution Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92410','C92410','Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92411','C92411','Volume of Distribution of Fraction Dose Observed Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92412','C92412','Volume of Distribution of Fraction Dose Observed Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92417','C92417','Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92418','C92418','Total Clearance Predicted by Fraction Dose Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92419','C92419','Total Clearance Predicted by Fraction Dose Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92420','C92420','Total Clearance Predicted by Fraction Dose Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92421','C92421','Total Clearance Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92422','C92422','Total Clearance Predicted Normalized by Dose','DB-NCIT'),('DBX-NCIT-C92423','C92423','Total Clearance Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92424','C92424','Total Clearance Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92425','C92425','Volume of Distribution Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92426','C92426','Volume of Distribution Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92427','C92427','Volume of Distribution Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92428','C92428','Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index','DB-NCIT'),('DBX-NCIT-C92429','C92429','Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area','DB-NCIT'),('DBX-NCIT-C92430','C92430','Volume of Distribution of Fraction Dose Predicted Normalized by Weight','DB-NCIT'),('DBX-NCIT-C92432','C92432','Chlamydia pneumoniae IgA Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92433','C92433','Chlamydia pneumoniae IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92514','C92514','Vascular Endothelial Growth Factor Measurement','DB-NCIT'),('DBX-NCIT-C92533','C92533','Soluble Vascular Cell Adhesion Molecule 1','DB-NCIT'),('DBX-NCIT-C92534','C92534','Hepatitis A Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92535','C92535','Hepatitis C Antibody Measurement','DB-NCIT'),('DBX-NCIT-C92541','C92541','Hepatitis A Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92542','C92542','Hepatitis B Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92543','C92543','Hepatitis C Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92544','C92544','HIV Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C92604','C92604','Patient in Body Sling','DB-NCIT'),('DBX-NCIT-C92613','C92613','Nanomole per Minute per Milliliter','DB-NCIT'),('DBX-NCIT-C92615','C92615','Kilonewton per Centimeter Squared','DB-NCIT'),('DBX-NCIT-C92616','C92616','Milliequivalent per Milliimole','DB-NCIT'),('DBX-NCIT-C92618','C92618','Unit per Millimole','DB-NCIT'),('DBX-NCIT-C9295','C9295','Mast Cell Neoplasm','DB-NCIT'),('DBX-NCIT-C93023','C93023','Newcastle Disease Virus','DB-NCIT'),('DBX-NCIT-C9305','C9305','Malignant Neoplasm','DB-NCIT'),('DBX-NCIT-C9309','C9309','Seminoma','DB-NCIT'),('DBX-NCIT-C93179','C93179','Upper Lobe of Kidney','DB-NCIT'),('DBX-NCIT-C93180','C93180','Lower Lobe of Kidney','DB-NCIT'),('DBX-NCIT-C9325','C9325','Adrenal Cortex Carcinoma','DB-NCIT'),('DBX-NCIT-C93324','C93324','Hepatitis D Virus','DB-NCIT'),('DBX-NCIT-C9344','C9344','Pineoblastoma','DB-NCIT'),('DBX-NCIT-C9360','C9360','Lymphoblastic Lymphoma','DB-NCIT'),('DBX-NCIT-C9385','C9385','Renal Cell Carcinoma','DB-NCIT'),('DBX-NCIT-C94393','C94393','Rostral','DB-NCIT'),('DBX-NCIT-C94520','C94520','Target Lesion Identification','DB-NCIT'),('DBX-NCIT-C94521','C94521','Non-Target Lesion Identification','DB-NCIT'),('DBX-NCIT-C94522','C94522','New Lesion Identification','DB-NCIT'),('DBX-NCIT-C94523','C94523','Tumor Identification','DB-NCIT'),('DBX-NCIT-C94525','C94525','Matted Tumor Mass Present','DB-NCIT'),('DBX-NCIT-C94527','C94527','Photography','DB-NCIT'),('DBX-NCIT-C94528','C94528','Panendoscopy','DB-NCIT'),('DBX-NCIT-C94530','C94530','Radiologist 1','DB-NCIT'),('DBX-NCIT-C94531','C94531','Radiologist 2','DB-NCIT'),('DBX-NCIT-C94532','C94532','Reader 1','DB-NCIT'),('DBX-NCIT-C94533','C94533','Reader 2','DB-NCIT'),('DBX-NCIT-C94534','C94534','Response in Target Lesion','DB-NCIT'),('DBX-NCIT-C94535','C94535','Response in Non-Target Lesion','DB-NCIT'),('DBX-NCIT-C94536','C94536','Best Overall Response','DB-NCIT'),('DBX-NCIT-C94636','C94636','Subtenon Route of Administration','DB-NCIT'),('DBX-NCIT-C9477','C9477','Anaplastic Astrocytoma','DB-NCIT'),('DBX-NCIT-C94862','C94862','Attenuation Correction','DB-NCIT'),('DBX-NCIT-C94908','C94908','Hounsfield Unit','DB-NCIT'),('DBX-NCIT-C94982','C94982','Short Axis','DB-NCIT'),('DBX-NCIT-C95007','C95007','Effective Half-life','DB-NCIT'),('DBX-NCIT-C95087','C95087','Death Diagnosis Domain','DB-NCIT'),('DBX-NCIT-C95088','C95088','Developmental Milestone Domain','DB-NCIT'),('DBX-NCIT-C95095','C95095','Microscopic Findings Domain','DB-NCIT'),('DBX-NCIT-C95098','C95098','Respiratory Domain','DB-NCIT'),('DBX-NCIT-C95100','C95100','Tumor Findings Domain','DB-NCIT'),('DBX-NCIT-C95101','C95101','Trial Paths Domain','DB-NCIT'),('DBX-NCIT-C95103','C95103','Trial Sets Domain','DB-NCIT'),('DBX-NCIT-C95109','C95109','Hair or Fur Cover','DB-NCIT'),('DBX-NCIT-C95110','C95110','Consistency','DB-NCIT'),('DBX-NCIT-C95120','C95120','CDISC SDTM Physical Properties Test Name Terminology','DB-NCIT'),('DBX-NCIT-C95121','C95121','CDISC SDTM Physical Properties Test Code Terminology','DB-NCIT'),('DBX-NCIT-C95938','C95938','Double-Stranded RNA','DB-NCIT'),('DBX-NCIT-C95940','C95940','Genomic DNA','DB-NCIT'),('DBX-NCIT-C95941','C95941','Nuclear DNA','DB-NCIT'),('DBX-NCIT-C95942','C95942','Transposon','DB-NCIT'),('DBX-NCIT-C95943','C95943','Ribosomal RNA Gene','DB-NCIT'),('DBX-NCIT-C95950','C95950','Signal Recognition Particle RNA','DB-NCIT'),('DBX-NCIT-C95951','C95951','7SK Small Nuclear RNA','DB-NCIT'),('DBX-NCIT-C95952','C95952','Guide RNA','DB-NCIT'),('DBX-NCIT-C95953','C95953','Piwi-Interacting RNA','DB-NCIT'),('DBX-NCIT-C95954','C95954','Transfer-Messenger RNA','DB-NCIT'),('DBX-NCIT-C96209','C96209','Femoral Shaft','DB-NCIT'),('DBX-NCIT-C96524','C96524','Orthopoxvirus','DB-NCIT'),('DBX-NCIT-C96527','C96527','Variola Virus','DB-NCIT'),('DBX-NCIT-C96559','C96559','Acetylcholine Receptor Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96560','C96560','Acetylcholinesterase Measurement','DB-NCIT'),('DBX-NCIT-C96561','C96561','Adjudicator','DB-NCIT'),('DBX-NCIT-C96562','C96562','Alpha Fetoprotein L1 Measurement','DB-NCIT'),('DBX-NCIT-C96563','C96563','Alpha Fetoprotein L2 Measurement','DB-NCIT'),('DBX-NCIT-C96564','C96564','Alpha Fetoprotein L3 Measurement','DB-NCIT'),('DBX-NCIT-C96565','C96565','Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96566','C96566','Average Metabolic Standard Uptake Value','DB-NCIT'),('DBX-NCIT-C96567','C96567','Basophilic Stippling Measurement','DB-NCIT'),('DBX-NCIT-C96568','C96568','Beta-Hydroxybutyrate Measurement','DB-NCIT'),('DBX-NCIT-C96569','C96569','Biological Aunt','DB-NCIT'),('DBX-NCIT-C96570','C96570','Biological Brother','DB-NCIT'),('DBX-NCIT-C96571','C96571','Biological Cousin','DB-NCIT'),('DBX-NCIT-C96572','C96572','Biological Father','DB-NCIT'),('DBX-NCIT-C96573','C96573','Biological Grandfather','DB-NCIT'),('DBX-NCIT-C96574','C96574','Biological Grandmother','DB-NCIT'),('DBX-NCIT-C96575','C96575','Biological Maternal Aunt','DB-NCIT'),('DBX-NCIT-C96576','C96576','Biological Maternal Cousin','DB-NCIT'),('DBX-NCIT-C96577','C96577','Biological Maternal Grandfather','DB-NCIT'),('DBX-NCIT-C96578','C96578','Biological Maternal Grandmother','DB-NCIT'),('DBX-NCIT-C96579','C96579','Biological Maternal Uncle','DB-NCIT'),('DBX-NCIT-C96580','C96580','Biological Mother','DB-NCIT'),('DBX-NCIT-C96581','C96581','Biological Paternal Aunt','DB-NCIT'),('DBX-NCIT-C96582','C96582','Biological Paternal Cousin','DB-NCIT'),('DBX-NCIT-C96583','C96583','Biological Paternal Grandfather','DB-NCIT'),('DBX-NCIT-C96584','C96584','Biological Paternal Grandmother','DB-NCIT'),('DBX-NCIT-C96585','C96585','Biological Paternal Uncle','DB-NCIT'),('DBX-NCIT-C96586','C96586','Biological Sister','DB-NCIT'),('DBX-NCIT-C96587','C96587','Biological Uncle','DB-NCIT'),('DBX-NCIT-C96588','C96588','Broad Casts Measurement','DB-NCIT'),('DBX-NCIT-C96589','C96589','Calcium Clearance Measurement','DB-NCIT'),('DBX-NCIT-C96590','C96590','Calcium Sulphate Measurement','DB-NCIT'),('DBX-NCIT-C96591','C96591','Carboxyhemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C96592','C96592','Circulating Endothelial Cell Count','DB-NCIT'),('DBX-NCIT-C96593','C96593','Circulating Tumor Cell Count','DB-NCIT'),('DBX-NCIT-C96594','C96594','Clarity Measurement','DB-NCIT'),('DBX-NCIT-C96595','C96595','Cyclic Citrullinated Peptide Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96596','C96596','Cytomegalovirus IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96597','C96597','Cytomegalovirus IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96598','C96598','Eccentrocyte Count','DB-NCIT'),('DBX-NCIT-C96599','C96599','Ehrlich Unit','DB-NCIT'),('DBX-NCIT-C96600','C96600','Epstein-Barr Capsid IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96601','C96601','Epstein-Barr Capsid IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96602','C96602','Epstein-Barr Early Antigen Measurement','DB-NCIT'),('DBX-NCIT-C96603','C96603','Epstein-Barr Nuclear Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96604','C96604','Epstein-Barr Nuclear Antigen Measurement','DB-NCIT'),('DBX-NCIT-C96605','C96605','Erythrocyte Ghost Count','DB-NCIT'),('DBX-NCIT-C96606','C96606','Neurologist 2','DB-NCIT'),('DBX-NCIT-C96608','C96608','Non-Radiological Progression','DB-NCIT'),('DBX-NCIT-C96610','C96610','N-Terminal ProB-type Natriuretic Peptide Measurement','DB-NCIT'),('DBX-NCIT-C96611','C96611','Oncologist 1','DB-NCIT'),('DBX-NCIT-C96612','C96612','Oncologist 2','DB-NCIT'),('DBX-NCIT-C96613','C96613','Overall Response','DB-NCIT'),('DBX-NCIT-C96614','C96614','Oxygen Capacity Measurement','DB-NCIT'),('DBX-NCIT-C96616','C96616','Oxyhemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C96617','C96617','Parvovirus B19 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96618','C96618','Parvovirus B19 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96619','C96619','Per High Powered Field','DB-NCIT'),('DBX-NCIT-C96620','C96620','Per Low Powered Field','DB-NCIT'),('DBX-NCIT-C96621','C96621','Percent Change From Baseline','DB-NCIT'),('DBX-NCIT-C96622','C96622','Percent Change From Nadir','DB-NCIT'),('DBX-NCIT-C96623','C96623','Phospholipid Measurement','DB-NCIT'),('DBX-NCIT-C96624','C96624','Platelet Clumps Count','DB-NCIT'),('DBX-NCIT-C96625','C96625','Procollagen 1 N-Terminal Propeptide Measurement','DB-NCIT'),('DBX-NCIT-C96626','C96626','Prothrombin Measurement','DB-NCIT'),('DBX-NCIT-C96627','C96627','Radiodensity','DB-NCIT'),('DBX-NCIT-C96628','C96628','Reptilase Time Measurement','DB-NCIT'),('DBX-NCIT-C96629','C96629','Sulfated DHEA Measurement','DB-NCIT'),('DBX-NCIT-C96630','C96630','Sum of Areas','DB-NCIT'),('DBX-NCIT-C96631','C96631','Sum of Diameters','DB-NCIT'),('DBX-NCIT-C96632','C96632','Sum of Longest Diameters','DB-NCIT'),('DBX-NCIT-C96633','C96633','Sum of Longest Perpendiculars','DB-NCIT'),('DBX-NCIT-C96634','C96634','Sum of Viable Diameters','DB-NCIT'),('DBX-NCIT-C96635','C96635','Sum of Volumes','DB-NCIT'),('DBX-NCIT-C96636','C96636','Target Cell Count','DB-NCIT'),('DBX-NCIT-C96638','C96638','Thyroperoxidase Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96639','C96639','Thyroperoxidase Measurement','DB-NCIT'),('DBX-NCIT-C96640','C96640','Total Body Radiography','DB-NCIT'),('DBX-NCIT-C96641','C96641','Toxic Granulation Measurement','DB-NCIT'),('DBX-NCIT-C96642','C96642','Tumor Split','DB-NCIT'),('DBX-NCIT-C96643','C96643','Tumor Status','DB-NCIT'),('DBX-NCIT-C96644','C96644','Unequivocal Progression','DB-NCIT'),('DBX-NCIT-C96645','C96645','Urea to Creatinine Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96646','C96646','Viable Tumor Diameter','DB-NCIT'),('DBX-NCIT-C96648','C96648','Fat Measurement','DB-NCIT'),('DBX-NCIT-C96649','C96649','Fibrinogen Equivalent Unit','DB-NCIT'),('DBX-NCIT-C96650','C96650','Fibroblast Growth Factor 23 Measurement','DB-NCIT'),('DBX-NCIT-C96651','C96651','Giant Neutrophil Count','DB-NCIT'),('DBX-NCIT-C96652','C96652','Glucose Clearance Measurement','DB-NCIT'),('DBX-NCIT-C96653','C96653','Glutamic Acid Decarboxylase Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96654','C96654','Granulocyte Count','DB-NCIT'),('DBX-NCIT-C96655','C96655','Half-brother with Father as Common Parent','DB-NCIT'),('DBX-NCIT-C96656','C96656','Half-brother with Mother as Common Parent','DB-NCIT'),('DBX-NCIT-C96657','C96657','Half-sister with Father as Common Parent','DB-NCIT'),('DBX-NCIT-C96658','C96658','Half-sister with Mother as Common Parent','DB-NCIT'),('DBX-NCIT-C96659','C96659','Hemosiderin Measurement','DB-NCIT'),('DBX-NCIT-C96660','C96660','Hepatitis B Virus Core Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96661','C96661','Hepatitis B Virus Core IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96662','C96662','Hepatitis B Virus e Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96663','C96663','Hepatitis B Virus e Antigen Measurement','DB-NCIT'),('DBX-NCIT-C96664','C96664','Hepatitis D Virus Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96665','C96665','Hepatitis E Virus IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96666','C96666','Herpes Simplex Virus 1 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96667','C96667','Herpes Simplex Virus 2 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96668','C96668','Hexokinase Measurement','DB-NCIT'),('DBX-NCIT-C96669','C96669','Hyperchromia Measurement','DB-NCIT'),('DBX-NCIT-C96670','C96670','Immature Basophil Count','DB-NCIT'),('DBX-NCIT-C96671','C96671','Immature Basophil to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96672','C96672','Immature Cell Count','DB-NCIT'),('DBX-NCIT-C96673','C96673','Immature Eosinophil Count','DB-NCIT'),('DBX-NCIT-C96674','C96674','Immature Eosinophil to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96675','C96675','Immature Granulocyte Count','DB-NCIT'),('DBX-NCIT-C96676','C96676','Immature Monocyte Count','DB-NCIT'),('DBX-NCIT-C96677','C96677','Immature Monocyte to Leukocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96678','C96678','Immature Neutrophil Count','DB-NCIT'),('DBX-NCIT-C96679','C96679','Immature Plasma Cell Count','DB-NCIT'),('DBX-NCIT-C96680','C96680','Immature Plasma Cell to Lymphocyte Ratio Measurement','DB-NCIT'),('DBX-NCIT-C96681','C96681','Inhibin B Measurement','DB-NCIT'),('DBX-NCIT-C96682','C96682','Kurloff Cells Measurement','DB-NCIT'),('DBX-NCIT-C96683','C96683','Liver Kidney Microsomal Type 1 Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96684','C96684','Longest Diameter','DB-NCIT'),('DBX-NCIT-C96685','C96685','Longest Perpendicular','DB-NCIT'),('DBX-NCIT-C96686','C96686','Mean Platelet Component Measurement','DB-NCIT'),('DBX-NCIT-C96687','C96687','Median Fluorescence Intensity','DB-NCIT'),('DBX-NCIT-C96688','C96688','Megakaryocyte Count','DB-NCIT'),('DBX-NCIT-C96689','C96689','Methemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C96690','C96690','Methylmalonic Acid Measurement','DB-NCIT'),('DBX-NCIT-C96691','C96691','Molecule of Equivalent Soluble Fluorochrome','DB-NCIT'),('DBX-NCIT-C96692','C96692','Neurologist 1','DB-NCIT'),('DBX-NCIT-C96695','C96695','AUC Infinity Observed Normalized by Dose','DB-NCIT'),('DBX-NCIT-C96696','C96696','Dilute Russell\'s Viper Venom Time Measurement','DB-NCIT'),('DBX-NCIT-C96697','C96697','Herpes Simplex Virus 1/2 IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96698','C96698','Herpes Simplex Virus 1/2 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C96700','C96700','Non Complete Response/Non Progressive Disease','DB-NCIT'),('DBX-NCIT-C96777','C96777','CDISC SDTM Medical Evaluator Terminology','DB-NCIT'),('DBX-NCIT-C96778','C96778','CDISC SDTM Tumor or Lesion Properties Test Name Terminology','DB-NCIT'),('DBX-NCIT-C96779','C96779','CDISC SDTM Tumor or Lesion Properties Test Code Terminology','DB-NCIT'),('DBX-NCIT-C96780','C96780','CDISC SDTM Tumor and Lesion Identification Result Terminology','DB-NCIT'),('DBX-NCIT-C96781','C96781','CDISC SDTM Tumor Response Assessment Test Name Terminology','DB-NCIT'),('DBX-NCIT-C96782','C96782','CDISC SDTM Tumor Response Assessment Test Code Terminology','DB-NCIT'),('DBX-NCIT-C96783','C96783','CDISC SDTM Tumor Identification Test Name Terminology','DB-NCIT'),('DBX-NCIT-C96784','C96784','CDISC SDTM Tumor Identification Test Code Terminology','DB-NCIT'),('DBX-NCIT-C96785','C96785','CDISC SDTM Tumor Response Result Terminology','DB-NCIT'),('DBX-NCIT-C96805','C96805','Peripheral Intrahepatic Cholangiocarcinoma','DB-NCIT'),('DBX-NCIT-C97156','C97156','Yellow Fever Virus','DB-NCIT'),('DBX-NCIT-C97157','C97157','Influenza C Virus','DB-NCIT'),('DBX-NCIT-C97197','C97197','Caplet Dosage Form','DB-NCIT'),('DBX-NCIT-C97333','C97333','Locus Coeruleus','DB-NCIT'),('DBX-NCIT-C97335','C97335','Raphe Nuclei','DB-NCIT'),('DBX-NCIT-C97338','C97338','Entorhinal Cortex','DB-NCIT'),('DBX-NCIT-C97339','C97339','Primary Motor Cortex','DB-NCIT'),('DBX-NCIT-C97340','C97340','Primary Visual Cortex','DB-NCIT'),('DBX-NCIT-C97341','C97341','Pars Compacta','DB-NCIT'),('DBX-NCIT-C97342','C97342','Nucleus of Diagonal Band','DB-NCIT'),('DBX-NCIT-C97351','C97351','South Sudan','DB-NCIT'),('DBX-NCIT-C97925','C97925','Para-Spinal Ganglion','DB-NCIT'),('DBX-NCIT-C98182','C98182','Epitrochlear Lymph Node','DB-NCIT'),('DBX-NCIT-C98183','C98183','Femoral Lymph Node','DB-NCIT'),('DBX-NCIT-C98187','C98187','Pulmonary Hilar Lymph Node','DB-NCIT'),('DBX-NCIT-C98188','C98188','Occipital Lymph Node','DB-NCIT'),('DBX-NCIT-C98189','C98189','Retroperitoneal Lymph Node','DB-NCIT'),('DBX-NCIT-C98388','C98388','Interventional Study','DB-NCIT'),('DBX-NCIT-C98703','C98703','Actual Subject Number','DB-NCIT'),('DBX-NCIT-C98704','C98704','Adaptive Design','DB-NCIT'),('DBX-NCIT-C98705','C98705','Adenovirus Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C98706','C98706','Anti-Factor Xa Activity Measurement','DB-NCIT'),('DBX-NCIT-C98708','C98708','Benign Histiocytoma','DB-NCIT'),('DBX-NCIT-C98709','C98709','Benign Melanocytoma','DB-NCIT'),('DBX-NCIT-C98710','C98710','BK Virus Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C98712','C98712','Cerebral Subcortex','DB-NCIT'),('DBX-NCIT-C98714','C98714','Clinical Trial Registry Identifier','DB-NCIT'),('DBX-NCIT-C98715','C98715','Confirmed Response Minimum Duration','DB-NCIT'),('DBX-NCIT-C98716','C98716','Cytomegalovirus Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C98717','C98717','Data Cutoff Date','DB-NCIT'),('DBX-NCIT-C98718','C98718','Data Cutoff Date Description','DB-NCIT'),('DBX-NCIT-C98719','C98719','DNA Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C98720','C98720','Eosinophils to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98721','C98721','Epstein-Barr Virus Viral Load Measurement','DB-NCIT'),('DBX-NCIT-C98722','C98722','Expanded Access Study','DB-NCIT'),('DBX-NCIT-C98723','C98723','Experimental Organism Pituitary Gland Adenoma','DB-NCIT'),('DBX-NCIT-C98724','C98724','Exploratory Outcome Measure','DB-NCIT'),('DBX-NCIT-C98725','C98725','Factor IX Measurement','DB-NCIT'),('DBX-NCIT-C98726','C98726','Factor V Measurement','DB-NCIT'),('DBX-NCIT-C98727','C98727','Factor X Measurement','DB-NCIT'),('DBX-NCIT-C98728','C98728','Fat Droplet Measurement','DB-NCIT'),('DBX-NCIT-C98729','C98729','Food Effect Study','DB-NCIT'),('DBX-NCIT-C98730','C98730','Free Kappa Light Chain Measurement','DB-NCIT'),('DBX-NCIT-C98731','C98731','Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98732','C98732','Free Lambda Light Chain Measurement','DB-NCIT'),('DBX-NCIT-C98734','C98734','Glomerular Filtration Rate Adjusted for BSA','DB-NCIT'),('DBX-NCIT-C98735','C98735','Glomerular Filtration Rate from Creatinine Adjusted for BSA','DB-NCIT'),('DBX-NCIT-C98736','C98736','Glomerular Filtration Rate from Cystatin C Adjusted for BSA','DB-NCIT'),('DBX-NCIT-C98737','C98737','Healthy Subject Indicator','DB-NCIT'),('DBX-NCIT-C98738','C98738','Herpes Simplex Virus 1 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98739','C98739','Herpes Simplex Virus 2 IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98740','C98740','Human Anti-Sheep IgE Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98741','C98741','Human Anti-Sheep IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98742','C98742','Human Anti-Sheep IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98743','C98743','Hundred Thousand per High Powered Field','DB-NCIT'),('DBX-NCIT-C98744','C98744','Icteric Specimen','DB-NCIT'),('DBX-NCIT-C98745','C98745','Immunoglobulin D Measurement','DB-NCIT'),('DBX-NCIT-C98746','C98746','Intervention Model','DB-NCIT'),('DBX-NCIT-C98747','C98747','Intervention Type','DB-NCIT'),('DBX-NCIT-C98748','C98748','Inulin Clearance','DB-NCIT'),('DBX-NCIT-C98749','C98749','Iothalamate Clearance','DB-NCIT'),('DBX-NCIT-C98750','C98750','Iothalamate Clearance Adjusted for BSA','DB-NCIT'),('DBX-NCIT-C98751','C98751','Lymphocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98752','C98752','Megakaryoblast Cell Count','DB-NCIT'),('DBX-NCIT-C98753','C98753','Megakaryoblast to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98754','C98754','Metamyelocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98755','C98755','Milliliter per Centimeter of Water','DB-NCIT'),('DBX-NCIT-C98756','C98756','Million DNA Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C98757','C98757','Million International Units per Milliliter','DB-NCIT'),('DBX-NCIT-C98758','C98758','Million per Gram','DB-NCIT'),('DBX-NCIT-C98759','C98759','Million per High Powered Field','DB-NCIT'),('DBX-NCIT-C98760','C98760','Million RNA Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C98761','C98761','Myeloblast to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98762','C98762','Natural Killer Cell Count','DB-NCIT'),('DBX-NCIT-C98763','C98763','Neutrophil to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98764','C98764','Normoblast to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98767','C98767','Pancreatic Amylase Measurement','DB-NCIT'),('DBX-NCIT-C98768','C98768','Pharmacological Class of Investigational Therapy','DB-NCIT'),('DBX-NCIT-C98769','C98769','Physical Medical Procedure','DB-NCIT'),('DBX-NCIT-C98770','C98770','Planned Country of Investigational Site','DB-NCIT'),('DBX-NCIT-C98771','C98771','Planned Number of Arms','DB-NCIT'),('DBX-NCIT-C98772','C98772','Primary Outcome Measure','DB-NCIT'),('DBX-NCIT-C98773','C98773','Promyelocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98774','C98774','Prothrombin Activity Measurement','DB-NCIT'),('DBX-NCIT-C98775','C98775','Randomization Quotient','DB-NCIT'),('DBX-NCIT-C98776','C98776','Reticulocyte Hemoglobin Measurement','DB-NCIT'),('DBX-NCIT-C98779','C98779','Run-in Period','DB-NCIT'),('DBX-NCIT-C98780','C98780','Salivary Amylase Measurement','DB-NCIT'),('DBX-NCIT-C98781','C98781','Secondary Outcome Measure','DB-NCIT'),('DBX-NCIT-C98783','C98783','Stable Disease Minimum Duration','DB-NCIT'),('DBX-NCIT-C98785','C98785','Subscapular Skinfold Thickness','DB-NCIT'),('DBX-NCIT-C98786','C98786','Ten Million per Liter','DB-NCIT'),('DBX-NCIT-C98787','C98787','Ten Thousand per High Powered Field','DB-NCIT'),('DBX-NCIT-C98788','C98788','Thousand DNA Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C98789','C98789','Thousand per High Powered Field','DB-NCIT'),('DBX-NCIT-C98790','C98790','Thousand RNA Copies per Milliliter','DB-NCIT'),('DBX-NCIT-C98791','C98791','Tolerability Study','DB-NCIT'),('DBX-NCIT-C98792','C98792','Transferrin Saturation Measurement','DB-NCIT'),('DBX-NCIT-C98793','C98793','Triceps Skinfold Thickness','DB-NCIT'),('DBX-NCIT-C98794','C98794','Undetermined Sertoli Cell Tumor','DB-NCIT'),('DBX-NCIT-C98795','C98795','Varicella Zoster Virus IgA Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98796','C98796','Varicella Zoster Virus IgG Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98797','C98797','Varicella Zoster Virus IgM Antibody Measurement','DB-NCIT'),('DBX-NCIT-C98798','C98798','Ventrolateral','DB-NCIT'),('DBX-NCIT-C98799','C98799','von Willebrand Factor Measurement','DB-NCIT'),('DBX-NCIT-C98800','C98800','Zymbal\'s Gland Adenoma','DB-NCIT'),('DBX-NCIT-C98801','C98801','Zymbal\'s Gland Carcinoma','DB-NCIT'),('DBX-NCIT-C98849','C98849','Five Times Daily','DB-NCIT'),('DBX-NCIT-C98850','C98850','Five Times Monthly','DB-NCIT'),('DBX-NCIT-C98851','C98851','Five Times Yearly','DB-NCIT'),('DBX-NCIT-C98852','C98852','Four Times Monthly','DB-NCIT'),('DBX-NCIT-C98853','C98853','Four Times Yearly','DB-NCIT'),('DBX-NCIT-C98854','C98854','Seven Times Weekly','DB-NCIT'),('DBX-NCIT-C98855','C98855','Six Times Daily','DB-NCIT'),('DBX-NCIT-C98856','C98856','Six Times Monthly','DB-NCIT'),('DBX-NCIT-C98857','C98857','Six Times Weekly','DB-NCIT'),('DBX-NCIT-C98858','C98858','Six Times Yearly','DB-NCIT'),('DBX-NCIT-C98859','C98859','Three Times Monthly','DB-NCIT'),('DBX-NCIT-C98860','C98860','Three Times Yearly','DB-NCIT'),('DBX-NCIT-C98861','C98861','Two Times Yearly','DB-NCIT'),('DBX-NCIT-C98862','C98862','Activated PTT/Standard Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98865','C98865','Basophil to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98866','C98866','Granulocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98867','C98867','Megakaryocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98868','C98868','Myelocyte to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98869','C98869','Plasma Cell to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98870','C98870','Pronormoblast to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C98872','C98872','Monocytes to Total Cell Ratio Measurement','DB-NCIT'),('DBX-NCIT-C99073','C99073','CDISC SDTM Laterality Terminology','DB-NCIT'),('DBX-NCIT-C99074','C99074','CDISC SDTM Directionality Terminology','DB-NCIT'),('DBX-NCIT-C99075','C99075','CDISC SDTM Portion/Totality Terminology','DB-NCIT'),('DBX-NCIT-C99076','C99076','CDISC SDTM Intervention Model Terminology','DB-NCIT'),('DBX-NCIT-C99077','C99077','CDISC SDTM Study Type Terminology','DB-NCIT'),('DBX-NCIT-C99078','C99078','CDISC SDTM Intervention Type Terminology','DB-NCIT'),('DBX-NCIT-C99079','C99079','CDISC SDTM Epoch Terminology','DB-NCIT'),('DBX-NCIT-C99148','C99148','Perianal Region','DB-NCIT'),('DBX-NCIT-C99158','C99158','Clinical Study Follow-up','DB-NCIT'),('DBX-NCIT-C99285','C99285','Model Number','DB-NCIT'),('DBX-NCIT-C99481','C99481','Pyrosequencing','DB-NCIT'),('DBX-NCIT-C99507','C99507','Mildly Abnormal Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99508','C99508','Moderately Abnormal Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99509','C99509','Severely Abnormal Ventricular Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99512','C99512','Hyperdynamic Ventricular Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99513','C99513','Normal Ventricular Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99521','C99521','Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99524','C99524','Left Ventricular Ejection Fraction','DB-NCIT'),('DBX-NCIT-C99528','C99528','Failure of Cardiac Pacemaker to Pace','DB-NCIT'),('DBX-NCIT-C99531','C99531','Primary Cause of Death','DB-NCIT'),('DBX-NCIT-C99535','C99535','Intravascular Ultrasound','DB-NCIT'),('DBX-NCIT-C99906','C99906','Abandoned Lead','DB-NCIT'),('DBX-NCIT-C99907','C99907','Ablation of Cardiac Accessory Pathway','DB-NCIT'),('DBX-NCIT-C99908','C99908','Ablation of Cardiac Atrioventricular Node','DB-NCIT'),('DBX-NCIT-C99909','C99909','Federal Health Care Facility','DB-NCIT'),('DBX-NCIT-C99910','C99910','Hospice Care at Medical Facility','DB-NCIT'),('DBX-NCIT-C99911','C99911','Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital','DB-NCIT'),('DBX-NCIT-C99912','C99912','Intermediate Care Facility','DB-NCIT'),('DBX-NCIT-C99913','C99913','Nursing Facility Certified Under Medicaid but Not Certified Under Medicare','DB-NCIT'),('DBX-NCIT-C99914','C99914','Skilled Nursing Facility with Medicare Certification in Anticipation of Covered Skilled Care','DB-NCIT'),('DBX-NCIT-C99915','C99915','Aortic Anastomosis of Graft','DB-NCIT'),('DBX-NCIT-C99916','C99916','Aortic Balloon Valvotomy','DB-NCIT'),('DBX-NCIT-C99917','C99917','Atypical Coronary Artery Disease Symptom','DB-NCIT'),('DBX-NCIT-C99918','C99918','Body of Graft','DB-NCIT'),('DBX-NCIT-C99919','C99919','Candidate to Receive Cardiac Transplant','DB-NCIT'),('DBX-NCIT-C99920','C99920','Cardiac Arrest Prior to Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99921','C99921','Cardiac Atrial Pacing Malfunction','DB-NCIT'),('DBX-NCIT-C99922','C99922','Cardiac Defibrillator Issue','DB-NCIT'),('DBX-NCIT-C99923','C99923','Cardiac Defibrillator Malfunction','DB-NCIT'),('DBX-NCIT-C99924','C99924','Cardiac Device Conductor Failure','DB-NCIT'),('DBX-NCIT-C99925','C99925','Cardiac Device Generator is Being Replaced at Time of Lead Revision','DB-NCIT'),('DBX-NCIT-C99926','C99926','Cardiac Device Oversensing','DB-NCIT'),('DBX-NCIT-C99927','C99927','Cardiac Device Oversensing with Shock or Anti-Tachycardia Pacing','DB-NCIT'),('DBX-NCIT-C99928','C99928','Cardiac Device Oversensing without Shock or Anti-Tachycardia Pacing','DB-NCIT'),('DBX-NCIT-C99929','C99929','Cardiac Device Set Screw Problem','DB-NCIT'),('DBX-NCIT-C99930','C99930','Cardiac Device Undersensing','DB-NCIT'),('DBX-NCIT-C99931','C99931','Cardiac Lead Erosion','DB-NCIT'),('DBX-NCIT-C99932','C99932','Cardiac Lead Insulation Failure','DB-NCIT'),('DBX-NCIT-C99933','C99933','Cardiac Lead Position Results in Undesirable Stimulation of Diaphragm','DB-NCIT'),('DBX-NCIT-C99934','C99934','Cardiac Lead Procedure','DB-NCIT'),('DBX-NCIT-C99935','C99935','Cardiac Tricuspid Valve Repair','DB-NCIT'),('DBX-NCIT-C99936','C99936','Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding','DB-NCIT'),('DBX-NCIT-C99937','C99937','Chemical Cardioversion','DB-NCIT'),('DBX-NCIT-C99938','C99938','Chronic Total Occlusion Vessel','DB-NCIT'),('DBX-NCIT-C99939','C99939','Closure of Cardiac Atrial Septum','DB-NCIT'),('DBX-NCIT-C99940','C99940','Closure of Cardiac Ventricle Septum','DB-NCIT'),('DBX-NCIT-C99941','C99941','Co-Dominant Artery','DB-NCIT'),('DBX-NCIT-C99942','C99942','Coronary Artery Right Dominance','DB-NCIT'),('DBX-NCIT-C99943','C99943','Device Generator Malfunction','DB-NCIT'),('DBX-NCIT-C99944','C99944','Died in a Medical Facility','DB-NCIT'),('DBX-NCIT-C99945','C99945','Difficult Vascular Access','DB-NCIT'),('DBX-NCIT-C99946','C99946','Difficulty Crossing Culprit Lesion During Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99947','C99947','Donor for Cardiac Transplant','DB-NCIT'),('DBX-NCIT-C99948','C99948','Electric Cardioversion','DB-NCIT'),('DBX-NCIT-C99949','C99949','End of Expected Battery Life','DB-NCIT'),('DBX-NCIT-C99950','C99950','Endotracheal Intubation before Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99951','C99951','Extracardiac Stimulation','DB-NCIT'),('DBX-NCIT-C99953','C99953','Failure to Capture with Acceptable Safety Margin','DB-NCIT'),('DBX-NCIT-C99954','C99954','Failure to Shock with Inadequate Defibrillator Threshold Safety Margin','DB-NCIT'),('DBX-NCIT-C99955','C99955','High Coronary Artery Disease Risk','DB-NCIT'),('DBX-NCIT-C99957','C99957','Home Care','DB-NCIT'),('DBX-NCIT-C99958','C99958','Home Hospice','DB-NCIT'),('DBX-NCIT-C99959','C99959','Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care','DB-NCIT'),('DBX-NCIT-C99960','C99960','Hospital with Medicare Approved Swing Bed','DB-NCIT'),('DBX-NCIT-C99961','C99961','Immediate Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction','DB-NCIT'),('DBX-NCIT-C99962','C99962','Inserted During a Non-Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99963','C99963','Inserted During a Procedure but Prior to Percutaneous Coronary Intervention','DB-NCIT'),('DBX-NCIT-C99964','C99964','Inserted During Procedure and After Percutaneous Coronary Intervention Began','DB-NCIT'),('DBX-NCIT-C99965','C99965','Intentional Left Cardiac Atrial Appendage Occlusion Procedure','DB-NCIT'),('DBX-NCIT-C99966','C99966','Intermediate Coronary Artery Disease Risk','DB-NCIT'),('DBX-NCIT-C99968','C99968','Known Coronary Artery Disease','DB-NCIT'),('DBX-NCIT-C99969','C99969','Left Against Medical Advice','DB-NCIT'),('DBX-NCIT-C99970','C99970','Left Atrium Dimension','DB-NCIT'),('DBX-NCIT-C99971','C99971','Left Cardiac Artery Dominance','DB-NCIT'),('DBX-NCIT-C99973','C99973','Left Cardiac Ventricular Pacing Malfunction','DB-NCIT'),('DBX-NCIT-C99975','C99975','Left Cardiac Ventricular Systolic Dysfunction Evaluation','DB-NCIT'),('DBX-NCIT-C99976','C99976','Left Ventricle Dimension at End-Diastole','DB-NCIT'),('DBX-NCIT-C99977','C99977','Left Ventricular Dimension at End-Systole','DB-NCIT'),('DBX-NCIT-C99978','C99978','Low Coronary Artery Disease Risk','DB-NCIT'),('DBX-NCIT-C99980','C99980','Manufacturer Recognized a Recurring Performance Failure','DB-NCIT'),('DBX-NCIT-C99981','C99981','Mechanical Circulatory Support in Place at Start of Procedure','DB-NCIT'),('DBX-NCIT-C99982','C99982','Medical Condition or Procedure Affects Implantation Site','DB-NCIT'),('DBX-NCIT-C99983','C99983','Medical or Surgical Procedure Requiring Relocation of Lead','DB-NCIT'),('DBX-NCIT-C99984','C99984','Medicare Certified Long Term Care Hospital','DB-NCIT'),('DBX-NCIT-C99985','C99985','Mild Cardiac Valve Regurgitation','DB-NCIT'),('DBX-NCIT-C99986','C99986','Mild Cardiac Valve Stenosis','DB-NCIT'),('DBX-NCIT-C99987','C99987','Mitral Balloon Valvotomy','DB-NCIT'),('DBX-NCIT-C99988','C99988','Mitral Commissurotomy','DB-NCIT'),('DBX-NCIT-C99989','C99989','Moderate Cardiac Valve Regurgitation','DB-NCIT'),('DBX-NCIT-C99990','C99990','Moderate Cardiac Valve Stenosis','DB-NCIT'),('DBX-NCIT-C99991','C99991','No Cardiac Valve Regurgitation','DB-NCIT'),('DBX-NCIT-C99992','C99992','No Cardiac Valve Stenosis','DB-NCIT'),('DBX-NCIT-C99993','C99993','No Evidence of Coronary Artery Disease','DB-NCIT'),('DBX-NCIT-C99994','C99994','No Treatment for Diabetes','DB-NCIT'),('DBX-NCIT-C99995','C99995','Non-Cardiovascular Surgery','DB-NCIT'),('DBX-NCIT-C99996','C99996','Number of Diseased Coronary Artery Vessels','DB-NCIT'),('DBX-NCIT-C99997','C99997','One Coronary Vessel Disease','DB-NCIT'),('DBX-NCIT-C99998','C99998','Pacemaker Procedure','DB-NCIT'),('DBX-NCIT-C99999','C99999','Percutaneous Coronary Intervention for High Risk Non-ST Elevation Myocardial Infarction or Unstable Angina','DB-NCIT');
/*!40000 ALTER TABLE `DBxreferences` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping data for table `Dictionaries`
--

LOCK TABLES `Dictionaries` WRITE;
/*!40000 ALTER TABLE `Dictionaries` DISABLE KEYS */;
INSERT INTO `Dictionaries` VALUES ('CL-ACN','Action Taken with Study Treatment','Terminology specifying changes to the study treatment as a result of an adverse event.','DBX-NCIT-C66767'),('CL-ACSPCAT','Acute Coronary Syndrome Presentation Category','A classification of the presentation of acute coronary syndrome.','DBX-NCIT-C101865'),('CL-AESEV','Severity/Intensity Scale for Adverse Events','A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)','DBX-NCIT-C66769'),('CL-AGEU','Age Unit','Those units of time that are routinely used to express the age of a subject.','DBX-NCIT-C66781'),('CL-ASYDT','ASSAY DESIGN TYPE','',NULL),('CL-ASYMT','ASSAY MEASUREMENT TYPE','Terms used to describe assay measurement types',NULL),('CL-ASYTP','ASSAY TECHNOLOGY PLATFORM','Terms used to describe assay technology platforms',NULL),('CL-ASYTT','ASSAY TECHNOLOGY TYPE','Terms used to describe assay technology types',NULL),('CL-CACRDSC','Canadian Cardiovascular Society Classification','The anginal classifications as measured by the Canadian Cardiovascular Society grading scale.','DBX-NCIT-C101842'),('CL-CADPRSN','Coronary Artery Disease Presentation','A terminology codelist associated with coronary artery disease presentation.','DBX-NCIT-C101843'),('CL-CADRISK','Coronary Artery Disease Risk','A terminology codelist to describe the relative risk of coronary artery disease.','DBX-NCIT-C101849'),('CL-CADSYMP','Coronary Artery Disease Symptoms','A terminology codelist that contains symptoms associated with coronary artery disease.','DBX-NCIT-C101844'),('CL-CARTDOM','Coronary Artery Dominance','A codelist to describe whether the posterior descending artery comes from the right or left vessel system.','DBX-NCIT-C101860'),('CL-CCINVTYP','Contact Case Investigation Contact Type','Terminology relevant to the identification and clinical investigation of disease contacts.','DBX-NCIT-C102575'),('CL-CCRCLS','Consensus Cardiac Classification System Test Name','Classification system test name for cardiac parameters that are authored or endorsed by organizations.','DBX-NCIT-C101837'),('CL-CCRCLSCD','Consensus Cardiac Classification System Test Code','Classification system test code for cardiac parameters that are authored or endorsed by organizations.','DBX-NCIT-C101838'),('CL-Compliance','Compliance','Compliance',NULL),('CL-COUNTRY','Country','A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)','DBX-NCIT-C66786'),('CL-CRYDFMAN','Cardiac Rhythm Device Failure Manifestation','The effect that a cardiac rhythm device malfunction had on the ability to stimulate the heart.','DBX-NCIT-C101866'),('CL-CSLVLNIM','Reason CS/LV Lead Not Implanted','The reason that a Coronary Sinus Access or Left Ventricular (CS/LV) lead was not implanted.','DBX-NCIT-C101864'),('CL-CVEXAM','Cardiovascular Test Name','A terminology codelist to describe the findings test name from a cardiac examination.','DBX-NCIT-C101846'),('CL-CVEXAMCD','Cardiovascular Test Code','A terminology codelist to describe the findings test code from a cardiac examination.','DBX-NCIT-C101847'),('CL-CVLSTSEV','Cardiac Valvular Stenosis Severity','A terminology codelist to describe the severity of cardiac valvular stenosis.','DBX-NCIT-C101854'),('CL-CVLVRSEV','Cardiac Valvular Regurgitation Severity','A terminology codelist to describe the severity of cardiac valvular regurgitation.','DBX-NCIT-C101853'),('CL-CVPRCIND','Cardiac Procedure Indication','The reason that a subject had a cardiac procedure.','DBX-NCIT-C101859'),('CL-CVSLDEXT','Coronary Vessel Disease Extent','A terminology codelist to describe the extent of coronary artery disease.','DBX-NCIT-C101850'),('CL-DATEST','Drug Accountability Test Name','The name of the test for the drug accountability assessment.','DBX-NCIT-C78731'),('CL-DATESTCD','Drug Accountability Test Code','The short name, or code, of the test for the drug accountability assessment.','DBX-NCIT-C78732'),('CL-DDTEST','Death Details Test Name','Terminology relevant to the death detail assessment name.','DBX-NCIT-C116107'),('CL-DDTESTCD','Death Details Test Code','Terminology relevant to the death detail assessment short name.','DBX-NCIT-C116108'),('CL-DEACNDEV','Device Events Action Taken with Device','A terminology codelist based on the action taken with respect to the device.','DBX-NCIT-C111110'),('CL-DECAT','Device Events Category','A terminology codelist based on the category of related records for the device event.','DBX-NCIT-C111109'),('CL-DIABTHPY','Diabetes Therapy','A terminology codelist that describes the treatment method for diabetes.','DBX-NCIT-C101857'),('CL-DICTNAM','Dictionary Name','A name given to a reference source that lists words and gives their meaning. (NCI)','DBX-NCIT-C66788'),('CL-DIPARM','Device Identifier Long Name','A terminology codelist for the long name of the identifier characteristic of the device.','DBX-NCIT-C106480'),('CL-DIPARMCD','Device Identifier Short Name','A terminology codelist for the short name of the identifier characteristic of the device.','DBX-NCIT-C106481'),('CL-DIR','Directionality','CDISC terminology for anatomical location or specimen further detailing directionality.','DBX-NCIT-C99074'),('CL-DISCHDX','Discharge Disposition','The destination or circumstance at the time of discharge.','DBX-NCIT-C101863'),('CL-DOBSTLOC','Directly Observed Therapy Location','Terminology relevant to the physical location at which the medication or therapy was observed, by the healthcare provider, as being taken by the subject.','DBX-NCIT-C102576'),('CL-DOMAIN','SDTM Domain Abbreviation','A unique, 2-character domain code used in the regulatory submission process. The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most','DBX-NCIT-C66734'),('CL-DOTEST','Device Properties Test Name','A terminology codelist based on the test name used to obtain the device property.','DBX-NCIT-C111112'),('CL-DOTESTCD','Device Properties Test Code','A terminology codelist based on the test code used to obtain the device property.','DBX-NCIT-C111111'),('CL-DRSTAT','Drug Resistance Status','Terminology relevant to the state or condition of the microbe or lesion to indicate whether it is resistant to drugs normally used in treatment.','DBX-NCIT-C102577'),('CL-DSCAT','Category for Disposition Event','Classifications that describe and group pertinent events that occur throughout the conduct of a clinical trial.','DBX-NCIT-C74558'),('CL-DSSOUT','Disease Outcome','Terminology relevant to the measurable result or effect of treatment on a disease.','DBX-NCIT-C102578'),('CL-DTDECOD','Device Tracking and Disposition Event Dictionary Derived Term','A terminology codelist based on the verbatim or preprinted term for the device tracking and disposition event that occurs.','DBX-NCIT-C112037'),('CL-DUTEST','Device-In-Use Test Name','A terminology codelist for the test name of the test or examination used to obtain the measurement or finding of the device in use.','DBX-NCIT-C106482'),('CL-DUTESTCD','Device-In-Use Test Code','A terminology codelist for the test code of the test or examination used to obtain the measurement or finding of the device in use.','DBX-NCIT-C106483'),('CL-EGLEAD','ECG Lead','Terminology related to electrocardiogram lead names.','DBX-NCIT-C90013'),('CL-EGMETHOD','ECG Test Method','Terminology codelist used with ECG Test Methods within CDISC.','DBX-NCIT-C71151'),('CL-EGSTRESC','ECG Result','Terminology codelist used with ECG Findings and Abnormalities within CDISC.','DBX-NCIT-C71150'),('CL-EGTEST','ECG Test Name','Terminology codelist used with ECG Test Names within CDISC.','DBX-NCIT-C71152'),('CL-EGTESTCD','ECG Test Code','Terminology codelist used with ECG Tests within CDISC.','DBX-NCIT-C71153'),('CL-EMPSTAT','Employment Status','Terminology relevant to the state of being engaged in an activity or service for wages or salary.','DBX-NCIT-C111108'),('CL-EPOCH','Epoch','The name of the EPOCH.','DBX-NCIT-C99079'),('CL-ETHNIC','Ethnic Group','A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of ','DBX-NCIT-C66790'),('CL-EVAL','Evaluator','The role that the individual or entity plays with respect to a specific situation or person.','DBX-NCIT-C78735'),('CL-EVDRETRT','Supporting Evidence for Re-Treatment','Terminology relevant to the clinical evidence to support reason for re-treatment of disease.','DBX-NCIT-C102579'),('CL-FATEST','Findings About Test Name','Terminology relevant to the test names that describe findings about an event or intervention.','DBX-NCIT-C101833'),('CL-FATESTCD','Findings About Test Code','Terminology relevant to the test codes that describe findings about an event or intervention.','DBX-NCIT-C101832'),('CL-FEATDBS','Feature Annotation Databases','Databases for reporter or composite element annotation',NULL),('CL-FREQ','Frequency','The terminology that includes terms pertaining to frequency within CDISC.','DBX-NCIT-C71113'),('CL-FRM','Pharmaceutical Dosage Form','The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form co','DBX-NCIT-C66726'),('CL-GENSMP','Genetic Sample Type','Terminology relevant to the type of nucleic acid which was derived from the collected sample.','DBX-NCIT-C111114'),('CL-GNRLOBSC','General Observation Class','Terminology related to the classification of a CDISC domain.','DBX-NCIT-C103329'),('CL-GRAFTTYP','Graft Type','A terminology codelist relevant to the type of graft implanted in the subject.','DBX-NCIT-C117737'),('CL-GRSTNLOC','Location of Most Severe Stenosis Within a Graft','Terminology used to describe the part of the graft that is most severely stenotic.','DBX-NCIT-C101851'),('CL-HEFATS','Hepatic Findings About Test Name','Terminology relevant to the test names that describe hepatic findings.','DBX-NCIT-C117738'),('CL-HEFATSCD','Hepatic Findings About Test Code','Terminology relevant to the test codes that describe hepatic findings.','DBX-NCIT-C117739'),('CL-HEPENCGR','West Haven Hepatic Encephalopathy Grade','A grading system to describe the severity of hepatic encephalopathy based on the level of mental status by the West Haven Hepatic Encephalopathy Grade.','DBX-NCIT-C117746'),('CL-IECAT','Category for Inclusion/Exclusion','A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)','DBX-NCIT-C66797'),('CL-INTMODEL','Intervention Model','The trial design developed to compare treatment groups.','DBX-NCIT-C99076'),('CL-INTTYPE','Intervention Type','The kind of product or procedure studied in a trial.','DBX-NCIT-C99078'),('CL-KILLIPC','Killip Class Responses','A terminology codelist based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic bl','DBX-NCIT-C101840'),('CL-LAT','Laterality','CDISC terminology for anatomical location or specimen further detailing the side(s) of interest.','DBX-NCIT-C99073'),('CL-LBSTRESC','Laboratory Test Standard Character Result','Terminology relevant to the standardized results, in character format, for laboratory tests.','DBX-NCIT-C102580'),('CL-LBTEST','Laboratory Test Name','Terminology used for laboratory test names of the CDISC Standard Data Tabulation Model.','DBX-NCIT-C67154'),('CL-LBTESTCD','Laboratory Test Code','Terminology used for laboratory test codes of the CDISC Standard Data Tabulation Model.','DBX-NCIT-C65047'),('CL-LEADABN','Lead Abnormality','Terminology related to the complications of cardiac lead systems.','DBX-NCIT-C101862'),('CL-LEADSTAT','Lead Status','The status of the lead.','DBX-NCIT-C101867'),('CL-LOC','Anatomical Location','Terminology codelist used for anatomical location within CDISC.','DBX-NCIT-C74456'),('CL-LSNCMPX','Lesion Complexity','Terminology related to the risk of percutaneous coronary intervention for a particular lesion.','DBX-NCIT-C101861'),('CL-LVEFMRE','Left Ventricular Ejection Fraction Measurement Result','Terminology for results of left ventricular ejection fraction assessments.','DBX-NCIT-C101868'),('CL-MARISTAT','Marital Status','A demographic parameter indicating a person\'s current conjugal status.','DBX-NCIT-C76348'),('CL-MCIDCERT','Microbial Identification Certainty','Terminology relevant to the degree of certainty of the correctness of a microbial identification test result.','DBX-NCIT-C102581'),('CL-MCRCSPTM','Mechanical Circulatory Support Placement Timing','A terminology codelist to describe the timing of mechanical circulatory support placement.','DBX-NCIT-C101845'),('CL-MEDEVAL','Medical Evaluator','The individual responsible for the medical assessment.','DBX-NCIT-C96777'),('CL-METHOD','Method','Method is any technique or procedure (an action) that determines how an observation or clinical finding was made.','DBX-NCIT-C85492'),('CL-MICROORG','Microorganism','Microorganisms, bacteria, fungi and other organisms.','DBX-NCIT-C85491'),('CL-MOTEST','Morphology Test Name','A terminology codelist based on the test names for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies.','DBX-NCIT-C114116'),('CL-MOTESTCD','Morphology Test Code','A terminology codelist based on the test codes for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies.','DBX-NCIT-C114117'),('CL-MSFATS','Multiple Sclerosis Findings About Test Name','Terminology relevant to the test names that describe multiple sclerosis findings.','DBX-NCIT-C117740'),('CL-MSFATSCD','Multiple Sclerosis Findings About Test Code','Terminology relevant to the test codes that describe multiple sclerosis findings.','DBX-NCIT-C117741'),('CL-MSRESCAT','Microbiology Susceptibility Testing Result Category','Used to categorize the result of a finding in a standard format.','DBX-NCIT-C85495'),('CL-NCF','Never/Current/Former Classification','A classification of usage or experience that falls into three categories; never, current, or former.','DBX-NCIT-C78738'),('CL-NCOMPLT','Completion/Reason for Non-Completion','The status of the subject\'s completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study.','DBX-NCIT-C66727'),('CL-ND','Not Done','Indicates a task, process or examination that has either not been initiated or completed. (NCI)','DBX-NCIT-C66789'),('CL-NEOPLASM','Neoplasm Type','The terminology that includes concepts relevant to benign or malignant tissue growth.','DBX-NCIT-C88025'),('CL-NORMABNM','Normal Abnormal Response','A terminology codelist to describe a normal or abnormal response.','DBX-NCIT-C101834'),('CL-NRIND','Reference Range Indicator','A description of the results relative to the normal or expected range of values.','DBX-NCIT-C78736'),('CL-NSYSPCID','Non-system Reason for PCI Delay','A terminology codelist that contains reasons for non-system PCI delay.','DBX-NCIT-C101855'),('CL-NVTEST','Nervous System Physiology Test Name','Terminology relevant to the test names that describe nervous system physiology findings.','DBX-NCIT-C116103'),('CL-NVTESTCD','Nervous System Physiology Test Code','Terminology relevant to the test codes that describe nervous system physiology findings.','DBX-NCIT-C116104'),('CL-NY','No Yes Response','A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.','DBX-NCIT-C66742'),('CL-NYHAC','New York Heart Association Classification','A terminology codelist based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease.','DBX-NCIT-C101839'),('CL-OETEST','Ophthalmic Exam Test Name','Terminology relevant to the test names that describe findings from ophthalmic examinations.','DBX-NCIT-C117742'),('CL-OETESTCD','Ophthalmic Exam Test Code','Terminology relevant to the test codes that describe findings from ophthalmic examinations.','DBX-NCIT-C117743'),('CL-OUT','Outcome of Event','A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)','DBX-NCIT-C66768'),('CL-PBSTMT','Pharmacogenomics Biomarker Medical Statement','A terminology codelist relevant to the medical conclusion such as confirmation of a diagnosis or drug resistance based on genetic biological markers.','DBX-NCIT-C114119'),('CL-PFTEST','Pharmacogenomics Findings Test Name','Terminology relevant to the test names that describe pharmacogenomics findings.','DBX-NCIT-C116105'),('CL-PFTESTCD','Pharmacogenomics Findings Test Code','Terminology relevant to the test codes that describe pharmacogenomics findings.','DBX-NCIT-C116106'),('CL-PHSPRP','Physical Properties Test Name','Terminology relevant to the test names that describe the physical characteristics of an entity.','DBX-NCIT-C95120'),('CL-PHSPRPCD','Physical Properties Test Code','Terminology relevant to the test codes that describe the physical characteristics of an entity.','DBX-NCIT-C95121'),('CL-PKPARM','PK Parameters','Parameters used to describe the time-concentration curve.','DBX-NCIT-C85493'),('CL-PKPARMCD','PK Parameters Code','Parameter codes used to describe the time-concentration curve.','DBX-NCIT-C85839'),('CL-PKUNIT','PK Units of Measure','Units of measure for pharmacokinetic data and parameters.','DBX-NCIT-C85494'),('CL-PORTOT','Portion/Totality','Qualifier for anatomical location or specimen further detailing the portion or totality, which means arrangement of, or apportioning of an entity.','DBX-NCIT-C99075'),('CL-POSITION','Position','Terminology codelist used with Body Position within CDISC.','DBX-NCIT-C71148'),('CL-PRITBCON','Priority of Tuberculosis Contact','Terminology relevant to the prioritization of tuberculosis contacts.','DBX-NCIT-C102582'),('CL-PROCEDUR','Procedure','A terminology codelist to describe any activity considered to be a therapeutic or diagnostic procedure.','DBX-NCIT-C101858'),('CL-PROTMLST','Protocol Milestone','A terminology codelist relevant to protocol-specified, point-in-time events during a study.','DBX-NCIT-C114118'),('CL-PRURGNCY','Procedure Urgency Status','A terminology codelist that describes the degree of urgency for a procedure.','DBX-NCIT-C101856'),('CL-RACE','Race','Terminology codelist used to identify the race of an individual within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.','DBX-NCIT-C74457'),('CL-REASTINT','Reason for Treatment Interruption','Terminology relevant to the reason the drug or therapy was temporarily ceased.','DBX-NCIT-C102583'),('CL-REASTRT','Reason For Treatment','Terminology relevant to the reason the treatment was administered.','DBX-NCIT-C102584'),('CL-REASTRTF','Treatment Failure Reason','Terminology relevant to the reason the drug or therapy was unsuccessful in treating the condition.','DBX-NCIT-C102585'),('CL-RELSUB','Relationship to Subject','The relationship of a person to a study subject.','DBX-NCIT-C100130'),('CL-RELTYPE','Relationship Type','The description of relationship types between a record or set of records.','DBX-NCIT-C78737'),('CL-RETEST','Respiratory Test Name','A terminology codelist based on the test names for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.','DBX-NCIT-C111107'),('CL-RETESTCD','Respiratory Test Code','A terminology codelist based on the test codes for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.','DBX-NCIT-C111106'),('CL-RISKSOC','Social Risk Factor','Terminology relevant to the social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.','DBX-NCIT-C102587'),('CL-Role','Role','Role',NULL),('CL-ROUTE','Route of Administration','The course by which a substance was administered in order to reach the site of action in the body.','DBX-NCIT-C66729'),('CL-RPTEST','Reproductive System Findings Test Name','A terminology codelist for the physiological test names related to the male and female reproductive systems.','DBX-NCIT-C106478'),('CL-RPTESTCD','Reproductive System Findings Test Code','A terminology codelist for the physiological test codes related to the male and female reproductive systems.','DBX-NCIT-C106479'),('CL-RSKASMT','Risk Assessment','A terminology codelist to describe the risk of a disease, disorder or abnormal condition.','DBX-NCIT-C101848'),('CL-RSSTRESC','Tumor Response Result','The result of an assessment of tumor response to treatment or therapy.','DBX-NCIT-C96785'),('CL-RSTEST','Tumor Response Assessment Test Name','Terminology relevant to the test names that describe an assessment of tumor response to treatment or therapy.','DBX-NCIT-C96781'),('CL-RSTESTCD','Tumor Response Assessment Test Code','Terminology relevant to the test codes that describe an assessment of tumor response to treatment or therapy.','DBX-NCIT-C96782'),('CL-RSTRTNA','Reason Treatment Not Administered','Terminology relevant to the reason the treatment was not administered.','DBX-NCIT-C102586'),('CL-SCTEST','Subject Characteristic Test Name','The test name representing each subject characteristic.','DBX-NCIT-C103330'),('CL-SCTESTCD','Subject Characteristic Test Code','The test code representing each subject characteristic.','DBX-NCIT-C74559'),('CL-SDTHSDTP','Sudden Death Syndrome Type','A terminology codelist that describes syndromes or conditions that put a subject at risk for sudden death.','DBX-NCIT-C101852'),('CL-SETCON','Contact Setting','Terminology relevant to the environment within which the subject may have come into contact with a disease carrier, or played the role of a disease carrier.','DBX-NCIT-C102588'),('CL-SEX','Sex','The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)','DBX-NCIT-C66731'),('CL-SEXPOP','Sex of Participants','The specific sex, either male, female, or mixed of the subject group being studied. (NCI)','DBX-NCIT-C66732'),('CL-SIZE','Size','The physical magnitude of something. (NCI)','DBX-NCIT-C66733'),('CL-SKINCLAS','Skin Classification','A classification system used to categorize the sensitivity of a subject\'s skin to sunlight.','DBX-NCIT-C76351'),('CL-SKINTYP','Skin Type','A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.','DBX-NCIT-C74561'),('CL-SPCIES','SDTM Species','Terminology relevant to the species of the pathogen to which the subject is a host when the pathogen is the focus of the test or interpretation.','DBX-NCIT-C116111'),('CL-SPECCOND','Specimen Condition','The physical state or quality of a biological specimen.','DBX-NCIT-C78733'),('CL-SPECTYPE','Specimen Type','The name and description of a biological specimen.','DBX-NCIT-C78734'),('CL-SRTEST','Skin Response Test Name','A terminology codelist based on the test names for dermal responses to antigens.','DBX-NCIT-C112023'),('CL-SRTESTCD','Skin Response Test Code','A terminology codelist based on the test codes for dermal responses to antigens.','DBX-NCIT-C112024'),('CL-STENRF','Relation to Reference Period','The relative relationship of a timepoint to a reference timepoint.','DBX-NCIT-C66728'),('CL-STYPE','Study Type','Describes the role the study plays in determining the interventions a subject receives.','DBX-NCIT-C99077'),('CL-TBLIND','Trial Blinding Schema','The name of a code list that contains terms to define the type of blinding for the trial. (NCI)','DBX-NCIT-C66735'),('CL-TCNTRL','Control Type','Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).','DBX-NCIT-C66785'),('CL-TDIGRP','Diagnosis Group','A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a ','DBX-NCIT-C66787'),('CL-TIMIFLOW','TIMI Flow Responses','A terminology codelist of acceptable values to describe TIMI Flow.','DBX-NCIT-C101841'),('CL-TINDTP','Trial Indication Type','The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)','DBX-NCIT-C66736'),('CL-TOXGRV3','Common Terminology Criteria for Adverse Events V3.0','A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Admin','DBX-NCIT-C66784'),('CL-TOXGRV4','Common Terminology Criteria for Adverse Events V4.0','The version 4.0 standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used to study adverse event summaries and Investigational New Drug reports to the Food ','DBX-NCIT-C87162'),('CL-TPHASE','Trial Phase','Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure wheth','DBX-NCIT-C66737'),('CL-TRTEPSD','Treatment Episode','Terminology relevant to whether an individual is being treated for a disease for the first time.','DBX-NCIT-C102589'),('CL-TRTEST','Tumor or Lesion Properties Test Name','Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease.','DBX-NCIT-C96778'),('CL-TRTESTCD','Tumor or Lesion Properties Test Code','Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease.','DBX-NCIT-C96779'),('CL-TSPARM','Trial Summary Parameter Test Name','The test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.','DBX-NCIT-C67152'),('CL-TSPARMCD','Trial Summary Parameter Test Code','The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.','DBX-NCIT-C66738'),('CL-TTYPE','Trial Type','The type of clinical trial performed e.g. efficacy, safety. (NCI)','DBX-NCIT-C66739'),('CL-TUMIDENT','Tumor and Lesion Identification Results','Terminology relevant to tumor and lesion identification results.','DBX-NCIT-C96780'),('CL-TUTEST','Tumor Identification Test Name','Terminology relevant to the test names that describe tumor assessments for identification purposes.','DBX-NCIT-C96783'),('CL-TUTESTCD','Tumor Identification Test Code','Terminology relevant to the test codes that describe tumor assessments for identification purposes.','DBX-NCIT-C96784'),('CL-UNIT','Unit','Terminology codelist used for units within CDISC.','DBX-NCIT-C71620'),('CL-VCNEVD','Vaccination Evidence Source','Terminology relevant to the source of information regarding the subject\'s vaccination status.','DBX-NCIT-C102590'),('CL-VRTEST','Viral Resistance Findings Test Name','Terminology used for virology test names of the CDISC Standard Data Tabulation Model.','DBX-NCIT-C116109'),('CL-VRTESTCD','Viral Resistance Findings Test Code','Terminology used for virology test codes of the CDISC Standard Data Tabulation Model.','DBX-NCIT-C116110'),('CL-VSRESU','Units for Vital Signs Results','The unit used to record and describe the result of a test investigating a vital sign. (NCI)','DBX-NCIT-C66770'),('CL-VSTEST','Vital Signs Test Name','The test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.','DBX-NCIT-C67153'),('CL-VSTESTCD','Vital Signs Test Code','The test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.','DBX-NCIT-C66741');
/*!40000 ALTER TABLE `Dictionaries` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping data for table `CVterms`
--

LOCK TABLES `CVterms` WRITE;
/*!40000 ALTER TABLE `CVterms` DISABLE KEYS */;
INSERT INTO `CVterms` VALUES ('CL-ACN-T-1',NULL,'DOSE INCREASED','An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)','\0','','CL-ACN','DBX-NCIT-C49503'),('CL-ACN-T-2',NULL,'DOSE NOT CHANGED','An indication that a medication schedule was maintained. (NCI)','\0','','CL-ACN','DBX-NCIT-C49504'),('CL-ACN-T-3',NULL,'DOSE REDUCED','An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)','\0','','CL-ACN','DBX-NCIT-C49505'),('CL-ACN-T-4',NULL,'DRUG INTERRUPTED','An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)','\0','','CL-ACN','DBX-NCIT-C49501'),('CL-ACN-T-5',NULL,'DRUG WITHDRAWN','An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)','\0','','CL-ACN','DBX-NCIT-C49502'),('CL-ACN-T-6',NULL,'NOT APPLICABLE','Determination of a value is not relevant in the current context. (NCI)','\0','NA; Not Applicable','CL-ACN','DBX-NCIT-C48660'),('CL-ACN-T-7',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-ACN','DBX-NCIT-C17998'),('CL-ACSPCAT-T-1',NULL,'NON-ST ELEVATION MYOCARDIAL INFARCTION','A myocardial infarction that does not produce elevation in the ST segments of the ECG.','\0','NON-STEMI; NSTEMI','CL-ACSPCAT','DBX-NCIT-C80383'),('CL-ACSPCAT-T-2',NULL,'OTHER','Different than the one(s) previously specified or mentioned. (NCI)','\0','Other','CL-ACSPCAT','DBX-NCIT-C17649'),('CL-ACSPCAT-T-3',NULL,'ST ELEVATION MYOCARDIAL INFARCTION','A myocardial infarction that produces elevation in the ST segments of the ECG.','\0','STEMI','CL-ACSPCAT','DBX-NCIT-C101888'),('CL-ACSPCAT-T-4',NULL,'STABLE ANGINA','Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications.','\0','','CL-ACSPCAT','DBX-NCIT-C66914'),('CL-ACSPCAT-T-5',NULL,'UNSTABLE ANGINA','Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.','\0','','CL-ACSPCAT','DBX-NCIT-C66911'),('CL-AESEV-T-1',NULL,'MILD','A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.','\0','1; Grade 1','CL-AESEV','DBX-NCIT-C41338'),('CL-AESEV-T-2',NULL,'MODERATE','A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research partici','\0','2; Grade 2','CL-AESEV','DBX-NCIT-C41339'),('CL-AESEV-T-3',NULL,'SEVERE','A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.','\0','3; Grade 3','CL-AESEV','DBX-NCIT-C41340'),('CL-AGEU-T-1',NULL,'DAYS','The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)','\0','Day','CL-AGEU','DBX-NCIT-C25301'),('CL-AGEU-T-2',NULL,'HOURS','A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)','\0','Hour; hr','CL-AGEU','DBX-NCIT-C25529'),('CL-AGEU-T-3',NULL,'MONTHS','One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon\'s phases, about 30 days or 4 weeks. (NCI)','\0','Month','CL-AGEU','DBX-NCIT-C29846'),('CL-AGEU-T-4',NULL,'WEEKS','Any period of seven consecutive days. (NCI)','\0','Week','CL-AGEU','DBX-NCIT-C29844'),('CL-AGEU-T-5',NULL,'YEARS','The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)','\0','Year','CL-AGEU','DBX-NCIT-C29848'),('CL-ASYMT-1',NULL,'Gene Expression Profiling',NULL,NULL,NULL,'CL-ASYMT',NULL),('CL-ASYMT-2',NULL,'Protein Profiling',NULL,NULL,NULL,'CL-ASYMT',NULL),('CL-ASYMT-3',NULL,'Cytokines Profiling',NULL,NULL,NULL,'CL-ASYMT',NULL),('CL-ASYTP-1',NULL,'Agilent',NULL,NULL,NULL,'CL-ASYTP',NULL),('CL-ASYTP-2',NULL,'CyTOF',NULL,NULL,NULL,'CL-ASYTP',NULL),('CL-ASYTP-3',NULL,'Luminex',NULL,NULL,NULL,'CL-ASYTP',NULL),('CL-ASYTP-4',NULL,'FACS',NULL,NULL,NULL,'CL-ASYTP',NULL),('CL-ASYTT-T-1',NULL,'DNA Microarray',NULL,NULL,NULL,'CL-ASYTT',NULL),('CL-ASYTT-T-2',NULL,'Mass Cytometry',NULL,NULL,NULL,'CL-ASYTT',NULL),('CL-ASYTT-T-3',NULL,'Flow Cytometry',NULL,NULL,NULL,'CL-ASYTT',NULL),('CL-ASYTT-T-4',NULL,'Multiplex Immuno Assays',NULL,NULL,NULL,'CL-ASYTT',NULL),('CL-CACRDSC-T-1',NULL,'CCS CLASS 1','Ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation.','\0','Canadian Cardiovascular Society Classification 1','CL-CACRDSC','DBX-NCIT-C77265'),('CL-CACRDSC-T-2',NULL,'CCS CLASS 2','Slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, or in cold, in wind, or under emotional stress, or only during the few hours after awakening. Angina occur','\0','Canadian Cardiovascular Society Classification 2','CL-CACRDSC','DBX-NCIT-C77266'),('CL-CACRDSC-T-3',NULL,'CCS CLASS 3','Marked limitations of ordinary physical activity. Angina occurs on walking 1 to 2 blocks on the level and climbing 1 flight of stairs in normal conditions and at a normal pace.','\0','Canadian Cardiovascular Society Classification 3','CL-CACRDSC','DBX-NCIT-C77267'),('CL-CACRDSC-T-4',NULL,'CCS CLASS 4','Inability to perform any physical activity without discomfort - anginal symptoms may be present at rest.','\0','Canadian Cardiovascular Society Classification 4','CL-CACRDSC','DBX-NCIT-C77268'),('CL-CADPRSN-T-1',NULL,'NON-ST ELEVATION MYOCARDIAL INFARCTION','A myocardial infarction that does not produce elevation in the ST segments of the ECG.','\0','NON-STEMI; NSTEMI','CL-CADPRSN','DBX-NCIT-C80383'),('CL-CADPRSN-T-2',NULL,'ST ELEVATION MYOCARDIAL INFARCTION','A myocardial infarction that produces elevation in the ST segments of the ECG.','\0','STEMI','CL-CADPRSN','DBX-NCIT-C101888'),('CL-CADPRSN-T-3',NULL,'STABLE ANGINA','Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications.','\0','','CL-CADPRSN','DBX-NCIT-C66914'),('CL-CADPRSN-T-4',NULL,'UNSTABLE ANGINA','Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.','\0','','CL-CADPRSN','DBX-NCIT-C66911'),('CL-CADPRSN-T-5',NULL,'VARIANT ANGINA','A variant form of angina pectoris caused by coronary artery vasospasm, usually occurring spontaneously and frequently associated with ST segment elevation.','\0','','CL-CADPRSN','DBX-NCIT-C66915'),('CL-CADRISK-T-1',NULL,'HIGH CAD RISK','The likelihood an individual will develop coronary artery disease is almost certain or greater than 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O\'Reilly MG, Winters WL Jr. ACC/AHA 20','\0','High Coronary Artery Disease Risk','CL-CADRISK','DBX-NCIT-C99955'),('CL-CADRISK-T-2',NULL,'INTERMEDIATE CAD RISK','The likelihood an individual will develop coronary artery disease (CAD) is moderate or between 10% and 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O\'Reilly MG, Winters WL Jr. ACC/AHA','\0','Intermediate Coronary Artery Disease Risk','CL-CADRISK','DBX-NCIT-C99966'),('CL-CADRISK-T-3',NULL,'KNOWN CAD','The individual has coronary artery disease (CAD). (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O\'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of t','\0','Known Coronary Artery Disease','CL-CADRISK','DBX-NCIT-C99968'),('CL-CADRISK-T-4',NULL,'LOW CAD RISK','The likelihood an individual will develop coronary artery disease (CAD) is minimal or less than10%.(Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O\'Reilly MG, Winters WL Jr. ACC/AHA 2002 gui','\0','Low Coronary Artery Disease Risk','CL-CADRISK','DBX-NCIT-C99978'),('CL-CADSYMP-T-1',NULL,'ATYPICAL CORONARY ARTERY DISEASE SYMPTOMS','Sharp stabbing chest pain or reproduction of pain on palpation. Less common isolated presentations, primarily in older adults, include nausea and vomiting, diaphoresis, and unexplained fatigue. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02','\0','','CL-CADSYMP','DBX-NCIT-C99917'),('CL-CADSYMP-T-2',NULL,'NO SYMPTOMS','The finding of no indications of a particular disease or injury.','\0','','CL-CADSYMP','DBX-NCIT-C3833'),('CL-CADSYMP-T-3',NULL,'NON-CARDIAC CHEST PAIN','A discomfort in the chest area that is not related to the heart.','\0','','CL-CADSYMP','DBX-NCIT-C78504'),('CL-CADSYMP-T-4',NULL,'TYPICAL CORONARY ARTERY DISEASE SYMPTOMS','Deep, poorly localized chest or arm discomfort that is reproducibly associated with physical exertion or emotional stress and is relieved promptly (ie, in less than 5 minutes) with rest and/or the use of sublingual nitroglycerin. Some patients may have no','\0','','CL-CADSYMP','DBX-NCIT-C100024'),('CL-CARTDOM-T-1',NULL,'CO-DOMINANT','The right coronary artery supplies the posterior descending artery (PDA) and the circumflex supplies the posterolateral artery (PLA). Thus, there is approximately equal contribution to the inferior surface of the left ventricle from both the left circumfl','\0','','CL-CARTDOM','DBX-NCIT-C99941'),('CL-CARTDOM-T-2',NULL,'LEFT DOMINANCE','The posterior descending artery (PDA) and posterolateral artery (PLA) arises from the left circumflex artery.','\0','','CL-CARTDOM','DBX-NCIT-C99971'),('CL-CARTDOM-T-3',NULL,'RIGHT DOMINANCE','The posterior descending artery (PDA) and posterolateral artery (PLA) arises from the right coronary artery.','\0','','CL-CARTDOM','DBX-NCIT-C99942'),('CL-CCINVTYP-T-1',NULL,'CASUAL CONTACT','A way of contracting a disease through everyday interactions (nonsexual) with an infected person.','\0','','CL-CCINVTYP','DBX-NCIT-C102606'),('CL-CCINVTYP-T-2',NULL,'CONTACT WITH EXPOSURE DURING MEDICAL PROCEDURE','A way of contracting a disease by interacting with an individual that has been exposed to the disease while undergoing a medical procedure.','\0','','CL-CCINVTYP','DBX-NCIT-C102609'),('CL-CCINVTYP-T-3',NULL,'CONTACT WITH EXPOSURE IN CROWD SETTING','A way of contracting a disease by physically associating with an infected group of individuals.','\0','','CL-CCINVTYP','DBX-NCIT-C102610'),('CL-CCINVTYP-T-4',NULL,'CONTACT WITH MEDICAL RISK FACTOR','A way of contracting a disease by interacting with an individual that is considered at high risk for having the disease.','\0','','CL-CCINVTYP','DBX-NCIT-C102611'),('CL-CCINVTYP-T-5',NULL,'HOUSEHOLD CONTACT','A way of contracting a disease through interactions with an infected person in the same residence.','\0','','CL-CCINVTYP','DBX-NCIT-C102646'),('CL-CCRCLS-T-1',NULL,'ACC/AHA Lesion Complexity Class','A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization.','\0','ACC/AHA Lesion Complexity Class','CL-CCRCLS','DBX-NCIT-C100032'),('CL-CCRCLS-T-2',NULL,'Canadian CV Society Grading Scale','A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the l','\0','Canadian CV Society Grading Scale','CL-CCRCLS','DBX-NCIT-C66910'),('CL-CCRCLS-T-3',NULL,'Killip Class','A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decrease','\0','Killip Class','CL-CCRCLS','DBX-NCIT-C66916'),('CL-CCRCLS-T-4',NULL,'New York Heart Association Class','A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage ','\0','New York Heart Association Class','CL-CCRCLS','DBX-NCIT-C66909'),('CL-CCRCLS-T-5',NULL,'TIMI Flow','A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels.','\0','TIMI Flow','CL-CCRCLS','DBX-NCIT-C100021'),('CL-CCRCLSCD-T-1',NULL,'CCSGRDS','A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the l','\0','Canadian CV Society Grading Scale','CL-CCRCLSCD','DBX-NCIT-C66910'),('CL-CCRCLSCD-T-2',NULL,'KILLIPCL','A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decrease','\0','Killip Class','CL-CCRCLSCD','DBX-NCIT-C66916'),('CL-CCRCLSCD-T-3',NULL,'LSNCPCLS','A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization.','\0','ACC/AHA Lesion Complexity Class','CL-CCRCLSCD','DBX-NCIT-C100032'),('CL-CCRCLSCD-T-4',NULL,'NYHACLS','A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage ','\0','New York Heart Association Class','CL-CCRCLSCD','DBX-NCIT-C66909'),('CL-CCRCLSCD-T-5',NULL,'TIMIFLOW','A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels.','\0','TIMI Flow','CL-CCRCLSCD','DBX-NCIT-C100021'),('CL-Compliance-T-1',NULL,'Required','Required','\0',NULL,'CL-Compliance',NULL),('CL-Compliance-T-2',NULL,'Expected','Expected','\0',NULL,'CL-Compliance',NULL),('CL-Compliance-T-3',NULL,'Permissible','Permissible','\0',NULL,'CL-Compliance',NULL),('CL-COUNTRY-T-1',NULL,'ABW','Island in the Caribbean Sea, north of Venezuela. (NCI)','\0','ARUBA','CL-COUNTRY','DBX-NCIT-C17884'),('CL-COUNTRY-T-10',NULL,'ARM','A country in Southwestern Asia, east of Turkey. (NCI)','\0','ARMENIA','CL-COUNTRY','DBX-NCIT-C16306'),('CL-COUNTRY-T-100',NULL,'HRV','A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia. (NCI)','\0','CROATIA','CL-COUNTRY','DBX-NCIT-C16474'),('CL-COUNTRY-T-101',NULL,'HTI','A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic. (NCI)','\0','HAITI','CL-COUNTRY','DBX-NCIT-C16660'),('CL-COUNTRY-T-102',NULL,'HUN','A country in Central Europe, northwest of Romania. (NCI)','\0','HUNGARY','CL-COUNTRY','DBX-NCIT-C16699'),('CL-COUNTRY-T-103',NULL,'IDN','A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean. (NCI)','\0','INDONESIA','CL-COUNTRY','DBX-NCIT-C16728'),('CL-COUNTRY-T-104',NULL,'IMN','An island in the Irish Sea, between Great Britain and Ireland. (NCI)','\0','ISLE OF MAN','CL-COUNTRY','DBX-NCIT-C44480'),('CL-COUNTRY-T-105',NULL,'IND','A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. (NCI)','\0','INDIA','CL-COUNTRY','DBX-NCIT-C16727'),('CL-COUNTRY-T-106',NULL,'IOT','An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia. (NCI)','\0','BRITISH INDIAN OCEAN TERRITORY','CL-COUNTRY','DBX-NCIT-C16365'),('CL-COUNTRY-T-107',NULL,'IRL','A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. (NCI)','\0','IRELAND','CL-COUNTRY','DBX-NCIT-C16757'),('CL-COUNTRY-T-108',NULL,'IRN','A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. (NCI)','\0','IRAN','CL-COUNTRY','DBX-NCIT-C16755'),('CL-COUNTRY-T-109',NULL,'IRQ','A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait. (NCI)','\0','IRAQ','CL-COUNTRY','DBX-NCIT-C16756'),('CL-COUNTRY-T-11',NULL,'ASM','A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand. (NCI)','\0','AMERICAN SAMOA','CL-COUNTRY','DBX-NCIT-C17739'),('CL-COUNTRY-T-110',NULL,'ISL','A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI)','\0','ICELAND','CL-COUNTRY','DBX-NCIT-C16704'),('CL-COUNTRY-T-111',NULL,'ISR','A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. (NCI)','\0','ISRAEL','CL-COUNTRY','DBX-NCIT-C16760'),('CL-COUNTRY-T-112',NULL,'ITA','A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. (NCI)','\0','ITALY','CL-COUNTRY','DBX-NCIT-C16761'),('CL-COUNTRY-T-113',NULL,'JAM','An island in the Caribbean Sea, south of Cuba. (NCI)','\0','JAMAICA','CL-COUNTRY','DBX-NCIT-C16763'),('CL-COUNTRY-T-114',NULL,'JEY','Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK. (NCI)','\0','JERSEY','CL-COUNTRY','DBX-NCIT-C64374'),('CL-COUNTRY-T-115',NULL,'JOR','A country in the Middle East, northwest of Saudi Arabia. (NCI)','\0','JORDAN','CL-COUNTRY','DBX-NCIT-C16765'),('CL-COUNTRY-T-116',NULL,'JPN','A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. (NCI)','\0','JAPAN','CL-COUNTRY','DBX-NCIT-C16764'),('CL-COUNTRY-T-117',NULL,'KAZ','A country in Central Asia, northwest of China. (NCI)','\0','KAZAKHSTAN','CL-COUNTRY','DBX-NCIT-C20107'),('CL-COUNTRY-T-118',NULL,'KEN','A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI)','\0','KENYA','CL-COUNTRY','DBX-NCIT-C16769'),('CL-COUNTRY-T-119',NULL,'KGZ','A country in Central Asia, west of China. (NCI)','\0','KYRGYZSTAN','CL-COUNTRY','DBX-NCIT-C16771'),('CL-COUNTRY-T-12',NULL,'ATA','The continent lying mostly south of the Antarctic Circle. (NCI)','\0','ANTARCTICA','CL-COUNTRY','DBX-NCIT-C18007'),('CL-COUNTRY-T-120',NULL,'KHM','A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. (NCI)','\0','CAMBODIA','CL-COUNTRY','DBX-NCIT-C16378'),('CL-COUNTRY-T-121',NULL,'KIR','A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia. (NCI)','\0','KIRIBATI','CL-COUNTRY','DBX-NCIT-C16639'),('CL-COUNTRY-T-122',NULL,'KNA','Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago. (NCI)','\0','SAINT KITTS AND NEVIS','CL-COUNTRY','DBX-NCIT-C17885'),('CL-COUNTRY-T-123',NULL,'KOR','A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea. (NCI)','\0','KOREA, REPUBLIC OF; SOUTH KOREA','CL-COUNTRY','DBX-NCIT-C16774'),('CL-COUNTRY-T-124',NULL,'KWT','A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia. (NCI)','\0','KUWAIT','CL-COUNTRY','DBX-NCIT-C16775'),('CL-COUNTRY-T-125',NULL,'LAO','A country in Southeastern Asia, northeast of Thailand, west of Vietnam. (NCI)','\0','LAO PEOPLE\'S DEMOCRATIC REPUBLIC','CL-COUNTRY','DBX-NCIT-C16780'),('CL-COUNTRY-T-126',NULL,'LBN','A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. (NCI)','\0','LEBANON','CL-COUNTRY','DBX-NCIT-C16784'),('CL-COUNTRY-T-127',NULL,'LBR','A country in Western Africa, bordering the North Atlantic Ocean, between Cote d\'Ivoire and Sierra Leone. (NCI)','\0','LIBERIA','CL-COUNTRY','DBX-NCIT-C16791'),('CL-COUNTRY-T-128',NULL,'LBY','A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia. (NCI)','\0','LIBYA','CL-COUNTRY','DBX-NCIT-C16793'),('CL-COUNTRY-T-129',NULL,'LCA','A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago. (NCI)','\0','SAINT LUCIA','CL-COUNTRY','DBX-NCIT-C17113'),('CL-COUNTRY-T-13',NULL,'ATF','Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia. (NCI)','\0','FRENCH SOUTHERN TERRITORIES','CL-COUNTRY','DBX-NCIT-C20105'),('CL-COUNTRY-T-130',NULL,'LIE','A country in Central Europe, between Austria and Switzerland. (NCI)','\0','LIECHTENSTEIN','CL-COUNTRY','DBX-NCIT-C16794'),('CL-COUNTRY-T-131',NULL,'LKA','A country in Southern Asia, occupying an island in the Indian Ocean, south of India. (NCI)','\0','SRI LANKA','CL-COUNTRY','DBX-NCIT-C17163'),('CL-COUNTRY-T-132',NULL,'LSO','A country in Southern Africa, an enclave of South Africa. (NCI)','\0','LESOTHO','CL-COUNTRY','DBX-NCIT-C16787'),('CL-COUNTRY-T-133',NULL,'LTU','A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia. (NCI)','\0','LITHUANIA','CL-COUNTRY','DBX-NCIT-C16799'),('CL-COUNTRY-T-134',NULL,'LUX','A country in Western Europe, between France, Belgium, and Germany. (NCI)','\0','LUXEMBOURG','CL-COUNTRY','DBX-NCIT-C16803'),('CL-COUNTRY-T-135',NULL,'LVA','A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania. (NCI)','\0','LATVIA','CL-COUNTRY','DBX-NCIT-C16783'),('CL-COUNTRY-T-136',NULL,'MAC','A country in Eastern Asia, bordering the South China Sea and China. (NCI)','\0','MACAO','CL-COUNTRY','DBX-NCIT-C16807'),('CL-COUNTRY-T-137',NULL,'MAF','An island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI)','\0','SAINT MARTIN (FRENCH PART); SAINT MARTIN, FRENCH','CL-COUNTRY','DBX-NCIT-C83610'),('CL-COUNTRY-T-138',NULL,'MAR','A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara. (NCI)','\0','MOROCCO','CL-COUNTRY','DBX-NCIT-C16878'),('CL-COUNTRY-T-139',NULL,'MCO','A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy. (NCI)','\0','MONACO','CL-COUNTRY','DBX-NCIT-C16874'),('CL-COUNTRY-T-14',NULL,'ATG','Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico. (NCI)','\0','ANTIGUA AND BARBUDA','CL-COUNTRY','DBX-NCIT-C16303'),('CL-COUNTRY-T-140',NULL,'MDA','A country in Eastern Europe, northeast of Romania. (NCI)','\0','MOLDOVA, REPUBLIC OF','CL-COUNTRY','DBX-NCIT-C16871'),('CL-COUNTRY-T-141',NULL,'MDG','A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique. (NCI)','\0','MADAGASCAR','CL-COUNTRY','DBX-NCIT-C16808'),('CL-COUNTRY-T-142',NULL,'MDV','A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India. (NCI)','\0','MALDIVES','CL-COUNTRY','DBX-NCIT-C16815'),('CL-COUNTRY-T-143',NULL,'MEX','A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US. (NCI)','\0','MEXICO','CL-COUNTRY','DBX-NCIT-C16850'),('CL-COUNTRY-T-144',NULL,'MHL','A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)','\0','MARSHALL ISLANDS','CL-COUNTRY','DBX-NCIT-C16822'),('CL-COUNTRY-T-145',NULL,'MKD','A country in Southeastern Europe, north of Greece. (NCI)','\0','MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF; REPUBLIC OF MACEDONIA','CL-COUNTRY','DBX-NCIT-C17654'),('CL-COUNTRY-T-146',NULL,'MLI','A country in Western Africa, southwest of Algeria. (NCI)','\0','MALI','CL-COUNTRY','DBX-NCIT-C16816'),('CL-COUNTRY-T-147',NULL,'MLT','A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy). (NCI)','\0','MALTA','CL-COUNTRY','DBX-NCIT-C16817'),('CL-COUNTRY-T-148',NULL,'MMR','A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand. (NCI)','\0','MYANMAR','CL-COUNTRY','DBX-NCIT-C16370'),('CL-COUNTRY-T-149',NULL,'MNE','A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)','\0','MONTENEGRO','CL-COUNTRY','DBX-NCIT-C64378'),('CL-COUNTRY-T-15',NULL,'AUS','The continent between the Indian Ocean and the South Pacific Ocean. (NCI)','\0','AUSTRALIA','CL-COUNTRY','DBX-NCIT-C16311'),('CL-COUNTRY-T-150',NULL,'MNG','A country in Northern Asia, between China and Russia. (NCI)','\0','MONGOLIA','CL-COUNTRY','DBX-NCIT-C16875'),('CL-COUNTRY-T-151',NULL,'MNP','A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)','\0','NORTHERN MARIANA ISLANDS','CL-COUNTRY','DBX-NCIT-C17882'),('CL-COUNTRY-T-152',NULL,'MOZ','A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania. (NCI)','\0','MOZAMBIQUE','CL-COUNTRY','DBX-NCIT-C16882'),('CL-COUNTRY-T-153',NULL,'MRT','A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara. (NCI)','\0','MAURITANIA','CL-COUNTRY','DBX-NCIT-C16826'),('CL-COUNTRY-T-154',NULL,'MSR','A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico. (NCI)','\0','MONTSERRAT','CL-COUNTRY','DBX-NCIT-C16876'),('CL-COUNTRY-T-155',NULL,'MTQ','An island in the Caribbean Sea, north of Trinidad and Tobago. (NCI)','\0','MARTINIQUE','CL-COUNTRY','DBX-NCIT-C16823'),('CL-COUNTRY-T-156',NULL,'MUS','A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)','\0','MAURITIUS','CL-COUNTRY','DBX-NCIT-C16827'),('CL-COUNTRY-T-157',NULL,'MWI','A country in Southern Africa, east of Zambia. (NCI)','\0','MALAWI','CL-COUNTRY','DBX-NCIT-C16813'),('CL-COUNTRY-T-158',NULL,'MYS','A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam. (NCI)','\0','MALAYSIA','CL-COUNTRY','DBX-NCIT-C16814'),('CL-COUNTRY-T-159',NULL,'MYT','A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique. (NCI)','\0','MAYOTTE','CL-COUNTRY','DBX-NCIT-C16828'),('CL-COUNTRY-T-16',NULL,'AUT','A country in Central Europe, north of Italy and Slovenia. (NCI)','\0','AUSTRIA','CL-COUNTRY','DBX-NCIT-C16312'),('CL-COUNTRY-T-160',NULL,'NAM','A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI)','\0','NAMIBIA','CL-COUNTRY','DBX-NCIT-C16891'),('CL-COUNTRY-T-161',NULL,'NCL','A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia. (NCI)','\0','NEW CALEDONIA','CL-COUNTRY','DBX-NCIT-C16913'),('CL-COUNTRY-T-162',NULL,'NER','A country in Western Africa, southeast of Algeria. (NCI)','\0','NIGER','CL-COUNTRY','DBX-NCIT-C16916'),('CL-COUNTRY-T-163',NULL,'NFK','A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia. (NCI)','\0','NORFOLK ISLAND','CL-COUNTRY','DBX-NCIT-C16919'),('CL-COUNTRY-T-164',NULL,'NGA','A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon. (NCI)','\0','NIGERIA','CL-COUNTRY','DBX-NCIT-C16917'),('CL-COUNTRY-T-165',NULL,'NIC','A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras. (NCI)','\0','NICARAGUA','CL-COUNTRY','DBX-NCIT-C16915'),('CL-COUNTRY-T-166',NULL,'NIU','A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga. (NCI)','\0','NIUE','CL-COUNTRY','DBX-NCIT-C16918'),('CL-COUNTRY-T-167',NULL,'NLD','A country in Western Europe, bordering the North Sea, between Belgium and Germany. (NCI)','\0','NETHERLANDS','CL-COUNTRY','DBX-NCIT-C16903'),('CL-COUNTRY-T-168',NULL,'NOR','A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (NCI)','\0','NORWAY','CL-COUNTRY','DBX-NCIT-C16920'),('CL-COUNTRY-T-169',NULL,'NPL','A country in Southern Asia, between China and India. (NCI)','\0','NEPAL','CL-COUNTRY','DBX-NCIT-C16901'),('CL-COUNTRY-T-17',NULL,'AZE','A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia. (NCI)','\0','AZERBAIJAN','CL-COUNTRY','DBX-NCIT-C16316'),('CL-COUNTRY-T-170',NULL,'NRU','A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands. (NCI)','\0','NAURU','CL-COUNTRY','DBX-NCIT-C16896'),('CL-COUNTRY-T-171',NULL,'NZL','A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia. (NCI)','\0','NEW ZEALAND','CL-COUNTRY','DBX-NCIT-C16914'),('CL-COUNTRY-T-172',NULL,'OMN','A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates. (NCI)','\0','OMAN','CL-COUNTRY','DBX-NCIT-C16933'),('CL-COUNTRY-T-173',NULL,'PAK','A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. (NCI)','\0','PAKISTAN','CL-COUNTRY','DBX-NCIT-C16949'),('CL-COUNTRY-T-174',NULL,'PAN','A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica. (NCI)','\0','PANAMA','CL-COUNTRY','DBX-NCIT-C16951'),('CL-COUNTRY-T-175',NULL,'PCN','A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand. (NCI)','\0','PITCAIRN','CL-COUNTRY','DBX-NCIT-C16993'),('CL-COUNTRY-T-176',NULL,'PER','A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador. (NCI)','\0','PERU','CL-COUNTRY','DBX-NCIT-C16972'),('CL-COUNTRY-T-177',NULL,'PHL','A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam. (NCI)','\0','PHILIPPINES','CL-COUNTRY','DBX-NCIT-C16978'),('CL-COUNTRY-T-178',NULL,'PLW','A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines. (NCI)','\0','PALAU','CL-COUNTRY','DBX-NCIT-C17733'),('CL-COUNTRY-T-179',NULL,'PNG','A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia. (NCI)','\0','PAPUA NEW GUINEA','CL-COUNTRY','DBX-NCIT-C16952'),('CL-COUNTRY-T-18',NULL,'BDI','A country in Central Africa, east of Democratic Republic of the Congo. (NCI)','\0','BURUNDI','CL-COUNTRY','DBX-NCIT-C16371'),('CL-COUNTRY-T-180',NULL,'POL','A country in Central Europe, east of Germany. (NCI)','\0','POLAND','CL-COUNTRY','DBX-NCIT-C17002'),('CL-COUNTRY-T-181',NULL,'PRI','An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic. (NCI)','\0','PUERTO RICO','CL-COUNTRY','DBX-NCIT-C17043'),('CL-COUNTRY-T-182',NULL,'PRK','A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea. (NCI)','\0','KOREA, DEMOCRATIC PEOPLE\'S REPUBLIC OF; NORTH KOREA','CL-COUNTRY','DBX-NCIT-C16773'),('CL-COUNTRY-T-183',NULL,'PRT','A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain. (NCI)','\0','PORTUGAL','CL-COUNTRY','DBX-NCIT-C17006'),('CL-COUNTRY-T-184',NULL,'PRY','A country in Central South America, northeast of Argentina. (NCI)','\0','PARAGUAY','CL-COUNTRY','DBX-NCIT-C16953'),('CL-COUNTRY-T-185',NULL,'PSE','A collective name for the West Bank and the Gaza Strip, two territories in Palestine. (NCI)','\0','PALESTINIAN TERRITORY, OCCUPIED','CL-COUNTRY','DBX-NCIT-C20110'),('CL-COUNTRY-T-186',NULL,'PYF','An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia. (NCI)','\0','FRENCH POLYNESIA','CL-COUNTRY','DBX-NCIT-C16594'),('CL-COUNTRY-T-187',NULL,'QAT','A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia. (NCI)','\0','QATAR','CL-COUNTRY','DBX-NCIT-C17045'),('CL-COUNTRY-T-188',NULL,'REU','A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)','\0','REUNION','CL-COUNTRY','DBX-NCIT-C17095'),('CL-COUNTRY-T-189',NULL,'ROU','A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. (NCI)','\0','ROMANIA','CL-COUNTRY','DBX-NCIT-C17108'),('CL-COUNTRY-T-19',NULL,'BEL','A country in Western Europe, bordering the North Sea, between France and the Netherlands. (NCI)','\0','BELGIUM','CL-COUNTRY','DBX-NCIT-C16329'),('CL-COUNTRY-T-190',NULL,'RUS','A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean. (NCI)','\0','RUSSIAN FEDERATION','CL-COUNTRY','DBX-NCIT-C17111'),('CL-COUNTRY-T-191',NULL,'RWA','A country in Central Africa, east of Democratic Republic of the Congo. (NCI)','\0','RWANDA','CL-COUNTRY','DBX-NCIT-C17112'),('CL-COUNTRY-T-192',NULL,'SAU','A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. (NCI)','\0','SAUDI ARABIA','CL-COUNTRY','DBX-NCIT-C17117'),('CL-COUNTRY-T-193',NULL,'SDN','A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea. (NCI)','\0','SUDAN','CL-COUNTRY','DBX-NCIT-C17170'),('CL-COUNTRY-T-194',NULL,'SEN','A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania. (NCI)','\0','SENEGAL','CL-COUNTRY','DBX-NCIT-C17121'),('CL-COUNTRY-T-195',NULL,'SGP','A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia. (NCI)','\0','SINGAPORE','CL-COUNTRY','DBX-NCIT-C17134'),('CL-COUNTRY-T-196',NULL,'SGS','A group of islands in the South Atlantic Ocean, east of the tip of South America. (NCI)','\0','SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS','CL-COUNTRY','DBX-NCIT-C20111'),('CL-COUNTRY-T-197',NULL,'SHN','Islands in the South Atlantic Ocean, about midway between South America and Africa. (NCI)','\0','SAINT HELENA; SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA','CL-COUNTRY','DBX-NCIT-C17164'),('CL-COUNTRY-T-198',NULL,'SJM','Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway. (NCI)','\0','SVALBARD AND JAN MAYEN','CL-COUNTRY','DBX-NCIT-C17178'),('CL-COUNTRY-T-199',NULL,'SLB','A group of islands in the South Pacific Ocean, east of Papua New Guinea. (NCI)','\0','SOLOMON ISLANDS','CL-COUNTRY','DBX-NCIT-C17148'),('CL-COUNTRY-T-2',NULL,'AFG','A country in Southern Asia, north and west of Pakistan, east of Iran. (NCI)','\0','AFGHANISTAN','CL-COUNTRY','DBX-NCIT-C16267'),('CL-COUNTRY-T-20',NULL,'BEN','A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo. (NCI)','\0','BENIN; BENIN REPUBLIC','CL-COUNTRY','DBX-NCIT-C16333'),('CL-COUNTRY-T-200',NULL,'SLE','A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia. (NCI)','\0','SIERRA LEONE','CL-COUNTRY','DBX-NCIT-C17130'),('CL-COUNTRY-T-201',NULL,'SLV','A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras. (NCI)','\0','EL SALVADOR','CL-COUNTRY','DBX-NCIT-C16532'),('CL-COUNTRY-T-202',NULL,'SMR','A country in Southern Europe, an enclave in central Italy. (NCI)','\0','SAN MARINO','CL-COUNTRY','DBX-NCIT-C17115'),('CL-COUNTRY-T-203',NULL,'SOM','A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia. (NCI)','\0','SOMALIA','CL-COUNTRY','DBX-NCIT-C17149'),('CL-COUNTRY-T-204',NULL,'SPM','A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada). (NCI)','\0','SAINT PIERRE AND MIQUELON','CL-COUNTRY','DBX-NCIT-C17165'),('CL-COUNTRY-T-205',NULL,'SRB','A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)','\0','SERBIA','CL-COUNTRY','DBX-NCIT-C64377'),('CL-COUNTRY-T-206',NULL,'SSD','A northeastern African country located in the Sahel region and bordered by Sudan in the north, Uganda and Kenya in the south and Ethiopia in the west. (NCI)','\0','SOUTH SUDAN','CL-COUNTRY','DBX-NCIT-C97351'),('CL-COUNTRY-T-207',NULL,'STP','A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon. (NCI)','\0','SAO TOME AND PRINCIPE','CL-COUNTRY','DBX-NCIT-C17116'),('CL-COUNTRY-T-208',NULL,'SUR','A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana. (NCI)','\0','SURINAME','CL-COUNTRY','DBX-NCIT-C17175'),('CL-COUNTRY-T-209',NULL,'SVK','A country in Central Europe, south of Poland. (NCI)','\0','SLOVAKIA','CL-COUNTRY','DBX-NCIT-C17669'),('CL-COUNTRY-T-21',NULL,'BES','Three Caribbean islands that are part of the Lesser Antilles; Bonaire is east of Aruba and Curacao off the coast of Venezuela, Sint Eustatius and Saba are located south of Sint Maarten and northeast of Saint Kitts and Nevis. (NCI)','\0','BONAIRE, SINT EUSTATIUS AND SABA','CL-COUNTRY','DBX-NCIT-C101224'),('CL-COUNTRY-T-210',NULL,'SVN','A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia. (NCI)','\0','SLOVENIA','CL-COUNTRY','DBX-NCIT-C17138'),('CL-COUNTRY-T-211',NULL,'SWE','A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (NCI)','\0','SWEDEN','CL-COUNTRY','DBX-NCIT-C17180'),('CL-COUNTRY-T-212',NULL,'SWZ','A country in Southern Africa, between Mozambique and South Africa. (NCI)','\0','SWAZILAND','CL-COUNTRY','DBX-NCIT-C17179'),('CL-COUNTRY-T-213',NULL,'SXM','The southern portion of an island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI)','\0','SINT MAARTEN (DUTCH PART); SINT MAARTEN (DUTCH)','CL-COUNTRY','DBX-NCIT-C101226'),('CL-COUNTRY-T-214',NULL,'SYC','A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar. (NCI)','\0','SEYCHELLES','CL-COUNTRY','DBX-NCIT-C17129'),('CL-COUNTRY-T-215',NULL,'SYR','A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey. (NCI)','\0','SYRIAN ARAB REPUBLIC','CL-COUNTRY','DBX-NCIT-C17182'),('CL-COUNTRY-T-216',NULL,'TCA','Two island groups in the North Atlantic Ocean, southeast of The Bahamas. (NCI)','\0','TURKS AND CAICOS ISLANDS','CL-COUNTRY','DBX-NCIT-C17224'),('CL-COUNTRY-T-217',NULL,'TCD','A country in Central Africa, south of Libya. (NCI)','\0','CHAD','CL-COUNTRY','DBX-NCIT-C16412'),('CL-COUNTRY-T-218',NULL,'TGO','A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana. (NCI)','\0','TOGO','CL-COUNTRY','DBX-NCIT-C17202'),('CL-COUNTRY-T-219',NULL,'THA','A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma. (NCI)','\0','THAILAND','CL-COUNTRY','DBX-NCIT-C17192'),('CL-COUNTRY-T-22',NULL,'BFA','A country in Western Africa, north of Ghana. (NCI)','\0','BURKINA FASO','CL-COUNTRY','DBX-NCIT-C16369'),('CL-COUNTRY-T-220',NULL,'TJK','A country in Central Asia, west of China. (NCI)','\0','TAJIKISTAN','CL-COUNTRY','DBX-NCIT-C17183'),('CL-COUNTRY-T-221',NULL,'TKL','A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)','\0','TOKELAU','CL-COUNTRY','DBX-NCIT-C17704'),('CL-COUNTRY-T-222',NULL,'TKM','A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan. (NCI)','\0','TURKMENISTAN','CL-COUNTRY','DBX-NCIT-C17223'),('CL-COUNTRY-T-223',NULL,'TLS','A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the i','\0','TIMOR-LESTE','CL-COUNTRY','DBX-NCIT-C17200'),('CL-COUNTRY-T-224',NULL,'TON','An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)','\0','TONGA','CL-COUNTRY','DBX-NCIT-C17205'),('CL-COUNTRY-T-225',NULL,'TTO','Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)','\0','TRINIDAD AND TOBAGO','CL-COUNTRY','DBX-NCIT-C17217'),('CL-COUNTRY-T-226',NULL,'TUN','A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya. (NCI)','\0','TUNISIA','CL-COUNTRY','DBX-NCIT-C17221'),('CL-COUNTRY-T-227',NULL,'TUR','A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between G','\0','TURKEY','CL-COUNTRY','DBX-NCIT-C17222'),('CL-COUNTRY-T-228',NULL,'TUV','An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)','\0','TUVALU','CL-COUNTRY','DBX-NCIT-C17225'),('CL-COUNTRY-T-229',NULL,'TWN','A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. (NCI)','\0','TAIWAN','CL-COUNTRY','DBX-NCIT-C17184'),('CL-COUNTRY-T-23',NULL,'BGD','A country in Southern Asia, bordering the Bay of Bengal, between Burma and India. (NCI)','\0','BANGLADESH','CL-COUNTRY','DBX-NCIT-C16323'),('CL-COUNTRY-T-230',NULL,'TZA','A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique. (NCI)','\0','TANZANIA, UNITED REPUBLIC OF','CL-COUNTRY','DBX-NCIT-C17185'),('CL-COUNTRY-T-231',NULL,'UGA','A country in Eastern Africa, west of Kenya. (NCI)','\0','UGANDA','CL-COUNTRY','DBX-NCIT-C17228'),('CL-COUNTRY-T-232',NULL,'UKR','A country in Eastern Europe, bordering the Black Sea, between Poland and Russia. (NCI)','\0','UKRAINE','CL-COUNTRY','DBX-NCIT-C17229'),('CL-COUNTRY-T-233',NULL,'UMI','The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll). (NCI)','\0','UNITED STATES MINOR OUTLYING ISLANDS','CL-COUNTRY','DBX-NCIT-C20112'),('CL-COUNTRY-T-234',NULL,'URY','A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil. (NCI)','\0','URUGUAY','CL-COUNTRY','DBX-NCIT-C17244'),('CL-COUNTRY-T-235',NULL,'USA','A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico. (NCI)','\0','UNITED STATES','CL-COUNTRY','DBX-NCIT-C17234'),('CL-COUNTRY-T-236',NULL,'UZB','A country in Central Asia, north of Afghanistan. (NCI)','\0','UZBEKISTAN','CL-COUNTRY','DBX-NCIT-C17246'),('CL-COUNTRY-T-237',NULL,'VAT','An enclave of Rome (Italy). (NCI)','\0','VATICAN CITY STATE','CL-COUNTRY','DBX-NCIT-C17249'),('CL-COUNTRY-T-238',NULL,'VCT','A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago. (NCI)','\0','SAINT VINCENT AND THE GRENADINES','CL-COUNTRY','DBX-NCIT-C17114'),('CL-COUNTRY-T-239',NULL,'VEN','A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (NCI)','\0','VENEZUELA; VENEZUELA, BOLIVARIAN REPUBLIC OF','CL-COUNTRY','DBX-NCIT-C17250'),('CL-COUNTRY-T-24',NULL,'BGR','A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. (NCI)','\0','BULGARIA','CL-COUNTRY','DBX-NCIT-C16368'),('CL-COUNTRY-T-240',NULL,'VGB','Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)','\0','VIRGIN ISLANDS, BRITISH','CL-COUNTRY','DBX-NCIT-C17653'),('CL-COUNTRY-T-241',NULL,'VIR','Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)','\0','VIRGIN ISLANDS, U.S.','CL-COUNTRY','DBX-NCIT-C17255'),('CL-COUNTRY-T-242',NULL,'VNM','A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia. (NCI)','\0','VIET NAM; VIETNAM','CL-COUNTRY','DBX-NCIT-C17252'),('CL-COUNTRY-T-243',NULL,'VUT','A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia. (NCI)','\0','VANUATU','CL-COUNTRY','DBX-NCIT-C17247'),('CL-COUNTRY-T-244',NULL,'WLF','Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)','\0','WALLIS AND FUTUNA','CL-COUNTRY','DBX-NCIT-C17259'),('CL-COUNTRY-T-245',NULL,'WSM','A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)','\0','SAMOA','CL-COUNTRY','DBX-NCIT-C17740'),('CL-COUNTRY-T-246',NULL,'YEM','A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia. (NCI)','\0','YEMEN','CL-COUNTRY','DBX-NCIT-C17264'),('CL-COUNTRY-T-247',NULL,'ZAF','A country in Southern Africa, at the southern tip of the continent of Africa. (NCI)','\0','SOUTH AFRICA','CL-COUNTRY','DBX-NCIT-C17151'),('CL-COUNTRY-T-248',NULL,'ZMB','A country in Southern Africa, east of Angola. (NCI)','\0','ZAMBIA','CL-COUNTRY','DBX-NCIT-C17267'),('CL-COUNTRY-T-249',NULL,'ZWE','A country in Southern Africa, between South Africa and Zambia. (NCI)','\0','ZIMBABWE','CL-COUNTRY','DBX-NCIT-C17268'),('CL-COUNTRY-T-25',NULL,'BHR','An archipelago in the Persian Gulf, east of Saudi Arabia. (NCI)','\0','BAHRAIN','CL-COUNTRY','DBX-NCIT-C16322'),('CL-COUNTRY-T-26',NULL,'BHS','A chain of islands in the North Atlantic Ocean, southeast of Florida. (NCI)','\0','BAHAMAS','CL-COUNTRY','DBX-NCIT-C16321'),('CL-COUNTRY-T-27',NULL,'BIH','A country in Southeastern Europe, bordering the Adriatic Sea and Croatia. (NCI)','\0','BOSNIA AND HERZEGOVINA; BOSNIA-HERZEGOVINA','CL-COUNTRY','DBX-NCIT-C16361'),('CL-COUNTRY-T-28',NULL,'BLM','An island in the Caribbean sea, between Saint Martin and Saint Kitts and Nevis. (NCI)','\0','SAINT BARTHELEMY','CL-COUNTRY','DBX-NCIT-C83609'),('CL-COUNTRY-T-29',NULL,'BLR','A country in Eastern Europe, east of Poland. (NCI)','\0','BELARUS','CL-COUNTRY','DBX-NCIT-C16372'),('CL-COUNTRY-T-3',NULL,'AGO','A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo. (NCI)','\0','ANGOLA','CL-COUNTRY','DBX-NCIT-C16292'),('CL-COUNTRY-T-30',NULL,'BLZ','A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico. (NCI)','\0','BELIZE','CL-COUNTRY','DBX-NCIT-C16331'),('CL-COUNTRY-T-31',NULL,'BMU','A group of islands in the North Atlantic Ocean, east of South Carolina. (NCI)','\0','BERMUDA','CL-COUNTRY','DBX-NCIT-C16334'),('CL-COUNTRY-T-32',NULL,'BOL','A country in Central South America, southwest of Brazil. (NCI)','\0','BOLIVIA; BOLIVIA, PLURINATIONAL STATE OF','CL-COUNTRY','DBX-NCIT-C16359'),('CL-COUNTRY-T-33',NULL,'BRA','A country in Eastern South America, bordering the Atlantic Ocean. (NCI)','\0','BRAZIL','CL-COUNTRY','DBX-NCIT-C16364'),('CL-COUNTRY-T-34',NULL,'BRB','An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)','\0','BARBADOS','CL-COUNTRY','DBX-NCIT-C16324'),('CL-COUNTRY-T-35',NULL,'BRN','A country in Southeastern Asia, bordering the South China Sea and Malaysia. (NCI)','\0','BRUNEI; BRUNEI DARUSSALAM','CL-COUNTRY','DBX-NCIT-C16367'),('CL-COUNTRY-T-36',NULL,'BTN','A country in Southern Asia, between China and India. (NCI)','\0','BHUTAN','CL-COUNTRY','DBX-NCIT-C16336'),('CL-COUNTRY-T-37',NULL,'BVT','An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa). (NCI)','\0','BOUVET ISLAND','CL-COUNTRY','DBX-NCIT-C20104'),('CL-COUNTRY-T-38',NULL,'BWA','A country in Southern Africa, north of South Africa. (NCI)','\0','BOTSWANA','CL-COUNTRY','DBX-NCIT-C16363'),('CL-COUNTRY-T-39',NULL,'CAF','A country in Central Africa, north of Democratic Republic of the Congo. (NCI)','\0','CENTRAL AFRICAN REPUBLIC','CL-COUNTRY','DBX-NCIT-C16409'),('CL-COUNTRY-T-4',NULL,'AIA','An island in the Caribbean Sea, east of Puerto Rico. (NCI)','\0','ANGUILLA','CL-COUNTRY','DBX-NCIT-C20133'),('CL-COUNTRY-T-40',NULL,'CAN','A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US. (NCI)','\0','CANADA','CL-COUNTRY','DBX-NCIT-C16380'),('CL-COUNTRY-T-41',NULL,'CCK','A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka. (NCI)','\0','COCOS (KEELING) ISLANDS','CL-COUNTRY','DBX-NCIT-C16445'),('CL-COUNTRY-T-42',NULL,'CHE','A country in Central Europe, east of France, north of Italy. (NCI)','\0','SWITZERLAND','CL-COUNTRY','DBX-NCIT-C17181'),('CL-COUNTRY-T-43',NULL,'CHL','A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru. (NCI)','\0','CHILE','CL-COUNTRY','DBX-NCIT-C16427'),('CL-COUNTRY-T-44',NULL,'CHN','A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam. (NCI)','\0','CHINA','CL-COUNTRY','DBX-NCIT-C16428'),('CL-COUNTRY-T-45',NULL,'CIV','A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia. (NCI)','\0','COTE D\'IVOIRE','CL-COUNTRY','DBX-NCIT-C16762'),('CL-COUNTRY-T-46',NULL,'CMR','A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria. (NCI)','\0','CAMEROON','CL-COUNTRY','DBX-NCIT-C16379'),('CL-COUNTRY-T-47',NULL,'COD','A country in Central Africa, northeast of Angola. (NCI)','\0','CONGO, THE DEMOCRATIC REPUBLIC OF; DEMOCRATIC REPUBLIC OF THE CONGO','CL-COUNTRY','DBX-NCIT-C17266'),('CL-COUNTRY-T-48',NULL,'COG','A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon. (NCI)','\0','CONGO','CL-COUNTRY','DBX-NCIT-C16467'),('CL-COUNTRY-T-49',NULL,'COK','A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)','\0','COOK ISLANDS','CL-COUNTRY','DBX-NCIT-C16469'),('CL-COUNTRY-T-5',NULL,'ALA','An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland. (NCI)','\0','ALAND ISLANDS','CL-COUNTRY','DBX-NCIT-C44481'),('CL-COUNTRY-T-50',NULL,'COL','A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama. (NCI)','\0','COLOMBIA','CL-COUNTRY','DBX-NCIT-C16449'),('CL-COUNTRY-T-51',NULL,'COM','A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique. (NCI)','\0','COMOROS','CL-COUNTRY','DBX-NCIT-C16458'),('CL-COUNTRY-T-52',NULL,'CPV','A group of islands in the North Atlantic Ocean, west of Senegal. (NCI)','\0','CAPE VERDE','CL-COUNTRY','DBX-NCIT-C16382'),('CL-COUNTRY-T-53',NULL,'CRI','A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama. (NCI)','\0','COSTA RICA','CL-COUNTRY','DBX-NCIT-C16470'),('CL-COUNTRY-T-54',NULL,'CUB','An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida. (NCI)','\0','CUBA','CL-COUNTRY','DBX-NCIT-C16477'),('CL-COUNTRY-T-55',NULL,'CUW','An island nation located in the Caribbean Sea off the coast of Venezuela. (NCI)','\0','CURACAO','CL-COUNTRY','DBX-NCIT-C101225'),('CL-COUNTRY-T-56',NULL,'CXR','An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia. (NCI)','\0','CHRISTMAS ISLAND','CL-COUNTRY','DBX-NCIT-C44482'),('CL-COUNTRY-T-57',NULL,'CYM','An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras. (NCI)','\0','CAYMAN ISLANDS','CL-COUNTRY','DBX-NCIT-C16391'),('CL-COUNTRY-T-58',NULL,'CYP','An island in the Mediterranean Sea, south of Turkey. (NCI)','\0','CYPRUS','CL-COUNTRY','DBX-NCIT-C16480'),('CL-COUNTRY-T-59',NULL,'CZE','A country in Central Europe, southeast of Germany. (NCI)','\0','CZECH REPUBLIC','CL-COUNTRY','DBX-NCIT-C17668'),('CL-COUNTRY-T-6',NULL,'ALB','A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro. (NCI)','\0','ALBANIA','CL-COUNTRY','DBX-NCIT-C16271'),('CL-COUNTRY-T-60',NULL,'DEU','A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. (NCI)','\0','GERMANY','CL-COUNTRY','DBX-NCIT-C16636'),('CL-COUNTRY-T-61',NULL,'DJI','A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia. (NCI)','\0','DJIBOUTI','CL-COUNTRY','DBX-NCIT-C16506'),('CL-COUNTRY-T-62',NULL,'DMA','An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago. (NCI)','\0','DOMINICA','CL-COUNTRY','DBX-NCIT-C16519'),('CL-COUNTRY-T-63',NULL,'DNK','A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (NCI)','\0','DENMARK','CL-COUNTRY','DBX-NCIT-C16496'),('CL-COUNTRY-T-64',NULL,'DOM','A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti. (NCI)','\0','DOMINICAN REPUBLIC','CL-COUNTRY','DBX-NCIT-C16520'),('CL-COUNTRY-T-65',NULL,'DZA','A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia. (NCI)','\0','ALGERIA','CL-COUNTRY','DBX-NCIT-C16274'),('CL-COUNTRY-T-66',NULL,'ECU','A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru. (NCI)','\0','ECUADOR','CL-COUNTRY','DBX-NCIT-C16528'),('CL-COUNTRY-T-67',NULL,'EGY','A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip. (NCI)','\0','EGYPT','CL-COUNTRY','DBX-NCIT-C16530'),('CL-COUNTRY-T-68',NULL,'ERI','A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan. (NCI)','\0','ERITREA','CL-COUNTRY','DBX-NCIT-C16558'),('CL-COUNTRY-T-69',NULL,'ESH','A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco. (NCI)','\0','WESTERN SAHARA','CL-COUNTRY','DBX-NCIT-C20113'),('CL-COUNTRY-T-7',NULL,'AND','A country in Southwestern Europe, between France and Spain. (NCI)','\0','ANDORRA','CL-COUNTRY','DBX-NCIT-C16289'),('CL-COUNTRY-T-70',NULL,'ESP','A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (NCI)','\0','SPAIN','CL-COUNTRY','DBX-NCIT-C17152'),('CL-COUNTRY-T-71',NULL,'EST','A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia. (NCI)','\0','ESTONIA','CL-COUNTRY','DBX-NCIT-C16562'),('CL-COUNTRY-T-72',NULL,'ETH','A country in Eastern Africa, west of Somalia. (NCI)','\0','ETHIOPIA','CL-COUNTRY','DBX-NCIT-C16563'),('CL-COUNTRY-T-73',NULL,'FIN','A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (NCI)','\0','FINLAND','CL-COUNTRY','DBX-NCIT-C16584'),('CL-COUNTRY-T-74',NULL,'FJI','An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)','\0','FIJI','CL-COUNTRY','DBX-NCIT-C16582'),('CL-COUNTRY-T-75',NULL,'FLK','Islands in the South Atlantic Ocean, east of southern Argentina. (NCI)','\0','FALKLAND ISLANDS; FALKLAND ISLANDS (MALVINAS)','CL-COUNTRY','DBX-NCIT-C17954'),('CL-COUNTRY-T-76',NULL,'FRA','A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain. (NCI)','\0','FRANCE','CL-COUNTRY','DBX-NCIT-C16592'),('CL-COUNTRY-T-77',NULL,'FRO','An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway. (NCI)','\0','FAROE ISLANDS','CL-COUNTRY','DBX-NCIT-C16573'),('CL-COUNTRY-T-78',NULL,'FSM','An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia. (NCI)','\0','MICRONESIA, FEDERATED STATES OF','CL-COUNTRY','DBX-NCIT-C17881'),('CL-COUNTRY-T-79',NULL,'GAB','A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea. (NCI)','\0','GABON','CL-COUNTRY','DBX-NCIT-C16596'),('CL-COUNTRY-T-8',NULL,'ARE','A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia. (NCI)','\0','UNITED ARAB EMIRATES','CL-COUNTRY','DBX-NCIT-C17232'),('CL-COUNTRY-T-80',NULL,'GBR','A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France. (NCI)','\0','UNITED KINGDOM','CL-COUNTRY','DBX-NCIT-C17233'),('CL-COUNTRY-T-81',NULL,'GEO','A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia. (NCI)','\0','GEORGIA','CL-COUNTRY','DBX-NCIT-C16634'),('CL-COUNTRY-T-82',NULL,'GGY','The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK. (NCI)','\0','GUERNSEY','CL-COUNTRY','DBX-NCIT-C64375'),('CL-COUNTRY-T-83',NULL,'GHA','A country in Western Africa, bordering the Gulf of Guinea, between Cote d\'Ivoire and Togo. (NCI)','\0','GHANA','CL-COUNTRY','DBX-NCIT-C26330'),('CL-COUNTRY-T-84',NULL,'GIB','A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain. (NCI)','\0','GIBRALTAR','CL-COUNTRY','DBX-NCIT-C16638'),('CL-COUNTRY-T-85',NULL,'GIN','A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone. (NCI)','\0','GUINEA','CL-COUNTRY','DBX-NCIT-C16655'),('CL-COUNTRY-T-86',NULL,'GLP','Islands in the eastern Caribbean Sea, southeast of Puerto Rico. (NCI)','\0','GUADELOUPE','CL-COUNTRY','DBX-NCIT-C16651'),('CL-COUNTRY-T-87',NULL,'GMB','A country in Western Africa, bordering the North Atlantic Ocean and Senegal. (NCI)','\0','GAMBIA','CL-COUNTRY','DBX-NCIT-C16598'),('CL-COUNTRY-T-88',NULL,'GNB','A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal. (NCI)','\0','GUINEA-BISSAU','CL-COUNTRY','DBX-NCIT-C16656'),('CL-COUNTRY-T-89',NULL,'GNQ','A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands. (NCI)','\0','EQUATORIAL GUINEA','CL-COUNTRY','DBX-NCIT-C16557'),('CL-COUNTRY-T-9',NULL,'ARG','A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (NCI)','\0','ARGENTINA','CL-COUNTRY','DBX-NCIT-C16305'),('CL-COUNTRY-T-90',NULL,'GRC','A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (NCI)','\0','GREECE','CL-COUNTRY','DBX-NCIT-C16645'),('CL-COUNTRY-T-91',NULL,'GRD','An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago. (NCI)','\0','GRENADA','CL-COUNTRY','DBX-NCIT-C16647'),('CL-COUNTRY-T-92',NULL,'GRL','An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada. (NCI)','\0','GREENLAND','CL-COUNTRY','DBX-NCIT-C16646'),('CL-COUNTRY-T-93',NULL,'GTM','A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico. (NCI)','\0','GUATEMALA','CL-COUNTRY','DBX-NCIT-C16654'),('CL-COUNTRY-T-94',NULL,'GUF','A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname. (NCI)','\0','FRENCH GUIANA','CL-COUNTRY','DBX-NCIT-C16593'),('CL-COUNTRY-T-95',NULL,'GUM','Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)','\0','GUAM','CL-COUNTRY','DBX-NCIT-C16652'),('CL-COUNTRY-T-96',NULL,'GUY','A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela. (NCI)','\0','GUYANA','CL-COUNTRY','DBX-NCIT-C16657'),('CL-COUNTRY-T-97',NULL,'HKG','A special administrative region of China, bordering the South China Sea and China. (NCI)','\0','HONG KONG','CL-COUNTRY','DBX-NCIT-C16695'),('CL-COUNTRY-T-98',NULL,'HMD','Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica. (NCI)','\0','HEARD ISLAND AND MCDONALD ISLANDS','CL-COUNTRY','DBX-NCIT-C20106'),('CL-COUNTRY-T-99',NULL,'HND','A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua. (NCI)','\0','HONDURAS','CL-COUNTRY','DBX-NCIT-C16694'),('CL-CRYDFMAN-T-1',NULL,'ATRIAL PACING MALFUNCTION','The cardiac rhythm device malfunction affected atrial pacing.','\0','','CL-CRYDFMAN','DBX-NCIT-C99921'),('CL-CRYDFMAN-T-2',NULL,'DEFIBRILLATION MALFUNCTION','The cardiac rhythm device malfunction affected the defibrillator.','\0','','CL-CRYDFMAN','DBX-NCIT-C99923'),('CL-CRYDFMAN-T-3',NULL,'LEFT VENTRICULAR PACING MALFUNCTION','The cardiac rhythm device malfunction affected the left ventricular (LV) pacing.','\0','','CL-CRYDFMAN','DBX-NCIT-C99973'),('CL-CRYDFMAN-T-4',NULL,'RIGHT VENTRICULAR PACING MALFUNCTION','The cardiac rhythm device malfunction affected the right ventricular (RV) pacing.','\0','','CL-CRYDFMAN','DBX-NCIT-C100011'),('CL-CSLVLNIM-T-1',NULL,'Could Not Obtain Acceptable Pacing Thresholds','The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain acceptable pacing thresholds.','\0','','CL-CSLVLNIM','DBX-NCIT-C100025'),('CL-CSLVLNIM-T-2',NULL,'Lead Position Results in Undesirable Stimulation of the Diaphragm','The coronary sinus/left ventricular lead was not implanted because the lead position resulted in undesirable stimulation of the diaphragm.','\0','','CL-CSLVLNIM','DBX-NCIT-C99933'),('CL-CSLVLNIM-T-3',NULL,'Previously Implanted','The coronary sinus/left ventricular lead was not implanted because a lead had been previously implanted.','\0','','CL-CSLVLNIM','DBX-NCIT-C100007'),('CL-CSLVLNIM-T-4',NULL,'Unable to Obtain Satisfactory Coronary Sinus Access','The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory coronary sinus access.','\0','','CL-CSLVLNIM','DBX-NCIT-C100026'),('CL-CSLVLNIM-T-5',NULL,'Unable to Obtain Satisfactory Vascular Access','The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory vascular access.','\0','','CL-CSLVLNIM','DBX-NCIT-C100027'),('CL-CSLVLNIM-T-6',NULL,'Unable to Position Lead Due to Coronary Sinus Dissection','The coronary sinus/left ventricular lead was not implanted because the coronary sinus was dissected.','\0','','CL-CSLVLNIM','DBX-NCIT-C100028'),('CL-CSLVLNIM-T-7',NULL,'Unable to Position Lead in Tributary Vein of Coronary Sinus','The coronary sinus/left ventricular lead was not implanted because the operator was unable to position the lead in the tributary vein of the coronary sinus.','\0','','CL-CSLVLNIM','DBX-NCIT-C100029'),('CL-CVEXAM-T-1',NULL,'Cardiac Valvular Regurgitation Severity','The qualitative measurement of the severity of cardiac valvular regurgitation.','\0','Cardiac Valvular Regurgitation Severity','CL-CVEXAM','DBX-NCIT-C102244'),('CL-CVEXAM-T-2',NULL,'Cardiac Valvular Stenosis Severity','The qualitative measurement of the severity of cardiac valvular stenosis.','\0','Cardiac Valvular Stenosis Severity','CL-CVEXAM','DBX-NCIT-C102245'),('CL-CVEXAM-T-3',NULL,'Coronary Artery Dominance','The contribution of blood supply from the right or left vessel system to the posterior descending artery. (ACC)','\0','Coronary Anatomy Dominance; Coronary Artery Dominance','CL-CVEXAM','DBX-NCIT-C100086'),('CL-CVEXAM-T-4',NULL,'Ischemic Myocardium Percentage','The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia).','\0','Ischemic Myocardium Percentage','CL-CVEXAM','DBX-NCIT-C80494'),('CL-CVEXAM-T-5',NULL,'Left Atrium Dimension','The diameter across the left atrium measured at the end of systole.','\0','Left Atrium Dimension','CL-CVEXAM','DBX-NCIT-C99970'),('CL-CVEXAM-T-6',NULL,'Left Ventricle Dimension, End-Diastole','The diameter across the ventricle at the end of diastole, excluding the thickness of the walls.','\0','Left Ventricle Dimension, End-Diastole','CL-CVEXAM','DBX-NCIT-C99976'),('CL-CVEXAM-T-7',NULL,'Left Ventricular Dimension, End-Systole','The diameter across the ventricle at the end of systole, excluding the thickness of the walls.','\0','Left Ventricular Dimension, End-Systole','CL-CVEXAM','DBX-NCIT-C99977'),('CL-CVEXAM-T-8',NULL,'Left Ventricular Ejection Fraction','The percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume.','\0','Left Ventricular Ejection Fraction','CL-CVEXAM','DBX-NCIT-C99524'),('CL-CVEXAM-T-9',NULL,'Number of Diseased Coronary Vessels','Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area.','\0','Number of Diseased Coronary Vessels','CL-CVEXAM','DBX-NCIT-C99996'),('CL-CVEXAMCD-T-1',NULL,'COARTDOM','The contribution of blood supply from the right or left vessel system to the posterior descending artery. (ACC)','\0','Coronary Anatomy Dominance; Coronary Artery Dominance','CL-CVEXAMCD','DBX-NCIT-C100086'),('CL-CVEXAMCD-T-2',NULL,'CVLREGTS','The qualitative measurement of the severity of cardiac valvular regurgitation.','\0','Cardiac Valvular Regurgitation Severity','CL-CVEXAMCD','DBX-NCIT-C102244'),('CL-CVEXAMCD-T-3',NULL,'CVLSTNS','The qualitative measurement of the severity of cardiac valvular stenosis.','\0','Cardiac Valvular Stenosis Severity','CL-CVEXAMCD','DBX-NCIT-C102245'),('CL-CVEXAMCD-T-4',NULL,'ISHMYOP','The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia).','\0','Ischemic Myocardium Percentage','CL-CVEXAMCD','DBX-NCIT-C80494'),('CL-CVEXAMCD-T-5',NULL,'LADMN','The diameter across the left atrium measured at the end of systole.','\0','Left Atrium Dimension','CL-CVEXAMCD','DBX-NCIT-C99970'),('CL-CVEXAMCD-T-6',NULL,'LVDMNED','The diameter across the ventricle at the end of diastole, excluding the thickness of the walls.','\0','Left Ventricle Dimension, End-Diastole','CL-CVEXAMCD','DBX-NCIT-C99976'),('CL-CVEXAMCD-T-7',NULL,'LVDMNES','The diameter across the ventricle at the end of systole, excluding the thickness of the walls.','\0','Left Ventricular Dimension, End-Systole','CL-CVEXAMCD','DBX-NCIT-C99977'),('CL-CVEXAMCD-T-8',NULL,'LVEF','The percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume.','\0','Left Ventricular Ejection Fraction','CL-CVEXAMCD','DBX-NCIT-C99524'),('CL-CVEXAMCD-T-9',NULL,'NUMDCAV','Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area.','\0','Number of Diseased Coronary Vessels','CL-CVEXAMCD','DBX-NCIT-C99996'),('CL-CVLSTSEV-T-1',NULL,'MILD CARDIAC VALVE STENOSIS','The cardiac valve orifice is abnormally narrow, to a mild degree.','\0','','CL-CVLSTSEV','DBX-NCIT-C99986'),('CL-CVLSTSEV-T-2',NULL,'MODERATE CARDIAC VALVE STENOSIS','The cardiac valve orifice is abnormally narrow, to a moderate degree.','\0','','CL-CVLSTSEV','DBX-NCIT-C99990'),('CL-CVLSTSEV-T-3',NULL,'NO CARDIAC VALVE STENOSIS','The cardiac valve orifice is not abnormally narrow.','\0','','CL-CVLSTSEV','DBX-NCIT-C99992'),('CL-CVLSTSEV-T-4',NULL,'SEVERE CARDIAC VALVE STENOSIS','The cardiac valve orifice is abnormally narrow, to a severe degree.','\0','','CL-CVLSTSEV','DBX-NCIT-C100013'),('CL-CVLVRSEV-T-1',NULL,'MILD CARDIAC VALVE REGURGITATION','Evidence of mild retrograde blood flow through the valve(s) of the heart.','\0','','CL-CVLVRSEV','DBX-NCIT-C99985'),('CL-CVLVRSEV-T-2',NULL,'MODERATE CARDIAC VALVE REGURGITATION','Evidence of moderate retrograde blood flow through the valve(s) of the heart.','\0','','CL-CVLVRSEV','DBX-NCIT-C99989'),('CL-CVLVRSEV-T-3',NULL,'NO CARDIAC VALVE REGURGITATION','No evidence of any retrograde blood flow through the valve(s) in the heart.','\0','','CL-CVLVRSEV','DBX-NCIT-C99991'),('CL-CVLVRSEV-T-4',NULL,'SEVERE CARDIAC VALVE REGURGITATION','Evidence of severe retrograde blood flow through the valve(s) of the heart.','\0','','CL-CVLVRSEV','DBX-NCIT-C100012'),('CL-CVPRCIND-T-1',NULL,'Candidate to Receive Cardiac Transplant','The intended recipient of a heart transplant.','\0','','CL-CVPRCIND','DBX-NCIT-C99919'),('CL-CVPRCIND-T-10',NULL,'Immediate Percutaneous Coronary Intervention (PCI) for St Elevation Myocardial Infarction (STEMI)','An immediate percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation.','\0','','CL-CVPRCIND','DBX-NCIT-C99961'),('CL-CVPRCIND-T-11',NULL,'Infection','A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. (NCI)','\0','','CL-CVPRCIND','DBX-NCIT-C26726'),('CL-CVPRCIND-T-12',NULL,'Lead Erosion','A cardiac lead has damaged local tissue enough to require treatment.','\0','','CL-CVPRCIND','DBX-NCIT-C99931'),('CL-CVPRCIND-T-13',NULL,'Left Ventricular Systolic Dysfunction','The degree of impairment of the left cardiac ventricle to contract efficiently.','\0','','CL-CVPRCIND','DBX-NCIT-C64251'),('CL-CVPRCIND-T-14',NULL,'Manufacturer Recall','An imperative issued by the manufacturer of a device that the device needs to be returned to a designated source for repair or replacement.','\0','','CL-CVPRCIND','DBX-NCIT-C100045'),('CL-CVPRCIND-T-15',NULL,'Manufacturer Recognized a Recurring Performance Failure','The device manufacturer had recognized a recurrent performance failure in the device.','\0','','CL-CVPRCIND','DBX-NCIT-C99980'),('CL-CVPRCIND-T-16',NULL,'Medical Condition Or Procedure Affects Implantation Site','The medical condition or the procedure affects the device implantation site.','\0','','CL-CVPRCIND','DBX-NCIT-C99982'),('CL-CVPRCIND-T-17',NULL,'Medical Or Surgical Procedure Requiring Relocation of Lead','An intended medical or surgical procedure necessitates the relocation of a cardiac lead.','\0','','CL-CVPRCIND','DBX-NCIT-C99983'),('CL-CVPRCIND-T-18',NULL,'Percutaneous Coronary Intervention (PCI) for High Risk Non-St Elevation Myocardial Infarction Or Unstable Angina','Includes patients with unstable angina or Non-STEMI who have high risk features for short-term risk of death or nonfatal MI. High risk features includes at least one of the following: history of accelerating tempo of ischemic symptoms in preceding 48 hour','\0','','CL-CVPRCIND','DBX-NCIT-C99999'),('CL-CVPRCIND-T-19',NULL,'Percutaneous Coronary Intervention (PCI) for St Elevation Myocardial Infarction (STEMI) (Stable After Successful Full-Dose Thrombolytics)','A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia after a successful do','\0','','CL-CVPRCIND','DBX-NCIT-C100001'),('CL-CVPRCIND-T-2',NULL,'Cardiac Arrest/Arrhythmia Etiology Unknown','An episode of cardiac arrest or arrhythmia where the etiology was unknown.','\0','','CL-CVPRCIND','DBX-NCIT-C100033'),('CL-CVPRCIND-T-20',NULL,'Percutaneous Coronary Intervention (PCI) for St Elevation Myocardial Infarction (STEMI) (Stable, >12 Hrs From Symptom Onset)','A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is ','\0','','CL-CVPRCIND','DBX-NCIT-C100000'),('CL-CVPRCIND-T-21',NULL,'Percutaneous Coronary Intervention (PCI) for St Elevation Myocardial Infarction (STEMI) (Unstable, >12 Hrs From Symptom Onset)','A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject has recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelv','\0','','CL-CVPRCIND','DBX-NCIT-C100002'),('CL-CVPRCIND-T-22',NULL,'Post-Cardiac Transplant','A procedure to evaluate the health of the an individual after receiving a heart transplant.','\0','','CL-CVPRCIND','DBX-NCIT-C100005'),('CL-CVPRCIND-T-23',NULL,'Pre-Operative Evaluation for Non-Cardiovascular Surgery','A procedure to evaluate the health of the cardiac system to determine feasibility of a non-cardiac related surgical procedure.','\0','','CL-CVPRCIND','DBX-NCIT-C100006'),('CL-CVPRCIND-T-24',NULL,'Primary Prevention','A procedure performed to avoid the first occurrence of a disease condition.','\0','','CL-CVPRCIND','DBX-NCIT-C15306'),('CL-CVPRCIND-T-25',NULL,'Rescue Percutaneous Coronary Intervention (PCI) for St Elevation Myocardial Infarction (STEMI) (After Failed Full-Dose Thrombolytics)','A percutaneous coronary intervention is imperative for a myocardial infarction that presents with ST segment elevation after an unsatisfactory response to a full dose of thrombolytic therapy.','\0','','CL-CVPRCIND','DBX-NCIT-C100008'),('CL-CVPRCIND-T-26',NULL,'Secondary Prevention','A procedure performed to avoid a subsequent occurrence of a disease condition.','\0','','CL-CVPRCIND','DBX-NCIT-C15712'),('CL-CVPRCIND-T-27',NULL,'Spontaneous Sustained Ventricular Tachycardia','Ventricular tachycardia that occurs without provocation and does not resolve spontaneously.','\0','','CL-CVPRCIND','DBX-NCIT-C100014'),('CL-CVPRCIND-T-28',NULL,'Staged Percutaneous Coronary Intervention (PCI)','A subsequent Percutaneous Coronary Intervention in a planned series of procedures, where the first PCI could have been during a prior admission, or during this admission.','\0','','CL-CVPRCIND','DBX-NCIT-C100015'),('CL-CVPRCIND-T-29',NULL,'Syncope with High Risk Characteristics','A sudden loss of consciousness with loss of postural tone not related to anesthesia with high risk characteristics. High risk characteristics include non-ischemic dilated cardiomyopathy, or ischemic heart disease with significant ventricular dysfunction, ','\0','','CL-CVPRCIND','DBX-NCIT-C100018'),('CL-CVPRCIND-T-3',NULL,'Cardiomyopathy','A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.','\0','','CL-CVPRCIND','DBX-NCIT-C34830'),('CL-CVPRCIND-T-30',NULL,'Syncope with Inducible Ventricular Tachycardia','Sudden loss of consciousness with loss of postural tone not related to anesthesia with ventricular tachycardia (VT) that can be induced during an electrophysiological study.','\0','','CL-CVPRCIND','DBX-NCIT-C100019'),('CL-CVPRCIND-T-31',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-CVPRCIND','DBX-NCIT-C17998'),('CL-CVPRCIND-T-32',NULL,'Upgrade to a Device with Additional Pacing Capabilities','A device with additional pacing capabilities is replacing the current device.','\0','','CL-CVPRCIND','DBX-NCIT-C100030'),('CL-CVPRCIND-T-33',NULL,'Ventricular Fibrillation','Ventricular Fibrillation is characterized by rapid, usually more than 300 bpm (cycle length: 180 ms or less), grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude.','\0','','CL-CVPRCIND','DBX-NCIT-C50799'),('CL-CVPRCIND-T-4',NULL,'Chronic Total Occlusion','A longstanding, complete blockage of a vessel.','\0','','CL-CVPRCIND','DBX-NCIT-C99938'),('CL-CVPRCIND-T-5',NULL,'Donor for Cardiac Transplant','The subject contributing a heart for a cardiac transplant.','\0','','CL-CVPRCIND','DBX-NCIT-C99947'),('CL-CVPRCIND-T-6',NULL,'End of Expected Battery Life','The battery that supplies the device has reached the end of its life.','\0','','CL-CVPRCIND','DBX-NCIT-C99949'),('CL-CVPRCIND-T-7',NULL,'Faulty Connector/Header','There is a faulty connector/header in the device.','\0','','CL-CVPRCIND','DBX-NCIT-C100035'),('CL-CVPRCIND-T-8',NULL,'Generator is Being Replaced at the Time of Lead Revision','A cardiac lead requires revision, at which time the generator to the device will be replaced.','\0','','CL-CVPRCIND','DBX-NCIT-C99925'),('CL-CVPRCIND-T-9',NULL,'Generator Malfunction','The device has a generator malfunction.','\0','','CL-CVPRCIND','DBX-NCIT-C99943'),('CL-CVSLDEXT-T-1',NULL,'INDETERMINATE','Cannot distinguish between two or more possible values in the current context. (NCI)','\0','Inconclusive','CL-CVSLDEXT','DBX-NCIT-C48658'),('CL-CVSLDEXT-T-2',NULL,'NO DISEASE','There was less than 50% stenosis (reduction in cross-sectional area) in all coronary artery branches.','\0','','CL-CVSLDEXT','DBX-NCIT-C99993'),('CL-CVSLDEXT-T-3',NULL,'ONE VESSEL DISEASE','There was greater than or equal to 50% stenosis (reduction in cross-sectional area) in one coronary artery.','\0','','CL-CVSLDEXT','DBX-NCIT-C99997'),('CL-CVSLDEXT-T-4',NULL,'THREE VESSEL DISEASE','There was greater than or equal to 50% stenosis (reduction in cross-sectional area) in three coronary arteries (or greater than or equal to 50% stenosis in the left main coronary artery and greater than or equal to 50% stenosis in the right coronary arter','\0','','CL-CVSLDEXT','DBX-NCIT-C100020'),('CL-CVSLDEXT-T-5',NULL,'TWO VESSEL DISEASE','There was greater than or equal to 50% stenosis (reduction in cross-sectional area) in two coronary arteries (or greater than or equal to 50% stenosis in the left main coronary artery).','\0','','CL-CVSLDEXT','DBX-NCIT-C100023'),('CL-CVSLDEXT-T-6',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-CVSLDEXT','DBX-NCIT-C17998'),('CL-DATEST-T-1',NULL,'Dispensed Amount','The quantity of a product that has been dispensed. (NCI)','\0','Dispensed Amount','CL-DATEST','DBX-NCIT-C78721'),('CL-DATEST-T-2',NULL,'Returned Amount','The quantity of a product that has been returned. (NCI)','\0','Returned Amount','CL-DATEST','DBX-NCIT-C78722'),('CL-DATESTCD-T-1',NULL,'DISPAMT','The quantity of a product that has been dispensed. (NCI)','\0','Dispensed Amount','CL-DATESTCD','DBX-NCIT-C78721'),('CL-DATESTCD-T-2',NULL,'RETAMT','The quantity of a product that has been returned. (NCI)','\0','Returned Amount','CL-DATESTCD','DBX-NCIT-C78722'),('CL-DDTEST-T-1',NULL,'Primary Cause of Death','The primary significant event which ultimately led to death.','\0','Primary Cause of Death','CL-DDTEST','DBX-NCIT-C99531'),('CL-DDTEST-T-2',NULL,'Secondary Cause of Death','The secondary significant event which ultimately led to death.','\0','Secondary Cause of Death','CL-DDTEST','DBX-NCIT-C116142'),('CL-DDTESTCD-T-1',NULL,'PRCDTH','The primary significant event which ultimately led to death.','\0','Primary Cause of Death','CL-DDTESTCD','DBX-NCIT-C99531'),('CL-DDTESTCD-T-2',NULL,'SECDTH','The secondary significant event which ultimately led to death.','\0','Secondary Cause of Death','CL-DDTESTCD','DBX-NCIT-C116142'),('CL-DEACNDEV-T-1',NULL,'CALIBRATION','The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument. (NCI)','\0','','CL-DEACNDEV','DBX-NCIT-C69187'),('CL-DEACNDEV-T-2',NULL,'REMOVAL','The act of taking out, extracting, or withdrawing an entity from a location.','\0','','CL-DEACNDEV','DBX-NCIT-C61575'),('CL-DEACNDEV-T-3',NULL,'REPROGRAMMING','The act of rewriting program code or application software. (NCI)','\0','','CL-DEACNDEV','DBX-NCIT-C111306'),('CL-DECAT-T-1',NULL,'CALIBRATION FAILURE','Issue associated with the failure of the device to perform a self-calibration procedure or process designed to assure the accuracy and proper performance of the device. (FDA)','\0','Calibrate, Failure To; Failure to Calibrate','CL-DECAT','DBX-NCIT-C62994'),('CL-DECAT-T-2',NULL,'COMPUTER SOFTWARE ISSUE','Issue associated with written programs, codes, and/or software system that affects device performance or communication with another device. (NCI)','\0','Software Malfunction','CL-DECAT','DBX-NCIT-C63269'),('CL-DECAT-T-3',NULL,'DATA STORAGE FAILURE','Issue associated with the failure of the software to store collected data.','\0','','CL-DECAT','DBX-NCIT-C116121'),('CL-DECAT-T-4',NULL,'DEVICE OPERATIONAL ISSUE','Issue associated with any deviations from specifications relating to device operations (e.g. deployment, connection, electrical, computer software, infusion/flow, output, protective-measure, and incompatibility issues).','\0','Device Operational Malfunction','CL-DECAT','DBX-NCIT-C62954'),('CL-DECAT-T-5',NULL,'NON-STUDY EQUIPMENT ISSUE','Issue associated with any deviations from specifications relating to non-study device or equipment operations.','\0','Non-Study Equipment Malfunction','CL-DECAT','DBX-NCIT-C112361'),('CL-DECAT-T-6',NULL,'SCHEDULED MAINTENANCE','An inspection and/or surveillance activity that has been anticipated to occur and was assigned a time or date when that activity is to be performed. (NCI)','\0','','CL-DECAT','DBX-NCIT-C111309'),('CL-DECAT-T-7',NULL,'SOFTWARE UPDATE','All program coding after initial deployment to correct coding errors, enhance the functionality of the software, and perfect the functioning of the software. (NCI)','\0','','CL-DECAT','DBX-NCIT-C67227'),('CL-DIABTHPY-T-1',NULL,'DIET','A form of therapy which includes dietary approaches and special diets.','\0','','CL-DIABTHPY','DBX-NCIT-C15383'),('CL-DIABTHPY-T-2',NULL,'INSULIN','A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus.','\0','','CL-DIABTHPY','DBX-NCIT-C581'),('CL-DIABTHPY-T-3',NULL,'NO TREATMENT','No treatment for diabetes.','\0','','CL-DIABTHPY','DBX-NCIT-C99994'),('CL-DIABTHPY-T-4',NULL,'ORAL MEDICATION','A pharmacological medication intended for administration through the mouth.','\0','','CL-DIABTHPY','DBX-NCIT-C102246'),('CL-DICTNAM-T-1',NULL,'COSTART','A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)','\0','Coding Symbols for a Thesaurus of Adverse Reaction Terms','CL-DICTNAM','DBX-NCIT-C49471'),('CL-DICTNAM-T-2',NULL,'ICD','A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health O','\0','International Classification of Diseases','CL-DICTNAM','DBX-NCIT-C49474'),('CL-DICTNAM-T-3',NULL,'LOINC','Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)','\0','Logical Observation Identifiers Names and Codes','CL-DICTNAM','DBX-NCIT-C49476'),('CL-DICTNAM-T-4',NULL,'MedDRA','MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the Intern','\0','Medical Dictionary for Regulatory Activities','CL-DICTNAM','DBX-NCIT-C43820'),('CL-DICTNAM-T-5',NULL,'SNOMED','A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)','\0','Systematized Nomenclature of Medicine','CL-DICTNAM','DBX-NCIT-C53489'),('CL-DICTNAM-T-6',NULL,'WHOART','A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)','\0','World Health Organization Adverse Reaction Terms','CL-DICTNAM','DBX-NCIT-C49468'),('CL-DICTNAM-T-7',NULL,'WHODD','A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)','\0','World Health Organization Drug Dictionary','CL-DICTNAM','DBX-NCIT-C49475'),('CL-DIPARM-T-1',NULL,'Batch Number','A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous.','\0','Batch Identifier; Batch Number','CL-DIPARM','DBX-NCIT-C104504'),('CL-DIPARM-T-2',NULL,'Device Type','Generic category of medical device within the device classification established by a regulatory authority.','\0','Device Type','CL-DIPARM','DBX-NCIT-C53265'),('CL-DIPARM-T-3',NULL,'FDA Unique Device Identification','A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number','\0','FDA Unique Device Identification','CL-DIPARM','DBX-NCIT-C112279'),('CL-DIPARM-T-4',NULL,'Lot Number','A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch.','\0','Lot Identifier; Lot Number','CL-DIPARM','DBX-NCIT-C70848'),('CL-DIPARM-T-5',NULL,'Manufacturer','The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG)','\0','Manufacturer','CL-DIPARM','DBX-NCIT-C25392'),('CL-DIPARM-T-6',NULL,'Model','The identifier assigned to a particular design of a device, usually an alphanumeric text string.','\0','Model; Model Identifier; Model Number','CL-DIPARM','DBX-NCIT-C99285'),('CL-DIPARM-T-7',NULL,'Secure Lead Type','The type of locking device used to securely fasten the electrical leads to the device. (NCI)','\0','Secure Lead Type','CL-DIPARM','DBX-NCIT-C111191'),('CL-DIPARM-T-8',NULL,'Serial Number','A unique identifier assigned to an individual object.','\0','Serial Number','CL-DIPARM','DBX-NCIT-C73518'),('CL-DIPARM-T-9',NULL,'Stereotactic Surgery Frame Type','The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI)','\0','Stereotactic Surgery Frame Type','CL-DIPARM','DBX-NCIT-C106570'),('CL-DIPARMCD-T-1',NULL,'BATCH','A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous.','\0','Batch Identifier; Batch Number','CL-DIPARMCD','DBX-NCIT-C104504'),('CL-DIPARMCD-T-2',NULL,'DEVTYPE','Generic category of medical device within the device classification established by a regulatory authority.','\0','Device Type','CL-DIPARMCD','DBX-NCIT-C53265'),('CL-DIPARMCD-T-3',NULL,'FDAUDI','A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number','\0','FDA Unique Device Identification','CL-DIPARMCD','DBX-NCIT-C112279'),('CL-DIPARMCD-T-4',NULL,'LOT','A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch.','\0','Lot Identifier; Lot Number','CL-DIPARMCD','DBX-NCIT-C70848'),('CL-DIPARMCD-T-5',NULL,'MANUF','The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG)','\0','Manufacturer','CL-DIPARMCD','DBX-NCIT-C25392'),('CL-DIPARMCD-T-6',NULL,'MODEL','The identifier assigned to a particular design of a device, usually an alphanumeric text string.','\0','Model; Model Identifier; Model Number','CL-DIPARMCD','DBX-NCIT-C99285'),('CL-DIPARMCD-T-7',NULL,'SECURLD','The type of locking device used to securely fasten the electrical leads to the device. (NCI)','\0','Secure Lead Type','CL-DIPARMCD','DBX-NCIT-C111191'),('CL-DIPARMCD-T-8',NULL,'SERIAL','A unique identifier assigned to an individual object.','\0','Serial Number','CL-DIPARMCD','DBX-NCIT-C73518'),('CL-DIPARMCD-T-9',NULL,'SFMTYP','The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI)','\0','Stereotactic Surgery Frame Type','CL-DIPARMCD','DBX-NCIT-C106570'),('CL-DIR-T-1',NULL,'ANTERIOR','Denoting the front portion of the body or a structure.','\0','','CL-DIR','DBX-NCIT-C25231'),('CL-DIR-T-10',NULL,'DORSOLATERAL','Toward the back and side of a body.','\0','','CL-DIR','DBX-NCIT-C90376'),('CL-DIR-T-11',NULL,'FORE','Of or involving the front of a main body. (NCI)','\0','','CL-DIR','DBX-NCIT-C90386'),('CL-DIR-T-12',NULL,'HIND','Of or involving the back of a main body. (NCI)','\0','','CL-DIR','DBX-NCIT-C90393'),('CL-DIR-T-13',NULL,'INFERIOR','Pertaining to a point below a given reference point.','\0','','CL-DIR','DBX-NCIT-C25353'),('CL-DIR-T-14',NULL,'INNER','Inside or closer to the inside of the body or object. (NCI)','\0','','CL-DIR','DBX-NCIT-C37980'),('CL-DIR-T-15',NULL,'INTERMEDIATE','Located between two points or extremes.','\0','','CL-DIR','DBX-NCIT-C73705'),('CL-DIR-T-16',NULL,'LOWER','The bottom one of two. (NCI)','\0','','CL-DIR','DBX-NCIT-C25309'),('CL-DIR-T-17',NULL,'MEDIAL','Toward the middle or in a limb toward the median plane.','\0','','CL-DIR','DBX-NCIT-C25232'),('CL-DIR-T-18',NULL,'MIDLINE','A medial line, especially the medial line or medial plane of the body (or some part of the body).','\0','','CL-DIR','DBX-NCIT-C81170'),('CL-DIR-T-19',NULL,'NASAL','Of, or related to, or in the direction of the nose.','\0','','CL-DIR','DBX-NCIT-C27958'),('CL-DIR-T-2',NULL,'APICAL','Relating to or located at the apex.','\0','','CL-DIR','DBX-NCIT-C25423'),('CL-DIR-T-20',NULL,'OUTER','Being on or toward the outside of the body or object. (NCI)','\0','','CL-DIR','DBX-NCIT-C38166'),('CL-DIR-T-21',NULL,'PERIPHERAL','On or near an edge or constituting an outer boundary; the outer area. (NCI)','\0','','CL-DIR','DBX-NCIT-C25233'),('CL-DIR-T-22',NULL,'POSTERIOR','Denoting the back portion of the body or a structure.','\0','','CL-DIR','DBX-NCIT-C25622'),('CL-DIR-T-23',NULL,'PROXIMAL','Situated nearest to a point of reference.','\0','','CL-DIR','DBX-NCIT-C25236'),('CL-DIR-T-24',NULL,'ROSTRAL','Toward the muzzle in the head.','\0','','CL-DIR','DBX-NCIT-C94393'),('CL-DIR-T-25',NULL,'SUPERFICIAL','Of or pertaining to the exterior surface. (NCI)','\0','','CL-DIR','DBX-NCIT-C25239'),('CL-DIR-T-26',NULL,'SUPERIOR','Pertaining to a point above a given reference point.','\0','','CL-DIR','DBX-NCIT-C25235'),('CL-DIR-T-27',NULL,'SURFACE','The extended two-dimensional outer layer or area of a three-dimensional object. (NCI)','\0','','CL-DIR','DBX-NCIT-C25245'),('CL-DIR-T-28',NULL,'TEMPORAL','Of, or related to, anatomic sites that are located in the cranium, brain, and eye.','\0','','CL-DIR','DBX-NCIT-C117754'),('CL-DIR-T-29',NULL,'TIP','The pointed end of a structure.','\0','','CL-DIR','DBX-NCIT-C90069'),('CL-DIR-T-3',NULL,'BASAL','Relating to or located at the lowest portion of a structure.','\0','','CL-DIR','DBX-NCIT-C90067'),('CL-DIR-T-30',NULL,'UPPER','The top one of two.','\0','','CL-DIR','DBX-NCIT-C25355'),('CL-DIR-T-31',NULL,'VENTRAL','Pertaining to the front or lower surface of the body.','\0','','CL-DIR','DBX-NCIT-C45875'),('CL-DIR-T-32',NULL,'VENTROLATERAL','Of or pertaining to the front and side of a main body. (NCI)','\0','','CL-DIR','DBX-NCIT-C98798'),('CL-DIR-T-4',NULL,'CAUDAL','Toward the tail in a body.','\0','','CL-DIR','DBX-NCIT-C73851'),('CL-DIR-T-5',NULL,'CENTRAL','A point or area that is approximately central within some larger region or structure. (NCI)','\0','','CL-DIR','DBX-NCIT-C25445'),('CL-DIR-T-6',NULL,'CRANIAL','Toward the head in a body.','\0','','CL-DIR','DBX-NCIT-C37936'),('CL-DIR-T-7',NULL,'DEEP','Extending relatively far inward. (NCI)','\0','','CL-DIR','DBX-NCIT-C25240'),('CL-DIR-T-8',NULL,'DISTAL','Situated farthest from a point of reference.','\0','','CL-DIR','DBX-NCIT-C25237'),('CL-DIR-T-9',NULL,'DORSAL','Pertaining to the back or upper surface of the body.','\0','','CL-DIR','DBX-NCIT-C45874'),('CL-DISCHDX-T-1',NULL,'Expired','The absence of life or state of being dead. (NCI)','\0','Died','CL-DISCHDX','DBX-NCIT-C28554'),('CL-DISCHDX-T-10',NULL,'Institution Not Defined','The patient will be admitted into an alternative facility not listed.','\0','','CL-DISCHDX','DBX-NCIT-C102247'),('CL-DISCHDX-T-11',NULL,'Intermediate Care Facility','The patient will be admitted into a medical center that provides care 24 hours per day.','\0','','CL-DISCHDX','DBX-NCIT-C99912'),('CL-DISCHDX-T-12',NULL,'Left Against Medical Advice or Discontinued Care','The patient vacated the medical center or ceased medical care contrary to the recommendation of a trained healthcare provider.','\0','','CL-DISCHDX','DBX-NCIT-C99969'),('CL-DISCHDX-T-13',NULL,'Medicare-certified Long Term Care Hospital (LTCH)','The patient will be admitted into a Medicare funded medical center for a considerable length of time.','\0','','CL-DISCHDX','DBX-NCIT-C99984'),('CL-DISCHDX-T-14',NULL,'Nursing Facility Certified Under Medicaid but Not Certified Under Medicare','The patient will be admitted into a medical center which is eligible to receive funding from Medicaid but not Medicare.','\0','','CL-DISCHDX','DBX-NCIT-C99913'),('CL-DISCHDX-T-15',NULL,'Psychiatric Hospital or a Psychiatric-distinct Part Unit of a Hospital','The patient will be admitted into a free standing medical facility or a unit within a general medical facility used for the treatment of mental health disorders.','\0','','CL-DISCHDX','DBX-NCIT-C53536'),('CL-DISCHDX-T-16',NULL,'Short Term General Hospital','The patient will remain in a basic hospital environment for a brief time.','\0','','CL-DISCHDX','DBX-NCIT-C102248'),('CL-DISCHDX-T-17',NULL,'Skilled Nursing Facility (SNF) with Medicare Certification in Anticipation of Covered Skilled Care','The patient will be admitted into a medical center equipped with a trained nursing staff that is eligible to receive Medicare funding.','\0','','CL-DISCHDX','DBX-NCIT-C99914'),('CL-DISCHDX-T-2',NULL,'Expired in a Medical Facility','The patient died while in a medical center such as a hospital, skilled nursing facility (SNF), intermediate care facility (ICF), or a freestanding hospice center.','\0','','CL-DISCHDX','DBX-NCIT-C99944'),('CL-DISCHDX-T-3',NULL,'Federal Health Care Facility','The patient will be admitted to a medical center that is funded by the federal government (e.g. Veterans Affairs Hospital).','\0','','CL-DISCHDX','DBX-NCIT-C99909'),('CL-DISCHDX-T-4',NULL,'Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care','The patient will return home but personal health maintenance will be administered and monitored by a member of a healthcare organization that is eligible to receive Medicare funding.','\0','','CL-DISCHDX','DBX-NCIT-C99959'),('CL-DISCHDX-T-5',NULL,'Home, Hospice','The patient will receive end-of-life care which will be administered in the patient\'s home.','\0','','CL-DISCHDX','DBX-NCIT-C99958'),('CL-DISCHDX-T-6',NULL,'Home, Self Care','A routine discharge where personal health maintenance will be administered and monitored by the patient from their home.','\0','','CL-DISCHDX','DBX-NCIT-C99957'),('CL-DISCHDX-T-7',NULL,'Hospice - Medical Facility','The patient will receive end-of-life care which will be administered in a medical center.','\0','','CL-DISCHDX','DBX-NCIT-C99910'),('CL-DISCHDX-T-8',NULL,'Hospital-based Medicare-approved Swing Bed','The patient will be admitted into a medical center and receive a type of hospital bed that will be paid for my Medicare.','\0','','CL-DISCHDX','DBX-NCIT-C99960'),('CL-DISCHDX-T-9',NULL,'Inpatient Rehabilitation Facility (IRF) Including Rehabilitation Distinct Part Units of a Hospital','The patient will be admitted full time into a free standing rehabilitation center or a rehabilitation center within a general medical facility.','\0','','CL-DISCHDX','DBX-NCIT-C99911'),('CL-DOBSTLOC-T-1',NULL,'FIELD','A setting outside the clinic or a comparable health care facility, e.g. a doctor\'s office, the subject\'s home or workplace, a school, a public park, or a restaurant.','\0','','CL-DOBSTLOC','DBX-NCIT-C102650'),('CL-DOBSTLOC-T-2',NULL,'HEALTH FACILITY','The buildings and organizations where healthcare services are provided.','\0','','CL-DOBSTLOC','DBX-NCIT-C21541'),('CL-DOMAIN-T-1',NULL,'AD','Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.','\0','Analysis Dataset','CL-DOMAIN','DBX-NCIT-C49563'),('CL-DOMAIN-T-10',NULL,'CE','A dataset used to capture clinical events of interest that would not be classified as adverse events.','\0','Clinical Events','CL-DOMAIN','DBX-NCIT-C85441'),('CL-DOMAIN-T-11',NULL,'CM','Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condit','\0','Concomitant Meds','CL-DOMAIN','DBX-NCIT-C49568'),('CL-DOMAIN-T-12',NULL,'CO','The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.','\0','Comments','CL-DOMAIN','DBX-NCIT-C49569'),('CL-DOMAIN-T-13',NULL,'CV','A domain for physiological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels.','\0','Cardiovascular System Findings','CL-DOMAIN','DBX-NCIT-C102605'),('CL-DOMAIN-T-14',NULL,'DA','Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.','\0','Drug Accountability','CL-DOMAIN','DBX-NCIT-C49578'),('CL-DOMAIN-T-15',NULL,'DD','This domain captures the diagnosis of the cause of death for a subject.','\0','Death Diagnosis','CL-DOMAIN','DBX-NCIT-C95087'),('CL-DOMAIN-T-16',NULL,'DE','A domain for device-related events.','\0','Device Events','CL-DOMAIN','DBX-NCIT-C102616'),('CL-DOMAIN-T-17',NULL,'DI','A domain for the submission of information that identifies a specific device unit.','\0','Device Identifiers','CL-DOMAIN','DBX-NCIT-C102618'),('CL-DOMAIN-T-18',NULL,'DM','The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects.','\0','Demographics','CL-DOMAIN','DBX-NCIT-C49572'),('CL-DOMAIN-T-19',NULL,'DO','A domain for the characteristics of the device that do not vary over the course of the study.','\0','Device Properties','CL-DOMAIN','DBX-NCIT-C102619'),('CL-DOMAIN-T-2',NULL,'AE','Adverse events may be captured either as free text or a pre-specified list of terms.','\0','Adverse Events','CL-DOMAIN','DBX-NCIT-C49562'),('CL-DOMAIN-T-20',NULL,'DP','This domain captures the outcome of developmental milestone testing during a scheduled period of observation.','\0','Developmental Milestone','CL-DOMAIN','DBX-NCIT-C95088'),('CL-DOMAIN-T-21',NULL,'DR','A domain for the linkage of each subject to the device(s) to which they may have been exposed.','\0','Device to Subject Relationship','CL-DOMAIN','DBX-NCIT-C102620'),('CL-DOMAIN-T-22',NULL,'DS','A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)','\0','Disposition','CL-DOMAIN','DBX-NCIT-C49576'),('CL-DOMAIN-T-23',NULL,'DT','A domain for logistics and disposition information specific to a given device.','\0','Device Tracking and Disposition','CL-DOMAIN','DBX-NCIT-C102621'),('CL-DOMAIN-T-24',NULL,'DU','A domain for the findings for the values of measurements and settings that are intentionally set on a device when it is in use. These are characteristics that exist for the device, and have a specific setting for a use instance.','\0','Device-In-Use','CL-DOMAIN','DBX-NCIT-C102622'),('CL-DOMAIN-T-25',NULL,'DV','The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.','\0','Protocol Deviations','CL-DOMAIN','DBX-NCIT-C49585'),('CL-DOMAIN-T-26',NULL,'DX','A domain for a subject\'s exposure to a medical device under study.','\0','Device Exposure','CL-DOMAIN','DBX-NCIT-C102617'),('CL-DOMAIN-T-27',NULL,'ED','A domain for physiological findings related to the endocrine system, including the glands and cells that make hormones that are released directly into the blood and travel to tissues and organs all over the body.','\0','Endocrine System Findings','CL-DOMAIN','DBX-NCIT-C102630'),('CL-DOMAIN-T-28',NULL,'EG','Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.','\0','Electrocardiogram','CL-DOMAIN','DBX-NCIT-C49626'),('CL-DOMAIN-T-29',NULL,'EX','The Exposure domain model records the details of a subject\'s exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied ','\0','Exposure','CL-DOMAIN','DBX-NCIT-C49587'),('CL-DOMAIN-T-3',NULL,'AG','A domain for the agents administered to the subject as part of a procedure or assessment as opposed to drugs, medications and therapies administered with therapeutic intent.','\0','Procedure Agents','CL-DOMAIN','DBX-NCIT-C117755'),('CL-DOMAIN-T-30',NULL,'FA','A dataset used to capture the findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier.','\0','Findings About Events or Interventions','CL-DOMAIN','DBX-NCIT-C85442'),('CL-DOMAIN-T-31',NULL,'FH','A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)','\0','Family History','CL-DOMAIN','DBX-NCIT-C49588'),('CL-DOMAIN-T-32',NULL,'FT','A domain for named, stand-alone task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive ability.','\0','Functional Tests','CL-DOMAIN','DBX-NCIT-C117756'),('CL-DOMAIN-T-33',NULL,'GI','A domain for physiological findings related to the gastrointestinal system, including the esophagus, stomach, small and large intestine, anus, liver, biliary tract and pancreas.','\0','Gastrointestinal System Findings','CL-DOMAIN','DBX-NCIT-C102640'),('CL-DOMAIN-T-34',NULL,'HM','A domain for physiological findings related to the hematopoietic system, including the bone marrow and lymph nodes involved in the production of blood.','\0','Hematopoietic System Findings','CL-DOMAIN','DBX-NCIT-C102641'),('CL-DOMAIN-T-35',NULL,'HO','A domain for inpatient and outpatient healthcare events.','\0','Healthcare Encounters','CL-DOMAIN','DBX-NCIT-C117757'),('CL-DOMAIN-T-36',NULL,'HU','Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.','\0','Healthcare Resource Utilization','CL-DOMAIN','DBX-NCIT-C49589'),('CL-DOMAIN-T-37',NULL,'IE','The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.','\0','Inclusion/Exclusion','CL-DOMAIN','DBX-NCIT-C61536'),('CL-DOMAIN-T-38',NULL,'IG','A domain for physiological findings related to the integumentary system, including the epidermis, dermis, all of the derivatives of the epidermis, hairs, nails, sudoriferous and sebaceous glands, and mammary glands.','\0','Integumentary System Findings','CL-DOMAIN','DBX-NCIT-C102651'),('CL-DOMAIN-T-39',NULL,'IM','A domain for physiological findings related to the immune system, including the thymus, spleen and tonsils.','\0','Immune System Findings','CL-DOMAIN','DBX-NCIT-C102649'),('CL-DOMAIN-T-4',NULL,'AU','Additional data about deaths, specific to findings from autopsies.','\0','Autopsy','CL-DOMAIN','DBX-NCIT-C49565'),('CL-DOMAIN-T-40',NULL,'IS','A findings domain for assessments that determine whether a therapy induced an immune response.','\0','Immunogenicity Specimen Assessments','CL-DOMAIN','DBX-NCIT-C112320'),('CL-DOMAIN-T-41',NULL,'LB','Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.','\0','Laboratory Data','CL-DOMAIN','DBX-NCIT-C49592'),('CL-DOMAIN-T-42',NULL,'MB','Microbiology specimen findings, including gram stain results, and organisms found.','\0','Microbiology','CL-DOMAIN','DBX-NCIT-C49602'),('CL-DOMAIN-T-43',NULL,'MH','The medical history dataset includes the subject\'s prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.','\0','Medical History','CL-DOMAIN','DBX-NCIT-C49603'),('CL-DOMAIN-T-44',NULL,'MI','The histopathology findings and microscopic evaluations recorded.','\0','Microscopic Findings','CL-DOMAIN','DBX-NCIT-C95095'),('CL-DOMAIN-T-45',NULL,'MK','A domain for physiological findings related to the system of muscles, tendons, ligaments, bones, joints and associated tissues.','\0','Musculoskeletal Findings, Connective and Soft Tissue Findings','CL-DOMAIN','DBX-NCIT-C102674'),('CL-DOMAIN-T-46',NULL,'ML','Information regarding the subject\'s meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.','\0','Meal Data','CL-DOMAIN','DBX-NCIT-C49604'),('CL-DOMAIN-T-47',NULL,'MO','A domain relevant to the science of the form and structure of an organism or of its parts.','\0','Morphology Findings','CL-DOMAIN','DBX-NCIT-C102671'),('CL-DOMAIN-T-48',NULL,'MS','This includes microbiology susceptibility test results, plus results of any other organism-related tests.','\0','Microbiology Susceptibility','CL-DOMAIN','DBX-NCIT-C61531'),('CL-DOMAIN-T-49',NULL,'NV','A domain for physiological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses.','\0','Nervous System Findings','CL-DOMAIN','DBX-NCIT-C102677'),('CL-DOMAIN-T-5',NULL,'AX','Prefix to indicate an analysis dataset that is not compliant with a defined ADaM structure.','\0','Non-Compliant ADaM Datasets','CL-DOMAIN','DBX-NCIT-C111282'),('CL-DOMAIN-T-50',NULL,'PB','A special-purpose domain that relates a set of genetic variations to an inference about the medical meaning of that set of genetic variations.','\0','Pharmacogenomics Biomarker','CL-DOMAIN','DBX-NCIT-C106552'),('CL-DOMAIN-T-51',NULL,'PC','Concentrations of drugs/metabolites in fluids or tissues as a function of time.','\0','Pharmacokinetic Concentration','CL-DOMAIN','DBX-NCIT-C49606'),('CL-DOMAIN-T-52',NULL,'PE','Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.','\0','Physical Exam','CL-DOMAIN','DBX-NCIT-C49608'),('CL-DOMAIN-T-53',NULL,'PF','A findings domain for gene expression and genetic variation assessments.','\0','Pharmacogenomics Findings','CL-DOMAIN','DBX-NCIT-C111289'),('CL-DOMAIN-T-54',NULL,'PG','Pharmacogenomics findings that initially focus on genotype and gene expression data.','\0','Pharmacogenomics/Genetics Methods and Supporting Information','CL-DOMAIN','DBX-NCIT-C61529'),('CL-DOMAIN-T-55',NULL,'PP','Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.','\0','Pharmacokinetic Parameters','CL-DOMAIN','DBX-NCIT-C49607'),('CL-DOMAIN-T-56',NULL,'PR','A domain relevant to an interventional activity that is intended to have diagnostic, preventive, therapeutic, or palliative effects.','\0','Procedure','CL-DOMAIN','DBX-NCIT-C102700'),('CL-DOMAIN-T-57',NULL,'PS','A special purpose domain that contains the protocol summary information for pharmacogenomics assessments.','\0','Protocol Summary for PGx','CL-DOMAIN','DBX-NCIT-C111300'),('CL-DOMAIN-T-58',NULL,'PT','A special purpose domain that contains design parameters used in performing pharmacogenomic assessments.','\0','Pharmacogenomics Trial Characteristics','CL-DOMAIN','DBX-NCIT-C111290'),('CL-DOMAIN-T-59',NULL,'QS','Questionnaires are named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented m','\0','Questionnaires','CL-DOMAIN','DBX-NCIT-C49609'),('CL-DOMAIN-T-6',NULL,'BE','An events domain that documents biospecimen collection and storage information.','\0','Biospecimen Events','CL-DOMAIN','DBX-NCIT-C111138'),('CL-DOMAIN-T-60',NULL,'RE','A domain for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.','\0','Respiratory System Findings','CL-DOMAIN','DBX-NCIT-C95098'),('CL-DOMAIN-T-61',NULL,'RP','A domain for physiological findings related to the male and female reproductive systems.','\0','Reproductive System Findings','CL-DOMAIN','DBX-NCIT-C102707'),('CL-DOMAIN-T-62',NULL,'RS','The disease response (RS) domain represents disease response evaluations determined from collected data in the tumor results (TR) domain and/or other SDTM domains.','\0','Disease Response','CL-DOMAIN','DBX-NCIT-C107097'),('CL-DOMAIN-T-63',NULL,'SB','A special purpose domain that associates the subject with the medical conclusions contained in the pharmacogenomics biological state (PB) domain based on the observations reported in pharmacogenomics findings (PF) domain.','\0','Subject Biomarker','CL-DOMAIN','DBX-NCIT-C106571'),('CL-DOMAIN-T-64',NULL,'SC','The subject characteristics domain is for data not collected in other domains that is subject-related.','\0','Subject Characteristics','CL-DOMAIN','DBX-NCIT-C49610'),('CL-DOMAIN-T-65',NULL,'SE','The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.','\0','Subject Element','CL-DOMAIN','DBX-NCIT-C49616'),('CL-DOMAIN-T-66',NULL,'SG','Surgical information.','\0','Surgery','CL-DOMAIN','DBX-NCIT-C49611'),('CL-DOMAIN-T-67',NULL,'SK','Findings from diagnostic skin tests.','\0','Skin Test','CL-DOMAIN','DBX-NCIT-C49612'),('CL-DOMAIN-T-68',NULL,'SL','Findings from diagnostic sleep tests (polysomnography).','\0','Sleep Polysomnography Data','CL-DOMAIN','DBX-NCIT-C49613'),('CL-DOMAIN-T-69',NULL,'SR','A findings about domain for submitting dermal responses to antigens.','\0','Skin Response','CL-DOMAIN','DBX-NCIT-C112420'),('CL-DOMAIN-T-7',NULL,'BM','Findings resulting from evaluations of bone mineral density.','\0','Bone Measurements','CL-DOMAIN','DBX-NCIT-C49566'),('CL-DOMAIN-T-70',NULL,'SU','The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.','\0','Substance Use','CL-DOMAIN','DBX-NCIT-C49615'),('CL-DOMAIN-T-71',NULL,'SV','The subject visits table describes the actual start and end data/time for each visit of each individual subject.','\0','Subject Visits','CL-DOMAIN','DBX-NCIT-C49617'),('CL-DOMAIN-T-72',NULL,'TA','The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.','\0','Trial Arms','CL-DOMAIN','DBX-NCIT-C49618'),('CL-DOMAIN-T-73',NULL,'TE','The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.','\0','Trial Elements','CL-DOMAIN','DBX-NCIT-C49619'),('CL-DOMAIN-T-74',NULL,'TF','This domain captures the tumor findings of the nonclinical subject.','\0','Tumor Findings','CL-DOMAIN','DBX-NCIT-C95100'),('CL-DOMAIN-T-75',NULL,'TI','The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.','\0','Trial Inclusion/Exclusion Criteria','CL-DOMAIN','DBX-NCIT-C49620'),('CL-DOMAIN-T-76',NULL,'TP','The trial paths domain is not subject oriented. This domain provides the complete planned non-treatment related sequences of stages for each path in a study.','\0','Trial Paths','CL-DOMAIN','DBX-NCIT-C95101'),('CL-DOMAIN-T-77',NULL,'TR','This domain represents quantitative measurements and/or qualitative assessments of the tumors identified in the tumor identifier (TU) domain.','\0','Tumor Results','CL-DOMAIN','DBX-NCIT-C106578'),('CL-DOMAIN-T-78',NULL,'TS','The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.','\0','Trial Summary','CL-DOMAIN','DBX-NCIT-C53483'),('CL-DOMAIN-T-79',NULL,'TU','This domain represents data that uniquely identifies tumors.','\0','Tumor Identifier','CL-DOMAIN','DBX-NCIT-C106577'),('CL-DOMAIN-T-8',NULL,'BR','Findings resulting from biopsies.','\0','Biopsy','CL-DOMAIN','DBX-NCIT-C49567'),('CL-DOMAIN-T-80',NULL,'TV','The trial visits table describes the planned order and number of visits in the study within each arm.','\0','Trial Visits','CL-DOMAIN','DBX-NCIT-C49621'),('CL-DOMAIN-T-81',NULL,'TX','The trial stages domain is not subject oriented. It contains one record for each trial set characteristic including experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations.','\0','Trial Sets','CL-DOMAIN','DBX-NCIT-C95103'),('CL-DOMAIN-T-82',NULL,'UR','A domain for physiological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra.','\0','Urinary System Findings','CL-DOMAIN','DBX-NCIT-C102726'),('CL-DOMAIN-T-83',NULL,'VR','A findings domain that contains information about virus drug-resistance.','\0','Viral Resistance Findings','CL-DOMAIN','DBX-NCIT-C106581'),('CL-DOMAIN-T-84',NULL,'VS','Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.','\0','Vital Signs','CL-DOMAIN','DBX-NCIT-C49622'),('CL-DOMAIN-T-9',NULL,'BS','A findings domain that documents biospecimen handling information.','\0','Biospecimen','CL-DOMAIN','DBX-NCIT-C111137'),('CL-DOTEST-T-1',NULL,'Composition','The materials from which something is made.','\0','Composition','CL-DOTEST','DBX-NCIT-C53414'),('CL-DOTEST-T-10',NULL,'Size','The physical magnitude of something. (NCI)','\0','Size','CL-DOTEST','DBX-NCIT-C25681'),('CL-DOTEST-T-11',NULL,'Software Version','A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)','\0','Software Version','CL-DOTEST','DBX-NCIT-C111093'),('CL-DOTEST-T-12',NULL,'Surgical Mesh Open Area','A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure.','\0','Surgical Mesh Open Area','CL-DOTEST','DBX-NCIT-C112421'),('CL-DOTEST-T-13',NULL,'Temperature','The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somati','\0','Temperature','CL-DOTEST','DBX-NCIT-C25206'),('CL-DOTEST-T-14',NULL,'Thickness','The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.','\0','Thickness','CL-DOTEST','DBX-NCIT-C41145'),('CL-DOTEST-T-2',NULL,'FDA Device Classification','The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).','\0','FDA Device Classification','CL-DOTEST','DBX-NCIT-C112278'),('CL-DOTEST-T-3',NULL,'Indication for Use','A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate.','\0','Indication for Use','CL-DOTEST','DBX-NCIT-C41184'),('CL-DOTEST-T-4',NULL,'MRI Coil Type','The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast.','\0','MRI Coil Type','CL-DOTEST','DBX-NCIT-C116119'),('CL-DOTEST-T-5',NULL,'Multiplex Probe Parameter','A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate.','\0','Multiplex Probe Parameter','CL-DOTEST','DBX-NCIT-C116118'),('CL-DOTEST-T-6',NULL,'Pore Size','A quantitative or qualitative measurement of the physical dimensions of the pores in a material.','\0','Pore Size','CL-DOTEST','DBX-NCIT-C112332'),('CL-DOTEST-T-7',NULL,'Reagent Lot','The lot number of the reagent.','\0','Reagent Lot','CL-DOTEST','DBX-NCIT-C112406'),('CL-DOTEST-T-8',NULL,'Scintillation Crystal Type','The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure.','\0','Scintillation Crystal Type','CL-DOTEST','DBX-NCIT-C116120'),('CL-DOTEST-T-9',NULL,'Shelf Life','The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured.','\0','Shelf Life','CL-DOTEST','DBX-NCIT-C70855'),('CL-DOTESTCD-T-1',NULL,'COMPOS','The materials from which something is made.','\0','Composition','CL-DOTESTCD','DBX-NCIT-C53414'),('CL-DOTESTCD-T-10',NULL,'SHLFLIFE','The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured.','\0','Shelf Life','CL-DOTESTCD','DBX-NCIT-C70855'),('CL-DOTESTCD-T-11',NULL,'SIZE','The physical magnitude of something. (NCI)','\0','Size','CL-DOTESTCD','DBX-NCIT-C25681'),('CL-DOTESTCD-T-12',NULL,'SRGMSHOA','A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure.','\0','Surgical Mesh Open Area','CL-DOTESTCD','DBX-NCIT-C112421'),('CL-DOTESTCD-T-13',NULL,'TEMP','The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somati','\0','Temperature','CL-DOTESTCD','DBX-NCIT-C25206'),('CL-DOTESTCD-T-14',NULL,'THICKNSS','The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.','\0','Thickness','CL-DOTESTCD','DBX-NCIT-C41145'),('CL-DOTESTCD-T-2',NULL,'FDADEVCL','The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).','\0','FDA Device Classification','CL-DOTESTCD','DBX-NCIT-C112278'),('CL-DOTESTCD-T-3',NULL,'INDC','A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate.','\0','Indication for Use','CL-DOTESTCD','DBX-NCIT-C41184'),('CL-DOTESTCD-T-4',NULL,'MRICTYPE','The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast.','\0','MRI Coil Type','CL-DOTESTCD','DBX-NCIT-C116119'),('CL-DOTESTCD-T-5',NULL,'MULTPLEX','A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate.','\0','Multiplex Probe Parameter','CL-DOTESTCD','DBX-NCIT-C116118'),('CL-DOTESTCD-T-6',NULL,'PORESIZE','A quantitative or qualitative measurement of the physical dimensions of the pores in a material.','\0','Pore Size','CL-DOTESTCD','DBX-NCIT-C112332'),('CL-DOTESTCD-T-7',NULL,'REAGLOT','The lot number of the reagent.','\0','Reagent Lot','CL-DOTESTCD','DBX-NCIT-C112406'),('CL-DOTESTCD-T-8',NULL,'SCRYSTYP','The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure.','\0','Scintillation Crystal Type','CL-DOTESTCD','DBX-NCIT-C116120'),('CL-DOTESTCD-T-9',NULL,'SFTWRVER','A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)','\0','Software Version','CL-DOTESTCD','DBX-NCIT-C111093'),('CL-DRSTAT-T-1',NULL,'EXTENSIVE DRUG RESISTANCE','Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.','\0','XDR','CL-DRSTAT','DBX-NCIT-C102633'),('CL-DRSTAT-T-2',NULL,'MULTIPLE DRUG RESISTANCE','Simultaneous resistance to a spectrum of unrelated drugs following exposure to a single agent. Mechanisms involve expression of multidrug efflux pumps (p-glycoprotein), altered glutathione metabolism, decreased topoisomerase II activity, and changes in va','\0','MDR','CL-DRSTAT','DBX-NCIT-C17745'),('CL-DRSTAT-T-3',NULL,'SUSCEPTIBLE','The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.','\0','Susceptible','CL-DRSTAT','DBX-NCIT-C85563'),('CL-DSCAT-T-1',NULL,'DISPOSITION EVENT','The group of incidents that occur during a clinical trial and describe whether a subject completed the study epoch or the reason this event did not occur. The subject\'s disposition is often described for each phase of the study.','\0','Disposition Event','CL-DSCAT','DBX-NCIT-C74590'),('CL-DSCAT-T-2',NULL,'OTHER EVENT','Other important events that occur during a trial but are not driven by protocol requirements.','\0','Other Event','CL-DSCAT','DBX-NCIT-C74589'),('CL-DSCAT-T-3',NULL,'PROTOCOL MILESTONE','Occurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is \"Informed Consent Obtained\" which usually documents the start of the study.','\0','Protocol Milestone','CL-DSCAT','DBX-NCIT-C74588'),('CL-DSSOUT-T-1',NULL,'BACTERIOLOGICAL CURE','There are no indicators of bacterial infection in an individual who previously had an infection.','\0','','CL-DSSOUT','DBX-NCIT-C102600'),('CL-DSSOUT-T-2',NULL,'BACTERIOLOGICAL FAILURE','There are indicators of bacterial infection in the individual who previously had an infection.','\0','','CL-DSSOUT','DBX-NCIT-C102601'),('CL-DSSOUT-T-3',NULL,'CLINICAL CURE','There are no signs or symptoms of disease in the individual who previously had a disease.','\0','','CL-DSSOUT','DBX-NCIT-C102607'),('CL-DSSOUT-T-4',NULL,'CLINICAL FAILURE','There are still signs or symptoms of disease in the individual who previously had an infection.','\0','','CL-DSSOUT','DBX-NCIT-C102608'),('CL-DSSOUT-T-5',NULL,'RECURRENT DISEASE','The return of a disease after a period of remission.','\0','Recurrent Disease','CL-DSSOUT','DBX-NCIT-C38155'),('CL-DTDECOD-T-1',NULL,'DEPLOYED','The act of instantiating, positioning or activating a medical device inside of the body.','\0','','CL-DTDECOD','DBX-NCIT-C101231'),('CL-DTDECOD-T-2',NULL,'DESTROYED','A finding referring to a product that has been demolished.','\0','','CL-DTDECOD','DBX-NCIT-C112270'),('CL-DTDECOD-T-3',NULL,'EXPLANTED','A status indicating that a device is removed from a surgically or naturally formed cavity of the human body.','\0','','CL-DTDECOD','DBX-NCIT-C114146'),('CL-DTDECOD-T-4',NULL,'IMPLANTED','A status indicating that a device is placed into a surgically or naturally formed cavity of the human body.','\0','','CL-DTDECOD','DBX-NCIT-C80457'),('CL-DTDECOD-T-5',NULL,'INTENDED BUT NOT USED','A status indicating that a device was introduced to the subject for use but did not meet its intended goal and was removed. (NCI)','\0','','CL-DTDECOD','DBX-NCIT-C117758'),('CL-DTDECOD-T-6',NULL,'LOST','A finding referring to a product that is no longer held or possessed; incapable of being recovered or regained.','\0','','CL-DTDECOD','DBX-NCIT-C112329'),('CL-DTDECOD-T-7',NULL,'RECEIVED','The status of coming into possession of or acting as the receptacle or recipient of an item conveyed by an intermediary to the intended destination, from a sender.','\0','','CL-DTDECOD','DBX-NCIT-C25639'),('CL-DTDECOD-T-8',NULL,'SHIPPED','The status of being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver.','\0','','CL-DTDECOD','DBX-NCIT-C40353'),('CL-DUTEST-T-1',NULL,'Anatomical Plane','The position and orientation of the image slice relative to the patient-based coordinate system. (NCI)','\0','Anatomical Plane','CL-DUTEST','DBX-NCIT-C102516'),('CL-DUTEST-T-10',NULL,'Image Acquisition Matrix Size','A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI)','\0','Image Acquisition Matrix Size','CL-DUTEST','DBX-NCIT-C106533'),('CL-DUTEST-T-11',NULL,'Image Weighting Type','A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state.','\0','Image Weighting Type','CL-DUTEST','DBX-NCIT-C116122'),('CL-DUTEST-T-12',NULL,'Interslice Distance','A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment.','\0','Interslice Distance','CL-DUTEST','DBX-NCIT-C116123'),('CL-DUTEST-T-13',NULL,'Inversion Time','The time between the inversion and excitation pulses in an inversion recovery pulse sequence.','\0','Inversion Time','CL-DUTEST','DBX-NCIT-C116124'),('CL-DUTEST-T-14',NULL,'Number of Coil Channels','The number of channels, or elements, in the coil component of the device.','\0','Number of Coil Channels','CL-DUTEST','DBX-NCIT-C112364'),('CL-DUTEST-T-15',NULL,'Number of Slices','The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image.','\0','Number of Slices','CL-DUTEST','DBX-NCIT-C116125'),('CL-DUTEST-T-16',NULL,'Pulse Sequence','A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI)','\0','Pulse Sequence','CL-DUTEST','DBX-NCIT-C106562'),('CL-DUTEST-T-17',NULL,'Randoms Correction Indicator','An indication as to whether the device was set to correct for random noise generated by deflected positrons.','\0','Randoms Correction Indicator','CL-DUTEST','DBX-NCIT-C116128'),('CL-DUTEST-T-18',NULL,'Receiver Bandwidth','The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI)','\0','RXBW; Receiver Bandwidth; rBW','CL-DUTEST','DBX-NCIT-C106563'),('CL-DUTEST-T-19',NULL,'Reconstruction Filter Type','A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image.','\0','Reconstruction Filter Type','CL-DUTEST','DBX-NCIT-C106564'),('CL-DUTEST-T-2',NULL,'Attenuation Correction Type','The adjustment for the effect of tissue thicknesses through which gamma\'s travel from an activity concentration origin to the scanner\'s detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma\'s path.','\0','Attenuation Correction Type','CL-DUTEST','DBX-NCIT-C94862'),('CL-DUTEST-T-20',NULL,'Reconstruction of Raw Data Type','The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI)','\0','Reconstruction of Raw Data Type','CL-DUTEST','DBX-NCIT-C111303'),('CL-DUTEST-T-21',NULL,'Repetition Time','The amount of time in milliseconds between successive pulse sequences applied to the same slice.','\0','Repetition Time; TR','CL-DUTEST','DBX-NCIT-C82330'),('CL-DUTEST-T-22',NULL,'Signal Amplitude','A measurement of the height of the signal.','\0','Signal Amplitude','CL-DUTEST','DBX-NCIT-C112416'),('CL-DUTEST-T-23',NULL,'Signal Frequency','A measurement of the number of cycles of a periodic wave or pulse per unit of time.','\0','Signal Frequency','CL-DUTEST','DBX-NCIT-C112417'),('CL-DUTEST-T-24',NULL,'Signal Width','A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave.','\0','Signal Width','CL-DUTEST','DBX-NCIT-C112418'),('CL-DUTEST-T-25',NULL,'Slice Number','The numeric identifier used to identify an image slice. (NCI)','\0','Slice Number','CL-DUTEST','DBX-NCIT-C111314'),('CL-DUTEST-T-26',NULL,'Slice Thickness','The dimension between two surfaces of an imaging plane. (NCI)','\0','Slice Thickness','CL-DUTEST','DBX-NCIT-C106534'),('CL-DUTEST-T-27',NULL,'Software Version','A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)','\0','Software Version','CL-DUTEST','DBX-NCIT-C111093'),('CL-DUTEST-T-28',NULL,'Stimulation Parameter','The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ.','\0','Stimulation Parameter','CL-DUTEST','DBX-NCIT-C114145'),('CL-DUTEST-T-29',NULL,'X-axis Pixel Spacing','A measurement of the distance between the centers of two adjacent pixels located along the X-axis.','\0','X-axis Pixel Spacing','CL-DUTEST','DBX-NCIT-C69201'),('CL-DUTEST-T-3',NULL,'Checkerboard Square Size','A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway.','\0','Checkerboard Square Size','CL-DUTEST','DBX-NCIT-C117759'),('CL-DUTEST-T-30',NULL,'Y-axis Pixel Spacing','A measurement of the distance between the centers of two adjacent pixels located along the Y-axis.','\0','Y-axis Pixel Spacing','CL-DUTEST','DBX-NCIT-C69210'),('CL-DUTEST-T-4',NULL,'Coil Strength','The maximum voltage allowable to pass through an electromagnetic coil. (NCI)','\0','Coil Strength','CL-DUTEST','DBX-NCIT-C106510'),('CL-DUTEST-T-5',NULL,'Decay Correction Indicator','An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition.','\0','Decay Correction Indicator','CL-DUTEST','DBX-NCIT-C116127'),('CL-DUTEST-T-6',NULL,'Echo Time','The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI)','\0','Echo Time; TE','CL-DUTEST','DBX-NCIT-C82331'),('CL-DUTEST-T-7',NULL,'Field of View','The extent of an area that is visible. (NCI)','\0','FOV; Field of View','CL-DUTEST','DBX-NCIT-C74298'),('CL-DUTEST-T-8',NULL,'Flip Angle','In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI)','\0','Flip Angle','CL-DUTEST','DBX-NCIT-C73792'),('CL-DUTEST-T-9',NULL,'Image Acquisition Dimensionality','The number of dimensions that the acquired image(s) are presented in.','\0','Image Acquisition Dimensionality','CL-DUTEST','DBX-NCIT-C116126'),('CL-DUTESTCD-T-1',NULL,'ANTPLANE','The position and orientation of the image slice relative to the patient-based coordinate system. (NCI)','\0','Anatomical Plane','CL-DUTESTCD','DBX-NCIT-C102516'),('CL-DUTESTCD-T-10',NULL,'FLIPANGL','In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI)','\0','Flip Angle','CL-DUTESTCD','DBX-NCIT-C73792'),('CL-DUTESTCD-T-11',NULL,'IMAQDIM','The number of dimensions that the acquired image(s) are presented in.','\0','Image Acquisition Dimensionality','CL-DUTESTCD','DBX-NCIT-C116126'),('CL-DUTESTCD-T-12',NULL,'IMWGTTYP','A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state.','\0','Image Weighting Type','CL-DUTESTCD','DBX-NCIT-C116122'),('CL-DUTESTCD-T-13',NULL,'INTDISTM','A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment.','\0','Interslice Distance','CL-DUTESTCD','DBX-NCIT-C116123'),('CL-DUTESTCD-T-14',NULL,'INVRTIME','The time between the inversion and excitation pulses in an inversion recovery pulse sequence.','\0','Inversion Time','CL-DUTESTCD','DBX-NCIT-C116124'),('CL-DUTESTCD-T-15',NULL,'NUMSLICE','The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image.','\0','Number of Slices','CL-DUTESTCD','DBX-NCIT-C116125'),('CL-DUTESTCD-T-16',NULL,'PIXSPCX','A measurement of the distance between the centers of two adjacent pixels located along the X-axis.','\0','X-axis Pixel Spacing','CL-DUTESTCD','DBX-NCIT-C69201'),('CL-DUTESTCD-T-17',NULL,'PIXSPCY','A measurement of the distance between the centers of two adjacent pixels located along the Y-axis.','\0','Y-axis Pixel Spacing','CL-DUTESTCD','DBX-NCIT-C69210'),('CL-DUTESTCD-T-18',NULL,'PULSSEQ','A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI)','\0','Pulse Sequence','CL-DUTESTCD','DBX-NCIT-C106562'),('CL-DUTESTCD-T-19',NULL,'RANDCORR','An indication as to whether the device was set to correct for random noise generated by deflected positrons.','\0','Randoms Correction Indicator','CL-DUTESTCD','DBX-NCIT-C116128'),('CL-DUTESTCD-T-2',NULL,'AQMTRXSZ','A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI)','\0','Image Acquisition Matrix Size','CL-DUTESTCD','DBX-NCIT-C106533'),('CL-DUTESTCD-T-20',NULL,'RCBDWDTH','The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI)','\0','RXBW; Receiver Bandwidth; rBW','CL-DUTESTCD','DBX-NCIT-C106563'),('CL-DUTESTCD-T-21',NULL,'RCFLTRTP','A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image.','\0','Reconstruction Filter Type','CL-DUTESTCD','DBX-NCIT-C106564'),('CL-DUTESTCD-T-22',NULL,'RECONDAT','The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI)','\0','Reconstruction of Raw Data Type','CL-DUTESTCD','DBX-NCIT-C111303'),('CL-DUTESTCD-T-23',NULL,'REPTIME','The amount of time in milliseconds between successive pulse sequences applied to the same slice.','\0','Repetition Time; TR','CL-DUTESTCD','DBX-NCIT-C82330'),('CL-DUTESTCD-T-24',NULL,'SFTWRVER','A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)','\0','Software Version','CL-DUTESTCD','DBX-NCIT-C111093'),('CL-DUTESTCD-T-25',NULL,'SIGAMP','A measurement of the height of the signal.','\0','Signal Amplitude','CL-DUTESTCD','DBX-NCIT-C112416'),('CL-DUTESTCD-T-26',NULL,'SIGFREQ','A measurement of the number of cycles of a periodic wave or pulse per unit of time.','\0','Signal Frequency','CL-DUTESTCD','DBX-NCIT-C112417'),('CL-DUTESTCD-T-27',NULL,'SIGW','A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave.','\0','Signal Width','CL-DUTESTCD','DBX-NCIT-C112418'),('CL-DUTESTCD-T-28',NULL,'SLICNUM','The numeric identifier used to identify an image slice. (NCI)','\0','Slice Number','CL-DUTESTCD','DBX-NCIT-C111314'),('CL-DUTESTCD-T-29',NULL,'STHICK','The dimension between two surfaces of an imaging plane. (NCI)','\0','Slice Thickness','CL-DUTESTCD','DBX-NCIT-C106534'),('CL-DUTESTCD-T-3',NULL,'ATTCRCT','The adjustment for the effect of tissue thicknesses through which gamma\'s travel from an activity concentration origin to the scanner\'s detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma\'s path.','\0','Attenuation Correction Type','CL-DUTESTCD','DBX-NCIT-C94862'),('CL-DUTESTCD-T-30',NULL,'STIMPARM','The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ.','\0','Stimulation Parameter','CL-DUTESTCD','DBX-NCIT-C114145'),('CL-DUTESTCD-T-4',NULL,'CHCKSIZE','A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway.','\0','Checkerboard Square Size','CL-DUTESTCD','DBX-NCIT-C117759'),('CL-DUTESTCD-T-5',NULL,'COILNUM','The number of channels, or elements, in the coil component of the device.','\0','Number of Coil Channels','CL-DUTESTCD','DBX-NCIT-C112364'),('CL-DUTESTCD-T-6',NULL,'COILSTR','The maximum voltage allowable to pass through an electromagnetic coil. (NCI)','\0','Coil Strength','CL-DUTESTCD','DBX-NCIT-C106510'),('CL-DUTESTCD-T-7',NULL,'DECCORR','An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition.','\0','Decay Correction Indicator','CL-DUTESTCD','DBX-NCIT-C116127'),('CL-DUTESTCD-T-8',NULL,'ECHOTIME','The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI)','\0','Echo Time; TE','CL-DUTESTCD','DBX-NCIT-C82331'),('CL-DUTESTCD-T-9',NULL,'FLDVIEW','The extent of an area that is visible. (NCI)','\0','FOV; Field of View','CL-DUTESTCD','DBX-NCIT-C74298'),('CL-EGLEAD-T-1',NULL,'LEAD aV6','An augmented unipolar lead placed at the sixth intercostal space on the midaxillary line. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90403'),('CL-EGLEAD-T-10',NULL,'LEAD II','A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left pelvic limb. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90409'),('CL-EGLEAD-T-11',NULL,'LEAD III','A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the left thoracic limb and the positive electrode on the left pelvic limb. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90410'),('CL-EGLEAD-T-12',NULL,'LEAD rV2','A unipolar precordial lead placed at the second intercostal space to the left of the sternum. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90411'),('CL-EGLEAD-T-13',NULL,'LEAD V1','A unipolar electrocardiogram lead site; the electrode is placed at the fourth intercostal space on the anterior chest wall (between ribs 4 and 5) to the right of the sternal border. In small animals, it is placed at the right fifth intercostal space near ','\0','','CL-EGLEAD','DBX-NCIT-C90412'),('CL-EGLEAD-T-14',NULL,'LEAD V10','A unipolar chest lead at which the electrode is placed over the dorsal spinous process of 7th thoracic vertebra. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90413'),('CL-EGLEAD-T-15',NULL,'LEAD V2','A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall at the fourth intercostal space (between ribs 4 and 5) to the left of the sternal border. In small animals it corresponds to V2-V3 where it is placed at the 6th lef','\0','','CL-EGLEAD','DBX-NCIT-C90414'),('CL-EGLEAD-T-16',NULL,'LEAD V3','A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall midway between leads V2 and V4. In large and small animals, it is placed over the dorsal spinous process of the 7th thoracic vertebra. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90415'),('CL-EGLEAD-T-17',NULL,'LEAD V4','A unipolar electrocardiogram lead site; the electrode is placed at the fifth intercostal space on the anterior chest wall (between ribs 5 and 6) at the left midclavicular line. In small animals it corresponds to V4-V6 where it is placed at the 6th left in','\0','','CL-EGLEAD','DBX-NCIT-C90416'),('CL-EGLEAD-T-18',NULL,'LEAD V5','A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall level with lead V4 at the left anterior axillary line. In large animals it is placed on the sixth ICS on the right side of the thorax along a line parallel to the l','\0','','CL-EGLEAD','DBX-NCIT-C90417'),('CL-EGLEAD-T-19',NULL,'LEAD V6','A unipolar electrocardiogram lead site at which the electrode is placed on the anterior chest wall level with lead V5 at the left midaxillary line .','\0','','CL-EGLEAD','DBX-NCIT-C90418'),('CL-EGLEAD-T-2',NULL,'LEAD aVF','An augmented unipolar electrocardiogram limb lead in which the positive (red) electrode is situated on the left pelvic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left thoracic limb (black) electro','\0','','CL-EGLEAD','DBX-NCIT-C90360'),('CL-EGLEAD-T-20',NULL,'SML','Measurement methodology using multiple leads for the determination of an ECG parameter. This is often visually represented as a superimposition of the median beats from multiple leads.','\0','Global Median Beat; Superimposition of Multiple Leads','CL-EGLEAD','DBX-NCIT-C117760'),('CL-EGLEAD-T-3',NULL,'LEAD aVL','An augmented unipolar electrocardiogram limb lead in which the positive (black) electrode is situated on the left thoracic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left pelvic limb (red) electro','\0','','CL-EGLEAD','DBX-NCIT-C90361'),('CL-EGLEAD-T-4',NULL,'LEAD aVR','An augmented unipolar electrocardiogram limb lead in which the positive (white) electrode is situated on the right thoracic limb and the negative electrode is a combination of the left thoracic limb (black) electrode and the left pelvic limb (red) electro','\0','','CL-EGLEAD','DBX-NCIT-C90362'),('CL-EGLEAD-T-5',NULL,'LEAD CM5','A bipolar EKG lead with the right thoracic limb electrode placed on the manubrium and left thoracic limb electrode placed at the surface marking of the V5 position (just above the 5th interspace in the anterior axillary line). The left pelvic limb lead ac','\0','','CL-EGLEAD','DBX-NCIT-C90404'),('CL-EGLEAD-T-6',NULL,'LEAD CV5RL','A unipolar chest lead used mostly in large animals. Placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the humeralradial joint.','\0','','CL-EGLEAD','DBX-NCIT-C90405'),('CL-EGLEAD-T-7',NULL,'LEAD CV6LL','V1 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the humeralradial joint.','\0','','CL-EGLEAD','DBX-NCIT-C90406'),('CL-EGLEAD-T-8',NULL,'LEAD CV6LU','V2 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the shoulder. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90407'),('CL-EGLEAD-T-9',NULL,'LEAD I','A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left thoracic limb. (NCI)','\0','','CL-EGLEAD','DBX-NCIT-C90408'),('CL-EGMETHOD-T-1',NULL,'10 LEAD STANDARD','An electrocardiogram lead placement on the subject using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart.','\0','10 Lead Standard','CL-EGMETHOD','DBX-NCIT-C90349'),('CL-EGMETHOD-T-10',NULL,'12 LEAD STANDARD','An electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left ','\0','12 Lead Standard','CL-EGMETHOD','DBX-NCIT-C71102'),('CL-EGMETHOD-T-11',NULL,'12 LEAD UNSPECIFIED','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI)','\0','12 Lead Unspecified','CL-EGMETHOD','DBX-NCIT-C71101'),('CL-EGMETHOD-T-12',NULL,'6 LEAD STANDARD','An electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart.','\0','6 Lead Standard','CL-EGMETHOD','DBX-NCIT-C90350'),('CL-EGMETHOD-T-13',NULL,'BIPOLAR UNCORRECTED XYZ LEAD SYSTEM','An electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of t','\0','Bipolar uncorrected XYZ lead system','CL-EGMETHOD','DBX-NCIT-C71121'),('CL-EGMETHOD-T-14',NULL,'CUBE LEAD SYSTEM','An electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI)','\0','Cube lead system','CL-EGMETHOD','DBX-NCIT-C71120'),('CL-EGMETHOD-T-15',NULL,'FRANK LEAD SYSTEM','An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the','\0','Frank lead system','CL-EGMETHOD','DBX-NCIT-C71118'),('CL-EGMETHOD-T-16',NULL,'MCFEE-PARUNGAO LEAD SYSTEM','An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneo','\0','McFee-Parungao lead system','CL-EGMETHOD','DBX-NCIT-C71119'),('CL-EGMETHOD-T-17',NULL,'PSEUDO-ORTHOGONAL XYZ LEAD SYSTEM','An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is pla','\0','Pseudo-orthogonal XYZ lead system','CL-EGMETHOD','DBX-NCIT-C71122'),('CL-EGMETHOD-T-18',NULL,'STANDARD 12-LEAD AND CC5-CM5-ML','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI)','\0','Standard 12-lead and CC5-CM5-ML','CL-EGMETHOD','DBX-NCIT-C71128'),('CL-EGMETHOD-T-19',NULL,'STANDARD 12-LEAD AND CM5-CC5-CH5','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5)','\0','Standard 12-lead and CM5-CC5-CH5','CL-EGMETHOD','DBX-NCIT-C71126'),('CL-EGMETHOD-T-2',NULL,'12 LEAD 1 LEAD MISSING','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI)','\0','12 Lead 1 Lead Missing','CL-EGMETHOD','DBX-NCIT-C71125'),('CL-EGMETHOD-T-20',NULL,'STANDARD 12-LEAD EXTENDED LEFT','An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. (NCI)','\0','Standard 12-lead extended to the left by V7, V8, V9','CL-EGMETHOD','DBX-NCIT-C71131'),('CL-EGMETHOD-T-21',NULL,'STANDARD 12-LEAD EXTENDED RIGHT','An electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R. (NCI)','\0','Standard 12-lead extended to the right by V5R, V4R, V3R','CL-EGMETHOD','DBX-NCIT-C71130'),('CL-EGMETHOD-T-22',NULL,'STANDARD LEADS FOR BICYCLE EXERCISE','Limb leads on the back (shoulder and on the hips). (NCI)','\0','Standard leads for bicycle exercise. Limb leads on the back (shoulder and on the hips)','CL-EGMETHOD','DBX-NCIT-C71115'),('CL-EGMETHOD-T-23',NULL,'STANDARD LEADS ONE INTERCOSTAL SPACE HIGHER','An electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI)','\0','Standard leads one intercostal space higher','CL-EGMETHOD','DBX-NCIT-C71117'),('CL-EGMETHOD-T-24',NULL,'VECTORCARDIOGRAPH CORRECTED','A recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI)','\0','Vectorcardiograph Corrected','CL-EGMETHOD','DBX-NCIT-C71092'),('CL-EGMETHOD-T-25',NULL,'VECTORCARDIOGRAPH UNCORRECTED','A recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI)','\0','Vectorcardiograph Uncorrected','CL-EGMETHOD','DBX-NCIT-C71093'),('CL-EGMETHOD-T-3',NULL,'12 LEAD CABRERA','An electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to ob','\0','12 Lead Cabrera','CL-EGMETHOD','DBX-NCIT-C71116'),('CL-EGMETHOD-T-4',NULL,'12 LEAD EASI DOWER TRANSFORMATION','An electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in th','\0','12 Lead EASI Dower Transformation','CL-EGMETHOD','DBX-NCIT-C71123'),('CL-EGMETHOD-T-5',NULL,'12 LEAD MASON LIKAR','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the','\0','12 Lead Mason Likar','CL-EGMETHOD','DBX-NCIT-C71103'),('CL-EGMETHOD-T-6',NULL,'12 LEAD MODIFIED MASON LIKAR','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI)','\0','12 Lead Modified Mason Likar','CL-EGMETHOD','DBX-NCIT-C71110'),('CL-EGMETHOD-T-7',NULL,'12 LEAD NON-STANDARD','An electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI)','\0','12 Lead Non-Standard','CL-EGMETHOD','DBX-NCIT-C71114'),('CL-EGMETHOD-T-8',NULL,'12 LEAD RIGHT-SIDED PRECORDIAL LEADS','An electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest.','\0','12 Lead Right-sided Precordial Leads; Right-sided Chest Leads','CL-EGMETHOD','DBX-NCIT-C116139'),('CL-EGMETHOD-T-9',NULL,'12 LEAD SINGLE PAD','An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI)','\0','12 Lead Single Pad','CL-EGMETHOD','DBX-NCIT-C71112'),('CL-EGSTRESC-T-1',NULL,'1ST DEGREE AV BLOCK','An electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds. Note that other thresholds may be applicable.','\0','1st degree AV block; PR Prolongation; Prolonged PR interval','CL-EGSTRESC','DBX-NCIT-C111088'),('CL-EGSTRESC-T-10',NULL,'ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle.','\0','Acute Anterior MI; Acute Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71065'),('CL-EGSTRESC-T-100',NULL,'NEW ANTEROLATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs.','\0','New Anterolateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102733'),('CL-EGSTRESC-T-101',NULL,'NEW ANTEROSEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs.','\0','New Anteroseptal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102734'),('CL-EGSTRESC-T-102',NULL,'NEW EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs.','\0','New Extensive Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102735'),('CL-EGSTRESC-T-103',NULL,'NEW HIGH LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs.','\0','New High Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102736'),('CL-EGSTRESC-T-104',NULL,'NEW INFERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs.','\0','New Inferior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102737'),('CL-EGSTRESC-T-105',NULL,'NEW LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs.','\0','New Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102738'),('CL-EGSTRESC-T-106',NULL,'NEW MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization.','\0','New Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102731'),('CL-EGSTRESC-T-107',NULL,'NEW POSTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and w','\0','','CL-EGSTRESC','DBX-NCIT-C106548'),('CL-EGSTRESC-T-108',NULL,'NEW SEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs.','\0','New Septal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102739'),('CL-EGSTRESC-T-109',NULL,'NO ECG WAVEFORMS PRESENT','An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present.','\0','','CL-EGSTRESC','DBX-NCIT-C114163'),('CL-EGSTRESC-T-11',NULL,'ACUTE ANTEROLATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle.','\0','Acute Anterolateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102591'),('CL-EGSTRESC-T-110',NULL,'NON Q WAVE MYOCARDIAL INFARCTION','An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart.','\0','Non Q Wave Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71080'),('CL-EGSTRESC-T-111',NULL,'NON-DIAGNOSTIC Q WAVES','An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met.','\0','','CL-EGSTRESC','DBX-NCIT-C116134'),('CL-EGSTRESC-T-112',NULL,'NON-SPECIFIC ST-T CHANGES','An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI)','\0','Non-specific ST-T changes','CL-EGSTRESC','DBX-NCIT-C71031'),('CL-EGSTRESC-T-113',NULL,'NON-SUSTAINED ATRIAL TACHYCARDIA','An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds.','\0','Non-Sustained Atrial Tachycardia','CL-EGSTRESC','DBX-NCIT-C102680'),('CL-EGSTRESC-T-114',NULL,'NON-SUSTAINED VENTRICULAR TACHYCARDIA','An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI)','\0','Non-sustained ventricular tachycardia; Ventricular tachycardia, unsustained','CL-EGSTRESC','DBX-NCIT-C71053'),('CL-EGSTRESC-T-115',NULL,'NORMAL SINUS RHYTHM','An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. There are no extra beats or conduction abnormalities.','\0','Normal Sinus Rhythm','CL-EGSTRESC','DBX-NCIT-C102681'),('CL-EGSTRESC-T-116',NULL,'NORTHWEST AXIS','An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees.','\0','Northwest Axis; Right superior axis','CL-EGSTRESC','DBX-NCIT-C102634'),('CL-EGSTRESC-T-117',NULL,'NOTCHED T WAVES','An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave.','\0','Notched T Waves','CL-EGSTRESC','DBX-NCIT-C71032'),('CL-EGSTRESC-T-118',NULL,'OLD OR AGE INDETERMINATE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102684'),('CL-EGSTRESC-T-119',NULL,'OLD OR AGE INDETERMINATE ANTEROLATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102685'),('CL-EGSTRESC-T-12',NULL,'ACUTE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle.','\0','Acute Anteroseptal Wall Myocardial Infarction; Acute anteroseptal MI','CL-EGSTRESC','DBX-NCIT-C102592'),('CL-EGSTRESC-T-120',NULL,'OLD OR AGE INDETERMINATE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102686'),('CL-EGSTRESC-T-121',NULL,'OLD OR AGE INDETERMINATE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102687'),('CL-EGSTRESC-T-122',NULL,'OLD OR AGE INDETERMINATE HIGH LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate High Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102688'),('CL-EGSTRESC-T-123',NULL,'OLD OR AGE INDETERMINATE INFERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Inferior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102689'),('CL-EGSTRESC-T-124',NULL,'OLD OR AGE INDETERMINATE LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102690'),('CL-EGSTRESC-T-125',NULL,'OLD OR AGE INDETERMINATE POSTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, witho','\0','Old Or Age Indeterminate Posterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102691'),('CL-EGSTRESC-T-126',NULL,'OLD OR AGE INDETERMINATE SEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction.','\0','Old Or Age Indeterminate Septal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102693'),('CL-EGSTRESC-T-127',NULL,'OLD OR AGE INDETERMINATE WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization.','\0','Old Or Age Indeterminate Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C101597'),('CL-EGSTRESC-T-128',NULL,'OLD OR AGE UNDETERMINED RIGHT VENTRICULAR MYOCARDIAL INFARCTION','An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R.','\0','','CL-EGSTRESC','DBX-NCIT-C102692'),('CL-EGSTRESC-T-129',NULL,'OTHER INCORRECT ELECTRODE PLACEMENT','An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided.','\0','','CL-EGSTRESC','DBX-NCIT-C114176'),('CL-EGSTRESC-T-13',NULL,'ACUTE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle.','\0','','CL-EGSTRESC','DBX-NCIT-C106496'),('CL-EGSTRESC-T-130',NULL,'P WAVE ABNORMALITY','An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI)','\0','P Wave Abnormality','CL-EGSTRESC','DBX-NCIT-C90430'),('CL-EGSTRESC-T-131',NULL,'P WAVE NOTCHED','An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal.','\0','P Wave Notched','CL-EGSTRESC','DBX-NCIT-C90431'),('CL-EGSTRESC-T-132',NULL,'PACED ATRIAL AND VENTRICULAR RHYTHM','An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker.','\0','AV dual-paced complex(es) or rhythm; Paced Atrial And Ventricular Rhythm','CL-EGSTRESC','DBX-NCIT-C92232'),('CL-EGSTRESC-T-133',NULL,'PACED ATRIAL RHYTHM','An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.','\0','Atrial-paced complex(es) or rhythm; Paced Atrial Rhythm','CL-EGSTRESC','DBX-NCIT-C92233'),('CL-EGSTRESC-T-134',NULL,'PACED RHYTHM','An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.','\0','Atrial and/or Ventricular Paced Rhythm; Paced Rhythm','CL-EGSTRESC','DBX-NCIT-C88140'),('CL-EGSTRESC-T-135',NULL,'PACED VENTRICULAR RHYTHM','An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.','\0','Paced Ventricular Rhythm; Ventricular-paced complex(es) or rhythm','CL-EGSTRESC','DBX-NCIT-C92234'),('CL-EGSTRESC-T-136',NULL,'PAROXYSMAL AV BLOCK','An electrocardiographic finding of the sudden onset of transient AV block, which is often associated with preexisting conduction disorders.','\0','Paroxysmal AV block','CL-EGSTRESC','DBX-NCIT-C62250'),('CL-EGSTRESC-T-137',NULL,'PAROXYSMAL VENTRICULAR TACHYCARDIA','An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI)','\0','Paroxysmal Ventricular Tachycardia','CL-EGSTRESC','DBX-NCIT-C34902'),('CL-EGSTRESC-T-138',NULL,'POOR QUALITY ECG','An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described.','\0','','CL-EGSTRESC','DBX-NCIT-C114172'),('CL-EGSTRESC-T-139',NULL,'POOR R WAVE PROGRESSION','An electrocardiographic finding of a lack of progression of R wave height across precordial leads.','\0','Poor R Wave Progression','CL-EGSTRESC','DBX-NCIT-C71033'),('CL-EGSTRESC-T-14',NULL,'ACUTE HIGH LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle.','\0','Acute High Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102593'),('CL-EGSTRESC-T-140',NULL,'POSTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evide','\0','Posterior MI; Posterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C35399'),('CL-EGSTRESC-T-141',NULL,'PR SEGMENT DEPRESSION','An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads.','\0','PR Depression','CL-EGSTRESC','DBX-NCIT-C116135'),('CL-EGSTRESC-T-142',NULL,'PRE-EXCITATION','An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. The PR interval is usually shortened and delta waves are frequently present.','\0','Pre-excitation; Ventricular preexcitation','CL-EGSTRESC','DBX-NCIT-C34940'),('CL-EGSTRESC-T-143',NULL,'PRECORDIAL ELECTRODE V1 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1.','\0','','CL-EGSTRESC','DBX-NCIT-C114153'),('CL-EGSTRESC-T-144',NULL,'PRECORDIAL ELECTRODE V2 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2.','\0','','CL-EGSTRESC','DBX-NCIT-C114154'),('CL-EGSTRESC-T-145',NULL,'PRECORDIAL ELECTRODE V3 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3.','\0','','CL-EGSTRESC','DBX-NCIT-C114155'),('CL-EGSTRESC-T-146',NULL,'PRECORDIAL ELECTRODE V4 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4.','\0','','CL-EGSTRESC','DBX-NCIT-C114156'),('CL-EGSTRESC-T-147',NULL,'PRECORDIAL ELECTRODE V5 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5.','\0','','CL-EGSTRESC','DBX-NCIT-C114157'),('CL-EGSTRESC-T-148',NULL,'PRECORDIAL ELECTRODE V6 DISCONNECTED','An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6.','\0','','CL-EGSTRESC','DBX-NCIT-C114158'),('CL-EGSTRESC-T-149',NULL,'PRECORDIAL ELECTRODE(S) POSITIONED INCORRECTLY','An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads.','\0','','CL-EGSTRESC','DBX-NCIT-C114160'),('CL-EGSTRESC-T-15',NULL,'ACUTE INFERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle.','\0','Acute Inferior MI; Acute Inferior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71066'),('CL-EGSTRESC-T-150',NULL,'PRECORDIAL ELECTRODES INTERCHANGED','An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads.','\0','Precordial Lead Reversal','CL-EGSTRESC','DBX-NCIT-C114152'),('CL-EGSTRESC-T-151',NULL,'PREMATURE ATRIAL COMPLEXES','An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also s','\0','APC; Atrial premature complex(es); PAC; Premature atrial complex; SVE; Supraventricular Extra Beat','CL-EGSTRESC','DBX-NCIT-C62257'),('CL-EGSTRESC-T-152',NULL,'PREMATURE ATRIAL COMPLEXES BLOCKED','An electrocardiographic finding of premature atrial complexes which are not conducted to the ventricle, and which are not followed by a QRS complex.','\0','Atrial premature complexes, nonconducted; Non-conducted SVE; Premature Atrial Complexes Blocked; Premature Atrial Complexes Non-conducted','CL-EGSTRESC','DBX-NCIT-C102603'),('CL-EGSTRESC-T-153',NULL,'PREMATURE ATRIAL COMPLEXES MULTIFOCAL','An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site.','\0','Multifocal SVE; Multifocal Supraventricular Extra Beats; Premature Atrial Complexes Multifocal','CL-EGSTRESC','DBX-NCIT-C102672'),('CL-EGSTRESC-T-154',NULL,'PREMATURE ATRIAL COMPLEXES UNIFOCAL','An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site.','\0','Premature Atrial Complexes Unifocal','CL-EGSTRESC','DBX-NCIT-C102724'),('CL-EGSTRESC-T-155',NULL,'PREMATURE VENTRICULAR COMPLEX','An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is ','\0','PVC; VE; VPC; Ventricular Extra Beat; Ventricular premature complex(es)','CL-EGSTRESC','DBX-NCIT-C62256'),('CL-EGSTRESC-T-156',NULL,'PREMATURE VENTRICULAR COMPLEX INTERPOLATED','An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing.','\0','Interpolated VE; Interpolated VPC; Interpolated Ventricular Extra Beat; Premature Ventricular Complexes Interpolated','CL-EGSTRESC','DBX-NCIT-C107100'),('CL-EGSTRESC-T-157',NULL,'PREMATURE VENTRICULAR COMPLEXES MULTIFOCAL','An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site.','\0','Multifocal VES; Multifocal VPCS; Multifocal Ventricular Extra Beats; Premature Ventricular Complexes Multifocal','CL-EGSTRESC','DBX-NCIT-C102673'),('CL-EGSTRESC-T-158',NULL,'PREMATURE VENTRICULAR COMPLEXES UNIFOCAL','An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site.','\0','Premature Ventricular Complexes Unifocal; Unifocal VES; Unifocal VPCS; Unifocal Ventricular Extra Beats','CL-EGSTRESC','DBX-NCIT-C102725'),('CL-EGSTRESC-T-159',NULL,'PROLONGED QT','An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist.','\0','Prolonged QT; Prolonged QT interval','CL-EGSTRESC','DBX-NCIT-C71034'),('CL-EGSTRESC-T-16',NULL,'ACUTE LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle.','\0','Acute Lateral MI; Acute Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71067'),('CL-EGSTRESC-T-160',NULL,'PROLONGED ST SEGMENT','An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. This may be observed in hypocalcemia.','\0','','CL-EGSTRESC','DBX-NCIT-C116137'),('CL-EGSTRESC-T-161',NULL,'Q AXIS, LEFT AXIS DEVIATION','An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees.','\0','Left-axis deviation; Q Axis, Left axis deviation; QRS axis, left axis deviation','CL-EGSTRESC','DBX-NCIT-C71094'),('CL-EGSTRESC-T-162',NULL,'Q AXIS, RIGHT AXIS DEVIATION','An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees.','\0','Q Axis, Right axis deviation; QRS axis, right axis deviation; Right-axis deviation','CL-EGSTRESC','DBX-NCIT-C71095'),('CL-EGSTRESC-T-163',NULL,'QRS COMPLEX ABNORMALITY','An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity.','\0','QRS Complex Abnormality','CL-EGSTRESC','DBX-NCIT-C90440'),('CL-EGSTRESC-T-164',NULL,'QTC PROLONGATION','An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist.','\0','QTc Prolongation','CL-EGSTRESC','DBX-NCIT-C83817'),('CL-EGSTRESC-T-165',NULL,'QTCB PROLONGATION','An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett\'s formula is prolonged. Thresholds for different age, gender, and patient populations exist.','\0','PROLONGED QTcB','CL-EGSTRESC','DBX-NCIT-C107098'),('CL-EGSTRESC-T-166',NULL,'QTCF PROLONGATION','An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia\'s formula is prolonged. Thresholds for different age, gender, and patient populations exist.','\0','PROLONGED QTcF','CL-EGSTRESC','DBX-NCIT-C107099'),('CL-EGSTRESC-T-167',NULL,'QUALITY PROBLEM NOT OTHERWISE SPECIFIED','An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise.','\0','Unknown Quality Problem','CL-EGSTRESC','DBX-NCIT-C114161'),('CL-EGSTRESC-T-168',NULL,'R ON T PHENOMENON','An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat.','\0','R on T phenomenon','CL-EGSTRESC','DBX-NCIT-C61395'),('CL-EGSTRESC-T-169',NULL,'R WAVE NOTCHED','An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI)','\0','R Wave Notched','CL-EGSTRESC','DBX-NCIT-C90444'),('CL-EGSTRESC-T-17',NULL,'ACUTE MYOCARDIAL INFARCTION','An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization.','\0','Acute Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C101596'),('CL-EGSTRESC-T-170',NULL,'REPOLARIZATION ABNORMALITY','An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization.','\0','Repolarization Abnormality','CL-EGSTRESC','DBX-NCIT-C102574'),('CL-EGSTRESC-T-171',NULL,'REPOLARIZATION ABNORMALITY SECONDARY TO VENTRICULAR HYPERTROPHY','An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy.','\0','Repolarization Abnormality Secondary To Ventricular Hypertrophy; ST-T change due to ventricular hypertrophy','CL-EGSTRESC','DBX-NCIT-C102706'),('CL-EGSTRESC-T-172',NULL,'RIGHT ATRIAL ABNORMALITY','An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in ','\0','P-pulmonale; Right Atrial Enlargement','CL-EGSTRESC','DBX-NCIT-C71041'),('CL-EGSTRESC-T-173',NULL,'RIGHT BUNDLE BRANCH BLOCK','An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration greater than or e','\0','Complete RBBB; Right bundle branch block; Right bundle-branch block','CL-EGSTRESC','DBX-NCIT-C62270'),('CL-EGSTRESC-T-174',NULL,'RIGHT VENTRICULAR CONDUCTION DELAY','An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired with a maximal QRS duration of 110 ms and which does not meet the criteria for Incomplete Right Bundle Branch Block.','\0','Right Ventricular Conduction Delay; Right Ventricular Delay','CL-EGSTRESC','DBX-NCIT-C92235'),('CL-EGSTRESC-T-175',NULL,'RIGHT VENTRICULAR HYPERTROPHY','An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depre','\0','Right ventricular Hypertrophy','CL-EGSTRESC','DBX-NCIT-C71077'),('CL-EGSTRESC-T-176',NULL,'RSR PRIME','An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflecti','\0','RSR\'','CL-EGSTRESC','DBX-NCIT-C92227'),('CL-EGSTRESC-T-177',NULL,'SEPTAL MYOCARDIAL INFARCTION','An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI)','\0','Septal myocardial infarction','CL-EGSTRESC','DBX-NCIT-C35519'),('CL-EGSTRESC-T-178',NULL,'SHORT PR INTERVAL','An electrocardiographic finding of an abnormally short PR interval. Thresholds for different age, gender, and patient populations exist.','\0','Short PR interval','CL-EGSTRESC','DBX-NCIT-C62246'),('CL-EGSTRESC-T-179',NULL,'SHORT QTC INTERVAL','An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Thresholds for different age, gender, and patient populations exist.','\0','Short QTc Interval','CL-EGSTRESC','DBX-NCIT-C102709'),('CL-EGSTRESC-T-18',NULL,'ACUTE POSTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior','\0','Acute Posterior MI; Acute Posterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71068'),('CL-EGSTRESC-T-180',NULL,'SHORT QTCB','An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett\'s formula is shortened. Thresholds for different age, gender, and patient populations exist.','\0','','CL-EGSTRESC','DBX-NCIT-C112402'),('CL-EGSTRESC-T-181',NULL,'SHORT QTCF','An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia\'s formula is shortened. Thresholds for different age, gender, and patient populations exist.','\0','','CL-EGSTRESC','DBX-NCIT-C112403'),('CL-EGSTRESC-T-182',NULL,'SHORT ST SEGMENT','An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. This may be observed in hypercalcemia.','\0','','CL-EGSTRESC','DBX-NCIT-C116136'),('CL-EGSTRESC-T-183',NULL,'SINOATRIAL EXIT BLOCK','An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm.','\0','SA Block; Sinoatrial Block; Sinoatrial exit block','CL-EGSTRESC','DBX-NCIT-C50553'),('CL-EGSTRESC-T-184',NULL,'SINUS ARREST/PAUSE','An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. The threshold for the prolongation of the P-P interval is not well defined.','\0','Sinus arrest/pause; Sinus pause or arrest','CL-EGSTRESC','DBX-NCIT-C62242'),('CL-EGSTRESC-T-185',NULL,'SINUS ARRHYTHMIA','An electrocardiographic finding in which the sinus rate fluctuates with the respiratory cycle.','\0','Respiratory Sinus Arrhythmia; Sinus arrhythmia','CL-EGSTRESC','DBX-NCIT-C62239'),('CL-EGSTRESC-T-186',NULL,'SINUS BRADYCARDIA','An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist.','\0','Sinus bradycardia','CL-EGSTRESC','DBX-NCIT-C111097'),('CL-EGSTRESC-T-187',NULL,'SINUS RHYTHM','An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population.','\0','Sinus Rhythm','CL-EGSTRESC','DBX-NCIT-C100076'),('CL-EGSTRESC-T-188',NULL,'SINUS TACHYCARDIA','An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist.','\0','Sinus tachycardia','CL-EGSTRESC','DBX-NCIT-C111104'),('CL-EGSTRESC-T-189',NULL,'ST DEPRESSION','An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI)','\0','ST depression','CL-EGSTRESC','DBX-NCIT-C41330'),('CL-EGSTRESC-T-19',NULL,'ACUTE RIGHT VENTRICULAR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricul','\0','Acute Right Ventricular Wall Myocardial Infarction; Acute Right ventricular MI','CL-EGSTRESC','DBX-NCIT-C102594'),('CL-EGSTRESC-T-190',NULL,'ST ELEVATION','An electrocardiographic finding of ST segment elevation above the baseline. (NCI)','\0','ST elevation','CL-EGSTRESC','DBX-NCIT-C50540'),('CL-EGSTRESC-T-191',NULL,'ST ELEVATION PERICARDITIS','An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression.','\0','ST elevation pericarditis','CL-EGSTRESC','DBX-NCIT-C71029'),('CL-EGSTRESC-T-192',NULL,'SUPRAVENTRICULAR TACHYCARDIA','An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present.','\0','Supraventricular tachycardia','CL-EGSTRESC','DBX-NCIT-C111100'),('CL-EGSTRESC-T-193',NULL,'SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES NO REVERSAL','An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct.','\0','','CL-EGSTRESC','DBX-NCIT-C114173'),('CL-EGSTRESC-T-194',NULL,'SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES REVERSAL','An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged.','\0','','CL-EGSTRESC','DBX-NCIT-C114174'),('CL-EGSTRESC-T-195',NULL,'SUSTAINED VENTRICULAR TACHYCARDIA','An electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI)','\0','Sustained ventricular tachycardia','CL-EGSTRESC','DBX-NCIT-C71052'),('CL-EGSTRESC-T-196',NULL,'T WAVE ALTERNANS','An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next.','\0','T Wave Alternans','CL-EGSTRESC','DBX-NCIT-C102718'),('CL-EGSTRESC-T-197',NULL,'T WAVE INVERSION','An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI)','\0','T Wave Inversion','CL-EGSTRESC','DBX-NCIT-C71085'),('CL-EGSTRESC-T-198',NULL,'T WAVE PEAKED','An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI)','\0','T wave peaked','CL-EGSTRESC','DBX-NCIT-C71086'),('CL-EGSTRESC-T-199',NULL,'T WAVES BIPHASIC','An electrocardiographic finding of a T wave with both positive and negative components.','\0','T waves biphasic','CL-EGSTRESC','DBX-NCIT-C71087'),('CL-EGSTRESC-T-2',NULL,'2:1 AV BLOCK','An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS compl','\0','2:1 AV block','CL-EGSTRESC','DBX-NCIT-C71044'),('CL-EGSTRESC-T-20',NULL,'ACUTE SEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum.','\0','Acute Septal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102595'),('CL-EGSTRESC-T-200',NULL,'T WAVES FLAT','An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI)','\0','T waves flat','CL-EGSTRESC','DBX-NCIT-C71088'),('CL-EGSTRESC-T-201',NULL,'TACHYCARDIA','An electrocardiographic finding of abnormally rapid heart rate. Thresholds for different age, gender, and patient populations exist.','\0','Tachycardia','CL-EGSTRESC','DBX-NCIT-C111121'),('CL-EGSTRESC-T-202',NULL,'TORSADES DE POINTES','An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex d','\0','Torsades de pointes; Ventricular tachycardia, torsades de pointes','CL-EGSTRESC','DBX-NCIT-C50779'),('CL-EGSTRESC-T-203',NULL,'U WAVE ABNORMALITY','An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave.','\0','Abnormal U Wave','CL-EGSTRESC','DBX-NCIT-C106579'),('CL-EGSTRESC-T-204',NULL,'UNABLE TO DIGITIZE ECG LEADS','A statement indicating the inability to digitize a paper ECG.','\0','','CL-EGSTRESC','DBX-NCIT-C114170'),('CL-EGSTRESC-T-205',NULL,'UNDETERMINED RHYTHM','An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG.','\0','','CL-EGSTRESC','DBX-NCIT-C116131'),('CL-EGSTRESC-T-206',NULL,'VENTRICULAR BIGEMINY','An electrocardiographic finding of a normal QRS followed by a premature ventricular complex; a rhythmic pairing of normal and abnormal beats originating in the ventricles in a 1-1 ratio.','\0','Bigeminy','CL-EGSTRESC','DBX-NCIT-C71054'),('CL-EGSTRESC-T-207',NULL,'VENTRICULAR COUPLET','An electrocardiographic finding in which two premature ventricular complexes occur sequentially.','\0','Ventricular Pair; Ventricular couplet','CL-EGSTRESC','DBX-NCIT-C62259'),('CL-EGSTRESC-T-208',NULL,'VENTRICULAR ESCAPE BEAT','An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval.','\0','Ventricular Escape Beat; Ventricular escape complex(es)','CL-EGSTRESC','DBX-NCIT-C90483'),('CL-EGSTRESC-T-209',NULL,'VENTRICULAR FIBRILLATION','An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm.','\0','Ventricular fibrillation','CL-EGSTRESC','DBX-NCIT-C111102'),('CL-EGSTRESC-T-21',NULL,'ADVANCED/HIGH GRADE AV BLOCK','An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves.','\0','Advanced/High Grade AV Block','CL-EGSTRESC','DBX-NCIT-C102642'),('CL-EGSTRESC-T-210',NULL,'VENTRICULAR FLUTTER','A ventricular tachyarrhythmia characterized by a high ventricular rate (180 to 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being mer','\0','Ventricular flutter','CL-EGSTRESC','DBX-NCIT-C111115'),('CL-EGSTRESC-T-211',NULL,'VENTRICULAR PARASYSTOLE','An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm.','\0','Parasystole; Ventricular Parasystole','CL-EGSTRESC','DBX-NCIT-C102728'),('CL-EGSTRESC-T-212',NULL,'VENTRICULAR TACHYCARDIA','An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology.','\0','Ventricular tachycardia','CL-EGSTRESC','DBX-NCIT-C111103'),('CL-EGSTRESC-T-213',NULL,'VENTRICULAR TACHYCARDIA, MONOMORPHIC','An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology.','\0','Ventricular tachycardia, monomorphic','CL-EGSTRESC','DBX-NCIT-C62234'),('CL-EGSTRESC-T-214',NULL,'VENTRICULAR TACHYCARDIA, POLYMORPHIC','An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate.','\0','Ventricular tachycardia, polymorphic; Ventricular tachycardia, polymorphous','CL-EGSTRESC','DBX-NCIT-C62236'),('CL-EGSTRESC-T-215',NULL,'VENTRICULAR TRIGEMINY','An electrocardiographic finding of two sinus beats followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio.','\0','Trigeminy','CL-EGSTRESC','DBX-NCIT-C71055'),('CL-EGSTRESC-T-216',NULL,'WANDERING ATRIAL PACEMAKER','An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beat','\0','Wandering atrial pacemaker','CL-EGSTRESC','DBX-NCIT-C62240'),('CL-EGSTRESC-T-217',NULL,'WIDE QRS TACHYCARDIA','An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used).','\0','Wide QRS tachycardia; Wide-QRS tachycardia','CL-EGSTRESC','DBX-NCIT-C71090'),('CL-EGSTRESC-T-218',NULL,'WOLFF-PARKINSON-WHITE SYNDROME','An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave.','\0','WPW; Wolff-Parkinson-White syndrome','CL-EGSTRESC','DBX-NCIT-C35132'),('CL-EGSTRESC-T-22',NULL,'ALL PRECORDIAL ELECTRODES DISCONNECTED','An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6.','\0','','CL-EGSTRESC','DBX-NCIT-C114159'),('CL-EGSTRESC-T-23',NULL,'ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle.','\0','Anterior MI; Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C71069'),('CL-EGSTRESC-T-24',NULL,'ANTEROLATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle.','\0','Anterolateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C35303'),('CL-EGSTRESC-T-25',NULL,'ANTEROSEPTAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle.','\0','Anteroseptal MI; Anteroseptal Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C35304'),('CL-EGSTRESC-T-26',NULL,'ARTIFACT','An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity.','\0','','CL-EGSTRESC','DBX-NCIT-C114162'),('CL-EGSTRESC-T-27',NULL,'ASYSTOLE','An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording.','\0','','CL-EGSTRESC','DBX-NCIT-C116130'),('CL-EGSTRESC-T-28',NULL,'ATRIAL BIGEMINY','An electrocardiographic finding of a sinus beat followed by a premature atrial complexes for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio.','\0','Atrial Bigeminy','CL-EGSTRESC','DBX-NCIT-C102596'),('CL-EGSTRESC-T-29',NULL,'ATRIAL COUPLETS','An electrocardiographic finding in which two premature atrial complexes occur sequentially.','\0','Atrial Couplets','CL-EGSTRESC','DBX-NCIT-C102597'),('CL-EGSTRESC-T-3',NULL,'2ND DEGREE AV BLOCK','An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes.','\0','2nd degree AV block','CL-EGSTRESC','DBX-NCIT-C62016'),('CL-EGSTRESC-T-30',NULL,'ATRIAL ENLARGEMENT','An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves.','\0','Atrial Enlargement','CL-EGSTRESC','DBX-NCIT-C71039'),('CL-EGSTRESC-T-31',NULL,'ATRIAL FIBRILLATION','An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventric','\0','Atrial fibrillation','CL-EGSTRESC','DBX-NCIT-C111092'),('CL-EGSTRESC-T-32',NULL,'ATRIAL FLUTTER','An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes.','\0','Atrial flutter','CL-EGSTRESC','DBX-NCIT-C111094'),('CL-EGSTRESC-T-33',NULL,'ATRIAL TACHYCARDIA','An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate between 101 and 240 beats per minute. The P wave morphology must be distinct from the sinus P wave morphology.','\0','Atrial tachycardia','CL-EGSTRESC','DBX-NCIT-C111105'),('CL-EGSTRESC-T-34',NULL,'ATRIAL TRIGEMINY','An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio.','\0','Atrial Trigeminy','CL-EGSTRESC','DBX-NCIT-C102598'),('CL-EGSTRESC-T-35',NULL,'ATRIOVENTRICULAR DISSOCIATION','An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another.','\0','AV Dissociation; Atrioventricular dissociation','CL-EGSTRESC','DBX-NCIT-C71045'),('CL-EGSTRESC-T-36',NULL,'AV MOBITZ I','An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse.','\0','AV Mobitz I; Mobitz I Second Degree AV Block; Second degree AV block- Mobitz type I; Second-degree AV block, Mobitz type I (Wenckebach); Type 1 2nd degree AV Block; Wenckebach','CL-EGSTRESC','DBX-NCIT-C111089'),('CL-EGSTRESC-T-37',NULL,'AV MOBITZ II','An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse.','\0','AV Mobitz II; Mobitz II Second Degree AV Block; Second degree AV block- Mobitz type II; Second-degree AV block, Mobitz type II; Type 2 2nd degree AV Block','CL-EGSTRESC','DBX-NCIT-C111090'),('CL-EGSTRESC-T-38',NULL,'AV NODE RE-ENTRY','An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the Q','\0','AV node re-entry','CL-EGSTRESC','DBX-NCIT-C35058'),('CL-EGSTRESC-T-39',NULL,'AV RE-ENTRANT TACHYCARDIA','An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm','\0','AV re-entrant tachycardia','CL-EGSTRESC','DBX-NCIT-C62261'),('CL-EGSTRESC-T-4',NULL,'3RD DEGREE AV BLOCK','An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate.','\0','3rd degree AV block; AV block, complete (third-degree); Complete Heart Block','CL-EGSTRESC','DBX-NCIT-C111091'),('CL-EGSTRESC-T-40',NULL,'BASELINE WANDER','An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes.','\0','','CL-EGSTRESC','DBX-NCIT-C114147'),('CL-EGSTRESC-T-41',NULL,'BIFASCICULAR BLOCK','An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the hear','\0','Bifascicular block','CL-EGSTRESC','DBX-NCIT-C71046'),('CL-EGSTRESC-T-42',NULL,'BIVENTRICULAR HYPERTROPHY','An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation.','\0','','CL-EGSTRESC','DBX-NCIT-C106502'),('CL-EGSTRESC-T-43',NULL,'BORDERLINE QTcB','An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett\'s formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist.','\0','Borderline QTcB','CL-EGSTRESC','DBX-NCIT-C92228'),('CL-EGSTRESC-T-44',NULL,'BORDERLINE QTcF','An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia\'s formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist.','\0','Borderline QTcF','CL-EGSTRESC','DBX-NCIT-C92229'),('CL-EGSTRESC-T-45',NULL,'BRADYCARDIA','An electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist.','\0','Bradycardia','CL-EGSTRESC','DBX-NCIT-C111120'),('CL-EGSTRESC-T-46',NULL,'BRUGADA SYNDROME PATTERN','An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge.','\0','','CL-EGSTRESC','DBX-NCIT-C106503'),('CL-EGSTRESC-T-47',NULL,'CV ENDPOINTS ISCHEMIC ECG CHANGES','An electrocardiographic finding, in the absence of left ventricular hypertrophy (LVH) and left bundle branch block pattern on ECG, of either a) new (or presumed new) ST elevation at the J point in two contiguous leads with the following cut-points: >=0.1 ','\0','','CL-EGSTRESC','DBX-NCIT-C116138'),('CL-EGSTRESC-T-48',NULL,'DELTA WAVE','An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome.','\0','Delta wave','CL-EGSTRESC','DBX-NCIT-C62258'),('CL-EGSTRESC-T-49',NULL,'DEXTROCARDIA','An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes.','\0','Dextrocardia','CL-EGSTRESC','DBX-NCIT-C102623'),('CL-EGSTRESC-T-5',NULL,'50 Hz NOISE','An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz).','\0','50 Hz Artifact; 50 Hz Noise','CL-EGSTRESC','DBX-NCIT-C114165'),('CL-EGSTRESC-T-50',NULL,'EARLY R WAVE TRANSITION','An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2.','\0','Early R Wave Progression; Early R Wave Transition','CL-EGSTRESC','DBX-NCIT-C102628'),('CL-EGSTRESC-T-51',NULL,'EARLY REPOLARIZATION','An electrocardiographic finding of J point and ST segment elevation in the absence of other signs of acute ischemia or pericarditis.','\0','Early Repolarization','CL-EGSTRESC','DBX-NCIT-C102629'),('CL-EGSTRESC-T-52',NULL,'ECG ACQUIRED WITH PRECORDIAL ELECTRODES PLACED ON RIGHT CHEST','An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG.','\0','','CL-EGSTRESC','DBX-NCIT-C114175'),('CL-EGSTRESC-T-53',NULL,'ECG EVALUATION NOT PERFORMED DUE TO CORRUPTED DIGITAL ECG FILE','A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed.','\0','','CL-EGSTRESC','DBX-NCIT-C114181'),('CL-EGSTRESC-T-54',NULL,'ECG EVALUATION NOT PERFORMED DUE TO POOR QUALITY OF PRINTED ECG','A printed electrocardiographic recording with poor printout quality (e.g. a faded paper ECG tracing or ECG with inconsistent printing speed) such that measurements and/or interpretation cannot be performed.','\0','','CL-EGSTRESC','DBX-NCIT-C114180'),('CL-EGSTRESC-T-55',NULL,'ECG EVALUATION NOT PERFORMED DUE TO UNKNOWN ECG AMPLITUDE GAIN OR RECORDING SPEED','An electrocardiographic recording in which measurements and/or interpretation are not performed because the ECG amplitude gain and/or recording speed are not known.','\0','','CL-EGSTRESC','DBX-NCIT-C114178'),('CL-EGSTRESC-T-56',NULL,'ECTOPIC ATRIAL RHYTHM','An electrocardiographic finding of a regular atrial rhythm with atrial rate of less than 101 beats per minute which does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinu','\0','Ectopic atrial rhythm','CL-EGSTRESC','DBX-NCIT-C62245'),('CL-EGSTRESC-T-57',NULL,'ECTOPIC VENTRICULAR RHYTHM','An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology.','\0','Ectopic ventricular rhythm','CL-EGSTRESC','DBX-NCIT-C71042'),('CL-EGSTRESC-T-58',NULL,'ELECTRICAL ALTERNANS','An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI)','\0','Electrical alternans','CL-EGSTRESC','DBX-NCIT-C71035'),('CL-EGSTRESC-T-59',NULL,'EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle.','\0','','CL-EGSTRESC','DBX-NCIT-C106520'),('CL-EGSTRESC-T-6',NULL,'60 Hz NOISE','An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz).','\0','60 Hz Artifact; 60 Hz Noise','CL-EGSTRESC','DBX-NCIT-C114164'),('CL-EGSTRESC-T-60',NULL,'FUSION COMPLEX','An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different site','\0','Fusion Complex; Fusion complex(es)','CL-EGSTRESC','DBX-NCIT-C102639'),('CL-EGSTRESC-T-61',NULL,'HIGH LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle.','\0','High Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102643'),('CL-EGSTRESC-T-62',NULL,'IDIOVENTRICULAR RHYTHM','An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology.','\0','Idioventricular Rhythm','CL-EGSTRESC','DBX-NCIT-C50599'),('CL-EGSTRESC-T-63',NULL,'INCOMPLETE ECG','An electrocardiographic recording which is limited in duration or which does not display all of the expected leads.','\0','','CL-EGSTRESC','DBX-NCIT-C114167'),('CL-EGSTRESC-T-64',NULL,'INCOMPLETE LEFT BUNDLE BRANCH BLOCK','An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration less than 120 ms.','\0','Incomplete left bundle branch block','CL-EGSTRESC','DBX-NCIT-C71047'),('CL-EGSTRESC-T-65',NULL,'INCOMPLETE MEASUREMENTS DUE TO TRUNCATION OF QRS COMPLEXES','An electrocardiographic recording in which measurements (particularly of QRS amplitudes) and/or interpretations are not performed because QRS complexes have been truncated.','\0','','CL-EGSTRESC','DBX-NCIT-C114179'),('CL-EGSTRESC-T-66',NULL,'INCOMPLETE RIGHT BUNDLE BRANCH BLOCK','An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration less than 120 ms.','\0','Incomplete right bundle branch block; Incomplete right bundle-branch block','CL-EGSTRESC','DBX-NCIT-C71048'),('CL-EGSTRESC-T-67',NULL,'INCOMPLETELY DIGITIZED ECG LEAD(S)','A digital electrocardiographic recording which was digitized from paper ECG tracings and which does not contain all leads present on the original paper printout.','\0','','CL-EGSTRESC','DBX-NCIT-C114169'),('CL-EGSTRESC-T-68',NULL,'INCORRECTLY SCALED ECG','An electrocardiographic recording in which the ECG signal is not displayed at the indicated recording speed and/or amplitude resolution.','\0','','CL-EGSTRESC','DBX-NCIT-C114168'),('CL-EGSTRESC-T-69',NULL,'INDETERMINATE QRS AXIS','An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated.','\0','Indeterminate Axis; Indeterminate QRS Axis; QRS Axis Indeterminate','CL-EGSTRESC','DBX-NCIT-C102701'),('CL-EGSTRESC-T-7',NULL,'ABERRANTLY CONDUCTED COMPLEXES','An electrocardiographic finding of abnormal wide QRS complex(es) of supraventricular in origin and wide due to aberrant AV conduction.','\0','Aberrantly Conducted Beats','CL-EGSTRESC','DBX-NCIT-C116132'),('CL-EGSTRESC-T-70',NULL,'INFERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle.','\0','Inferior MI; Inferior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C35398'),('CL-EGSTRESC-T-71',NULL,'INSUFFICENT NUMBER OF BEATS TO COMPLETELY EVALUATE ECG','An electrocardiographic recording in which fewer than the required number of cardiac complexes are available for measurement and/or interpretation due to a shorter than planned recording or due to cardiac complexes which are present but are not suitable f','\0','','CL-EGSTRESC','DBX-NCIT-C114177'),('CL-EGSTRESC-T-72',NULL,'INTRAATRIAL CONDUCTION DELAY','An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1.','\0','Intraatrial Conduction Delay','CL-EGSTRESC','DBX-NCIT-C71073'),('CL-EGSTRESC-T-73',NULL,'INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFIC','An electrocardiographic finding of a widened QRS duration typically greater than 110 ms which does not meet the morphologic criteria for any of the standard bundle branch or fascicular block patterns.','\0','Intraventricular conduction delay; Intraventricular conduction delay, nonspecific','CL-EGSTRESC','DBX-NCIT-C62271'),('CL-EGSTRESC-T-74',NULL,'INVALID ECG WAVEFORMS','An electrocardiographic recording for which the displayed leads do not represent the individual\'s true ECG lead information.','\0','','CL-EGSTRESC','DBX-NCIT-C114171'),('CL-EGSTRESC-T-75',NULL,'ISORHYTHMIC DISSOCIATION','An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently.','\0','Isorhythmic dissociation','CL-EGSTRESC','DBX-NCIT-C62248'),('CL-EGSTRESC-T-76',NULL,'J POINT ELEVATION','An electrocardiographic finding of a significant elevation above the baseline of the J point.','\0','J point elevation','CL-EGSTRESC','DBX-NCIT-C71030'),('CL-EGSTRESC-T-77',NULL,'JUNCTIONAL BRADYCARDIA','An electrocardiographic finding of a junctional rhythm with a heat rate which is abnormally low.','\0','Junctional bradycardia','CL-EGSTRESC','DBX-NCIT-C71074'),('CL-EGSTRESC-T-78',NULL,'JUNCTIONAL ESCAPE COMPLEXES','An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave.','\0','Junctional Escape Beats','CL-EGSTRESC','DBX-NCIT-C116129'),('CL-EGSTRESC-T-79',NULL,'JUNCTIONAL PREMATURE COMPLEX','An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave.','\0','Junctional Extra Beat; Junctional Premature Complex; Junctional premature complex(es)','CL-EGSTRESC','DBX-NCIT-C102652'),('CL-EGSTRESC-T-8',NULL,'AC NOISE','An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz).','\0','AC Noise','CL-EGSTRESC','DBX-NCIT-C114149'),('CL-EGSTRESC-T-80',NULL,'JUNCTIONAL RHYTHM','An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may ','\0','Junctional rhythm','CL-EGSTRESC','DBX-NCIT-C71051'),('CL-EGSTRESC-T-81',NULL,'JUNCTIONAL TACHYCARDIA','An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated.','\0','Junctional tachycardia','CL-EGSTRESC','DBX-NCIT-C35059'),('CL-EGSTRESC-T-82',NULL,'LATE R WAVE TRANSITION','An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6.','\0','Late R Wave Transition','CL-EGSTRESC','DBX-NCIT-C102653'),('CL-EGSTRESC-T-83',NULL,'LATERAL WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle.','\0','Lateral MI; Lateral Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C35586'),('CL-EGSTRESC-T-84',NULL,'LEFT ANTERIOR FASCICULAR BLOCK','An electrocardiographic finding of a slightly widened QRS duration (typically less than 120 ms) with leftward frontal plane QRS axis and typically small Q waves in leads I and aVL.','\0','Left Anterior Hemiblock; Left anterior fascicular block','CL-EGSTRESC','DBX-NCIT-C62267'),('CL-EGSTRESC-T-85',NULL,'LEFT ATRIAL ABNORMALITY','An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of g','\0','Left Atrial Enlargement; P-mitrale','CL-EGSTRESC','DBX-NCIT-C71040'),('CL-EGSTRESC-T-86',NULL,'LEFT BUNDLE BRANCH BLOCK','An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration greater than or equal to 120 ms.','\0','Complete LBBB; Left bundle branch block; Left bundle-branch block','CL-EGSTRESC','DBX-NCIT-C62269'),('CL-EGSTRESC-T-87',NULL,'LEFT POSTERIOR FASCICULAR BLOCK','An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH).','\0','Left Posterior Hemiblock; Left posterior fascicular block','CL-EGSTRESC','DBX-NCIT-C62268'),('CL-EGSTRESC-T-88',NULL,'LEFT VENTRICULAR CONDUCTION DELAY','An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired.','\0','Left Ventricular Conduction Delay','CL-EGSTRESC','DBX-NCIT-C92231'),('CL-EGSTRESC-T-89',NULL,'LEFT VENTRICULAR HYPERTROPHY','An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion.','\0','Left Ventricular Hypertrophy','CL-EGSTRESC','DBX-NCIT-C71076'),('CL-EGSTRESC-T-9',NULL,'ACCELERATED IDIOVENTRICULAR RHYTHM','An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute.','\0','Accelerated idioventricular rhythm','CL-EGSTRESC','DBX-NCIT-C62266'),('CL-EGSTRESC-T-90',NULL,'LEFT VENTRICULAR HYPERTROPHY WITH STRAIN','An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion.','\0','Left Ventricular Hypertrophy With Strain','CL-EGSTRESC','DBX-NCIT-C102655'),('CL-EGSTRESC-T-91',NULL,'LIMB ELECTRODE(S) DISCONNECTED','An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads.','\0','','CL-EGSTRESC','DBX-NCIT-C114151'),('CL-EGSTRESC-T-92',NULL,'LIMB ELECTRODES INTERCHANGED','An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads.','\0','Limb Lead Reversal','CL-EGSTRESC','DBX-NCIT-C114150'),('CL-EGSTRESC-T-93',NULL,'LOW AMPLITUDE SIGNAL','An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual.','\0','Low Amplitude QRS Complex','CL-EGSTRESC','DBX-NCIT-C114166'),('CL-EGSTRESC-T-94',NULL,'LOW QRS VOLTAGE','An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads.','\0','Low QRS voltage','CL-EGSTRESC','DBX-NCIT-C71078'),('CL-EGSTRESC-T-95',NULL,'LOW VOLTAGE - LIMB LEADS ONLY','An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads.','\0','','CL-EGSTRESC','DBX-NCIT-C116133'),('CL-EGSTRESC-T-96',NULL,'MULTIFOCAL ATRIAL TACHYCARDIA','An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically 100-150 beats ','\0','Multifocal atrial tachycardia','CL-EGSTRESC','DBX-NCIT-C71050'),('CL-EGSTRESC-T-97',NULL,'MUSCLE TREMOR','An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity.','\0','','CL-EGSTRESC','DBX-NCIT-C114148'),('CL-EGSTRESC-T-98',NULL,'MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization.','\0','Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C101589'),('CL-EGSTRESC-T-99',NULL,'NEW ANTERIOR WALL MYOCARDIAL INFARCTION','An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs.','\0','New Anterior MI; New Anterior Wall Myocardial Infarction','CL-EGSTRESC','DBX-NCIT-C102732'),('CL-EGTEST-T-1',NULL,'Acute Myocardial Ischemia ECG Change','An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf','\0','Acute Myocardial Ischemia ECG Change','CL-EGTEST','DBX-NCIT-C116140'),('CL-EGTEST-T-10',NULL,'JT Interval, Aggregate','An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','JT Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117762'),('CL-EGTEST-T-100',NULL,'Summary (Median) QT Duration','The median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles','\0','Summary (Median) QT Duration','CL-EGTEST','DBX-NCIT-C102252'),('CL-EGTEST-T-101',NULL,'Summary (Median) QTcF','The median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia\'s correction Formula.','\0','Summary (Median) QTcF','CL-EGTEST','DBX-NCIT-C102253'),('CL-EGTEST-T-102',NULL,'Summary (Median) RR Duration','The median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate.','\0','Summary (Median) RR Duration','CL-EGTEST','DBX-NCIT-C102254'),('CL-EGTEST-T-103',NULL,'Summary (Min) Heart Rate','The maximum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Min) Heart Rate','CL-EGTEST','DBX-NCIT-C62096'),('CL-EGTEST-T-104',NULL,'Summary (Min) JT Interval','The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end','\0','Summary (Min) JT Interval','CL-EGTEST','DBX-NCIT-C62116'),('CL-EGTEST-T-105',NULL,'Summary (Min) PR Duration','The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wav','\0','Summary (Min) PR Duration','CL-EGTEST','DBX-NCIT-C62125'),('CL-EGTEST-T-106',NULL,'Summary (Min) QT Duration','The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricle','\0','Summary (Min) QT Duration','CL-EGTEST','DBX-NCIT-C62133'),('CL-EGTEST-T-107',NULL,'Summary (Min) RR Duration','The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)','\0','Summary (Min) RR Duration','CL-EGTEST','DBX-NCIT-C62093'),('CL-EGTEST-T-108',NULL,'Summary (Min) ST Depression','The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Min) ST Depression','CL-EGTEST','DBX-NCIT-C62162'),('CL-EGTEST-T-109',NULL,'Summary (Min) ST Deviation','The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Min) ST Deviation','CL-EGTEST','DBX-NCIT-C62156'),('CL-EGTEST-T-11',NULL,'JT Interval, Single Beat','An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads.','\0','JT Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117769'),('CL-EGTEST-T-110',NULL,'Summary (Min) ST Elevation','The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Min) ST Elevation','CL-EGTEST','DBX-NCIT-C62159'),('CL-EGTEST-T-111',NULL,'Summary (Min) Ventricular Rate','The minimum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Min) Ventricular Rate','CL-EGTEST','DBX-NCIT-C62153'),('CL-EGTEST-T-112',NULL,'Supraventricular Arrhythmias','An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias.','\0','Supraventricular Arrhythmias','CL-EGTEST','DBX-NCIT-C111320'),('CL-EGTEST-T-113',NULL,'Supraventricular Tachyarrhythmias','An electrocardiographic assessment of supraventricular tachyarrhythmias.','\0','Supraventricular Tachyarrhythmias','CL-EGTEST','DBX-NCIT-C111321'),('CL-EGTEST-T-114',NULL,'T Wave Amplitude, Aggregate','An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117814'),('CL-EGTEST-T-115',NULL,'T Wave Amplitude, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','T Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117815'),('CL-EGTEST-T-116',NULL,'T Wave Area, Aggregate','An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Area, Aggregate','CL-EGTEST','DBX-NCIT-C117810'),('CL-EGTEST-T-117',NULL,'T Wave Area, Single Beat','An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads.','\0','T Wave Area, Single Beat','CL-EGTEST','DBX-NCIT-C117811'),('CL-EGTEST-T-118',NULL,'T Wave Axis','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane.','\0','T Wave Axis','CL-EGTEST','DBX-NCIT-C118166'),('CL-EGTEST-T-119',NULL,'T Wave Duration, Aggregate','An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Duration, Aggregate','CL-EGTEST','DBX-NCIT-C117812'),('CL-EGTEST-T-12',NULL,'JTcB - Bazett\'s Correction Formula','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and t','\0','JTcB - Bazett\'s Correction Formula','CL-EGTEST','DBX-NCIT-C62118'),('CL-EGTEST-T-120',NULL,'T Wave Duration, Single Beat','An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads.','\0','T Wave Duration, Single Beat','CL-EGTEST','DBX-NCIT-C117813'),('CL-EGTEST-T-121',NULL,'Technical Quality','A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis.','\0','Technical Quality','CL-EGTEST','DBX-NCIT-C117807'),('CL-EGTEST-T-122',NULL,'Tpeak-Tend Interval, Aggregate','An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','Tpeak-Tend Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117808'),('CL-EGTEST-T-123',NULL,'Tpeak-Tend Interval, Single Beat','An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads.','\0','Tpeak-Tend Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117809'),('CL-EGTEST-T-124',NULL,'Ventricular Arrhythmias','An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias.','\0','Ventricular Arrhythmias','CL-EGTEST','DBX-NCIT-C111330'),('CL-EGTEST-T-125',NULL,'Ventricular Tachyarrhythmias','An electrocardiographic assessment of supraventricular tachyarrhythmias.','\0','Ventricular Tachyarrhythmias','CL-EGTEST','DBX-NCIT-C111331'),('CL-EGTEST-T-13',NULL,'JTCB Interval, Aggregate','A JTAG interval corrected for heart rate using Bazett\'s formula.','\0','JTCB Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117763'),('CL-EGTEST-T-14',NULL,'JTCB Interval, Single Beat','A JTSB interval corrected for heart rate using Bazett\'s formula.','\0','JTCB Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117764'),('CL-EGTEST-T-15',NULL,'JTcF - Fridericia\'s Correction Formula','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and','\0','JTcF - Fridericia\'s Correction Formula','CL-EGTEST','DBX-NCIT-C62119'),('CL-EGTEST-T-16',NULL,'JTCF Interval, Aggregate','A JTAG interval corrected for heart rate using Fridericia\'s formula.','\0','JTCF Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117765'),('CL-EGTEST-T-17',NULL,'JTCF Interval, Single Beat','A JTSB interval corrected for heart rate using Fridericia\'s formula.','\0','JTCF Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117766'),('CL-EGTEST-T-18',NULL,'JTcLC - Linear Correction Formula','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained ','\0','JTcLC - Linear Correction Formula','CL-EGTEST','DBX-NCIT-C62120'),('CL-EGTEST-T-19',NULL,'Myocardial Infarction','An electrocardiographic assessment of findings suggestive of myocardial infarction.','\0','Myocardial Infarction','CL-EGTEST','DBX-NCIT-C111280'),('CL-EGTEST-T-2',NULL,'Atrioventricular Conduction','An electrocardiographic assessment of cardiac atrioventricular conduction.','\0','Atrioventricular Conduction','CL-EGTEST','DBX-NCIT-C111131'),('CL-EGTEST-T-20',NULL,'New Q Wave','An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Defi','\0','New Q Wave','CL-EGTEST','DBX-NCIT-C117770'),('CL-EGTEST-T-21',NULL,'P Wave Amplitude, Aggregate','An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','P Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117777'),('CL-EGTEST-T-22',NULL,'P Wave Amplitude, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','P Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117778'),('CL-EGTEST-T-23',NULL,'P Wave Axis','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane.','\0','P Wave Axis','CL-EGTEST','DBX-NCIT-C118164'),('CL-EGTEST-T-24',NULL,'P Wave Duration, Aggregate','An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','P Wave Duration, Aggregate','CL-EGTEST','DBX-NCIT-C117775'),('CL-EGTEST-T-25',NULL,'P Wave Duration, Single Beat','An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads.','\0','P Wave Duration, Single Beat','CL-EGTEST','DBX-NCIT-C117776'),('CL-EGTEST-T-26',NULL,'Pacemaker','An electrocardiographic assessment of presence of artificial electronic pacing.','\0','Pacemaker','CL-EGTEST','DBX-NCIT-C111285'),('CL-EGTEST-T-27',NULL,'PP Interval, Aggregate','An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','PP Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117771'),('CL-EGTEST-T-28',NULL,'PP Interval, Single Measurement','An electrocardiographic measurement of the interval between the onsets of two consecutive P waves.','\0','PP Interval, Single Measurement','CL-EGTEST','DBX-NCIT-C117772'),('CL-EGTEST-T-29',NULL,'PR Interval, Aggregate','An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','PR Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117773'),('CL-EGTEST-T-3',NULL,'Axis and Voltage','An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage.','\0','Axis and Voltage','CL-EGTEST','DBX-NCIT-C111132'),('CL-EGTEST-T-30',NULL,'PR Interval, Single Beat','An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads.','\0','PR Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117774'),('CL-EGTEST-T-31',NULL,'Q Wave Amplitude, Aggregate','An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','Q Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117789'),('CL-EGTEST-T-32',NULL,'Q Wave Amplitude, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','Q Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117790'),('CL-EGTEST-T-33',NULL,'QRS Axis','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane.','\0','QRS Axis','CL-EGTEST','DBX-NCIT-C118165'),('CL-EGTEST-T-34',NULL,'QRS Duration Ventricular Paced','The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time ','\0','QRS Duration Ventricular Paced','CL-EGTEST','DBX-NCIT-C100390'),('CL-EGTEST-T-35',NULL,'QRS Duration, Aggregate','An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QRS Duration, Aggregate','CL-EGTEST','DBX-NCIT-C117779'),('CL-EGTEST-T-36',NULL,'QRS Duration, Single Beat','An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.','\0','QRS Duration, Single Beat','CL-EGTEST','DBX-NCIT-C117780'),('CL-EGTEST-T-37',NULL,'QRS Duration, Ventr. Paced, Aggregate','An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QRS Duration, Ventr. Paced, Aggregate','CL-EGTEST','DBX-NCIT-C117781'),('CL-EGTEST-T-38',NULL,'QRS Duration, Ventr. Paced, Single Beat','An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.','\0','QRS Duration, Ventr. Paced, Single Beat','CL-EGTEST','DBX-NCIT-C117782'),('CL-EGTEST-T-39',NULL,'QT Interval, Aggregate','An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QT Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117783'),('CL-EGTEST-T-4',NULL,'Chamber Hypertrophy or Enlargement','An electrocardiographic assessment of chamber hypertrophy or enlargement.','\0','Chamber Hypertrophy or Enlargement','CL-EGTEST','DBX-NCIT-C111155'),('CL-EGTEST-T-40',NULL,'QT Interval, Corrected','The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.','\0','QT Interval, Corrected','CL-EGTEST','DBX-NCIT-C100391'),('CL-EGTEST-T-41',NULL,'QT Interval, Single Beat','An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads.','\0','QT Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117788'),('CL-EGTEST-T-42',NULL,'QTcB - Bazett\'s Correction Formula','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and t','\0','QTcB - Bazett\'s Correction Formula','CL-EGTEST','DBX-NCIT-C62112'),('CL-EGTEST-T-43',NULL,'QTCB Interval, Aggregate','A QTAG interval corrected for heart rate using Bazett\'s formula.','\0','QTCB Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117784'),('CL-EGTEST-T-44',NULL,'QTCB Interval, Single Beat','A QTSB interval corrected for heart rate using Bazett\'s formula.','\0','QTCB Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117785'),('CL-EGTEST-T-45',NULL,'QTcF - Fridericia\'s Correction Formula','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and','\0','QTcF - Fridericia\'s Correction Formula','CL-EGTEST','DBX-NCIT-C62113'),('CL-EGTEST-T-46',NULL,'QTCF Interval, Aggregate','A QTAG interval corrected for heart rate using Fridericia\'s formula.','\0','QTCF Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117786'),('CL-EGTEST-T-47',NULL,'QTCF Interval, Single Beat','A QTSB interval corrected for heart rate using Fridericia\'s formula.','\0','QTCF Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117787'),('CL-EGTEST-T-48',NULL,'QTcLC - Linear Correction Formula','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained ','\0','QTcLC - Linear Correction Formula','CL-EGTEST','DBX-NCIT-C62114'),('CL-EGTEST-T-49',NULL,'QTcV - Van de Water\'s Correction Formula','A mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (N','\0','QTcV - Van de Water\'s Correction Formula','CL-EGTEST','DBX-NCIT-C90442'),('CL-EGTEST-T-5',NULL,'Comparison to a Prior ECG','A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated.','\0','Comparison to a Prior ECG','CL-EGTEST','DBX-NCIT-C117761'),('CL-EGTEST-T-50',NULL,'R Wave Amplitude, Aggregate','An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','R Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117795'),('CL-EGTEST-T-51',NULL,'R Wave Amplitude, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','R Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117796'),('CL-EGTEST-T-52',NULL,'Rhythm Not Otherwise Specified','An electrocardiographic assessment of cardiac rhythm not otherwise specified.','\0','Rhythm Not Otherwise Specified','CL-EGTEST','DBX-NCIT-C111307'),('CL-EGTEST-T-53',NULL,'RR Interval, Aggregate','An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','RR Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117791'),('CL-EGTEST-T-54',NULL,'RR Interval, Single Measurement','An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats.','\0','RR Interval, Single Measurement','CL-EGTEST','DBX-NCIT-C117792'),('CL-EGTEST-T-55',NULL,'RS Wave Amplitude, Aggregate','An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','RS Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117793'),('CL-EGTEST-T-56',NULL,'RS Wave Amplitude, Single Beat','An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads.','\0','RS Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117794'),('CL-EGTEST-T-57',NULL,'S Wave Amplitude, Aggregate','An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','S Wave Amplitude, Aggregate','CL-EGTEST','DBX-NCIT-C117805'),('CL-EGTEST-T-58',NULL,'S Wave Amplitude, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','S Wave Amplitude, Single Beat','CL-EGTEST','DBX-NCIT-C117806'),('CL-EGTEST-T-59',NULL,'Sinus Node Rhythms and Arrhythmias','An electrocardiographic assessment of sinus node rhythms and arrhythmias.','\0','Sinus Node Rhythms and Arrhythmias','CL-EGTEST','DBX-NCIT-C111312'),('CL-EGTEST-T-6',NULL,'Interpretation','An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connect','\0','Interpretation','CL-EGTEST','DBX-NCIT-C41255'),('CL-EGTEST-T-60',NULL,'ST Segment Depression, Aggregate','An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Depression, Aggregate','CL-EGTEST','DBX-NCIT-C117797'),('CL-EGTEST-T-61',NULL,'ST Segment Depression, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recordin','\0','ST Segment Depression, Single Beat','CL-EGTEST','DBX-NCIT-C117798'),('CL-EGTEST-T-62',NULL,'ST Segment Deviation, Aggregate','An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Deviation, Aggregate','CL-EGTEST','DBX-NCIT-C117799'),('CL-EGTEST-T-63',NULL,'ST Segment Deviation, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the ','\0','ST Segment Deviation, Single Beat','CL-EGTEST','DBX-NCIT-C117800'),('CL-EGTEST-T-64',NULL,'ST Segment Duration, Aggregate','An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Duration, Aggregate','CL-EGTEST','DBX-NCIT-C117803'),('CL-EGTEST-T-65',NULL,'ST Segment Duration, Single Beat','An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads.','\0','ST Segment Duration, Single Beat','CL-EGTEST','DBX-NCIT-C117804'),('CL-EGTEST-T-66',NULL,'ST Segment Elevation, Aggregate','An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Elevation, Aggregate','CL-EGTEST','DBX-NCIT-C117801'),('CL-EGTEST-T-67',NULL,'ST Segment Elevation, Single Beat','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording','\0','ST Segment Elevation, Single Beat','CL-EGTEST','DBX-NCIT-C117802'),('CL-EGTEST-T-68',NULL,'ST Segment, T wave, and U wave','An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave.','\0','ST Segment, T wave, and U wave','CL-EGTEST','DBX-NCIT-C111363'),('CL-EGTEST-T-69',NULL,'Summary (Max) Heart Rate','The minimum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Max) Heart Rate','CL-EGTEST','DBX-NCIT-C39779'),('CL-EGTEST-T-7',NULL,'Intraventricular-Intraatrial Conduction','An electrocardiographic assessment of intraventricular and intra-atrial conduction.','\0','Intraventricular-Intraatrial Conduction','CL-EGTEST','DBX-NCIT-C111238'),('CL-EGTEST-T-70',NULL,'Summary (Max) JT Interval','The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end','\0','Summary (Max) JT Interval','CL-EGTEST','DBX-NCIT-C62117'),('CL-EGTEST-T-71',NULL,'Summary (Max) PR Duration','The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wav','\0','Summary (Max) PR Duration','CL-EGTEST','DBX-NCIT-C62131'),('CL-EGTEST-T-72',NULL,'Summary (Max) QT Duration','The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricle','\0','Summary (Max) QT Duration','CL-EGTEST','DBX-NCIT-C62135'),('CL-EGTEST-T-73',NULL,'Summary (Max) RR Duration','The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)','\0','Summary (Max) RR Duration','CL-EGTEST','DBX-NCIT-C62094'),('CL-EGTEST-T-74',NULL,'Summary (Max) ST Depression','The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Max) ST Depression','CL-EGTEST','DBX-NCIT-C62163'),('CL-EGTEST-T-75',NULL,'Summary (Max) ST Deviation','The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Max) ST Deviation','CL-EGTEST','DBX-NCIT-C62157'),('CL-EGTEST-T-76',NULL,'Summary (Max) ST Elevation','The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Max) ST Elevation','CL-EGTEST','DBX-NCIT-C62160'),('CL-EGTEST-T-77',NULL,'Summary (Max) Ventricular Rate','The maximum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Max) Ventricular Rate','CL-EGTEST','DBX-NCIT-C62154'),('CL-EGTEST-T-78',NULL,'Summary (Mean) Heart Rate','The average (mean) number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Mean) Heart Rate','CL-EGTEST','DBX-NCIT-C62095'),('CL-EGTEST-T-79',NULL,'Summary (Mean) JT Interval','The average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to ','\0','Summary (Mean) JT Interval','CL-EGTEST','DBX-NCIT-C62115'),('CL-EGTEST-T-8',NULL,'J-Tpeak Interval, Aggregate','An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','J-Tpeak Interval, Aggregate','CL-EGTEST','DBX-NCIT-C117767'),('CL-EGTEST-T-80',NULL,'Summary (Mean) P Wave Duration','The average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)','\0','Summary (Mean) P Wave Duration','CL-EGTEST','DBX-NCIT-C62123'),('CL-EGTEST-T-81',NULL,'Summary (Mean) P Wave Height','The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measuremen','\0','Summary (Mean) P Wave Height','CL-EGTEST','DBX-NCIT-C62124'),('CL-EGTEST-T-82',NULL,'Summary (Mean) PR Duration','The average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of th','\0','Summary (Mean) PR Duration','CL-EGTEST','DBX-NCIT-C62086'),('CL-EGTEST-T-83',NULL,'Summary (Mean) QRS Duration','The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes fo','\0','Summary (Mean) QRS Duration','CL-EGTEST','DBX-NCIT-C62087'),('CL-EGTEST-T-84',NULL,'Summary (Mean) QT Duration','The average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ve','\0','Summary (Mean) QT Duration','CL-EGTEST','DBX-NCIT-C62089'),('CL-EGTEST-T-85',NULL,'Summary (Mean) R Wave Amplitude','The average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) R Wave Amplitude','CL-EGTEST','DBX-NCIT-C62136'),('CL-EGTEST-T-86',NULL,'Summary (Mean) R+S Amplitude','The average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) R+S Amplitude','CL-EGTEST','DBX-NCIT-C62144'),('CL-EGTEST-T-87',NULL,'Summary (Mean) RR Duration','The average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)','\0','Summary (Mean) RR Duration','CL-EGTEST','DBX-NCIT-C62090'),('CL-EGTEST-T-88',NULL,'Summary (Mean) S Wave Amplitude','The average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) S Wave Amplitude','CL-EGTEST','DBX-NCIT-C62137'),('CL-EGTEST-T-89',NULL,'Summary (Mean) ST Depression','The average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Mean) ST Depression','CL-EGTEST','DBX-NCIT-C62161'),('CL-EGTEST-T-9',NULL,'J-Tpeak Interval, Single Beat','An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads.','\0','J-Tpeak Interval, Single Beat','CL-EGTEST','DBX-NCIT-C117768'),('CL-EGTEST-T-90',NULL,'Summary (Mean) ST Deviation','The average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Mean) ST Deviation','CL-EGTEST','DBX-NCIT-C62155'),('CL-EGTEST-T-91',NULL,'Summary (Mean) ST Elevation','The average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Mean) ST Elevation','CL-EGTEST','DBX-NCIT-C62158'),('CL-EGTEST-T-92',NULL,'Summary (Mean) ST Segment Duration','The average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave.','\0','Summary (Mean) ST Segment Duration','CL-EGTEST','DBX-NCIT-C62145'),('CL-EGTEST-T-93',NULL,'Summary (Mean) T Wave Area','The average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)','\0','Summary (Mean) T Wave Area','CL-EGTEST','DBX-NCIT-C62148'),('CL-EGTEST-T-94',NULL,'Summary (Mean) T Wave Duration','The average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (N','\0','Summary (Mean) T Wave Duration','CL-EGTEST','DBX-NCIT-C62147'),('CL-EGTEST-T-95',NULL,'Summary (Mean) T Wave Height','The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)','\0','Summary (Mean) T Wave Height','CL-EGTEST','DBX-NCIT-C62149'),('CL-EGTEST-T-96',NULL,'Summary (Mean) Ventricular Rate','The average (mean) number of cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Mean) Ventricular Rate','CL-EGTEST','DBX-NCIT-C62152'),('CL-EGTEST-T-97',NULL,'Summary (Median) Heart Rate','The median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate.','\0','Summary (Median) Heart Rate','CL-EGTEST','DBX-NCIT-C102249'),('CL-EGTEST-T-98',NULL,'Summary (Median) PR Duration','The median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave','\0','Summary (Median) PR Duration','CL-EGTEST','DBX-NCIT-C102250'),('CL-EGTEST-T-99',NULL,'Summary (Median) QRS Duration','The median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ve','\0','Summary (Median) QRS Duration','CL-EGTEST','DBX-NCIT-C102251'),('CL-EGTESTCD-T-1',NULL,'AMIEGCHG','An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf','\0','Acute Myocardial Ischemia ECG Change','CL-EGTESTCD','DBX-NCIT-C116140'),('CL-EGTESTCD-T-10',NULL,'INTP','An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connect','\0','Interpretation','CL-EGTESTCD','DBX-NCIT-C41255'),('CL-EGTESTCD-T-100',NULL,'STESB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording','\0','ST Segment Elevation, Single Beat','CL-EGTESTCD','DBX-NCIT-C117802'),('CL-EGTESTCD-T-101',NULL,'STSDURAG','An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Duration, Aggregate','CL-EGTESTCD','DBX-NCIT-C117803'),('CL-EGTESTCD-T-102',NULL,'STSDURSB','An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads.','\0','ST Segment Duration, Single Beat','CL-EGTESTCD','DBX-NCIT-C117804'),('CL-EGTESTCD-T-103',NULL,'STSEGDUR','The average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave.','\0','Summary (Mean) ST Segment Duration','CL-EGTESTCD','DBX-NCIT-C62145'),('CL-EGTESTCD-T-104',NULL,'STSTWUW','An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave.','\0','ST Segment, T wave, and U wave','CL-EGTESTCD','DBX-NCIT-C111363'),('CL-EGTESTCD-T-105',NULL,'SWAAG','An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','S Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117805'),('CL-EGTESTCD-T-106',NULL,'SWASB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','S Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117806'),('CL-EGTESTCD-T-107',NULL,'SWAVEAMP','The average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) S Wave Amplitude','CL-EGTESTCD','DBX-NCIT-C62137'),('CL-EGTESTCD-T-108',NULL,'T_AXIS','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane.','\0','T Wave Axis','CL-EGTESTCD','DBX-NCIT-C118166'),('CL-EGTESTCD-T-109',NULL,'TECHQUAL','A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis.','\0','Technical Quality','CL-EGTESTCD','DBX-NCIT-C117807'),('CL-EGTESTCD-T-11',NULL,'IVTIACD','An electrocardiographic assessment of intraventricular and intra-atrial conduction.','\0','Intraventricular-Intraatrial Conduction','CL-EGTESTCD','DBX-NCIT-C111238'),('CL-EGTESTCD-T-110',NULL,'TPTEAG','An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','Tpeak-Tend Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117808'),('CL-EGTESTCD-T-111',NULL,'TPTESB','An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads.','\0','Tpeak-Tend Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117809'),('CL-EGTESTCD-T-112',NULL,'TWARAG','An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Area, Aggregate','CL-EGTESTCD','DBX-NCIT-C117810'),('CL-EGTESTCD-T-113',NULL,'TWARSB','An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads.','\0','T Wave Area, Single Beat','CL-EGTESTCD','DBX-NCIT-C117811'),('CL-EGTESTCD-T-114',NULL,'TWAVAREA','The average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)','\0','Summary (Mean) T Wave Area','CL-EGTESTCD','DBX-NCIT-C62148'),('CL-EGTESTCD-T-115',NULL,'TWAVEDUR','The average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (N','\0','Summary (Mean) T Wave Duration','CL-EGTESTCD','DBX-NCIT-C62147'),('CL-EGTESTCD-T-116',NULL,'TWAVEHT','The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)','\0','Summary (Mean) T Wave Height','CL-EGTESTCD','DBX-NCIT-C62149'),('CL-EGTESTCD-T-117',NULL,'TWDURAG','An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Duration, Aggregate','CL-EGTESTCD','DBX-NCIT-C117812'),('CL-EGTESTCD-T-118',NULL,'TWDURSB','An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads.','\0','T Wave Duration, Single Beat','CL-EGTESTCD','DBX-NCIT-C117813'),('CL-EGTESTCD-T-119',NULL,'TWHAG','An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','T Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117814'),('CL-EGTESTCD-T-12',NULL,'JTAG','An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','JT Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117762'),('CL-EGTESTCD-T-120',NULL,'TWHSB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','T Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117815'),('CL-EGTESTCD-T-121',NULL,'VRMAX','The maximum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Max) Ventricular Rate','CL-EGTESTCD','DBX-NCIT-C62154'),('CL-EGTESTCD-T-122',NULL,'VRMEAN','The average (mean) number of cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Mean) Ventricular Rate','CL-EGTESTCD','DBX-NCIT-C62152'),('CL-EGTESTCD-T-123',NULL,'VRMIN','The minimum time between successive cycles of contraction and subsequent relaxation of the ventricles, usually expressed as beats per minute, obtained from a set of measurements of the ventricular rate. (NCI)','\0','Summary (Min) Ventricular Rate','CL-EGTESTCD','DBX-NCIT-C62153'),('CL-EGTESTCD-T-124',NULL,'VTARRY','An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias.','\0','Ventricular Arrhythmias','CL-EGTESTCD','DBX-NCIT-C111330'),('CL-EGTESTCD-T-125',NULL,'VTTARRY','An electrocardiographic assessment of supraventricular tachyarrhythmias.','\0','Ventricular Tachyarrhythmias','CL-EGTESTCD','DBX-NCIT-C111331'),('CL-EGTESTCD-T-13',NULL,'JTCB','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and t','\0','JTcB - Bazett\'s Correction Formula','CL-EGTESTCD','DBX-NCIT-C62118'),('CL-EGTESTCD-T-14',NULL,'JTCBAG','A JTAG interval corrected for heart rate using Bazett\'s formula.','\0','JTCB Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117763'),('CL-EGTESTCD-T-15',NULL,'JTCBSB','A JTSB interval corrected for heart rate using Bazett\'s formula.','\0','JTCB Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117764'),('CL-EGTESTCD-T-16',NULL,'JTCF','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and','\0','JTcF - Fridericia\'s Correction Formula','CL-EGTESTCD','DBX-NCIT-C62119'),('CL-EGTESTCD-T-17',NULL,'JTCFAG','A JTAG interval corrected for heart rate using Fridericia\'s formula.','\0','JTCF Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117765'),('CL-EGTESTCD-T-18',NULL,'JTCFSB','A JTSB interval corrected for heart rate using Fridericia\'s formula.','\0','JTCF Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117766'),('CL-EGTESTCD-T-19',NULL,'JTCLC','A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained ','\0','JTcLC - Linear Correction Formula','CL-EGTESTCD','DBX-NCIT-C62120'),('CL-EGTESTCD-T-2',NULL,'AVCOND','An electrocardiographic assessment of cardiac atrioventricular conduction.','\0','Atrioventricular Conduction','CL-EGTESTCD','DBX-NCIT-C111131'),('CL-EGTESTCD-T-20',NULL,'JTMAX','The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end','\0','Summary (Max) JT Interval','CL-EGTESTCD','DBX-NCIT-C62117'),('CL-EGTESTCD-T-21',NULL,'JTMEAN','The average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to ','\0','Summary (Mean) JT Interval','CL-EGTESTCD','DBX-NCIT-C62115'),('CL-EGTESTCD-T-22',NULL,'JTMIN','The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end','\0','Summary (Min) JT Interval','CL-EGTESTCD','DBX-NCIT-C62116'),('CL-EGTESTCD-T-23',NULL,'JTPAG','An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','J-Tpeak Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117767'),('CL-EGTESTCD-T-24',NULL,'JTPSB','An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads.','\0','J-Tpeak Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117768'),('CL-EGTESTCD-T-25',NULL,'JTSB','An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads.','\0','JT Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117769'),('CL-EGTESTCD-T-26',NULL,'MI','An electrocardiographic assessment of findings suggestive of myocardial infarction.','\0','Myocardial Infarction','CL-EGTESTCD','DBX-NCIT-C111280'),('CL-EGTESTCD-T-27',NULL,'NEWQWAVE','An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Defi','\0','New Q Wave','CL-EGTESTCD','DBX-NCIT-C117770'),('CL-EGTESTCD-T-28',NULL,'P_AXIS','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane.','\0','P Wave Axis','CL-EGTESTCD','DBX-NCIT-C118164'),('CL-EGTESTCD-T-29',NULL,'PACEMAKR','An electrocardiographic assessment of presence of artificial electronic pacing.','\0','Pacemaker','CL-EGTESTCD','DBX-NCIT-C111285'),('CL-EGTESTCD-T-3',NULL,'AXISVOLT','An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage.','\0','Axis and Voltage','CL-EGTESTCD','DBX-NCIT-C111132'),('CL-EGTESTCD-T-30',NULL,'PPAG','An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','PP Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117771'),('CL-EGTESTCD-T-31',NULL,'PPSM','An electrocardiographic measurement of the interval between the onsets of two consecutive P waves.','\0','PP Interval, Single Measurement','CL-EGTESTCD','DBX-NCIT-C117772'),('CL-EGTESTCD-T-32',NULL,'PRAG','An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','PR Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117773'),('CL-EGTESTCD-T-33',NULL,'PRMAX','The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wav','\0','Summary (Max) PR Duration','CL-EGTESTCD','DBX-NCIT-C62131'),('CL-EGTESTCD-T-34',NULL,'PRMEAN','The average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of th','\0','Summary (Mean) PR Duration','CL-EGTESTCD','DBX-NCIT-C62086'),('CL-EGTESTCD-T-35',NULL,'PRMED','The median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave','\0','Summary (Median) PR Duration','CL-EGTESTCD','DBX-NCIT-C102250'),('CL-EGTESTCD-T-36',NULL,'PRMIN','The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wav','\0','Summary (Min) PR Duration','CL-EGTESTCD','DBX-NCIT-C62125'),('CL-EGTESTCD-T-37',NULL,'PRSB','An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads.','\0','PR Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117774'),('CL-EGTESTCD-T-38',NULL,'PWAVEDUR','The average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)','\0','Summary (Mean) P Wave Duration','CL-EGTESTCD','DBX-NCIT-C62123'),('CL-EGTESTCD-T-39',NULL,'PWAVEHT','The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measuremen','\0','Summary (Mean) P Wave Height','CL-EGTESTCD','DBX-NCIT-C62124'),('CL-EGTESTCD-T-4',NULL,'CHYPTENL','An electrocardiographic assessment of chamber hypertrophy or enlargement.','\0','Chamber Hypertrophy or Enlargement','CL-EGTESTCD','DBX-NCIT-C111155'),('CL-EGTESTCD-T-40',NULL,'PWDURAG','An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','P Wave Duration, Aggregate','CL-EGTESTCD','DBX-NCIT-C117775'),('CL-EGTESTCD-T-41',NULL,'PWDURSB','An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads.','\0','P Wave Duration, Single Beat','CL-EGTESTCD','DBX-NCIT-C117776'),('CL-EGTESTCD-T-42',NULL,'PWHTAG','An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','P Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117777'),('CL-EGTESTCD-T-43',NULL,'PWHTSB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','P Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117778'),('CL-EGTESTCD-T-44',NULL,'QRS_AXIS','A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane.','\0','QRS Axis','CL-EGTESTCD','DBX-NCIT-C118165'),('CL-EGTESTCD-T-45',NULL,'QRSAG','An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QRS Duration, Aggregate','CL-EGTESTCD','DBX-NCIT-C117779'),('CL-EGTESTCD-T-46',NULL,'QRSDUR','The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes fo','\0','Summary (Mean) QRS Duration','CL-EGTESTCD','DBX-NCIT-C62087'),('CL-EGTESTCD-T-47',NULL,'QRSDURVP','The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time ','\0','QRS Duration Ventricular Paced','CL-EGTESTCD','DBX-NCIT-C100390'),('CL-EGTESTCD-T-48',NULL,'QRSMED','The median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ve','\0','Summary (Median) QRS Duration','CL-EGTESTCD','DBX-NCIT-C102251'),('CL-EGTESTCD-T-49',NULL,'QRSSB','An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.','\0','QRS Duration, Single Beat','CL-EGTESTCD','DBX-NCIT-C117780'),('CL-EGTESTCD-T-5',NULL,'EGCOMP','A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated.','\0','Comparison to a Prior ECG','CL-EGTESTCD','DBX-NCIT-C117761'),('CL-EGTESTCD-T-50',NULL,'QRVDVPAG','An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QRS Duration, Ventr. Paced, Aggregate','CL-EGTESTCD','DBX-NCIT-C117781'),('CL-EGTESTCD-T-51',NULL,'QRVDVPSB','An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.','\0','QRS Duration, Ventr. Paced, Single Beat','CL-EGTESTCD','DBX-NCIT-C117782'),('CL-EGTESTCD-T-52',NULL,'QTAG','An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','QT Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117783'),('CL-EGTESTCD-T-53',NULL,'QTC','The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.','\0','QT Interval, Corrected','CL-EGTESTCD','DBX-NCIT-C100391'),('CL-EGTESTCD-T-54',NULL,'QTCB','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and t','\0','QTcB - Bazett\'s Correction Formula','CL-EGTESTCD','DBX-NCIT-C62112'),('CL-EGTESTCD-T-55',NULL,'QTCBAG','A QTAG interval corrected for heart rate using Bazett\'s formula.','\0','QTCB Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117784'),('CL-EGTESTCD-T-56',NULL,'QTCBSB','A QTSB interval corrected for heart rate using Bazett\'s formula.','\0','QTCB Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117785'),('CL-EGTESTCD-T-57',NULL,'QTCF','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and','\0','QTcF - Fridericia\'s Correction Formula','CL-EGTESTCD','DBX-NCIT-C62113'),('CL-EGTESTCD-T-58',NULL,'QTCFAG','A QTAG interval corrected for heart rate using Fridericia\'s formula.','\0','QTCF Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117786'),('CL-EGTESTCD-T-59',NULL,'QTCFMED','The median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia\'s correction Formula.','\0','Summary (Median) QTcF','CL-EGTESTCD','DBX-NCIT-C102253'),('CL-EGTESTCD-T-6',NULL,'HRMAX','The minimum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Max) Heart Rate','CL-EGTESTCD','DBX-NCIT-C39779'),('CL-EGTESTCD-T-60',NULL,'QTCFSB','A QTSB interval corrected for heart rate using Fridericia\'s formula.','\0','QTCF Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117787'),('CL-EGTESTCD-T-61',NULL,'QTCLC','A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained ','\0','QTcLC - Linear Correction Formula','CL-EGTESTCD','DBX-NCIT-C62114'),('CL-EGTESTCD-T-62',NULL,'QTCV','A mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (N','\0','QTcV - Van de Water\'s Correction Formula','CL-EGTESTCD','DBX-NCIT-C90442'),('CL-EGTESTCD-T-63',NULL,'QTMAX','The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricle','\0','Summary (Max) QT Duration','CL-EGTESTCD','DBX-NCIT-C62135'),('CL-EGTESTCD-T-64',NULL,'QTMEAN','The average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ve','\0','Summary (Mean) QT Duration','CL-EGTESTCD','DBX-NCIT-C62089'),('CL-EGTESTCD-T-65',NULL,'QTMED','The median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles','\0','Summary (Median) QT Duration','CL-EGTESTCD','DBX-NCIT-C102252'),('CL-EGTESTCD-T-66',NULL,'QTMIN','The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricle','\0','Summary (Min) QT Duration','CL-EGTESTCD','DBX-NCIT-C62133'),('CL-EGTESTCD-T-67',NULL,'QTSB','An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads.','\0','QT Interval, Single Beat','CL-EGTESTCD','DBX-NCIT-C117788'),('CL-EGTESTCD-T-68',NULL,'QWAAG','An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','Q Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117789'),('CL-EGTESTCD-T-69',NULL,'QWASB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','Q Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117790'),('CL-EGTESTCD-T-7',NULL,'HRMEAN','The average (mean) number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Mean) Heart Rate','CL-EGTESTCD','DBX-NCIT-C62095'),('CL-EGTESTCD-T-70',NULL,'RHYNOS','An electrocardiographic assessment of cardiac rhythm not otherwise specified.','\0','Rhythm Not Otherwise Specified','CL-EGTESTCD','DBX-NCIT-C111307'),('CL-EGTESTCD-T-71',NULL,'RRAG','An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','RR Interval, Aggregate','CL-EGTESTCD','DBX-NCIT-C117791'),('CL-EGTESTCD-T-72',NULL,'RRMAX','The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)','\0','Summary (Max) RR Duration','CL-EGTESTCD','DBX-NCIT-C62094'),('CL-EGTESTCD-T-73',NULL,'RRMEAN','The average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)','\0','Summary (Mean) RR Duration','CL-EGTESTCD','DBX-NCIT-C62090'),('CL-EGTESTCD-T-74',NULL,'RRMED','The median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate.','\0','Summary (Median) RR Duration','CL-EGTESTCD','DBX-NCIT-C102254'),('CL-EGTESTCD-T-75',NULL,'RRMIN','The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)','\0','Summary (Min) RR Duration','CL-EGTESTCD','DBX-NCIT-C62093'),('CL-EGTESTCD-T-76',NULL,'RRSM','An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats.','\0','RR Interval, Single Measurement','CL-EGTESTCD','DBX-NCIT-C117792'),('CL-EGTESTCD-T-77',NULL,'RSAAG','An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','RS Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117793'),('CL-EGTESTCD-T-78',NULL,'RSAMP','The average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) R+S Amplitude','CL-EGTESTCD','DBX-NCIT-C62144'),('CL-EGTESTCD-T-79',NULL,'RSASB','An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads.','\0','RS Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117794'),('CL-EGTESTCD-T-8',NULL,'HRMED','The median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate.','\0','Summary (Median) Heart Rate','CL-EGTESTCD','DBX-NCIT-C102249'),('CL-EGTESTCD-T-80',NULL,'RWAAG','An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','R Wave Amplitude, Aggregate','CL-EGTESTCD','DBX-NCIT-C117795'),('CL-EGTESTCD-T-81',NULL,'RWASB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement m','\0','R Wave Amplitude, Single Beat','CL-EGTESTCD','DBX-NCIT-C117796'),('CL-EGTESTCD-T-82',NULL,'RWAVEAMP','The average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)','\0','Summary (Mean) R Wave Amplitude','CL-EGTESTCD','DBX-NCIT-C62136'),('CL-EGTESTCD-T-83',NULL,'SNRARRY','An electrocardiographic assessment of sinus node rhythms and arrhythmias.','\0','Sinus Node Rhythms and Arrhythmias','CL-EGTESTCD','DBX-NCIT-C111312'),('CL-EGTESTCD-T-84',NULL,'SPRARRY','An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias.','\0','Supraventricular Arrhythmias','CL-EGTESTCD','DBX-NCIT-C111320'),('CL-EGTESTCD-T-85',NULL,'SPRTARRY','An electrocardiographic assessment of supraventricular tachyarrhythmias.','\0','Supraventricular Tachyarrhythmias','CL-EGTESTCD','DBX-NCIT-C111321'),('CL-EGTESTCD-T-86',NULL,'STDAG','An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Depression, Aggregate','CL-EGTESTCD','DBX-NCIT-C117797'),('CL-EGTESTCD-T-87',NULL,'STDPMAX','The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Max) ST Depression','CL-EGTESTCD','DBX-NCIT-C62163'),('CL-EGTESTCD-T-88',NULL,'STDPMEAN','The average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Mean) ST Depression','CL-EGTESTCD','DBX-NCIT-C62161'),('CL-EGTESTCD-T-89',NULL,'STDPMIN','The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)','\0','Summary (Min) ST Depression','CL-EGTESTCD','DBX-NCIT-C62162'),('CL-EGTESTCD-T-9',NULL,'HRMIN','The maximum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. (NCI)','\0','Summary (Min) Heart Rate','CL-EGTESTCD','DBX-NCIT-C62096'),('CL-EGTESTCD-T-90',NULL,'STDSB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recordin','\0','ST Segment Depression, Single Beat','CL-EGTESTCD','DBX-NCIT-C117798'),('CL-EGTESTCD-T-91',NULL,'STDVAG','An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Deviation, Aggregate','CL-EGTESTCD','DBX-NCIT-C117799'),('CL-EGTESTCD-T-92',NULL,'STDVMAX','The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Max) ST Deviation','CL-EGTESTCD','DBX-NCIT-C62157'),('CL-EGTESTCD-T-93',NULL,'STDVMEAN','The average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Mean) ST Deviation','CL-EGTESTCD','DBX-NCIT-C62155'),('CL-EGTESTCD-T-94',NULL,'STDVMIN','The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)','\0','Summary (Min) ST Deviation','CL-EGTESTCD','DBX-NCIT-C62156'),('CL-EGTESTCD-T-95',NULL,'STDVSB','An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the ','\0','ST Segment Deviation, Single Beat','CL-EGTESTCD','DBX-NCIT-C117800'),('CL-EGTESTCD-T-96',NULL,'STEAG','An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.','\0','ST Segment Elevation, Aggregate','CL-EGTESTCD','DBX-NCIT-C117801'),('CL-EGTESTCD-T-97',NULL,'STELMAX','The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Max) ST Elevation','CL-EGTESTCD','DBX-NCIT-C62160'),('CL-EGTESTCD-T-98',NULL,'STELMEAN','The average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Mean) ST Elevation','CL-EGTESTCD','DBX-NCIT-C62158'),('CL-EGTESTCD-T-99',NULL,'STELMIN','The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)','\0','Summary (Min) ST Elevation','CL-EGTESTCD','DBX-NCIT-C62159'),('CL-EMPSTAT-T-1',NULL,'FULL-TIME','Employment involving the standard or customary working time.','\0','','CL-EMPSTAT','DBX-NCIT-C52658'),('CL-EMPSTAT-T-2',NULL,'NOT EMPLOYED','The state of not having a job.','\0','','CL-EMPSTAT','DBX-NCIT-C75563'),('CL-EMPSTAT-T-3',NULL,'PART-TIME','Employment involving less than the standard or customary working time.','\0','','CL-EMPSTAT','DBX-NCIT-C75562'),('CL-EPOCH-T-1',NULL,'BLINDED TREATMENT','A period in a clinical study during which subjects receive blinded therapeutic treatment.','\0','','CL-EPOCH','DBX-NCIT-C102255'),('CL-EPOCH-T-2',NULL,'FOLLOW-UP','A period in a clinical study during which information about the health status of an individual is obtained after study procedures and treatments have concluded.','\0','','CL-EPOCH','DBX-NCIT-C99158'),('CL-EPOCH-T-3',NULL,'LONG-TERM FOLLOW-UP','A period in a clinical study during which information about the health status of an individual is obtained long after study procedures and treatments have concluded.','\0','','CL-EPOCH','DBX-NCIT-C16032'),('CL-EPOCH-T-4',NULL,'OPEN LABEL TREATMENT','A period in a clinical study during which subjects receive open label therapeutic treatment.','\0','','CL-EPOCH','DBX-NCIT-C102256'),('CL-EPOCH-T-5',NULL,'RUN-IN','A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or eva','\0','','CL-EPOCH','DBX-NCIT-C98779'),('CL-EPOCH-T-6',NULL,'SCREENING','A period in a clinical study during which subjects are evaluated for participation in the study.','\0','','CL-EPOCH','DBX-NCIT-C48262'),('CL-EPOCH-T-7',NULL,'TREATMENT','A period in a clinical study during which subjects receive therapeutic treatment.','\0','','CL-EPOCH','DBX-NCIT-C101526'),('CL-EPOCH-T-8',NULL,'WASHOUT','A period of time during a clinical study when a participant is taken off of a study drug or other medication in order to eliminate the effects of the treatment.','\0','','CL-EPOCH','DBX-NCIT-C42872'),('CL-ETHNIC-T-1',NULL,'HISPANIC OR LATINO','A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI)','\0','','CL-ETHNIC','DBX-NCIT-C17459'),('CL-ETHNIC-T-2',NULL,'NOT HISPANIC OR LATINO','A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)','\0','','CL-ETHNIC','DBX-NCIT-C41222'),('CL-ETHNIC-T-3',NULL,'NOT REPORTED','Not provided or available.','\0','Not reported','CL-ETHNIC','DBX-NCIT-C43234'),('CL-ETHNIC-T-4',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-ETHNIC','DBX-NCIT-C17998'),('CL-EVAL-T-1',NULL,'ADJUDICATION COMMITTEE','An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met. (NCI)','\0','','CL-EVAL','DBX-NCIT-C78726'),('CL-EVAL-T-10',NULL,'HEALTH CARE PROFESSIONAL','A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood. (NCI)','\0','','CL-EVAL','DBX-NCIT-C53287'),('CL-EVAL-T-11',NULL,'INDEPENDENT ASSESSOR','An individual qualified to perform an evaluation who is masked from a subject\'s data in order to minimize bias or maximize consistency and quality. (NCI)','\0','','CL-EVAL','DBX-NCIT-C78720'),('CL-EVAL-T-12',NULL,'INVESTIGATOR','A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principle investigator.','\0','','CL-EVAL','DBX-NCIT-C25936'),('CL-EVAL-T-13',NULL,'PARENT','A mother or a father.','\0','','CL-EVAL','DBX-NCIT-C42709'),('CL-EVAL-T-14',NULL,'SPOUSE','A person\'s partner in marriage. (NCI)','\0','Spouse','CL-EVAL','DBX-NCIT-C62649'),('CL-EVAL-T-15',NULL,'STUDY SUBJECT','An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.','\0','','CL-EVAL','DBX-NCIT-C41189'),('CL-EVAL-T-16',NULL,'VENDOR','A person or agency that promotes or exchanges goods or services for money. (NCI)','\0','','CL-EVAL','DBX-NCIT-C68608'),('CL-EVAL-T-2',NULL,'CAREGIVER','The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI)','\0','Caregiver','CL-EVAL','DBX-NCIT-C17445'),('CL-EVAL-T-3',NULL,'CHILD','A son or a daughter.','\0','','CL-EVAL','DBX-NCIT-C42708'),('CL-EVAL-T-4',NULL,'CLINICAL RESEARCH ASSOCIATE','A person who is employed by a study sponsor or by a contract research organization (CRO), operates independently from the clinical study site and functions as a monitor, and/or auditor, and/or a project director within a particular trial or institution. (','\0','Research Associate','CL-EVAL','DBX-NCIT-C25465'),('CL-EVAL-T-5',NULL,'CLINICAL RESEARCH COORDINATOR','A person to whom a clinical investigator delegates routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subj','\0','','CL-EVAL','DBX-NCIT-C51811'),('CL-EVAL-T-6',NULL,'CLINICAL STUDY SPONSOR','An entity that is responsible for the initiation, management, and/or financing of a clinical study.','\0','Clinical Study Sponsor; Sponsor; Study Sponsor','CL-EVAL','DBX-NCIT-C70793'),('CL-EVAL-T-7',NULL,'DOMESTIC PARTNER','Person declares that a domestic partnership relationship exists. (HL7)','\0','Domestic Partner','CL-EVAL','DBX-NCIT-C53262'),('CL-EVAL-T-8',NULL,'FRIEND','A person whom an individual knows, likes, and trusts. (NCI)','\0','','CL-EVAL','DBX-NCIT-C72884'),('CL-EVAL-T-9',NULL,'GUARDIAN','An individual who is authorized under applicable State or local law to consent on behalf of a child or incapable person to general medical care including participation in clinical research. (NCI)','\0','','CL-EVAL','DBX-NCIT-C51828'),('CL-EVDRETRT-T-1',NULL,'BACTERIOLOGICAL FINDING','Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure.','\0','','CL-EVDRETRT','DBX-NCIT-C102602'),('CL-EVDRETRT-T-2',NULL,'CLINICAL FINDING','Objective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom).','\0','Clinical Signs','CL-EVDRETRT','DBX-NCIT-C100104'),('CL-EVDRETRT-T-3',NULL,'RADIOLOGIC FINDING','Objective evidence of disease perceptible to the examiner by radiological procedure.','\0','','CL-EVDRETRT','DBX-NCIT-C35869'),('CL-FATEST-T-1',NULL,'Drug Resistance Status','The state or condition of not responding to a pharmacological agent.','\0','Drug Resistance Status','CL-FATEST','DBX-NCIT-C102626'),('CL-FATESTCD-T-1',NULL,'DRSTAT','The state or condition of not responding to a pharmacological agent.','\0','Drug Resistance Status','CL-FATESTCD','DBX-NCIT-C102626'),('CL-FEATDBS-abrc_stock',NULL,'abrc_stock','Arabidopsis Biological Resource Center (ABRC) at The Ohio State University','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-AmoebaDB',NULL,'AmoebaDB','Amoeba DB','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-asrp',NULL,'asrp','Arabidopsis Small RNA Project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-atcc',NULL,'atcc','ATCC','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-bdgp',NULL,'bdgp','Berkeley Drosophila Genome Project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-beebase',NULL,'beebase','Bee base','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-candidadb',NULL,'candidadb','Candida database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-candida_genome_db',NULL,'candida_genome_db','Candida genome database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-catma',NULL,'catma','Complete Arabidopsis Transcriptome MicroArray (CATMA) project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-celera_transcript',NULL,'celera_transcript','Celera transcript','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-cog',NULL,'cog','NCBI COG (Phylogenetic classification of proteins encoded in complete genomes)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dbsnp',NULL,'dbsnp','NCBI dbSNP','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_asgi',NULL,'dfci_asgi','DFCI Atlantic Salmon Gene Index (AsGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_atgi',NULL,'dfci_atgi','DFCI Arabidopsis Gene Index','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_mtgi',NULL,'dfci_mtgi','DFCI Medicago truncatula Gene Index (MtGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_rgi',NULL,'dfci_rgi','DFCI Rat Gene Index','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_ssgi',NULL,'dfci_ssgi','DFCI Porcine Gene Index (SsGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_stgi',NULL,'dfci_stgi','DFCI Solanum tuberosum Gene Index (StGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_zgi',NULL,'dfci_zgi','DFCI Zebrafish Gene Index (ZGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dfci_zmgi',NULL,'dfci_zmgi','DFCI Maize Gene Index (ZGI)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-dictybase',NULL,'dictybase','dictyBase for Dictyostelium discoideum','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-embl',NULL,'embl','European Nucleotide Archive at EMBL-EBI','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ensembl',NULL,'ensembl','Ensembl','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ens_fam_id',NULL,'ens_fam_id','Ensembl gene family stable identifier','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ens_gene_id',NULL,'ens_gene_id','Ensembl gene stable identifier','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ens_trscrpt_id',NULL,'ens_trscrpt_id','Ensembl transcript stable identifier','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-entrez',NULL,'entrez','NCBI Entrez','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-entrez_gene',NULL,'entrez_gene','NCBI Entrez gene identifier','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-flybase',NULL,'flybase','Flybase','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-flybase_bt',NULL,'flybase_bt','Flybase (body parts)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-flybase_computed_gene',NULL,'flybase_computed_gene','Flybase (computed gene)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-flybase_dv',NULL,'flybase_dv','Flybase (developmental stages)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-genbank',NULL,'genbank','GenBank','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-genecards',NULL,'genecards','Genecards','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-genedb',NULL,'genedb','Gene DB','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-genesnps',NULL,'genesnps','GeneSNPs','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-genolevures',NULL,'genolevures','Genomic Exploration of the Hemiascomycete Yeasts','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-go',NULL,'go','Gene Ontology','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-gpcrdb',NULL,'gpcrdb','GPCRDB (information system for G protein-coupled receptors)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-gxd',NULL,'gxd','Gene Expression Database at Jackson Laboratory (mouse data)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-halolex',NULL,'halolex','HaloLex (the information system for halophilic archaea)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-HarvEST35',NULL,'HarvEST35','ESTs from HarvEST project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-hgmd',NULL,'hgmd','The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-howdy',NULL,'howdy','Human Organized Whole Genome Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-hpa',NULL,'hpa','The human protein atlas','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-hugo',NULL,'hugo','Human Genome Organization (gene names)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-image',NULL,'image','IMAGE consortium','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-incyte',NULL,'incyte','Incyte Genomics','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-insdc_locus_tag',NULL,'insdc_locus_tag','INSDC locus tags','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-interpro',NULL,'interpro','InterPro at EMBL-EBI','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-kegg',NULL,'kegg','KEGG pathway database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-locus',NULL,'locus','NCBI Gene','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-mgc',NULL,'mgc','NCBI Mammalian Gene Collection','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-mgd',NULL,'mgd','Mouse Genome Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-mips',NULL,'mips','The MIPS Mammalian Protein-Protein Interaction Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-mirbase',NULL,'mirbase','microRNA database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-MO',NULL,'MO','MGED Ontology','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-msu_rga',NULL,'msu_rga','Rice Genome Annotation Project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-mtb',NULL,'mtb','Mouse Tumor Biology (MTB) Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-nasc',NULL,'nasc','The European Arabidopsis Stock Centre','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ncbitax',NULL,'ncbitax','NCBI Taxonomy database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ncbi_clone_registry',NULL,'ncbi_clone_registry','NCBI Clone registry','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-netaffx',NULL,'netaffx','Affymetrix NetAffx','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-neurosporadb',NULL,'neurosporadb','Neurospora database at Broad Institute','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-nia_nih',NULL,'nia_nih','NIH National Institute of Ageing','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-omim',NULL,'omim','Online Mendelian Inheritance in Men','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-pdb',NULL,'pdb','Protein Data Bank','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-pfam',NULL,'pfam','Protein family','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-pharmgkb',NULL,'pharmgkb','PharmaGKB (pharacogenomics knowledgebase)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-phyca11',NULL,'phyca11','Phytophthora capsici sequencing project','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-pir',NULL,'pir','Protein Information Resource','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-plantgdb',NULL,'plantgdb','Plant GDB (resources for comparative plant genomics)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-PlantOntology',NULL,'PlantOntology','Plant Ontology database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-plasmodb',NULL,'plasmodb','Plasmodium Genomics Resource','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-populusDB',NULL,'populusDB','Populus tremula x tremuloides genomic sequence database.','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-prf',NULL,'prf','Synthetic compounds database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-prodom',NULL,'prodom','ProDom (a comprehensive set of protein domain families automatically generated from the UniProt Knowledge Database)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-prosite',NULL,'prosite','Prosite, database of protein domains, families and functional sites','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-pubmed',NULL,'pubmed','PubMed literature database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-refseq',NULL,'refseq','NCBI RefSeq','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-rgd',NULL,'rgd','Rat Genome Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-rgd_qtl',NULL,'rgd_qtl','Rat Genome Database QTLs','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-rhizobase',NULL,'rhizobase','Rhizobase (soil and rhizosphere bacteria of agronomic importance)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-scop',NULL,'scop','Structural classification of proteins','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-sgd',NULL,'sgd','Saccharomyces Genome Database (SGD)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-sgn',NULL,'sgn','Tomatoes genomics network','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-subtilist',NULL,'subtilist','Subtilist, Bacillus subtilis database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-sulfolobus',NULL,'sulfolobus','Sulfolobus Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-swissprot',NULL,'swissprot','UniProt/SwissProt (manually annotated and reviewed protein sequences)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-tair',NULL,'tair','The Arabidopsis Information Resource.','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-tair_anat',NULL,'tair_anat','TAIR Anatomy Ontology.','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-tair_dev',NULL,'tair_dev','TAIR Development Ontology.','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-tigr_tagi',NULL,'tigr_tagi','TIGR: TaGI. The TIGR Anopheles gambiae (mosquito) Database.','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-ToxoDB',NULL,'ToxoDB','ToxoDB: Toxoplasma genomics resources','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-toxoest',NULL,'toxoest','ToxoDB ESTs','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-trembl',NULL,'trembl','UniProt/trEMBL (automatically annotated protein sequences)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-TriTrypDB',NULL,'TriTrypDB','Database for pathogens of the family Trypanosomatidae, including organisms in both Leishmania and Trypanosoma genera','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-tuberculist',NULL,'tuberculist','Genomic information on tubercle bacilli such as M. tuberculosis','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-uhn_cpg',NULL,'uhn_cpg','UHN CpG Island Database','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-unigene',NULL,'unigene','UniGene. Non-redundant, gene-oriented clusters','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-uniprot',NULL,'uniprot','UniProt','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-unists',NULL,'unists','NCBI UniSTS (now retired)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-vectorbase',NULL,'vectorbase','VectorBase, for Invertebrate Vectors of Human Pathogens','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-vega_cf',NULL,'vega_cf','The Vertebrate Genome Annotation (VEGA) database (dog data)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-vega_dr',NULL,'vega_dr','The Vertebrate Genome Annotation (VEGA) database (zebrafish data)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-vega_hs',NULL,'vega_hs','The Vertebrate Genome Annotation (VEGA) database (human data)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-vega_mm',NULL,'vega_mm','The Vertebrate Genome Annotation (VEGA) database (mouse data)','\0',NULL,'CL-FEATDBS',NULL),('CL-FEATDBS-wormbase',NULL,'wormbase','Wormbase, Genome and biology of C. elegans','\0',NULL,'CL-FEATDBS',NULL),('CL-FREQ-T-1',NULL,'1 TIME PER WEEK','One time per week. (NCI)','\0','One Time Per Week','CL-FREQ','DBX-NCIT-C64526'),('CL-FREQ-T-10',NULL,'5 TIMES PER DAY','Five times per day. (NCI)','\0','5 Times Daily','CL-FREQ','DBX-NCIT-C98849'),('CL-FREQ-T-11',NULL,'5 TIMES PER MONTH','Five times per month. (NCI)','\0','5 Times Per Month','CL-FREQ','DBX-NCIT-C98850'),('CL-FREQ-T-12',NULL,'5 TIMES PER WEEK','Five times per week. (NCI)','\0','5 Times Per Week','CL-FREQ','DBX-NCIT-C85552'),('CL-FREQ-T-13',NULL,'5 TIMES PER YEAR','Five times per year. (NCI)','\0','5 Times Per Year','CL-FREQ','DBX-NCIT-C98851'),('CL-FREQ-T-14',NULL,'6 TIMES PER DAY','Six times per day. (NCI)','\0','6 Times Daily','CL-FREQ','DBX-NCIT-C98855'),('CL-FREQ-T-15',NULL,'6 TIMES PER MONTH','Six times per month. (NCI)','\0','6 Times Per Month','CL-FREQ','DBX-NCIT-C98856'),('CL-FREQ-T-16',NULL,'6 TIMES PER WEEK','Six times per week. (NCI)','\0','6 Times Per Week','CL-FREQ','DBX-NCIT-C98857'),('CL-FREQ-T-17',NULL,'6 TIMES PER YEAR','Six times per year. (NCI)','\0','6 Times Per Year','CL-FREQ','DBX-NCIT-C98858'),('CL-FREQ-T-18',NULL,'7 TIMES PER WEEK','Seven times per week. (NCI)','\0','7 Times Per Week','CL-FREQ','DBX-NCIT-C98854'),('CL-FREQ-T-19',NULL,'AD LIBITUM','As much as desired.','\0','Ad Libitum','CL-FREQ','DBX-NCIT-C64636'),('CL-FREQ-T-2',NULL,'2 TIMES PER WEEK','Two times per week. (NCI)','\0','BIS; Twice per week','CL-FREQ','DBX-NCIT-C64497'),('CL-FREQ-T-20',NULL,'BID','Two times per day, at unspecified times. (NCI)','\0','BD; Twice per day','CL-FREQ','DBX-NCIT-C64496'),('CL-FREQ-T-21',NULL,'BIM','Twice per month. (NCI)','\0','Twice per month','CL-FREQ','DBX-NCIT-C71129'),('CL-FREQ-T-22',NULL,'CONTINUOUS','Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)','\0','Continuous','CL-FREQ','DBX-NCIT-C53279'),('CL-FREQ-T-23',NULL,'EVERY 2 WEEKS','Every two weeks. (NCI)','\0','Every 2 weeks; Q2S','CL-FREQ','DBX-NCIT-C71127'),('CL-FREQ-T-24',NULL,'EVERY 3 WEEKS','Every three weeks. (NCI)','\0','Every 3 weeks; Q3S','CL-FREQ','DBX-NCIT-C64535'),('CL-FREQ-T-25',NULL,'EVERY 4 WEEKS','Every four weeks. (NCI)','\0','Every 4 weeks; Q4S','CL-FREQ','DBX-NCIT-C64529'),('CL-FREQ-T-26',NULL,'EVERY 5 WEEKS','Every five weeks. (NCI)','\0','Every 5 weeks; Q5S','CL-FREQ','DBX-NCIT-C103390'),('CL-FREQ-T-27',NULL,'EVERY 6 WEEKS','Every six weeks. (NCI)','\0','Every 6 Weeks; Q6S','CL-FREQ','DBX-NCIT-C89788'),('CL-FREQ-T-28',NULL,'EVERY 7 WEEKS','Every seven weeks.','\0','Every 7 weeks; Q7S','CL-FREQ','DBX-NCIT-C116149'),('CL-FREQ-T-29',NULL,'EVERY 8 WEEKS','Every eight weeks. (NCI)','\0','Every 8 weeks; Q8S','CL-FREQ','DBX-NCIT-C103389'),('CL-FREQ-T-3',NULL,'2 TIMES PER YEAR','Two times per year. (NCI)','\0','2 Times Per Year','CL-FREQ','DBX-NCIT-C98861'),('CL-FREQ-T-30',NULL,'EVERY WEEK','Every week. (NCI)','\0','Every week; Per Week; QS','CL-FREQ','DBX-NCIT-C67069'),('CL-FREQ-T-31',NULL,'INTERMITTENT','Periodically stopping and starting. (NCI)','\0','Intermittent','CL-FREQ','DBX-NCIT-C71325'),('CL-FREQ-T-32',NULL,'OCCASIONAL','Not occurring regularly or at short intervals.','\0','Occasional','CL-FREQ','DBX-NCIT-C64954'),('CL-FREQ-T-33',NULL,'ONCE','A one time intervention. (NCI)','\0','Once','CL-FREQ','DBX-NCIT-C64576'),('CL-FREQ-T-34',NULL,'PA','A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.','\0','/Year; Every Year; Per Annum; Per Year','CL-FREQ','DBX-NCIT-C74924'),('CL-FREQ-T-35',NULL,'PRN','As needed. (NCI)','\0','As needed','CL-FREQ','DBX-NCIT-C64499'),('CL-FREQ-T-36',NULL,'Q10H','Every ten hours. (NCI)','\0','Every 10 hours','CL-FREQ','DBX-NCIT-C64500'),('CL-FREQ-T-37',NULL,'Q11H','Every eleven hours. (NCI)','\0','Every 11 hours','CL-FREQ','DBX-NCIT-C64501'),('CL-FREQ-T-38',NULL,'Q12H','Every twelve hours. (NCI)','\0','Every 12 hours','CL-FREQ','DBX-NCIT-C64502'),('CL-FREQ-T-39',NULL,'Q13H','Every thirteen hours. (NCI)','\0','Every 13 hours','CL-FREQ','DBX-NCIT-C64503'),('CL-FREQ-T-4',NULL,'3 TIMES PER MONTH','Three times per month. (NCI)','\0','3 Times Per Month','CL-FREQ','DBX-NCIT-C98859'),('CL-FREQ-T-40',NULL,'Q14H','Every fourteen hours. (NCI)','\0','Every 14 hours','CL-FREQ','DBX-NCIT-C64504'),('CL-FREQ-T-41',NULL,'Q15H','Every fifteen hours. (NCI)','\0','Every 15 hours','CL-FREQ','DBX-NCIT-C64505'),('CL-FREQ-T-42',NULL,'Q16H','Every sixteen hours. (NCI)','\0','Every 16 hours','CL-FREQ','DBX-NCIT-C64506'),('CL-FREQ-T-43',NULL,'Q17H','Every seventeen hours. (NCI)','\0','Every 17 hours','CL-FREQ','DBX-NCIT-C64507'),('CL-FREQ-T-44',NULL,'Q18H','Every eighteen hours. (NCI)','\0','Every 18 hours','CL-FREQ','DBX-NCIT-C64508'),('CL-FREQ-T-45',NULL,'Q19H','Every nineteen hours. (NCI)','\0','Every 19 hours','CL-FREQ','DBX-NCIT-C64509'),('CL-FREQ-T-46',NULL,'Q20H','Every twenty hours. (NCI)','\0','Every 20 hours','CL-FREQ','DBX-NCIT-C64511'),('CL-FREQ-T-47',NULL,'Q21H','Every twenty-one hours. (NCI)','\0','Every 21 hours','CL-FREQ','DBX-NCIT-C64512'),('CL-FREQ-T-48',NULL,'Q22H','Every twenty-two hours. (NCI)','\0','Every 22 hours','CL-FREQ','DBX-NCIT-C64513'),('CL-FREQ-T-49',NULL,'Q23H','Every twenty-three hours. (NCI)','\0','Every 23 hours','CL-FREQ','DBX-NCIT-C64514'),('CL-FREQ-T-5',NULL,'3 TIMES PER WEEK','Three times per week. (NCI)','\0','TIS; Three times a week','CL-FREQ','DBX-NCIT-C64528'),('CL-FREQ-T-50',NULL,'Q24H','Every twenty-four hours. (NCI)','\0','Every 24 hours','CL-FREQ','DBX-NCIT-C64515'),('CL-FREQ-T-51',NULL,'Q2H','Every two hours. (NCI)','\0','Every 2 hours','CL-FREQ','DBX-NCIT-C64516'),('CL-FREQ-T-52',NULL,'Q2M','Every two months. (NCI)','\0','Every two months','CL-FREQ','DBX-NCIT-C64536'),('CL-FREQ-T-53',NULL,'Q3D','Every three days. (NCI)','\0','Every 3 days','CL-FREQ','DBX-NCIT-C64533'),('CL-FREQ-T-54',NULL,'Q3H','Every three hours. (NCI)','\0','Every 3 hours','CL-FREQ','DBX-NCIT-C64517'),('CL-FREQ-T-55',NULL,'Q3M','Every three months. (NCI)','\0','Every 3 months','CL-FREQ','DBX-NCIT-C64537'),('CL-FREQ-T-56',NULL,'Q4D','Every four days. (NCI)','\0','Every 4 days','CL-FREQ','DBX-NCIT-C64534'),('CL-FREQ-T-57',NULL,'Q4H','Every four hours. (NCI)','\0','Every 4 hours','CL-FREQ','DBX-NCIT-C64518'),('CL-FREQ-T-58',NULL,'Q4M','Every four months. (NCI)','\0','Every 4 months','CL-FREQ','DBX-NCIT-C64538'),('CL-FREQ-T-59',NULL,'Q5D','Every five days. (NCI)','\0','Every 5 days','CL-FREQ','DBX-NCIT-C71124'),('CL-FREQ-T-6',NULL,'3 TIMES PER YEAR','Three times per year. (NCI)','\0','3 Times Per Year','CL-FREQ','DBX-NCIT-C98860'),('CL-FREQ-T-60',NULL,'Q5H','Every five hours. (NCI)','\0','Every 5 hours','CL-FREQ','DBX-NCIT-C64519'),('CL-FREQ-T-61',NULL,'Q6H','Every six hours. (NCI)','\0','Every 6 hours','CL-FREQ','DBX-NCIT-C64520'),('CL-FREQ-T-62',NULL,'Q6M','Every six months. (NCI)','\0','Every 6 Months','CL-FREQ','DBX-NCIT-C89789'),('CL-FREQ-T-63',NULL,'Q7H','Every seven hours. (NCI)','\0','Every 7 hours','CL-FREQ','DBX-NCIT-C64521'),('CL-FREQ-T-64',NULL,'Q8H','Every eight hours. (NCI)','\0','Every 8 hours','CL-FREQ','DBX-NCIT-C64523'),('CL-FREQ-T-65',NULL,'Q9H','Every nine hours. (NCI)','\0','Every 9 hours','CL-FREQ','DBX-NCIT-C64524'),('CL-FREQ-T-66',NULL,'QD','Occurring or done each day. (NCI)','\0','Daily; Per Day','CL-FREQ','DBX-NCIT-C25473'),('CL-FREQ-T-67',NULL,'QH','Every hour. (NCI)','\0','Every hour','CL-FREQ','DBX-NCIT-C64510'),('CL-FREQ-T-68',NULL,'QID','Four times per day. (NCI)','\0','4 times per day','CL-FREQ','DBX-NCIT-C64530'),('CL-FREQ-T-69',NULL,'QM','Every month. (NCI)','\0','Every Month; Per Month','CL-FREQ','DBX-NCIT-C64498'),('CL-FREQ-T-7',NULL,'4 TIMES PER MONTH','Four times per month. (NCI)','\0','4 Times Per Month','CL-FREQ','DBX-NCIT-C98852'),('CL-FREQ-T-70',NULL,'QOD','Every other day. (NCI)','\0','Every other day','CL-FREQ','DBX-NCIT-C64525'),('CL-FREQ-T-71',NULL,'TID','Three times per day. (NCI)','\0','3 times per day','CL-FREQ','DBX-NCIT-C64527'),('CL-FREQ-T-72',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-FREQ','DBX-NCIT-C17998'),('CL-FREQ-T-8',NULL,'4 TIMES PER WEEK','Four times per week. (NCI)','\0','4 times per week; QIS','CL-FREQ','DBX-NCIT-C64531'),('CL-FREQ-T-9',NULL,'4 TIMES PER YEAR','Four times per year. (NCI)','\0','4 Times Per Year','CL-FREQ','DBX-NCIT-C98853'),('CL-FRM-T-1',NULL,'AEROSOL','A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasa','\0','aer','CL-FRM','DBX-NCIT-C42887'),('CL-FRM-T-10',NULL,'CAPLET','A solid dosage form in which a tablet has been compacted into capsule shape.','\0','','CL-FRM','DBX-NCIT-C97197'),('CL-FRM-T-100',NULL,'OINTMENT','A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1:','\0','oint','CL-FRM','DBX-NCIT-C42966'),('CL-FRM-T-101',NULL,'OINTMENT, AUGMENTED','An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria ','\0','','CL-FRM','DBX-NCIT-C60984'),('CL-FRM-T-102',NULL,'PACKING','A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.','\0','','CL-FRM','DBX-NCIT-C47887'),('CL-FRM-T-103',NULL,'PASTE','A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or','\0','','CL-FRM','DBX-NCIT-C42967'),('CL-FRM-T-104',NULL,'PASTE, DENTIFRICE','A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)','\0','','CL-FRM','DBX-NCIT-C42907'),('CL-FRM-T-105',NULL,'PASTILLE','An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth.','\0','','CL-FRM','DBX-NCIT-C60985'),('CL-FRM-T-106',NULL,'PATCH','A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, t','\0','','CL-FRM','DBX-NCIT-C42968'),('CL-FRM-T-107',NULL,'PATCH, EXTENDED RELEASE','A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosag','\0','','CL-FRM','DBX-NCIT-C42923'),('CL-FRM-T-108',NULL,'PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED','A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prom','\0','','CL-FRM','DBX-NCIT-C42911'),('CL-FRM-T-109',NULL,'PELLET','A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)','\0','','CL-FRM','DBX-NCIT-C42969'),('CL-FRM-T-11',NULL,'CAPSULE','A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)','\0','cap','CL-FRM','DBX-NCIT-C25158'),('CL-FRM-T-110',NULL,'PELLET, IMPLANTABLE','A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of provi','\0','','CL-FRM','DBX-NCIT-C42943'),('CL-FRM-T-111',NULL,'PELLETS, COATED, EXTENDED RELEASE','A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drug','\0','','CL-FRM','DBX-NCIT-C42918'),('CL-FRM-T-112',NULL,'PILL','A dose of medicine in the form of a small pellet. (NCI)','\0','','CL-FRM','DBX-NCIT-C25394'),('CL-FRM-T-113',NULL,'PLASTER','Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and t','\0','','CL-FRM','DBX-NCIT-C42970'),('CL-FRM-T-114',NULL,'POULTICE','A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)','\0','','CL-FRM','DBX-NCIT-C47913'),('CL-FRM-T-115',NULL,'POWDER','An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)','\0','','CL-FRM','DBX-NCIT-C42972'),('CL-FRM-T-116',NULL,'POWDER, DENTIFRICE','A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)','\0','','CL-FRM','DBX-NCIT-C42908'),('CL-FRM-T-117',NULL,'POWDER, FOR SOLUTION','An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)','\0','','CL-FRM','DBX-NCIT-C42973'),('CL-FRM-T-118',NULL,'POWDER, FOR SUSPENSION','An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)','\0','','CL-FRM','DBX-NCIT-C42975'),('CL-FRM-T-119',NULL,'POWDER, METERED','A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)','\0','','CL-FRM','DBX-NCIT-C42961'),('CL-FRM-T-12',NULL,'CAPSULE, COATED','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or \"shell\" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating.','\0','','CL-FRM','DBX-NCIT-C42895'),('CL-FRM-T-120',NULL,'RING','A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects.','\0','','CL-FRM','DBX-NCIT-C60988'),('CL-FRM-T-121',NULL,'RINSE','A liquid used to cleanse by flushing. (NCI)','\0','','CL-FRM','DBX-NCIT-C42979'),('CL-FRM-T-122',NULL,'SALVE','A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)','\0','','CL-FRM','DBX-NCIT-C42980'),('CL-FRM-T-123',NULL,'SHAMPOO','A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)','\0','','CL-FRM','DBX-NCIT-C42981'),('CL-FRM-T-124',NULL,'SHAMPOO, SUSPENSION','A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)','\0','','CL-FRM','DBX-NCIT-C42982'),('CL-FRM-T-125',NULL,'SOAP','Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)','\0','','CL-FRM','DBX-NCIT-C42983'),('CL-FRM-T-126',NULL,'SOLUTION','A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newt','\0','','CL-FRM','DBX-NCIT-C42986'),('CL-FRM-T-127',NULL,'SOLUTION, CONCENTRATE','A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI','\0','','CL-FRM','DBX-NCIT-C42898'),('CL-FRM-T-128',NULL,'SOLUTION, FOR SLUSH','A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)','\0','','CL-FRM','DBX-NCIT-C42987'),('CL-FRM-T-129',NULL,'SOLUTION, GEL FORMING / DROPS','A solution, which after usually being administered in a drop-wise fashion, forms a gel.','\0','','CL-FRM','DBX-NCIT-C60994'),('CL-FRM-T-13',NULL,'CAPSULE, COATED PELLETS','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or \'shell\' made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)','\0','','CL-FRM','DBX-NCIT-C42896'),('CL-FRM-T-130',NULL,'SOLUTION, GEL FORMING, EXTENDED RELEASE','A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency.','\0','','CL-FRM','DBX-NCIT-C42935'),('CL-FRM-T-131',NULL,'SOLUTION/ DROPS','A solution which is usually administered in a drop-wise fashion.','\0','','CL-FRM','DBX-NCIT-C60992'),('CL-FRM-T-132',NULL,'SPONGE','A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape.','\0','','CL-FRM','DBX-NCIT-C47912'),('CL-FRM-T-133',NULL,'SPRAY','A liquid minutely divided as by a jet of air or steam. (NCI)','\0','','CL-FRM','DBX-NCIT-C42989'),('CL-FRM-T-134',NULL,'SPRAY, METERED','A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)','\0','','CL-FRM','DBX-NCIT-C42962'),('CL-FRM-T-135',NULL,'SPRAY, SUSPENSION','A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)','\0','','CL-FRM','DBX-NCIT-C42990'),('CL-FRM-T-136',NULL,'STICK','A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)','\0','','CL-FRM','DBX-NCIT-C42991'),('CL-FRM-T-137',NULL,'STRIP','A long narrow piece of material.','\0','','CL-FRM','DBX-NCIT-C47914'),('CL-FRM-T-138',NULL,'SUPPOSITORY','A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature.','\0','supp','CL-FRM','DBX-NCIT-C42993'),('CL-FRM-T-139',NULL,'SUPPOSITORY, EXTENDED RELEASE','A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)','\0','','CL-FRM','DBX-NCIT-C42924'),('CL-FRM-T-14',NULL,'CAPSULE, COATED, EXTENDED RELEASE','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or \"shell\" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a ','\0','','CL-FRM','DBX-NCIT-C42917'),('CL-FRM-T-140',NULL,'SUSPENSION','A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.','\0','susp','CL-FRM','DBX-NCIT-C42994'),('CL-FRM-T-141',NULL,'SUSPENSION, EXTENDED RELEASE','A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presen','\0','','CL-FRM','DBX-NCIT-C42925'),('CL-FRM-T-142',NULL,'SUSPENSION/DROPS','A suspension which is usually administered in a dropwise fashion.','\0','','CL-FRM','DBX-NCIT-C60995'),('CL-FRM-T-143',NULL,'SUTURE','A strand or fiber used to hold wound edges in apposition during healing. (NCI)','\0','','CL-FRM','DBX-NCIT-C47889'),('CL-FRM-T-144',NULL,'SWAB','A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing.','\0','','CL-FRM','DBX-NCIT-C47898'),('CL-FRM-T-145',NULL,'SYRUP','An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI)','\0','','CL-FRM','DBX-NCIT-C42996'),('CL-FRM-T-146',NULL,'TABLET','A solid dosage form containing medicinal substances with or without suitable diluents. (NCI)','\0','tab','CL-FRM','DBX-NCIT-C42998'),('CL-FRM-T-147',NULL,'TABLET, CHEWABLE','A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (N','\0','','CL-FRM','DBX-NCIT-C42893'),('CL-FRM-T-148',NULL,'TABLET, COATED','A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)','\0','','CL-FRM','DBX-NCIT-C42897'),('CL-FRM-T-149',NULL,'TABLET, COATED PARTICLES','A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating.','\0','','CL-FRM','DBX-NCIT-C60997'),('CL-FRM-T-15',NULL,'CAPSULE, DELAYED RELEASE','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are del','\0','','CL-FRM','DBX-NCIT-C42902'),('CL-FRM-T-150',NULL,'TABLET, DELAYED RELEASE','A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)','\0','','CL-FRM','DBX-NCIT-C42905'),('CL-FRM-T-151',NULL,'TABLET, DELAYED RELEASE PARTICLES','A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)','\0','','CL-FRM','DBX-NCIT-C42997'),('CL-FRM-T-152',NULL,'TABLET, EFFERVESCENT','A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.','\0','','CL-FRM','DBX-NCIT-C42910'),('CL-FRM-T-153',NULL,'TABLET, EXTENDED RELEASE','A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)','\0','','CL-FRM','DBX-NCIT-C42927'),('CL-FRM-T-154',NULL,'TABLET, FILM COATED','A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)','\0','','CL-FRM','DBX-NCIT-C42931'),('CL-FRM-T-155',NULL,'TABLET, FILM COATED, EXTENDED RELEASE','A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available o','\0','','CL-FRM','DBX-NCIT-C42930'),('CL-FRM-T-156',NULL,'TABLET, FOR SOLUTION','A tablet that forms a solution when placed in a liquid.','\0','','CL-FRM','DBX-NCIT-C61004'),('CL-FRM-T-157',NULL,'TABLET, FOR SUSPENSION','A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).','\0','','CL-FRM','DBX-NCIT-C61005'),('CL-FRM-T-158',NULL,'TABLET, MULTILAYER','A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)','\0','','CL-FRM','DBX-NCIT-C42964'),('CL-FRM-T-159',NULL,'TABLET, MULTILAYER, EXTENDED RELEASE','A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a design','\0','','CL-FRM','DBX-NCIT-C42963'),('CL-FRM-T-16',NULL,'CAPSULE, DELAYED RELEASE PELLETS','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or \"shell\" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release o','\0','','CL-FRM','DBX-NCIT-C42904'),('CL-FRM-T-160',NULL,'TABLET, ORALLY DISINTEGRATING','A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI)','\0','','CL-FRM','DBX-NCIT-C42999'),('CL-FRM-T-161',NULL,'TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE','A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration.','\0','','CL-FRM','DBX-NCIT-C61006'),('CL-FRM-T-162',NULL,'TABLET, SOLUBLE','A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)','\0','','CL-FRM','DBX-NCIT-C42985'),('CL-FRM-T-163',NULL,'TABLET, SUGAR COATED','A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)','\0','','CL-FRM','DBX-NCIT-C42992'),('CL-FRM-T-164',NULL,'TAMPON','A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)','\0','','CL-FRM','DBX-NCIT-C47892'),('CL-FRM-T-165',NULL,'TAPE','A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)','\0','','CL-FRM','DBX-NCIT-C47897'),('CL-FRM-T-166',NULL,'TINCTURE','An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI)','\0','','CL-FRM','DBX-NCIT-C43000'),('CL-FRM-T-167',NULL,'TROCHE','A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI)','\0','','CL-FRM','DBX-NCIT-C43001'),('CL-FRM-T-168',NULL,'UNASSIGNED','A dosage form has yet to be assigned. (NCI)','\0','','CL-FRM','DBX-NCIT-C43002'),('CL-FRM-T-169',NULL,'WAFER','A thin slice of material containing a medicinal agent. (NCI)','\0','','CL-FRM','DBX-NCIT-C43003'),('CL-FRM-T-17',NULL,'CAPSULE, EXTENDED RELEASE','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug ','\0','','CL-FRM','DBX-NCIT-C42916'),('CL-FRM-T-18',NULL,'CAPSULE, FILM COATED, EXTENDED RELEASE','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or \'shell\' made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in su','\0','','CL-FRM','DBX-NCIT-C42928'),('CL-FRM-T-19',NULL,'CAPSULE, GELATIN COATED','A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)','\0','','CL-FRM','DBX-NCIT-C42936'),('CL-FRM-T-2',NULL,'AEROSOL, FOAM','A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the','\0','','CL-FRM','DBX-NCIT-C42888'),('CL-FRM-T-20',NULL,'CAPSULE, LIQUID FILLED','A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typical','\0','','CL-FRM','DBX-NCIT-C42954'),('CL-FRM-T-21',NULL,'CEMENT','A substance that serves to produce solid union between two surfaces. (NCI)','\0','','CL-FRM','DBX-NCIT-C45414'),('CL-FRM-T-22',NULL,'CIGARETTE','A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.','\0','','CL-FRM','DBX-NCIT-C42678'),('CL-FRM-T-23',NULL,'CLOTH','A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing.','\0','','CL-FRM','DBX-NCIT-C60884'),('CL-FRM-T-24',NULL,'CONCENTRATE','A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)','\0','','CL-FRM','DBX-NCIT-C60891'),('CL-FRM-T-25',NULL,'CONE','A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extracti','\0','','CL-FRM','DBX-NCIT-C42900'),('CL-FRM-T-26',NULL,'CORE, EXTENDED RELEASE','An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)','\0','','CL-FRM','DBX-NCIT-C42919'),('CL-FRM-T-27',NULL,'CREAM','A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)','\0','','CL-FRM','DBX-NCIT-C28944'),('CL-FRM-T-28',NULL,'CREAM, AUGMENTED','A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that','\0','','CL-FRM','DBX-NCIT-C60897'),('CL-FRM-T-29',NULL,'CRYSTAL','A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.','\0','','CL-FRM','DBX-NCIT-C42901'),('CL-FRM-T-3',NULL,'AEROSOL, METERED','A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)','\0','','CL-FRM','DBX-NCIT-C42960'),('CL-FRM-T-30',NULL,'CULTURE','The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)','\0','','CL-FRM','DBX-NCIT-C45415'),('CL-FRM-T-31',NULL,'DIAPHRAGM','A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)','\0','','CL-FRM','DBX-NCIT-C47890'),('CL-FRM-T-32',NULL,'DISC','A circular plate-like organ or structure.','\0','','CL-FRM','DBX-NCIT-C43525'),('CL-FRM-T-33',NULL,'DOUCHE','A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. ','\0','','CL-FRM','DBX-NCIT-C42679'),('CL-FRM-T-34',NULL,'DRESSING','The application of various materials for protecting a wound.','\0','','CL-FRM','DBX-NCIT-C42763'),('CL-FRM-T-35',NULL,'DRUG DELIVERY SYSTEM','Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body.','\0','','CL-FRM','DBX-NCIT-C17423'),('CL-FRM-T-36',NULL,'ELIXIR','A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)','\0','','CL-FRM','DBX-NCIT-C42912'),('CL-FRM-T-37',NULL,'EMULSION','A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or m','\0','','CL-FRM','DBX-NCIT-C42913'),('CL-FRM-T-38',NULL,'ENEMA','A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI)','\0','','CL-FRM','DBX-NCIT-C42915'),('CL-FRM-T-39',NULL,'EXTRACT','A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to t','\0','','CL-FRM','DBX-NCIT-C42929'),('CL-FRM-T-4',NULL,'AEROSOL, POWDER','A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)','\0','','CL-FRM','DBX-NCIT-C42971'),('CL-FRM-T-40',NULL,'FIBER, EXTENDED RELEASE','A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.','\0','','CL-FRM','DBX-NCIT-C60926'),('CL-FRM-T-41',NULL,'FILM','A thin layer or coating. (NCI)','\0','','CL-FRM','DBX-NCIT-C42932'),('CL-FRM-T-42',NULL,'FILM, EXTENDED RELEASE','A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)','\0','','CL-FRM','DBX-NCIT-C42920'),('CL-FRM-T-43',NULL,'FILM, SOLUBLE','A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)','\0','','CL-FRM','DBX-NCIT-C42984'),('CL-FRM-T-44',NULL,'FOR SOLUTION','A product, usually a solid, intended for solution prior to administration.','\0','','CL-FRM','DBX-NCIT-C60927'),('CL-FRM-T-45',NULL,'FOR SUSPENSION','A product, usually a solid, intended for suspension prior to administration.','\0','','CL-FRM','DBX-NCIT-C60928'),('CL-FRM-T-46',NULL,'FOR SUSPENSION, EXTENDED RELEASE','A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period.','\0','','CL-FRM','DBX-NCIT-C60929'),('CL-FRM-T-47',NULL,'GAS','Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)','\0','','CL-FRM','DBX-NCIT-C42933'),('CL-FRM-T-48',NULL,'GEL','A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room te','\0','','CL-FRM','DBX-NCIT-C42934'),('CL-FRM-T-49',NULL,'GEL, DENTIFRICE','A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)','\0','','CL-FRM','DBX-NCIT-C42906'),('CL-FRM-T-5',NULL,'AEROSOL, SPRAY','An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)','\0','','CL-FRM','DBX-NCIT-C42889'),('CL-FRM-T-50',NULL,'GEL, METERED','A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation.','\0','','CL-FRM','DBX-NCIT-C60930'),('CL-FRM-T-51',NULL,'GENERATOR','An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)','\0','','CL-FRM','DBX-NCIT-C48193'),('CL-FRM-T-52',NULL,'GLOBULE','Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion ','\0','','CL-FRM','DBX-NCIT-C42937'),('CL-FRM-T-53',NULL,'GRAFT','A slip of skin or of other tissue for implantation. (NCI)','\0','','CL-FRM','DBX-NCIT-C45416'),('CL-FRM-T-54',NULL,'GRANULE','A small particle or grain. (NCI)','\0','','CL-FRM','DBX-NCIT-C42938'),('CL-FRM-T-55',NULL,'GRANULE, DELAYED RELEASE','A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)','\0','','CL-FRM','DBX-NCIT-C42903'),('CL-FRM-T-56',NULL,'GRANULE, EFFERVESCENT','A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)','\0','','CL-FRM','DBX-NCIT-C42909'),('CL-FRM-T-57',NULL,'GRANULE, FOR SOLUTION','A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other des','\0','','CL-FRM','DBX-NCIT-C42939'),('CL-FRM-T-58',NULL,'GRANULE, FOR SUSPENSION','A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavoran','\0','','CL-FRM','DBX-NCIT-C42940'),('CL-FRM-T-59',NULL,'GRANULE, FOR SUSPENSION, EXTENDED RELEASE','A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and','\0','','CL-FRM','DBX-NCIT-C42921'),('CL-FRM-T-6',NULL,'BAR, CHEWABLE','A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)','\0','','CL-FRM','DBX-NCIT-C42892'),('CL-FRM-T-60',NULL,'GUM','A mucilaginous excretion from various plants. (NCI)','\0','','CL-FRM','DBX-NCIT-C42941'),('CL-FRM-T-61',NULL,'GUM, CHEWING','A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)','\0','','CL-FRM','DBX-NCIT-C42894'),('CL-FRM-T-62',NULL,'GUM, RESIN','Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)','\0','','CL-FRM','DBX-NCIT-C42978'),('CL-FRM-T-63',NULL,'IMPLANT','A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)','\0','','CL-FRM','DBX-NCIT-C42942'),('CL-FRM-T-64',NULL,'INHALANT','A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generall','\0','','CL-FRM','DBX-NCIT-C42944'),('CL-FRM-T-65',NULL,'INJECTABLE, LIPOSOMAL','An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance).','\0','','CL-FRM','DBX-NCIT-C60931'),('CL-FRM-T-66',NULL,'INJECTION','A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)','\0','','CL-FRM','DBX-NCIT-C42946'),('CL-FRM-T-67',NULL,'INJECTION, EMULSION','An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.','\0','','CL-FRM','DBX-NCIT-C42914'),('CL-FRM-T-68',NULL,'INJECTION, LIPID COMPLEX','[definition pending]','\0','','CL-FRM','DBX-NCIT-C42950'),('CL-FRM-T-69',NULL,'INJECTION, POWDER, FOR SOLUTION','A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)','\0','','CL-FRM','DBX-NCIT-C42974'),('CL-FRM-T-7',NULL,'BEAD','A solid dosage form in the shape of a small ball. (NCI)','\0','','CL-FRM','DBX-NCIT-C42890'),('CL-FRM-T-70',NULL,'INJECTION, POWDER, FOR SUSPENSION','A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)','\0','','CL-FRM','DBX-NCIT-C42976'),('CL-FRM-T-71',NULL,'INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE','A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a so','\0','','CL-FRM','DBX-NCIT-C42977'),('CL-FRM-T-72',NULL,'INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION','A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug subst','\0','','CL-FRM','DBX-NCIT-C42959'),('CL-FRM-T-73',NULL,'INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION','A dosage form intended for the solution prepared by lyophilization (\'freeze drying\'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create ','\0','','CL-FRM','DBX-NCIT-C42957'),('CL-FRM-T-74',NULL,'INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION','A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophil','\0','','CL-FRM','DBX-NCIT-C42958'),('CL-FRM-T-75',NULL,'INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE','A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution','\0','','CL-FRM','DBX-NCIT-C42956'),('CL-FRM-T-76',NULL,'INJECTION, SOLUTION','A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)','\0','','CL-FRM','DBX-NCIT-C42945'),('CL-FRM-T-77',NULL,'INJECTION, SOLUTION, CONCENTRATE','A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)','\0','','CL-FRM','DBX-NCIT-C42899'),('CL-FRM-T-78',NULL,'INJECTION, SUSPENSION','A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)','\0','','CL-FRM','DBX-NCIT-C42995'),('CL-FRM-T-79',NULL,'INJECTION, SUSPENSION, EXTENDED RELEASE','A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, con','\0','','CL-FRM','DBX-NCIT-C42926'),('CL-FRM-T-8',NULL,'BEAD, IMPLANT, EXTENDED RELEASE','A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)','\0','','CL-FRM','DBX-NCIT-C43451'),('CL-FRM-T-80',NULL,'INJECTION, SUSPENSION, LIPOSOMAL','A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vi','\0','','CL-FRM','DBX-NCIT-C42951'),('CL-FRM-T-81',NULL,'INJECTION, SUSPENSION, SONICATED','A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this resul','\0','','CL-FRM','DBX-NCIT-C42988'),('CL-FRM-T-82',NULL,'INSERT','A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects.','\0','','CL-FRM','DBX-NCIT-C60933'),('CL-FRM-T-83',NULL,'INSERT, EXTENDED RELEASE','A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to','\0','','CL-FRM','DBX-NCIT-C42922'),('CL-FRM-T-84',NULL,'INTRAUTERINE DEVICE','A device inserted and left in the uterus to prevent effective conception. (NCI)','\0','','CL-FRM','DBX-NCIT-C47915'),('CL-FRM-T-85',NULL,'IRRIGANT','A sterile solution intended to bathe or flush open wounds or body cavities; they\'re used topically, never parenterally. (NCI)','\0','','CL-FRM','DBX-NCIT-C42947'),('CL-FRM-T-86',NULL,'JELLY','A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (','\0','','CL-FRM','DBX-NCIT-C42948'),('CL-FRM-T-87',NULL,'KIT','A packaged collection of related material. (NCI)','\0','','CL-FRM','DBX-NCIT-C47916'),('CL-FRM-T-88',NULL,'LINER, DENTAL','A material applied to the inside of the dental cavity, for protection or insulation of the surface.','\0','','CL-FRM','DBX-NCIT-C45413'),('CL-FRM-T-89',NULL,'LINIMENT','A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)','\0','','CL-FRM','DBX-NCIT-C42949'),('CL-FRM-T-9',NULL,'BLOCK','Solid dosage form, usually in the shape of a square or rectangle. (NCI)','\0','','CL-FRM','DBX-NCIT-C42891'),('CL-FRM-T-90',NULL,'LIPSTICK','A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)','\0','','CL-FRM','DBX-NCIT-C42952'),('CL-FRM-T-91',NULL,'LIQUID','A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow ','\0','','CL-FRM','DBX-NCIT-C42953'),('CL-FRM-T-92',NULL,'LIQUID, EXTENDED RELEASE','A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.','\0','','CL-FRM','DBX-NCIT-C60934'),('CL-FRM-T-93',NULL,'LOTION','An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. No','\0','','CL-FRM','DBX-NCIT-C29167'),('CL-FRM-T-94',NULL,'LOTION, AUGMENTED','A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria tha','\0','','CL-FRM','DBX-NCIT-C60957'),('CL-FRM-T-95',NULL,'LOTION/SHAMPOO','A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents.','\0','','CL-FRM','DBX-NCIT-C60958'),('CL-FRM-T-96',NULL,'LOZENGE','A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.','\0','','CL-FRM','DBX-NCIT-C42955'),('CL-FRM-T-97',NULL,'MOUTHWASH','An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)','\0','','CL-FRM','DBX-NCIT-C29269'),('CL-FRM-T-98',NULL,'NOT APPLICABLE','The use of a dosage form term is not relevant or appropriate. (NCI)','\0','','CL-FRM','DBX-NCIT-C48624'),('CL-FRM-T-99',NULL,'OIL','An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)','\0','','CL-FRM','DBX-NCIT-C42965'),('CL-GENSMP-T-1',NULL,'7SK RNA','7SK small nuclear RNA is encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II.','\0','7SK Small Nuclear RNA; 7SK snRNA','CL-GENSMP','DBX-NCIT-C95951'),('CL-GENSMP-T-10',NULL,'mRNA','A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.','\0','Messenger RNA','CL-GENSMP','DBX-NCIT-C813'),('CL-GENSMP-T-11',NULL,'msDNA','A DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule. (NCI)','\0','Multicopy Single-stranded DNA','CL-GENSMP','DBX-NCIT-C111279'),('CL-GENSMP-T-12',NULL,'msdRNA','The RNA portion of the msDNA molecule, which contains two stem-loop stuctures and varies widely in length across bacterial species. (NCI)','\0','MSR','CL-GENSMP','DBX-NCIT-C111278'),('CL-GENSMP-T-13',NULL,'mtDNA','Typically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reacti','\0','Mitochondrial DNA; mDNA','CL-GENSMP','DBX-NCIT-C28512'),('CL-GENSMP-T-14',NULL,'nDNA','The DNA that is normally located in the nucleus of a eukaryotic cell.','\0','Nuclear DNA','CL-GENSMP','DBX-NCIT-C95941'),('CL-GENSMP-T-15',NULL,'pDNA','A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication.','\0','Plasmid; Plasmid DNA','CL-GENSMP','DBX-NCIT-C754'),('CL-GENSMP-T-16',NULL,'piRNA','Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing.','\0','Piwi-Interacting RNA','CL-GENSMP','DBX-NCIT-C95953'),('CL-GENSMP-T-17',NULL,'pre-mRNA','A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA. (NCI)','\0','Precursor mRNA','CL-GENSMP','DBX-NCIT-C111298'),('CL-GENSMP-T-18',NULL,'pri-miRNA','The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 n','\0','Pri-MIR; Pri-miRNA; Pri-microRNA; Primary MicroRNA','CL-GENSMP','DBX-NCIT-C25967'),('CL-GENSMP-T-19',NULL,'rDNA','The genomic sequences that code for ribosomal RNA molecules.','\0','Ribosomal DNA; Ribosomal RNA Genes','CL-GENSMP','DBX-NCIT-C95943'),('CL-GENSMP-T-2',NULL,'cDNA','Single-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase.','\0','Complementary DNA','CL-GENSMP','DBX-NCIT-C324'),('CL-GENSMP-T-20',NULL,'RIBOZYME','RNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein.','\0','Catalytic RNA; Ribonucleic Enzyme','CL-GENSMP','DBX-NCIT-C1292'),('CL-GENSMP-T-21',NULL,'RNA','Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.','\0','Ribonucleic Acid','CL-GENSMP','DBX-NCIT-C812'),('CL-GENSMP-T-22',NULL,'rRNA','An RNA molecule that does not contain protein-coding sequence information and constitutes the majority of the cellular RNA (~80%). This nucleic acid associates with multiple proteins to form ribosomes, which are the organelles that drive mRNA-directed pro','\0','Ribosomal RNA','CL-GENSMP','DBX-NCIT-C814'),('CL-GENSMP-T-23',NULL,'siRNA','A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference.','\0','Small Interfering RNA','CL-GENSMP','DBX-NCIT-C2191'),('CL-GENSMP-T-24',NULL,'snoRNA','Small RNA molecules that are present in the nucleolus. They associate with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. (NCI)','\0','Small Nucleolar RNA','CL-GENSMP','DBX-NCIT-C111316'),('CL-GENSMP-T-25',NULL,'snRNA','A small RNA molecule (100-300 nucleotides) located in the cell nucleus. This nucleic acid plays a role in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification.','\0','Small Nuclear RNA; Small Nuclear Ribonucleic Acid; U-RNA','CL-GENSMP','DBX-NCIT-C815'),('CL-GENSMP-T-26',NULL,'SRP RNA','A non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes.','\0','7SL RNA; SRP RNA; Signal Recognition Particle RNA; srpRNA','CL-GENSMP','DBX-NCIT-C95950'),('CL-GENSMP-T-27',NULL,'ssDNA','A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI)','\0','Single-stranded DNA','CL-GENSMP','DBX-NCIT-C111311'),('CL-GENSMP-T-28',NULL,'tmRNA','An RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation.','\0','10Sa RNA; SsrA; Transfer-Messenger RNA','CL-GENSMP','DBX-NCIT-C95954'),('CL-GENSMP-T-29',NULL,'TRANSPOSON','A class of mobile genetic elements that can move from one genomic position to another.','\0','Jumping Gene; Jumping Genes; Transposable Element','CL-GENSMP','DBX-NCIT-C95942'),('CL-GENSMP-T-3',NULL,'cpDNA','The DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants. (NCI)','\0','Chloroplast DNA','CL-GENSMP','DBX-NCIT-C111158'),('CL-GENSMP-T-30',NULL,'tRNA','A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Each transfer RNA comprises a three-nucleotide sequence that is complementary to the triplet n','\0','Transfer RNA; Triplet Codon-Amino Acid Adaptor','CL-GENSMP','DBX-NCIT-C816'),('CL-GENSMP-T-4',NULL,'DNA','A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information.','\0','Deoxyribonucleic Acid; Double-stranded DNA; dsDNA','CL-GENSMP','DBX-NCIT-C449'),('CL-GENSMP-T-5',NULL,'dsRNA','An RNA complex consisting of two base-paired strands of complementary RNA.','\0','Double-stranded RNA','CL-GENSMP','DBX-NCIT-C95938'),('CL-GENSMP-T-6',NULL,'gDNA','The DNA that is part of the normal chromosomal complement of an organism.','\0','Genomic DNA','CL-GENSMP','DBX-NCIT-C95940'),('CL-GENSMP-T-7',NULL,'gRNA','A small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastids.','\0','Guide RNA','CL-GENSMP','DBX-NCIT-C95952'),('CL-GENSMP-T-8',NULL,'hnRNA','A diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications.','\0','Heterogeneous Nuclear RNA','CL-GENSMP','DBX-NCIT-C28454'),('CL-GENSMP-T-9',NULL,'miRNA','A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins.','\0','MicroRNA','CL-GENSMP','DBX-NCIT-C25966'),('CL-GNRLOBSC-T-1',NULL,'ADAM OTHER','An ADaM analysis dataset that doesn\'t conform to the ADSL or BDS structure.','\0','','CL-GNRLOBSC','DBX-NCIT-C103375'),('CL-GNRLOBSC-T-2',NULL,'BASIC DATA STRUCTURE','An ADaM BDS dataset contains one or more records per subject, per analysis parameter, per analysis time point. Variables include the value being analyzed (e.g., AVAL) and the description of the value being analyzed (e.g., PARAM). Other variables in the da','\0','BDS','CL-GNRLOBSC','DBX-NCIT-C103371'),('CL-GNRLOBSC-T-3',NULL,'EVENTS','This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.','\0','','CL-GNRLOBSC','DBX-NCIT-C103372'),('CL-GNRLOBSC-T-4',NULL,'FINDINGS','This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires.','\0','','CL-GNRLOBSC','DBX-NCIT-C103373'),('CL-GNRLOBSC-T-5',NULL,'INTERVENTIONS','This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with t','\0','','CL-GNRLOBSC','DBX-NCIT-C103374'),('CL-GNRLOBSC-T-6',NULL,'RELATIONSHIP','This SDTM class provides a means to link related records between datasets. It includes the RELREC and SUPPQUAL datasets.','\0','','CL-GNRLOBSC','DBX-NCIT-C103376'),('CL-GNRLOBSC-T-7',NULL,'SPECIAL PURPOSE','This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV.','\0','','CL-GNRLOBSC','DBX-NCIT-C103377'),('CL-GNRLOBSC-T-8',NULL,'SUBJECT LEVEL ANALYSIS DATASET','The Subject-Level Analysis Dataset (ADSL) is a one-record-per-subject dataset which contains variables that describe subject demographic characteristics and group the subjects for analysis. ADSL is the primary source for subject-level variables included i','\0','ADSL','CL-GNRLOBSC','DBX-NCIT-C103378'),('CL-GNRLOBSC-T-9',NULL,'TRIAL DESIGN','This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of events, control group, method of allocating treatments, blinding methods, assignment of epochs that subjects pass through in t','\0','','CL-GNRLOBSC','DBX-NCIT-C103379'),('CL-GRAFTTYP-T-1',NULL,'ARTERIAL GRAFT, FREE','A vessel graft comprised of an artery that has been completely detached from its original location.  (NCI)','\0','','CL-GRAFTTYP','DBX-NCIT-C117816'),('CL-GRAFTTYP-T-2',NULL,'ARTERIAL GRAFT, IN-SITU','A vessel graft comprised of an artery whose origin remains intact.','\0','','CL-GRAFTTYP','DBX-NCIT-C117817'),('CL-GRAFTTYP-T-3',NULL,'AUTOLOGOUS VEIN GRAFT','A vessel graft comprised of a vein harvested from a different anatomical location.','\0','','CL-GRAFTTYP','DBX-NCIT-C117818'),('CL-GRAFTTYP-T-4',NULL,'CADAVERIC GRAFT, ARTERIAL','An arterial graft harvested from a cadaver. (NCI)','\0','','CL-GRAFTTYP','DBX-NCIT-C117819'),('CL-GRAFTTYP-T-5',NULL,'CADAVERIC GRAFT, VENOUS','A venous graft harvested from a cadaver. (NCI)','\0','','CL-GRAFTTYP','DBX-NCIT-C117820'),('CL-GRAFTTYP-T-6',NULL,'COMPOSITE GRAFT','A vessel graft comprised of two or more conduit materials.','\0','','CL-GRAFTTYP','DBX-NCIT-C117821'),('CL-GRAFTTYP-T-7',NULL,'SAPHENOUS VEIN GRAFT','A vessel graft comprised of the saphenous vein.','\0','SVG','CL-GRAFTTYP','DBX-NCIT-C117822'),('CL-GRAFTTYP-T-8',NULL,'SYNTHETIC GRAFT','A vessel graft comprised of non-biological material.','\0','','CL-GRAFTTYP','DBX-NCIT-C117823'),('CL-GRSTNLOC-T-1',NULL,'AORTIC ANASTOMOSIS OF THE GRAFT','The connection where the graft joins the aorta usually less than or equal to 3 mm from insertion point.','\0','','CL-GRSTNLOC','DBX-NCIT-C99915'),('CL-GRSTNLOC-T-2',NULL,'BODY OF THE GRAFT','The portion of the graft that lies between its anastomoses.','\0','','CL-GRSTNLOC','DBX-NCIT-C99918'),('CL-GRSTNLOC-T-3',NULL,'CORONARY ANASTOMOSIS OF THE GRAFT','The connection where the graft joins the coronary artery usually less than or equal to 3 mm from insertion point.','\0','Coronary Graft Anastomoses','CL-GRSTNLOC','DBX-NCIT-C80476'),('CL-HEFATS-T-1',NULL,'West Haven Hepatic Encephalopathy Grade','A grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI)','\0','West Haven Hepatic Encephalopathy Grade','CL-HEFATS','DBX-NCIT-C117747'),('CL-HEFATSCD-T-1',NULL,'WHHEGR','A grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI)','\0','West Haven Hepatic Encephalopathy Grade','CL-HEFATSCD','DBX-NCIT-C117747'),('CL-HEPENCGR-T-1',NULL,'GRADE 0','Minimal - symptoms or pathological characteristics include minimal hepatic encephalopathy, lack of detectable changes in personality or behavior, minimal changes in memory, concentration and intellectual function, and absence of coordination asterixis. (A','\0','','CL-HEPENCGR','DBX-NCIT-C117824'),('CL-HEPENCGR-T-2',NULL,'GRADE 1','Mild - symptoms or pathological characteristics include trivial lack of awareness, shortened attention span, impaired ability to perform addition or subtraction, hypersomnia, insomnia, or inversion of sleep pattern, euphoria, depression or irritability, m','\0','','CL-HEPENCGR','DBX-NCIT-C117825'),('CL-HEPENCGR-T-3',NULL,'GRADE 2','Moderate - symptoms or pathological characteristics include lethargy or apathy, disorientation, inappropriate behavior, slurred speech, obvious asterixis, drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes','\0','','CL-HEPENCGR','DBX-NCIT-C117826'),('CL-HEPENCGR-T-4',NULL,'GRADE 3','Severe - symptoms or pathological characteristics include somnolence with some arousability, inability to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech. (','\0','','CL-HEPENCGR','DBX-NCIT-C117827'),('CL-HEPENCGR-T-5',NULL,'GRADE 4','Coma - symptoms or pathological characteristics include coma with or without response to painful stimuli. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.)','\0','','CL-HEPENCGR','DBX-NCIT-C117828'),('CL-IECAT-T-1',NULL,'EXCLUSION','List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)','\0','','CL-IECAT','DBX-NCIT-C25370'),('CL-IECAT-T-2',NULL,'INCLUSION','The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)','\0','','CL-IECAT','DBX-NCIT-C25532'),('CL-INTMODEL-T-1',NULL,'CROSS-OVER','Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.','\0','','CL-INTMODEL','DBX-NCIT-C82637'),('CL-INTMODEL-T-2',NULL,'FACTORIAL','Two or more interventions, each alone and in combination, are evaluated in parallel against a control group.','\0','','CL-INTMODEL','DBX-NCIT-C82638'),('CL-INTMODEL-T-3',NULL,'PARALLEL','Participants are assigned to one of two or more arms in parallel for the duration of the study.','\0','','CL-INTMODEL','DBX-NCIT-C82639'),('CL-INTMODEL-T-4',NULL,'SINGLE GROUP','Single arm study.','\0','','CL-INTMODEL','DBX-NCIT-C82640'),('CL-INTTYPE-T-1',NULL,'BEHAVIORAL THERAPY','A technique used to change subjects\' behavior, for example, psychotherapy, lifestyle counseling or hypnosis.','\0','','CL-INTTYPE','DBX-NCIT-C15184'),('CL-INTTYPE-T-2',NULL,'BIOLOGIC','A substance made from living organisms or things they produce, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product.','\0','','CL-INTTYPE','DBX-NCIT-C307'),('CL-INTTYPE-T-3',NULL,'DEVICE','An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is recognized in the official National Formulary, or the United States Pharmacope','\0','','CL-INTTYPE','DBX-NCIT-C16830'),('CL-INTTYPE-T-4',NULL,'DIETARY SUPPLEMENT','Oral preparations containing dietary ingredient(s) intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs, amino acids, extracts and metabolites.','\0','','CL-INTTYPE','DBX-NCIT-C1505'),('CL-INTTYPE-T-5',NULL,'DRUG','An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect ','\0','','CL-INTTYPE','DBX-NCIT-C1909'),('CL-INTTYPE-T-6',NULL,'GENETIC','Application of genetic material into cells in order to correct an inherited or acquired disease.','\0','','CL-INTTYPE','DBX-NCIT-C15238'),('CL-INTTYPE-T-7',NULL,'OTHER','Different than the one(s) previously specified or mentioned. (NCI)','\0','Other','CL-INTTYPE','DBX-NCIT-C17649'),('CL-INTTYPE-T-8',NULL,'PROCEDURE','A treatment procedure performed by manual and/or instrumental means, for example: surgery, lithotripsy, or external manipulation.','\0','','CL-INTTYPE','DBX-NCIT-C98769'),('CL-INTTYPE-T-9',NULL,'RADIATION','Treatment of a disease by means of exposure of the target or the whole body to radiation.','\0','','CL-INTTYPE','DBX-NCIT-C15313'),('CL-KILLIPC-T-1',NULL,'Killip CLASS I','The absence of rales over the lung fields and absence of third heart sound (S3). (ACC/AHA)','\0','','CL-KILLIPC','DBX-NCIT-C77269'),('CL-KILLIPC-T-2',NULL,'Killip CLASS II','The presence of rales over 50% or less of the lung fields or the presence of a third heart sound (S3).(ACC/AHA)','\0','','CL-KILLIPC','DBX-NCIT-C77270'),('CL-KILLIPC-T-3',NULL,'Killip CLASS III','The presence of rales over more than 50% of the lung fields. (ACC/AHA)','\0','','CL-KILLIPC','DBX-NCIT-C77271'),('CL-KILLIPC-T-4',NULL,'Killip CLASS IV','The presence of cardiogenic shock (systolic BP less than 90 mm Hg) for greater than 30 minutes, not responsive to fluid resuscitation alone, and felt to be secondary to cardiac dysfunction. (ACC/AHA)','\0','','CL-KILLIPC','DBX-NCIT-C77272'),('CL-LAT-T-1',NULL,'BILATERAL','Affecting both sides of the body, or a pair of organs.','\0','','CL-LAT','DBX-NCIT-C13332'),('CL-LAT-T-2',NULL,'CONTRALATERAL','Having to do with the opposite side of the body, in relation to a pre-existing reference point.','\0','','CL-LAT','DBX-NCIT-C25307'),('CL-LAT-T-3',NULL,'IPSILATERAL','Having to do with the same side of the body, in relation to a pre-existing reference point.','\0','','CL-LAT','DBX-NCIT-C25308'),('CL-LAT-T-4',NULL,'LATERAL','Situated at or extending to the side.','\0','','CL-LAT','DBX-NCIT-C25230'),('CL-LAT-T-5',NULL,'LEFT','Being or located on or directed toward the side of the body to the west when facing north.','\0','','CL-LAT','DBX-NCIT-C25229'),('CL-LAT-T-6',NULL,'RIGHT','Being or located on or directed toward the side of the body to the east when facing north.','\0','','CL-LAT','DBX-NCIT-C25228'),('CL-LAT-T-7',NULL,'UNILATERAL','Affecting one side of the body or one of a pair of organs.','\0','','CL-LAT','DBX-NCIT-C68598'),('CL-LBSTRESC-T-1',NULL,'BORDERLINE','Straddling the dividing line between two categories.','\0','','CL-LBSTRESC','DBX-NCIT-C14157'),('CL-LBSTRESC-T-2',NULL,'INDETERMINATE','Cannot distinguish between two or more possible values in the current context. (NCI)','\0','Inconclusive','CL-LBSTRESC','DBX-NCIT-C48658'),('CL-LBSTRESC-T-3',NULL,'INVALID','Not valid data.','\0','','CL-LBSTRESC','DBX-NCIT-C50913'),('CL-LBSTRESC-T-4',NULL,'NEGATIVE','A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.','\0','','CL-LBSTRESC','DBX-NCIT-C38757'),('CL-LBSTRESC-T-5',NULL,'POSITIVE','An observation confirming something, such as the presence of a disease, condition, or microorganism.','\0','','CL-LBSTRESC','DBX-NCIT-C38758'),('CL-LBTEST-T-1',NULL,'1, 25-Dihydroxyvitamin D','A measurement of the total active Vitamin D in a biological specimen.','\0','1, 25-Dihydroxyvitamin D; Active Vitamin D','CL-LBTEST','DBX-NCIT-C92267'),('CL-LBTEST-T-10',NULL,'A Fetoprotein L3/A Fetoprotein','A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.','\0','A Fetoprotein L3/A Fetoprotein','CL-LBTEST','DBX-NCIT-C96565'),('CL-LBTEST-T-100',NULL,'Antiglobulin Test, Indirect','A test that uses Coombs\' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen.','\0','Antiglobulin Test, Indirect; Indirect Coombs Test','CL-LBTEST','DBX-NCIT-C91372'),('CL-LBTEST-T-1000',NULL,'Round Epithelial Cells','A measurement of the round epithelial cells present in a biological specimen.','\0','Round Epithelial Cells','CL-LBTEST','DBX-NCIT-C74698'),('CL-LBTEST-T-1001',NULL,'Rubella IgG Antibody','A measurement of the Rubella IgG antibody in a biological specimen.','\0','Rubella IgG Antibody','CL-LBTEST','DBX-NCIT-C103440'),('CL-LBTEST-T-1002',NULL,'Rubeola IgG Antibody','A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen.','\0','Measles IgG Antibody; Rubeola IgG Antibody','CL-LBTEST','DBX-NCIT-C112412'),('CL-LBTEST-T-1003',NULL,'Rubeola IgM Antibody','A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen.','\0','Measles IgM Antibody; Rubeola IgM Antibody','CL-LBTEST','DBX-NCIT-C112413'),('CL-LBTEST-T-1004',NULL,'Schistocytes','A measurement of the schistocytes (fragmented red blood cells) in a biological specimen.','\0','Schistocytes','CL-LBTEST','DBX-NCIT-C74706'),('CL-LBTEST-T-1005',NULL,'Scl-70 Antibody','A measurement of the Scl-70 antibody in a biological specimen.','\0','Scl-70 Antibody; Scleroderma-70 Antibody','CL-LBTEST','DBX-NCIT-C100458'),('CL-LBTEST-T-1006',NULL,'Sclerostin','A measurement of the sclerostin in a biological specimen.','\0','Sclerostin','CL-LBTEST','DBX-NCIT-C117857'),('CL-LBTEST-T-1007',NULL,'Secretin','A measurement of the secretin hormone in a biological specimen.','\0','Secretin','CL-LBTEST','DBX-NCIT-C74871'),('CL-LBTEST-T-1008',NULL,'Sediment Examination','An observation, assessment or examination of the sediment in a biological specimen.','\0','Microscopic Sediment Analysis; Sediment Analysis; Sediment Examination','CL-LBTEST','DBX-NCIT-C105744'),('CL-LBTEST-T-1009',NULL,'Serotonin','A measurement of the serotonin hormone in a biological specimen.','\0','Serotonin','CL-LBTEST','DBX-NCIT-C74872'),('CL-LBTEST-T-101',NULL,'Antimitochondrial Antibodies','A measurement of the antimitochondrial antibodies in a biological specimen.','\0','Antimitochondrial Antibodies; Mitochondrial Antibody','CL-LBTEST','DBX-NCIT-C81975'),('CL-LBTEST-T-1010',NULL,'Sex Hormone Binding Globulin','A measurement of the sex hormone binding (globulin) protein in a biological specimen.','\0','Sex Hormone Binding Globulin; Sex Hormone Binding Protein','CL-LBTEST','DBX-NCIT-C74745'),('CL-LBTEST-T-1011',NULL,'Sezary Cells','A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.','\0','Sezary Cells','CL-LBTEST','DBX-NCIT-C74625'),('CL-LBTEST-T-1012',NULL,'Sezary Cells/Lymphocytes','A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.','\0','Sezary Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C74655'),('CL-LBTEST-T-1013',NULL,'Sialyl SSEA-1 Antigen','A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen.','\0','SLeX; Sialyl Lewis X Antigen; Sialyl Lex; Sialyl SSEA-1 Antigen; Sialyl-CD15','CL-LBTEST','DBX-NCIT-C114223'),('CL-LBTEST-T-1014',NULL,'Sickle Cells','A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.','\0','Sickle Cells','CL-LBTEST','DBX-NCIT-C74626'),('CL-LBTEST-T-1015',NULL,'Sickle Cells/Erythrocytes','A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.','\0','Sickle Cells/Erythrocytes','CL-LBTEST','DBX-NCIT-C74656'),('CL-LBTEST-T-1016',NULL,'Sideroblast','A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.','\0','Sideroblast','CL-LBTEST','DBX-NCIT-C100418'),('CL-LBTEST-T-1017',NULL,'Sjogrens SS-A Antibody','A measurement of the Sjogrens SS-A antibody in a biological specimen.','\0','Ro Antibody; Sjogrens SS-A Antibody','CL-LBTEST','DBX-NCIT-C92236'),('CL-LBTEST-T-1018',NULL,'Sjogrens SS-B Antibody','A measurement of the Sjogrens SS-B antibody in a biological specimen.','\0','La Antibody; Sjogrens SS-B Antibody','CL-LBTEST','DBX-NCIT-C92237'),('CL-LBTEST-T-1019',NULL,'Smith Antibody','A measurement of the Smith antibody in a biological specimen.','\0','Smith Antibody','CL-LBTEST','DBX-NCIT-C92281'),('CL-LBTEST-T-102',NULL,'Antinuclear Antibodies','A measurement of the antinuclear antibodies (antibodies that attack the body\'s own tissue) in a biological specimen.','\0','Antinuclear Antibodies','CL-LBTEST','DBX-NCIT-C74916'),('CL-LBTEST-T-1020',NULL,'Smooth Muscle Antibody','A measurement of the smooth muscle antibody in a biological specimen.','\0','Anti-Smooth Muscle Antibody; Smooth Muscle Antibody','CL-LBTEST','DBX-NCIT-C111317'),('CL-LBTEST-T-1021',NULL,'Smudge Cells','A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.','\0','Basket Cells; Smudge Cells','CL-LBTEST','DBX-NCIT-C74627'),('CL-LBTEST-T-1022',NULL,'Sodium','A measurement of the sodium in a biological specimen.','\0','Sodium','CL-LBTEST','DBX-NCIT-C64809'),('CL-LBTEST-T-1023',NULL,'Sodium Clearance','A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Sodium Clearance','CL-LBTEST','DBX-NCIT-C106568'),('CL-LBTEST-T-1024',NULL,'Sodium Excretion Rate','A measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour).','\0','Sodium Excretion Rate','CL-LBTEST','DBX-NCIT-C117856'),('CL-LBTEST-T-1025',NULL,'Sodium/Creatinine','A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.','\0','Sodium/Creatinine','CL-LBTEST','DBX-NCIT-C79464'),('CL-LBTEST-T-1026',NULL,'Soluble Immunoglobulin','A measurement of the soluble total immunoglobulin in a biological specimen.','\0','Soluble Immunoglobulin','CL-LBTEST','DBX-NCIT-C117835'),('CL-LBTEST-T-1027',NULL,'Soluble Interleukin 2 Receptor Activity','A measurement of the soluble interleukin 2 receptor activity in a biological specimen.','\0','Soluble Interleukin 2 Receptor Activity','CL-LBTEST','DBX-NCIT-C102280'),('CL-LBTEST-T-1028',NULL,'Soluble Interleukin 6 Receptor','A measurement of the soluble interleukin 6 receptor in a biological specimen.','\0','Soluble Interleukin 6 Receptor','CL-LBTEST','DBX-NCIT-C117837'),('CL-LBTEST-T-1029',NULL,'Soluble Interleukin-1 Receptor Type I','A measurement of the soluble interleukin-1 receptor type I in a biological specimen.','\0','Soluble Interleukin-1 Receptor Type I','CL-LBTEST','DBX-NCIT-C117836'),('CL-LBTEST-T-103',NULL,'Antiphospholipid Antibodies','A measurement of the antiphospholipid antibodies in a biological specimen.','\0','Antiphospholipid Antibodies','CL-LBTEST','DBX-NCIT-C102258'),('CL-LBTEST-T-1030',NULL,'Soluble TNF Receptor Type I','A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen.','\0','Soluble TNF Receptor Type I','CL-LBTEST','DBX-NCIT-C117863'),('CL-LBTEST-T-1031',NULL,'Soluble TNF Receptor Type II','A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen.','\0','Soluble TNF Receptor Type II','CL-LBTEST','DBX-NCIT-C117864'),('CL-LBTEST-T-1032',NULL,'Soluble Transferrin Receptor','A measurement of the soluble transferrin receptor in a biological specimen.','\0','Soluble Transferrin Receptor','CL-LBTEST','DBX-NCIT-C100438'),('CL-LBTEST-T-1033',NULL,'Soluble Tumor Necrosis Factor Receptor','A measurement of the total soluble tumor necrosis factor receptor in a biological specimen.','\0','Soluble Tumor Necrosis Factor Receptor','CL-LBTEST','DBX-NCIT-C117749'),('CL-LBTEST-T-1034',NULL,'Soluble Vasc Cell Adhesion Molecule 1','A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.','\0','Soluble Vascular Cell Adhesion Molecule 1','CL-LBTEST','DBX-NCIT-C92533'),('CL-LBTEST-T-1035',NULL,'Somatotrophin','A measurement of the somatotrophin (growth) hormone in a biological specimen.','\0','Growth Hormone; Somatotrophin','CL-LBTEST','DBX-NCIT-C80360'),('CL-LBTEST-T-1036',NULL,'Sorbitol Dehydrogenase','A measurement of the sorbitol dehydrogenase in a biological specimen.','\0','Sorbitol Dehydrogenase','CL-LBTEST','DBX-NCIT-C79465'),('CL-LBTEST-T-1037',NULL,'Specific Gravity','A ratio of the density of a fluid to the density of water.','\0','Specific Gravity','CL-LBTEST','DBX-NCIT-C64832'),('CL-LBTEST-T-1038',NULL,'Specimen Appearance','The outward or visible aspect of a specimen.','\0','Specimen Appearance','CL-LBTEST','DBX-NCIT-C25377'),('CL-LBTEST-T-1039',NULL,'Specimen Weight','A measurement of the weight of a biological specimen.','\0','Specimen Weight','CL-LBTEST','DBX-NCIT-C106569'),('CL-LBTEST-T-104',NULL,'Antithrombin','A measurement of the antithrombin activity in a biological specimen.','\0','Antithrombin; Antithrombin Activity; Antithrombin III; Antithrombin III Activity','CL-LBTEST','DBX-NCIT-C81958'),('CL-LBTEST-T-1040',NULL,'Sperm Motility','A measurement of the sperm capable of forward, progressive movement in a semen specimen.','\0','Sperm Motility','CL-LBTEST','DBX-NCIT-C102281'),('CL-LBTEST-T-1041',NULL,'Spermatozoa','A measurement of the spermatozoa cells present in a biological specimen.','\0','Spermatozoa','CL-LBTEST','DBX-NCIT-C74663'),('CL-LBTEST-T-1042',NULL,'Spherocytes','A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.','\0','Spherocytes','CL-LBTEST','DBX-NCIT-C74707'),('CL-LBTEST-T-1043',NULL,'Squamous Epithelial Cells','A measurement of the squamous epithelial cells present in a biological specimen.','\0','Squamous Epithelial Cells','CL-LBTEST','DBX-NCIT-C74773'),('CL-LBTEST-T-1044',NULL,'Squamous Transitional Epithelial Cells','A measurement of the squamous transitional epithelial cells present in a biological specimen.','\0','Epithelial Cells; Squamous Transitional Epithelial Cells','CL-LBTEST','DBX-NCIT-C74774'),('CL-LBTEST-T-1045',NULL,'Starch Crystals','A measurement of the starch crystals in a biological specimen.','\0','Starch Crystals','CL-LBTEST','DBX-NCIT-C81951'),('CL-LBTEST-T-1046',NULL,'Stem Cell Factor','A measurement of the stem cell factor in a biological specimen.','\0','KIT Ligand; Stem Cell Factor','CL-LBTEST','DBX-NCIT-C82035'),('CL-LBTEST-T-1047',NULL,'Stomatocytes','A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.','\0','Stomatocytes','CL-LBTEST','DBX-NCIT-C74708'),('CL-LBTEST-T-1048',NULL,'Streptolysin O Antibody','A measurement of Streptolysin O Antibody in a biological specimen.','\0','Antistreptolysin O; Streptolysin O Antibody','CL-LBTEST','DBX-NCIT-C92282'),('CL-LBTEST-T-1049',NULL,'Strongyloides IgG Antibody','A measurement of strongyloides IgG antibody in a biological specimen.','\0','Strongyloides IgG Antibody','CL-LBTEST','DBX-NCIT-C117858'),('CL-LBTEST-T-105',NULL,'Antithrombin Antigen','A measurement of the antithrombin antigen in a biological specimen.','\0','Antithrombin Antigen; Antithrombin III Antigen','CL-LBTEST','DBX-NCIT-C81977'),('CL-LBTEST-T-1050',NULL,'Sulfa Crystals','A measurement of the sulfa crystals present in a biological specimen.','\0','Sulfa Crystals','CL-LBTEST','DBX-NCIT-C74755'),('CL-LBTEST-T-1051',NULL,'Sulfur Dioxide','A measurement of the sulfur dioxide in a biological specimen.','\0','Sulfur Dioxide','CL-LBTEST','DBX-NCIT-C114224'),('CL-LBTEST-T-1052',NULL,'Surfactant Protein D','A measurement of the surfactant protein D in a biological specimen.','\0','SP-D; Surfactant Protein D','CL-LBTEST','DBX-NCIT-C111322'),('CL-LBTEST-T-1053',NULL,'Target Cells','A measurement of the target cells in a biological specimen.','\0','Codocytes; Leptocytes; Mexican Hat Cells; Target Cells','CL-LBTEST','DBX-NCIT-C96636'),('CL-LBTEST-T-1054',NULL,'Tartrate-Resistant Acid Phosphatase 5b','A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen.','\0','TRAP5B; Tartrate-Resistant Acid Phosphatase 5b','CL-LBTEST','DBX-NCIT-C117865'),('CL-LBTEST-T-1055',NULL,'Tau Protein','A measurement of the total Tau protein in a biological specimen.','\0','Tau Protein; Total Tau Protein','CL-LBTEST','DBX-NCIT-C84810'),('CL-LBTEST-T-1056',NULL,'Terminal Deoxynucleotidyl Transferase Ag','A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen.','\0','Terminal Deoxynucleotidyl Transferase Ag; Terminal Deoxynucleotidyl Transferase Antigen','CL-LBTEST','DBX-NCIT-C117859'),('CL-LBTEST-T-1057',NULL,'Testosterone','A measurement of the total (free and bound) testosterone in a biological specimen.','\0','Testosterone; Total Testosterone','CL-LBTEST','DBX-NCIT-C74793'),('CL-LBTEST-T-1058',NULL,'Testosterone, Free','A measurement of the free testosterone in a biological specimen.','\0','Testosterone, Free','CL-LBTEST','DBX-NCIT-C74785'),('CL-LBTEST-T-1059',NULL,'Theophylline','A measurement of the Theophylline present in a biological specimen.','\0','Theophylline','CL-LBTEST','DBX-NCIT-C105445'),('CL-LBTEST-T-106',NULL,'Apolipoprotein A1','A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.','\0','Apolipoprotein A1','CL-LBTEST','DBX-NCIT-C74733'),('CL-LBTEST-T-1060',NULL,'Thiamine','A measurement of the thiamine in a biological specimen.','\0','Thiamine; Vitamin B1','CL-LBTEST','DBX-NCIT-C74896'),('CL-LBTEST-T-1061',NULL,'Thrombin Time','A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)','\0','Thrombin Time','CL-LBTEST','DBX-NCIT-C80365'),('CL-LBTEST-T-1062',NULL,'Thrombin/Antithrombin','A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample.','\0','Thrombin/Antithrombin; Thrombin/Antithrombin III','CL-LBTEST','DBX-NCIT-C106574'),('CL-LBTEST-T-1063',NULL,'Thrombocytes','A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates.','\0','Nucleated Thrombocytes; Thrombocytes','CL-LBTEST','DBX-NCIT-C111283'),('CL-LBTEST-T-1064',NULL,'Thrombopoietin','A measurement of the thrombopoietin hormone in a biological specimen.','\0','Thrombopoietin','CL-LBTEST','DBX-NCIT-C74873'),('CL-LBTEST-T-1065',NULL,'Thromboxane B2','A measurement of the thromboxane B2 in a biological specimen.','\0','Thromboxane B2','CL-LBTEST','DBX-NCIT-C103445'),('CL-LBTEST-T-1066',NULL,'Thyroglobulin','A measurement of the thyroglobulin in a biological specimen.','\0','TG; Thyroglobulin','CL-LBTEST','DBX-NCIT-C103446'),('CL-LBTEST-T-1067',NULL,'Thyroid Antibodies','A measurement of the thyroid antibodies in a biological specimen.','\0','Thyroid Antibodies','CL-LBTEST','DBX-NCIT-C81990'),('CL-LBTEST-T-1068',NULL,'Thyroid Antimicrosomal Antibodies','A measurement of the thyroid antimicrosomal antibodies in a biological specimen.','\0','Thyroid Antimicrosomal Antibodies','CL-LBTEST','DBX-NCIT-C81991'),('CL-LBTEST-T-1069',NULL,'Thyroid Antithyroglobulin Antibodies','A measurement of the thyroid antithyroglobulin antibodies in a biological specimen.','\0','Thyroid Antithyroglobulin Antibodies','CL-LBTEST','DBX-NCIT-C81992'),('CL-LBTEST-T-107',NULL,'Apolipoprotein A4','A measurement of the apolipoprotein A4 in a biological specimen.','\0','Apolipoprotein A4','CL-LBTEST','DBX-NCIT-C103354'),('CL-LBTEST-T-1070',NULL,'Thyroperoxidase','A measurement of the thyroperoxidase in a biological specimen.','\0','Thyroid Peroxidase; Thyroperoxidase','CL-LBTEST','DBX-NCIT-C96639'),('CL-LBTEST-T-1071',NULL,'Thyroperoxidase Antibody','A measurement of the thyroperoxidase antibody in a biological specimen.','\0','Thyroperoxidase Antibody','CL-LBTEST','DBX-NCIT-C96638'),('CL-LBTEST-T-1072',NULL,'Thyrotropin','A measurement of the thyrotropin in a biological specimen.','\0','Thyroid Stimulating Hormone; Thyrotropin','CL-LBTEST','DBX-NCIT-C64813'),('CL-LBTEST-T-1073',NULL,'Thyrotropin Releasing Hormone','A measurement of the thyrotropin releasing hormone in a biological specimen.','\0','Thyrotropin Releasing Factor; Thyrotropin Releasing Hormone','CL-LBTEST','DBX-NCIT-C74874'),('CL-LBTEST-T-1074',NULL,'Thyroxine','A measurement of the total (free and bound) thyroxine in a biological specimen.','\0','Thyroxine; Total T4','CL-LBTEST','DBX-NCIT-C74794'),('CL-LBTEST-T-1075',NULL,'Thyroxine Binding Globulin','A measurement of the thyroxine binding globulin protein in a biological specimen.','\0','Thyroxine Binding Globulin','CL-LBTEST','DBX-NCIT-C74746'),('CL-LBTEST-T-1076',NULL,'Thyroxine, Free','A measurement of the free thyroxine in a biological specimen.','\0','Free T4; Thyroxine, Free','CL-LBTEST','DBX-NCIT-C74786'),('CL-LBTEST-T-1077',NULL,'TIMP1/Creatinine','A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample.','\0','TIMP1/Creatinine; Tissue Inhibitor of Metalloproteinase 1/Creatinine','CL-LBTEST','DBX-NCIT-C106575'),('CL-LBTEST-T-1078',NULL,'Tissue Inhibitor of Metalloproteinase 1','A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.','\0','Tissue Inhibitor of Metalloproteinase 1','CL-LBTEST','DBX-NCIT-C82036'),('CL-LBTEST-T-1079',NULL,'Tissue Plasminogen Activator Antigen','A measurement of the tissue plasminogen activator antigen in a biological specimen.','\0','Tissue Plasminogen Activator Antigen','CL-LBTEST','DBX-NCIT-C81993'),('CL-LBTEST-T-108',NULL,'Apolipoprotein A5','A measurement of the apolipoprotein A5 in a biological specimen.','\0','Apolipoprotein A5','CL-LBTEST','DBX-NCIT-C103355'),('CL-LBTEST-T-1080',NULL,'TNF-a Production Inhibitory Activity','A measurement of TNF-a production inhibitory activity in a biological specimen.','\0','TNF-a Production Inhibitory Activity','CL-LBTEST','DBX-NCIT-C117862'),('CL-LBTEST-T-1081',NULL,'Total Iron Binding Capacity','A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.','\0','Total Iron Binding Capacity','CL-LBTEST','DBX-NCIT-C74718'),('CL-LBTEST-T-1082',NULL,'Total Radical-Trap Antioxidant Potential','A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.','\0','Total Radical-Trap Antioxidant Potential','CL-LBTEST','DBX-NCIT-C80208'),('CL-LBTEST-T-1083',NULL,'Toxic Granulation','A measurement of the toxic granulation in neutrophilic blood cells.','\0','Toxic Granulation','CL-LBTEST','DBX-NCIT-C96641'),('CL-LBTEST-T-1084',NULL,'Transferrin','A measurement of the transferrin in a biological specimen.','\0','Transferrin','CL-LBTEST','DBX-NCIT-C82037'),('CL-LBTEST-T-1085',NULL,'Transferrin Saturation','A measurement of the iron bound to transferrin in a biological specimen.','\0','Iron Binding Capacity Saturation; Iron Saturation; Iron Saturation Percent; Serum Iron to TIBC Ratio; Transferrin Iron Saturation; Transferrin Saturation','CL-LBTEST','DBX-NCIT-C98792'),('CL-LBTEST-T-1086',NULL,'Transforming Growth Factor Beta 1','A measurement of the transforming growth factor beta 1 in a biological specimen.','\0','Transforming Growth Factor Beta 1','CL-LBTEST','DBX-NCIT-C117861'),('CL-LBTEST-T-1087',NULL,'Transitional Epithelial Cells','A measurement of the transitional epithelial cells present in a biological specimen.','\0','Transitional Epithelial Cells','CL-LBTEST','DBX-NCIT-C92251'),('CL-LBTEST-T-1088',NULL,'Trichomonas','Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.','\0','Trichomonas','CL-LBTEST','DBX-NCIT-C92238'),('CL-LBTEST-T-1089',NULL,'Tricyclic Antidepressants','A measurement of tricyclic antidepressants in a biological specimen.','\0','Tricyclic Antidepressants','CL-LBTEST','DBX-NCIT-C100420'),('CL-LBTEST-T-109',NULL,'Apolipoprotein AII','A measurement of the apolipoprotein AII in a biological specimen.','\0','Apolipoprotein AII','CL-LBTEST','DBX-NCIT-C82000'),('CL-LBTEST-T-1090',NULL,'Triglycerides','A measurement of the triglycerides in a biological specimen.','\0','Triglycerides','CL-LBTEST','DBX-NCIT-C64812'),('CL-LBTEST-T-1091',NULL,'Triiodothyronine','A measurement of the total (free and bound) triiodothyronine in a biological specimen.','\0','Total T3; Triiodothyronine','CL-LBTEST','DBX-NCIT-C74747'),('CL-LBTEST-T-1092',NULL,'Triiodothyronine Uptake','A measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.','\0','Triiodothyronine Uptake','CL-LBTEST','DBX-NCIT-C74748'),('CL-LBTEST-T-1093',NULL,'Triiodothyronine, Free','A measurement of the free triiodothyronine in a biological specimen.','\0','Free T3; Triiodothyronine, Free','CL-LBTEST','DBX-NCIT-C74787'),('CL-LBTEST-T-1094',NULL,'Triiodothyronine, Reverse','A measurement of the reverse triiodothyronine in a biological specimen.','\0','Triiodothyronine, Reverse','CL-LBTEST','DBX-NCIT-C81968'),('CL-LBTEST-T-1095',NULL,'Triple Phosphate Crystals','A measurement of the triple phosphate crystals present in a biological specimen.','\0','Triple Phosphate Crystals','CL-LBTEST','DBX-NCIT-C74756'),('CL-LBTEST-T-1096',NULL,'Troponin','A measurement of the total troponin in a biological specimen.','\0','Troponin','CL-LBTEST','DBX-NCIT-C111327'),('CL-LBTEST-T-1097',NULL,'Troponin I','A measurement of the actin binding troponin in a biological specimen.','\0','Troponin I','CL-LBTEST','DBX-NCIT-C74749'),('CL-LBTEST-T-1098',NULL,'Troponin T','A measurement of the tropomyosin binding troponin in a biological specimen.','\0','Troponin T','CL-LBTEST','DBX-NCIT-C74750'),('CL-LBTEST-T-1099',NULL,'Tryptase','A measurement of the tryptase in a biological specimen.','\0','Tryptase','CL-LBTEST','DBX-NCIT-C92292'),('CL-LBTEST-T-11',NULL,'A Proliferation-Inducing Ligand','A measurement of the a proliferation-inducing ligand in a biological specimen.','\0','A Proliferation-Inducing Ligand; CD256; TNFSF13; Tumor Necrosis Factor Ligand Superfamily Member 13','CL-LBTEST','DBX-NCIT-C111123'),('CL-LBTEST-T-110',NULL,'Apolipoprotein B','A measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.','\0','Apolipoprotein B','CL-LBTEST','DBX-NCIT-C74734'),('CL-LBTEST-T-1100',NULL,'Tubular Epithelial Cells','A measurement of the tubular epithelial cells present in a biological specimen.','\0','Renal Tubular Epithelial Cells; Tubular Epithelial Cells','CL-LBTEST','DBX-NCIT-C74775'),('CL-LBTEST-T-1101',NULL,'Tumor Necrosis Factor','A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.','\0','Tumor Necrosis Factor; Tumor Necrosis Factor alpha','CL-LBTEST','DBX-NCIT-C74751'),('CL-LBTEST-T-1102',NULL,'Turbidity','A measurement of the opacity of a biological specimen.','\0','Turbidity','CL-LBTEST','DBX-NCIT-C74723'),('CL-LBTEST-T-1103',NULL,'Type I Collagen C-Telopeptides','A measurement of the type I collagen C-telopeptides in a biological specimen.','\0','Type I Collagen C-Telopeptides; Type I Collagen X-linked C-telopeptide','CL-LBTEST','DBX-NCIT-C82038'),('CL-LBTEST-T-1104',NULL,'Type I Collagen N-Telopeptides','A measurement of the type I collagen N-telopeptides in a biological specimen.','\0','Type I Collagen N-Telopeptides','CL-LBTEST','DBX-NCIT-C82039'),('CL-LBTEST-T-1105',NULL,'Type I Myeloblasts','A measurement of type I myeloblast cells per unit of a biological specimen.','\0','Type I Myeloblasts','CL-LBTEST','DBX-NCIT-C92283'),('CL-LBTEST-T-1106',NULL,'Type II Collagen C-Telopeptides','A measurement of the type II collagen C-telopeptides in a biological specimen.','\0','Type II Collagen C-Telopeptides','CL-LBTEST','DBX-NCIT-C82040'),('CL-LBTEST-T-1107',NULL,'Type II Collagen N-Telopeptides','A measurement of the type II collagen N-telopeptides in a biological specimen.','\0','Type II Collagen N-Telopeptides','CL-LBTEST','DBX-NCIT-C82041'),('CL-LBTEST-T-1108',NULL,'Type II Myeloblasts','A measurement of type II myeloblast cells per unit of a biological specimen.','\0','Type II Myeloblasts','CL-LBTEST','DBX-NCIT-C92284'),('CL-LBTEST-T-1109',NULL,'Type III Myeloblasts','A measurement of type III myeloblast cells per unit of a biological specimen.','\0','Type III Myeloblasts','CL-LBTEST','DBX-NCIT-C92285'),('CL-LBTEST-T-111',NULL,'Apolipoprotein B/Apolipoprotein A1','A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen.','\0','Apolipoprotein B/Apolipoprotein A1','CL-LBTEST','DBX-NCIT-C103356'),('CL-LBTEST-T-1110',NULL,'Tyrosine Crystals','A measurement of the tyrosine crystals present in a biological specimen.','\0','Tyrosine Crystals','CL-LBTEST','DBX-NCIT-C74683'),('CL-LBTEST-T-1111',NULL,'Unclassified Casts','A measurement of the unclassifiable casts present in a biological specimen.','\0','Unclassified Casts','CL-LBTEST','DBX-NCIT-C74776'),('CL-LBTEST-T-1112',NULL,'Unclassified Crystals','A measurement of the unclassifiable crystals present in a biological specimen.','\0','Unclassified Crystals','CL-LBTEST','DBX-NCIT-C74757'),('CL-LBTEST-T-1113',NULL,'Unsaturated Iron Binding Capacity','A measurement of the binding capacity of unsaturated iron in a biological specimen.','\0','Unsaturated Iron Binding Capacity','CL-LBTEST','DBX-NCIT-C74719'),('CL-LBTEST-T-1114',NULL,'Unspecified Cells','A measurement of the cells not otherwise identified or specified in a biological specimen.','\0','Unspecified Cells','CL-LBTEST','DBX-NCIT-C112241'),('CL-LBTEST-T-1115',NULL,'Unspecified Cells/Total Cells','A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen.','\0','Unspecified Cells/Total Cells','CL-LBTEST','DBX-NCIT-C114225'),('CL-LBTEST-T-1116',NULL,'Urate','A measurement of the urate in a biological specimen.','\0','Urate; Uric Acid','CL-LBTEST','DBX-NCIT-C64814'),('CL-LBTEST-T-1117',NULL,'Urate/Creatinine','A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen.','\0','Urate/Creatinine','CL-LBTEST','DBX-NCIT-C117866'),('CL-LBTEST-T-1118',NULL,'Urea','A measurement of the urea in a biological specimen.','\0','Urea','CL-LBTEST','DBX-NCIT-C64815'),('CL-LBTEST-T-1119',NULL,'Urea/Creatinine','A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.','\0','Urea/Creatinine','CL-LBTEST','DBX-NCIT-C96645'),('CL-LBTEST-T-112',NULL,'Apolipoprotein C2','A measurement of the apolipoprotein C2 in a biological specimen.','\0','Apolipoprotein C2; Apolipoprotein CII','CL-LBTEST','DBX-NCIT-C100427'),('CL-LBTEST-T-1120',NULL,'Uric Acid Crystals','A measurement of the uric acid crystals present in a biological specimen.','\0','Uric Acid Crystals','CL-LBTEST','DBX-NCIT-C74684'),('CL-LBTEST-T-1121',NULL,'Urine Conductivity','A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine.','\0','Urine Conductivity','CL-LBTEST','DBX-NCIT-C102282'),('CL-LBTEST-T-1122',NULL,'Urobilinogen','A measurement of the urobilinogen in a biological specimen.','\0','Urobilinogen','CL-LBTEST','DBX-NCIT-C64816'),('CL-LBTEST-T-1123',NULL,'Vacuolated Lymphocytes','A measurement of the vacuolated lymphocytes in a biological specimen.','\0','Vacuolated Lymphocytes','CL-LBTEST','DBX-NCIT-C111329'),('CL-LBTEST-T-1124',NULL,'Vacuolated Neutrophils','A measurement of the neutrophils containing small vacuoles in a biological specimen.','\0','Vacuolated Neutrophils','CL-LBTEST','DBX-NCIT-C74628'),('CL-LBTEST-T-1125',NULL,'Vanillyl Mandelic Acid','A measurement of the vanillyl mandelic acid metabolite in a biological specimen.','\0','Vanillyl Mandelic Acid; Vanilmandelic Acid','CL-LBTEST','DBX-NCIT-C74875'),('CL-LBTEST-T-1126',NULL,'Varicella Zoster Virus Antibody','A measurement of the total varicella zoster virus antibody in a biological specimen.','\0','Varicella Zoster Virus Antibody','CL-LBTEST','DBX-NCIT-C117867'),('CL-LBTEST-T-1127',NULL,'Varicella Zoster Virus IgA Antibody','A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.','\0','Varicella Zoster Virus IgA Antibody','CL-LBTEST','DBX-NCIT-C98795'),('CL-LBTEST-T-1128',NULL,'Varicella Zoster Virus IgG Antibody','A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.','\0','Varicella Zoster Virus IgG Antibody','CL-LBTEST','DBX-NCIT-C98796'),('CL-LBTEST-T-1129',NULL,'Varicella Zoster Virus IgM Antibody','A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.','\0','Varicella Zoster Virus IgM Antibody','CL-LBTEST','DBX-NCIT-C98797'),('CL-LBTEST-T-113',NULL,'Apolipoprotein CIII','A measurement of the apolipoprotein CIII in a biological specimen.','\0','Apolipoprotein CIII','CL-LBTEST','DBX-NCIT-C82001'),('CL-LBTEST-T-1130',NULL,'Vascular Cell Adhesion Molecule 1','A measurement of the vascular cell adhesion molecule 1 in a biological specimen.','\0','Vascular Cell Adhesion Molecule 1','CL-LBTEST','DBX-NCIT-C82042'),('CL-LBTEST-T-1131',NULL,'Vascular Endothelial Growth Factor','A measurement of the vascular endothelial growth factor in a biological specimen.','\0','Vascular Endothelial Growth Factor','CL-LBTEST','DBX-NCIT-C92514'),('CL-LBTEST-T-1132',NULL,'Viscosity','The resistance of a liquid to sheer forces and flow. (NCI)','\0','Viscosity','CL-LBTEST','DBX-NCIT-C75912'),('CL-LBTEST-T-1133',NULL,'Vitamin A','A measurement of the Vitamin A in a biological specimen.','\0','Retinol; Vitamin A','CL-LBTEST','DBX-NCIT-C74895'),('CL-LBTEST-T-1134',NULL,'Vitamin B12','A measurement of the Vitamin B12 in a serum specimen.','\0','Vitamin B12','CL-LBTEST','DBX-NCIT-C64817'),('CL-LBTEST-T-1135',NULL,'Vitamin B17','A measurement of the Vitamin B17 in a biological specimen.','\0','Amygdalin; Vitamin B17','CL-LBTEST','DBX-NCIT-C74897'),('CL-LBTEST-T-1136',NULL,'Vitamin B5','A measurement of the Vitamin B5 in a biological specimen.','\0','Pantothenic Acid; Vitamin B5','CL-LBTEST','DBX-NCIT-C74900'),('CL-LBTEST-T-1137',NULL,'Vitamin B6','A measurement of the Vitamin B6 in a biological specimen.','\0','Pyridoxine; Vitamin B6','CL-LBTEST','DBX-NCIT-C74901'),('CL-LBTEST-T-1138',NULL,'Vitamin B7','A measurement of the Vitamin B7 in a biological specimen.','\0','Biotin; Vitamin B7','CL-LBTEST','DBX-NCIT-C74902'),('CL-LBTEST-T-1139',NULL,'Vitamin B9','A measurement of the folic acid in a biological specimen.','\0','Folic Acid; Vitamin B9','CL-LBTEST','DBX-NCIT-C74676'),('CL-LBTEST-T-114',NULL,'Apolipoprotein E','A measurement of the apolipoprotein E in a biological specimen.','\0','Apolipoprotein E','CL-LBTEST','DBX-NCIT-C82002'),('CL-LBTEST-T-1140',NULL,'Vitamin C','A measurement of the Vitamin C in a biological specimen.','\0','Ascorbic Acid; Vitamin C','CL-LBTEST','DBX-NCIT-C74903'),('CL-LBTEST-T-1141',NULL,'Vitamin D','A measurement of the total Vitamin D in a biological specimen.','\0','Total Vitamin D; Vitamin D','CL-LBTEST','DBX-NCIT-C84818'),('CL-LBTEST-T-1142',NULL,'Vitamin D2','A measurement of the Vitamin D2 in a biological specimen.','\0','Ergocalciferol; Vitamin D2','CL-LBTEST','DBX-NCIT-C74904'),('CL-LBTEST-T-1143',NULL,'Vitamin D3','A measurement of the Vitamin D3 in a biological specimen.','\0','Cholecalciferol; Vitamin D3','CL-LBTEST','DBX-NCIT-C74905'),('CL-LBTEST-T-1144',NULL,'Vitamin E','A measurement of the Vitamin E in a biological specimen.','\0','Vitamin E','CL-LBTEST','DBX-NCIT-C74906'),('CL-LBTEST-T-1145',NULL,'Vitamin E/Cholesterol','A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen.','\0','Vitamin E/Cholesterol','CL-LBTEST','DBX-NCIT-C103448'),('CL-LBTEST-T-1146',NULL,'Vitamin K','A measurement of the total Vitamin K in a biological specimen.','\0','Naphthoquinone; Vitamin K','CL-LBTEST','DBX-NCIT-C74907'),('CL-LBTEST-T-1147',NULL,'Vitamin K1','A measurement of the Vitamin K1 in a biological specimen.','\0','Phylloquinone; Phytomenadione','CL-LBTEST','DBX-NCIT-C103449'),('CL-LBTEST-T-1148',NULL,'VLDL Cholesterol','A measurement of the very low density lipoprotein cholesterol in a biological specimen.','\0','VLDL Cholesterol','CL-LBTEST','DBX-NCIT-C105589'),('CL-LBTEST-T-1149',NULL,'VLDL Particle Size','A measurement of the average particle size of very-low-density lipoprotein in a biological specimen.','\0','VLDL Particle Size','CL-LBTEST','DBX-NCIT-C103450'),('CL-LBTEST-T-115',NULL,'Apolipoprotein E4','A measurement of the apolipoprotein E4 in a biological specimen.','\0','Apolipoprotein E4','CL-LBTEST','DBX-NCIT-C92293'),('CL-LBTEST-T-1150',NULL,'Volume','A measurement of the volume of a biological specimen.','\0','Volume','CL-LBTEST','DBX-NCIT-C74720'),('CL-LBTEST-T-1151',NULL,'von Willebrand Factor','A measurement of the von Willebrand factor in a biological specimen.','\0','von Willebrand Factor; von Willebrand Factor Antigen','CL-LBTEST','DBX-NCIT-C98799'),('CL-LBTEST-T-1152',NULL,'Waxy Casts','A measurement of the waxy casts present in a biological specimen.','\0','Waxy Casts','CL-LBTEST','DBX-NCIT-C74777'),('CL-LBTEST-T-1153',NULL,'WBC Casts','A measurement of the white blood cell casts present in a biological specimen.','\0','WBC Casts','CL-LBTEST','DBX-NCIT-C74778'),('CL-LBTEST-T-1154',NULL,'Yeast Budding','Examination of a biological specimen to detect the presence of any yeast cells that are in the budding phase of asexual reproduction.','\0','Budding Yeast; Yeast Budding','CL-LBTEST','DBX-NCIT-C106504'),('CL-LBTEST-T-1155',NULL,'Yeast Cells','A measurement of the yeast cells present in a biological specimen.','\0','Yeast Cells','CL-LBTEST','DBX-NCIT-C74664'),('CL-LBTEST-T-1156',NULL,'Yeast Hyphae','Examination of a biological specimen to detect the presence of any yeast cells that are in the long, filamentous and branching phase of growth.','\0','Yeast Hyphae','CL-LBTEST','DBX-NCIT-C92239'),('CL-LBTEST-T-1157',NULL,'Zinc','A measurement of the zinc in a biological specimen.','\0','Zinc','CL-LBTEST','DBX-NCIT-C80210'),('CL-LBTEST-T-116',NULL,'Apolipoprotein H','A measurement of the apolipoprotein H in a biological specimen.','\0','Apolipoprotein H','CL-LBTEST','DBX-NCIT-C82003'),('CL-LBTEST-T-117',NULL,'Apolipoprotein J','A measurement of the apolipoprotein J in a biological specimen.','\0','Apolipoprotein J; Clusterin','CL-LBTEST','DBX-NCIT-C100428'),('CL-LBTEST-T-118',NULL,'Apolipoprotein J/Creatinine','A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen.','\0','Apolipoprotein J/Creatinine; Clusterin/Creatinine','CL-LBTEST','DBX-NCIT-C111130'),('CL-LBTEST-T-119',NULL,'Arachidonic Acid','A measurement of the arachidonic acid present in a biological specimen.','\0','Arachidonic Acid','CL-LBTEST','DBX-NCIT-C102259'),('CL-LBTEST-T-12',NULL,'Abnormal Cells','A measurement of the abnormal cells in a biological specimen.','\0','Abnormal Cells','CL-LBTEST','DBX-NCIT-C111124'),('CL-LBTEST-T-120',NULL,'Aspartate Aminotransferase','A measurement of the aspartate aminotransferase in a biological specimen.','\0','Aspartate Aminotransferase; SGOT','CL-LBTEST','DBX-NCIT-C64467'),('CL-LBTEST-T-121',NULL,'Aspartate Aminotransferase Antigen','A measurement of the aspartate aminotransferase antigen in a biological specimen.','\0','Aspartate Aminotransferase Antigen; SGOT Antigen','CL-LBTEST','DBX-NCIT-C81978'),('CL-LBTEST-T-122',NULL,'Aspartate Aminotransferase/Creatinine','A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen.','\0','Aspartate Aminotransferase/Creatinine','CL-LBTEST','DBX-NCIT-C117830'),('CL-LBTEST-T-123',NULL,'Atrial Natriuretic Peptide','A measurement of the atrial natriuretic peptide in a biological specimen.','\0','Atrial Natriuretic Peptide; Atriopeptin','CL-LBTEST','DBX-NCIT-C74886'),('CL-LBTEST-T-124',NULL,'Auer Rods','A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.','\0','Auer Rods','CL-LBTEST','DBX-NCIT-C74657'),('CL-LBTEST-T-125',NULL,'Azurophilic Granules','An observation of azurophilic granules in a biological specimen.','\0','Azurophilic Granulation; Azurophilic Granules','CL-LBTEST','DBX-NCIT-C116185'),('CL-LBTEST-T-126',NULL,'B-Cell Activating Factor','A measurement of the B-cell activating factor in a biological specimen.','\0','B-Cell Activating Factor','CL-LBTEST','DBX-NCIT-C111135'),('CL-LBTEST-T-127',NULL,'Bacteria','A measurement of the bacteria in a biological specimen.','\0','Bacteria','CL-LBTEST','DBX-NCIT-C64469'),('CL-LBTEST-T-128',NULL,'Bacterial Casts','A measurement of the bacterial casts present in a biological specimen.','\0','Bacterial Casts','CL-LBTEST','DBX-NCIT-C74762'),('CL-LBTEST-T-129',NULL,'Barbiturates','A measurement of any barbiturate class drug present in a biological specimen.','\0','Barbiturates','CL-LBTEST','DBX-NCIT-C74688'),('CL-LBTEST-T-13',NULL,'Acanthocytes','A measurement of the acanthocytes in a biological specimen.','\0','Acanthocytes','CL-LBTEST','DBX-NCIT-C74699'),('CL-LBTEST-T-130',NULL,'Basophilic Stippling','A measurement of the basophilic stippling in a biological specimen.','\0','Basophilic Stippling','CL-LBTEST','DBX-NCIT-C96567'),('CL-LBTEST-T-131',NULL,'Basophils','A measurement of the basophils in a biological specimen.','\0','Basophils','CL-LBTEST','DBX-NCIT-C64470'),('CL-LBTEST-T-132',NULL,'Basophils/Leukocytes','A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.','\0','Basophils/Leukocytes','CL-LBTEST','DBX-NCIT-C64471'),('CL-LBTEST-T-133',NULL,'Basophils/Total Cells','A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Basophils/Total Cells','CL-LBTEST','DBX-NCIT-C98865'),('CL-LBTEST-T-134',NULL,'Bence-Jones Protein','A measurement of the total Bence-Jones protein in a biological specimen.','\0','Bence-Jones Protein; Immunoglobulin Light Chains','CL-LBTEST','DBX-NCIT-C111136'),('CL-LBTEST-T-135',NULL,'Benzodiazepine','A measurement of any benzodiazepine class drug present in a biological specimen.','\0','Benzodiazepine','CL-LBTEST','DBX-NCIT-C74692'),('CL-LBTEST-T-136',NULL,'Benzoylecgonine','A measurement of the benzoylecgonine in a biological specimen.','\0','Benzoylecgonine; Cocaine Metabolite','CL-LBTEST','DBX-NCIT-C75350'),('CL-LBTEST-T-137',NULL,'Beta Carotene','A measurement of the beta carotene in a biological specimen.','\0','Beta Carotene; Beta Carotin; b-Carotene','CL-LBTEST','DBX-NCIT-C100472'),('CL-LBTEST-T-138',NULL,'Beta Catenin','A measurement of the beta catenin in a biological specimen.','\0','Beta Catenin','CL-LBTEST','DBX-NCIT-C103357'),('CL-LBTEST-T-139',NULL,'Beta Globulin','A measurement of the proteins contributing to the beta fraction in a biological specimen.','\0','Beta Globulin','CL-LBTEST','DBX-NCIT-C92256'),('CL-LBTEST-T-14',NULL,'Acanthocytes/Erythrocytes','A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.','\0','Acanthocytes/Erythrocytes','CL-LBTEST','DBX-NCIT-C74633'),('CL-LBTEST-T-140',NULL,'Beta Globulin/Total Protein','A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.','\0','Beta Globulin/Total Protein','CL-LBTEST','DBX-NCIT-C92294'),('CL-LBTEST-T-141',NULL,'Beta-2 Glycoprotein 1 IgG Antibody','A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen.','\0','Beta-2 Glycoprotein 1 IgG Antibody','CL-LBTEST','DBX-NCIT-C103358'),('CL-LBTEST-T-142',NULL,'Beta-2 Glycoprotein 1 IgM Antibody','A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen.','\0','Beta-2 Glycoprotein 1 IgM Antibody','CL-LBTEST','DBX-NCIT-C103359'),('CL-LBTEST-T-143',NULL,'Beta-2 Glycoprotein Antibody','A measurement of the beta-2 glycoprotein antibody in a biological specimen.','\0','Beta-2 Glycoprotein Antibody','CL-LBTEST','DBX-NCIT-C81979'),('CL-LBTEST-T-144',NULL,'Beta-2 Microglobulin','A measurement of the beta-2 microglobulin in a biological specimen.','\0','Beta-2 Microglobulin','CL-LBTEST','DBX-NCIT-C81980'),('CL-LBTEST-T-145',NULL,'Beta-Hydroxybutyrate','A measurement of the total Beta-hydroxybutyrate in a biological specimen.','\0','3-Hydroxybutyrate; B-Hydroxybutyrate; Beta-Hydroxybutyrate','CL-LBTEST','DBX-NCIT-C96568'),('CL-LBTEST-T-146',NULL,'Beta-Trace Protein','A measurement of the beta-trace protein in a biological specimen.','\0','Beta-Trace Protein','CL-LBTEST','DBX-NCIT-C100426'),('CL-LBTEST-T-147',NULL,'Bicarbonate','A measurement of the bicarbonate in a biological specimen.','\0','Bicarbonate; HCO3','CL-LBTEST','DBX-NCIT-C74667'),('CL-LBTEST-T-148',NULL,'Bile Acid','A measurement of the total bile acids in a biological specimen.','\0','Bile Acid; Bile Acids; Bile Salt; Bile Salts','CL-LBTEST','DBX-NCIT-C74800'),('CL-LBTEST-T-149',NULL,'Bilirubin','A measurement of the total bilirubin in a biological specimen.','\0','Bilirubin; Total Bilirubin','CL-LBTEST','DBX-NCIT-C38037'),('CL-LBTEST-T-15',NULL,'Acetoacetic Acid','A measurement of the acetoacetic acid in a biological specimen.','\0','Acetoacetate; Acetoacetic Acid','CL-LBTEST','DBX-NCIT-C92247'),('CL-LBTEST-T-150',NULL,'Bilirubin Crystals','A measurement of the bilirubin crystals present in a biological specimen.','\0','Bilirubin Crystals','CL-LBTEST','DBX-NCIT-C74668'),('CL-LBTEST-T-151',NULL,'Bioavailable Testosterone','A measurement of bioavailable testosterone in a biological specimen.','\0','Bioavailable Testosterone','CL-LBTEST','DBX-NCIT-C117860'),('CL-LBTEST-T-152',NULL,'Bite Cells','A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen.','\0','Bite Cells','CL-LBTEST','DBX-NCIT-C74700'),('CL-LBTEST-T-153',NULL,'Bite Cells/Erythrocytes','A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen.','\0','Bite Cells/Erythrocytes','CL-LBTEST','DBX-NCIT-C74634'),('CL-LBTEST-T-154',NULL,'BKV Viral Load','A measurement of the BK virus viral load in a biological specimen.','\0','BKV Viral Load','CL-LBTEST','DBX-NCIT-C98710'),('CL-LBTEST-T-155',NULL,'Blasts','A measurement of the blast cells in a biological specimen.','\0','Blasts','CL-LBTEST','DBX-NCIT-C74605'),('CL-LBTEST-T-156',NULL,'Blasts/Leukocytes','A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.','\0','Blasts/Leukocytes','CL-LBTEST','DBX-NCIT-C64487'),('CL-LBTEST-T-157',NULL,'Blood Urea Nitrogen','A measurement of the urea nitrogen in a blood specimen.','\0','Blood Urea Nitrogen','CL-LBTEST','DBX-NCIT-C61019'),('CL-LBTEST-T-158',NULL,'Bone Specific Alkaline Phosphatase','A measurement of the bone specific alkaline phosphatase isoform in a biological specimen.','\0','Bone Specific Alkaline Phosphatase','CL-LBTEST','DBX-NCIT-C92287'),('CL-LBTEST-T-159',NULL,'Brain Natriuretic Peptide','A measurement of the brain (B-type) natriuretic peptide in a biological specimen.','\0','B-Type Natriuretic Peptide; Brain Natriuretic Peptide','CL-LBTEST','DBX-NCIT-C74735'),('CL-LBTEST-T-16',NULL,'Acetylcholine','A measurement of the acetylcholine hormone in a biological specimen.','\0','Acetylcholine','CL-LBTEST','DBX-NCIT-C74838'),('CL-LBTEST-T-160',NULL,'Brain-Derived Neurotrophic Factor','A measurement of the brain-derived neurotrophic factor in a biological specimen.','\0','Brain-Derived Neurotrophic Factor','CL-LBTEST','DBX-NCIT-C82004'),('CL-LBTEST-T-161',NULL,'Broad Casts','A measurement of the broad casts in a biological specimen.','\0','Broad Casts','CL-LBTEST','DBX-NCIT-C96588'),('CL-LBTEST-T-162',NULL,'BUN/Creatinine','A relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.','\0','BUN/Creatinine','CL-LBTEST','DBX-NCIT-C74753'),('CL-LBTEST-T-163',NULL,'Burr Cells','A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.','\0','Burr Cells; Keratocytes','CL-LBTEST','DBX-NCIT-C74701'),('CL-LBTEST-T-164',NULL,'Butyrylcholinesterase','A measurement of the total butyrylcholinesterase in a biological specimen.','\0','Acylcholine Acylhydrolase; Butyrylcholinesterase; Non-neuronal Cholinesterase; Plasma Cholinesterase; Pseudocholinesterase','CL-LBTEST','DBX-NCIT-C111142'),('CL-LBTEST-T-165',NULL,'C Reactive Protein','A measurement of the C reactive protein in a biological specimen.','\0','C Reactive Protein','CL-LBTEST','DBX-NCIT-C64548'),('CL-LBTEST-T-166',NULL,'C-peptide','A measurement of the C (connecting) peptide of insulin in a biological specimen.','\0','C-peptide','CL-LBTEST','DBX-NCIT-C74736'),('CL-LBTEST-T-167',NULL,'Cabot Rings','A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.','\0','Cabot Rings','CL-LBTEST','DBX-NCIT-C74702'),('CL-LBTEST-T-168',NULL,'Caffeine','A measurement of the caffeine in a biological specimen.','\0','Caffeine','CL-LBTEST','DBX-NCIT-C75346'),('CL-LBTEST-T-169',NULL,'Calcitonin','A measurement of the calcitonin hormone in a biological specimen.','\0','Calcitonin','CL-LBTEST','DBX-NCIT-C74848'),('CL-LBTEST-T-17',NULL,'Acetylcholine Receptor Antibody','A measurement of the acetylcholine receptor antibody in a biological specimen.','\0','Acetylcholine Receptor Antibody','CL-LBTEST','DBX-NCIT-C96559'),('CL-LBTEST-T-170',NULL,'Calcitriol','A measurement of the calcitriol hormone in a biological specimen.','\0','Calcitriol','CL-LBTEST','DBX-NCIT-C74849'),('CL-LBTEST-T-171',NULL,'Calcium','A measurement of the calcium in a biological specimen.','\0','Calcium','CL-LBTEST','DBX-NCIT-C64488'),('CL-LBTEST-T-172',NULL,'Calcium - Phosphorus Product','A measurement of the product of the calcium and phosphate measurements in a biological specimen.','\0','Calcium - Phosphorus Product','CL-LBTEST','DBX-NCIT-C103360'),('CL-LBTEST-T-173',NULL,'Calcium Carbonate Crystals','A measurement of the calcium carbonate crystals present in a biological specimen.','\0','Calcium Carbonate Crystals','CL-LBTEST','DBX-NCIT-C74669'),('CL-LBTEST-T-174',NULL,'Calcium Clearance','A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Calcium Clearance','CL-LBTEST','DBX-NCIT-C96589'),('CL-LBTEST-T-175',NULL,'Calcium Excretion Rate','A measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour).','\0','Calcium Excretion Rate','CL-LBTEST','DBX-NCIT-C117831'),('CL-LBTEST-T-176',NULL,'Calcium Oxalate Crystals','A measurement of the calcium oxalate crystals present in a biological specimen.','\0','Calcium Oxalate Crystals','CL-LBTEST','DBX-NCIT-C74670'),('CL-LBTEST-T-177',NULL,'Calcium Phosphate Crystals','A measurement of the calcium phosphate crystals present in a biological specimen.','\0','Calcium Phosphate Crystals','CL-LBTEST','DBX-NCIT-C74671'),('CL-LBTEST-T-178',NULL,'Calcium Sulphate','A measurement of the calcium sulphate in a biological specimen.','\0','Calcium Sulphate','CL-LBTEST','DBX-NCIT-C96590'),('CL-LBTEST-T-179',NULL,'Calcium, Ionized','A measurement of the ionized calcium in a biological specimen.','\0','Calcium, Ionized','CL-LBTEST','DBX-NCIT-C81948'),('CL-LBTEST-T-18',NULL,'Acetylcholinesterase','A measurement of the acetylcholinesterase in a biological specimen.','\0','Acetylcholinesterase','CL-LBTEST','DBX-NCIT-C96560'),('CL-LBTEST-T-180',NULL,'Calcium/Creatinine','A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.','\0','Calcium/Creatinine','CL-LBTEST','DBX-NCIT-C79439'),('CL-LBTEST-T-181',NULL,'Calprotectin','A measurement of the calprotectin in a biological specimen.','\0','Calprotectin','CL-LBTEST','DBX-NCIT-C82005'),('CL-LBTEST-T-182',NULL,'Cancer Antigen 1','A measurement of the cancer antigen 1 in a biological specimen.','\0','Cancer Antigen 1','CL-LBTEST','DBX-NCIT-C103361'),('CL-LBTEST-T-183',NULL,'Cancer Antigen 125','A measurement of the cancer antigen 125 in a biological specimen.','\0','Cancer Antigen 125','CL-LBTEST','DBX-NCIT-C79089'),('CL-LBTEST-T-184',NULL,'Cancer Antigen 15-3','A measurement of the cancer antigen 15-3 in a biological specimen.','\0','Cancer Antigen 15-3','CL-LBTEST','DBX-NCIT-C103362'),('CL-LBTEST-T-185',NULL,'Cancer Antigen 19-9','A measurement of the cancer antigen 19-9 in a biological specimen.','\0','Cancer Antigen 19-9','CL-LBTEST','DBX-NCIT-C81982'),('CL-LBTEST-T-186',NULL,'Cancer Antigen 27-29','A measurement of the cancer antigen 27-29 in a biological specimen.','\0','Cancer Antigen 27-29','CL-LBTEST','DBX-NCIT-C111143'),('CL-LBTEST-T-187',NULL,'Cancer Antigen 72-4','A measurement of the cancer antigen 72-4 in a biological specimen.','\0','CA 72-4; Cancer Antigen 72-4; Carbohydrate Antigen 72-4','CL-LBTEST','DBX-NCIT-C106505'),('CL-LBTEST-T-188',NULL,'Cannabinoids','A measurement of any cannabinoid class drug present in a biological specimen.','\0','Cannabinoids','CL-LBTEST','DBX-NCIT-C74689'),('CL-LBTEST-T-189',NULL,'Carbohydrate-Deficient Transferrin','A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.','\0','Carbohydrate-Deficient Transferrin','CL-LBTEST','DBX-NCIT-C101016'),('CL-LBTEST-T-19',NULL,'Acid Phosphatase','A measurement of the acid phosphatase in a biological specimen.','\0','Acid Phosphatase','CL-LBTEST','DBX-NCIT-C80163'),('CL-LBTEST-T-190',NULL,'Carbon Dioxide','A measurement of the carbon dioxide gas in a biological specimen.','\0','Carbon Dioxide','CL-LBTEST','DBX-NCIT-C64545'),('CL-LBTEST-T-191',NULL,'Carboxyhemoglobin','A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen.','\0','Carboxyhemoglobin','CL-LBTEST','DBX-NCIT-C96591'),('CL-LBTEST-T-192',NULL,'Carcinoembryonic Antigen','A measurement of the carcinoembryonic antigen in a biological specimen.','\0','Carcinoembryonic Antigen','CL-LBTEST','DBX-NCIT-C81983'),('CL-LBTEST-T-193',NULL,'Cardiolipin IgG Antibody','A measurement of the cardiolipin IgG antibody in a biological specimen.','\0','Anti-Cardiolipin IgG Antibody; Cardiolipin IgG Antibody','CL-LBTEST','DBX-NCIT-C111144'),('CL-LBTEST-T-194',NULL,'Cardiolipin IgM Antibody','A measurement of the cardiolipin IgM antibodies in a biological specimen.','\0','Cardiolipin IgM Antibody','CL-LBTEST','DBX-NCIT-C103363'),('CL-LBTEST-T-195',NULL,'Carnitine','A measurement of the total carnitine in a biological specimen.','\0','Carnitine','CL-LBTEST','DBX-NCIT-C74682'),('CL-LBTEST-T-196',NULL,'Carnitine Acetyl Transferase','A measurement of the carnitine acetyl transferase in a biological specimen.','\0','Carnitine Acetyl Transferase','CL-LBTEST','DBX-NCIT-C92288'),('CL-LBTEST-T-197',NULL,'Carnitine, Free','A measurement of the free carnitine in a biological specimen.','\0','Carnitine, Free','CL-LBTEST','DBX-NCIT-C74677'),('CL-LBTEST-T-198',NULL,'Cartilage Oligomeric Matrix Protein','A measurement of the cartilage oligomeric matrix protein in a biological specimen.','\0','Cartilage Oligomeric Matrix Protein','CL-LBTEST','DBX-NCIT-C111145'),('CL-LBTEST-T-199',NULL,'Casts','A statement that indicates casts were looked for in a biological specimen.','\0','Casts','CL-LBTEST','DBX-NCIT-C74763'),('CL-LBTEST-T-2',NULL,'11-Dehydro-Thromboxane B2','A measurement of the 11-dehydro-thromboxane B2 in a biological specimen.','\0','11-Dehydro-Thromboxane B2','CL-LBTEST','DBX-NCIT-C103344'),('CL-LBTEST-T-20',NULL,'Acid Urate Crystals','A measurement of the acid urate crystals present in a biological specimen.','\0','Acid Urate Crystals','CL-LBTEST','DBX-NCIT-C74912'),('CL-LBTEST-T-200',NULL,'CD1','A count of the CD1 expressing cells per unit of a biological specimen.','\0','CD1','CL-LBTEST','DBX-NCIT-C103364'),('CL-LBTEST-T-201',NULL,'CD10','A measurement of the CD10 expressing cells per unit in a biological specimen.','\0','CD10','CL-LBTEST','DBX-NCIT-C111146'),('CL-LBTEST-T-202',NULL,'CD11A','A count of the CD11a expressing cells per unit of a biological specimen.','\0','CD11A; CD11a','CL-LBTEST','DBX-NCIT-C105439'),('CL-LBTEST-T-203',NULL,'CD11B','A count of the CD11b expressing cells per unit of a biological specimen.','\0','CD11B; CD11b','CL-LBTEST','DBX-NCIT-C105440'),('CL-LBTEST-T-204',NULL,'CD13','A measurement of the CD13 expressing cells per unit in a biological specimen.','\0','CD13','CL-LBTEST','DBX-NCIT-C111147'),('CL-LBTEST-T-205',NULL,'CD14','A count of the CD14 expressing cells per unit of a biological specimen.','\0','CD14','CL-LBTEST','DBX-NCIT-C103365'),('CL-LBTEST-T-206',NULL,'CD19','A count of the CD19 expressing cells per unit in a biological specimen.','\0','CD19','CL-LBTEST','DBX-NCIT-C103808'),('CL-LBTEST-T-207',NULL,'CD19/Lymphocytes','A relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen.','\0','CD19/Lymphocytes','CL-LBTEST','DBX-NCIT-C103812'),('CL-LBTEST-T-208',NULL,'CD2','A count of the CD2 expressing cells per unit of a biological specimen.','\0','CD2','CL-LBTEST','DBX-NCIT-C103366'),('CL-LBTEST-T-209',NULL,'CD2/Lymphocytes','A relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen.','\0','CD2/Lymphocytes','CL-LBTEST','DBX-NCIT-C103367'),('CL-LBTEST-T-21',NULL,'Activated Coagulation Time','A measurement of the inhibition of blood coagulation in response to anticoagulant therapies.','\0','Activated Clot Time; Activated Clotting Time; Coagulation Activated','CL-LBTEST','DBX-NCIT-C103348'),('CL-LBTEST-T-210',NULL,'CD20','A count of the CD20 expressing cells per unit of a biological specimen.','\0','CD20','CL-LBTEST','DBX-NCIT-C103368'),('CL-LBTEST-T-211',NULL,'CD22','A measurement of the CD22 expressing cells per unit in a biological specimen.','\0','CD22','CL-LBTEST','DBX-NCIT-C111148'),('CL-LBTEST-T-212',NULL,'CD23','A measurement of the CD23 expressing cells per unit in a biological specimen.','\0','CD23','CL-LBTEST','DBX-NCIT-C111149'),('CL-LBTEST-T-213',NULL,'CD3','A count of the CD3 expressing cells per unit in a biological specimen.','\0','CD3','CL-LBTEST','DBX-NCIT-C103809'),('CL-LBTEST-T-214',NULL,'CD3/Lymphocytes','A relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen.','\0','CD3/Lymphocytes','CL-LBTEST','DBX-NCIT-C103813'),('CL-LBTEST-T-215',NULL,'CD33','A measurement of the CD33 expressing cells per unit in a biological specimen.','\0','CD33','CL-LBTEST','DBX-NCIT-C111150'),('CL-LBTEST-T-216',NULL,'CD34','A measurement of the CD34 expressing cells per unit in a biological specimen.','\0','CD34','CL-LBTEST','DBX-NCIT-C102260'),('CL-LBTEST-T-217',NULL,'CD38','A measurement of the CD38 expressing cells per unit in a biological specimen.','\0','CD38','CL-LBTEST','DBX-NCIT-C111151'),('CL-LBTEST-T-218',NULL,'CD4','A count of the CD4 expressing cells per unit in a biological specimen.','\0','CD4','CL-LBTEST','DBX-NCIT-C103810'),('CL-LBTEST-T-219',NULL,'CD4/CD8','A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen.','\0','CD4/CD8','CL-LBTEST','DBX-NCIT-C103814'),('CL-LBTEST-T-22',NULL,'Activated Partial Thromboplastin Time','A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.','\0','Activated Partial Thromboplastin Time','CL-LBTEST','DBX-NCIT-C38462'),('CL-LBTEST-T-220',NULL,'CD4/Lymphocytes','A relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen.','\0','CD4/Lymphocytes','CL-LBTEST','DBX-NCIT-C103815'),('CL-LBTEST-T-221',NULL,'CD40','A count of the CD40 cells per unit in a biological specimen.','\0','CD40','CL-LBTEST','DBX-NCIT-C82006'),('CL-LBTEST-T-222',NULL,'CD40 Ligand','A count of the CD40 ligand cells per unit in a biological specimen.','\0','CD40 Ligand','CL-LBTEST','DBX-NCIT-C82007'),('CL-LBTEST-T-223',NULL,'CD5','A count of the CD5 expressing cells per unit of a biological specimen.','\0','CD5','CL-LBTEST','DBX-NCIT-C103369'),('CL-LBTEST-T-224',NULL,'CD56','A count of the CD56 expressing cells per unit of a biological specimen.','\0','CD56','CL-LBTEST','DBX-NCIT-C103370'),('CL-LBTEST-T-225',NULL,'CD79A','A measurement of the CD79A expressing cells per unit in a biological specimen.','\0','CD79A','CL-LBTEST','DBX-NCIT-C111152'),('CL-LBTEST-T-226',NULL,'CD8','A count of the CD8 expressing cells per unit in a biological specimen.','\0','CD8','CL-LBTEST','DBX-NCIT-C103811'),('CL-LBTEST-T-227',NULL,'CD8/Lymphocytes','A relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen.','\0','CD8/Lymphocytes','CL-LBTEST','DBX-NCIT-C103816'),('CL-LBTEST-T-228',NULL,'Cellular Casts','A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.','\0','Cellular Casts','CL-LBTEST','DBX-NCIT-C74764'),('CL-LBTEST-T-229',NULL,'Cellularity','A measurement of the degree, quality or condition of cells in a biological specimen.','\0','Cellularity; Cellularity Grade','CL-LBTEST','DBX-NCIT-C111153'),('CL-LBTEST-T-23',NULL,'Activated Protein C Resistance','A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.','\0','Activated Protein C Resistance; Factor V Leiden Screen','CL-LBTEST','DBX-NCIT-C100471'),('CL-LBTEST-T-230',NULL,'Centromere B Antibodies','A measurement of centromere B antibodies in a biological specimen.','\0','Anti-Centromere B Antibodies','CL-LBTEST','DBX-NCIT-C111154'),('CL-LBTEST-T-231',NULL,'Ceruloplasmin','A measurement of ceruloplasmin in a biological specimen.','\0','Caeruloplasmin; Ceruloplasmin','CL-LBTEST','DBX-NCIT-C100432'),('CL-LBTEST-T-232',NULL,'Chemokine (C-C Motif) Ligand 17','A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen.','\0','ABCD-2; Chemokine (C-C Motif) Ligand 17; SCYA17; TARC; Thymus and Activation Regulated Chemokine','CL-LBTEST','DBX-NCIT-C112236'),('CL-LBTEST-T-233',NULL,'Chemokine (C-C Motif) Ligand 18','A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen.','\0','AMAC-1; AMAC1; CKB7; Chemokine (C-C Motif) Ligand 18; DC-CK1; DCCK1; MIP-4; Macrophage inflammatory protein-4; PARC; Pulmonary and Activation-Regulated Chemokine; SCYA18','CL-LBTEST','DBX-NCIT-C112237'),('CL-LBTEST-T-234',NULL,'Chemokine (C-X-C Motif) Ligand 10','A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen.','\0','Chemokine (C-X-C Motif) Ligand 10; IP-10; Interferon Gamma-induced Protein 10; Small-inducible Cytokine B10','CL-LBTEST','DBX-NCIT-C112238'),('CL-LBTEST-T-235',NULL,'Chemokine (C-X-C Motif) Receptor 3','A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.','\0','CD183; CXCR3; Chemokine (C-X-C Motif) Receptor 3; GPR9','CL-LBTEST','DBX-NCIT-C100431'),('CL-LBTEST-T-236',NULL,'Chlamydia pneumoniae IgA Antibody','A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.','\0','Chlamydia pneumoniae IgA Antibody','CL-LBTEST','DBX-NCIT-C92432'),('CL-LBTEST-T-237',NULL,'Chlamydia pneumoniae IgM Antibody','A measurement of the Chlamydia pneumoniae IgM in a biological specimen.','\0','Chlamydia pneumoniae IgM Antibody','CL-LBTEST','DBX-NCIT-C92433'),('CL-LBTEST-T-238',NULL,'Chlamydia trachomatis IgA Antibody','A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.','\0','Chlamydia trachomatis IgA Antibody','CL-LBTEST','DBX-NCIT-C100464'),('CL-LBTEST-T-239',NULL,'Chlamydia trachomatis IgG Antibody','A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.','\0','Chlamydia trachomatis IgG Antibody','CL-LBTEST','DBX-NCIT-C100466'),('CL-LBTEST-T-24',NULL,'Activated PTT/Standard','A relative measurement (ratio or percentage) of the subject\'s partial thromboplastin time to a standard or control partial thromboplastin time.','\0','Activated PTT/Standard; Activated PTT/Standard PTT; Activated Partial Thromboplastin Time/Standard Thromboplastin Time','CL-LBTEST','DBX-NCIT-C98862'),('CL-LBTEST-T-240',NULL,'Chlamydia trachomatis IgM Antibody','A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.','\0','Chlamydia trachomatis IgM Antibody','CL-LBTEST','DBX-NCIT-C100465'),('CL-LBTEST-T-241',NULL,'Chloride','A measurement of the chloride in a biological specimen.','\0','Chloride','CL-LBTEST','DBX-NCIT-C64495'),('CL-LBTEST-T-242',NULL,'Chloride Clearance','A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute).','\0','Chloride Clearance','CL-LBTEST','DBX-NCIT-C106509'),('CL-LBTEST-T-243',NULL,'Chloride Excretion Rate','A measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour).','\0','Chloride Excretion Rate','CL-LBTEST','DBX-NCIT-C117832'),('CL-LBTEST-T-244',NULL,'Chloride/Creatinine','A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.','\0','Chloride/Creatinine','CL-LBTEST','DBX-NCIT-C79440'),('CL-LBTEST-T-245',NULL,'Cholecystokinin','A measurement of the cholecystokinin hormone in a biological specimen.','\0','Cholecystokinin; Pancreozymin','CL-LBTEST','DBX-NCIT-C74850'),('CL-LBTEST-T-246',NULL,'Cholera Toxin B Subunit IgG Antibody','A measurement of the cholera toxin B subunit IgG antibody in a biological specimen.','\0','Cholera Toxin B Subunit IgG Antibody','CL-LBTEST','DBX-NCIT-C116194'),('CL-LBTEST-T-247',NULL,'Cholesterol','A measurement of the cholesterol in a biological specimen.','\0','Cholesterol; Total Cholesterol','CL-LBTEST','DBX-NCIT-C105586'),('CL-LBTEST-T-248',NULL,'Cholesterol Crystals','A measurement of the cholesterol crystals present in a biological specimen.','\0','Cholesterol Crystals','CL-LBTEST','DBX-NCIT-C74672'),('CL-LBTEST-T-249',NULL,'Cholesterol/HDL-Cholesterol','A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.','\0','Cholesterol/HDL-Cholesterol','CL-LBTEST','DBX-NCIT-C80171'),('CL-LBTEST-T-25',NULL,'Active Ghrelin','A measurement of active ghrelin in a biological specimen.','\0','Active Ghrelin; Ghrelin','CL-LBTEST','DBX-NCIT-C112219'),('CL-LBTEST-T-250',NULL,'Cholesteryl Ester Transfer Protein Act','A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen.','\0','Cholesteryl Ester Transfer Protein Act','CL-LBTEST','DBX-NCIT-C103380'),('CL-LBTEST-T-251',NULL,'Cholinesterase','A measurement of the cholinesterase in a biological specimen.','\0','Cholinesterase','CL-LBTEST','DBX-NCIT-C92289'),('CL-LBTEST-T-252',NULL,'Choriogonadotropin Beta','A measurement of the Choriogonadotropin Beta in a biological specimen.','\0','Choriogonadotropin Beta; Pregnancy Test','CL-LBTEST','DBX-NCIT-C64851'),('CL-LBTEST-T-253',NULL,'Chymotrypsin','A measurement of the total chymotrypsin in a biological specimen.','\0','Chymotrypsin','CL-LBTEST','DBX-NCIT-C111159'),('CL-LBTEST-T-254',NULL,'Circulating Endothelial Cells','A measurement of the circulating endothelial cells in a biological specimen.','\0','Circulating Endothelial Cells','CL-LBTEST','DBX-NCIT-C96592'),('CL-LBTEST-T-255',NULL,'Circulating Tumor Cells','A measurement of the circulating tumor cells in a biological specimen.','\0','Circulating Tumor Cells','CL-LBTEST','DBX-NCIT-C96593'),('CL-LBTEST-T-256',NULL,'Citrate','A measurement of the citrate in a biological specimen.','\0','Citrate','CL-LBTEST','DBX-NCIT-C92248'),('CL-LBTEST-T-257',NULL,'Clarity','A measurement of the transparency of a biological specimen.','\0','Clarity','CL-LBTEST','DBX-NCIT-C96594'),('CL-LBTEST-T-258',NULL,'Clostridium difficile Toxin','A measurement of the Clostridium difficile toxin in a biological specimen.','\0','Clostridium difficile Toxin','CL-LBTEST','DBX-NCIT-C103381'),('CL-LBTEST-T-259',NULL,'Clostridium tetani IgG Antibody','A measurement of the Clostridium tetani IgG antibody in a biological specimen.','\0','Clostridium tetani IgG Antibody','CL-LBTEST','DBX-NCIT-C103382'),('CL-LBTEST-T-26',NULL,'Acyl Coenzyme A Oxidase','A measurement of the acyl coenzyme A oxidase in a biological specimen.','\0','Acyl CoA Oxidase; Acyl Coenzyme A Oxidase; Fatty Acyl Coenzyme A Oxidase','CL-LBTEST','DBX-NCIT-C92286'),('CL-LBTEST-T-260',NULL,'Clue Cells','A measurement of the clue cells in a biological specimen.','\0','Clue Cells','CL-LBTEST','DBX-NCIT-C102261'),('CL-LBTEST-T-261',NULL,'CMV Viral Load','A measurement of the cytomegalovirus viral load in a biological specimen.','\0','CMV Viral Load','CL-LBTEST','DBX-NCIT-C98716'),('CL-LBTEST-T-262',NULL,'Coagulation Index','A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.','\0','CI; Coagulation Index','CL-LBTEST','DBX-NCIT-C112239'),('CL-LBTEST-T-263',NULL,'Cocaine','A measurement of the cocaine present in a biological specimen.','\0','Cocaine','CL-LBTEST','DBX-NCIT-C74690'),('CL-LBTEST-T-264',NULL,'Coccidioides Antibody','A measurement of the coccidioides antibody in a biological specimen.','\0','Coccidioides Antibody','CL-LBTEST','DBX-NCIT-C111160'),('CL-LBTEST-T-265',NULL,'Codeine','A measurement of the codeine present in a biological specimen.','\0','Codeine','CL-LBTEST','DBX-NCIT-C74877'),('CL-LBTEST-T-266',NULL,'Collagen Type IV','A measurement of the collagen type IV in a biological specimen.','\0','Collagen Type IV','CL-LBTEST','DBX-NCIT-C103383'),('CL-LBTEST-T-267',NULL,'Color','A measurement of the color of a biological specimen.','\0','Color','CL-LBTEST','DBX-NCIT-C64546'),('CL-LBTEST-T-268',NULL,'Complement Bb','A measurement of the Bb fragment of complement factor B in a biological specimen.','\0','Bb Fragment of Complement Factor B; Bb Fragment of Factor B; Complement Bb','CL-LBTEST','DBX-NCIT-C80172'),('CL-LBTEST-T-269',NULL,'Complement C1q Antibody','A measurement of the complement C1q antibody in a biological specimen.','\0','Complement C1q Antibody','CL-LBTEST','DBX-NCIT-C80173'),('CL-LBTEST-T-27',NULL,'Adenosine Diphosphate','A measurement of the adenosine diphosphate in a biological specimen.','\0','Adenosine Diphosphate','CL-LBTEST','DBX-NCIT-C102257'),('CL-LBTEST-T-270',NULL,'Complement C3','A measurement of the complement C3 in a biological specimen.','\0','Complement C3','CL-LBTEST','DBX-NCIT-C80174'),('CL-LBTEST-T-271',NULL,'Complement C3a','A measurement of the complement C3a in a biological specimen.','\0','ASP, Complement C3 DesArg, Acetylation-stimulating Protein; Complement C3a','CL-LBTEST','DBX-NCIT-C80175'),('CL-LBTEST-T-272',NULL,'Complement C3b','A measurement of the complement C3b in a biological specimen.','\0','Complement C3b','CL-LBTEST','DBX-NCIT-C80176'),('CL-LBTEST-T-273',NULL,'Complement C4','A measurement of the complement C4 in a biological specimen.','\0','Complement C4','CL-LBTEST','DBX-NCIT-C80177'),('CL-LBTEST-T-274',NULL,'Complement C4a','A measurement of the complement C4a in a biological specimen.','\0','Complement C4a','CL-LBTEST','DBX-NCIT-C80178'),('CL-LBTEST-T-275',NULL,'Complement C5a','A measurement of the complement C5a in a biological specimen.','\0','Complement C5a','CL-LBTEST','DBX-NCIT-C80179'),('CL-LBTEST-T-276',NULL,'Complement CH50','A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.','\0','CH50; Complement CH50; Total Hemolytic Complement','CL-LBTEST','DBX-NCIT-C100423'),('CL-LBTEST-T-277',NULL,'Complement Total','A measurement of the total complement in a biological specimen.','\0','Complement Total','CL-LBTEST','DBX-NCIT-C80160'),('CL-LBTEST-T-278',NULL,'Copper','A measurement of copper in a biological specimen.','\0','Copper; Cu','CL-LBTEST','DBX-NCIT-C111161'),('CL-LBTEST-T-279',NULL,'Corticosterone','A measurement of corticosterone in a biological specimen.','\0','Corticosterone','CL-LBTEST','DBX-NCIT-C79434'),('CL-LBTEST-T-28',NULL,'Adenovirus Antibody','A measurement of the adenovirus antibody in a biological specimen.','\0','Adenovirus Antibody','CL-LBTEST','DBX-NCIT-C111125'),('CL-LBTEST-T-280',NULL,'Corticosterone/Creatinine','A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample.','\0','Corticosterone/Creatinine','CL-LBTEST','DBX-NCIT-C106511'),('CL-LBTEST-T-281',NULL,'Corticotropin Releasing Hormone','A measurement of the corticotropin releasing hormone in a biological specimen.','\0','Corticotropin Releasing Factor; Corticotropin Releasing Hormone','CL-LBTEST','DBX-NCIT-C74851'),('CL-LBTEST-T-282',NULL,'Cortisol','A measurement of the cortisol in a biological specimen.','\0','Cortisol; Total Cortisol','CL-LBTEST','DBX-NCIT-C74781'),('CL-LBTEST-T-283',NULL,'Cortisol, Free','A measurement of the free, unbound cortisol in a biological specimen.','\0','Cortisol, Free','CL-LBTEST','DBX-NCIT-C88113'),('CL-LBTEST-T-284',NULL,'Cortisol/Creatinine','A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample.','\0','Cortisol/Creatinine','CL-LBTEST','DBX-NCIT-C106512'),('CL-LBTEST-T-285',NULL,'Cotinine','A measurement of the cotinine in a biological specimen.','\0','Cotinine','CL-LBTEST','DBX-NCIT-C92249'),('CL-LBTEST-T-286',NULL,'Creatine Kinase','A measurement of the total creatine kinase in a biological specimen.','\0','Creatine Kinase','CL-LBTEST','DBX-NCIT-C64489'),('CL-LBTEST-T-287',NULL,'Creatine Kinase BB','A measurement of the homozygous B-type creatine kinase in a biological specimen.','\0','Creatine Kinase BB','CL-LBTEST','DBX-NCIT-C64490'),('CL-LBTEST-T-288',NULL,'Creatine Kinase BB/Total Creatine Kinase','A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase BB/Total Creatine Kinase','CL-LBTEST','DBX-NCIT-C79466'),('CL-LBTEST-T-289',NULL,'Creatine Kinase MB','A measurement of the heterozygous MB-type creatine kinase in a biological specimen.','\0','Creatine Kinase MB','CL-LBTEST','DBX-NCIT-C64491'),('CL-LBTEST-T-29',NULL,'Adiponectin','A measurement of the adiponectin hormone in a biological specimen.','\0','Adiponectin','CL-LBTEST','DBX-NCIT-C74839'),('CL-LBTEST-T-290',NULL,'Creatine Kinase MB/Total Creatine Kinase','A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase MB/Total Creatine Kinase','CL-LBTEST','DBX-NCIT-C79441'),('CL-LBTEST-T-291',NULL,'Creatine Kinase MM','A measurement of the homozygous M-type creatine kinase in a biological specimen.','\0','Creatine Kinase MM','CL-LBTEST','DBX-NCIT-C64494'),('CL-LBTEST-T-292',NULL,'Creatine Kinase MM/Total Creatine Kinase','A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase MM/Total Creatine Kinase','CL-LBTEST','DBX-NCIT-C79442'),('CL-LBTEST-T-293',NULL,'Creatinine','A measurement of the creatinine in a biological specimen.','\0','Creatinine','CL-LBTEST','DBX-NCIT-C64547'),('CL-LBTEST-T-294',NULL,'Creatinine Clearance','A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).','\0','Creatinine Clearance','CL-LBTEST','DBX-NCIT-C25747'),('CL-LBTEST-T-295',NULL,'Creatinine Excretion Rate','A measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour).','\0','Creatinine Excretion Rate','CL-LBTEST','DBX-NCIT-C117833'),('CL-LBTEST-T-296',NULL,'Crenated Cells','A measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.','\0','Crenated Cells; Echinocytes','CL-LBTEST','DBX-NCIT-C74703'),('CL-LBTEST-T-297',NULL,'Cryoglobulin','A measurement of cryoglobulin in a biological specimen.','\0','Cryoglobulin','CL-LBTEST','DBX-NCIT-C111164'),('CL-LBTEST-T-298',NULL,'Crystals','A statement that indicates crystals were looked for in a biological specimen.','\0','Crystals','CL-LBTEST','DBX-NCIT-C74673'),('CL-LBTEST-T-299',NULL,'Cyclic Citrullinated Peptide Antibody','A measurement of the cyclic citrullinated peptide antibody in a biological specimen.','\0','Cyclic Citrullinated Peptide Antibody','CL-LBTEST','DBX-NCIT-C96595'),('CL-LBTEST-T-3',NULL,'25-Hydroxyvitamin D','A measurement of the total inactive Vitamin D in a biological specimen.','\0','25-Hydroxyvitamin D; Inactive Vitamin D','CL-LBTEST','DBX-NCIT-C92268'),('CL-LBTEST-T-30',NULL,'Adrenocorticotropic Hormone','A measurement of the adrenocorticotropic hormone in a biological specimen.','\0','Adrenocorticotropic Hormone','CL-LBTEST','DBX-NCIT-C74780'),('CL-LBTEST-T-300',NULL,'Cyclic Guanosine Monophosphate','A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen.','\0','Cyclic Guanosine 3,5-Monophosphate','CL-LBTEST','DBX-NCIT-C111165'),('CL-LBTEST-T-301',NULL,'Cystatin C','A measurement of the cystatin C in a biological specimen.','\0','Cystatin C','CL-LBTEST','DBX-NCIT-C92290'),('CL-LBTEST-T-302',NULL,'Cystatin C/Creatinine','A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample.','\0','Cystatin C/Creatinine','CL-LBTEST','DBX-NCIT-C106513'),('CL-LBTEST-T-303',NULL,'Cystine','A measurement of the cystine in a biological specimen.','\0','Cystine','CL-LBTEST','DBX-NCIT-C105441'),('CL-LBTEST-T-304',NULL,'Cystine Crystals','A measurement of the cystine crystals present in a biological specimen.','\0','Cystine Crystals','CL-LBTEST','DBX-NCIT-C74674'),('CL-LBTEST-T-305',NULL,'Cytokeratin Fragment 21-1','A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen.','\0','CYFRA21-1; Cytokeratin 19 Fragment; Cytokeratin Fragment 21-1','CL-LBTEST','DBX-NCIT-C106514'),('CL-LBTEST-T-306',NULL,'Cytomegalovirus IgG Antibody','A measurement of the cytomegalovirus IgG antibody in a biological specimen.','\0','Cytomegalovirus IgG Antibody','CL-LBTEST','DBX-NCIT-C96596'),('CL-LBTEST-T-307',NULL,'Cytomegalovirus IgM Antibody','A measurement of the cytomegalovirus IgM antibody in a biological specimen.','\0','Cytomegalovirus IgM Antibody','CL-LBTEST','DBX-NCIT-C96597'),('CL-LBTEST-T-308',NULL,'Cytoplasmic Basophilia Neutrophil','A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content.','\0','Cytoplasmic Basophilia Neutrophil','CL-LBTEST','DBX-NCIT-C111166'),('CL-LBTEST-T-309',NULL,'D-Dimer','A measurement of the d-dimers in a biological specimen.','\0','D-Dimer','CL-LBTEST','DBX-NCIT-C82621'),('CL-LBTEST-T-31',NULL,'ADV Viral Load','A measurement of the adenovirus viral load in a biological specimen.','\0','ADV Viral Load','CL-LBTEST','DBX-NCIT-C98705'),('CL-LBTEST-T-310',NULL,'Dacryocytes','A measurement of dacryocytes in a biological specimen.','\0','Dacryocytes; Tear Shaped Erythrocytes; Teardrop Cells','CL-LBTEST','DBX-NCIT-C64801'),('CL-LBTEST-T-311',NULL,'Degenerated Leukocytes','A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen.','\0','Degenerated Leukocytes; Degenerated WBC; Degenerated White Blood Cells','CL-LBTEST','DBX-NCIT-C111190'),('CL-LBTEST-T-312',NULL,'Dehydroepiandrosterone','A measurement of the dehydroepiandrosterone hormone in a biological specimen.','\0','Dehydroepiandrosterone; Dehydroisoandrosterone','CL-LBTEST','DBX-NCIT-C74852'),('CL-LBTEST-T-313',NULL,'Dehydroepiandrosterone Sulfate','A measurement of the sulfated Dehydroepiandrosterone in a biological specimen.','\0','DHEA Sulfate; DHEA-S; Dehydroepiandrosterone Sulfate; sDHEA','CL-LBTEST','DBX-NCIT-C96629'),('CL-LBTEST-T-314',NULL,'Deoxypyridinoline','A measurement of the deoxypyridinoline in a biological specimen.','\0','Deoxypyridinoline','CL-LBTEST','DBX-NCIT-C79443'),('CL-LBTEST-T-315',NULL,'Deoxypyridinoline/Creatinine','A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.','\0','Deoxypyridinoline/Creatinine','CL-LBTEST','DBX-NCIT-C79444'),('CL-LBTEST-T-316',NULL,'Dextroamphetamine','A measurement of the dextroamphetamine in a biological specimen.','\0','Dextroamphetamine; d-amphetamine','CL-LBTEST','DBX-NCIT-C102262'),('CL-LBTEST-T-317',NULL,'Dihydrocodeine','A measurement of the dihydrocodeine present in a biological specimen.','\0','Dihydrocodeine','CL-LBTEST','DBX-NCIT-C74878'),('CL-LBTEST-T-318',NULL,'Dihydrotestosterone','A measurement of the dihydrotestosterone hormone in a biological specimen.','\0','Androstanalone; Dihydrotestosterone','CL-LBTEST','DBX-NCIT-C74853'),('CL-LBTEST-T-319',NULL,'Dilute Russell\'s Viper Venom Time','A measurement of the time it takes a plasma sample to clot after adding dilute Russell\'s viper venom.','\0','Dilute Russell\'s Viper Venom Time; Lupus Anticoagulant Test','CL-LBTEST','DBX-NCIT-C96696'),('CL-LBTEST-T-32',NULL,'Aggrecan Chondroitin Sulfate Epitope 846','A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen.','\0','846-Epitope; Aggrecan Chondroitin Sulfate Epitope 846; CS846; Chondroitin Sulfate Epitope 846; Chondroitin Sulfate Proteoglycan 1 Epitope 846','CL-LBTEST','DBX-NCIT-C112220'),('CL-LBTEST-T-320',NULL,'Dilute Russell\'s Viper Venom Time Ratio','A relative measurement (ratio or percentage) of the dilute Russell\'s viper venom time in a subject sample to a control sample.','\0','Lupus Anticoagulant Ratio','CL-LBTEST','DBX-NCIT-C103386'),('CL-LBTEST-T-321',NULL,'Dimorphic Erythrocyte Population','Examination of a biological specimen to detect the presence of dimorphic erythrocyte population.','\0','Dimorphic Erythrocyte Population; Dimorphic RBC Population','CL-LBTEST','DBX-NCIT-C117853'),('CL-LBTEST-T-322',NULL,'Dipeptidyl Peptidase-4 Activity','A measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen.','\0','DPPIV Activity','CL-LBTEST','DBX-NCIT-C103387'),('CL-LBTEST-T-323',NULL,'Diphtheria IgG Antibody','A measurement of the Diphtheria IgG antibodies in a biological specimen.','\0','Diphtheria IgG Antibody','CL-LBTEST','DBX-NCIT-C103388'),('CL-LBTEST-T-324',NULL,'Direct Bilirubin','A measurement of the conjugated or water-soluble bilirubin in a biological specimen.','\0','Direct Bilirubin','CL-LBTEST','DBX-NCIT-C64481'),('CL-LBTEST-T-325',NULL,'DNase-B Antibody','A measurement of Dnase-B antibody in a biological specimen.','\0','Anti-Dnase B; DNase-B Antibody','CL-LBTEST','DBX-NCIT-C100463'),('CL-LBTEST-T-326',NULL,'Dohle Bodies','A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.','\0','Dohle Bodies','CL-LBTEST','DBX-NCIT-C74610'),('CL-LBTEST-T-327',NULL,'Dopamine','A measurement of the dopamine hormone in a biological specimen.','\0','Dopamine','CL-LBTEST','DBX-NCIT-C74854'),('CL-LBTEST-T-328',NULL,'Drug Screen','An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen.','\0','Drug Screen','CL-LBTEST','DBX-NCIT-C78139'),('CL-LBTEST-T-329',NULL,'DTPA Clearance','A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.','\0','DTPA Clearance','CL-LBTEST','DBX-NCIT-C100441'),('CL-LBTEST-T-33',NULL,'Agranular Neutrophils','A measurement of the agranular neutrophils in a biological specimen.','\0','Agranular Neutrophils','CL-LBTEST','DBX-NCIT-C116200'),('CL-LBTEST-T-330',NULL,'EBV Profile Interpretation','An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests.','\0','EBV Profile Interpretation; Epstein-Barr Virus Antibody Profile; Epstein-Barr Virus Panel; Epstein-Barr Virus Profile Interpretation','CL-LBTEST','DBX-NCIT-C106519'),('CL-LBTEST-T-331',NULL,'EBV Viral Load','A measurement of the Epstein-Barr virus viral load in a biological specimen.','\0','EBV Viral Load','CL-LBTEST','DBX-NCIT-C98721'),('CL-LBTEST-T-332',NULL,'Ecarin Clotting Time','A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.','\0','Ecarin Clotting Time','CL-LBTEST','DBX-NCIT-C100422'),('CL-LBTEST-T-333',NULL,'Eccentrocytes','A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.','\0','Eccentrocytes','CL-LBTEST','DBX-NCIT-C96598'),('CL-LBTEST-T-334',NULL,'EDTA Clearance','A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.','\0','EDTA Clearance','CL-LBTEST','DBX-NCIT-C100440'),('CL-LBTEST-T-335',NULL,'Elliptocytes','A measurement of the elliptically shaped erythrocytes in a biological specimen.','\0','Elliptocytes; Ovalocytes','CL-LBTEST','DBX-NCIT-C64549'),('CL-LBTEST-T-336',NULL,'Endogenous Thrombin Potential','A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample.','\0','Endogenous Thrombin Potential','CL-LBTEST','DBX-NCIT-C102266'),('CL-LBTEST-T-337',NULL,'Endothelin-1','A measurement of the endothelin-1 in a biological specimen.','\0','Endothelin-1','CL-LBTEST','DBX-NCIT-C82008'),('CL-LBTEST-T-338',NULL,'Eosinophilic Metamyelocytes','A measurement of the eosinphilic metamyelocytes in a biological specimen.','\0','Eosinophilic Metamyelocytes','CL-LBTEST','DBX-NCIT-C84819'),('CL-LBTEST-T-339',NULL,'Eosinophilic Myelocytes','A measurement of the eosinophilic myelocytes in a biological specimen.','\0','Eosinophilic Myelocytes','CL-LBTEST','DBX-NCIT-C84821'),('CL-LBTEST-T-34',NULL,'Alanine Aminopeptidase','A measurement of the alanine aminopeptidase in a biological specimen.','\0','Alanine Aminopeptidase','CL-LBTEST','DBX-NCIT-C100430'),('CL-LBTEST-T-340',NULL,'Eosinophils','A measurement of the eosinophils in a biological specimen.','\0','Eosinophils','CL-LBTEST','DBX-NCIT-C64550'),('CL-LBTEST-T-341',NULL,'Eosinophils Band Form','A measurement of the banded eosinophils in a biological specimen.','\0','Eosinophils Band Form','CL-LBTEST','DBX-NCIT-C114216'),('CL-LBTEST-T-342',NULL,'Eosinophils Band Form/Leukocytes','A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen.','\0','Eosinophils Band Form/Leukocytes','CL-LBTEST','DBX-NCIT-C114217'),('CL-LBTEST-T-343',NULL,'Eosinophils/Leukocytes','A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.','\0','Eosinophils/Leukocytes','CL-LBTEST','DBX-NCIT-C64604'),('CL-LBTEST-T-344',NULL,'Eosinophils/Total Cells','A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Eosinophils/Total Cells','CL-LBTEST','DBX-NCIT-C98720'),('CL-LBTEST-T-345',NULL,'Eotaxin-1','A measurement of the eotaxin-1 in a biological specimen.','\0','Chemokine Ligand 11; Eotaxin-1','CL-LBTEST','DBX-NCIT-C81952'),('CL-LBTEST-T-346',NULL,'Eotaxin-2','A measurement of the eotaxin-2 in a biological specimen.','\0','Chemokine Ligand 24; Eotaxin-2','CL-LBTEST','DBX-NCIT-C81953'),('CL-LBTEST-T-347',NULL,'Eotaxin-3','A measurement of the eotaxin-3 in a biological specimen.','\0','CCL26; Chemokine (C-C Motif) Ligand 26; Chemokine Ligand 26; Eotaxin-3','CL-LBTEST','DBX-NCIT-C81954'),('CL-LBTEST-T-348',NULL,'Epidermal Growth Factor','A measurement of the epidermal growth factor in a biological specimen.','\0','Epidermal Growth Factor','CL-LBTEST','DBX-NCIT-C82009'),('CL-LBTEST-T-349',NULL,'Epidermal Growth Factor Receptor','A measurement of the cells with positive expression of EGFR in a biological specimen.','\0','ERBB1; Epidermal Growth Factor Receptor; HER1','CL-LBTEST','DBX-NCIT-C112273'),('CL-LBTEST-T-35',NULL,'Alanine Aminotransferase','A measurement of the alanine aminotransferase in a biological specimen.','\0','Alanine Aminotransferase; SGPT','CL-LBTEST','DBX-NCIT-C64433'),('CL-LBTEST-T-350',NULL,'Epinephrine','A measurement of the epinephrine hormone in a biological specimen.','\0','Adrenaline; Epinephrine','CL-LBTEST','DBX-NCIT-C79445'),('CL-LBTEST-T-351',NULL,'Epith Neutrophil-Activating Peptide 78','A measurement of the epithelial neutrophil-activating peptide in a biological specimen.','\0','Epith Neutrophil-Activating Peptide 78','CL-LBTEST','DBX-NCIT-C82010'),('CL-LBTEST-T-352',NULL,'Epithelial Casts','A measurement of the epithelial cell casts present in a biological specimen.','\0','Epithelial Casts','CL-LBTEST','DBX-NCIT-C74779'),('CL-LBTEST-T-353',NULL,'Epithelial Cells','A measurement of the epithelial cells in a biological specimen.','\0','Epithelial Cells','CL-LBTEST','DBX-NCIT-C64605'),('CL-LBTEST-T-354',NULL,'Epstein-Barr Capsid IgG Antibody','A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.','\0','Epstein-Barr Capsid IgG Antibody','CL-LBTEST','DBX-NCIT-C96600'),('CL-LBTEST-T-355',NULL,'Epstein-Barr Capsid IgM Antibody','A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.','\0','Epstein-Barr Capsid IgM Antibody','CL-LBTEST','DBX-NCIT-C96601'),('CL-LBTEST-T-356',NULL,'Epstein-Barr Early Antigen','A measurement of the Epstein-Barr early antigen in a biological specimen.','\0','Epstein-Barr Early Antigen','CL-LBTEST','DBX-NCIT-C96602'),('CL-LBTEST-T-357',NULL,'Epstein-Barr Nuclear Antibody','A measurement of the Epstein-Barr nuclear antibody in a biological specimen.','\0','Epstein-Barr Nuclear Antibody; Epstein-Barr Nuclear Antigen Antibody','CL-LBTEST','DBX-NCIT-C96603'),('CL-LBTEST-T-358',NULL,'Epstein-Barr Nuclear Antigen','A measurement of the Epstein-Barr nuclear antigen in a biological specimen.','\0','Epstein-Barr Nuclear Antigen','CL-LBTEST','DBX-NCIT-C96604'),('CL-LBTEST-T-359',NULL,'Epstein-Barr Nuclear Antigen 1 IgG Ab','A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen.','\0','Epstein-Barr Nuclear Antigen 1 IgG Ab','CL-LBTEST','DBX-NCIT-C106518'),('CL-LBTEST-T-36',NULL,'Albumin','A measurement of the albumin protein in a biological specimen.','\0','Albumin; Microalbumin','CL-LBTEST','DBX-NCIT-C64431'),('CL-LBTEST-T-360',NULL,'Ery. Mean Corpuscular Hemoglobin','A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.','\0','Ery. Mean Corpuscular Hemoglobin','CL-LBTEST','DBX-NCIT-C64797'),('CL-LBTEST-T-361',NULL,'Ery. Mean Corpuscular HGB Concentration','A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.','\0','Ery. Mean Corpuscular HGB Concentration','CL-LBTEST','DBX-NCIT-C64798'),('CL-LBTEST-T-362',NULL,'Ery. Mean Corpuscular Volume','A quantitative measurement of the mean volume of erythrocytes in a biological specimen.','\0','Ery. Mean Corpuscular Volume; Erythrocytes Mean Corpuscular Volume; RBC Mean Corpuscular Volume','CL-LBTEST','DBX-NCIT-C64799'),('CL-LBTEST-T-363',NULL,'Erythrocyte Agglutination','A measurement of the erythrocyte agglutination in a biological specimen.','\0','Autoagglutination; Erythrocyte Agglutination; RBC Agglutination','CL-LBTEST','DBX-NCIT-C111197'),('CL-LBTEST-T-364',NULL,'Erythrocyte Cell Clumps','A measurement of red blood cell clumps in a biological specimen.','\0','Erythrocyte Cell Clumps; RBC Clumps; Red Blood Cell Clumps','CL-LBTEST','DBX-NCIT-C92245'),('CL-LBTEST-T-365',NULL,'Erythrocyte Cell Morphology','An examination or assessment of the form and structure of red blood cells.','\0','Erythrocyte Cell Morphology; RBC Morphology; Red Blood Cell Morphology','CL-LBTEST','DBX-NCIT-C92296'),('CL-LBTEST-T-366',NULL,'Erythrocyte Fragment','A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen.','\0','Erythrocyte Fragment; RBC Fragment','CL-LBTEST','DBX-NCIT-C116212'),('CL-LBTEST-T-367',NULL,'Erythrocyte Ghosts','A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.','\0','Erythrocyte Ghosts; RBC Ghosts','CL-LBTEST','DBX-NCIT-C96605'),('CL-LBTEST-T-368',NULL,'Erythrocyte Sedimentation Rate','The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).','\0','Biernacki Reaction; Erythrocyte Sedimentation Rate','CL-LBTEST','DBX-NCIT-C74611'),('CL-LBTEST-T-369',NULL,'Erythrocytes','A measurement of the total erythrocytes in a biological specimen.','\0','Erythrocytes; Red Blood Cells','CL-LBTEST','DBX-NCIT-C51946'),('CL-LBTEST-T-37',NULL,'Albumin Excretion Rate','A measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour).','\0','Albumin Excretion Rate','CL-LBTEST','DBX-NCIT-C117829'),('CL-LBTEST-T-370',NULL,'Erythrocytes Distribution Width','A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.','\0','Erythrocytes Distribution Width; Red Blood Cell Distribution Width','CL-LBTEST','DBX-NCIT-C64800'),('CL-LBTEST-T-371',NULL,'Erythropoietin','A measurement of the erythropoietin hormone in a biological specimen.','\0','Erythropoietin; Hematopoietin','CL-LBTEST','DBX-NCIT-C74855'),('CL-LBTEST-T-372',NULL,'Estradiol','A measurement of the estradiol in a biological specimen.','\0','Estradiol; Oestradiol','CL-LBTEST','DBX-NCIT-C74782'),('CL-LBTEST-T-373',NULL,'Estriol','A measurement of the estriol hormone in a biological specimen.','\0','Estriol; Oestriol','CL-LBTEST','DBX-NCIT-C74856'),('CL-LBTEST-T-374',NULL,'Estriol, Free','A measurement of the free estriol in a biological specimen.','\0','Estriol, Free','CL-LBTEST','DBX-NCIT-C81963'),('CL-LBTEST-T-375',NULL,'Estrogen Receptor','A measurement of the cells with positive expression of estrogen receptor in a biological specimen.','\0','ER; ESR; Estrogen Receptor; Oestrogen Receptor','CL-LBTEST','DBX-NCIT-C112274'),('CL-LBTEST-T-376',NULL,'Estrone','A measurement of the estrone hormone in a biological specimen.','\0','Estrone; Oestrone','CL-LBTEST','DBX-NCIT-C74857'),('CL-LBTEST-T-377',NULL,'Ethanol','A measurement of the ethanol present in a biological specimen.','\0','Alcohol; Ethanol','CL-LBTEST','DBX-NCIT-C74693'),('CL-LBTEST-T-378',NULL,'ETP Area Under Curve','A measurement of the area under the thrombin generation curve.','\0','ETP Area Under Curve; Endogenous Thrombin Potential Area Under Curve','CL-LBTEST','DBX-NCIT-C102263'),('CL-LBTEST-T-379',NULL,'ETP Lag Time','A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.','\0','ETP Lag Time; Endogenous Thrombin Potential Lag Time','CL-LBTEST','DBX-NCIT-C102264'),('CL-LBTEST-T-38',NULL,'Albumin/Creatinine','A relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.','\0','Albumin/Creatinine; Microalbumin/Creatinine Ratio','CL-LBTEST','DBX-NCIT-C74761'),('CL-LBTEST-T-380',NULL,'ETP Lag Time Relative','A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.','\0','ETP Lag Time Relative; Endogenous Thrombin Potential Lag Time Relative','CL-LBTEST','DBX-NCIT-C102265'),('CL-LBTEST-T-381',NULL,'ETP Peak Height','A measurement of the maximum concentration of thrombin generated during a thrombin generation test.','\0','ETP Peak Height; Endogenous Thrombin Potential Peak Height','CL-LBTEST','DBX-NCIT-C102267'),('CL-LBTEST-T-382',NULL,'ETP Peak Height Relative','A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test.','\0','ETP Peak Height Relative; Endogenous Thrombin Potential Peak Height Relative','CL-LBTEST','DBX-NCIT-C102268'),('CL-LBTEST-T-383',NULL,'ETP Time to Peak','A measurement of the time it takes to generate the maximum concentration of thrombin.','\0','ETP Time to Peak; Endogenous Thrombin Potential Time to Peak','CL-LBTEST','DBX-NCIT-C102269'),('CL-LBTEST-T-384',NULL,'ETP Time to Peak Relative','A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin.','\0','ETP Time to Peak Relative; Endogenous Thrombin Potential Time to Peak Relative','CL-LBTEST','DBX-NCIT-C102270'),('CL-LBTEST-T-385',NULL,'Extracell Newly Ident RAGE Bind Protein','A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.','\0','Extracell Newly Ident RAGE Bind Protein; S100 Calcium Binding Protein A12','CL-LBTEST','DBX-NCIT-C82011'),('CL-LBTEST-T-386',NULL,'Extractable Nuclear Antigen Antibody','A measurement of the extractable nuclear antigen antibody in a biological specimen.','\0','Anti-ENA; Extractable Nuclear Antigen Antibody','CL-LBTEST','DBX-NCIT-C92270'),('CL-LBTEST-T-387',NULL,'F2-Isoprostane','A measurement of the F2-isoprostane in a biological specimen.','\0','F2-Isoprostane','CL-LBTEST','DBX-NCIT-C80180'),('CL-LBTEST-T-388',NULL,'Factor II','A measurement of the Factor II in a biological specimen.','\0','Factor II; Prothrombin','CL-LBTEST','DBX-NCIT-C96626'),('CL-LBTEST-T-389',NULL,'Factor III','A measurement of the factor III in a biological specimen.','\0','Factor III; Tissue Factor, CD142','CL-LBTEST','DBX-NCIT-C81959'),('CL-LBTEST-T-39',NULL,'Albumin/Globulin','The ratio of albumin to globulin in a biological specimen.','\0','Albumin/Globulin','CL-LBTEST','DBX-NCIT-C74894'),('CL-LBTEST-T-390',NULL,'Factor IX','A measurement of the factor IX in a biological specimen.','\0','Christmas Factor; Factor IX','CL-LBTEST','DBX-NCIT-C98725'),('CL-LBTEST-T-391',NULL,'Factor IX Activity','A measurement of the biological activity of factor IX in a biological specimen.','\0','Christmas Factor Activity','CL-LBTEST','DBX-NCIT-C103395'),('CL-LBTEST-T-392',NULL,'Factor V','A measurement of the factor V in a biological specimen.','\0','Factor V; Labile Factor','CL-LBTEST','DBX-NCIT-C98726'),('CL-LBTEST-T-393',NULL,'Factor V Activity','A measurement of the biological activity of factor V in a biological specimen.','\0','Labile Factor Activity','CL-LBTEST','DBX-NCIT-C103396'),('CL-LBTEST-T-394',NULL,'Factor V Leiden','A measurement of the Factor V Leiden in a biological specimen.','\0','Factor V Leiden','CL-LBTEST','DBX-NCIT-C102271'),('CL-LBTEST-T-395',NULL,'Factor VII','A measurement of the factor VII in a biological specimen.','\0','Factor VII; Proconvertin; Stable Factor','CL-LBTEST','DBX-NCIT-C81960'),('CL-LBTEST-T-396',NULL,'Factor VII Activity','A measurement of the biological activity of factor VII in a biological specimen.','\0','Proconvertin Activity; Stable Factor Activity','CL-LBTEST','DBX-NCIT-C103397'),('CL-LBTEST-T-397',NULL,'Factor VIIa Activity','A measurement of the biological activity of factor VIIa in a biological specimen.','\0','Factor VIIa Activity','CL-LBTEST','DBX-NCIT-C103398'),('CL-LBTEST-T-398',NULL,'Factor VIII','A measurement of the factor VIII in a biological specimen.','\0','Anti-hemophilic Factor; Factor VIII','CL-LBTEST','DBX-NCIT-C81961'),('CL-LBTEST-T-399',NULL,'Factor VIII Activity','A measurement of the biological activity of factor VIII in a biological specimen.','\0','Anti-hemophilic Factor Activity','CL-LBTEST','DBX-NCIT-C103399'),('CL-LBTEST-T-4',NULL,'3,4-Dihydroxyphenylacetic Acid','A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen.','\0','3,4-Dihydroxyphenylacetic Acid','CL-LBTEST','DBX-NCIT-C103345'),('CL-LBTEST-T-40',NULL,'Albumin/Total Protein','A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen.','\0','Albumin/Total Protein','CL-LBTEST','DBX-NCIT-C103453'),('CL-LBTEST-T-400',NULL,'Factor X','A measurement of the factor X in a biological specimen.','\0','Factor X','CL-LBTEST','DBX-NCIT-C98727'),('CL-LBTEST-T-401',NULL,'Factor XIII','A measurement of the factor XIII in a biological specimen.','\0','Factor XIII; Fibrin Stablizing Factor','CL-LBTEST','DBX-NCIT-C112277'),('CL-LBTEST-T-402',NULL,'Factor XIV','A measurement of the factor XIV in a biological specimen.','\0','Autoprothrombin IIA; Factor XIV; Protein C; Protein C Antigen','CL-LBTEST','DBX-NCIT-C102272'),('CL-LBTEST-T-403',NULL,'Factor XIV Activity','A measurement of the factor XIV activity in a biological specimen.','\0','Factor XIV Activity; Protein C Activity; Protein C Function','CL-LBTEST','DBX-NCIT-C105442'),('CL-LBTEST-T-404',NULL,'Fat','A measurement of the fat in a biological specimen.','\0','Fat','CL-LBTEST','DBX-NCIT-C96648'),('CL-LBTEST-T-405',NULL,'Fat Bodies, Oval','A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.','\0','Fat Bodies, Oval','CL-LBTEST','DBX-NCIT-C81947'),('CL-LBTEST-T-406',NULL,'Fat Droplet','A measurement of the triglyceride aggregates within a biological specimen.','\0','Fat Droplet','CL-LBTEST','DBX-NCIT-C98728'),('CL-LBTEST-T-407',NULL,'Fatty Acid Binding Protein 1','A measurement of the fatty acid binding protein 1 in a biological specimen.','\0','Fatty Acid Binding Protein 1','CL-LBTEST','DBX-NCIT-C82012'),('CL-LBTEST-T-408',NULL,'Fatty Acid Binding Protein 3','A measurement of the fatty acid binding protein 3 in a biological specimen.','\0','Fatty Acid Binding Protein 3','CL-LBTEST','DBX-NCIT-C106521'),('CL-LBTEST-T-409',NULL,'Fatty Casts','A measurement of the fatty casts present in a biological specimen.','\0','Fatty Casts','CL-LBTEST','DBX-NCIT-C74766'),('CL-LBTEST-T-41',NULL,'Aldolase','A measurement of the aldolase enzyme in a biological specimen.','\0','Aldolase','CL-LBTEST','DBX-NCIT-C74731'),('CL-LBTEST-T-410',NULL,'Ferritin','A measurement of the ferritin in a biological specimen.','\0','Ferritin','CL-LBTEST','DBX-NCIT-C74737'),('CL-LBTEST-T-411',NULL,'Fibrin Degradation Products','A measurement of the fibrin degradation products in a biological specimen.','\0','Fibrin Degradation Products','CL-LBTEST','DBX-NCIT-C82013'),('CL-LBTEST-T-412',NULL,'Fibrinogen','A measurement of the fibrinogen in a biological specimen.','\0','Fibrinogen','CL-LBTEST','DBX-NCIT-C64606'),('CL-LBTEST-T-413',NULL,'Fibroblast Growth Factor 21','A measurement of the fibroblast growth factor 21 in a biological specimen.','\0','FGF 21; Fibroblast Growth Factor 21','CL-LBTEST','DBX-NCIT-C112280'),('CL-LBTEST-T-414',NULL,'Fibroblast Growth Factor 23','A measurement of the fibroblast growth factor 23 in a biological specimen.','\0','Fibroblast Growth Factor 23; Phosphatonin','CL-LBTEST','DBX-NCIT-C96650'),('CL-LBTEST-T-415',NULL,'Fibroblast Growth Factor Basic Form','A measurement of the basic form of fibroblast growth factor in a biological specimen.','\0','FGF2; Fibroblast Growth Factor Basic Form','CL-LBTEST','DBX-NCIT-C82014'),('CL-LBTEST-T-416',NULL,'FibroTest Score','A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taki','\0','FibroSURE Score; FibroTest Score','CL-LBTEST','DBX-NCIT-C105443'),('CL-LBTEST-T-417',NULL,'Follicle Stimulating Hormone','A measurement of the follicle stimulating hormone (FSH) in a biological specimen.','\0','Follicle Stimulating Hormone','CL-LBTEST','DBX-NCIT-C74783'),('CL-LBTEST-T-418',NULL,'Fractional Calcium Excretion','A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine.','\0','Fractional Calcium Excretion','CL-LBTEST','DBX-NCIT-C114219'),('CL-LBTEST-T-419',NULL,'Fractional Chloride Excretion','A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine.','\0','Fractional Chloride Excretion','CL-LBTEST','DBX-NCIT-C114220'),('CL-LBTEST-T-42',NULL,'Aldosterone','A measurement of the aldosterone hormone in a biological specimen.','\0','Aldosterone','CL-LBTEST','DBX-NCIT-C74841'),('CL-LBTEST-T-420',NULL,'Fractional Phosphorus Excretion','A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine.','\0','Fractional Inorganic Phosphate Excretion; Fractional Phosphorus Excretion','CL-LBTEST','DBX-NCIT-C114221'),('CL-LBTEST-T-421',NULL,'Fractional Potassium Excretion','A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine.','\0','Fractional Potassium Excretion','CL-LBTEST','DBX-NCIT-C114222'),('CL-LBTEST-T-422',NULL,'Fractional Sodium Excretion','A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine.','\0','Fractional Sodium Excretion','CL-LBTEST','DBX-NCIT-C107435'),('CL-LBTEST-T-423',NULL,'Free Fatty Acid','A measurement of the total non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid; Non-Esterified Fatty Acid, Free','CL-LBTEST','DBX-NCIT-C80200'),('CL-LBTEST-T-424',NULL,'Free Fatty Acid, Saturated','A measurement of the saturated non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid, Saturated; Non-esterified Fatty Acid, Saturated','CL-LBTEST','DBX-NCIT-C80206'),('CL-LBTEST-T-425',NULL,'Free Fatty Acid, Unsaturated','A measurement of the unsaturated non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid, Unsaturated; Non-esterified Fatty Acid, Unsaturated','CL-LBTEST','DBX-NCIT-C80209'),('CL-LBTEST-T-426',NULL,'Free Glycerol','A measurement of the amount of unbound glycerol in a biological specimen.','\0','Free Glycerin; Free Glycerol','CL-LBTEST','DBX-NCIT-C100448'),('CL-LBTEST-T-427',NULL,'Fructosamine','A measurement of the fructosamine in a biological specimen.','\0','Fructosamine; Glycated Serum Protein','CL-LBTEST','DBX-NCIT-C74678'),('CL-LBTEST-T-428',NULL,'Galanin','A measurement of the galanin in a biological specimen.','\0','Galanin','CL-LBTEST','DBX-NCIT-C80182'),('CL-LBTEST-T-429',NULL,'Gamma Globulin','A measurement of the proteins contributing to the gamma fraction in a biological specimen.','\0','Gamma Globulin','CL-LBTEST','DBX-NCIT-C92257'),('CL-LBTEST-T-43',NULL,'Alkaline Phosphatase','A measurement of the alkaline phosphatase in a biological specimen.','\0','Alkaline Phosphatase','CL-LBTEST','DBX-NCIT-C64432'),('CL-LBTEST-T-430',NULL,'Gamma Globulin/Total Protein','A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.','\0','Gamma Globulin/Total Protein','CL-LBTEST','DBX-NCIT-C92295'),('CL-LBTEST-T-431',NULL,'Gamma Glutamyl Transferase','A measurement of the gamma glutamyl transferase in a biological specimen.','\0','Gamma Glutamyl Transferase','CL-LBTEST','DBX-NCIT-C64847'),('CL-LBTEST-T-432',NULL,'Gamma Glutamyl Transferase/Creatinine','A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.','\0','Gamma Glutamyl Transferase/Creatinine','CL-LBTEST','DBX-NCIT-C79446'),('CL-LBTEST-T-433',NULL,'Gamma Tocopherol','A measurement of the gamma tocopherol in a biological specimen.','\0','Gamma Tocopherol','CL-LBTEST','DBX-NCIT-C116211'),('CL-LBTEST-T-434',NULL,'Gastrin','A measurement of the gastrin hormone in a biological specimen.','\0','Gastrin','CL-LBTEST','DBX-NCIT-C74858'),('CL-LBTEST-T-435',NULL,'GFR from B-2 Microglobulin Adj for BSA','A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.','\0','GFR from B-2 Microglobulin Adj for BSA','CL-LBTEST','DBX-NCIT-C100450'),('CL-LBTEST-T-436',NULL,'GFR from Beta-Trace Protein Adj for BSA','A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.','\0','GFR from Beta-Trace Protein Adj for BSA','CL-LBTEST','DBX-NCIT-C100449'),('CL-LBTEST-T-437',NULL,'GFR from Creatinine Adjusted for BSA','An estimation of the glomerular filtration rate adjusted for body size based on creatinine.','\0','GFR from Creatinine Adjusted for BSA','CL-LBTEST','DBX-NCIT-C98735'),('CL-LBTEST-T-438',NULL,'GFR from Cystatin C Adjusted for BSA','An estimation of the glomerular filtration rate adjusted for body size based on cystatin C.','\0','GFR from Cystatin C Adjusted for BSA','CL-LBTEST','DBX-NCIT-C98736'),('CL-LBTEST-T-439',NULL,'Ghrelin','A measurement of total ghrelin in a biological specimen.','\0','Ghrelin; Growth Hormone Secretagogue Receptor Ligand; Motilin-related Peptide; Total Ghrelin','CL-LBTEST','DBX-NCIT-C112286'),('CL-LBTEST-T-44',NULL,'Alkaline Phosphatase/Creatinine','A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.','\0','Alkaline Phosphatase/Creatinine','CL-LBTEST','DBX-NCIT-C79438'),('CL-LBTEST-T-440',NULL,'Giant Neutrophils','A measurement of the giant neutrophils in a biological specimen.','\0','Giant Neutrophils','CL-LBTEST','DBX-NCIT-C96651'),('CL-LBTEST-T-441',NULL,'Giant Platelets','A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.','\0','Giant Platelets','CL-LBTEST','DBX-NCIT-C74728'),('CL-LBTEST-T-442',NULL,'Globulin','A measurement of the globulin protein in a biological specimen.','\0','Globulin','CL-LBTEST','DBX-NCIT-C74738'),('CL-LBTEST-T-443',NULL,'Glomerular Filtration Rate','A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman\'s capsule per unit of time.','\0','Glomerular Filtration Rate','CL-LBTEST','DBX-NCIT-C90505'),('CL-LBTEST-T-444',NULL,'Glomerular Filtration Rate Adj for BSA','A measurement of the glomerular filtration rate adjusted for body size.','\0','Glomerular Filtration Rate Adj for BSA','CL-LBTEST','DBX-NCIT-C98734'),('CL-LBTEST-T-445',NULL,'Glucagon','A measurement of the glucagon hormone in a biological specimen.','\0','Glucagon','CL-LBTEST','DBX-NCIT-C74859'),('CL-LBTEST-T-446',NULL,'Glucagon-Like Peptide-1','A measurement of the total glucagon-like peptide-1 in a biological specimen.','\0','Glucagon-Like Peptide-1; Total Glucagon-Like Peptide-1','CL-LBTEST','DBX-NCIT-C80183'),('CL-LBTEST-T-447',NULL,'Glucagon-Like Peptide-1, Active Form','A measurement of the active form of glucagon-like peptide-1 in a biological specimen.','\0','Glucagon-Like Peptide-1, Active Form','CL-LBTEST','DBX-NCIT-C80164'),('CL-LBTEST-T-448',NULL,'Glucose','A measurement of the glucose in a biological specimen.','\0','Glucose','CL-LBTEST','DBX-NCIT-C105585'),('CL-LBTEST-T-449',NULL,'Glucose Clearance','A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute).','\0','Glucose Clearance','CL-LBTEST','DBX-NCIT-C96652'),('CL-LBTEST-T-45',NULL,'Alpha Fetoprotein','A measurement of the alpha fetoprotein in a biological specimen.','\0','Alpha Fetoprotein','CL-LBTEST','DBX-NCIT-C74732'),('CL-LBTEST-T-450',NULL,'Glucose Excretion Rate','A measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour).','\0','Glucose Excretion Rate','CL-LBTEST','DBX-NCIT-C117834'),('CL-LBTEST-T-451',NULL,'Glucose-6-Phosphate Dehydrogenase','A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.','\0','Glucose-6-Phosphate Dehydrogenase','CL-LBTEST','DBX-NCIT-C80184'),('CL-LBTEST-T-452',NULL,'Glucose-dep Insulinotropic Pep, Intact','A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen.','\0','Glucose-dep Insulinotropic Pep, Intact; Intact GIP; Intact Gastric Inhibitory Polypeptide; Intact Glucose-dependent Insulinotropic Peptide','CL-LBTEST','DBX-NCIT-C106537'),('CL-LBTEST-T-453',NULL,'Glucose/Creatinine','A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.','\0','Glucose/Creatinine','CL-LBTEST','DBX-NCIT-C79447'),('CL-LBTEST-T-454',NULL,'Glucuronidase, Alpha','A measurement of the alpha glucuronidase in a biological specimen.','\0','Glucuronidase, Alpha','CL-LBTEST','DBX-NCIT-C80165'),('CL-LBTEST-T-455',NULL,'Glucuronidase, Beta','A measurement of the beta glucuronidase in a biological specimen.','\0','Glucuronidase, Beta','CL-LBTEST','DBX-NCIT-C80170'),('CL-LBTEST-T-456',NULL,'Glutamate','A measurement of the glutamate in a biological specimen.','\0','Glutamate; Glutamic Acid','CL-LBTEST','DBX-NCIT-C74739'),('CL-LBTEST-T-457',NULL,'Glutamate Dehydrogenase','A measurement of the glutamate dehydrogenase in a biological specimen.','\0','Glutamate Dehydrogenase','CL-LBTEST','DBX-NCIT-C79448'),('CL-LBTEST-T-458',NULL,'Glutamic Acid Decarboxylase 1','A measurement of the glutamic acid decarboxylase 1 in a biological specimen.','\0','Glutamic Acid Decarboxylase 1; Glutamic Acid Decarboxylase 67','CL-LBTEST','DBX-NCIT-C82015'),('CL-LBTEST-T-459',NULL,'Glutamic Acid Decarboxylase 2','A measurement of the glutamic acid decarboxylase 2 in a biological specimen.','\0','Glutamic Acid Decarboxylase 2; Glutamic Acid Decarboxylase 65','CL-LBTEST','DBX-NCIT-C82016'),('CL-LBTEST-T-46',NULL,'Alpha Fetoprotein Activity','A measurement of the alpha fetoprotein activity in a biological specimen.','\0','Alpha Fetoprotein Activity','CL-LBTEST','DBX-NCIT-C106499'),('CL-LBTEST-T-460',NULL,'Glutamic Acid Decarboxylase 2 Antibody','A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.','\0','Glutamic Acid Decarboxylase 2 Antibody; Glutamic Acid Decarboxylase 65 Antibody','CL-LBTEST','DBX-NCIT-C82017'),('CL-LBTEST-T-461',NULL,'Glutamic Acid Decarboxylase Antibody','A measurement of the glutamic acid decarboxylase antibody in a biological specimen.','\0','GAD Antibody; Glutamic Acid Decarboxylase Antibody','CL-LBTEST','DBX-NCIT-C96653'),('CL-LBTEST-T-462',NULL,'Glutathione S-Transferase, Alpha/Creat','A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.','\0','Glutathione S-Transferase, Alpha/Creat','CL-LBTEST','DBX-NCIT-C80166'),('CL-LBTEST-T-463',NULL,'Glutathione S-Transferase, Pi','A measurement of the Pi glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Pi','CL-LBTEST','DBX-NCIT-C80203'),('CL-LBTEST-T-464',NULL,'Glutathione S-Transferase, Theta','A measurement of the theta glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Theta','CL-LBTEST','DBX-NCIT-C80207'),('CL-LBTEST-T-465',NULL,'Glutathione S-Transferase, Total','A measurement of the total glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Total','CL-LBTEST','DBX-NCIT-C80185'),('CL-LBTEST-T-466',NULL,'Glutathione-S-Transferase/Creatinine','A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.','\0','Glutathione-S-Transferase/Creatinine','CL-LBTEST','DBX-NCIT-C79435'),('CL-LBTEST-T-467',NULL,'Gold','A measurement of the gold in a biological specimen.','\0','Gold','CL-LBTEST','DBX-NCIT-C80186'),('CL-LBTEST-T-468',NULL,'Gonadotropin Releasing Hormone','A measurement of the gonadotropin releasing hormone in a biological specimen.','\0','Gonadotropin Releasing Hormone; Luteinising Hormone Releasing Hormone','CL-LBTEST','DBX-NCIT-C74860'),('CL-LBTEST-T-469',NULL,'Granular Casts','A measurement of the granular (coarse and fine) casts present in a biological specimen.','\0','Granular Casts','CL-LBTEST','DBX-NCIT-C74768'),('CL-LBTEST-T-47',NULL,'Alpha Fetoprotein L1','A measurement of the alpha fetoprotein L1 in a biological specimen.','\0','Alpha Fetoprotein L1','CL-LBTEST','DBX-NCIT-C96562'),('CL-LBTEST-T-470',NULL,'Granular Coarse Casts','A measurement of the coarse granular casts present in a biological specimen.','\0','Granular Coarse Casts','CL-LBTEST','DBX-NCIT-C74765'),('CL-LBTEST-T-471',NULL,'Granular Fine Casts','A measurement of the fine granular casts present in a biological specimen.','\0','Granular Fine Casts','CL-LBTEST','DBX-NCIT-C74769'),('CL-LBTEST-T-472',NULL,'Granulocyte Colony Stimulating Factor','A measurement of the granulocyte colony stimulating factor in a biological specimen.','\0','Granulocyte Colony Stimulating Factor','CL-LBTEST','DBX-NCIT-C82018'),('CL-LBTEST-T-473',NULL,'Granulocyte Macrophage Colony Stm Factor','A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.','\0','Granulocyte Macrophage Colony Stm Factor','CL-LBTEST','DBX-NCIT-C82019'),('CL-LBTEST-T-474',NULL,'Granulocytes','A measurement of the granulocytes in a biological specimen.','\0','Granulocytes','CL-LBTEST','DBX-NCIT-C96654'),('CL-LBTEST-T-475',NULL,'Granulocytes/Total Cells','A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Granulocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98866'),('CL-LBTEST-T-476',NULL,'Growth Hormone Inhibiting Hormone','A measurement of the growth hormone inhibiting hormone in a biological specimen.','\0','Growth Hormone Inhibiting Hormone; Somatostatin','CL-LBTEST','DBX-NCIT-C74861'),('CL-LBTEST-T-477',NULL,'Growth Hormone Releasing Hormone','A measurement of the growth hormone releasing hormone in a biological specimen.','\0','Growth Hormone Releasing Hormone; Somatocrinin','CL-LBTEST','DBX-NCIT-C74862'),('CL-LBTEST-T-478',NULL,'Hairy Cells','A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.','\0','Hairy Cells','CL-LBTEST','DBX-NCIT-C74604'),('CL-LBTEST-T-479',NULL,'Hairy Cells/Lymphocytes','A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .','\0','Hairy Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C74640'),('CL-LBTEST-T-48',NULL,'Alpha Fetoprotein L2','A measurement of the alpha fetoprotein L2 in a biological specimen.','\0','Alpha Fetoprotein L2','CL-LBTEST','DBX-NCIT-C96563'),('CL-LBTEST-T-480',NULL,'Haptoglobin','A measurement of the haptoglobin protein in a biological specimen.','\0','Haptoglobin','CL-LBTEST','DBX-NCIT-C74740'),('CL-LBTEST-T-481',NULL,'HAV Viral Load','A measurement of the hepatitis A viral load in a biological specimen.','\0','HAV Viral Load','CL-LBTEST','DBX-NCIT-C92541'),('CL-LBTEST-T-482',NULL,'HBV Viral Load','A measurement of the hepatitis B viral load in a biological specimen.','\0','HBV Viral Load','CL-LBTEST','DBX-NCIT-C92542'),('CL-LBTEST-T-483',NULL,'HCT Corrected Reticulocytes/Erythrocytes','A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen.','\0','HCT Corrected Reticulocytes/Erythrocytes','CL-LBTEST','DBX-NCIT-C102274'),('CL-LBTEST-T-484',NULL,'HCV Viral Load','A measurement of the hepatitis C viral load in a biological specimen.','\0','HCV RNA; HCV Viral Load; Hepatitis C RNA','CL-LBTEST','DBX-NCIT-C92543'),('CL-LBTEST-T-485',NULL,'HDL Cholesterol','A measurement of the high density lipoprotein cholesterol in a biological specimen.','\0','HDL Cholesterol','CL-LBTEST','DBX-NCIT-C105587'),('CL-LBTEST-T-486',NULL,'HDL Cholesterol/LDL Cholesterol Ratio','A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.','\0','HDL Cholesterol/LDL Cholesterol Ratio','CL-LBTEST','DBX-NCIT-C100425'),('CL-LBTEST-T-487',NULL,'HDL Particle Size','A measurement of the average particle size of high-density lipoprotein in a biological specimen.','\0','HDL Particle Size','CL-LBTEST','DBX-NCIT-C103402'),('CL-LBTEST-T-488',NULL,'HDL-Cholesterol Subclass 2','A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.','\0','HDL-Cholesterol Subclass 2','CL-LBTEST','DBX-NCIT-C80187'),('CL-LBTEST-T-489',NULL,'HDL-Cholesterol Subclass 3','A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.','\0','HDL-Cholesterol Subclass 3','CL-LBTEST','DBX-NCIT-C80188'),('CL-LBTEST-T-49',NULL,'Alpha Fetoprotein L3','A measurement of the alpha fetoprotein L3 in a biological specimen.','\0','Alpha Fetoprotein L3','CL-LBTEST','DBX-NCIT-C96564'),('CL-LBTEST-T-490',NULL,'Heinz Bodies','A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.','\0','Heinz Bodies; Heinz-Erhlich Bodies','CL-LBTEST','DBX-NCIT-C74709'),('CL-LBTEST-T-491',NULL,'Heinz Bodies/Erythrocytes','A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen.','\0','Heinz Bodies/Erythrocytes','CL-LBTEST','DBX-NCIT-C111206'),('CL-LBTEST-T-492',NULL,'Helicobacter pylori IgG Antibody','A measurement of the Helicobacter pylori IgG antibody in a biological specimen.','\0','Helicobacter pylori IgG Antibody','CL-LBTEST','DBX-NCIT-C103403'),('CL-LBTEST-T-493',NULL,'Helmet Cells','A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.','\0','Helmet Cells','CL-LBTEST','DBX-NCIT-C74658'),('CL-LBTEST-T-494',NULL,'Hematocrit','The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).','\0','EVF; Erythrocyte Volume Fraction; Hematocrit; PCV; Packed Cell Volume','CL-LBTEST','DBX-NCIT-C64796'),('CL-LBTEST-T-495',NULL,'Hematocrit Corrected Reticulocytes','A measurement of the hematocrit corrected reticulocytes in a biological specimen.','\0','Hematocrit Corrected Reticulocytes','CL-LBTEST','DBX-NCIT-C102273'),('CL-LBTEST-T-496',NULL,'Hemoglobin','A measurement of the hemoglobin in a biological specimen.','\0','Hemoglobin','CL-LBTEST','DBX-NCIT-C64848'),('CL-LBTEST-T-497',NULL,'Hemoglobin A','A measurement of the hemoglobin A in a biological specimen.','\0','Hemoglobin A','CL-LBTEST','DBX-NCIT-C92258'),('CL-LBTEST-T-498',NULL,'Hemoglobin A1C','A measurement of the glycosylated hemoglobin in a biological specimen.','\0','Glycosylated Hemoglobin; Hemoglobin A1C','CL-LBTEST','DBX-NCIT-C64849'),('CL-LBTEST-T-499',NULL,'Hemoglobin A1C/Hemoglobin','A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen.','\0','Hemoglobin A1C/Hemoglobin','CL-LBTEST','DBX-NCIT-C111207'),('CL-LBTEST-T-5',NULL,'3,4-Dihydroxyphenylglycol','A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.','\0','3,4-Dihydroxyphenylglycol; 3.4 Dihydroxyphenylglycol','CL-LBTEST','DBX-NCIT-C101017'),('CL-LBTEST-T-50',NULL,'Alpha Glutathione-S-Transferase','A measurement of the alpha form of glutathione S-transferase in a biological specimen.','\0','Alpha Glutathione-S-Transferase','CL-LBTEST','DBX-NCIT-C79433'),('CL-LBTEST-T-500',NULL,'Hemoglobin A2','A measurement of the hemoglobin A2 in a biological specimen.','\0','Hemoglobin A2','CL-LBTEST','DBX-NCIT-C92259'),('CL-LBTEST-T-501',NULL,'Hemoglobin B','A measurement of the hemoglobin B in a biological specimen.','\0','Hemoglobin B','CL-LBTEST','DBX-NCIT-C92260'),('CL-LBTEST-T-502',NULL,'Hemoglobin C','A measurement of the hemoglobin C in a biological specimen.','\0','Hemoglobin C','CL-LBTEST','DBX-NCIT-C92261'),('CL-LBTEST-T-503',NULL,'Hemoglobin C Crystals','A measurement of hemoglobin C crystals in a biological specimen.','\0','Hemoglobin C Crystals','CL-LBTEST','DBX-NCIT-C112288'),('CL-LBTEST-T-504',NULL,'Hemoglobin Distribution Width','A measurement of the distribution of the hemoglobin concentration in red blood cells.','\0','Hemoglobin Distribution Width','CL-LBTEST','DBX-NCIT-C106525'),('CL-LBTEST-T-505',NULL,'Hemoglobin F','A measurement of the hemoglobin F in a biological specimen.','\0','Fetal Hemoglobin; Hemoglobin F','CL-LBTEST','DBX-NCIT-C92262'),('CL-LBTEST-T-506',NULL,'Hemolytic Index','A measurement of the destruction of red blood cells in a biological specimen.','\0','Hemolysis; Hemolytic Index','CL-LBTEST','DBX-NCIT-C111208'),('CL-LBTEST-T-507',NULL,'Hemosiderin','A measurement of the hemosiderin complex in a biological specimen.','\0','Hemosiderin','CL-LBTEST','DBX-NCIT-C96659'),('CL-LBTEST-T-508',NULL,'Hepatitis A Virus Antibody','A measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.','\0','Hepatitis A Virus Antibody','CL-LBTEST','DBX-NCIT-C92534'),('CL-LBTEST-T-509',NULL,'Hepatitis A Virus Antibody IgM','A measurement of hepatitis A virus antibody IgM in a biological specimen.','\0','Hepatitis A Virus Antibody IgM','CL-LBTEST','DBX-NCIT-C92271'),('CL-LBTEST-T-51',NULL,'Alpha Hydroxybutyrate Dehydrogenase','A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen.','\0','Alpha Hydroxybutyrate Dehydrogenase','CL-LBTEST','DBX-NCIT-C111126'),('CL-LBTEST-T-510',NULL,'Hepatitis B DNA','A measurement of hepatitis B virus DNA in a biological specimen.','\0','Hepatitis B DNA','CL-LBTEST','DBX-NCIT-C103404'),('CL-LBTEST-T-511',NULL,'Hepatitis B Virus Core Antibody','A measurement of the hepatitis B virus core antibody in a biological specimen.','\0','Hepatitis B Virus Core Antibody','CL-LBTEST','DBX-NCIT-C96660'),('CL-LBTEST-T-512',NULL,'Hepatitis B Virus Core IgM Antibody','A measurement of the hepatitis B virus core IgM antibody in a biological specimen.','\0','Hepatitis B Virus Core IgM Antibody','CL-LBTEST','DBX-NCIT-C96661'),('CL-LBTEST-T-513',NULL,'Hepatitis B Virus e Antibody','A measurement of the hepatitis B e antibody in a biological specimen.','\0','Hepatitis B Virus e Antibody','CL-LBTEST','DBX-NCIT-C96662'),('CL-LBTEST-T-514',NULL,'Hepatitis B Virus e Antigen','A measurement of the hepatitis B e antigen in a biological specimen.','\0','Hepatitis B Virus e Antigen','CL-LBTEST','DBX-NCIT-C96663'),('CL-LBTEST-T-515',NULL,'Hepatitis B Virus Surface Antibody','A measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.','\0','Anti-HBs; HBsAb; Hepatitis B Virus Surface Antibody','CL-LBTEST','DBX-NCIT-C74711'),('CL-LBTEST-T-516',NULL,'Hepatitis B Virus Surface Antigen','A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.','\0','HBsAg; Hepatitis B Virus Surface Antigen','CL-LBTEST','DBX-NCIT-C64850'),('CL-LBTEST-T-517',NULL,'Hepatitis C Virus Antibody','A measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.','\0','Hepatitis C Virus Antibody','CL-LBTEST','DBX-NCIT-C92535'),('CL-LBTEST-T-518',NULL,'Hepatitis C Virus Antigen','A measurement of the hepatitis C virus antigen in a biological specimen.','\0','Hepatitis C Virus Antigen','CL-LBTEST','DBX-NCIT-C116196'),('CL-LBTEST-T-519',NULL,'Hepatitis D Virus Antibody','A measurement of the hepatitis D virus antibody in a biological specimen.','\0','Hepatitis D Virus Antibody; Hepatitis Delta Antibody','CL-LBTEST','DBX-NCIT-C96664'),('CL-LBTEST-T-52',NULL,'Alpha Tocopherol','A measurement of the alpha tocopherol in a biological specimen.','\0','Alpha Tocopherol','CL-LBTEST','DBX-NCIT-C103349'),('CL-LBTEST-T-520',NULL,'Hepatitis E Virus IgG Antibody','A measurement of IgG antibody to the hepatitis E virus in a biological specimen.','\0','Hepatitis E Virus IgG Antibody','CL-LBTEST','DBX-NCIT-C106526'),('CL-LBTEST-T-521',NULL,'Hepatitis E Virus IgM Antibody','A measurement of the hepatitis E virus IgM antibody in a biological specimen.','\0','Hepatitis E Virus IgM Antibody','CL-LBTEST','DBX-NCIT-C96665'),('CL-LBTEST-T-522',NULL,'Hepatitis G RNA','A measurement of the Hepatitis G RNA in a biological specimen.','\0','Hepatitis G RNA','CL-LBTEST','DBX-NCIT-C92272'),('CL-LBTEST-T-523',NULL,'HER2 Antigen','A measurement of the HER2 antigen in a biological specimen.','\0','HER2 Antigen; HER2/NEU Antigen','CL-LBTEST','DBX-NCIT-C112291'),('CL-LBTEST-T-524',NULL,'Herpes Simplex Virus 1 IgG Antibody','A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.','\0','HSV-1 IgG Antibody; Herpes Simplex Virus 1 IgG Antibody','CL-LBTEST','DBX-NCIT-C96666'),('CL-LBTEST-T-525',NULL,'Herpes Simplex Virus 1 IgM Antibody','A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.','\0','Herpes Simplex Virus 1 IgM Antibody','CL-LBTEST','DBX-NCIT-C98738'),('CL-LBTEST-T-526',NULL,'Herpes Simplex Virus 1/2 IgG Antibody','A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.','\0','HSV-1/2 IgG Ab; Herpes Simplex Virus 1/2 IgG Antibody','CL-LBTEST','DBX-NCIT-C96697'),('CL-LBTEST-T-527',NULL,'Herpes Simplex Virus 1/2 IgM Antibody','A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.','\0','HSV-1/2 IgM Ab; Herpes Simplex Virus 1/2 IgM Antibody','CL-LBTEST','DBX-NCIT-C96698'),('CL-LBTEST-T-528',NULL,'Herpes Simplex Virus 2 IgG Antibody','A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.','\0','HSV-2 IgG Antibody; Herpes Simplex Virus 2 IgG Antibody','CL-LBTEST','DBX-NCIT-C96667'),('CL-LBTEST-T-529',NULL,'Herpes Simplex Virus 2 IgM Antibody','A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.','\0','Herpes Simplex Virus 2 IgM Antibody','CL-LBTEST','DBX-NCIT-C98739'),('CL-LBTEST-T-53',NULL,'Alpha Tocopherol/Vitamin E','A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen.','\0','Vitamin E Alpha Tocopherol','CL-LBTEST','DBX-NCIT-C103350'),('CL-LBTEST-T-530',NULL,'Herpes Simplex Virus 6 Antibody','A measurement of the herpes simplex virus 6 antibody in a biological specimen.','\0','Herpes Simplex Virus 6 Antibody','CL-LBTEST','DBX-NCIT-C112292'),('CL-LBTEST-T-531',NULL,'Heterophile Antibodies','A measurement of the heterophile antibodies in a biological specimen.','\0','Heterophile Antibodies','CL-LBTEST','DBX-NCIT-C81984'),('CL-LBTEST-T-532',NULL,'Heterophils','A measurement of heterophils (granular leukocytes) in a biological specimen from avian species.','\0','Heterophils','CL-LBTEST','DBX-NCIT-C116186'),('CL-LBTEST-T-533',NULL,'Heterophils/Leukocytes','A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species.','\0','Heterophils/Leukocytes','CL-LBTEST','DBX-NCIT-C116187'),('CL-LBTEST-T-534',NULL,'Hexokinase','A measurement of the hexokinase in a biological specimen.','\0','Hexokinase','CL-LBTEST','DBX-NCIT-C96668'),('CL-LBTEST-T-535',NULL,'High Absorption Retic/Reticulocytes','A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen.','\0','High Absorption Retic/Reticulocytes','CL-LBTEST','DBX-NCIT-C116189'),('CL-LBTEST-T-536',NULL,'High Absorption Reticulocytes','A measurement of the high absorption reticulocytes in a biological specimen.','\0','High Absorption Reticulocytes','CL-LBTEST','DBX-NCIT-C116188'),('CL-LBTEST-T-537',NULL,'Hippuric Acid Crystals','A measurement of the hippuric acid crystals present in a biological specimen.','\0','Hippuric Acid Crystals','CL-LBTEST','DBX-NCIT-C74754'),('CL-LBTEST-T-538',NULL,'Histamine','A measurement of the histamine in a biological specimen.','\0','Histamine','CL-LBTEST','DBX-NCIT-C80189'),('CL-LBTEST-T-539',NULL,'Histone 1 Antibody','A measurement of the total histone 1 antibodies in a biological specimen.','\0','Histone 1 Antibody','CL-LBTEST','DBX-NCIT-C112293'),('CL-LBTEST-T-54',NULL,'Alpha-1 Acid Glycoprotein','A measurement of the alpha-1 acid glycoprotein in a biological specimen.','\0','Alpha-1 Acid Glycoprotein','CL-LBTEST','DBX-NCIT-C100429'),('CL-LBTEST-T-540',NULL,'Histone 2A Antibody','A measurement of the total histone 2A antibodies in a biological specimen.','\0','Histone 2A Antibody','CL-LBTEST','DBX-NCIT-C112294'),('CL-LBTEST-T-541',NULL,'Histone 2B Antibody','A measurement of the total histone 2B antibodies in a biological specimen.','\0','Histone 2B Antibody','CL-LBTEST','DBX-NCIT-C112295'),('CL-LBTEST-T-542',NULL,'Histone 3 Antibody','A measurement of the total histone 3 antibodies in a biological specimen.','\0','Histone 3 Antibody','CL-LBTEST','DBX-NCIT-C112296'),('CL-LBTEST-T-543',NULL,'Histone 4 Antibody','A measurement of the total histone 4 antibodies in a biological specimen.','\0','Histone 4 Antibody','CL-LBTEST','DBX-NCIT-C112297'),('CL-LBTEST-T-544',NULL,'Histone Antibodies','A measurement of histone antibodies in a biological specimen.','\0','Anti-Histone Antibodies; Histone Antibodies','CL-LBTEST','DBX-NCIT-C111209'),('CL-LBTEST-T-545',NULL,'HIV Antibody','A measurement of the antibody reaction of a biological specimen to the HIV virus.','\0','HIV Antibody','CL-LBTEST','DBX-NCIT-C106527'),('CL-LBTEST-T-546',NULL,'HIV Viral Load','A measurement of the HIV viral load in a biological specimen.','\0','HIV Viral Load','CL-LBTEST','DBX-NCIT-C92544'),('CL-LBTEST-T-547',NULL,'HIV-1 Antibody','A measurement of the antibody reaction of a biological specimen to the HIV-1 virus.','\0','HIV-1 Antibody','CL-LBTEST','DBX-NCIT-C74713'),('CL-LBTEST-T-548',NULL,'HIV-1 Group M and O Nucleic Acid','A measurement of the HIV-1 group M and O nucleic acids in a biological specimen.','\0','HIV-1 Group M and O Nucleic Acid','CL-LBTEST','DBX-NCIT-C92263'),('CL-LBTEST-T-549',NULL,'HIV-1 Group O Antibody','A measurement of the HIV-1 group O antibody in a biological specimen.','\0','HIV-1 Group O Antibody','CL-LBTEST','DBX-NCIT-C92264'),('CL-LBTEST-T-55',NULL,'Alpha-1 Antitrypsin','A measurement of the alpha-1 antitrypsin in a biological specimen.','\0','Alpha-1 Antitrypsin; Serum Trypsin Inhibitor','CL-LBTEST','DBX-NCIT-C80167'),('CL-LBTEST-T-550',NULL,'HIV-1 p24 Antigen','A measurement of the HIV-1 p24 antigen in a biological specimen.','\0','HIV-1 p24 Antigen','CL-LBTEST','DBX-NCIT-C92265'),('CL-LBTEST-T-551',NULL,'HIV-1/2 Antibody','A measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.','\0','HIV-1/2 Antibody','CL-LBTEST','DBX-NCIT-C74714'),('CL-LBTEST-T-552',NULL,'HIV-2 Antibody','A measurement of the antibody reaction of a biological specimen to the HIV-2 virus.','\0','HIV-2 Antibody','CL-LBTEST','DBX-NCIT-C74715'),('CL-LBTEST-T-553',NULL,'HIV-2 Nucleic Acid','A measurement of the HIV-2 nucleic acids in a biological specimen.','\0','HIV-2 Nucleic Acid','CL-LBTEST','DBX-NCIT-C92266'),('CL-LBTEST-T-554',NULL,'HLA-B27 Antigen','A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.','\0','HLA-B27 Antigen; Human Leukocyte Antigen B27','CL-LBTEST','DBX-NCIT-C100460'),('CL-LBTEST-T-555',NULL,'Homocysteine','A measurement of the homocysteine amino acid in a biological specimen.','\0','Homocysteine','CL-LBTEST','DBX-NCIT-C74741'),('CL-LBTEST-T-556',NULL,'Homostat Model Assess of Insulin Rstn','An assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.','\0','Homeostatic Model Assessment of Insulin Resistance; Homostat Model Assess of Insulin Rstn','CL-LBTEST','DBX-NCIT-C100447'),('CL-LBTEST-T-557',NULL,'Homovanillic Acid','A measurement of the homovanillic acid metabolite in a biological specimen.','\0','Homovanillic Acid','CL-LBTEST','DBX-NCIT-C74863'),('CL-LBTEST-T-558',NULL,'Howell-Jolly Bodies','A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.','\0','Howell-Jolly Bodies','CL-LBTEST','DBX-NCIT-C74704'),('CL-LBTEST-T-559',NULL,'Human Albumin Antibody','A measurement of the human albumin antibody in a biological specimen.','\0','Human Albumin Antibody','CL-LBTEST','DBX-NCIT-C103405'),('CL-LBTEST-T-56',NULL,'Alpha-1 Globulin','A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.','\0','A1-Globulin; Alpha-1 Globulin','CL-LBTEST','DBX-NCIT-C92252'),('CL-LBTEST-T-560',NULL,'Human Anti-Mouse Antibody','A measurement of the human anti-mouse antibody in a biological specimen.','\0','HAMA','CL-LBTEST','DBX-NCIT-C103406'),('CL-LBTEST-T-561',NULL,'Human Anti-Sheep IgE Antibody','A measurement of the human anti-sheep IgE antibodies in a biological specimen.','\0','Human Anti-Sheep IgE Antibody','CL-LBTEST','DBX-NCIT-C98740'),('CL-LBTEST-T-562',NULL,'Human Anti-Sheep IgG Antibody','A measurement of the human anti-sheep IgG antibodies in a biological specimen.','\0','Human Anti-Sheep IgG Antibody','CL-LBTEST','DBX-NCIT-C98741'),('CL-LBTEST-T-563',NULL,'Human Anti-Sheep IgM Antibody','A measurement of the human anti-sheep IgM antibodies in a biological specimen.','\0','Human Anti-Sheep IgM Antibody','CL-LBTEST','DBX-NCIT-C98742'),('CL-LBTEST-T-564',NULL,'Human Epidermal Growth Factor Receptor 2','A measurement of the cells with positive expression of HER2 in a biological specimen.','\0','ERBB2; HER2/NEU; Human Epidermal Growth Factor Receptor 2','CL-LBTEST','DBX-NCIT-C112312'),('CL-LBTEST-T-565',NULL,'Hyaline Casts','A measurement of the hyaline casts present in a biological specimen.','\0','Hyaline Casts','CL-LBTEST','DBX-NCIT-C74770'),('CL-LBTEST-T-566',NULL,'Hyaluronic Acid','A measurement of hyaluronic acid in a biological specimen.','\0','Hyaluronic Acid','CL-LBTEST','DBX-NCIT-C112319'),('CL-LBTEST-T-567',NULL,'Hydrocodone','A measurement of the hydrocodone present in a biological specimen.','\0','Hydrocodone','CL-LBTEST','DBX-NCIT-C74879'),('CL-LBTEST-T-568',NULL,'Hydrogen','A measurement of the hydrogen in a biological specimen.','\0','Hydrogen','CL-LBTEST','DBX-NCIT-C102275'),('CL-LBTEST-T-569',NULL,'Hydromorphone','A measurement of the hydromorphone present in a biological specimen.','\0','Hydromorphone','CL-LBTEST','DBX-NCIT-C74880'),('CL-LBTEST-T-57',NULL,'Alpha-1 Globulin/Total Protein','A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.','\0','Alpha-1 Globulin/Total Protein','CL-LBTEST','DBX-NCIT-C92253'),('CL-LBTEST-T-570',NULL,'Hydroxyproline','A measurement of the total hydroxyproline in a biological specimen.','\0','Hydroxyproline','CL-LBTEST','DBX-NCIT-C80190'),('CL-LBTEST-T-571',NULL,'Hyperchromia','A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.','\0','Hyperchromia','CL-LBTEST','DBX-NCIT-C96669'),('CL-LBTEST-T-572',NULL,'Hypersegmented Cells','A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.','\0','Hypersegmented Cells','CL-LBTEST','DBX-NCIT-C74612'),('CL-LBTEST-T-573',NULL,'Hypochromia','An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.','\0','Hypochromia','CL-LBTEST','DBX-NCIT-C64802'),('CL-LBTEST-T-574',NULL,'Hypogranular Neutrophils','A measurement of the hypogranular neutrophils in a biological specimen.','\0','Hypogranular Neutrophils','CL-LBTEST','DBX-NCIT-C116201'),('CL-LBTEST-T-575',NULL,'Icteric Index','A measurement of the yellow color of a biological specimen, due to the presence of bile pigments.','\0','Icteric Index; Icterus','CL-LBTEST','DBX-NCIT-C111232'),('CL-LBTEST-T-576',NULL,'IDL Cholesterol','A measurement of the intermediate density lipoprotein in a biological specimen.','\0','IDL Cholesterol; Intermediate Density Lipoprotein','CL-LBTEST','DBX-NCIT-C112325'),('CL-LBTEST-T-577',NULL,'IDL Particles','A measurement of the concentration of IDL particles in a biological specimen.','\0','IDL Particles; Intermediate Density Lipoproteins Particles','CL-LBTEST','DBX-NCIT-C116197'),('CL-LBTEST-T-578',NULL,'IgG IgM IgA Total','A measurement of the total IgG, IgM, and IgA in a biological specimen.','\0','IgG IgM IgA Total','CL-LBTEST','DBX-NCIT-C111233'),('CL-LBTEST-T-579',NULL,'Immature Basophils','A measurement of the immature basophils in a biological specimen.','\0','Immature Basophils','CL-LBTEST','DBX-NCIT-C96670'),('CL-LBTEST-T-58',NULL,'Alpha-1 Microglobulin','A measurement of the alpha-1 microglobulin in a biological specimen.','\0','Alpha-1 Microglobulin; Protein HC','CL-LBTEST','DBX-NCIT-C100461'),('CL-LBTEST-T-580',NULL,'Immature Basophils/Leukocytes','A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.','\0','Immature Basophils/Leukocytes','CL-LBTEST','DBX-NCIT-C96671'),('CL-LBTEST-T-581',NULL,'Immature Cells','A measurement of the total immature cells in a blood specimen.','\0','Immature Cells','CL-LBTEST','DBX-NCIT-C96672'),('CL-LBTEST-T-582',NULL,'Immature Cells/Total Cells','A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen.','\0','Immature Cells/Total Cells','CL-LBTEST','DBX-NCIT-C111234'),('CL-LBTEST-T-583',NULL,'Immature Eosinophils','A measurement of the immature eosinophils in a biological specimen.','\0','Immature Eosinophils','CL-LBTEST','DBX-NCIT-C96673'),('CL-LBTEST-T-584',NULL,'Immature Eosinophils/Leukocytes','A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.','\0','Immature Eosinophils/Leukocytes','CL-LBTEST','DBX-NCIT-C96674'),('CL-LBTEST-T-585',NULL,'Immature Granulocytes','A measurement of the total immature granulocytes in a biological specimen.','\0','Immature Granulocytes','CL-LBTEST','DBX-NCIT-C96675'),('CL-LBTEST-T-586',NULL,'Immature Granulocytes/Leukocytes','A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).','\0','Immature Granulocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C100445'),('CL-LBTEST-T-587',NULL,'Immature Lymphocytes','A measurement of the immature lymphocytes in a biological specimen.','\0','Immature Lymphocytes','CL-LBTEST','DBX-NCIT-C100444'),('CL-LBTEST-T-588',NULL,'Immature Lymphocytes/Leukocytes','A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.','\0','Immature Lymphocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C100443'),('CL-LBTEST-T-589',NULL,'Immature Monocytes','A measurement of the immature monocytes in a biological specimen.','\0','Immature Monocytes','CL-LBTEST','DBX-NCIT-C96676'),('CL-LBTEST-T-59',NULL,'Alpha-1 Microglobulin/Creatinine','A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.','\0','Alpha-1 Microglobulin/Creatinine','CL-LBTEST','DBX-NCIT-C100462'),('CL-LBTEST-T-590',NULL,'Immature Monocytes/Leukocytes','A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.','\0','Immature Monocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C96677'),('CL-LBTEST-T-591',NULL,'Immature Neutrophils','A measurement of the total immature neutrophils in a biological specimen.','\0','Immature Neutrophils','CL-LBTEST','DBX-NCIT-C96678'),('CL-LBTEST-T-592',NULL,'Immature Neutrophils/Leukocytes','A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.','\0','Immature Neutrophils/Leukocytes','CL-LBTEST','DBX-NCIT-C100442'),('CL-LBTEST-T-593',NULL,'Immature Plasma Cells','A measurement of the immature plasma cells in a biological specimen.','\0','Immature Plasma Cells','CL-LBTEST','DBX-NCIT-C96679'),('CL-LBTEST-T-594',NULL,'Immature Plasma Cells/Lymphocytes','A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.','\0','Immature Plasma Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C96680'),('CL-LBTEST-T-595',NULL,'Immature Reticulocyte Fraction','A measurement of the immature reticulocyte fraction present in a biological specimen.','\0','Immature Reticulocyte Fraction','CL-LBTEST','DBX-NCIT-C102276'),('CL-LBTEST-T-596',NULL,'Immunoblasts','A measurement of the immunoblasts in a biological specimen.','\0','Lymphocytes, Immunoblastic','CL-LBTEST','DBX-NCIT-C103407'),('CL-LBTEST-T-597',NULL,'Immunoblasts/Lymphocytes','A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample.','\0','Immunoblasts/Lymphocytes; Lymphocytes, Immunoblastic/Lymphocytes','CL-LBTEST','DBX-NCIT-C106535'),('CL-LBTEST-T-598',NULL,'Immunoglobulin A','A measurement of the Immunoglobulin A in a biological specimen.','\0','Immunoglobulin A','CL-LBTEST','DBX-NCIT-C81969'),('CL-LBTEST-T-599',NULL,'Immunoglobulin D','A measurement of the Immunoglobulin D in a biological specimen.','\0','Immunoglobulin D','CL-LBTEST','DBX-NCIT-C98745'),('CL-LBTEST-T-6',NULL,'3,4-methylenedioxymethamphetamine','A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen.','\0','3,4-methylenedioxymethamphetamine; Ecstasy','CL-LBTEST','DBX-NCIT-C75359'),('CL-LBTEST-T-60',NULL,'Alpha-2 Antiplasmin','A measurement of the alpha-2 antiplasmin in a biological specimen.','\0','Alpha-2 Plasmin Inhibitor','CL-LBTEST','DBX-NCIT-C103351'),('CL-LBTEST-T-600',NULL,'Immunoglobulin E','A measurement of the Immunoglobulin E in a biological specimen.','\0','Immunoglobulin E','CL-LBTEST','DBX-NCIT-C81970'),('CL-LBTEST-T-601',NULL,'Immunoglobulin G','A measurement of the Immunoglobulin G in a biological specimen.','\0','Immunoglobulin G','CL-LBTEST','DBX-NCIT-C81971'),('CL-LBTEST-T-602',NULL,'Immunoglobulin M','A measurement of the Immunoglobulin M in a biological specimen.','\0','Immunoglobulin M','CL-LBTEST','DBX-NCIT-C81972'),('CL-LBTEST-T-603',NULL,'Inclusion Bodies','A measurement of the inclusion bodies in a biological specimen.','\0','Inclusion Bodies','CL-LBTEST','DBX-NCIT-C116184'),('CL-LBTEST-T-604',NULL,'Indican','A measurement of the indican present in a biological specimen.','\0','Indican','CL-LBTEST','DBX-NCIT-C82044'),('CL-LBTEST-T-605',NULL,'Indirect Bilirubin','A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.','\0','Indirect Bilirubin','CL-LBTEST','DBX-NCIT-C64483'),('CL-LBTEST-T-606',NULL,'Influenza A H1N1 Viral Load','A measurement of the Influenza A H1N1 viral load in a biological specimen.','\0','Influenza A H1N1 Viral Load','CL-LBTEST','DBX-NCIT-C92273'),('CL-LBTEST-T-607',NULL,'Influenza A IgG Antibody','A measurement of the Influenza A IgG antibody in a biological specimen.','\0','Influenza A IgG Antibody','CL-LBTEST','DBX-NCIT-C103408'),('CL-LBTEST-T-608',NULL,'Influenza A Viral Load','A measurement of the Influenza A viral load in a biological specimen.','\0','Influenza A Viral Load','CL-LBTEST','DBX-NCIT-C92274'),('CL-LBTEST-T-609',NULL,'Influenza B IgG Antibody','A measurement of the Influenza B IgG antibody in a biological specimen.','\0','Influenza B IgG Antibody','CL-LBTEST','DBX-NCIT-C103409'),('CL-LBTEST-T-61',NULL,'Alpha-2 Globulin','A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.','\0','A2-Globulin; Alpha-2 Globulin','CL-LBTEST','DBX-NCIT-C92254'),('CL-LBTEST-T-610',NULL,'Inhibin A','A measurement of the inhibin A in a biological specimen.','\0','Inhibin A','CL-LBTEST','DBX-NCIT-C82020'),('CL-LBTEST-T-611',NULL,'Inhibin B','A measurement of the inhibin B in a biological specimen.','\0','Inhibin B','CL-LBTEST','DBX-NCIT-C96681'),('CL-LBTEST-T-612',NULL,'Insulin','A measurement of the insulin in a biological specimen.','\0','Insulin','CL-LBTEST','DBX-NCIT-C74788'),('CL-LBTEST-T-613',NULL,'Insulin-Like Growth Factor Binding Prot3','A measurement of the insulin-like growth factor binding protein 3 in a biological specimen.','\0','Insulin-Like Growth Factor Binding Prot3; Insulin-Like Growth Factor Binding Protein 3','CL-LBTEST','DBX-NCIT-C112322'),('CL-LBTEST-T-614',NULL,'Insulin-like Growth Factor-1','A measurement of the insulin-like growth factor-1 in a biological specimen.','\0','Insulin-like Growth Factor-1','CL-LBTEST','DBX-NCIT-C74864'),('CL-LBTEST-T-615',NULL,'Insulin-like Growth Factor-2','A measurement of the insulin-like growth factor-2 in a biological specimen.','\0','Insulin-like Growth Factor-2','CL-LBTEST','DBX-NCIT-C74865'),('CL-LBTEST-T-616',NULL,'Interferon Alpha','A measurement of the interferon alpha in a biological specimen.','\0','Interferon Alpha','CL-LBTEST','DBX-NCIT-C81994'),('CL-LBTEST-T-617',NULL,'Interferon Beta','A measurement of the interferon beta in a biological specimen.','\0','Interferon Beta','CL-LBTEST','DBX-NCIT-C81995'),('CL-LBTEST-T-618',NULL,'Interferon Gamma','A measurement of the interferon gamma in a biological specimen.','\0','Interferon Gamma','CL-LBTEST','DBX-NCIT-C81996'),('CL-LBTEST-T-619',NULL,'Interleukin 1','A measurement of the interleukin 1 in a biological specimen.','\0','Interleukin 1','CL-LBTEST','DBX-NCIT-C74805'),('CL-LBTEST-T-62',NULL,'Alpha-2 Globulin/Total Protein','A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.','\0','Alpha-2 Globulin/Total Protein','CL-LBTEST','DBX-NCIT-C92255'),('CL-LBTEST-T-620',NULL,'Interleukin 1 Beta','A measurement of interleukin 1 beta in a biological specimen.','\0','IL-1B; IL1Beta; Interleukin 1 Beta; Interleukin 1B','CL-LBTEST','DBX-NCIT-C112323'),('CL-LBTEST-T-621',NULL,'Interleukin 1 Receptor Antagonist','A measurement of the interleukin 1 receptor antagonist in a biological specimen.','\0','IL-1RA; Interleukin 1 Receptor Antagonist','CL-LBTEST','DBX-NCIT-C112324'),('CL-LBTEST-T-622',NULL,'Interleukin 10','A measurement of the interleukin 10 in a biological specimen.','\0','Interleukin 10','CL-LBTEST','DBX-NCIT-C74806'),('CL-LBTEST-T-623',NULL,'Interleukin 11','A measurement of the interleukin 11 in a biological specimen.','\0','Interleukin 11','CL-LBTEST','DBX-NCIT-C74807'),('CL-LBTEST-T-624',NULL,'Interleukin 12','A measurement of the interleukin 12 in a biological specimen.','\0','Interleukin 12','CL-LBTEST','DBX-NCIT-C74808'),('CL-LBTEST-T-625',NULL,'Interleukin 13','A measurement of the interleukin 13 in a biological specimen.','\0','Interleukin 13','CL-LBTEST','DBX-NCIT-C74809'),('CL-LBTEST-T-626',NULL,'Interleukin 14','A measurement of the interleukin 14 in a biological specimen.','\0','Interleukin 14','CL-LBTEST','DBX-NCIT-C74810'),('CL-LBTEST-T-627',NULL,'Interleukin 15','A measurement of the interleukin 15 in a biological specimen.','\0','Interleukin 15','CL-LBTEST','DBX-NCIT-C74811'),('CL-LBTEST-T-628',NULL,'Interleukin 16','A measurement of the interleukin 16 in a biological specimen.','\0','Interleukin 16','CL-LBTEST','DBX-NCIT-C74812'),('CL-LBTEST-T-629',NULL,'Interleukin 17','A measurement of the interleukin 17 in a biological specimen.','\0','Interleukin 17','CL-LBTEST','DBX-NCIT-C74813'),('CL-LBTEST-T-63',NULL,'Alpha-2 Macroglobulin','A measurement of the alpha-2 macroglobulin in a biological specimen.','\0','Alpha-2 Macroglobulin','CL-LBTEST','DBX-NCIT-C80168'),('CL-LBTEST-T-630',NULL,'Interleukin 18','A measurement of the interleukin 18 in a biological specimen.','\0','Interleukin 18','CL-LBTEST','DBX-NCIT-C74814'),('CL-LBTEST-T-631',NULL,'Interleukin 19','A measurement of the interleukin 19 in a biological specimen.','\0','Interleukin 19','CL-LBTEST','DBX-NCIT-C74815'),('CL-LBTEST-T-632',NULL,'Interleukin 2','A measurement of the interleukin 2 in a biological specimen.','\0','Interleukin 2','CL-LBTEST','DBX-NCIT-C74816'),('CL-LBTEST-T-633',NULL,'Interleukin 20','A measurement of the interleukin 20 in a biological specimen.','\0','Interleukin 20','CL-LBTEST','DBX-NCIT-C74817'),('CL-LBTEST-T-634',NULL,'Interleukin 21','A measurement of the interleukin 21 in a biological specimen.','\0','Interleukin 21','CL-LBTEST','DBX-NCIT-C74818'),('CL-LBTEST-T-635',NULL,'Interleukin 22','A measurement of the interleukin 22 in a biological specimen.','\0','Interleukin 22','CL-LBTEST','DBX-NCIT-C74819'),('CL-LBTEST-T-636',NULL,'Interleukin 23','A measurement of the interleukin 23 in a biological specimen.','\0','Interleukin 23','CL-LBTEST','DBX-NCIT-C74820'),('CL-LBTEST-T-637',NULL,'Interleukin 24','A measurement of the interleukin 24 in a biological specimen.','\0','Interleukin 24','CL-LBTEST','DBX-NCIT-C74821'),('CL-LBTEST-T-638',NULL,'Interleukin 25','A measurement of the interleukin 25 in a biological specimen.','\0','Interleukin 25','CL-LBTEST','DBX-NCIT-C74822'),('CL-LBTEST-T-639',NULL,'Interleukin 26','A measurement of the interleukin 26 in a biological specimen.','\0','Interleukin 26','CL-LBTEST','DBX-NCIT-C74823'),('CL-LBTEST-T-64',NULL,'ALT/AST','A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample.','\0','ALT/AST','CL-LBTEST','DBX-NCIT-C106498'),('CL-LBTEST-T-640',NULL,'Interleukin 27','A measurement of the interleukin 27 in a biological specimen.','\0','Interleukin 27','CL-LBTEST','DBX-NCIT-C74824'),('CL-LBTEST-T-641',NULL,'Interleukin 28','A measurement of the interleukin 28 in a biological specimen.','\0','Interleukin 28','CL-LBTEST','DBX-NCIT-C74825'),('CL-LBTEST-T-642',NULL,'Interleukin 29','A measurement of the interleukin 29 in a biological specimen.','\0','Interleukin 29','CL-LBTEST','DBX-NCIT-C74826'),('CL-LBTEST-T-643',NULL,'Interleukin 3','A measurement of the interleukin 3 in a biological specimen.','\0','Interleukin 3','CL-LBTEST','DBX-NCIT-C74827'),('CL-LBTEST-T-644',NULL,'Interleukin 30','A measurement of the interleukin 30 in a biological specimen.','\0','Interleukin 30','CL-LBTEST','DBX-NCIT-C74828'),('CL-LBTEST-T-645',NULL,'Interleukin 31','A measurement of the interleukin 31 in a biological specimen.','\0','Interleukin 31','CL-LBTEST','DBX-NCIT-C74829'),('CL-LBTEST-T-646',NULL,'Interleukin 32','A measurement of the interleukin 32 in a biological specimen.','\0','Interleukin 32','CL-LBTEST','DBX-NCIT-C74830'),('CL-LBTEST-T-647',NULL,'Interleukin 33','A measurement of the interleukin 33 in a biological specimen.','\0','Interleukin 33','CL-LBTEST','DBX-NCIT-C74831'),('CL-LBTEST-T-648',NULL,'Interleukin 4','A measurement of the interleukin 4 in a biological specimen.','\0','Interleukin 4','CL-LBTEST','DBX-NCIT-C74832'),('CL-LBTEST-T-649',NULL,'Interleukin 5','A measurement of the interleukin 5 in a biological specimen.','\0','Interleukin 5','CL-LBTEST','DBX-NCIT-C74833'),('CL-LBTEST-T-65',NULL,'Aluminum','A measurement of aluminum in a biological specimen.','\0','Al; Aluminum','CL-LBTEST','DBX-NCIT-C111127'),('CL-LBTEST-T-650',NULL,'Interleukin 6','A measurement of the interleukin 6 in a biological specimen.','\0','Interleukin 6','CL-LBTEST','DBX-NCIT-C74834'),('CL-LBTEST-T-651',NULL,'Interleukin 7','A measurement of the interleukin 7 in a biological specimen.','\0','Interleukin 7','CL-LBTEST','DBX-NCIT-C74835'),('CL-LBTEST-T-652',NULL,'Interleukin 8','A measurement of the interleukin 8 in a biological specimen.','\0','Interleukin 8','CL-LBTEST','DBX-NCIT-C74836'),('CL-LBTEST-T-653',NULL,'Interleukin 9','A measurement of the interleukin 9 in a biological specimen.','\0','Interleukin 9','CL-LBTEST','DBX-NCIT-C74837'),('CL-LBTEST-T-654',NULL,'Inulin Clearance','A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).','\0','Inulin Clearance','CL-LBTEST','DBX-NCIT-C98748'),('CL-LBTEST-T-655',NULL,'Iohexol Clearance','A measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.','\0','Iohexol Clearance','CL-LBTEST','DBX-NCIT-C100439'),('CL-LBTEST-T-656',NULL,'Iothalamate Clearance','A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).','\0','Iothalamate Clearance','CL-LBTEST','DBX-NCIT-C98749'),('CL-LBTEST-T-657',NULL,'Iothalamate Clearance Adjusted for BSA','A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.','\0','Iothalamate Clearance Adjusted for BSA','CL-LBTEST','DBX-NCIT-C98750'),('CL-LBTEST-T-658',NULL,'Iron','A measurement of the iron in a biological specimen.','\0','FE; Iron','CL-LBTEST','DBX-NCIT-C74679'),('CL-LBTEST-T-659',NULL,'Iron Excretion Rate','A measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour).','\0','Iron Excretion Rate','CL-LBTEST','DBX-NCIT-C117838'),('CL-LBTEST-T-66',NULL,'Ammonia','A measurement of the ammonia in a biological specimen.','\0','Ammonia; NH3','CL-LBTEST','DBX-NCIT-C74799'),('CL-LBTEST-T-660',NULL,'Islet Cell 512 Antibody','A measurement of the islet cell 512 antibody in a biological specimen.','\0','Islet Cell 512 Antibody','CL-LBTEST','DBX-NCIT-C81985'),('CL-LBTEST-T-661',NULL,'Islet Cell 512 Antigen','A measurement of the islet cell 512 antigen in a biological specimen.','\0','Islet Cell 512 Antigen','CL-LBTEST','DBX-NCIT-C81986'),('CL-LBTEST-T-662',NULL,'Islet Neogenesis Assoc Protein Antibody','A measurement of the islet neogenesis associated protein antibody in a biological specimen.','\0','Islet Neogenesis Assoc Protein Antibody','CL-LBTEST','DBX-NCIT-C81987'),('CL-LBTEST-T-663',NULL,'Isoleucine','A measurement of the isoleucine in a biological specimen.','\0','Isoleucine','CL-LBTEST','DBX-NCIT-C103410'),('CL-LBTEST-T-664',NULL,'JC Virus Antibody','A measurement of the JC virus antibody in a biological specimen.','\0','JC Polyomavirus Antibody; JC Virus Antibody; JCV Antibody; John Cunningham Virus Antibody','CL-LBTEST','DBX-NCIT-C112326'),('CL-LBTEST-T-665',NULL,'Jo-1 Antibody','A measurement of the Jo-1 antibody in a biological specimen.','\0','Jo-1 Antibody','CL-LBTEST','DBX-NCIT-C100459'),('CL-LBTEST-T-666',NULL,'Kappa Light Chain, Free','A measurement of the free kappa light chain in a biological specimen.','\0','Kappa Light Chain, Free','CL-LBTEST','DBX-NCIT-C98730'),('CL-LBTEST-T-667',NULL,'Kappa Lt Chain,Free/Lambda Lt Chain,Free','A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.','\0','Kappa Lt Chain,Free/Lambda Lt Chain,Free','CL-LBTEST','DBX-NCIT-C98731'),('CL-LBTEST-T-668',NULL,'Ketone Bodies','A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen.','\0','Ketone Bodies','CL-LBTEST','DBX-NCIT-C111239'),('CL-LBTEST-T-669',NULL,'Ketones','A measurement of the ketones in a biological specimen.','\0','Ketones','CL-LBTEST','DBX-NCIT-C64854'),('CL-LBTEST-T-67',NULL,'Ammonium Biurate Crystals','A measurement of the ammonium biurate crystals present in a biological specimen.','\0','Acid Ammonium Urate Crystals; Ammonium Biurate Crystals; Ammonium Urate Crystals','CL-LBTEST','DBX-NCIT-C105590'),('CL-LBTEST-T-670',NULL,'Kidney Injury Molecule-1','A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.','\0','Hepatitis A Virus Cellular Receptor 1; KIM-1; Kidney Injury Molecule-1','CL-LBTEST','DBX-NCIT-C100433'),('CL-LBTEST-T-671',NULL,'Kurloff Cells','A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.','\0','Kurloff Cells','CL-LBTEST','DBX-NCIT-C96682'),('CL-LBTEST-T-672',NULL,'Lactate Dehydrogenase','A measurement of the lactate dehydrogenase in a biological specimen.','\0','Lactate Dehydrogenase','CL-LBTEST','DBX-NCIT-C64855'),('CL-LBTEST-T-673',NULL,'Lactate Dehydrogenase/Creatinine','A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.','\0','Lactate Dehydrogenase/Creatinine','CL-LBTEST','DBX-NCIT-C79449'),('CL-LBTEST-T-674',NULL,'Lactic Acid','A measurement of the lactic acid in a biological specimen.','\0','2-hydroxypropanoic acid; Lactate; Lactic Acid','CL-LBTEST','DBX-NCIT-C79450'),('CL-LBTEST-T-675',NULL,'Lactoferrin','A measurement of the lactoferrin in a biological specimen.','\0','Lactoferrin; Lactotransferrin','CL-LBTEST','DBX-NCIT-C82021'),('CL-LBTEST-T-676',NULL,'Lambda Light Chain, Free','A measurement of the free lambda light chain in a biological specimen.','\0','Lambda Light Chain, Free','CL-LBTEST','DBX-NCIT-C98732'),('CL-LBTEST-T-677',NULL,'Large Platelets','A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.','\0','Large Platelets','CL-LBTEST','DBX-NCIT-C74729'),('CL-LBTEST-T-678',NULL,'Large Unstained Cells','A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.','\0','Large Unstained Cells','CL-LBTEST','DBX-NCIT-C74659'),('CL-LBTEST-T-679',NULL,'Large Unstained Cells/Leukocytes','A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.','\0','Large Unstained Cells/Leukocytes','CL-LBTEST','DBX-NCIT-C79467'),('CL-LBTEST-T-68',NULL,'Ammonium Oxalate Crystals','A measurement of the ammonium oxalate crystals present in a urine specimen.','\0','Ammonium Oxalate Crystals','CL-LBTEST','DBX-NCIT-C74759'),('CL-LBTEST-T-680',NULL,'LDH Isoenzyme 1','A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.','\0','LDH Isoenzyme 1','CL-LBTEST','DBX-NCIT-C74887'),('CL-LBTEST-T-681',NULL,'LDH Isoenzyme 1/LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 1/LDH','CL-LBTEST','DBX-NCIT-C79451'),('CL-LBTEST-T-682',NULL,'LDH Isoenzyme 2','A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.','\0','LDH Isoenzyme 2','CL-LBTEST','DBX-NCIT-C74888'),('CL-LBTEST-T-683',NULL,'LDH Isoenzyme 2/LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 2/LDH','CL-LBTEST','DBX-NCIT-C79452'),('CL-LBTEST-T-684',NULL,'LDH Isoenzyme 3','A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.','\0','LDH Isoenzyme 3','CL-LBTEST','DBX-NCIT-C74889'),('CL-LBTEST-T-685',NULL,'LDH Isoenzyme 3/LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 3/LDH','CL-LBTEST','DBX-NCIT-C79453'),('CL-LBTEST-T-686',NULL,'LDH Isoenzyme 4','A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.','\0','LDH Isoenzyme 4','CL-LBTEST','DBX-NCIT-C74890'),('CL-LBTEST-T-687',NULL,'LDH Isoenzyme 4/LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 4/LDH','CL-LBTEST','DBX-NCIT-C79454'),('CL-LBTEST-T-688',NULL,'LDH Isoenzyme 5','A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.','\0','LDH Isoenzyme 5','CL-LBTEST','DBX-NCIT-C74891'),('CL-LBTEST-T-689',NULL,'LDH Isoenzyme 5/LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 5/LDH','CL-LBTEST','DBX-NCIT-C79455'),('CL-LBTEST-T-69',NULL,'Amorphous Crystals','A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.','\0','Amorphous Crystals','CL-LBTEST','DBX-NCIT-C74665'),('CL-LBTEST-T-690',NULL,'LDL Cholesterol','A measurement of the low density lipoprotein cholesterol in a biological specimen.','\0','LDL Cholesterol','CL-LBTEST','DBX-NCIT-C105588'),('CL-LBTEST-T-691',NULL,'LDL Particle Size','A measurement of the average particle size of low-density lipoprotein in a biological specimen.','\0','LDL Particle Size','CL-LBTEST','DBX-NCIT-C103412'),('CL-LBTEST-T-692',NULL,'Left Shift Neutrophils','An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen.','\0','Left Shift Neutrophils','CL-LBTEST','DBX-NCIT-C116202'),('CL-LBTEST-T-693',NULL,'Legionella pneumophila Antigen','A measurement of the Legionella pneumophila antigen in a biological specimen.','\0','Legionella pneumophila Antigen','CL-LBTEST','DBX-NCIT-C92275'),('CL-LBTEST-T-694',NULL,'Legionella pneumophila IgG Antibody','A measurement of the Legionella pneumophila IgG antibody in a biological specimen.','\0','Legionella pneumophila IgG Antibody','CL-LBTEST','DBX-NCIT-C92276'),('CL-LBTEST-T-695',NULL,'Legionella pneumophila IgG IgM Antibody','A measurement of the Legionella pneumophila IgG and IgM in a biological specimen.','\0','Legionella pneumophila IgG IgM Antibody','CL-LBTEST','DBX-NCIT-C92277'),('CL-LBTEST-T-696',NULL,'Legionella pneumophila IgM Antibody','A measurement of the Legionella pneumophila IgM antibody in a biological specimen.','\0','Legionella pneumophila IgM Antibody','CL-LBTEST','DBX-NCIT-C92278'),('CL-LBTEST-T-697',NULL,'Leptin','A measurement of the leptin hormone in a biological specimen.','\0','Leptin','CL-LBTEST','DBX-NCIT-C74866'),('CL-LBTEST-T-698',NULL,'Leucine Crystals','A measurement of the leucine crystals present in a biological specimen.','\0','Leucine Crystals','CL-LBTEST','DBX-NCIT-C74680'),('CL-LBTEST-T-699',NULL,'Leukemic Blasts','A measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.','\0','Leukemic Blasts','CL-LBTEST','DBX-NCIT-C74630'),('CL-LBTEST-T-7',NULL,'5 Prime Nucleotidase','A measurement of the 5\'-nucleotidase in a biological specimen.','\0','5 Prime Nucleotidase; 5\'-Ribonucleotide Phosphohydrolase','CL-LBTEST','DBX-NCIT-C79437'),('CL-LBTEST-T-70',NULL,'Amorphous Phosphate Crystals','A measurement of the amorphous phosphate crystals in a biological specimen.','\0','Amorphous Phosphate Crystals','CL-LBTEST','DBX-NCIT-C92243'),('CL-LBTEST-T-700',NULL,'Leukemic Blasts/Lymphocytes','A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.','\0','Leukemic Blasts/Lymphocytes','CL-LBTEST','DBX-NCIT-C74641'),('CL-LBTEST-T-701',NULL,'Leukemic Cells','A measurement of the leukemic cells in a biological specimen.','\0','Leukemic Cells; Residual Leukemic Cells','CL-LBTEST','DBX-NCIT-C116195'),('CL-LBTEST-T-702',NULL,'Leukocyte Cell Clumps','A measurement of white blood cell clumps in a biological specimen.','\0','Leukocyte Cell Clumps; WBC Clumps; White Blood Cell Clumps','CL-LBTEST','DBX-NCIT-C92246'),('CL-LBTEST-T-703',NULL,'Leukocyte Cell Morphology','An examination or assessment of the form and structure of white blood cells.','\0','Leukocyte Cell Morphology; WBC Morphology; White Blood Cell Morphology','CL-LBTEST','DBX-NCIT-C92297'),('CL-LBTEST-T-704',NULL,'Leukocyte Esterase','A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.','\0','Leukocyte Esterase','CL-LBTEST','DBX-NCIT-C64856'),('CL-LBTEST-T-705',NULL,'Leukocytes','A measurement of the leukocytes in a biological specimen.','\0','Leukocytes; White Blood Cells','CL-LBTEST','DBX-NCIT-C51948'),('CL-LBTEST-T-706',NULL,'Leukotriene B4','A measurement of the leukotriene B4 in a biological specimen.','\0','Leukotriene B4','CL-LBTEST','DBX-NCIT-C103413'),('CL-LBTEST-T-707',NULL,'Leukotriene D4','A measurement of the leukotriene D4 in a biological specimen.','\0','Leukotriene D4','CL-LBTEST','DBX-NCIT-C103414'),('CL-LBTEST-T-708',NULL,'Leukotriene E4','A measurement of the leukotriene E4 in a biological specimen.','\0','Leukotriene E4','CL-LBTEST','DBX-NCIT-C103415'),('CL-LBTEST-T-709',NULL,'Lipase','A measurement of the total lipase in a biological specimen.','\0','Lipase; Total Lipase','CL-LBTEST','DBX-NCIT-C117748'),('CL-LBTEST-T-71',NULL,'Amorphous Sediment','A measurement of the amorphous sediment present in a biological specimen.','\0','Amorphous Debris; Amorphous Sediment','CL-LBTEST','DBX-NCIT-C74666'),('CL-LBTEST-T-710',NULL,'Lipase, Gastric','A measurement of the gastric triacylglycerol lipase in a biological specimen.','\0','Gastric Triacylglycerol Lipase; LIPF; Lipase, Gastric','CL-LBTEST','DBX-NCIT-C117840'),('CL-LBTEST-T-711',NULL,'Lipase, Lysosomal Acid','A measurement of the lysosomal acid lipase in a biological specimen.','\0','Acid Cholesteryl Ester Hydrolase; LAL; LIPA; Lipase, Lysosomal Acid; Lysosomal Lipase','CL-LBTEST','DBX-NCIT-C117842'),('CL-LBTEST-T-712',NULL,'Lipase, Pancreatic','A measurement of the pancreatic triacylglycerol lipase in a biological specimen.','\0','Lipase, Pancreatic; PNLIP; Pancreatic Triacylglycerol Lipase','CL-LBTEST','DBX-NCIT-C117841'),('CL-LBTEST-T-713',NULL,'Lipemic Index','A measurement of the abnormally high concentration of lipid in a biological specimen.','\0','Lipemia; Lipemic Index','CL-LBTEST','DBX-NCIT-C111242'),('CL-LBTEST-T-714',NULL,'Lipocalin-2','A measurement of lipocalin-2 in a biological specimen.','\0','Lipocalin-2','CL-LBTEST','DBX-NCIT-C106539'),('CL-LBTEST-T-715',NULL,'Lipocalin-2/Creatinine','A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample.','\0','Lipocalin-2/Creatinine','CL-LBTEST','DBX-NCIT-C106540'),('CL-LBTEST-T-716',NULL,'Lipoprotein-a','A measurement of the lipoprotein-a in a biological specimen.','\0','Lipoprotein-a','CL-LBTEST','DBX-NCIT-C82022'),('CL-LBTEST-T-717',NULL,'Liver Kidney Microsomal Type 1 Antibody','A measurement of the liver kidney microsomal type 1 antibody in a biological specimen.','\0','LKM-1; Liver Kidney Microsomal Type 1 Antibody','CL-LBTEST','DBX-NCIT-C96683'),('CL-LBTEST-T-718',NULL,'Liver Kidney Microsomal Type 1 IgA Ab','A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgA Ab','CL-LBTEST','DBX-NCIT-C100456'),('CL-LBTEST-T-719',NULL,'Liver Kidney Microsomal Type 1 IgG Ab','A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgG Ab','CL-LBTEST','DBX-NCIT-C100454'),('CL-LBTEST-T-72',NULL,'Amorphous Urate Crystals','A measurement of the amorphous urate crystals in a biological specimen.','\0','Amorphous Urate Crystals','CL-LBTEST','DBX-NCIT-C92244'),('CL-LBTEST-T-720',NULL,'Liver Kidney Microsomal Type 1 IgM Ab','A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgM Ab','CL-LBTEST','DBX-NCIT-C100455'),('CL-LBTEST-T-721',NULL,'Low Absorption Retic/Reticulocytes','A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen.','\0','Low Absorption Retic/Reticulocytes','CL-LBTEST','DBX-NCIT-C116191'),('CL-LBTEST-T-722',NULL,'Low Absorption Reticulocytes','A measurement of the low absorption reticulocytes in a biological specimen.','\0','Low Absorption Reticulocytes','CL-LBTEST','DBX-NCIT-C116190'),('CL-LBTEST-T-723',NULL,'Lupus Anticoagulant Sensitive APTT','A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen.','\0','APTT-LA; Lupus Anticoagulant Sensitive APTT','CL-LBTEST','DBX-NCIT-C102277'),('CL-LBTEST-T-724',NULL,'Luteinizing Hormone','A measurement of the luteinizing hormone in a biological specimen.','\0','Luteinizing Hormone','CL-LBTEST','DBX-NCIT-C74790'),('CL-LBTEST-T-725',NULL,'Lymphoblasts','A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen.','\0','Lymphoblasts','CL-LBTEST','DBX-NCIT-C102278'),('CL-LBTEST-T-726',NULL,'Lymphoblasts/Leukocytes','A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen.','\0','Lymphoblasts/Leukocytes','CL-LBTEST','DBX-NCIT-C105444'),('CL-LBTEST-T-727',NULL,'Lymphocytes','A measurement of the lymphocytes in a biological specimen.','\0','Lymphocytes','CL-LBTEST','DBX-NCIT-C51949'),('CL-LBTEST-T-728',NULL,'Lymphocytes Atypical','A measurement of the atypical lymphocytes in a biological specimen.','\0','Lymphocytes Atypical','CL-LBTEST','DBX-NCIT-C64818'),('CL-LBTEST-T-729',NULL,'Lymphocytes Atypical/Leukocytes','A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.','\0','Lymphocytes Atypical/Leukocytes','CL-LBTEST','DBX-NCIT-C64819'),('CL-LBTEST-T-73',NULL,'Amphetamine','A measurement of any amphetamine class drug present in a biological specimen.','\0','Amphetamine','CL-LBTEST','DBX-NCIT-C74687'),('CL-LBTEST-T-730',NULL,'Lymphocytes/Leukocytes','A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.','\0','Lymphocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C64820'),('CL-LBTEST-T-731',NULL,'Lymphocytes/Total Cells','A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Lymphocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98751'),('CL-LBTEST-T-732',NULL,'Lymphoma Cells','A measurement of the malignant lymphocytes in a biological specimen.','\0','Lymphoma Cells','CL-LBTEST','DBX-NCIT-C74613'),('CL-LBTEST-T-733',NULL,'Lymphoma Cells/Lymphocytes','A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.','\0','Lymphoma Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C74910'),('CL-LBTEST-T-734',NULL,'Lymphotactin','A measurement of the lymphotactin in a biological specimen.','\0','Chemokine Ligand 1; Lymphotactin','CL-LBTEST','DBX-NCIT-C81955'),('CL-LBTEST-T-735',NULL,'Lysergic Acid Diethylamide','A measurement of the lysergic acid diethylamine (LSD) in a biological specimen.','\0','Acid; Lysergic Acid Diethylamide','CL-LBTEST','DBX-NCIT-C75354'),('CL-LBTEST-T-736',NULL,'M. tuberculosis IFN Gamma Response','A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.','\0','Mycobacterium tuberculosis IFN Gamma Response','CL-LBTEST','DBX-NCIT-C92241'),('CL-LBTEST-T-737',NULL,'Macroamylase','A measurement of macroamylase in a biological specimen.','\0','Macroamylase','CL-LBTEST','DBX-NCIT-C111243'),('CL-LBTEST-T-738',NULL,'Macrocytes','A measurement of the macrocytes in a biological specimen.','\0','Macrocytes','CL-LBTEST','DBX-NCIT-C64821'),('CL-LBTEST-T-739',NULL,'Macrophage Colony Stimulating Factor','A measurement of the macrophage colony stimulating factor in a biological specimen.','\0','Macrophage Colony Stimulating Factor','CL-LBTEST','DBX-NCIT-C80191'),('CL-LBTEST-T-74',NULL,'Amylase','A measurement of the total enzyme amylase in a biological specimen.','\0','Amylase','CL-LBTEST','DBX-NCIT-C64434'),('CL-LBTEST-T-740',NULL,'Macrophage Inflammatory Protein 1 Alpha','A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.','\0','Chemokine Ligand 3; Macrophage Inflammatory Protein 1 Alpha','CL-LBTEST','DBX-NCIT-C82023'),('CL-LBTEST-T-741',NULL,'Macrophage Inflammatory Protein 1 Beta','A measurement of the macrophage inflammatory protein 1 beta in a biological specimen.','\0','Chemokine Ligand 4; Macrophage Inflammatory Protein 1 Beta','CL-LBTEST','DBX-NCIT-C82024'),('CL-LBTEST-T-742',NULL,'Macrophage-Derived Chemokine','A measurement of the macrophage-derived chemokine in a biological specimen.','\0','Chemokine Ligand 22; Macrophage-Derived Chemokine','CL-LBTEST','DBX-NCIT-C81956'),('CL-LBTEST-T-743',NULL,'Macrophages','A measurement of the macrophages in a biological specimen.','\0','Macrophages','CL-LBTEST','DBX-NCIT-C74798'),('CL-LBTEST-T-744',NULL,'Macrophages/Total Cells','A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen.','\0','Macrophages/Total Cells','CL-LBTEST','DBX-NCIT-C111244'),('CL-LBTEST-T-745',NULL,'Magnesium','A measurement of the magnesium in a biological specimen.','\0','Magnesium','CL-LBTEST','DBX-NCIT-C64840'),('CL-LBTEST-T-746',NULL,'Magnesium/Creatinine','A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.','\0','Magnesium/Creatinine','CL-LBTEST','DBX-NCIT-C79456'),('CL-LBTEST-T-747',NULL,'Malignant Cells, NOS','A measurement of the malignant cells of all types in a biological specimen.','\0','Malignant Cells, NOS','CL-LBTEST','DBX-NCIT-C74660'),('CL-LBTEST-T-748',NULL,'Malignant Cells, NOS/Blood Cells','A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.','\0','Malignant Cells, NOS/Blood Cells','CL-LBTEST','DBX-NCIT-C74643'),('CL-LBTEST-T-749',NULL,'Mast Cells','A measurement of the mast cells in a biological specimen.','\0','Mast Cells; Mastocytes','CL-LBTEST','DBX-NCIT-C111246'),('CL-LBTEST-T-75',NULL,'Amylase, Pancreatic','A measurement of the pancreatic enzyme amylase in a biological specimen.','\0','Amylase, Pancreatic','CL-LBTEST','DBX-NCIT-C98767'),('CL-LBTEST-T-750',NULL,'Mast Cells/Total Cells','A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen.','\0','Mast Cells/Total Cells','CL-LBTEST','DBX-NCIT-C111247'),('CL-LBTEST-T-751',NULL,'Matrix Metalloproteinase 1','A measurement of the matrix metalloproteinase 1 in a biological specimen.','\0','Interstitial Collagenase; Matrix Metalloproteinase 1','CL-LBTEST','DBX-NCIT-C80192'),('CL-LBTEST-T-752',NULL,'Matrix Metalloproteinase 2','A measurement of the matrix metalloproteinase 2 in a biological specimen.','\0','Gelatinase A; Matrix Metalloproteinase 2','CL-LBTEST','DBX-NCIT-C80193'),('CL-LBTEST-T-753',NULL,'Matrix Metalloproteinase 3','A measurement of the matrix metalloproteinase 3 in a biological specimen.','\0','Matrix Metalloproteinase 3; Stromelysin 1','CL-LBTEST','DBX-NCIT-C80194'),('CL-LBTEST-T-754',NULL,'Matrix Metalloproteinase 7','A measurement of the matrix metalloproteinase 7 in a biological specimen.','\0','Matrilysin; Matrix Metalloproteinase 7','CL-LBTEST','DBX-NCIT-C80195'),('CL-LBTEST-T-755',NULL,'Matrix Metalloproteinase 8','A measurement of the matrix metalloproteinase 8 in a biological specimen.','\0','Matrix Metalloproteinase 8; Neutrophil Collagenase','CL-LBTEST','DBX-NCIT-C80196'),('CL-LBTEST-T-756',NULL,'Matrix Metalloproteinase 9','A measurement of the matrix metalloproteinase 9 in a biological specimen.','\0','Gelatinase B; Matrix Metalloproteinase 9','CL-LBTEST','DBX-NCIT-C80197'),('CL-LBTEST-T-757',NULL,'Mature Plasma Cells','A measurement of the mature plasma cells (plasmacytes) in a biological specimen.','\0','Mature Plasma Cells; Plasmacytes','CL-LBTEST','DBX-NCIT-C74661'),('CL-LBTEST-T-758',NULL,'Mature Plasma Cells/Lymphocytes','A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.','\0','Mature Plasma Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C74911'),('CL-LBTEST-T-759',NULL,'May-Hegglin Anomaly','A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.','\0','May-Hegglin Anomaly','CL-LBTEST','DBX-NCIT-C74614'),('CL-LBTEST-T-76',NULL,'Amylase, Salivary','A measurement of the salivary enzyme amylase in a biological specimen.','\0','Amylase, Salivary','CL-LBTEST','DBX-NCIT-C98780'),('CL-LBTEST-T-760',NULL,'MCV Reticulocytes','A measurement of the mean volume of reticulocytes in a biological specimen.','\0','MCV Reticulocytes; Mean Corpuscular Volume Reticulocytes','CL-LBTEST','DBX-NCIT-C114215'),('CL-LBTEST-T-761',NULL,'Mean Platelet Component','A measurement of the mean platelet component (platelet activity) in a blood specimen.','\0','Mean Platelet Component','CL-LBTEST','DBX-NCIT-C96686'),('CL-LBTEST-T-762',NULL,'Mean Platelet Dry Mass','A measurement of the mean platelet dry mass in a biological specimen.','\0','Mean Platelet Dry Mass','CL-LBTEST','DBX-NCIT-C114214'),('CL-LBTEST-T-763',NULL,'Mean Platelet Volume','A measurement of the average size of the platelets present in a blood sample.','\0','Mean Platelet Volume','CL-LBTEST','DBX-NCIT-C74730'),('CL-LBTEST-T-764',NULL,'Medium Absorption Retic/Reticulocytes','A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen.','\0','Medium Absorption Retic/Reticulocytes','CL-LBTEST','DBX-NCIT-C116193'),('CL-LBTEST-T-765',NULL,'Medium Absorption Reticulocytes','A measurement of the medium absorption reticulocytes in a biological specimen.','\0','Medium Absorption Reticulocytes','CL-LBTEST','DBX-NCIT-C116192'),('CL-LBTEST-T-766',NULL,'Megakaryoblasts','A measurement of the megakaryoblasts in a biological specimen.','\0','Megakaryoblasts','CL-LBTEST','DBX-NCIT-C98752'),('CL-LBTEST-T-767',NULL,'Megakaryoblasts/Total Cells','A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Megakaryoblasts/Total Cells','CL-LBTEST','DBX-NCIT-C98753'),('CL-LBTEST-T-768',NULL,'Megakaryocytes','A measurement of the megakaryocytes per unit of a biological specimen.','\0','Megakaryocytes','CL-LBTEST','DBX-NCIT-C96688'),('CL-LBTEST-T-769',NULL,'Megakaryocytes/Total Cells','A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Megakaryocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98867'),('CL-LBTEST-T-77',NULL,'Amyloid Beta 1-38','A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen.','\0','Amyloid Beta 1-38; Amyloid Beta 38; Amyloid Beta 38 Protein','CL-LBTEST','DBX-NCIT-C103352'),('CL-LBTEST-T-770',NULL,'Melatonin','A measurement of the melatonin hormone in a biological specimen.','\0','Melatonin','CL-LBTEST','DBX-NCIT-C74867'),('CL-LBTEST-T-771',NULL,'Meningeal Cells','A measurement of the mengingeal cells in a biological specimen.','\0','Meningeal Cells','CL-LBTEST','DBX-NCIT-C111250'),('CL-LBTEST-T-772',NULL,'Meningeal Cells/Total Cells','A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen.','\0','Meningeal Cells/Total Cells','CL-LBTEST','DBX-NCIT-C111251'),('CL-LBTEST-T-773',NULL,'Metamyelocytes','A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.','\0','Metamyelocytes','CL-LBTEST','DBX-NCIT-C74615'),('CL-LBTEST-T-774',NULL,'Metamyelocytes/Leukocytes','A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.','\0','Metamyelocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C74645'),('CL-LBTEST-T-775',NULL,'Metamyelocytes/Total Cells','A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Metamyelocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98754'),('CL-LBTEST-T-776',NULL,'Metanephrine','A measurement of the metanephrine in a biological specimen.','\0','Metadrenaline; Metanephrine','CL-LBTEST','DBX-NCIT-C116198'),('CL-LBTEST-T-777',NULL,'Methadone','A measurement of the methadone present in a biological specimen.','\0','Methadone','CL-LBTEST','DBX-NCIT-C74881'),('CL-LBTEST-T-778',NULL,'Methamphetamine','A measurement of the methamphetamine drug present in a biological specimen.','\0','Methamphetamine','CL-LBTEST','DBX-NCIT-C75348'),('CL-LBTEST-T-779',NULL,'Methaqualone','A measurement of the methaqualone present in a biological specimen.','\0','Methaqualone','CL-LBTEST','DBX-NCIT-C74882'),('CL-LBTEST-T-78',NULL,'Amyloid Beta 1-40','A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen.','\0','Amyloid Beta 1-40; Amyloid Beta 40; Amyloid Beta 40 Protein','CL-LBTEST','DBX-NCIT-C103353'),('CL-LBTEST-T-780',NULL,'Methemoglobin','A measurement of the methemoglobin in a biological specimen.','\0','Methemoglobin','CL-LBTEST','DBX-NCIT-C96689'),('CL-LBTEST-T-781',NULL,'Methylmalonic Acid','A measurement of the methylmalonic acid in a biological specimen.','\0','Methylmalonic Acid','CL-LBTEST','DBX-NCIT-C96690'),('CL-LBTEST-T-782',NULL,'Microcytes','A measurement of the microcytes in a biological specimen.','\0','Microcytes','CL-LBTEST','DBX-NCIT-C64822'),('CL-LBTEST-T-783',NULL,'Microfilaria','Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids.','\0','Microfilaria','CL-LBTEST','DBX-NCIT-C117843'),('CL-LBTEST-T-784',NULL,'Mid Cell Fraction','A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen.','\0','Mid Cell Fraction; Mid Cells','CL-LBTEST','DBX-NCIT-C116199'),('CL-LBTEST-T-785',NULL,'Mixed Casts','A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.','\0','Mixed Casts','CL-LBTEST','DBX-NCIT-C74771'),('CL-LBTEST-T-786',NULL,'Mixed Lymphocyte Reaction','A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals.','\0','Mixed Leukocyte Reaction; Mixed Lymphocyte Reaction','CL-LBTEST','DBX-NCIT-C16790'),('CL-LBTEST-T-787',NULL,'Monoblasts','A measurement of the monoblast cells in a biological specimen.','\0','Monoblasts','CL-LBTEST','DBX-NCIT-C74631'),('CL-LBTEST-T-788',NULL,'Monoblasts/Leukocytes','A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.','\0','Monoblasts/Leukocytes','CL-LBTEST','DBX-NCIT-C74646'),('CL-LBTEST-T-789',NULL,'Monoclonal Protein','A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.','\0','Monoclonal Immunoglobulin Protein; Paraprotein','CL-LBTEST','DBX-NCIT-C92291'),('CL-LBTEST-T-79',NULL,'Amyloid Beta 1-42','A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen.','\0','Amyloid Beta 1-42; Amyloid Beta 42; Amyloid Beta 42 Protein','CL-LBTEST','DBX-NCIT-C84809'),('CL-LBTEST-T-790',NULL,'Monoclonal Protein Spike','A measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein.','\0','Monoclonal Protein Spike','CL-LBTEST','DBX-NCIT-C117844'),('CL-LBTEST-T-791',NULL,'Monocyte Chemotactic Protein 1','A measurement of the monocyte chemotactic protein 1 in a biological specimen.','\0','Monocyte Chemotactic Protein 1','CL-LBTEST','DBX-NCIT-C82025'),('CL-LBTEST-T-792',NULL,'Monocytes','A measurement of the monocytes in a biological specimen.','\0','Monocytes','CL-LBTEST','DBX-NCIT-C64823'),('CL-LBTEST-T-793',NULL,'Monocytes/Leukocytes','A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.','\0','Monocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C64824'),('CL-LBTEST-T-794',NULL,'Monocytes/Macrocytes','A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample.','\0','Monocytes/Macrocytes','CL-LBTEST','DBX-NCIT-C106544'),('CL-LBTEST-T-795',NULL,'Monocytes/Total Cells','A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Monocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98872'),('CL-LBTEST-T-796',NULL,'Monocytoid Cells','A measurement of the monocytoid cells in a biological specimen.','\0','Monocytoid Cells','CL-LBTEST','DBX-NCIT-C111276'),('CL-LBTEST-T-797',NULL,'Monocytoid Cells/Total Cells','A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen.','\0','Monocytoid Cells/Total Cells','CL-LBTEST','DBX-NCIT-C111277'),('CL-LBTEST-T-798',NULL,'Monosodium Urate Crystals','A measurement of the monosodium urate crystals present in a biological specimen.','\0','Monosodium Urate Crystals','CL-LBTEST','DBX-NCIT-C74681'),('CL-LBTEST-T-799',NULL,'Morphine','A measurement of the morphine present in a biological specimen.','\0','Morphine','CL-LBTEST','DBX-NCIT-C74883'),('CL-LBTEST-T-8',NULL,'5-Hydroxyindoleacetic Acid','A measurement of 5-hydroxyindoleacetic acid in a biological specimen.','\0','5-Hydroxyindoleacetic Acid','CL-LBTEST','DBX-NCIT-C112217'),('CL-LBTEST-T-80',NULL,'Amyloid Beta Precursor Protein','A measurement of the amyloid beta precursor protein present in a biological specimen.','\0','Amyloid Beta Precursor; Amyloid Beta Precursor Protein; Amyloid Precursor Beta; Amyloid Precursor Protein','CL-LBTEST','DBX-NCIT-C105438'),('CL-LBTEST-T-800',NULL,'Mu Glutathione-S-Transferase','A measurement of the mu form of glutathione S-transferase in a biological specimen.','\0','Mu Glutathione-S-Transferase','CL-LBTEST','DBX-NCIT-C79457'),('CL-LBTEST-T-801',NULL,'Mu Glutathione-S-Transferase/Creatinine','A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.','\0','Mu Glutathione-S-Transferase/Creatinine','CL-LBTEST','DBX-NCIT-C79458'),('CL-LBTEST-T-802',NULL,'Mucous Threads','A measurement of the mucous threads present in a biological specimen.','\0','Mucous Threads','CL-LBTEST','DBX-NCIT-C74721'),('CL-LBTEST-T-803',NULL,'Mycobacterium tuberculosis Nucleic Acid','A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.','\0','Mycobacterium tuberculosis Nucleic Acid','CL-LBTEST','DBX-NCIT-C92279'),('CL-LBTEST-T-804',NULL,'Myelin Antibodies','A measurement of the myelin antibodies in a biological specimen.','\0','Myelin Antibodies','CL-LBTEST','DBX-NCIT-C103418'),('CL-LBTEST-T-805',NULL,'Myeloblasts','A measurement of the myeloblast cells in a biological specimen.','\0','Myeloblasts','CL-LBTEST','DBX-NCIT-C74632'),('CL-LBTEST-T-806',NULL,'Myeloblasts/Leukocytes','A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.','\0','Myeloblasts/Leukocytes','CL-LBTEST','DBX-NCIT-C64825'),('CL-LBTEST-T-807',NULL,'Myeloblasts/Total Cells','A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Myeloblasts/Total Cells','CL-LBTEST','DBX-NCIT-C98761'),('CL-LBTEST-T-808',NULL,'Myelocytes','A measurement of the myelocytes in a biological specimen.','\0','Myelocytes','CL-LBTEST','DBX-NCIT-C74662'),('CL-LBTEST-T-809',NULL,'Myelocytes/Leukocytes','A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.','\0','Myelocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C64826'),('CL-LBTEST-T-81',NULL,'Amyloid P','A measurement of the total amyloid P in a biological specimen.','\0','Amyloid P','CL-LBTEST','DBX-NCIT-C81998'),('CL-LBTEST-T-810',NULL,'Myelocytes/Total Cells','A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Myelocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98868'),('CL-LBTEST-T-811',NULL,'Myeloid/Erythroid Ratio','A relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.','\0','Myeloid/Erythroid Ratio','CL-LBTEST','DBX-NCIT-C92242'),('CL-LBTEST-T-812',NULL,'Myeloperoxidase','A measurement of the myeloperoxidase in a biological specimen.','\0','Myeloperoxidase','CL-LBTEST','DBX-NCIT-C80198'),('CL-LBTEST-T-813',NULL,'Myeloperoxidase Antibody','A measurement of the myeloperoxidase antibody in a biological specimen.','\0','Myeloperoxidase Antibody','CL-LBTEST','DBX-NCIT-C92280'),('CL-LBTEST-T-814',NULL,'Myoglobin','A measurement of myoglobin in a biological specimen.','\0','Myoglobin','CL-LBTEST','DBX-NCIT-C79436'),('CL-LBTEST-T-815',NULL,'Myoglobin/Creatinine','A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample.','\0','Myoglobin/Creatinine','CL-LBTEST','DBX-NCIT-C106546'),('CL-LBTEST-T-816',NULL,'Myosin Light Chain 3','A measurement of myosin light chain 3 in a biological specimen.','\0','Cardiac myosin light chain 1; Myosin Light Chain 3; Myosin light chain 1, slow-twitch muscle B/ventricular isoform','CL-LBTEST','DBX-NCIT-C106547'),('CL-LBTEST-T-817',NULL,'N-Acetyl Glucosamide','A measurement of N-acetyl glucosamide in a biological specimen.','\0','N-Acetyl Glucosamide; N-Acetyl Glucosamine','CL-LBTEST','DBX-NCIT-C79459'),('CL-LBTEST-T-818',NULL,'N-Acetyl Glucosamide/Creatinine','A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.','\0','N-Acetyl Glucosamide/Creatinine','CL-LBTEST','DBX-NCIT-C79460'),('CL-LBTEST-T-819',NULL,'N-acetyl-beta-D-glucosaminidase','A measurement of the N-acetyl-beta-D-glucosaminidase in a biological specimen.','\0','Beta-N-acetyl-D-glucosaminidase; NAG','CL-LBTEST','DBX-NCIT-C103419'),('CL-LBTEST-T-82',NULL,'Amyloid, Beta','A measurement of the total amyloid beta in a biological specimen.','\0','Amyloid, Beta; Beta Amyloid','CL-LBTEST','DBX-NCIT-C81999'),('CL-LBTEST-T-820',NULL,'N-telopeptide','A measurement of the N-telopeptide in a biological specimen.','\0','N-telopeptide','CL-LBTEST','DBX-NCIT-C74743'),('CL-LBTEST-T-821',NULL,'N-Terminal ProB-type Natriuretic Peptide','A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.','\0','N-Terminal ProB-type Natriuretic Peptide; N-terminal pro-Brain Natriuretic Peptide; NT proBNP II','CL-LBTEST','DBX-NCIT-C96610'),('CL-LBTEST-T-822',NULL,'Natural Killer Cell Function','A measurement of the natural killer cell function in a biological specimen.','\0','Natural Killer Cell Activity; Natural Killer Cell Function','CL-LBTEST','DBX-NCIT-C116203'),('CL-LBTEST-T-823',NULL,'Natural Killer Cells','A measurement of the total natural killer cells in a biological specimen.','\0','Natural Killer Cells','CL-LBTEST','DBX-NCIT-C98762'),('CL-LBTEST-T-824',NULL,'Neisseria gonorrhoeae Screening','Examination of a biological specimen to detect the presence of Neisseria gonorrhoeae.','\0','Neisseria gonorrhoeae Screening','CL-LBTEST','DBX-NCIT-C92298'),('CL-LBTEST-T-825',NULL,'Neopterin','A measurement of the neopterin in a biological specimen.','\0','Neopterin','CL-LBTEST','DBX-NCIT-C80199'),('CL-LBTEST-T-826',NULL,'Neuron Specific Enolase','A measurement of the neuron specific enolase in a biological specimen.','\0','Enolase 2; Gamma-enolase; Neuron Specific Enolase','CL-LBTEST','DBX-NCIT-C116205'),('CL-LBTEST-T-827',NULL,'Neuropeptide Y','A measurement of the neuropeptide Y in a biological specimen.','\0','Neuropeptide Y','CL-LBTEST','DBX-NCIT-C74892'),('CL-LBTEST-T-828',NULL,'Neutrophil Elastase','A measurement of the neutrophil elastase in a biological specimen.','\0','Neutrophil Elastase','CL-LBTEST','DBX-NCIT-C82026'),('CL-LBTEST-T-829',NULL,'Neutrophil Elastase, Polymorphonuclear','A measurement of the polymorphonuclear neutrophil elastase in a biological specimen.','\0','Neutrophil Elastase, Polymorphonuclear','CL-LBTEST','DBX-NCIT-C82027'),('CL-LBTEST-T-83',NULL,'Androstenediol','A measurement of the androstenediol metabolite in a biological specimen.','\0','Androstenediol','CL-LBTEST','DBX-NCIT-C74842'),('CL-LBTEST-T-830',NULL,'Neutrophilic Metamyelocytes','A measurement of the neutrophilic metamyelocytes in a biological specimen.','\0','Neutrophilic Metamyelocytes','CL-LBTEST','DBX-NCIT-C84822'),('CL-LBTEST-T-831',NULL,'Neutrophilic Myelocytes','A measurement of the neutrophilic myelocytes in a biological specimen.','\0','Neutrophilic Myelocytes','CL-LBTEST','DBX-NCIT-C84823'),('CL-LBTEST-T-832',NULL,'Neutrophils','A measurement of the neutrophils in a biological specimen.','\0','Neutrophils','CL-LBTEST','DBX-NCIT-C63321'),('CL-LBTEST-T-833',NULL,'Neutrophils Band Form','A measurement of the banded neutrophils in a biological specimen.','\0','Neutrophils Band Form','CL-LBTEST','DBX-NCIT-C64830'),('CL-LBTEST-T-834',NULL,'Neutrophils Band Form/Leukocytes','A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.','\0','Neutrophils Band Form/Leukocytes','CL-LBTEST','DBX-NCIT-C64831'),('CL-LBTEST-T-835',NULL,'Neutrophils, Segmented','A measurement of the segmented neutrophils in a biological specimen.','\0','Neutrophils, Segmented','CL-LBTEST','DBX-NCIT-C81997'),('CL-LBTEST-T-836',NULL,'Neutrophils, Segmented/Leukocytes','A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.','\0','Neutrophils, Segmented/Leukocytes','CL-LBTEST','DBX-NCIT-C82045'),('CL-LBTEST-T-837',NULL,'Neutrophils/Leukocytes','A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.','\0','Neutrophils/Leukocytes','CL-LBTEST','DBX-NCIT-C64827'),('CL-LBTEST-T-838',NULL,'Neutrophils/Total Cells','A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Neutrophils/Total Cells','CL-LBTEST','DBX-NCIT-C98763'),('CL-LBTEST-T-839',NULL,'Niacin','A measurement of the niacin in a biological specimen.','\0','Niacin; Vitamin B3','CL-LBTEST','DBX-NCIT-C74899'),('CL-LBTEST-T-84',NULL,'Androstenedione','A measurement of the androstenedione hormone in a biological specimen.','\0','4-Androstenedione; Androstenedione','CL-LBTEST','DBX-NCIT-C74843'),('CL-LBTEST-T-840',NULL,'Nitric Oxide','A measurement of the nitric oxide in a biological specimen.','\0','NO; Nitric Oxide','CL-LBTEST','DBX-NCIT-C112360'),('CL-LBTEST-T-841',NULL,'Nitrite','A measurement of the nitrite in a urine specimen.','\0','Nitrite','CL-LBTEST','DBX-NCIT-C64810'),('CL-LBTEST-T-842',NULL,'Non-HDL Cholesterol','A measurement of the non-high density lipoprotein cholesterol in a biological specimen.','\0','Non-HDL Cholesterol; Non-High Density Lipoprotein','CL-LBTEST','DBX-NCIT-C116204'),('CL-LBTEST-T-843',NULL,'Non-Phosphorylated Tau Protein','A measurement of the non-phosphorylated Tau protein in a biological specimen.','\0','Non-Phosphorylated Tau Protein','CL-LBTEST','DBX-NCIT-C84811'),('CL-LBTEST-T-844',NULL,'Non-Prostatic Acid Phosphatase','A measurement of the non-prostatic acid phosphatase in a biological specimen.','\0','Non-Prostatic Acid Phosphatase','CL-LBTEST','DBX-NCIT-C100434'),('CL-LBTEST-T-845',NULL,'Norepinephrine','A measurement of the norepinephrine hormone in a biological specimen.','\0','Noradrenaline; Norepinephrine','CL-LBTEST','DBX-NCIT-C74868'),('CL-LBTEST-T-846',NULL,'Normoblasts/Total Cells','A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Normoblasts/Total Cells','CL-LBTEST','DBX-NCIT-C98764'),('CL-LBTEST-T-847',NULL,'Nuclear Swelling','A measurement of the expansion of the nucleus of the cells in a biological specimen.','\0','Nuclear Swelling','CL-LBTEST','DBX-NCIT-C114213'),('CL-LBTEST-T-848',NULL,'Nucleated Erythrocytes','A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.','\0','Nucleated Erythrocytes; Nucleated Red Blood Cells','CL-LBTEST','DBX-NCIT-C74705'),('CL-LBTEST-T-849',NULL,'Nucleated Erythrocytes/Erythrocytes','A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.','\0','Nucleated Erythrocytes/Erythrocytes; Nucleated Red Blood Cells/Erythrocytes','CL-LBTEST','DBX-NCIT-C74647'),('CL-LBTEST-T-85',NULL,'Angiopoietin 1','A measurement of angiopoietin 1 in a biological specimen.','\0','Angiopoietin 1','CL-LBTEST','DBX-NCIT-C111128'),('CL-LBTEST-T-850',NULL,'Nucleated Erythrocytes/Leukocytes','A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.','\0','Nucleated Erythrocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C82046'),('CL-LBTEST-T-851',NULL,'Occult Blood','A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination.','\0','Occult Blood','CL-LBTEST','DBX-NCIT-C74686'),('CL-LBTEST-T-852',NULL,'Opiate','A measurement of any opiate class drug present in a biological specimen.','\0','Opiate','CL-LBTEST','DBX-NCIT-C74796'),('CL-LBTEST-T-853',NULL,'Osmolality','A measurement of the osmoles of solute per unit of biological specimen.','\0','Osmolality','CL-LBTEST','DBX-NCIT-C74801'),('CL-LBTEST-T-854',NULL,'Osmolarity','A measurement of the osmoles of solute per liter of solution.','\0','Osmolarity','CL-LBTEST','DBX-NCIT-C74802'),('CL-LBTEST-T-855',NULL,'Osteocalcin','A measurement of the osteocalcin in a biological specimen.','\0','Osteocalcin','CL-LBTEST','DBX-NCIT-C74744'),('CL-LBTEST-T-856',NULL,'Osteoprotegerin','A measurement of the osteoprotegerin in a biological specimen.','\0','OCIF; Osteoclastogenesis Inhibitory Factor; Osteoprotegerin; TNFRS11B; Tumor Necrosis Factor Receptor Superfamily Member 11b','CL-LBTEST','DBX-NCIT-C116206'),('CL-LBTEST-T-857',NULL,'Ova and Parasite','A measurement of the parasites and ova in a biological specimen.','\0','Ova and Parasite','CL-LBTEST','DBX-NCIT-C100452'),('CL-LBTEST-T-858',NULL,'Oxalate','A measurement of the oxalate in a biological specimen.','\0','Ethanedioate; Oxalate','CL-LBTEST','DBX-NCIT-C92250'),('CL-LBTEST-T-859',NULL,'Oxalate/Creatinine','A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen.','\0','Oxalate/Creatinine','CL-LBTEST','DBX-NCIT-C117983'),('CL-LBTEST-T-86',NULL,'Angiotensin Converting Enzyme','A measurement of the angiotensin converting enzyme in a biological specimen.','\0','Angiotensin Converting Enzyme','CL-LBTEST','DBX-NCIT-C80169'),('CL-LBTEST-T-860',NULL,'Oxycodone','A measurement of the oxycodone present in a biological specimen.','\0','Oxycodone; Oxycontin','CL-LBTEST','DBX-NCIT-C74884'),('CL-LBTEST-T-861',NULL,'Oxygen Capacity','A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.','\0','Oxygen Capacity','CL-LBTEST','DBX-NCIT-C96614'),('CL-LBTEST-T-862',NULL,'Oxygen Content','A measurement of the amount of oxygen content in a biological specimen.','\0','Oxygen Content','CL-LBTEST','DBX-NCIT-C111284'),('CL-LBTEST-T-863',NULL,'Oxygen Saturation','A measurement of the oxygen-hemoglobin saturation of a volume of blood.','\0','Oxygen Saturation','CL-LBTEST','DBX-NCIT-C60832'),('CL-LBTEST-T-864',NULL,'Oxyhemoglobin','A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen.','\0','Oxyhemoglobin','CL-LBTEST','DBX-NCIT-C96616'),('CL-LBTEST-T-865',NULL,'Oxytocin','A measurement of the oxytocin hormone in a biological specimen.','\0','Oxytocin; Oxytoxin','CL-LBTEST','DBX-NCIT-C74869'),('CL-LBTEST-T-866',NULL,'P-Selectin','A measurement of total P-selectin in a biological specimen.','\0','GMP-140; P-Selectin','CL-LBTEST','DBX-NCIT-C117850'),('CL-LBTEST-T-867',NULL,'P50 Oxygen','A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen.','\0','P50 Oxygen','CL-LBTEST','DBX-NCIT-C102279'),('CL-LBTEST-T-868',NULL,'Pancreatic Elastase 1','A measurement of the pancreatic elastase 1 in a biological specimen.','\0','Pancreatic Elastase 1','CL-LBTEST','DBX-NCIT-C82028'),('CL-LBTEST-T-869',NULL,'Pancreatic Elastase 1, Polymorphonuclear','A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.','\0','Pancreatic Elastase 1, Polymorphonuclear','CL-LBTEST','DBX-NCIT-C82029'),('CL-LBTEST-T-87',NULL,'Angiotensin I','A measurement of the angiotensin I hormone in a biological specimen.','\0','Angiotensin I','CL-LBTEST','DBX-NCIT-C74844'),('CL-LBTEST-T-870',NULL,'Pancreatic Polypeptide','A measurement of the pancreatic polypeptide in a biological specimen.','\0','Pancreatic Polypeptide','CL-LBTEST','DBX-NCIT-C80201'),('CL-LBTEST-T-871',NULL,'Panel Reactive Antibody','A measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen.','\0','PRA Score; Panel Reactive Antibody; Percent Panel Reactive Antibody; Percent Reactive Antibody','CL-LBTEST','DBX-NCIT-C116210'),('CL-LBTEST-T-872',NULL,'Pappenheimer Bodies','A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.','\0','Pappenheimer Bodies','CL-LBTEST','DBX-NCIT-C74616'),('CL-LBTEST-T-873',NULL,'Parathyroid Hormone, C-Terminal','A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, C-Terminal','CL-LBTEST','DBX-NCIT-C81964'),('CL-LBTEST-T-874',NULL,'Parathyroid Hormone, Fragmented','A measurement of the fragmented parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, Fragmented','CL-LBTEST','DBX-NCIT-C74784'),('CL-LBTEST-T-875',NULL,'Parathyroid Hormone, Intact','A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.','\0','Parathyroid Hormone, Intact','CL-LBTEST','DBX-NCIT-C74789'),('CL-LBTEST-T-876',NULL,'Parathyroid Hormone, Mid-Molecule','A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, Mid-Molecule','CL-LBTEST','DBX-NCIT-C81965'),('CL-LBTEST-T-877',NULL,'Parathyroid Hormone, N-Terminal','A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, N-Terminal','CL-LBTEST','DBX-NCIT-C81966'),('CL-LBTEST-T-878',NULL,'Parathyroid Hormone, Whole','A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen.','\0','Parathyroid Hormone, Whole','CL-LBTEST','DBX-NCIT-C103451'),('CL-LBTEST-T-879',NULL,'Parathyroid Hormone-related Protein','A measurement of parathyroid hormone-related protein in a biological specimen.','\0','Parathyroid Hormone-related Peptide; Parathyroid Hormone-related Protein','CL-LBTEST','DBX-NCIT-C117851'),('CL-LBTEST-T-88',NULL,'Angiotensin II','A measurement of the angiotensin II hormone in a biological specimen.','\0','Angiotensin II','CL-LBTEST','DBX-NCIT-C74845'),('CL-LBTEST-T-880',NULL,'Parietal Cell Antibody','A measurement of the parietal cell antibody in a biological specimen.','\0','Anti-Parietal Cell Antibody; Parietal Cell Antibody','CL-LBTEST','DBX-NCIT-C116207'),('CL-LBTEST-T-881',NULL,'Partial Pressure Carbon Dioxide','A measurement of the pressure of carbon dioxide in a biological specimen.','\0','Partial Pressure Carbon Dioxide','CL-LBTEST','DBX-NCIT-C82625'),('CL-LBTEST-T-882',NULL,'Partial Pressure Oxygen','A measurement of the pressure of oxygen in a biological specimen.','\0','Partial Pressure Oxygen','CL-LBTEST','DBX-NCIT-C71251'),('CL-LBTEST-T-883',NULL,'Parvovirus B19 IgG Antibody','A measurement of the Parvovirus B19 IgG antibody in a biological specimen.','\0','Parvovirus B19 IgG Antibody','CL-LBTEST','DBX-NCIT-C96617'),('CL-LBTEST-T-884',NULL,'Parvovirus B19 IgM Antibody','A measurement of the Parvovirus B19 IgM antibody in a biological specimen.','\0','Parvovirus B19 IgM Antibody','CL-LBTEST','DBX-NCIT-C96618'),('CL-LBTEST-T-885',NULL,'Pelger Huet Anomaly','A measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.','\0','Pelger Huet Anomaly','CL-LBTEST','DBX-NCIT-C74617'),('CL-LBTEST-T-886',NULL,'Pemphigoid Antibodies','A measurement of the pemphigoid antibodies in a biological specimen.','\0','Pemphigoid Antibodies','CL-LBTEST','DBX-NCIT-C81988'),('CL-LBTEST-T-887',NULL,'Pepsinogen','A measurement of the pepsinogen in a biological specimen.','\0','Pepsinogen','CL-LBTEST','DBX-NCIT-C100122'),('CL-LBTEST-T-888',NULL,'Pepsinogen A','A measurement of the pepsinogen A in a biological specimen.','\0','PGA; Pepsinogen A','CL-LBTEST','DBX-NCIT-C100469'),('CL-LBTEST-T-889',NULL,'Pepsinogen C','A measurement of the pepsinogen C in a biological specimen.','\0','PGC; Pepsinogen C','CL-LBTEST','DBX-NCIT-C100470'),('CL-LBTEST-T-89',NULL,'Angiotensinogen','A measurement of the angiotensinogen hormone in a biological specimen.','\0','Angiotensin Precursor; Angiotensinogen','CL-LBTEST','DBX-NCIT-C74846'),('CL-LBTEST-T-890',NULL,'Pepsinogen I','A measurement of the pepsinogen I in a biological specimen.','\0','PGI; Pepsinogen I','CL-LBTEST','DBX-NCIT-C100467'),('CL-LBTEST-T-891',NULL,'Pepsinogen II','A measurement of the pepsinogen II in a biological specimen.','\0','PGII; Pepsinogen II','CL-LBTEST','DBX-NCIT-C100468'),('CL-LBTEST-T-892',NULL,'Peptide YY','A measurement of the peptide YY in a biological specimen.','\0','Peptide Tyrosine Tyrosine; Peptide YY','CL-LBTEST','DBX-NCIT-C80202'),('CL-LBTEST-T-893',NULL,'Periostin','A measurement of the periostin in a biological specimen.','\0','OSF2; Osteoblast Specific Factor 2; POSTN; Periostin','CL-LBTEST','DBX-NCIT-C112395'),('CL-LBTEST-T-894',NULL,'pH','The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid.','\0','pH','CL-LBTEST','DBX-NCIT-C45997'),('CL-LBTEST-T-895',NULL,'Phencyclidine','A measurement of the phencyclidine present in a biological specimen.','\0','Phencyclidine; Phenylcyclohexylpiperidine','CL-LBTEST','DBX-NCIT-C74694'),('CL-LBTEST-T-896',NULL,'Phenothiazine','A measurement of the phenothiazine present in a biological specimen.','\0','Dibenzothiazine; Phenothiazine','CL-LBTEST','DBX-NCIT-C74695'),('CL-LBTEST-T-897',NULL,'Phosphate','A measurement of the phosphate in a biological specimen.','\0','Inorganic Phosphate; Phosphate; Phosphorus','CL-LBTEST','DBX-NCIT-C64857'),('CL-LBTEST-T-898',NULL,'Phosphate Clearance','A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute).','\0','Phosphate Clearance','CL-LBTEST','DBX-NCIT-C106553'),('CL-LBTEST-T-899',NULL,'Phosphate/Creatinine','A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.','\0','Phosphate/Creatinine','CL-LBTEST','DBX-NCIT-C79461'),('CL-LBTEST-T-9',NULL,'6-Monoacetylmorphine','A measurement of the 6-monoacetylmorphine present in a biological specimen.','\0','6-Monoacetylmorphine','CL-LBTEST','DBX-NCIT-C74876'),('CL-LBTEST-T-90',NULL,'Anion Gap','A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.','\0','Anion Gap','CL-LBTEST','DBX-NCIT-C74685'),('CL-LBTEST-T-900',NULL,'Phospholipid','A measurement of the phospholipids in a biological specimen.','\0','Phospholipid','CL-LBTEST','DBX-NCIT-C96623'),('CL-LBTEST-T-901',NULL,'Phosphorus Excretion Rate','A measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour).','\0','Phosphorus Excretion Rate','CL-LBTEST','DBX-NCIT-C117845'),('CL-LBTEST-T-902',NULL,'Phosphorylated Tau Protein','A measurement of the phosphorylated Tau protein in a biological specimen.','\0','Phosphorylated Tau Protein','CL-LBTEST','DBX-NCIT-C84812'),('CL-LBTEST-T-903',NULL,'Plasma Cells/Total Cells','A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Plasma Cells/Total Cells','CL-LBTEST','DBX-NCIT-C98869'),('CL-LBTEST-T-904',NULL,'Plasmacytoid Lymphocytes','A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.','\0','Plasmacytoid Lymphocytes; Plymphocytes','CL-LBTEST','DBX-NCIT-C74618'),('CL-LBTEST-T-905',NULL,'Plasmacytoid Lymphocytes/Lymphocytes','A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.','\0','Plasmacytoid Lymphocytes/Lymphocytes','CL-LBTEST','DBX-NCIT-C74648'),('CL-LBTEST-T-906',NULL,'Plasminogen Activator Inhibitor-1','A measurement of the plasminogen activator inhibitor-1 in a biological specimen.','\0','Plasminogen Activator Inhibitor-1','CL-LBTEST','DBX-NCIT-C82030'),('CL-LBTEST-T-907',NULL,'Plasminogen Activator Inhibitor-1 AG','A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.','\0','Plasminogen Activator Inhibitor-1 AG','CL-LBTEST','DBX-NCIT-C81989'),('CL-LBTEST-T-908',NULL,'Plasmodium','Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.','\0','Plasmodium','CL-LBTEST','DBX-NCIT-C100453'),('CL-LBTEST-T-909',NULL,'Platelet Activating Factor','A measurement of the platelet activating factor in a biological specimen.','\0','Platelet Activating Factor','CL-LBTEST','DBX-NCIT-C111292'),('CL-LBTEST-T-91',NULL,'Anisocytes','A measurement of the inequality in the size of the red blood cells in a whole blood specimen.','\0','Anisocytes','CL-LBTEST','DBX-NCIT-C74797'),('CL-LBTEST-T-910',NULL,'Platelet Aggregation','A measurement of the association of platelets to one another via adhesion molecules in a biological sample.','\0','Platelet Aggregation; Platelet Function','CL-LBTEST','DBX-NCIT-C103427'),('CL-LBTEST-T-911',NULL,'Platelet Aggregation Amplitude','A measurement of the magnitude of the platelet aggregation in a biological specimen.','\0','Platelet Aggregation Amplitude','CL-LBTEST','DBX-NCIT-C111293'),('CL-LBTEST-T-912',NULL,'Platelet Aggregation Curve Type','The classification of the curve pattern that is formed as a result of platelet aggregation.','\0','Platelet Aggregation Curve Type','CL-LBTEST','DBX-NCIT-C114210'),('CL-LBTEST-T-913',NULL,'Platelet Aggregation Mean Amplitude','An average of the measurements of the magnitude of the platelet aggregation in a biological specimen.','\0','Platelet Aggregation Mean Amplitude','CL-LBTEST','DBX-NCIT-C114211'),('CL-LBTEST-T-914',NULL,'Platelet Aggregation Mean Curve Type','The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements.','\0','Platelet Aggregation Mean Curve Type','CL-LBTEST','DBX-NCIT-C114212'),('CL-LBTEST-T-915',NULL,'Platelet Clumps','A measurement of the platelet clumps in a biological specimen.','\0','PLT Clumps; Platelet Clumps','CL-LBTEST','DBX-NCIT-C96624'),('CL-LBTEST-T-916',NULL,'Platelet Component Distribution Width','A measurement of a marker of platelet shape change in a biological specimen.','\0','Platelet Component Distribution Width','CL-LBTEST','DBX-NCIT-C111294'),('CL-LBTEST-T-917',NULL,'Platelet Derived Growth Factor Isoform AB','A measurement of the platelet derived growth factor isoform AB in a biological specimen.','\0','PDGF Isoform AB; Platelet Derived Growth Factor Isoform AB; Platelet Derived Growth Factor-AB Isoform','CL-LBTEST','DBX-NCIT-C116208'),('CL-LBTEST-T-918',NULL,'Platelet Distribution Width','A measurement of the range of platelet sizes in a biological specimen.','\0','Platelet Distribution Width','CL-LBTEST','DBX-NCIT-C81962'),('CL-LBTEST-T-919',NULL,'Platelet Function Closure Time','A measurement of the platelet function closure time in a biological specimen.','\0','PFCT; Platelet Function Closure Time','CL-LBTEST','DBX-NCIT-C111295'),('CL-LBTEST-T-92',NULL,'Anti-DNA Antibodies','A measurement of the anti-DNA antibodies in a biological specimen.','\0','Anti-DNA Antibodies; Anti-ds-DNA Antibodies','CL-LBTEST','DBX-NCIT-C81973'),('CL-LBTEST-T-920',NULL,'Platelet Hematocrit','A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.','\0','Platelet Hematocrit; Thrombocytocrit','CL-LBTEST','DBX-NCIT-C100424'),('CL-LBTEST-T-921',NULL,'Platelet Morphology','An examination or assessment of the form and structure of platelets.','\0','Platelet Morphology','CL-LBTEST','DBX-NCIT-C111296'),('CL-LBTEST-T-922',NULL,'Platelet Satellitism','An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen.','\0','Platelet Satellitism','CL-LBTEST','DBX-NCIT-C116209'),('CL-LBTEST-T-923',NULL,'Platelets','A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.','\0','Platelets','CL-LBTEST','DBX-NCIT-C51951'),('CL-LBTEST-T-924',NULL,'Poikilocytes','A measurement of the odd-shaped erythrocytes in a whole blood specimen.','\0','Poikilocytes','CL-LBTEST','DBX-NCIT-C79602'),('CL-LBTEST-T-925',NULL,'Poikilocytes/Erythrocytes','A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.','\0','Poikilocytes/Erythrocytes','CL-LBTEST','DBX-NCIT-C74649'),('CL-LBTEST-T-926',NULL,'Polychromasia','A measurement of the blue-staining characteristic of newly generated erythrocytes.','\0','Polychromasia','CL-LBTEST','DBX-NCIT-C64803'),('CL-LBTEST-T-927',NULL,'Potassium','A measurement of the potassium in a biological specimen.','\0','Potassium','CL-LBTEST','DBX-NCIT-C64853'),('CL-LBTEST-T-928',NULL,'Potassium Clearance','A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Potassium Clearance','CL-LBTEST','DBX-NCIT-C106560'),('CL-LBTEST-T-929',NULL,'Potassium Excretion Rate','A measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour).','\0','Potassium Excretion Rate','CL-LBTEST','DBX-NCIT-C117839'),('CL-LBTEST-T-93',NULL,'Anti-Double Stranded DNA','A measurement of the anti-double stranded DNA antibody in a biological specimen.','\0','Anti-Double Stranded DNA','CL-LBTEST','DBX-NCIT-C74913'),('CL-LBTEST-T-930',NULL,'Potassium/Creatinine','A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.','\0','Potassium/Creatinine','CL-LBTEST','DBX-NCIT-C79462'),('CL-LBTEST-T-931',NULL,'Prealbumin','A measurement of the prealbumin in a biological specimen.','\0','Prealbumin','CL-LBTEST','DBX-NCIT-C100435'),('CL-LBTEST-T-932',NULL,'Precursor Plasma Cells','A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.','\0','Plasmablast; Precursor Plasma Cells','CL-LBTEST','DBX-NCIT-C74619'),('CL-LBTEST-T-933',NULL,'Precursor Plasma Cells/Lymphocytes','A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.','\0','Precursor Plasma Cells/Lymphocytes','CL-LBTEST','DBX-NCIT-C74650'),('CL-LBTEST-T-934',NULL,'Pregnancy-Associated Plasma Protein-A','A measurement of the pregnancy-associated plasma protein-A in a biological specimen.','\0','Pregnancy-Associated Plasma Protein-A','CL-LBTEST','DBX-NCIT-C82031'),('CL-LBTEST-T-935',NULL,'ProB-type Natriuretic Peptide','A measurement of the proB-type natriuretic peptide in a biological specimen.','\0','Pro-Brain Natriuretic Peptide; ProB-type Natriuretic Peptide; proBNP','CL-LBTEST','DBX-NCIT-C82032'),('CL-LBTEST-T-936',NULL,'Procalcitonin','A measurement of the procalcitonin in a biological specimen.','\0','Procalcitonin','CL-LBTEST','DBX-NCIT-C103430'),('CL-LBTEST-T-937',NULL,'Procollagen 1 N-Terminal Propeptide','A measurement of the procollagen 1 N-terminal propeptide in a biological specimen.','\0','Amino-terminal propeptide of type 1 procollagen; P1NP Aminoterm Type 1; Procollagen 1 N-Terminal Propeptide','CL-LBTEST','DBX-NCIT-C96625'),('CL-LBTEST-T-938',NULL,'Procollagen Type I Carboxy Term Peptide','A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.','\0','Procollagen Type I Carboxy Term Peptide','CL-LBTEST','DBX-NCIT-C82033'),('CL-LBTEST-T-939',NULL,'Proerythroblast','A measurement of the proerythroblasts in a biological specimen.','\0','Proerythroblast','CL-LBTEST','DBX-NCIT-C100446'),('CL-LBTEST-T-94',NULL,'Anti-Factor Xa Activity','A measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.','\0','Anti-Factor Xa Activity','CL-LBTEST','DBX-NCIT-C98706'),('CL-LBTEST-T-940',NULL,'Progesterone','A measurement of the progesterone hormone in a biological specimen.','\0','Progesterone','CL-LBTEST','DBX-NCIT-C74791'),('CL-LBTEST-T-941',NULL,'Progesterone Receptor','A measurement of the progesterone receptor in a biological specimen.','\0','NR3C3; PR; Progesterone Receptor','CL-LBTEST','DBX-NCIT-C117846'),('CL-LBTEST-T-942',NULL,'Proinsulin','A measurement of the proinsulin in a biological specimen.','\0','Proinsulin','CL-LBTEST','DBX-NCIT-C81967'),('CL-LBTEST-T-943',NULL,'Proinsulin/Insulin Ratio','A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen.','\0','Proinsulin/Insulin Ratio','CL-LBTEST','DBX-NCIT-C111299'),('CL-LBTEST-T-944',NULL,'Prolactin','A measurement of the prolactin hormone in a biological specimen.','\0','Prolactin','CL-LBTEST','DBX-NCIT-C74870'),('CL-LBTEST-T-945',NULL,'Prolymphocytes','A measurement of the prolymphocytes in a biological specimen.','\0','Prolymphocytes','CL-LBTEST','DBX-NCIT-C74620'),('CL-LBTEST-T-946',NULL,'Prolymphocytes/Leukocytes','A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.','\0','Prolymphocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C64829'),('CL-LBTEST-T-947',NULL,'Prolymphocytes/Lymphocytes','A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.','\0','Prolymphocytes/Lymphocytes','CL-LBTEST','DBX-NCIT-C74651'),('CL-LBTEST-T-948',NULL,'Promonocytes','A measurement of the promonocytes in a biological specimen.','\0','Promonocytes','CL-LBTEST','DBX-NCIT-C74621'),('CL-LBTEST-T-949',NULL,'Promonocytes/Leukocytes','A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.','\0','Promonocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C74652'),('CL-LBTEST-T-95',NULL,'Anti-Saccharomyces cerevisiae Antibody','A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.','\0','Anti-Saccharomyces cerevisiae Antibody','CL-LBTEST','DBX-NCIT-C81976'),('CL-LBTEST-T-950',NULL,'Promyeloblasts','A measurement of the promyeloblasts in a biological specimen.','\0','Promyeloblasts','CL-LBTEST','DBX-NCIT-C117847'),('CL-LBTEST-T-951',NULL,'Promyelocytes','A measurement of the promyelocytes (immature myelocytes) in a biological specimen.','\0','Promyelocytes','CL-LBTEST','DBX-NCIT-C74622'),('CL-LBTEST-T-952',NULL,'Promyelocytes/Leukocytes','A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.','\0','Promyelocytes/Leukocytes','CL-LBTEST','DBX-NCIT-C74653'),('CL-LBTEST-T-953',NULL,'Promyelocytes/Total Cells','A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Promyelocytes/Total Cells','CL-LBTEST','DBX-NCIT-C98773'),('CL-LBTEST-T-954',NULL,'Pronormoblasts/Total Cells','A relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Pronormoblasts/Total Cells','CL-LBTEST','DBX-NCIT-C98870'),('CL-LBTEST-T-955',NULL,'Propoxyphene','A measurement of the propoxyphene present in a biological specimen.','\0','Propoxyphene','CL-LBTEST','DBX-NCIT-C74885'),('CL-LBTEST-T-956',NULL,'Prostaglandin','A measurement of the total prostaglandin in a biological specimen.','\0','Total Prostaglandin','CL-LBTEST','DBX-NCIT-C103343'),('CL-LBTEST-T-957',NULL,'Prostaglandin D2','A measurement of the prostaglandin D2 in a biological specimen.','\0','Prostaglandin D2','CL-LBTEST','DBX-NCIT-C103431'),('CL-LBTEST-T-958',NULL,'Prostaglandin D2 Synthase','A measurement of the prostaglandin D2 synthase in a biological specimen.','\0','Prostaglandin D2 Synthase','CL-LBTEST','DBX-NCIT-C103432'),('CL-LBTEST-T-959',NULL,'Prostaglandin E Synthase','A measurement of the prostaglandin E synthase in a biological specimen.','\0','Prostaglandin E Synthase','CL-LBTEST','DBX-NCIT-C103433'),('CL-LBTEST-T-96',NULL,'Anti-Single Stranded DNA IgG','A measurement of the anti-single stranded DNA IgG antibody in a biological specimen.','\0','Anti-Single Stranded DNA IgG','CL-LBTEST','DBX-NCIT-C92269'),('CL-LBTEST-T-960',NULL,'Prostaglandin E1','A measurement of the prostaglandin E1 in a biological specimen.','\0','Prostaglandin E1','CL-LBTEST','DBX-NCIT-C103434'),('CL-LBTEST-T-961',NULL,'Prostaglandin E2','A measurement of the prostaglandin E2 in a biological specimen.','\0','Prostaglandin E2','CL-LBTEST','DBX-NCIT-C103435'),('CL-LBTEST-T-962',NULL,'Prostaglandin F1 Alpha','A measurement of the prostaglandin F1 alpha in a biological specimen.','\0','Prostaglandin F1 Alpha','CL-LBTEST','DBX-NCIT-C103436'),('CL-LBTEST-T-963',NULL,'Prostaglandin F2 Alpha','A measurement of the prostaglandin F2 alpha in a biological specimen.','\0','Prostaglandin F2 Alpha','CL-LBTEST','DBX-NCIT-C103437'),('CL-LBTEST-T-964',NULL,'Prostate Specific Antigen','A measurement of the prostate specific antigen in a biological specimen.','\0','Prostate Specific Antigen','CL-LBTEST','DBX-NCIT-C17634'),('CL-LBTEST-T-965',NULL,'Prostatic Acid Phosphatase','A measurement of the prostatic acid phosphatase in a biological specimen.','\0','Prostatic Acid Phosphatase','CL-LBTEST','DBX-NCIT-C80204'),('CL-LBTEST-T-966',NULL,'Protein','A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.','\0','Protein','CL-LBTEST','DBX-NCIT-C64858'),('CL-LBTEST-T-967',NULL,'Protein Excretion Rate','A measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour).','\0','Protein Excretion Rate','CL-LBTEST','DBX-NCIT-C117848'),('CL-LBTEST-T-968',NULL,'Protein S','A measurement of the protein S in a biological specimen.','\0','Protein S','CL-LBTEST','DBX-NCIT-C100436'),('CL-LBTEST-T-969',NULL,'Protein/Creatinine','A relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.','\0','Protein/Creatinine','CL-LBTEST','DBX-NCIT-C79463'),('CL-LBTEST-T-97',NULL,'Antidepressants','A measurement of any antidepressant class drug present in a biological specimen.','\0','Antidepressants','CL-LBTEST','DBX-NCIT-C74691'),('CL-LBTEST-T-970',NULL,'Protein/Osmolality','A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.','\0','Protein/Osmolality; Protein/Osmolality Ratio','CL-LBTEST','DBX-NCIT-C92240'),('CL-LBTEST-T-971',NULL,'Prothrombin Activity','A measurement of the biological activity of prothrombin in a biological specimen.','\0','Factor II Activity; Prothrombin Activity','CL-LBTEST','DBX-NCIT-C98774'),('CL-LBTEST-T-972',NULL,'Prothrombin Fragments 1 + 2','A measurement of the prothrombin fragments 1 and 2 in a biological specimen.','\0','Prothrombin Fragments 1 + 2','CL-LBTEST','DBX-NCIT-C82034'),('CL-LBTEST-T-973',NULL,'Prothrombin Intl. Normalized Ratio','A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.','\0','Prothrombin Intl. Normalized Ratio','CL-LBTEST','DBX-NCIT-C64805'),('CL-LBTEST-T-974',NULL,'Prothrombin Time','A blood clotting measurement that evaluates the extrinsic pathway of coagulation.','\0','Prothrombin Time','CL-LBTEST','DBX-NCIT-C62656'),('CL-LBTEST-T-975',NULL,'Protozoa','Examination of a biological specimen to detect the presence of protozoa in a biological specimen.','\0','Protozoa','CL-LBTEST','DBX-NCIT-C117849'),('CL-LBTEST-T-976',NULL,'Pseudoephedrine','A measurement of the pseudoephedrine present in a biological specimen.','\0','Pseudoephedrine','CL-LBTEST','DBX-NCIT-C74696'),('CL-LBTEST-T-977',NULL,'Pyridinoline','A measurement of the pyridinoline in a biological specimen.','\0','Pyridinoline','CL-LBTEST','DBX-NCIT-C80211'),('CL-LBTEST-T-978',NULL,'Rapid Plasma Reagin','A measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.','\0','Rapid Plasma Reagin','CL-LBTEST','DBX-NCIT-C74716'),('CL-LBTEST-T-979',NULL,'RBC Casts','A measurement of the red blood cell casts present in a biological specimen.','\0','RBC Casts','CL-LBTEST','DBX-NCIT-C74772'),('CL-LBTEST-T-98',NULL,'Antidiuretic Hormone','A measurement of the antidiuretic hormone in a biological specimen.','\0','Antidiuretic Hormone; Vasopressin','CL-LBTEST','DBX-NCIT-C74847'),('CL-LBTEST-T-980',NULL,'Reactive Lymphocytes','A measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.','\0','Reactive Lymphocytes','CL-LBTEST','DBX-NCIT-C74629'),('CL-LBTEST-T-981',NULL,'Reactive Lymphocytes/Lymphocytes','A relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.','\0','Reactive Lymphocytes/Lymphocytes','CL-LBTEST','DBX-NCIT-C74654'),('CL-LBTEST-T-982',NULL,'Receptor Activator Nuclear KappaB Ligand','A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen.','\0','Receptor Activator Nuclear KappaB Ligand; Receptor Activator of Nuclear Kappa-B Ligand','CL-LBTEST','DBX-NCIT-C117852'),('CL-LBTEST-T-983',NULL,'Reg upon Act Normal T-cell Exprd Secrtd','A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.','\0','Chemokine Ligand 5; Reg upon Act Normal T-cell Exprd Secrtd','CL-LBTEST','DBX-NCIT-C81957'),('CL-LBTEST-T-984',NULL,'Renin','A measurement of the renin in a biological specimen.','\0','Active Renin; Angiotensinogenase; Direct Renin; Renin','CL-LBTEST','DBX-NCIT-C74893'),('CL-LBTEST-T-985',NULL,'Renin Activity','A measurement of the renin activity in a biological specimen.','\0','PRA; Plasma Renin Activity; Renin Activity; URA; Urinary Renin Activity','CL-LBTEST','DBX-NCIT-C111305'),('CL-LBTEST-T-986',NULL,'Reptilase Time','A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.','\0','Reptilase Time','CL-LBTEST','DBX-NCIT-C96628'),('CL-LBTEST-T-987',NULL,'Resistin','A measurement of the resistin in a biological specimen.','\0','Resistin','CL-LBTEST','DBX-NCIT-C80205'),('CL-LBTEST-T-988',NULL,'Ret. Corpuscular Hemoglobin Content','A quantitative measurement of the total amount of hemoglobin in the reticulocyte population.','\0','CHr; Ret. Corpuscular Hemoglobin Content','CL-LBTEST','DBX-NCIT-C117854'),('CL-LBTEST-T-989',NULL,'Ret. Mean Corpuscular Hemoglobin','A quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen.','\0','CHCMr; Ret. Mean Corpuscular Hemoglobin','CL-LBTEST','DBX-NCIT-C117855'),('CL-LBTEST-T-99',NULL,'Antiglobulin Test, Direct','A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.','\0','Antiglobulin Test, Direct; Direct Coombs Test','CL-LBTEST','DBX-NCIT-C81974'),('CL-LBTEST-T-990',NULL,'Reticulocyte Distribution Width','A measurement of the range of reticulocyte sizes in a biological specimen.','\0','Reticulocyte Distribution Width','CL-LBTEST','DBX-NCIT-C114218'),('CL-LBTEST-T-991',NULL,'Reticulocyte Hemoglobin','A measurement of the amount of hemoglobin in reticulocytes.','\0','Reticulocyte Hemoglobin','CL-LBTEST','DBX-NCIT-C98776'),('CL-LBTEST-T-992',NULL,'Reticulocytes','A measurement of the reticulocytes in a biological specimen.','\0','Reticulocytes','CL-LBTEST','DBX-NCIT-C51947'),('CL-LBTEST-T-993',NULL,'Reticulocytes/Erythrocytes','A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.','\0','Reticulocytes/Erythrocytes','CL-LBTEST','DBX-NCIT-C64828'),('CL-LBTEST-T-994',NULL,'Retinol Binding Protein','A measurement of the total retinol binding protein in a biological specimen.','\0','Retinol Binding Protein','CL-LBTEST','DBX-NCIT-C100437'),('CL-LBTEST-T-995',NULL,'Rheumatoid Factor','A measurement of the rheumatoid factor antibody in a biological specimen.','\0','Rheumatoid Factor','CL-LBTEST','DBX-NCIT-C74717'),('CL-LBTEST-T-996',NULL,'Riboflavin','A measurement of the riboflavin in a biological specimen.','\0','Riboflavin; Vitamin B2','CL-LBTEST','DBX-NCIT-C74898'),('CL-LBTEST-T-997',NULL,'Ribonucleoprotein Antibody','A measurement of the ribonucleoprotein antibody in a biological specimen.','\0','RNP Antibody; Ribonucleoprotein Antibody','CL-LBTEST','DBX-NCIT-C100457'),('CL-LBTEST-T-998',NULL,'Ringed Sideroblasts','A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.','\0','Ringed Sideroblasts','CL-LBTEST','DBX-NCIT-C100419'),('CL-LBTEST-T-999',NULL,'Rouleaux Formation','A measurement of the number of stacking red blood cells within a biological specimen.','\0','Rouleaux Formation','CL-LBTEST','DBX-NCIT-C74624'),('CL-LBTESTCD-T-1',NULL,'A1AGLP','A measurement of the alpha-1 acid glycoprotein in a biological specimen.','\0','Alpha-1 Acid Glycoprotein','CL-LBTESTCD','DBX-NCIT-C100429'),('CL-LBTESTCD-T-10',NULL,'ACE','A measurement of the angiotensin converting enzyme in a biological specimen.','\0','Angiotensin Converting Enzyme','CL-LBTESTCD','DBX-NCIT-C80169'),('CL-LBTESTCD-T-100',NULL,'ASSDNA','A measurement of the anti-single stranded DNA IgG antibody in a biological specimen.','\0','Anti-Single Stranded DNA IgG','CL-LBTESTCD','DBX-NCIT-C92269'),('CL-LBTESTCD-T-1000',NULL,'RDW','A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.','\0','Erythrocytes Distribution Width; Red Blood Cell Distribution Width','CL-LBTESTCD','DBX-NCIT-C64800'),('CL-LBTESTCD-T-1001',NULL,'RENIN','A measurement of the renin in a biological specimen.','\0','Active Renin; Angiotensinogenase; Direct Renin; Renin','CL-LBTESTCD','DBX-NCIT-C74893'),('CL-LBTESTCD-T-1002',NULL,'RENINA','A measurement of the renin activity in a biological specimen.','\0','PRA; Plasma Renin Activity; Renin Activity; URA; Urinary Renin Activity','CL-LBTESTCD','DBX-NCIT-C111305'),('CL-LBTESTCD-T-1003',NULL,'RESISTIN','A measurement of the resistin in a biological specimen.','\0','Resistin','CL-LBTESTCD','DBX-NCIT-C80205'),('CL-LBTESTCD-T-1004',NULL,'RETCRRBC','A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen.','\0','HCT Corrected Reticulocytes/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C102274'),('CL-LBTESTCD-T-1005',NULL,'RETI','A measurement of the reticulocytes in a biological specimen.','\0','Reticulocytes','CL-LBTESTCD','DBX-NCIT-C51947'),('CL-LBTESTCD-T-1006',NULL,'RETICDW','A measurement of the range of reticulocyte sizes in a biological specimen.','\0','Reticulocyte Distribution Width','CL-LBTESTCD','DBX-NCIT-C114218'),('CL-LBTESTCD-T-1007',NULL,'RETICH','A quantitative measurement of the total amount of hemoglobin in the reticulocyte population.','\0','CHr; Ret. Corpuscular Hemoglobin Content','CL-LBTESTCD','DBX-NCIT-C117854'),('CL-LBTESTCD-T-1008',NULL,'RETIH','A measurement of the high absorption reticulocytes in a biological specimen.','\0','High Absorption Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116188'),('CL-LBTESTCD-T-1009',NULL,'RETIHCR','A measurement of the hematocrit corrected reticulocytes in a biological specimen.','\0','Hematocrit Corrected Reticulocytes','CL-LBTESTCD','DBX-NCIT-C102273'),('CL-LBTESTCD-T-101',NULL,'AST','A measurement of the aspartate aminotransferase in a biological specimen.','\0','Aspartate Aminotransferase; SGOT','CL-LBTESTCD','DBX-NCIT-C64467'),('CL-LBTESTCD-T-1010',NULL,'RETIHGB','A measurement of the amount of hemoglobin in reticulocytes.','\0','Reticulocyte Hemoglobin','CL-LBTESTCD','DBX-NCIT-C98776'),('CL-LBTESTCD-T-1011',NULL,'RETIHRTC','A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen.','\0','High Absorption Retic/Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116189'),('CL-LBTESTCD-T-1012',NULL,'RETIL','A measurement of the low absorption reticulocytes in a biological specimen.','\0','Low Absorption Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116190'),('CL-LBTESTCD-T-1013',NULL,'RETILRTC','A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen.','\0','Low Absorption Retic/Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116191'),('CL-LBTESTCD-T-1014',NULL,'RETIM','A measurement of the medium absorption reticulocytes in a biological specimen.','\0','Medium Absorption Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116192'),('CL-LBTESTCD-T-1015',NULL,'RETIMCH','A quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen.','\0','CHCMr; Ret. Mean Corpuscular Hemoglobin','CL-LBTESTCD','DBX-NCIT-C117855'),('CL-LBTESTCD-T-1016',NULL,'RETIMRTC','A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen.','\0','Medium Absorption Retic/Reticulocytes','CL-LBTESTCD','DBX-NCIT-C116193'),('CL-LBTESTCD-T-1017',NULL,'RETIRBC','A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.','\0','Reticulocytes/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C64828'),('CL-LBTESTCD-T-1018',NULL,'RF','A measurement of the rheumatoid factor antibody in a biological specimen.','\0','Rheumatoid Factor','CL-LBTESTCD','DBX-NCIT-C74717'),('CL-LBTESTCD-T-1019',NULL,'RNPAB','A measurement of the ribonucleoprotein antibody in a biological specimen.','\0','RNP Antibody; Ribonucleoprotein Antibody','CL-LBTESTCD','DBX-NCIT-C100457'),('CL-LBTESTCD-T-102',NULL,'ASTAG','A measurement of the aspartate aminotransferase antigen in a biological specimen.','\0','Aspartate Aminotransferase Antigen; SGOT Antigen','CL-LBTESTCD','DBX-NCIT-C81978'),('CL-LBTESTCD-T-1020',NULL,'ROULEAUX','A measurement of the number of stacking red blood cells within a biological specimen.','\0','Rouleaux Formation','CL-LBTESTCD','DBX-NCIT-C74624'),('CL-LBTESTCD-T-1021',NULL,'RPR','A measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.','\0','Rapid Plasma Reagin','CL-LBTESTCD','DBX-NCIT-C74716'),('CL-LBTESTCD-T-1022',NULL,'RPTLTIME','A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.','\0','Reptilase Time','CL-LBTESTCD','DBX-NCIT-C96628'),('CL-LBTESTCD-T-1023',NULL,'RT3','A measurement of the reverse triiodothyronine in a biological specimen.','\0','Triiodothyronine, Reverse','CL-LBTESTCD','DBX-NCIT-C81968'),('CL-LBTESTCD-T-1024',NULL,'RUBIGGAB','A measurement of the Rubella IgG antibody in a biological specimen.','\0','Rubella IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103440'),('CL-LBTESTCD-T-1025',NULL,'SCF','A measurement of the stem cell factor in a biological specimen.','\0','KIT Ligand; Stem Cell Factor','CL-LBTESTCD','DBX-NCIT-C82035'),('CL-LBTESTCD-T-1026',NULL,'SCHISTO','A measurement of the schistocytes (fragmented red blood cells) in a biological specimen.','\0','Schistocytes','CL-LBTESTCD','DBX-NCIT-C74706'),('CL-LBTESTCD-T-1027',NULL,'SCKCERBC','A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.','\0','Sickle Cells/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C74656'),('CL-LBTESTCD-T-1028',NULL,'SCKLCE','A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.','\0','Sickle Cells','CL-LBTESTCD','DBX-NCIT-C74626'),('CL-LBTESTCD-T-1029',NULL,'SCL70AB','A measurement of the Scl-70 antibody in a biological specimen.','\0','Scl-70 Antibody; Scleroderma-70 Antibody','CL-LBTESTCD','DBX-NCIT-C100458'),('CL-LBTESTCD-T-103',NULL,'ASTCREAT','A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen.','\0','Aspartate Aminotransferase/Creatinine','CL-LBTESTCD','DBX-NCIT-C117830'),('CL-LBTESTCD-T-1030',NULL,'SDH','A measurement of the sorbitol dehydrogenase in a biological specimen.','\0','Sorbitol Dehydrogenase','CL-LBTESTCD','DBX-NCIT-C79465'),('CL-LBTESTCD-T-1031',NULL,'SECRETIN','A measurement of the secretin hormone in a biological specimen.','\0','Secretin','CL-LBTESTCD','DBX-NCIT-C74871'),('CL-LBTESTCD-T-1032',NULL,'SEDEXAM','An observation, assessment or examination of the sediment in a biological specimen.','\0','Microscopic Sediment Analysis; Sediment Analysis; Sediment Examination','CL-LBTESTCD','DBX-NCIT-C105744'),('CL-LBTESTCD-T-1033',NULL,'SEZCE','A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.','\0','Sezary Cells','CL-LBTESTCD','DBX-NCIT-C74625'),('CL-LBTESTCD-T-1034',NULL,'SEZCELY','A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.','\0','Sezary Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74655'),('CL-LBTESTCD-T-1035',NULL,'SFTPD','A measurement of the surfactant protein D in a biological specimen.','\0','SP-D; Surfactant Protein D','CL-LBTESTCD','DBX-NCIT-C111322'),('CL-LBTESTCD-T-1036',NULL,'SHBG','A measurement of the sex hormone binding (globulin) protein in a biological specimen.','\0','Sex Hormone Binding Globulin; Sex Hormone Binding Protein','CL-LBTESTCD','DBX-NCIT-C74745'),('CL-LBTESTCD-T-1037',NULL,'SIXMAM','A measurement of the 6-monoacetylmorphine present in a biological specimen.','\0','6-Monoacetylmorphine','CL-LBTESTCD','DBX-NCIT-C74876'),('CL-LBTESTCD-T-1038',NULL,'SJSSAAB','A measurement of the Sjogrens SS-A antibody in a biological specimen.','\0','Ro Antibody; Sjogrens SS-A Antibody','CL-LBTESTCD','DBX-NCIT-C92236'),('CL-LBTESTCD-T-1039',NULL,'SJSSBAB','A measurement of the Sjogrens SS-B antibody in a biological specimen.','\0','La Antibody; Sjogrens SS-B Antibody','CL-LBTESTCD','DBX-NCIT-C92237'),('CL-LBTESTCD-T-104',NULL,'ATPVITE','A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen.','\0','Vitamin E Alpha Tocopherol','CL-LBTESTCD','DBX-NCIT-C103350'),('CL-LBTESTCD-T-1040',NULL,'SLTFRNRC','A measurement of the soluble transferrin receptor in a biological specimen.','\0','Soluble Transferrin Receptor','CL-LBTESTCD','DBX-NCIT-C100438'),('CL-LBTESTCD-T-1041',NULL,'SLXAG','A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen.','\0','SLeX; Sialyl Lewis X Antigen; Sialyl Lex; Sialyl SSEA-1 Antigen; Sialyl-CD15','CL-LBTESTCD','DBX-NCIT-C114223'),('CL-LBTESTCD-T-1042',NULL,'SMDGCE','A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.','\0','Basket Cells; Smudge Cells','CL-LBTESTCD','DBX-NCIT-C74627'),('CL-LBTESTCD-T-1043',NULL,'SMTHAB','A measurement of the Smith antibody in a biological specimen.','\0','Smith Antibody','CL-LBTESTCD','DBX-NCIT-C92281'),('CL-LBTESTCD-T-1044',NULL,'SMUSCAB','A measurement of the smooth muscle antibody in a biological specimen.','\0','Anti-Smooth Muscle Antibody; Smooth Muscle Antibody','CL-LBTESTCD','DBX-NCIT-C111317'),('CL-LBTESTCD-T-1045',NULL,'SO2','A measurement of the sulfur dioxide in a biological specimen.','\0','Sulfur Dioxide','CL-LBTESTCD','DBX-NCIT-C114224'),('CL-LBTESTCD-T-1046',NULL,'SODIUM','A measurement of the sodium in a biological specimen.','\0','Sodium','CL-LBTESTCD','DBX-NCIT-C64809'),('CL-LBTESTCD-T-1047',NULL,'SODMEXR','A measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour).','\0','Sodium Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117856'),('CL-LBTESTCD-T-1048',NULL,'SOMATRO','A measurement of the somatotrophin (growth) hormone in a biological specimen.','\0','Growth Hormone; Somatotrophin','CL-LBTESTCD','DBX-NCIT-C80360'),('CL-LBTESTCD-T-1049',NULL,'SOST','A measurement of the sclerostin in a biological specimen.','\0','Sclerostin','CL-LBTESTCD','DBX-NCIT-C117857'),('CL-LBTESTCD-T-105',NULL,'AUERRODS','A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.','\0','Auer Rods','CL-LBTESTCD','DBX-NCIT-C74657'),('CL-LBTESTCD-T-1050',NULL,'SPERM','A measurement of the spermatozoa cells present in a biological specimen.','\0','Spermatozoa','CL-LBTESTCD','DBX-NCIT-C74663'),('CL-LBTESTCD-T-1051',NULL,'SPERMMTL','A measurement of the sperm capable of forward, progressive movement in a semen specimen.','\0','Sperm Motility','CL-LBTESTCD','DBX-NCIT-C102281'),('CL-LBTESTCD-T-1052',NULL,'SPGRAV','A ratio of the density of a fluid to the density of water.','\0','Specific Gravity','CL-LBTESTCD','DBX-NCIT-C64832'),('CL-LBTESTCD-T-1053',NULL,'SPHERO','A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.','\0','Spherocytes','CL-LBTESTCD','DBX-NCIT-C74707'),('CL-LBTESTCD-T-1054',NULL,'SPWEIGHT','A measurement of the weight of a biological specimen.','\0','Specimen Weight','CL-LBTESTCD','DBX-NCIT-C106569'),('CL-LBTESTCD-T-1055',NULL,'SRTONIN','A measurement of the serotonin hormone in a biological specimen.','\0','Serotonin','CL-LBTESTCD','DBX-NCIT-C74872'),('CL-LBTESTCD-T-1056',NULL,'STIPBASO','A measurement of the basophilic stippling in a biological specimen.','\0','Basophilic Stippling','CL-LBTESTCD','DBX-NCIT-C96567'),('CL-LBTESTCD-T-1057',NULL,'STOMCY','A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.','\0','Stomatocytes','CL-LBTESTCD','DBX-NCIT-C74708'),('CL-LBTESTCD-T-1058',NULL,'STRIGGAB','A measurement of strongyloides IgG antibody in a biological specimen.','\0','Strongyloides IgG Antibody','CL-LBTESTCD','DBX-NCIT-C117858'),('CL-LBTESTCD-T-1059',NULL,'STRPLOAB','A measurement of Streptolysin O Antibody in a biological specimen.','\0','Antistreptolysin O; Streptolysin O Antibody','CL-LBTESTCD','DBX-NCIT-C92282'),('CL-LBTESTCD-T-106',NULL,'AZURGRAN','An observation of azurophilic granules in a biological specimen.','\0','Azurophilic Granulation; Azurophilic Granules','CL-LBTESTCD','DBX-NCIT-C116185'),('CL-LBTESTCD-T-1060',NULL,'SVCAM1','A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.','\0','Soluble Vascular Cell Adhesion Molecule 1','CL-LBTESTCD','DBX-NCIT-C92533'),('CL-LBTESTCD-T-1061',NULL,'T3','A measurement of the total (free and bound) triiodothyronine in a biological specimen.','\0','Total T3; Triiodothyronine','CL-LBTESTCD','DBX-NCIT-C74747'),('CL-LBTESTCD-T-1062',NULL,'T3FR','A measurement of the free triiodothyronine in a biological specimen.','\0','Free T3; Triiodothyronine, Free','CL-LBTESTCD','DBX-NCIT-C74787'),('CL-LBTESTCD-T-1063',NULL,'T3UP','A measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.','\0','Triiodothyronine Uptake','CL-LBTESTCD','DBX-NCIT-C74748'),('CL-LBTESTCD-T-1064',NULL,'T4','A measurement of the total (free and bound) thyroxine in a biological specimen.','\0','Thyroxine; Total T4','CL-LBTESTCD','DBX-NCIT-C74794'),('CL-LBTESTCD-T-1065',NULL,'T4FR','A measurement of the free thyroxine in a biological specimen.','\0','Free T4; Thyroxine, Free','CL-LBTESTCD','DBX-NCIT-C74786'),('CL-LBTESTCD-T-1066',NULL,'TAT','A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample.','\0','Thrombin/Antithrombin; Thrombin/Antithrombin III','CL-LBTESTCD','DBX-NCIT-C106574'),('CL-LBTESTCD-T-1067',NULL,'TBG','A measurement of the thyroxine binding globulin protein in a biological specimen.','\0','Thyroxine Binding Globulin','CL-LBTESTCD','DBX-NCIT-C74746'),('CL-LBTESTCD-T-1068',NULL,'TDTAG','A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen.','\0','Terminal Deoxynucleotidyl Transferase Ag; Terminal Deoxynucleotidyl Transferase Antigen','CL-LBTESTCD','DBX-NCIT-C117859'),('CL-LBTESTCD-T-1069',NULL,'TEARDCY','A measurement of dacryocytes in a biological specimen.','\0','Dacryocytes; Tear Shaped Erythrocytes; Teardrop Cells','CL-LBTESTCD','DBX-NCIT-C64801'),('CL-LBTESTCD-T-107',NULL,'B2G1GGAB','A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen.','\0','Beta-2 Glycoprotein 1 IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103358'),('CL-LBTESTCD-T-1070',NULL,'TESTOS','A measurement of the total (free and bound) testosterone in a biological specimen.','\0','Testosterone; Total Testosterone','CL-LBTESTCD','DBX-NCIT-C74793'),('CL-LBTESTCD-T-1071',NULL,'TESTOSBA','A measurement of bioavailable testosterone in a biological specimen.','\0','Bioavailable Testosterone','CL-LBTESTCD','DBX-NCIT-C117860'),('CL-LBTESTCD-T-1072',NULL,'TESTOSFR','A measurement of the free testosterone in a biological specimen.','\0','Testosterone, Free','CL-LBTESTCD','DBX-NCIT-C74785'),('CL-LBTESTCD-T-1073',NULL,'TFERRIN','A measurement of the transferrin in a biological specimen.','\0','Transferrin','CL-LBTESTCD','DBX-NCIT-C82037'),('CL-LBTESTCD-T-1074',NULL,'TFRRNSAT','A measurement of the iron bound to transferrin in a biological specimen.','\0','Iron Binding Capacity Saturation; Iron Saturation; Iron Saturation Percent; Serum Iron to TIBC Ratio; Transferrin Iron Saturation; Transferrin Saturation','CL-LBTESTCD','DBX-NCIT-C98792'),('CL-LBTESTCD-T-1075',NULL,'TGFB1','A measurement of the transforming growth factor beta 1 in a biological specimen.','\0','Transforming Growth Factor Beta 1','CL-LBTESTCD','DBX-NCIT-C117861'),('CL-LBTESTCD-T-1076',NULL,'TGLOB','A measurement of the thyroglobulin in a biological specimen.','\0','TG; Thyroglobulin','CL-LBTESTCD','DBX-NCIT-C103446'),('CL-LBTESTCD-T-1077',NULL,'THEOPHYL','A measurement of the Theophylline present in a biological specimen.','\0','Theophylline','CL-LBTESTCD','DBX-NCIT-C105445'),('CL-LBTESTCD-T-1078',NULL,'THRMPTN','A measurement of the thrombopoietin hormone in a biological specimen.','\0','Thrombopoietin','CL-LBTESTCD','DBX-NCIT-C74873'),('CL-LBTESTCD-T-1079',NULL,'THROMNUC','A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates.','\0','Nucleated Thrombocytes; Thrombocytes','CL-LBTESTCD','DBX-NCIT-C111283'),('CL-LBTESTCD-T-108',NULL,'B2G1GMAB','A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen.','\0','Beta-2 Glycoprotein 1 IgM Antibody','CL-LBTESTCD','DBX-NCIT-C103359'),('CL-LBTESTCD-T-1080',NULL,'THYAB','A measurement of the thyroid antibodies in a biological specimen.','\0','Thyroid Antibodies','CL-LBTESTCD','DBX-NCIT-C81990'),('CL-LBTESTCD-T-1081',NULL,'THYAMAB','A measurement of the thyroid antimicrosomal antibodies in a biological specimen.','\0','Thyroid Antimicrosomal Antibodies','CL-LBTESTCD','DBX-NCIT-C81991'),('CL-LBTESTCD-T-1082',NULL,'THYATAB','A measurement of the thyroid antithyroglobulin antibodies in a biological specimen.','\0','Thyroid Antithyroglobulin Antibodies','CL-LBTESTCD','DBX-NCIT-C81992'),('CL-LBTESTCD-T-1083',NULL,'THYPXD','A measurement of the thyroperoxidase in a biological specimen.','\0','Thyroid Peroxidase; Thyroperoxidase','CL-LBTESTCD','DBX-NCIT-C96639'),('CL-LBTESTCD-T-1084',NULL,'THYPXDAB','A measurement of the thyroperoxidase antibody in a biological specimen.','\0','Thyroperoxidase Antibody','CL-LBTESTCD','DBX-NCIT-C96638'),('CL-LBTESTCD-T-1085',NULL,'TIMP1','A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.','\0','Tissue Inhibitor of Metalloproteinase 1','CL-LBTESTCD','DBX-NCIT-C82036'),('CL-LBTESTCD-T-1086',NULL,'TIMP1CRE','A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample.','\0','TIMP1/Creatinine; Tissue Inhibitor of Metalloproteinase 1/Creatinine','CL-LBTESTCD','DBX-NCIT-C106575'),('CL-LBTESTCD-T-1087',NULL,'TNF','A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.','\0','Tumor Necrosis Factor; Tumor Necrosis Factor alpha','CL-LBTESTCD','DBX-NCIT-C74751'),('CL-LBTESTCD-T-1088',NULL,'TNFAPIA','A measurement of TNF-a production inhibitory activity in a biological specimen.','\0','TNF-a Production Inhibitory Activity','CL-LBTESTCD','DBX-NCIT-C117862'),('CL-LBTESTCD-T-1089',NULL,'TNFSR','A measurement of the total soluble tumor necrosis factor receptor in a biological specimen.','\0','Soluble Tumor Necrosis Factor Receptor','CL-LBTESTCD','DBX-NCIT-C117749'),('CL-LBTESTCD-T-109',NULL,'B2GLYAB','A measurement of the beta-2 glycoprotein antibody in a biological specimen.','\0','Beta-2 Glycoprotein Antibody','CL-LBTESTCD','DBX-NCIT-C81979'),('CL-LBTESTCD-T-1090',NULL,'TNFSR1','A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen.','\0','Soluble TNF Receptor Type I','CL-LBTESTCD','DBX-NCIT-C117863'),('CL-LBTESTCD-T-1091',NULL,'TNFSR2','A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen.','\0','Soluble TNF Receptor Type II','CL-LBTESTCD','DBX-NCIT-C117864'),('CL-LBTESTCD-T-1092',NULL,'TOXGRAN','A measurement of the toxic granulation in neutrophilic blood cells.','\0','Toxic Granulation','CL-LBTESTCD','DBX-NCIT-C96641'),('CL-LBTESTCD-T-1093',NULL,'TPAAG','A measurement of the tissue plasminogen activator antigen in a biological specimen.','\0','Tissue Plasminogen Activator Antigen','CL-LBTESTCD','DBX-NCIT-C81993'),('CL-LBTESTCD-T-1094',NULL,'TPRONP','A measurement of the non-phosphorylated Tau protein in a biological specimen.','\0','Non-Phosphorylated Tau Protein','CL-LBTESTCD','DBX-NCIT-C84811'),('CL-LBTESTCD-T-1095',NULL,'TPROT','A measurement of the total Tau protein in a biological specimen.','\0','Tau Protein; Total Tau Protein','CL-LBTESTCD','DBX-NCIT-C84810'),('CL-LBTESTCD-T-1096',NULL,'TPROTP','A measurement of the phosphorylated Tau protein in a biological specimen.','\0','Phosphorylated Tau Protein','CL-LBTESTCD','DBX-NCIT-C84812'),('CL-LBTESTCD-T-1097',NULL,'TRACP5B','A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen.','\0','TRAP5B; Tartrate-Resistant Acid Phosphatase 5b','CL-LBTESTCD','DBX-NCIT-C117865'),('CL-LBTESTCD-T-1098',NULL,'TRAP','A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.','\0','Total Radical-Trap Antioxidant Potential','CL-LBTESTCD','DBX-NCIT-C80208'),('CL-LBTESTCD-T-1099',NULL,'TRCYANDP','A measurement of tricyclic antidepressants in a biological specimen.','\0','Tricyclic Antidepressants','CL-LBTESTCD','DBX-NCIT-C100420'),('CL-LBTESTCD-T-11',NULL,'ACETOAC','A measurement of the acetoacetic acid in a biological specimen.','\0','Acetoacetate; Acetoacetic Acid','CL-LBTESTCD','DBX-NCIT-C92247'),('CL-LBTESTCD-T-110',NULL,'B2MICG','A measurement of the beta-2 microglobulin in a biological specimen.','\0','Beta-2 Microglobulin','CL-LBTESTCD','DBX-NCIT-C81980'),('CL-LBTESTCD-T-1100',NULL,'TRGTCE','A measurement of the target cells in a biological specimen.','\0','Codocytes; Leptocytes; Mexican Hat Cells; Target Cells','CL-LBTESTCD','DBX-NCIT-C96636'),('CL-LBTESTCD-T-1101',NULL,'TRH','A measurement of the thyrotropin releasing hormone in a biological specimen.','\0','Thyrotropin Releasing Factor; Thyrotropin Releasing Hormone','CL-LBTESTCD','DBX-NCIT-C74874'),('CL-LBTESTCD-T-1102',NULL,'TRICH','Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.','\0','Trichomonas','CL-LBTESTCD','DBX-NCIT-C92238'),('CL-LBTESTCD-T-1103',NULL,'TRIG','A measurement of the triglycerides in a biological specimen.','\0','Triglycerides','CL-LBTESTCD','DBX-NCIT-C64812'),('CL-LBTESTCD-T-1104',NULL,'TROPONI','A measurement of the actin binding troponin in a biological specimen.','\0','Troponin I','CL-LBTESTCD','DBX-NCIT-C74749'),('CL-LBTESTCD-T-1105',NULL,'TROPONIN','A measurement of the total troponin in a biological specimen.','\0','Troponin','CL-LBTESTCD','DBX-NCIT-C111327'),('CL-LBTESTCD-T-1106',NULL,'TROPONT','A measurement of the tropomyosin binding troponin in a biological specimen.','\0','Troponin T','CL-LBTESTCD','DBX-NCIT-C74750'),('CL-LBTESTCD-T-1107',NULL,'TRYPTASE','A measurement of the tryptase in a biological specimen.','\0','Tryptase','CL-LBTESTCD','DBX-NCIT-C92292'),('CL-LBTESTCD-T-1108',NULL,'TSH','A measurement of the thyrotropin in a biological specimen.','\0','Thyroid Stimulating Hormone; Thyrotropin','CL-LBTESTCD','DBX-NCIT-C64813'),('CL-LBTESTCD-T-1109',NULL,'TT','A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)','\0','Thrombin Time','CL-LBTESTCD','DBX-NCIT-C80365'),('CL-LBTESTCD-T-111',NULL,'BACT','A measurement of the bacteria in a biological specimen.','\0','Bacteria','CL-LBTESTCD','DBX-NCIT-C64469'),('CL-LBTESTCD-T-1110',NULL,'TURB','A measurement of the opacity of a biological specimen.','\0','Turbidity','CL-LBTESTCD','DBX-NCIT-C74723'),('CL-LBTESTCD-T-1111',NULL,'TXB2','A measurement of the thromboxane B2 in a biological specimen.','\0','Thromboxane B2','CL-LBTESTCD','DBX-NCIT-C103445'),('CL-LBTESTCD-T-1112',NULL,'TXB2_D11','A measurement of the 11-dehydro-thromboxane B2 in a biological specimen.','\0','11-Dehydro-Thromboxane B2','CL-LBTESTCD','DBX-NCIT-C103344'),('CL-LBTESTCD-T-1113',NULL,'UNSPCE','A measurement of the cells not otherwise identified or specified in a biological specimen.','\0','Unspecified Cells','CL-LBTESTCD','DBX-NCIT-C112241'),('CL-LBTESTCD-T-1114',NULL,'UNSPCECE','A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen.','\0','Unspecified Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C114225'),('CL-LBTESTCD-T-1115',NULL,'URATE','A measurement of the urate in a biological specimen.','\0','Urate; Uric Acid','CL-LBTESTCD','DBX-NCIT-C64814'),('CL-LBTESTCD-T-1116',NULL,'URATECRT','A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen.','\0','Urate/Creatinine','CL-LBTESTCD','DBX-NCIT-C117866'),('CL-LBTESTCD-T-1117',NULL,'UREA','A measurement of the urea in a biological specimen.','\0','Urea','CL-LBTESTCD','DBX-NCIT-C64815'),('CL-LBTESTCD-T-1118',NULL,'UREACRT','A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.','\0','Urea/Creatinine','CL-LBTESTCD','DBX-NCIT-C96645'),('CL-LBTESTCD-T-1119',NULL,'UROBIL','A measurement of the urobilinogen in a biological specimen.','\0','Urobilinogen','CL-LBTESTCD','DBX-NCIT-C64816'),('CL-LBTESTCD-T-112',NULL,'BAFF','A measurement of the B-cell activating factor in a biological specimen.','\0','B-Cell Activating Factor','CL-LBTESTCD','DBX-NCIT-C111135'),('CL-LBTESTCD-T-1120',NULL,'VCAM1','A measurement of the vascular cell adhesion molecule 1 in a biological specimen.','\0','Vascular Cell Adhesion Molecule 1','CL-LBTESTCD','DBX-NCIT-C82042'),('CL-LBTESTCD-T-1121',NULL,'VEGF','A measurement of the vascular endothelial growth factor in a biological specimen.','\0','Vascular Endothelial Growth Factor','CL-LBTESTCD','DBX-NCIT-C92514'),('CL-LBTESTCD-T-1122',NULL,'VISC','The resistance of a liquid to sheer forces and flow. (NCI)','\0','Viscosity','CL-LBTESTCD','DBX-NCIT-C75912'),('CL-LBTESTCD-T-1123',NULL,'VITA','A measurement of the Vitamin A in a biological specimen.','\0','Retinol; Vitamin A','CL-LBTESTCD','DBX-NCIT-C74895'),('CL-LBTESTCD-T-1124',NULL,'VITB1','A measurement of the thiamine in a biological specimen.','\0','Thiamine; Vitamin B1','CL-LBTESTCD','DBX-NCIT-C74896'),('CL-LBTESTCD-T-1125',NULL,'VITB12','A measurement of the Vitamin B12 in a serum specimen.','\0','Vitamin B12','CL-LBTESTCD','DBX-NCIT-C64817'),('CL-LBTESTCD-T-1126',NULL,'VITB17','A measurement of the Vitamin B17 in a biological specimen.','\0','Amygdalin; Vitamin B17','CL-LBTESTCD','DBX-NCIT-C74897'),('CL-LBTESTCD-T-1127',NULL,'VITB2','A measurement of the riboflavin in a biological specimen.','\0','Riboflavin; Vitamin B2','CL-LBTESTCD','DBX-NCIT-C74898'),('CL-LBTESTCD-T-1128',NULL,'VITB3','A measurement of the niacin in a biological specimen.','\0','Niacin; Vitamin B3','CL-LBTESTCD','DBX-NCIT-C74899'),('CL-LBTESTCD-T-1129',NULL,'VITB5','A measurement of the Vitamin B5 in a biological specimen.','\0','Pantothenic Acid; Vitamin B5','CL-LBTESTCD','DBX-NCIT-C74900'),('CL-LBTESTCD-T-113',NULL,'BARB','A measurement of any barbiturate class drug present in a biological specimen.','\0','Barbiturates','CL-LBTESTCD','DBX-NCIT-C74688'),('CL-LBTESTCD-T-1130',NULL,'VITB6','A measurement of the Vitamin B6 in a biological specimen.','\0','Pyridoxine; Vitamin B6','CL-LBTESTCD','DBX-NCIT-C74901'),('CL-LBTESTCD-T-1131',NULL,'VITB7','A measurement of the Vitamin B7 in a biological specimen.','\0','Biotin; Vitamin B7','CL-LBTESTCD','DBX-NCIT-C74902'),('CL-LBTESTCD-T-1132',NULL,'VITB9','A measurement of the folic acid in a biological specimen.','\0','Folic Acid; Vitamin B9','CL-LBTESTCD','DBX-NCIT-C74676'),('CL-LBTESTCD-T-1133',NULL,'VITC','A measurement of the Vitamin C in a biological specimen.','\0','Ascorbic Acid; Vitamin C','CL-LBTESTCD','DBX-NCIT-C74903'),('CL-LBTESTCD-T-1134',NULL,'VITD','A measurement of the total Vitamin D in a biological specimen.','\0','Total Vitamin D; Vitamin D','CL-LBTESTCD','DBX-NCIT-C84818'),('CL-LBTESTCD-T-1135',NULL,'VITD2','A measurement of the Vitamin D2 in a biological specimen.','\0','Ergocalciferol; Vitamin D2','CL-LBTESTCD','DBX-NCIT-C74904'),('CL-LBTESTCD-T-1136',NULL,'VITD3','A measurement of the Vitamin D3 in a biological specimen.','\0','Cholecalciferol; Vitamin D3','CL-LBTESTCD','DBX-NCIT-C74905'),('CL-LBTESTCD-T-1137',NULL,'VITDAT','A measurement of the total active Vitamin D in a biological specimen.','\0','1, 25-Dihydroxyvitamin D; Active Vitamin D','CL-LBTESTCD','DBX-NCIT-C92267'),('CL-LBTESTCD-T-1138',NULL,'VITDIT','A measurement of the total inactive Vitamin D in a biological specimen.','\0','25-Hydroxyvitamin D; Inactive Vitamin D','CL-LBTESTCD','DBX-NCIT-C92268'),('CL-LBTESTCD-T-1139',NULL,'VITE','A measurement of the Vitamin E in a biological specimen.','\0','Vitamin E','CL-LBTESTCD','DBX-NCIT-C74906'),('CL-LBTESTCD-T-114',NULL,'BASO','A measurement of the basophils in a biological specimen.','\0','Basophils','CL-LBTESTCD','DBX-NCIT-C64470'),('CL-LBTESTCD-T-1140',NULL,'VITECHOL','A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen.','\0','Vitamin E/Cholesterol','CL-LBTESTCD','DBX-NCIT-C103448'),('CL-LBTESTCD-T-1141',NULL,'VITK','A measurement of the total Vitamin K in a biological specimen.','\0','Naphthoquinone; Vitamin K','CL-LBTESTCD','DBX-NCIT-C74907'),('CL-LBTESTCD-T-1142',NULL,'VITK1','A measurement of the Vitamin K1 in a biological specimen.','\0','Phylloquinone; Phytomenadione','CL-LBTESTCD','DBX-NCIT-C103449'),('CL-LBTESTCD-T-1143',NULL,'VLDL','A measurement of the very low density lipoprotein cholesterol in a biological specimen.','\0','VLDL Cholesterol','CL-LBTESTCD','DBX-NCIT-C105589'),('CL-LBTESTCD-T-1144',NULL,'VLDLPSZ','A measurement of the average particle size of very-low-density lipoprotein in a biological specimen.','\0','VLDL Particle Size','CL-LBTESTCD','DBX-NCIT-C103450'),('CL-LBTESTCD-T-1145',NULL,'VMA','A measurement of the vanillyl mandelic acid metabolite in a biological specimen.','\0','Vanillyl Mandelic Acid; Vanilmandelic Acid','CL-LBTESTCD','DBX-NCIT-C74875'),('CL-LBTESTCD-T-1146',NULL,'VOLUME','A measurement of the volume of a biological specimen.','\0','Volume','CL-LBTESTCD','DBX-NCIT-C74720'),('CL-LBTESTCD-T-1147',NULL,'VZVAB','A measurement of the total varicella zoster virus antibody in a biological specimen.','\0','Varicella Zoster Virus Antibody','CL-LBTESTCD','DBX-NCIT-C117867'),('CL-LBTESTCD-T-1148',NULL,'VZVIGAAB','A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.','\0','Varicella Zoster Virus IgA Antibody','CL-LBTESTCD','DBX-NCIT-C98795'),('CL-LBTESTCD-T-1149',NULL,'VZVIGGAB','A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.','\0','Varicella Zoster Virus IgG Antibody','CL-LBTESTCD','DBX-NCIT-C98796'),('CL-LBTESTCD-T-115',NULL,'BASOCE','A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Basophils/Total Cells','CL-LBTESTCD','DBX-NCIT-C98865'),('CL-LBTESTCD-T-1150',NULL,'VZVIGMAB','A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.','\0','Varicella Zoster Virus IgM Antibody','CL-LBTESTCD','DBX-NCIT-C98797'),('CL-LBTESTCD-T-1151',NULL,'WBC','A measurement of the leukocytes in a biological specimen.','\0','Leukocytes; White Blood Cells','CL-LBTESTCD','DBX-NCIT-C51948'),('CL-LBTESTCD-T-1152',NULL,'WBCCLMP','A measurement of white blood cell clumps in a biological specimen.','\0','Leukocyte Cell Clumps; WBC Clumps; White Blood Cell Clumps','CL-LBTESTCD','DBX-NCIT-C92246'),('CL-LBTESTCD-T-1153',NULL,'WBCMORPH','An examination or assessment of the form and structure of white blood cells.','\0','Leukocyte Cell Morphology; WBC Morphology; White Blood Cell Morphology','CL-LBTESTCD','DBX-NCIT-C92297'),('CL-LBTESTCD-T-1154',NULL,'YEAST','A measurement of the yeast cells present in a biological specimen.','\0','Yeast Cells','CL-LBTESTCD','DBX-NCIT-C74664'),('CL-LBTESTCD-T-1155',NULL,'YEASTBUD','Examination of a biological specimen to detect the presence of any yeast cells that are in the budding phase of asexual reproduction.','\0','Budding Yeast; Yeast Budding','CL-LBTESTCD','DBX-NCIT-C106504'),('CL-LBTESTCD-T-1156',NULL,'YEASTHYP','Examination of a biological specimen to detect the presence of any yeast cells that are in the long, filamentous and branching phase of growth.','\0','Yeast Hyphae','CL-LBTESTCD','DBX-NCIT-C92239'),('CL-LBTESTCD-T-1157',NULL,'ZINC','A measurement of the zinc in a biological specimen.','\0','Zinc','CL-LBTESTCD','DBX-NCIT-C80210'),('CL-LBTESTCD-T-116',NULL,'BASOIM','A measurement of the immature basophils in a biological specimen.','\0','Immature Basophils','CL-LBTESTCD','DBX-NCIT-C96670'),('CL-LBTESTCD-T-117',NULL,'BASOIMLE','A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.','\0','Immature Basophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C96671'),('CL-LBTESTCD-T-118',NULL,'BASOLE','A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.','\0','Basophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64471'),('CL-LBTESTCD-T-119',NULL,'BDNF','A measurement of the brain-derived neurotrophic factor in a biological specimen.','\0','Brain-Derived Neurotrophic Factor','CL-LBTESTCD','DBX-NCIT-C82004'),('CL-LBTESTCD-T-12',NULL,'ACH','A measurement of the acetylcholine hormone in a biological specimen.','\0','Acetylcholine','CL-LBTESTCD','DBX-NCIT-C74838'),('CL-LBTESTCD-T-120',NULL,'BETACRTN','A measurement of the beta carotene in a biological specimen.','\0','Beta Carotene; Beta Carotin; b-Carotene','CL-LBTESTCD','DBX-NCIT-C100472'),('CL-LBTESTCD-T-121',NULL,'BHYXBTR','A measurement of the total Beta-hydroxybutyrate in a biological specimen.','\0','3-Hydroxybutyrate; B-Hydroxybutyrate; Beta-Hydroxybutyrate','CL-LBTESTCD','DBX-NCIT-C96568'),('CL-LBTESTCD-T-122',NULL,'BICARB','A measurement of the bicarbonate in a biological specimen.','\0','Bicarbonate; HCO3','CL-LBTESTCD','DBX-NCIT-C74667'),('CL-LBTESTCD-T-123',NULL,'BILDIR','A measurement of the conjugated or water-soluble bilirubin in a biological specimen.','\0','Direct Bilirubin','CL-LBTESTCD','DBX-NCIT-C64481'),('CL-LBTESTCD-T-124',NULL,'BILEAC','A measurement of the total bile acids in a biological specimen.','\0','Bile Acid; Bile Acids; Bile Salt; Bile Salts','CL-LBTESTCD','DBX-NCIT-C74800'),('CL-LBTESTCD-T-125',NULL,'BILI','A measurement of the total bilirubin in a biological specimen.','\0','Bilirubin; Total Bilirubin','CL-LBTESTCD','DBX-NCIT-C38037'),('CL-LBTESTCD-T-126',NULL,'BILIND','A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.','\0','Indirect Bilirubin','CL-LBTESTCD','DBX-NCIT-C64483'),('CL-LBTESTCD-T-127',NULL,'BITECE','A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen.','\0','Bite Cells','CL-LBTESTCD','DBX-NCIT-C74700'),('CL-LBTESTCD-T-128',NULL,'BJPROT','A measurement of the total Bence-Jones protein in a biological specimen.','\0','Bence-Jones Protein; Immunoglobulin Light Chains','CL-LBTESTCD','DBX-NCIT-C111136'),('CL-LBTESTCD-T-129',NULL,'BKVVLD','A measurement of the BK virus viral load in a biological specimen.','\0','BKV Viral Load','CL-LBTESTCD','DBX-NCIT-C98710'),('CL-LBTESTCD-T-13',NULL,'ACHE','A measurement of the acetylcholinesterase in a biological specimen.','\0','Acetylcholinesterase','CL-LBTESTCD','DBX-NCIT-C96560'),('CL-LBTESTCD-T-130',NULL,'BLAST','A measurement of the blast cells in a biological specimen.','\0','Blasts','CL-LBTESTCD','DBX-NCIT-C74605'),('CL-LBTESTCD-T-131',NULL,'BLASTIMM','A measurement of the immunoblasts in a biological specimen.','\0','Lymphocytes, Immunoblastic','CL-LBTESTCD','DBX-NCIT-C103407'),('CL-LBTESTCD-T-132',NULL,'BLASTLE','A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.','\0','Blasts/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64487'),('CL-LBTESTCD-T-133',NULL,'BLASTLM','A measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.','\0','Leukemic Blasts','CL-LBTESTCD','DBX-NCIT-C74630'),('CL-LBTESTCD-T-134',NULL,'BLSTIMLY','A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample.','\0','Immunoblasts/Lymphocytes; Lymphocytes, Immunoblastic/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C106535'),('CL-LBTESTCD-T-135',NULL,'BLSTLMLY','A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.','\0','Leukemic Blasts/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74641'),('CL-LBTESTCD-T-136',NULL,'BLSTLY','A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen.','\0','Lymphoblasts','CL-LBTESTCD','DBX-NCIT-C102278'),('CL-LBTESTCD-T-137',NULL,'BLSTLYLE','A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen.','\0','Lymphoblasts/Leukocytes','CL-LBTESTCD','DBX-NCIT-C105444'),('CL-LBTESTCD-T-138',NULL,'BLSTMBCE','A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Myeloblasts/Total Cells','CL-LBTESTCD','DBX-NCIT-C98761'),('CL-LBTESTCD-T-139',NULL,'BLSTMGK','A measurement of the megakaryoblasts in a biological specimen.','\0','Megakaryoblasts','CL-LBTESTCD','DBX-NCIT-C98752'),('CL-LBTESTCD-T-14',NULL,'ACHRAB','A measurement of the acetylcholine receptor antibody in a biological specimen.','\0','Acetylcholine Receptor Antibody','CL-LBTESTCD','DBX-NCIT-C96559'),('CL-LBTESTCD-T-140',NULL,'BLSTMKCE','A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Megakaryoblasts/Total Cells','CL-LBTESTCD','DBX-NCIT-C98753'),('CL-LBTESTCD-T-141',NULL,'BLSTNMCE','A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Normoblasts/Total Cells','CL-LBTESTCD','DBX-NCIT-C98764'),('CL-LBTESTCD-T-142',NULL,'BLSTPNCE','A relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).','\0','Pronormoblasts/Total Cells','CL-LBTESTCD','DBX-NCIT-C98870'),('CL-LBTESTCD-T-143',NULL,'BLSTRSID','A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.','\0','Ringed Sideroblasts','CL-LBTESTCD','DBX-NCIT-C100419'),('CL-LBTESTCD-T-144',NULL,'BLSTSID','A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.','\0','Sideroblast','CL-LBTESTCD','DBX-NCIT-C100418'),('CL-LBTESTCD-T-145',NULL,'BNP','A measurement of the brain (B-type) natriuretic peptide in a biological specimen.','\0','B-Type Natriuretic Peptide; Brain Natriuretic Peptide','CL-LBTESTCD','DBX-NCIT-C74735'),('CL-LBTESTCD-T-146',NULL,'BNPPRO','A measurement of the proB-type natriuretic peptide in a biological specimen.','\0','Pro-Brain Natriuretic Peptide; ProB-type Natriuretic Peptide; proBNP','CL-LBTESTCD','DBX-NCIT-C82032'),('CL-LBTESTCD-T-147',NULL,'BNPPRONT','A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.','\0','N-Terminal ProB-type Natriuretic Peptide; N-terminal pro-Brain Natriuretic Peptide; NT proBNP II','CL-LBTESTCD','DBX-NCIT-C96610'),('CL-LBTESTCD-T-148',NULL,'BNZDZPN','A measurement of any benzodiazepine class drug present in a biological specimen.','\0','Benzodiazepine','CL-LBTESTCD','DBX-NCIT-C74692'),('CL-LBTESTCD-T-149',NULL,'BNZLCGN','A measurement of the benzoylecgonine in a biological specimen.','\0','Benzoylecgonine; Cocaine Metabolite','CL-LBTESTCD','DBX-NCIT-C75350'),('CL-LBTESTCD-T-15',NULL,'ACPHOS','A measurement of the acid phosphatase in a biological specimen.','\0','Acid Phosphatase','CL-LBTESTCD','DBX-NCIT-C80163'),('CL-LBTESTCD-T-150',NULL,'BTECERBC','A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen.','\0','Bite Cells/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C74634'),('CL-LBTESTCD-T-151',NULL,'BTP','A measurement of the beta-trace protein in a biological specimen.','\0','Beta-Trace Protein','CL-LBTESTCD','DBX-NCIT-C100426'),('CL-LBTESTCD-T-152',NULL,'BUCHE','A measurement of the total butyrylcholinesterase in a biological specimen.','\0','Acylcholine Acylhydrolase; Butyrylcholinesterase; Non-neuronal Cholinesterase; Plasma Cholinesterase; Pseudocholinesterase','CL-LBTESTCD','DBX-NCIT-C111142'),('CL-LBTESTCD-T-153',NULL,'BUN','A measurement of the urea nitrogen in a blood specimen.','\0','Blood Urea Nitrogen','CL-LBTESTCD','DBX-NCIT-C61019'),('CL-LBTESTCD-T-154',NULL,'BUNCREAT','A relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.','\0','BUN/Creatinine','CL-LBTESTCD','DBX-NCIT-C74753'),('CL-LBTESTCD-T-155',NULL,'BURRCE','A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.','\0','Burr Cells; Keratocytes','CL-LBTESTCD','DBX-NCIT-C74701'),('CL-LBTESTCD-T-156',NULL,'C1QAB','A measurement of the complement C1q antibody in a biological specimen.','\0','Complement C1q Antibody','CL-LBTESTCD','DBX-NCIT-C80173'),('CL-LBTESTCD-T-157',NULL,'C3','A measurement of the complement C3 in a biological specimen.','\0','Complement C3','CL-LBTESTCD','DBX-NCIT-C80174'),('CL-LBTESTCD-T-158',NULL,'C3A','A measurement of the complement C3a in a biological specimen.','\0','ASP, Complement C3 DesArg, Acetylation-stimulating Protein; Complement C3a','CL-LBTESTCD','DBX-NCIT-C80175'),('CL-LBTESTCD-T-159',NULL,'C3B','A measurement of the complement C3b in a biological specimen.','\0','Complement C3b','CL-LBTESTCD','DBX-NCIT-C80176'),('CL-LBTESTCD-T-16',NULL,'ACT','A measurement of the inhibition of blood coagulation in response to anticoagulant therapies.','\0','Activated Clot Time; Activated Clotting Time; Coagulation Activated','CL-LBTESTCD','DBX-NCIT-C103348'),('CL-LBTESTCD-T-160',NULL,'C4','A measurement of the complement C4 in a biological specimen.','\0','Complement C4','CL-LBTESTCD','DBX-NCIT-C80177'),('CL-LBTESTCD-T-161',NULL,'C4A','A measurement of the complement C4a in a biological specimen.','\0','Complement C4a','CL-LBTESTCD','DBX-NCIT-C80178'),('CL-LBTESTCD-T-162',NULL,'C5A','A measurement of the complement C5a in a biological specimen.','\0','Complement C5a','CL-LBTESTCD','DBX-NCIT-C80179'),('CL-LBTESTCD-T-163',NULL,'CA','A measurement of the calcium in a biological specimen.','\0','Calcium','CL-LBTESTCD','DBX-NCIT-C64488'),('CL-LBTESTCD-T-164',NULL,'CA125AG','A measurement of the cancer antigen 125 in a biological specimen.','\0','Cancer Antigen 125','CL-LBTESTCD','DBX-NCIT-C79089'),('CL-LBTESTCD-T-165',NULL,'CA15_3AG','A measurement of the cancer antigen 15-3 in a biological specimen.','\0','Cancer Antigen 15-3','CL-LBTESTCD','DBX-NCIT-C103362'),('CL-LBTESTCD-T-166',NULL,'CA19_9AG','A measurement of the cancer antigen 19-9 in a biological specimen.','\0','Cancer Antigen 19-9','CL-LBTESTCD','DBX-NCIT-C81982'),('CL-LBTESTCD-T-167',NULL,'CA1AG','A measurement of the cancer antigen 1 in a biological specimen.','\0','Cancer Antigen 1','CL-LBTESTCD','DBX-NCIT-C103361'),('CL-LBTESTCD-T-168',NULL,'CA2729AG','A measurement of the cancer antigen 27-29 in a biological specimen.','\0','Cancer Antigen 27-29','CL-LBTESTCD','DBX-NCIT-C111143'),('CL-LBTESTCD-T-169',NULL,'CA72_4AG','A measurement of the cancer antigen 72-4 in a biological specimen.','\0','CA 72-4; Cancer Antigen 72-4; Carbohydrate Antigen 72-4','CL-LBTESTCD','DBX-NCIT-C106505'),('CL-LBTESTCD-T-17',NULL,'ACTH','A measurement of the adrenocorticotropic hormone in a biological specimen.','\0','Adrenocorticotropic Hormone','CL-LBTESTCD','DBX-NCIT-C74780'),('CL-LBTESTCD-T-170',NULL,'CABOT','A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.','\0','Cabot Rings','CL-LBTESTCD','DBX-NCIT-C74702'),('CL-LBTESTCD-T-171',NULL,'CACLR','A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Calcium Clearance','CL-LBTESTCD','DBX-NCIT-C96589'),('CL-LBTESTCD-T-172',NULL,'CACREAT','A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.','\0','Calcium/Creatinine','CL-LBTESTCD','DBX-NCIT-C79439'),('CL-LBTESTCD-T-173',NULL,'CAEXR','A measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour).','\0','Calcium Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117831'),('CL-LBTESTCD-T-174',NULL,'CAFFEINE','A measurement of the caffeine in a biological specimen.','\0','Caffeine','CL-LBTESTCD','DBX-NCIT-C75346'),('CL-LBTESTCD-T-175',NULL,'CAION','A measurement of the ionized calcium in a biological specimen.','\0','Calcium, Ionized','CL-LBTESTCD','DBX-NCIT-C81948'),('CL-LBTESTCD-T-176',NULL,'CALPRO','A measurement of the calprotectin in a biological specimen.','\0','Calprotectin','CL-LBTESTCD','DBX-NCIT-C82005'),('CL-LBTESTCD-T-177',NULL,'CANNAB','A measurement of any cannabinoid class drug present in a biological specimen.','\0','Cannabinoids','CL-LBTESTCD','DBX-NCIT-C74689'),('CL-LBTESTCD-T-178',NULL,'CAPHOSPD','A measurement of the product of the calcium and phosphate measurements in a biological specimen.','\0','Calcium - Phosphorus Product','CL-LBTESTCD','DBX-NCIT-C103360'),('CL-LBTESTCD-T-179',NULL,'CARBXHGB','A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen.','\0','Carboxyhemoglobin','CL-LBTESTCD','DBX-NCIT-C96591'),('CL-LBTESTCD-T-18',NULL,'ACYLCAOX','A measurement of the acyl coenzyme A oxidase in a biological specimen.','\0','Acyl CoA Oxidase; Acyl Coenzyme A Oxidase; Fatty Acyl Coenzyme A Oxidase','CL-LBTESTCD','DBX-NCIT-C92286'),('CL-LBTESTCD-T-180',NULL,'CARNIT','A measurement of the total carnitine in a biological specimen.','\0','Carnitine','CL-LBTESTCD','DBX-NCIT-C74682'),('CL-LBTESTCD-T-181',NULL,'CARNITAT','A measurement of the carnitine acetyl transferase in a biological specimen.','\0','Carnitine Acetyl Transferase','CL-LBTESTCD','DBX-NCIT-C92288'),('CL-LBTESTCD-T-182',NULL,'CARNITF','A measurement of the free carnitine in a biological specimen.','\0','Carnitine, Free','CL-LBTESTCD','DBX-NCIT-C74677'),('CL-LBTESTCD-T-183',NULL,'CASTS','A statement that indicates casts were looked for in a biological specimen.','\0','Casts','CL-LBTESTCD','DBX-NCIT-C74763'),('CL-LBTESTCD-T-184',NULL,'CASULPH','A measurement of the calcium sulphate in a biological specimen.','\0','Calcium Sulphate','CL-LBTESTCD','DBX-NCIT-C96590'),('CL-LBTESTCD-T-185',NULL,'CATNINB','A measurement of the beta catenin in a biological specimen.','\0','Beta Catenin','CL-LBTESTCD','DBX-NCIT-C103357'),('CL-LBTESTCD-T-186',NULL,'CBB','A measurement of the Bb fragment of complement factor B in a biological specimen.','\0','Bb Fragment of Complement Factor B; Bb Fragment of Factor B; Complement Bb','CL-LBTESTCD','DBX-NCIT-C80172'),('CL-LBTESTCD-T-187',NULL,'CCK','A measurement of the cholecystokinin hormone in a biological specimen.','\0','Cholecystokinin; Pancreozymin','CL-LBTESTCD','DBX-NCIT-C74850'),('CL-LBTESTCD-T-188',NULL,'CCL17','A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen.','\0','ABCD-2; Chemokine (C-C Motif) Ligand 17; SCYA17; TARC; Thymus and Activation Regulated Chemokine','CL-LBTESTCD','DBX-NCIT-C112236'),('CL-LBTESTCD-T-189',NULL,'CCL18','A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen.','\0','AMAC-1; AMAC1; CKB7; Chemokine (C-C Motif) Ligand 18; DC-CK1; DCCK1; MIP-4; Macrophage inflammatory protein-4; PARC; Pulmonary and Activation-Regulated Chemokine; SCYA18','CL-LBTESTCD','DBX-NCIT-C112237'),('CL-LBTESTCD-T-19',NULL,'ADENOVAB','A measurement of the adenovirus antibody in a biological specimen.','\0','Adenovirus Antibody','CL-LBTESTCD','DBX-NCIT-C111125'),('CL-LBTESTCD-T-190',NULL,'CCPAB','A measurement of the cyclic citrullinated peptide antibody in a biological specimen.','\0','Cyclic Citrullinated Peptide Antibody','CL-LBTESTCD','DBX-NCIT-C96595'),('CL-LBTESTCD-T-191',NULL,'CD1','A count of the CD1 expressing cells per unit of a biological specimen.','\0','CD1','CL-LBTESTCD','DBX-NCIT-C103364'),('CL-LBTESTCD-T-192',NULL,'CD10','A measurement of the CD10 expressing cells per unit in a biological specimen.','\0','CD10','CL-LBTESTCD','DBX-NCIT-C111146'),('CL-LBTESTCD-T-193',NULL,'CD11A','A count of the CD11a expressing cells per unit of a biological specimen.','\0','CD11A; CD11a','CL-LBTESTCD','DBX-NCIT-C105439'),('CL-LBTESTCD-T-194',NULL,'CD11B','A count of the CD11b expressing cells per unit of a biological specimen.','\0','CD11B; CD11b','CL-LBTESTCD','DBX-NCIT-C105440'),('CL-LBTESTCD-T-195',NULL,'CD13','A measurement of the CD13 expressing cells per unit in a biological specimen.','\0','CD13','CL-LBTESTCD','DBX-NCIT-C111147'),('CL-LBTESTCD-T-196',NULL,'CD14','A count of the CD14 expressing cells per unit of a biological specimen.','\0','CD14','CL-LBTESTCD','DBX-NCIT-C103365'),('CL-LBTESTCD-T-197',NULL,'CD19','A count of the CD19 expressing cells per unit in a biological specimen.','\0','CD19','CL-LBTESTCD','DBX-NCIT-C103808'),('CL-LBTESTCD-T-198',NULL,'CD19LY','A relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen.','\0','CD19/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C103812'),('CL-LBTESTCD-T-199',NULL,'CD2','A count of the CD2 expressing cells per unit of a biological specimen.','\0','CD2','CL-LBTESTCD','DBX-NCIT-C103366'),('CL-LBTESTCD-T-2',NULL,'A1ANTRYP','A measurement of the alpha-1 antitrypsin in a biological specimen.','\0','Alpha-1 Antitrypsin; Serum Trypsin Inhibitor','CL-LBTESTCD','DBX-NCIT-C80167'),('CL-LBTESTCD-T-20',NULL,'ADH','A measurement of the antidiuretic hormone in a biological specimen.','\0','Antidiuretic Hormone; Vasopressin','CL-LBTESTCD','DBX-NCIT-C74847'),('CL-LBTESTCD-T-200',NULL,'CD20','A count of the CD20 expressing cells per unit of a biological specimen.','\0','CD20','CL-LBTESTCD','DBX-NCIT-C103368'),('CL-LBTESTCD-T-201',NULL,'CD22','A measurement of the CD22 expressing cells per unit in a biological specimen.','\0','CD22','CL-LBTESTCD','DBX-NCIT-C111148'),('CL-LBTESTCD-T-202',NULL,'CD23','A measurement of the CD23 expressing cells per unit in a biological specimen.','\0','CD23','CL-LBTESTCD','DBX-NCIT-C111149'),('CL-LBTESTCD-T-203',NULL,'CD2LY','A relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen.','\0','CD2/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C103367'),('CL-LBTESTCD-T-204',NULL,'CD3','A count of the CD3 expressing cells per unit in a biological specimen.','\0','CD3','CL-LBTESTCD','DBX-NCIT-C103809'),('CL-LBTESTCD-T-205',NULL,'CD33','A measurement of the CD33 expressing cells per unit in a biological specimen.','\0','CD33','CL-LBTESTCD','DBX-NCIT-C111150'),('CL-LBTESTCD-T-206',NULL,'CD34','A measurement of the CD34 expressing cells per unit in a biological specimen.','\0','CD34','CL-LBTESTCD','DBX-NCIT-C102260'),('CL-LBTESTCD-T-207',NULL,'CD38','A measurement of the CD38 expressing cells per unit in a biological specimen.','\0','CD38','CL-LBTESTCD','DBX-NCIT-C111151'),('CL-LBTESTCD-T-208',NULL,'CD3LY','A relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen.','\0','CD3/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C103813'),('CL-LBTESTCD-T-209',NULL,'CD4','A count of the CD4 expressing cells per unit in a biological specimen.','\0','CD4','CL-LBTESTCD','DBX-NCIT-C103810'),('CL-LBTESTCD-T-21',NULL,'ADP','A measurement of the adenosine diphosphate in a biological specimen.','\0','Adenosine Diphosphate','CL-LBTESTCD','DBX-NCIT-C102257'),('CL-LBTESTCD-T-210',NULL,'CD40','A count of the CD40 cells per unit in a biological specimen.','\0','CD40','CL-LBTESTCD','DBX-NCIT-C82006'),('CL-LBTESTCD-T-211',NULL,'CD40L','A count of the CD40 ligand cells per unit in a biological specimen.','\0','CD40 Ligand','CL-LBTESTCD','DBX-NCIT-C82007'),('CL-LBTESTCD-T-212',NULL,'CD4CD8','A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen.','\0','CD4/CD8','CL-LBTESTCD','DBX-NCIT-C103814'),('CL-LBTESTCD-T-213',NULL,'CD4LY','A relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen.','\0','CD4/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C103815'),('CL-LBTESTCD-T-214',NULL,'CD5','A count of the CD5 expressing cells per unit of a biological specimen.','\0','CD5','CL-LBTESTCD','DBX-NCIT-C103369'),('CL-LBTESTCD-T-215',NULL,'CD56','A count of the CD56 expressing cells per unit of a biological specimen.','\0','CD56','CL-LBTESTCD','DBX-NCIT-C103370'),('CL-LBTESTCD-T-216',NULL,'CD79A','A measurement of the CD79A expressing cells per unit in a biological specimen.','\0','CD79A','CL-LBTESTCD','DBX-NCIT-C111152'),('CL-LBTESTCD-T-217',NULL,'CD8','A count of the CD8 expressing cells per unit in a biological specimen.','\0','CD8','CL-LBTESTCD','DBX-NCIT-C103811'),('CL-LBTESTCD-T-218',NULL,'CD8LY','A relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen.','\0','CD8/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C103816'),('CL-LBTESTCD-T-219',NULL,'CDFTXN','A measurement of the Clostridium difficile toxin in a biological specimen.','\0','Clostridium difficile Toxin','CL-LBTESTCD','DBX-NCIT-C103381'),('CL-LBTESTCD-T-22',NULL,'ADPNCTN','A measurement of the adiponectin hormone in a biological specimen.','\0','Adiponectin','CL-LBTESTCD','DBX-NCIT-C74839'),('CL-LBTESTCD-T-220',NULL,'CDT','A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.','\0','Carbohydrate-Deficient Transferrin','CL-LBTESTCD','DBX-NCIT-C101016'),('CL-LBTESTCD-T-221',NULL,'CEA','A measurement of the carcinoembryonic antigen in a biological specimen.','\0','Carcinoembryonic Antigen','CL-LBTESTCD','DBX-NCIT-C81983'),('CL-LBTESTCD-T-222',NULL,'CEC','A measurement of the circulating endothelial cells in a biological specimen.','\0','Circulating Endothelial Cells','CL-LBTESTCD','DBX-NCIT-C96592'),('CL-LBTESTCD-T-223',NULL,'CEIMCE','A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen.','\0','Immature Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C111234'),('CL-LBTESTCD-T-224',NULL,'CELLSIM','A measurement of the total immature cells in a blood specimen.','\0','Immature Cells','CL-LBTESTCD','DBX-NCIT-C96672'),('CL-LBTESTCD-T-225',NULL,'CELLULAR','A measurement of the degree, quality or condition of cells in a biological specimen.','\0','Cellularity; Cellularity Grade','CL-LBTESTCD','DBX-NCIT-C111153'),('CL-LBTESTCD-T-226',NULL,'CENTROAB','A measurement of centromere B antibodies in a biological specimen.','\0','Anti-Centromere B Antibodies','CL-LBTESTCD','DBX-NCIT-C111154'),('CL-LBTESTCD-T-227',NULL,'CETPA','A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen.','\0','Cholesteryl Ester Transfer Protein Act','CL-LBTESTCD','DBX-NCIT-C103380'),('CL-LBTESTCD-T-228',NULL,'CGMP','A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen.','\0','Cyclic Guanosine 3,5-Monophosphate','CL-LBTESTCD','DBX-NCIT-C111165'),('CL-LBTESTCD-T-229',NULL,'CH50','A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.','\0','CH50; Complement CH50; Total Hemolytic Complement','CL-LBTESTCD','DBX-NCIT-C100423'),('CL-LBTESTCD-T-23',NULL,'ADSDNA','A measurement of the anti-double stranded DNA antibody in a biological specimen.','\0','Anti-Double Stranded DNA','CL-LBTESTCD','DBX-NCIT-C74913'),('CL-LBTESTCD-T-230',NULL,'CHOL','A measurement of the cholesterol in a biological specimen.','\0','Cholesterol; Total Cholesterol','CL-LBTESTCD','DBX-NCIT-C105586'),('CL-LBTESTCD-T-231',NULL,'CHOLHDL','A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.','\0','Cholesterol/HDL-Cholesterol','CL-LBTESTCD','DBX-NCIT-C80171'),('CL-LBTESTCD-T-232',NULL,'CHOLINES','A measurement of the cholinesterase in a biological specimen.','\0','Cholinesterase','CL-LBTESTCD','DBX-NCIT-C92289'),('CL-LBTESTCD-T-233',NULL,'CHYTRYP','A measurement of the total chymotrypsin in a biological specimen.','\0','Chymotrypsin','CL-LBTESTCD','DBX-NCIT-C111159'),('CL-LBTESTCD-T-234',NULL,'CITRATE','A measurement of the citrate in a biological specimen.','\0','Citrate','CL-LBTESTCD','DBX-NCIT-C92248'),('CL-LBTESTCD-T-235',NULL,'CK','A measurement of the total creatine kinase in a biological specimen.','\0','Creatine Kinase','CL-LBTESTCD','DBX-NCIT-C64489'),('CL-LBTESTCD-T-236',NULL,'CKBB','A measurement of the homozygous B-type creatine kinase in a biological specimen.','\0','Creatine Kinase BB','CL-LBTESTCD','DBX-NCIT-C64490'),('CL-LBTESTCD-T-237',NULL,'CKBBCK','A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase BB/Total Creatine Kinase','CL-LBTESTCD','DBX-NCIT-C79466'),('CL-LBTESTCD-T-238',NULL,'CKMB','A measurement of the heterozygous MB-type creatine kinase in a biological specimen.','\0','Creatine Kinase MB','CL-LBTESTCD','DBX-NCIT-C64491'),('CL-LBTESTCD-T-239',NULL,'CKMBCK','A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase MB/Total Creatine Kinase','CL-LBTESTCD','DBX-NCIT-C79441'),('CL-LBTESTCD-T-24',NULL,'ADVVLD','A measurement of the adenovirus viral load in a biological specimen.','\0','ADV Viral Load','CL-LBTESTCD','DBX-NCIT-C98705'),('CL-LBTESTCD-T-240',NULL,'CKMM','A measurement of the homozygous M-type creatine kinase in a biological specimen.','\0','Creatine Kinase MM','CL-LBTESTCD','DBX-NCIT-C64494'),('CL-LBTESTCD-T-241',NULL,'CKMMCK','A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.','\0','Creatine Kinase MM/Total Creatine Kinase','CL-LBTESTCD','DBX-NCIT-C79442'),('CL-LBTESTCD-T-242',NULL,'CL','A measurement of the chloride in a biological specimen.','\0','Chloride','CL-LBTESTCD','DBX-NCIT-C64495'),('CL-LBTESTCD-T-243',NULL,'CLARITY','A measurement of the transparency of a biological specimen.','\0','Clarity','CL-LBTESTCD','DBX-NCIT-C96594'),('CL-LBTESTCD-T-244',NULL,'CLCLR','A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute).','\0','Chloride Clearance','CL-LBTESTCD','DBX-NCIT-C106509'),('CL-LBTESTCD-T-245',NULL,'CLCREAT','A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.','\0','Chloride/Creatinine','CL-LBTESTCD','DBX-NCIT-C79440'),('CL-LBTESTCD-T-246',NULL,'CLCTONN','A measurement of the calcitonin hormone in a biological specimen.','\0','Calcitonin','CL-LBTESTCD','DBX-NCIT-C74848'),('CL-LBTESTCD-T-247',NULL,'CLCTRIOL','A measurement of the calcitriol hormone in a biological specimen.','\0','Calcitriol','CL-LBTESTCD','DBX-NCIT-C74849'),('CL-LBTESTCD-T-248',NULL,'CLEXR','A measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour).','\0','Chloride Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117832'),('CL-LBTESTCD-T-249',NULL,'CLUECE','A measurement of the clue cells in a biological specimen.','\0','Clue Cells','CL-LBTESTCD','DBX-NCIT-C102261'),('CL-LBTESTCD-T-25',NULL,'AFACTXAA','A measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.','\0','Anti-Factor Xa Activity','CL-LBTESTCD','DBX-NCIT-C98706'),('CL-LBTESTCD-T-250',NULL,'CMVIGGAB','A measurement of the cytomegalovirus IgG antibody in a biological specimen.','\0','Cytomegalovirus IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96596'),('CL-LBTESTCD-T-251',NULL,'CMVIGMAB','A measurement of the cytomegalovirus IgM antibody in a biological specimen.','\0','Cytomegalovirus IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96597'),('CL-LBTESTCD-T-252',NULL,'CMVVLD','A measurement of the cytomegalovirus viral load in a biological specimen.','\0','CMV Viral Load','CL-LBTESTCD','DBX-NCIT-C98716'),('CL-LBTESTCD-T-253',NULL,'CO2','A measurement of the carbon dioxide gas in a biological specimen.','\0','Carbon Dioxide','CL-LBTESTCD','DBX-NCIT-C64545'),('CL-LBTESTCD-T-254',NULL,'COAGIDX','A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.','\0','CI; Coagulation Index','CL-LBTESTCD','DBX-NCIT-C112239'),('CL-LBTESTCD-T-255',NULL,'COCAINE','A measurement of the cocaine present in a biological specimen.','\0','Cocaine','CL-LBTESTCD','DBX-NCIT-C74690'),('CL-LBTESTCD-T-256',NULL,'COCCAB','A measurement of the coccidioides antibody in a biological specimen.','\0','Coccidioides Antibody','CL-LBTESTCD','DBX-NCIT-C111160'),('CL-LBTESTCD-T-257',NULL,'CODEINE','A measurement of the codeine present in a biological specimen.','\0','Codeine','CL-LBTESTCD','DBX-NCIT-C74877'),('CL-LBTESTCD-T-258',NULL,'COL4','A measurement of the collagen type IV in a biological specimen.','\0','Collagen Type IV','CL-LBTESTCD','DBX-NCIT-C103383'),('CL-LBTESTCD-T-259',NULL,'COLOR','A measurement of the color of a biological specimen.','\0','Color','CL-LBTESTCD','DBX-NCIT-C64546'),('CL-LBTESTCD-T-26',NULL,'AFP','A measurement of the alpha fetoprotein in a biological specimen.','\0','Alpha Fetoprotein','CL-LBTESTCD','DBX-NCIT-C74732'),('CL-LBTESTCD-T-260',NULL,'COMP','A measurement of the cartilage oligomeric matrix protein in a biological specimen.','\0','Cartilage Oligomeric Matrix Protein','CL-LBTESTCD','DBX-NCIT-C111145'),('CL-LBTESTCD-T-261',NULL,'CONDUCTU','A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine.','\0','Urine Conductivity','CL-LBTESTCD','DBX-NCIT-C102282'),('CL-LBTESTCD-T-262',NULL,'COPPER','A measurement of copper in a biological specimen.','\0','Copper; Cu','CL-LBTESTCD','DBX-NCIT-C111161'),('CL-LBTESTCD-T-263',NULL,'CORCREAT','A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample.','\0','Cortisol/Creatinine','CL-LBTESTCD','DBX-NCIT-C106512'),('CL-LBTESTCD-T-264',NULL,'CORTFR','A measurement of the free, unbound cortisol in a biological specimen.','\0','Cortisol, Free','CL-LBTESTCD','DBX-NCIT-C88113'),('CL-LBTESTCD-T-265',NULL,'CORTISOL','A measurement of the cortisol in a biological specimen.','\0','Cortisol; Total Cortisol','CL-LBTESTCD','DBX-NCIT-C74781'),('CL-LBTESTCD-T-266',NULL,'COTININE','A measurement of the cotinine in a biological specimen.','\0','Cotinine','CL-LBTESTCD','DBX-NCIT-C92249'),('CL-LBTESTCD-T-267',NULL,'CPEPTIDE','A measurement of the C (connecting) peptide of insulin in a biological specimen.','\0','C-peptide','CL-LBTESTCD','DBX-NCIT-C74736'),('CL-LBTESTCD-T-268',NULL,'CPNIGAAB','A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.','\0','Chlamydia pneumoniae IgA Antibody','CL-LBTESTCD','DBX-NCIT-C92432'),('CL-LBTESTCD-T-269',NULL,'CPNIGMAB','A measurement of the Chlamydia pneumoniae IgM in a biological specimen.','\0','Chlamydia pneumoniae IgM Antibody','CL-LBTESTCD','DBX-NCIT-C92433'),('CL-LBTESTCD-T-27',NULL,'AFPA','A measurement of the alpha fetoprotein activity in a biological specimen.','\0','Alpha Fetoprotein Activity','CL-LBTESTCD','DBX-NCIT-C106499'),('CL-LBTESTCD-T-270',NULL,'CRDIGGAB','A measurement of the cardiolipin IgG antibody in a biological specimen.','\0','Anti-Cardiolipin IgG Antibody; Cardiolipin IgG Antibody','CL-LBTESTCD','DBX-NCIT-C111144'),('CL-LBTESTCD-T-271',NULL,'CRDIGMAB','A measurement of the cardiolipin IgM antibodies in a biological specimen.','\0','Cardiolipin IgM Antibody','CL-LBTESTCD','DBX-NCIT-C103363'),('CL-LBTESTCD-T-272',NULL,'CREAT','A measurement of the creatinine in a biological specimen.','\0','Creatinine','CL-LBTESTCD','DBX-NCIT-C64547'),('CL-LBTESTCD-T-273',NULL,'CREATCLR','A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).','\0','Creatinine Clearance','CL-LBTESTCD','DBX-NCIT-C25747'),('CL-LBTESTCD-T-274',NULL,'CREATEXR','A measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour).','\0','Creatinine Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117833'),('CL-LBTESTCD-T-275',NULL,'CRENCE','A measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.','\0','Crenated Cells; Echinocytes','CL-LBTESTCD','DBX-NCIT-C74703'),('CL-LBTESTCD-T-276',NULL,'CRH','A measurement of the corticotropin releasing hormone in a biological specimen.','\0','Corticotropin Releasing Factor; Corticotropin Releasing Hormone','CL-LBTESTCD','DBX-NCIT-C74851'),('CL-LBTESTCD-T-277',NULL,'CRLPLSMN','A measurement of ceruloplasmin in a biological specimen.','\0','Caeruloplasmin; Ceruloplasmin','CL-LBTESTCD','DBX-NCIT-C100432'),('CL-LBTESTCD-T-278',NULL,'CRP','A measurement of the C reactive protein in a biological specimen.','\0','C Reactive Protein','CL-LBTESTCD','DBX-NCIT-C64548'),('CL-LBTESTCD-T-279',NULL,'CRTCREAT','A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample.','\0','Corticosterone/Creatinine','CL-LBTESTCD','DBX-NCIT-C106511'),('CL-LBTESTCD-T-28',NULL,'AFPL1','A measurement of the alpha fetoprotein L1 in a biological specimen.','\0','Alpha Fetoprotein L1','CL-LBTESTCD','DBX-NCIT-C96562'),('CL-LBTESTCD-T-280',NULL,'CRTRONE','A measurement of corticosterone in a biological specimen.','\0','Corticosterone','CL-LBTESTCD','DBX-NCIT-C79434'),('CL-LBTESTCD-T-281',NULL,'CRYOGLBN','A measurement of cryoglobulin in a biological specimen.','\0','Cryoglobulin','CL-LBTESTCD','DBX-NCIT-C111164'),('CL-LBTESTCD-T-282',NULL,'CRYSTALS','A statement that indicates crystals were looked for in a biological specimen.','\0','Crystals','CL-LBTESTCD','DBX-NCIT-C74673'),('CL-LBTESTCD-T-283',NULL,'CSBACT','A measurement of the bacterial casts present in a biological specimen.','\0','Bacterial Casts','CL-LBTESTCD','DBX-NCIT-C74762'),('CL-LBTESTCD-T-284',NULL,'CSBROAD','A measurement of the broad casts in a biological specimen.','\0','Broad Casts','CL-LBTESTCD','DBX-NCIT-C96588'),('CL-LBTESTCD-T-285',NULL,'CSCELL','A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.','\0','Cellular Casts','CL-LBTESTCD','DBX-NCIT-C74764'),('CL-LBTESTCD-T-286',NULL,'CSEPI','A measurement of the epithelial cell casts present in a biological specimen.','\0','Epithelial Casts','CL-LBTESTCD','DBX-NCIT-C74779'),('CL-LBTESTCD-T-287',NULL,'CSEPI846','A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen.','\0','846-Epitope; Aggrecan Chondroitin Sulfate Epitope 846; CS846; Chondroitin Sulfate Epitope 846; Chondroitin Sulfate Proteoglycan 1 Epitope 846','CL-LBTESTCD','DBX-NCIT-C112220'),('CL-LBTESTCD-T-288',NULL,'CSFAT','A measurement of the fatty casts present in a biological specimen.','\0','Fatty Casts','CL-LBTESTCD','DBX-NCIT-C74766'),('CL-LBTESTCD-T-289',NULL,'CSGRAN','A measurement of the granular (coarse and fine) casts present in a biological specimen.','\0','Granular Casts','CL-LBTESTCD','DBX-NCIT-C74768'),('CL-LBTESTCD-T-29',NULL,'AFPL2','A measurement of the alpha fetoprotein L2 in a biological specimen.','\0','Alpha Fetoprotein L2','CL-LBTESTCD','DBX-NCIT-C96563'),('CL-LBTESTCD-T-290',NULL,'CSGRANC','A measurement of the coarse granular casts present in a biological specimen.','\0','Granular Coarse Casts','CL-LBTESTCD','DBX-NCIT-C74765'),('CL-LBTESTCD-T-291',NULL,'CSGRANF','A measurement of the fine granular casts present in a biological specimen.','\0','Granular Fine Casts','CL-LBTESTCD','DBX-NCIT-C74769'),('CL-LBTESTCD-T-292',NULL,'CSHYAL','A measurement of the hyaline casts present in a biological specimen.','\0','Hyaline Casts','CL-LBTESTCD','DBX-NCIT-C74770'),('CL-LBTESTCD-T-293',NULL,'CSMIX','A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.','\0','Mixed Casts','CL-LBTESTCD','DBX-NCIT-C74771'),('CL-LBTESTCD-T-294',NULL,'CSRBC','A measurement of the red blood cell casts present in a biological specimen.','\0','RBC Casts','CL-LBTESTCD','DBX-NCIT-C74772'),('CL-LBTESTCD-T-295',NULL,'CSUNCLA','A measurement of the unclassifiable casts present in a biological specimen.','\0','Unclassified Casts','CL-LBTESTCD','DBX-NCIT-C74776'),('CL-LBTESTCD-T-296',NULL,'CSWAX','A measurement of the waxy casts present in a biological specimen.','\0','Waxy Casts','CL-LBTESTCD','DBX-NCIT-C74777'),('CL-LBTESTCD-T-297',NULL,'CSWBC','A measurement of the white blood cell casts present in a biological specimen.','\0','WBC Casts','CL-LBTESTCD','DBX-NCIT-C74778'),('CL-LBTESTCD-T-298',NULL,'CTBIGGAB','A measurement of the cholera toxin B subunit IgG antibody in a biological specimen.','\0','Cholera Toxin B Subunit IgG Antibody','CL-LBTESTCD','DBX-NCIT-C116194'),('CL-LBTESTCD-T-299',NULL,'CTC','A measurement of the circulating tumor cells in a biological specimen.','\0','Circulating Tumor Cells','CL-LBTESTCD','DBX-NCIT-C96593'),('CL-LBTESTCD-T-3',NULL,'A1MCREAT','A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.','\0','Alpha-1 Microglobulin/Creatinine','CL-LBTESTCD','DBX-NCIT-C100462'),('CL-LBTESTCD-T-30',NULL,'AFPL3','A measurement of the alpha fetoprotein L3 in a biological specimen.','\0','Alpha Fetoprotein L3','CL-LBTESTCD','DBX-NCIT-C96564'),('CL-LBTESTCD-T-300',NULL,'CTOT','A measurement of the total complement in a biological specimen.','\0','Complement Total','CL-LBTESTCD','DBX-NCIT-C80160'),('CL-LBTESTCD-T-301',NULL,'CTRIGAAB','A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.','\0','Chlamydia trachomatis IgA Antibody','CL-LBTESTCD','DBX-NCIT-C100464'),('CL-LBTESTCD-T-302',NULL,'CTRIGGAB','A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.','\0','Chlamydia trachomatis IgG Antibody','CL-LBTESTCD','DBX-NCIT-C100466'),('CL-LBTESTCD-T-303',NULL,'CTRIGMAB','A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.','\0','Chlamydia trachomatis IgM Antibody','CL-LBTESTCD','DBX-NCIT-C100465'),('CL-LBTESTCD-T-304',NULL,'CTTIGGAB','A measurement of the Clostridium tetani IgG antibody in a biological specimen.','\0','Clostridium tetani IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103382'),('CL-LBTESTCD-T-305',NULL,'CTXI','A measurement of the type I collagen C-telopeptides in a biological specimen.','\0','Type I Collagen C-Telopeptides; Type I Collagen X-linked C-telopeptide','CL-LBTESTCD','DBX-NCIT-C82038'),('CL-LBTESTCD-T-306',NULL,'CTXII','A measurement of the type II collagen C-telopeptides in a biological specimen.','\0','Type II Collagen C-Telopeptides','CL-LBTESTCD','DBX-NCIT-C82040'),('CL-LBTESTCD-T-307',NULL,'CXCL10','A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen.','\0','Chemokine (C-X-C Motif) Ligand 10; IP-10; Interferon Gamma-induced Protein 10; Small-inducible Cytokine B10','CL-LBTESTCD','DBX-NCIT-C112238'),('CL-LBTESTCD-T-308',NULL,'CXCR3','A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.','\0','CD183; CXCR3; Chemokine (C-X-C Motif) Receptor 3; GPR9','CL-LBTESTCD','DBX-NCIT-C100431'),('CL-LBTESTCD-T-309',NULL,'CYACIDU','A measurement of the acid urate crystals present in a biological specimen.','\0','Acid Urate Crystals','CL-LBTESTCD','DBX-NCIT-C74912'),('CL-LBTESTCD-T-31',NULL,'AFPL3AFP','A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.','\0','A Fetoprotein L3/A Fetoprotein','CL-LBTESTCD','DBX-NCIT-C96565'),('CL-LBTESTCD-T-310',NULL,'CYAMMBIU','A measurement of the ammonium biurate crystals present in a biological specimen.','\0','Acid Ammonium Urate Crystals; Ammonium Biurate Crystals; Ammonium Urate Crystals','CL-LBTESTCD','DBX-NCIT-C105590'),('CL-LBTESTCD-T-311',NULL,'CYAMMOX','A measurement of the ammonium oxalate crystals present in a urine specimen.','\0','Ammonium Oxalate Crystals','CL-LBTESTCD','DBX-NCIT-C74759'),('CL-LBTESTCD-T-312',NULL,'CYAMORPH','A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.','\0','Amorphous Crystals','CL-LBTESTCD','DBX-NCIT-C74665'),('CL-LBTESTCD-T-313',NULL,'CYAMPPH','A measurement of the amorphous phosphate crystals in a biological specimen.','\0','Amorphous Phosphate Crystals','CL-LBTESTCD','DBX-NCIT-C92243'),('CL-LBTESTCD-T-314',NULL,'CYAMPURT','A measurement of the amorphous urate crystals in a biological specimen.','\0','Amorphous Urate Crystals','CL-LBTESTCD','DBX-NCIT-C92244'),('CL-LBTESTCD-T-315',NULL,'CYBILI','A measurement of the bilirubin crystals present in a biological specimen.','\0','Bilirubin Crystals','CL-LBTESTCD','DBX-NCIT-C74668'),('CL-LBTESTCD-T-316',NULL,'CYCACAR','A measurement of the calcium carbonate crystals present in a biological specimen.','\0','Calcium Carbonate Crystals','CL-LBTESTCD','DBX-NCIT-C74669'),('CL-LBTESTCD-T-317',NULL,'CYCAOXA','A measurement of the calcium oxalate crystals present in a biological specimen.','\0','Calcium Oxalate Crystals','CL-LBTESTCD','DBX-NCIT-C74670'),('CL-LBTESTCD-T-318',NULL,'CYCAPHOS','A measurement of the calcium phosphate crystals present in a biological specimen.','\0','Calcium Phosphate Crystals','CL-LBTESTCD','DBX-NCIT-C74671'),('CL-LBTESTCD-T-319',NULL,'CYCHOL','A measurement of the cholesterol crystals present in a biological specimen.','\0','Cholesterol Crystals','CL-LBTESTCD','DBX-NCIT-C74672'),('CL-LBTESTCD-T-32',NULL,'AHBDH','A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen.','\0','Alpha Hydroxybutyrate Dehydrogenase','CL-LBTESTCD','DBX-NCIT-C111126'),('CL-LBTESTCD-T-320',NULL,'CYCYSTIN','A measurement of the cystine crystals present in a biological specimen.','\0','Cystine Crystals','CL-LBTESTCD','DBX-NCIT-C74674'),('CL-LBTESTCD-T-321',NULL,'CYFRA211','A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen.','\0','CYFRA21-1; Cytokeratin 19 Fragment; Cytokeratin Fragment 21-1','CL-LBTESTCD','DBX-NCIT-C106514'),('CL-LBTESTCD-T-322',NULL,'CYHGBC','A measurement of hemoglobin C crystals in a biological specimen.','\0','Hemoglobin C Crystals','CL-LBTESTCD','DBX-NCIT-C112288'),('CL-LBTESTCD-T-323',NULL,'CYHIPPAC','A measurement of the hippuric acid crystals present in a biological specimen.','\0','Hippuric Acid Crystals','CL-LBTESTCD','DBX-NCIT-C74754'),('CL-LBTESTCD-T-324',NULL,'CYLEUC','A measurement of the leucine crystals present in a biological specimen.','\0','Leucine Crystals','CL-LBTESTCD','DBX-NCIT-C74680'),('CL-LBTESTCD-T-325',NULL,'CYMSU','A measurement of the monosodium urate crystals present in a biological specimen.','\0','Monosodium Urate Crystals','CL-LBTESTCD','DBX-NCIT-C74681'),('CL-LBTESTCD-T-326',NULL,'CYSCREAT','A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample.','\0','Cystatin C/Creatinine','CL-LBTESTCD','DBX-NCIT-C106513'),('CL-LBTESTCD-T-327',NULL,'CYSTARCH','A measurement of the starch crystals in a biological specimen.','\0','Starch Crystals','CL-LBTESTCD','DBX-NCIT-C81951'),('CL-LBTESTCD-T-328',NULL,'CYSTATC','A measurement of the cystatin C in a biological specimen.','\0','Cystatin C','CL-LBTESTCD','DBX-NCIT-C92290'),('CL-LBTESTCD-T-329',NULL,'CYSTINE','A measurement of the cystine in a biological specimen.','\0','Cystine','CL-LBTESTCD','DBX-NCIT-C105441'),('CL-LBTESTCD-T-33',NULL,'ALB','A measurement of the albumin protein in a biological specimen.','\0','Albumin; Microalbumin','CL-LBTESTCD','DBX-NCIT-C64431'),('CL-LBTESTCD-T-330',NULL,'CYSULFA','A measurement of the sulfa crystals present in a biological specimen.','\0','Sulfa Crystals','CL-LBTESTCD','DBX-NCIT-C74755'),('CL-LBTESTCD-T-331',NULL,'CYTRPHOS','A measurement of the triple phosphate crystals present in a biological specimen.','\0','Triple Phosphate Crystals','CL-LBTESTCD','DBX-NCIT-C74756'),('CL-LBTESTCD-T-332',NULL,'CYTYRO','A measurement of the tyrosine crystals present in a biological specimen.','\0','Tyrosine Crystals','CL-LBTESTCD','DBX-NCIT-C74683'),('CL-LBTESTCD-T-333',NULL,'CYUNCLA','A measurement of the unclassifiable crystals present in a biological specimen.','\0','Unclassified Crystals','CL-LBTESTCD','DBX-NCIT-C74757'),('CL-LBTESTCD-T-334',NULL,'CYURIAC','A measurement of the uric acid crystals present in a biological specimen.','\0','Uric Acid Crystals','CL-LBTESTCD','DBX-NCIT-C74684'),('CL-LBTESTCD-T-335',NULL,'DDIMER','A measurement of the d-dimers in a biological specimen.','\0','D-Dimer','CL-LBTESTCD','DBX-NCIT-C82621'),('CL-LBTESTCD-T-336',NULL,'DGNWBC','A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen.','\0','Degenerated Leukocytes; Degenerated WBC; Degenerated White Blood Cells','CL-LBTESTCD','DBX-NCIT-C111190'),('CL-LBTESTCD-T-337',NULL,'DHEA','A measurement of the dehydroepiandrosterone hormone in a biological specimen.','\0','Dehydroepiandrosterone; Dehydroisoandrosterone','CL-LBTESTCD','DBX-NCIT-C74852'),('CL-LBTESTCD-T-338',NULL,'DHEAS','A measurement of the sulfated Dehydroepiandrosterone in a biological specimen.','\0','DHEA Sulfate; DHEA-S; Dehydroepiandrosterone Sulfate; sDHEA','CL-LBTESTCD','DBX-NCIT-C96629'),('CL-LBTESTCD-T-339',NULL,'DHPG','A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.','\0','3,4-Dihydroxyphenylglycol; 3.4 Dihydroxyphenylglycol','CL-LBTESTCD','DBX-NCIT-C101017'),('CL-LBTESTCD-T-34',NULL,'ALBCREAT','A relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.','\0','Albumin/Creatinine; Microalbumin/Creatinine Ratio','CL-LBTESTCD','DBX-NCIT-C74761'),('CL-LBTESTCD-T-340',NULL,'DHT','A measurement of the dihydrotestosterone hormone in a biological specimen.','\0','Androstanalone; Dihydrotestosterone','CL-LBTESTCD','DBX-NCIT-C74853'),('CL-LBTESTCD-T-341',NULL,'DIHYDCDN','A measurement of the dihydrocodeine present in a biological specimen.','\0','Dihydrocodeine','CL-LBTESTCD','DBX-NCIT-C74878'),('CL-LBTESTCD-T-342',NULL,'DNAAB','A measurement of the anti-DNA antibodies in a biological specimen.','\0','Anti-DNA Antibodies; Anti-ds-DNA Antibodies','CL-LBTESTCD','DBX-NCIT-C81973'),('CL-LBTESTCD-T-343',NULL,'DNASEBAB','A measurement of Dnase-B antibody in a biological specimen.','\0','Anti-Dnase B; DNase-B Antibody','CL-LBTESTCD','DBX-NCIT-C100463'),('CL-LBTESTCD-T-344',NULL,'DOHLE','A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.','\0','Dohle Bodies','CL-LBTESTCD','DBX-NCIT-C74610'),('CL-LBTESTCD-T-345',NULL,'DOPAC','A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen.','\0','3,4-Dihydroxyphenylacetic Acid','CL-LBTESTCD','DBX-NCIT-C103345'),('CL-LBTESTCD-T-346',NULL,'DOPAMINE','A measurement of the dopamine hormone in a biological specimen.','\0','Dopamine','CL-LBTESTCD','DBX-NCIT-C74854'),('CL-LBTESTCD-T-347',NULL,'DPD','A measurement of the deoxypyridinoline in a biological specimen.','\0','Deoxypyridinoline','CL-LBTESTCD','DBX-NCIT-C79443'),('CL-LBTESTCD-T-348',NULL,'DPDCREAT','A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.','\0','Deoxypyridinoline/Creatinine','CL-LBTESTCD','DBX-NCIT-C79444'),('CL-LBTESTCD-T-349',NULL,'DPPIVA','A measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen.','\0','DPPIV Activity','CL-LBTESTCD','DBX-NCIT-C103387'),('CL-LBTESTCD-T-35',NULL,'ALBEXR','A measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour).','\0','Albumin Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117829'),('CL-LBTESTCD-T-350',NULL,'DPTIGGAB','A measurement of the Diphtheria IgG antibodies in a biological specimen.','\0','Diphtheria IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103388'),('CL-LBTESTCD-T-351',NULL,'DRUGSCR','An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen.','\0','Drug Screen','CL-LBTESTCD','DBX-NCIT-C78139'),('CL-LBTESTCD-T-352',NULL,'DRVVT','A measurement of the time it takes a plasma sample to clot after adding dilute Russell\'s viper venom.','\0','Dilute Russell\'s Viper Venom Time; Lupus Anticoagulant Test','CL-LBTESTCD','DBX-NCIT-C96696'),('CL-LBTESTCD-T-353',NULL,'DRVVTRT','A relative measurement (ratio or percentage) of the dilute Russell\'s viper venom time in a subject sample to a control sample.','\0','Lupus Anticoagulant Ratio','CL-LBTESTCD','DBX-NCIT-C103386'),('CL-LBTESTCD-T-354',NULL,'DTPACLR','A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.','\0','DTPA Clearance','CL-LBTESTCD','DBX-NCIT-C100441'),('CL-LBTESTCD-T-355',NULL,'EBCIGGAB','A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.','\0','Epstein-Barr Capsid IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96600'),('CL-LBTESTCD-T-356',NULL,'EBCIGMAB','A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.','\0','Epstein-Barr Capsid IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96601'),('CL-LBTESTCD-T-357',NULL,'EBEAG','A measurement of the Epstein-Barr early antigen in a biological specimen.','\0','Epstein-Barr Early Antigen','CL-LBTESTCD','DBX-NCIT-C96602'),('CL-LBTESTCD-T-358',NULL,'EBN1IGAB','A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen.','\0','Epstein-Barr Nuclear Antigen 1 IgG Ab','CL-LBTESTCD','DBX-NCIT-C106518'),('CL-LBTESTCD-T-359',NULL,'EBNAB','A measurement of the Epstein-Barr nuclear antibody in a biological specimen.','\0','Epstein-Barr Nuclear Antibody; Epstein-Barr Nuclear Antigen Antibody','CL-LBTESTCD','DBX-NCIT-C96603'),('CL-LBTESTCD-T-36',NULL,'ALBGLOB','The ratio of albumin to globulin in a biological specimen.','\0','Albumin/Globulin','CL-LBTESTCD','DBX-NCIT-C74894'),('CL-LBTESTCD-T-360',NULL,'EBNAG','A measurement of the Epstein-Barr nuclear antigen in a biological specimen.','\0','Epstein-Barr Nuclear Antigen','CL-LBTESTCD','DBX-NCIT-C96604'),('CL-LBTESTCD-T-361',NULL,'EBVINTP','An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests.','\0','EBV Profile Interpretation; Epstein-Barr Virus Antibody Profile; Epstein-Barr Virus Panel; Epstein-Barr Virus Profile Interpretation','CL-LBTESTCD','DBX-NCIT-C106519'),('CL-LBTESTCD-T-362',NULL,'EBVVLD','A measurement of the Epstein-Barr virus viral load in a biological specimen.','\0','EBV Viral Load','CL-LBTESTCD','DBX-NCIT-C98721'),('CL-LBTESTCD-T-363',NULL,'ECCENTCY','A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.','\0','Eccentrocytes','CL-LBTESTCD','DBX-NCIT-C96598'),('CL-LBTESTCD-T-364',NULL,'ECT','A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.','\0','Ecarin Clotting Time','CL-LBTESTCD','DBX-NCIT-C100422'),('CL-LBTESTCD-T-365',NULL,'EDTACLR','A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.','\0','EDTA Clearance','CL-LBTESTCD','DBX-NCIT-C100440'),('CL-LBTESTCD-T-366',NULL,'EGF','A measurement of the epidermal growth factor in a biological specimen.','\0','Epidermal Growth Factor','CL-LBTESTCD','DBX-NCIT-C82009'),('CL-LBTESTCD-T-367',NULL,'EGFR','A measurement of the cells with positive expression of EGFR in a biological specimen.','\0','ERBB1; Epidermal Growth Factor Receptor; HER1','CL-LBTESTCD','DBX-NCIT-C112273'),('CL-LBTESTCD-T-368',NULL,'ELA1','A measurement of the pancreatic elastase 1 in a biological specimen.','\0','Pancreatic Elastase 1','CL-LBTESTCD','DBX-NCIT-C82028'),('CL-LBTESTCD-T-369',NULL,'ELA1PMN','A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.','\0','Pancreatic Elastase 1, Polymorphonuclear','CL-LBTESTCD','DBX-NCIT-C82029'),('CL-LBTESTCD-T-37',NULL,'ALBPROT','A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen.','\0','Albumin/Total Protein','CL-LBTESTCD','DBX-NCIT-C103453'),('CL-LBTESTCD-T-370',NULL,'ELA2','A measurement of the neutrophil elastase in a biological specimen.','\0','Neutrophil Elastase','CL-LBTESTCD','DBX-NCIT-C82026'),('CL-LBTESTCD-T-371',NULL,'ELA2PMN','A measurement of the polymorphonuclear neutrophil elastase in a biological specimen.','\0','Neutrophil Elastase, Polymorphonuclear','CL-LBTESTCD','DBX-NCIT-C82027'),('CL-LBTESTCD-T-372',NULL,'ELLIPCY','A measurement of the elliptically shaped erythrocytes in a biological specimen.','\0','Elliptocytes; Ovalocytes','CL-LBTESTCD','DBX-NCIT-C64549'),('CL-LBTESTCD-T-373',NULL,'ENA78','A measurement of the epithelial neutrophil-activating peptide in a biological specimen.','\0','Epith Neutrophil-Activating Peptide 78','CL-LBTESTCD','DBX-NCIT-C82010'),('CL-LBTESTCD-T-374',NULL,'ENAAB','A measurement of the extractable nuclear antigen antibody in a biological specimen.','\0','Anti-ENA; Extractable Nuclear Antigen Antibody','CL-LBTESTCD','DBX-NCIT-C92270'),('CL-LBTESTCD-T-375',NULL,'ENDOTH1','A measurement of the endothelin-1 in a biological specimen.','\0','Endothelin-1','CL-LBTESTCD','DBX-NCIT-C82008'),('CL-LBTESTCD-T-376',NULL,'ENRAGE','A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.','\0','Extracell Newly Ident RAGE Bind Protein; S100 Calcium Binding Protein A12','CL-LBTESTCD','DBX-NCIT-C82011'),('CL-LBTESTCD-T-377',NULL,'EOS','A measurement of the eosinophils in a biological specimen.','\0','Eosinophils','CL-LBTESTCD','DBX-NCIT-C64550'),('CL-LBTESTCD-T-378',NULL,'EOSB','A measurement of the banded eosinophils in a biological specimen.','\0','Eosinophils Band Form','CL-LBTESTCD','DBX-NCIT-C114216'),('CL-LBTESTCD-T-379',NULL,'EOSBLE','A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen.','\0','Eosinophils Band Form/Leukocytes','CL-LBTESTCD','DBX-NCIT-C114217'),('CL-LBTESTCD-T-38',NULL,'ALDOLASE','A measurement of the aldolase enzyme in a biological specimen.','\0','Aldolase','CL-LBTESTCD','DBX-NCIT-C74731'),('CL-LBTESTCD-T-380',NULL,'EOSCE','A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Eosinophils/Total Cells','CL-LBTESTCD','DBX-NCIT-C98720'),('CL-LBTESTCD-T-381',NULL,'EOSIM','A measurement of the immature eosinophils in a biological specimen.','\0','Immature Eosinophils','CL-LBTESTCD','DBX-NCIT-C96673'),('CL-LBTESTCD-T-382',NULL,'EOSIMLE','A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.','\0','Immature Eosinophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C96674'),('CL-LBTESTCD-T-383',NULL,'EOSLE','A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.','\0','Eosinophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64604'),('CL-LBTESTCD-T-384',NULL,'EOSMM','A measurement of the eosinphilic metamyelocytes in a biological specimen.','\0','Eosinophilic Metamyelocytes','CL-LBTESTCD','DBX-NCIT-C84819'),('CL-LBTESTCD-T-385',NULL,'EOSMYL','A measurement of the eosinophilic myelocytes in a biological specimen.','\0','Eosinophilic Myelocytes','CL-LBTESTCD','DBX-NCIT-C84821'),('CL-LBTESTCD-T-386',NULL,'EOTAXIN1','A measurement of the eotaxin-1 in a biological specimen.','\0','Chemokine Ligand 11; Eotaxin-1','CL-LBTESTCD','DBX-NCIT-C81952'),('CL-LBTESTCD-T-387',NULL,'EOTAXIN2','A measurement of the eotaxin-2 in a biological specimen.','\0','Chemokine Ligand 24; Eotaxin-2','CL-LBTESTCD','DBX-NCIT-C81953'),('CL-LBTESTCD-T-388',NULL,'EOTAXIN3','A measurement of the eotaxin-3 in a biological specimen.','\0','CCL26; Chemokine (C-C Motif) Ligand 26; Chemokine Ligand 26; Eotaxin-3','CL-LBTESTCD','DBX-NCIT-C81954'),('CL-LBTESTCD-T-389',NULL,'EPIC','A measurement of the epithelial cells in a biological specimen.','\0','Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C64605'),('CL-LBTESTCD-T-39',NULL,'ALDSTRN','A measurement of the aldosterone hormone in a biological specimen.','\0','Aldosterone','CL-LBTESTCD','DBX-NCIT-C74841'),('CL-LBTESTCD-T-390',NULL,'EPIN','A measurement of the epinephrine hormone in a biological specimen.','\0','Adrenaline; Epinephrine','CL-LBTESTCD','DBX-NCIT-C79445'),('CL-LBTESTCD-T-391',NULL,'EPIROCE','A measurement of the round epithelial cells present in a biological specimen.','\0','Round Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C74698'),('CL-LBTESTCD-T-392',NULL,'EPISQCE','A measurement of the squamous epithelial cells present in a biological specimen.','\0','Squamous Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C74773'),('CL-LBTESTCD-T-393',NULL,'EPISQTCE','A measurement of the squamous transitional epithelial cells present in a biological specimen.','\0','Epithelial Cells; Squamous Transitional Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C74774'),('CL-LBTESTCD-T-394',NULL,'EPITCE','A measurement of the transitional epithelial cells present in a biological specimen.','\0','Transitional Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C92251'),('CL-LBTESTCD-T-395',NULL,'EPITUCE','A measurement of the tubular epithelial cells present in a biological specimen.','\0','Renal Tubular Epithelial Cells; Tubular Epithelial Cells','CL-LBTESTCD','DBX-NCIT-C74775'),('CL-LBTESTCD-T-396',NULL,'EPO','A measurement of the erythropoietin hormone in a biological specimen.','\0','Erythropoietin; Hematopoietin','CL-LBTESTCD','DBX-NCIT-C74855'),('CL-LBTESTCD-T-397',NULL,'ESR','The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).','\0','Biernacki Reaction; Erythrocyte Sedimentation Rate','CL-LBTESTCD','DBX-NCIT-C74611'),('CL-LBTESTCD-T-398',NULL,'ESTRCPT','A measurement of the cells with positive expression of estrogen receptor in a biological specimen.','\0','ER; ESR; Estrogen Receptor; Oestrogen Receptor','CL-LBTESTCD','DBX-NCIT-C112274'),('CL-LBTESTCD-T-399',NULL,'ESTRDIOL','A measurement of the estradiol in a biological specimen.','\0','Estradiol; Oestradiol','CL-LBTESTCD','DBX-NCIT-C74782'),('CL-LBTESTCD-T-4',NULL,'A1MICG','A measurement of the alpha-1 microglobulin in a biological specimen.','\0','Alpha-1 Microglobulin; Protein HC','CL-LBTESTCD','DBX-NCIT-C100461'),('CL-LBTESTCD-T-40',NULL,'ALP','A measurement of the alkaline phosphatase in a biological specimen.','\0','Alkaline Phosphatase','CL-LBTESTCD','DBX-NCIT-C64432'),('CL-LBTESTCD-T-400',NULL,'ESTRIOL','A measurement of the estriol hormone in a biological specimen.','\0','Estriol; Oestriol','CL-LBTESTCD','DBX-NCIT-C74856'),('CL-LBTESTCD-T-401',NULL,'ESTRIOLF','A measurement of the free estriol in a biological specimen.','\0','Estriol, Free','CL-LBTESTCD','DBX-NCIT-C81963'),('CL-LBTESTCD-T-402',NULL,'ESTRONE','A measurement of the estrone hormone in a biological specimen.','\0','Estrone; Oestrone','CL-LBTESTCD','DBX-NCIT-C74857'),('CL-LBTESTCD-T-403',NULL,'ETHANOL','A measurement of the ethanol present in a biological specimen.','\0','Alcohol; Ethanol','CL-LBTESTCD','DBX-NCIT-C74693'),('CL-LBTESTCD-T-404',NULL,'ETP','A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample.','\0','Endogenous Thrombin Potential','CL-LBTESTCD','DBX-NCIT-C102266'),('CL-LBTESTCD-T-405',NULL,'ETPAUC','A measurement of the area under the thrombin generation curve.','\0','ETP Area Under Curve; Endogenous Thrombin Potential Area Under Curve','CL-LBTESTCD','DBX-NCIT-C102263'),('CL-LBTESTCD-T-406',NULL,'ETPLT','A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.','\0','ETP Lag Time; Endogenous Thrombin Potential Lag Time','CL-LBTESTCD','DBX-NCIT-C102264'),('CL-LBTESTCD-T-407',NULL,'ETPLTR','A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.','\0','ETP Lag Time Relative; Endogenous Thrombin Potential Lag Time Relative','CL-LBTESTCD','DBX-NCIT-C102265'),('CL-LBTESTCD-T-408',NULL,'ETPPH','A measurement of the maximum concentration of thrombin generated during a thrombin generation test.','\0','ETP Peak Height; Endogenous Thrombin Potential Peak Height','CL-LBTESTCD','DBX-NCIT-C102267'),('CL-LBTESTCD-T-409',NULL,'ETPPHR','A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test.','\0','ETP Peak Height Relative; Endogenous Thrombin Potential Peak Height Relative','CL-LBTESTCD','DBX-NCIT-C102268'),('CL-LBTESTCD-T-41',NULL,'ALPBS','A measurement of the bone specific alkaline phosphatase isoform in a biological specimen.','\0','Bone Specific Alkaline Phosphatase','CL-LBTESTCD','DBX-NCIT-C92287'),('CL-LBTESTCD-T-410',NULL,'ETPTP','A measurement of the time it takes to generate the maximum concentration of thrombin.','\0','ETP Time to Peak; Endogenous Thrombin Potential Time to Peak','CL-LBTESTCD','DBX-NCIT-C102269'),('CL-LBTESTCD-T-411',NULL,'ETPTPR','A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin.','\0','ETP Time to Peak Relative; Endogenous Thrombin Potential Time to Peak Relative','CL-LBTESTCD','DBX-NCIT-C102270'),('CL-LBTESTCD-T-412',NULL,'FABP1','A measurement of the fatty acid binding protein 1 in a biological specimen.','\0','Fatty Acid Binding Protein 1','CL-LBTESTCD','DBX-NCIT-C82012'),('CL-LBTESTCD-T-413',NULL,'FABP3','A measurement of the fatty acid binding protein 3 in a biological specimen.','\0','Fatty Acid Binding Protein 3','CL-LBTESTCD','DBX-NCIT-C106521'),('CL-LBTESTCD-T-414',NULL,'FACTII','A measurement of the Factor II in a biological specimen.','\0','Factor II; Prothrombin','CL-LBTESTCD','DBX-NCIT-C96626'),('CL-LBTESTCD-T-415',NULL,'FACTIII','A measurement of the factor III in a biological specimen.','\0','Factor III; Tissue Factor, CD142','CL-LBTESTCD','DBX-NCIT-C81959'),('CL-LBTESTCD-T-416',NULL,'FACTIX','A measurement of the factor IX in a biological specimen.','\0','Christmas Factor; Factor IX','CL-LBTESTCD','DBX-NCIT-C98725'),('CL-LBTESTCD-T-417',NULL,'FACTIXA','A measurement of the biological activity of factor IX in a biological specimen.','\0','Christmas Factor Activity','CL-LBTESTCD','DBX-NCIT-C103395'),('CL-LBTESTCD-T-418',NULL,'FACTV','A measurement of the factor V in a biological specimen.','\0','Factor V; Labile Factor','CL-LBTESTCD','DBX-NCIT-C98726'),('CL-LBTESTCD-T-419',NULL,'FACTVA','A measurement of the biological activity of factor V in a biological specimen.','\0','Labile Factor Activity','CL-LBTESTCD','DBX-NCIT-C103396'),('CL-LBTESTCD-T-42',NULL,'ALPCREAT','A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.','\0','Alkaline Phosphatase/Creatinine','CL-LBTESTCD','DBX-NCIT-C79438'),('CL-LBTESTCD-T-420',NULL,'FACTVII','A measurement of the factor VII in a biological specimen.','\0','Factor VII; Proconvertin; Stable Factor','CL-LBTESTCD','DBX-NCIT-C81960'),('CL-LBTESTCD-T-421',NULL,'FACTVIIA','A measurement of the biological activity of factor VII in a biological specimen.','\0','Proconvertin Activity; Stable Factor Activity','CL-LBTESTCD','DBX-NCIT-C103397'),('CL-LBTESTCD-T-422',NULL,'FACTVIII','A measurement of the factor VIII in a biological specimen.','\0','Anti-hemophilic Factor; Factor VIII','CL-LBTESTCD','DBX-NCIT-C81961'),('CL-LBTESTCD-T-423',NULL,'FACTVL','A measurement of the Factor V Leiden in a biological specimen.','\0','Factor V Leiden','CL-LBTESTCD','DBX-NCIT-C102271'),('CL-LBTESTCD-T-424',NULL,'FACTVW','A measurement of the von Willebrand factor in a biological specimen.','\0','von Willebrand Factor; von Willebrand Factor Antigen','CL-LBTESTCD','DBX-NCIT-C98799'),('CL-LBTESTCD-T-425',NULL,'FACTX','A measurement of the factor X in a biological specimen.','\0','Factor X','CL-LBTESTCD','DBX-NCIT-C98727'),('CL-LBTESTCD-T-426',NULL,'FACTXIII','A measurement of the factor XIII in a biological specimen.','\0','Factor XIII; Fibrin Stablizing Factor','CL-LBTESTCD','DBX-NCIT-C112277'),('CL-LBTESTCD-T-427',NULL,'FACTXIV','A measurement of the factor XIV in a biological specimen.','\0','Autoprothrombin IIA; Factor XIV; Protein C; Protein C Antigen','CL-LBTESTCD','DBX-NCIT-C102272'),('CL-LBTESTCD-T-428',NULL,'FACTXIVA','A measurement of the factor XIV activity in a biological specimen.','\0','Factor XIV Activity; Protein C Activity; Protein C Function','CL-LBTESTCD','DBX-NCIT-C105442'),('CL-LBTESTCD-T-429',NULL,'FAT','A measurement of the fat in a biological specimen.','\0','Fat','CL-LBTESTCD','DBX-NCIT-C96648'),('CL-LBTESTCD-T-43',NULL,'ALT','A measurement of the alanine aminotransferase in a biological specimen.','\0','Alanine Aminotransferase; SGPT','CL-LBTESTCD','DBX-NCIT-C64433'),('CL-LBTESTCD-T-430',NULL,'FATACFR','A measurement of the total non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid; Non-Esterified Fatty Acid, Free','CL-LBTESTCD','DBX-NCIT-C80200'),('CL-LBTESTCD-T-431',NULL,'FATACFRS','A measurement of the saturated non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid, Saturated; Non-esterified Fatty Acid, Saturated','CL-LBTESTCD','DBX-NCIT-C80206'),('CL-LBTESTCD-T-432',NULL,'FATACFRU','A measurement of the unsaturated non-esterified fatty acids in a biological specimen.','\0','Free Fatty Acid, Unsaturated; Non-esterified Fatty Acid, Unsaturated','CL-LBTESTCD','DBX-NCIT-C80209'),('CL-LBTESTCD-T-433',NULL,'FATBODOV','A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.','\0','Fat Bodies, Oval','CL-LBTESTCD','DBX-NCIT-C81947'),('CL-LBTESTCD-T-434',NULL,'FATDROP','A measurement of the triglyceride aggregates within a biological specimen.','\0','Fat Droplet','CL-LBTESTCD','DBX-NCIT-C98728'),('CL-LBTESTCD-T-435',NULL,'FBRTST','A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taki','\0','FibroSURE Score; FibroTest Score','CL-LBTESTCD','DBX-NCIT-C105443'),('CL-LBTESTCD-T-436',NULL,'FCTVIIAA','A measurement of the biological activity of factor VIIa in a biological specimen.','\0','Factor VIIa Activity','CL-LBTESTCD','DBX-NCIT-C103398'),('CL-LBTESTCD-T-437',NULL,'FCTVIIIA','A measurement of the biological activity of factor VIII in a biological specimen.','\0','Anti-hemophilic Factor Activity','CL-LBTESTCD','DBX-NCIT-C103399'),('CL-LBTESTCD-T-438',NULL,'FDP','A measurement of the fibrin degradation products in a biological specimen.','\0','Fibrin Degradation Products','CL-LBTESTCD','DBX-NCIT-C82013'),('CL-LBTESTCD-T-439',NULL,'FECA','A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine.','\0','Fractional Calcium Excretion','CL-LBTESTCD','DBX-NCIT-C114219'),('CL-LBTESTCD-T-44',NULL,'ALTAST','A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample.','\0','ALT/AST','CL-LBTESTCD','DBX-NCIT-C106498'),('CL-LBTESTCD-T-440',NULL,'FECL','A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine.','\0','Fractional Chloride Excretion','CL-LBTESTCD','DBX-NCIT-C114220'),('CL-LBTESTCD-T-441',NULL,'FEK','A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine.','\0','Fractional Potassium Excretion','CL-LBTESTCD','DBX-NCIT-C114222'),('CL-LBTESTCD-T-442',NULL,'FENA','A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine.','\0','Fractional Sodium Excretion','CL-LBTESTCD','DBX-NCIT-C107435'),('CL-LBTESTCD-T-443',NULL,'FEPI','A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine.','\0','Fractional Inorganic Phosphate Excretion; Fractional Phosphorus Excretion','CL-LBTESTCD','DBX-NCIT-C114221'),('CL-LBTESTCD-T-444',NULL,'FERRITIN','A measurement of the ferritin in a biological specimen.','\0','Ferritin','CL-LBTESTCD','DBX-NCIT-C74737'),('CL-LBTESTCD-T-445',NULL,'FGF21','A measurement of the fibroblast growth factor 21 in a biological specimen.','\0','FGF 21; Fibroblast Growth Factor 21','CL-LBTESTCD','DBX-NCIT-C112280'),('CL-LBTESTCD-T-446',NULL,'FGF23','A measurement of the fibroblast growth factor 23 in a biological specimen.','\0','Fibroblast Growth Factor 23; Phosphatonin','CL-LBTESTCD','DBX-NCIT-C96650'),('CL-LBTESTCD-T-447',NULL,'FGFBF','A measurement of the basic form of fibroblast growth factor in a biological specimen.','\0','FGF2; Fibroblast Growth Factor Basic Form','CL-LBTESTCD','DBX-NCIT-C82014'),('CL-LBTESTCD-T-448',NULL,'FIBRINO','A measurement of the fibrinogen in a biological specimen.','\0','Fibrinogen','CL-LBTESTCD','DBX-NCIT-C64606'),('CL-LBTESTCD-T-449',NULL,'FRUCT','A measurement of the fructosamine in a biological specimen.','\0','Fructosamine; Glycated Serum Protein','CL-LBTESTCD','DBX-NCIT-C74678'),('CL-LBTESTCD-T-45',NULL,'ALTCPHRL','A measurement of the alpha tocopherol in a biological specimen.','\0','Alpha Tocopherol','CL-LBTESTCD','DBX-NCIT-C103349'),('CL-LBTESTCD-T-450',NULL,'FSH','A measurement of the follicle stimulating hormone (FSH) in a biological specimen.','\0','Follicle Stimulating Hormone','CL-LBTESTCD','DBX-NCIT-C74783'),('CL-LBTESTCD-T-451',NULL,'G6PD','A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.','\0','Glucose-6-Phosphate Dehydrogenase','CL-LBTESTCD','DBX-NCIT-C80184'),('CL-LBTESTCD-T-452',NULL,'GAD1','A measurement of the glutamic acid decarboxylase 1 in a biological specimen.','\0','Glutamic Acid Decarboxylase 1; Glutamic Acid Decarboxylase 67','CL-LBTESTCD','DBX-NCIT-C82015'),('CL-LBTESTCD-T-453',NULL,'GAD2','A measurement of the glutamic acid decarboxylase 2 in a biological specimen.','\0','Glutamic Acid Decarboxylase 2; Glutamic Acid Decarboxylase 65','CL-LBTESTCD','DBX-NCIT-C82016'),('CL-LBTESTCD-T-454',NULL,'GAD2AB','A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.','\0','Glutamic Acid Decarboxylase 2 Antibody; Glutamic Acid Decarboxylase 65 Antibody','CL-LBTESTCD','DBX-NCIT-C82017'),('CL-LBTESTCD-T-455',NULL,'GADAB','A measurement of the glutamic acid decarboxylase antibody in a biological specimen.','\0','GAD Antibody; Glutamic Acid Decarboxylase Antibody','CL-LBTESTCD','DBX-NCIT-C96653'),('CL-LBTESTCD-T-456',NULL,'GALANIN','A measurement of the galanin in a biological specimen.','\0','Galanin','CL-LBTESTCD','DBX-NCIT-C80182'),('CL-LBTESTCD-T-457',NULL,'GASTRIN','A measurement of the gastrin hormone in a biological specimen.','\0','Gastrin','CL-LBTESTCD','DBX-NCIT-C74858'),('CL-LBTESTCD-T-458',NULL,'GATCPHRL','A measurement of the gamma tocopherol in a biological specimen.','\0','Gamma Tocopherol','CL-LBTESTCD','DBX-NCIT-C116211'),('CL-LBTESTCD-T-459',NULL,'GCSF','A measurement of the granulocyte colony stimulating factor in a biological specimen.','\0','Granulocyte Colony Stimulating Factor','CL-LBTESTCD','DBX-NCIT-C82018'),('CL-LBTESTCD-T-46',NULL,'ALUMINUM','A measurement of aluminum in a biological specimen.','\0','Al; Aluminum','CL-LBTESTCD','DBX-NCIT-C111127'),('CL-LBTESTCD-T-460',NULL,'GFR','A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman\'s capsule per unit of time.','\0','Glomerular Filtration Rate','CL-LBTESTCD','DBX-NCIT-C90505'),('CL-LBTESTCD-T-461',NULL,'GFRBSA','A measurement of the glomerular filtration rate adjusted for body size.','\0','Glomerular Filtration Rate Adj for BSA','CL-LBTESTCD','DBX-NCIT-C98734'),('CL-LBTESTCD-T-462',NULL,'GFRBSB2M','A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.','\0','GFR from B-2 Microglobulin Adj for BSA','CL-LBTESTCD','DBX-NCIT-C100450'),('CL-LBTESTCD-T-463',NULL,'GFRBSBTP','A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.','\0','GFR from Beta-Trace Protein Adj for BSA','CL-LBTESTCD','DBX-NCIT-C100449'),('CL-LBTESTCD-T-464',NULL,'GFRBSCRT','An estimation of the glomerular filtration rate adjusted for body size based on creatinine.','\0','GFR from Creatinine Adjusted for BSA','CL-LBTESTCD','DBX-NCIT-C98735'),('CL-LBTESTCD-T-465',NULL,'GFRBSCYC','An estimation of the glomerular filtration rate adjusted for body size based on cystatin C.','\0','GFR from Cystatin C Adjusted for BSA','CL-LBTESTCD','DBX-NCIT-C98736'),('CL-LBTESTCD-T-466',NULL,'GGT','A measurement of the gamma glutamyl transferase in a biological specimen.','\0','Gamma Glutamyl Transferase','CL-LBTESTCD','DBX-NCIT-C64847'),('CL-LBTESTCD-T-467',NULL,'GGTCREAT','A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.','\0','Gamma Glutamyl Transferase/Creatinine','CL-LBTESTCD','DBX-NCIT-C79446'),('CL-LBTESTCD-T-468',NULL,'GHRELIN','A measurement of total ghrelin in a biological specimen.','\0','Ghrelin; Growth Hormone Secretagogue Receptor Ligand; Motilin-related Peptide; Total Ghrelin','CL-LBTESTCD','DBX-NCIT-C112286'),('CL-LBTESTCD-T-469',NULL,'GHRELINA','A measurement of active ghrelin in a biological specimen.','\0','Active Ghrelin; Ghrelin','CL-LBTESTCD','DBX-NCIT-C112219'),('CL-LBTESTCD-T-47',NULL,'AMA','A measurement of the antimitochondrial antibodies in a biological specimen.','\0','Antimitochondrial Antibodies; Mitochondrial Antibody','CL-LBTESTCD','DBX-NCIT-C81975'),('CL-LBTESTCD-T-470',NULL,'GIPI','A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen.','\0','Glucose-dep Insulinotropic Pep, Intact; Intact GIP; Intact Gastric Inhibitory Polypeptide; Intact Glucose-dependent Insulinotropic Peptide','CL-LBTESTCD','DBX-NCIT-C106537'),('CL-LBTESTCD-T-471',NULL,'GLDH','A measurement of the glutamate dehydrogenase in a biological specimen.','\0','Glutamate Dehydrogenase','CL-LBTESTCD','DBX-NCIT-C79448'),('CL-LBTESTCD-T-472',NULL,'GLOBA1','A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.','\0','A1-Globulin; Alpha-1 Globulin','CL-LBTESTCD','DBX-NCIT-C92252'),('CL-LBTESTCD-T-473',NULL,'GLOBA1PT','A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.','\0','Alpha-1 Globulin/Total Protein','CL-LBTESTCD','DBX-NCIT-C92253'),('CL-LBTESTCD-T-474',NULL,'GLOBA2','A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.','\0','A2-Globulin; Alpha-2 Globulin','CL-LBTESTCD','DBX-NCIT-C92254'),('CL-LBTESTCD-T-475',NULL,'GLOBA2PT','A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.','\0','Alpha-2 Globulin/Total Protein','CL-LBTESTCD','DBX-NCIT-C92255'),('CL-LBTESTCD-T-476',NULL,'GLOBB','A measurement of the proteins contributing to the beta fraction in a biological specimen.','\0','Beta Globulin','CL-LBTESTCD','DBX-NCIT-C92256'),('CL-LBTESTCD-T-477',NULL,'GLOBBPT','A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.','\0','Beta Globulin/Total Protein','CL-LBTESTCD','DBX-NCIT-C92294'),('CL-LBTESTCD-T-478',NULL,'GLOBG','A measurement of the proteins contributing to the gamma fraction in a biological specimen.','\0','Gamma Globulin','CL-LBTESTCD','DBX-NCIT-C92257'),('CL-LBTESTCD-T-479',NULL,'GLOBGPT','A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.','\0','Gamma Globulin/Total Protein','CL-LBTESTCD','DBX-NCIT-C92295'),('CL-LBTESTCD-T-48',NULL,'AMMONIA','A measurement of the ammonia in a biological specimen.','\0','Ammonia; NH3','CL-LBTESTCD','DBX-NCIT-C74799'),('CL-LBTESTCD-T-480',NULL,'GLOBUL','A measurement of the globulin protein in a biological specimen.','\0','Globulin','CL-LBTESTCD','DBX-NCIT-C74738'),('CL-LBTESTCD-T-481',NULL,'GLP1','A measurement of the total glucagon-like peptide-1 in a biological specimen.','\0','Glucagon-Like Peptide-1; Total Glucagon-Like Peptide-1','CL-LBTESTCD','DBX-NCIT-C80183'),('CL-LBTESTCD-T-482',NULL,'GLP1AC','A measurement of the active form of glucagon-like peptide-1 in a biological specimen.','\0','Glucagon-Like Peptide-1, Active Form','CL-LBTESTCD','DBX-NCIT-C80164'),('CL-LBTESTCD-T-483',NULL,'GLUC','A measurement of the glucose in a biological specimen.','\0','Glucose','CL-LBTESTCD','DBX-NCIT-C105585'),('CL-LBTESTCD-T-484',NULL,'GLUCAGON','A measurement of the glucagon hormone in a biological specimen.','\0','Glucagon','CL-LBTESTCD','DBX-NCIT-C74859'),('CL-LBTESTCD-T-485',NULL,'GLUCCLR','A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute).','\0','Glucose Clearance','CL-LBTESTCD','DBX-NCIT-C96652'),('CL-LBTESTCD-T-486',NULL,'GLUCCRT','A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.','\0','Glucose/Creatinine','CL-LBTESTCD','DBX-NCIT-C79447'),('CL-LBTESTCD-T-487',NULL,'GLUCEXR','A measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour).','\0','Glucose Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117834'),('CL-LBTESTCD-T-488',NULL,'GLUTAM','A measurement of the glutamate in a biological specimen.','\0','Glutamate; Glutamic Acid','CL-LBTESTCD','DBX-NCIT-C74739'),('CL-LBTESTCD-T-489',NULL,'GLYCRLFR','A measurement of the amount of unbound glycerol in a biological specimen.','\0','Free Glycerin; Free Glycerol','CL-LBTESTCD','DBX-NCIT-C100448'),('CL-LBTESTCD-T-49',NULL,'AMORPHSD','A measurement of the amorphous sediment present in a biological specimen.','\0','Amorphous Debris; Amorphous Sediment','CL-LBTESTCD','DBX-NCIT-C74666'),('CL-LBTESTCD-T-490',NULL,'GMCSF','A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.','\0','Granulocyte Macrophage Colony Stm Factor','CL-LBTESTCD','DBX-NCIT-C82019'),('CL-LBTESTCD-T-491',NULL,'GNRH','A measurement of the gonadotropin releasing hormone in a biological specimen.','\0','Gonadotropin Releasing Hormone; Luteinising Hormone Releasing Hormone','CL-LBTESTCD','DBX-NCIT-C74860'),('CL-LBTESTCD-T-492',NULL,'GOLD','A measurement of the gold in a biological specimen.','\0','Gold','CL-LBTESTCD','DBX-NCIT-C80186'),('CL-LBTESTCD-T-493',NULL,'GRAN','A measurement of the granulocytes in a biological specimen.','\0','Granulocytes','CL-LBTESTCD','DBX-NCIT-C96654'),('CL-LBTESTCD-T-494',NULL,'GRANCE','A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Granulocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98866'),('CL-LBTESTCD-T-495',NULL,'GRANIM','A measurement of the total immature granulocytes in a biological specimen.','\0','Immature Granulocytes','CL-LBTESTCD','DBX-NCIT-C96675'),('CL-LBTESTCD-T-496',NULL,'GRANIMLE','A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).','\0','Immature Granulocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C100445'),('CL-LBTESTCD-T-497',NULL,'GRWHIH','A measurement of the growth hormone inhibiting hormone in a biological specimen.','\0','Growth Hormone Inhibiting Hormone; Somatostatin','CL-LBTESTCD','DBX-NCIT-C74861'),('CL-LBTESTCD-T-498',NULL,'GRWHRH','A measurement of the growth hormone releasing hormone in a biological specimen.','\0','Growth Hormone Releasing Hormone; Somatocrinin','CL-LBTESTCD','DBX-NCIT-C74862'),('CL-LBTESTCD-T-499',NULL,'GST','A measurement of the total glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Total','CL-LBTESTCD','DBX-NCIT-C80185'),('CL-LBTESTCD-T-5',NULL,'A2MACG','A measurement of the alpha-2 macroglobulin in a biological specimen.','\0','Alpha-2 Macroglobulin','CL-LBTESTCD','DBX-NCIT-C80168'),('CL-LBTESTCD-T-50',NULL,'AMPHET','A measurement of any amphetamine class drug present in a biological specimen.','\0','Amphetamine','CL-LBTESTCD','DBX-NCIT-C74687'),('CL-LBTESTCD-T-500',NULL,'GSTAL','A measurement of the alpha form of glutathione S-transferase in a biological specimen.','\0','Alpha Glutathione-S-Transferase','CL-LBTESTCD','DBX-NCIT-C79433'),('CL-LBTESTCD-T-501',NULL,'GSTALCRT','A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.','\0','Glutathione S-Transferase, Alpha/Creat','CL-LBTESTCD','DBX-NCIT-C80166'),('CL-LBTESTCD-T-502',NULL,'GSTCREAT','A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.','\0','Glutathione-S-Transferase/Creatinine','CL-LBTESTCD','DBX-NCIT-C79435'),('CL-LBTESTCD-T-503',NULL,'GSTMU','A measurement of the mu form of glutathione S-transferase in a biological specimen.','\0','Mu Glutathione-S-Transferase','CL-LBTESTCD','DBX-NCIT-C79457'),('CL-LBTESTCD-T-504',NULL,'GSTMUCRT','A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.','\0','Mu Glutathione-S-Transferase/Creatinine','CL-LBTESTCD','DBX-NCIT-C79458'),('CL-LBTESTCD-T-505',NULL,'GSTPI','A measurement of the Pi glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Pi','CL-LBTESTCD','DBX-NCIT-C80203'),('CL-LBTESTCD-T-506',NULL,'GSTTH','A measurement of the theta glutathione-s-transferase in a biological specimen.','\0','Glutathione S-Transferase, Theta','CL-LBTESTCD','DBX-NCIT-C80207'),('CL-LBTESTCD-T-507',NULL,'GUSA','A measurement of the alpha glucuronidase in a biological specimen.','\0','Glucuronidase, Alpha','CL-LBTESTCD','DBX-NCIT-C80165'),('CL-LBTESTCD-T-508',NULL,'GUSB','A measurement of the beta glucuronidase in a biological specimen.','\0','Glucuronidase, Beta','CL-LBTESTCD','DBX-NCIT-C80170'),('CL-LBTESTCD-T-509',NULL,'HAAB','A measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.','\0','Hepatitis A Virus Antibody','CL-LBTESTCD','DBX-NCIT-C92534'),('CL-LBTESTCD-T-51',NULL,'AMPHETD','A measurement of the dextroamphetamine in a biological specimen.','\0','Dextroamphetamine; d-amphetamine','CL-LBTESTCD','DBX-NCIT-C102262'),('CL-LBTESTCD-T-510',NULL,'HAABIGM','A measurement of hepatitis A virus antibody IgM in a biological specimen.','\0','Hepatitis A Virus Antibody IgM','CL-LBTESTCD','DBX-NCIT-C92271'),('CL-LBTESTCD-T-511',NULL,'HAIRYCE','A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.','\0','Hairy Cells','CL-LBTESTCD','DBX-NCIT-C74604'),('CL-LBTESTCD-T-512',NULL,'HALBAB','A measurement of the human albumin antibody in a biological specimen.','\0','Human Albumin Antibody','CL-LBTESTCD','DBX-NCIT-C103405'),('CL-LBTESTCD-T-513',NULL,'HAMAB','A measurement of the human anti-mouse antibody in a biological specimen.','\0','HAMA','CL-LBTESTCD','DBX-NCIT-C103406'),('CL-LBTESTCD-T-514',NULL,'HAPTOG','A measurement of the haptoglobin protein in a biological specimen.','\0','Haptoglobin','CL-LBTESTCD','DBX-NCIT-C74740'),('CL-LBTESTCD-T-515',NULL,'HASIGEAB','A measurement of the human anti-sheep IgE antibodies in a biological specimen.','\0','Human Anti-Sheep IgE Antibody','CL-LBTESTCD','DBX-NCIT-C98740'),('CL-LBTESTCD-T-516',NULL,'HASIGGAB','A measurement of the human anti-sheep IgG antibodies in a biological specimen.','\0','Human Anti-Sheep IgG Antibody','CL-LBTESTCD','DBX-NCIT-C98741'),('CL-LBTESTCD-T-517',NULL,'HASIGMAB','A measurement of the human anti-sheep IgM antibodies in a biological specimen.','\0','Human Anti-Sheep IgM Antibody','CL-LBTESTCD','DBX-NCIT-C98742'),('CL-LBTESTCD-T-518',NULL,'HAVVLD','A measurement of the hepatitis A viral load in a biological specimen.','\0','HAV Viral Load','CL-LBTESTCD','DBX-NCIT-C92541'),('CL-LBTESTCD-T-519',NULL,'HBA1C','A measurement of the glycosylated hemoglobin in a biological specimen.','\0','Glycosylated Hemoglobin; Hemoglobin A1C','CL-LBTESTCD','DBX-NCIT-C64849'),('CL-LBTESTCD-T-52',NULL,'AMYLASE','A measurement of the total enzyme amylase in a biological specimen.','\0','Amylase','CL-LBTESTCD','DBX-NCIT-C64434'),('CL-LBTESTCD-T-520',NULL,'HBA1CHGB','A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen.','\0','Hemoglobin A1C/Hemoglobin','CL-LBTESTCD','DBX-NCIT-C111207'),('CL-LBTESTCD-T-521',NULL,'HBCAB','A measurement of the hepatitis B virus core antibody in a biological specimen.','\0','Hepatitis B Virus Core Antibody','CL-LBTESTCD','DBX-NCIT-C96660'),('CL-LBTESTCD-T-522',NULL,'HBCIGMAB','A measurement of the hepatitis B virus core IgM antibody in a biological specimen.','\0','Hepatitis B Virus Core IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96661'),('CL-LBTESTCD-T-523',NULL,'HBDNA','A measurement of hepatitis B virus DNA in a biological specimen.','\0','Hepatitis B DNA','CL-LBTESTCD','DBX-NCIT-C103404'),('CL-LBTESTCD-T-524',NULL,'HBEAB','A measurement of the hepatitis B e antibody in a biological specimen.','\0','Hepatitis B Virus e Antibody','CL-LBTESTCD','DBX-NCIT-C96662'),('CL-LBTESTCD-T-525',NULL,'HBEAG','A measurement of the hepatitis B e antigen in a biological specimen.','\0','Hepatitis B Virus e Antigen','CL-LBTESTCD','DBX-NCIT-C96663'),('CL-LBTESTCD-T-526',NULL,'HBSAB','A measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.','\0','Anti-HBs; HBsAb; Hepatitis B Virus Surface Antibody','CL-LBTESTCD','DBX-NCIT-C74711'),('CL-LBTESTCD-T-527',NULL,'HBSAG','A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.','\0','HBsAg; Hepatitis B Virus Surface Antigen','CL-LBTESTCD','DBX-NCIT-C64850'),('CL-LBTESTCD-T-528',NULL,'HBVVLD','A measurement of the hepatitis B viral load in a biological specimen.','\0','HBV Viral Load','CL-LBTESTCD','DBX-NCIT-C92542'),('CL-LBTESTCD-T-529',NULL,'HCAB','A measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.','\0','Hepatitis C Virus Antibody','CL-LBTESTCD','DBX-NCIT-C92535'),('CL-LBTESTCD-T-53',NULL,'AMYLASEM','A measurement of macroamylase in a biological specimen.','\0','Macroamylase','CL-LBTESTCD','DBX-NCIT-C111243'),('CL-LBTESTCD-T-530',NULL,'HCAG','A measurement of the hepatitis C virus antigen in a biological specimen.','\0','Hepatitis C Virus Antigen','CL-LBTESTCD','DBX-NCIT-C116196'),('CL-LBTESTCD-T-531',NULL,'HCG','A measurement of the Choriogonadotropin Beta in a biological specimen.','\0','Choriogonadotropin Beta; Pregnancy Test','CL-LBTESTCD','DBX-NCIT-C64851'),('CL-LBTESTCD-T-532',NULL,'HCT','The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).','\0','EVF; Erythrocyte Volume Fraction; Hematocrit; PCV; Packed Cell Volume','CL-LBTESTCD','DBX-NCIT-C64796'),('CL-LBTESTCD-T-533',NULL,'HCVVLD','A measurement of the hepatitis C viral load in a biological specimen.','\0','HCV RNA; HCV Viral Load; Hepatitis C RNA','CL-LBTESTCD','DBX-NCIT-C92543'),('CL-LBTESTCD-T-534',NULL,'HDAB','A measurement of the hepatitis D virus antibody in a biological specimen.','\0','Hepatitis D Virus Antibody; Hepatitis Delta Antibody','CL-LBTESTCD','DBX-NCIT-C96664'),('CL-LBTESTCD-T-535',NULL,'HDL','A measurement of the high density lipoprotein cholesterol in a biological specimen.','\0','HDL Cholesterol','CL-LBTESTCD','DBX-NCIT-C105587'),('CL-LBTESTCD-T-536',NULL,'HDL2','A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.','\0','HDL-Cholesterol Subclass 2','CL-LBTESTCD','DBX-NCIT-C80187'),('CL-LBTESTCD-T-537',NULL,'HDL3','A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.','\0','HDL-Cholesterol Subclass 3','CL-LBTESTCD','DBX-NCIT-C80188'),('CL-LBTESTCD-T-538',NULL,'HDLCLDLC','A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.','\0','HDL Cholesterol/LDL Cholesterol Ratio','CL-LBTESTCD','DBX-NCIT-C100425'),('CL-LBTESTCD-T-539',NULL,'HDLPSZ','A measurement of the average particle size of high-density lipoprotein in a biological specimen.','\0','HDL Particle Size','CL-LBTESTCD','DBX-NCIT-C103402'),('CL-LBTESTCD-T-54',NULL,'AMYLASEP','A measurement of the pancreatic enzyme amylase in a biological specimen.','\0','Amylase, Pancreatic','CL-LBTESTCD','DBX-NCIT-C98767'),('CL-LBTESTCD-T-540',NULL,'HDW','A measurement of the distribution of the hemoglobin concentration in red blood cells.','\0','Hemoglobin Distribution Width','CL-LBTESTCD','DBX-NCIT-C106525'),('CL-LBTESTCD-T-541',NULL,'HEIGGAB','A measurement of IgG antibody to the hepatitis E virus in a biological specimen.','\0','Hepatitis E Virus IgG Antibody','CL-LBTESTCD','DBX-NCIT-C106526'),('CL-LBTESTCD-T-542',NULL,'HEIGMAB','A measurement of the hepatitis E virus IgM antibody in a biological specimen.','\0','Hepatitis E Virus IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96665'),('CL-LBTESTCD-T-543',NULL,'HEINZ','A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.','\0','Heinz Bodies; Heinz-Erhlich Bodies','CL-LBTESTCD','DBX-NCIT-C74709'),('CL-LBTESTCD-T-544',NULL,'HEINZRBC','A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen.','\0','Heinz Bodies/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C111206'),('CL-LBTESTCD-T-545',NULL,'HELMETCE','A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.','\0','Helmet Cells','CL-LBTESTCD','DBX-NCIT-C74658'),('CL-LBTESTCD-T-546',NULL,'HEMOLYSI','A measurement of the destruction of red blood cells in a biological specimen.','\0','Hemolysis; Hemolytic Index','CL-LBTESTCD','DBX-NCIT-C111208'),('CL-LBTESTCD-T-547',NULL,'HER2','A measurement of the cells with positive expression of HER2 in a biological specimen.','\0','ERBB2; HER2/NEU; Human Epidermal Growth Factor Receptor 2','CL-LBTESTCD','DBX-NCIT-C112312'),('CL-LBTESTCD-T-548',NULL,'HER2AG','A measurement of the HER2 antigen in a biological specimen.','\0','HER2 Antigen; HER2/NEU Antigen','CL-LBTESTCD','DBX-NCIT-C112291'),('CL-LBTESTCD-T-549',NULL,'HETRPH','A measurement of heterophils (granular leukocytes) in a biological specimen from avian species.','\0','Heterophils','CL-LBTESTCD','DBX-NCIT-C116186'),('CL-LBTESTCD-T-55',NULL,'AMYLASES','A measurement of the salivary enzyme amylase in a biological specimen.','\0','Amylase, Salivary','CL-LBTESTCD','DBX-NCIT-C98780'),('CL-LBTESTCD-T-550',NULL,'HETRPHLE','A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species.','\0','Heterophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C116187'),('CL-LBTESTCD-T-551',NULL,'HEXK','A measurement of the hexokinase in a biological specimen.','\0','Hexokinase','CL-LBTESTCD','DBX-NCIT-C96668'),('CL-LBTESTCD-T-552',NULL,'HGB','A measurement of the hemoglobin in a biological specimen.','\0','Hemoglobin','CL-LBTESTCD','DBX-NCIT-C64848'),('CL-LBTESTCD-T-553',NULL,'HGBA','A measurement of the hemoglobin A in a biological specimen.','\0','Hemoglobin A','CL-LBTESTCD','DBX-NCIT-C92258'),('CL-LBTESTCD-T-554',NULL,'HGBA2','A measurement of the hemoglobin A2 in a biological specimen.','\0','Hemoglobin A2','CL-LBTESTCD','DBX-NCIT-C92259'),('CL-LBTESTCD-T-555',NULL,'HGBB','A measurement of the hemoglobin B in a biological specimen.','\0','Hemoglobin B','CL-LBTESTCD','DBX-NCIT-C92260'),('CL-LBTESTCD-T-556',NULL,'HGBC','A measurement of the hemoglobin C in a biological specimen.','\0','Hemoglobin C','CL-LBTESTCD','DBX-NCIT-C92261'),('CL-LBTESTCD-T-557',NULL,'HGBF','A measurement of the hemoglobin F in a biological specimen.','\0','Fetal Hemoglobin; Hemoglobin F','CL-LBTESTCD','DBX-NCIT-C92262'),('CL-LBTESTCD-T-558',NULL,'HGBMET','A measurement of the methemoglobin in a biological specimen.','\0','Methemoglobin','CL-LBTESTCD','DBX-NCIT-C96689'),('CL-LBTESTCD-T-559',NULL,'HGBOXY','A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen.','\0','Oxyhemoglobin','CL-LBTESTCD','DBX-NCIT-C96616'),('CL-LBTESTCD-T-56',NULL,'AMYLB38','A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen.','\0','Amyloid Beta 1-38; Amyloid Beta 38; Amyloid Beta 38 Protein','CL-LBTESTCD','DBX-NCIT-C103352'),('CL-LBTESTCD-T-560',NULL,'HGRNA','A measurement of the Hepatitis G RNA in a biological specimen.','\0','Hepatitis G RNA','CL-LBTESTCD','DBX-NCIT-C92272'),('CL-LBTESTCD-T-561',NULL,'HIST1AB','A measurement of the total histone 1 antibodies in a biological specimen.','\0','Histone 1 Antibody','CL-LBTESTCD','DBX-NCIT-C112293'),('CL-LBTESTCD-T-562',NULL,'HIST2AAB','A measurement of the total histone 2A antibodies in a biological specimen.','\0','Histone 2A Antibody','CL-LBTESTCD','DBX-NCIT-C112294'),('CL-LBTESTCD-T-563',NULL,'HIST2BAB','A measurement of the total histone 2B antibodies in a biological specimen.','\0','Histone 2B Antibody','CL-LBTESTCD','DBX-NCIT-C112295'),('CL-LBTESTCD-T-564',NULL,'HIST3AB','A measurement of the total histone 3 antibodies in a biological specimen.','\0','Histone 3 Antibody','CL-LBTESTCD','DBX-NCIT-C112296'),('CL-LBTESTCD-T-565',NULL,'HIST4AB','A measurement of the total histone 4 antibodies in a biological specimen.','\0','Histone 4 Antibody','CL-LBTESTCD','DBX-NCIT-C112297'),('CL-LBTESTCD-T-566',NULL,'HISTAB','A measurement of histone antibodies in a biological specimen.','\0','Anti-Histone Antibodies; Histone Antibodies','CL-LBTESTCD','DBX-NCIT-C111209'),('CL-LBTESTCD-T-567',NULL,'HISTAMIN','A measurement of the histamine in a biological specimen.','\0','Histamine','CL-LBTESTCD','DBX-NCIT-C80189'),('CL-LBTESTCD-T-568',NULL,'HIV124AG','A measurement of the HIV-1 p24 antigen in a biological specimen.','\0','HIV-1 p24 Antigen','CL-LBTESTCD','DBX-NCIT-C92265'),('CL-LBTESTCD-T-569',NULL,'HIV12AB','A measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.','\0','HIV-1/2 Antibody','CL-LBTESTCD','DBX-NCIT-C74714'),('CL-LBTESTCD-T-57',NULL,'AMYLB40','A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen.','\0','Amyloid Beta 1-40; Amyloid Beta 40; Amyloid Beta 40 Protein','CL-LBTESTCD','DBX-NCIT-C103353'),('CL-LBTESTCD-T-570',NULL,'HIV1AB','A measurement of the antibody reaction of a biological specimen to the HIV-1 virus.','\0','HIV-1 Antibody','CL-LBTESTCD','DBX-NCIT-C74713'),('CL-LBTESTCD-T-571',NULL,'HIV1MONA','A measurement of the HIV-1 group M and O nucleic acids in a biological specimen.','\0','HIV-1 Group M and O Nucleic Acid','CL-LBTESTCD','DBX-NCIT-C92263'),('CL-LBTESTCD-T-572',NULL,'HIV1OAB','A measurement of the HIV-1 group O antibody in a biological specimen.','\0','HIV-1 Group O Antibody','CL-LBTESTCD','DBX-NCIT-C92264'),('CL-LBTESTCD-T-573',NULL,'HIV2AB','A measurement of the antibody reaction of a biological specimen to the HIV-2 virus.','\0','HIV-2 Antibody','CL-LBTESTCD','DBX-NCIT-C74715'),('CL-LBTESTCD-T-574',NULL,'HIV2NUAC','A measurement of the HIV-2 nucleic acids in a biological specimen.','\0','HIV-2 Nucleic Acid','CL-LBTESTCD','DBX-NCIT-C92266'),('CL-LBTESTCD-T-575',NULL,'HIVAB','A measurement of the antibody reaction of a biological specimen to the HIV virus.','\0','HIV Antibody','CL-LBTESTCD','DBX-NCIT-C106527'),('CL-LBTESTCD-T-576',NULL,'HIVVLD','A measurement of the HIV viral load in a biological specimen.','\0','HIV Viral Load','CL-LBTESTCD','DBX-NCIT-C92544'),('CL-LBTESTCD-T-577',NULL,'HLAB27AG','A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.','\0','HLA-B27 Antigen; Human Leukocyte Antigen B27','CL-LBTESTCD','DBX-NCIT-C100460'),('CL-LBTESTCD-T-578',NULL,'HMOSIDRN','A measurement of the hemosiderin complex in a biological specimen.','\0','Hemosiderin','CL-LBTESTCD','DBX-NCIT-C96659'),('CL-LBTESTCD-T-579',NULL,'HOMAIR','An assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.','\0','Homeostatic Model Assessment of Insulin Resistance; Homostat Model Assess of Insulin Rstn','CL-LBTESTCD','DBX-NCIT-C100447'),('CL-LBTESTCD-T-58',NULL,'AMYLB42','A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen.','\0','Amyloid Beta 1-42; Amyloid Beta 42; Amyloid Beta 42 Protein','CL-LBTESTCD','DBX-NCIT-C84809'),('CL-LBTESTCD-T-580',NULL,'HOMOCY','A measurement of the homocysteine amino acid in a biological specimen.','\0','Homocysteine','CL-LBTESTCD','DBX-NCIT-C74741'),('CL-LBTESTCD-T-581',NULL,'HOWJOL','A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.','\0','Howell-Jolly Bodies','CL-LBTESTCD','DBX-NCIT-C74704'),('CL-LBTESTCD-T-582',NULL,'HPLIGGAB','A measurement of the Helicobacter pylori IgG antibody in a biological specimen.','\0','Helicobacter pylori IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103403'),('CL-LBTESTCD-T-583',NULL,'HPOCROM','An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.','\0','Hypochromia','CL-LBTESTCD','DBX-NCIT-C64802'),('CL-LBTESTCD-T-584',NULL,'HRYCELY','A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .','\0','Hairy Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74640'),('CL-LBTESTCD-T-585',NULL,'HS12GGAB','A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.','\0','HSV-1/2 IgG Ab; Herpes Simplex Virus 1/2 IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96697'),('CL-LBTESTCD-T-586',NULL,'HS12GMAB','A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.','\0','HSV-1/2 IgM Ab; Herpes Simplex Virus 1/2 IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96698'),('CL-LBTESTCD-T-587',NULL,'HS1IGGAB','A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.','\0','HSV-1 IgG Antibody; Herpes Simplex Virus 1 IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96666'),('CL-LBTESTCD-T-588',NULL,'HS1IGMAB','A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.','\0','Herpes Simplex Virus 1 IgM Antibody','CL-LBTESTCD','DBX-NCIT-C98738'),('CL-LBTESTCD-T-589',NULL,'HS2IGGAB','A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.','\0','HSV-2 IgG Antibody; Herpes Simplex Virus 2 IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96667'),('CL-LBTESTCD-T-59',NULL,'AMYLOIDB','A measurement of the total amyloid beta in a biological specimen.','\0','Amyloid, Beta; Beta Amyloid','CL-LBTESTCD','DBX-NCIT-C81999'),('CL-LBTESTCD-T-590',NULL,'HS2IGMAB','A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.','\0','Herpes Simplex Virus 2 IgM Antibody','CL-LBTESTCD','DBX-NCIT-C98739'),('CL-LBTESTCD-T-591',NULL,'HS6AB','A measurement of the herpes simplex virus 6 antibody in a biological specimen.','\0','Herpes Simplex Virus 6 Antibody','CL-LBTESTCD','DBX-NCIT-C112292'),('CL-LBTESTCD-T-592',NULL,'HTPHAB','A measurement of the heterophile antibodies in a biological specimen.','\0','Heterophile Antibodies','CL-LBTESTCD','DBX-NCIT-C81984'),('CL-LBTESTCD-T-593',NULL,'HVA','A measurement of the homovanillic acid metabolite in a biological specimen.','\0','Homovanillic Acid','CL-LBTESTCD','DBX-NCIT-C74863'),('CL-LBTESTCD-T-594',NULL,'HYALUAC','A measurement of hyaluronic acid in a biological specimen.','\0','Hyaluronic Acid','CL-LBTESTCD','DBX-NCIT-C112319'),('CL-LBTESTCD-T-595',NULL,'HYDCDN','A measurement of the hydrocodone present in a biological specimen.','\0','Hydrocodone','CL-LBTESTCD','DBX-NCIT-C74879'),('CL-LBTESTCD-T-596',NULL,'HYDMRPHN','A measurement of the hydromorphone present in a biological specimen.','\0','Hydromorphone','CL-LBTESTCD','DBX-NCIT-C74880'),('CL-LBTESTCD-T-597',NULL,'HYDROGEN','A measurement of the hydrogen in a biological specimen.','\0','Hydrogen','CL-LBTESTCD','DBX-NCIT-C102275'),('CL-LBTESTCD-T-598',NULL,'HYPERCHR','A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.','\0','Hyperchromia','CL-LBTESTCD','DBX-NCIT-C96669'),('CL-LBTESTCD-T-599',NULL,'HYPRLN','A measurement of the total hydroxyproline in a biological specimen.','\0','Hydroxyproline','CL-LBTESTCD','DBX-NCIT-C80190'),('CL-LBTESTCD-T-6',NULL,'AAP','A measurement of the alanine aminopeptidase in a biological specimen.','\0','Alanine Aminopeptidase','CL-LBTESTCD','DBX-NCIT-C100430'),('CL-LBTESTCD-T-60',NULL,'AMYLOIDP','A measurement of the total amyloid P in a biological specimen.','\0','Amyloid P','CL-LBTESTCD','DBX-NCIT-C81998'),('CL-LBTESTCD-T-600',NULL,'HYPSEGCE','A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.','\0','Hypersegmented Cells','CL-LBTESTCD','DBX-NCIT-C74612'),('CL-LBTESTCD-T-601',NULL,'IAA5OH','A measurement of 5-hydroxyindoleacetic acid in a biological specimen.','\0','5-Hydroxyindoleacetic Acid','CL-LBTESTCD','DBX-NCIT-C112217'),('CL-LBTESTCD-T-602',NULL,'IAH1N1VL','A measurement of the Influenza A H1N1 viral load in a biological specimen.','\0','Influenza A H1N1 Viral Load','CL-LBTESTCD','DBX-NCIT-C92273'),('CL-LBTESTCD-T-603',NULL,'IAIGGAB','A measurement of the Influenza A IgG antibody in a biological specimen.','\0','Influenza A IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103408'),('CL-LBTESTCD-T-604',NULL,'IBCT','A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.','\0','Total Iron Binding Capacity','CL-LBTESTCD','DBX-NCIT-C74718'),('CL-LBTESTCD-T-605',NULL,'IBCU','A measurement of the binding capacity of unsaturated iron in a biological specimen.','\0','Unsaturated Iron Binding Capacity','CL-LBTESTCD','DBX-NCIT-C74719'),('CL-LBTESTCD-T-606',NULL,'IBIGGAB','A measurement of the Influenza B IgG antibody in a biological specimen.','\0','Influenza B IgG Antibody','CL-LBTESTCD','DBX-NCIT-C103409'),('CL-LBTESTCD-T-607',NULL,'IC512AB','A measurement of the islet cell 512 antibody in a biological specimen.','\0','Islet Cell 512 Antibody','CL-LBTESTCD','DBX-NCIT-C81985'),('CL-LBTESTCD-T-608',NULL,'IC512AG','A measurement of the islet cell 512 antigen in a biological specimen.','\0','Islet Cell 512 Antigen','CL-LBTESTCD','DBX-NCIT-C81986'),('CL-LBTESTCD-T-609',NULL,'ICTERUSI','A measurement of the yellow color of a biological specimen, due to the presence of bile pigments.','\0','Icteric Index; Icterus','CL-LBTESTCD','DBX-NCIT-C111232'),('CL-LBTESTCD-T-61',NULL,'ANA','A measurement of the antinuclear antibodies (antibodies that attack the body\'s own tissue) in a biological specimen.','\0','Antinuclear Antibodies','CL-LBTESTCD','DBX-NCIT-C74916'),('CL-LBTESTCD-T-610',NULL,'IDL','A measurement of the intermediate density lipoprotein in a biological specimen.','\0','IDL Cholesterol; Intermediate Density Lipoprotein','CL-LBTESTCD','DBX-NCIT-C112325'),('CL-LBTESTCD-T-611',NULL,'IDLP','A measurement of the concentration of IDL particles in a biological specimen.','\0','IDL Particles; Intermediate Density Lipoproteins Particles','CL-LBTESTCD','DBX-NCIT-C116197'),('CL-LBTESTCD-T-612',NULL,'IFNA','A measurement of the interferon alpha in a biological specimen.','\0','Interferon Alpha','CL-LBTESTCD','DBX-NCIT-C81994'),('CL-LBTESTCD-T-613',NULL,'IFNB','A measurement of the interferon beta in a biological specimen.','\0','Interferon Beta','CL-LBTESTCD','DBX-NCIT-C81995'),('CL-LBTESTCD-T-614',NULL,'IFNG','A measurement of the interferon gamma in a biological specimen.','\0','Interferon Gamma','CL-LBTESTCD','DBX-NCIT-C81996'),('CL-LBTESTCD-T-615',NULL,'IGA','A measurement of the Immunoglobulin A in a biological specimen.','\0','Immunoglobulin A','CL-LBTESTCD','DBX-NCIT-C81969'),('CL-LBTESTCD-T-616',NULL,'IGAGM','A measurement of the total IgG, IgM, and IgA in a biological specimen.','\0','IgG IgM IgA Total','CL-LBTESTCD','DBX-NCIT-C111233'),('CL-LBTESTCD-T-617',NULL,'IGD','A measurement of the Immunoglobulin D in a biological specimen.','\0','Immunoglobulin D','CL-LBTESTCD','DBX-NCIT-C98745'),('CL-LBTESTCD-T-618',NULL,'IGE','A measurement of the Immunoglobulin E in a biological specimen.','\0','Immunoglobulin E','CL-LBTESTCD','DBX-NCIT-C81970'),('CL-LBTESTCD-T-619',NULL,'IGF1','A measurement of the insulin-like growth factor-1 in a biological specimen.','\0','Insulin-like Growth Factor-1','CL-LBTESTCD','DBX-NCIT-C74864'),('CL-LBTESTCD-T-62',NULL,'ANDSTNDL','A measurement of the androstenediol metabolite in a biological specimen.','\0','Androstenediol','CL-LBTESTCD','DBX-NCIT-C74842'),('CL-LBTESTCD-T-620',NULL,'IGF2','A measurement of the insulin-like growth factor-2 in a biological specimen.','\0','Insulin-like Growth Factor-2','CL-LBTESTCD','DBX-NCIT-C74865'),('CL-LBTESTCD-T-621',NULL,'IGFBP3','A measurement of the insulin-like growth factor binding protein 3 in a biological specimen.','\0','Insulin-Like Growth Factor Binding Prot3; Insulin-Like Growth Factor Binding Protein 3','CL-LBTESTCD','DBX-NCIT-C112322'),('CL-LBTESTCD-T-622',NULL,'IGG','A measurement of the Immunoglobulin G in a biological specimen.','\0','Immunoglobulin G','CL-LBTESTCD','DBX-NCIT-C81971'),('CL-LBTESTCD-T-623',NULL,'IGM','A measurement of the Immunoglobulin M in a biological specimen.','\0','Immunoglobulin M','CL-LBTESTCD','DBX-NCIT-C81972'),('CL-LBTESTCD-T-624',NULL,'IGSOL','A measurement of the soluble total immunoglobulin in a biological specimen.','\0','Soluble Immunoglobulin','CL-LBTESTCD','DBX-NCIT-C117835'),('CL-LBTESTCD-T-625',NULL,'IL1SR1','A measurement of the soluble interleukin-1 receptor type I in a biological specimen.','\0','Soluble Interleukin-1 Receptor Type I','CL-LBTESTCD','DBX-NCIT-C117836'),('CL-LBTESTCD-T-626',NULL,'IL2SRA','A measurement of the soluble interleukin 2 receptor activity in a biological specimen.','\0','Soluble Interleukin 2 Receptor Activity','CL-LBTESTCD','DBX-NCIT-C102280'),('CL-LBTESTCD-T-627',NULL,'IL6SR','A measurement of the soluble interleukin 6 receptor in a biological specimen.','\0','Soluble Interleukin 6 Receptor','CL-LBTESTCD','DBX-NCIT-C117837'),('CL-LBTESTCD-T-628',NULL,'ILE','A measurement of the isoleucine in a biological specimen.','\0','Isoleucine','CL-LBTESTCD','DBX-NCIT-C103410'),('CL-LBTESTCD-T-629',NULL,'INCLBOD','A measurement of the inclusion bodies in a biological specimen.','\0','Inclusion Bodies','CL-LBTESTCD','DBX-NCIT-C116184'),('CL-LBTESTCD-T-63',NULL,'ANDSTNDN','A measurement of the androstenedione hormone in a biological specimen.','\0','4-Androstenedione; Androstenedione','CL-LBTESTCD','DBX-NCIT-C74843'),('CL-LBTESTCD-T-630',NULL,'INDICAN','A measurement of the indican present in a biological specimen.','\0','Indican','CL-LBTESTCD','DBX-NCIT-C82044'),('CL-LBTESTCD-T-631',NULL,'INFAVLD','A measurement of the Influenza A viral load in a biological specimen.','\0','Influenza A Viral Load','CL-LBTESTCD','DBX-NCIT-C92274'),('CL-LBTESTCD-T-632',NULL,'INGAPAB','A measurement of the islet neogenesis associated protein antibody in a biological specimen.','\0','Islet Neogenesis Assoc Protein Antibody','CL-LBTESTCD','DBX-NCIT-C81987'),('CL-LBTESTCD-T-633',NULL,'INHIBINA','A measurement of the inhibin A in a biological specimen.','\0','Inhibin A','CL-LBTESTCD','DBX-NCIT-C82020'),('CL-LBTESTCD-T-634',NULL,'INHIBINB','A measurement of the inhibin B in a biological specimen.','\0','Inhibin B','CL-LBTESTCD','DBX-NCIT-C96681'),('CL-LBTESTCD-T-635',NULL,'INLCLR','A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).','\0','Inulin Clearance','CL-LBTESTCD','DBX-NCIT-C98748'),('CL-LBTESTCD-T-636',NULL,'INR','A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.','\0','Prothrombin Intl. Normalized Ratio','CL-LBTESTCD','DBX-NCIT-C64805'),('CL-LBTESTCD-T-637',NULL,'INSULIN','A measurement of the insulin in a biological specimen.','\0','Insulin','CL-LBTESTCD','DBX-NCIT-C74788'),('CL-LBTESTCD-T-638',NULL,'INTLK1','A measurement of the interleukin 1 in a biological specimen.','\0','Interleukin 1','CL-LBTESTCD','DBX-NCIT-C74805'),('CL-LBTESTCD-T-639',NULL,'INTLK10','A measurement of the interleukin 10 in a biological specimen.','\0','Interleukin 10','CL-LBTESTCD','DBX-NCIT-C74806'),('CL-LBTESTCD-T-64',NULL,'ANGLBIND','A test that uses Coombs\' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen.','\0','Antiglobulin Test, Indirect; Indirect Coombs Test','CL-LBTESTCD','DBX-NCIT-C91372'),('CL-LBTESTCD-T-640',NULL,'INTLK11','A measurement of the interleukin 11 in a biological specimen.','\0','Interleukin 11','CL-LBTESTCD','DBX-NCIT-C74807'),('CL-LBTESTCD-T-641',NULL,'INTLK12','A measurement of the interleukin 12 in a biological specimen.','\0','Interleukin 12','CL-LBTESTCD','DBX-NCIT-C74808'),('CL-LBTESTCD-T-642',NULL,'INTLK13','A measurement of the interleukin 13 in a biological specimen.','\0','Interleukin 13','CL-LBTESTCD','DBX-NCIT-C74809'),('CL-LBTESTCD-T-643',NULL,'INTLK14','A measurement of the interleukin 14 in a biological specimen.','\0','Interleukin 14','CL-LBTESTCD','DBX-NCIT-C74810'),('CL-LBTESTCD-T-644',NULL,'INTLK15','A measurement of the interleukin 15 in a biological specimen.','\0','Interleukin 15','CL-LBTESTCD','DBX-NCIT-C74811'),('CL-LBTESTCD-T-645',NULL,'INTLK16','A measurement of the interleukin 16 in a biological specimen.','\0','Interleukin 16','CL-LBTESTCD','DBX-NCIT-C74812'),('CL-LBTESTCD-T-646',NULL,'INTLK17','A measurement of the interleukin 17 in a biological specimen.','\0','Interleukin 17','CL-LBTESTCD','DBX-NCIT-C74813'),('CL-LBTESTCD-T-647',NULL,'INTLK18','A measurement of the interleukin 18 in a biological specimen.','\0','Interleukin 18','CL-LBTESTCD','DBX-NCIT-C74814'),('CL-LBTESTCD-T-648',NULL,'INTLK19','A measurement of the interleukin 19 in a biological specimen.','\0','Interleukin 19','CL-LBTESTCD','DBX-NCIT-C74815'),('CL-LBTESTCD-T-649',NULL,'INTLK1B','A measurement of interleukin 1 beta in a biological specimen.','\0','IL-1B; IL1Beta; Interleukin 1 Beta; Interleukin 1B','CL-LBTESTCD','DBX-NCIT-C112323'),('CL-LBTESTCD-T-65',NULL,'ANGLOBDR','A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.','\0','Antiglobulin Test, Direct; Direct Coombs Test','CL-LBTESTCD','DBX-NCIT-C81974'),('CL-LBTESTCD-T-650',NULL,'INTLK1RA','A measurement of the interleukin 1 receptor antagonist in a biological specimen.','\0','IL-1RA; Interleukin 1 Receptor Antagonist','CL-LBTESTCD','DBX-NCIT-C112324'),('CL-LBTESTCD-T-651',NULL,'INTLK2','A measurement of the interleukin 2 in a biological specimen.','\0','Interleukin 2','CL-LBTESTCD','DBX-NCIT-C74816'),('CL-LBTESTCD-T-652',NULL,'INTLK20','A measurement of the interleukin 20 in a biological specimen.','\0','Interleukin 20','CL-LBTESTCD','DBX-NCIT-C74817'),('CL-LBTESTCD-T-653',NULL,'INTLK21','A measurement of the interleukin 21 in a biological specimen.','\0','Interleukin 21','CL-LBTESTCD','DBX-NCIT-C74818'),('CL-LBTESTCD-T-654',NULL,'INTLK22','A measurement of the interleukin 22 in a biological specimen.','\0','Interleukin 22','CL-LBTESTCD','DBX-NCIT-C74819'),('CL-LBTESTCD-T-655',NULL,'INTLK23','A measurement of the interleukin 23 in a biological specimen.','\0','Interleukin 23','CL-LBTESTCD','DBX-NCIT-C74820'),('CL-LBTESTCD-T-656',NULL,'INTLK24','A measurement of the interleukin 24 in a biological specimen.','\0','Interleukin 24','CL-LBTESTCD','DBX-NCIT-C74821'),('CL-LBTESTCD-T-657',NULL,'INTLK25','A measurement of the interleukin 25 in a biological specimen.','\0','Interleukin 25','CL-LBTESTCD','DBX-NCIT-C74822'),('CL-LBTESTCD-T-658',NULL,'INTLK26','A measurement of the interleukin 26 in a biological specimen.','\0','Interleukin 26','CL-LBTESTCD','DBX-NCIT-C74823'),('CL-LBTESTCD-T-659',NULL,'INTLK27','A measurement of the interleukin 27 in a biological specimen.','\0','Interleukin 27','CL-LBTESTCD','DBX-NCIT-C74824'),('CL-LBTESTCD-T-66',NULL,'ANGPT1','A measurement of angiopoietin 1 in a biological specimen.','\0','Angiopoietin 1','CL-LBTESTCD','DBX-NCIT-C111128'),('CL-LBTESTCD-T-660',NULL,'INTLK28','A measurement of the interleukin 28 in a biological specimen.','\0','Interleukin 28','CL-LBTESTCD','DBX-NCIT-C74825'),('CL-LBTESTCD-T-661',NULL,'INTLK29','A measurement of the interleukin 29 in a biological specimen.','\0','Interleukin 29','CL-LBTESTCD','DBX-NCIT-C74826'),('CL-LBTESTCD-T-662',NULL,'INTLK3','A measurement of the interleukin 3 in a biological specimen.','\0','Interleukin 3','CL-LBTESTCD','DBX-NCIT-C74827'),('CL-LBTESTCD-T-663',NULL,'INTLK30','A measurement of the interleukin 30 in a biological specimen.','\0','Interleukin 30','CL-LBTESTCD','DBX-NCIT-C74828'),('CL-LBTESTCD-T-664',NULL,'INTLK31','A measurement of the interleukin 31 in a biological specimen.','\0','Interleukin 31','CL-LBTESTCD','DBX-NCIT-C74829'),('CL-LBTESTCD-T-665',NULL,'INTLK32','A measurement of the interleukin 32 in a biological specimen.','\0','Interleukin 32','CL-LBTESTCD','DBX-NCIT-C74830'),('CL-LBTESTCD-T-666',NULL,'INTLK33','A measurement of the interleukin 33 in a biological specimen.','\0','Interleukin 33','CL-LBTESTCD','DBX-NCIT-C74831'),('CL-LBTESTCD-T-667',NULL,'INTLK4','A measurement of the interleukin 4 in a biological specimen.','\0','Interleukin 4','CL-LBTESTCD','DBX-NCIT-C74832'),('CL-LBTESTCD-T-668',NULL,'INTLK5','A measurement of the interleukin 5 in a biological specimen.','\0','Interleukin 5','CL-LBTESTCD','DBX-NCIT-C74833'),('CL-LBTESTCD-T-669',NULL,'INTLK6','A measurement of the interleukin 6 in a biological specimen.','\0','Interleukin 6','CL-LBTESTCD','DBX-NCIT-C74834'),('CL-LBTESTCD-T-67',NULL,'ANGTNS1','A measurement of the angiotensin I hormone in a biological specimen.','\0','Angiotensin I','CL-LBTESTCD','DBX-NCIT-C74844'),('CL-LBTESTCD-T-670',NULL,'INTLK7','A measurement of the interleukin 7 in a biological specimen.','\0','Interleukin 7','CL-LBTESTCD','DBX-NCIT-C74835'),('CL-LBTESTCD-T-671',NULL,'INTLK8','A measurement of the interleukin 8 in a biological specimen.','\0','Interleukin 8','CL-LBTESTCD','DBX-NCIT-C74836'),('CL-LBTESTCD-T-672',NULL,'INTLK9','A measurement of the interleukin 9 in a biological specimen.','\0','Interleukin 9','CL-LBTESTCD','DBX-NCIT-C74837'),('CL-LBTESTCD-T-673',NULL,'IOHEXCLR','A measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.','\0','Iohexol Clearance','CL-LBTESTCD','DBX-NCIT-C100439'),('CL-LBTESTCD-T-674',NULL,'IOTCLR','A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).','\0','Iothalamate Clearance','CL-LBTESTCD','DBX-NCIT-C98749'),('CL-LBTESTCD-T-675',NULL,'IOTCLRBS','A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.','\0','Iothalamate Clearance Adjusted for BSA','CL-LBTESTCD','DBX-NCIT-C98750'),('CL-LBTESTCD-T-676',NULL,'IRF','A measurement of the immature reticulocyte fraction present in a biological specimen.','\0','Immature Reticulocyte Fraction','CL-LBTESTCD','DBX-NCIT-C102276'),('CL-LBTESTCD-T-677',NULL,'IRON','A measurement of the iron in a biological specimen.','\0','FE; Iron','CL-LBTESTCD','DBX-NCIT-C74679'),('CL-LBTESTCD-T-678',NULL,'IRONEXR','A measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour).','\0','Iron Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117838'),('CL-LBTESTCD-T-679',NULL,'ISOPRF2','A measurement of the F2-isoprostane in a biological specimen.','\0','F2-Isoprostane','CL-LBTESTCD','DBX-NCIT-C80180'),('CL-LBTESTCD-T-68',NULL,'ANGTNS2','A measurement of the angiotensin II hormone in a biological specimen.','\0','Angiotensin II','CL-LBTESTCD','DBX-NCIT-C74845'),('CL-LBTESTCD-T-680',NULL,'JCVAB','A measurement of the JC virus antibody in a biological specimen.','\0','JC Polyomavirus Antibody; JC Virus Antibody; JCV Antibody; John Cunningham Virus Antibody','CL-LBTESTCD','DBX-NCIT-C112326'),('CL-LBTESTCD-T-681',NULL,'JO1AB','A measurement of the Jo-1 antibody in a biological specimen.','\0','Jo-1 Antibody','CL-LBTESTCD','DBX-NCIT-C100459'),('CL-LBTESTCD-T-682',NULL,'K','A measurement of the potassium in a biological specimen.','\0','Potassium','CL-LBTESTCD','DBX-NCIT-C64853'),('CL-LBTESTCD-T-683',NULL,'KCLR','A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Potassium Clearance','CL-LBTESTCD','DBX-NCIT-C106560'),('CL-LBTESTCD-T-684',NULL,'KCREAT','A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.','\0','Potassium/Creatinine','CL-LBTESTCD','DBX-NCIT-C79462'),('CL-LBTESTCD-T-685',NULL,'KETONEBD','A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen.','\0','Ketone Bodies','CL-LBTESTCD','DBX-NCIT-C111239'),('CL-LBTESTCD-T-686',NULL,'KETONES','A measurement of the ketones in a biological specimen.','\0','Ketones','CL-LBTESTCD','DBX-NCIT-C64854'),('CL-LBTESTCD-T-687',NULL,'KEXR','A measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour).','\0','Potassium Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117839'),('CL-LBTESTCD-T-688',NULL,'KIM1','A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.','\0','Hepatitis A Virus Cellular Receptor 1; KIM-1; Kidney Injury Molecule-1','CL-LBTESTCD','DBX-NCIT-C100433'),('CL-LBTESTCD-T-689',NULL,'KLCFR','A measurement of the free kappa light chain in a biological specimen.','\0','Kappa Light Chain, Free','CL-LBTESTCD','DBX-NCIT-C98730'),('CL-LBTESTCD-T-69',NULL,'ANGTNSGN','A measurement of the angiotensinogen hormone in a biological specimen.','\0','Angiotensin Precursor; Angiotensinogen','CL-LBTESTCD','DBX-NCIT-C74846'),('CL-LBTESTCD-T-690',NULL,'KLCLLCFR','A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.','\0','Kappa Lt Chain,Free/Lambda Lt Chain,Free','CL-LBTESTCD','DBX-NCIT-C98731'),('CL-LBTESTCD-T-691',NULL,'KRCYMG','A measurement of the megakaryocytes per unit of a biological specimen.','\0','Megakaryocytes','CL-LBTESTCD','DBX-NCIT-C96688'),('CL-LBTESTCD-T-692',NULL,'KRCYMGCE','A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Megakaryocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98867'),('CL-LBTESTCD-T-693',NULL,'KURLOFCE','A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.','\0','Kurloff Cells','CL-LBTESTCD','DBX-NCIT-C96682'),('CL-LBTESTCD-T-694',NULL,'LACTICAC','A measurement of the lactic acid in a biological specimen.','\0','2-hydroxypropanoic acid; Lactate; Lactic Acid','CL-LBTESTCD','DBX-NCIT-C79450'),('CL-LBTESTCD-T-695',NULL,'LCN2','A measurement of lipocalin-2 in a biological specimen.','\0','Lipocalin-2','CL-LBTESTCD','DBX-NCIT-C106539'),('CL-LBTESTCD-T-696',NULL,'LCN2CREA','A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample.','\0','Lipocalin-2/Creatinine','CL-LBTESTCD','DBX-NCIT-C106540'),('CL-LBTESTCD-T-697',NULL,'LDH','A measurement of the lactate dehydrogenase in a biological specimen.','\0','Lactate Dehydrogenase','CL-LBTESTCD','DBX-NCIT-C64855'),('CL-LBTESTCD-T-698',NULL,'LDH1','A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.','\0','LDH Isoenzyme 1','CL-LBTESTCD','DBX-NCIT-C74887'),('CL-LBTESTCD-T-699',NULL,'LDH1LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 1/LDH','CL-LBTESTCD','DBX-NCIT-C79451'),('CL-LBTESTCD-T-7',NULL,'ABNCE','A measurement of the abnormal cells in a biological specimen.','\0','Abnormal Cells','CL-LBTESTCD','DBX-NCIT-C111124'),('CL-LBTESTCD-T-70',NULL,'ANIONG','A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.','\0','Anion Gap','CL-LBTESTCD','DBX-NCIT-C74685'),('CL-LBTESTCD-T-700',NULL,'LDH2','A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.','\0','LDH Isoenzyme 2','CL-LBTESTCD','DBX-NCIT-C74888'),('CL-LBTESTCD-T-701',NULL,'LDH2LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 2/LDH','CL-LBTESTCD','DBX-NCIT-C79452'),('CL-LBTESTCD-T-702',NULL,'LDH3','A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.','\0','LDH Isoenzyme 3','CL-LBTESTCD','DBX-NCIT-C74889'),('CL-LBTESTCD-T-703',NULL,'LDH3LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 3/LDH','CL-LBTESTCD','DBX-NCIT-C79453'),('CL-LBTESTCD-T-704',NULL,'LDH4','A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.','\0','LDH Isoenzyme 4','CL-LBTESTCD','DBX-NCIT-C74890'),('CL-LBTESTCD-T-705',NULL,'LDH4LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 4/LDH','CL-LBTESTCD','DBX-NCIT-C79454'),('CL-LBTESTCD-T-706',NULL,'LDH5','A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.','\0','LDH Isoenzyme 5','CL-LBTESTCD','DBX-NCIT-C74891'),('CL-LBTESTCD-T-707',NULL,'LDH5LDH','A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.','\0','LDH Isoenzyme 5/LDH','CL-LBTESTCD','DBX-NCIT-C79455'),('CL-LBTESTCD-T-708',NULL,'LDHCREAT','A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.','\0','Lactate Dehydrogenase/Creatinine','CL-LBTESTCD','DBX-NCIT-C79449'),('CL-LBTESTCD-T-709',NULL,'LDL','A measurement of the low density lipoprotein cholesterol in a biological specimen.','\0','LDL Cholesterol','CL-LBTESTCD','DBX-NCIT-C105588'),('CL-LBTESTCD-T-71',NULL,'ANISO','A measurement of the inequality in the size of the red blood cells in a whole blood specimen.','\0','Anisocytes','CL-LBTESTCD','DBX-NCIT-C74797'),('CL-LBTESTCD-T-710',NULL,'LDLPSZ','A measurement of the average particle size of low-density lipoprotein in a biological specimen.','\0','LDL Particle Size','CL-LBTESTCD','DBX-NCIT-C103412'),('CL-LBTESTCD-T-711',NULL,'LEPTIN','A measurement of the leptin hormone in a biological specimen.','\0','Leptin','CL-LBTESTCD','DBX-NCIT-C74866'),('CL-LBTESTCD-T-712',NULL,'LEUKASE','A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.','\0','Leukocyte Esterase','CL-LBTESTCD','DBX-NCIT-C64856'),('CL-LBTESTCD-T-713',NULL,'LEUKCE','A measurement of the leukemic cells in a biological specimen.','\0','Leukemic Cells; Residual Leukemic Cells','CL-LBTESTCD','DBX-NCIT-C116195'),('CL-LBTESTCD-T-714',NULL,'LGLUCLE','A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.','\0','Large Unstained Cells/Leukocytes','CL-LBTESTCD','DBX-NCIT-C79467'),('CL-LBTESTCD-T-715',NULL,'LGUNSCE','A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.','\0','Large Unstained Cells','CL-LBTESTCD','DBX-NCIT-C74659'),('CL-LBTESTCD-T-716',NULL,'LH','A measurement of the luteinizing hormone in a biological specimen.','\0','Luteinizing Hormone','CL-LBTESTCD','DBX-NCIT-C74790'),('CL-LBTESTCD-T-717',NULL,'LIPASEG','A measurement of the gastric triacylglycerol lipase in a biological specimen.','\0','Gastric Triacylglycerol Lipase; LIPF; Lipase, Gastric','CL-LBTESTCD','DBX-NCIT-C117840'),('CL-LBTESTCD-T-718',NULL,'LIPASEP','A measurement of the pancreatic triacylglycerol lipase in a biological specimen.','\0','Lipase, Pancreatic; PNLIP; Pancreatic Triacylglycerol Lipase','CL-LBTESTCD','DBX-NCIT-C117841'),('CL-LBTESTCD-T-719',NULL,'LIPASET','A measurement of the total lipase in a biological specimen.','\0','Lipase; Total Lipase','CL-LBTESTCD','DBX-NCIT-C117748'),('CL-LBTESTCD-T-72',NULL,'ANP','A measurement of the atrial natriuretic peptide in a biological specimen.','\0','Atrial Natriuretic Peptide; Atriopeptin','CL-LBTESTCD','DBX-NCIT-C74886'),('CL-LBTESTCD-T-720',NULL,'LIPASLAL','A measurement of the lysosomal acid lipase in a biological specimen.','\0','Acid Cholesteryl Ester Hydrolase; LAL; LIPA; Lipase, Lysosomal Acid; Lysosomal Lipase','CL-LBTESTCD','DBX-NCIT-C117842'),('CL-LBTESTCD-T-721',NULL,'LIPEMIAI','A measurement of the abnormally high concentration of lipid in a biological specimen.','\0','Lipemia; Lipemic Index','CL-LBTESTCD','DBX-NCIT-C111242'),('CL-LBTESTCD-T-722',NULL,'LKM1AB','A measurement of the liver kidney microsomal type 1 antibody in a biological specimen.','\0','LKM-1; Liver Kidney Microsomal Type 1 Antibody','CL-LBTESTCD','DBX-NCIT-C96683'),('CL-LBTESTCD-T-723',NULL,'LKM1IAAB','A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgA Ab','CL-LBTESTCD','DBX-NCIT-C100456'),('CL-LBTESTCD-T-724',NULL,'LKM1IGAB','A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgG Ab','CL-LBTESTCD','DBX-NCIT-C100454'),('CL-LBTESTCD-T-725',NULL,'LKM1IMAB','A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.','\0','Liver Kidney Microsomal Type 1 IgM Ab','CL-LBTESTCD','DBX-NCIT-C100455'),('CL-LBTESTCD-T-726',NULL,'LLCFR','A measurement of the free lambda light chain in a biological specimen.','\0','Lambda Light Chain, Free','CL-LBTESTCD','DBX-NCIT-C98732'),('CL-LBTESTCD-T-727',NULL,'LPA','A measurement of the lipoprotein-a in a biological specimen.','\0','Lipoprotein-a','CL-LBTESTCD','DBX-NCIT-C82022'),('CL-LBTESTCD-T-728',NULL,'LPNAG','A measurement of the Legionella pneumophila antigen in a biological specimen.','\0','Legionella pneumophila Antigen','CL-LBTESTCD','DBX-NCIT-C92275'),('CL-LBTESTCD-T-729',NULL,'LPNGMAB','A measurement of the Legionella pneumophila IgG and IgM in a biological specimen.','\0','Legionella pneumophila IgG IgM Antibody','CL-LBTESTCD','DBX-NCIT-C92277'),('CL-LBTESTCD-T-73',NULL,'ANTHRM','A measurement of the antithrombin activity in a biological specimen.','\0','Antithrombin; Antithrombin Activity; Antithrombin III; Antithrombin III Activity','CL-LBTESTCD','DBX-NCIT-C81958'),('CL-LBTESTCD-T-730',NULL,'LPNIGGAB','A measurement of the Legionella pneumophila IgG antibody in a biological specimen.','\0','Legionella pneumophila IgG Antibody','CL-LBTESTCD','DBX-NCIT-C92276'),('CL-LBTESTCD-T-731',NULL,'LPNIGMAB','A measurement of the Legionella pneumophila IgM antibody in a biological specimen.','\0','Legionella pneumophila IgM Antibody','CL-LBTESTCD','DBX-NCIT-C92278'),('CL-LBTESTCD-T-732',NULL,'LSD','A measurement of the lysergic acid diethylamine (LSD) in a biological specimen.','\0','Acid; Lysergic Acid Diethylamide','CL-LBTESTCD','DBX-NCIT-C75354'),('CL-LBTESTCD-T-733',NULL,'LTB4','A measurement of the leukotriene B4 in a biological specimen.','\0','Leukotriene B4','CL-LBTESTCD','DBX-NCIT-C103413'),('CL-LBTESTCD-T-734',NULL,'LTD4','A measurement of the leukotriene D4 in a biological specimen.','\0','Leukotriene D4','CL-LBTESTCD','DBX-NCIT-C103414'),('CL-LBTESTCD-T-735',NULL,'LTE4','A measurement of the leukotriene E4 in a biological specimen.','\0','Leukotriene E4','CL-LBTESTCD','DBX-NCIT-C103415'),('CL-LBTESTCD-T-736',NULL,'LTF','A measurement of the lactoferrin in a biological specimen.','\0','Lactoferrin; Lactotransferrin','CL-LBTESTCD','DBX-NCIT-C82021'),('CL-LBTESTCD-T-737',NULL,'LYM','A measurement of the lymphocytes in a biological specimen.','\0','Lymphocytes','CL-LBTESTCD','DBX-NCIT-C51949'),('CL-LBTESTCD-T-738',NULL,'LYMAT','A measurement of the atypical lymphocytes in a biological specimen.','\0','Lymphocytes Atypical','CL-LBTESTCD','DBX-NCIT-C64818'),('CL-LBTESTCD-T-739',NULL,'LYMATLE','A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.','\0','Lymphocytes Atypical/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64819'),('CL-LBTESTCD-T-74',NULL,'ANTHRMAG','A measurement of the antithrombin antigen in a biological specimen.','\0','Antithrombin Antigen; Antithrombin III Antigen','CL-LBTESTCD','DBX-NCIT-C81977'),('CL-LBTESTCD-T-740',NULL,'LYMCE','A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Lymphocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98751'),('CL-LBTESTCD-T-741',NULL,'LYMIM','A measurement of the immature lymphocytes in a biological specimen.','\0','Immature Lymphocytes','CL-LBTESTCD','DBX-NCIT-C100444'),('CL-LBTESTCD-T-742',NULL,'LYMIMLE','A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.','\0','Immature Lymphocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C100443'),('CL-LBTESTCD-T-743',NULL,'LYMLE','A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.','\0','Lymphocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64820'),('CL-LBTESTCD-T-744',NULL,'LYMMCE','A measurement of the malignant lymphocytes in a biological specimen.','\0','Lymphoma Cells','CL-LBTESTCD','DBX-NCIT-C74613'),('CL-LBTESTCD-T-745',NULL,'LYMMCELY','A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.','\0','Lymphoma Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74910'),('CL-LBTESTCD-T-746',NULL,'LYMPHOTC','A measurement of the lymphotactin in a biological specimen.','\0','Chemokine Ligand 1; Lymphotactin','CL-LBTESTCD','DBX-NCIT-C81955'),('CL-LBTESTCD-T-747',NULL,'LYMPL','A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.','\0','Plasmacytoid Lymphocytes; Plymphocytes','CL-LBTESTCD','DBX-NCIT-C74618'),('CL-LBTESTCD-T-748',NULL,'LYMPLLY','A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.','\0','Plasmacytoid Lymphocytes/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74648'),('CL-LBTESTCD-T-749',NULL,'LYMRCT','A measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.','\0','Reactive Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74629'),('CL-LBTESTCD-T-75',NULL,'ANTIDPRS','A measurement of any antidepressant class drug present in a biological specimen.','\0','Antidepressants','CL-LBTESTCD','DBX-NCIT-C74691'),('CL-LBTESTCD-T-750',NULL,'LYMRCTLY','A relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.','\0','Reactive Lymphocytes/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74654'),('CL-LBTESTCD-T-751',NULL,'LYMVAC','A measurement of the vacuolated lymphocytes in a biological specimen.','\0','Vacuolated Lymphocytes','CL-LBTESTCD','DBX-NCIT-C111329'),('CL-LBTESTCD-T-752',NULL,'MACROCY','A measurement of the macrocytes in a biological specimen.','\0','Macrocytes','CL-LBTESTCD','DBX-NCIT-C64821'),('CL-LBTESTCD-T-753',NULL,'MASTCE','A measurement of the mast cells in a biological specimen.','\0','Mast Cells; Mastocytes','CL-LBTESTCD','DBX-NCIT-C111246'),('CL-LBTESTCD-T-754',NULL,'MASTCECE','A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen.','\0','Mast Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C111247'),('CL-LBTESTCD-T-755',NULL,'MAYHEG','A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.','\0','May-Hegglin Anomaly','CL-LBTESTCD','DBX-NCIT-C74614'),('CL-LBTESTCD-T-756',NULL,'MCH','A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.','\0','Ery. Mean Corpuscular Hemoglobin','CL-LBTESTCD','DBX-NCIT-C64797'),('CL-LBTESTCD-T-757',NULL,'MCHC','A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.','\0','Ery. Mean Corpuscular HGB Concentration','CL-LBTESTCD','DBX-NCIT-C64798'),('CL-LBTESTCD-T-758',NULL,'MCP1','A measurement of the monocyte chemotactic protein 1 in a biological specimen.','\0','Monocyte Chemotactic Protein 1','CL-LBTESTCD','DBX-NCIT-C82025'),('CL-LBTESTCD-T-759',NULL,'MCPHG','A measurement of the macrophages in a biological specimen.','\0','Macrophages','CL-LBTESTCD','DBX-NCIT-C74798'),('CL-LBTESTCD-T-76',NULL,'APLAB','A measurement of the antiphospholipid antibodies in a biological specimen.','\0','Antiphospholipid Antibodies','CL-LBTESTCD','DBX-NCIT-C102258'),('CL-LBTESTCD-T-760',NULL,'MCPHGCE','A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen.','\0','Macrophages/Total Cells','CL-LBTESTCD','DBX-NCIT-C111244'),('CL-LBTESTCD-T-761',NULL,'MCPROT','A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.','\0','Monoclonal Immunoglobulin Protein; Paraprotein','CL-LBTESTCD','DBX-NCIT-C92291'),('CL-LBTESTCD-T-762',NULL,'MCSF','A measurement of the macrophage colony stimulating factor in a biological specimen.','\0','Macrophage Colony Stimulating Factor','CL-LBTESTCD','DBX-NCIT-C80191'),('CL-LBTESTCD-T-763',NULL,'MCV','A quantitative measurement of the mean volume of erythrocytes in a biological specimen.','\0','Ery. Mean Corpuscular Volume; Erythrocytes Mean Corpuscular Volume; RBC Mean Corpuscular Volume','CL-LBTESTCD','DBX-NCIT-C64799'),('CL-LBTESTCD-T-764',NULL,'MCVRETIC','A measurement of the mean volume of reticulocytes in a biological specimen.','\0','MCV Reticulocytes; Mean Corpuscular Volume Reticulocytes','CL-LBTESTCD','DBX-NCIT-C114215'),('CL-LBTESTCD-T-765',NULL,'MDC','A measurement of the macrophage-derived chemokine in a biological specimen.','\0','Chemokine Ligand 22; Macrophage-Derived Chemokine','CL-LBTESTCD','DBX-NCIT-C81956'),('CL-LBTESTCD-T-766',NULL,'MDMA','A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen.','\0','3,4-methylenedioxymethamphetamine; Ecstasy','CL-LBTESTCD','DBX-NCIT-C75359'),('CL-LBTESTCD-T-767',NULL,'MENGL','A measurement of the mengingeal cells in a biological specimen.','\0','Meningeal Cells','CL-LBTESTCD','DBX-NCIT-C111250'),('CL-LBTESTCD-T-768',NULL,'MENGLCE','A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen.','\0','Meningeal Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C111251'),('CL-LBTESTCD-T-769',NULL,'METAMY','A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.','\0','Metamyelocytes','CL-LBTESTCD','DBX-NCIT-C74615'),('CL-LBTESTCD-T-77',NULL,'APLSMA2','A measurement of the alpha-2 antiplasmin in a biological specimen.','\0','Alpha-2 Plasmin Inhibitor','CL-LBTESTCD','DBX-NCIT-C103351'),('CL-LBTESTCD-T-770',NULL,'METAMYCE','A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Metamyelocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98754'),('CL-LBTESTCD-T-771',NULL,'METAMYLE','A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.','\0','Metamyelocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C74645'),('CL-LBTESTCD-T-772',NULL,'METANEPH','A measurement of the metanephrine in a biological specimen.','\0','Metadrenaline; Metanephrine','CL-LBTESTCD','DBX-NCIT-C116198'),('CL-LBTESTCD-T-773',NULL,'METHAMPH','A measurement of the methamphetamine drug present in a biological specimen.','\0','Methamphetamine','CL-LBTESTCD','DBX-NCIT-C75348'),('CL-LBTESTCD-T-774',NULL,'METHDN','A measurement of the methadone present in a biological specimen.','\0','Methadone','CL-LBTESTCD','DBX-NCIT-C74881'),('CL-LBTESTCD-T-775',NULL,'METHQLDN','A measurement of the methaqualone present in a biological specimen.','\0','Methaqualone','CL-LBTESTCD','DBX-NCIT-C74882'),('CL-LBTESTCD-T-776',NULL,'MFILARIA','Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids.','\0','Microfilaria','CL-LBTESTCD','DBX-NCIT-C117843'),('CL-LBTESTCD-T-777',NULL,'MG','A measurement of the magnesium in a biological specimen.','\0','Magnesium','CL-LBTESTCD','DBX-NCIT-C64840'),('CL-LBTESTCD-T-778',NULL,'MGB','A measurement of myoglobin in a biological specimen.','\0','Myoglobin','CL-LBTESTCD','DBX-NCIT-C79436'),('CL-LBTESTCD-T-779',NULL,'MGBCREAT','A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample.','\0','Myoglobin/Creatinine','CL-LBTESTCD','DBX-NCIT-C106546'),('CL-LBTESTCD-T-78',NULL,'APOA1','A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.','\0','Apolipoprotein A1','CL-LBTESTCD','DBX-NCIT-C74733'),('CL-LBTESTCD-T-780',NULL,'MGCREAT','A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.','\0','Magnesium/Creatinine','CL-LBTESTCD','DBX-NCIT-C79456'),('CL-LBTESTCD-T-781',NULL,'MICROCY','A measurement of the microcytes in a biological specimen.','\0','Microcytes','CL-LBTESTCD','DBX-NCIT-C64822'),('CL-LBTESTCD-T-782',NULL,'MIDCEF','A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen.','\0','Mid Cell Fraction; Mid Cells','CL-LBTESTCD','DBX-NCIT-C116199'),('CL-LBTESTCD-T-783',NULL,'MIP1A','A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.','\0','Chemokine Ligand 3; Macrophage Inflammatory Protein 1 Alpha','CL-LBTESTCD','DBX-NCIT-C82023'),('CL-LBTESTCD-T-784',NULL,'MIP1B','A measurement of the macrophage inflammatory protein 1 beta in a biological specimen.','\0','Chemokine Ligand 4; Macrophage Inflammatory Protein 1 Beta','CL-LBTESTCD','DBX-NCIT-C82024'),('CL-LBTESTCD-T-785',NULL,'MLATONIN','A measurement of the melatonin hormone in a biological specimen.','\0','Melatonin','CL-LBTESTCD','DBX-NCIT-C74867'),('CL-LBTESTCD-T-786',NULL,'MLIGCE','A measurement of the malignant cells of all types in a biological specimen.','\0','Malignant Cells, NOS','CL-LBTESTCD','DBX-NCIT-C74660'),('CL-LBTESTCD-T-787',NULL,'MLIGCEBC','A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.','\0','Malignant Cells, NOS/Blood Cells','CL-LBTESTCD','DBX-NCIT-C74643'),('CL-LBTESTCD-T-788',NULL,'MLR','A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals.','\0','Mixed Leukocyte Reaction; Mixed Lymphocyte Reaction','CL-LBTESTCD','DBX-NCIT-C16790'),('CL-LBTESTCD-T-789',NULL,'MMA','A measurement of the methylmalonic acid in a biological specimen.','\0','Methylmalonic Acid','CL-LBTESTCD','DBX-NCIT-C96690'),('CL-LBTESTCD-T-79',NULL,'APOA2','A measurement of the apolipoprotein AII in a biological specimen.','\0','Apolipoprotein AII','CL-LBTESTCD','DBX-NCIT-C82000'),('CL-LBTESTCD-T-790',NULL,'MMP1','A measurement of the matrix metalloproteinase 1 in a biological specimen.','\0','Interstitial Collagenase; Matrix Metalloproteinase 1','CL-LBTESTCD','DBX-NCIT-C80192'),('CL-LBTESTCD-T-791',NULL,'MMP2','A measurement of the matrix metalloproteinase 2 in a biological specimen.','\0','Gelatinase A; Matrix Metalloproteinase 2','CL-LBTESTCD','DBX-NCIT-C80193'),('CL-LBTESTCD-T-792',NULL,'MMP3','A measurement of the matrix metalloproteinase 3 in a biological specimen.','\0','Matrix Metalloproteinase 3; Stromelysin 1','CL-LBTESTCD','DBX-NCIT-C80194'),('CL-LBTESTCD-T-793',NULL,'MMP7','A measurement of the matrix metalloproteinase 7 in a biological specimen.','\0','Matrilysin; Matrix Metalloproteinase 7','CL-LBTESTCD','DBX-NCIT-C80195'),('CL-LBTESTCD-T-794',NULL,'MMP8','A measurement of the matrix metalloproteinase 8 in a biological specimen.','\0','Matrix Metalloproteinase 8; Neutrophil Collagenase','CL-LBTESTCD','DBX-NCIT-C80196'),('CL-LBTESTCD-T-795',NULL,'MMP9','A measurement of the matrix metalloproteinase 9 in a biological specimen.','\0','Gelatinase B; Matrix Metalloproteinase 9','CL-LBTESTCD','DBX-NCIT-C80197'),('CL-LBTESTCD-T-796',NULL,'MOCYCE','A measurement of the monocytoid cells in a biological specimen.','\0','Monocytoid Cells','CL-LBTESTCD','DBX-NCIT-C111276'),('CL-LBTESTCD-T-797',NULL,'MOCYCECE','A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen.','\0','Monocytoid Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C111277'),('CL-LBTESTCD-T-798',NULL,'MONO','A measurement of the monocytes in a biological specimen.','\0','Monocytes','CL-LBTESTCD','DBX-NCIT-C64823'),('CL-LBTESTCD-T-799',NULL,'MONOBL','A measurement of the monoblast cells in a biological specimen.','\0','Monoblasts','CL-LBTESTCD','DBX-NCIT-C74631'),('CL-LBTESTCD-T-8',NULL,'ACANT','A measurement of the acanthocytes in a biological specimen.','\0','Acanthocytes','CL-LBTESTCD','DBX-NCIT-C74699'),('CL-LBTESTCD-T-80',NULL,'APOA4','A measurement of the apolipoprotein A4 in a biological specimen.','\0','Apolipoprotein A4','CL-LBTESTCD','DBX-NCIT-C103354'),('CL-LBTESTCD-T-800',NULL,'MONOBLLE','A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.','\0','Monoblasts/Leukocytes','CL-LBTESTCD','DBX-NCIT-C74646'),('CL-LBTESTCD-T-801',NULL,'MONOCE','A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Monocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98872'),('CL-LBTESTCD-T-802',NULL,'MONOIM','A measurement of the immature monocytes in a biological specimen.','\0','Immature Monocytes','CL-LBTESTCD','DBX-NCIT-C96676'),('CL-LBTESTCD-T-803',NULL,'MONOIMLE','A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.','\0','Immature Monocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C96677'),('CL-LBTESTCD-T-804',NULL,'MONOLE','A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.','\0','Monocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64824'),('CL-LBTESTCD-T-805',NULL,'MONOMA','A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample.','\0','Monocytes/Macrocytes','CL-LBTESTCD','DBX-NCIT-C106544'),('CL-LBTESTCD-T-806',NULL,'MORPHINE','A measurement of the morphine present in a biological specimen.','\0','Morphine','CL-LBTESTCD','DBX-NCIT-C74883'),('CL-LBTESTCD-T-807',NULL,'MPC','A measurement of the mean platelet component (platelet activity) in a blood specimen.','\0','Mean Platelet Component','CL-LBTESTCD','DBX-NCIT-C96686'),('CL-LBTESTCD-T-808',NULL,'MPM','A measurement of the mean platelet dry mass in a biological specimen.','\0','Mean Platelet Dry Mass','CL-LBTESTCD','DBX-NCIT-C114214'),('CL-LBTESTCD-T-809',NULL,'MPO','A measurement of the myeloperoxidase in a biological specimen.','\0','Myeloperoxidase','CL-LBTESTCD','DBX-NCIT-C80198'),('CL-LBTESTCD-T-81',NULL,'APOA5','A measurement of the apolipoprotein A5 in a biological specimen.','\0','Apolipoprotein A5','CL-LBTESTCD','DBX-NCIT-C103355'),('CL-LBTESTCD-T-810',NULL,'MPOAB','A measurement of the myeloperoxidase antibody in a biological specimen.','\0','Myeloperoxidase Antibody','CL-LBTESTCD','DBX-NCIT-C92280'),('CL-LBTESTCD-T-811',NULL,'MPV','A measurement of the average size of the platelets present in a blood sample.','\0','Mean Platelet Volume','CL-LBTESTCD','DBX-NCIT-C74730'),('CL-LBTESTCD-T-812',NULL,'MSPIKE','A measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein.','\0','Monoclonal Protein Spike','CL-LBTESTCD','DBX-NCIT-C117844'),('CL-LBTESTCD-T-813',NULL,'MUCTHR','A measurement of the mucous threads present in a biological specimen.','\0','Mucous Threads','CL-LBTESTCD','DBX-NCIT-C74721'),('CL-LBTESTCD-T-814',NULL,'MYBLA','A measurement of the myeloblast cells in a biological specimen.','\0','Myeloblasts','CL-LBTESTCD','DBX-NCIT-C74632'),('CL-LBTESTCD-T-815',NULL,'MYBLALE','A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.','\0','Myeloblasts/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64825'),('CL-LBTESTCD-T-816',NULL,'MYBLAT1','A measurement of type I myeloblast cells per unit of a biological specimen.','\0','Type I Myeloblasts','CL-LBTESTCD','DBX-NCIT-C92283'),('CL-LBTESTCD-T-817',NULL,'MYBLAT2','A measurement of type II myeloblast cells per unit of a biological specimen.','\0','Type II Myeloblasts','CL-LBTESTCD','DBX-NCIT-C92284'),('CL-LBTESTCD-T-818',NULL,'MYBLAT3','A measurement of type III myeloblast cells per unit of a biological specimen.','\0','Type III Myeloblasts','CL-LBTESTCD','DBX-NCIT-C92285'),('CL-LBTESTCD-T-819',NULL,'MYCY','A measurement of the myelocytes in a biological specimen.','\0','Myelocytes','CL-LBTESTCD','DBX-NCIT-C74662'),('CL-LBTESTCD-T-82',NULL,'APOB','A measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.','\0','Apolipoprotein B','CL-LBTESTCD','DBX-NCIT-C74734'),('CL-LBTESTCD-T-820',NULL,'MYCYCE','A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).','\0','Myelocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98868'),('CL-LBTESTCD-T-821',NULL,'MYCYLE','A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.','\0','Myelocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64826'),('CL-LBTESTCD-T-822',NULL,'MYELINAB','A measurement of the myelin antibodies in a biological specimen.','\0','Myelin Antibodies','CL-LBTESTCD','DBX-NCIT-C103418'),('CL-LBTESTCD-T-823',NULL,'MYL3','A measurement of myosin light chain 3 in a biological specimen.','\0','Cardiac myosin light chain 1; Myosin Light Chain 3; Myosin light chain 1, slow-twitch muscle B/ventricular isoform','CL-LBTESTCD','DBX-NCIT-C106547'),('CL-LBTESTCD-T-824',NULL,'MYPCERPC','A relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.','\0','Myeloid/Erythroid Ratio','CL-LBTESTCD','DBX-NCIT-C92242'),('CL-LBTESTCD-T-825',NULL,'MYTBGIR','A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.','\0','Mycobacterium tuberculosis IFN Gamma Response','CL-LBTESTCD','DBX-NCIT-C92241'),('CL-LBTESTCD-T-826',NULL,'MYTBNUAC','A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.','\0','Mycobacterium tuberculosis Nucleic Acid','CL-LBTESTCD','DBX-NCIT-C92279'),('CL-LBTESTCD-T-827',NULL,'NACLR','A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute).','\0','Sodium Clearance','CL-LBTESTCD','DBX-NCIT-C106568'),('CL-LBTESTCD-T-828',NULL,'NACREAT','A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.','\0','Sodium/Creatinine','CL-LBTESTCD','DBX-NCIT-C79464'),('CL-LBTESTCD-T-829',NULL,'NAG','A measurement of N-acetyl glucosamide in a biological specimen.','\0','N-Acetyl Glucosamide; N-Acetyl Glucosamine','CL-LBTESTCD','DBX-NCIT-C79459'),('CL-LBTESTCD-T-83',NULL,'APOBAPA1','A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen.','\0','Apolipoprotein B/Apolipoprotein A1','CL-LBTESTCD','DBX-NCIT-C103356'),('CL-LBTESTCD-T-830',NULL,'NAGASE','A measurement of the N-acetyl-beta-D-glucosaminidase in a biological specimen.','\0','Beta-N-acetyl-D-glucosaminidase; NAG','CL-LBTESTCD','DBX-NCIT-C103419'),('CL-LBTESTCD-T-831',NULL,'NAGCREAT','A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.','\0','N-Acetyl Glucosamide/Creatinine','CL-LBTESTCD','DBX-NCIT-C79460'),('CL-LBTESTCD-T-832',NULL,'NCTD5P','A measurement of the 5\'-nucleotidase in a biological specimen.','\0','5 Prime Nucleotidase; 5\'-Ribonucleotide Phosphohydrolase','CL-LBTESTCD','DBX-NCIT-C79437'),('CL-LBTESTCD-T-833',NULL,'NEOPTERN','A measurement of the neopterin in a biological specimen.','\0','Neopterin','CL-LBTESTCD','DBX-NCIT-C80199'),('CL-LBTESTCD-T-834',NULL,'NEUT','A measurement of the neutrophils in a biological specimen.','\0','Neutrophils','CL-LBTESTCD','DBX-NCIT-C63321'),('CL-LBTESTCD-T-835',NULL,'NEUTAGR','A measurement of the agranular neutrophils in a biological specimen.','\0','Agranular Neutrophils','CL-LBTESTCD','DBX-NCIT-C116200'),('CL-LBTESTCD-T-836',NULL,'NEUTB','A measurement of the banded neutrophils in a biological specimen.','\0','Neutrophils Band Form','CL-LBTESTCD','DBX-NCIT-C64830'),('CL-LBTESTCD-T-837',NULL,'NEUTBLE','A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.','\0','Neutrophils Band Form/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64831'),('CL-LBTESTCD-T-838',NULL,'NEUTCE','A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).','\0','Neutrophils/Total Cells','CL-LBTESTCD','DBX-NCIT-C98763'),('CL-LBTESTCD-T-839',NULL,'NEUTCYBS','A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content.','\0','Cytoplasmic Basophilia Neutrophil','CL-LBTESTCD','DBX-NCIT-C111166'),('CL-LBTESTCD-T-84',NULL,'APOC2','A measurement of the apolipoprotein C2 in a biological specimen.','\0','Apolipoprotein C2; Apolipoprotein CII','CL-LBTESTCD','DBX-NCIT-C100427'),('CL-LBTESTCD-T-840',NULL,'NEUTGT','A measurement of the giant neutrophils in a biological specimen.','\0','Giant Neutrophils','CL-LBTESTCD','DBX-NCIT-C96651'),('CL-LBTESTCD-T-841',NULL,'NEUTHYGR','A measurement of the hypogranular neutrophils in a biological specimen.','\0','Hypogranular Neutrophils','CL-LBTESTCD','DBX-NCIT-C116201'),('CL-LBTESTCD-T-842',NULL,'NEUTIM','A measurement of the total immature neutrophils in a biological specimen.','\0','Immature Neutrophils','CL-LBTESTCD','DBX-NCIT-C96678'),('CL-LBTESTCD-T-843',NULL,'NEUTIMLE','A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.','\0','Immature Neutrophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C100442'),('CL-LBTESTCD-T-844',NULL,'NEUTLE','A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.','\0','Neutrophils/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64827'),('CL-LBTESTCD-T-845',NULL,'NEUTLS','An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen.','\0','Left Shift Neutrophils','CL-LBTESTCD','DBX-NCIT-C116202'),('CL-LBTESTCD-T-846',NULL,'NEUTMM','A measurement of the neutrophilic metamyelocytes in a biological specimen.','\0','Neutrophilic Metamyelocytes','CL-LBTESTCD','DBX-NCIT-C84822'),('CL-LBTESTCD-T-847',NULL,'NEUTMY','A measurement of the neutrophilic myelocytes in a biological specimen.','\0','Neutrophilic Myelocytes','CL-LBTESTCD','DBX-NCIT-C84823'),('CL-LBTESTCD-T-848',NULL,'NEUTSG','A measurement of the segmented neutrophils in a biological specimen.','\0','Neutrophils, Segmented','CL-LBTESTCD','DBX-NCIT-C81997'),('CL-LBTESTCD-T-849',NULL,'NEUTSGLE','A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.','\0','Neutrophils, Segmented/Leukocytes','CL-LBTESTCD','DBX-NCIT-C82045'),('CL-LBTESTCD-T-85',NULL,'APOC3','A measurement of the apolipoprotein CIII in a biological specimen.','\0','Apolipoprotein CIII','CL-LBTESTCD','DBX-NCIT-C82001'),('CL-LBTESTCD-T-850',NULL,'NEUTVAC','A measurement of the neutrophils containing small vacuoles in a biological specimen.','\0','Vacuolated Neutrophils','CL-LBTESTCD','DBX-NCIT-C74628'),('CL-LBTESTCD-T-851',NULL,'NGON','Examination of a biological specimen to detect the presence of Neisseria gonorrhoeae.','\0','Neisseria gonorrhoeae Screening','CL-LBTESTCD','DBX-NCIT-C92298'),('CL-LBTESTCD-T-852',NULL,'NITRICOX','A measurement of the nitric oxide in a biological specimen.','\0','NO; Nitric Oxide','CL-LBTESTCD','DBX-NCIT-C112360'),('CL-LBTESTCD-T-853',NULL,'NITRITE','A measurement of the nitrite in a urine specimen.','\0','Nitrite','CL-LBTESTCD','DBX-NCIT-C64810'),('CL-LBTESTCD-T-854',NULL,'NKCE','A measurement of the total natural killer cells in a biological specimen.','\0','Natural Killer Cells','CL-LBTESTCD','DBX-NCIT-C98762'),('CL-LBTESTCD-T-855',NULL,'NKCEFUNC','A measurement of the natural killer cell function in a biological specimen.','\0','Natural Killer Cell Activity; Natural Killer Cell Function','CL-LBTESTCD','DBX-NCIT-C116203'),('CL-LBTESTCD-T-856',NULL,'NONHDL','A measurement of the non-high density lipoprotein cholesterol in a biological specimen.','\0','Non-HDL Cholesterol; Non-High Density Lipoprotein','CL-LBTESTCD','DBX-NCIT-C116204'),('CL-LBTESTCD-T-857',NULL,'NOREPIN','A measurement of the norepinephrine hormone in a biological specimen.','\0','Noradrenaline; Norepinephrine','CL-LBTESTCD','DBX-NCIT-C74868'),('CL-LBTESTCD-T-858',NULL,'NPAP','A measurement of the non-prostatic acid phosphatase in a biological specimen.','\0','Non-Prostatic Acid Phosphatase','CL-LBTESTCD','DBX-NCIT-C100434'),('CL-LBTESTCD-T-859',NULL,'NPY','A measurement of the neuropeptide Y in a biological specimen.','\0','Neuropeptide Y','CL-LBTESTCD','DBX-NCIT-C74892'),('CL-LBTESTCD-T-86',NULL,'APOE','A measurement of the apolipoprotein E in a biological specimen.','\0','Apolipoprotein E','CL-LBTESTCD','DBX-NCIT-C82002'),('CL-LBTESTCD-T-860',NULL,'NSE','A measurement of the neuron specific enolase in a biological specimen.','\0','Enolase 2; Gamma-enolase; Neuron Specific Enolase','CL-LBTESTCD','DBX-NCIT-C116205'),('CL-LBTESTCD-T-861',NULL,'NTELOP','A measurement of the N-telopeptide in a biological specimen.','\0','N-telopeptide','CL-LBTESTCD','DBX-NCIT-C74743'),('CL-LBTESTCD-T-862',NULL,'NTXI','A measurement of the type I collagen N-telopeptides in a biological specimen.','\0','Type I Collagen N-Telopeptides','CL-LBTESTCD','DBX-NCIT-C82039'),('CL-LBTESTCD-T-863',NULL,'NTXII','A measurement of the type II collagen N-telopeptides in a biological specimen.','\0','Type II Collagen N-Telopeptides','CL-LBTESTCD','DBX-NCIT-C82041'),('CL-LBTESTCD-T-864',NULL,'NUCSWELL','A measurement of the expansion of the nucleus of the cells in a biological specimen.','\0','Nuclear Swelling','CL-LBTESTCD','DBX-NCIT-C114213'),('CL-LBTESTCD-T-865',NULL,'O2CT','A measurement of the amount of oxygen content in a biological specimen.','\0','Oxygen Content','CL-LBTESTCD','DBX-NCIT-C111284'),('CL-LBTESTCD-T-866',NULL,'OCCBLD','A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination.','\0','Occult Blood','CL-LBTESTCD','DBX-NCIT-C74686'),('CL-LBTESTCD-T-867',NULL,'OPG','A measurement of the osteoprotegerin in a biological specimen.','\0','OCIF; Osteoclastogenesis Inhibitory Factor; Osteoprotegerin; TNFRS11B; Tumor Necrosis Factor Receptor Superfamily Member 11b','CL-LBTESTCD','DBX-NCIT-C116206'),('CL-LBTESTCD-T-868',NULL,'OPIATE','A measurement of any opiate class drug present in a biological specimen.','\0','Opiate','CL-LBTESTCD','DBX-NCIT-C74796'),('CL-LBTESTCD-T-869',NULL,'OSMLTY','A measurement of the osmoles of solute per unit of biological specimen.','\0','Osmolality','CL-LBTESTCD','DBX-NCIT-C74801'),('CL-LBTESTCD-T-87',NULL,'APOE4','A measurement of the apolipoprotein E4 in a biological specimen.','\0','Apolipoprotein E4','CL-LBTESTCD','DBX-NCIT-C92293'),('CL-LBTESTCD-T-870',NULL,'OSMRTY','A measurement of the osmoles of solute per liter of solution.','\0','Osmolarity','CL-LBTESTCD','DBX-NCIT-C74802'),('CL-LBTESTCD-T-871',NULL,'OSTEOC','A measurement of the osteocalcin in a biological specimen.','\0','Osteocalcin','CL-LBTESTCD','DBX-NCIT-C74744'),('CL-LBTESTCD-T-872',NULL,'OVAPARS','A measurement of the parasites and ova in a biological specimen.','\0','Ova and Parasite','CL-LBTESTCD','DBX-NCIT-C100452'),('CL-LBTESTCD-T-873',NULL,'OXACREAT','A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen.','\0','Oxalate/Creatinine','CL-LBTESTCD','DBX-NCIT-C117983'),('CL-LBTESTCD-T-874',NULL,'OXALATE','A measurement of the oxalate in a biological specimen.','\0','Ethanedioate; Oxalate','CL-LBTESTCD','DBX-NCIT-C92250'),('CL-LBTESTCD-T-875',NULL,'OXYCAP','A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.','\0','Oxygen Capacity','CL-LBTESTCD','DBX-NCIT-C96614'),('CL-LBTESTCD-T-876',NULL,'OXYCDN','A measurement of the oxycodone present in a biological specimen.','\0','Oxycodone; Oxycontin','CL-LBTESTCD','DBX-NCIT-C74884'),('CL-LBTESTCD-T-877',NULL,'OXYSAT','A measurement of the oxygen-hemoglobin saturation of a volume of blood.','\0','Oxygen Saturation','CL-LBTESTCD','DBX-NCIT-C60832'),('CL-LBTESTCD-T-878',NULL,'OXYTOCIN','A measurement of the oxytocin hormone in a biological specimen.','\0','Oxytocin; Oxytoxin','CL-LBTESTCD','DBX-NCIT-C74869'),('CL-LBTESTCD-T-879',NULL,'P1NP','A measurement of the procollagen 1 N-terminal propeptide in a biological specimen.','\0','Amino-terminal propeptide of type 1 procollagen; P1NP Aminoterm Type 1; Procollagen 1 N-Terminal Propeptide','CL-LBTESTCD','DBX-NCIT-C96625'),('CL-LBTESTCD-T-88',NULL,'APOH','A measurement of the apolipoprotein H in a biological specimen.','\0','Apolipoprotein H','CL-LBTESTCD','DBX-NCIT-C82003'),('CL-LBTESTCD-T-880',NULL,'P50OXYGN','A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen.','\0','P50 Oxygen','CL-LBTESTCD','DBX-NCIT-C102279'),('CL-LBTESTCD-T-881',NULL,'PAF','A measurement of the platelet activating factor in a biological specimen.','\0','Platelet Activating Factor','CL-LBTESTCD','DBX-NCIT-C111292'),('CL-LBTESTCD-T-882',NULL,'PAI1','A measurement of the plasminogen activator inhibitor-1 in a biological specimen.','\0','Plasminogen Activator Inhibitor-1','CL-LBTESTCD','DBX-NCIT-C82030'),('CL-LBTESTCD-T-883',NULL,'PAI1AG','A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.','\0','Plasminogen Activator Inhibitor-1 AG','CL-LBTESTCD','DBX-NCIT-C81989'),('CL-LBTESTCD-T-884',NULL,'PAP','A measurement of the prostatic acid phosphatase in a biological specimen.','\0','Prostatic Acid Phosphatase','CL-LBTESTCD','DBX-NCIT-C80204'),('CL-LBTESTCD-T-885',NULL,'PAPPA','A measurement of the pregnancy-associated plasma protein-A in a biological specimen.','\0','Pregnancy-Associated Plasma Protein-A','CL-LBTESTCD','DBX-NCIT-C82031'),('CL-LBTESTCD-T-886',NULL,'PAPPEN','A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.','\0','Pappenheimer Bodies','CL-LBTESTCD','DBX-NCIT-C74616'),('CL-LBTESTCD-T-887',NULL,'PARICEAB','A measurement of the parietal cell antibody in a biological specimen.','\0','Anti-Parietal Cell Antibody; Parietal Cell Antibody','CL-LBTESTCD','DBX-NCIT-C116207'),('CL-LBTESTCD-T-888',NULL,'PB19GGAB','A measurement of the Parvovirus B19 IgG antibody in a biological specimen.','\0','Parvovirus B19 IgG Antibody','CL-LBTESTCD','DBX-NCIT-C96617'),('CL-LBTESTCD-T-889',NULL,'PB19GMAB','A measurement of the Parvovirus B19 IgM antibody in a biological specimen.','\0','Parvovirus B19 IgM Antibody','CL-LBTESTCD','DBX-NCIT-C96618'),('CL-LBTESTCD-T-89',NULL,'APOJ','A measurement of the apolipoprotein J in a biological specimen.','\0','Apolipoprotein J; Clusterin','CL-LBTESTCD','DBX-NCIT-C100428'),('CL-LBTESTCD-T-890',NULL,'PCDW','A measurement of a marker of platelet shape change in a biological specimen.','\0','Platelet Component Distribution Width','CL-LBTESTCD','DBX-NCIT-C111294'),('CL-LBTESTCD-T-891',NULL,'PCO2','A measurement of the pressure of carbon dioxide in a biological specimen.','\0','Partial Pressure Carbon Dioxide','CL-LBTESTCD','DBX-NCIT-C82625'),('CL-LBTESTCD-T-892',NULL,'PCP','A measurement of the phencyclidine present in a biological specimen.','\0','Phencyclidine; Phenylcyclohexylpiperidine','CL-LBTESTCD','DBX-NCIT-C74694'),('CL-LBTESTCD-T-893',NULL,'PCT','A measurement of the procalcitonin in a biological specimen.','\0','Procalcitonin','CL-LBTESTCD','DBX-NCIT-C103430'),('CL-LBTESTCD-T-894',NULL,'PDGFAB','A measurement of the platelet derived growth factor isoform AB in a biological specimen.','\0','PDGF Isoform AB; Platelet Derived Growth Factor Isoform AB; Platelet Derived Growth Factor-AB Isoform','CL-LBTESTCD','DBX-NCIT-C116208'),('CL-LBTESTCD-T-895',NULL,'PDW','A measurement of the range of platelet sizes in a biological specimen.','\0','Platelet Distribution Width','CL-LBTESTCD','DBX-NCIT-C81962'),('CL-LBTESTCD-T-896',NULL,'PELGERH','A measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.','\0','Pelger Huet Anomaly','CL-LBTESTCD','DBX-NCIT-C74617'),('CL-LBTESTCD-T-897',NULL,'PEMAB','A measurement of the pemphigoid antibodies in a biological specimen.','\0','Pemphigoid Antibodies','CL-LBTESTCD','DBX-NCIT-C81988'),('CL-LBTESTCD-T-898',NULL,'PEPSNG','A measurement of the pepsinogen in a biological specimen.','\0','Pepsinogen','CL-LBTESTCD','DBX-NCIT-C100122'),('CL-LBTESTCD-T-899',NULL,'PEPSNGA','A measurement of the pepsinogen A in a biological specimen.','\0','PGA; Pepsinogen A','CL-LBTESTCD','DBX-NCIT-C100469'),('CL-LBTESTCD-T-9',NULL,'ACANTRBC','A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.','\0','Acanthocytes/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C74633'),('CL-LBTESTCD-T-90',NULL,'APOJCRT','A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen.','\0','Apolipoprotein J/Creatinine; Clusterin/Creatinine','CL-LBTESTCD','DBX-NCIT-C111130'),('CL-LBTESTCD-T-900',NULL,'PEPSNGC','A measurement of the pepsinogen C in a biological specimen.','\0','PGC; Pepsinogen C','CL-LBTESTCD','DBX-NCIT-C100470'),('CL-LBTESTCD-T-901',NULL,'PEPSNGI','A measurement of the pepsinogen I in a biological specimen.','\0','PGI; Pepsinogen I','CL-LBTESTCD','DBX-NCIT-C100467'),('CL-LBTESTCD-T-902',NULL,'PEPSNGII','A measurement of the pepsinogen II in a biological specimen.','\0','PGII; Pepsinogen II','CL-LBTESTCD','DBX-NCIT-C100468'),('CL-LBTESTCD-T-903',NULL,'PERIOSTN','A measurement of the periostin in a biological specimen.','\0','OSF2; Osteoblast Specific Factor 2; POSTN; Periostin','CL-LBTESTCD','DBX-NCIT-C112395'),('CL-LBTESTCD-T-904',NULL,'PERTHRBL','A measurement of the proerythroblasts in a biological specimen.','\0','Proerythroblast','CL-LBTESTCD','DBX-NCIT-C100446'),('CL-LBTESTCD-T-905',NULL,'PFCT','A measurement of the platelet function closure time in a biological specimen.','\0','PFCT; Platelet Function Closure Time','CL-LBTESTCD','DBX-NCIT-C111295'),('CL-LBTESTCD-T-906',NULL,'PG','A measurement of the total prostaglandin in a biological specimen.','\0','Total Prostaglandin','CL-LBTESTCD','DBX-NCIT-C103343'),('CL-LBTESTCD-T-907',NULL,'PGD2','A measurement of the prostaglandin D2 in a biological specimen.','\0','Prostaglandin D2','CL-LBTESTCD','DBX-NCIT-C103431'),('CL-LBTESTCD-T-908',NULL,'PGD2S','A measurement of the prostaglandin D2 synthase in a biological specimen.','\0','Prostaglandin D2 Synthase','CL-LBTESTCD','DBX-NCIT-C103432'),('CL-LBTESTCD-T-909',NULL,'PGE1','A measurement of the prostaglandin E1 in a biological specimen.','\0','Prostaglandin E1','CL-LBTESTCD','DBX-NCIT-C103434'),('CL-LBTESTCD-T-91',NULL,'APP','A measurement of the amyloid beta precursor protein present in a biological specimen.','\0','Amyloid Beta Precursor; Amyloid Beta Precursor Protein; Amyloid Precursor Beta; Amyloid Precursor Protein','CL-LBTESTCD','DBX-NCIT-C105438'),('CL-LBTESTCD-T-910',NULL,'PGE2','A measurement of the prostaglandin E2 in a biological specimen.','\0','Prostaglandin E2','CL-LBTESTCD','DBX-NCIT-C103435'),('CL-LBTESTCD-T-911',NULL,'PGES','A measurement of the prostaglandin E synthase in a biological specimen.','\0','Prostaglandin E Synthase','CL-LBTESTCD','DBX-NCIT-C103433'),('CL-LBTESTCD-T-912',NULL,'PGF1A','A measurement of the prostaglandin F1 alpha in a biological specimen.','\0','Prostaglandin F1 Alpha','CL-LBTESTCD','DBX-NCIT-C103436'),('CL-LBTESTCD-T-913',NULL,'PGF2A','A measurement of the prostaglandin F2 alpha in a biological specimen.','\0','Prostaglandin F2 Alpha','CL-LBTESTCD','DBX-NCIT-C103437'),('CL-LBTESTCD-T-914',NULL,'PH','The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid.','\0','pH','CL-LBTESTCD','DBX-NCIT-C45997'),('CL-LBTESTCD-T-915',NULL,'PHENTHZ','A measurement of the phenothiazine present in a biological specimen.','\0','Dibenzothiazine; Phenothiazine','CL-LBTESTCD','DBX-NCIT-C74695'),('CL-LBTESTCD-T-916',NULL,'PHOS','A measurement of the phosphate in a biological specimen.','\0','Inorganic Phosphate; Phosphate; Phosphorus','CL-LBTESTCD','DBX-NCIT-C64857'),('CL-LBTESTCD-T-917',NULL,'PHOSCLR','A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute).','\0','Phosphate Clearance','CL-LBTESTCD','DBX-NCIT-C106553'),('CL-LBTESTCD-T-918',NULL,'PHOSCRT','A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.','\0','Phosphate/Creatinine','CL-LBTESTCD','DBX-NCIT-C79461'),('CL-LBTESTCD-T-919',NULL,'PHOSEXR','A measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour).','\0','Phosphorus Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117845'),('CL-LBTESTCD-T-92',NULL,'APPEAR','The outward or visible aspect of a specimen.','\0','Specimen Appearance','CL-LBTESTCD','DBX-NCIT-C25377'),('CL-LBTESTCD-T-920',NULL,'PHOSLPD','A measurement of the phospholipids in a biological specimen.','\0','Phospholipid','CL-LBTESTCD','DBX-NCIT-C96623'),('CL-LBTESTCD-T-921',NULL,'PICP','A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.','\0','Procollagen Type I Carboxy Term Peptide','CL-LBTESTCD','DBX-NCIT-C82033'),('CL-LBTESTCD-T-922',NULL,'PLAGGCVT','The classification of the curve pattern that is formed as a result of platelet aggregation.','\0','Platelet Aggregation Curve Type','CL-LBTESTCD','DBX-NCIT-C114210'),('CL-LBTESTCD-T-923',NULL,'PLAGMAMP','An average of the measurements of the magnitude of the platelet aggregation in a biological specimen.','\0','Platelet Aggregation Mean Amplitude','CL-LBTESTCD','DBX-NCIT-C114211'),('CL-LBTESTCD-T-924',NULL,'PLAGMCVT','The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements.','\0','Platelet Aggregation Mean Curve Type','CL-LBTESTCD','DBX-NCIT-C114212'),('CL-LBTESTCD-T-925',NULL,'PLAT','A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.','\0','Platelets','CL-LBTESTCD','DBX-NCIT-C51951'),('CL-LBTESTCD-T-926',NULL,'PLATAGGR','A measurement of the association of platelets to one another via adhesion molecules in a biological sample.','\0','Platelet Aggregation; Platelet Function','CL-LBTESTCD','DBX-NCIT-C103427'),('CL-LBTESTCD-T-927',NULL,'PLATCLMP','A measurement of the platelet clumps in a biological specimen.','\0','PLT Clumps; Platelet Clumps','CL-LBTESTCD','DBX-NCIT-C96624'),('CL-LBTESTCD-T-928',NULL,'PLATGNT','A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.','\0','Giant Platelets','CL-LBTESTCD','DBX-NCIT-C74728'),('CL-LBTESTCD-T-929',NULL,'PLATHCT','A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.','\0','Platelet Hematocrit; Thrombocytocrit','CL-LBTESTCD','DBX-NCIT-C100424'),('CL-LBTESTCD-T-93',NULL,'APRIL','A measurement of the a proliferation-inducing ligand in a biological specimen.','\0','A Proliferation-Inducing Ligand; CD256; TNFSF13; Tumor Necrosis Factor Ligand Superfamily Member 13','CL-LBTESTCD','DBX-NCIT-C111123'),('CL-LBTESTCD-T-930',NULL,'PLATLRG','A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.','\0','Large Platelets','CL-LBTESTCD','DBX-NCIT-C74729'),('CL-LBTESTCD-T-931',NULL,'PLATSAT','An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen.','\0','Platelet Satellitism','CL-LBTESTCD','DBX-NCIT-C116209'),('CL-LBTESTCD-T-932',NULL,'PLSCECE','A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Plasma Cells/Total Cells','CL-LBTESTCD','DBX-NCIT-C98869'),('CL-LBTESTCD-T-933',NULL,'PLSIMCE','A measurement of the immature plasma cells in a biological specimen.','\0','Immature Plasma Cells','CL-LBTESTCD','DBX-NCIT-C96679'),('CL-LBTESTCD-T-934',NULL,'PLSIMCLY','A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.','\0','Immature Plasma Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C96680'),('CL-LBTESTCD-T-935',NULL,'PLSMCE','A measurement of the mature plasma cells (plasmacytes) in a biological specimen.','\0','Mature Plasma Cells; Plasmacytes','CL-LBTESTCD','DBX-NCIT-C74661'),('CL-LBTESTCD-T-936',NULL,'PLSMCELY','A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.','\0','Mature Plasma Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74911'),('CL-LBTESTCD-T-937',NULL,'PLSMDM','Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.','\0','Plasmodium','CL-LBTESTCD','DBX-NCIT-C100453'),('CL-LBTESTCD-T-938',NULL,'PLSPCE','A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.','\0','Plasmablast; Precursor Plasma Cells','CL-LBTESTCD','DBX-NCIT-C74619'),('CL-LBTESTCD-T-939',NULL,'PLSPCELY','A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.','\0','Precursor Plasma Cells/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74650'),('CL-LBTESTCD-T-94',NULL,'APROTCRS','A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.','\0','Activated Protein C Resistance; Factor V Leiden Screen','CL-LBTESTCD','DBX-NCIT-C100471'),('CL-LBTESTCD-T-940',NULL,'PLTAGAMP','A measurement of the magnitude of the platelet aggregation in a biological specimen.','\0','Platelet Aggregation Amplitude','CL-LBTESTCD','DBX-NCIT-C111293'),('CL-LBTESTCD-T-941',NULL,'PLTMORPH','An examination or assessment of the form and structure of platelets.','\0','Platelet Morphology','CL-LBTESTCD','DBX-NCIT-C111296'),('CL-LBTESTCD-T-942',NULL,'PNCTPP','A measurement of the pancreatic polypeptide in a biological specimen.','\0','Pancreatic Polypeptide','CL-LBTESTCD','DBX-NCIT-C80201'),('CL-LBTESTCD-T-943',NULL,'PO2','A measurement of the pressure of oxygen in a biological specimen.','\0','Partial Pressure Oxygen','CL-LBTESTCD','DBX-NCIT-C71251'),('CL-LBTESTCD-T-944',NULL,'POIKILO','A measurement of the odd-shaped erythrocytes in a whole blood specimen.','\0','Poikilocytes','CL-LBTESTCD','DBX-NCIT-C79602'),('CL-LBTESTCD-T-945',NULL,'POIKRBC','A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.','\0','Poikilocytes/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C74649'),('CL-LBTESTCD-T-946',NULL,'POLYCHR','A measurement of the blue-staining characteristic of newly generated erythrocytes.','\0','Polychromasia','CL-LBTESTCD','DBX-NCIT-C64803'),('CL-LBTESTCD-T-947',NULL,'PRA','A measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen.','\0','PRA Score; Panel Reactive Antibody; Percent Panel Reactive Antibody; Percent Reactive Antibody','CL-LBTESTCD','DBX-NCIT-C116210'),('CL-LBTESTCD-T-948',NULL,'PREALB','A measurement of the prealbumin in a biological specimen.','\0','Prealbumin','CL-LBTESTCD','DBX-NCIT-C100435'),('CL-LBTESTCD-T-949',NULL,'PRINSINS','A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen.','\0','Proinsulin/Insulin Ratio','CL-LBTESTCD','DBX-NCIT-C111299'),('CL-LBTESTCD-T-95',NULL,'APTT','A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.','\0','Activated Partial Thromboplastin Time','CL-LBTESTCD','DBX-NCIT-C38462'),('CL-LBTESTCD-T-950',NULL,'PRLYMLE','A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.','\0','Prolymphocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C64829'),('CL-LBTESTCD-T-951',NULL,'PROGEST','A measurement of the progesterone hormone in a biological specimen.','\0','Progesterone','CL-LBTESTCD','DBX-NCIT-C74791'),('CL-LBTESTCD-T-952',NULL,'PROGESTR','A measurement of the progesterone receptor in a biological specimen.','\0','NR3C3; PR; Progesterone Receptor','CL-LBTESTCD','DBX-NCIT-C117846'),('CL-LBTESTCD-T-953',NULL,'PROINSUL','A measurement of the proinsulin in a biological specimen.','\0','Proinsulin','CL-LBTESTCD','DBX-NCIT-C81967'),('CL-LBTESTCD-T-954',NULL,'PROLCTN','A measurement of the prolactin hormone in a biological specimen.','\0','Prolactin','CL-LBTESTCD','DBX-NCIT-C74870'),('CL-LBTESTCD-T-955',NULL,'PROLYM','A measurement of the prolymphocytes in a biological specimen.','\0','Prolymphocytes','CL-LBTESTCD','DBX-NCIT-C74620'),('CL-LBTESTCD-T-956',NULL,'PROLYMLY','A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.','\0','Prolymphocytes/Lymphocytes','CL-LBTESTCD','DBX-NCIT-C74651'),('CL-LBTESTCD-T-957',NULL,'PROMONLE','A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.','\0','Promonocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C74652'),('CL-LBTESTCD-T-958',NULL,'PROMONO','A measurement of the promonocytes in a biological specimen.','\0','Promonocytes','CL-LBTESTCD','DBX-NCIT-C74621'),('CL-LBTESTCD-T-959',NULL,'PROMY','A measurement of the promyelocytes (immature myelocytes) in a biological specimen.','\0','Promyelocytes','CL-LBTESTCD','DBX-NCIT-C74622'),('CL-LBTESTCD-T-96',NULL,'APTTLAS','A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen.','\0','APTT-LA; Lupus Anticoagulant Sensitive APTT','CL-LBTESTCD','DBX-NCIT-C102277'),('CL-LBTESTCD-T-960',NULL,'PROMYB','A measurement of the promyeloblasts in a biological specimen.','\0','Promyeloblasts','CL-LBTESTCD','DBX-NCIT-C117847'),('CL-LBTESTCD-T-961',NULL,'PROMYCE','A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).','\0','Promyelocytes/Total Cells','CL-LBTESTCD','DBX-NCIT-C98773'),('CL-LBTESTCD-T-962',NULL,'PROMYLE','A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.','\0','Promyelocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C74653'),('CL-LBTESTCD-T-963',NULL,'PROPOX','A measurement of the propoxyphene present in a biological specimen.','\0','Propoxyphene','CL-LBTESTCD','DBX-NCIT-C74885'),('CL-LBTESTCD-T-964',NULL,'PROT','A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.','\0','Protein','CL-LBTESTCD','DBX-NCIT-C64858'),('CL-LBTESTCD-T-965',NULL,'PROTCRT','A relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.','\0','Protein/Creatinine','CL-LBTESTCD','DBX-NCIT-C79463'),('CL-LBTESTCD-T-966',NULL,'PROTEXR','A measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour).','\0','Protein Excretion Rate','CL-LBTESTCD','DBX-NCIT-C117848'),('CL-LBTESTCD-T-967',NULL,'PROTOSML','A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.','\0','Protein/Osmolality; Protein/Osmolality Ratio','CL-LBTESTCD','DBX-NCIT-C92240'),('CL-LBTESTCD-T-968',NULL,'PROTOZOA','Examination of a biological specimen to detect the presence of protozoa in a biological specimen.','\0','Protozoa','CL-LBTESTCD','DBX-NCIT-C117849'),('CL-LBTESTCD-T-969',NULL,'PROTS','A measurement of the protein S in a biological specimen.','\0','Protein S','CL-LBTESTCD','DBX-NCIT-C100436'),('CL-LBTESTCD-T-97',NULL,'APTTSTND','A relative measurement (ratio or percentage) of the subject\'s partial thromboplastin time to a standard or control partial thromboplastin time.','\0','Activated PTT/Standard; Activated PTT/Standard PTT; Activated Partial Thromboplastin Time/Standard Thromboplastin Time','CL-LBTESTCD','DBX-NCIT-C98862'),('CL-LBTESTCD-T-970',NULL,'PSA','A measurement of the prostate specific antigen in a biological specimen.','\0','Prostate Specific Antigen','CL-LBTESTCD','DBX-NCIT-C17634'),('CL-LBTESTCD-T-971',NULL,'PSDEPHD','A measurement of the pseudoephedrine present in a biological specimen.','\0','Pseudoephedrine','CL-LBTESTCD','DBX-NCIT-C74696'),('CL-LBTESTCD-T-972',NULL,'PSELECT','A measurement of total P-selectin in a biological specimen.','\0','GMP-140; P-Selectin','CL-LBTESTCD','DBX-NCIT-C117850'),('CL-LBTESTCD-T-973',NULL,'PT','A blood clotting measurement that evaluates the extrinsic pathway of coagulation.','\0','Prothrombin Time','CL-LBTESTCD','DBX-NCIT-C62656'),('CL-LBTESTCD-T-974',NULL,'PTA','A measurement of the biological activity of prothrombin in a biological specimen.','\0','Factor II Activity; Prothrombin Activity','CL-LBTESTCD','DBX-NCIT-C98774'),('CL-LBTESTCD-T-975',NULL,'PTF1_2','A measurement of the prothrombin fragments 1 and 2 in a biological specimen.','\0','Prothrombin Fragments 1 + 2','CL-LBTESTCD','DBX-NCIT-C82034'),('CL-LBTESTCD-T-976',NULL,'PTHCT','A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, C-Terminal','CL-LBTESTCD','DBX-NCIT-C81964'),('CL-LBTESTCD-T-977',NULL,'PTHFG','A measurement of the fragmented parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, Fragmented','CL-LBTESTCD','DBX-NCIT-C74784'),('CL-LBTESTCD-T-978',NULL,'PTHI','A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.','\0','Parathyroid Hormone, Intact','CL-LBTESTCD','DBX-NCIT-C74789'),('CL-LBTESTCD-T-979',NULL,'PTHMM','A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, Mid-Molecule','CL-LBTESTCD','DBX-NCIT-C81965'),('CL-LBTESTCD-T-98',NULL,'ARA','A measurement of the arachidonic acid present in a biological specimen.','\0','Arachidonic Acid','CL-LBTESTCD','DBX-NCIT-C102259'),('CL-LBTESTCD-T-980',NULL,'PTHNT','A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.','\0','Parathyroid Hormone, N-Terminal','CL-LBTESTCD','DBX-NCIT-C81966'),('CL-LBTESTCD-T-981',NULL,'PTHRP','A measurement of parathyroid hormone-related protein in a biological specimen.','\0','Parathyroid Hormone-related Peptide; Parathyroid Hormone-related Protein','CL-LBTESTCD','DBX-NCIT-C117851'),('CL-LBTESTCD-T-982',NULL,'PTHW','A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen.','\0','Parathyroid Hormone, Whole','CL-LBTESTCD','DBX-NCIT-C103451'),('CL-LBTESTCD-T-983',NULL,'PYRIDNLN','A measurement of the pyridinoline in a biological specimen.','\0','Pyridinoline','CL-LBTESTCD','DBX-NCIT-C80211'),('CL-LBTESTCD-T-984',NULL,'PYY','A measurement of the peptide YY in a biological specimen.','\0','Peptide Tyrosine Tyrosine; Peptide YY','CL-LBTESTCD','DBX-NCIT-C80202'),('CL-LBTESTCD-T-985',NULL,'RANKL','A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen.','\0','Receptor Activator Nuclear KappaB Ligand; Receptor Activator of Nuclear Kappa-B Ligand','CL-LBTESTCD','DBX-NCIT-C117852'),('CL-LBTESTCD-T-986',NULL,'RANTES','A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.','\0','Chemokine Ligand 5; Reg upon Act Normal T-cell Exprd Secrtd','CL-LBTESTCD','DBX-NCIT-C81957'),('CL-LBTESTCD-T-987',NULL,'RBC','A measurement of the total erythrocytes in a biological specimen.','\0','Erythrocytes; Red Blood Cells','CL-LBTESTCD','DBX-NCIT-C51946'),('CL-LBTESTCD-T-988',NULL,'RBCAGGLU','A measurement of the erythrocyte agglutination in a biological specimen.','\0','Autoagglutination; Erythrocyte Agglutination; RBC Agglutination','CL-LBTESTCD','DBX-NCIT-C111197'),('CL-LBTESTCD-T-989',NULL,'RBCCLMP','A measurement of red blood cell clumps in a biological specimen.','\0','Erythrocyte Cell Clumps; RBC Clumps; Red Blood Cell Clumps','CL-LBTESTCD','DBX-NCIT-C92245'),('CL-LBTESTCD-T-99',NULL,'ASCAB','A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.','\0','Anti-Saccharomyces cerevisiae Antibody','CL-LBTESTCD','DBX-NCIT-C81976'),('CL-LBTESTCD-T-990',NULL,'RBCDIPOP','Examination of a biological specimen to detect the presence of dimorphic erythrocyte population.','\0','Dimorphic Erythrocyte Population; Dimorphic RBC Population','CL-LBTESTCD','DBX-NCIT-C117853'),('CL-LBTESTCD-T-991',NULL,'RBCFRAG','A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen.','\0','Erythrocyte Fragment; RBC Fragment','CL-LBTESTCD','DBX-NCIT-C116212'),('CL-LBTESTCD-T-992',NULL,'RBCGHOST','A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.','\0','Erythrocyte Ghosts; RBC Ghosts','CL-LBTESTCD','DBX-NCIT-C96605'),('CL-LBTESTCD-T-993',NULL,'RBCMORPH','An examination or assessment of the form and structure of red blood cells.','\0','Erythrocyte Cell Morphology; RBC Morphology; Red Blood Cell Morphology','CL-LBTESTCD','DBX-NCIT-C92296'),('CL-LBTESTCD-T-994',NULL,'RBCNUC','A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.','\0','Nucleated Erythrocytes; Nucleated Red Blood Cells','CL-LBTESTCD','DBX-NCIT-C74705'),('CL-LBTESTCD-T-995',NULL,'RBCNUCLE','A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.','\0','Nucleated Erythrocytes/Leukocytes','CL-LBTESTCD','DBX-NCIT-C82046'),('CL-LBTESTCD-T-996',NULL,'RBCNURBC','A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.','\0','Nucleated Erythrocytes/Erythrocytes; Nucleated Red Blood Cells/Erythrocytes','CL-LBTESTCD','DBX-NCIT-C74647'),('CL-LBTESTCD-T-997',NULL,'RBOIGGAB','A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen.','\0','Measles IgG Antibody; Rubeola IgG Antibody','CL-LBTESTCD','DBX-NCIT-C112412'),('CL-LBTESTCD-T-998',NULL,'RBOIGMAB','A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen.','\0','Measles IgM Antibody; Rubeola IgM Antibody','CL-LBTESTCD','DBX-NCIT-C112413'),('CL-LBTESTCD-T-999',NULL,'RBP','A measurement of the total retinol binding protein in a biological specimen.','\0','Retinol Binding Protein','CL-LBTESTCD','DBX-NCIT-C100437'),('CL-LEADABN-T-1',NULL,'CONDUCTOR FAILURE','Conductor failure manifests by high lead impedance either absolutely (above manufacturer\'s product specifications) or by a significant increase from previously stable chronic values.','\0','','CL-LEADABN','DBX-NCIT-C99924'),('CL-LEADABN-T-10',NULL,'OVERSENSING WITH SHOCK OR ATP','This manifests as sensing of non-cardiac depolarization signals that met arrhythmia detection criteria and elicited programmed tachyarrhythmia therapy.','\0','','CL-LEADABN','DBX-NCIT-C99927'),('CL-LEADABN-T-11',NULL,'OVERSENSING WITHOUT SHOCK OR ATP','This manifests as sensing of non-cardiac depolarization signals that did not meet arrhythmia detection criteria and do not elicit programmed tachyarrhythmia therapy.','\0','','CL-LEADABN','DBX-NCIT-C99928'),('CL-LEADABN-T-12',NULL,'SET SCREW PROBLEM','The pacing and/or sensing problem associated with high impedance due to a poor connection between a lead and generator caused by a loose set screw.','\0','','CL-LEADABN','DBX-NCIT-C99929'),('CL-LEADABN-T-13',NULL,'UNDERSENSING','Undersensing manifests as failure to sense appropriate cardiac depolarizations that cannot be resolved with reprogramming.','\0','','CL-LEADABN','DBX-NCIT-C99930'),('CL-LEADABN-T-2',NULL,'DEFIBRILLATION ISSUES','The cardiac lead is not performing as expected with issues such as oversensing with or without shock or ATP, or failed shocks or inadequate DFT safety margins defibrillation activity.','\0','','CL-LEADABN','DBX-NCIT-C99922'),('CL-LEADABN-T-3',NULL,'EXTRACARDIAC STIMULATION','This manifests as stimulation by the lead of non-cardiac structures such as the diaphragm, chest wall, or pectoral muscle.','\0','','CL-LEADABN','DBX-NCIT-C99951'),('CL-LEADABN-T-4',NULL,'FAILED TO SHOCK WITH INADEQUATE DFT SAFETY MARGIN','The cardiac lead failed to administer a shock and had an inadequate defibrillator threshold safety margin.','\0','','CL-LEADABN','DBX-NCIT-C99954'),('CL-LEADABN-T-5',NULL,'FAILURE TO CAPTURE WITH ACCEPTABLE SAFETY MARGIN','Failure to capture manifests as a high pacing threshold that results in either intermittent failure to capture at maximal programmed output or excessive battery drain leading to premature battery exhaustion.','\0','','CL-LEADABN','DBX-NCIT-C99953'),('CL-LEADABN-T-6',NULL,'FAILURE TO PACE','Failure to pace manifests as absence of pacemaker stimulation artifacts on electrocardiographic recordings despite rates below pacemaker programmed rate.','\0','','CL-LEADABN','DBX-NCIT-C99528'),('CL-LEADABN-T-7',NULL,'INSULATION FAILURE','Insulation failure manifests as low lead impedance either absolutely (below manufacturer\'s product specifications) or by a significant decrease from previously stable chronic values.','\0','','CL-LEADABN','DBX-NCIT-C99932'),('CL-LEADABN-T-8',NULL,'LEAD DISLODGEMENT REQUIRING REPOSITION/REOPERATION','The movement (macroscopic or microscopic) of an existing lead within the heart or vascular tree away from the original implantation site.','\0','','CL-LEADABN','DBX-NCIT-C100034'),('CL-LEADABN-T-9',NULL,'OVERSENSING','Oversensing manifests as sensing of electrical signals not related to cardiac depolarization of the lead chamber that cannot be resolved acceptably by device reprogramming.','\0','','CL-LEADABN','DBX-NCIT-C99926'),('CL-LEADSTAT-T-1',NULL,'ABANDONED','The lead has been left in situ but is not in use.','\0','','CL-LEADSTAT','DBX-NCIT-C99906'),('CL-LEADSTAT-T-2',NULL,'EXTRACTED','The lead has been removed from the body.','\0','','CL-LEADSTAT','DBX-NCIT-C102283'),('CL-LEADSTAT-T-3',NULL,'REUSED','The lead has been left in situ and reused.','\0','','CL-LEADSTAT','DBX-NCIT-C102284'),('CL-LOC-T-1',NULL,'5TH LUMBAR SPINOUS PROCESS','The spinous process of the 5th lumbar vertebra.','\0','','CL-LOC','DBX-NCIT-C116163'),('CL-LOC-T-10',NULL,'ACROMIOCLAVICULAR JOINT','The junction of the upper distal end of the scapula to the distal edge of the collarbone, also known as the acromion and the clavicle. (NCI)','\0','Acromioclavicular Joint','CL-LOC','DBX-NCIT-C32047'),('CL-LOC-T-100',NULL,'CLAVICLE','A bone linking the scapula and the sternum. The clavicle is part of the pectoral girdle.','\0','Clavicle','CL-LOC','DBX-NCIT-C12695'),('CL-LOC-T-101',NULL,'CLITORIS','The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris.','\0','','CL-LOC','DBX-NCIT-C12308'),('CL-LOC-T-102',NULL,'COCCYGEAL VERTEBRA','Four vertebral segments positioned at the base of the spine that are fused. (NCI)','\0','Coccygeal Vertebra','CL-LOC','DBX-NCIT-C32334'),('CL-LOC-T-103',NULL,'COCCYX','A small bone located at the bottom of the spine. The coccyx is a result of 3-5 fused rudimentary vertebrae. (NCI)','\0','Coccyx','CL-LOC','DBX-NCIT-C12696'),('CL-LOC-T-104',NULL,'COLON','The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion. (NCI)','\0','Colon','CL-LOC','DBX-NCIT-C12382'),('CL-LOC-T-105',NULL,'COLON, ASCENDING','The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI)','\0','Ascending Colon','CL-LOC','DBX-NCIT-C12265'),('CL-LOC-T-106',NULL,'COLON, DESCENDING','The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. (NCI)','\0','Descending Colon','CL-LOC','DBX-NCIT-C12268'),('CL-LOC-T-107',NULL,'COLON, LEFT','The portion of the large intestine that includes the descending and sigmoid colon. (NCI)','\0','Left Colon','CL-LOC','DBX-NCIT-C33929'),('CL-LOC-T-108',NULL,'COLON, RECTOSIGMOID','A portion of the large intestine that includes the descending colon, sigmoid colon and rectum.','\0','','CL-LOC','DBX-NCIT-C103438'),('CL-LOC-T-109',NULL,'COLON, RIGHT','The proximal segment of the large intestine that is located in the right side of the abdominal cavity. It includes the cecum (with the attached appendix) and the ascending colon. (NCI)','\0','Right Colon','CL-LOC','DBX-NCIT-C12383'),('CL-LOC-T-11',NULL,'ACROMION','The upper distal process of the scapula. (NCI)','\0','Acromion','CL-LOC','DBX-NCIT-C32048'),('CL-LOC-T-110',NULL,'COLON, SIGMOID','The portion of the colon that connects to the descending colon above and the rectum below. (NCI)','\0','Sigmoid Colon','CL-LOC','DBX-NCIT-C12384'),('CL-LOC-T-111',NULL,'COLON, TRANSVERSE','The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant. (NCI)','\0','Transverse Colon','CL-LOC','DBX-NCIT-C12385'),('CL-LOC-T-112',NULL,'COMMON FEMORAL ARTERY','An artery arising from the external iliac artery at the inguinal ligament which bifurcates forming the deep and superficial femoral arteries.','\0','','CL-LOC','DBX-NCIT-C32354'),('CL-LOC-T-113',NULL,'COMMON ILIAC ARTERY','An artery arising from the bifurcation of the abdominal aorta which then bifurcates forming the internal and external iliac arteries.','\0','','CL-LOC','DBX-NCIT-C32357'),('CL-LOC-T-114',NULL,'COMMON ILIAC LYMPH NODE','A lymph node located adjacent to the common iliac artery. (NCI)','\0','','CL-LOC','DBX-NCIT-C103384'),('CL-LOC-T-115',NULL,'CONJUNCTIVA','A thin, transparent tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball). (NCI)','\0','Conjunctiva','CL-LOC','DBX-NCIT-C12341'),('CL-LOC-T-116',NULL,'CORNEA','A dome-shaped, transparent, avascular tissue covering the front of the eye. It is composed of five layers: squamous epithelium, Bowman\'s membrane, stroma, Descemet\'s membrane, and endothelium. Refraction of light contributing to eye\'s focusing ability is ','\0','Cornea','CL-LOC','DBX-NCIT-C12342'),('CL-LOC-T-117',NULL,'CORONARY ARTERY','A principal artery that originates in the aorta. It supplies blood to the muscular tissue of the heart. (NCI)','\0','Coronary Artery','CL-LOC','DBX-NCIT-C12843'),('CL-LOC-T-118',NULL,'CORONARY ARTERY, ANTERIOR DESCENDING','A left coronary artery branch that descends on the anterior portion of the heart through the anterior interventricular groove. (NCI)','\0','Anterior Descending Coronary Artery; Left Anterior Descending Coronary Artery','CL-LOC','DBX-NCIT-C32089'),('CL-LOC-T-119',NULL,'CORONARY ARTERY, LEFT','A coronary artery that arises from the aorta and bifurcates into the left anterior descending artery and the left circumflex artery. (NCI)','\0','LM; Left Coronary Artery; Left Main Coronary Artery; Left Main Coronary Artery Segment','CL-LOC','DBX-NCIT-C12872'),('CL-LOC-T-12',NULL,'ACUTE MARGINAL ARTERY','The arteries that arise at the junction of the proximal and mid-right coronary artery conduit segments.','\0','ACUTE MARGINAL ARTERY SEGMENT(S); AMARG','CL-LOC','DBX-NCIT-C102285'),('CL-LOC-T-120',NULL,'CORONARY ARTERY, RIGHT','A coronary artery that originates above the right coronary cusp and supplies blood predominantly to the right side of the heart. (NCI)','\0','Right Coronary Artery','CL-LOC','DBX-NCIT-C12875'),('CL-LOC-T-121',NULL,'CORONARY SINUS','The coronary vein that terminates in the right atrium and transports deoxygenated blood from the coronary circulation.','\0','','CL-LOC','DBX-NCIT-C32378'),('CL-LOC-T-122',NULL,'CORONARY VEIN','A blood vessel in the heart which returns coronary blood to the right atrium.','\0','','CL-LOC','DBX-NCIT-C12882'),('CL-LOC-T-123',NULL,'CORPUS CALLOSUM','A white matter structure within the cleft that separates the left and right cerebral hemispheres in the mammalian brain. It is composed of a wide, flat bundle of 200-250 million axonal projections. (NCI)','\0','','CL-LOC','DBX-NCIT-C12446'),('CL-LOC-T-124',NULL,'CORPUS LUTEUM','A group of cells that remain of the Graafian follicle following ovulation. This structure is composed of endocrine tissue and produces progesterone. This is needed to prepare the uterine lining for implantation by the fertilized egg. (NCI)','\0','Corpus Luteum','CL-LOC','DBX-NCIT-C26465'),('CL-LOC-T-125',NULL,'CORPUS STRIATUM','The portion of the brain consisting of the neostriatum and globus pallidus.','\0','','CL-LOC','DBX-NCIT-C12448'),('CL-LOC-T-126',NULL,'COSTAL CARTILAGE','The cartilage positioned between the anterior end of the rib and the sternum. Its elasticity allows the ribcage to expand while breathing. (NCI)','\0','Costal Cartilage','CL-LOC','DBX-NCIT-C32391'),('CL-LOC-T-127',NULL,'COSTOCHONDRAL JOINT 1','The first hyaline cartilaginous joint between the ribs and costal cartilage.','\0','','CL-LOC','DBX-NCIT-C102288'),('CL-LOC-T-128',NULL,'COSTOCHONDRAL JOINT 7','The seventh hyaline cartilaginous joint between the ribs and costal cartilage.','\0','','CL-LOC','DBX-NCIT-C102289'),('CL-LOC-T-129',NULL,'CRANIAL NERVE','Any of the 12 paired nerves that originate in the brain stem. (NCI)','\0','','CL-LOC','DBX-NCIT-C12700'),('CL-LOC-T-13',NULL,'ADRENAL GLAND','Suprarenal gland. A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex). (NCI)','\0','Adrenal Gland','CL-LOC','DBX-NCIT-C12666'),('CL-LOC-T-130',NULL,'CUBOID BONE','A bone on the lateral side of the tarsus between the calcaneus and the fourth and fifth metatarsal bones. (NCI)','\0','Cuboid Bone','CL-LOC','DBX-NCIT-C32414'),('CL-LOC-T-131',NULL,'DIAPHRAGM','Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration.','\0','','CL-LOC','DBX-NCIT-C12702'),('CL-LOC-T-132',NULL,'DISTAL CIRCUMFLEX ARTERY','The segment of the left circumflex artery that is between the second and third obtuse marginal branches.','\0','DCIRC; DISTAL CIRCUMFLEX ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102290'),('CL-LOC-T-133',NULL,'DISTAL INTERPHALANGEAL JOINT 2','A condyloid synovial joint within the second digit of the hand or foot connecting the middle and distal phalanges. (NCI)','\0','DIP2','CL-LOC','DBX-NCIT-C102291'),('CL-LOC-T-134',NULL,'DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT','A ginglymoid (hinge) synovial joint within the second digit of the foot connecting the middle and distal phalanges. (NCI)','\0','DIP2 of the Foot','CL-LOC','DBX-NCIT-C114198'),('CL-LOC-T-135',NULL,'DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND','A ginglymoid (hinge) synovial joint within the second digit of the hand connecting the middle and distal phalanges. (NCI)','\0','DIP2 of the Hand','CL-LOC','DBX-NCIT-C114188'),('CL-LOC-T-136',NULL,'DISTAL INTERPHALANGEAL JOINT 3','A condyloid synovial joint within the third digit of the hand or foot connecting the middle and distal phalanges. (NCI)','\0','DIP3','CL-LOC','DBX-NCIT-C102292'),('CL-LOC-T-137',NULL,'DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT','A ginglymoid (hinge) synovial joint within the third digit of the foot connecting the middle and distal phalanges. (NCI)','\0','DIP3 of the Foot','CL-LOC','DBX-NCIT-C114199'),('CL-LOC-T-138',NULL,'DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND','A ginglymoid (hinge) synovial joint within the third digit of the hand connecting the middle and distal phalanges. (NCI)','\0','DIP3 of the Hand','CL-LOC','DBX-NCIT-C114189'),('CL-LOC-T-139',NULL,'DISTAL INTERPHALANGEAL JOINT 4','A condyloid synovial joint within the fourth digit of the hand or foot connecting the middle and distal phalanges. (NCI)','\0','DIP4','CL-LOC','DBX-NCIT-C102293'),('CL-LOC-T-14',NULL,'AMYGDALA','An almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system. (MESH)','\0','Amygdaloid Nucleus','CL-LOC','DBX-NCIT-C12440'),('CL-LOC-T-140',NULL,'DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT','A ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the middle and distal phalanges. (NCI)','\0','DIP4 of the Foot','CL-LOC','DBX-NCIT-C114275'),('CL-LOC-T-141',NULL,'DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND','A ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the middle and distal phalanges. (NCI)','\0','DIP4 of the Hand','CL-LOC','DBX-NCIT-C114273'),('CL-LOC-T-142',NULL,'DISTAL INTERPHALANGEAL JOINT 5','A condyloid synovial joint within the fifth digit of the hand or foot connecting the middle and distal phalanges. (NCI)','\0','DIP5','CL-LOC','DBX-NCIT-C102294'),('CL-LOC-T-143',NULL,'DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT','A ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the middle and distal phalanges. (NCI)','\0','DIP5 of the Foot','CL-LOC','DBX-NCIT-C114276'),('CL-LOC-T-144',NULL,'DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND','A ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the middle and distal phalanges. (NCI)','\0','DIP5 of the Hand','CL-LOC','DBX-NCIT-C114274'),('CL-LOC-T-145',NULL,'DISTAL LAD ARTERY','The segment of the left anterior descending (LAD) artery that is distal to the third diagonal branch.','\0','DISTAL LAD ARTERY SEGMENT; DLAD','CL-LOC','DBX-NCIT-C102295'),('CL-LOC-T-146',NULL,'DISTAL RIGHT CORONARY ARTERY CONDUIT','The section of the right coronary artery distal to the origin of the acute marginal artery.','\0','DISTAL RIGHT CORONARY ARTERY CONDUIT SEGMENT; DRCA','CL-LOC','DBX-NCIT-C102296'),('CL-LOC-T-147',NULL,'DORSAL MOTOR NUCLEUS','A brain nucleus located in the medulla oblongata. (NCI)','\0','','CL-LOC','DBX-NCIT-C12934'),('CL-LOC-T-148',NULL,'DORSALIS PEDIS ARTERY','An artery of the dorsal surface of the foot, originating from the anterior tibial artery of the lower leg. The following arterial branches originate from the dorsalis pedis artery: the arcuate artery of the foot and deep plantar artery. (NCI)','\0','Dorsalis Pedis Artery','CL-LOC','DBX-NCIT-C32478'),('CL-LOC-T-149',NULL,'DUODENUM','A jointed tube 25-30 cm long that connects the stomach to the jejunum. (NCI)','\0','','CL-LOC','DBX-NCIT-C12263'),('CL-LOC-T-15',NULL,'ANASTOMOSIS','A natural or surgically-induced connection between tubular structures in the body. (NCI)','\0','Anastomosis','CL-LOC','DBX-NCIT-C15609'),('CL-LOC-T-150',NULL,'DURAL VENOUS SINUS','Venous channels within the dura mater of the brain which receives both blood from blood vessels within the brain as well as cerebrospinal fluid then drains into the internal jugular vein. Unlike other blood vessels, dural venous sinuses lack valves and ot','\0','','CL-LOC','DBX-NCIT-C102627'),('CL-LOC-T-151',NULL,'EAR','A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contai','\0','Ear','CL-LOC','DBX-NCIT-C12394'),('CL-LOC-T-152',NULL,'EAR, INNER','The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online)','\0','Cochlea; Internal Ear; Labyrinth','CL-LOC','DBX-NCIT-C12499'),('CL-LOC-T-153',NULL,'EAR, OUTER','The external part of the ear. (NCI)','\0','Auricle; External Ear','CL-LOC','DBX-NCIT-C12292'),('CL-LOC-T-154',NULL,'ELBOW JOINT','A joint involving the humerus, radius and ulna bones.','\0','Elbow Joint','CL-LOC','DBX-NCIT-C32497'),('CL-LOC-T-155',NULL,'ENDOCARDIUM','The layer of endothelial cells and connective tissue lining the chambers of the heart. (NCI)','\0','','CL-LOC','DBX-NCIT-C13004'),('CL-LOC-T-156',NULL,'ENDOCERVIX','The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI)','\0','','CL-LOC','DBX-NCIT-C12309'),('CL-LOC-T-157',NULL,'ENDOMETRIAL CAVITY','A space inside the uterus lined by a layer of mucus membranes called the endometrium. (NCI)','\0','Endometrial Cavity','CL-LOC','DBX-NCIT-C32514'),('CL-LOC-T-158',NULL,'ENTORHINAL CORTEX','A brain region in the medial temporal lobe near the hippocampus. (NCI)','\0','','CL-LOC','DBX-NCIT-C97338'),('CL-LOC-T-159',NULL,'EPICARDIUM','The outer membranous connective tissue layer of the heart tissue. (NCI)','\0','','CL-LOC','DBX-NCIT-C13164'),('CL-LOC-T-16',NULL,'ANKLE JOINT','A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI)','\0','Ankle; Ankle Joint','CL-LOC','DBX-NCIT-C32078'),('CL-LOC-T-160',NULL,'EPICONDYLE','A bone prominence to which ligaments and tendons of the joints are attached. (NCI)','\0','Epicondyle','CL-LOC','DBX-NCIT-C69300'),('CL-LOC-T-161',NULL,'EPIDIDYMIS','A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis. (NCI)','\0','','CL-LOC','DBX-NCIT-C12328'),('CL-LOC-T-162',NULL,'EPIGLOTTIS','A small cartilagenous flap-like valve that closes over the larynx during swallowing to prevent food entering the lungs. (NCI)','\0','Epiglottis','CL-LOC','DBX-NCIT-C12709'),('CL-LOC-T-163',NULL,'EPITROCHLEAR LYMPH NODE','A lymph node located above and adjacent to the elbow. (NCI)','\0','','CL-LOC','DBX-NCIT-C98182'),('CL-LOC-T-164',NULL,'ESOPHAGUS','The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal','\0','Esophagus','CL-LOC','DBX-NCIT-C12389'),('CL-LOC-T-165',NULL,'ESOPHAGUS, ABDOMINAL','Clinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI)','\0','Abdominal Esophagus','CL-LOC','DBX-NCIT-C12252'),('CL-LOC-T-166',NULL,'ESOPHAGUS, CERVICAL','Clinical esophageal segment composed of skeletal muscle. It corresponds to the superior part of the upper third topographic segment of the esophagus. (NCI)','\0','Cervical Esophagus','CL-LOC','DBX-NCIT-C12250'),('CL-LOC-T-167',NULL,'ESOPHAGUS, LOWER THIRD','The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type. (NCI)','\0','Lower Third of the Esophagus','CL-LOC','DBX-NCIT-C12255'),('CL-LOC-T-168',NULL,'ESOPHAGUS, MIDDLE THIRD','The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types.','\0','Middle Third of the Esophagus','CL-LOC','DBX-NCIT-C12254'),('CL-LOC-T-169',NULL,'ESOPHAGUS, THORACIC','Clinical esophageal segment composed of smooth muscle. It includes the middle third topographic segment, as well as parts of the upper and lower thirds. (NCI)','\0','Thoracic Esophagus','CL-LOC','DBX-NCIT-C12251'),('CL-LOC-T-17',NULL,'ANKLE MORTISE','A rectangular socket or bony arch that connects the ends of the tibia and fibula to the talus.','\0','Talar Mortise','CL-LOC','DBX-NCIT-C117868'),('CL-LOC-T-170',NULL,'ESOPHAGUS, UPPER THIRD','The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type. (NCI)','\0','Upper Third of the Esophagus','CL-LOC','DBX-NCIT-C12253'),('CL-LOC-T-171',NULL,'ETHMOID BONE','A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and','\0','Ethmoid Bone','CL-LOC','DBX-NCIT-C12711'),('CL-LOC-T-172',NULL,'ETHMOID SINUS','A sinus of the meatuses of the nasal cavity. (NCI)','\0','Ethmoid Sinus','CL-LOC','DBX-NCIT-C12276'),('CL-LOC-T-173',NULL,'EXTERNAL ILIAC ARTERY','An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg.','\0','','CL-LOC','DBX-NCIT-C32558'),('CL-LOC-T-174',NULL,'EXTERNAL ILIAC LYMPH NODE','A lymph node located along the external iliac artery. (NCI)','\0','','CL-LOC','DBX-NCIT-C88143'),('CL-LOC-T-175',NULL,'EXTRAHEPATIC BILE DUCT','The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI)','\0','','CL-LOC','DBX-NCIT-C32573'),('CL-LOC-T-176',NULL,'EYE','The organ of sight or vision. (NCI)','\0','Eye; Eyeball','CL-LOC','DBX-NCIT-C12401'),('CL-LOC-T-177',NULL,'EYE, ANTERIOR CHAMBER','The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (','\0','','CL-LOC','DBX-NCIT-C12667'),('CL-LOC-T-178',NULL,'EYE, VITREOUS CHAMBER','The largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor. (NCI)','\0','Postremal Chamber','CL-LOC','DBX-NCIT-C33885'),('CL-LOC-T-179',NULL,'EYELASH','Anyone of the short hairs that grow on the edge of the eyelid. (NCI)','\0','','CL-LOC','DBX-NCIT-C32576'),('CL-LOC-T-18',NULL,'ANTERIOR TIBIAL ARTERY','An artery of the lower extremity that supplies blood to the anterior part of the leg and the foot.','\0','','CL-LOC','DBX-NCIT-C12825'),('CL-LOC-T-180',NULL,'EYELID','A thin membrane of skin with the purpose of covering and protecting an eye. (NCI)','\0','Eyelid; Palpebra','CL-LOC','DBX-NCIT-C12713'),('CL-LOC-T-181',NULL,'FACE','The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws. (NCI)','\0','Face; Facial','CL-LOC','DBX-NCIT-C13071'),('CL-LOC-T-182',NULL,'FACET JOINT','A synovial joint between two adjacent vertebrae. The facet joint links the articular process of one vertebra and the inferior articular process of the adjacent vertebra. (NCI)','\0','Facet Joint','CL-LOC','DBX-NCIT-C32577'),('CL-LOC-T-183',NULL,'FACIAL BONE','Any bone that contributes to the facial structures, except those bones that are part of the braincase. (NCI)','\0','Facial Bone','CL-LOC','DBX-NCIT-C63706'),('CL-LOC-T-184',NULL,'FACIAL NERVE','The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to t','\0','Seventh Cranial Nerve','CL-LOC','DBX-NCIT-C12714'),('CL-LOC-T-185',NULL,'FALLOPIAN TUBE','One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur. (NCI)','\0','Fallopian Tube','CL-LOC','DBX-NCIT-C12403'),('CL-LOC-T-186',NULL,'FASCIA','A sheet or band of fibrous connective tissue enveloping, separating, or binding together muscles, organs and other soft structures of the body.','\0','','CL-LOC','DBX-NCIT-C13108'),('CL-LOC-T-187',NULL,'FEMALE GENITALIA','Female internal and external organs of reproduction.','\0','Female Genitalia','CL-LOC','DBX-NCIT-C61600'),('CL-LOC-T-188',NULL,'FEMALE REPRODUCTIVE SYSTEM','The sex organs of the female.','\0','','CL-LOC','DBX-NCIT-C12402'),('CL-LOC-T-189',NULL,'FEMORAL ARTERY','An artery that starts within the inguinal region and extends to the lower extremities. (NCI)','\0','Femoral Artery','CL-LOC','DBX-NCIT-C12715'),('CL-LOC-T-19',NULL,'ANTRUM PYLORI','The initial part of the pyloric canal of the stomach. This site contains endocrine cells that produce gastrin and somatostatin. (NCI)','\0','Antrum Pylori','CL-LOC','DBX-NCIT-C12259'),('CL-LOC-T-190',NULL,'FEMORAL CONDYLE','The rounded bony projection at the distal end of the femur.','\0','','CL-LOC','DBX-NCIT-C114186'),('CL-LOC-T-191',NULL,'FEMORAL HEAD','The highest portion of the femoral bone that articulates with the acetabulum. (NCI)','\0','Femur Head','CL-LOC','DBX-NCIT-C32718'),('CL-LOC-T-192',NULL,'FEMORAL LYMPH NODE','A lymph node located in the upper inner portion of the thigh. (NCI)','\0','','CL-LOC','DBX-NCIT-C98183'),('CL-LOC-T-193',NULL,'FEMORAL NECK','The short, constricted portion of the thigh bone between the femur head and the trochanter. (NCI)','\0','Femoral Neck','CL-LOC','DBX-NCIT-C61563'),('CL-LOC-T-194',NULL,'FEMORAL VEIN','A vein that starts within the inguinal region and extends to the lower extremities. (NCI)','\0','Femoral Vein','CL-LOC','DBX-NCIT-C12716'),('CL-LOC-T-195',NULL,'FEMORO-POPLITEAL PERIPHERAL ARTERY','The segment of the blood vessels that includes the popliteal artery and its origin from the femoral artery.','\0','','CL-LOC','DBX-NCIT-C116167'),('CL-LOC-T-196',NULL,'FEMUR','The upper leg bone positioned between the pelvis and the knee. (NCI)','\0','Bone, Femoral; Femur','CL-LOC','DBX-NCIT-C12717'),('CL-LOC-T-197',NULL,'FEMUR SHAFT','The cylindrical body of the femur. (NCI)','\0','','CL-LOC','DBX-NCIT-C96209'),('CL-LOC-T-198',NULL,'FIBULA','The small, lateral calf bone extending from the knee to the ankle. (NCI)','\0','Fibula','CL-LOC','DBX-NCIT-C12718'),('CL-LOC-T-199',NULL,'FINGER','Any of the digits of the hand. (NCI)','\0','Finger','CL-LOC','DBX-NCIT-C32608'),('CL-LOC-T-2',NULL,'ABDOMINAL CAVITY','The portion of the body that lies between the thorax and the pelvis. (NCI)','\0','Abdomen; Abdominal Cavity','CL-LOC','DBX-NCIT-C12664'),('CL-LOC-T-20',NULL,'ANUS','The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded. (NCI)','\0','Anus','CL-LOC','DBX-NCIT-C43362'),('CL-LOC-T-200',NULL,'FINGERNAIL','The nail at the end of a finger. (NCI)','\0','Fingernail','CL-LOC','DBX-NCIT-C32609'),('CL-LOC-T-201',NULL,'FIRST DIAGONAL BRANCH ARTERY','The first artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.','\0','1ST DIAG; FIRST DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102297'),('CL-LOC-T-202',NULL,'FIRST LEFT POSTEROLATERAL BRANCH ARTERY','In an individual with a left-dominant heart, this is the first branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.','\0','1ST LPL; FIRST LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102298'),('CL-LOC-T-203',NULL,'FIRST OBTUSE MARGINAL BRANCH ARTERY','The first artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.','\0','1ST OM; FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102299'),('CL-LOC-T-204',NULL,'FIRST RIGHT POSTEROLATERAL ARTERY','In an individual with a right-dominant heart, this is the first branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.','\0','1ST RPL; FIRST RIGHT POSTEROLATERAL ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102300'),('CL-LOC-T-205',NULL,'FLOOR OF MOUTH','The area of the mouth under the ventral surface of the tongue.','\0','','CL-LOC','DBX-NCIT-C54187'),('CL-LOC-T-206',NULL,'FOOT','The structure found below the ankle joint required for locomotion. (NCI)','\0','Feet; Foot','CL-LOC','DBX-NCIT-C32622'),('CL-LOC-T-207',NULL,'FOOT DIGIT 1','The largest and most medial toe of the foot. (NCI)','\0','Big Toe','CL-LOC','DBX-NCIT-C52839'),('CL-LOC-T-208',NULL,'FOOT DIGIT 2','The second toe from the medial side of the foot. (NCI)','\0','Index Toe','CL-LOC','DBX-NCIT-C52840'),('CL-LOC-T-209',NULL,'FOOT DIGIT 3','The middle or third toe from the medial side of the foot. (NCI)','\0','Middle Toe','CL-LOC','DBX-NCIT-C52841'),('CL-LOC-T-21',NULL,'AORTA','The major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the le','\0','Aorta','CL-LOC','DBX-NCIT-C12669'),('CL-LOC-T-210',NULL,'FOOT DIGIT 4','The fourth toe from the medial side of the foot. (NCI)','\0','Fourth Toe','CL-LOC','DBX-NCIT-C52842'),('CL-LOC-T-211',NULL,'FOOT DIGIT 5','The smallest and most lateral toe of the foot. (NCI)','\0','Little Toe','CL-LOC','DBX-NCIT-C52843'),('CL-LOC-T-212',NULL,'FOOT PHALANX','A bone of the foot. (NCI)','\0','Foot Phalanx','CL-LOC','DBX-NCIT-C52772'),('CL-LOC-T-213',NULL,'FOREARM','The structure on the upper limb, between the elbow and the wrist. (NCI)','\0','Forearm','CL-LOC','DBX-NCIT-C32628'),('CL-LOC-T-214',NULL,'FOREBRAIN','The largest part of the brain composed of the cerebral hemispheres, thalamus, hypothalamus, and the limbic system. (NCI)','\0','','CL-LOC','DBX-NCIT-C40185'),('CL-LOC-T-215',NULL,'FOREHEAD','The part of the face between the eyebrows and the normal hairline.','\0','Forehead','CL-LOC','DBX-NCIT-C89803'),('CL-LOC-T-216',NULL,'FRONTAL LOBE','The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI)','\0','Frontal Lobe','CL-LOC','DBX-NCIT-C12352'),('CL-LOC-T-217',NULL,'FRONTAL SINUS','The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages. (NCI)','\0','Frontal Sinus','CL-LOC','DBX-NCIT-C12277'),('CL-LOC-T-218',NULL,'FUNDUS OF THE STOMACH','The portion of the stomach that lies above the cardiac notch. It allows for the accumulation of gases produced by chemical digestion. (NCI)','\0','Fundus of the Stomach','CL-LOC','DBX-NCIT-C12257'),('CL-LOC-T-219',NULL,'GALLBLADDER','A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods. (NCI)','\0','Gallbladder','CL-LOC','DBX-NCIT-C12377'),('CL-LOC-T-22',NULL,'AORTIC ARCH','The curved segment of the aorta between the ascending and the descending segments.','\0','Aortic Arch','CL-LOC','DBX-NCIT-C32123'),('CL-LOC-T-220',NULL,'GANGLION','A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS). (NCI)','\0','Ganglia; Ganglion; Neural Ganglion','CL-LOC','DBX-NCIT-C12719'),('CL-LOC-T-221',NULL,'GASTRIC CARDIA','The area around the esophagogastric mucosal junction where the esophageal mucosa transitions into the gastric mucosa. (NCI)','\0','Gastric Cardia','CL-LOC','DBX-NCIT-C12256'),('CL-LOC-T-222',NULL,'GASTROESOPHAGEAL JUNCTION','The anatomical location where the esophagus joins to the stomach. (NCI)','\0','Gastroesophageal Junction','CL-LOC','DBX-NCIT-C32668'),('CL-LOC-T-223',NULL,'GASTROINTESTINAL SYSTEM','The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas. (NCI)','\0','Gastrointestinal System','CL-LOC','DBX-NCIT-C12378'),('CL-LOC-T-224',NULL,'GASTROINTESTINAL TRACT','The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI','\0','Gastrointestinal Tract','CL-LOC','DBX-NCIT-C34082'),('CL-LOC-T-225',NULL,'GASTROINTESTINAL TRACT, LOWER','The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine. (NCI)','\0','Lower Gastrointestinal Tract','CL-LOC','DBX-NCIT-C33010'),('CL-LOC-T-226',NULL,'GASTROINTESTINAL TRACT, UPPER','The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum. (NCI)','\0','Upper Gastrointestinal Tract','CL-LOC','DBX-NCIT-C33837'),('CL-LOC-T-227',NULL,'GENITALIA','The external sex organs. (NCI)','\0','','CL-LOC','DBX-NCIT-C25177'),('CL-LOC-T-228',NULL,'GINGIVA','The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering. (NCI)','\0','Gingiva; Gum','CL-LOC','DBX-NCIT-C32677'),('CL-LOC-T-229',NULL,'GLENOID FOSSA','The trough in the head of the scapula that receives the head of the humerus to form the shoulder joint. (NCI)','\0','Glenoid Fossa','CL-LOC','DBX-NCIT-C32682'),('CL-LOC-T-23',NULL,'AORTIC VALVE','A valve that is located between and controls the flow of blood from the left ventricle of the heart and the aorta. (NCI)','\0','','CL-LOC','DBX-NCIT-C12670'),('CL-LOC-T-230',NULL,'GLOSSOPHARYNGEAL NERVE','The ninth cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12723'),('CL-LOC-T-231',NULL,'GLOTTIS','The space in which the vocal cords are located. (NCI)','\0','Glottis','CL-LOC','DBX-NCIT-C12724'),('CL-LOC-T-232',NULL,'GLUTEUS MAXIMUS','The outermost and largest muscle of the buttocks. (NCI)','\0','','CL-LOC','DBX-NCIT-C52560'),('CL-LOC-T-233',NULL,'GREAT TROCHANTER','A large, irregular, quadrilateral area of bone found at the neck of the femur. (NCI)','\0','Great Trochanter','CL-LOC','DBX-NCIT-C32698'),('CL-LOC-T-234',NULL,'GREATER CURVATURE OF THE STOMACH','The lateral and inferior border of the stomach. Attached to it is the greater omentum. (NCI)','\0','Greater Curvature of the Stomach','CL-LOC','DBX-NCIT-C12262'),('CL-LOC-T-235',NULL,'HAIR','The filamentous outgrowth of the epidermis. (NCI)','\0','Hair','CL-LOC','DBX-NCIT-C32705'),('CL-LOC-T-236',NULL,'HAIR BULB','The lower segment of the hair that circles the dermal papilla and the hair matrix. (NCI)','\0','','CL-LOC','DBX-NCIT-C32706'),('CL-LOC-T-237',NULL,'HAIR FOLLICLE','A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from t','\0','','CL-LOC','DBX-NCIT-C13317'),('CL-LOC-T-238',NULL,'HAIR ROOT','The portion of the hair that is enclosed within the hair follicle. (NCI)','\0','','CL-LOC','DBX-NCIT-C32711'),('CL-LOC-T-239',NULL,'HAIR SHAFT','The segment of the hair that projects above the skin surface. (NCI)','\0','Shaft of the Hair','CL-LOC','DBX-NCIT-C33543'),('CL-LOC-T-24',NULL,'AORTO-ILIAC PERIPHERAL ARTERY','The segment of the blood vessels that includes the iliac artery and its origin from the aorta.','\0','','CL-LOC','DBX-NCIT-C116166'),('CL-LOC-T-240',NULL,'HAMATE BONE','The medial bone in the distal row of carpal bones. (NCI)','\0','Hamate Bone','CL-LOC','DBX-NCIT-C12860'),('CL-LOC-T-241',NULL,'HAND','The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI)','\0','Hand','CL-LOC','DBX-NCIT-C32712'),('CL-LOC-T-242',NULL,'HAND DIGIT 1','The thick and short hand digit which is next to the index finger in humans. (NCI)','\0','Thumb','CL-LOC','DBX-NCIT-C52834'),('CL-LOC-T-243',NULL,'HAND DIGIT 2','The second finger from the radial side of the hand, next to the thumb. (NCI)','\0','Index Finger','CL-LOC','DBX-NCIT-C52835'),('CL-LOC-T-244',NULL,'HAND DIGIT 3','The middle or third finger from the radial side of the hand. (NCI)','\0','Middle Finger','CL-LOC','DBX-NCIT-C52836'),('CL-LOC-T-245',NULL,'HAND DIGIT 4','The fourth finger from the radial side of the hand. (NCI)','\0','Ring Finger','CL-LOC','DBX-NCIT-C52837'),('CL-LOC-T-246',NULL,'HAND DIGIT 5','The fifth and smallest finger from the radial side of the hand. (NCI)','\0','Little Finger','CL-LOC','DBX-NCIT-C52838'),('CL-LOC-T-247',NULL,'HAND PHALANX','A bone of the hand. (NCI)','\0','Hand Phalanx','CL-LOC','DBX-NCIT-C52771'),('CL-LOC-T-248',NULL,'HARD PALATE','The bony anterior part of the roof of the mouth separating the nose from the mouth. (NCI)','\0','Hard Palate','CL-LOC','DBX-NCIT-C12230'),('CL-LOC-T-249',NULL,'HEAD','The anterior and superior part of a human or animal bearing the mouth, the brain and sensory organs.','\0','Head','CL-LOC','DBX-NCIT-C12419'),('CL-LOC-T-25',NULL,'AORTOPULMONARY WINDOW LYMPH NODE','A lymph node located in the aortopulmonary window.','\0','','CL-LOC','DBX-NCIT-C116165'),('CL-LOC-T-250',NULL,'HEAD AND NECK','The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas.','\0','','CL-LOC','DBX-NCIT-C12418'),('CL-LOC-T-251',NULL,'HEAD OF THE HUMERUS','The upper rounded part of the humerus that fits into the glenoid cavity of the scapula. (NCI)','\0','Head of the Humerus','CL-LOC','DBX-NCIT-C32720'),('CL-LOC-T-252',NULL,'HEART','A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium)','\0','Cardiac; Heart','CL-LOC','DBX-NCIT-C12727'),('CL-LOC-T-253',NULL,'HEART, APEX','The most outer superficial part of the heart which is situated on the left 5th intercostal space. (NCI)','\0','Apex of the Heart','CL-LOC','DBX-NCIT-C32126'),('CL-LOC-T-254',NULL,'HEART, ATRIUM','The paired upper chambers of the heart. The left atrium receives oxygenated blood from the pulmonary vein and pumps blood into the left ventricle. The right atrium receives venous deoxygenated blood from the entire body via the superior and inferior vena ','\0','Cardiac Atrium','CL-LOC','DBX-NCIT-C12728'),('CL-LOC-T-255',NULL,'HEART, BASE','The superior portion of the heart located opposite to the apical portion. It is formed mainly by the left atrium. (NCI)','\0','Base of the Heart','CL-LOC','DBX-NCIT-C48589'),('CL-LOC-T-256',NULL,'HEART, LEFT VENTRICLE','The left lower chamber of the heart that receives blood from the left atrium and pumps it through the aorta to the body. (NCI)','\0','Left Ventricle','CL-LOC','DBX-NCIT-C12871'),('CL-LOC-T-257',NULL,'HEART, RIGHT VENTRICLE','The lower chamber of the heart located in the right side. It receives blood from the right atrium that is no longer oxygenated and it pumps it to the pulmonary artery. (NCI)','\0','Right Ventricle','CL-LOC','DBX-NCIT-C12870'),('CL-LOC-T-258',NULL,'HEART, SEPTUM','The tissue in the heart that separates the two atria (atrial septum) and the two ventricles (ventricular septum). (NCI)','\0','Cardiac Septum','CL-LOC','DBX-NCIT-C49485'),('CL-LOC-T-259',NULL,'HEART, VENTRICLE','The lower right and left chambers of the heart. The right pumps venous blood into the lungs and the left pumps oxygenated blood into the systemic arterial circulation. (MeSH)','\0','Cardiac Ventricle','CL-LOC','DBX-NCIT-C12730'),('CL-LOC-T-26',NULL,'APPENDICEAL TIP','The distal end of the appendix. (NCI)','\0','','CL-LOC','DBX-NCIT-C83470'),('CL-LOC-T-260',NULL,'HEPATIC LYMPH NODE','Any of the lymph nodes adjacent to the stomach and duodenum. (NCI)','\0','','CL-LOC','DBX-NCIT-C77640'),('CL-LOC-T-261',NULL,'HILAR','Refers to the area associated with the hilum. (NCI)','\0','Hilar','CL-LOC','DBX-NCIT-C25724'),('CL-LOC-T-262',NULL,'HILAR LYMPH NODE','A lymph node located in the hilum of the lung within the mediastinum.','\0','','CL-LOC','DBX-NCIT-C98187'),('CL-LOC-T-263',NULL,'HIP','The lateral prominence of the pelvis from the waist to the thigh. (NCI)','\0','Hip','CL-LOC','DBX-NCIT-C64193'),('CL-LOC-T-264',NULL,'HIP JOINT','A ball-and-socket joint between the head of the femur and the acetabulum. (NCI)','\0','Coxofemoral Joint; Hip Joint','CL-LOC','DBX-NCIT-C32742'),('CL-LOC-T-265',NULL,'HIPPOCAMPUS','A curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the brain. (NCI)','\0','Hippocampus','CL-LOC','DBX-NCIT-C12444'),('CL-LOC-T-266',NULL,'HUMERAL EPICONDYLE','The bone prominence at the distal end of the humerus to which ligaments and tendons of the joints are attached.','\0','','CL-LOC','DBX-NCIT-C114187'),('CL-LOC-T-267',NULL,'HUMERUS','The upper arm bone between the shoulder and elbow. (NCI)','\0','Bone, Humeral; Humerus','CL-LOC','DBX-NCIT-C12731'),('CL-LOC-T-268',NULL,'HYOID BONE','A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI)','\0','Hyoid Bone','CL-LOC','DBX-NCIT-C32752'),('CL-LOC-T-269',NULL,'HYPOGLOSSAL NERVE','The twelfth cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12732'),('CL-LOC-T-27',NULL,'APPENDICULAR SKELETON','The part of the skeleton that includes the bones of the upper and lower limbs, including the shoulder and pelvic girdles','\0','','CL-LOC','DBX-NCIT-C49477'),('CL-LOC-T-270',NULL,'HYPOPHARYNX','The lower part of the pharynx that connects to the esophagus. (NCI)','\0','Hypopharynx','CL-LOC','DBX-NCIT-C12246'),('CL-LOC-T-271',NULL,'HYPOTHALAMUS','The supervisory center in the brain, rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function.','\0','Hypothalamus','CL-LOC','DBX-NCIT-C12458'),('CL-LOC-T-272',NULL,'ILEUM','The final section of the small intestine. (NCI)','\0','Ileum','CL-LOC','DBX-NCIT-C12387'),('CL-LOC-T-273',NULL,'ILEUM, TERMINAL','The most distal section of the ileum that is continuous with the cecum. (NCI)','\0','Terminal Ileum','CL-LOC','DBX-NCIT-C33757'),('CL-LOC-T-274',NULL,'ILIAC CREST','A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine.','\0','','CL-LOC','DBX-NCIT-C103818'),('CL-LOC-T-275',NULL,'ILIAC FOSSA','The large smooth and concave surface of the ilium. (NCI)','\0','','CL-LOC','DBX-NCIT-C103454'),('CL-LOC-T-276',NULL,'ILIAC LYMPH NODE','One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral. (NCI)','\0','Iliac Lymph Node','CL-LOC','DBX-NCIT-C32761'),('CL-LOC-T-277',NULL,'ILIUM','The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis. (NCI)','\0','Ilium','CL-LOC','DBX-NCIT-C32765'),('CL-LOC-T-278',NULL,'INCISOR','One of the teeth in front of the canines in either jaw designed for cutting or gnawing. (NCI)','\0','Incisor','CL-LOC','DBX-NCIT-C32769'),('CL-LOC-T-279',NULL,'INCUS','One of the three bones comprising the middle ear. This anvil-shaped bone is positioned between the malleus and the stapes. (NCI)','\0','Incus','CL-LOC','DBX-NCIT-C32770'),('CL-LOC-T-28',NULL,'APPENDIX','Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ. (NCI)','\0','Appendix','CL-LOC','DBX-NCIT-C12380'),('CL-LOC-T-280',NULL,'INFRACLAVICULAR LYMPH NODE','A lymph node located in the area below the clavicle. (NCI)','\0','Infraclavicular Lymph Node','CL-LOC','DBX-NCIT-C63705'),('CL-LOC-T-281',NULL,'INFRARENAL AORTA','The portion of the abdominal aorta that lies below the kidneys.','\0','','CL-LOC','DBX-NCIT-C116179'),('CL-LOC-T-282',NULL,'INGUINAL LYMPH NODE','A superficial or deep lymph node located in the inguinal area. (NCI)','\0','Inguinal Lymph Node','CL-LOC','DBX-NCIT-C32801'),('CL-LOC-T-283',NULL,'INGUINAL REGION','The lower region of the anterior abdominal wall located laterally to the pubic region. (NCI)','\0','Groin; Inguinal Region','CL-LOC','DBX-NCIT-C12726'),('CL-LOC-T-284',NULL,'INTERNAL ILIAC ARTERY','A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh.','\0','','CL-LOC','DBX-NCIT-C32845'),('CL-LOC-T-285',NULL,'INTERNAL MAMMARY ARTERY','The blood vessel that supplies the breast and the anterior chest wall with arterial blood. It is located in the chest wall. (NCI)','\0','','CL-LOC','DBX-NCIT-C52941'),('CL-LOC-T-286',NULL,'INTERNAL MAMMARY LYMPH NODE','Any of the lymph nodes of the breast located under the ribcage, near the sternum. (NCI)','\0','','CL-LOC','DBX-NCIT-C32853'),('CL-LOC-T-287',NULL,'INTERPHALANGEAL JOINT 1','A ginglymoid (hinge) synovial joint within the first digit of the hand or foot connecting the proximal and distal phalanges. (NCI)','\0','IP1','CL-LOC','DBX-NCIT-C102301'),('CL-LOC-T-288',NULL,'INTERPHALANGEAL JOINT 1 OF THE FOOT','A ginglymoid (hinge) synovial joint within the first digit of the foot connecting the proximal and distal phalanges. (NCI)','\0','IP1 of the Foot','CL-LOC','DBX-NCIT-C114200'),('CL-LOC-T-289',NULL,'INTERPHALANGEAL JOINT 2','A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand or foot. (NCI)','\0','IP2','CL-LOC','DBX-NCIT-C102302'),('CL-LOC-T-29',NULL,'ARM','The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb. (NCI)','\0','Arm','CL-LOC','DBX-NCIT-C32141'),('CL-LOC-T-290',NULL,'INTERPHALANGEAL JOINT 2 OF THE FOOT','A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the foot. (NCI)','\0','IP2 of the Foot','CL-LOC','DBX-NCIT-C114201'),('CL-LOC-T-291',NULL,'INTERPHALANGEAL JOINT 2 OF THE HAND','A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand. (NCI)','\0','IP2 of the Hand','CL-LOC','DBX-NCIT-C114190'),('CL-LOC-T-292',NULL,'INTERPHALANGEAL JOINT 3','A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand or foot. (NCI)','\0','IP3','CL-LOC','DBX-NCIT-C102303'),('CL-LOC-T-293',NULL,'INTERPHALANGEAL JOINT 3 OF THE FOOT','A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the foot. (NCI)','\0','IP3 of the Foot','CL-LOC','DBX-NCIT-C114202'),('CL-LOC-T-294',NULL,'INTERPHALANGEAL JOINT 3 OF THE HAND','A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand. (NCI)','\0','IP3 of the Hand','CL-LOC','DBX-NCIT-C114191'),('CL-LOC-T-295',NULL,'INTERPHALANGEAL JOINT 4','A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand or foot. (NCI)','\0','IP4','CL-LOC','DBX-NCIT-C102304'),('CL-LOC-T-296',NULL,'INTERPHALANGEAL JOINT 4 OF THE FOOT','A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the foot. (NCI)','\0','IP4 of the Foot','CL-LOC','DBX-NCIT-C114203'),('CL-LOC-T-297',NULL,'INTERPHALANGEAL JOINT 4 OF THE HAND','A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand. (NCI)','\0','IP4 of the Hand','CL-LOC','DBX-NCIT-C114192'),('CL-LOC-T-298',NULL,'INTERPHALANGEAL JOINT 5','A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand or foot. (NCI)','\0','IP5','CL-LOC','DBX-NCIT-C102305'),('CL-LOC-T-299',NULL,'INTERPHALANGEAL JOINT 5 OF THE FOOT','A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the foot. (NCI)','\0','IP5 of the Foot','CL-LOC','DBX-NCIT-C114204'),('CL-LOC-T-3',NULL,'ABDOMINAL LYMPH NODE','Any lymph node within the abdomen.','\0','','CL-LOC','DBX-NCIT-C12360'),('CL-LOC-T-30',NULL,'ARM SKIN','The skin or integument covering the arm. (NCI)','\0','Arm Skin','CL-LOC','DBX-NCIT-C52754'),('CL-LOC-T-300',NULL,'INTERPHALANGEAL JOINT 5 OF THE HAND','A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand. (NCI)','\0','IP5 of the Hand','CL-LOC','DBX-NCIT-C114193'),('CL-LOC-T-301',NULL,'INTERPHALANGEAL JOINT OF THE HAND','The hinge synovial joints between the phalanges of the fingers. (NCI)','\0','Interphalangeal Joint of the Hand','CL-LOC','DBX-NCIT-C32868'),('CL-LOC-T-302',NULL,'INTERPHALANGEAL OF THE FOOT','The hinge synovial joints between the bones of the toes. (NCI)','\0','IP of the Foot','CL-LOC','DBX-NCIT-C32867'),('CL-LOC-T-303',NULL,'INTERPHALANGEAL THUMB JOINT','A condyloid synovial joint within the thumb connecting the proximal and distal phalanges.','\0','IP THUMB; IP1 of the Hand; Interphalangeal Joint 1 of the Hand','CL-LOC','DBX-NCIT-C102306'),('CL-LOC-T-304',NULL,'INTERVENTRICULAR SEPTUM','The wall that separates the left and right ventricles of the heart. (NCI)','\0','','CL-LOC','DBX-NCIT-C32874'),('CL-LOC-T-305',NULL,'INTESTINE','The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine. (NCI)','\0','Intestine','CL-LOC','DBX-NCIT-C12736'),('CL-LOC-T-306',NULL,'INTRAHEPATIC BILE DUCT','The bile ducts that pass through and drain bile from the liver. (NCI)','\0','','CL-LOC','DBX-NCIT-C12677'),('CL-LOC-T-307',NULL,'INTRATHORACIC LYMPH NODE','Any lymph node within the thoracic cavity.','\0','','CL-LOC','DBX-NCIT-C12359'),('CL-LOC-T-308',NULL,'ISCHIAL TUBEROSITY','The bony prominence of the lower part of the ischium. (NCI)','\0','','CL-LOC','DBX-NCIT-C105446'),('CL-LOC-T-309',NULL,'ISCHIORECTAL FOSSA','A tetrahedral region of adipose tissue located in the ischiorectal region with its base between the tuberosity of the ischium and the lower end of the rectum and its apex at the point where the obturator fascia and the Levator ani membrane divide.','\0','','CL-LOC','DBX-NCIT-C103455'),('CL-LOC-T-31',NULL,'ARTERY','A blood vessel that carries blood away from the heart. (NCI)','\0','Artery','CL-LOC','DBX-NCIT-C12372'),('CL-LOC-T-310',NULL,'ISCHIUM','The most posterior and ventral bone making up the pelvis. (NCI)','\0','Ischium','CL-LOC','DBX-NCIT-C32884'),('CL-LOC-T-311',NULL,'JEJUNUM','The portion of the small intestine that extends from the duodenum to the ileum. (NCI)','\0','Jejunum','CL-LOC','DBX-NCIT-C12388'),('CL-LOC-T-312',NULL,'JOINT','The connection point between two bones or skeletal elements. The joint may be fixed or movable. (NCI)','\0','Articulation; Joint','CL-LOC','DBX-NCIT-C13044'),('CL-LOC-T-313',NULL,'JUGULAR VEIN','Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins. (NCI)','\0','Vena Jugularis','CL-LOC','DBX-NCIT-C12738'),('CL-LOC-T-314',NULL,'KIDNEY','One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blo','\0','Kidney','CL-LOC','DBX-NCIT-C12415'),('CL-LOC-T-315',NULL,'KIDNEY, CORTEX','The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. (MSH2001)','\0','Renal Cortex','CL-LOC','DBX-NCIT-C12739'),('CL-LOC-T-316',NULL,'KIDNEY, HILUM','The concave area of the kidney through which the renal artery enters and the renal vein and ureter exit the organ. (NCI)','\0','Hilar Area of the Kidney','CL-LOC','DBX-NCIT-C32740'),('CL-LOC-T-317',NULL,'KIDNEY, LOWER LOBE','The lobe of the kidney located in the lowest portion of the kidney. (NCI)','\0','Lower Lobe of the Kidney','CL-LOC','DBX-NCIT-C93180'),('CL-LOC-T-318',NULL,'KIDNEY, MEDULLA','The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. (MSH2001)','\0','Renal Medulla','CL-LOC','DBX-NCIT-C12740'),('CL-LOC-T-319',NULL,'KIDNEY, UPPER LOBE','The lobe of the kidney located in the uppermost region of the kidney. (NCI)','\0','Upper Lobe of the Kidney','CL-LOC','DBX-NCIT-C93179'),('CL-LOC-T-32',NULL,'AXIAL SKELETON','The part of the skeleton that includes the skull and spinal column and sternum and ribs. (NCI)','\0','','CL-LOC','DBX-NCIT-C32172'),('CL-LOC-T-320',NULL,'KNEE JOINT','A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, ','\0','Knee Joint; Tibiofemoral Joint','CL-LOC','DBX-NCIT-C32898'),('CL-LOC-T-321',NULL,'L1 VERTEBRA','The first lumbar vertebra counting from the top down. (NCI)','\0','L1 Vertebra','CL-LOC','DBX-NCIT-C32899'),('CL-LOC-T-322',NULL,'L2 VERTEBRA','The second lumbar vertebra counting from the top down. (NCI)','\0','L2 Vertebra','CL-LOC','DBX-NCIT-C32900'),('CL-LOC-T-323',NULL,'L2-L3 INTERVERTEBRAL SPACE','The space between the L2 and L3 vertebrae.','\0','','CL-LOC','DBX-NCIT-C112327'),('CL-LOC-T-324',NULL,'L3 VERTEBRA','The third lumbar vertebra counting from the top down. (NCI)','\0','L3 Vertebra','CL-LOC','DBX-NCIT-C32901'),('CL-LOC-T-325',NULL,'L3-L4 INTERVERTEBRAL SPACE','The space between the L3 and L4 vertebrae.','\0','','CL-LOC','DBX-NCIT-C112328'),('CL-LOC-T-326',NULL,'L4 VERTEBRA','The fourth lumbar vertebra counting from the top down. (NCI)','\0','L4 Vertebra','CL-LOC','DBX-NCIT-C32902'),('CL-LOC-T-327',NULL,'L5 VERTEBRA','The fifth lumbar vertebra counting from the top down. (NCI)','\0','L5 Vertebra','CL-LOC','DBX-NCIT-C32903'),('CL-LOC-T-328',NULL,'LACRIMAL BONE','A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones. (NCI)','\0','Lacrimal Bone','CL-LOC','DBX-NCIT-C32906'),('CL-LOC-T-329',NULL,'LACRIMAL GLAND','Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears. (NCI)','\0','','CL-LOC','DBX-NCIT-C12346'),('CL-LOC-T-33',NULL,'AXILLA','The underside concavity where the arm and the shoulder are joined. (NCI)','\0','Axilla','CL-LOC','DBX-NCIT-C12674'),('CL-LOC-T-330',NULL,'LAD SEPTAL PERFORATOR ARTERY','The arteries that arise from the left anterior descending (LAD) artery that supply the interventricular septum.','\0','LAD SEPTAL PERFORATOR ARTERY SEGMENTS; LAD SP','CL-LOC','DBX-NCIT-C102313'),('CL-LOC-T-331',NULL,'LARGE INTESTINE','A muscular tube that extends from the end of the small intestine to the anus. (NCI)','\0','Large Intestine','CL-LOC','DBX-NCIT-C12379'),('CL-LOC-T-332',NULL,'LARYNX','The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production. (NCI)','\0','Larynx','CL-LOC','DBX-NCIT-C12420'),('CL-LOC-T-333',NULL,'LATERAL FIRST DIAGONAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the first diagonal artery.','\0','LAT 1ST DIAG; LATERAL FIRST DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102307'),('CL-LOC-T-334',NULL,'LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the first obtuse marginal artery.','\0','First Obtuse Marginal Lateral Branch; LAT 1ST OM; LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102308'),('CL-LOC-T-335',NULL,'LATERAL RAMUS INTERMEDIUS ARTERY','The lateral branch distal to a bifurcation of the ramus intermedius artery.','\0','LAT RAMUS; LATERAL RAMUS INTERMEDIUS ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102309'),('CL-LOC-T-336',NULL,'LATERAL SECOND DIAGONAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the second diagonal artery.','\0','LAT 2ND DIAG; LATERAL SECOND DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102310'),('CL-LOC-T-337',NULL,'LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the second obtuse marginal artery.','\0','LAT 2ND OM; LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT; Second Obtuse Marginal Lateral Branch','CL-LOC','DBX-NCIT-C102311'),('CL-LOC-T-338',NULL,'LATERAL THIRD DIAGONAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the third diagonal artery.','\0','LAT 3RD DIAG; LATERAL THIRD DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102312'),('CL-LOC-T-339',NULL,'LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY','The lateral branch distal to a bifurcation of the third obtuse marginal artery.','\0','LAT 3RD OM; LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT; Third Obtuse Marginal Lateral Branch','CL-LOC','DBX-NCIT-C102425'),('CL-LOC-T-34',NULL,'AXILLARY ARTERY','An artery that originates from the subclavian artery at the lateral margin of the first rib. It supplies the brachial artery.','\0','','CL-LOC','DBX-NCIT-C32169'),('CL-LOC-T-340',NULL,'LEFT ANTERIOR DESCENDING ARTERY OSTIUM','The opening of the left anterior descending coronary artery at its origin.','\0','','CL-LOC','DBX-NCIT-C116175'),('CL-LOC-T-341',NULL,'LEFT ATRIOVENTRICULAR ARTERY','The first posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations.','\0','','CL-LOC','DBX-NCIT-C116177'),('CL-LOC-T-342',NULL,'LEFT CIRCUMFLEX ARTERY OSTIUM','The opening of the left circumflex artery at its origin.','\0','','CL-LOC','DBX-NCIT-C116176'),('CL-LOC-T-343',NULL,'LEFT CIRCUMFLEX CORONARY ARTERY','An artery arising from the bifurcation of the left coronary artery that runs along the coronary groove.','\0','','CL-LOC','DBX-NCIT-C12874'),('CL-LOC-T-344',NULL,'LEFT MAIN CORONARY ARTERY BIFURCATION','The portion of the distal end of the left main coronary artery that branches into the left anterior descending artery and the left circumflex artery.','\0','','CL-LOC','DBX-NCIT-C116174'),('CL-LOC-T-345',NULL,'LEFT MAIN CORONARY ARTERY BODY','The segment of the left main coronary artery that is bounded by its ostium and bifurcation.','\0','','CL-LOC','DBX-NCIT-C116173'),('CL-LOC-T-346',NULL,'LEFT MAIN CORONARY ARTERY OSTIUM','The opening of the left coronary artery at its origin.','\0','','CL-LOC','DBX-NCIT-C116172'),('CL-LOC-T-347',NULL,'LEFT POSTERIOR DESCENDING ARTERY','The second posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations.','\0','','CL-LOC','DBX-NCIT-C116178'),('CL-LOC-T-348',NULL,'LEFT POSTEROLATERAL DESCENDING ARTERY','In an individual with a left-dominant heart, this branch arises from the circumflex artery atrioventricular groove continuation and supplies the inferior apex of the heart.','\0','LEFT POSTEROLATERAL DESCENDING ARTERY SEGMENT; LPDA','CL-LOC','DBX-NCIT-C102314'),('CL-LOC-T-349',NULL,'LEFT VENTRICULAR EPICARDIUM','The outermost layer of cardiac tissue lining of the left ventricle.','\0','','CL-LOC','DBX-NCIT-C102315'),('CL-LOC-T-35',NULL,'AXILLARY LYMPH NODE','One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. (NCI)','\0','Axillary Lymph Node','CL-LOC','DBX-NCIT-C12904'),('CL-LOC-T-350',NULL,'LEG','One of the two lower extremities in humans used for locomotion and support. (NCI)','\0','Leg','CL-LOC','DBX-NCIT-C32974'),('CL-LOC-T-351',NULL,'LEG SKIN','The skin or integument surrounding the leg. (NCI)','\0','Leg Skin','CL-LOC','DBX-NCIT-C52749'),('CL-LOC-T-352',NULL,'LENS','A biconvex transparent structure of the eye through which light is focused on the retina. The lens sits behind the iris and is supported by the zonule, which connects it to the ciliary body. The lens is an avascular structure. (NCI)','\0','Crystalline Lens; Lens; Lens Of Eye; Ocular Lens','CL-LOC','DBX-NCIT-C12743'),('CL-LOC-T-353',NULL,'LESSER TROCHANTER','A cone-shaped projection in the shaft of the femur in which the iliopsoas muscle is attached. (NCI)','\0','','CL-LOC','DBX-NCIT-C32982'),('CL-LOC-T-354',NULL,'LIGAMENT','Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI)','\0','Ligament','CL-LOC','DBX-NCIT-C13046'),('CL-LOC-T-355',NULL,'LIMB','A body region referring to an upper or lower extremity. (NCI)','\0','Extremities; Limb','CL-LOC','DBX-NCIT-C12429'),('CL-LOC-T-356',NULL,'LIMB, LOWER','The limb that is composed of the hip, thigh, leg and foot. (NCI)','\0','Lower Extremity','CL-LOC','DBX-NCIT-C12742'),('CL-LOC-T-357',NULL,'LIMB, UPPER','The region of the body that includes the arm, the forearm, and hand. (NCI)','\0','Upper Extremity','CL-LOC','DBX-NCIT-C12671'),('CL-LOC-T-358',NULL,'LINGULA OF THE LUNG','A small tongue-like projection from the lower portion of the upper lobe of the left lung.','\0','','CL-LOC','DBX-NCIT-C40373'),('CL-LOC-T-359',NULL,'LIP','Fleshy fold which surrounds the opening of the mouth. (NCI)','\0','Lip','CL-LOC','DBX-NCIT-C12220'),('CL-LOC-T-36',NULL,'AXILLARY VEIN','A large blood vessel which returns blood to the heart from the lateral thorax, axilla and upper limb. Each side of the body contains one axillary vein.','\0','','CL-LOC','DBX-NCIT-C32171'),('CL-LOC-T-360',NULL,'LIP, LOWER','The external surface of the lower lip. (NCI)','\0','External Lower Lip','CL-LOC','DBX-NCIT-C12222'),('CL-LOC-T-361',NULL,'LIP, UPPER','The external surface of the upper lip. (NCI)','\0','External Upper Lip','CL-LOC','DBX-NCIT-C12221'),('CL-LOC-T-362',NULL,'LIVER','A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to r','\0','Liver','CL-LOC','DBX-NCIT-C12392'),('CL-LOC-T-363',NULL,'LIVER FISSURE','A groove on the surface of the liver.','\0','Liver Fissure','CL-LOC','DBX-NCIT-C32996'),('CL-LOC-T-364',NULL,'LIVER, CAUDATE LOBE','The lobe of the liver situated posteriorly located between the left lobe and the inferior vena cava.','\0','','CL-LOC','DBX-NCIT-C33000'),('CL-LOC-T-365',NULL,'LIVER, LEFT LOBE','The smaller lobe of the liver extending into the left side of the body.','\0','','CL-LOC','DBX-NCIT-C32965'),('CL-LOC-T-366',NULL,'LIVER, QUADRATE LOBE','An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis.','\0','','CL-LOC','DBX-NCIT-C112404'),('CL-LOC-T-367',NULL,'LIVER, RIGHT LOBE','The larger lobe of the liver extending into the right side of the body.','\0','','CL-LOC','DBX-NCIT-C33481'),('CL-LOC-T-368',NULL,'LOCUS CERULEUS','A brainstem nucleus. It is the major brain site for the synthesis and secretion of norepinephrine. (NCI)','\0','','CL-LOC','DBX-NCIT-C97333'),('CL-LOC-T-369',NULL,'LUMBAR REGION','The area of the body below the ribs and above the hipbones. (NCI)','\0','','CL-LOC','DBX-NCIT-C34004'),('CL-LOC-T-37',NULL,'BACK','The dorsal area between the base of the neck and the sacrum. (NCI)','\0','Back','CL-LOC','DBX-NCIT-C13062'),('CL-LOC-T-370',NULL,'LUMBAR SPINE','The vertebrae located below the thoracic and above the sacral vertebrae.','\0','','CL-LOC','DBX-NCIT-C69314'),('CL-LOC-T-371',NULL,'LUMBAR VERTEBRA','Any of the vertebrae situated between the thoracic vertebrae and the sacrum in the lower part of the spine.','\0','Lumbar Vertebra','CL-LOC','DBX-NCIT-C12744'),('CL-LOC-T-372',NULL,'LUNATE BONE','The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. (NCI)','\0','Lunate Bone','CL-LOC','DBX-NCIT-C12786'),('CL-LOC-T-373',NULL,'LUNG','One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, ','\0','Lung','CL-LOC','DBX-NCIT-C12468'),('CL-LOC-T-374',NULL,'LUNG, HILUM','The wedge-shaped area at the central portion of the lung through which the bronchi, vessels and nerves enter or exit the organ. (NCI)','\0','Hilar Area of the Lung','CL-LOC','DBX-NCIT-C49282'),('CL-LOC-T-375',NULL,'LUNG, LEFT','The 2-lobed lung located on the left side of the body. (NCI)','\0','Left Lung','CL-LOC','DBX-NCIT-C32967'),('CL-LOC-T-376',NULL,'LUNG, LEFT LOWER LOBE','The larger lobe of the left lung, situated below and behind the oblique fissure. (NCI)','\0','Lower Lobe of the Left Lung','CL-LOC','DBX-NCIT-C33020'),('CL-LOC-T-377',NULL,'LUNG, LEFT UPPER LOBE','The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex. (NCI)','\0','Upper Lobe of the Left Lung','CL-LOC','DBX-NCIT-C33021'),('CL-LOC-T-378',NULL,'LUNG, RIGHT','The 3-lobed lung located on the right side of the body. (NCI)','\0','Right Lung','CL-LOC','DBX-NCIT-C33483'),('CL-LOC-T-379',NULL,'LUNG, RIGHT LOWER LOBE','The lobe of the right lung situated below the oblique fissure. (NCI)','\0','Lower Lobe of the Right Lung','CL-LOC','DBX-NCIT-C33022'),('CL-LOC-T-38',NULL,'BASAL GANGLIA','Clusters of neurons comprising the globus pallidus, putamen, caudate, nucleus accumbens, substantia nigra and subthalamic nucleus. They are involved with high level aspects of inhibitory motor activity in coordination with the excitation commands issued f','\0','Basal Ganglia','CL-LOC','DBX-NCIT-C12447'),('CL-LOC-T-380',NULL,'LUNG, RIGHT MIDDLE LOBE','The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure. (NCI)','\0','Middle Lobe of the Right Lung','CL-LOC','DBX-NCIT-C12286'),('CL-LOC-T-381',NULL,'LUNG, RIGHT UPPER LOBE','The lobe of the right lung, situated above the horizontal fissure, which includes the apex. (NCI)','\0','Upper Lobe of the Right Lung','CL-LOC','DBX-NCIT-C33023'),('CL-LOC-T-382',NULL,'LYMPH NODE','A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found through out the body. It is composed predominantly of lymphocytes and its main function is immune protection. (NCI)','\0','Lymph Node; Lymphatic Gland','CL-LOC','DBX-NCIT-C12745'),('CL-LOC-T-383',NULL,'LYMPH NODE HILUM','The concave side of the lymph node. (NCI)','\0','Lymph Node Hilum','CL-LOC','DBX-NCIT-C33031'),('CL-LOC-T-384',NULL,'MAIN BRONCHUS, LEFT','One of the two main bronchi. It is narrower but longer than the right main bronchus and connects to the left lung. (NCI)','\0','Left Main Bronchus','CL-LOC','DBX-NCIT-C32968'),('CL-LOC-T-385',NULL,'MAIN BRONCHUS, RIGHT','One of the two main bronchi. It is wider but shorter than the left main bronchus and connects to the right lung. (NCI)','\0','Right Main Bronchus','CL-LOC','DBX-NCIT-C33486'),('CL-LOC-T-386',NULL,'MALE GENITALIA','Male internal and external organs of reproduction.','\0','Male Genitalia','CL-LOC','DBX-NCIT-C61599'),('CL-LOC-T-387',NULL,'MALE REPRODUCTIVE SYSTEM','The sex organs of the male.','\0','','CL-LOC','DBX-NCIT-C12722'),('CL-LOC-T-388',NULL,'MALLEUS','A hammer-shaped bone, part of three interconnected small bones located in the middle ear. It is attached to the inner surface of the tympanic membrane and its function is to transmit sound vibrations. (NCI)','\0','Malleus','CL-LOC','DBX-NCIT-C33051'),('CL-LOC-T-389',NULL,'MAMMARY GLAND','Lactiferous glands consisting of fibrous tissue connecting the lobes and fatty tissue in between the lobes.','\0','','CL-LOC','DBX-NCIT-C12367'),('CL-LOC-T-39',NULL,'BASILIC VEIN','One of the moderately large superficial veins of the forearm that transports blood from the hand and the medial aspect of the forearm to the axillary vein. (NCI)','\0','Basilic Vein','CL-LOC','DBX-NCIT-C32197'),('CL-LOC-T-390',NULL,'MANDIBLE','The lower jaw bone holding the lower teeth. (NCI)','\0','Bone, Mandibular; Inferior Maxillary Bone; Lower Jaw; Mandible','CL-LOC','DBX-NCIT-C12290'),('CL-LOC-T-391',NULL,'MASTOID PROCESS','A honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear. (NCI)','\0','Mastoid Process','CL-LOC','DBX-NCIT-C12503'),('CL-LOC-T-392',NULL,'MAXILLA','The upper jawbone in vertebrates: it is fused to the cranium. (NCI)','\0','Maxilla','CL-LOC','DBX-NCIT-C26470'),('CL-LOC-T-393',NULL,'MAXILLARY SINUS','A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is th','\0','Maxillary Sinus','CL-LOC','DBX-NCIT-C12275'),('CL-LOC-T-394',NULL,'MEDIAN OR LOWER CERVICAL LYMPH NODE','A lymph node located in the median or lower region of the neck. (NCI)','\0','','CL-LOC','DBX-NCIT-C103417'),('CL-LOC-T-395',NULL,'MEDIASTINAL LYMPH NODE','A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent. (NCI)','\0','Mediastinal Lymph Node','CL-LOC','DBX-NCIT-C33073'),('CL-LOC-T-396',NULL,'MEDIASTINUM','A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contai','\0','Mediastinum','CL-LOC','DBX-NCIT-C12748'),('CL-LOC-T-397',NULL,'MEDIASTINUM, ANTERIOR','The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery. (NCI)','\0','Anterior Mediastinum','CL-LOC','DBX-NCIT-C32098'),('CL-LOC-T-398',NULL,'MEDIASTINUM, MIDDLE','The broadest part of the lower portion of the mediastinum. It contains the heart and the great vessels. (NCI)','\0','Middle Mediastinum','CL-LOC','DBX-NCIT-C33123'),('CL-LOC-T-399',NULL,'MEDIASTINUM, POSTERIOR','The part of the lower portion of the mediastinum that is located behind the pericardium. (NCI)','\0','Posterior Mediastinum','CL-LOC','DBX-NCIT-C33368'),('CL-LOC-T-4',NULL,'ABDOMINAL SKIN','The skin or integument surrounding the abdomen. (NCI)','\0','Abdominal Skin','CL-LOC','DBX-NCIT-C52758'),('CL-LOC-T-40',NULL,'BICEPS FEMORIS MUSCLE','A muscle in the back of the thigh. Its action involves the knee flexion and hip extension. (NCI)','\0','','CL-LOC','DBX-NCIT-C53147'),('CL-LOC-T-400',NULL,'MEDIASTINUM, SUPERIOR','The part of the mediastinum that is located between the upper part of the sternum in the front and the upper thoracic vertebrae in the back. (NCI)','\0','Superior Mediastinum','CL-LOC','DBX-NCIT-C33684'),('CL-LOC-T-401',NULL,'MEDULLA OBLONGATA','The lower portion of the brainstem located between the pons and brainstem. This structure contains several descending and ascending tracts, lower cranial nerve nuclei, a significant proportion of the reticular system of the brainstem and other structures.','\0','Medulla Oblongata','CL-LOC','DBX-NCIT-C12442'),('CL-LOC-T-402',NULL,'MESENTERIC LYMPH NODE','A lymph node located in the mesentery. (NCI)','\0','','CL-LOC','DBX-NCIT-C77641'),('CL-LOC-T-403',NULL,'MESENTERY','A double layer of peritoneum that attaches to the back wall of the abdominal cavity and supports the small intestines. (NCI)','\0','','CL-LOC','DBX-NCIT-C33103'),('CL-LOC-T-404',NULL,'METACARPOPHALANGEAL JOINT 1','A condyloid synovial joint within the first digit of the hand connecting the metacarpal to the proximal phalanx.','\0','MCP1','CL-LOC','DBX-NCIT-C102316'),('CL-LOC-T-405',NULL,'METACARPOPHALANGEAL JOINT 2','A condyloid synovial joint within the second digit of the hand connecting the metacarpal to the proximal phalanx.','\0','MCP2','CL-LOC','DBX-NCIT-C102317'),('CL-LOC-T-406',NULL,'METACARPOPHALANGEAL JOINT 3','A condyloid synovial joint within the third digit of the hand connecting the metacarpal to the proximal phalanx.','\0','MCP3','CL-LOC','DBX-NCIT-C102318'),('CL-LOC-T-407',NULL,'METACARPOPHALANGEAL JOINT 4','A condyloid synovial joint within the fourth digit of the hand connecting the metacarpal to the proximal phalanx.','\0','MCP4','CL-LOC','DBX-NCIT-C102319'),('CL-LOC-T-408',NULL,'METACARPOPHALANGEAL JOINT 5','A condyloid synovial joint within the fifth digit of the hand connecting the metacarpal to the proximal phalanx.','\0','MCP5','CL-LOC','DBX-NCIT-C102320'),('CL-LOC-T-409',NULL,'METATARSAL BONE','A bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side. (NCI)','\0','Metatarsal Bone','CL-LOC','DBX-NCIT-C12752'),('CL-LOC-T-41',NULL,'BILE DUCT','Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct.','\0','','CL-LOC','DBX-NCIT-C12376'),('CL-LOC-T-410',NULL,'METATARSOPHALANGEAL JOINT','A spheroid joint located between the heads of the metatarsal bone and the base of the proximal phalanx of the toe. (NCI)','\0','Metatarsophalangeal Joint','CL-LOC','DBX-NCIT-C33108'),('CL-LOC-T-411',NULL,'METATARSOPHALANGEAL JOINT 1','A condyloid synovial joint within the first digit of the foot connecting metatarsal with the proximal phalanx.','\0','MTP1','CL-LOC','DBX-NCIT-C102321'),('CL-LOC-T-412',NULL,'METATARSOPHALANGEAL JOINT 2','A condyloid synovial joint within the second digit of the foot connecting metatarsal with the proximal phalanx.','\0','MTP2','CL-LOC','DBX-NCIT-C102322'),('CL-LOC-T-413',NULL,'METATARSOPHALANGEAL JOINT 3','A condyloid synovial joint within the third digit of the foot connecting metatarsal with the proximal phalanx.','\0','MTP3','CL-LOC','DBX-NCIT-C102323'),('CL-LOC-T-414',NULL,'METATARSOPHALANGEAL JOINT 4','A condyloid synovial joint within the fourth digit of the foot connecting metatarsal with the proximal phalanx.','\0','MTP4','CL-LOC','DBX-NCIT-C102324'),('CL-LOC-T-415',NULL,'METATARSOPHALANGEAL JOINT 5','A condyloid synovial joint within the fifth digit of the foot connecting metatarsal with the proximal phalanx.','\0','MTP5','CL-LOC','DBX-NCIT-C102325'),('CL-LOC-T-416',NULL,'MID-CIRCUMFLEX ARTERY','The segment of the left circumflex artery between the first and second marginal branches.','\0','MCIRC; MID-CIRCUMFLEX ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102326'),('CL-LOC-T-417',NULL,'MID-LAD ARTERY','The segment of the left anterior descending (LAD) artery between the first and third diagonal branches.','\0','MID-LAD ARTERY SEGMENT; MLAD','CL-LOC','DBX-NCIT-C102328'),('CL-LOC-T-418',NULL,'MID-RIGHT CORONARY ARTERY CONDUIT','The section of the right coronary artery between the right ventricular artery and the acute marginal artery.','\0','MID-RIGHT CORONARY ARTERY CONDUIT SEGMENT; MRCA; Mid-right Coronary Artery','CL-LOC','DBX-NCIT-C102329'),('CL-LOC-T-419',NULL,'MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES','All of the arterial branches distal to the proximal left anterior descending coronary artery.','\0','','CL-LOC','DBX-NCIT-C102327'),('CL-LOC-T-42',NULL,'BILIARY TRACT','The duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gal','\0','Biliary Tract','CL-LOC','DBX-NCIT-C12678'),('CL-LOC-T-420',NULL,'MIDBRAIN','The uppermost portion of the brainstem located between the pons and the diencephalon. The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts. (NCI)','\0','Mesencephalon; Midbrain','CL-LOC','DBX-NCIT-C12510'),('CL-LOC-T-421',NULL,'MIDDLE EAR','The part of the ear including the eardrum and ossicles. The middle ear leads to the inner ear. (NCI)','\0','Middle Ear','CL-LOC','DBX-NCIT-C12274'),('CL-LOC-T-422',NULL,'MOTOR CORTEX','A brain region that is located in the dorsal part of the precentral gyrus. (NCI)','\0','','CL-LOC','DBX-NCIT-C97339'),('CL-LOC-T-423',NULL,'MUCOSA','The moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid).','\0','Mucosa; Mucous Membrane','CL-LOC','DBX-NCIT-C13166'),('CL-LOC-T-424',NULL,'MUCOSA OF THE LIP','The lining of the fleshy folds surrounding the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. (NCI)','\0','','CL-LOC','DBX-NCIT-C12226'),('CL-LOC-T-425',NULL,'MUSCLE','A fibrous soft tissue with the ability to contract to produce force and motion.','\0','','CL-LOC','DBX-NCIT-C13056'),('CL-LOC-T-426',NULL,'MYOMETRIUM','The smooth muscle lining the uterus. (NCI)','\0','Myometrium','CL-LOC','DBX-NCIT-C12314'),('CL-LOC-T-427',NULL,'NAIL','The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI)','\0','Nail','CL-LOC','DBX-NCIT-C33156'),('CL-LOC-T-428',NULL,'NASAL BONE','One of two small oblong bones placed side by side at the middle and upper part of the face. (NCI)','\0','Nasal Bone','CL-LOC','DBX-NCIT-C33157'),('CL-LOC-T-429',NULL,'NASAL CAVITY','The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from','\0','Nasal Cavity','CL-LOC','DBX-NCIT-C12424'),('CL-LOC-T-43',NULL,'BLADDER','The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI)','\0','Bladder','CL-LOC','DBX-NCIT-C12414'),('CL-LOC-T-430',NULL,'NASAL SEPTUM','The thin wall between the two nasal cavities. (NCI)','\0','Nasal Septum','CL-LOC','DBX-NCIT-C33160'),('CL-LOC-T-431',NULL,'NASOPHARYNX','The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages. (NCI)','\0','Nasopharynx','CL-LOC','DBX-NCIT-C12423'),('CL-LOC-T-432',NULL,'NAVICULAR BONE','An oval-shaped bone of the tarsus found on the medial side of the foot. (NCI)','\0','Navicular Bone','CL-LOC','DBX-NCIT-C33162'),('CL-LOC-T-433',NULL,'NECK','The region that connects the head to the rest of the body. (NCI)','\0','Neck','CL-LOC','DBX-NCIT-C13063'),('CL-LOC-T-434',NULL,'NERVE','A bundle of fibers that transmits electrochemical impulses encoding sensory and motor information from one body part to another.','\0','','CL-LOC','DBX-NCIT-C12466'),('CL-LOC-T-435',NULL,'NIPPLE','The pigmented protuberance on the surface of the breast through which milk is drawn from the breast. (NCI)','\0','Nipple','CL-LOC','DBX-NCIT-C12299'),('CL-LOC-T-436',NULL,'NOSE','A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI)','\0','Nose','CL-LOC','DBX-NCIT-C12756'),('CL-LOC-T-437',NULL,'NOSTRIL','One of the two channels of the nose, from the point where they divide to the external opening. (NCI)','\0','Nostril','CL-LOC','DBX-NCIT-C33178'),('CL-LOC-T-438',NULL,'NUCLEUS OF DIAGONAL BAND','A brain structure that is part of the septal nuclear complex. It is connected with the hippocampus, hypothalamus and amygdala.','\0','BASAL NUCLEUS/DIAGONAL BAND','CL-LOC','DBX-NCIT-C97342'),('CL-LOC-T-439',NULL,'OCCIPITAL LOBE','The posterior part of the cerebral hemisphere. (MeSH)','\0','','CL-LOC','DBX-NCIT-C12355'),('CL-LOC-T-44',NULL,'BLADDER, DOME','The upper, convex surface of the bladder. (NCI)','\0','Dome of the Bladder','CL-LOC','DBX-NCIT-C12332'),('CL-LOC-T-440',NULL,'OCCIPITAL LYMPH NODE','A lymph node located in the back of the head adjacent to the trapezius muscle.','\0','','CL-LOC','DBX-NCIT-C98188'),('CL-LOC-T-441',NULL,'OCCIPITAL SCALP','The occipital region of the skin that covers the top of the head. (NCI)','\0','','CL-LOC','DBX-NCIT-C103456'),('CL-LOC-T-442',NULL,'OCULOMOTOR NERVE','The third cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12758'),('CL-LOC-T-443',NULL,'ODONTOGENIC TISSUE','The tissue that forms the tooth. It consists of the dental pulp, dentin, enamel, cementum, odontogenic epithelium, and periodontium. (NCI)','\0','Teeth','CL-LOC','DBX-NCIT-C33794'),('CL-LOC-T-444',NULL,'OLECRANON','A prominence at the proximal end of the ulna. It forms the tip of the elbow. (NCI)','\0','Olecranon','CL-LOC','DBX-NCIT-C33200'),('CL-LOC-T-445',NULL,'OLFACTORY BULB','Anatomical structure located in the vertebral forebrain that receives neural input regarding odors that have been detected by cells within the nasal cavity. The axons of olfactory receptor cells extend into the olfactory bulb. (NCI)','\0','Olfactory Bulb','CL-LOC','DBX-NCIT-C28401'),('CL-LOC-T-446',NULL,'OLFACTORY MUCOSA','The part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman\'s glands. The mucus moistens the epithelium and helps dissolve odor-containing gases. (NCI)','\0','Olfactory Mucosa','CL-LOC','DBX-NCIT-C33205'),('CL-LOC-T-447',NULL,'OLFACTORY NERVE','The first cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12759'),('CL-LOC-T-448',NULL,'OMENTUM','A fold of peritoneum originating at the stomach and supporting the viscera. (NCI)','\0','Omental Fat','CL-LOC','DBX-NCIT-C33209'),('CL-LOC-T-449',NULL,'OPTIC DISC','A portion of the retina at which the axons of the ganglion cells exit the eyeball to form the optic nerve. No light-sensitive photoreceptors are contained within this portion of the retina. (NCI)','\0','Optic Nerve Head; Optic Papilla; Second Cranial Nerve','CL-LOC','DBX-NCIT-C12760'),('CL-LOC-T-45',NULL,'BLADDER, FUNDUS','The portion of the bladder that is formed by the posterior wall and is located opposite to the bladder opening. (NCI)','\0','Fundus of the Bladder','CL-LOC','DBX-NCIT-C48939'),('CL-LOC-T-450',NULL,'OPTIC NERVE','The second cranial nerve. (NCI)','\0','Optic Nerve','CL-LOC','DBX-NCIT-C12761'),('CL-LOC-T-451',NULL,'ORAL CAVITY','The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. (NCI)','\0','Mouth; Oral Cavity','CL-LOC','DBX-NCIT-C12421'),('CL-LOC-T-452',NULL,'ORAL MUCOSA','Moist tissue lining the oral cavity, containing mucus secreting glands.','\0','','CL-LOC','DBX-NCIT-C77637'),('CL-LOC-T-453',NULL,'ORBIT','The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine ','\0','Eye Socket; Ocular Orbit; Orbit; Orbital Cavity','CL-LOC','DBX-NCIT-C12347'),('CL-LOC-T-454',NULL,'OROPHARYNX','The part of the pharynx between the soft palate and the upper portion of the epiglottis. (NCI)','\0','','CL-LOC','DBX-NCIT-C12762'),('CL-LOC-T-455',NULL,'OVARY','One of the paired female reproductive glands containing the ova or germ cells; the ovary\'s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova. (NCI)','\0','Ovary','CL-LOC','DBX-NCIT-C12404'),('CL-LOC-T-456',NULL,'PALATINE BONE','An irregularly shaped bone positioned at the back part of the nasal cavity between the maxilla and the pterygoid process of the sphenoid. It forms the posterior part of the hard palate and the lateral wall of the nasal fossa and helps to form the floor of','\0','Palatine Bone','CL-LOC','DBX-NCIT-C52745'),('CL-LOC-T-457',NULL,'PALM','The undersurface of the hand. (NCI)','\0','','CL-LOC','DBX-NCIT-C33252'),('CL-LOC-T-458',NULL,'PANCREAS','An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) f','\0','Pancreas','CL-LOC','DBX-NCIT-C12393'),('CL-LOC-T-459',NULL,'PANCREAS, BODY','The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament. (NCI)','\0','Body of the Pancreas','CL-LOC','DBX-NCIT-C12270'),('CL-LOC-T-46',NULL,'BLADDER, NECK','The inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. (NCI)','\0','Neck of the Bladder','CL-LOC','DBX-NCIT-C12336'),('CL-LOC-T-460',NULL,'PANCREAS, ENDOCRINE','The pancreatic tissue that contains the islets of Langerhans. It is responsible for the production and secretions of the pancreatic hormones. (NCI)','\0','Endocrine Pancreas','CL-LOC','DBX-NCIT-C12608'),('CL-LOC-T-461',NULL,'PANCREAS, EXOCRINE','An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI','\0','Exocrine Pancreas','CL-LOC','DBX-NCIT-C32546'),('CL-LOC-T-462',NULL,'PANCREAS, HEAD','That portion of the pancreas lying in the concavity of the duodenum. (NCI)','\0','Head of the Pancreas','CL-LOC','DBX-NCIT-C12269'),('CL-LOC-T-463',NULL,'PANCREAS, TAIL','The left extremity of the pancreas within the lienorenal ligament. (NCI)','\0','Tail of the Pancreas','CL-LOC','DBX-NCIT-C12271'),('CL-LOC-T-464',NULL,'PARA-AORTIC LYMPH NODE','A lymph node located adjacent to the lumbar region of the spine. (NCI)','\0','Lymph Node, Para-Aortic','CL-LOC','DBX-NCIT-C77643'),('CL-LOC-T-465',NULL,'PARACAVAL LYMPH NODE','A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI)','\0','','CL-LOC','DBX-NCIT-C117869'),('CL-LOC-T-466',NULL,'PARAMETRIUM','The subserous connective tissue of the pelvic floor of the supracervical portion of the uterus. The parametrium extends laterally between the layers of the broad ligament. (NCI)','\0','Parametrium','CL-LOC','DBX-NCIT-C12320'),('CL-LOC-T-467',NULL,'PARANASAL SINUS','An air-filled cavity adjacent to the nasal cavity lined by a mucous membrane and located in the bones of the skull. There are four paranasal sinuses on each side of the face: ethmoid, frontal, maxillary, and sphenoid sinus. (NCI)','\0','Accessory Sinuses; Nasal Cavity; Nasal Sinuses; Paranasal Sinus','CL-LOC','DBX-NCIT-C12763'),('CL-LOC-T-468',NULL,'PARASYMPATHETIC GANGLIA','A usually small autonomic ganglion of the parasympathetic nervous system. The majority are located near or in the organs that they innervate. (NCI)','\0','','CL-LOC','DBX-NCIT-C52557'),('CL-LOC-T-469',NULL,'PARATHYROID GLAND','One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and p','\0','','CL-LOC','DBX-NCIT-C12765'),('CL-LOC-T-47',NULL,'BLADDER, TRIGONE','The triangular area in the bladder mucosa that is formed by the two ureteral orifices and the urethral orifice. (NCI)','\0','Trigone of the Bladder','CL-LOC','DBX-NCIT-C12331'),('CL-LOC-T-470',NULL,'PARATRACHEAL LYMPH NODE','A lymph node located adjacent to the trachea within the mediastinum. (NCI)','\0','','CL-LOC','DBX-NCIT-C103426'),('CL-LOC-T-471',NULL,'PARAVERTEBRAL GANGLIA','A cluster of neuronal cell bodies and their dendrites located just ventral and lateral to the spinal cord that give rise to the sympathetic nervous system.','\0','','CL-LOC','DBX-NCIT-C97925'),('CL-LOC-T-472',NULL,'PARIETAL LOBE','One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main function. (NCI)','\0','Parietal Lobe','CL-LOC','DBX-NCIT-C12354'),('CL-LOC-T-473',NULL,'PAROTID GLAND','The largest of the three paired salivary glands, located in front of the ear. (NCI)','\0','Parotid Gland','CL-LOC','DBX-NCIT-C12427'),('CL-LOC-T-474',NULL,'PAROTID GLAND LYMPH NODE','A lymph node located close to, on, or within the parotid gland. (NCI)','\0','Parotid Gland Lymph Node','CL-LOC','DBX-NCIT-C33278'),('CL-LOC-T-475',NULL,'PARS COMPACTA','A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. (NCI)','\0','','CL-LOC','DBX-NCIT-C97341'),('CL-LOC-T-476',NULL,'PATELLA','A small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint. (NCI)','\0','Patella','CL-LOC','DBX-NCIT-C33282'),('CL-LOC-T-477',NULL,'PELVIC BONE','The caudal portion of the trunk, bounded anteriorly and laterally by the two hip bones incorporating the socket portion of the hip joint for each leg. Posteriorly it is bounded by the sacrum and coccyx. (NCI)','\0','Pelvic Bone; Pelvis Bone','CL-LOC','DBX-NCIT-C33287'),('CL-LOC-T-478',NULL,'PELVIC LYMPH NODE','Any lymph node within the pelvic region. (NCI)','\0','Pelvic Lymph Node','CL-LOC','DBX-NCIT-C12363'),('CL-LOC-T-479',NULL,'PELVIS','The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans. (NCI)','\0','Pelvic Cavity; Pelvic Region; Pelvis','CL-LOC','DBX-NCIT-C12767'),('CL-LOC-T-48',NULL,'BLOOD','A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.','\0','Blood; Peripheral Blood','CL-LOC','DBX-NCIT-C12434'),('CL-LOC-T-480',NULL,'PENIS','The male organ of urination and copulation. (NCI)','\0','Penis','CL-LOC','DBX-NCIT-C12409'),('CL-LOC-T-481',NULL,'PERIANAL REGION','The skin area around the anus. (NCI)','\0','','CL-LOC','DBX-NCIT-C99148'),('CL-LOC-T-482',NULL,'PERICARDIAL CAVITY','The potential body space formed between the parietal and visceral layers of the pericardial sac. (NCI)','\0','Pericardial Cavity','CL-LOC','DBX-NCIT-C38662'),('CL-LOC-T-483',NULL,'PERICARDIAL LYMPH NODE','A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI)','\0','','CL-LOC','DBX-NCIT-C117870'),('CL-LOC-T-484',NULL,'PERICARDIUM','A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained. (NCI)','\0','Pericardium','CL-LOC','DBX-NCIT-C13005'),('CL-LOC-T-485',NULL,'PERIHILAR LYMPH NODE','A lymph node located in the area around the hilum.','\0','','CL-LOC','DBX-NCIT-C102330'),('CL-LOC-T-486',NULL,'PERINEUM','The area located between the anus and vulva in females, and anus and scrotum in males. (NCI)','\0','Perineum','CL-LOC','DBX-NCIT-C33301'),('CL-LOC-T-487',NULL,'PERIPANCREATIC LYMPH NODE','A lymph node of the pancreas. (NCI)','\0','','CL-LOC','DBX-NCIT-C77642'),('CL-LOC-T-488',NULL,'PERIPHERAL NERVE','Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI)','\0','Peripheral Nerve','CL-LOC','DBX-NCIT-C12768'),('CL-LOC-T-489',NULL,'PERITONEAL CAVITY','The lower part of the abdomen that contains the intestines (the last part of the digestive tract), the stomach, and the liver. It is bound by thin membranes. (NCI)','\0','Peritoneal Cavity','CL-LOC','DBX-NCIT-C12769'),('CL-LOC-T-49',NULL,'BLOOD VESSEL','A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI)','\0','Blood Vessel','CL-LOC','DBX-NCIT-C12679'),('CL-LOC-T-490',NULL,'PERITONEUM','The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery. (NCI)','\0','Peritoneum','CL-LOC','DBX-NCIT-C12770'),('CL-LOC-T-491',NULL,'PERIURETHRAL REGION','The tissue surrounding the urethra.','\0','','CL-LOC','DBX-NCIT-C111287'),('CL-LOC-T-492',NULL,'PERONEAL ARTERY','An artery arising from the posterior tibial artery that supplies the muscles on the lateral side of the lower leg.','\0','','CL-LOC','DBX-NCIT-C33314'),('CL-LOC-T-493',NULL,'PHARYNGEAL TONSIL','A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx. (NCI)','\0','Adenoid; Pharyngeal Tonsil','CL-LOC','DBX-NCIT-C33318'),('CL-LOC-T-494',NULL,'PHARYNX','A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus. (NCI)','\0','Pharynx','CL-LOC','DBX-NCIT-C12425'),('CL-LOC-T-495',NULL,'PINEAL GLAND','A small endocrine gland within the diencephalon of the brain, situated beneath the back part of the corpus callosum, that secretes melatonin.','\0','','CL-LOC','DBX-NCIT-C12398'),('CL-LOC-T-496',NULL,'PISIFORM BONE','The medial bone of the proximal row of carpal bones. (NCI)','\0','Pisiform Bone','CL-LOC','DBX-NCIT-C12855'),('CL-LOC-T-497',NULL,'PITUITARY GLAND','Pea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus. (NCI)','\0','Hypophysis; Hypophysis Cerebri','CL-LOC','DBX-NCIT-C12399'),('CL-LOC-T-498',NULL,'PLEURA','The tissue that lines the wall of the thoracic cavity and the surface of the lungs. (NCI)','\0','Pleural Tissue','CL-LOC','DBX-NCIT-C12469'),('CL-LOC-T-499',NULL,'PLEURAL CAVITY','The cavity lined by the pleura, located in the thorax and contains heart and lungs. (NCI)','\0','Pleural Cavity','CL-LOC','DBX-NCIT-C12840'),('CL-LOC-T-5',NULL,'ABDOMINAL WALL','The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles. (NCI)','\0','','CL-LOC','DBX-NCIT-C77608'),('CL-LOC-T-50',NULL,'BODY','The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI)','\0','Body','CL-LOC','DBX-NCIT-C13041'),('CL-LOC-T-500',NULL,'PONS VAROLII','The middle portion of the brainstem located between the midbrain and the medulla oblongata.','\0','Pons Varolii','CL-LOC','DBX-NCIT-C12511'),('CL-LOC-T-501',NULL,'POPLITEAL ARTERY ABOVE KNEE','The segment of the popliteal artery that is located above the knee.','\0','','CL-LOC','DBX-NCIT-C116180'),('CL-LOC-T-502',NULL,'POPLITEAL ARTERY BELOW KNEE','The segment of the popliteal artery that is located below the knee.','\0','','CL-LOC','DBX-NCIT-C116181'),('CL-LOC-T-503',NULL,'POPLITEAL LYMPH NODE','Lymph node located within the fat layer of the knee joint. (NCI)','\0','','CL-LOC','DBX-NCIT-C53146'),('CL-LOC-T-504',NULL,'PORTA HEPATIS LYMPH NODE','A lymph node located in the transverse fissure of the liver. (NCI)','\0','','CL-LOC','DBX-NCIT-C117871'),('CL-LOC-T-505',NULL,'PORTACAVAL LYMPH NODE','A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI)','\0','Portocaval Lymph Node','CL-LOC','DBX-NCIT-C117872'),('CL-LOC-T-506',NULL,'PORTAL LYMPH NODE','Lymph nodes surrounding the portal vein. (NCI)','\0','Periportal Lymph Node','CL-LOC','DBX-NCIT-C77645'),('CL-LOC-T-507',NULL,'PORTAL VEIN','A short thick trunk vein that transports blood containing the absorbed products of digestion from the intestine directly to the liver. (NCI)','\0','Hepatic Portal Vein; Portal Vein','CL-LOC','DBX-NCIT-C33343'),('CL-LOC-T-508',NULL,'POSTERIOR CERVICAL LYMPH NODE','A lymph node located in the posterior region of the neck. (NCI)','\0','','CL-LOC','DBX-NCIT-C103428'),('CL-LOC-T-509',NULL,'POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY','The arteries arising from the right posterior descending artery that supply the interventricular septum.','\0','PDSP; POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102348'),('CL-LOC-T-51',NULL,'BODY OF STOMACH','The main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively. (NCI)','\0','Body of Stomach','CL-LOC','DBX-NCIT-C12258'),('CL-LOC-T-510',NULL,'POSTERIOR TIBIAL ARTERY','A terminal branch of the popliteal artery that runs along the tibia from the lower portion of the popliteus muscle to the lower ankle with numerous branches supplying the lower leg and foot.','\0','','CL-LOC','DBX-NCIT-C12826'),('CL-LOC-T-511',NULL,'POSTEROLATERAL SEGMENTAL ARTERY','In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery in the posterior atrioventricular groove after the origin of the right posterior descending artery.','\0','','CL-LOC','DBX-NCIT-C116170'),('CL-LOC-T-512',NULL,'PREAURICULAR LYMPH NODE','A lymph node located anterior to the auricle of the ear. (NCI)','\0','','CL-LOC','DBX-NCIT-C103429'),('CL-LOC-T-513',NULL,'PRECUNEUS','The posteromedial region of the parietal lobe bounded by the marginal branch of the cingulate sulcus anteriorly, by the medial portion of the parieto-occipital fissure posteriorly and by the subparietal sulcus inferiorly.','\0','','CL-LOC','DBX-NCIT-C112399'),('CL-LOC-T-514',NULL,'PREPUTIAL GLAND','Exocrine glands located at the anterior aspect of the genitals of some mammals, such as mice and rats, that produce and secrete pheromones. (NCI)','\0','','CL-LOC','DBX-NCIT-C79432'),('CL-LOC-T-515',NULL,'PRIMARY VISUAL CORTEX','A brain region in the occipital cortex that receives visual stimuli from the retina. (NCI)','\0','','CL-LOC','DBX-NCIT-C97340'),('CL-LOC-T-516',NULL,'PROFUNDA FEMORIS ARTERY','An artery arising from the common femoral artery just below the inguinal ligament running close to the femur and ending in the lower third of the thigh with branches supplying the thigh muscles.','\0','','CL-LOC','DBX-NCIT-C32436'),('CL-LOC-T-517',NULL,'PROSTATE GLAND','The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. (NCI)','\0','Prostate Gland','CL-LOC','DBX-NCIT-C12410'),('CL-LOC-T-518',NULL,'PROSTATE GLAND, LATERAL LOBE','The prostate gland lobe that is located on the lateral side of the organ. (NCI)','\0','Lateral Lobe of the Prostate','CL-LOC','DBX-NCIT-C13092'),('CL-LOC-T-519',NULL,'PROSTATE GLAND, MIDDLE LOBE','The upper, smaller part of the prostate between the ejaculatory ducts and the urethra. (NCI)','\0','Middle Lobe of the Prostate','CL-LOC','DBX-NCIT-C13094'),('CL-LOC-T-52',NULL,'BONE','Calcified connective tissue that forms the skeletal components of the body. (NCI)','\0','Bone','CL-LOC','DBX-NCIT-C12366'),('CL-LOC-T-520',NULL,'PROSTATE GLAND, POSTERIOR LOBE','The prostate gland lobe that is located on the posterior side of the organ. (NCI)','\0','Posterior Lobe of the Prostate','CL-LOC','DBX-NCIT-C13093'),('CL-LOC-T-521',NULL,'PROXIMAL CIRCUMFLEX ARTERY','The section of the left circumflex coronary artery that arises from the left main coronary artery and extends to the first marginal branch.','\0','PCIRC; PROXIMAL CIRCUMFLEX ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102331'),('CL-LOC-T-522',NULL,'PROXIMAL INTERPHALANGEAL JOINT 2','A condyloid synovial joint within the second digit of the hand or foot connecting the proximal and middle phalanges. (NCI)','\0','PIP2','CL-LOC','DBX-NCIT-C102332'),('CL-LOC-T-523',NULL,'PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT','A ginglymoid (hinge) synovial joint within the second digit of the foot connecting the proximal and middle phalanges. (NCI)','\0','PIP2 of the Foot','CL-LOC','DBX-NCIT-C114205'),('CL-LOC-T-524',NULL,'PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND','A ginglymoid (hinge) synovial joint within the second digit of the hand connecting the proximal and middle phalanges. (NCI)','\0','PIP2 of the Hand','CL-LOC','DBX-NCIT-C114194'),('CL-LOC-T-525',NULL,'PROXIMAL INTERPHALANGEAL JOINT 3','A condyloid synovial joint within the third digit of the hand or foot connecting the proximal and middle phalanges. (NCI)','\0','PIP3','CL-LOC','DBX-NCIT-C102333'),('CL-LOC-T-526',NULL,'PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT','A ginglymoid (hinge) synovial joint within the third digit of the foot connecting the proximal and middle phalanges. (NCI)','\0','PIP3 of the Foot','CL-LOC','DBX-NCIT-C114206'),('CL-LOC-T-527',NULL,'PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND','A ginglymoid (hinge) synovial joint within the third digit of the hand connecting the proximal and middle phalanges. (NCI)','\0','PIP3 of the Hand','CL-LOC','DBX-NCIT-C114195'),('CL-LOC-T-528',NULL,'PROXIMAL INTERPHALANGEAL JOINT 4','A condyloid synovial joint within the fourth digit of the hand or foot connecting the proximal and middle phalanges. (NCI)','\0','PIP4','CL-LOC','DBX-NCIT-C102334'),('CL-LOC-T-529',NULL,'PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT','A ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the proximal and middle phalanges. (NCI)','\0','PIP4 of the Foot','CL-LOC','DBX-NCIT-C114207'),('CL-LOC-T-53',NULL,'BONE MARROW','The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI)','\0','Bone Marrow','CL-LOC','DBX-NCIT-C12431'),('CL-LOC-T-530',NULL,'PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND','A ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the proximal and middle phalanges. (NCI)','\0','PIP4 of the Hand','CL-LOC','DBX-NCIT-C114196'),('CL-LOC-T-531',NULL,'PROXIMAL INTERPHALANGEAL JOINT 5','A condyloid synovial joint within the fifth digit of the hand or foot connecting the proximal and middle phalanges. (NCI)','\0','PIP5','CL-LOC','DBX-NCIT-C102335'),('CL-LOC-T-532',NULL,'PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT','A ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the proximal and middle phalanges. (NCI)','\0','PIP5 of the Foot','CL-LOC','DBX-NCIT-C114208'),('CL-LOC-T-533',NULL,'PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND','A ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the proximal and middle phalanges. (NCI)','\0','PIP5 of the Hand','CL-LOC','DBX-NCIT-C114197'),('CL-LOC-T-534',NULL,'PROXIMAL LAD ARTERY','The section of the left anterior descending coronary artery that arises from the left main coronary artery and extends to the first diagonal branch.','\0','PLAD; PROXIMAL LAD ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102336'),('CL-LOC-T-535',NULL,'PROXIMAL RIGHT CORONARY ARTERY CONDUIT','The section of the right coronary artery proximal to the origin of the right ventricular artery.','\0','PRCA; PROXIMAL RIGHT CORONARY ARTERY CONDUIT SEGMENT','CL-LOC','DBX-NCIT-C102337'),('CL-LOC-T-536',NULL,'PUTAMEN','The largest and most lateral of the basal ganglia lying between the lateral medullary lamina of the globus pallidus and the external capsule. It is part of the neostriatum and forms part of the lentiform nucleus along with the globus pallidus. (MeSH)','\0','Putamen','CL-LOC','DBX-NCIT-C12452'),('CL-LOC-T-537',NULL,'PYLORIC SPHINCTER','The muscular structure at the distal portion of the stomach, opening into the duodenum. (NCI)','\0','Pyloric Sphincter','CL-LOC','DBX-NCIT-C33433'),('CL-LOC-T-538',NULL,'QUADRICEPS MUSCLE','A group of four powerful muscles in the front of the thigh. Their actions involve the extension of the knee joint. (NCI)','\0','Muscle, Quadriceps; Muscle, Thigh','CL-LOC','DBX-NCIT-C33441'),('CL-LOC-T-539',NULL,'RADIAL ARTERY','The branch of the brachial artery that passes down the forearm. (NCI)','\0','Radial Artery','CL-LOC','DBX-NCIT-C12838'),('CL-LOC-T-54',NULL,'BRACHIAL ARTERY','An artery originating at the axillary artery and branching into the radial and ulnar arteries. (NCI)','\0','Brachial Artery','CL-LOC','DBX-NCIT-C12681'),('CL-LOC-T-540',NULL,'RADIUS','The long bone that extends from the lateral aspect of the elbow to the medial side of the carpus.','\0','Radius; Radius Bone','CL-LOC','DBX-NCIT-C12777'),('CL-LOC-T-541',NULL,'RAMUS INTERMEDIUS ARTERY','An artery that arises from the left main coronary artery and is positioned between the left anterior descending coronary artery and the circumflex artery.','\0','RAMUS; RAMUS ARTERY; RAMUS INTERMEDIUS ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102338'),('CL-LOC-T-542',NULL,'RAPHE','A group of nuclei that are located in the midline of the brainstem and release serotonin. (NCI)','\0','','CL-LOC','DBX-NCIT-C97335'),('CL-LOC-T-543',NULL,'RECTOSIGMOID JUNCTION','The area where the sigmoid colon joins the rectum.','\0','','CL-LOC','DBX-NCIT-C54188'),('CL-LOC-T-544',NULL,'RECTUM','The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal. (NCI)','\0','','CL-LOC','DBX-NCIT-C12390'),('CL-LOC-T-545',NULL,'RECTUS FEMORIS MUSCLE','One of the four quadriceps muscles, located in the middle of the front of the thigh. Its actions involve the extension of the knee joint and flexion of the hip. (NCI)','\0','','CL-LOC','DBX-NCIT-C53175'),('CL-LOC-T-546',NULL,'REGIONAL LYMPH NODE','A lymph node that drains lymph from a region of interest. (NCI)','\0','Regional Lymph Node','CL-LOC','DBX-NCIT-C49018'),('CL-LOC-T-547',NULL,'RENAL ARTERY','Either of two arteries (right or left) that arise from the aorta to supply the kidneys.','\0','','CL-LOC','DBX-NCIT-C12778'),('CL-LOC-T-548',NULL,'RETINA','A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain. (NCI)','\0','Retina','CL-LOC','DBX-NCIT-C12343'),('CL-LOC-T-549',NULL,'RETROCRURAL LYMPH NODE','A lymph node located within the most inferior portion of the posterior mediastinum. (NCI)','\0','','CL-LOC','DBX-NCIT-C103439'),('CL-LOC-T-55',NULL,'BRACHIAL LYMPH NODE','An axillary lymph node along the brachial vein. (NCI)','\0','','CL-LOC','DBX-NCIT-C92221'),('CL-LOC-T-550',NULL,'RETROPERITONEAL LYMPH NODE','A lymph node located in the retroperitoneal space. (NCI)','\0','','CL-LOC','DBX-NCIT-C98189'),('CL-LOC-T-551',NULL,'RETROPERITONEUM','The back of the abdomen where the kidneys lie and the great blood vessels run. (NCI)','\0','RETROPERITONEAL CAVITY','CL-LOC','DBX-NCIT-C12298'),('CL-LOC-T-552',NULL,'RIB','Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum by their co','\0','Rib','CL-LOC','DBX-NCIT-C12782'),('CL-LOC-T-553',NULL,'RIB 1','The first rib counting from the top of the rib cage down. (NCI)','\0','Rib 1','CL-LOC','DBX-NCIT-C52770'),('CL-LOC-T-554',NULL,'RIB 10','The tenth rib counting from the top of the rib cage down. (NCI)','\0','Rib 10','CL-LOC','DBX-NCIT-C52769'),('CL-LOC-T-555',NULL,'RIB 11','The eleventh rib counting from the top of the rib cage down. (NCI)','\0','Rib 11','CL-LOC','DBX-NCIT-C52768'),('CL-LOC-T-556',NULL,'RIB 12','The twelfth rib counting from the top of the rib cage down. (NCI)','\0','Rib 12','CL-LOC','DBX-NCIT-C52767'),('CL-LOC-T-557',NULL,'RIB 2','The second rib counting from the top of the rib cage down. (NCI)','\0','Rib 2','CL-LOC','DBX-NCIT-C52766'),('CL-LOC-T-558',NULL,'RIB 3','The third rib counting from the top of the rib cage down. (NCI)','\0','Rib 3','CL-LOC','DBX-NCIT-C52765'),('CL-LOC-T-559',NULL,'RIB 4','The fourth rib counting from the top of the rib cage down. (NCI)','\0','Rib 4','CL-LOC','DBX-NCIT-C52764'),('CL-LOC-T-56',NULL,'BRACHIAL PLEXUS','A nerve network originating from C5 to T1 that supplies cutaneous and muscular innervation to the arm and hand. (NCI)','\0','Brachial Plexus','CL-LOC','DBX-NCIT-C12682'),('CL-LOC-T-560',NULL,'RIB 5','The fifth rib counting from the top of the rib cage down. (NCI)','\0','Rib 5','CL-LOC','DBX-NCIT-C52763'),('CL-LOC-T-561',NULL,'RIB 6','The sixth rib counting from the top of the rib cage down. (NCI)','\0','Rib 6','CL-LOC','DBX-NCIT-C52762'),('CL-LOC-T-562',NULL,'RIB 7','The seventh rib counting from the top of the rib cage down. (NCI)','\0','Rib 7','CL-LOC','DBX-NCIT-C52761'),('CL-LOC-T-563',NULL,'RIB 8','The eighth rib counting from the top of the rib cage down. (NCI)','\0','Rib 8','CL-LOC','DBX-NCIT-C52760'),('CL-LOC-T-564',NULL,'RIB 9','The ninth rib counting from the top of the rib cage down. (NCI)','\0','Rib 9','CL-LOC','DBX-NCIT-C52759'),('CL-LOC-T-565',NULL,'RIGHT ATRIAL ENDOCARDIUM','The innermost layer of endothelial cells and connective tissue that lines the right atrium.','\0','','CL-LOC','DBX-NCIT-C102339'),('CL-LOC-T-566',NULL,'RIGHT CORONARY ARTERY OSTIUM','The opening of the right coronary artery at its origin.','\0','','CL-LOC','DBX-NCIT-C116169'),('CL-LOC-T-567',NULL,'RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES','The right coronary artery and all of its branches.','\0','','CL-LOC','DBX-NCIT-C102340'),('CL-LOC-T-568',NULL,'RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY','The arterial branch between the right posterior descending artery segment and the first right posterolateral segment.','\0','RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY SEGMENT; RPAV','CL-LOC','DBX-NCIT-C102341'),('CL-LOC-T-569',NULL,'RIGHT POSTERIOR DESCENDING ARTERY','In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery between the acute marginal artery and the first right posterolateral segment. It supplies the inferior apex of the heart.','\0','RIGHT POSTERIOR DESCENDING ARTERY SEGMENT; RPDA','CL-LOC','DBX-NCIT-C102342'),('CL-LOC-T-57',NULL,'BRAIN','An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium. (NCI)','\0','Brain; Nervous System, Brain','CL-LOC','DBX-NCIT-C12439'),('CL-LOC-T-570',NULL,'RIGHT VENTRICULAR BRANCH','The branch of the right coronary artery that supplies blood to the right ventricular wall.','\0','','CL-LOC','DBX-NCIT-C116171'),('CL-LOC-T-571',NULL,'RIGHT VENTRICULAR ENDOCARDIUM','The innermost layer of endothelial cells and connective tissue that lines the right ventricle.','\0','','CL-LOC','DBX-NCIT-C102343'),('CL-LOC-T-572',NULL,'SACRAL TUBEROSITY','The prominence on the lateral surface of the sacrum, posterior to the auricular surface of the sacrum. (NCI)','\0','','CL-LOC','DBX-NCIT-C105447'),('CL-LOC-T-573',NULL,'SACRAL VERTEBRA','Any of the vertebrae forming the triangular bone just below the lumbar vertebrae.','\0','Sacral Vertebra','CL-LOC','DBX-NCIT-C12853'),('CL-LOC-T-574',NULL,'SACROILIAC JOINT','The joint located between the sacrum and the ilium. (NCI)','\0','Sacroiliac Joint','CL-LOC','DBX-NCIT-C33507'),('CL-LOC-T-575',NULL,'SACRUM','The triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx. (NCI)','\0','Sacrum','CL-LOC','DBX-NCIT-C33508'),('CL-LOC-T-576',NULL,'SALIVARY GLAND','An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity.','\0','','CL-LOC','DBX-NCIT-C12426'),('CL-LOC-T-577',NULL,'SAPHENOUS VEIN','One of two (Greater, Small) superficial veins of the leg and thigh. (NCI)','\0','Saphenous Vein','CL-LOC','DBX-NCIT-C33511'),('CL-LOC-T-578',NULL,'SCALP','The skin which covers the top of the head and which is usually covered by hair. (NCI)','\0','','CL-LOC','DBX-NCIT-C89807'),('CL-LOC-T-579',NULL,'SCAPHOID BONE','A nut-shaped bone of the wrist located in the radial site of the hand. It is one of the eight carpal bones. (NCI)','\0','Scaphoid Bone','CL-LOC','DBX-NCIT-C12854'),('CL-LOC-T-58',NULL,'BRAIN STEM','The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the mesencephalon, pons, and medulla oblongata. (NCI)','\0','Brain Stem','CL-LOC','DBX-NCIT-C12441'),('CL-LOC-T-580',NULL,'SCAPULA','The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder. (NCI)','\0','Scapula; Shoulder Blade','CL-LOC','DBX-NCIT-C12783'),('CL-LOC-T-581',NULL,'SCIATIC NERVE','The longest single nerve that is formed by the merging of the ventral rami of the L4, L5, and S1 in the pelvis and passes down the lower limb where it divides into the common peroneal and tibial nerves. (NCI)','\0','Sciatic Nerve','CL-LOC','DBX-NCIT-C52810'),('CL-LOC-T-582',NULL,'SCLERA','The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of inserti','\0','','CL-LOC','DBX-NCIT-C12784'),('CL-LOC-T-583',NULL,'SCROTUM','The musculocutaneous pouch that encloses the testicles. (NCI)','\0','Scrotum','CL-LOC','DBX-NCIT-C12785'),('CL-LOC-T-584',NULL,'SEBACEOUS GLAND','Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair. (NCI)','\0','','CL-LOC','DBX-NCIT-C33519'),('CL-LOC-T-585',NULL,'SECOND DIAGONAL BRANCH ARTERY','The second artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.','\0','2ND DIAG; SECOND DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102344'),('CL-LOC-T-586',NULL,'SECOND LEFT POSTEROLATERAL BRANCH ARTERY','In an individual with a left-dominant heart, this is the second branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.','\0','2ND LPL; SECOND LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102345'),('CL-LOC-T-587',NULL,'SECOND OBTUSE MARGINAL BRANCH ARTERY','The second artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.','\0','2ND OM; SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102346'),('CL-LOC-T-588',NULL,'SECOND RIGHT POSTEROLATERAL ARTERY','In an individual with a right-dominant heart, this is the second branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.','\0','2ND RPL; SECOND RIGHT POSTEROLATERAL ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102347'),('CL-LOC-T-589',NULL,'SEMINAL VESICLE','One of the two paired glands in the male genitourinary system, posterior to the bladder and superior to the prostate gland, that produces fructose-rich seminal fluid which is a component of semen. These glands join the ipsilateral ductus deferens to form ','\0','Seminal Sacs','CL-LOC','DBX-NCIT-C12787'),('CL-LOC-T-59',NULL,'BRAIN VENTRICLE','The four connected cavities (hollow spaces) centrally located within the brain that connect posteriorly with the central canal of the spinal cord. (NCI)','\0','Brain Ventricle','CL-LOC','DBX-NCIT-C12356'),('CL-LOC-T-590',NULL,'SEMITENDINOSUS MUSCLE','A muscle located at the posterior and medial aspect of the thigh that extends the hip joint, flexes the knee joint and assists in medially rotating the knee.','\0','','CL-LOC','DBX-NCIT-C53176'),('CL-LOC-T-591',NULL,'SHOULDER','The region of the body between the neck and the upper arm. (NCI)','\0','Shoulder','CL-LOC','DBX-NCIT-C25203'),('CL-LOC-T-592',NULL,'SHOULDER JOINT','A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula. (NCI)','\0','Shoulder Joint','CL-LOC','DBX-NCIT-C33548'),('CL-LOC-T-593',NULL,'SINUS','A recess, cavity, or channel. (NCI)','\0','Sinus','CL-LOC','DBX-NCIT-C33556'),('CL-LOC-T-594',NULL,'SKIN','An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI)','\0','Integument; Skin','CL-LOC','DBX-NCIT-C12470'),('CL-LOC-T-595',NULL,'SKIN OF THE AXILLA','The skin or integument surrounding the axilla, or underarm.','\0','','CL-LOC','DBX-NCIT-C116164'),('CL-LOC-T-596',NULL,'SKIN OF THE HEAD','The skin or integument surrounding the head.','\0','','CL-LOC','DBX-NCIT-C52757'),('CL-LOC-T-597',NULL,'SKIN OF THE LIP','The skin portion of the lip that contains hair.','\0','','CL-LOC','DBX-NCIT-C12291'),('CL-LOC-T-598',NULL,'SKIN OF THE NECK','The skin or integument surrounding the neck.','\0','','CL-LOC','DBX-NCIT-C52756'),('CL-LOC-T-599',NULL,'SKIN OF THE TRUNK','The skin or integument surrounding the trunk of the body. (NCI)','\0','Skin of the Trunk','CL-LOC','DBX-NCIT-C12295'),('CL-LOC-T-6',NULL,'ABDUCENS NERVE','The sixth cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12665'),('CL-LOC-T-60',NULL,'BREAST','One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI)','\0','Breast','CL-LOC','DBX-NCIT-C12971'),('CL-LOC-T-600',NULL,'SKULL','The bones that form the head, made up of the bones of the braincase and face. (NCI)','\0','Bone, Cranial; Cranium; Skull','CL-LOC','DBX-NCIT-C12789'),('CL-LOC-T-601',NULL,'SMALL INTESTINE','The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the l','\0','Small Intestine','CL-LOC','DBX-NCIT-C12386'),('CL-LOC-T-602',NULL,'SOFT PALATE','A movable fold suspended from the posterior border of the hard palate. (MeSH)','\0','','CL-LOC','DBX-NCIT-C12231'),('CL-LOC-T-603',NULL,'SOLE','The undersurface of the foot. (NCI)','\0','','CL-LOC','DBX-NCIT-C33326'),('CL-LOC-T-604',NULL,'SPINAL ACCESSORY NERVE','The eleventh cranial nerve.','\0','ACCESSORY NERVE; CRANIAL ACCESSORY NERVE','CL-LOC','DBX-NCIT-C32041'),('CL-LOC-T-605',NULL,'SPINAL CORD','The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge. (NCI)','\0','Medulla Spinalis','CL-LOC','DBX-NCIT-C12464'),('CL-LOC-T-606',NULL,'SPINOUS PROCESS','A bony projection arising from the posterior vertebral arch that serves for the attachment of muscles and ligaments.','\0','','CL-LOC','DBX-NCIT-C116112'),('CL-LOC-T-607',NULL,'SPLEEN','An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storag','\0','Spleen','CL-LOC','DBX-NCIT-C12432'),('CL-LOC-T-608',NULL,'SPLEEN, HILUM','The area of the spleen through which the vessels and nerves enter or exit the organ. (NCI)','\0','Splenic Hilum','CL-LOC','DBX-NCIT-C33601'),('CL-LOC-T-609',NULL,'SPLENIC HILAR LYMPH NODE','A lymph node located in the hilar region of the spleen. (NCI)','\0','','CL-LOC','DBX-NCIT-C33600'),('CL-LOC-T-61',NULL,'BRONCHUS','Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole). (NCI)','\0','Bronchi; Bronchus','CL-LOC','DBX-NCIT-C12683'),('CL-LOC-T-610',NULL,'STERNAL MANUBRIUM','The upper segment of the sternum, quadrangular in shape, as well as wider superiorly and narrower inferiorly. The sternal manubrium articulates with the clavicle and first two ribs. (NCI)','\0','Sternal Manubrium','CL-LOC','DBX-NCIT-C52730'),('CL-LOC-T-611',NULL,'STERNOCLAVICULAR JOINT','The synovial juncture between the medial end of the clavicle and the anterior segment of the sternum. (NCI)','\0','Sternoclavicular Joint','CL-LOC','DBX-NCIT-C33615'),('CL-LOC-T-612',NULL,'STERNUM','The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle. (NCI)','\0','Sterna; Sternum','CL-LOC','DBX-NCIT-C12793'),('CL-LOC-T-613',NULL,'STOMACH','An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion. (NCI)','\0','Stomach','CL-LOC','DBX-NCIT-C12391'),('CL-LOC-T-614',NULL,'SUBCARINAL LYMPH NODE','A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI)','\0','','CL-LOC','DBX-NCIT-C117873'),('CL-LOC-T-615',NULL,'SUBCLAVIAN VEIN','The vein that drains the axillary vein and joins the internal jugular vein to form the brachiocephalic vein. It runs parallel to the subclavian artery.','\0','','CL-LOC','DBX-NCIT-C12794'),('CL-LOC-T-616',NULL,'SUBCUTIS','Adipose tissue located under the dermis. It binds underlying structures with the skin. The subcutis is important in the regulation of temperature of the skin itself and the body. The size of this layer varies throughout the body and from subject to subjec','\0','Subcutaneous Adipose Tissue; Subcutaneous Tissue','CL-LOC','DBX-NCIT-C33645'),('CL-LOC-T-617',NULL,'SUBGLOTTIS','The area of the larynx below the vocal cords down to the trachea. (NCI)','\0','Subglottis','CL-LOC','DBX-NCIT-C12280'),('CL-LOC-T-618',NULL,'SUBLINGUAL REGION','A body region relating to the area under or adjacent to the tongue.','\0','','CL-LOC','DBX-NCIT-C102349'),('CL-LOC-T-619',NULL,'SUBMANDIBULAR LYMPH NODE','A lymph node located beneath the floor of the oral cavity. (NCI)','\0','Lymph Node, Submandibular','CL-LOC','DBX-NCIT-C77650'),('CL-LOC-T-62',NULL,'BUTTOCK','Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles.','\0','Buttock','CL-LOC','DBX-NCIT-C89806'),('CL-LOC-T-620',NULL,'SUBSTANTIA NIGRA','A large cell mass extending forward, over the dorsal surface of the crus cerebri, from the rostral border of the pons into the subthalamic region. It is composed of a dorsal stratum of closely spaced pigmented cells, the pars compacta, and a larger ventra','\0','Substantia Nigra','CL-LOC','DBX-NCIT-C12453'),('CL-LOC-T-621',NULL,'SUBTALAR JOINT','The plane synovial joint between the talus and calcaneus bones of the foot.','\0','Talocalcaneal Joint','CL-LOC','DBX-NCIT-C33653'),('CL-LOC-T-622',NULL,'SUDORIFEROUS GLAND','The small coiled tubular glands in the skin that produce and secrete sweat.','\0','Sweat Gland','CL-LOC','DBX-NCIT-C33712'),('CL-LOC-T-623',NULL,'SUPERFICIAL FEMORAL ARTERY','The portion of the femoral artery distal to the branching of the deep femoral artery that runs close to the skin.','\0','','CL-LOC','DBX-NCIT-C33661'),('CL-LOC-T-624',NULL,'SUPERFICIAL LYMPH NODE','A lymph node located in a superficial part of the body.','\0','','CL-LOC','DBX-NCIT-C102716'),('CL-LOC-T-625',NULL,'SUPERIOR VENA CAVA','The large vein that terminates in the right atrium and transports deoxygenated blood from the head, neck, arms, and chest to the heart.','\0','','CL-LOC','DBX-NCIT-C12816'),('CL-LOC-T-626',NULL,'SUPRACLAVICULAR LYMPH NODE','A lymph node which is located above the clavicle. (NCI)','\0','Supraclavicular Lymph Node','CL-LOC','DBX-NCIT-C12903'),('CL-LOC-T-627',NULL,'SYMPATHETIC GANGLIA','A mass containing the cell bodies of sympathetic nerves. Sympathetic ganglia exist as paravertebral ganglia (located bilaterally adjacent to the spinal cord) or prevertebral ganglia (located close to the target organ).','\0','','CL-LOC','DBX-NCIT-C12467'),('CL-LOC-T-628',NULL,'SYNOVIAL FLUID','A viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI)','\0','Synovia; Synovial Fluid','CL-LOC','DBX-NCIT-C33718'),('CL-LOC-T-629',NULL,'T1 VERTEBRA','The first thoracic vertebra counting from the top down. (NCI)','\0','T1 Vertebra','CL-LOC','DBX-NCIT-C33720'),('CL-LOC-T-63',NULL,'C1 VERTEBRA','The first of the seven cervical vertebrae. (NCI)','\0','C1 Vertebra','CL-LOC','DBX-NCIT-C32239'),('CL-LOC-T-630',NULL,'T10 VERTEBRA','The tenth thoracic vertebra counting from the top down. (NCI)','\0','T10 Vertebra','CL-LOC','DBX-NCIT-C33721'),('CL-LOC-T-631',NULL,'T11 VERTEBRA','The eleventh thoracic vertebra counting from the top down. (NCI)','\0','T11 Vertebra','CL-LOC','DBX-NCIT-C33722'),('CL-LOC-T-632',NULL,'T12 VERTEBRA','The twelfth thoracic vertebra counting from the top down. (NCI)','\0','T12 Vertebra','CL-LOC','DBX-NCIT-C33723'),('CL-LOC-T-633',NULL,'T2 VERTEBRA','The second thoracic vertebra counting from the top down. (NCI)','\0','T2 Vertebra','CL-LOC','DBX-NCIT-C33724'),('CL-LOC-T-634',NULL,'T3 VERTEBRA','The third thoracic vertebra counting from the top down. (NCI)','\0','T3 Vertebra','CL-LOC','DBX-NCIT-C33725'),('CL-LOC-T-635',NULL,'T4 VERTEBRA','The fourth thoracic vertebra counting from the top down. (NCI)','\0','T4 Vertebra','CL-LOC','DBX-NCIT-C33726'),('CL-LOC-T-636',NULL,'T5 VERTEBRA','The fifth thoracic vertebra counting from the top down. (NCI)','\0','T5 Vertebra','CL-LOC','DBX-NCIT-C33727'),('CL-LOC-T-637',NULL,'T6 VERTEBRA','The sixth thoracic vertebra counting from the top down. (NCI)','\0','T6 Vertebra','CL-LOC','DBX-NCIT-C33728'),('CL-LOC-T-638',NULL,'T7 VERTEBRA','The seventh thoracic vertebra counting from the top down. (NCI)','\0','T7 Vertebra','CL-LOC','DBX-NCIT-C33729'),('CL-LOC-T-639',NULL,'T8 VERTEBRA','The eighth thoracic vertebra counting from the top down. (NCI)','\0','T8 Vertebra','CL-LOC','DBX-NCIT-C33730'),('CL-LOC-T-64',NULL,'C2 VERTEBRA','The second of the seven cervical vertebrae. (NCI)','\0','C2 Vertebra','CL-LOC','DBX-NCIT-C32240'),('CL-LOC-T-640',NULL,'T9 VERTEBRA','The ninth thoracic vertebra counting from the top down. (NCI)','\0','T9 Vertebra','CL-LOC','DBX-NCIT-C33731'),('CL-LOC-T-641',NULL,'TALUS','The bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI)','\0','Talus','CL-LOC','DBX-NCIT-C52799'),('CL-LOC-T-642',NULL,'TARSUS BONE','Any one of the seven bones forming the instep of the foot. (NCI)','\0','Bone, Tarsal; Tarsus; Tarsus Bone','CL-LOC','DBX-NCIT-C12796'),('CL-LOC-T-643',NULL,'TEMPORAL BONE','A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the v','\0','Temporal Bone','CL-LOC','DBX-NCIT-C12797'),('CL-LOC-T-644',NULL,'TEMPORAL LOBE','Lower lateral part of the cerebral hemisphere. (MSH2001)','\0','','CL-LOC','DBX-NCIT-C12353'),('CL-LOC-T-645',NULL,'TEMPOROMANDIBULAR JOINT','The joint between the head of the lower mandible and the temporal bone. (NCI)','\0','Jaw Joint; TMJ','CL-LOC','DBX-NCIT-C32888'),('CL-LOC-T-646',NULL,'TESTIS','Either of the paired male reproductive glands that produce the male germ cells and the male hormones. (NCI)','\0','Testicle; Testis','CL-LOC','DBX-NCIT-C12412'),('CL-LOC-T-647',NULL,'THALAMUS','An ovoid mass composed predominantly of gray substance and associated laminae of white substance. The thalamus is divided into anterior, medial, and lateral parts. The function of the thalamus is to relay sensory impulses and cerebellar and basal ganglia ','\0','Thalamus','CL-LOC','DBX-NCIT-C12459'),('CL-LOC-T-648',NULL,'THIGH','A part of the lower limb, located between hip and knee. (NCI)','\0','Thigh','CL-LOC','DBX-NCIT-C33763'),('CL-LOC-T-649',NULL,'THIRD DIAGONAL BRANCH ARTERY','The third artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.','\0','3RD DIAG; THIRD DIAGONAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102350'),('CL-LOC-T-65',NULL,'C3 VERTEBRA','The third of the seven cervical vertebrae. (NCI)','\0','C3 Vertebra','CL-LOC','DBX-NCIT-C32241'),('CL-LOC-T-650',NULL,'THIRD OBTUSE MARGINAL BRANCH ARTERY','The third artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.','\0','3RD OM; THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102351'),('CL-LOC-T-651',NULL,'THIRD POSTEROLATERAL DESCENDING ARTERY','In an individual with a left-dominant heart, this is the third branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.','\0','3RD LPL; THIRD POSTEROLATERAL DESCENDING ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102352'),('CL-LOC-T-652',NULL,'THIRD RIGHT POSTEROLATERAL ARTERY','In an individual with a right-dominant heart, this is the third branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.','\0','3RD RPL; THIRD RIGHT POSTEROLATERAL ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102353'),('CL-LOC-T-653',NULL,'THORACIC CAVITY','The cavity in the vertebrate body enclosed by the ribs between the diaphragm and the neck and containing the lungs and heart. (NCI)','\0','Thoracic Cavity','CL-LOC','DBX-NCIT-C12905'),('CL-LOC-T-654',NULL,'THORACIC LYMPH NODE','Lymph node located in the thoracic cavity. (NCI)','\0','','CL-LOC','DBX-NCIT-C33769'),('CL-LOC-T-655',NULL,'THORACIC VERTEBRA','Any of the vertebrae situated between the cervical and lumbar vertebrae.','\0','Thoracic Vertebra','CL-LOC','DBX-NCIT-C12798'),('CL-LOC-T-656',NULL,'THORAX','The division of the body lying between the neck and the abdomen. (NCI)','\0','Thorax','CL-LOC','DBX-NCIT-C12799'),('CL-LOC-T-657',NULL,'THROAT','The narrow passage from the mouth to the cavity at the back of the mouth. (NCI)','\0','Throat','CL-LOC','DBX-NCIT-C54272'),('CL-LOC-T-658',NULL,'THYMUS GLAND','A bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes in','\0','Thymus Gland','CL-LOC','DBX-NCIT-C12433'),('CL-LOC-T-659',NULL,'THYROID GLAND','An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control. (NCI)','\0','Thyroid Gland','CL-LOC','DBX-NCIT-C12400'),('CL-LOC-T-66',NULL,'C4 VERTEBRA','The fourth of the seven cervical vertebrae. (NCI)','\0','C4 Vertebra','CL-LOC','DBX-NCIT-C32242'),('CL-LOC-T-660',NULL,'THYROID GLAND ISTHMUS','The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI)','\0','','CL-LOC','DBX-NCIT-C32887'),('CL-LOC-T-661',NULL,'THYROID GLAND, LEFT LOBE','The cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI)','\0','Left Thyroid Gland Lobe','CL-LOC','DBX-NCIT-C32973'),('CL-LOC-T-662',NULL,'THYROID GLAND, RIGHT LOBE','The cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI)','\0','Right Thyroid Gland Lobe','CL-LOC','DBX-NCIT-C33491'),('CL-LOC-T-663',NULL,'TIBIA','A bone located between the femur and the tarsus, being part of the lower leg. (NCI)','\0','Tibia','CL-LOC','DBX-NCIT-C12800'),('CL-LOC-T-664',NULL,'TIBIAL-CRURAL PERIPHERAL ARTERY','The blood vessels segment that includes the crural artery and the tibial artery.','\0','','CL-LOC','DBX-NCIT-C116168'),('CL-LOC-T-665',NULL,'TIBIALIS ANTERIOR MUSCLE','A muscle that originates from the lateral condyle of tibia, spans the upper two-thirds of the lateral surface of the tibia, and is attached to the first cuneiform and metatarsal bones of the foot. It is a dorsiflexor of the ankle and invertor of the foot.','\0','','CL-LOC','DBX-NCIT-C117874'),('CL-LOC-T-666',NULL,'TIBIO-PERONEAL TRUNK','An arterial trunk that contains parts of the posterior tibial artery and fibular artery.','\0','','CL-LOC','DBX-NCIT-C116182'),('CL-LOC-T-667',NULL,'TOE','One of the terminal digits of the foot. (NCI)','\0','Toe','CL-LOC','DBX-NCIT-C33788'),('CL-LOC-T-668',NULL,'TOENAIL','A thin, horny translucent plate covering the end of each toe. (NCI)','\0','Toenail','CL-LOC','DBX-NCIT-C33790'),('CL-LOC-T-669',NULL,'TONGUE','The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech. (NCI)','\0','Tongue','CL-LOC','DBX-NCIT-C12422'),('CL-LOC-T-67',NULL,'C5 VERTEBRA','The fifth of the seven cervical vertebrae. (NCI)','\0','C5 Vertebra','CL-LOC','DBX-NCIT-C32243'),('CL-LOC-T-670',NULL,'TONSIL','The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues. (NCI)','\0','Tonsil','CL-LOC','DBX-NCIT-C12802'),('CL-LOC-T-671',NULL,'TOOTH CANAL','The anatomic space in the root of a tooth that contains nerves, blood vessels, and connective tissue. (NCI)','\0','Tooth Canal','CL-LOC','DBX-NCIT-C66864'),('CL-LOC-T-672',NULL,'TRACHEA','The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi. (NCI)','\0','Trachea; Windpipe','CL-LOC','DBX-NCIT-C12428'),('CL-LOC-T-673',NULL,'TRACHEOBRONCHIAL TREE','An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI)','\0','','CL-LOC','DBX-NCIT-C117875'),('CL-LOC-T-674',NULL,'TRANSVERSE TARSAL JOINT','A combination of syndesmosis and synovial joints formed by the articulation of the talus with the navicular and the calcaneus with the cuboid.','\0','','CL-LOC','DBX-NCIT-C102354'),('CL-LOC-T-675',NULL,'TRAPEZIAL BONE','A carpal bone on the thumb side of the hand that articulates with the 1st and 2nd metacarpals. (NCI)','\0','Trapezial Bone','CL-LOC','DBX-NCIT-C12857'),('CL-LOC-T-676',NULL,'TRAPEZIUS MUSCLE','One of a pair of flat, large, triangular muscles that extend from the external occipital protuberance and the medial third of the superior nuchal line of the occipital bone to the middle of the back. The trapezius muscle is involved in moving the shoulder','\0','Trapezius Muscle','CL-LOC','DBX-NCIT-C33809'),('CL-LOC-T-677',NULL,'TRAPEZOID BONE','A carpal bone located between the trapezium and capitate bones. (NCI)','\0','Trapezoid Bone','CL-LOC','DBX-NCIT-C12859'),('CL-LOC-T-678',NULL,'TRIANGULAR BONE','A carpal bone located between the lunate and pisiform bones. (NCI)','\0','Triangular Bone','CL-LOC','DBX-NCIT-C12858'),('CL-LOC-T-679',NULL,'TRIGEMINAL NERVE','The fifth set of paired nerves of the face that emerge from the brain steam. These nerves have sensory and motor functions in the face, oral cavity, and nasal cavity. (NCI)','\0','Fifth Cranial Nerve; Nervus Trigeminus; Trigeminal Nerve','CL-LOC','DBX-NCIT-C12806'),('CL-LOC-T-68',NULL,'C6 VERTEBRA','The sixth of the seven cervical vertebrae. (NCI)','\0','C6 Vertebra','CL-LOC','DBX-NCIT-C32244'),('CL-LOC-T-680',NULL,'TROCHANTER','A bony protrusion on the femoral bone to which muscles are attached. (NCI)','\0','Trochanter','CL-LOC','DBX-NCIT-C33814'),('CL-LOC-T-681',NULL,'TROCHLEAR NERVE','The cranial nerve that controls the superior oblique muscle of the eye. (NCI)','\0','Trochlear Nerve','CL-LOC','DBX-NCIT-C12808'),('CL-LOC-T-682',NULL,'TRUNK','The body excluding the head and neck and limbs. (NCI)','\0','Trunk','CL-LOC','DBX-NCIT-C33816'),('CL-LOC-T-683',NULL,'TUNICA INTIMA','The inner most layer of the blood vessel wall. The consistency of the intima will vary depending on the type of blood vessel, but will always have an endothelial layer with a basal lamina. It may contain collagen and elastic fibers. (NCI)','\0','Tunica Intima','CL-LOC','DBX-NCIT-C33820'),('CL-LOC-T-684',NULL,'TYMPANIC MEMBRANE','A thin membrane that separates the external auditory canal from the middle ear. The movement of the tympanic membrane in response to air pressure changes in the external ear facilitates the transmission of sound energy by causing vibration of the ossicula','\0','Tympanic Membrane','CL-LOC','DBX-NCIT-C12502'),('CL-LOC-T-685',NULL,'ULNA','The long bone that extends from the elbow to the lateral side of the carpus.','\0','Ulna Bone','CL-LOC','DBX-NCIT-C12809'),('CL-LOC-T-686',NULL,'UMBILICUS','The depression or scar on the abdomen that marks the former site of attachment of the umbilical cord. (NCI)','\0','Navel','CL-LOC','DBX-NCIT-C77533'),('CL-LOC-T-687',NULL,'UNCINATE PROCESS OF PANCREAS','A portion of the pancreas that extends behind the superior mesenteric artery and superior mesenteric vein. (NCI)','\0','Uncinate Process of Pancreas','CL-LOC','DBX-NCIT-C62432'),('CL-LOC-T-688',NULL,'UPPER CERVICAL LYMPH NODE','A lymph node located in the upper region of the neck. (NCI)','\0','','CL-LOC','DBX-NCIT-C103447'),('CL-LOC-T-689',NULL,'UPPER RESPIRATORY SYSTEM','The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.','\0','','CL-LOC','DBX-NCIT-C33839'),('CL-LOC-T-69',NULL,'C7 VERTEBRA','The seventh of the seven cervical vertebrae. (NCI)','\0','C7 Vertebra','CL-LOC','DBX-NCIT-C32245'),('CL-LOC-T-690',NULL,'URETER','The thick-walled tube that carries urine from each kidney to the bladder. (NCI)','\0','Ureter','CL-LOC','DBX-NCIT-C12416'),('CL-LOC-T-691',NULL,'URETHRA','The tube carrying urine from the bladder to outside of the body. (NCI)','\0','Urethra','CL-LOC','DBX-NCIT-C12417'),('CL-LOC-T-692',NULL,'URETHRA, ANTERIOR','The portion of the urethra that extends from the meatus to the membranous urethra. (NCI)','\0','Anterior Portion of the Urethra','CL-LOC','DBX-NCIT-C61125'),('CL-LOC-T-693',NULL,'URETHRA, PENILE','The portion of the urethra that spans the corpus spongiosum. (NCI)','\0','Penile Portion of the Urethra','CL-LOC','DBX-NCIT-C61123'),('CL-LOC-T-694',NULL,'URETHRA, POSTERIOR','The portion of the urethra that is located on the posterior aspect of the urogenital diaphragm. (NCI)','\0','Posterior Portion of the Urethra','CL-LOC','DBX-NCIT-C61126'),('CL-LOC-T-695',NULL,'URETHRA, PROSTATIC','That part of the male urethra that passes through the prostate gland. (NCI)','\0','Prostatic Urethra','CL-LOC','DBX-NCIT-C13101'),('CL-LOC-T-696',NULL,'URINARY SYSTEM','The organs involved in the creation and excretion of urine. (NCI)','\0','Urinary System','CL-LOC','DBX-NCIT-C12413'),('CL-LOC-T-697',NULL,'UTERUS','A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy. (NCI)','\0','Uterus; Womb','CL-LOC','DBX-NCIT-C12405'),('CL-LOC-T-698',NULL,'UVEA','The pigmented layer of the eyeball between the tough, white outer coat of the eye and the retina. (NCI)','\0','Uvea','CL-LOC','DBX-NCIT-C12811'),('CL-LOC-T-699',NULL,'VAGINA','The female genital canal, extending from the uterus to the vulva. (NCI)','\0','Vagina','CL-LOC','DBX-NCIT-C12407'),('CL-LOC-T-7',NULL,'ACCESSORY RENAL ARTERY','An additional renal vessel originating from the aorta and entering the kidney at the proximal or distal end of the organ. Accessory renal arteries are found in 26-30% of humans.','\0','','CL-LOC','DBX-NCIT-C116183'),('CL-LOC-T-70',NULL,'CALCARINE SULCUS','A cerebral fissure that originates near the occipital lobe and terminates below the corpus callosum. (NCI)','\0','','CL-LOC','DBX-NCIT-C32252'),('CL-LOC-T-700',NULL,'VAGUS NERVE','The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thor','\0','','CL-LOC','DBX-NCIT-C12812'),('CL-LOC-T-701',NULL,'VAS DEFERENS','Duct carrying spermatozoa. (NCI)','\0','','CL-LOC','DBX-NCIT-C12813'),('CL-LOC-T-702',NULL,'VASTUS INTERMEDIUS MUSCLE','The portion of the quadriceps femoris muscle group that is underneath the Rectus Femoris muscle, spans and covers the upper two-thirds of the anterior and lateral surfaces of the femur, and inserts into the lateral border of the patella.','\0','','CL-LOC','DBX-NCIT-C117876'),('CL-LOC-T-703',NULL,'VASTUS LATERALIS MUSCLE','The largest muscle of the quadriceps femoris muscle group that extends laterally from the intertrochanteric line of the femur to the lateral aspects of the quadriceps femoris tendon and patella.','\0','','CL-LOC','DBX-NCIT-C53073'),('CL-LOC-T-704',NULL,'VASTUS MEDIALIS MUSCLE','The portion of the quadriceps femoris muscle group that extends medially from the intertrochanteric line of the femur to the medial aspects of the quadriceps femoris tendon and patella. (NCI)','\0','','CL-LOC','DBX-NCIT-C117736'),('CL-LOC-T-705',NULL,'VEIN','A blood vessel that carries blood towards the heart.','\0','Vein','CL-LOC','DBX-NCIT-C12814'),('CL-LOC-T-706',NULL,'VENA CAVA','A large vein which returns blood from the head, neck and extremities to the heart. (NCI)','\0','Vena Cava','CL-LOC','DBX-NCIT-C12817'),('CL-LOC-T-707',NULL,'VERTEBRAL COLUMN','A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord. (NC','\0','Vertebral Column','CL-LOC','DBX-NCIT-C12998'),('CL-LOC-T-708',NULL,'VESTIBULOCOCHLEAR NERVE','The eighth cranial nerve.','\0','','CL-LOC','DBX-NCIT-C12996'),('CL-LOC-T-709',NULL,'VOCAL CORD','A pair of small bands of muscle that stretch from the thyroid cartilage in front to the arytenoid cartilage in back of the larynx. The vocal cords help prevent food entering the lungs and produce sound through vibration. (NCI)','\0','Vocal Cord','CL-LOC','DBX-NCIT-C12822'),('CL-LOC-T-71',NULL,'CANINE TOOTH','A single-cusped (pointed) and usually single-rooted tooth located between the incisors and premolars. (NCI)','\0','Canine Tooth','CL-LOC','DBX-NCIT-C32258'),('CL-LOC-T-710',NULL,'VOMER','A thin, paired or unpaired, trapezoidal bone of the skull located in the floor of the nasal cavity. The vomer forms the posterior and inferior parts of the nasal septum. (NCI)','\0','Vomer','CL-LOC','DBX-NCIT-C33888'),('CL-LOC-T-711',NULL,'VULVA','The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia. (NCI)','\0','External Genitalia; Vulva','CL-LOC','DBX-NCIT-C12408'),('CL-LOC-T-712',NULL,'WAIST','The abdominal circumference at the navel. (NCI)','\0','Waist','CL-LOC','DBX-NCIT-C64192'),('CL-LOC-T-713',NULL,'WALDEYER\'S TONSILLAR RING','The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils. (NCI)','\0','','CL-LOC','DBX-NCIT-C73468'),('CL-LOC-T-714',NULL,'WRIST JOINT','A joint between the distal end of the radius and the proximal row of carpal bones. (NCI)','\0','Wrist Joint','CL-LOC','DBX-NCIT-C33894'),('CL-LOC-T-715',NULL,'XIPHOID PROCESS','The cartilage just below the sternal body. (NCI)','\0','Xiphoid Process','CL-LOC','DBX-NCIT-C33895'),('CL-LOC-T-72',NULL,'CAPITATE BONE','The largest of eight carpal bones, located in the center of the hand. (NCI)','\0','Capitate Bone','CL-LOC','DBX-NCIT-C12856'),('CL-LOC-T-73',NULL,'CAROTID ARTERY','One of two arteries that supply oxygenated blood to the head and neck; the left common carotid branches from the aorta and the right common carotid from the innominate (brachiocephalic artery). (NCI)','\0','Carotid Artery','CL-LOC','DBX-NCIT-C12687'),('CL-LOC-T-74',NULL,'CARPOMETACARPAL JOINT 1','A saddle-shaped synovial joint between the metacarpal of the thumb and the trapezium. (NCI)','\0','CMC1','CL-LOC','DBX-NCIT-C103912'),('CL-LOC-T-75',NULL,'CARPOMETACARPAL JOINT 2','A plane joint primarily between the second metacarpal and the trapezoid, which also connects with the trapezium and capitate. (NCI)','\0','CMC2','CL-LOC','DBX-NCIT-C103913'),('CL-LOC-T-76',NULL,'CARPOMETACARPAL JOINT 3','A plane joint between the third metacarpal and the capitate. (NCI)','\0','CMC3','CL-LOC','DBX-NCIT-C103914'),('CL-LOC-T-77',NULL,'CARPOMETACARPAL JOINT 4','A plane joint between the fourth metacarpal and the hamate. (NCI)','\0','CMC4','CL-LOC','DBX-NCIT-C103915'),('CL-LOC-T-78',NULL,'CARPOMETACARPAL JOINT 5','A plane joint between the fifth metacarpal and the pisiform. (NCI)','\0','CMC5','CL-LOC','DBX-NCIT-C103916'),('CL-LOC-T-79',NULL,'CAUDATE NUCLEUS','An elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. (MeSH)','\0','','CL-LOC','DBX-NCIT-C12451'),('CL-LOC-T-8',NULL,'ACETABULUM','Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip. (NCI)','\0','Acetabulum','CL-LOC','DBX-NCIT-C32042'),('CL-LOC-T-80',NULL,'CECUM','A blind pouch-like commencement of the colon in the right lower quadrant of the abdomen at the end of the small intestine and the start of the large intestine. (OMD)','\0','Cecal; Cecum','CL-LOC','DBX-NCIT-C12381'),('CL-LOC-T-81',NULL,'CELIAC LYMPH NODE','A lymph node at the base of the celiac artery. (NCI)','\0','Celiac Axis Lymph Node; Celiac Lymph Node','CL-LOC','DBX-NCIT-C65166'),('CL-LOC-T-82',NULL,'CENTRAL NERVOUS SYSTEM','The part of the nervous system that consists of the brain, spinal cord, and meninges. (NCI)','\0','','CL-LOC','DBX-NCIT-C12438'),('CL-LOC-T-83',NULL,'CEPHALIC VEIN','One of five superficial veins of the upper extremity, beginning at the radial aspect of the wrist area, wrapping around the forearm and emptying into the axillary vein. (NCI)','\0','Cephalic Vein; Vena Cephalica','CL-LOC','DBX-NCIT-C32286'),('CL-LOC-T-84',NULL,'CEREBELLUM','The portion of the brain located at the base of the skull that is responsible for balance, equilibrium and movement. (NCI)','\0','','CL-LOC','DBX-NCIT-C12445'),('CL-LOC-T-85',NULL,'CEREBRAL CORTEX','The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers. It is responsible for memory, attention, consciousness and other higher levels of mental function.','\0','Cerebral Cortex','CL-LOC','DBX-NCIT-C12443'),('CL-LOC-T-86',NULL,'CEREBRAL HEMISPHERE, LEFT','The left half of the cerebrum.','\0','','CL-LOC','DBX-NCIT-C32955'),('CL-LOC-T-87',NULL,'CEREBRAL HEMISPHERE, RIGHT','The right half of the cerebrum.','\0','','CL-LOC','DBX-NCIT-C33472'),('CL-LOC-T-88',NULL,'CEREBRAL SUBCORTEX','The layer located below the cerebral cortex that includes the forebrain, midbrain and hindbrain. (NCI)','\0','Cerebral Subcortex','CL-LOC','DBX-NCIT-C98712'),('CL-LOC-T-89',NULL,'CEREBRUM','One half of the cerebrum, the part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere con','\0','Cerebral Hemisphere','CL-LOC','DBX-NCIT-C12351'),('CL-LOC-T-9',NULL,'ACHILLES TENDON','The tendon that connects the heel bone to the calf muscles at the back of the lower leg. (NCI)','\0','Calcaneal Tendon','CL-LOC','DBX-NCIT-C32043'),('CL-LOC-T-90',NULL,'CERVICAL LYMPH NODE','Any of the lymph nodes located in the neck. (NCI)','\0','Cervical Lymph Node','CL-LOC','DBX-NCIT-C32298'),('CL-LOC-T-91',NULL,'CERVICAL VERTEBRA','Any one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine. (NCI)','\0','Cervical Vertebra','CL-LOC','DBX-NCIT-C12693'),('CL-LOC-T-92',NULL,'CERVIX UTERI','The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions. (NCI)','\0','Cervix Uteri; Uterine Cervix','CL-LOC','DBX-NCIT-C12311'),('CL-LOC-T-93',NULL,'CHEEK','The fleshy part of the face bounded by the eyes, nose, ear, and jaw line. (NCI)','\0','','CL-LOC','DBX-NCIT-C13070'),('CL-LOC-T-94',NULL,'CHEST','The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. (NCI)','\0','Chest','CL-LOC','DBX-NCIT-C25389'),('CL-LOC-T-95',NULL,'CHEST WALL','The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura. (NCI)','\0','Chest Wall','CL-LOC','DBX-NCIT-C62484'),('CL-LOC-T-96',NULL,'CHOROID PLEXUS','Blood vessels forming villous structures in the third, fourth, and lateral ventricles of the brain. (NCI)','\0','Choroid Plexus','CL-LOC','DBX-NCIT-C12694'),('CL-LOC-T-97',NULL,'CINGULATE CORTEX','Part of the medial aspect of the cerebral cortex. (NCI)','\0','','CL-LOC','DBX-NCIT-C52713'),('CL-LOC-T-98',NULL,'CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY','The segment of the left circumflex artery that is distal to the third marginal branch, located in the atrioventricular groove.','\0','CIRC AV; CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY SEGMENT','CL-LOC','DBX-NCIT-C102287'),('CL-LOC-T-99',NULL,'CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLETERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES','The left circumflex coronary artery and all of its branches.','\0','','CL-LOC','DBX-NCIT-C102286'),('CL-LSNCMPX-T-1',NULL,'ACC/AHA LESION COMPLEXITY SCORE A','Discrete (less than 10 mm length) and concentric and readily accessible and non-angulated segment less than 45 degrees and smooth contour and little or no calcification and less than totally occlusive and not ostial in location and no major branch involve','\0','Low Risk','CL-LSNCMPX','DBX-NCIT-C100037'),('CL-LSNCMPX-T-2',NULL,'ACC/AHA LESION COMPLEXITY SCORE B','Tubular (10-20 mm length) or eccentric or moderate tortuosity of proximal segment or moderately angulated segment, 45-90 degrees or irregular contour or moderate to heavy calcification or ostial in location or bifurcation lesions requiring double guidewir','\0','Medium Risk','CL-LSNCMPX','DBX-NCIT-C100038'),('CL-LSNCMPX-T-3',NULL,'ACC/AHA LESION COMPLEXITY SCORE C','Diffuse (length greater than 2cm) or excessive tortuosity of proximal segment or extremely angulated segments greater than 90 degrees or total occlusions greater than 3 months old and/or bridging collaterals or inability to protect major side branches or ','\0','High Risk','CL-LSNCMPX','DBX-NCIT-C100039'),('CL-LVEFMRE-T-1',NULL,'HYPERDYNAMIC','A pathologically high percentage of blood that is forced from the heart ventricle to produce cardiac output. This is often the result of ventricular dilation due to hypertrophic cardiomyopathy. Quantitatively, the ejection fraction is considered higher th','\0','','CL-LVEFMRE','DBX-NCIT-C99512'),('CL-LVEFMRE-T-2',NULL,'MILD DYSFUNCTION','Slightly less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 40% to 49%.','\0','','CL-LVEFMRE','DBX-NCIT-C99507'),('CL-LVEFMRE-T-3',NULL,'MODERATE DYSFUNCTION','Moderately less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 30% to 39%.','\0','','CL-LVEFMRE','DBX-NCIT-C99508'),('CL-LVEFMRE-T-4',NULL,'NORMAL EJECTION FRACTION','The usual amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 50% to 70%.','\0','','CL-LVEFMRE','DBX-NCIT-C99513'),('CL-LVEFMRE-T-5',NULL,'SEVERE DYSFUNCTION','Severely less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered less than 30%.','\0','','CL-LVEFMRE','DBX-NCIT-C99509'),('CL-MARISTAT-T-1',NULL,'ANNULLED','Marriage contract has been declared null and to not have existed. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C76240'),('CL-MARISTAT-T-2',NULL,'DIVORCED','Marriage contract has been declared dissolved and inactive. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C51776'),('CL-MARISTAT-T-3',NULL,'DOMESTIC PARTNER','Person declares that a domestic partnership relationship exists. (HL7)','\0','Domestic Partner','CL-MARISTAT','DBX-NCIT-C53262'),('CL-MARISTAT-T-4',NULL,'INTERLOCUTORY','Temporary order issued during the course of litigation. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C76241'),('CL-MARISTAT-T-5',NULL,'LEGALLY SEPARATED','A person living apart from his/her spouse by legal arrangement. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C51777'),('CL-MARISTAT-T-6',NULL,'MARRIED','A current marriage contract is active. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C51773'),('CL-MARISTAT-T-7',NULL,'NEVER MARRIED','No marriage contract has ever been entered. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C51774'),('CL-MARISTAT-T-8',NULL,'POLYGAMOUS','More than 1 current spouse. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C76242'),('CL-MARISTAT-T-9',NULL,'WIDOWED','The spouse has died. (HL7)','\0','','CL-MARISTAT','DBX-NCIT-C51775'),('CL-MCIDCERT-T-1',NULL,'DEFINITIVE','Supplying or being a final or conclusive settlement or result.','\0','','CL-MCIDCERT','DBX-NCIT-C62607'),('CL-MCIDCERT-T-2',NULL,'PRESUMPTIVE','Supplying or being a probable or reasonable settlement or result.','\0','','CL-MCIDCERT','DBX-NCIT-C102697'),('CL-MCRCSPTM-T-1',NULL,'IN PLACE AT START OF PROCEDURE','Mechanical Circulatory Support was in place at the start of the procedure.','\0','In Place at Start of Procedure','CL-MCRCSPTM','DBX-NCIT-C99981'),('CL-MCRCSPTM-T-2',NULL,'INSERTED DURING A NON-PERCUTANEOUS CORONARY INTERVENTION PROCEDURE','Mechanical Circulatory Support was inserted during a non-Percutaneous Coronary Intervention (PCI) procedure.','\0','Inserted during a Non PCI Procedure','CL-MCRCSPTM','DBX-NCIT-C99962'),('CL-MCRCSPTM-T-3',NULL,'INSERTED DURING PROCEDURE AND AFTER PERCUTANEOUS CORONARY INTERVENTION STARTED','Mechanical Circulatory Support was inserted during the procedure after Percutaneous Coronary Intervention (PCI) started.','\0','Inserted during Procedure and after PCI Started','CL-MCRCSPTM','DBX-NCIT-C99964'),('CL-MCRCSPTM-T-4',NULL,'INSERTED DURING PROCEDURE BUT PRIOR TO PERCUTANEOUS CORONARY INTERVENTION','Mechanical Circulatory Support was inserted during the procedure prior to percutaneous coronary intervention (PCI).','\0','Inserted during Procedure but Prior to PCI','CL-MCRCSPTM','DBX-NCIT-C99963'),('CL-MEDEVAL-T-1',NULL,'ADJUDICATOR','An individual that presides over and arbitrates between individuals or organizations.','\0','','CL-MEDEVAL','DBX-NCIT-C96561'),('CL-MEDEVAL-T-10',NULL,'RADIOLOGIST 2','A radiologist performing the assessment that is given the designation of two.','\0','','CL-MEDEVAL','DBX-NCIT-C94531'),('CL-MEDEVAL-T-11',NULL,'READER','An individual who takes non-quantifiable data and provides quantifiable assessments for that data.','\0','','CL-MEDEVAL','DBX-NCIT-C28747'),('CL-MEDEVAL-T-12',NULL,'READER 1','A reader performing the assessment that is given the designation of one.','\0','','CL-MEDEVAL','DBX-NCIT-C94532'),('CL-MEDEVAL-T-13',NULL,'READER 2','A reader performing the assessment that is given the designation of two.','\0','','CL-MEDEVAL','DBX-NCIT-C94533'),('CL-MEDEVAL-T-2',NULL,'NEUROLOGIST','A physician who specializes in diagnosing and treating diseases and disorders of the nervous system.','\0','','CL-MEDEVAL','DBX-NCIT-C17721'),('CL-MEDEVAL-T-3',NULL,'NEUROLOGIST 1','A neurologist performing the assessment that is given the designation of one.','\0','','CL-MEDEVAL','DBX-NCIT-C96692'),('CL-MEDEVAL-T-4',NULL,'NEUROLOGIST 2','A neurologist performing the assessment that is given the designation of two.','\0','','CL-MEDEVAL','DBX-NCIT-C96606'),('CL-MEDEVAL-T-5',NULL,'ONCOLOGIST','A physician who specializes in diagnosing and treating cancer. (NCI)','\0','','CL-MEDEVAL','DBX-NCIT-C17821'),('CL-MEDEVAL-T-6',NULL,'ONCOLOGIST 1','An oncologist performing the assessment that is given the designation of one.','\0','','CL-MEDEVAL','DBX-NCIT-C96611'),('CL-MEDEVAL-T-7',NULL,'ONCOLOGIST 2','An oncologist performing the assessment that is given the designation of two.','\0','','CL-MEDEVAL','DBX-NCIT-C96612'),('CL-MEDEVAL-T-8',NULL,'RADIOLOGIST','A physician who specializes in the diagnostic and/or therapeutic uses of radiation. (NCI)','\0','','CL-MEDEVAL','DBX-NCIT-C17824'),('CL-MEDEVAL-T-9',NULL,'RADIOLOGIST 1','A radiologist performing the assessment that is given the designation of one.','\0','','CL-MEDEVAL','DBX-NCIT-C94530'),('CL-METHOD-T-1',NULL,'ACID FAST STAIN','A microscopy staining method used to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria.','\0','','CL-METHOD','DBX-NCIT-C23015'),('CL-METHOD-T-10',NULL,'ATOMIC ABSORPTION SPECTROMETRY','A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat.','\0','','CL-METHOD','DBX-NCIT-C85574'),('CL-METHOD-T-100',NULL,'MANUAL CLOT DETECTION','A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111245'),('CL-METHOD-T-101',NULL,'MAPH','A screening method used to determine changes in complex genomes. This method uses unique short probes which are quantitatively recovered and amplified after hybridization to genomic DNA.','\0','Multiplex Amplifiable Probe Hybridization','CL-METHOD','DBX-NCIT-C116159'),('CL-METHOD-T-102',NULL,'MASS SPECTROMETRY','An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.','\0','MassSpec','CL-METHOD','DBX-NCIT-C17156'),('CL-METHOD-T-103',NULL,'MECHANICAL CLOT DETECTION','A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111249'),('CL-METHOD-T-104',NULL,'MICRO BROTH DILUTION','A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is','\0','','CL-METHOD','DBX-NCIT-C85701'),('CL-METHOD-T-105',NULL,'MICROARRAY','A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array. The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.','\0','','CL-METHOD','DBX-NCIT-C44282'),('CL-METHOD-T-106',NULL,'MICROBIAL BIOCHEMICAL IDENTIFICATION','Any of a number of biochemical tests performed to identify the genus and/or species of a microorganism. These may include the assessment of gram reaction or metabolic characteristics.','\0','','CL-METHOD','DBX-NCIT-C51955'),('CL-METHOD-T-107',NULL,'MICROBIAL CONCENTRATION','Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms.','\0','','CL-METHOD','DBX-NCIT-C85702'),('CL-METHOD-T-108',NULL,'MICROBIAL CULTURE','Any method for growing microorganisms.','\0','Culture Procedure','CL-METHOD','DBX-NCIT-C25300'),('CL-METHOD-T-109',NULL,'MICROBIAL CULTURE, LIQUID','A method for growing microorganisms in liquid culture media.','\0','','CL-METHOD','DBX-NCIT-C102668'),('CL-METHOD-T-11',NULL,'AUDIOMETRY','Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss.','\0','','CL-METHOD','DBX-NCIT-C38036'),('CL-METHOD-T-110',NULL,'MICROBIAL CULTURE, SOLID','A method for growing microorganisms in solid culture media.','\0','','CL-METHOD','DBX-NCIT-C102669'),('CL-METHOD-T-111',NULL,'MICROPARTICLE ENZYME IMMUNOASSAY','An enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding.','\0','MEIA','CL-METHOD','DBX-NCIT-C111252'),('CL-METHOD-T-112',NULL,'MICROSCOPY','The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. (NCI)','\0','','CL-METHOD','DBX-NCIT-C16853'),('CL-METHOD-T-113',NULL,'MODIFIED ACID FAST STAIN','A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia.','\0','','CL-METHOD','DBX-NCIT-C85736'),('CL-METHOD-T-114',NULL,'MRI','Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including can','\0','Magnetic Resonance Imaging','CL-METHOD','DBX-NCIT-C16809'),('CL-METHOD-T-115',NULL,'MRI WITHOUT CONTRAST','A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents.','\0','','CL-METHOD','DBX-NCIT-C114184'),('CL-METHOD-T-116',NULL,'MRS','Magnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules','\0','Magnetic Resonance Spectroscopy','CL-METHOD','DBX-NCIT-C29934'),('CL-METHOD-T-117',NULL,'MUGA','A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. (NCI)','\0','','CL-METHOD','DBX-NCIT-C38073'),('CL-METHOD-T-118',NULL,'MULTI-SLICE SPIRAL CT','A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice). (NCI)','\0','','CL-METHOD','DBX-NCIT-C106545'),('CL-METHOD-T-119',NULL,'MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING','A DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target.','\0','Multiple Complete Digestion','CL-METHOD','DBX-NCIT-C116160'),('CL-METHOD-T-12',NULL,'AURAMINE STAIN','A microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms.','\0','Auramine O','CL-METHOD','DBX-NCIT-C102599'),('CL-METHOD-T-120',NULL,'MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION','A type of high-throughput , multiplex PCR method that uses a single pair of PCR primers to amplify multiple targets and to determine changes in complex genomes.','\0','MLPA','CL-METHOD','DBX-NCIT-C116161'),('CL-METHOD-T-121',NULL,'NEPHELOMETRY','A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer.','\0','','CL-METHOD','DBX-NCIT-C111281'),('CL-METHOD-T-122',NULL,'NEXT GENERATION SEQUENCING','Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA, using spatially separated, clonally amplified DNA templates or molecules in a flow cell.','\0','Massively Parallel Sequencing','CL-METHOD','DBX-NCIT-C101293'),('CL-METHOD-T-123',NULL,'NUCLEIC ACID AMPLIFICATION TEST','Any of a number of molecular biological techniques that are used to copy nucleic acid sequences within a specimen, leading to an increase in the number of copies of that sequence of interest. These techniques may be used for detection of a particular gene','\0','NAAT','CL-METHOD','DBX-NCIT-C20055'),('CL-METHOD-T-124',NULL,'NUCLEIC ACID HYBRIDIZATION','A method in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific s','\0','','CL-METHOD','DBX-NCIT-C16924'),('CL-METHOD-T-125',NULL,'NUCLEIC ACID SEQUENCING','The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.','\0','','CL-METHOD','DBX-NCIT-C18881'),('CL-METHOD-T-126',NULL,'OBSERVATION','Watching something and taking note of what happens.','\0','','CL-METHOD','DBX-NCIT-C25598'),('CL-METHOD-T-127',NULL,'OLIGO ACGH','A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides as targets for hybridization.','\0','Oligonucleotide Array-based CGH; Oligonucleotide Array-based Comparative Genomic Hybridization','CL-METHOD','DBX-NCIT-C116156'),('CL-METHOD-T-128',NULL,'OPTICAL COHERENCE TOMOGRAPHY','Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths','\0','','CL-METHOD','DBX-NCIT-C20828'),('CL-METHOD-T-129',NULL,'OPTICAL DENSITY MEASUREMENT','A quantification of the amount of light that is absorbed by or transmitted through a substance.','\0','','CL-METHOD','DBX-NCIT-C85776'),('CL-METHOD-T-13',NULL,'AUSCULTATION','Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen.','\0','','CL-METHOD','DBX-NCIT-C85573'),('CL-METHOD-T-130',NULL,'OPTICAL MAPPING','A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope.','\0','Optical Map','CL-METHOD','DBX-NCIT-C116162'),('CL-METHOD-T-131',NULL,'PALPATION','A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient\'s body to examine the size, consistency, texture, location and tenderness of an organ or body part.','\0','','CL-METHOD','DBX-NCIT-C16950'),('CL-METHOD-T-132',NULL,'PANENDOSCOPY','An endoscopic examination of the pharynx, larynx, trachea and esophagus.','\0','','CL-METHOD','DBX-NCIT-C94528'),('CL-METHOD-T-133',NULL,'PELLI-ROBSON EYE CHART','A diagrammatic method to test visual acuity and contrast sensitivity, which uses large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom.','\0','','CL-METHOD','DBX-NCIT-C117878'),('CL-METHOD-T-134',NULL,'PERCUSSION','A diagnostic test performed on a tooth by tapping on the crown with a dental instrument.','\0','','CL-METHOD','DBX-NCIT-C62298'),('CL-METHOD-T-135',NULL,'PERIODIC ACID SCHIFF STAIN','A microscopy staining method that utilizes Schiff\'s reagent, a solution composed of pararosanilin treated with sulfurous acid, which selectively reacts with and stains aldehydes pink to determine the presence of glycogen, mucin, mucoprotein, glycoprotein,','\0','','CL-METHOD','DBX-NCIT-C23019'),('CL-METHOD-T-136',NULL,'PERIPHERAL ANGIOGRAPHY','A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs.','\0','','CL-METHOD','DBX-NCIT-C117879'),('CL-METHOD-T-137',NULL,'PET SCAN','An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached t','\0','','CL-METHOD','DBX-NCIT-C17007'),('CL-METHOD-T-138',NULL,'PET/CT SCAN','An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.','\0','','CL-METHOD','DBX-NCIT-C103512'),('CL-METHOD-T-139',NULL,'PET/MRI SCAN','An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.','\0','','CL-METHOD','DBX-NCIT-C103514'),('CL-METHOD-T-14',NULL,'BAC ACGH','A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments','\0','BAC Array-based CGH; Bacterial Artificial Chromosome Array-based CGH; Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization','CL-METHOD','DBX-NCIT-C116157'),('CL-METHOD-T-140',NULL,'PET/SPECT SCAN','An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine.','\0','','CL-METHOD','DBX-NCIT-C111297'),('CL-METHOD-T-141',NULL,'PHASE CONTRAST MICROSCOPY','A microscopic technique in which the amplitude shift that occurs when light passes through a specimen highlights structures or details within the specimen.','\0','','CL-METHOD','DBX-NCIT-C16857'),('CL-METHOD-T-142',NULL,'PHOTOGRAPHY','The process by which an image is acquired by recording light emissions.','\0','','CL-METHOD','DBX-NCIT-C94527'),('CL-METHOD-T-143',NULL,'PHOTOMETRIC CLOT DETECTION','A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111291'),('CL-METHOD-T-144',NULL,'PHOTOMETRY','Measurement of the properties of light, especially luminous intensity. (NCI)','\0','','CL-METHOD','DBX-NCIT-C65109'),('CL-METHOD-T-145',NULL,'PHYSICAL EXAMINATION','A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual\'s health assessment.','\0','Physical Exam','CL-METHOD','DBX-NCIT-C20989'),('CL-METHOD-T-146',NULL,'POLYMERASE CHAIN REACTION','A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase. This results in duplication of the ta','\0','PCR','CL-METHOD','DBX-NCIT-C17003'),('CL-METHOD-T-147',NULL,'POLYSOMNOGRAPHY','A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles.','\0','PSG','CL-METHOD','DBX-NCIT-C114185'),('CL-METHOD-T-148',NULL,'PYROSEQUENCING','A DNA sequencing technique that is based on the detection of released pyrophosphate during DNA synthesis.','\0','','CL-METHOD','DBX-NCIT-C99481'),('CL-METHOD-T-149',NULL,'QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION','A modified polymerase chain reaction (PCR) technique in which RNA sequences are reverse transcribed into complementary DNA (cDNA) transcripts by the enzyme reverse transcriptase. The cDNA is then amplified by a PCR reaction and quantified by comparing to ','\0','qRT-PCR','CL-METHOD','DBX-NCIT-C28408'),('CL-METHOD-T-15',NULL,'BETA LACTAMASE','A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae.','\0','','CL-METHOD','DBX-NCIT-C85576'),('CL-METHOD-T-150',NULL,'REAL-TIME POLYMERASE CHAIN REACTION ASSAY','A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture.','\0','Quantitative PCR; Real Time-PCR; qPCR','CL-METHOD','DBX-NCIT-C51962'),('CL-METHOD-T-151',NULL,'REFLECTANCE SPECTROSCOPY','The spectroscopic analysis of light reflected from a polished sample.','\0','','CL-METHOD','DBX-NCIT-C19340'),('CL-METHOD-T-152',NULL,'REFRACTOMETRY','A method to measure the refractive index (propensity for light to bend) of a sample. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111304'),('CL-METHOD-T-153',NULL,'REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS','A genomic microarray-based method that analyzes two restriction enzyme digested full genomes to identify regions in the genome that have undergone large scale variation.','\0','ROMA','CL-METHOD','DBX-NCIT-C40211'),('CL-METHOD-T-154',NULL,'REVERSE TRANSCRIPTASE PCR','A molecular biology technique used to recreate and amplify complimentary DNA (cDNA) from total RNA or messenger RNA (mRNA).','\0','RT-PCR; Reverse Transcription Polymerase Chain Reaction','CL-METHOD','DBX-NCIT-C18136'),('CL-METHOD-T-155',NULL,'RIA','Radioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly.','\0','Radioimmunoassay','CL-METHOD','DBX-NCIT-C17057'),('CL-METHOD-T-156',NULL,'RYAN BLUE STAIN','A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining meth','\0','','CL-METHOD','DBX-NCIT-C85801'),('CL-METHOD-T-157',NULL,'SCANNING ELECTRON MICROSCOPY','An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through a specimen that has been coated with a heavy metal.','\0','','CL-METHOD','DBX-NCIT-C16855'),('CL-METHOD-T-158',NULL,'SCINTIGRAPHY','An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels thr','\0','','CL-METHOD','DBX-NCIT-C62667'),('CL-METHOD-T-159',NULL,'SEQUENCING','A process to identify and determine the primary structure of, and the order of constituents in a biopolymer. Used when a more specific sequencing methodology is not specified.','\0','','CL-METHOD','DBX-NCIT-C116155'),('CL-METHOD-T-16',NULL,'BIOPSY','The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.','\0','','CL-METHOD','DBX-NCIT-C15189'),('CL-METHOD-T-160',NULL,'SINGLE-SLICE SPIRAL CT','A type of spiral computed tomography that employs only one detector and produces one image (slice). (NCI)','\0','','CL-METHOD','DBX-NCIT-C106567'),('CL-METHOD-T-161',NULL,'SLIT LAMP','Examination of the anterior segment of the eye using a medical instrument called a slit lamp.','\0','','CL-METHOD','DBX-NCIT-C75583'),('CL-METHOD-T-162',NULL,'SLOAN LETTER EYE CHART 1.25%','A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 1.25% contrast level.','\0','','CL-METHOD','DBX-NCIT-C117880'),('CL-METHOD-T-163',NULL,'SLOAN LETTER EYE CHART 2.5%','A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 2.5% contrast level.','\0','','CL-METHOD','DBX-NCIT-C117881'),('CL-METHOD-T-164',NULL,'SMEAR','The action of spreading a thin layer of material across a surface.','\0','','CL-METHOD','DBX-NCIT-C65126'),('CL-METHOD-T-165',NULL,'SNP ARRAY','A genomic microarray-based method able to detect single nucleotide polymorphisms.','\0','Genotype Chip; SNP Genotyping; SNP Probe; Single Nucleotide Polymorphism Array','CL-METHOD','DBX-NCIT-C116151'),('CL-METHOD-T-166',NULL,'SPIRAL CT','A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.','\0','Spiral Computed Tomography','CL-METHOD','DBX-NCIT-C20645'),('CL-METHOD-T-167',NULL,'TEST STRIP','A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance.','\0','','CL-METHOD','DBX-NCIT-C50322'),('CL-METHOD-T-168',NULL,'THICK SMEAR','A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.','\0','','CL-METHOD','DBX-NCIT-C85819'),('CL-METHOD-T-169',NULL,'THIN SMEAR','A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.','\0','','CL-METHOD','DBX-NCIT-C85820'),('CL-METHOD-T-17',NULL,'CALCOFLUOR WHITE STAIN','A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus.','\0','','CL-METHOD','DBX-NCIT-C85577'),('CL-METHOD-T-170',NULL,'TOLUIDINE BLUE STAIN','A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans.','\0','','CL-METHOD','DBX-NCIT-C92302'),('CL-METHOD-T-171',NULL,'TOTAL BODY IRRADIATION','A therapeutic procedure that involves the irradiation of the whole body with ionizing or non-ionizing radiation. (NCI)','\0','','CL-METHOD','DBX-NCIT-C15350'),('CL-METHOD-T-172',NULL,'TOTAL BODY RADIOGRAPHY','A diagnostic radiologic test that involves the examination of the entire body in a single procedure.','\0','','CL-METHOD','DBX-NCIT-C96640'),('CL-METHOD-T-173',NULL,'TRANSMISSION ELECTRON MICROSCOPY','An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen.','\0','','CL-METHOD','DBX-NCIT-C18216'),('CL-METHOD-T-174',NULL,'TRICHROME STAIN','A microscopy staining method that utilizes two or more colored, acidic dyes of contrasting colors. Masson trichrome is a mixture of three dyes including aniline blue, Beibrich scarlet and Weigert\'s iron hematoxylin. Other related, modified trichrome stain','\0','','CL-METHOD','DBX-NCIT-C23012'),('CL-METHOD-T-175',NULL,'TURBIDIMETRY','A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample.','\0','','CL-METHOD','DBX-NCIT-C111328'),('CL-METHOD-T-176',NULL,'TWO-COLOR MICROARRAY','A genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray. The relative fluorescence intensity of each dye is being measured.','\0','Dual-channel Microarray; Two-channel Expression Array; Two-channel Microarray; Two-color Microarray-based Gene Expression','CL-METHOD','DBX-NCIT-C116153'),('CL-METHOD-T-177',NULL,'ULTRASOUND','A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.','\0','','CL-METHOD','DBX-NCIT-C17230'),('CL-METHOD-T-178',NULL,'URANYL ACETATE STAIN','A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy.','\0','','CL-METHOD','DBX-NCIT-C92303'),('CL-METHOD-T-179',NULL,'WEBER GREEN STAIN','A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid.','\0','','CL-METHOD','DBX-NCIT-C85828'),('CL-METHOD-T-18',NULL,'CALCULATION','The procedure or activity of determining a result by mathematical or logical methods. (NCI)','\0','','CL-METHOD','DBX-NCIT-C54125'),('CL-METHOD-T-180',NULL,'WESTERN BLOT','A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymaticall','\0','','CL-METHOD','DBX-NCIT-C16357'),('CL-METHOD-T-181',NULL,'WRIGHT STAIN','A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining.','\0','','CL-METHOD','DBX-NCIT-C85829'),('CL-METHOD-T-182',NULL,'WRIGHT-GIEMSA STAIN','A microscopy staining method that is a combination of the Wright and Giemsa staining protocols and utilizes the Romanowsky stains, which are mixtures of eosin and thiazine dyes such as methylene blue. It produces darker blue and magenta shades than the gi','\0','','CL-METHOD','DBX-NCIT-C23041'),('CL-METHOD-T-183',NULL,'X-RAY','A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.','\0','Radiography','CL-METHOD','DBX-NCIT-C38101'),('CL-METHOD-T-184',NULL,'X-RAY FLUORESCENCE SPECTROMETRY','A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray.','\0','','CL-METHOD','DBX-NCIT-C85830'),('CL-METHOD-T-185',NULL,'ZIEHL NEELSEN ACID FAST STAIN','A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step ','\0','','CL-METHOD','DBX-NCIT-C85831'),('CL-METHOD-T-19',NULL,'CELLULOSE TAPE','A microbiological technique for specimen collection and mounting for microscopic examination that utilizes a cellulose-based adhesive ribbon.','\0','','CL-METHOD','DBX-NCIT-C85578'),('CL-METHOD-T-2',NULL,'ACRIDINE ORANGE STAIN','A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosom','\0','','CL-METHOD','DBX-NCIT-C85554'),('CL-METHOD-T-20',NULL,'CHROMATOGRAPHY','A technique for the separation of complex mixtures that relies on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass.','\0','','CL-METHOD','DBX-NCIT-C16431'),('CL-METHOD-T-21',NULL,'CISH','A laboratory procedure that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualiz','\0','Chromogenic in Situ Hybridization','CL-METHOD','DBX-NCIT-C40960'),('CL-METHOD-T-22',NULL,'CLIP','A type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps.','\0','Cross-Linking and Immunoprecipitation','CL-METHOD','DBX-NCIT-C111163'),('CL-METHOD-T-23',NULL,'CLIP SEQUENCING','A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions.','\0','CLIP-Seq; Cross-linking Immunoprecipitation High-throughput Sequencing; HITS-CLIP','CL-METHOD','DBX-NCIT-C116152'),('CL-METHOD-T-24',NULL,'CLOT DETECTION','Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111095'),('CL-METHOD-T-25',NULL,'COLORIMETRY','A method to measure the absorbance of visible wavelengths of light using a colorimeter.','\0','','CL-METHOD','DBX-NCIT-C111096'),('CL-METHOD-T-26',NULL,'CONTRAST ENHANCED MRI','A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI)','\0','','CL-METHOD','DBX-NCIT-C46087'),('CL-METHOD-T-27',NULL,'CORONARY ANGIOGRAPHY','A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries.','\0','','CL-METHOD','DBX-NCIT-C100085'),('CL-METHOD-T-28',NULL,'CT SCAN','A series of detailed pictures of areas inside the body; the pictures are created by a computer linked to an x-ray machine.','\0','CT; Computed Tomography','CL-METHOD','DBX-NCIT-C17204'),('CL-METHOD-T-29',NULL,'DARK FIELD MICROSCOPY','A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structure','\0','','CL-METHOD','DBX-NCIT-C85837'),('CL-METHOD-T-3',NULL,'AGAR DILUTION','A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed.','\0','','CL-METHOD','DBX-NCIT-C85555'),('CL-METHOD-T-30',NULL,'DIGITAL PCR ARRAY','A technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as','\0','Digital PCR; Digital Polymerase Chain Reaction; dPCR','CL-METHOD','DBX-NCIT-C116158'),('CL-METHOD-T-31',NULL,'DIPSTICK','A strip of composite material that is coated or impregnated with reagents designed to detect the presence of an analyte in a liquid by producing a color change.','\0','','CL-METHOD','DBX-NCIT-C106516'),('CL-METHOD-T-32',NULL,'DIRECT SEQUENCING','A technique used to identify the sequence of individual nucleotides in a single strand of DNA fragment template which does not require subcloning and can be a plasmid insert, genomic DNA or a PCR product.','\0','','CL-METHOD','DBX-NCIT-C116154'),('CL-METHOD-T-33',NULL,'DISK DIFFUSION','A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibi','\0','','CL-METHOD','DBX-NCIT-C85595'),('CL-METHOD-T-34',NULL,'DNA MICROARRAY','An orderly array of DNA samples affixed to a support. The chip is used in various types of hybridization experiments. Used when a more specific microarray methodology is not specified.','\0','DNA Chip; Gene Chip; Gene Expression Array','CL-METHOD','DBX-NCIT-C18158'),('CL-METHOD-T-35',NULL,'DXA SCAN','A technique for scanning bone and measuring bone mineral density (BMD).','\0','','CL-METHOD','DBX-NCIT-C48789'),('CL-METHOD-T-36',NULL,'DYNAMIC CONTRAST ENHANCED MRI','A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.','\0','','CL-METHOD','DBX-NCIT-C62665'),('CL-METHOD-T-37',NULL,'DYNAMIC LIGHT SCATTERING','A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering.','\0','Photon Correlation Spectroscopy; Quasi-elastic Light Scattering','CL-METHOD','DBX-NCIT-C62329'),('CL-METHOD-T-38',NULL,'ECHOCARDIOGRAM','A procedure that uses high-frequency sound waves (ultrasound) to create an image of the heart.','\0','','CL-METHOD','DBX-NCIT-C16525'),('CL-METHOD-T-39',NULL,'EEG','A technique used to capture and record spontaneous electrical activity of the brain by the application of electrodes to the scalp.','\0','ELECTROENCEPHALOGRAPHY','CL-METHOD','DBX-NCIT-C38054'),('CL-METHOD-T-4',NULL,'ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN','A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differential','\0','','CL-METHOD','DBX-NCIT-C92304'),('CL-METHOD-T-40',NULL,'EIA','Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT).','\0','Enzyme Immunoassay','CL-METHOD','DBX-NCIT-C17455'),('CL-METHOD-T-41',NULL,'ELASTOGRAPHY','An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI)','\0','','CL-METHOD','DBX-NCIT-C106517'),('CL-METHOD-T-42',NULL,'ELECTROCHEMILUMINESCENCE','A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111193'),('CL-METHOD-T-43',NULL,'ELECTROCHEMILUMINESCENCE IMMUNOASSAY','A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes.','\0','','CL-METHOD','DBX-NCIT-C111194'),('CL-METHOD-T-44',NULL,'ELECTROPHORESIS','The motion of charged particles in a colloid under the influence of an electric field; particles with a positive charge go to the cathode and negative to the anode.','\0','','CL-METHOD','DBX-NCIT-C16536'),('CL-METHOD-T-45',NULL,'ELISA','An immunoassay for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody','\0','Enzyme-linked Immunosorbent Assay','CL-METHOD','DBX-NCIT-C16553'),('CL-METHOD-T-46',NULL,'ELISPOT','A highly sensitive immunoassay capable of detecting secreted materials from individuals cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Bi','\0','Enzyme-linked Immunosorbent Spot Assay','CL-METHOD','DBX-NCIT-C102632'),('CL-METHOD-T-47',NULL,'ENDOSCOPY','An examination of the body using an endoscope.','\0','','CL-METHOD','DBX-NCIT-C16546'),('CL-METHOD-T-48',NULL,'ENZYMATIC COLORIMETRY','A type of colorimetry that makes use of an enzymatic reaction to induce a color change. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111195'),('CL-METHOD-T-49',NULL,'ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE','A type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric anal','\0','EMIT','CL-METHOD','DBX-NCIT-C111196'),('CL-METHOD-T-5',NULL,'ALCIAN BLUE STAIN','A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans.','\0','','CL-METHOD','DBX-NCIT-C92299'),('CL-METHOD-T-50',NULL,'EPSILOMETER','A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concen','\0','','CL-METHOD','DBX-NCIT-C85596'),('CL-METHOD-T-51',NULL,'ETDRS EYE CHART','A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes.','\0','','CL-METHOD','DBX-NCIT-C117877'),('CL-METHOD-T-52',NULL,'FDGPET','An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is intr','\0','FDG-PET Scan','CL-METHOD','DBX-NCIT-C103400'),('CL-METHOD-T-53',NULL,'FISH','A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene m','\0','Fluorescence in Situ Hybridization','CL-METHOD','DBX-NCIT-C17563'),('CL-METHOD-T-54',NULL,'FLAME PHOTOMETRY','A type of atomic spectroscopy that qualitatively or quantitatively measures select cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a','\0','','CL-METHOD','DBX-NCIT-C106523'),('CL-METHOD-T-55',NULL,'FLOW CYTOMETRY','A technique for counting, examining or sorting microscopic particles suspended in a stream of fluid.','\0','','CL-METHOD','DBX-NCIT-C16585'),('CL-METHOD-T-56',NULL,'FLOW MICROSCOPY','A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells to determine the presence of foreign particles, cell co','\0','','CL-METHOD','DBX-NCIT-C112284'),('CL-METHOD-T-57',NULL,'FLTPET','An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is intr','\0','FLT-PET Scan','CL-METHOD','DBX-NCIT-C103401'),('CL-METHOD-T-58',NULL,'FLUORESCENT IMMUNOASSAY','A bioassay in which fluorescent-coupled antibodies or antigens are used to quantify or qualify a biological response to a stimulus.','\0','Fluorescent Antibody Assay; Immunofluorescence Assay','CL-METHOD','DBX-NCIT-C17370'),('CL-METHOD-T-59',NULL,'FLUORESCENT MICROSCOPY','Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light.','\0','','CL-METHOD','DBX-NCIT-C16856'),('CL-METHOD-T-6',NULL,'ANGIOGRAM','An image of blood vessels.','\0','','CL-METHOD','DBX-NCIT-C16290'),('CL-METHOD-T-60',NULL,'FLUORIMETRY','An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state. (NCI)','\0','','CL-METHOD','DBX-NCIT-C62322'),('CL-METHOD-T-61',NULL,'FUNCTIONAL MRI','A type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images.','\0','fMRI','CL-METHOD','DBX-NCIT-C17958'),('CL-METHOD-T-62',NULL,'GC/MS','An analytical technique where gas chromatography is coupled with mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI)','\0','Gas Chromatography/Mass Spectrometry','CL-METHOD','DBX-NCIT-C111203'),('CL-METHOD-T-63',NULL,'GEL ELECTROPHORESIS','A method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix. Subject to an electric field, each molecule in the sample mixture migrates through th','\0','','CL-METHOD','DBX-NCIT-C18091'),('CL-METHOD-T-64',NULL,'GIEMSA STAIN','A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thy','\0','','CL-METHOD','DBX-NCIT-C85598'),('CL-METHOD-T-65',NULL,'GRADIENT DIFFUSION','A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory co','\0','','CL-METHOD','DBX-NCIT-C85599'),('CL-METHOD-T-66',NULL,'GRAM STAIN','A microscopy staining method for staining and identifying bacteria, based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms wil','\0','','CL-METHOD','DBX-NCIT-C23014'),('CL-METHOD-T-67',NULL,'HANSEL STAIN','A microscopy staining method that uses Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI)','\0','','CL-METHOD','DBX-NCIT-C111205'),('CL-METHOD-T-68',NULL,'HEMATOXYLIN AND EOSIN STAIN','A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is','\0','H&E Stain','CL-METHOD','DBX-NCIT-C23011'),('CL-METHOD-T-69',NULL,'HIGH LEVEL AMINOGLYCOSIDE SCREEN','A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics.','\0','','CL-METHOD','DBX-NCIT-C85556'),('CL-METHOD-T-7',NULL,'ANGIOGRAPHY','A method used to create an image of blood vessels.','\0','','CL-METHOD','DBX-NCIT-C20080'),('CL-METHOD-T-70',NULL,'HPLC','Frequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary pha','\0','High Performance Liquid Chromatography','CL-METHOD','DBX-NCIT-C16434'),('CL-METHOD-T-71',NULL,'HPLC/MS','An analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.','\0','High Performance Liquid Chromatography/Mass Spectrometry','CL-METHOD','DBX-NCIT-C103513'),('CL-METHOD-T-72',NULL,'IHC','Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic ','\0','Immunohistochemistry','CL-METHOD','DBX-NCIT-C23020'),('CL-METHOD-T-73',NULL,'IMMUNOASSAY','An immunological procedure involving the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes.','\0','','CL-METHOD','DBX-NCIT-C16714'),('CL-METHOD-T-74',NULL,'IMMUNOBLOT','A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies. (NCI)','\0','','CL-METHOD','DBX-NCIT-C17638');
INSERT INTO `CVterms` VALUES ('CL-METHOD-T-75',NULL,'IMMUNOCHEMILUMINOMETRIC ASSAY','An immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction.','\0','Chemiluminesence Immunoassay; ICMA','CL-METHOD','DBX-NCIT-C111235'),('CL-METHOD-T-76',NULL,'IMMUNOPRECIPITATION','Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI)','\0','','CL-METHOD','DBX-NCIT-C16724'),('CL-METHOD-T-77',NULL,'IMMUNORADIOMETRIC ASSAY','An antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand.','\0','IRMA','CL-METHOD','DBX-NCIT-C111236'),('CL-METHOD-T-78',NULL,'IMMUNOTURBIDIMETRY','A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte. (NCI)','\0','','CL-METHOD','DBX-NCIT-C106536'),('CL-METHOD-T-79',NULL,'IN SITU HYBRIDIZATION','Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI)','\0','','CL-METHOD','DBX-NCIT-C17562'),('CL-METHOD-T-8',NULL,'ANTIBIOTIC AGAR SCREEN','A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix.','\0','','CL-METHOD','DBX-NCIT-C85557'),('CL-METHOD-T-80',NULL,'INDIA INK STAIN','A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in bla','\0','','CL-METHOD','DBX-NCIT-C85642'),('CL-METHOD-T-81',NULL,'INFRARED SPECTROMETRY','A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light.','\0','','CL-METHOD','DBX-NCIT-C85643'),('CL-METHOD-T-82',NULL,'INTRAVASCULAR ULTRASOUND','An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram).','\0','IVUS','CL-METHOD','DBX-NCIT-C99535'),('CL-METHOD-T-83',NULL,'IODINE STAIN','A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color.','\0','','CL-METHOD','DBX-NCIT-C85649'),('CL-METHOD-T-84',NULL,'IRON HEMATOXYLIN STAIN','A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blu','\0','','CL-METHOD','DBX-NCIT-C85650'),('CL-METHOD-T-85',NULL,'KARYOTYPING','The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell sample.','\0','','CL-METHOD','DBX-NCIT-C16768'),('CL-METHOD-T-86',NULL,'KINETIC MICROPARTICLE IMMUNOASSAY','A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen prese','\0','','CL-METHOD','DBX-NCIT-C111240'),('CL-METHOD-T-87',NULL,'KINYOUN STAIN','A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step invo','\0','','CL-METHOD','DBX-NCIT-C85651'),('CL-METHOD-T-88',NULL,'LASER CAPTURE MICRODISSECTION','A technique used for the highly specific and selective capture and isolation of a cell population from a heterogeneous tissue section, cytological preparation, or live cell culture. This technique uses direct visualization of the cells via microscopy as w','\0','LCM; LMD; Laser Microdissection','CL-METHOD','DBX-NCIT-C19263'),('CL-METHOD-T-89',NULL,'LC/MS','An analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.','\0','Liquid Chromatography/Mass Spectrometry','CL-METHOD','DBX-NCIT-C18475'),('CL-METHOD-T-9',NULL,'ANTIMICROBIAL COMBINATION TESTING','A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive.','\0','','CL-METHOD','DBX-NCIT-C85558'),('CL-METHOD-T-90',NULL,'LEAD CITRATE STAIN','A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining.','\0','','CL-METHOD','DBX-NCIT-C92301'),('CL-METHOD-T-91',NULL,'LIGHT MICROSCOPY','Light microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be d','\0','','CL-METHOD','DBX-NCIT-C17995'),('CL-METHOD-T-92',NULL,'LIGHT SCATTERING SPECTROSCOPY','A type of spectroscopy that measures power spectral density of surface morphology by exploiting the tendency of light to disperse into a range of directions as a result of physical interaction.','\0','LiSSP','CL-METHOD','DBX-NCIT-C20059'),('CL-METHOD-T-93',NULL,'LINE PROBE ASSAY','A microbial identification technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes.','\0','LPA; LiPA','CL-METHOD','DBX-NCIT-C102656'),('CL-METHOD-T-94',NULL,'LOOP-MEDIATED ISOTHERMAL AMPLIFICATION','A type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cy','\0','LAMP','CL-METHOD','DBX-NCIT-C102661'),('CL-METHOD-T-95',NULL,'LUXOL FAST BLUE AND CRESYL VIOLET STAIN','A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and camp','\0','','CL-METHOD','DBX-NCIT-C92300'),('CL-METHOD-T-96',NULL,'MACRO BROTH DILUTION','A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubat','\0','','CL-METHOD','DBX-NCIT-C85697'),('CL-METHOD-T-97',NULL,'MALDI','A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the las','\0','Matrix-Assisted Laser Desorption Ionization Mass Spectrometry','CL-METHOD','DBX-NCIT-C48040'),('CL-METHOD-T-98',NULL,'MALDI-TOF','In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated fligh','\0','Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry','CL-METHOD','DBX-NCIT-C19935'),('CL-METHOD-T-99',NULL,'MAMMOGRAPHY','A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image.','\0','','CL-METHOD','DBX-NCIT-C16818'),('CL-MICROORG-T-1',NULL,'ABIOTROPHIA','Any bacteria that is not assigned to the species level but can be assigned to the Abiotrophia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86077'),('CL-MICROORG-T-10',NULL,'ACIDOVORAX DELAFIELDII','Any bacterial organism that can be assigned to the species Acidovorax delafieldii.','\0','','CL-MICROORG','DBX-NCIT-C86086'),('CL-MICROORG-T-100',NULL,'BACILLUS ANTHRACIS','Any bacterial organism that can be assigned to the species Bacillus anthracis.','\0','','CL-MICROORG','DBX-NCIT-C86160'),('CL-MICROORG-T-1000',NULL,'WOLINELLA SUCCINOGENES','Any bacterial organism that can be assigned to the species Wolinella succinogenes.','\0','','CL-MICROORG','DBX-NCIT-C86851'),('CL-MICROORG-T-1001',NULL,'YARROWIA LIPOLYTICA','Any fungal organism that can be assigned to the species Yarrowia lipolytica.','\0','M. lipolytica; Mycotorula lipolytica; Y. lipolytica','CL-MICROORG','DBX-NCIT-C114257'),('CL-MICROORG-T-1002',NULL,'YELLOW FEVER VIRUS','Any viral organism that can be assigned to the species Yellow fever virus.','\0','Flavivirus febricis; YFV','CL-MICROORG','DBX-NCIT-C97156'),('CL-MICROORG-T-1003',NULL,'YERSINIA','Any bacteria that is not assigned to the species level but can be assigned to the Yersinia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86852'),('CL-MICROORG-T-1004',NULL,'YERSINIA ALDOVAE','Any bacterial organism that can be assigned to the species Yersinia aldovae.','\0','','CL-MICROORG','DBX-NCIT-C86853'),('CL-MICROORG-T-1005',NULL,'YERSINIA BERCOVIERI','Any bacterial organism that can be assigned to the species Yersinia bercovieri.','\0','YERSINIA ENTEROLITICA BIOGROUP 3B','CL-MICROORG','DBX-NCIT-C86854'),('CL-MICROORG-T-1006',NULL,'YERSINIA ENTEROCOLITICA','Any bacterial organism that can be assigned to the species Yersinia enterocolitica.','\0','PASTEURELLA ENTEROCOLITICA','CL-MICROORG','DBX-NCIT-C86855'),('CL-MICROORG-T-1007',NULL,'YERSINIA FREDERIKSENII','Any bacterial organism that can be assigned to the species Yersinia frederiksenii.','\0','','CL-MICROORG','DBX-NCIT-C86856'),('CL-MICROORG-T-1008',NULL,'YERSINIA INTERMEDIA','Any bacterial organism that can be assigned to the species Yersinia intermedia.','\0','','CL-MICROORG','DBX-NCIT-C86857'),('CL-MICROORG-T-1009',NULL,'YERSINIA KRISTENSENII','Any bacterial organism that can be assigned to the species Yersinia kristensenii.','\0','','CL-MICROORG','DBX-NCIT-C86858'),('CL-MICROORG-T-101',NULL,'BACILLUS CEREUS','Any bacterial organism that can be assigned to the species Bacillus cereus.','\0','','CL-MICROORG','DBX-NCIT-C86161'),('CL-MICROORG-T-1010',NULL,'YERSINIA MOLLARETII','Any bacterial organism that can be assigned to the species Yersinia mollaretii.','\0','YERSINIA ENTEROLITICA BIOGROUP 3A','CL-MICROORG','DBX-NCIT-C86859'),('CL-MICROORG-T-1011',NULL,'YERSINIA PESTIS','Any bacterial organism that can be assigned to the species Yersinia pestis.','\0','PASTEURELLA PESTIS','CL-MICROORG','DBX-NCIT-C86860'),('CL-MICROORG-T-1012',NULL,'YERSINIA PSEUDOTUBERCULOSIS','Any bacterial organism that can be assigned to the species Yersinia pseudotuberculosis.','\0','PASTEURELLA PSEUDOTUBERCULOSIS','CL-MICROORG','DBX-NCIT-C86861'),('CL-MICROORG-T-1013',NULL,'YERSINIA ROHDEI','Any bacterial organism that can be assigned to the species Yersinia rohdei.','\0','','CL-MICROORG','DBX-NCIT-C86862'),('CL-MICROORG-T-1014',NULL,'YERSINIA RUCKERI','Any bacterial organism that can be assigned to the species Yersinia ruckeri.','\0','','CL-MICROORG','DBX-NCIT-C86863'),('CL-MICROORG-T-1015',NULL,'YOKENELLA','Any bacteria that is not assigned to the species level but can be assigned to the Yokenella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86864'),('CL-MICROORG-T-1016',NULL,'YOKENELLA REGENSBURGEI','Any bacterial organism that can be assigned to the species Yokenella regensburgei.','\0','CDC ENTERIC GROUP 45','CL-MICROORG','DBX-NCIT-C86865'),('CL-MICROORG-T-1017',NULL,'ZIMMERMANNELLA','Any bacteria that is not assigned to the species level but can be assigned to the Zimmermannella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86866'),('CL-MICROORG-T-1018',NULL,'ZIMMERMANNELLA ALBA','Any bacterial organism that can be assigned to the species Zimmermannella alba.','\0','','CL-MICROORG','DBX-NCIT-C86867'),('CL-MICROORG-T-1019',NULL,'ZIMMERMANNELLA BIFIDA','Any bacterial organism that can be assigned to the species Zimmermannella bifida.','\0','','CL-MICROORG','DBX-NCIT-C86868'),('CL-MICROORG-T-102',NULL,'BACILLUS LENTUS','Any bacterial organism that can be assigned to the species Bacillus lentus.','\0','','CL-MICROORG','DBX-NCIT-C86162'),('CL-MICROORG-T-103',NULL,'BACILLUS LICHENIFORMIS','Any bacterial organism that can be assigned to the species Bacillus licheniformis.','\0','','CL-MICROORG','DBX-NCIT-C86163'),('CL-MICROORG-T-104',NULL,'BACILLUS MEGATERIUM','Any bacterial organism that can be assigned to the species Bacillus megaterium.','\0','','CL-MICROORG','DBX-NCIT-C86164'),('CL-MICROORG-T-105',NULL,'BACILLUS MYCOIDES','Any bacterial organism that can be assigned to the species Bacillus mycoides.','\0','','CL-MICROORG','DBX-NCIT-C86165'),('CL-MICROORG-T-106',NULL,'BACILLUS POLYMYXA','Any bacterial organism that can be assigned to the species Bacillus polymyxa.','\0','','CL-MICROORG','DBX-NCIT-C86166'),('CL-MICROORG-T-107',NULL,'BACILLUS SUBTILIS','Any bacterial organism that can be assigned to the species Bacillus subtilis.','\0','','CL-MICROORG','DBX-NCIT-C86167'),('CL-MICROORG-T-108',NULL,'BACTERIA','Any organism assigned to the kingdom Bacteria.','\0','BACTERIUM; EUBACTERIA','CL-MICROORG','DBX-NCIT-C14187'),('CL-MICROORG-T-109',NULL,'BACTEROIDES','Any bacteria that is not assigned to the species level but can be assigned to the Bacteroides genus level.','\0','','CL-MICROORG','DBX-NCIT-C76204'),('CL-MICROORG-T-11',NULL,'ACIDOVORAX FACILIS','Any bacterial organism that can be assigned to the species Acidovorax facilis.','\0','','CL-MICROORG','DBX-NCIT-C86087'),('CL-MICROORG-T-110',NULL,'BACTEROIDES CACCAE','Any bacterial organism that can be assigned to the species Bacteroides caccae.','\0','BACTEROIDES FRAGILIS GROUP 3452A','CL-MICROORG','DBX-NCIT-C86168'),('CL-MICROORG-T-111',NULL,'BACTEROIDES CAPILLOSUS','Any bacterial organism that can be assigned to the species Bacteroides capillosus.','\0','','CL-MICROORG','DBX-NCIT-C86169'),('CL-MICROORG-T-112',NULL,'BACTEROIDES CELLULOSOLVENS','Any bacterial organism that can be assigned to the species Bacteroides cellulosolvens.','\0','','CL-MICROORG','DBX-NCIT-C86170'),('CL-MICROORG-T-113',NULL,'BACTEROIDES DOREI','Any bacterial organism that can be assigned to the species Bacteroides dorei.','\0','','CL-MICROORG','DBX-NCIT-C111133'),('CL-MICROORG-T-114',NULL,'BACTEROIDES EGGERTHII','Any bacterial organism that can be assigned to the species Bacteroides eggerthii.','\0','','CL-MICROORG','DBX-NCIT-C86171'),('CL-MICROORG-T-115',NULL,'BACTEROIDES FAECIS','Any bacterial organism that can be assigned to the species Bacteroides faecis.','\0','','CL-MICROORG','DBX-NCIT-C111134'),('CL-MICROORG-T-116',NULL,'BACTEROIDES FRAGILIS','Any bacterial organism that can be assigned to the species Bacteroides fragilis.','\0','','CL-MICROORG','DBX-NCIT-C86172'),('CL-MICROORG-T-117',NULL,'BACTEROIDES FRAGILIS GROUP','A bacteria that belongs to the Fragilis group of the genus Bacteroides.','\0','','CL-MICROORG','DBX-NCIT-C86173'),('CL-MICROORG-T-118',NULL,'BACTEROIDES NORDII','Any bacterial organism that can be assigned to the species Bacteroides nordii.','\0','','CL-MICROORG','DBX-NCIT-C86174'),('CL-MICROORG-T-119',NULL,'BACTEROIDES OVATUS','Any bacterial organism that can be assigned to the species Bacteroides ovatus.','\0','','CL-MICROORG','DBX-NCIT-C86175'),('CL-MICROORG-T-12',NULL,'ACIDOVORAX TEMPERANS','Any bacterial organism that can be assigned to the species Acidovorax temperans.','\0','','CL-MICROORG','DBX-NCIT-C86088'),('CL-MICROORG-T-120',NULL,'BACTEROIDES STERCORIS','Any bacterial organism that can be assigned to the species Bacteroides stercoris.','\0','BACTEROIDES FRAGILIS SUBSP. A','CL-MICROORG','DBX-NCIT-C86177'),('CL-MICROORG-T-121',NULL,'BACTEROIDES TECTUS','Any bacterial organism that can be assigned to the species Bacteroides tectus.','\0','BACTEROIDES TECTUM','CL-MICROORG','DBX-NCIT-C86178'),('CL-MICROORG-T-122',NULL,'BACTEROIDES THETAIOTAOMICRON','Any bacterial organism that can be assigned to the species Bacteroides thetaiotamicron.','\0','','CL-MICROORG','DBX-NCIT-C86179'),('CL-MICROORG-T-123',NULL,'BACTEROIDES UNIFORMIS','Any bacterial organism that can be assigned to the species Bacteroides uniformis.','\0','','CL-MICROORG','DBX-NCIT-C86180'),('CL-MICROORG-T-124',NULL,'BACTEROIDES UREOLYTICUS','Any bacterial organism that can be assigned to the species Bacteroides ureolyticus.','\0','BACTEROIDES CORRODENS','CL-MICROORG','DBX-NCIT-C86181'),('CL-MICROORG-T-125',NULL,'BACTEROIDES VULGATUS','Any bacterial organism that can be assigned to the species Bacteroides vulgatus.','\0','','CL-MICROORG','DBX-NCIT-C86182'),('CL-MICROORG-T-126',NULL,'BARMAH FOREST VIRUS','Any viral organism that can be assigned to the species Barmah Forest virus.','\0','','CL-MICROORG','DBX-NCIT-C112232'),('CL-MICROORG-T-127',NULL,'BARTONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Bartonella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86184'),('CL-MICROORG-T-128',NULL,'BARTONELLA ELIZABETHAE','Any bacterial organism that can be assigned to the species Bartonella elizabethae.','\0','ROCHALIMAEA ELIZABETHAE','CL-MICROORG','DBX-NCIT-C86185'),('CL-MICROORG-T-129',NULL,'BARTONELLA HENSELAE','Any bacterial organism that can be assigned to the species Bartonella henselae.','\0','ROCHALIMAEA HENSELAE','CL-MICROORG','DBX-NCIT-C86186'),('CL-MICROORG-T-13',NULL,'ACINETOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Acinetobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C76200'),('CL-MICROORG-T-130',NULL,'BARTONELLA QUINTANA','Any bacterial organism that can be assigned to the species Bartonella quintana.','\0','ROCHALIMAEA QUINTANA','CL-MICROORG','DBX-NCIT-C86187'),('CL-MICROORG-T-131',NULL,'BERGEYELLA','Any bacteria that is not assigned to the species level but can be assigned to the Bergeyella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86188'),('CL-MICROORG-T-132',NULL,'BERGEYELLA ZOOHELCUM','Any bacterial organism that can be assigned to the species Bergeyella zoohelcum.','\0','WEEKSELLA ZOOHELCUM','CL-MICROORG','DBX-NCIT-C86189'),('CL-MICROORG-T-133',NULL,'BETA STREPTOCOCCUS, GROUP C','A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the C group.','\0','','CL-MICROORG','DBX-NCIT-C86191'),('CL-MICROORG-T-134',NULL,'BETA STREPTOCOCCUS, GROUP F','A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the F group.','\0','','CL-MICROORG','DBX-NCIT-C86192'),('CL-MICROORG-T-135',NULL,'BETA STREPTOCOCCUS, GROUP G','A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the G group.','\0','','CL-MICROORG','DBX-NCIT-C86193'),('CL-MICROORG-T-136',NULL,'BIFIDOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Bifidobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86194'),('CL-MICROORG-T-137',NULL,'BIFIDOBACTERIUM ADOLESCENTIS','Any bacterial organism that can be assigned to the species Bifidobacterium adolescentis.','\0','','CL-MICROORG','DBX-NCIT-C86195'),('CL-MICROORG-T-138',NULL,'BIFIDOBACTERIUM ANGULATUM','Any bacterial organism that can be assigned to the species Bifidobacterium angulatum.','\0','','CL-MICROORG','DBX-NCIT-C86196'),('CL-MICROORG-T-139',NULL,'BIFIDOBACTERIUM BIFIDUM','Any bacterial organism that can be assigned to the species Bifidobacterium bifidum.','\0','','CL-MICROORG','DBX-NCIT-C86197'),('CL-MICROORG-T-14',NULL,'ACINETOBACTER ANITRATUS','Any bacterial organism that can be assigned to the species Acinetobacter anitratus.','\0','ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS SUBSP. ANITRATUS','CL-MICROORG','DBX-NCIT-C86089'),('CL-MICROORG-T-140',NULL,'BIFIDOBACTERIUM DENTIUM','Any bacterial organism that can be assigned to the species Bifidobacterium dentium.','\0','BIFIDOBACTERIUM APPENDICITIS','CL-MICROORG','DBX-NCIT-C86198'),('CL-MICROORG-T-141',NULL,'BIFIDOBACTERIUM LONGUM','Any bacterial organism that can be assigned to the species Bifidobacterium longum.','\0','','CL-MICROORG','DBX-NCIT-C86199'),('CL-MICROORG-T-142',NULL,'BILOPHILA','Any bacteria that is not assigned to the species level but can be assigned to the Bilophila genus level.','\0','','CL-MICROORG','DBX-NCIT-C86200'),('CL-MICROORG-T-143',NULL,'BILOPHILA WADSWORTHIA','Any bacterial organism that can be assigned to the species Bilophila wadsworthia.','\0','','CL-MICROORG','DBX-NCIT-C86201'),('CL-MICROORG-T-144',NULL,'BK POLYOMAVIRUS','Any viral organism that can be assigned to the species BK polyomavirus.','\0','BK Virus','CL-MICROORG','DBX-NCIT-C89820'),('CL-MICROORG-T-145',NULL,'BORDETELLA','Any bacteria that is not assigned to the species level but can be assigned to the Bordetella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86202'),('CL-MICROORG-T-146',NULL,'BORDETELLA AVIUM','Any bacterial organism that can be assigned to the species Bordetella avium.','\0','','CL-MICROORG','DBX-NCIT-C86203'),('CL-MICROORG-T-147',NULL,'BORDETELLA BRONCHISEPTICA','Any bacterial organism that can be assigned to the species Bordetella bronchiseptica.','\0','BORDETELLA BRONCHICANIS','CL-MICROORG','DBX-NCIT-C86204'),('CL-MICROORG-T-148',NULL,'BORDETELLA PARAPERTUSSIS','Any bacterial organism that can be assigned to the species Bordetella parapertussis.','\0','','CL-MICROORG','DBX-NCIT-C86205'),('CL-MICROORG-T-149',NULL,'BORDETELLA PERTUSSIS','Any bacterial organism that can be assigned to the species Bordetella pertussis.','\0','','CL-MICROORG','DBX-NCIT-C76205'),('CL-MICROORG-T-15',NULL,'ACINETOBACTER CALCOACETICUS','Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus.','\0','','CL-MICROORG','DBX-NCIT-C86090'),('CL-MICROORG-T-150',NULL,'BORRELIA','Any bacteria that is not assigned to the species level but can be assigned to the Borrelia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86206'),('CL-MICROORG-T-151',NULL,'BORRELIA BURGDORFERI','Any bacterial organism that can be assigned to the species Borrelia burgdorferi.','\0','','CL-MICROORG','DBX-NCIT-C76208'),('CL-MICROORG-T-152',NULL,'BREVIBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Brevibacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86207'),('CL-MICROORG-T-153',NULL,'BREVIBACILLUS LATEROSPORUS','Any bacterial organism that can be assigned to the species Brevibacillus laterosporus.','\0','','CL-MICROORG','DBX-NCIT-C86208'),('CL-MICROORG-T-154',NULL,'BREVIBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Brevibacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86209'),('CL-MICROORG-T-155',NULL,'BREVIBACTERIUM CASEI','Any bacterial organism that can be assigned to the species Brevibacterium casei.','\0','','CL-MICROORG','DBX-NCIT-C86210'),('CL-MICROORG-T-156',NULL,'BREVIBACTERIUM EPIDERMIDIS','Any bacterial organism that can be assigned to the species Brevibacterium epidermidis.','\0','','CL-MICROORG','DBX-NCIT-C86211'),('CL-MICROORG-T-157',NULL,'BREVUNDIMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Brevundimonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86212'),('CL-MICROORG-T-158',NULL,'BREVUNDIMONAS DIMINUTA','Any bacterial organism that can be assigned to the species Brevundimonas diminuta.','\0','PSEUDOMONAS DIMINUTA','CL-MICROORG','DBX-NCIT-C86213'),('CL-MICROORG-T-159',NULL,'BREVUNDIMONAS VESICULARIS','Any bacterial organism that can be assigned to the species Brevundimonas vesicularis.','\0','PSEUDOMONAS VESICULARIS','CL-MICROORG','DBX-NCIT-C86214'),('CL-MICROORG-T-16',NULL,'ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX','A non-taxonomic grouping of bacteria assigned to the Acinetobacter genus that include the A. calcoaceticus and A. baumannii species.','\0','','CL-MICROORG','DBX-NCIT-C86091'),('CL-MICROORG-T-160',NULL,'BRUCELLA','Any bacteria that is not assigned to the species level but can be assigned to the Brucella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86215'),('CL-MICROORG-T-161',NULL,'BRUCELLA ABORTUS','Any bacterial organism that can be assigned to the species Brucella abortus.','\0','','CL-MICROORG','DBX-NCIT-C86216'),('CL-MICROORG-T-162',NULL,'BRUCELLA CANIS','Any bacterial organism that can be assigned to the species Brucella canis.','\0','','CL-MICROORG','DBX-NCIT-C86217'),('CL-MICROORG-T-163',NULL,'BRUCELLA MELITENSIS','Any bacterial organism that can be assigned to the species Brucella melitensis.','\0','','CL-MICROORG','DBX-NCIT-C86218'),('CL-MICROORG-T-164',NULL,'BRUCELLA SUIS','Any bacterial organism that can be assigned to the species Brucella suis.','\0','','CL-MICROORG','DBX-NCIT-C86219'),('CL-MICROORG-T-165',NULL,'BUDVICIA','Any bacteria that is not assigned to the species level but can be assigned to the Budvicia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86220'),('CL-MICROORG-T-166',NULL,'BUDVICIA AQUATICA','Any bacterial organism that can be assigned to the species Budvicia aquatica.','\0','','CL-MICROORG','DBX-NCIT-C86221'),('CL-MICROORG-T-167',NULL,'BURKHOLDERIA','Any bacteria that is not assigned to the species level but can be assigned to the Burkholderia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86222'),('CL-MICROORG-T-168',NULL,'BURKHOLDERIA CENOCEPACIA','Any bacterial organism that can be assigned to the species Burkholderia cenocepacia.','\0','','CL-MICROORG','DBX-NCIT-C86223'),('CL-MICROORG-T-169',NULL,'BURKHOLDERIA CEPACIA','Any bacterial organism that can be assigned to the species Burkholderia cepacia.','\0','CDC GROUP EO-1; PSEUDOMONAS CEPACIA','CL-MICROORG','DBX-NCIT-C76376'),('CL-MICROORG-T-17',NULL,'ACINETOBACTER HAEMOLYTICUS','Any bacterial organism that can be assigned to the species Acinetobacter haemolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86092'),('CL-MICROORG-T-170',NULL,'BURKHOLDERIA CEPACIA COMPLEX','A non-taxonomic grouping of bacteria assigned to and including at least nine related species from the Burkholderia genus.','\0','','CL-MICROORG','DBX-NCIT-C86224'),('CL-MICROORG-T-171',NULL,'BURKHOLDERIA GLADIOLI','Any bacterial organism that can be assigned to the species Burkholderia gladioli.','\0','PSEUDOMONAS GLADIOLI','CL-MICROORG','DBX-NCIT-C86225'),('CL-MICROORG-T-172',NULL,'BURKHOLDERIA MALLEI','Any bacterial organism that can be assigned to the species Burkholderia mallei.','\0','ACTINOBACILLUS MALLEI','CL-MICROORG','DBX-NCIT-C86226'),('CL-MICROORG-T-173',NULL,'BURKHOLDERIA PSEUDOMALLEI','Any bacterial organism that can be assigned to the species Burkholderia pseudomallei.','\0','BURKHOLDERIA PSEUDOMALLE; PSEUDOMONAS PSEUDOMALLEI','CL-MICROORG','DBX-NCIT-C86227'),('CL-MICROORG-T-174',NULL,'BUTTIAUXELLA','Any bacteria that is not assigned to the species level but can be assigned to the Buttiauxella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86228'),('CL-MICROORG-T-175',NULL,'BUTTIAUXELLA AGRESTIS','Any bacterial organism that can be assigned to the species Buttiauxella agrestis.','\0','','CL-MICROORG','DBX-NCIT-C86229'),('CL-MICROORG-T-176',NULL,'CALICIVIRUS','Any viral organism that can be assigned to the family Caliciviridae.','\0','Caliciviridae','CL-MICROORG','DBX-NCIT-C14304'),('CL-MICROORG-T-177',NULL,'CAMPYLOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Campylobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C76211'),('CL-MICROORG-T-178',NULL,'CAMPYLOBACTER COLI','Any bacterial organism that can be assigned to the species Campylobacter coli.','\0','','CL-MICROORG','DBX-NCIT-C86230'),('CL-MICROORG-T-179',NULL,'CAMPYLOBACTER CONCISUS','Any bacterial organism that can be assigned to the species Campylobacter concisus.','\0','CDC GROUP EF-22','CL-MICROORG','DBX-NCIT-C86231'),('CL-MICROORG-T-18',NULL,'ACINETOBACTER JOHNSONII','Any bacterial organism that can be assigned to the species Acinetobacter johnsonii.','\0','','CL-MICROORG','DBX-NCIT-C86093'),('CL-MICROORG-T-180',NULL,'CAMPYLOBACTER CURVUS','Any bacterial organism that can be assigned to the species Campylobacter curvus.','\0','WOLINELLA CURVA','CL-MICROORG','DBX-NCIT-C86232'),('CL-MICROORG-T-181',NULL,'CAMPYLOBACTER FETUS','Any bacterial organism that can be assigned to the species Campylobacter fetus.','\0','VIBRIO FETUS','CL-MICROORG','DBX-NCIT-C86233'),('CL-MICROORG-T-182',NULL,'CAMPYLOBACTER GRACILIS','Any bacterial organism that can be assigned to the species Campylobacter gracilis.','\0','BACTEROIDES GRACILIS','CL-MICROORG','DBX-NCIT-C86234'),('CL-MICROORG-T-183',NULL,'CAMPYLOBACTER JEJUNI','Any bacterial organism that can be assigned to the species Campylobacter jejuni.','\0','','CL-MICROORG','DBX-NCIT-C86235'),('CL-MICROORG-T-184',NULL,'CAMPYLOBACTER LARI','Any bacterial organism that can be assigned to the species Campylobacter lari.','\0','CAMPYLOBACTER LARIDIS','CL-MICROORG','DBX-NCIT-C86236'),('CL-MICROORG-T-185',NULL,'CAMPYLOBACTER RECTUS','Any bacterial organism that can be assigned to the species Campylobacter rectus.','\0','WOLINELLA RECTA','CL-MICROORG','DBX-NCIT-C86237'),('CL-MICROORG-T-186',NULL,'CAMPYLOBACTER UPSALIENSIS','Any bacterial organism that can be assigned to the species Campylobacter upsaliensis.','\0','','CL-MICROORG','DBX-NCIT-C86238'),('CL-MICROORG-T-187',NULL,'CANDIDA ALBICANS','Any fungal organism that can be assigned to the species Candida albicans.','\0','C. albicans','CL-MICROORG','DBX-NCIT-C77170'),('CL-MICROORG-T-188',NULL,'CANDIDA DUBLINIENSIS','Any fungal organism that can be assigned to the species Candida dubliniensis.','\0','C. dubliniensis','CL-MICROORG','DBX-NCIT-C114255'),('CL-MICROORG-T-189',NULL,'CANDIDA GLABRATA','Any fungal organism that can be assigned to the species Candida glabrata.','\0','C. glabrata; Torulopsis glabrata','CL-MICROORG','DBX-NCIT-C77179'),('CL-MICROORG-T-19',NULL,'ACINETOBACTER JUNII','Any bacterial organism that can be assigned to the species Acinetobacter junii.','\0','','CL-MICROORG','DBX-NCIT-C86094'),('CL-MICROORG-T-190',NULL,'CANDIDA ORTHOPSILOSIS','Any fungal organism that can be assigned to the species Candida orthopsilosis.','\0','C. orthopsilosis; Candida parapsilosis group II','CL-MICROORG','DBX-NCIT-C114260'),('CL-MICROORG-T-191',NULL,'CANDIDA PARAPSILOSIS','Any fungal organism that can be assigned to the species Candida parapsilosis.','\0','C. parapsilosis','CL-MICROORG','DBX-NCIT-C77176'),('CL-MICROORG-T-192',NULL,'CANDIDA PARARUGOSA','Any fungal organism that can be assigned to the species Candida pararugosa.','\0','C. pararugosa','CL-MICROORG','DBX-NCIT-C114258'),('CL-MICROORG-T-193',NULL,'CANDIDA RUGOSA','Any fungal organism that can be assigned to the species Candida rugosa.','\0','C. rugosa','CL-MICROORG','DBX-NCIT-C114254'),('CL-MICROORG-T-194',NULL,'CANDIDA TROPICALIS','Any fungal organism that can be assigned to the species Candida tropicalis.','\0','C. tropicalis','CL-MICROORG','DBX-NCIT-C77177'),('CL-MICROORG-T-195',NULL,'CANDIDA ZEYLANOIDES','Any fungal organism that can be assigned to the species Candida zeylanoides.','\0','C. krissii; C. zeylanoides; Candida krissii','CL-MICROORG','DBX-NCIT-C114261'),('CL-MICROORG-T-196',NULL,'CAPNOCYTOPHAGA','Any bacteria that is not assigned to the species level but can be assigned to the Capnocytophaga genus level.','\0','','CL-MICROORG','DBX-NCIT-C76269'),('CL-MICROORG-T-197',NULL,'CAPNOCYTOPHAGA CANIMORSUS','Any bacterial organism that can be assigned to the species Capnocytophaga canimorsus.','\0','CDC GROUP DF-2','CL-MICROORG','DBX-NCIT-C86239'),('CL-MICROORG-T-198',NULL,'CAPNOCYTOPHAGA GINGIVALIS','Any bacterial organism that can be assigned to the species Capnocytophaga gingivalis.','\0','','CL-MICROORG','DBX-NCIT-C86240'),('CL-MICROORG-T-199',NULL,'CAPNOCYTOPHAGA OCHRACEA','Any bacterial organism that can be assigned to the species Capnocytophaga ochracea.','\0','','CL-MICROORG','DBX-NCIT-C86241'),('CL-MICROORG-T-2',NULL,'ABIOTROPHIA DEFECTIVA','Any bacterial organism that can be assigned to the species Abiotrophia defectiva.','\0','','CL-MICROORG','DBX-NCIT-C86078'),('CL-MICROORG-T-20',NULL,'ACINETOBACTER LWOFFII','Any bacterial organism that can be assigned to the species Acinetobacter lwoffii.','\0','ACINETOBACTER CALCOACETICUS SUBSP. LWOFFII','CL-MICROORG','DBX-NCIT-C86095'),('CL-MICROORG-T-200',NULL,'CAPNOCYTOPHAGA SPUTIGENA','Any bacterial organism that can be assigned to the species Capnocytophaga sputigena.','\0','','CL-MICROORG','DBX-NCIT-C86242'),('CL-MICROORG-T-201',NULL,'CARDIOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Cardiobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86243'),('CL-MICROORG-T-202',NULL,'CARDIOBACTERIUM HOMINIS','Any bacterial organism that can be assigned to the species Cardiobacterium hominis.','\0','CDC GROUP IID','CL-MICROORG','DBX-NCIT-C86244'),('CL-MICROORG-T-203',NULL,'CEDECEA','Any bacteria that is not assigned to the species level but can be assigned to the Cedecea genus level.','\0','','CL-MICROORG','DBX-NCIT-C86245'),('CL-MICROORG-T-204',NULL,'CEDECEA DAVISAE','Any bacterial organism that can be assigned to the species Cedecea davisae.','\0','CDC ENTERIC GROUP 15','CL-MICROORG','DBX-NCIT-C86246'),('CL-MICROORG-T-205',NULL,'CEDECEA LAPAGEI','Any bacterial organism that can be assigned to the species Cedecea lapagei.','\0','','CL-MICROORG','DBX-NCIT-C86247'),('CL-MICROORG-T-206',NULL,'CEDECEA NETERI','Any bacterial organism that can be assigned to the species Cedecea neteri.','\0','CEDECEA SPECIES 4','CL-MICROORG','DBX-NCIT-C86248'),('CL-MICROORG-T-207',NULL,'CELLULOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Cellulomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86249'),('CL-MICROORG-T-208',NULL,'CELLULOMONAS HOMINIS','Any bacterial organism that can be assigned to the species Cellulomonas hominis.','\0','','CL-MICROORG','DBX-NCIT-C86250'),('CL-MICROORG-T-209',NULL,'CELLULOSIMICROBIUM','Any bacteria that is not assigned to the species level but can be assigned to the Cellulosimicrobium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86251'),('CL-MICROORG-T-21',NULL,'ACINETOBACTER RADIORESISTENS','Any bacterial organism that can be assigned to the species Acinetobacter radioresistens.','\0','','CL-MICROORG','DBX-NCIT-C86096'),('CL-MICROORG-T-210',NULL,'CELLULOSIMICROBIUM CELLULANS','Any bacterial organism that can be assigned to the species Cellulosimicrobium cellulans.','\0','ARTHROBACTER LUTEUS; CELLULOMONAS CELLULANS; NOCARDIA CELLULANS; OERSKOVIA XANTHINEOLYTICA','CL-MICROORG','DBX-NCIT-C86252'),('CL-MICROORG-T-211',NULL,'CHLAMYDIA','Any bacteria that is not assigned to the species level but can be assigned to the Chlamydia genus level.','\0','','CL-MICROORG','DBX-NCIT-C76271'),('CL-MICROORG-T-212',NULL,'CHLAMYDIA TRACHOMATIS','Any bacterial organism that can be assigned to the species Chlamydia trachomatis.','\0','','CL-MICROORG','DBX-NCIT-C86253'),('CL-MICROORG-T-213',NULL,'CHLAMYDOPHILA','Any bacteria that is not assigned to the species level but can be assigned to the Chlamydophila genus level.','\0','','CL-MICROORG','DBX-NCIT-C86254'),('CL-MICROORG-T-214',NULL,'CHLAMYDOPHILA PNEUMONIAE','Any bacterial organism that can be assigned to the species Chlamydophila pneumoniae.','\0','CHLAMYDIA PNEUMONIAE','CL-MICROORG','DBX-NCIT-C76272'),('CL-MICROORG-T-215',NULL,'CHLAMYDOPHILA PSITTACI','Any bacterial organism that can be assigned to the species Chlamydophila psittaci.','\0','CHLAMYDIA PSITTACI','CL-MICROORG','DBX-NCIT-C86255'),('CL-MICROORG-T-216',NULL,'CHROMOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Chromobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86256'),('CL-MICROORG-T-217',NULL,'CHROMOBACTERIUM VIOLACEUM','Any bacterial organism that can be assigned to the species Chromobacterium violaceum.','\0','','CL-MICROORG','DBX-NCIT-C86257'),('CL-MICROORG-T-218',NULL,'CHRYSEOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Chryseobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86258'),('CL-MICROORG-T-219',NULL,'CHRYSEOBACTERIUM GLEUM','Any bacterial organism that can be assigned to the species Chryseobacterium gleum.','\0','FLAVOBACTERIUM GLEUM','CL-MICROORG','DBX-NCIT-C86259'),('CL-MICROORG-T-22',NULL,'ACTINOBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Actinobacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86097'),('CL-MICROORG-T-220',NULL,'CHRYSEOBACTERIUM INDOLOGENES','Any bacterial organism that can be assigned to the species Chryseobacterium indologenes.','\0','FLAVOBACTERIUM INDOLOGENES','CL-MICROORG','DBX-NCIT-C86260'),('CL-MICROORG-T-221',NULL,'CHRYSEOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Chryseomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86261'),('CL-MICROORG-T-222',NULL,'CITROBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Citrobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C76273'),('CL-MICROORG-T-223',NULL,'CITROBACTER AMALONATICUS','Any bacterial organism that can be assigned to the species Citrobacter amalonaticus.','\0','LEVINEA AMALONATICA','CL-MICROORG','DBX-NCIT-C86262'),('CL-MICROORG-T-224',NULL,'CITROBACTER BRAAKII','Any bacterial organism that can be assigned to the species Citrobacter braakii.','\0','','CL-MICROORG','DBX-NCIT-C86263'),('CL-MICROORG-T-225',NULL,'CITROBACTER FARMERI','Any bacterial organism that can be assigned to the species Citrobacter farmeri.','\0','CITROBACTER AMALONATICUS BIOGROUP 1','CL-MICROORG','DBX-NCIT-C86264'),('CL-MICROORG-T-226',NULL,'CITROBACTER FREUNDII','Any bacterial organism that can be assigned to the species Citrobacter freundii.','\0','COLOBACTRUM FREUNDII','CL-MICROORG','DBX-NCIT-C86265'),('CL-MICROORG-T-227',NULL,'CITROBACTER FREUNDII COMPLEX','A non-taxonomic grouping of bacteria assigned to and including eight related species from the Citrobacter genus.','\0','','CL-MICROORG','DBX-NCIT-C86266'),('CL-MICROORG-T-228',NULL,'CITROBACTER KOSERI','Any bacterial organism that can be assigned to the species Citrobacter koseri.','\0','CITROBACTER DIVERSUS','CL-MICROORG','DBX-NCIT-C86267'),('CL-MICROORG-T-229',NULL,'CITROBACTER YOUNGAE','Any bacterial organism that can be assigned to the species Citrobacter youngae.','\0','','CL-MICROORG','DBX-NCIT-C86268'),('CL-MICROORG-T-23',NULL,'ACTINOBACILLUS ACTINOMYCETEMCOMITANS','Any bacterial organism that can be assigned to the species Actinobacillus actinomycetemcomitans.','\0','CDC GROUP HB-3','CL-MICROORG','DBX-NCIT-C86098'),('CL-MICROORG-T-230',NULL,'CLAVISPORA LUSITANIAE','Any fungal organism that can be assigned to the species Clavispora lusitaniae.','\0','C. lusitaniae; Candida lusitaniae','CL-MICROORG','DBX-NCIT-C77174'),('CL-MICROORG-T-231',NULL,'CLOSTRIDIUM','Any bacteria that is not assigned to the species level but can be assigned to the Clostridium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76275'),('CL-MICROORG-T-232',NULL,'CLOSTRIDIUM ACETOBUTYLICUM','Any bacterial organism that can be assigned to the species Clostridium acetobutylicum.','\0','','CL-MICROORG','DBX-NCIT-C86269'),('CL-MICROORG-T-233',NULL,'CLOSTRIDIUM BARATII','Any bacterial organism that can be assigned to the species Clostridium baratii.','\0','CLOSTRIDIUM BARATI','CL-MICROORG','DBX-NCIT-C86270'),('CL-MICROORG-T-234',NULL,'CLOSTRIDIUM BEIJERINCKII','Any bacterial organism that can be assigned to the species Clostridium beijerinckii.','\0','','CL-MICROORG','DBX-NCIT-C86271'),('CL-MICROORG-T-235',NULL,'CLOSTRIDIUM BIFERMENTANS','Any bacterial organism that can be assigned to the species Clostridium bifermentans.','\0','','CL-MICROORG','DBX-NCIT-C86272'),('CL-MICROORG-T-236',NULL,'CLOSTRIDIUM BOLTEAE','Any bacterial organism that can be assigned to the species Clostridium bolteae.','\0','','CL-MICROORG','DBX-NCIT-C114250'),('CL-MICROORG-T-237',NULL,'CLOSTRIDIUM BUTYRICUM','Any bacterial organism that can be assigned to the species Clostridium butyricum.','\0','CLOSTRIDIUM PSEUDOTETANICUM','CL-MICROORG','DBX-NCIT-C86273'),('CL-MICROORG-T-238',NULL,'CLOSTRIDIUM CADAVERIS','Any bacterial organism that can be assigned to the species Clostridium cadaveris.','\0','','CL-MICROORG','DBX-NCIT-C86274'),('CL-MICROORG-T-239',NULL,'CLOSTRIDIUM CELATUM','Any bacterial organism that can be assigned to the species Clostridium celatum.','\0','','CL-MICROORG','DBX-NCIT-C86275'),('CL-MICROORG-T-24',NULL,'ACTINOBACILLUS EQUULI','Any bacterial organism that can be assigned to the species Actinobacillus equuli.','\0','','CL-MICROORG','DBX-NCIT-C86099'),('CL-MICROORG-T-240',NULL,'CLOSTRIDIUM CLOSTRIDIOFORME','Any bacterial organism that can be assigned to the species Clostridium clostridioforme.','\0','CLOSTRIDIUM CLOSTRIDIIFORME','CL-MICROORG','DBX-NCIT-C86276'),('CL-MICROORG-T-241',NULL,'CLOSTRIDIUM COCHLEARIUM','Any bacterial organism that can be assigned to the species Clostridium cochlearium.','\0','','CL-MICROORG','DBX-NCIT-C86277'),('CL-MICROORG-T-242',NULL,'CLOSTRIDIUM COCLEATUM','Any bacterial organism that can be assigned to the species Clostridium cocleatum.','\0','','CL-MICROORG','DBX-NCIT-C86278'),('CL-MICROORG-T-243',NULL,'CLOSTRIDIUM DIFFICILE','Any bacterial organism that can be assigned to the species Clostridium difficile.','\0','CLOSTRIDIUM DIFFICILIS','CL-MICROORG','DBX-NCIT-C76276'),('CL-MICROORG-T-244',NULL,'CLOSTRIDIUM FALLAX','Any bacterial organism that can be assigned to the species Clostridium fallax.','\0','CLOSTRIDIUM PSEUDOFALLAX','CL-MICROORG','DBX-NCIT-C86279'),('CL-MICROORG-T-245',NULL,'CLOSTRIDIUM GLYCOLICUM','Any bacterial organism that can be assigned to the species Clostridium glycolicum.','\0','','CL-MICROORG','DBX-NCIT-C86280'),('CL-MICROORG-T-246',NULL,'CLOSTRIDIUM HAEMOLYTICUM','Any bacterial organism that can be assigned to the species Clostridium haemolyticum.','\0','','CL-MICROORG','DBX-NCIT-C86281'),('CL-MICROORG-T-247',NULL,'CLOSTRIDIUM HATHEWAYI','Any bacterial organism that can be assigned to the species Clostridium hathewayi.','\0','','CL-MICROORG','DBX-NCIT-C114251'),('CL-MICROORG-T-248',NULL,'CLOSTRIDIUM HISTOLYTICUM','Any bacterial organism that can be assigned to the species Clostridium histolyticum.','\0','','CL-MICROORG','DBX-NCIT-C86282'),('CL-MICROORG-T-249',NULL,'CLOSTRIDIUM INNOCUUM','Any bacterial organism that can be assigned to the species Clostridium innocuum.','\0','','CL-MICROORG','DBX-NCIT-C86283'),('CL-MICROORG-T-25',NULL,'ACTINOBACILLUS LIGNIERESII','Any bacterial organism that can be assigned to the species Actinobacillus ligniersii.','\0','','CL-MICROORG','DBX-NCIT-C86100'),('CL-MICROORG-T-250',NULL,'CLOSTRIDIUM LIMOSUM','Any bacterial organism that can be assigned to the species Clostridium limosum.','\0','CLOSTRIDIUM SPECIES CDC GROUP P-1','CL-MICROORG','DBX-NCIT-C86284'),('CL-MICROORG-T-251',NULL,'CLOSTRIDIUM NOVYI','Any bacterial organism that can be assigned to the species Clostridium novyi.','\0','','CL-MICROORG','DBX-NCIT-C86285'),('CL-MICROORG-T-252',NULL,'CLOSTRIDIUM OCEANICUM','Any bacterial organism that can be assigned to the species Clostridium oceanicum.','\0','','CL-MICROORG','DBX-NCIT-C86286'),('CL-MICROORG-T-253',NULL,'CLOSTRIDIUM PARAPUTRIFICUM','Any bacterial organism that can be assigned to the species Clostridium paraputrificum.','\0','','CL-MICROORG','DBX-NCIT-C86287'),('CL-MICROORG-T-254',NULL,'CLOSTRIDIUM PERFRINGENS','Any bacterial organism that can be assigned to the species Clostridium perfringens.','\0','CLOSTRIDIUM WELCHII','CL-MICROORG','DBX-NCIT-C86288'),('CL-MICROORG-T-255',NULL,'CLOSTRIDIUM PUTRIFICUM','Any bacterial organism that can be assigned to the species Clostridium putrificum.','\0','CLOSTRIDIUM LENTOPUTRESCENS','CL-MICROORG','DBX-NCIT-C86289'),('CL-MICROORG-T-256',NULL,'CLOSTRIDIUM RAMOSUM','Any bacterial organism that can be assigned to the species Clostridium ramosum.','\0','ACTINOMYCES RAMOSUS','CL-MICROORG','DBX-NCIT-C86290'),('CL-MICROORG-T-257',NULL,'CLOSTRIDIUM RECTUM','Any bacterial organism that can be assigned to the species Clostridium rectum.','\0','','CL-MICROORG','DBX-NCIT-C86291'),('CL-MICROORG-T-258',NULL,'CLOSTRIDIUM SEPTICUM','Any bacterial organism that can be assigned to the species Clostridium septicum.','\0','','CL-MICROORG','DBX-NCIT-C86292'),('CL-MICROORG-T-259',NULL,'CLOSTRIDIUM SORDELLII','Any bacterial organism that can be assigned to the species Clostridium sordellii.','\0','','CL-MICROORG','DBX-NCIT-C86293'),('CL-MICROORG-T-26',NULL,'ACTINOBACILLUS PLEUROPNEUMONIAE','Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae.','\0','HAEMOPHILUS PLEUROPNEUMONIAE','CL-MICROORG','DBX-NCIT-C86101'),('CL-MICROORG-T-260',NULL,'CLOSTRIDIUM SPOROGENES','Any bacterial organism that can be assigned to the species Clostridium sporogenes.','\0','','CL-MICROORG','DBX-NCIT-C86294'),('CL-MICROORG-T-261',NULL,'CLOSTRIDIUM SUBTERMINALE','Any bacterial organism that can be assigned to the species Clostridium subterminale.','\0','','CL-MICROORG','DBX-NCIT-C86295'),('CL-MICROORG-T-262',NULL,'CLOSTRIDIUM SYMBIOSUM','Any bacterial organism that can be assigned to the species Clostridium symbiosum.','\0','BACTEROIDES SYMBIOSUS','CL-MICROORG','DBX-NCIT-C86296'),('CL-MICROORG-T-263',NULL,'CLOSTRIDIUM TERTIUM','Any bacterial organism that can be assigned to the species Clostridium tertium.','\0','','CL-MICROORG','DBX-NCIT-C86297'),('CL-MICROORG-T-264',NULL,'CLOSTRIDIUM TETANI','Any bacterial organism that can be assigned to the species Clostridium tetani.','\0','','CL-MICROORG','DBX-NCIT-C86298'),('CL-MICROORG-T-265',NULL,'CLOSTRIDIUM TYROBUTYRICUM','Any bacterial organism that can be assigned to the species Clostridium tyrobutyricum.','\0','','CL-MICROORG','DBX-NCIT-C86299'),('CL-MICROORG-T-266',NULL,'COAGULASE NEGATIVE STAPHYLOCOCCUS','Any bacteria assigned to the genus Staphylococcus that does not express the enzyme coagulase.','\0','','CL-MICROORG','DBX-NCIT-C62584'),('CL-MICROORG-T-267',NULL,'COAGULASE POSITIVE STAPHYLOCOCCUS','Any bacteria assigned to the genus Staphylococcus that expresses the enzyme coagulase.','\0','','CL-MICROORG','DBX-NCIT-C62585'),('CL-MICROORG-T-268',NULL,'COLLINSELLA','Any bacteria that is not assigned to the species level but can be assigned to the Collinsella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86300'),('CL-MICROORG-T-269',NULL,'COLLINSELLA AEROFACIENS','Any bacterial organism that can be assigned to the species Collinsella aerofaciens.','\0','EUBACTERIUM AEROFACIENS','CL-MICROORG','DBX-NCIT-C86301'),('CL-MICROORG-T-27',NULL,'ACTINOBACILLUS SUIS','Any bacterial organism that can be assigned to the species Actinobacillus suis.','\0','','CL-MICROORG','DBX-NCIT-C86102'),('CL-MICROORG-T-270',NULL,'COLLINSELLA INTESTINALIS','Any bacterial organism that can be assigned to the species Collinsella intestinalis.','\0','','CL-MICROORG','DBX-NCIT-C86302'),('CL-MICROORG-T-271',NULL,'COLORADO TICK FEVER VIRUS','Any viral organism that can be assigned to the species Colorado tick fever virus.','\0','CTFV','CL-MICROORG','DBX-NCIT-C112240'),('CL-MICROORG-T-272',NULL,'COMAMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Comamonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86303'),('CL-MICROORG-T-273',NULL,'COMAMONAS TERRIGENA','Any bacterial organism that can be assigned to the species Comamonas terrigena.','\0','CDC GROUP EF-19','CL-MICROORG','DBX-NCIT-C86304'),('CL-MICROORG-T-274',NULL,'COMAMONAS TESTOSTERONI','Any bacterial organism that can be assigned to the species Comamonas testosteroni.','\0','PSEUDOMONAS TESTOSTERONI','CL-MICROORG','DBX-NCIT-C86305'),('CL-MICROORG-T-275',NULL,'CORONAVIRUS','Any viral organism that can be assigned to the family Coronaviridae.','\0','Coronaviridae','CL-MICROORG','DBX-NCIT-C113205'),('CL-MICROORG-T-276',NULL,'CORYNEBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Corynebacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76308'),('CL-MICROORG-T-277',NULL,'CORYNEBACTERIUM ACCOLENS','Any bacterial organism that can be assigned to the species Corynebacterium accolens.','\0','CORYNEBACTERIUM GROUP G-1','CL-MICROORG','DBX-NCIT-C86306'),('CL-MICROORG-T-278',NULL,'CORYNEBACTERIUM AFERMENTANS','Any bacterial organism that can be assigned to the species Corynebacterium afermentans.','\0','CORYNEBACTERIUM ANF-1','CL-MICROORG','DBX-NCIT-C86307'),('CL-MICROORG-T-279',NULL,'CORYNEBACTERIUM AMYCOLATUM','Any bacterial organism that can be assigned to the species Corynebacterium amycolatum.','\0','','CL-MICROORG','DBX-NCIT-C86308'),('CL-MICROORG-T-28',NULL,'ACTINOBACILLUS UREAE','Any bacterial organism that can be assigned to the species Actinobacillus ureae.','\0','PASTEURELLA UREAE','CL-MICROORG','DBX-NCIT-C86103'),('CL-MICROORG-T-280',NULL,'CORYNEBACTERIUM ARGENTORATENSE','Any bacterial organism that can be assigned to the species Corynebacterium argentoratense.','\0','','CL-MICROORG','DBX-NCIT-C86309'),('CL-MICROORG-T-281',NULL,'CORYNEBACTERIUM AURIS','Any bacterial organism that can be assigned to the species Corynebacterium auris.','\0','','CL-MICROORG','DBX-NCIT-C86310'),('CL-MICROORG-T-282',NULL,'CORYNEBACTERIUM BOVIS','Any bacterial organism that can be assigned to the species Corynebacterium bovis.','\0','','CL-MICROORG','DBX-NCIT-C86311'),('CL-MICROORG-T-283',NULL,'CORYNEBACTERIUM DIPHTHERIAE','Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae.','\0','','CL-MICROORG','DBX-NCIT-C86312'),('CL-MICROORG-T-284',NULL,'CORYNEBACTERIUM GENITALIUM','Any bacterial organism that can be assigned to the species Corynebacterium genitalium.','\0','','CL-MICROORG','DBX-NCIT-C86313'),('CL-MICROORG-T-285',NULL,'CORYNEBACTERIUM GLUCURONOLYTICUM','Any bacterial organism that can be assigned to the species Corynebacterium glucuronolyticum.','\0','','CL-MICROORG','DBX-NCIT-C86955'),('CL-MICROORG-T-286',NULL,'CORYNEBACTERIUM JEIKEIUM','Any bacterial organism that can be assigned to the species Corynebacterium jeikeium.','\0','CDC GROUP JK; CORYNEBACTERIUM GROUP JK','CL-MICROORG','DBX-NCIT-C76307'),('CL-MICROORG-T-287',NULL,'CORYNEBACTERIUM KUTSCHERI','Any bacterial organism that can be assigned to the species Corynebacterium kutscheri.','\0','','CL-MICROORG','DBX-NCIT-C86314'),('CL-MICROORG-T-288',NULL,'CORYNEBACTERIUM MACGINLEYI','Any bacterial organism that can be assigned to the species Corynebacterium macginleyi.','\0','','CL-MICROORG','DBX-NCIT-C86315'),('CL-MICROORG-T-289',NULL,'CORYNEBACTERIUM MATRUCHOTII','Any bacterial organism that can be assigned to the species Corynebacterium matruchotii.','\0','BACTERIONEMA MATRUCHOTII','CL-MICROORG','DBX-NCIT-C86316'),('CL-MICROORG-T-29',NULL,'ACTINOMADURA','Any bacteria that is not assigned to the species level but can be assigned to the Actinomadura genus level.','\0','','CL-MICROORG','DBX-NCIT-C86104'),('CL-MICROORG-T-290',NULL,'CORYNEBACTERIUM MINUTISSIMUM','Any bacterial organism that can be assigned to the species Corynebacterium minutissimum.','\0','','CL-MICROORG','DBX-NCIT-C86317'),('CL-MICROORG-T-291',NULL,'CORYNEBACTERIUM PILOSUM','Any bacterial organism that can be assigned to the species Corynebacterium pilosum.','\0','','CL-MICROORG','DBX-NCIT-C86318'),('CL-MICROORG-T-292',NULL,'CORYNEBACTERIUM PROPINQUUM','Any bacterial organism that can be assigned to the species Corynebacterium propinquum.','\0','','CL-MICROORG','DBX-NCIT-C86319'),('CL-MICROORG-T-293',NULL,'CORYNEBACTERIUM PSEUDODIPHTHERITICUM','Any bacterial organism that can be assigned to the species Corynebacterium pseudodiphtheriticum.','\0','CORYNEBACTERIUM HOFMANNII','CL-MICROORG','DBX-NCIT-C86320'),('CL-MICROORG-T-294',NULL,'CORYNEBACTERIUM PSEUDOTUBERCULOSIS','Any bacterial organism that can be assigned to the species Corynebacterium pseudotuberculosis.','\0','','CL-MICROORG','DBX-NCIT-C86321'),('CL-MICROORG-T-295',NULL,'CORYNEBACTERIUM RENALE','Any bacterial organism that can be assigned to the species Corynebacterium renale.','\0','','CL-MICROORG','DBX-NCIT-C86322'),('CL-MICROORG-T-296',NULL,'CORYNEBACTERIUM STRIATUM','Any bacterial organism that can be assigned to the species Corynebacterium striatum.','\0','','CL-MICROORG','DBX-NCIT-C86323'),('CL-MICROORG-T-297',NULL,'CORYNEBACTERIUM TUBERCULOSTEARICUM','Any bacterial organism that can be assigned to the species Corynebacterium tuberculostearicum.','\0','','CL-MICROORG','DBX-NCIT-C114249'),('CL-MICROORG-T-298',NULL,'CORYNEBACTERIUM ULCERANS','Any bacterial organism that can be assigned to the species Corynebacterium ulcerans.','\0','','CL-MICROORG','DBX-NCIT-C86324'),('CL-MICROORG-T-299',NULL,'CORYNEBACTERIUM UREALYTICUM','Any bacterial organism that can be assigned to the species Corynebacterium urealyticum.','\0','CDC GROUP D2; CORYNEBACTERIUM GROUP D-2','CL-MICROORG','DBX-NCIT-C86325'),('CL-MICROORG-T-3',NULL,'ACHROMOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Achromobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86079'),('CL-MICROORG-T-30',NULL,'ACTINOMADURA MADURAE','Any bacterial organism that can be assigned to the species Actinomadura madurae.','\0','','CL-MICROORG','DBX-NCIT-C86105'),('CL-MICROORG-T-300',NULL,'CORYNEBACTERIUM XEROSIS','Any bacterial organism that can be assigned to the species Corynebacterium xerosis.','\0','','CL-MICROORG','DBX-NCIT-C86326'),('CL-MICROORG-T-301',NULL,'CORYNEFORM GRAM-POSITIVE BACILLUS','Any bacteria whose shape is similar to those bacteria assigned to the Corynebacterium genus and have a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','CORYNEFORM GRAM-POSITIVE ROD','CL-MICROORG','DBX-NCIT-C86327'),('CL-MICROORG-T-302',NULL,'COXIELLA','Any bacteria that is not assigned to the species level but can be assigned to the Coxiella genus level.','\0','','CL-MICROORG','DBX-NCIT-C76309'),('CL-MICROORG-T-303',NULL,'COXIELLA BURNETII','Any bacterial organism that can be assigned to the species Coxiella burnetii.','\0','','CL-MICROORG','DBX-NCIT-C86328'),('CL-MICROORG-T-304',NULL,'COXSACKIE A VIRUS','Any viral organism that can be assigned to the Enterovirus A species subtype Coxsackie A virus.','\0','Coxsackie Virus A','CL-MICROORG','DBX-NCIT-C112242'),('CL-MICROORG-T-305',NULL,'COXSACKIE B VIRUS','Any viral organism that can be assigned to the Enterovirus B species subtype Coxsackie B virus.','\0','Coxsackie Virus B','CL-MICROORG','DBX-NCIT-C112243'),('CL-MICROORG-T-306',NULL,'CRONOBACTER SAKAZAKII','Any bacterial organism that can be assigned to the species Cronobacter sakazakii.','\0','ENTEROBACTER SAKAZAKII','CL-MICROORG','DBX-NCIT-C86329'),('CL-MICROORG-T-307',NULL,'CRYPTOCOCCUS ALBIDUS','Any fungal organism that can be assigned to the species Cryptococcus albidus.','\0','C. albidus; R. albida; Rhodotorula albida; T. albida; T. nadaensis; T. neoformans var. albida; Torula albida; Torulopsis albida; Torulopsis nadaensis; Torulopsis neoformans var. albida','CL-MICROORG','DBX-NCIT-C114267'),('CL-MICROORG-T-308',NULL,'CRYPTOCOCCUS GATTII','Any fungal organism that can be assigned to the species Cryptococcus gattii.','\0','C. bacillisporus; C. gattii; Cryptococcus bacillisporus','CL-MICROORG','DBX-NCIT-C114268'),('CL-MICROORG-T-309',NULL,'CRYPTOCOCCUS LAURENTII','Any fungal organism that can be assigned to the species Cryptococcus laurentii.','\0','C. laurentii','CL-MICROORG','DBX-NCIT-C114269'),('CL-MICROORG-T-31',NULL,'ACTINOMADURA PELLETIERI','Any bacterial organism that can be assigned to the species Actinomadura pelletieri.','\0','','CL-MICROORG','DBX-NCIT-C86106'),('CL-MICROORG-T-310',NULL,'CRYPTOCOCCUS NEOFORMANS','Any fungal organism that can be assigned to the species Cryptococcus neoformans.','\0','B. neoformans; Blastomyces neoformans; C. neoformans; D. neoformans; Debaryomyces neoformans; L. neoformans; Lipomyces neoformans; S. neoformans; Saccharomyces neoformans; T. neoformans; Torula neoformans; Torulopsis neoformans','CL-MICROORG','DBX-NCIT-C14195'),('CL-MICROORG-T-311',NULL,'CRYPTOCOCCUS RANDHAWII','Any fungal organism that can be assigned to the species Cryptococcus randhawii.','\0','C. randhawii','CL-MICROORG','DBX-NCIT-C114266'),('CL-MICROORG-T-312',NULL,'CUPRIAVIDUS','Any bacteria that is not assigned to the species level but can be assigned to the Cupriavidus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86330'),('CL-MICROORG-T-313',NULL,'CUPRIAVIDUS PAUCULUS','Any bacterial organism that can be assigned to the species Cupriavidus pauculus.','\0','CDC GROUP IVC-2; RALSTONIA PAUCULA; WAUTERSIA PAUCULA','CL-MICROORG','DBX-NCIT-C86331'),('CL-MICROORG-T-314',NULL,'CYTOMEGALOVIRUS','Any viral organism that can be assigned to the genus Cytomegalovirus.','\0','','CL-MICROORG','DBX-NCIT-C14196'),('CL-MICROORG-T-315',NULL,'DELFTIA','Any bacteria that is not assigned to the species level but can be assigned to the Delftia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86332'),('CL-MICROORG-T-316',NULL,'DELFTIA ACIDOVORANS','Any bacterial organism that can be assigned to the species Delftia acidovorans.','\0','COMAMONAS ACIDOVORANS; PSEUDOMONAS ACIDOVORANS','CL-MICROORG','DBX-NCIT-C86333'),('CL-MICROORG-T-317',NULL,'DELTARETROVIRUS','Any viral organism that can be assigned to the genus Deltaretrovirus.','\0','','CL-MICROORG','DBX-NCIT-C14347'),('CL-MICROORG-T-318',NULL,'DENGUE VIRUS','Any viral organism that can be assigned to the species Dengue virus.','\0','','CL-MICROORG','DBX-NCIT-C112036'),('CL-MICROORG-T-319',NULL,'DENGUE VIRUS 1','Any viral organism that can be assigned to the Dengue virus serotype 1.','\0','DEN-1; DENV-1; Dengue Virus Type 1','CL-MICROORG','DBX-NCIT-C112266'),('CL-MICROORG-T-32',NULL,'ACTINOMYCES','Any bacteria that is not assigned to the species level but can be assigned to the Actinomyces genus level.','\0','','CL-MICROORG','DBX-NCIT-C76201'),('CL-MICROORG-T-320',NULL,'DENGUE VIRUS 2','Any viral organism that can be assigned to the Dengue virus serotype 2.','\0','DEN-2; DENV-2; Dengue Virus Type 2','CL-MICROORG','DBX-NCIT-C112267'),('CL-MICROORG-T-321',NULL,'DENGUE VIRUS 3','Any viral organism that can be assigned to the Dengue virus serotype 3.','\0','DEN-3; DENV-3; Dengue Virus Type 3','CL-MICROORG','DBX-NCIT-C112268'),('CL-MICROORG-T-322',NULL,'DENGUE VIRUS 4','Any viral organism that can be assigned to the Dengue virus serotype 4.','\0','DEN-4; DENV-4; Dengue Virus Type 4','CL-MICROORG','DBX-NCIT-C112269'),('CL-MICROORG-T-323',NULL,'DERMABACTER','Any bacteria that is not assigned to the species level but can be assigned to the Dermabacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86334'),('CL-MICROORG-T-324',NULL,'DERMABACTER HOMINIS','Any bacterial organism that can be assigned to the species Dermabacter hominis.','\0','','CL-MICROORG','DBX-NCIT-C86335'),('CL-MICROORG-T-325',NULL,'DERMACOCCUS NISHINOMIYAENSIS','Any bacterial organism that can be assigned to the species Dermacoccus nishinomiyaensis.','\0','MICROCOCCUS NISHINOMIYAENSIS','CL-MICROORG','DBX-NCIT-C86336'),('CL-MICROORG-T-326',NULL,'DERMATOPHILUS','Any bacteria that is not assigned to the species level but can be assigned to the Dermatophilus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86337'),('CL-MICROORG-T-327',NULL,'DERMATOPHILUS CONGOLENSIS','Any bacterial organism that can be assigned to the species Dermatophilus congolensis.','\0','','CL-MICROORG','DBX-NCIT-C86338'),('CL-MICROORG-T-328',NULL,'DESULFOVIBRIO','Any bacteria that is not assigned to the species level but can be assigned to the Desulfovibrio genus level.','\0','DESULFOMONAS SPECIES','CL-MICROORG','DBX-NCIT-C86339'),('CL-MICROORG-T-329',NULL,'DESULFOVIBRIO DESULFURICANS','Any bacterial organism that can be assigned to the species Desulfovibrio desulfuricans.','\0','','CL-MICROORG','DBX-NCIT-C86340'),('CL-MICROORG-T-33',NULL,'ACTINOMYCES BOVIS','Any bacterial organism that can be assigned to the species Actinomyces bovis.','\0','ACTINOCLADOTHRIX BOVIS; CLADOTHRIX BOVIS; DISCOMYCES BOVIS; NOCARDIA BOVIS; OOSPORA BOVIS; PROACTINOMYCES BOVIS; SARCOMYCES BOVIS; SPHAEROTILUS BOVIS; STREPTOTHRIX BOVIS','CL-MICROORG','DBX-NCIT-C86107'),('CL-MICROORG-T-330',NULL,'DESULFOVIBRIO FAIRFIELDENSIS','Any bacterial organism that can be assigned to the species Desulfovibrio fairfieldensis.','\0','','CL-MICROORG','DBX-NCIT-C86341'),('CL-MICROORG-T-331',NULL,'DESULFOVIBRIO PIGER','Any bacterial organism that can be assigned to the species Desulfovibrio piger.','\0','DESULFOMONAS PIGRA','CL-MICROORG','DBX-NCIT-C86342'),('CL-MICROORG-T-332',NULL,'DIPHTHEROID BACILLUS','Any of a number of rod-shaped bacteria that resemble Corynebacterium diphtheriae, either in morphology or etiology.','\0','','CL-MICROORG','DBX-NCIT-C86343'),('CL-MICROORG-T-333',NULL,'EBOLA VIRUS','Any viral organism that can be assigned to the genus Ebola virus.','\0','EBOV','CL-MICROORG','DBX-NCIT-C112271'),('CL-MICROORG-T-334',NULL,'ECHOVIRUS','Any viral organism that can be assigned to the species Echovirus.','\0','','CL-MICROORG','DBX-NCIT-C112272'),('CL-MICROORG-T-335',NULL,'EDWARDSIELLA','Any bacteria that is not assigned to the species level but can be assigned to the Edwardsiella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86344'),('CL-MICROORG-T-336',NULL,'EDWARDSIELLA HOSHINAE','Any bacterial organism that can be assigned to the species Edwardsiella hoshinae.','\0','','CL-MICROORG','DBX-NCIT-C86345'),('CL-MICROORG-T-337',NULL,'EDWARDSIELLA ICTALURI','Any bacterial organism that can be assigned to the species Edwardsiella ictaluri.','\0','','CL-MICROORG','DBX-NCIT-C86346'),('CL-MICROORG-T-338',NULL,'EDWARDSIELLA TARDA','Any bacterial organism that can be assigned to the species Edwardsiella tarda.','\0','','CL-MICROORG','DBX-NCIT-C86347'),('CL-MICROORG-T-339',NULL,'EGGERTHELLA','Any bacteria that is not assigned to the species level but can be assigned to the Eggerthella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86348'),('CL-MICROORG-T-34',NULL,'ACTINOMYCES ISRAELII','Any bacterial organism that can be assigned to the species Actinomyces israelii.','\0','','CL-MICROORG','DBX-NCIT-C86108'),('CL-MICROORG-T-340',NULL,'EGGERTHELLA LENTA','Any bacterial organism that can be assigned to the species Eggerthella lenta.','\0','EUBACTERIUM LENTUM','CL-MICROORG','DBX-NCIT-C86349'),('CL-MICROORG-T-341',NULL,'EIKENELLA','Any bacteria that is not assigned to the species level but can be assigned to the Eikenella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86350'),('CL-MICROORG-T-342',NULL,'EIKENELLA CORRODENS','Any bacterial organism that can be assigned to the species Eikenella corrodens.','\0','CDC GROUP HB-1','CL-MICROORG','DBX-NCIT-C86351'),('CL-MICROORG-T-343',NULL,'ELIZABETHKINGIA','Any bacteria that is not assigned to the species level but can be assigned to the Elizabethkingia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86352'),('CL-MICROORG-T-344',NULL,'ELIZABETHKINGIA MENINGOCEPTICA','Any bacterial organism that can be assigned to the species Elizabethkingia meningoceptica.','\0','CHRYSEOBACTERIUM MENINGOSEPTICUM; FLAVOBACTERIUM MENINGOSEPTICUM','CL-MICROORG','DBX-NCIT-C86353'),('CL-MICROORG-T-345',NULL,'EMPEDOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Empedobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86354'),('CL-MICROORG-T-346',NULL,'EMPEDOBACTER BREVIS','Any bacterial organism that can be assigned to the species Empedobacter brevis.','\0','FLAVOBACTERIUM BREVE','CL-MICROORG','DBX-NCIT-C86355'),('CL-MICROORG-T-347',NULL,'ENTEROBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Enterobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C76310'),('CL-MICROORG-T-348',NULL,'ENTEROBACTER AEROGENES','Any bacterial organism that can be assigned to the species Enterobacter aerogenes.','\0','AEROBACTER AEROGENES','CL-MICROORG','DBX-NCIT-C86356'),('CL-MICROORG-T-349',NULL,'ENTEROBACTER AMNIGENUS','Any bacterial organism that can be assigned to the species Enterobacter amnigenus.','\0','ENTEROBACTER AMNIGENUS I','CL-MICROORG','DBX-NCIT-C86357'),('CL-MICROORG-T-35',NULL,'ACTINOMYCES MEYERII','Any bacterial organism that can be assigned to the species Actinomyces meyerii.','\0','','CL-MICROORG','DBX-NCIT-C86109'),('CL-MICROORG-T-350',NULL,'ENTEROBACTER ASBURIAE','Any bacterial organism that can be assigned to the species Enterobacter asburiae.','\0','CDC ENTERIC GROUP 17','CL-MICROORG','DBX-NCIT-C86358'),('CL-MICROORG-T-351',NULL,'ENTEROBACTER CANCEROGENUS','Any bacterial organism that can be assigned to the species Enterobacter cancerogenus.','\0','CDC ENTERIC GROUP 19; ENTEROBACTER TAYLORAE','CL-MICROORG','DBX-NCIT-C86359'),('CL-MICROORG-T-352',NULL,'ENTEROBACTER CLOACAE','Any bacterial organism that can be assigned to the species Enterobacter cloacae.','\0','ENTEROBACTER CLOACAE STRAIN 1','CL-MICROORG','DBX-NCIT-C86360'),('CL-MICROORG-T-353',NULL,'ENTEROBACTER GERGOVIAE','Any bacterial organism that can be assigned to the species Enterobacter gergoviae.','\0','','CL-MICROORG','DBX-NCIT-C86361'),('CL-MICROORG-T-354',NULL,'ENTEROBACTER HORMAECHEI','Any bacterial organism that can be assigned to the species Enterobacter hormaechei.','\0','CDC ENTERIC GROUP 75','CL-MICROORG','DBX-NCIT-C86362'),('CL-MICROORG-T-355',NULL,'ENTEROBACTER TAYLORAE','Any bacterial organism that can be assigned to the species Enterobacter taylorae.','\0','','CL-MICROORG','DBX-NCIT-C86363'),('CL-MICROORG-T-356',NULL,'ENTEROCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Enterococcus genus level.','\0','PRESUMPTIVE ENTEROCOCCUS','CL-MICROORG','DBX-NCIT-C76311'),('CL-MICROORG-T-357',NULL,'ENTEROCOCCUS AVIUM','Any bacterial organism that can be assigned to the species Enterococcus avium.','\0','STREPTOCOCCUS AVIUM','CL-MICROORG','DBX-NCIT-C86364'),('CL-MICROORG-T-358',NULL,'ENTEROCOCCUS CASSELIFLAVUS','Any bacterial organism that can be assigned to the species Enterococcus casseliflavus.','\0','','CL-MICROORG','DBX-NCIT-C86365'),('CL-MICROORG-T-359',NULL,'ENTEROCOCCUS DISPAR','Any bacterial organism that can be assigned to the species Enterococcus dispar.','\0','','CL-MICROORG','DBX-NCIT-C86366'),('CL-MICROORG-T-36',NULL,'ACTINOMYCES NAESLUNDII','Any bacterial organism that can be assigned to the species Actinomyces naseslundii.','\0','','CL-MICROORG','DBX-NCIT-C86110'),('CL-MICROORG-T-360',NULL,'ENTEROCOCCUS DURANS','Any bacterial organism that can be assigned to the species Enterococcus durans.','\0','STREPTOCOCCUS DURANS','CL-MICROORG','DBX-NCIT-C86367'),('CL-MICROORG-T-361',NULL,'ENTEROCOCCUS FAECALIS','Any bacterial organism that can be assigned to the species Enterococcus faecalis.','\0','STREPTOCOCCUS FAECALIS','CL-MICROORG','DBX-NCIT-C86368'),('CL-MICROORG-T-362',NULL,'ENTEROCOCCUS FAECIUM','Any bacterial organism that can be assigned to the species Enterococcus faecium.','\0','STREPTOCOCCUS FAECIUM','CL-MICROORG','DBX-NCIT-C86369'),('CL-MICROORG-T-363',NULL,'ENTEROCOCCUS GALLINARUM','Any bacterial organism that can be assigned to the species Enterococcus gallinarum.','\0','','CL-MICROORG','DBX-NCIT-C86370'),('CL-MICROORG-T-364',NULL,'ENTEROCOCCUS HIRAE','Any bacterial organism that can be assigned to the species Enterococcus hirae.','\0','','CL-MICROORG','DBX-NCIT-C86371'),('CL-MICROORG-T-365',NULL,'ENTEROCOCCUS MALODORATUS','Any bacterial organism that can be assigned to the species Enterococcus malodoratus.','\0','','CL-MICROORG','DBX-NCIT-C86372'),('CL-MICROORG-T-366',NULL,'ENTEROCOCCUS MUNDTII','Any bacterial organism that can be assigned to the species Enterococcus mundtii.','\0','','CL-MICROORG','DBX-NCIT-C86373'),('CL-MICROORG-T-367',NULL,'ENTEROCOCCUS PSEUDOAVIUM','Any bacterial organism that can be assigned to the species Enterococcus pseudoavium.','\0','','CL-MICROORG','DBX-NCIT-C86374'),('CL-MICROORG-T-368',NULL,'ENTEROCOCCUS RAFFINOSUS','Any bacterial organism that can be assigned to the species Enterococcus raffinosus.','\0','','CL-MICROORG','DBX-NCIT-C86375'),('CL-MICROORG-T-369',NULL,'ENTEROCOCCUS THAILANDICUS','Any bacterial organism that can be assigned to the species Enterococcus thailandicus.','\0','Enterococcus sanguinicola','CL-MICROORG','DBX-NCIT-C114243'),('CL-MICROORG-T-37',NULL,'ACTINOMYCES NEUII','Any bacterial organism that can be assigned to the species Actinomyces neuii.','\0','','CL-MICROORG','DBX-NCIT-C86111'),('CL-MICROORG-T-370',NULL,'ENTEROVIRUS','Any viral organism that can be assigned to the genus Enterovirus.','\0','','CL-MICROORG','DBX-NCIT-C14203'),('CL-MICROORG-T-371',NULL,'ERYSIPELOTHRIX','Any bacteria that is not assigned to the species level but can be assigned to the Erysipelothrix genus level.','\0','ERYSIPELOTHRIX INSIDIOSA','CL-MICROORG','DBX-NCIT-C86376'),('CL-MICROORG-T-372',NULL,'ERYSIPELOTHRIX RHUSIOPATHIAE','Any bacterial organism that can be assigned to the species Erysipelothrix rhusiopathiae.','\0','','CL-MICROORG','DBX-NCIT-C86377'),('CL-MICROORG-T-373',NULL,'ESCHERICHIA','Any bacteria that is not assigned to the species level but can be assigned to the Escherichia genus level.','\0','','CL-MICROORG','DBX-NCIT-C77208'),('CL-MICROORG-T-374',NULL,'ESCHERICHIA ALBERTII','Any bacterial organism that can be assigned to the species Escherichia albertii.','\0','','CL-MICROORG','DBX-NCIT-C86378'),('CL-MICROORG-T-375',NULL,'ESCHERICHIA BLATTAE','Any bacterial organism that can be assigned to the species Escherichia blattae.','\0','','CL-MICROORG','DBX-NCIT-C86379'),('CL-MICROORG-T-376',NULL,'ESCHERICHIA COLI','Any bacterial organism that can be assigned to the species Escherichia coli.','\0','E. COLI','CL-MICROORG','DBX-NCIT-C14206'),('CL-MICROORG-T-377',NULL,'ESCHERICHIA COLI O111','Any bacterial organism that can be assigned to the species Escherichia coli and strain O111.','\0','','CL-MICROORG','DBX-NCIT-C86881'),('CL-MICROORG-T-378',NULL,'ESCHERICHIA COLI O157 (NOT H7)','Any bacterial organism that can be assigned to the species Escherichia coli and strain O157.','\0','','CL-MICROORG','DBX-NCIT-C86882'),('CL-MICROORG-T-379',NULL,'ESCHERICHIA COLI O157:H7','Any bacterial organism that can be assigned to the species Escherichia coli and strain O157:H7.','\0','','CL-MICROORG','DBX-NCIT-C86883'),('CL-MICROORG-T-38',NULL,'ACTINOMYCES ODONTOLYTICUS','Any bacterial organism that can be assigned to the species Actinomyces odontolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86112'),('CL-MICROORG-T-380',NULL,'ESCHERICHIA COLI O26','Any bacterial organism that can be assigned to the species Escherichia coli and strain O26.','\0','','CL-MICROORG','DBX-NCIT-C86884'),('CL-MICROORG-T-381',NULL,'ESCHERICHIA FERGUSONII','Any bacterial organism that can be assigned to the species Escherichia fergusonii.','\0','CDC ENTERIC GROUP 10','CL-MICROORG','DBX-NCIT-C86380'),('CL-MICROORG-T-382',NULL,'ESCHERICHIA HERMANNII','Any bacterial organism that can be assigned to the species Escherichia hermannii.','\0','CDC ENTERIC GROUP 11','CL-MICROORG','DBX-NCIT-C86381'),('CL-MICROORG-T-383',NULL,'ESCHERICHIA VULNERIS','Any bacterial organism that can be assigned to the species Escherichia vulneris.','\0','CDC ENTERIC GROUP 1','CL-MICROORG','DBX-NCIT-C86382'),('CL-MICROORG-T-384',NULL,'EUBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Eubacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86383'),('CL-MICROORG-T-385',NULL,'EUBACTERIUM ALACTOLYTICUM','Any bacterial organism that can be assigned to the species Eubacterium adactolyticum.','\0','','CL-MICROORG','DBX-NCIT-C86384'),('CL-MICROORG-T-386',NULL,'EUBACTERIUM CONTORTUM','Any bacterial organism that can be assigned to the species Eubacterium contortum.','\0','','CL-MICROORG','DBX-NCIT-C86385'),('CL-MICROORG-T-387',NULL,'EUBACTERIUM LIMOSUM','Any bacterial organism that can be assigned to the species Eubacterium limosum.','\0','','CL-MICROORG','DBX-NCIT-C86386'),('CL-MICROORG-T-388',NULL,'EUBACTERIUM NODATUM','Any bacterial organism that can be assigned to the species Eubacterium nodatum.','\0','','CL-MICROORG','DBX-NCIT-C86387'),('CL-MICROORG-T-389',NULL,'EUBACTERIUM RECTALE','Any bacterial organism that can be assigned to the species Eubacterium rectale.','\0','','CL-MICROORG','DBX-NCIT-C86388'),('CL-MICROORG-T-39',NULL,'ACTINOMYCES RADINGAE','Any bacterial organism that can be assigned to the species Actinomyces radingae.','\0','','CL-MICROORG','DBX-NCIT-C86113'),('CL-MICROORG-T-390',NULL,'EUBACTERIUM VENTRIOSUM','Any bacterial organism that can be assigned to the species Eubacterium ventriosum.','\0','','CL-MICROORG','DBX-NCIT-C86389'),('CL-MICROORG-T-391',NULL,'EWINGELLA','Any bacteria that is not assigned to the species level but can be assigned to the Ewingella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86390'),('CL-MICROORG-T-392',NULL,'EWINGELLA AMERICANA','Any bacterial organism that can be assigned to the species Ewingella americana.','\0','CDC ENTERIC GROUP 40','CL-MICROORG','DBX-NCIT-C86391'),('CL-MICROORG-T-393',NULL,'EXIGUOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Exiguobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86885'),('CL-MICROORG-T-394',NULL,'EXIGUOBACTERIUM ACETYLICUM','Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum.','\0','BREVIBACTERIUM ACETYLICUM','CL-MICROORG','DBX-NCIT-C86886'),('CL-MICROORG-T-395',NULL,'FACKLAMIA','Any bacteria that is not assigned to the species level but can be assigned to the Facklamia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86392'),('CL-MICROORG-T-396',NULL,'FAECALIBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Faecalibacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86393'),('CL-MICROORG-T-397',NULL,'FAECALIBACTERIUM PRAUSNITZII','Any bacterial organism that can be assigned to the species Faecalibacterium prausnitzii.','\0','FUSOBACTERIUM PRAUSNITZII','CL-MICROORG','DBX-NCIT-C86394'),('CL-MICROORG-T-398',NULL,'FERMENTATIVE GRAM-NEGATIVE BACILLUS','Any rod-shaped, anaerobic bacteria that can convert carbohydrates into acids and alcohols and has a cell wall contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','FERMENTATIVE GRAM-NEGATIVE ROD','CL-MICROORG','DBX-NCIT-C86395'),('CL-MICROORG-T-399',NULL,'FILOBASIDIUM UNIGUTTULATUM','Any fungal organism that can be assigned to the species Filobasidium uniguttulatum.','\0','C. neoformans var. uniguttulatus; C. uniguttulatus; Cryptococcus neoformans var. uniguttulatus; Cryptococcus uniguttulatus; E. uniguttulata; Eutorulopsis uniguttulata; F. uniguttulatum','CL-MICROORG','DBX-NCIT-C114265'),('CL-MICROORG-T-4',NULL,'ACHROMOBACTER DENITRIFICANS','Any bacterial organism that can be assigned to the species Achromobacter denitrificans.','\0','ALCALIGENES DENITRIFICANS','CL-MICROORG','DBX-NCIT-C86080'),('CL-MICROORG-T-40',NULL,'ACTINOMYCES TURICENSIS','Any bacterial organism that can be assigned to the species Actinomyces turicensis.','\0','','CL-MICROORG','DBX-NCIT-C86114'),('CL-MICROORG-T-400',NULL,'FILOVIRUS','Any viral organism that can be assigned to the family Filoviridae.','\0','Filoviridae','CL-MICROORG','DBX-NCIT-C112031'),('CL-MICROORG-T-401',NULL,'FINEGOLDIA','Any bacteria that is not assigned to the species level but can be assigned to the Finegoldia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86887'),('CL-MICROORG-T-402',NULL,'FINEGOLDIA MAGNA','Any bacterial organism that can be assigned to the species Finegoldia magna.','\0','PEPTOSTREPTOCOCCUS MAGNUS','CL-MICROORG','DBX-NCIT-C86888'),('CL-MICROORG-T-403',NULL,'FLAVIVIRUS','Any viral organism that can be assigned to the genus Flavivirus.','\0','','CL-MICROORG','DBX-NCIT-C14208'),('CL-MICROORG-T-404',NULL,'FLAVOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Flavobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76320'),('CL-MICROORG-T-405',NULL,'FRANCISELLA','Any bacteria that is not assigned to the species level but can be assigned to the Francisella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86396'),('CL-MICROORG-T-406',NULL,'FRANCISELLA TULARENSIS','Any bacterial organism that can be assigned to the species Francisella tularensis.','\0','PASTEURELLA TULARENSIS','CL-MICROORG','DBX-NCIT-C86397'),('CL-MICROORG-T-407',NULL,'FUSOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Fusobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76323'),('CL-MICROORG-T-408',NULL,'FUSOBACTERIUM GONIDIAFORMANS','Any bacterial organism that can be assigned to the species Fusobacterium gonidiaformans.','\0','','CL-MICROORG','DBX-NCIT-C86398'),('CL-MICROORG-T-409',NULL,'FUSOBACTERIUM MORTIFERUM','Any bacterial organism that can be assigned to the species Fusobacterium mortiferum.','\0','','CL-MICROORG','DBX-NCIT-C86399'),('CL-MICROORG-T-41',NULL,'ACTINOMYCES VISCOSUS','Any bacterial organism that can be assigned to the species Actinomyces viscosus.','\0','','CL-MICROORG','DBX-NCIT-C86115'),('CL-MICROORG-T-410',NULL,'FUSOBACTERIUM NAVIFORME','Any bacterial organism that can be assigned to the species Fusobacterium naviforme.','\0','Bacillus naviformis; Fusibacterium naviforme; Pseudobacterium naviformis; Ristella naviformis','CL-MICROORG','DBX-NCIT-C114252'),('CL-MICROORG-T-411',NULL,'FUSOBACTERIUM NECROGENES','Any bacterial organism that can be assigned to the species Fusobacterium necrogenes.','\0','','CL-MICROORG','DBX-NCIT-C86400'),('CL-MICROORG-T-412',NULL,'FUSOBACTERIUM NECROPHORUM','Any bacterial organism that can be assigned to the species Fusobacterium necrophorum.','\0','','CL-MICROORG','DBX-NCIT-C86401'),('CL-MICROORG-T-413',NULL,'FUSOBACTERIUM NUCLEATUM','Any bacterial organism that can be assigned to the species Fusobacterium nucleatum.','\0','','CL-MICROORG','DBX-NCIT-C86404'),('CL-MICROORG-T-414',NULL,'FUSOBACTERIUM RUSSII','Any bacterial organism that can be assigned to the species Fusobacterium russii.','\0','','CL-MICROORG','DBX-NCIT-C86405'),('CL-MICROORG-T-415',NULL,'FUSOBACTERIUM ULCERANS','Any bacterial organism that can be assigned to the species Fusobacterium ulcerans.','\0','','CL-MICROORG','DBX-NCIT-C86406'),('CL-MICROORG-T-416',NULL,'FUSOBACTERIUM VARIUM','Any bacterial organism that can be assigned to the species Fusobacterium varium.','\0','FUSOBACTERIUM NECROPHORUM BIOVAR C; FUSOBACTERIUM PSEUDONECROPHORUM','CL-MICROORG','DBX-NCIT-C86407'),('CL-MICROORG-T-417',NULL,'GARDNERELLA','Any bacteria that is not assigned to the species level but can be assigned to the Gardnerella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86409'),('CL-MICROORG-T-418',NULL,'GARDNERELLA VAGINALIS','Any bacterial organism that can be assigned to the species Gardnerella vaginalis.','\0','CORYNEBACTERIUM VAGINALIS','CL-MICROORG','DBX-NCIT-C86410'),('CL-MICROORG-T-419',NULL,'GEMELLA','Any bacteria that is not assigned to the species level but can be assigned to the Gemella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86889'),('CL-MICROORG-T-42',NULL,'ADENOVIRUS','Any viral organism that can be assigned to the family Adenoviridae.','\0','Adenoviridae','CL-MICROORG','DBX-NCIT-C14179'),('CL-MICROORG-T-420',NULL,'GEMELLA BERGERI','Any bacterial organism that can be assigned to the species Gemella bergeri.','\0','','CL-MICROORG','DBX-NCIT-C86890'),('CL-MICROORG-T-421',NULL,'GEMELLA HAEMOLYSANS','Any bacterial organism that can be assigned to the species Gemella haemolysans.','\0','NEISSERIA HAEMOLYSANS','CL-MICROORG','DBX-NCIT-C86891'),('CL-MICROORG-T-422',NULL,'GEMELLA MORBILLORUM','Any bacterial organism that can be assigned to the species Gemella morbillorum.','\0','STREPTOCOCCUS MORBILLORUM','CL-MICROORG','DBX-NCIT-C86892'),('CL-MICROORG-T-423',NULL,'GEMELLA SANGUINIS','Any bacterial organism that can be assigned to the species Gemella sanguinis.','\0','','CL-MICROORG','DBX-NCIT-C86893'),('CL-MICROORG-T-424',NULL,'GLOBICATELLA','Any bacteria that is not assigned to the species level but can be assigned to the Globicatella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86411'),('CL-MICROORG-T-425',NULL,'GLOBICATELLA SANGUINIS','Any bacterial organism that can be assigned to the species Globicatella sanguinis.','\0','GLOBICATELLA SANGUIS','CL-MICROORG','DBX-NCIT-C86412'),('CL-MICROORG-T-426',NULL,'GLOBICATELLA SULFIDIFACIENS','Any bacterial organism that can be assigned to the species Globicatella sulfidifaciens.','\0','','CL-MICROORG','DBX-NCIT-C86413'),('CL-MICROORG-T-427',NULL,'GORDONIA','Any bacteria that is not assigned to the species level but can be assigned to the Gordonia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86414'),('CL-MICROORG-T-428',NULL,'GORDONIA AICHIENSIS','Any bacterial organism that can be assigned to the species Gordonia aichiensis.','\0','GORDONA AICHIENSIS; TSUKAMURELLA AICHIENSIS','CL-MICROORG','DBX-NCIT-C86415'),('CL-MICROORG-T-429',NULL,'GORDONIA BRONCHIALIS','Any bacterial organism that can be assigned to the species Gordonia bronchialis.','\0','GORDONA BRONCHIALIS; RHODOCOCCUS BRONCHIALIS','CL-MICROORG','DBX-NCIT-C86416'),('CL-MICROORG-T-43',NULL,'AEROBIC GRAM-NEGATIVE BACILLUS','Any rod-shaped bacteria with an oxygen-based metabolism and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','AEROBIC GRAM-NEGATIVE ROD','CL-MICROORG','DBX-NCIT-C86116'),('CL-MICROORG-T-430',NULL,'GORDONIA RUBRIPERTINCTA','Any bacterial organism that can be assigned to the species Gordonia rubripertincta.','\0','GORDONA RUBROPERTINCTA; RHODOCOCCUS RUBRIPERTINCTA','CL-MICROORG','DBX-NCIT-C86417'),('CL-MICROORG-T-431',NULL,'GORDONIA SPUTI','Any bacterial organism that can be assigned to the species Gordonia sputi.','\0','GORDONA SPUTI','CL-MICROORG','DBX-NCIT-C86418'),('CL-MICROORG-T-432',NULL,'GORDONIA TERRAE','Any bacterial organism that can be assigned to the species Gordonia terrae.','\0','GORDONA TERRAE; RHODOCOCCUS TERRAE','CL-MICROORG','DBX-NCIT-C86419'),('CL-MICROORG-T-433',NULL,'GRACILIBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Gracilibacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86420'),('CL-MICROORG-T-434',NULL,'GRAM-NEGATIVE BACILLUS','Any rod-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86421'),('CL-MICROORG-T-435',NULL,'GRAM-NEGATIVE COCCUS','Any spherical-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86422'),('CL-MICROORG-T-436',NULL,'GRAM-POSITIVE BACILLUS','Any rod-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C62589'),('CL-MICROORG-T-437',NULL,'GRAM-POSITIVE COCCUS','Any spherical-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86424'),('CL-MICROORG-T-438',NULL,'GRANULICATELLA','Any bacteria that is not assigned to the species level but can be assigned to the Granulicatella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86425'),('CL-MICROORG-T-439',NULL,'GRANULICATELLA ADIACENS','Any bacterial organism that can be assigned to the species Granulicatella adiacens.','\0','ABIOTROPHIA ADJACENS; STREPTOCOCCUS ADJACENS','CL-MICROORG','DBX-NCIT-C86426'),('CL-MICROORG-T-44',NULL,'AEROBIC GRAM-NEGATIVE COCCUS','Any spherical-shaped bacteria with an oxygen-based metabolism and a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86117'),('CL-MICROORG-T-440',NULL,'GRANULICATELLA ELEGANS','Any bacterial organism that can be assigned to the species Granulicatella elegans.','\0','ABIOTROPHIA ELEGANS','CL-MICROORG','DBX-NCIT-C111204'),('CL-MICROORG-T-441',NULL,'GRIMONTIA HOLLISAE','Any bacterial organism that can be assigned to the species Grimontia hollisae.','\0','VIBRIO HOLLISAE','CL-MICROORG','DBX-NCIT-C86427'),('CL-MICROORG-T-442',NULL,'HAEMOPHILUS','Any bacteria that is not assigned to the species level but can be assigned to the Haemophilus genus level.','\0','','CL-MICROORG','DBX-NCIT-C76324'),('CL-MICROORG-T-443',NULL,'HAEMOPHILUS AEGYPTIUS','Any bacterial organism that can be assigned to the species Haemophilus aegyptius.','\0','','CL-MICROORG','DBX-NCIT-C86428'),('CL-MICROORG-T-444',NULL,'HAEMOPHILUS HAEMOGLOBINOPHILUS','Any bacterial organism that can be assigned to the species Haemophilus haemoglobinophilus.','\0','','CL-MICROORG','DBX-NCIT-C86429'),('CL-MICROORG-T-445',NULL,'HAEMOPHILUS HAEMOLYTICUS','Any bacterial organism that can be assigned to the species Haemophilus haemolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86430'),('CL-MICROORG-T-446',NULL,'HAEMOPHILUS INFLUENZAE','Any bacterial organism that can be assigned to the species Haemophilus influenzae.','\0','H-FLU','CL-MICROORG','DBX-NCIT-C86431'),('CL-MICROORG-T-447',NULL,'HAEMOPHILUS PARAHAEMOLYTICUS','Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86432'),('CL-MICROORG-T-448',NULL,'HAEMOPHILUS PARAINFLUENZAE','Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae.','\0','HEMOPHILUS PARAINFLUENZAE','CL-MICROORG','DBX-NCIT-C86433'),('CL-MICROORG-T-449',NULL,'HAFNIA','Any bacteria that is not assigned to the species level but can be assigned to the Hafnia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86434'),('CL-MICROORG-T-45',NULL,'AEROBIC GRAM-POSITIVE BACILLUS','Any rod-shaped bacteria with an oxygen-based metabolism and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','AEROBIC GRAM-POSITIVE ROD','CL-MICROORG','DBX-NCIT-C86118'),('CL-MICROORG-T-450',NULL,'HAFNIA ALVEI','Any bacterial organism that can be assigned to the species Hafnia alvei.','\0','ENTEROBACTER ALVEI','CL-MICROORG','DBX-NCIT-C86435'),('CL-MICROORG-T-451',NULL,'HALOBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Halobacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86436'),('CL-MICROORG-T-452',NULL,'HANTAVIRUS','Any viral organism that can be assigned to the genus Hantavirus.','\0','','CL-MICROORG','DBX-NCIT-C14213'),('CL-MICROORG-T-453',NULL,'HELCOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Helcococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86873'),('CL-MICROORG-T-454',NULL,'HELCOCOCCUS KUNZII','Any bacterial organism that can be assigned to the species Helcococcus kunzii.','\0','','CL-MICROORG','DBX-NCIT-C86878'),('CL-MICROORG-T-455',NULL,'HELCOCOCCUS PYOGENES','Any bacterial organism that can be assigned to the species Helcococcus pyogenes.','\0','','CL-MICROORG','DBX-NCIT-C86879'),('CL-MICROORG-T-456',NULL,'HELCOCOCCUS SUECIENSIS','Any bacterial organism that can be assigned to the species Helcococcus sueciensis.','\0','','CL-MICROORG','DBX-NCIT-C86880'),('CL-MICROORG-T-457',NULL,'HELICOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Helicobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C14296'),('CL-MICROORG-T-458',NULL,'HELICOBACTER CINAEDI','Any bacterial organism that can be assigned to the species Helicobacter cinaedi.','\0','CAMPYLOBACTER CINAEDI','CL-MICROORG','DBX-NCIT-C86437'),('CL-MICROORG-T-459',NULL,'HELICOBACTER FELIS','Any bacterial organism that can be assigned to the species Helicobacter felis.','\0','H. FELIS','CL-MICROORG','DBX-NCIT-C14330'),('CL-MICROORG-T-46',NULL,'AEROBIC GRAM-POSITIVE COCCUS','Any spherical-shaped bacteria with an oxygen-based metabolism and a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86119'),('CL-MICROORG-T-460',NULL,'HELICOBACTER FENNELLIAE','Any bacterial organism that can be assigned to the species Helicobacter fennelliae.','\0','CAMPYLOBACTER FENNELLIAE','CL-MICROORG','DBX-NCIT-C86438'),('CL-MICROORG-T-461',NULL,'HELICOBACTER MUSTELAE','Any bacterial organism that can be assigned to the species Helicobacter mustelae.','\0','CAMPYLOBACTER MUSTELAE','CL-MICROORG','DBX-NCIT-C86439'),('CL-MICROORG-T-462',NULL,'HELICOBACTER PYLORI','Any bacterial organism that can be assigned to the species Helicobacter pylori.','\0','CAMPYLOBACTER PYLORI; H. PYLORI','CL-MICROORG','DBX-NCIT-C14289'),('CL-MICROORG-T-463',NULL,'HELICOBACTER RAPPINI','Any bacterial organism that can be assigned to the species Helicobacter rappini.','\0','FLEXISPIRA RAPPINI','CL-MICROORG','DBX-NCIT-C86440'),('CL-MICROORG-T-464',NULL,'HENDRA VIRUS','Any viral organism that can be assigned to the species Hendra virus.','\0','','CL-MICROORG','DBX-NCIT-C112289'),('CL-MICROORG-T-465',NULL,'HENIPAVIRUS','Any viral organism that can be assigned to the genus Henipavirus.','\0','','CL-MICROORG','DBX-NCIT-C112290'),('CL-MICROORG-T-466',NULL,'HEPATITIS A VIRUS','Any viral organism that can be assigned to the species Hepatitis A virus.','\0','HAV','CL-MICROORG','DBX-NCIT-C14325'),('CL-MICROORG-T-467',NULL,'HEPATITIS B VIRUS','Any viral organism that can be assigned to the species Hepatitis B virus.','\0','HBV','CL-MICROORG','DBX-NCIT-C14215'),('CL-MICROORG-T-468',NULL,'HEPATITIS C VIRUS','Any viral organism that can be assigned to the species Hepatitis C virus.','\0','HCV','CL-MICROORG','DBX-NCIT-C14312'),('CL-MICROORG-T-469',NULL,'HEPATITIS D VIRUS','Any viral organism that can be assigned to the species Hepatitis D virus.','\0','HDV','CL-MICROORG','DBX-NCIT-C93324'),('CL-MICROORG-T-47',NULL,'AEROBIC STREPTOCOCCUS','Any bacteria assigned to the genus Streptococcus that requires oxygen to grow or respirate.','\0','','CL-MICROORG','DBX-NCIT-C86120'),('CL-MICROORG-T-470',NULL,'HEPATITIS E VIRUS','Any viral organism that can be assigned to the species Hepatitis E virus.','\0','HEV','CL-MICROORG','DBX-NCIT-C14295'),('CL-MICROORG-T-471',NULL,'HISTOPHILUS SOMNI','Any bacterial organism that can be assigned to the species Histophilus somni.','\0','HAEMOPHILUS SOMNUS','CL-MICROORG','DBX-NCIT-C86441'),('CL-MICROORG-T-472',NULL,'HOLDEMANIA','Any bacteria that is not assigned to the species level but can be assigned to the Holdemania genus level.','\0','','CL-MICROORG','DBX-NCIT-C86442'),('CL-MICROORG-T-473',NULL,'HOLDEMANIA FILIFORMIS','Any bacterial organism that can be assigned to the species Holdemania filiformis.','\0','','CL-MICROORG','DBX-NCIT-C86443'),('CL-MICROORG-T-474',NULL,'HUMAN HERPESVIRUS 1','Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus.','\0','HHV-1; HSV-1; Herpes Simplex Virus type 1','CL-MICROORG','DBX-NCIT-C14311'),('CL-MICROORG-T-475',NULL,'HUMAN HERPESVIRUS 2','Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus.','\0','HHV-2; HSV-2; Herpes Simplex Virus type 2','CL-MICROORG','DBX-NCIT-C112313'),('CL-MICROORG-T-476',NULL,'HUMAN HERPESVIRUS 3','Any viral organism that can be assigned to the species Human Herpesvirus 3.','\0','HHV-3; VZV; Varicella Zoster Virus','CL-MICROORG','DBX-NCIT-C71091'),('CL-MICROORG-T-477',NULL,'HUMAN HERPESVIRUS 4','Any viral organism that can be assigned to the species Human Herpesvirus 4.','\0','EBV; Epstein-Barr Virus; HHV-4','CL-MICROORG','DBX-NCIT-C14204'),('CL-MICROORG-T-478',NULL,'HUMAN HERPESVIRUS 5','Any viral organism that can be assigned to the species Human Herpesvirus 5.','\0','HCMV; HHV-5; Human Cytomegalovirus','CL-MICROORG','DBX-NCIT-C112314'),('CL-MICROORG-T-479',NULL,'HUMAN HERPESVIRUS 6','Any viral organism that can be assigned to the species Human Herpesvirus 6.','\0','HHV-6','CL-MICROORG','DBX-NCIT-C14218'),('CL-MICROORG-T-48',NULL,'AEROCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Aerococcus genus level.','\0','GAFFKYA SPECIES','CL-MICROORG','DBX-NCIT-C86121'),('CL-MICROORG-T-480',NULL,'HUMAN HERPESVIRUS 7','Any viral organism that can be assigned to the species Human Herpesvirus 7.','\0','HHV-7','CL-MICROORG','DBX-NCIT-C112315'),('CL-MICROORG-T-481',NULL,'HUMAN HERPESVIRUS 8','Any viral organism that can be assigned to the species Human herpesvirus 8.','\0','HHV-8; KSHV; Kaposi\'s sarcoma-associated herpesvirus','CL-MICROORG','DBX-NCIT-C14327'),('CL-MICROORG-T-482',NULL,'HUMAN IMMUNODEFICIENCY VIRUS 1','Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.','\0','HIV-1; LAV-1','CL-MICROORG','DBX-NCIT-C14220'),('CL-MICROORG-T-483',NULL,'HUMAN IMMUNODEFICIENCY VIRUS 2','Any viral organism that can be assigned to the species Human Immunodeficiency virus 2.','\0','HIV-2; LAV-2','CL-MICROORG','DBX-NCIT-C14221'),('CL-MICROORG-T-484',NULL,'HUMAN PAPILLOMAVIRUS','Any viral organism in humans that can be assigned to the family Papillomaviridae.','\0','HPV; Human Papilloma Virus','CL-MICROORG','DBX-NCIT-C14226'),('CL-MICROORG-T-485',NULL,'HUMAN PARAINFLUENZA VIRUS 1','Any viral organism that can be assigned to the Human Parainfluenza virus 1 serotype.','\0','HPIV-1; Human Parainfluenza Virus Type 1; hPIV-1','CL-MICROORG','DBX-NCIT-C14254'),('CL-MICROORG-T-486',NULL,'HUMAN PARAINFLUENZA VIRUS 2','Any viral organism that can be assigned to the Human Parainfluenza virus 2 serotype.','\0','HPIV-2; Human Parainfluenza Virus Type 2; hPIV-2','CL-MICROORG','DBX-NCIT-C112316'),('CL-MICROORG-T-487',NULL,'HUMAN PARAINFLUENZA VIRUS 3','Any viral organism that can be assigned to the Human Parainfluenza virus 3 serotype.','\0','HPIV-3; Human Parainfluenza Virus Type 3; hPIV-3','CL-MICROORG','DBX-NCIT-C112317'),('CL-MICROORG-T-488',NULL,'HUMAN PARAINFLUENZA VIRUS 4','Any viral organism that can be assigned to the Human Parainfluenza virus 4 serotype.','\0','HPIV-4; Human Parainfluenza Virus Type 4; hPIV-4','CL-MICROORG','DBX-NCIT-C112318'),('CL-MICROORG-T-489',NULL,'HUMAN PARVOVIRUS B19','Any viral organism that can be assigned to the species Human Parvovirus B19.','\0','B19 Virus; Human Erythrovirus B19; Parvovirus B19','CL-MICROORG','DBX-NCIT-C89772'),('CL-MICROORG-T-49',NULL,'AEROCOCCUS URINAE','Any bacterial organism that can be assigned to the species Aerococcus urinae.','\0','','CL-MICROORG','DBX-NCIT-C86122'),('CL-MICROORG-T-490',NULL,'HUMAN RESPIRATORY SYNCYTIAL VIRUS','Any viral organism that can be assigned to the species Human Respiratory Syncitial virus.','\0','Human RSV; RSV; hRSV','CL-MICROORG','DBX-NCIT-C14267'),('CL-MICROORG-T-491',NULL,'HUMAN T-LYMPHOTROPIC VIRUS 1','Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 1.','\0','Adult T-cell leukemia lymphoma ATLL; Adult T-cell lymphoma virus type 1; HTLV-1','CL-MICROORG','DBX-NCIT-C14223'),('CL-MICROORG-T-492',NULL,'HUMAN T-LYMPHOTROPIC VIRUS 2','Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 2.','\0','HTLV-2; HTLV-II','CL-MICROORG','DBX-NCIT-C14224'),('CL-MICROORG-T-493',NULL,'INFLUENZA A VIRUS','Any viral organism that can be assigned to the species Influenza A virus.','\0','FLUAV; Influenza Virus Type A','CL-MICROORG','DBX-NCIT-C53454'),('CL-MICROORG-T-494',NULL,'INFLUENZA B VIRUS','Any viral organism that can be assigned to the species Influenza B virus.','\0','FLUBV; Influenza Virus Type B','CL-MICROORG','DBX-NCIT-C53468'),('CL-MICROORG-T-495',NULL,'INFLUENZA C VIRUS','Any viral organism that can be assigned to the species Influenza C virus.','\0','FLUCV; Influenza Virus Type C','CL-MICROORG','DBX-NCIT-C97157'),('CL-MICROORG-T-496',NULL,'INQUILINUS','Any bacteria that is not assigned to the species level but can be assigned to the Inquilinus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86444'),('CL-MICROORG-T-497',NULL,'INQUILINUS LIMOSUS','Any bacterial organism that can be assigned to the species Inquilinus limosus.','\0','','CL-MICROORG','DBX-NCIT-C86445'),('CL-MICROORG-T-498',NULL,'JC VIRUS','Any viral organism that can be assigned to the species JC polyomavirus.','\0','Human polyomavirus (type JC); Polyomavirus hominis 2; polyomavirus JC','CL-MICROORG','DBX-NCIT-C14229'),('CL-MICROORG-T-499',NULL,'JEOTGALIBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Jeotgalibacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86446'),('CL-MICROORG-T-5',NULL,'ACHROMOBACTER PIECHAUDII','Any bacterial organism that can be assigned to the species Achromobacter piechaudii.','\0','','CL-MICROORG','DBX-NCIT-C86081'),('CL-MICROORG-T-50',NULL,'AEROCOCCUS VIRIDANS','Any bacterial organism that can be assigned to the species Aerococcus viridans.','\0','','CL-MICROORG','DBX-NCIT-C86123'),('CL-MICROORG-T-500',NULL,'JOHNSONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Johnsonella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86447'),('CL-MICROORG-T-501',NULL,'JOHNSONELLA IGNAVA','Any bacterial organism that can be assigned to the species Johnsonella ignava.','\0','','CL-MICROORG','DBX-NCIT-C86448'),('CL-MICROORG-T-502',NULL,'KINGELLA','Any bacteria that is not assigned to the species level but can be assigned to the Kingella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86449'),('CL-MICROORG-T-503',NULL,'KINGELLA DENITRIFICANS','Any bacterial organism that can be assigned to the species Kingella denitrificans.','\0','CDC GROUP TM-1','CL-MICROORG','DBX-NCIT-C86450'),('CL-MICROORG-T-504',NULL,'KINGELLA KINGAE','Any bacterial organism that can be assigned to the species Kingella kingae.','\0','MORAXELLA KINGAE','CL-MICROORG','DBX-NCIT-C86451'),('CL-MICROORG-T-505',NULL,'KINGELLA ORALIS','Any bacterial organism that can be assigned to the species Kingella oralis.','\0','','CL-MICROORG','DBX-NCIT-C86452'),('CL-MICROORG-T-506',NULL,'KINGELLA POTUS','Any bacterial organism that can be assigned to the species Kingella potus.','\0','','CL-MICROORG','DBX-NCIT-C86453'),('CL-MICROORG-T-507',NULL,'KLEBSIELLA','Any bacteria that is not assigned to the species level but can be assigned to the Klebsiella genus level.','\0','','CL-MICROORG','DBX-NCIT-C28165'),('CL-MICROORG-T-508',NULL,'KLEBSIELLA GRANULOMATIS','Any bacterial organism that can be assigned to the species Klebsiella granulomatis.','\0','','CL-MICROORG','DBX-NCIT-C86454'),('CL-MICROORG-T-509',NULL,'KLEBSIELLA OXYTOCA','Any bacterial organism that can be assigned to the species Klebsiella oxytoca.','\0','K. OXYTOCA','CL-MICROORG','DBX-NCIT-C86455'),('CL-MICROORG-T-51',NULL,'AEROMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Aeromonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86124'),('CL-MICROORG-T-510',NULL,'KLEBSIELLA OZAENAE','Any bacterial organism that can be assigned to the species Klebsiella ozaenae.','\0','KLEBSIELLA PNEUMONIAE SUBSP. OZAENAE','CL-MICROORG','DBX-NCIT-C86456'),('CL-MICROORG-T-511',NULL,'KLEBSIELLA PNEUMONIAE','Any bacterial organism that can be assigned to the species Klebsiella pneumoniae.','\0','K. PNEUMONIAE','CL-MICROORG','DBX-NCIT-C86457'),('CL-MICROORG-T-512',NULL,'KLEBSIELLA RHINOSCLEROMATIS','Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis.','\0','KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATIS','CL-MICROORG','DBX-NCIT-C86458'),('CL-MICROORG-T-513',NULL,'KLEBSIELLA SINGAPORENSIS','Any bacterial organism that can be assigned to the species Klebsiella singaporensis.','\0','','CL-MICROORG','DBX-NCIT-C86459'),('CL-MICROORG-T-514',NULL,'KLEBSIELLA VARIICOLA','Any bacterial organism that can be assigned to the species Klebsiella variicola.','\0','','CL-MICROORG','DBX-NCIT-C86460'),('CL-MICROORG-T-515',NULL,'KLUYVERA','Any bacteria that is not assigned to the species level but can be assigned to the Kluyvera genus level.','\0','','CL-MICROORG','DBX-NCIT-C86461'),('CL-MICROORG-T-516',NULL,'KLUYVERA ASCORBATA','Any bacterial organism that can be assigned to the species Kluyvera ascorbata.','\0','CDC ENTERIC GROUP 8','CL-MICROORG','DBX-NCIT-C86462'),('CL-MICROORG-T-517',NULL,'KLUYVERA CRYOCRESCENS','Any bacterial organism that can be assigned to the species Kluyvera cryocrescens.','\0','','CL-MICROORG','DBX-NCIT-C86463'),('CL-MICROORG-T-518',NULL,'KLUYVERA GEORGIANA','Any bacterial organism that can be assigned to the species Kluyvera georgiana.','\0','','CL-MICROORG','DBX-NCIT-C86464'),('CL-MICROORG-T-519',NULL,'KLUYVERA INTERMEDIA','Any bacterial organism that can be assigned to the species Kluyvera intermedia.','\0','ENTEROBACTER INTERMEDIUM; ENTEROBACTER INTERMEDIUS; KLUYVERA COCHLEAE','CL-MICROORG','DBX-NCIT-C86465'),('CL-MICROORG-T-52',NULL,'AEROMONAS HYDROPHILA','Any bacterial organism that can be assigned to the species Aeromonas hydrophila.','\0','AEROMONAS HYDROPHILA GROUP','CL-MICROORG','DBX-NCIT-C86125'),('CL-MICROORG-T-520',NULL,'KLUYVEROMYCES MARXIANUS','Any fungal organism that can be assigned to the species Kluyveromyces marxianus.','\0','C. pseudotropicalis; Candida pseudotropicalis; K. cicerisporus; K. fragilis; Kluyveromyces cicerisporus; Kluyveromyces fragilis','CL-MICROORG','DBX-NCIT-C114256'),('CL-MICROORG-T-521',NULL,'KNOELLIA','Any bacteria that is not assigned to the species level but can be assigned to the Knoellia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86466'),('CL-MICROORG-T-522',NULL,'KOCURIA','Any bacteria that is not assigned to the species level but can be assigned to the Kocuria genus level.','\0','','CL-MICROORG','DBX-NCIT-C86467'),('CL-MICROORG-T-523',NULL,'KOCURIA KRISTINAE','Any bacterial organism that can be assigned to the species Kocuria kristinae.','\0','MICROCOCCUS KRISTINAE','CL-MICROORG','DBX-NCIT-C86468'),('CL-MICROORG-T-524',NULL,'KOCURIA RHIZOPHILA','Any bacterial organism that can be assigned to the species Kocuria rhizophila.','\0','MICROCOCCUS LUTEUS; SARCINA LUTEA','CL-MICROORG','DBX-NCIT-C86513'),('CL-MICROORG-T-525',NULL,'KOCURIA ROSEA','Any bacterial organism that can be assigned to the species Kocuria rosea.','\0','','CL-MICROORG','DBX-NCIT-C86469'),('CL-MICROORG-T-526',NULL,'KOCURIA VARIANS','Any bacterial organism that can be assigned to the species Kocuria varians.','\0','','CL-MICROORG','DBX-NCIT-C86470'),('CL-MICROORG-T-527',NULL,'KURTHIA','Any bacteria that is not assigned to the species level but can be assigned to the Kurthia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86471'),('CL-MICROORG-T-528',NULL,'KYTOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Kytococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86472'),('CL-MICROORG-T-529',NULL,'KYTOCOCCUS SEDENTARIUS','Any bacterial organism that can be assigned to the species Kytococcus sedentarius.','\0','','CL-MICROORG','DBX-NCIT-C86473'),('CL-MICROORG-T-53',NULL,'AEROMONAS JANDAEI','Any bacterial organism that can be assigned to the species Aeromonas jandaei.','\0','','CL-MICROORG','DBX-NCIT-C86126'),('CL-MICROORG-T-530',NULL,'LACTOBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Lactobacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C76352'),('CL-MICROORG-T-531',NULL,'LACTOBACILLUS ACIDOPHILUS','Any bacterial organism that can be assigned to the species Lactobacillus acidophilus.','\0','','CL-MICROORG','DBX-NCIT-C86474'),('CL-MICROORG-T-532',NULL,'LACTOBACILLUS BREVIS','Any bacterial organism that can be assigned to the species Lactobacillus brevis.','\0','','CL-MICROORG','DBX-NCIT-C86475'),('CL-MICROORG-T-533',NULL,'LACTOBACILLUS CASEI','Any bacterial organism that can be assigned to the species Lactobacillus casei.','\0','','CL-MICROORG','DBX-NCIT-C86476'),('CL-MICROORG-T-534',NULL,'LACTOBACILLUS CATENAFORMIS','Any bacterial organism that can be assigned to the species Lactobacillus catenaformis.','\0','LACTOBACILLUS CATENAFORME','CL-MICROORG','DBX-NCIT-C86477'),('CL-MICROORG-T-535',NULL,'LACTOBACILLUS FERMENTUM','Any bacterial organism that can be assigned to the species Lactobacillus fermentum.','\0','','CL-MICROORG','DBX-NCIT-C86478'),('CL-MICROORG-T-536',NULL,'LACTOBACILLUS GALLINARUM','Any bacterial organism that can be assigned to the species Lactobacillus gallinarum.','\0','','CL-MICROORG','DBX-NCIT-C86479'),('CL-MICROORG-T-537',NULL,'LACTOBACILLUS JENSENII','Any bacterial organism that can be assigned to the species Lactobacillus jensenii.','\0','','CL-MICROORG','DBX-NCIT-C86480'),('CL-MICROORG-T-538',NULL,'LACTOBACILLUS JOHNSONII','Any bacterial organism that can be assigned to the species Lactobacillus johnsonii.','\0','','CL-MICROORG','DBX-NCIT-C86481'),('CL-MICROORG-T-539',NULL,'LACTOBACILLUS SALIVARIUS','Any bacterial organism that can be assigned to the species Lactobacillus salivarius.','\0','','CL-MICROORG','DBX-NCIT-C86482'),('CL-MICROORG-T-54',NULL,'AEROMONAS PUNCTATA','Any bacterial organism that can be assigned to the species Aeromonas punctata.','\0','AEROMONAS CAVIAE','CL-MICROORG','DBX-NCIT-C86127'),('CL-MICROORG-T-540',NULL,'LACTOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Lactococcus genus level.','\0','DOEDERLEIN BACILLUS','CL-MICROORG','DBX-NCIT-C86483'),('CL-MICROORG-T-541',NULL,'LACTOCOCCUS GARVIEAE','Any bacterial organism that can be assigned to the species Lactococcus garvieae.','\0','','CL-MICROORG','DBX-NCIT-C86484'),('CL-MICROORG-T-542',NULL,'LACTOCOCCUS LACTIS','Any bacterial organism that can be assigned to the species Lactococcus lactis.','\0','','CL-MICROORG','DBX-NCIT-C86485'),('CL-MICROORG-T-543',NULL,'LECLERCIA','Any bacteria that is not assigned to the species level but can be assigned to the Leclercia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86486'),('CL-MICROORG-T-544',NULL,'LECLERCIA ADECARBOXYLATA','Any bacterial organism that can be assigned to the species Leclercia adecarboxylata.','\0','CDC ENTERIC GROUP 41','CL-MICROORG','DBX-NCIT-C86487'),('CL-MICROORG-T-545',NULL,'LEGIONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Legionella genus level.','\0','','CL-MICROORG','DBX-NCIT-C76353'),('CL-MICROORG-T-546',NULL,'LEGIONELLA LONGBEACHAE','Any bacterial organism that can be assigned to the species Legionella longbeachae.','\0','','CL-MICROORG','DBX-NCIT-C86488'),('CL-MICROORG-T-547',NULL,'LEGIONELLA PNEUMOPHILA','Any bacterial organism that can be assigned to the species Legionella pneumophila.','\0','','CL-MICROORG','DBX-NCIT-C86489'),('CL-MICROORG-T-548',NULL,'LEIFSONIA','Any bacteria that is not assigned to the species level but can be assigned to the Leifsonia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86490'),('CL-MICROORG-T-549',NULL,'LEIFSONIA AQUATICA','Any bacterial organism that can be assigned to the species Leifsonia aquatica.','\0','CORYNEBACTERIUM AQUATICUM','CL-MICROORG','DBX-NCIT-C86491'),('CL-MICROORG-T-55',NULL,'AEROMONAS SALMONICIDA','Any bacterial organism that can be assigned to the species Aeromonas salmonicida.','\0','','CL-MICROORG','DBX-NCIT-C86128'),('CL-MICROORG-T-550',NULL,'LEMINORELLA','Any bacteria that is not assigned to the species level but can be assigned to the Leminorella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86492'),('CL-MICROORG-T-551',NULL,'LEMINORELLA GRIMONTII','Any bacterial organism that can be assigned to the species Leminorella grimontii.','\0','CDC ENTERIC GROUP 57','CL-MICROORG','DBX-NCIT-C86493'),('CL-MICROORG-T-552',NULL,'LEMINORELLA RICHARDII','Any bacterial organism that can be assigned to the species Leminorella richardii.','\0','','CL-MICROORG','DBX-NCIT-C86494'),('CL-MICROORG-T-553',NULL,'LENTIVIRUS','Any viral organism that can be assigned to the genus Lentivirus.','\0','Lentivirinae','CL-MICROORG','DBX-NCIT-C14290'),('CL-MICROORG-T-554',NULL,'LEPTOSPIRA','Any bacteria that is not assigned to the species level but can be assigned to the Leptospira genus level.','\0','','CL-MICROORG','DBX-NCIT-C76355'),('CL-MICROORG-T-555',NULL,'LEUCONOSTOC','Any bacteria that is not assigned to the species level but can be assigned to the Leuconostoc genus level.','\0','','CL-MICROORG','DBX-NCIT-C76357'),('CL-MICROORG-T-556',NULL,'LEUCONOSTOC CITREUM','Any bacterial organism that can be assigned to the species Leuconostoc citreum.','\0','','CL-MICROORG','DBX-NCIT-C86495'),('CL-MICROORG-T-557',NULL,'LEUCONOSTOC LACTIS','Any bacterial organism that can be assigned to the species Leuconostoc lactis.','\0','','CL-MICROORG','DBX-NCIT-C86496'),('CL-MICROORG-T-558',NULL,'LEUCONOSTOC MESENTEROIDES','Any bacterial organism that can be assigned to the species Leuconostoc mesenteroides.','\0','','CL-MICROORG','DBX-NCIT-C86497'),('CL-MICROORG-T-559',NULL,'LEUCONOSTOC PSEUDOMESENTEROIDES','Any bacterial organism that can be assigned to the species Leuconostoc pseudomesenteroides.','\0','','CL-MICROORG','DBX-NCIT-C86498'),('CL-MICROORG-T-56',NULL,'AEROMONAS SCHUBERTII','Any bacterial organism that can be assigned to the species Aeromonas schubertii.','\0','','CL-MICROORG','DBX-NCIT-C86129'),('CL-MICROORG-T-560',NULL,'LISTERIA','Any bacteria that is not assigned to the species level but can be assigned to the Listeria genus level.','\0','','CL-MICROORG','DBX-NCIT-C76359'),('CL-MICROORG-T-561',NULL,'LISTERIA GRAYI','Any bacterial organism that can be assigned to the species Listeria grayi.','\0','','CL-MICROORG','DBX-NCIT-C86499'),('CL-MICROORG-T-562',NULL,'LISTERIA INNOCUA','Any bacterial organism that can be assigned to the species Listeria innocua.','\0','','CL-MICROORG','DBX-NCIT-C86500'),('CL-MICROORG-T-563',NULL,'LISTERIA IVANOVII','Any bacterial organism that can be assigned to the species Listeria ivanovii.','\0','LISTERIA MONOCYTOGENES SEROVAR 5','CL-MICROORG','DBX-NCIT-C86501'),('CL-MICROORG-T-564',NULL,'LISTERIA MONOCYTOGENES','Any bacterial organism that can be assigned to the species Listeria monocytogenes.','\0','','CL-MICROORG','DBX-NCIT-C86502'),('CL-MICROORG-T-565',NULL,'LISTERIA SEELIGERI','Any bacterial organism that can be assigned to the species Listeria seeligeri.','\0','','CL-MICROORG','DBX-NCIT-C86503'),('CL-MICROORG-T-566',NULL,'LISTERIA WELSHIMERI','Any bacterial organism that can be assigned to the species Listeria welshimeri.','\0','','CL-MICROORG','DBX-NCIT-C86504'),('CL-MICROORG-T-567',NULL,'LYSSAVIRUS','Any viral organism that can be assigned to the genus Lyssavirus.','\0','','CL-MICROORG','DBX-NCIT-C112330'),('CL-MICROORG-T-568',NULL,'MACROCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Macrococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86505'),('CL-MICROORG-T-569',NULL,'MACROCOCCUS CASEOLYTICUS','Any bacterial organism that can be assigned to the species Macrococcus caseolyticus.','\0','STAPHYLOCOCCUS CASEOLYTICUS','CL-MICROORG','DBX-NCIT-C86506'),('CL-MICROORG-T-57',NULL,'AEROMONAS SOBRIA','Any bacterial organism that can be assigned to the species Aeromonas sobria.','\0','','CL-MICROORG','DBX-NCIT-C86130'),('CL-MICROORG-T-570',NULL,'MAGNUSIOMYCES CAPITATUS','Any fungal organism that can be assigned to the species Magnusiomyces capitatus.','\0','M. capitatus','CL-MICROORG','DBX-NCIT-C114263'),('CL-MICROORG-T-571',NULL,'MANNHEIMIA','Any bacteria that is not assigned to the species level but can be assigned to the Mannheimia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86507'),('CL-MICROORG-T-572',NULL,'MANNHEIMIA HAEMOLYTICA','Any bacterial organism that can be assigned to the species Mannheimia haemolytica.','\0','PASTEURELLA HAEMOLYTICA','CL-MICROORG','DBX-NCIT-C86508'),('CL-MICROORG-T-573',NULL,'MARBURGVIRUS','Any viral organism that can be assigned to the genus Marburgvirus.','\0','Marburg Virus','CL-MICROORG','DBX-NCIT-C112331'),('CL-MICROORG-T-574',NULL,'MEASLES VIRUS','Any viral organism that can be assigned to the species Measles virus.','\0','Rubeola Virus; SSPEV; rougeole virus; subacute sclerosing panencephalitis virus','CL-MICROORG','DBX-NCIT-C14237'),('CL-MICROORG-T-575',NULL,'MEGAMONAS FUNIFORMIS','Any bacterial organism that can be assigned to the species Megamonas funiformis.','\0','','CL-MICROORG','DBX-NCIT-C114247'),('CL-MICROORG-T-576',NULL,'MEGASPHAERA','Any bacteria that is not assigned to the species level but can be assigned to the Megasphaera genus level.','\0','','CL-MICROORG','DBX-NCIT-C86895'),('CL-MICROORG-T-577',NULL,'MEGASPHAERA ELSDENII','Any bacterial organism that can be assigned to the species Megasphaera elsdenii.','\0','PEPTOSTREPTOCOCCUS ELSDENII','CL-MICROORG','DBX-NCIT-C86896'),('CL-MICROORG-T-578',NULL,'METHYLOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Methylobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76361'),('CL-MICROORG-T-579',NULL,'METHYLOBACTERIUM MESOPHILICUM','Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum.','\0','PSEUDOMONAS MESOPHILICA','CL-MICROORG','DBX-NCIT-C86510'),('CL-MICROORG-T-58',NULL,'AEROMONAS VERONII','Any bacterial organism that can be assigned to the species Aeromonas veronii.','\0','','CL-MICROORG','DBX-NCIT-C86131'),('CL-MICROORG-T-580',NULL,'MEYEROZYMA GUILLIERMONDII','Any fungal organism that can be assigned to the species Meyerozyma guilliermondii.','\0','C. guilliermondii; Candida guilliermondii; M. guillliermondii','CL-MICROORG','DBX-NCIT-C77172'),('CL-MICROORG-T-581',NULL,'MICROBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Microbacterium genus level.','\0','CDC CORYNEFORM GROUP A-4, A-5','CL-MICROORG','DBX-NCIT-C85511'),('CL-MICROORG-T-582',NULL,'MICROBACTERIUM PARAOXYDANS','Any bacterial organism that can be assigned to the species Microbacterium paraoxydans.','\0','','CL-MICROORG','DBX-NCIT-C86512'),('CL-MICROORG-T-583',NULL,'MICROCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Micrococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C77086'),('CL-MICROORG-T-584',NULL,'MICROCOCCUS LYLAE','Any bacterial organism that can be assigned to the species Micrococcus lylae.','\0','','CL-MICROORG','DBX-NCIT-C86514'),('CL-MICROORG-T-585',NULL,'MITSUOKELLA','Any bacteria that is not assigned to the species level but can be assigned to the Mitsuokella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86515'),('CL-MICROORG-T-586',NULL,'MITSUOKELLA MULTACIDA','Any bacterial organism that can be assigned to the species Mitsuokella multacida.','\0','','CL-MICROORG','DBX-NCIT-C86516'),('CL-MICROORG-T-587',NULL,'MOBILUNCUS','Any bacteria that is not assigned to the species level but can be assigned to the Mobiluncus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86517'),('CL-MICROORG-T-588',NULL,'MOBILUNCUS CURTISII','Any bacterial organism that can be assigned to the species Mobiluncus curtisii.','\0','','CL-MICROORG','DBX-NCIT-C86518'),('CL-MICROORG-T-589',NULL,'MOBILUNCUS MULIERIS','Any bacterial organism that can be assigned to the species Mobiluncus mulieris.','\0','','CL-MICROORG','DBX-NCIT-C86519'),('CL-MICROORG-T-59',NULL,'AGGREGATIBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Aggregatibacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86132'),('CL-MICROORG-T-590',NULL,'MOELLERELLA','Any bacteria that is not assigned to the species level but can be assigned to the Moellerella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86520'),('CL-MICROORG-T-591',NULL,'MOELLERELLA WISCONSENSIS','Any bacterial organism that can be assigned to the species Moellerella wisconsensis.','\0','CDC ENTERIC GROUP 46','CL-MICROORG','DBX-NCIT-C86521'),('CL-MICROORG-T-592',NULL,'MOGIBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Mogibacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86898'),('CL-MICROORG-T-593',NULL,'MOGIBACTERIUM TIMIDUM','Any bacterial organism that can be assigned to the species Mogibacterium timidum.','\0','EUBACTERIUM TIMIDUM','CL-MICROORG','DBX-NCIT-C86899'),('CL-MICROORG-T-594',NULL,'MOLLUSCIPOXVIRUS','Any viral organism that can be assigned to the genus Molluscipoxvirus.','\0','Molluscipox Virus','CL-MICROORG','DBX-NCIT-C112356'),('CL-MICROORG-T-595',NULL,'MOLLUSCUM CONTAGIOSUM VIRUS','Any viral organism that can be assigned to the species Molluscum contagiosum virus.','\0','MCV; MOCV','CL-MICROORG','DBX-NCIT-C112357'),('CL-MICROORG-T-596',NULL,'MORAXELLA','Any bacteria that is not assigned to the species level but can be assigned to the Moraxella genus level.','\0','BRANHAMELLA SPECIES','CL-MICROORG','DBX-NCIT-C86009'),('CL-MICROORG-T-597',NULL,'MORAXELLA ATLANTAE','Any bacterial organism that can be assigned to the species Moraxella atlantae.','\0','CDC GROUP M-3','CL-MICROORG','DBX-NCIT-C86523'),('CL-MICROORG-T-598',NULL,'MORAXELLA BOVIS','Any bacterial organism that can be assigned to the species Moraxella bovis.','\0','','CL-MICROORG','DBX-NCIT-C86524'),('CL-MICROORG-T-599',NULL,'MORAXELLA CANIS','Any bacterial organism that can be assigned to the species Moraxella canis.','\0','','CL-MICROORG','DBX-NCIT-C86525'),('CL-MICROORG-T-6',NULL,'ACHROMOBACTER XYLOSOXIDANS','Any bacterial organism that can be assigned to the species Achromobacter xylosoxidans.','\0','ALCALIGENES XYLOSOXIDANS','CL-MICROORG','DBX-NCIT-C86082'),('CL-MICROORG-T-60',NULL,'AGGREGATIBACTER ACTINOMYCETEMCOMITANS','Any bacterial organism that can be assigned to the species Aggregatibacter actinomycetemcomitans.','\0','HAEMOPHILUS ACTINOMYCETEMCOMITANS','CL-MICROORG','DBX-NCIT-C86133'),('CL-MICROORG-T-600',NULL,'MORAXELLA CATARRHALIS','Any bacterial organism that can be assigned to the species Moraxella catarrhalis.','\0','BRANHAMELLA CATARRHALIS','CL-MICROORG','DBX-NCIT-C76210'),('CL-MICROORG-T-601',NULL,'MORAXELLA LACUNATA','Any bacterial organism that can be assigned to the species Moraxella lacunata.','\0','MORAXELLA LIQUEFACIENS','CL-MICROORG','DBX-NCIT-C86526'),('CL-MICROORG-T-602',NULL,'MORAXELLA LINCOLNII','Any bacterial organism that can be assigned to the species Moraxella lincolnii.','\0','','CL-MICROORG','DBX-NCIT-C86527'),('CL-MICROORG-T-603',NULL,'MORAXELLA NONLIQUEFACIENS','Any bacterial organism that can be assigned to the species Moraxella nonliquefaciens.','\0','','CL-MICROORG','DBX-NCIT-C86528'),('CL-MICROORG-T-604',NULL,'MORAXELLA OBLONGA','Any bacterial organism that can be assigned to the species Moraxella oblonga.','\0','','CL-MICROORG','DBX-NCIT-C86529'),('CL-MICROORG-T-605',NULL,'MORAXELLA OSLOENSIS','Any bacterial organism that can be assigned to the species Moraxella osloensis.','\0','','CL-MICROORG','DBX-NCIT-C86530'),('CL-MICROORG-T-606',NULL,'MORBILLIVIRUS','Any viral organism that can be assigned to the genus Morbillivirus.','\0','','CL-MICROORG','DBX-NCIT-C14309'),('CL-MICROORG-T-607',NULL,'MORGANELLA','Any bacteria that is not assigned to the species level but can be assigned to the Morganella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86531'),('CL-MICROORG-T-608',NULL,'MORGANELLA MORGANII','Any bacterial organism that can be assigned to the species Morganella morganii.','\0','PROTEUS MORGANII','CL-MICROORG','DBX-NCIT-C86015'),('CL-MICROORG-T-609',NULL,'MYCOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Mycobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C76369'),('CL-MICROORG-T-61',NULL,'AGGREGATIBACTER APHROPHILUS','Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus.','\0','BETA-LACTAMASE NEGATIVE HAEMOPHILUS PARAPHROPHILUS; CDC GROUP HB-2; HAEMOPHILUS APHROPHILUS; HAEMOPHILUS PARAPHROPHILUS','CL-MICROORG','DBX-NCIT-C86134'),('CL-MICROORG-T-610',NULL,'MYCOBACTERIUM ABSCESSUS','Any bacterial organism that can be assigned to the species Mycobacterium abscessus.','\0','MYCOBACTERIUM CHELONAE SUBSP. ABSCESSUS','CL-MICROORG','DBX-NCIT-C86533'),('CL-MICROORG-T-611',NULL,'MYCOBACTERIUM AFRICANUM','Any bacterial organism that can be assigned to the species Mycobacterium africanum.','\0','','CL-MICROORG','DBX-NCIT-C85544'),('CL-MICROORG-T-612',NULL,'MYCOBACTERIUM AVIUM','Any bacterial organism that can be assigned to the species Mycobacterium avium.','\0','','CL-MICROORG','DBX-NCIT-C86535'),('CL-MICROORG-T-613',NULL,'MYCOBACTERIUM AVIUM COMPLEX','A non-taxonomic grouping of bacteria assigned to and including at least three related subspecies from the Mycobacterium avium species.','\0','','CL-MICROORG','DBX-NCIT-C76368'),('CL-MICROORG-T-614',NULL,'MYCOBACTERIUM BOVIS','Any bacterial organism that can be assigned to the species Mycobacterium bovis.','\0','','CL-MICROORG','DBX-NCIT-C85545'),('CL-MICROORG-T-615',NULL,'MYCOBACTERIUM BOVIS BCG','An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine.','\0','','CL-MICROORG','DBX-NCIT-C85546'),('CL-MICROORG-T-616',NULL,'MYCOBACTERIUM CANETTII','Any bacterial organism that can be assigned to the species Mycobacterium canettii.','\0','','CL-MICROORG','DBX-NCIT-C85547'),('CL-MICROORG-T-617',NULL,'MYCOBACTERIUM CHELONAE','Any bacterial organism that can be assigned to the species Mycobacterium chelonae.','\0','MYCOBACTERIUM CHELONAE SUBSP. CHELONAE','CL-MICROORG','DBX-NCIT-C86536'),('CL-MICROORG-T-618',NULL,'MYCOBACTERIUM FLAVESCENS','Any bacterial organism that can be assigned to the species Mycobacterium flavescens.','\0','','CL-MICROORG','DBX-NCIT-C86537'),('CL-MICROORG-T-619',NULL,'MYCOBACTERIUM FORTUITUM','Any bacterial organism that can be assigned to the species Mycobacterium fortuitum.','\0','','CL-MICROORG','DBX-NCIT-C86538'),('CL-MICROORG-T-62',NULL,'AGGREGATIBACTER SEGNIS','Any bacterial organism that can be assigned to the species Aggregatibacter segnis.','\0','HAEMOPHILUS SEGNIS','CL-MICROORG','DBX-NCIT-C86135'),('CL-MICROORG-T-620',NULL,'MYCOBACTERIUM FORTUITUM COMPLEX','A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species and subspecies M. chelonei subsp. chelonei, M. chelonei subsp. abscessus, M. fortuitum, and M. peregrinum.','\0','','CL-MICROORG','DBX-NCIT-C86539'),('CL-MICROORG-T-621',NULL,'MYCOBACTERIUM GASTRI','Any bacterial organism that can be assigned to the species Mycobacterium gastri.','\0','','CL-MICROORG','DBX-NCIT-C86540'),('CL-MICROORG-T-622',NULL,'MYCOBACTERIUM GORDONAE','Any bacterial organism that can be assigned to the species Mycobacterium gordonae.','\0','MYCOBACTERIUM AQUAE','CL-MICROORG','DBX-NCIT-C86541'),('CL-MICROORG-T-623',NULL,'MYCOBACTERIUM HAEMOPHILUM','Any bacterial organism that can be assigned to the species Mycobacterium haemophilum.','\0','','CL-MICROORG','DBX-NCIT-C86542'),('CL-MICROORG-T-624',NULL,'MYCOBACTERIUM INTRACELLULARE','Any bacterial organism that can be assigned to the species Mycobacterium intracellulare.','\0','','CL-MICROORG','DBX-NCIT-C91843'),('CL-MICROORG-T-625',NULL,'MYCOBACTERIUM KANSASII','Any bacterial organism that can be assigned to the species Mycobacterium kansasii.','\0','','CL-MICROORG','DBX-NCIT-C85543'),('CL-MICROORG-T-626',NULL,'MYCOBACTERIUM LEPRAE','Any bacterial organism that can be assigned to the species Mycobacterium leprae.','\0','','CL-MICROORG','DBX-NCIT-C86544'),('CL-MICROORG-T-627',NULL,'MYCOBACTERIUM MARINUM','Any bacterial organism that can be assigned to the species Mycobacterium marinum.','\0','MYCOBACTERIUM BALNEI','CL-MICROORG','DBX-NCIT-C86545'),('CL-MICROORG-T-628',NULL,'MYCOBACTERIUM MICROTI','Any bacterial organism that can be assigned to the species Mycobacterium microti.','\0','','CL-MICROORG','DBX-NCIT-C85548'),('CL-MICROORG-T-629',NULL,'MYCOBACTERIUM PEREGRINUM','Any bacterial organism that can be assigned to the species Mycobacterium peregrinum.','\0','','CL-MICROORG','DBX-NCIT-C86546'),('CL-MICROORG-T-63',NULL,'AGROBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Agrobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86011'),('CL-MICROORG-T-630',NULL,'MYCOBACTERIUM SCROFULACEUM','Any bacterial organism that can be assigned to the species Mycobacterium scrofulaceum.','\0','','CL-MICROORG','DBX-NCIT-C86547'),('CL-MICROORG-T-631',NULL,'MYCOBACTERIUM SIMIAE','Any bacterial organism that can be assigned to the species Mycobacterium simiae.','\0','MYCOBACTERIUM HABANA','CL-MICROORG','DBX-NCIT-C86548'),('CL-MICROORG-T-632',NULL,'MYCOBACTERIUM SMEGMATIS','Any bacterial organism that can be assigned to the species Mycobacterium smegmatis.','\0','','CL-MICROORG','DBX-NCIT-C86590'),('CL-MICROORG-T-633',NULL,'MYCOBACTERIUM SZULGAI','Any bacterial organism that can be assigned to the species Mycobacterium szulgai.','\0','','CL-MICROORG','DBX-NCIT-C86591'),('CL-MICROORG-T-634',NULL,'MYCOBACTERIUM TERRAE','Any bacterial organism that can be assigned to the species Mycobacterium terrae.','\0','','CL-MICROORG','DBX-NCIT-C86592'),('CL-MICROORG-T-635',NULL,'MYCOBACTERIUM THERMORESISTIBILE','Any bacterial organism that can be assigned to the species Mycobacterium thermoresistibile.','\0','','CL-MICROORG','DBX-NCIT-C86593'),('CL-MICROORG-T-636',NULL,'MYCOBACTERIUM TUBERCULOSIS','Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis.','\0','','CL-MICROORG','DBX-NCIT-C76370'),('CL-MICROORG-T-637',NULL,'MYCOBACTERIUM TUBERCULOSIS COMPLEX','A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species M. tuberculosis, M. africanum, M. bovis, and M. microti.','\0','','CL-MICROORG','DBX-NCIT-C86594'),('CL-MICROORG-T-638',NULL,'MYCOBACTERIUM ULCERANS','Any bacterial organism that can be assigned to the species Mycobacterium ulcerans.','\0','MYCOBACTERIUM BURULI','CL-MICROORG','DBX-NCIT-C86595'),('CL-MICROORG-T-639',NULL,'MYCOPLASMA','Any bacteria that is not assigned to the species level but can be assigned to the Mycoplasma genus level.','\0','','CL-MICROORG','DBX-NCIT-C73540'),('CL-MICROORG-T-64',NULL,'AGROBACTERIUM RADIOBACTER','Any bacterial organism that can be assigned to the species Agrobacterium radiobacter.','\0','','CL-MICROORG','DBX-NCIT-C86137'),('CL-MICROORG-T-640',NULL,'MYCOPLASMA HOMINIS','Any bacterial organism that can be assigned to the species Mycoplasma hominis.','\0','','CL-MICROORG','DBX-NCIT-C86597'),('CL-MICROORG-T-641',NULL,'MYCOPLASMA ORALE','Any bacterial organism that can be assigned to the species Mycoplasma orale.','\0','','CL-MICROORG','DBX-NCIT-C86598'),('CL-MICROORG-T-642',NULL,'MYCOPLASMA PNEUMONIAE','Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae.','\0','','CL-MICROORG','DBX-NCIT-C86599'),('CL-MICROORG-T-643',NULL,'MYROIDES','Any bacteria that is not assigned to the species level but can be assigned to the Myroides genus level.','\0','','CL-MICROORG','DBX-NCIT-C86953'),('CL-MICROORG-T-644',NULL,'MYROIDES ODORATUS','Any bacterial organism that can be assigned to the species Myroides odoratus.','\0','FLAVOBACTERIUM ODORATUM','CL-MICROORG','DBX-NCIT-C86954'),('CL-MICROORG-T-645',NULL,'NAIROVIRUS','Any viral organism that can be assigned to the genus Nairovirus.','\0','','CL-MICROORG','DBX-NCIT-C112358'),('CL-MICROORG-T-646',NULL,'NEISSERIA','Any bacteria that is not assigned to the species level but can be assigned to the Neisseria genus level.','\0','','CL-MICROORG','DBX-NCIT-C76371'),('CL-MICROORG-T-647',NULL,'NEISSERIA CANIS','Any bacterial organism that can be assigned to the species Neisseria canis.','\0','','CL-MICROORG','DBX-NCIT-C86600'),('CL-MICROORG-T-648',NULL,'NEISSERIA CINEREA','Any bacterial organism that can be assigned to the species Neisseria cinerea.','\0','MICROCOCCUS CINEREUS','CL-MICROORG','DBX-NCIT-C86601'),('CL-MICROORG-T-649',NULL,'NEISSERIA FLAVESCENS','Any bacterial organism that can be assigned to the species Neisseria flavescens.','\0','','CL-MICROORG','DBX-NCIT-C86602'),('CL-MICROORG-T-65',NULL,'AGROBACTERIUM TUMEFACIENS','Any bacterial organism that can be assigned to the species Agrobacterium tumefaciens.','\0','CDC GROUP VD-3; RHIZOBIUM RADIOBACTER','CL-MICROORG','DBX-NCIT-C86138'),('CL-MICROORG-T-650',NULL,'NEISSERIA GONORRHOEAE','Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae.','\0','','CL-MICROORG','DBX-NCIT-C86603'),('CL-MICROORG-T-651',NULL,'NEISSERIA LACTAMICA','Any bacterial organism that can be assigned to the species Neisseria lactamica.','\0','','CL-MICROORG','DBX-NCIT-C86604'),('CL-MICROORG-T-652',NULL,'NEISSERIA MENINGITIDIS','Any bacterial organism that can be assigned to the species Neisseria meningitidis.','\0','BETA-LACTAMASE NEGATIVE NEISSERIA MENINGITIDIS','CL-MICROORG','DBX-NCIT-C86605'),('CL-MICROORG-T-653',NULL,'NEISSERIA MUCOSA','Any bacterial organism that can be assigned to the species Neisseria mucosa.','\0','','CL-MICROORG','DBX-NCIT-C86606'),('CL-MICROORG-T-654',NULL,'NEISSERIA POLYSACCHAREA','Any bacterial organism that can be assigned to the species Neisseria polysaccharea.','\0','','CL-MICROORG','DBX-NCIT-C86607'),('CL-MICROORG-T-655',NULL,'NEISSERIA SICCA','Any bacterial organism that can be assigned to the species Neisseria sicca.','\0','','CL-MICROORG','DBX-NCIT-C86608'),('CL-MICROORG-T-656',NULL,'NEISSERIA SUBFLAVA','Any bacterial organism that can be assigned to the species Neisseria subflava.','\0','','CL-MICROORG','DBX-NCIT-C86609'),('CL-MICROORG-T-657',NULL,'NEISSERIA WEAVERII','Any bacterial organism that can be assigned to the species Neisseria weaverii.','\0','CDC GROUP M-5','CL-MICROORG','DBX-NCIT-C86610'),('CL-MICROORG-T-658',NULL,'NEWCASTLE DISEASE VIRUS','Any viral organism that can be assigned to the species Newcastle disease virus.','\0','Avian Paramyxovirus Type 1; NDV','CL-MICROORG','DBX-NCIT-C93023'),('CL-MICROORG-T-659',NULL,'NIPAH VIRUS','Any viral organism that can be assigned to the species Nipah virus.','\0','NiV','CL-MICROORG','DBX-NCIT-C112359'),('CL-MICROORG-T-66',NULL,'ALCALIGENES','Any bacteria that is not assigned to the species level but can be assigned to the Alcaligenes genus level.','\0','','CL-MICROORG','DBX-NCIT-C86012'),('CL-MICROORG-T-660',NULL,'NOCARDIA','Any bacteria that is not assigned to the species level but can be assigned to the Nocardia genus level.','\0','','CL-MICROORG','DBX-NCIT-C76372'),('CL-MICROORG-T-661',NULL,'NOCARDIA ASTEROIDES','Any bacterial organism that can be assigned to the species Nocardia asteroides.','\0','','CL-MICROORG','DBX-NCIT-C86611'),('CL-MICROORG-T-662',NULL,'NOCARDIA ASTEROIDES COMPLEX','A non-taxonomic grouping of bacteria assigned to and including at least four related species from the Nocardia genus.','\0','','CL-MICROORG','DBX-NCIT-C86612'),('CL-MICROORG-T-663',NULL,'NOCARDIA BRASILIENSIS','Any bacterial organism that can be assigned to the species Nocardia brasiliensis.','\0','','CL-MICROORG','DBX-NCIT-C86613'),('CL-MICROORG-T-664',NULL,'NOCARDIA DASSONVILLEI','Any bacterial organism that can be assigned to the species Nocardia dassonvillei.','\0','','CL-MICROORG','DBX-NCIT-C86614'),('CL-MICROORG-T-665',NULL,'NOCARDIA FARCINICA','Any bacterial organism that can be assigned to the species Nocardia farcinica.','\0','','CL-MICROORG','DBX-NCIT-C86615'),('CL-MICROORG-T-666',NULL,'NOCARDIA NOVA','Any bacterial organism that can be assigned to the species Nocardia nova.','\0','','CL-MICROORG','DBX-NCIT-C86616'),('CL-MICROORG-T-667',NULL,'NOCARDIA OTITIDISCAVIARUM','Any bacterial organism that can be assigned to the species Nocardia otitidiscaviarum.','\0','NOCARDIA CAVIAE','CL-MICROORG','DBX-NCIT-C86617'),('CL-MICROORG-T-668',NULL,'NON-FERMENTATIVE GRAM-NEGATIVE BACILLUS','Any rod-shaped, anaerobic bacteria that cannot convert carbohydrates into acids and alcohols and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','NON-FERMENTATIVE GRAM-NEGATIVE ROD','CL-MICROORG','DBX-NCIT-C86618'),('CL-MICROORG-T-669',NULL,'NOROVIRUS','Any viral organism that can be assigned to the genus Norovirus.','\0','NoV; Norwalk-like virus','CL-MICROORG','DBX-NCIT-C112362'),('CL-MICROORG-T-67',NULL,'ALCALIGENES FAECALIS','Any bacterial organism that can be assigned to the species Alcaligenes faecalis.','\0','ALCALIGENES ODORANS','CL-MICROORG','DBX-NCIT-C86140'),('CL-MICROORG-T-670',NULL,'NORWALK VIRUS','Any viral organism that can be assigned to the species Norwalk virus.','\0','NV; Norwalk calicivirus','CL-MICROORG','DBX-NCIT-C112363'),('CL-MICROORG-T-671',NULL,'OCHROBACTRUM','Any bacteria that is not assigned to the species level but can be assigned to the Ochrobactrum genus level.','\0','','CL-MICROORG','DBX-NCIT-C86619'),('CL-MICROORG-T-672',NULL,'OCHROBACTRUM ANTHROPI','Any bacterial organism that can be assigned to the species Ochrobactrum anthropi.','\0','ACHROMOBACTER SUBSP. BIOTYPE 1','CL-MICROORG','DBX-NCIT-C86620'),('CL-MICROORG-T-673',NULL,'OCHROBACTRUM INTERMEDIUM','Any bacterial organism that can be assigned to the species Ochrobactrum intermedium.','\0','','CL-MICROORG','DBX-NCIT-C86621'),('CL-MICROORG-T-674',NULL,'ODORIBACTER SPLANCHNICUS','Any bacterial organism that can be assigned to the species Odoribacter splanchnicus.','\0','BACTEROIDES SPLANCHNICUS','CL-MICROORG','DBX-NCIT-C86176'),('CL-MICROORG-T-675',NULL,'OERSKOVIA','Any bacteria that is not assigned to the species level but can be assigned to the Oerskovia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86622'),('CL-MICROORG-T-676',NULL,'OERSKOVIA TURBATA','Any bacterial organism that can be assigned to the species Oerskovia turbata.','\0','','CL-MICROORG','DBX-NCIT-C86623'),('CL-MICROORG-T-677',NULL,'OLIGELLA','Any bacteria that is not assigned to the species level but can be assigned to the Oligella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86624'),('CL-MICROORG-T-678',NULL,'OLIGELLA UREOLYTICA','Any bacterial organism that can be assigned to the species Oligella ureolytica.','\0','CDC GROUP IVE','CL-MICROORG','DBX-NCIT-C86625'),('CL-MICROORG-T-679',NULL,'OLIGELLA URETHRALIS','Any bacterial organism that can be assigned to the species Oligella urethralis.','\0','CDC GROUP M-4','CL-MICROORG','DBX-NCIT-C86626'),('CL-MICROORG-T-68',NULL,'ALISTIPES PUTREDINIS','Any bacterial organism that can be assigned to the species Alistipes putredinis.','\0','BACTEROIDES PUTREDINIS','CL-MICROORG','DBX-NCIT-C86871'),('CL-MICROORG-T-680',NULL,'OLSENELLA','Any bacteria that is not assigned to the species level but can be assigned to the Olsenella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86627'),('CL-MICROORG-T-681',NULL,'OLSENELLA ULI','Any bacterial organism that can be assigned to the species Olsenella uli.','\0','LACTOBACILLUS ULI','CL-MICROORG','DBX-NCIT-C86628'),('CL-MICROORG-T-682',NULL,'ORBIVIRUS','Any viral organism that can be assigned to the genus Orbivirus.','\0','','CL-MICROORG','DBX-NCIT-C112365'),('CL-MICROORG-T-683',NULL,'ORTHOBUNYAVIRUS','Any viral organism that can be assigned to the genus Orthobunyavirus.','\0','Bunyavirus','CL-MICROORG','DBX-NCIT-C112366'),('CL-MICROORG-T-684',NULL,'ORTHOPOXVIRUS','Any viral organism that can be assigned to the genus Orthopoxvirus.','\0','','CL-MICROORG','DBX-NCIT-C96524'),('CL-MICROORG-T-685',NULL,'PANDORAEA','Any bacteria that is not assigned to the species level but can be assigned to the Pandoraea genus level.','\0','','CL-MICROORG','DBX-NCIT-C86629'),('CL-MICROORG-T-686',NULL,'PANDORAEA PNOMENUSA','Any bacterial organism that can be assigned to the species Pandoraea pnomenusa.','\0','','CL-MICROORG','DBX-NCIT-C86630'),('CL-MICROORG-T-687',NULL,'PANTOEA','Any bacteria that is not assigned to the species level but can be assigned to the Pantoea genus level.','\0','','CL-MICROORG','DBX-NCIT-C86631'),('CL-MICROORG-T-688',NULL,'PANTOEA AGGLOMERANS','Any bacterial organism that can be assigned to the species Pantoea agglomerans.','\0','ENTEROBACTER AGGLOMERANS','CL-MICROORG','DBX-NCIT-C86632'),('CL-MICROORG-T-689',NULL,'PARABACTEROIDES','Any bacteria that is not assigned to the species level but can be assigned to the Parabacteroides genus level.','\0','','CL-MICROORG','DBX-NCIT-C86633'),('CL-MICROORG-T-69',NULL,'ALISTIPES SHAHII','Any bacterial organism that can be assigned to the species Alistipes shahii.','\0','','CL-MICROORG','DBX-NCIT-C114246'),('CL-MICROORG-T-690',NULL,'PARABACTEROIDES DISTASONIS','Any bacterial organism that can be assigned to the species Parabacteroides distasonis.','\0','BACTEROIDES DISTASONIS','CL-MICROORG','DBX-NCIT-C86634'),('CL-MICROORG-T-691',NULL,'PARABACTEROIDES MERDAE','Any bacterial organism that can be assigned to the species Parabacteroides merdae.','\0','BACTEROIDES FRAGILIS T4-1; BACTEROIDES MERDAE','CL-MICROORG','DBX-NCIT-C86635'),('CL-MICROORG-T-692',NULL,'PARAPOXVIRUS','Any viral organism that can be assigned to the genus Parapoxvirus.','\0','','CL-MICROORG','DBX-NCIT-C112367'),('CL-MICROORG-T-693',NULL,'PARVIMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Parvimonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86900'),('CL-MICROORG-T-694',NULL,'PARVIMONAS MICRA','Any bacterial organism that can be assigned to the species Parvimonas micra.','\0','MICROMONAS MICROS; PEPTOSTREPTOCOCCUS MICROS','CL-MICROORG','DBX-NCIT-C86901'),('CL-MICROORG-T-695',NULL,'PASTEURELLA','Any bacteria that is not assigned to the species level but can be assigned to the Pasteurella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86636'),('CL-MICROORG-T-696',NULL,'PASTEURELLA AEROGENES','Any bacterial organism that can be assigned to the species Pasteurella aerogenes.','\0','','CL-MICROORG','DBX-NCIT-C86637'),('CL-MICROORG-T-697',NULL,'PASTEURELLA BETTYAE','Any bacterial organism that can be assigned to the species Pasteurella bettyae.','\0','CDC GROUP HB-5','CL-MICROORG','DBX-NCIT-C86638'),('CL-MICROORG-T-698',NULL,'PASTEURELLA CANIS','Any bacterial organism that can be assigned to the species Pasteurella canis.','\0','PASTEURELLA MULTOCIDA BIOTYPE 6','CL-MICROORG','DBX-NCIT-C86639'),('CL-MICROORG-T-699',NULL,'PASTEURELLA MULTOCIDA','Any bacterial organism that can be assigned to the species Pasteurella multocida.','\0','PASTEURELLA SEPTICA','CL-MICROORG','DBX-NCIT-C76373'),('CL-MICROORG-T-7',NULL,'ACIDAMINOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Acidaminococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86083'),('CL-MICROORG-T-70',NULL,'ALPHAVIRUS','Any viral organism that can be assigned to the genus Alphavirus.','\0','Arboviruses Group A','CL-MICROORG','DBX-NCIT-C112030'),('CL-MICROORG-T-700',NULL,'PASTEURELLA PNEUMOTROPICA','Any bacterial organism that can be assigned to the species Pasteurella pneumotropica.','\0','','CL-MICROORG','DBX-NCIT-C86640'),('CL-MICROORG-T-701',NULL,'PEDIOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Pediococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86641'),('CL-MICROORG-T-702',NULL,'PEPTOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Peptococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86642'),('CL-MICROORG-T-703',NULL,'PEPTOCOCCUS NIGER','Any bacterial organism that can be assigned to the species Peptococcus niger.','\0','MICROCOCCUS NIGER','CL-MICROORG','DBX-NCIT-C86643'),('CL-MICROORG-T-704',NULL,'PEPTONIPHILUS','Any bacteria that is not assigned to the species level but can be assigned to the Peptoniphilus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86902'),('CL-MICROORG-T-705',NULL,'PEPTONIPHILUS ASACCHAROLYTICUS','Any bacterial organism that can be assigned to the species Peptoniphilus asaccharolyticus.','\0','PEPTOCOCCUS ASACCHAROLYTICUS; PEPTOSTREPTOCOCCUS ASACCHAROLYTICUS','CL-MICROORG','DBX-NCIT-C86903'),('CL-MICROORG-T-706',NULL,'PEPTONIPHILUS HAREI','Any bacterial organism that can be assigned to the species Peptoniphilus harei.','\0','Peptostreptococcus harei; Schleiferella harei','CL-MICROORG','DBX-NCIT-C114245'),('CL-MICROORG-T-707',NULL,'PEPTONIPHILUS INDOLICUS','Any bacterial organism that can be assigned to the species Peptoniphilus indolicus.','\0','PEPTOSTREPTOCOCCUS INDOLICUS','CL-MICROORG','DBX-NCIT-C86904'),('CL-MICROORG-T-708',NULL,'PEPTOSTREPTOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Peptostreptococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86644'),('CL-MICROORG-T-709',NULL,'PEPTOSTREPTOCOCCUS ANAEROBIUS','Any bacterial organism that can be assigned to the species Peptostreptococcus anaerobius.','\0','','CL-MICROORG','DBX-NCIT-C86645'),('CL-MICROORG-T-71',NULL,'ANAEROBIC GRAM-NEGATIVE BACILLUS','Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','ANAEROBIC GRAM-NEGATIVE ROD','CL-MICROORG','DBX-NCIT-C86142'),('CL-MICROORG-T-710',NULL,'PHLEBOVIRUS','Any viral organism that can be assigned to the genus Phlebovirus.','\0','','CL-MICROORG','DBX-NCIT-C112397'),('CL-MICROORG-T-711',NULL,'PHOTOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Photobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86646'),('CL-MICROORG-T-712',NULL,'PHOTOBACTERIUM DAMSELAE','Any bacterial organism that can be assigned to the species Photobacterium damselae.','\0','CDC GROUP EF-5; PHOTOBACTERIUM DAMSELAE SUBSP. DAMSELAE; VIBRIO DAMSELA','CL-MICROORG','DBX-NCIT-C86647'),('CL-MICROORG-T-713',NULL,'PHOTORHABDUS','Any bacteria that is not assigned to the species level but can be assigned to the Photorhabdus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86648'),('CL-MICROORG-T-714',NULL,'PHOTORHABDUS LUMINESCENS','Any bacterial organism that can be assigned to the species Photorhabdus luminescens.','\0','','CL-MICROORG','DBX-NCIT-C86649'),('CL-MICROORG-T-715',NULL,'PICHIA KLUYVERI','Any fungal organism that can be assigned to the species Pichia kluyveri.','\0','P. kluyveri','CL-MICROORG','DBX-NCIT-C114270'),('CL-MICROORG-T-716',NULL,'PICHIA KUDRIAVZEVII','Any fungal organism that can be assigned to the species Pichia kudriavzevii.','\0','C. krusei; Candida krusei; I. orientalis; Issatchenkia orientalis; P. kudriavzevii','CL-MICROORG','DBX-NCIT-C77173'),('CL-MICROORG-T-717',NULL,'PICHIA NORVEGENSIS','Any fungal organism that can be assigned to the species Pichia norvegensis.','\0','C. mycoderma var. annulata; Candida mycoderma var. annulata; P. norvegensis','CL-MICROORG','DBX-NCIT-C114259'),('CL-MICROORG-T-718',NULL,'PLANOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Planococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86650'),('CL-MICROORG-T-719',NULL,'PLESIOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Plesiomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86651'),('CL-MICROORG-T-72',NULL,'ANAEROBIC GRAM-NEGATIVE COCCUS','Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86143'),('CL-MICROORG-T-720',NULL,'PLESIOMONAS SHIGELLOIDES','Any bacterial organism that can be assigned to the species Plesiomonas shigelloides.','\0','AEROMONAS SHIGELLOIDES','CL-MICROORG','DBX-NCIT-C86652'),('CL-MICROORG-T-721',NULL,'PNEUMOVIRUS','Any viral organism that can be assigned to the genus Pneumovirus.','\0','','CL-MICROORG','DBX-NCIT-C112398'),('CL-MICROORG-T-722',NULL,'POLIOVIRUS','Any viral organism that can be assigned to the species Poliovirus.','\0','Enterovirus C; Human enterovirus C','CL-MICROORG','DBX-NCIT-C14259'),('CL-MICROORG-T-723',NULL,'POLYOMAVIRUS','Any viral organism that can be assigned to the genus Polyomavirus.','\0','','CL-MICROORG','DBX-NCIT-C14260'),('CL-MICROORG-T-724',NULL,'PORPHYROMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Porphyromonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86653'),('CL-MICROORG-T-725',NULL,'PORPHYROMONAS ASACCHAROLYTICA','Any bacterial organism that can be assigned to the species Porphyromonas asaccharolytica.','\0','BACTEROIDES ASACCHAROLYTICUS','CL-MICROORG','DBX-NCIT-C86654'),('CL-MICROORG-T-726',NULL,'PORPHYROMONAS CATONIAE','Any bacterial organism that can be assigned to the species Porphyromonas catoniae.','\0','','CL-MICROORG','DBX-NCIT-C86655'),('CL-MICROORG-T-727',NULL,'PORPHYROMONAS ENDODONTALIS','Any bacterial organism that can be assigned to the species Porphyromonas endodontalis.','\0','BACTEROIDES ENDODONTALIS','CL-MICROORG','DBX-NCIT-C86656'),('CL-MICROORG-T-728',NULL,'PORPHYROMONAS GINGIVALIS','Any bacterial organism that can be assigned to the species Porphyromonas gingivalis.','\0','BACTEROIDES GINGIVALIS','CL-MICROORG','DBX-NCIT-C86657'),('CL-MICROORG-T-729',NULL,'PORPHYROMONAS LEVII','Any bacterial organism that can be assigned to the species Porphyromonas levii.','\0','BACTEROIDES LEVII; BACTEROIDES MELANINOGENICUS SUBSP. LEVII','CL-MICROORG','DBX-NCIT-C86658'),('CL-MICROORG-T-73',NULL,'ANAEROBIC GRAM-POSITIVE BACILLUS','Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','ANAEROBIC GRAM-POSITIVE ROD','CL-MICROORG','DBX-NCIT-C86144'),('CL-MICROORG-T-730',NULL,'PORPHYROMONAS SOMERAE','Any bacterial organism that can be assigned to the species Porphyromonas somerae.','\0','','CL-MICROORG','DBX-NCIT-C86659'),('CL-MICROORG-T-731',NULL,'PREVOTELLA','Any bacteria that is not assigned to the species level but can be assigned to the Prevotella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86660'),('CL-MICROORG-T-732',NULL,'PREVOTELLA BIVIA','Any bacterial organism that can be assigned to the species Prevotella bivia.','\0','BACTEROIDES BIVIA','CL-MICROORG','DBX-NCIT-C86661'),('CL-MICROORG-T-733',NULL,'PREVOTELLA BREVIS','Any bacterial organism that can be assigned to the species Prevotella brevis.','\0','BACTEROIDES RUMINICOLA SUBSP. BREVIS; BACTEROIDES RUMINICOLA SUBSP. BREVUS','CL-MICROORG','DBX-NCIT-C86662'),('CL-MICROORG-T-734',NULL,'PREVOTELLA BUCCAE','Any bacterial organism that can be assigned to the species Prevotella buccae.','\0','BACTEROIDES BUCCAE','CL-MICROORG','DBX-NCIT-C86663'),('CL-MICROORG-T-735',NULL,'PREVOTELLA BUCCALIS','Any bacterial organism that can be assigned to the species Prevotella buccalis.','\0','','CL-MICROORG','DBX-NCIT-C86664'),('CL-MICROORG-T-736',NULL,'PREVOTELLA CORPORIS','Any bacterial organism that can be assigned to the species Prevotella corporis.','\0','','CL-MICROORG','DBX-NCIT-C86665'),('CL-MICROORG-T-737',NULL,'PREVOTELLA DENTALIS','Any bacterial organism that can be assigned to the species Prevotella dentalis.','\0','','CL-MICROORG','DBX-NCIT-C86666'),('CL-MICROORG-T-738',NULL,'PREVOTELLA DENTICOLA','Any bacterial organism that can be assigned to the species Prevotella denticola.','\0','BACTEROIDES DENTICOLA','CL-MICROORG','DBX-NCIT-C86667'),('CL-MICROORG-T-739',NULL,'PREVOTELLA DISIENS','Any bacterial organism that can be assigned to the species Prevotella disiens.','\0','BACTEROIDES DISIENS','CL-MICROORG','DBX-NCIT-C86668'),('CL-MICROORG-T-74',NULL,'ANAEROBIC GRAM-POSITIVE COCCUS','Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.','\0','','CL-MICROORG','DBX-NCIT-C86145'),('CL-MICROORG-T-740',NULL,'PREVOTELLA HEPARINOLYTICA','Any bacterial organism that can be assigned to the species Prevotella heparinolytica.','\0','BACTEROIDES HEPARINOLYTICUS','CL-MICROORG','DBX-NCIT-C86669'),('CL-MICROORG-T-741',NULL,'PREVOTELLA INTERMEDIA','Any bacterial organism that can be assigned to the species Prevotella intermedia.','\0','BACTEROIDES INTERMEDIA','CL-MICROORG','DBX-NCIT-C86670'),('CL-MICROORG-T-742',NULL,'PREVOTELLA INTERMEDIA/NIGRESCENS GROUP','A non-taxonomic grouping of bacteria assigned to the Prevotella genus that include the P. intermedia and P. nigrescens species.','\0','','CL-MICROORG','DBX-NCIT-C86671'),('CL-MICROORG-T-743',NULL,'PREVOTELLA LOESCHEII','Any bacterial organism that can be assigned to the species Prevotella loescheii.','\0','','CL-MICROORG','DBX-NCIT-C86672'),('CL-MICROORG-T-744',NULL,'PREVOTELLA MELANINOGENICA','Any bacterial organism that can be assigned to the species Prevotella melaninogenica.','\0','BACTEROIDES MELANINOGENICUS','CL-MICROORG','DBX-NCIT-C86673'),('CL-MICROORG-T-745',NULL,'PREVOTELLA NIGRESCENS','Any bacterial organism that can be assigned to the species Prevotella nigrescens.','\0','','CL-MICROORG','DBX-NCIT-C86674'),('CL-MICROORG-T-746',NULL,'PREVOTELLA ORALIS','Any bacterial organism that can be assigned to the species Prevotella oralis.','\0','BACTEROIDES ORALIS','CL-MICROORG','DBX-NCIT-C86675'),('CL-MICROORG-T-747',NULL,'PREVOTELLA ORIS','Any bacterial organism that can be assigned to the species Prevotella oris.','\0','BACTEROIDES ORIS','CL-MICROORG','DBX-NCIT-C86676'),('CL-MICROORG-T-748',NULL,'PREVOTELLA RUMINICOLA','Any bacterial organism that can be assigned to the species Prevotella ruminicola.','\0','BACTEROIDES RUMINICOLA','CL-MICROORG','DBX-NCIT-C86677'),('CL-MICROORG-T-749',NULL,'PREVOTELLA TANNERAE','Any bacterial organism that can be assigned to the species Prevotella tannerae.','\0','','CL-MICROORG','DBX-NCIT-C86678'),('CL-MICROORG-T-75',NULL,'ANAEROBIC STREPTOCOCCUS','Any bacteria assigned to the genus Streptococcus that does not require oxygen to grow or respirate.','\0','','CL-MICROORG','DBX-NCIT-C86146'),('CL-MICROORG-T-750',NULL,'PREVOTELLA VERORALIS','Any bacterial organism that can be assigned to the species Prevotella veroralis.','\0','','CL-MICROORG','DBX-NCIT-C86679'),('CL-MICROORG-T-751',NULL,'PROPIONIBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Propionibacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86013'),('CL-MICROORG-T-752',NULL,'PROPIONIBACTERIUM ACNES','Any bacterial organism that can be assigned to the species Propionibacterium acnes.','\0','BACILLUS ACNES; C. PARVUM; CORYNEBACTERIUM ACNES; CORYNEBACTERIUM PARVUM; CPARV','CL-MICROORG','DBX-NCIT-C14378'),('CL-MICROORG-T-753',NULL,'PROPIONIBACTERIUM AVIDUM','Any bacterial organism that can be assigned to the species Propionibacterium avidum.','\0','','CL-MICROORG','DBX-NCIT-C86681'),('CL-MICROORG-T-754',NULL,'PROPIONIBACTERIUM GRANULOSUM','Any bacterial organism that can be assigned to the species Propionibacterium granulosum.','\0','CORYNEBACTERIUM GRANULOSUM','CL-MICROORG','DBX-NCIT-C86682'),('CL-MICROORG-T-755',NULL,'PROPIONIBACTERIUM PROPIONICUM','Any bacterial organism that can be assigned to the species Propionibacterium propionicum.','\0','ACTINOMYCES PROPIONICUS','CL-MICROORG','DBX-NCIT-C86683'),('CL-MICROORG-T-756',NULL,'PROTEUS','Any bacteria that is not assigned to the species level but can be assigned to the Proteus genus level.','\0','','CL-MICROORG','DBX-NCIT-C76374'),('CL-MICROORG-T-757',NULL,'PROTEUS HAUSERI','Any bacterial organism that can be assigned to the species Proteus hauseri.','\0','','CL-MICROORG','DBX-NCIT-C86684'),('CL-MICROORG-T-758',NULL,'PROTEUS INCONSTANS','Any bacterial organism that can be assigned to the species Proteus inconstans.','\0','PROVIDENCIA INCONSTANS','CL-MICROORG','DBX-NCIT-C84582'),('CL-MICROORG-T-759',NULL,'PROTEUS MIRABILIS','Any bacterial organism that can be assigned to the species Proteus mirabilis.','\0','','CL-MICROORG','DBX-NCIT-C86019'),('CL-MICROORG-T-76',NULL,'ANAEROCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Anaerococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86872'),('CL-MICROORG-T-760',NULL,'PROTEUS MYXOFACIENS','Any bacterial organism that can be assigned to the species Proteus myxofaciens.','\0','','CL-MICROORG','DBX-NCIT-C86687'),('CL-MICROORG-T-761',NULL,'PROTEUS PENNERI','Any bacterial organism that can be assigned to the species Proteus penneri.','\0','INDOLE NEGATIVE PROTEUS VULGARIS','CL-MICROORG','DBX-NCIT-C86688'),('CL-MICROORG-T-762',NULL,'PROTEUS VULGARIS','Any bacterial organism that can be assigned to the species Proteus vulgaris.','\0','','CL-MICROORG','DBX-NCIT-C85250'),('CL-MICROORG-T-763',NULL,'PROTOTHECA WICKERHAMII','Any algal organism that can be assigned to the species Prototheca wickerhamii.','\0','P. wickerhamii','CL-MICROORG','DBX-NCIT-C114271'),('CL-MICROORG-T-764',NULL,'PROVIDENCIA','Any bacteria that is not assigned to the species level but can be assigned to the Providencia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86690'),('CL-MICROORG-T-765',NULL,'PROVIDENCIA ALCALIFACIENS','Any bacterial organism that can be assigned to the species Providencia alcalifaciens.','\0','','CL-MICROORG','DBX-NCIT-C86691'),('CL-MICROORG-T-766',NULL,'PROVIDENCIA HEIMBACHAE','Any bacterial organism that can be assigned to the species Providencia heimbachae.','\0','','CL-MICROORG','DBX-NCIT-C86692'),('CL-MICROORG-T-767',NULL,'PROVIDENCIA RETTGERI','Any bacterial organism that can be assigned to the species Providencia rettgeri.','\0','','CL-MICROORG','DBX-NCIT-C86693'),('CL-MICROORG-T-768',NULL,'PROVIDENCIA RUSTIGIANII','Any bacterial organism that can be assigned to the species Providencia rustigianii.','\0','PROVIDENCIA ALCALIFACIENS BIOGROUP 3','CL-MICROORG','DBX-NCIT-C86694'),('CL-MICROORG-T-769',NULL,'PROVIDENCIA STUARTII','Any bacterial organism that can be assigned to the species Providencia stuartii.','\0','','CL-MICROORG','DBX-NCIT-C86695'),('CL-MICROORG-T-77',NULL,'ANAEROCOCCUS HYDROGENALIS','Any bacterial organism that can be assigned to the species Anaerococcus hydrogenalis.','\0','PEPTOSTREPTOCOCCUS HYDROGENALIS','CL-MICROORG','DBX-NCIT-C86874'),('CL-MICROORG-T-770',NULL,'PSEUDOCOWPOX VIRUS','Any viral organism that can be assigned to the species Pseudocowpox virus.','\0','Paravaccinia virus; Pseudocowpoxvirus','CL-MICROORG','DBX-NCIT-C112401'),('CL-MICROORG-T-771',NULL,'PSEUDOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Pseudomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C76375'),('CL-MICROORG-T-772',NULL,'PSEUDOMONAS AERUGINOSA','Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa.','\0','','CL-MICROORG','DBX-NCIT-C86696'),('CL-MICROORG-T-773',NULL,'PSEUDOMONAS ALCALIGENES','Any bacterial organism that can be assigned to the species Pseudomonas alcaligenes.','\0','','CL-MICROORG','DBX-NCIT-C86697'),('CL-MICROORG-T-774',NULL,'PSEUDOMONAS CHLORORAPHIS','Any bacterial organism that can be assigned to the species Pseudomonas chlororaphis.','\0','','CL-MICROORG','DBX-NCIT-C86699'),('CL-MICROORG-T-775',NULL,'PSEUDOMONAS FLUORESCENS/PUTIDA GROUP','A non-taxonomic grouping of bacteria assigned to the Pseudomonas genus that include the P. fluorescens and P. putida species.','\0','','CL-MICROORG','DBX-NCIT-C86962'),('CL-MICROORG-T-776',NULL,'PSEUDOMONAS LUTEOLA','Any bacterial organism that can be assigned to the species Pseudomonas luteola.','\0','CHRYSEOMONAS LUTEOLA','CL-MICROORG','DBX-NCIT-C86701'),('CL-MICROORG-T-777',NULL,'PSEUDOMONAS MENDOCINA','Any bacterial organism that can be assigned to the species Pseudomonas mendocina.','\0','CDC GROUP VB-2','CL-MICROORG','DBX-NCIT-C86702'),('CL-MICROORG-T-778',NULL,'PSEUDOMONAS MOSSELII','Any bacterial organism that can be assigned to the species Pseudomonas mosselii.','\0','','CL-MICROORG','DBX-NCIT-C86703'),('CL-MICROORG-T-779',NULL,'PSEUDOMONAS ORYZIHABITANS','Any bacterial organism that can be assigned to the species Pseudomonas oryzihabitans.','\0','FLAVIMONAS ORYZIHABITANS','CL-MICROORG','DBX-NCIT-C76319'),('CL-MICROORG-T-78',NULL,'ANAEROCOCCUS PREVOTII','Any bacterial organism that can be assigned to the species Anaerococcus prevotii.','\0','','CL-MICROORG','DBX-NCIT-C86875'),('CL-MICROORG-T-780',NULL,'PSEUDOMONAS PSEUDOALCALIGENES','Any bacterial organism that can be assigned to the species Pseudomonas pseudoalcaligenes.','\0','PSEUDOMONAS ALCALIGENES BIOTYPE B','CL-MICROORG','DBX-NCIT-C86704'),('CL-MICROORG-T-781',NULL,'PSEUDOMONAS PUTIDA','Any bacterial organism that can be assigned to the species Pseudomonas putida.','\0','','CL-MICROORG','DBX-NCIT-C86705'),('CL-MICROORG-T-782',NULL,'PSEUDOMONAS STUTZERI','Any bacterial organism that can be assigned to the species Pseudomonas stutzeri.','\0','PSEUDOMONAS GROUP VB-1','CL-MICROORG','DBX-NCIT-C86706'),('CL-MICROORG-T-783',NULL,'PSYCHROBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Psychrobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86707'),('CL-MICROORG-T-784',NULL,'PSYCHROBACTER IMMOBILIS','Any bacterial organism that can be assigned to the species Psychrobacter immobilis.','\0','','CL-MICROORG','DBX-NCIT-C86708'),('CL-MICROORG-T-785',NULL,'PSYCHROBACTER PHENYLPYRUVICUS','Any bacterial organism that can be assigned to the species Psychrobacter phenylpyruvicus.','\0','CDC GROUP M-2; MORAXELLA PHENYLPYRUVICA','CL-MICROORG','DBX-NCIT-C86709'),('CL-MICROORG-T-786',NULL,'RABIES VIRUS','Any viral organism that can be assigned to the species Rabies virus.','\0','','CL-MICROORG','DBX-NCIT-C112405'),('CL-MICROORG-T-787',NULL,'RAHNELLA','Any bacteria that is not assigned to the species level but can be assigned to the Rahnella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86710'),('CL-MICROORG-T-788',NULL,'RAHNELLA AQUATILIS','Any bacterial organism that can be assigned to the species Rahnella aquatilis.','\0','','CL-MICROORG','DBX-NCIT-C86711'),('CL-MICROORG-T-789',NULL,'RALSTONIA','Any bacteria that is not assigned to the species level but can be assigned to the Ralstonia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86712'),('CL-MICROORG-T-79',NULL,'ANAEROCOCCUS TETRADIUS','Any bacterial organism that can be assigned to the species Anaerococcus tetradius.','\0','GAFFKYA ANAEROBIA; PEPTOSTREPTOTOCCUS TETRADIUS','CL-MICROORG','DBX-NCIT-C86876'),('CL-MICROORG-T-790',NULL,'RALSTONIA MANNITOLILYTICA','Any bacterial organism that can be assigned to the species Ralstonia mannitolilytica.','\0','','CL-MICROORG','DBX-NCIT-C111302'),('CL-MICROORG-T-791',NULL,'RALSTONIA PICKETTII','Any bacterial organism that can be assigned to the species Ralstonia pickettii.','\0','BURKHOLDERIA PICKETTII; PSEUDOMONAS PICKETTII','CL-MICROORG','DBX-NCIT-C86713'),('CL-MICROORG-T-792',NULL,'RAOULTELLA','Any bacteria that is not assigned to the species level but can be assigned to the Raoultella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86714'),('CL-MICROORG-T-793',NULL,'RAOULTELLA ORNITHINOLYTICA','Any bacterial organism that can be assigned to the species Raoultella ornithinolytica.','\0','KLEBSIELLA ORNITHINOLYTICA','CL-MICROORG','DBX-NCIT-C86715'),('CL-MICROORG-T-794',NULL,'RAOULTELLA PLANTICOLA','Any bacterial organism that can be assigned to the species Raoultella planticola.','\0','','CL-MICROORG','DBX-NCIT-C86716'),('CL-MICROORG-T-795',NULL,'RAOULTELLA TERRIGENA','Any bacterial organism that can be assigned to the species Raoultella terrigena.','\0','KLEBSIELLA TERRIGENA','CL-MICROORG','DBX-NCIT-C86717'),('CL-MICROORG-T-796',NULL,'RESPIROVIRUS','Any viral organism that can be assigned to the genus Paramyxovirus.','\0','Paramyxovirus','CL-MICROORG','DBX-NCIT-C14310'),('CL-MICROORG-T-797',NULL,'RHINOVIRUS A','Any viral organism that can be assigned to the species Rhinovirus A.','\0','Human Rhinovirus A','CL-MICROORG','DBX-NCIT-C112407'),('CL-MICROORG-T-798',NULL,'RHINOVIRUS B','Any viral organism that can be assigned to the species Rhinovirus B.','\0','Human Rhinovirus B','CL-MICROORG','DBX-NCIT-C112408'),('CL-MICROORG-T-799',NULL,'RHINOVIRUS C','Any viral organism that can be assigned to the species Rhinovirus C.','\0','Human Rhinovirus C','CL-MICROORG','DBX-NCIT-C112409'),('CL-MICROORG-T-8',NULL,'ACIDAMINOCOCCUS FERMENTANS','Any bacterial organism that can be assigned to the species Acidaminococcus fermentans.','\0','','CL-MICROORG','DBX-NCIT-C86084'),('CL-MICROORG-T-80',NULL,'ANAEROCOCCUS VAGINALIS','Any bacterial organism that can be assigned to the species Anaerococcus vaginalis.','\0','','CL-MICROORG','DBX-NCIT-C86877'),('CL-MICROORG-T-800',NULL,'RHIZOBIUM','Any bacteria that is not assigned to the species level but can be assigned to the Rhizobium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86718'),('CL-MICROORG-T-801',NULL,'RHODOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Rhodococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C76378'),('CL-MICROORG-T-802',NULL,'RHODOCOCCUS EQUI','Any bacterial organism that can be assigned to the species Rhodococcus equi.','\0','CORYNEBACTERIUM EQUI','CL-MICROORG','DBX-NCIT-C86719'),('CL-MICROORG-T-803',NULL,'RHODOTORULA GLUTINIS','Any fungal organism that can be assigned to the species Rhodotorula glutinis.','\0','R. glutinis','CL-MICROORG','DBX-NCIT-C114264'),('CL-MICROORG-T-804',NULL,'RHODOTORULA MUCILAGINOSA','Any fungal organism that can be assigned to the species Rhodotorula mucilaginosa.','\0','R. mucilaginosa; R. pilimanae; R. rubra; Rhodotorula pilimanae; Rhodotorula rubra; S. albo-rubescens; Sporobolomyces albo-rubescens','CL-MICROORG','DBX-NCIT-C86027'),('CL-MICROORG-T-805',NULL,'RICKETTSIA','Any bacteria that is not assigned to the species level but can be assigned to the Rickettsia genus level.','\0','','CL-MICROORG','DBX-NCIT-C76379'),('CL-MICROORG-T-806',NULL,'RICKETTSIA AFRICAE','Any bacterial organism that can be assigned to the species Rickettsia africae.','\0','','CL-MICROORG','DBX-NCIT-C86720'),('CL-MICROORG-T-807',NULL,'RICKETTSIA FELIS','Any bacterial organism that can be assigned to the species Rickettsia felis.','\0','','CL-MICROORG','DBX-NCIT-C86721'),('CL-MICROORG-T-808',NULL,'RICKETTSIA JAPONICA','Any bacterial organism that can be assigned to the species Rickettsia japonica.','\0','','CL-MICROORG','DBX-NCIT-C86722'),('CL-MICROORG-T-809',NULL,'RICKETTSIA PROWAZEKII','Any bacterial organism that can be assigned to the species Rickettsia prowazekii.','\0','','CL-MICROORG','DBX-NCIT-C86723'),('CL-MICROORG-T-81',NULL,'APHTHOVIRUS','Any viral organism that can be assigned to the genus Aphthovirus.','\0','','CL-MICROORG','DBX-NCIT-C112229'),('CL-MICROORG-T-810',NULL,'RICKETTSIA RICKETTSII','Any bacterial organism that can be assigned to the species Rickettsia rickettsii.','\0','','CL-MICROORG','DBX-NCIT-C86724'),('CL-MICROORG-T-811',NULL,'RICKETTSIA TYPHI','Any bacterial organism that can be assigned to the species Rickettsia typhi.','\0','','CL-MICROORG','DBX-NCIT-C86725'),('CL-MICROORG-T-812',NULL,'ROSEOLOVIRUS','Any viral organism that can be assigned to the genus Roseolovirus.','\0','','CL-MICROORG','DBX-NCIT-C112410'),('CL-MICROORG-T-813',NULL,'ROSEOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Roseomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86726'),('CL-MICROORG-T-814',NULL,'ROSS RIVER VIRUS','Any viral organism that can be assigned to the species Ross River virus.','\0','RRV','CL-MICROORG','DBX-NCIT-C112411'),('CL-MICROORG-T-815',NULL,'ROTAVIRUS','Any viral organism that can be assigned to the genus Rotavirus.','\0','','CL-MICROORG','DBX-NCIT-C77199'),('CL-MICROORG-T-816',NULL,'ROTHIA','Any bacteria that is not assigned to the species level but can be assigned to the Rothia genus level.','\0','','CL-MICROORG','DBX-NCIT-C86727'),('CL-MICROORG-T-817',NULL,'ROTHIA DENTOCARIOSA','Any bacterial organism that can be assigned to the species Rothia dentocariosa.','\0','NOCARDIA DENTOCARIOSA','CL-MICROORG','DBX-NCIT-C86728'),('CL-MICROORG-T-818',NULL,'ROTHIA MUCILAGINOSA','Any bacterial organism that can be assigned to the species Rothia mucilaginosa.','\0','STOMATOCOCCUS MUCILAGINOSUS','CL-MICROORG','DBX-NCIT-C76382'),('CL-MICROORG-T-819',NULL,'RUBELLA VIRUS','Any viral organism that can be assigned to the species Rubella virus.','\0','German Measles Virus','CL-MICROORG','DBX-NCIT-C77198'),('CL-MICROORG-T-82',NULL,'ARBOVIRUS','A non-taxonomic grouping of viruses that are transmitted through an arthropod vector and replicate in a vertebrate host.','\0','Arthropod-Borne Virus','CL-MICROORG','DBX-NCIT-C112230'),('CL-MICROORG-T-820',NULL,'RUBIVIRUS','Any viral organism that can be assigned to the genus Rubivirus.','\0','','CL-MICROORG','DBX-NCIT-C112414'),('CL-MICROORG-T-821',NULL,'RUBULAVIRUS','Any viral organism that can be assigned to the genus Rubulavirus.','\0','','CL-MICROORG','DBX-NCIT-C14326'),('CL-MICROORG-T-822',NULL,'RUMINOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Ruminococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86729'),('CL-MICROORG-T-823',NULL,'RUMINOCOCCUS PRODUCTUS','Any bacterial organism that can be assigned to the species Ruminococcus productus.','\0','PEPTOSTREPTOCOCCUS PRODUCTUS','CL-MICROORG','DBX-NCIT-C86730'),('CL-MICROORG-T-824',NULL,'SACCHAROMYCES CEREVISIAE','Any fungal organism that can be assigned to the species Saccharomyces cerevisiae.','\0','Bakers Yeast; Brewers Yeast; S. capensis; S. cerevisiae; S. italicus; S. oviformis; S. uvarum var. melibiosus; Saccharomyces capensis; Saccharomyces italicus; Saccharomyces oviformis; Saccharomyces uvarum var. melibiosus','CL-MICROORG','DBX-NCIT-C14271'),('CL-MICROORG-T-825',NULL,'SALMONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Salmonella genus level.','\0','SALMONELLA SEROGROUP D (NOT S. TYPHI)','CL-MICROORG','DBX-NCIT-C76380'),('CL-MICROORG-T-826',NULL,'SALMONELLA BONGORI','Any bacterial organism that can be assigned to the species Salmonella bongori.','\0','','CL-MICROORG','DBX-NCIT-C91842'),('CL-MICROORG-T-827',NULL,'SALMONELLA ENTERICA','Any bacterial organism that can be assigned to the species Salmonella enterica.','\0','','CL-MICROORG','DBX-NCIT-C86731'),('CL-MICROORG-T-828',NULL,'SALMONELLA ENTERICA SUBSP. ARIZONAE','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies arizonae.','\0','','CL-MICROORG','DBX-NCIT-C86910'),('CL-MICROORG-T-829',NULL,'SALMONELLA ENTERICA SUBSP. DIARIZONAE','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies diarizonae.','\0','','CL-MICROORG','DBX-NCIT-C91844'),('CL-MICROORG-T-83',NULL,'ARCANOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Arcanobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86147'),('CL-MICROORG-T-830',NULL,'SALMONELLA ENTERICA SUBSP. ENTERICA','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica.','\0','','CL-MICROORG','DBX-NCIT-C86913'),('CL-MICROORG-T-831',NULL,'SALMONELLA ENTERICA SUBSP. HOUTENAE','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies houtenae.','\0','','CL-MICROORG','DBX-NCIT-C91845'),('CL-MICROORG-T-832',NULL,'SALMONELLA ENTERICA SUBSP. INDICA','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies indica.','\0','','CL-MICROORG','DBX-NCIT-C91846'),('CL-MICROORG-T-833',NULL,'SALMONELLA ENTERICA SUBSP. SALAMAE','Any bacterial organism that can be assigned to the species Salmonella enterica subspecies salamae.','\0','','CL-MICROORG','DBX-NCIT-C91847'),('CL-MICROORG-T-834',NULL,'SALMONELLA SEROTYPE CHOLERAESUIS','Any bacterial organism that can be assigned to the genus Salmonella with serotype Choleraesuis.','\0','','CL-MICROORG','DBX-NCIT-C86915'),('CL-MICROORG-T-835',NULL,'SALMONELLA SEROTYPE DUBLIN','Any bacterial organism that can be assigned to the genus Salmonella with serotype Dublin.','\0','','CL-MICROORG','DBX-NCIT-C86918'),('CL-MICROORG-T-836',NULL,'SALMONELLA SEROTYPE ENTERITIDIS','Any bacterial organism that can be assigned to the genus Salmonella with serotype Enteritidis.','\0','','CL-MICROORG','DBX-NCIT-C86919'),('CL-MICROORG-T-837',NULL,'SALMONELLA SEROTYPE NEWPORT','Any bacterial organism that can be assigned to the genus Salmonella with serotype Newport.','\0','','CL-MICROORG','DBX-NCIT-C86921'),('CL-MICROORG-T-838',NULL,'SALMONELLA SEROTYPE PARATYPHI A','Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi A.','\0','','CL-MICROORG','DBX-NCIT-C86922'),('CL-MICROORG-T-839',NULL,'SALMONELLA SEROTYPE PARATYPHI B','Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi B.','\0','','CL-MICROORG','DBX-NCIT-C86924'),('CL-MICROORG-T-84',NULL,'ARCANOBACTERIUM BERNARDIAE','Any bacterial organism that can be assigned to the species Arcanobacterium bernardiae.','\0','','CL-MICROORG','DBX-NCIT-C86148'),('CL-MICROORG-T-840',NULL,'SALMONELLA SEROTYPE PARATYPHI C','Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi C.','\0','','CL-MICROORG','DBX-NCIT-C86925'),('CL-MICROORG-T-841',NULL,'SALMONELLA SEROTYPE TYPHI','Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhi.','\0','','CL-MICROORG','DBX-NCIT-C86926'),('CL-MICROORG-T-842',NULL,'SALMONELLA SEROTYPE TYPHIMURIUM','Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhimurium.','\0','','CL-MICROORG','DBX-NCIT-C86927'),('CL-MICROORG-T-843',NULL,'SAPOVIRUS','Any viral organism that can be assigned to the genus Sapovirus.','\0','','CL-MICROORG','DBX-NCIT-C112029'),('CL-MICROORG-T-844',NULL,'SAPPORO VIRUS','Any viral organism that can be assigned to the species Sapporo virus.','\0','Human calicivirus SLV; Human calicivirus Sapporo-like Virus','CL-MICROORG','DBX-NCIT-C112415'),('CL-MICROORG-T-845',NULL,'SARS CORONAVIRUS','Any viral organism that can be assigned to the species SARS coronavirus.','\0','HCoV-SARS; SARS; Severe Acute Respiratory Syndrome Coronavirus','CL-MICROORG','DBX-NCIT-C112432'),('CL-MICROORG-T-846',NULL,'SELENOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Selenomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86732'),('CL-MICROORG-T-847',NULL,'SELENOMONAS NOXIA','Any bacterial organism that can be assigned to the species Selenomonas noxia.','\0','','CL-MICROORG','DBX-NCIT-C86733'),('CL-MICROORG-T-848',NULL,'SELENOMONAS SPUTIGENA','Any bacterial organism that can be assigned to the species Selenomonas sputigena.','\0','','CL-MICROORG','DBX-NCIT-C86734'),('CL-MICROORG-T-849',NULL,'SERRATIA','Any bacteria that is not assigned to the species level but can be assigned to the Serratia genus level.','\0','SERRATIA','CL-MICROORG','DBX-NCIT-C86010'),('CL-MICROORG-T-85',NULL,'ARCANOBACTERIUM HAEMOLYTICUM','Any bacterial organism that can be assigned to the species Arcanobacterium haemolyticum.','\0','CORYNEBACTERIUM HAEMOLYTICUM; CORYNEBACTERIUM HAEMOLYTICUS','CL-MICROORG','DBX-NCIT-C86149'),('CL-MICROORG-T-850',NULL,'SERRATIA FICARIA','Any bacterial organism that can be assigned to the species Serratia ficaria.','\0','','CL-MICROORG','DBX-NCIT-C86736'),('CL-MICROORG-T-851',NULL,'SERRATIA FONTICOLA','Any bacterial organism that can be assigned to the species Serratia fonticola.','\0','','CL-MICROORG','DBX-NCIT-C86737'),('CL-MICROORG-T-852',NULL,'SERRATIA LIQUEFACIENS','Any bacterial organism that can be assigned to the species Serratia liquefaciens.','\0','ENTEROBACTER LIQUEFACIENS','CL-MICROORG','DBX-NCIT-C86738'),('CL-MICROORG-T-853',NULL,'SERRATIA MARCESCENS','Any bacterial organism that can be assigned to the species Serratia marcescens.','\0','S. MARCESCENS','CL-MICROORG','DBX-NCIT-C14272'),('CL-MICROORG-T-854',NULL,'SERRATIA ODORIFERA','Any bacterial organism that can be assigned to the species Serratia odorifera.','\0','','CL-MICROORG','DBX-NCIT-C86739'),('CL-MICROORG-T-855',NULL,'SERRATIA PLYMUTHICA','Any bacterial organism that can be assigned to the species Serratia plymuthica.','\0','','CL-MICROORG','DBX-NCIT-C86740'),('CL-MICROORG-T-856',NULL,'SERRATIA RUBIDAEA','Any bacterial organism that can be assigned to the species Serratia rubidaea.','\0','SERRATIA MARINORUBRA','CL-MICROORG','DBX-NCIT-C86741'),('CL-MICROORG-T-857',NULL,'SHEWANELLA','Any bacteria that is not assigned to the species level but can be assigned to the Shewanella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86742'),('CL-MICROORG-T-858',NULL,'SHEWANELLA PUTREFACIENS','Any bacterial organism that can be assigned to the species Shewanella putrefaciens.','\0','ALTEROMONAS PUTREFACIENS; PSEUDOMONAS PUTREFACIENS','CL-MICROORG','DBX-NCIT-C86743'),('CL-MICROORG-T-859',NULL,'SHIGELLA','Any bacteria that is not assigned to the species level but can be assigned to the Shigella genus level.','\0','','CL-MICROORG','DBX-NCIT-C76381'),('CL-MICROORG-T-86',NULL,'ARCANOBACTERIUM PYOGENES','Any bacterial organism that can be assigned to the species Arcanobacterium pyogenes.','\0','ACTINOMYCES PYOGENES; CORYNEBACTERIUM PYOGENES','CL-MICROORG','DBX-NCIT-C86150'),('CL-MICROORG-T-860',NULL,'SHIGELLA BOYDII','Any bacterial organism that can be assigned to the species Shigella boydii.','\0','SHIGELLA BIOGROUP C','CL-MICROORG','DBX-NCIT-C86744'),('CL-MICROORG-T-861',NULL,'SHIGELLA DYSENTERIAE','Any bacterial organism that can be assigned to the species Shigella dysenteriae.','\0','SHIGELLA BIOGROUP A','CL-MICROORG','DBX-NCIT-C86745'),('CL-MICROORG-T-862',NULL,'SHIGELLA FLEXNERI','Any bacterial organism that can be assigned to the species Shigella flexneri.','\0','SHIGELLA BIOGROUP B','CL-MICROORG','DBX-NCIT-C86746'),('CL-MICROORG-T-863',NULL,'SHIGELLA SONNEI','Any bacterial organism that can be assigned to the species Shigella sonnei.','\0','SHIGELLA BIOGROUP D','CL-MICROORG','DBX-NCIT-C86747'),('CL-MICROORG-T-864',NULL,'SIMPLEXVIRUS','Any viral organism that can be assigned to the genus Simplexvirus.','\0','Human Herpes Simplex Virus','CL-MICROORG','DBX-NCIT-C112419'),('CL-MICROORG-T-865',NULL,'SLACKIA EXIGUA','Any bacterial organism that can be assigned to the species Slackia exigua.','\0','EUBACTERIUM EXIGUUM','CL-MICROORG','DBX-NCIT-C111313'),('CL-MICROORG-T-866',NULL,'SPHINGOBACTERIUM','Any bacteria that is not assigned to the species level but can be assigned to the Sphingobacterium genus level.','\0','','CL-MICROORG','DBX-NCIT-C86957'),('CL-MICROORG-T-867',NULL,'SPHINGOBACTERIUM MIZUTAII','Any bacterial organism that can be assigned to the species Sphingobacterium mizutaii.','\0','FLAVOBACTERIUM MIZUTAE','CL-MICROORG','DBX-NCIT-C86958'),('CL-MICROORG-T-868',NULL,'SPHINGOBACTERIUM MULTIVORUM','Any bacterial organism that can be assigned to the species Sphingobacterium multivorum.','\0','CDC GROUP IIK-2','CL-MICROORG','DBX-NCIT-C86959'),('CL-MICROORG-T-869',NULL,'SPHINGOBACTERIUM SPIRITIVORUM','Any bacterial organism that can be assigned to the species Sphingobacterium spiritivorum.','\0','CDC GROUP IIK-3','CL-MICROORG','DBX-NCIT-C86960'),('CL-MICROORG-T-87',NULL,'ARCOBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Arcobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86152'),('CL-MICROORG-T-870',NULL,'SPHINGOBACTERIUM THALPOPHILUM','Any bacterial organism that can be assigned to the species Sphingobacterium thalpophilum.','\0','FLAVOBACTERIUM THALPOPHILUM','CL-MICROORG','DBX-NCIT-C86961'),('CL-MICROORG-T-871',NULL,'SPHINGOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Sphingomonas genus level.','\0','','CL-MICROORG','DBX-NCIT-C86748'),('CL-MICROORG-T-872',NULL,'SPHINGOMONAS PAUCIMOBILIS','Any bacterial organism that can be assigned to the species Sphingomonas paucimobilis.','\0','CDC GROUP IIK-1; PSEUDOMONAS PAUCIMOBILIS','CL-MICROORG','DBX-NCIT-C86749'),('CL-MICROORG-T-873',NULL,'STAPHYLOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Staphylococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C62583'),('CL-MICROORG-T-874',NULL,'STAPHYLOCOCCUS ARLETTAE','Any bacterial organism that can be assigned to the species Staphylococcus arlettae.','\0','','CL-MICROORG','DBX-NCIT-C86750'),('CL-MICROORG-T-875',NULL,'STAPHYLOCOCCUS AUREUS','Any bacterial organism that can be assigned to the species Staphylococcus aureus.','\0','STAPH. AUREUS','CL-MICROORG','DBX-NCIT-C50921'),('CL-MICROORG-T-876',NULL,'STAPHYLOCOCCUS AURICULARIS','Any bacterial organism that can be assigned to the species Staphylococcus auricularis.','\0','','CL-MICROORG','DBX-NCIT-C86751'),('CL-MICROORG-T-877',NULL,'STAPHYLOCOCCUS CAPITIS','Any bacterial organism that can be assigned to the species Staphylococcus capitis.','\0','','CL-MICROORG','DBX-NCIT-C86752'),('CL-MICROORG-T-878',NULL,'STAPHYLOCOCCUS CAPRAE','Any bacterial organism that can be assigned to the species Staphylococcus caprae.','\0','','CL-MICROORG','DBX-NCIT-C86753'),('CL-MICROORG-T-879',NULL,'STAPHYLOCOCCUS CARNOSUS','Any bacterial organism that can be assigned to the species Staphylococcus carnosus.','\0','','CL-MICROORG','DBX-NCIT-C86754'),('CL-MICROORG-T-88',NULL,'ARCOBACTER BUTZLERI','Any bacterial organism that can be assigned to the species Arcobacter butzleri.','\0','CAMPYLOBACTER BUTZLERI','CL-MICROORG','DBX-NCIT-C86153'),('CL-MICROORG-T-880',NULL,'STAPHYLOCOCCUS CHROMOGENES','Any bacterial organism that can be assigned to the species Staphylococcus chromogenes.','\0','','CL-MICROORG','DBX-NCIT-C86755'),('CL-MICROORG-T-881',NULL,'STAPHYLOCOCCUS COHNII','Any bacterial organism that can be assigned to the species Staphylococcus cohnii.','\0','','CL-MICROORG','DBX-NCIT-C86756'),('CL-MICROORG-T-882',NULL,'STAPHYLOCOCCUS EPIDERMIDIS','Any bacterial organism that can be assigned to the species Staphylococcus epidermidis.','\0','STAPHYLOCOCCUS ALBUS','CL-MICROORG','DBX-NCIT-C86757'),('CL-MICROORG-T-883',NULL,'STAPHYLOCOCCUS EQUORUM','Any bacterial organism that can be assigned to the species Staphylococcus equorum.','\0','','CL-MICROORG','DBX-NCIT-C86758'),('CL-MICROORG-T-884',NULL,'STAPHYLOCOCCUS FELIS','Any bacterial organism that can be assigned to the species Staphylococcus felis.','\0','','CL-MICROORG','DBX-NCIT-C86759'),('CL-MICROORG-T-885',NULL,'STAPHYLOCOCCUS GALLINARUM','Any bacterial organism that can be assigned to the species Staphylococcus gallinarum.','\0','','CL-MICROORG','DBX-NCIT-C86760'),('CL-MICROORG-T-886',NULL,'STAPHYLOCOCCUS HAEMOLYTICUS','Any bacterial organism that can be assigned to the species Staphylococcus haemolyticus.','\0','STAPH. HAEMOLYTICUS','CL-MICROORG','DBX-NCIT-C86761'),('CL-MICROORG-T-887',NULL,'STAPHYLOCOCCUS HOMINIS','Any bacterial organism that can be assigned to the species Staphylococcus hominis.','\0','COAGULASE NEGATIVE STAPHYLOCOCCUS HOMINIS','CL-MICROORG','DBX-NCIT-C86762'),('CL-MICROORG-T-888',NULL,'STAPHYLOCOCCUS HYICUS','Any bacterial organism that can be assigned to the species Staphylococcus hyicus.','\0','','CL-MICROORG','DBX-NCIT-C86763'),('CL-MICROORG-T-889',NULL,'STAPHYLOCOCCUS INTERMEDIUS','Any bacterial organism that can be assigned to the species Staphylococcus intermedius.','\0','','CL-MICROORG','DBX-NCIT-C86764'),('CL-MICROORG-T-89',NULL,'ARCOBACTER CRYAEROPHILUS','Any bacterial organism that can be assigned to the species Arcobacter cryaerophilus.','\0','CAMPYLOBACTER CRYAEROPHILUS','CL-MICROORG','DBX-NCIT-C86154'),('CL-MICROORG-T-890',NULL,'STAPHYLOCOCCUS KLOOSII','Any bacterial organism that can be assigned to the species Staphylococcus kloosii.','\0','','CL-MICROORG','DBX-NCIT-C86765'),('CL-MICROORG-T-891',NULL,'STAPHYLOCOCCUS LENTUS','Any bacterial organism that can be assigned to the species Staphylococcus lentus.','\0','','CL-MICROORG','DBX-NCIT-C86766'),('CL-MICROORG-T-892',NULL,'STAPHYLOCOCCUS LUGDUNENSIS','Any bacterial organism that can be assigned to the species Staphylococcus lugdunensis.','\0','','CL-MICROORG','DBX-NCIT-C86767'),('CL-MICROORG-T-893',NULL,'STAPHYLOCOCCUS PASTEURI','Any bacterial organism that can be assigned to the species Staphylococcus pasteuri.','\0','','CL-MICROORG','DBX-NCIT-C86768'),('CL-MICROORG-T-894',NULL,'STAPHYLOCOCCUS SACCHAROLYTICUS','Any bacterial organism that can be assigned to the species Staphylococcus saccharolyticus.','\0','PEPTOCOCCUS SACCHAROLYTICUS','CL-MICROORG','DBX-NCIT-C86769'),('CL-MICROORG-T-895',NULL,'STAPHYLOCOCCUS SAPROPHYTICUS','Any bacterial organism that can be assigned to the species Staphylococcus saprophyticus.','\0','MICROCOCCUS SUBGROUP 3','CL-MICROORG','DBX-NCIT-C86770'),('CL-MICROORG-T-896',NULL,'STAPHYLOCOCCUS SCHLEIFERI','Any bacterial organism that can be assigned to the species Staphylococcus schleiferi.','\0','','CL-MICROORG','DBX-NCIT-C86771'),('CL-MICROORG-T-897',NULL,'STAPHYLOCOCCUS SCIURI','Any bacterial organism that can be assigned to the species Staphylococcus sciuri.','\0','','CL-MICROORG','DBX-NCIT-C86772'),('CL-MICROORG-T-898',NULL,'STAPHYLOCOCCUS SIMULANS','Any bacterial organism that can be assigned to the species Staphylococcus simulans.','\0','','CL-MICROORG','DBX-NCIT-C86773'),('CL-MICROORG-T-899',NULL,'STAPHYLOCOCCUS WARNERI','Any bacterial organism that can be assigned to the species Staphylococcus warneri.','\0','','CL-MICROORG','DBX-NCIT-C86774'),('CL-MICROORG-T-9',NULL,'ACIDOVORAX','Any bacteria that is not assigned to the species level but can be assigned to the Acidovorax genus level.','\0','','CL-MICROORG','DBX-NCIT-C86085'),('CL-MICROORG-T-90',NULL,'ARENAVIRUS','Any viral organism that can be assigned to the genus Arenavirus.','\0','','CL-MICROORG','DBX-NCIT-C14306'),('CL-MICROORG-T-900',NULL,'STAPHYLOCOCCUS XYLOSUS','Any bacterial organism that can be assigned to the species Staphylococcus xylosus.','\0','','CL-MICROORG','DBX-NCIT-C86775'),('CL-MICROORG-T-901',NULL,'STENOTROPHOMONAS','Any bacteria that is not assigned to the species level but can be assigned to the Stenotrophomonas genus level.','\0','STENOTROPHOMONAS','CL-MICROORG','DBX-NCIT-C86776'),('CL-MICROORG-T-902',NULL,'STENOTROPHOMONAS MALTOPHILIA','Any bacterial organism that can be assigned to the species Stenotrophomonas maltophilia.','\0','PSEUDOMONAS MALTOPHILIA; XANTHOMONAS MALTOPHILIA','CL-MICROORG','DBX-NCIT-C76377'),('CL-MICROORG-T-903',NULL,'STREPTOBACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Streptobacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86777'),('CL-MICROORG-T-904',NULL,'STREPTOBACILLUS MONILIFORMIS','Any bacterial organism that can be assigned to the species Streptobacillus moniliformis.','\0','HAVERHILLIA MULTIFORMIS','CL-MICROORG','DBX-NCIT-C86778'),('CL-MICROORG-T-905',NULL,'STREPTOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Streptococcus genus level.','\0','STREPTOCOCCI SP.','CL-MICROORG','DBX-NCIT-C76383'),('CL-MICROORG-T-906',NULL,'STREPTOCOCCUS ACIDOMINIMUS','Any bacterial organism that can be assigned to the species Streptococcus acidominimus.','\0','','CL-MICROORG','DBX-NCIT-C86779'),('CL-MICROORG-T-907',NULL,'STREPTOCOCCUS AGALACTIAE','Any bacterial organism that can be assigned to the species Streptococcus agalactiae.','\0','STREPT. GP B(AGALACT)','CL-MICROORG','DBX-NCIT-C86780'),('CL-MICROORG-T-908',NULL,'STREPTOCOCCUS ALACTOLYTICUS','Any bacterial organism that can be assigned to the species Streptococcus alactolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86781'),('CL-MICROORG-T-909',NULL,'STREPTOCOCCUS ALPHA-HEMOLYTIC','A bacteria that is assigned to the genus Streptococcus that is able to reduce the iron content in hemoglobin in red blood cells, thus producing green-colored colonies on blood agar plates.','\0','ALPHA-HEMOLYTIC STREPTOCOCCUS','CL-MICROORG','DBX-NCIT-C86141'),('CL-MICROORG-T-91',NULL,'ARTHROBACTER','Any bacteria that is not assigned to the species level but can be assigned to the Arthrobacter genus level.','\0','','CL-MICROORG','DBX-NCIT-C86155'),('CL-MICROORG-T-910',NULL,'STREPTOCOCCUS ANGINOSIS','Any bacterial organism that can be assigned to the species Streptococcus anginosis.','\0','','CL-MICROORG','DBX-NCIT-C86782'),('CL-MICROORG-T-911',NULL,'STREPTOCOCCUS ANGINOSUS GROUP','A bacteria that belongs to the Anginosus group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86783'),('CL-MICROORG-T-912',NULL,'STREPTOCOCCUS BETA-HEMOLYTIC','A bacteria that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates.','\0','BETA-HEMOLYTIC STREPTOCOCCUS','CL-MICROORG','DBX-NCIT-C86190'),('CL-MICROORG-T-913',NULL,'STREPTOCOCCUS BOVIS','Any bacterial organism that can be assigned to the species Streptococcus bovis.','\0','','CL-MICROORG','DBX-NCIT-C86784'),('CL-MICROORG-T-914',NULL,'STREPTOCOCCUS BOVIS GROUP','A bacteria that belongs to the Bovis group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86785'),('CL-MICROORG-T-915',NULL,'STREPTOCOCCUS CANIS','Any bacterial organism that can be assigned to the species Streptococcus canis.','\0','STREPTOCOCCUS DYSGALACTIAE','CL-MICROORG','DBX-NCIT-C86786'),('CL-MICROORG-T-916',NULL,'STREPTOCOCCUS CONSTELLATUS','Any bacterial organism that can be assigned to the species Streptococcus constellatus.','\0','','CL-MICROORG','DBX-NCIT-C86787'),('CL-MICROORG-T-917',NULL,'STREPTOCOCCUS CRISTATUS','Any bacterial organism that can be assigned to the species Streptococcus cristatus.','\0','','CL-MICROORG','DBX-NCIT-C86788'),('CL-MICROORG-T-918',NULL,'STREPTOCOCCUS DYSGALACTIAE SUBSP. DYSGALACTIAE','Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies dysgalactiae.','\0','','CL-MICROORG','DBX-NCIT-C91848'),('CL-MICROORG-T-919',NULL,'STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS','Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies equisimilis.','\0','STREPTOCOCCUS EQUISIMILIS','CL-MICROORG','DBX-NCIT-C86906'),('CL-MICROORG-T-92',NULL,'ARTHROBACTER CUMMINSII','Any bacterial organism that can be assigned to the species Arthrobacter cumminsii.','\0','','CL-MICROORG','DBX-NCIT-C114248'),('CL-MICROORG-T-920',NULL,'STREPTOCOCCUS EQUI','Any bacterial organism that can be assigned to the species Streptococcus equi.','\0','','CL-MICROORG','DBX-NCIT-C86789'),('CL-MICROORG-T-921',NULL,'STREPTOCOCCUS EQUINUS','Any bacterial organism that can be assigned to the species Streptococcus equinus.','\0','','CL-MICROORG','DBX-NCIT-C86790'),('CL-MICROORG-T-922',NULL,'STREPTOCOCCUS GALLOLYTICUS','Any bacterial organism that can be assigned to the species Streptococcus gallolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86791'),('CL-MICROORG-T-923',NULL,'STREPTOCOCCUS GAMMA-HEMOLYTIC','A bacteria that is assigned to the genus Streptococcus that is unable to facilitate red blood cell lysis.','\0','GAMMA-HEMOLYTIC STREPTOCOCCUS','CL-MICROORG','DBX-NCIT-C86408'),('CL-MICROORG-T-924',NULL,'STREPTOCOCCUS GORDONII','Any bacterial organism that can be assigned to the species Streptococcus gordonii.','\0','','CL-MICROORG','DBX-NCIT-C86792'),('CL-MICROORG-T-925',NULL,'STREPTOCOCCUS INFANTARIUS','Any bacterial organism that can be assigned to the species Streptococcus infantarius.','\0','','CL-MICROORG','DBX-NCIT-C86793'),('CL-MICROORG-T-926',NULL,'STREPTOCOCCUS INTERMEDIUS','Any bacterial organism that can be assigned to the species Streptococcus intermedius.','\0','','CL-MICROORG','DBX-NCIT-C86794'),('CL-MICROORG-T-927',NULL,'STREPTOCOCCUS MILLERI','Any bacterial organism that can be assigned to the species Streptococcus milleri.','\0','STREPTOCOCCUS MILLERI I','CL-MICROORG','DBX-NCIT-C86795'),('CL-MICROORG-T-928',NULL,'STREPTOCOCCUS MILLERI GROUP','A bacteria that belongs to the Milleri group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86796'),('CL-MICROORG-T-929',NULL,'STREPTOCOCCUS MITIS GROUP','A bacteria that belongs to the Mitis group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86797'),('CL-MICROORG-T-93',NULL,'ASTROVIRUS','Any viral organism that can be assigned to the family Astroviridae.','\0','Astroviridae','CL-MICROORG','DBX-NCIT-C112231'),('CL-MICROORG-T-930',NULL,'STREPTOCOCCUS MUTANS GROUP','A bacteria that belongs to the Mutans group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86798'),('CL-MICROORG-T-931',NULL,'STREPTOCOCCUS ORALIS','Any bacterial organism that can be assigned to the species Streptococcus oralis.','\0','','CL-MICROORG','DBX-NCIT-C86799'),('CL-MICROORG-T-932',NULL,'STREPTOCOCCUS PARASANGUINIS','Any bacterial organism that can be assigned to the species Streptococcus parasanguinis.','\0','STREPTOCOCCUS PARASANGUIS','CL-MICROORG','DBX-NCIT-C86800'),('CL-MICROORG-T-933',NULL,'STREPTOCOCCUS PNEUMONIAE','Any bacterial organism that can be assigned to the species Streptococcus pneumoniae.','\0','DIPLOCOCCUS PNEUMONIAE','CL-MICROORG','DBX-NCIT-C76384'),('CL-MICROORG-T-934',NULL,'STREPTOCOCCUS PORCINUS','Any bacterial organism that can be assigned to the species Streptococcus porcinus.','\0','','CL-MICROORG','DBX-NCIT-C86802'),('CL-MICROORG-T-935',NULL,'STREPTOCOCCUS PYOGENES','Any bacterial organism that can be assigned to the species Streptococcus pyogenes.','\0','GROUP A BETA-HEMOLYTIC STREPTOCOCCUS PYOGENES','CL-MICROORG','DBX-NCIT-C86803'),('CL-MICROORG-T-936',NULL,'STREPTOCOCCUS SALIVARIUS','Any bacterial organism that can be assigned to the species Streptococcus salivarius.','\0','','CL-MICROORG','DBX-NCIT-C86804'),('CL-MICROORG-T-937',NULL,'STREPTOCOCCUS SALIVARIUS GROUP','A bacteria that belongs to the Salivarius group of the genus Streptococcus.','\0','','CL-MICROORG','DBX-NCIT-C86805'),('CL-MICROORG-T-938',NULL,'STREPTOCOCCUS SANGUINIS','Any bacterial organism that can be assigned to the species Streptococcus sanguinis.','\0','STREPTOCOCCUS SANGUIS','CL-MICROORG','DBX-NCIT-C86806'),('CL-MICROORG-T-939',NULL,'STREPTOCOCCUS SUIS','Any bacterial organism that can be assigned to the species Streptococcus suis.','\0','','CL-MICROORG','DBX-NCIT-C86807'),('CL-MICROORG-T-94',NULL,'ATOPOBIUM MINUTUM','Any bacterial organism that can be assigned to the species Atopobium minutum.','\0','LACTOBACILLUS MINUTIS; LACTOBACILLUS MINUTUS','CL-MICROORG','DBX-NCIT-C86156'),('CL-MICROORG-T-940',NULL,'STREPTOCOCCUS THERMOPHILUS','Any bacterial organism that can be assigned to the species Streptococcus thermophilus.','\0','','CL-MICROORG','DBX-NCIT-C86808'),('CL-MICROORG-T-941',NULL,'STREPTOCOCCUS UBERIS','Any bacterial organism that can be assigned to the species Streptococcus uberis.','\0','','CL-MICROORG','DBX-NCIT-C86809'),('CL-MICROORG-T-942',NULL,'STREPTOCOCCUS VESTIBULARIS','Any bacterial organism that can be assigned to the species Streptococcus vestibularis.','\0','','CL-MICROORG','DBX-NCIT-C86810'),('CL-MICROORG-T-943',NULL,'STREPTOCOCCUS VIRIDANS GROUP','A non-taxonomic grouping of species within the Streptococcus genus that are alpha-hemolytic and do not express Lancefield antigens.','\0','STREPTOCOCCUS VIRIDANS; VIRIDANS STREPTOCOCCUS','CL-MICROORG','DBX-NCIT-C86811'),('CL-MICROORG-T-944',NULL,'STREPTOMYCES','Any bacteria that is not assigned to the species level but can be assigned to the Streptomyces genus level.','\0','','CL-MICROORG','DBX-NCIT-C14278'),('CL-MICROORG-T-945',NULL,'STREPTOMYCES ALBUS','Any bacterial organism that can be assigned to the species Streptomyces albus.','\0','','CL-MICROORG','DBX-NCIT-C86812'),('CL-MICROORG-T-946',NULL,'STREPTOMYCES GRISEUS','Any bacterial organism that can be assigned to the species Streptomyces griseus.','\0','','CL-MICROORG','DBX-NCIT-C86813'),('CL-MICROORG-T-947',NULL,'STREPTOMYCES SOMALIENSIS','Any bacterial organism that can be assigned to the species Streptomyces somaliensis.','\0','','CL-MICROORG','DBX-NCIT-C86814'),('CL-MICROORG-T-948',NULL,'SUTTERELLA','Any bacteria that is not assigned to the species level but can be assigned to the Sutterella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86956'),('CL-MICROORG-T-949',NULL,'SUTTONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Suttonella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86815'),('CL-MICROORG-T-95',NULL,'ATOPOBIUM PARVULUM','Any bacterial organism that can be assigned to the species Atopobium parvulum.','\0','STREPTOCOCCUS PARVULUS','CL-MICROORG','DBX-NCIT-C86157'),('CL-MICROORG-T-950',NULL,'SUTTONELLA INDOLOGENES','Any bacterial organism that can be assigned to the species Suttonella indologenes.','\0','KINGELLA INDOLOGENES','CL-MICROORG','DBX-NCIT-C86816'),('CL-MICROORG-T-951',NULL,'TATLOCKIA MICDADEI','Any bacterial organism that can be assigned to the species Legionella micdadei.','\0','LEGIONELLA MICDADEI','CL-MICROORG','DBX-NCIT-C86817'),('CL-MICROORG-T-952',NULL,'TATUMELLA','Any bacteria that is not assigned to the species level but can be assigned to the Tatumella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86818'),('CL-MICROORG-T-953',NULL,'TATUMELLA PTYSEOS','Any bacterial organism that can be assigned to the species Tatumella ptyseos.','\0','CDC GROUP EF-9','CL-MICROORG','DBX-NCIT-C86819'),('CL-MICROORG-T-954',NULL,'TETRAGENOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Tetragenococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86820'),('CL-MICROORG-T-955',NULL,'TETRAGENOCOCCUS SOLITARIUS','Any bacterial organism that can be assigned to the species Tetragenococcus solitarius.','\0','ENTEROCOCCUS SOLITARIUS','CL-MICROORG','DBX-NCIT-C86821'),('CL-MICROORG-T-956',NULL,'TICK-BORNE ENCEPHALITIS VIRUS','Any viral organism that can be assigned to the species Tick-borne encephalitis virus.','\0','FSME virus; TBEV','CL-MICROORG','DBX-NCIT-C112422'),('CL-MICROORG-T-957',NULL,'TISSIERELLA','Any bacteria that is not assigned to the species level but can be assigned to the Tissierella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86907'),('CL-MICROORG-T-958',NULL,'TISSIERELLA PRAEACUTA','Any bacterial organism that can be assigned to the species Tissierella praeacuta.','\0','','CL-MICROORG','DBX-NCIT-C86908'),('CL-MICROORG-T-959',NULL,'TRABULSIELLA','Any bacteria that is not assigned to the species level but can be assigned to the Trabulsiella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86822'),('CL-MICROORG-T-96',NULL,'ATOPOBIUM RIMAE','Any bacterial organism that can be assigned to the species Atopobium rimae.','\0','Lactobacillus rimae','CL-MICROORG','DBX-NCIT-C114244'),('CL-MICROORG-T-960',NULL,'TRABULSIELLA GUAMENSIS','Any bacterial organism that can be assigned to the species Trabulsiella guamensis.','\0','CDC ENTERIC GROUP 90','CL-MICROORG','DBX-NCIT-C86823'),('CL-MICROORG-T-961',NULL,'TREPONEMA','Any bacteria that is not assigned to the species level but can be assigned to the Treponema genus level.','\0','','CL-MICROORG','DBX-NCIT-C76385'),('CL-MICROORG-T-962',NULL,'TREPONEMA PALLIDUM','Any bacterial organism that can be assigned to the species Treponema pallidum.','\0','','CL-MICROORG','DBX-NCIT-C86825'),('CL-MICROORG-T-963',NULL,'TREPONEMA PALLIDUM SUBSP. ENDEMICUM','Any bacterial organism that can be assigned to the species Treponema pallidum subspecies endemicum.','\0','','CL-MICROORG','DBX-NCIT-C91850'),('CL-MICROORG-T-964',NULL,'TREPONEMA PALLIDUM SUBSP. PALLIDUM','Any bacterial organism that can be assigned to the species Treponema pallidum subspecies pallidum.','\0','','CL-MICROORG','DBX-NCIT-C91849'),('CL-MICROORG-T-965',NULL,'TREPONEMA PALLIDUM SUBSP. PERTENUE','Any bacterial organism that can be assigned to the species Treponema pallidum and subspecies pertenue.','\0','TREPONEMA PERTENUE','CL-MICROORG','DBX-NCIT-C86909'),('CL-MICROORG-T-966',NULL,'TRICHOSPORON ASAHII','Any fungal organism that can be assigned to the species Trichosporon asahii.','\0','T. asahii','CL-MICROORG','DBX-NCIT-C114272'),('CL-MICROORG-T-967',NULL,'TROPHERYMA','Any bacteria that is not assigned to the species level but can be assigned to the Tropheryma genus level.','\0','','CL-MICROORG','DBX-NCIT-C86826'),('CL-MICROORG-T-968',NULL,'TROPHERYMA WHIPPLEI','Any bacterial organism that can be assigned to the species Tropheryma whipplei.','\0','','CL-MICROORG','DBX-NCIT-C86827'),('CL-MICROORG-T-969',NULL,'TSUKAMURELLA','Any bacteria that is not assigned to the species level but can be assigned to the Tsukamurella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86828'),('CL-MICROORG-T-97',NULL,'AVIBACTERIUM PARAGALLINARUM','Any bacterial organism that can be assigned to the species Avibacterium paragallinarum.','\0','HAEMOPHILUS PARAGALLINARUM','CL-MICROORG','DBX-NCIT-C86158'),('CL-MICROORG-T-970',NULL,'TSUKAMURELLA PAUROMETABOLUM','Any bacterial organism that can be assigned to the species Tsukamurella paurometabolum.','\0','GORDONA AURANTIACA','CL-MICROORG','DBX-NCIT-C86829'),('CL-MICROORG-T-971',NULL,'TSUKAMURELLA PULMONIS','Any bacterial organism that can be assigned to the species Tsukamurella pulmonis.','\0','','CL-MICROORG','DBX-NCIT-C114253'),('CL-MICROORG-T-972',NULL,'TURICELLA','Any bacteria that is not assigned to the species level but can be assigned to the Turicella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86830'),('CL-MICROORG-T-973',NULL,'TURICELLA OTITIDIS','Any bacterial organism that can be assigned to the species Turicella otitidis.','\0','RHODOCOCCUS AURANTIAZUS','CL-MICROORG','DBX-NCIT-C86831'),('CL-MICROORG-T-974',NULL,'UREAPLASMA','Any bacteria that is not assigned to the species level but can be assigned to the Ureaplasma genus level.','\0','','CL-MICROORG','DBX-NCIT-C86832'),('CL-MICROORG-T-975',NULL,'UREAPLASMA UREALYTICUM','Any bacterial organism that can be assigned to the species Ureaplasma urealyticum.','\0','T-MYCOPLASMA','CL-MICROORG','DBX-NCIT-C86833'),('CL-MICROORG-T-976',NULL,'VACCINIA VIRUS','Any viral organism that can be assigned to the species Vaccinia virus.','\0','VV','CL-MICROORG','DBX-NCIT-C14281'),('CL-MICROORG-T-977',NULL,'VAGOCOCCUS','Any bacteria that is not assigned to the species level but can be assigned to the Vagococcus genus level.','\0','','CL-MICROORG','DBX-NCIT-C86834'),('CL-MICROORG-T-978',NULL,'VARIBACULUM','Any bacteria that is not assigned to the species level but can be assigned to the Varibaculum genus level.','\0','','CL-MICROORG','DBX-NCIT-C86835'),('CL-MICROORG-T-979',NULL,'VARIBACULUM CAMBRIENSE','Any bacterial organism that can be assigned to the species Varibaculum cambriense.','\0','','CL-MICROORG','DBX-NCIT-C86836'),('CL-MICROORG-T-98',NULL,'BACILLUS','Any bacteria that is not assigned to the species level but can be assigned to the Bacillus genus level.','\0','','CL-MICROORG','DBX-NCIT-C76202'),('CL-MICROORG-T-980',NULL,'VARICELLOVIRUS','Any viral organism that can be assigned to the genus Varicellovirus.','\0','Varicellavirus','CL-MICROORG','DBX-NCIT-C112426'),('CL-MICROORG-T-981',NULL,'VARIOLA VIRUS','Any viral organism that can be assigned to the species Variola virus.','\0','Smallpox Virus; Variola Virus VAR','CL-MICROORG','DBX-NCIT-C96527'),('CL-MICROORG-T-982',NULL,'VEILLONELLA','Any bacteria that is not assigned to the species level but can be assigned to the Veillonella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86837'),('CL-MICROORG-T-983',NULL,'VEILLONELLA DISPAR','Any bacterial organism that can be assigned to the species Veillonella dispar.','\0','','CL-MICROORG','DBX-NCIT-C86838'),('CL-MICROORG-T-984',NULL,'VEILLONELLA PARVULA','Any bacterial organism that can be assigned to the species Veillonella parvula.','\0','','CL-MICROORG','DBX-NCIT-C86839'),('CL-MICROORG-T-985',NULL,'VIBRIO','Any bacteria that is not assigned to the species level but can be assigned to the Vibrio genus level.','\0','','CL-MICROORG','DBX-NCIT-C76386'),('CL-MICROORG-T-986',NULL,'VIBRIO ALGINOLYTICUS','Any bacterial organism that can be assigned to the species Vibrio alginolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86840'),('CL-MICROORG-T-987',NULL,'VIBRIO CHOLERAE','Any bacterial organism that can be assigned to the species Vibrio cholerae.','\0','VIBRIO COMMA','CL-MICROORG','DBX-NCIT-C86841'),('CL-MICROORG-T-988',NULL,'VIBRIO FLUVIALIS','Any bacterial organism that can be assigned to the species Vibrio fluvialis.','\0','CDC GROUP EF-6','CL-MICROORG','DBX-NCIT-C86842'),('CL-MICROORG-T-989',NULL,'VIBRIO FURNISSII','Any bacterial organism that can be assigned to the species Vibrio furnissii.','\0','VIBRIO FLUVIALIS BIOGROUP 2','CL-MICROORG','DBX-NCIT-C86843'),('CL-MICROORG-T-99',NULL,'BACILLUS ALVEI','Any bacterial organism that can be assigned to the species Bacillus alvei.','\0','','CL-MICROORG','DBX-NCIT-C86159'),('CL-MICROORG-T-990',NULL,'VIBRIO METSCHNIKOVII','Any bacterial organism that can be assigned to the species Vibrio metschnikovii.','\0','CDC ENTERIC GROUP 16','CL-MICROORG','DBX-NCIT-C86844'),('CL-MICROORG-T-991',NULL,'VIBRIO MIMICUS','Any bacterial organism that can be assigned to the species Vibrio mimicus.','\0','SUCROSE NEGATIVE VIBRIO CHOLERAE','CL-MICROORG','DBX-NCIT-C86845'),('CL-MICROORG-T-992',NULL,'VIBRIO PARAHAEMOLYTICUS','Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus.','\0','','CL-MICROORG','DBX-NCIT-C86846'),('CL-MICROORG-T-993',NULL,'VIBRIO VULNIFICUS','Any bacterial organism that can be assigned to the species Vibrio vulnificus.','\0','BENECKEA VULNIFICA','CL-MICROORG','DBX-NCIT-C86847'),('CL-MICROORG-T-994',NULL,'WAUTERSIELLA FALSENII','Any bacterial organism that can be assigned to the species Wautersiella falsenii.','\0','','CL-MICROORG','DBX-NCIT-C111334'),('CL-MICROORG-T-995',NULL,'WEEKSELLA','Any bacteria that is not assigned to the species level but can be assigned to the Weeksella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86848'),('CL-MICROORG-T-996',NULL,'WEEKSELLA VIROSA','Any bacterial organism that can be assigned to the species Weeksella virosa.','\0','CDC GROUP IIF','CL-MICROORG','DBX-NCIT-C86849'),('CL-MICROORG-T-997',NULL,'WEST NILE VIRUS','Any viral organism that can be assigned to the species West Nile virus.','\0','WNV','CL-MICROORG','DBX-NCIT-C71877'),('CL-MICROORG-T-998',NULL,'WICKERHAMOMYCES ANOMALUS','Any fungal organism that can be assigned to the species Wickerhamomyces anomalus.','\0','C. pelliculosa; Candida pelliculosa; H. anomala; Hansenula anomala; P. anomala; Pichia anomala; W. anomalus','CL-MICROORG','DBX-NCIT-C114262'),('CL-MICROORG-T-999',NULL,'WOLINELLA','Any bacteria that is not assigned to the species level but can be assigned to the Wolinella genus level.','\0','','CL-MICROORG','DBX-NCIT-C86850'),('CL-MOTEST-T-1',NULL,'Boundary Shift Integral','A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time.','\0','Boundary Shift Integral','CL-MOTEST','DBX-NCIT-C114183'),('CL-MOTEST-T-10',NULL,'Minimum Vessel Lumen Diameter','The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view.','\0','Minimum Vessel Lumen Diameter','CL-MOTEST','DBX-NCIT-C116144'),('CL-MOTEST-T-11',NULL,'Percent Diameter Stenosis','The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD).','\0','Percent Diameter Stenosis','CL-MOTEST','DBX-NCIT-C116145'),('CL-MOTEST-T-12',NULL,'Thickness','The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.','\0','Thickness','CL-MOTEST','DBX-NCIT-C41145'),('CL-MOTEST-T-13',NULL,'Volume','The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)','\0','Volume','CL-MOTEST','DBX-NCIT-C25335'),('CL-MOTEST-T-14',NULL,'Weight','The vertical force exerted by a mass as a result of gravity. (NCI)','\0','Weight','CL-MOTEST','DBX-NCIT-C25208'),('CL-MOTEST-T-15',NULL,'Width','The extent or measurement of something from side to side. (NCI)','\0','Width','CL-MOTEST','DBX-NCIT-C25345'),('CL-MOTEST-T-2',NULL,'Depth','The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)','\0','Depth','CL-MOTEST','DBX-NCIT-C25333'),('CL-MOTEST-T-3',NULL,'In-Stent Restenosis Indicator','An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent.','\0','In-Stent Restenosis Indicator','CL-MOTEST','DBX-NCIT-C116148'),('CL-MOTEST-T-4',NULL,'Interpretation','An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connect','\0','Interpretation','CL-MOTEST','DBX-NCIT-C41255'),('CL-MOTEST-T-5',NULL,'Late Loss','The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography.','\0','Late Loss','CL-MOTEST','DBX-NCIT-C116146'),('CL-MOTEST-T-6',NULL,'Length','The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)','\0','Length','CL-MOTEST','DBX-NCIT-C25334'),('CL-MOTEST-T-7',NULL,'Lesion Restenosis Indicator','An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site.','\0','Lesion Restenosis Indicator','CL-MOTEST','DBX-NCIT-C116147'),('CL-MOTEST-T-8',NULL,'Mass','The amount of matter in an object.','\0','Mass','CL-MOTEST','DBX-NCIT-C43246'),('CL-MOTEST-T-9',NULL,'Mean Vessel Diameter','The mean of the inside diameters of the normal blood vessel segments.','\0','Mean Vessel Diameter','CL-MOTEST','DBX-NCIT-C116143'),('CL-MOTESTCD-T-1',NULL,'BSI','A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time.','\0','Boundary Shift Integral','CL-MOTESTCD','DBX-NCIT-C114183'),('CL-MOTESTCD-T-10',NULL,'MINLDIAM','The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view.','\0','Minimum Vessel Lumen Diameter','CL-MOTESTCD','DBX-NCIT-C116144'),('CL-MOTESTCD-T-11',NULL,'PCTDIAST','The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD).','\0','Percent Diameter Stenosis','CL-MOTESTCD','DBX-NCIT-C116145'),('CL-MOTESTCD-T-12',NULL,'THICK','The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.','\0','Thickness','CL-MOTESTCD','DBX-NCIT-C41145'),('CL-MOTESTCD-T-13',NULL,'VOLUME','The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)','\0','Volume','CL-MOTESTCD','DBX-NCIT-C25335'),('CL-MOTESTCD-T-14',NULL,'WEIGHT','The vertical force exerted by a mass as a result of gravity. (NCI)','\0','Weight','CL-MOTESTCD','DBX-NCIT-C25208'),('CL-MOTESTCD-T-15',NULL,'WIDTH','The extent or measurement of something from side to side. (NCI)','\0','Width','CL-MOTESTCD','DBX-NCIT-C25345'),('CL-MOTESTCD-T-2',NULL,'DEPTH','The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)','\0','Depth','CL-MOTESTCD','DBX-NCIT-C25333'),('CL-MOTESTCD-T-3',NULL,'INRSTIND','An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent.','\0','In-Stent Restenosis Indicator','CL-MOTESTCD','DBX-NCIT-C116148'),('CL-MOTESTCD-T-4',NULL,'INTP','An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connect','\0','Interpretation','CL-MOTESTCD','DBX-NCIT-C41255'),('CL-MOTESTCD-T-5',NULL,'LATELOSS','The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography.','\0','Late Loss','CL-MOTESTCD','DBX-NCIT-C116146'),('CL-MOTESTCD-T-6',NULL,'LENGTH','The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)','\0','Length','CL-MOTESTCD','DBX-NCIT-C25334'),('CL-MOTESTCD-T-7',NULL,'LRSTIND','An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site.','\0','Lesion Restenosis Indicator','CL-MOTESTCD','DBX-NCIT-C116147'),('CL-MOTESTCD-T-8',NULL,'MASS','The amount of matter in an object.','\0','Mass','CL-MOTESTCD','DBX-NCIT-C43246'),('CL-MOTESTCD-T-9',NULL,'MEANVDIA','The mean of the inside diameters of the normal blood vessel segments.','\0','Mean Vessel Diameter','CL-MOTESTCD','DBX-NCIT-C116143'),('CL-MSFATS-T-1',NULL,'Diagnostic Criteria Met','A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis.','\0','Diagnostic Criteria Met','CL-MSFATS','DBX-NCIT-C117883'),('CL-MSFATS-T-2',NULL,'Localization of Onset','The anatomical location of the beginning or early stages of a disease.','\0','Localization of Onset','CL-MSFATS','DBX-NCIT-C117884'),('CL-MSFATS-T-3',NULL,'Onset Unifocal or Multifocal','A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease.','\0','Onset Unifocal or Multifocal','CL-MSFATS','DBX-NCIT-C117885'),('CL-MSFATSCD-T-1',NULL,'DXCRITMT','A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis.','\0','Diagnostic Criteria Met','CL-MSFATSCD','DBX-NCIT-C117883'),('CL-MSFATSCD-T-2',NULL,'LOCONSET','The anatomical location of the beginning or early stages of a disease.','\0','Localization of Onset','CL-MSFATSCD','DBX-NCIT-C117884'),('CL-MSFATSCD-T-3',NULL,'OUNIMULT','A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease.','\0','Onset Unifocal or Multifocal','CL-MSFATSCD','DBX-NCIT-C117885'),('CL-MSRESCAT-T-1',NULL,'INTERMEDIATE','The growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should preven','\0','Intermediate','CL-MSRESCAT','DBX-NCIT-C85560'),('CL-MSRESCAT-T-2',NULL,'NONSUSCEPTIBLE','A category used for microorganisms that have only a susceptible interpretive criteria, but not an intermediate or resistant interpretive category (i.e., susceptible-only interpretive category). This category may be applied to new antimicrobial agents for ','\0','Non Susceptible','CL-MSRESCAT','DBX-NCIT-C85561'),('CL-MSRESCAT-T-3',NULL,'NOT APPLICABLE','Determination of a value is not relevant in the current context. (NCI)','\0','NA; Not Applicable','CL-MSRESCAT','DBX-NCIT-C48660'),('CL-MSRESCAT-T-4',NULL,'RESISTANT','The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mec','\0','Resistant','CL-MSRESCAT','DBX-NCIT-C85562'),('CL-MSRESCAT-T-5',NULL,'SUSCEPTIBLE','The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.','\0','Susceptible','CL-MSRESCAT','DBX-NCIT-C85563'),('CL-MSRESCAT-T-6',NULL,'SUSCEPTIBLE-DOSE DEPENDENT','The growth of microorganisms may be inhibited when higher than normal dosages of an antimicrobial agent are used and maximal possible blood concentration of the antimicrobial agent is achieved.','\0','Susceptible-Dose Dependent','CL-MSRESCAT','DBX-NCIT-C85559'),('CL-MSRESCAT-T-7',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-MSRESCAT','DBX-NCIT-C17998'),('CL-NCF-T-1',NULL,'CURRENT','Occurring in or belonging to the present time. (NCI)','\0','','CL-NCF','DBX-NCIT-C25471'),('CL-NCF-T-2',NULL,'FORMER','Occurring prior to something else. (NCI)','\0','Previous','CL-NCF','DBX-NCIT-C25627'),('CL-NCF-T-3',NULL,'NEVER','Not ever; at no time in the past.','\0','','CL-NCF','DBX-NCIT-C70543'),('CL-NCOMPLT-T-1',NULL,'ADVERSE EVENT','Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign ','\0','','CL-NCOMPLT','DBX-NCIT-C41331'),('CL-NCOMPLT-T-10',NULL,'PHYSICIAN DECISION','A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C48250'),('CL-NCOMPLT-T-11',NULL,'PREGNANCY','Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C25742'),('CL-NCOMPLT-T-12',NULL,'PROGRESSIVE DISEASE','A disease process that is increasing in scope or severity. (NCI)','\0','Progressive Disease','CL-NCOMPLT','DBX-NCIT-C35571'),('CL-NCOMPLT-T-13',NULL,'PROTOCOL DEVIATION','An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C48251'),('CL-NCOMPLT-T-14',NULL,'RECOVERY','A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C25746'),('CL-NCOMPLT-T-15',NULL,'SCREEN FAILURE','The potential subject who does not meet one or more criteria required for participation in a trial.','\0','','CL-NCOMPLT','DBX-NCIT-C49628'),('CL-NCOMPLT-T-16',NULL,'SITE TERMINATED BY SPONSOR','An indication that a clinical study was stopped at a particular site by its sponsor. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C106576'),('CL-NCOMPLT-T-17',NULL,'STUDY TERMINATED BY SPONSOR','An indication that a clinical study was stopped by its sponsor. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C49632'),('CL-NCOMPLT-T-18',NULL,'TECHNICAL PROBLEMS','A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C49633'),('CL-NCOMPLT-T-19',NULL,'WITHDRAWAL BY PARENT/GUARDIAN','An indication that a study participant has been removed from the study by the parent or legal guardian.','\0','','CL-NCOMPLT','DBX-NCIT-C102355'),('CL-NCOMPLT-T-2',NULL,'COMPLETED','To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C25250'),('CL-NCOMPLT-T-20',NULL,'WITHDRAWAL BY SUBJECT','An indication that a study participant has removed itself from the study. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C49634'),('CL-NCOMPLT-T-3',NULL,'DEATH','The absence of life or state of being dead. (NCI)','\0','Died','CL-NCOMPLT','DBX-NCIT-C28554'),('CL-NCOMPLT-T-4',NULL,'DISEASE RELAPSE','The return of a disease after a period of remission.','\0','Recurrent Disease','CL-NCOMPLT','DBX-NCIT-C38155'),('CL-NCOMPLT-T-5',NULL,'FAILURE TO MEET RANDOMIZATION CRITERIA','An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group.','\0','','CL-NCOMPLT','DBX-NCIT-C105448'),('CL-NCOMPLT-T-6',NULL,'LACK OF EFFICACY','The lack of expected or desired effect related to a therapy. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C48226'),('CL-NCOMPLT-T-7',NULL,'LOST TO FOLLOW-UP','The loss or lack of continuation of a subject to follow-up.','\0','','CL-NCOMPLT','DBX-NCIT-C48227'),('CL-NCOMPLT-T-8',NULL,'NON-COMPLIANCE WITH STUDY DRUG','An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)','\0','','CL-NCOMPLT','DBX-NCIT-C49631'),('CL-NCOMPLT-T-9',NULL,'OTHER','Different than the one(s) previously specified or mentioned. (NCI)','\0','Other','CL-NCOMPLT','DBX-NCIT-C17649'),('CL-ND-T-1',NULL,'NOT DONE','Indicates a task, process or examination that has either not been initiated or completed. (NCI)','\0','','CL-ND','DBX-NCIT-C49484'),('CL-NEOPLASM-T-1',NULL,'ACINAR-ISLET CELL TUMOR, BENIGN','A benign tumor of the pancreas with morphologic characteristics of endocrine, acinar and ductal cells. (INHAND)','\0','','CL-NEOPLASM','DBX-NCIT-C116215'),('CL-NEOPLASM-T-10',NULL,'ADENOCARCINOMA, SEBACEOUS, MALIGNANT','An adenocarcinoma with sebaceous differentiation.','\0','CARCINOMA OF SEBACEOUS GLAND; CARCINOMA OF THE SEBACEOUS GLAND; SEBACEOUS GLAND CARCINOMA','CL-NEOPLASM','DBX-NCIT-C40310'),('CL-NEOPLASM-T-100',NULL,'CHEMODECTOMA, UNDETERMINED','A neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale) for which the malignancy status has not be established.','\0','CAROTID BODY CHEMODECTOMA; CAROTID BODY TUMOR; CHEMODECTOMA; PARAGANGLIOMA OF CAROTID BODY; PARAGANGLIOMA OF THE CAROTID BODY; TUMOR OF CAROTID BODY; TUMOR OF THE CAROTID BODY','CL-NEOPLASM','DBX-NCIT-C2932'),('CL-NEOPLASM-T-101',NULL,'CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT','A malignant neoplasm of the liver arising from/comprising cells resembling those of bile ducts.','\0','INTRAHEPATIC BILE DUCT CARCINOMA; INTRAHEPATIC CARCINOMA OF BILE DUCT; INTRAHEPATIC CARCINOMA OF THE BILE DUCT','CL-NEOPLASM','DBX-NCIT-C35417'),('CL-NEOPLASM-T-102',NULL,'CHOLANGIOCARCINOMA, MALIGNANT','A malignant neoplasm arising from/comprising cells resembling those of bile ducts.','\0','CHOLANGIOCELLULAR CARCINOMA','CL-NEOPLASM','DBX-NCIT-C4436'),('CL-NEOPLASM-T-103',NULL,'CHOLANGIOMA, BENIGN','A benign neoplasm arising from/comprising cells resembling those of bile ducts.','\0','ADENOMA OF BILE DUCT; ADENOMA OF THE BILE DUCT; CHOLANGIOADENOMA; CHOLANGIOMA; HEPATOCHOLANGIOCELLULAR ADENOMA; HEPATOCHOLANGIOMA','CL-NEOPLASM','DBX-NCIT-C2942'),('CL-NEOPLASM-T-104',NULL,'CHONDROMA, BENIGN','A benign, well circumscribed neoplasm arising from the hyaline cartilage in soft tissue or bone. It is characterized by the presence of chondrocytes.','\0','','CL-NEOPLASM','DBX-NCIT-C53459'),('CL-NEOPLASM-T-105',NULL,'CHONDROSARCOMA, MALIGNANT','A malignant mesenchymal neoplasm arising from cartilage-forming tissues.','\0','','CL-NEOPLASM','DBX-NCIT-C2946'),('CL-NEOPLASM-T-106',NULL,'CHORDOMA, BENIGN','A benign bone neoplasm arising from the remnants of the fetal notochord.','\0','','CL-NEOPLASM','DBX-NCIT-C60334'),('CL-NEOPLASM-T-107',NULL,'CHORDOMA, MALIGNANT','A malignant bone neoplasm arising from the remnants of the fetal notochord.','\0','','CL-NEOPLASM','DBX-NCIT-C2947'),('CL-NEOPLASM-T-108',NULL,'CHORIOCARCINOMA, MALIGNANT','A malignant neoplasm arising from placental trophoblast cells. They generally arise in the uterus.','\0','CHORIOEPITHELIOMA','CL-NEOPLASM','DBX-NCIT-C2948'),('CL-NEOPLASM-T-109',NULL,'CONNECTIVE AND SOFT TISSUE NEOPLASM, BENIGN','A benign neoplasm arising from connective and soft tissues that does not invade adjacent tissues or metastasize to other anatomic sites.','\0','BENIGN CONNECTIVE AND SOFT TISSUE NEOPLASM; BENIGN CONNECTIVE AND SOFT TISSUE TUMOR; BENIGN MESENCHYMAL CELL NEOPLASM; BENIGN NEOPLASM OF THE SOFT TISSUE AND BONE; BENIGN TUMOR OF THE SOFT TISSUE AND BONE','CL-NEOPLASM','DBX-NCIT-C53684'),('CL-NEOPLASM-T-11',NULL,'ADENOFIBROMA, BENIGN','Benign mixed neoplasm comprised of epithelial/glandular and mesenchymal structures.','\0','BENIGN MIXED MUELLERIAN TUMOR','CL-NEOPLASM','DBX-NCIT-C8984'),('CL-NEOPLASM-T-110',NULL,'CRANIOPHARYNGIOMA, BENIGN','A benign epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium.','\0','CYSTOMA; NEOPLASM OF RATHKE\'S POUCH; RATHKE POUCH NEOPLASM; RATHKE POUCH TUMOR; RATHKE\'S POUCH NEOPLASM; RATHKE\'S POUCH TUMOR; TUMOR OF RATHKE\'S POUCH','CL-NEOPLASM','DBX-NCIT-C2964'),('CL-NEOPLASM-T-111',NULL,'CRANIOPHARYNGIOMA, MALIGNANT','A malignant epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium.','\0','CARCINOMA ARISING FROM CRANIOPHARYNGIOMA','CL-NEOPLASM','DBX-NCIT-C79949'),('CL-NEOPLASM-T-112',NULL,'CYSTADENOCARCINOMA, MALIGNANT','A malignant cystic epithelial neoplasm arising from glandular epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C2971'),('CL-NEOPLASM-T-113',NULL,'CYSTADENOCARCINOMA, PAPILLARY, MALIGNANT','A malignant cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures.','\0','','CL-NEOPLASM','DBX-NCIT-C3777'),('CL-NEOPLASM-T-114',NULL,'CYSTADENOMA, BENIGN','A benign cystic epithelial neoplasm arising from glandular epithelium.','\0','CYSTOMA','CL-NEOPLASM','DBX-NCIT-C2972'),('CL-NEOPLASM-T-115',NULL,'CYSTADENOMA, PAPILLARY, BENIGN','A benign cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures.','\0','','CL-NEOPLASM','DBX-NCIT-C2974'),('CL-NEOPLASM-T-116',NULL,'DECIDUOMA, MALIGNANT','A malignant neoplasm arising from decidua (placental) cells.','\0','MALIGNANT NEOPLASM OF PLACENTA; MALIGNANT NEOPLASM OF THE PLACENTA; MALIGNANT PLACENTAL NEOPLASM; MALIGNANT PLACENTAL TUMOR; MALIGNANT TUMOR OF PLACENTA; MALIGNANT TUMOR OF THE PLACENTA','CL-NEOPLASM','DBX-NCIT-C3555'),('CL-NEOPLASM-T-117',NULL,'DECIDUOMA, UNDETERMINED','A neoplasm arising from decidua (placental) cells in which the malignancy status has not been established.','\0','NEOPLASM OF PLACENTA; NEOPLASM OF THE PLACENTA; PLACENTA NEOPLASM; PLACENTA NEOPLASMS; PLACENTA TUMOR; PLACENTA TUMORS; PLACENTAL TUMOR; PLACENTAL TUMORS; TUMOR OF PLACENTA; TUMOR OF THE PLACENTA','CL-NEOPLASM','DBX-NCIT-C4858'),('CL-NEOPLASM-T-118',NULL,'DERMOID CYST, BENIGN','A benign neoplasm comprised of a cyst, lined by mature epidermis-like tissue with dermal appendages.','\0','BENIGN CYSTIC TERATOMA; DERMOID; MATURE CYSTIC TERATOMA','CL-NEOPLASM','DBX-NCIT-C9011'),('CL-NEOPLASM-T-119',NULL,'DYSGERMINOMA, MALIGNANT','A malignant germ cell neoplasm characterized by the presence of a monotonous primitive germ cell population, primarily in the ovary.','\0','','CL-NEOPLASM','DBX-NCIT-C2996'),('CL-NEOPLASM-T-12',NULL,'ADENOLIPOMA, BENIGN','Benign mixed neoplasm comprised of epithelial/glandular and lipomatous structures.','\0','','CL-NEOPLASM','DBX-NCIT-C4159'),('CL-NEOPLASM-T-120',NULL,'EPENDYMOMA, ANAPLASTIC, MALIGNANT','A malignant neoplasm of ependymal origin with anaplastic cellular morphology.','\0','ANAPLASTIC EPENDYMAL NEOPLASM; ANAPLASTIC EPENDYMAL TUMOR; MALIGNANT EPENDYMOMA; UNDIFFERENTIATED EPENDYMAL NEOPLASM; UNDIFFERENTIATED EPENDYMAL TUMOR; UNDIFFERENTIATED EPENDYMOMA; WHO GRADE III EPENDYMAL NEOPLASM; WHO GRADE III EPENDYMAL TUMOR','CL-NEOPLASM','DBX-NCIT-C4049'),('CL-NEOPLASM-T-121',NULL,'EPENDYMOMA, BENIGN','A benign neoplasm of ependymal origin.','\0','','CL-NEOPLASM','DBX-NCIT-C3697'),('CL-NEOPLASM-T-122',NULL,'EPENDYMOMA, UNDETERMINED','A neoplasm of ependymal origin, for which the malignancy status has not been established.','\0','WHO GRADE II EPENDYMAL NEOPLASM; WHO GRADE II EPENDYMAL TUMOR','CL-NEOPLASM','DBX-NCIT-C3017'),('CL-NEOPLASM-T-123',NULL,'EPITHELIOMA, BENIGN','A benign neoplasm arising from epithelial cells of the skin.','\0','BENIGN EPITHELIAL TUMOR; BENIGN EPITHELIOMA; BENIGN NEOPLASM OF EPITHELIUM; BENIGN NEOPLASM OF THE EPITHELIUM; BENIGN TUMOR OF EPITHELIUM; BENIGN TUMOR OF THE EPITHELIUM','CL-NEOPLASM','DBX-NCIT-C4092'),('CL-NEOPLASM-T-124',NULL,'EPITHELIOMA, CYSTIC KERATINIZING, BENIGN','A benign cystic epithelial neoplasm featuring a central keratin mass surrounded by squamous epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C80349'),('CL-NEOPLASM-T-125',NULL,'EPITHELIOMA, NON-KERATINIZING, BENIGN','A benign cystic epithelial neoplasm characterized by the absence of keratin production.','\0','','CL-NEOPLASM','DBX-NCIT-C84356'),('CL-NEOPLASM-T-126',NULL,'FIBROADENOCARCINOMA, MALIGNANT','A malignant neoplasm originating from glandular cells with a fibrous or fibroblastic component.','\0','ADENOCARCINOMA WITH PRODUCTIVE FIBROSIS; FIBROCARCINOMA; SCIRRHOUS CARCINOMA','CL-NEOPLASM','DBX-NCIT-C2928'),('CL-NEOPLASM-T-127',NULL,'FIBROADENOMA, BENIGN','A benign neoplasm originating from glandular cells with a fibrous or fibroblastic component.','\0','BREAST FIBROADENOMA; FIBROADENOMA OF BREAST; FIBROADENOMA OF THE BREAST','CL-NEOPLASM','DBX-NCIT-C3744'),('CL-NEOPLASM-T-128',NULL,'FIBROLIPOMA, BENIGN','A benign neoplasm comprising mature adipocytes, characterized by areas of abundant fibrous tissue.','\0','','CL-NEOPLASM','DBX-NCIT-C4249'),('CL-NEOPLASM-T-129',NULL,'FIBROMA, BENIGN','A benign neoplasm arising from fibrous tissue.','\0','','CL-NEOPLASM','DBX-NCIT-C3041'),('CL-NEOPLASM-T-13',NULL,'ADENOMA, ACINAR CELL, BENIGN','A benign glandular epithelial neoplasm comprising secretory cells forming acinar patterns.','\0','ACINAR ADENOMA; ACINIC CELL ADENOMA','CL-NEOPLASM','DBX-NCIT-C4196'),('CL-NEOPLASM-T-130',NULL,'FIBROMA, ODONTOGENIC, BENIGN','A benign intraosseous neoplasm arising from tooth-forming tissues in the mandible and maxilla, characterized by the presence of islands of odontogenic epithelium.','\0','CENTRAL ODONTOGENIC FIBROMA','CL-NEOPLASM','DBX-NCIT-C4314'),('CL-NEOPLASM-T-131',NULL,'FIBROMA, OSSIFYING, BENIGN','A benign fibrous neoplasm characterized by a mineralized component (woven bone, lamellar bone, or cementum-like material).','\0','CEMENTIFYING FIBROMA; CEMENTO-OSSIFYING FIBROMA; OSSIFYING FIBROMA','CL-NEOPLASM','DBX-NCIT-C8422'),('CL-NEOPLASM-T-132',NULL,'FIBROMYXOMA, BENIGN','A benign soft-tissue neoplasm of uncertain lineage, characterized by the presence of neoplastic spindle-shaped to round cells and a fibromyxoid stroma.','\0','FIBROMYXOMA','CL-NEOPLASM','DBX-NCIT-C66760'),('CL-NEOPLASM-T-133',NULL,'FIBROPAPILLOMA, BENIGN','A benign polypoid tumor comprising fibrous tissue and epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C3337'),('CL-NEOPLASM-T-134',NULL,'FIBROSARCOMA, MALIGNANT','A malignant mesenchymal neoplasm of the soft tissue and bone.','\0','','CL-NEOPLASM','DBX-NCIT-C3043'),('CL-NEOPLASM-T-135',NULL,'GANGLIOGLIOMA, UNDETERMINED','A neuroepithelial neoplasm comprised of neoplastic ganglion cells and neoplastic glial cells, in which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3788'),('CL-NEOPLASM-T-136',NULL,'GANGLIONEUROBLASTOMA, MALIGNANT','A malignant neoplasm characterized by the presence of neuroblastic and ganglion cells and a stroma with Schwannian differentiation.','\0','','CL-NEOPLASM','DBX-NCIT-C3790'),('CL-NEOPLASM-T-137',NULL,'GANGLIONEUROMA, BENIGN','A benign neoplasm characterized by the presence of ganglion cells and spindle cell proliferation, located primarily in the brain, ganglia, or adrenal medulla.','\0','NEURAL CREST TUMOR, BENIGN','CL-NEOPLASM','DBX-NCIT-C3049'),('CL-NEOPLASM-T-138',NULL,'GIANT CELL TUMOR, BENIGN','A benign neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells.','\0','BENIGN BONE GIANT CELL TUMOR; OSTEOCLASTOMA, BENIGN','CL-NEOPLASM','DBX-NCIT-C27477'),('CL-NEOPLASM-T-139',NULL,'GIANT CELL TUMOR, MALIGNANT','A malignant neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells.','\0','MALIGNANT GIANT CELL TUMOR','CL-NEOPLASM','DBX-NCIT-C4090'),('CL-NEOPLASM-T-14',NULL,'ADENOMA, ADNEXAL, BENIGN','A benign epithelial neoplasm arising from the sebaceous or sweat glands.','\0','ADENOMA OF ADNEXA; ADENOMA OF SKIN APPENDAGE; ADNEXAL ADENOMA','CL-NEOPLASM','DBX-NCIT-C7580'),('CL-NEOPLASM-T-140',NULL,'GIANT CELL TUMOR, UNDETERMINED','A neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells, for which the malignancy status has not been established.','\0','TUMOR OF GIANT CELL; TUMOR OF THE GIANT CELL','CL-NEOPLASM','DBX-NCIT-C3055'),('CL-NEOPLASM-T-141',NULL,'GLIOMA, MALIGNANT','A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others.','\0','MALIGNANT GLIAL NEOPLASM; MALIGNANT GLIAL TUMOR; MALIGNANT NEUROGLIAL NEOPLASM; MALIGNANT NEUROGLIAL TUMOR','CL-NEOPLASM','DBX-NCIT-C4822'),('CL-NEOPLASM-T-142',NULL,'GLIOMA, MIXED, MALIGNANT','A malignant neoplasm comprising two or more glial cell types (e.g., astrocytes, ependymal cells, oligodendrocytes).','\0','GLIOMA, MIXED; MIXED GLIAL NEOPLASM; MIXED GLIAL TUMOR; MIXED NEUROGLIAL NEOPLASM; MIXED NEUROGLIAL TUMOR','CL-NEOPLASM','DBX-NCIT-C3903'),('CL-NEOPLASM-T-143',NULL,'GRANULAR CELL TUMOR, BENIGN','A benign neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues.','\0','BENIGN GRANULAR CELL MYOBLASTOMA; BENIGN GRANULAR CELL NEOPLASM; BENIGN GRANULAR CELL TUMOR; MYOBLASTOMA','CL-NEOPLASM','DBX-NCIT-C3252'),('CL-NEOPLASM-T-144',NULL,'GRANULAR CELL TUMOR, MALIGNANT','A malignant neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues.','\0','MALIGNANT GRANULAR CELL MYOBLASTOMA; MALIGNANT GRANULAR CELL NEOPLASM; MYOBLASTOMA, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C4336'),('CL-NEOPLASM-T-145',NULL,'GRANULOSA CELL TUMOR, BENIGN','A benign neoplasm of the ovary, originating from granulosa cells.','\0','','CL-NEOPLASM','DBX-NCIT-C60340'),('CL-NEOPLASM-T-146',NULL,'GRANULOSA CELL TUMOR, MALIGNANT','A malignant neoplasm of the ovary, originating from granulosa cells.','\0','MALIGNANT GRANULOSA CELL TUMOR','CL-NEOPLASM','DBX-NCIT-C4205'),('CL-NEOPLASM-T-147',NULL,'GRANULOSA CELL TUMOR, UNDETERMINED','A neoplasm of the ovary (or testis), originating from granulosa cells for which the malignancy status has not been established.','\0','GRANULOSA CELL NEOPLASM','CL-NEOPLASM','DBX-NCIT-C3070'),('CL-NEOPLASM-T-148',NULL,'HAIR FOLLICLE NEOPLASM, BENIGN','A benign neoplasm that arises from the hair follicle.','\0','BENIGN FOLLICULAR NEOPLASM; BENIGN FOLLICULAR TUMOR; BENIGN HAIR FOLLICLE TUMOR','CL-NEOPLASM','DBX-NCIT-C27520'),('CL-NEOPLASM-T-149',NULL,'HAIR FOLLICLE NEOPLASM, MALIGNANT','A malignant neoplasm that arises from the hair follicle.','\0','MALIGNANT HAIR FOLLICLE TUMOR','CL-NEOPLASM','DBX-NCIT-C43310'),('CL-NEOPLASM-T-15',NULL,'ADENOMA, ADRENOCORTICAL, BENIGN','A benign neoplasm arising from any of the adrenal cortical layers.','\0','ADENOMA OF ADRENAL CORTEX; ADENOMA OF ADRENAL GLAND; ADENOMA OF THE ADRENAL CORTEX; ADENOMA OF THE ADRENAL GLAND; ADRENAL ADENOMA; ADRENAL CORTICAL ADENOMA; ADRENAL GLAND ADENOMA; ADRENOCORTICAL ADENOMA; BENIGN ADENOMA OF ADRENAL GLAND; BENIGN ADENOMA OF ','CL-NEOPLASM','DBX-NCIT-C9003'),('CL-NEOPLASM-T-150',NULL,'HAIR FOLLICLE NEOPLASM, UNDETERMINED','A neoplasm that arises from the hair follicle, for which the malignancy status has not been established.','\0','HAIR FOLLICLE TUMOR; HAIR MATRIX NEOPLASM; HAIR MATRIX TUMOR; NEOPLASM OF HAIR FOLLICLE; NEOPLASM OF THE HAIR FOLLICLE','CL-NEOPLASM','DBX-NCIT-C7367'),('CL-NEOPLASM-T-151',NULL,'HEMANGIOMA, BENIGN','A benign vascular neoplasm characterized by the formation of capillary-sized or cavernous vascular channels.','\0','ANGIOMA; BENIGN ANGIOMA; BENIGN HEMANGIOMA','CL-NEOPLASM','DBX-NCIT-C3085'),('CL-NEOPLASM-T-152',NULL,'HEMANGIOPERICYTOMA, BENIGN','A benign neoplasm originating from vascular pericytes (cells in the periphery of vessels).','\0','','CL-NEOPLASM','DBX-NCIT-C4300'),('CL-NEOPLASM-T-153',NULL,'HEMANGIOPERICYTOMA, MALIGNANT','A malignant neoplasm originating from vascular pericytes (cells in the periphery of vessels).','\0','MALIGNANT HEMANGIOPERICYTOMA NOS','CL-NEOPLASM','DBX-NCIT-C4301'),('CL-NEOPLASM-T-154',NULL,'HEMANGIOPERICYTOMA, UNDETERMINED','A neoplasm originating from vascular pericytes (cells in the periphery of vessels), for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3087'),('CL-NEOPLASM-T-155',NULL,'HEMANGIOSARCOMA, MALIGNANT','A malignant vascular neoplasm arising from endothelial cells.','\0','HEMANGIOSARCOMA','CL-NEOPLASM','DBX-NCIT-C3088'),('CL-NEOPLASM-T-156',NULL,'HEPATOBLASTOMA, MALIGNANT','A malignant liver neoplasm composed of immature hepatocytic elements.','\0','HBL; PEDIATRIC EMBRYONAL HEPATOMA; PEDIATRIC HEPATOBLASTOMA','CL-NEOPLASM','DBX-NCIT-C3728'),('CL-NEOPLASM-T-157',NULL,'HIBERNOMA, BENIGN','A benign neoplasm of the brown adipose tissue.','\0','BROWN FAT NEOPLASM; BROWN FAT TUMOR; FETAL FAT CELL LIPOMA','CL-NEOPLASM','DBX-NCIT-C3702'),('CL-NEOPLASM-T-158',NULL,'HIBERNOMA, MALIGNANT','A malignant neoplasm arising from the brown adipose tissue in animals, usually in the subcutis and the thoracic cavity.','\0','MALIGNANT HIBERNOMA','CL-NEOPLASM','DBX-NCIT-C103394'),('CL-NEOPLASM-T-159',NULL,'HISTIOCYTOMA, BENIGN','A benign dermal neoplasm comprising of round cells, resembling histiocytes. The tumor commonly occurs in young dogs and may regress spontaneously.','\0','','CL-NEOPLASM','DBX-NCIT-C98708'),('CL-NEOPLASM-T-16',NULL,'ADENOMA, ANTERIOR LOBE PITUITARY GLAND, BENIGN','A benign neoplasm of the anterior lobe of the pituitary gland.','\0','ADENOMA OF PITUITARY; ADENOMA OF PITUITARY GLAND; ADENOMA OF THE PITUITARY; ADENOMA OF THE PITUITARY GLAND; PITUITARY ADENOMA','CL-NEOPLASM','DBX-NCIT-C3329'),('CL-NEOPLASM-T-160',NULL,'HISTIOCYTOMA, FIBROUS, BENIGN','A benign neoplasm composed of a fibroblastic and a histiocytic component.','\0','FIBROUS HISTIOCYTOMA','CL-NEOPLASM','DBX-NCIT-C3739'),('CL-NEOPLASM-T-161',NULL,'HISTIOCYTOMA, FIBROUS, MALIGNANT','A malignant neoplasm composed of a fibroblastic and a histiocytic component.','\0','FIBROXANTHOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA OF SOFT TISSUE AND BONE; MALIGNANT FIBROUS HISTIOCYTOMA OF THE SOFT TISSUE AND BONE; MALIGNANT FIBROXANTHOMA; MFH','CL-NEOPLASM','DBX-NCIT-C4247'),('CL-NEOPLASM-T-162',NULL,'HISTIOCYTOMA, FIBROUS, UNDETERMINED','A neoplasm composed of a fibroblastic and a histiocytic component, for which the malignancy status has not been established.','\0','FIBROHISTIOCYTIC TUMOR','CL-NEOPLASM','DBX-NCIT-C8402'),('CL-NEOPLASM-T-163',NULL,'HISTIOCYTOMA, UNDETERMINED','A neoplasm composed of histiocytic cells, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C35765'),('CL-NEOPLASM-T-164',NULL,'ITO CELL TUMOR, BENIGN','A benign neoplasm of the liver composed of hepatic stellate cells (Ito cells).','\0','BENIGN SPONGIOTIC PERICYTOMA','CL-NEOPLASM','DBX-NCIT-C80351'),('CL-NEOPLASM-T-165',NULL,'ITO CELL TUMOR, MALIGNANT','A malignant neoplasm of the liver composed of hepatic stellate cells (Ito cells).','\0','MALIGNANT SPONGIOTIC PERICYTOMA','CL-NEOPLASM','DBX-NCIT-C80352'),('CL-NEOPLASM-T-166',NULL,'KERATOACANTHOMA, BENIGN','A benign neoplasm in the superficial dermis with direct association to the epidermis, composed of well differentiated squamous epithelium and a central cavity filled with concentric layers of keratin; a pore (opening in the epidermis) may be present.','\0','','CL-NEOPLASM','DBX-NCIT-C117977'),('CL-NEOPLASM-T-167',NULL,'KERATOACANTHOMA, UNDETERMINED','An epithelial skin neoplasm, composed of squamous cells, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3146'),('CL-NEOPLASM-T-168',NULL,'LEIOMYOBLASTOMA, BENIGN','A benign neoplasm of the gastro-intestinal tract, originating from smooth muscle cells.','\0','','CL-NEOPLASM','DBX-NCIT-C81854'),('CL-NEOPLASM-T-169',NULL,'LEIOMYOBLASTOMA, MALIGNANT','A malignant neoplasm of the gastro-intestinal tract, originating from smooth muscle cells.','\0','','CL-NEOPLASM','DBX-NCIT-C81855'),('CL-NEOPLASM-T-17',NULL,'ADENOMA, BASAL CELL, BENIGN','A benign epithelial neoplasm with a uniform, monomorphic appearance that is dominated by basal cells.','\0','BASAL CELL ADENOMA; BENIGN BASAL CELL TUMOR','CL-NEOPLASM','DBX-NCIT-C111198'),('CL-NEOPLASM-T-170',NULL,'LEIOMYOBLASTOMA, UNDETERMINED','A neoplasm of the gastro-intestinal tract, originating from smooth muscle cells, for which the malignancy status has not been established.','\0','EPITHELIOID CELL TYPE GIST; LEIOMYOBLASTOMA; STOUT\'S LEIOMYOBLASTOMA','CL-NEOPLASM','DBX-NCIT-C3486'),('CL-NEOPLASM-T-171',NULL,'LEIOMYOMA, BENIGN','A benign neoplasm, originating from smooth muscle cells.','\0','FIBROID; FIBROID NEOPLASM; FIBROID TUMOR; LEIOMYOMATOUS NEOPLASM; LEIOMYOMATOUS TUMOR','CL-NEOPLASM','DBX-NCIT-C3157'),('CL-NEOPLASM-T-172',NULL,'LEIOMYOSARCOMA, MALIGNANT','A malignant neoplasm, originating from smooth muscle cells.','\0','LEIOMYOSARCOMAS','CL-NEOPLASM','DBX-NCIT-C3158'),('CL-NEOPLASM-T-173',NULL,'LEUKEMIA, ERYTHROID, MALIGNANT','A progressive, proliferative disease of blood cells, originating from immature erythroid cells.','\0','ACUTE ERYTHROBLASTIC LEUKEMIA; ERYTHROBLASTIC LEUKEMIA; FAB M6; M6 ACUTE MYELOID LEUKEMIA','CL-NEOPLASM','DBX-NCIT-C8923'),('CL-NEOPLASM-T-174',NULL,'LEUKEMIA, GRANULOCYTIC, MALIGNANT','A progressive, proliferative disease of blood cells, originating from immature granulocytes.','\0','LEUKEMIA GRANULOCYTIC; LEUKEMIA MYELOID; MYELOCYTIC LEUKEMIA; MYELOGENOUS LEUKEMIA; NON-LYMPHOBLASTIC LEUKEMIA; NON-LYMPHOCYTIC LEUKEMIA','CL-NEOPLASM','DBX-NCIT-C3172'),('CL-NEOPLASM-T-175',NULL,'LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC, MALIGNANT','A progressive, proliferative disease of blood cells which are large and granular, originating from lymphoid cells.','\0','LARGE CELL GRANULAR LYMPHOGENOUS LEUKEMIA; LARGE CELL GRANULAR LYMPHOID LEUKEMIA; LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; LARGE GRANULAR LYMPHOCYTOSIS; LGLL; T GAMMA LYMPHOPROLIFERATIVE DISORDER; T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; T-GAMMA LYMPHOPROL','CL-NEOPLASM','DBX-NCIT-C4664'),('CL-NEOPLASM-T-176',NULL,'LEUKEMIA, LYMPHOBLASTIC, MALIGNANT','A progressive, proliferative disease of blood cells, originating from immature lymphoid cells.','\0','ACUTE LYMPHOCYTIC LEUKAEMIA; ACUTE LYMPHOCYTIC LEUKEMIAS; ACUTE LYMPHOGENOUS LEUKEMIA; ACUTE LYMPHOID LEUKEMIA; ALL; ALL - ACUTE LYMPHOCYTIC LEUKEMIA; LYMPHOBLASTIC LEUKEMIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA; PRECURSOR LYMPHOBLASIC LEUKEMIA','CL-NEOPLASM','DBX-NCIT-C3167'),('CL-NEOPLASM-T-177',NULL,'LEUKEMIA, LYMPHOCYTIC, MALIGNANT','A progressive, proliferative disease of blood cells, originating from lymphoid cells.','\0','LYMPHOCYTIC LEUKEMIA; LYMPHOGENOUS LEUKEMIA','CL-NEOPLASM','DBX-NCIT-C7539'),('CL-NEOPLASM-T-178',NULL,'LEUKEMIA, MALIGNANT','A progressive, proliferative disease of blood cells, originating from myeloid or lymphoid stem cells.','\0','BLOOD (LEUKEMIA); LEUKEMIA NOS; LEUKEMIAS; LEUKEMIAS, GENERAL','CL-NEOPLASM','DBX-NCIT-C3161'),('CL-NEOPLASM-T-179',NULL,'LEUKEMIA, MEGAKARYOCYTIC, MALIGNANT','A progressive, proliferative disease of blood cells, originating from immature megakaryocytes.','\0','ACUTE M7 MYELOID LEUKEMIA; ACUTE MEGAKARYOBLASTIC LEUKEMIA (FAB TYPE M7); ACUTE MEGAKARYOCYTIC LEUKEMIA; FAB M7','CL-NEOPLASM','DBX-NCIT-C3170'),('CL-NEOPLASM-T-18',NULL,'ADENOMA, BENIGN','A benign neoplasm arising from epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C2855'),('CL-NEOPLASM-T-180',NULL,'LEUKEMIA, MONOCYTIC, MALIGNANT','A progressive, proliferative disease of blood cells, originating from immature monocytes.','\0','ACUTE MONOCYTIC LEUKEMIA (FAB M5B); MONOCYTIC LEUKEMIA','CL-NEOPLASM','DBX-NCIT-C4861'),('CL-NEOPLASM-T-181',NULL,'LEYDIG CELL TUMOR, BENIGN','A benign neoplasm of the testis originating from interstitial (Leydig) cells.','\0','ADENOMA, INTERSTITIAL; BENIGN INTERSTITIAL CELL NEOPLASM; BENIGN INTERSTITIAL CELL TUMOR; BENIGN LEYDIG CELL NEOPLASM','CL-NEOPLASM','DBX-NCIT-C4212'),('CL-NEOPLASM-T-182',NULL,'LEYDIG CELL TUMOR, MALIGNANT','A malignant neoplasm of the testis originating from interstitial (Leydig) cells.','\0','MALIGNANT INTERSTITIAL CELL NEOPLASM; MALIGNANT INTERSTITIAL CELL TUMOR; MALIGNANT LEYDIG CELL NEOPLASM','CL-NEOPLASM','DBX-NCIT-C4213'),('CL-NEOPLASM-T-183',NULL,'LEYDIG CELL TUMOR, UNDETERMINED','A neoplasm of the testis originating from interstitial (Leydig) cells, for which the malignancy status has not been established.','\0','INTERSTITIAL CELL NEOPLASM; INTERSTITIAL CELL TUMOR; LEYDIG CELL NEOPLASM; LEYDIG CELL TUMOR','CL-NEOPLASM','DBX-NCIT-C3188'),('CL-NEOPLASM-T-184',NULL,'LIPOMA, BENIGN','A benign neoplasm composed of adipose tissue.','\0','','CL-NEOPLASM','DBX-NCIT-C3192'),('CL-NEOPLASM-T-185',NULL,'LIPOSARCOMA, MALIGNANT','A malignant neoplasm composed of adipose tissue.','\0','','CL-NEOPLASM','DBX-NCIT-C3194'),('CL-NEOPLASM-T-186',NULL,'LUTEOMA, BENIGN','A benign neoplasm of the ovary, composed of leuteinized granulosa-theca cells.','\0','LUTEAL CELL NEOPLASM; LUTEAL CELL TUMOR; LUTEINOMA; LUTEOMA; OVARIAN STROMA LUTEOMA','CL-NEOPLASM','DBX-NCIT-C3202'),('CL-NEOPLASM-T-187',NULL,'LYMPHANGIOMA, BENIGN','A benign neoplasm arising from the lymphatics.','\0','','CL-NEOPLASM','DBX-NCIT-C8965'),('CL-NEOPLASM-T-188',NULL,'LYMPHANGIOSARCOMA, MALIGNANT','A malignant neoplasm arising from the endothelial cells of the lymphatic vessels.','\0','LYMPHANGIOENDOTHELIAL SARCOMA; MALIGNANT LYMPHANGIOENDOTHELIOMA','CL-NEOPLASM','DBX-NCIT-C3205'),('CL-NEOPLASM-T-189',NULL,'LYMPHOMA, FOLLICULAR, MALIGNANT','A neoplasm of lymphoid cells which has at least a partial follicular pattern.','\0','FOLLICLE CENTER LYMPHOMA; FOLLICULAR CENTRE CELL LYMPHOMA; FOLLICULAR NON-HODGKIN LYMPHOMA; FOLLICULAR NON-HODGKIN\'S LYMPHOMA; LYMPHOMA, FOLLICULAR CENTRE CELL','CL-NEOPLASM','DBX-NCIT-C3209'),('CL-NEOPLASM-T-19',NULL,'ADENOMA, BRONCHIAL, BENIGN','A benign neoplasia of the lung, arising from bronchial epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C3494'),('CL-NEOPLASM-T-190',NULL,'LYMPHOMA, HISTIOCYTIC, MALIGNANT','A malignant neoplasm of large lymphocytes, which resemble histiocytes.','\0','LYMPHOMA, LARGE CELL, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C114110'),('CL-NEOPLASM-T-191',NULL,'LYMPHOMA, IMMUNOBLASTIC, MALIGNANT','A malignant neoplasm composed of immunoblasts (large B cells).','\0','','CL-NEOPLASM','DBX-NCIT-C3461'),('CL-NEOPLASM-T-192',NULL,'LYMPHOMA, LYMPHOBLASTIC, MALIGNANT','A malignant neoplasm composed of lymphoblasts (lymphoid precursor cells).','\0','PRECURSOR CELL LYMPHOBLASTIC LYMPHOMA; PRECURSOR LYMPHOBLASTIC LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C9360'),('CL-NEOPLASM-T-193',NULL,'LYMPHOMA, LYMPHOPLASMACYTIC, MALIGNANT','A malignant neoplasm composed of lymphocytes (B-cells), lymphoplasmacytoid cells, and plasma cells.','\0','IMMUNOCYTOMA, LYMPHOPLASMACYTIC TYPE; LYMPHOMA, PLASMACYTIC; LYMPHOPLASMACYTOID LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C3212'),('CL-NEOPLASM-T-194',NULL,'LYMPHOMA, MALIGNANT','A malignant neoplasm composed of lymphocytes of B- or T/NK-cell phenotype.','\0','LYMPHOMA (HODGKIN AND NON-HODGKIN); LYMPHOMA (HODGKIN\'S AND NON-HODGKIN\'S); MALIGNANT LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C3208'),('CL-NEOPLASM-T-195',NULL,'LYMPHOMA, MIXED, MALIGNANT','A malignant neoplasm composed of a mixed lymphocyte population.','\0','DIFFUSE MIXED LARGE AND SMALL CELL LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C114111'),('CL-NEOPLASM-T-196',NULL,'LYMPHOMA, SMALL LYMPHOCYTIC, MALIGNANT','A malignant neoplasm composed of small lymphocytes.','\0','B-CELL SMALL LYMPHOCYTIC LYMPHOMA; LYMPHOMA, LYMPHOCYTIC, MALIGNANT; SLL; SMALL B-CELL LYMPHOCYTIC LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C7540'),('CL-NEOPLASM-T-197',NULL,'LYMPHOSARCOMA, MALIGNANT','An antiquated term referring to a malignant lymphoma that is diffused and composed of small and large lymphocytes.','\0','','CL-NEOPLASM','DBX-NCIT-C114112'),('CL-NEOPLASM-T-198',NULL,'MAST CELL TUMOR, BENIGN','A benign neoplasm composed of mast cells.','\0','','CL-NEOPLASM','DBX-NCIT-C3217'),('CL-NEOPLASM-T-199',NULL,'MAST CELL TUMOR, MALIGNANT','A malignant neoplasm composed of mast cells.','\0','','CL-NEOPLASM','DBX-NCIT-C8991'),('CL-NEOPLASM-T-2',NULL,'ACINAR-ISLET CELL TUMOR, MALIGNANT','A malignant pancreatic neoplasm characterized by the presence of a mixture of acinar and islet cell elements.','\0','','CL-NEOPLASM','DBX-NCIT-C6878'),('CL-NEOPLASM-T-20',NULL,'ADENOMA, BRONCHIOLOALVEOLAR, BENIGN','A benign lung neoplasm arising from the alveolar/bronchiolar epithelium.','\0','ADENOMA OF ALVEOLI; ADENOMA OF THE ALVEOLI','CL-NEOPLASM','DBX-NCIT-C4140'),('CL-NEOPLASM-T-200',NULL,'MAST CELL TUMOR, UNDETERMINED','A neoplasm composed of mast cells, for which the malignancy status has not been determined.','\0','MAST CELL PROLIFERATIVE DISEASE; MAST CELL TUMOR; NEOPLASM OF MAST CELLS; NEOPLASM OF THE MAST CELLS; TUMOR OF MAST CELLS; TUMOR OF THE MAST CELLS','CL-NEOPLASM','DBX-NCIT-C9295'),('CL-NEOPLASM-T-201',NULL,'MEDULLOBLASTOMA, MALIGNANT','A malignant, invasive embryonal neoplasm arising from the cerebellum.','\0','MEDULLOBLASTOMAS','CL-NEOPLASM','DBX-NCIT-C3222'),('CL-NEOPLASM-T-202',NULL,'MELANOMA, AMELANOTIC, MALIGNANT','A malignant neoplasm composed of melanocytes, which lack melanin.','\0','','CL-NEOPLASM','DBX-NCIT-C3802'),('CL-NEOPLASM-T-203',NULL,'MELANOMA, BENIGN','A benign neoplasm or hamartoma composed of melanocytes.','\0','BENIGN MELANOCYTOMA; MELANOCYTOMA, BENIGN','CL-NEOPLASM','DBX-NCIT-C98709'),('CL-NEOPLASM-T-204',NULL,'MELANOMA, MALIGNANT','A malignant neoplasm composed of melanocytes.','\0','MALIGNANT MELANOMA','CL-NEOPLASM','DBX-NCIT-C3224'),('CL-NEOPLASM-T-205',NULL,'MELANOMA, UVEAL, MALIGNANT','A malignant neoplasm of the uvea composed of melanocytes.','\0','INTRAOCULAR MELANOMA; MELANOMA OF THE UVEA; MELANOMA OF UVEA','CL-NEOPLASM','DBX-NCIT-C7712'),('CL-NEOPLASM-T-206',NULL,'MENINGIOMA, ANAPLASTIC, MALIGNANT','A malignant neoplasm of the meninges, exhibiting poor differentiation (anaplasia).','\0','ANAPLASTIC MENINGIOMA; MALIGNANT MENINGIOMA; MENINGIOMA, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C4051'),('CL-NEOPLASM-T-207',NULL,'MENINGIOMA, BENIGN','A benign neoplasm of the meninges.','\0','MENINGIOMA, BENIGN','CL-NEOPLASM','DBX-NCIT-C4055'),('CL-NEOPLASM-T-208',NULL,'MENINGIOMA, MALIGNANT','A malignant neoplasm of the meninges.','\0','GRADE 3 MENINGIOMA; GRADE III MENINGIOMA; WHO GRADE III MENINGIOMA','CL-NEOPLASM','DBX-NCIT-C38938'),('CL-NEOPLASM-T-209',NULL,'MENINGIOMA, UNDETERMINED','A neoplasm of the meninges, for which the status of malignancy has not been determined.','\0','','CL-NEOPLASM','DBX-NCIT-C3230'),('CL-NEOPLASM-T-21',NULL,'ADENOMA, C-CELL, BENIGN','A benign neoplasm arising from C-cells of the thyroid gland.','\0','PARAFOLLICULAR CELL ADENOMA','CL-NEOPLASM','DBX-NCIT-C46101'),('CL-NEOPLASM-T-210',NULL,'MESENCHYMAL TUMOR, BENIGN','A benign soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation.','\0','','CL-NEOPLASM','DBX-NCIT-C4267'),('CL-NEOPLASM-T-211',NULL,'MESENCHYMAL TUMOR, MALIGNANT','A malignant soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation.','\0','','CL-NEOPLASM','DBX-NCIT-C64118'),('CL-NEOPLASM-T-212',NULL,'MESOTHELIOMA, BENIGN','A benign neoplasm arising from mesothelial cells.','\0','ADENOMATOID TUMOR, BENIGN; BENIGN LOCALIZED EPITHELIAL MESOTHELIOMA; BENIGN MESOTHELIAL NEOPLASM; BENIGN MESOTHELIAL TUMOR; BENIGN MESOTHELIOMA; BENIGN NEOPLASM OF MESOTHELIUM; BENIGN NEOPLASM OF THE MESOTHELIUM; BENIGN TUMOR OF MESOTHELIUM; BENIGN TUMOR ','CL-NEOPLASM','DBX-NCIT-C3762'),('CL-NEOPLASM-T-213',NULL,'MESOTHELIOMA, MALIGNANT','A malignant neoplasm originating from mesothelial cells of the pleura or peritoneum.','\0','MALIGNANT MESOTHELIAL NEOPLASM; MALIGNANT MESOTHELIAL TUMOR; MALIGNANT NEOPLASM OF MESOTHELIUM; MALIGNANT NEOPLASM OF THE MESOTHELIUM; MALIGNANT TUMOR OF MESOTHELIUM; MALIGNANT TUMOR OF THE MESOTHELIUM','CL-NEOPLASM','DBX-NCIT-C4456'),('CL-NEOPLASM-T-214',NULL,'MESOTHELIOMA, UNDETERMINED','A neoplasm originating from mesothelial cells of the pleura or peritoneum, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3234'),('CL-NEOPLASM-T-215',NULL,'MIXED GLIOMA, BENIGN','A benign neoplasm of the central nervous system with an astrocytic and oligodendrocytic component.','\0','','CL-NEOPLASM','DBX-NCIT-C4050'),('CL-NEOPLASM-T-216',NULL,'MIXED TUMOR, BENIGN','A benign neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component.','\0','','CL-NEOPLASM','DBX-NCIT-C8602'),('CL-NEOPLASM-T-217',NULL,'MIXED TUMOR, MALIGNANT','A malignant neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component. A general term for which the transformed cell types have not been specified.','\0','MALIGNANT MIXED TUMOR','CL-NEOPLASM','DBX-NCIT-C3729'),('CL-NEOPLASM-T-218',NULL,'MIXED TUMOR, UNDETERMINED','A neoplasm composed of an epithelial component and/or a mesenchymal component, for which the malignancy status has not been established. A general term for which the transformed cell types have not been specified.','\0','MIXED TUMOR; TUMOR, MIXED','CL-NEOPLASM','DBX-NCIT-C6930'),('CL-NEOPLASM-T-219',NULL,'MUELLERIAN TUMOR, MIXED, MALIGNANT','A malignant neoplasm of the female reproductive system (mostly uterus and ovaries) originating from the Muellerian ducts and composed of carcinomatous and sarcomatous elements.','\0','MALIGNANT MIXED MESODERMAL TUMOR; MALIGNANT MIXED MULLERIAN TUMOR; MMMT','CL-NEOPLASM','DBX-NCIT-C8975'),('CL-NEOPLASM-T-22',NULL,'ADENOMA, CERUMINOUS GLAND, BENIGN','A benign epithelial neoplasm derived from ceruminous glands in the external auditory canal.','\0','CERUMINOMA; CERUMINOUS ADENOMA; CERUMINOUS ADENOMA OF EXTERNAL AUDITORY CANAL; CERUMINOUS ADENOMA OF THE EXTERNAL AUDITORY CANAL','CL-NEOPLASM','DBX-NCIT-C6088'),('CL-NEOPLASM-T-220',NULL,'MYELOLIPOMA, BENIGN','A benign tumor of the adrenal gland composed of adipocytes and hematopoietic/lymphoid cells.','\0','MYELOLIPOMA','CL-NEOPLASM','DBX-NCIT-C3736'),('CL-NEOPLASM-T-221',NULL,'MYELOMA, PLASMA CELL, MALIGNANT','A malignant neoplasm of the bone marrow composed of plasma cells.','\0','MULTIPLE MYELOMA; MYELOMA','CL-NEOPLASM','DBX-NCIT-C3242'),('CL-NEOPLASM-T-222',NULL,'MYOEPITHELIOMA, BENIGN','A benign neoplasm composed of myoepithelial cells.','\0','','CL-NEOPLASM','DBX-NCIT-C7442'),('CL-NEOPLASM-T-223',NULL,'MYOEPITHELIOMA, MALIGNANT','A malignant neoplasm composed of myoepithelial cells.','\0','MALIGNANT MYOEPITHELIOMA; MYOEPITHELIAL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C7596'),('CL-NEOPLASM-T-224',NULL,'MYXOMA, BENIGN','A benign soft tissue neoplasm with a myxoid stroma formation.','\0','','CL-NEOPLASM','DBX-NCIT-C6577'),('CL-NEOPLASM-T-225',NULL,'MYXOSARCOMA, MALIGNANT','A malignant soft tissue neoplasm with a myxoid stroma formation.','\0','','CL-NEOPLASM','DBX-NCIT-C3255'),('CL-NEOPLASM-T-226',NULL,'NEOPLASM, BENIGN','A general term used to describe autonomous growth of tissue where the originating cell type has not been characterized. The term benign indicates the absence of morphologic features associated with malignancy (for instance severe atypia, nuclear pleomorph','\0','BENIGN TUMOR; BENIGN UNCLASSIFIABLE TUMOR','CL-NEOPLASM','DBX-NCIT-C3677'),('CL-NEOPLASM-T-227',NULL,'NEOPLASM, MALIGNANT','A general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifica','\0','CA; CANCER; MALIGNANCY; MALIGNANT TUMOR','CL-NEOPLASM','DBX-NCIT-C9305'),('CL-NEOPLASM-T-228',NULL,'NEOPLASM, UNDETERMINED','A general term for autonomous tissue growth in which the malignancy status has not been established and for which the transformed cell type has not been specifically identified.','\0','','CL-NEOPLASM','DBX-NCIT-C3262'),('CL-NEOPLASM-T-229',NULL,'NEPHROBLASTOMA, BENIGN','A benign embryonal neoplasm of the kidney.','\0','','CL-NEOPLASM','DBX-NCIT-C114235'),('CL-NEOPLASM-T-23',NULL,'ADENOMA, CLEAR CELL, BENIGN','A benign neoplasm comprising glands containing epithelial clear cells.','\0','','CL-NEOPLASM','DBX-NCIT-C4151'),('CL-NEOPLASM-T-230',NULL,'NEPHROBLASTOMA, MALIGNANT','A malignant embryonal neoplasm of the kidney.','\0','EMBRYONAL NEPHROMA; NEPHROBLASTOMA; RENAL WILMS\' TUMOR; WILMS TUMOR OF THE KIDNEY; WILMS\' TUMOR OF THE KIDNEY','CL-NEOPLASM','DBX-NCIT-C40407'),('CL-NEOPLASM-T-231',NULL,'NEURAL CREST TUMOR, UNDETERMINED','A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C6963'),('CL-NEOPLASM-T-232',NULL,'NEUROBLASTOMA, MALIGNANT','A malignant neoplasm composed of neuroblastic cells.','\0','NEURAL CREST TUMOR, MALIGNANT; NEUROBLASTOMA (SCHWANNIAN STROMA-POOR)','CL-NEOPLASM','DBX-NCIT-C3270'),('CL-NEOPLASM-T-233',NULL,'NEUROBLASTOMA, OLFACTORY, MALIGNANT','A malignant neoplasm of the olfactory receptor cells, composed of neuroblastic cells.','\0','ESTHESIONEUROBLASTOMA; ESTHESIONEUROEPITHELIOMA; OLFACTORY ESTHESIONEUROBLASTOMA; OLFACTORY NEUROEPITHELIOMA','CL-NEOPLASM','DBX-NCIT-C3789'),('CL-NEOPLASM-T-234',NULL,'NEUROFIBROMA, BENIGN','An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths, composed of perineurial-like fibroblasts and Schwann cells.','\0','','CL-NEOPLASM','DBX-NCIT-C3272'),('CL-NEOPLASM-T-235',NULL,'NEUROGLIAL TUMOR, UNDETERMINED','A neoplasm of the central nervous system composed of glial cells (astrocytes, oligodendrocytes, ependymal cells), for which the malignancy status has not been determined.','\0','GLIAL NEOPLASM; GLIAL TUMOR; GLIOMA; NEOPLASM OF NEUROGLIA; NEOPLASM OF THE NEUROGLIA; NEOPLASMS OF NEUROGLIA; NEUROGLIAL NEOPLASM; NEUROGLIAL NEOPLASMS; TUMOR OF NEUROGLIA; TUMOR OF THE NEUROGLIA; TUMORS OF NEUROGLIA','CL-NEOPLASM','DBX-NCIT-C3059'),('CL-NEOPLASM-T-236',NULL,'NEUROMYOBLASTOMA, MALIGNANT','A malignant tumor that arises in the brain stem or adjacent cranial nerves, consisting of variable populations of cells with neuronal and myoblast differentiation. (INHAND)','\0','','CL-NEOPLASM','DBX-NCIT-C116214'),('CL-NEOPLASM-T-237',NULL,'ODONTOGENIC TUMOR, BENIGN','A benign neoplasm arising from tooth-forming tissues.','\0','BENIGN ODONTOGENIC TUMOR','CL-NEOPLASM','DBX-NCIT-C4306'),('CL-NEOPLASM-T-238',NULL,'ODONTOGENIC TUMOR, UNDETERMINED','A neoplasm arising from tooth-forming tissues, for which the malignancy status has not been established.','\0','ODONTOGENIC TUMOR','CL-NEOPLASM','DBX-NCIT-C3286'),('CL-NEOPLASM-T-239',NULL,'ODONTOMA, AMELOBLASTIC, BENIGN','A benign neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation).','\0','AMELOBLASTIC FIBROODONTOMA; FIBROAMELOBLASTIC ODONTOMA','CL-NEOPLASM','DBX-NCIT-C3710'),('CL-NEOPLASM-T-24',NULL,'ADENOMA, FOLLICULAR CELL, BENIGN','A benign neoplasm arising from follicular cells of the thyroid gland.','\0','ADENOMA OF THE THYROID; ADENOMA OF THE THYROID GLAND; ADENOMA OF THYROID; ADENOMA OF THYROID GLAND; FOLLICULAR ADENOMA; FOLLICULAR ADENOMA OF THE THYROID; FOLLICULAR ADENOMA OF THE THYROID GLAND; FOLLICULAR ADENOMA OF THYROID; FOLLICULAR ADENOMA OF THYROI','CL-NEOPLASM','DBX-NCIT-C3502'),('CL-NEOPLASM-T-240',NULL,'ODONTOMA, AMELOBLASTIC, MALIGNANT','A malignant neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation).','\0','','CL-NEOPLASM','DBX-NCIT-C7492'),('CL-NEOPLASM-T-241',NULL,'ODONTOMA, BENIGN','A benign neoplasm of tooth origin.','\0','FIBRO-ODONTOMA; FIBROODONTOMA','CL-NEOPLASM','DBX-NCIT-C3287'),('CL-NEOPLASM-T-242',NULL,'ODONTOMA, MALIGNANT','A malignant neoplasm of tooth origin.','\0','MALIGNANT ODONTOGENIC TUMOR; ODONTOGENIC CARCINOMA; ODONTOGENIC CARCINOSARCOMA','CL-NEOPLASM','DBX-NCIT-C4812'),('CL-NEOPLASM-T-243',NULL,'OLIGODENDROGLIOMA, ANAPLASTIC, MALIGNANT','A malignant neoplasm of the central nervous system arising from oligodendrocytes, exhibiting poor differentiation (anaplasia).','\0','MALIGNANT; MALIGNANT OLIGODENDROGLIOMA; OLIGODENDROGLIOMA; UNDIFFERENTIATED OLIGODENDROGLIOMA; WHO GRADE III OLIGODENDROGLIAL NEOPLASM; WHO GRADE III OLIGODENDROGLIAL TUMOR','CL-NEOPLASM','DBX-NCIT-C4326'),('CL-NEOPLASM-T-244',NULL,'OLIGODENDROGLIOMA, UNDETERMINED','A neoplasm of the central nervous system arising from oligodendrocytes, for which the malignancy status has not been determined.','\0','WELL DIFFERENTIATED OLIGODENDROGLIAL TUMOR; WELL DIFFERENTIATED OLIGODENDROGLIOMA; WHO GRADE II OLIGODENDROGLIAL NEOPLASM; WHO GRADE II OLIGODENDROGLIAL TUMOR','CL-NEOPLASM','DBX-NCIT-C3288'),('CL-NEOPLASM-T-245',NULL,'ONCOCYTOMA, BENIGN','A benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm (oncocytes).','\0','ONCOCYTIC TUMOR; ONCOCYTOMA','CL-NEOPLASM','DBX-NCIT-C7072'),('CL-NEOPLASM-T-246',NULL,'ONCOCYTOMA, MALIGNANT','A malignant neoplasm composed of large epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes).','\0','HURTHLE CELL ADENOCARCINOMA; HURTHLE CELL CARCINOMA; ONCOCYTIC ADENOCARCINOMA; ONCOCYTIC CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3679'),('CL-NEOPLASM-T-247',NULL,'OSTEOBLASTOMA, BENIGN','A benign neoplasm of bone, characterized by the formation of osteoid tissue and large osteoblast-like cells.','\0','GIANT OSTEOID OSTEOMA; OSSIFYING GIANT CELL TUMOR','CL-NEOPLASM','DBX-NCIT-C3294'),('CL-NEOPLASM-T-248',NULL,'OSTEOCHONDROMA, BENIGN','A benign cartiliginous neoplasm arising from the metaphysis of bone.','\0','','CL-NEOPLASM','DBX-NCIT-C3295'),('CL-NEOPLASM-T-249',NULL,'OSTEOCHONDROSARCOMA, MALIGNANT','A malignant cartiliginous neoplasm of bone.','\0','CONVENTIONAL CHONDROSARCOMA OF BONE; PRIMARY BONE CHONDROSARCOMA; PRIMARY CHONDROSARCOMA; PRIMARY CHONDROSARCOMA OF BONE; PRIMARY CHONDROSARCOMA OF THE BONE','CL-NEOPLASM','DBX-NCIT-C7155'),('CL-NEOPLASM-T-25',NULL,'ADENOMA, HEPATOCELLULAR, BENIGN','A benign epithelial neoplasm arising from hepatocytes.','\0','ADENOMA OF LIVER CELLS; ADENOMA OF THE LIVER CELLS; HCA; LIVER CELL ADENOMA','CL-NEOPLASM','DBX-NCIT-C3758'),('CL-NEOPLASM-T-250',NULL,'OSTEOCLASTOMA, MALIGNANT','A malignant neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells.','\0','DEDIFFERENTIATED GIANT CELL TUMOR; GIANT CELL BONE SARCOMA; GIANT CELL SARCOMA OF BONE; GIANT CELL SARCOMA OF THE BONE','CL-NEOPLASM','DBX-NCIT-C4304'),('CL-NEOPLASM-T-251',NULL,'OSTEOCLASTOMA, UNDETERMINED','A neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells, for which the malignancy status has not been established.','\0','BONE GIANT CELL NEOPLASM; BONE GIANT CELL TUMOR; GIANT CELL NEOPLASM OF BONE','CL-NEOPLASM','DBX-NCIT-C3738'),('CL-NEOPLASM-T-252',NULL,'OSTEOFIBROMA, BENIGN','A benign neoplasm characterized by osteolysis and the presence of a rich collagenous stroma and spindle cells.','\0','DESMOID TUMOR OF BONE; DESMOPLASTIC FIBROMA; DESMOPLASTIC FIBROMA OF BONE; DESMOPLASTIC FIBROMA OF THE BONE; OSSEOUS DESMOPLASTIC FIBROMA','CL-NEOPLASM','DBX-NCIT-C3740'),('CL-NEOPLASM-T-253',NULL,'OSTEOFIBROMA, BONE, BENIGN','A benign neoplasm, morphologically a fibroma with osseous components.','\0','OSTEOFIBROMA, BONE','CL-NEOPLASM','DBX-NCIT-C103392'),('CL-NEOPLASM-T-254',NULL,'OSTEOMA, BENIGN','A benign well-differentiated neoplasm of bone.','\0','','CL-NEOPLASM','DBX-NCIT-C3296'),('CL-NEOPLASM-T-255',NULL,'OSTEOSARCOMA, EXTRASKELETAL, MALIGNANT','A malignant bone-forming neoplasm, arising in tissue other than bone.','\0','EXTRAOSSEOUS OSTEOSARCOMA; EXTRASKELETAL OSTEOGENIC SARCOMA; SOFT TISSUE OSTEOSARCOMA','CL-NEOPLASM','DBX-NCIT-C8810'),('CL-NEOPLASM-T-256',NULL,'OSTEOSARCOMA, MALIGNANT','A malignant neoplasm usually arising from bone.','\0','OSTEOGENIC SARCOMA','CL-NEOPLASM','DBX-NCIT-C9145'),('CL-NEOPLASM-T-257',NULL,'OVARIAN SEX CORD-STROMAL TUMOR, BENIGN','A benign neoplasm of the ovary, originating from the sex-cord stroma.','\0','BENIGN OVARIAN SEX CORD-STROMAL NEOPLASM; BENIGN SEX CORD-STROMAL NEOPLASM OF OVARY; BENIGN SEX CORD-STROMAL NEOPLASM OF THE OVARY; BENIGN SEX CORD-STROMAL TUMOR OF OVARY; BENIGN SEX CORD-STROMAL TUMOR OF THE OVARY; SEX CORD STROMAL TUMOR, BENIGN','CL-NEOPLASM','DBX-NCIT-C6803'),('CL-NEOPLASM-T-258',NULL,'PAPILLOMA, BENIGN','A benign epithelial neoplasm that projects above the surrounding epithelial surface.','\0','','CL-NEOPLASM','DBX-NCIT-C7440'),('CL-NEOPLASM-T-259',NULL,'PAPILLOMA, CHOROID PLEXUS, BENIGN','A benign neoplasm of the choroid plexus of the central nervous system.','\0','PAPILLOMA OF CHOROID PLEXUS; PAPILLOMA OF THE CHOROID PLEXUS','CL-NEOPLASM','DBX-NCIT-C3698'),('CL-NEOPLASM-T-26',NULL,'ADENOMA, HEPATOCHOLANGIOCELLULAR, BENIGN','A benign neoplasm arising from the intrahepatic bile duct.','\0','','CL-NEOPLASM','DBX-NCIT-C7126'),('CL-NEOPLASM-T-260',NULL,'PAPILLOMA, SQUAMOUS CELL, BENIGN','A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells.','\0','EPIDERMOID CELL PAPILLOMA; EPIDERMOID PAPILLOMA; KERATOTIC PAPILLOMA; SQUAMOUS CELL PAPILLOMA','CL-NEOPLASM','DBX-NCIT-C3712'),('CL-NEOPLASM-T-261',NULL,'PAPILLOMA, TRANSITIONAL CELL, BENIGN','A benign papillary neoplasm composed of transitional cells.','\0','TRANSITIONAL PAPILLOMA','CL-NEOPLASM','DBX-NCIT-C4115'),('CL-NEOPLASM-T-262',NULL,'PARAGANGLIOMA, BENIGN','A benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.','\0','BENIGN NEUROENDOCRINE CELL TUMOR; BENIGN PARAGANGLIONIC NEOPLASM','CL-NEOPLASM','DBX-NCIT-C48314'),('CL-NEOPLASM-T-263',NULL,'PARAGANGLIOMA, MALIGNANT','A malignant neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.','\0','MALIGNANT; MALIGNANT NEOPLASM OF PARAGANGLION; MALIGNANT NEOPLASM OF THE PARAGANGLION; MALIGNANT PARAGANGLION NEOPLASM; MALIGNANT PARAGANGLION TUMOR; MALIGNANT PARAGANGLIONIC NEOPLASM; MALIGNANT PARAGANGLIONIC TUMOR; MALIGNANT TUMOR OF PARAGANGLION; MALIG','CL-NEOPLASM','DBX-NCIT-C8559'),('CL-NEOPLASM-T-264',NULL,'PARAGANGLIOMA, UNDETERMINED','A neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells, for which the malignancy status has not been established.','\0','NEOPLASM OF PARAGANGLION; NEOPLASM OF THE PARAGANGLION; PARAGANGLION NEOPLASM; PARAGANGLION TUMOR; PARAGANGLIONIC NEOPLASM; PARAGANGLIONIC TUMOR; TUMOR OF PARAGANGLION; TUMOR OF THE PARAGANGLION','CL-NEOPLASM','DBX-NCIT-C3308'),('CL-NEOPLASM-T-265',NULL,'PERIPHERAL CHOLANGIOCARCINOMA, MALIGNANT','A malignant intrahepatic neoplasm arising from the small interlobular bile ducts.','\0','PERIPHERAL CHOLANGIOCARCINOMA','CL-NEOPLASM','DBX-NCIT-C96805'),('CL-NEOPLASM-T-266',NULL,'PERIPHERAL NERVE SHEATH TUMOR, MALIGNANT','A malignant neoplasm, originating from the sheaths of the peripheral nerve.','\0','MALIGNANT NEOPLASM OF PERIPHERAL NERVE SHEATH; MALIGNANT NEOPLASM OF THE PERIPHERAL NERVE SHEATH; MALIGNANT NEURILEMMOMA; MALIGNANT NEURILEMOMA; MALIGNANT PERIPHERAL NERVE SHEATH NEOPLASM; MALIGNANT PERIPHERAL NERVE SHEATH TUMOUR; MALIGNANT SCHWANNOMA; MA','CL-NEOPLASM','DBX-NCIT-C3798'),('CL-NEOPLASM-T-267',NULL,'PHEOCHROMOCYTOMA, BENIGN','A benign neoplasm of the adrenal gland medulla.','\0','','CL-NEOPLASM','DBX-NCIT-C48305'),('CL-NEOPLASM-T-268',NULL,'PHEOCHROMOCYTOMA, COMPLEX, BENIGN','A benign neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components.','\0','','CL-NEOPLASM','DBX-NCIT-C92181'),('CL-NEOPLASM-T-269',NULL,'PHEOCHROMOCYTOMA, COMPLEX, MALIGNANT','A malignant neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components.','\0','','CL-NEOPLASM','DBX-NCIT-C92184'),('CL-NEOPLASM-T-27',NULL,'ADENOMA, ISLET CELL, BENIGN','A benign neoplasm arising from the islet cells of the pancreas.','\0','ISLET CELL ADENOMA','CL-NEOPLASM','DBX-NCIT-C114108'),('CL-NEOPLASM-T-270',NULL,'PHEOCHROMOCYTOMA, COMPLEX, UNDETERMINED','A neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C48306'),('CL-NEOPLASM-T-271',NULL,'PHEOCHROMOCYTOMA, MALIGNANT','A malignant neoplasm of the adrenal gland medulla.','\0','MALIGNANT ADRENAL GLAND CHROMAFFIN NEOPLASM; MALIGNANT ADRENAL GLAND CHROMAFFIN PARAGANGLIOMA; MALIGNANT ADRENAL GLAND CHROMAFFIN TUMOR; MALIGNANT ADRENAL GLAND CHROMAFFINOMA; MALIGNANT ADRENAL GLAND PARAGANGLIOMA; MALIGNANT ADRENAL MEDULLARY PARAGANGLIOM','CL-NEOPLASM','DBX-NCIT-C4220'),('CL-NEOPLASM-T-272',NULL,'PHEOCHROMOCYTOMA, UNDETERMINED','A neoplasm of the adrenal gland medulla, for which the malignancy status has not been established.','\0','ADRENAL GLAND CHROMAFFIN PARAGANGLIOMA; ADRENAL GLAND CHROMAFFINOMA; ADRENAL GLAND PARAGANGLIOMA; ADRENAL MEDULLARY PARAGANGLIOMA; ADRENAL MEDULLARY PHEOCHROMOCYTOMA; ADRENAL PHEOCHROMOCYTOMA; CHROMAFFIN PARAGANGLIOMA OF THE ADRENAL GLAND; INTRAADRENAL PA','CL-NEOPLASM','DBX-NCIT-C3326'),('CL-NEOPLASM-T-273',NULL,'PILOMATRIXOMA, BENIGN','A benign adnexal neoplasm arising from hair-bearing skin surfaces.','\0','BENIGN HAIR FOLLICLE NEOPLASM; BENIGN PILOMATRICOMA; BENIGN PILOMATRIXOMA; CALCIFYING EPITHERLIOMA OF MALHERBE; PILOMATRIXOMA','CL-NEOPLASM','DBX-NCIT-C7368'),('CL-NEOPLASM-T-274',NULL,'PINEOBLASTOMA, MALIGNANT','A poorly differentiated malignant embryonal neoplasm arising from the pineal region of the brain.','\0','PINEAL GLAND PNET; PINEAL GLAND PRIMITIVE NEUROECTODERMAL NEOPLASM; PINEAL GLAND PRIMITIVE NEUROECTODERMAL TUMOR; PINEAL PNET; PINEAL PRIMITIVE NEUROECTODERMAL NEOPLASM; PINEAL PRIMITIVE NEUROECTODERMAL TUMOR; PNET OF PINEAL GLAND; PNET OF THE PINEAL GLAN','CL-NEOPLASM','DBX-NCIT-C9344'),('CL-NEOPLASM-T-275',NULL,'PINEOCYTOMA, BENIGN','A benign neoplasm of the brain arising from the pineal gland.','\0','BENIGN PINEALOMA; PINEALOMA','CL-NEOPLASM','DBX-NCIT-C6966'),('CL-NEOPLASM-T-276',NULL,'PITUICYTOMA, BENIGN','A neoplasm arising from the posterior lobe of the pituitary gland.','\0','NEUROHYPOPHYSIS NEOPLASM; NEUROHYPOPHYSIS TUMOR; POSTERIOR PITUITARY GLAND TUMOR; POSTERIOR PITUITARY NEOPLASM; POSTERIOR PITUITARY TUMOR','CL-NEOPLASM','DBX-NCIT-C7157'),('CL-NEOPLASM-T-277',NULL,'PLASMA CELL TUMOR, MALIGNANT','A malignant neoplasm composed of plasma cells.','\0','PLASMA CELL DYSCRASIA; PLASMA CELL TUMOR; PLASMACYTIC NEOPLASM; PLASMACYTIC TUMOR','CL-NEOPLASM','DBX-NCIT-C4665'),('CL-NEOPLASM-T-278',NULL,'POLYP, ADENOMATOUS, UNDETERMINED','A neoplasm, originating from glandular epithelium, exhibiting polypoid growth, for which the malignancy status has not been determined.','\0','POLYPOID ADENOMA','CL-NEOPLASM','DBX-NCIT-C3764'),('CL-NEOPLASM-T-279',NULL,'POLYP, BENIGN','A benign polypoid neoplasm of an epithelial lining projecting into a lumen or cavity.','\0','','CL-NEOPLASM','DBX-NCIT-C112275'),('CL-NEOPLASM-T-28',NULL,'ADENOMA, LIGHT CELL, BENIGN','A benign epithelial neoplasm of the thyroid gland comprising follicular cells with cytoplasmic clearing.','\0','','CL-NEOPLASM','DBX-NCIT-C46119'),('CL-NEOPLASM-T-280',NULL,'POLYP, ENDOMETRIAL STROMAL, BENIGN','A benign polypoid neoplasm of the endometrium projecting into the endometrial cavity.','\0','ADENOMA, ENDOMETRIAL; ENDOMETRIAL ADENOMA; ENDOMETRIAL STROMAL POLYP; GLANDULAR ENDOMETRIAL POLYP; POLYP OF ENDOMETRIUM; POLYP OF THE ENDOMETRIUM; POLYP, STROMAL','CL-NEOPLASM','DBX-NCIT-C6433'),('CL-NEOPLASM-T-281',NULL,'POLYP, UNDETERMINED','A protruding growth attached to the underlying tissue by a broad base or a thin stalk, which can be either inflammatory, hamartomatous, or neoplastic.','\0','','CL-NEOPLASM','DBX-NCIT-C3340'),('CL-NEOPLASM-T-282',NULL,'POLYP, VAGINAL, BENIGN','A benign polypoid growth arising from the vaginal wall.','\0','POLYP OF THE VAGINA; POLYP OF VAGINA','CL-NEOPLASM','DBX-NCIT-C3664'),('CL-NEOPLASM-T-283',NULL,'RETICULOSIS, MALIGNANT','A malignant lymphoid neoplasm composed of EBV-positive NK/T cells arranged in an angiocentric pattern.','\0','ANGIOCENTRIC T-CELL LYMPHOMA','CL-NEOPLASM','DBX-NCIT-C4684'),('CL-NEOPLASM-T-284',NULL,'RETINOBLASTOMA, MALIGNANT','A malignant neoplasm originating in the nuclear layer of the retina.','\0','RB','CL-NEOPLASM','DBX-NCIT-C7541'),('CL-NEOPLASM-T-285',NULL,'RHABDOMYOMA, BENIGN','A benign neoplasm arising from skeletal muscle, characterized by the presence of rhabdomyoblasts.','\0','','CL-NEOPLASM','DBX-NCIT-C3358'),('CL-NEOPLASM-T-286',NULL,'RHABDOMYOSARCOMA, MALIGNANT','A malignant mesenchymal neoplasm arising from skeletal muscle.','\0','','CL-NEOPLASM','DBX-NCIT-C3359'),('CL-NEOPLASM-T-287',NULL,'SARCOMA, GRANULOCYTIC, MALIGNANT','A malignant neoplasm composed of myeloblasts, neutrophils and neutrophil precursors.','\0','','CL-NEOPLASM','DBX-NCIT-C35815'),('CL-NEOPLASM-T-288',NULL,'SARCOMA, HISTIOCYTIC, MALIGNANT','A malignant neoplasm composed of cells resembling histiocytes.','\0','','CL-NEOPLASM','DBX-NCIT-C27349'),('CL-NEOPLASM-T-289',NULL,'SARCOMA, LEPTOMENINGEAL, MALIGNANT','A malignant mesenchymal neoplasm arising from the leptomeninges.','\0','SARCOMA OF LEPTOMENINGES; SARCOMA OF THE LEPTOMENINGES; SARCOMA, MENINGEAL','CL-NEOPLASM','DBX-NCIT-C8312'),('CL-NEOPLASM-T-29',NULL,'ADENOMA, MUCINOUS, BENIGN','A benign, cystic epithelial neoplasm comprising cells containing intracytoplasmic mucin.','\0','MUCINOUS ADENOMA; MUCINOUS CYSTOMA; PSEUDOMUCINOUS CYSTADENOMA','CL-NEOPLASM','DBX-NCIT-C2973'),('CL-NEOPLASM-T-290',NULL,'SARCOMA, MALIGNANT','A malignant mesenchymal neoplasm. A general term for which the transformed cell type has not been specified.','\0','MESENCHYMAL TUMOR, MALIGNANT; SARCOMA; SARCOMA OF SOFT TISSUE AND BONE; SARCOMA OF THE SOFT TISSUE AND BONE','CL-NEOPLASM','DBX-NCIT-C9118'),('CL-NEOPLASM-T-291',NULL,'SARCOMA, MYELOID, MALIGNANT','A malignant neoplasm composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone.','\0','CHLOROMA; EXTRAMEDULLARY MYELOID TUMOR','CL-NEOPLASM','DBX-NCIT-C3520'),('CL-NEOPLASM-T-292',NULL,'SARCOMA, SYNOVIAL, MALIGNANT','A malignant neoplasm that usually arises in the synovial membranes of the joints and the synovial cells of the tendons and bursae.','\0','SS','CL-NEOPLASM','DBX-NCIT-C3400'),('CL-NEOPLASM-T-293',NULL,'SARCOMA, UNDIFFERENTIATED, MALIGNANT','A rare malignant neoplasm of the liver that is most common in youth.','\0','EMBRYONAL SARCOMA, UNDIFFERENTIATED','CL-NEOPLASM','DBX-NCIT-C27096'),('CL-NEOPLASM-T-294',NULL,'SCHWANNOMA, BENIGN','A benign neoplasm of the peripheral nervous system composed of well-differentiated Schwann cells.','\0','NEURILEMMOMA; NEURINOMA; SCHWANNOMA; SCHWANNOMA (WHO GRADE I)','CL-NEOPLASM','DBX-NCIT-C3269'),('CL-NEOPLASM-T-295',NULL,'SEMINOMA, BENIGN','A benign germ cell neoplasm of the testis.','\0','','CL-NEOPLASM','DBX-NCIT-C112276'),('CL-NEOPLASM-T-296',NULL,'SEMINOMA, MALIGNANT','A malignant germ cell neoplasm of the testis.','\0','SEMINOMA; SEMINOMA, PURE','CL-NEOPLASM','DBX-NCIT-C9309'),('CL-NEOPLASM-T-297',NULL,'SERTOLI CELL TUMOR, BENIGN','A benign neoplasm of the testis or ovary, originating from Sertoli cells.','\0','BENIGN ANDROBLASTOMA','CL-NEOPLASM','DBX-NCIT-C67012'),('CL-NEOPLASM-T-298',NULL,'SERTOLI CELL TUMOR, MALIGNANT','A malignant neoplasm of the testis or ovary, originating from Sertoli cells.','\0','MALIGNANT ANDROBLASTOMA','CL-NEOPLASM','DBX-NCIT-C67006'),('CL-NEOPLASM-T-299',NULL,'SERTOLI CELL TUMOR, UNDETERMINED','An ovarian neoplasm comprising Sertoli cells in which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C98794'),('CL-NEOPLASM-T-3',NULL,'ADAMANTINOMA, MALIGNANT','A low-grade malignant neoplasm composed of epithelial cells and a spindle cell osteo-fibrous proliferation.','\0','ADAMANTINOMA','CL-NEOPLASM','DBX-NCIT-C7644'),('CL-NEOPLASM-T-30',NULL,'ADENOMA, PAPILLARY, BENIGN','A benign epithelial neoplasm characterized by the presence of papillary epithelial patterns.','\0','','CL-NEOPLASM','DBX-NCIT-C79951'),('CL-NEOPLASM-T-300',NULL,'STROMAL NEPHROMA, MALIGNANT','A congenital malignant neoplasm of the kidney characterized by the presence of fibroblastic cells.','\0','CMN; MESOBLASTIC NEPHROMA','CL-NEOPLASM','DBX-NCIT-C6569'),('CL-NEOPLASM-T-301',NULL,'STROMAL SARCOMA, ENDOMETRIAL, MALIGNANT','A malignant, mesenchymal tumor of the uterine stroma.','\0','ESS','CL-NEOPLASM','DBX-NCIT-C8973'),('CL-NEOPLASM-T-302',NULL,'STROMAL SARCOMA, MALIGNANT','A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells.','\0','STROMAL TUMOR, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C6926'),('CL-NEOPLASM-T-303',NULL,'STROMAL TUMOR, BENIGN','A benign neoplasm composed of mesenchymal stromal cells.','\0','','CL-NEOPLASM','DBX-NCIT-C114113'),('CL-NEOPLASM-T-304',NULL,'STROMAL TUMOR, GONADAL, MALIGNANT','A malignant neoplasm originating from the gonadal sex cord stroma.','\0','SEX CORD STROMAL TUMOR, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C67561'),('CL-NEOPLASM-T-305',NULL,'STROMAL TUMOR, GONADAL, UNDETERMINED','A neoplasm originating from the gonadal sex cord stroma, for which the status of malignancy has not been determined.','\0','SEX CORD-STROMAL NEOPLASM; SEX CORD-STROMAL TUMOR, UNDETERMINED','CL-NEOPLASM','DBX-NCIT-C3794'),('CL-NEOPLASM-T-306',NULL,'SUBEPENDYMOMA, BENIGN','A benign neoplasm of the brain localized in the vicinity of a ventricular wall and is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic changes.','\0','SUBEPENDYMAL GLIOMA; WHO GRADE I EPENDYMAL NEOPLASM; WHO GRADE I EPENDYMAL TUMOR','CL-NEOPLASM','DBX-NCIT-C3795'),('CL-NEOPLASM-T-307',NULL,'SYNOVIOMA, BENIGN','A benign neoplasm arising from the synovial membrane.','\0','BENIGN NEOPLASM OF SYNOVIUM; BENIGN NEOPLASM OF THE SYNOVIUM; BENIGN SYNOVIAL TUMOR; BENIGN SYNOVIOMA; BENIGN TUMOR OF SYNOVIUM; BENIGN TUMOR OF THE SYNOVIUM','CL-NEOPLASM','DBX-NCIT-C3829'),('CL-NEOPLASM-T-308',NULL,'TERATOMA, BENIGN','A benign germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers.','\0','','CL-NEOPLASM','DBX-NCIT-C114114'),('CL-NEOPLASM-T-309',NULL,'TERATOMA, MALIGNANT','A malignant germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers.','\0','IMMATURE TERATOMA','CL-NEOPLASM','DBX-NCIT-C4286'),('CL-NEOPLASM-T-31',NULL,'ADENOMA, PARS DISTALIS, BENIGN','A benign epithelial neoplasm arising from the pars distalis of the anterior pituitary gland.','\0','Rat Pars Distalis Adenoma','CL-NEOPLASM','DBX-NCIT-C60490'),('CL-NEOPLASM-T-310',NULL,'TERATOMA, UNDETERMINED','A germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3403'),('CL-NEOPLASM-T-311',NULL,'THECOMA, BENIGN','A benign sex-cord neoplasm of the ovary, originating from theca cells.','\0','BENIGN OVARIAN THECAL CELL NEOPLASM; BENIGN OVARIAN THECAL CELL TUMOR; BENIGN THECAL CELL NEOPLASM OF OVARY; BENIGN THECAL CELL NEOPLASM OF THE OVARY; BENIGN THECAL CELL TUMOR OF OVARY; BENIGN THECAL CELL TUMOR OF THE OVARY; BENIGN THECOMA OF OVARY; BENIG','CL-NEOPLASM','DBX-NCIT-C5219'),('CL-NEOPLASM-T-312',NULL,'THECOMA, OVARIAN, MALIGNANT','A malignant sex-cord neoplasm of the ovary, originating from theca cells.','\0','MALIGNANT OVARIAN THECAL CELL NEOPLASM; MALIGNANT OVARIAN THECAL CELL TUMOR; MALIGNANT THECAL CELL NEOPLASM OF OVARY; MALIGNANT THECAL CELL NEOPLASM OF THE OVARY; MALIGNANT THECAL CELL TUMOR OF OVARY; MALIGNANT THECAL CELL TUMOR OF THE OVARY; MALIGNANT TH','CL-NEOPLASM','DBX-NCIT-C6929'),('CL-NEOPLASM-T-313',NULL,'THYMOMA, BENIGN','A benign neoplasm of the thymus, originating from epithelial thymus cells.','\0','','CL-NEOPLASM','DBX-NCIT-C114115'),('CL-NEOPLASM-T-314',NULL,'THYMOMA, MALIGNANT','A malignant neoplasm of the thymus, originating from epithelial thymus cells.','\0','','CL-NEOPLASM','DBX-NCIT-C7612'),('CL-NEOPLASM-T-315',NULL,'THYMOMA, UNDETERMINED','A neoplasm of the thymus, originating from epithelial thymus cells, for which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C3411'),('CL-NEOPLASM-T-316',NULL,'TRICHOEPITHELIOMA, BENIGN','A benign hair follicle neoplasm with trichoblastic differentiation.','\0','BROOKE\'S TUMOR; TRICHOEPITHELIOMA; TRICHOGENIC ADNEXAL TUMOR; TRICHOGENIC TRICHOBLASTOMA','CL-NEOPLASM','DBX-NCIT-C27132'),('CL-NEOPLASM-T-317',NULL,'YOLK SAC TUMOR, BENIGN','A benign epithelial neoplasm arising from the yolk sac.','\0','','CL-NEOPLASM','DBX-NCIT-C84357'),('CL-NEOPLASM-T-318',NULL,'YOLK SAC TUMOR, MALIGNANT','A non-seminomatous malignant germ cell tumor composed of primitive germ cells and which produce an eosinophilic substance (alpha-fetoprotein).','\0','ENDODERMAL SINUS NEOPLASM; ENDODERMAL SINUS TUMOR; YOLK SAC NEOPLASM; YOLK SAC TUMOR SITE UNSPECIFIED','CL-NEOPLASM','DBX-NCIT-C3011'),('CL-NEOPLASM-T-32',NULL,'ADENOMA, PARS INTERMEDIA, BENIGN','A benign epithelial neoplasm arising from the pars intermedia of the anterior pituitary gland.','\0','Rat Pars Intermedia Adenoma','CL-NEOPLASM','DBX-NCIT-C60493'),('CL-NEOPLASM-T-33',NULL,'ADENOMA, PITUITARY GLAND, BENIGN','A benign neoplasm of the pituitary gland.','\0','','CL-NEOPLASM','DBX-NCIT-C98723'),('CL-NEOPLASM-T-34',NULL,'ADENOMA, RENAL CELL, BENIGN','A benign neoplasm arising from the renal cortex.','\0','RENAL TUBULE ADENOMA','CL-NEOPLASM','DBX-NCIT-C8383'),('CL-NEOPLASM-T-35',NULL,'ADENOMA, RETE TESTIS, BENIGN','A benign epithelial neoplasm arising from the rete testis.','\0','','CL-NEOPLASM','DBX-NCIT-C39956'),('CL-NEOPLASM-T-36',NULL,'ADENOMA, SEBACEOUS, BENIGN','A benign neoplasm arising from sebaceous glands.','\0','ADENOMA OF SEBACEOUS GLAND; ADENOMA OF THE SEBACEOUS GLAND; SEBACEOUS GLAND ADENOMA; SKIN APPENDAGE SEBACEOUS ADENOMA','CL-NEOPLASM','DBX-NCIT-C4174'),('CL-NEOPLASM-T-37',NULL,'ADENOMA, SERTOLIFORM TUBULAR, BENIGN','A benign tubular adenoma with Sertoli cell differentiation.','\0','Rat Sertoliform Tubular Adenoma','CL-NEOPLASM','DBX-NCIT-C92180'),('CL-NEOPLASM-T-38',NULL,'ADENOMA, SWEAT GLAND, BENIGN','A benign epithelias neoplasm arising from sweat glands.','\0','ADENOMA OF SWEAT GLAND; ADENOMA OF THE SWEAT GLAND','CL-NEOPLASM','DBX-NCIT-C7560'),('CL-NEOPLASM-T-39',NULL,'ADENOMA, TUBULAR CELL, BENIGN','A benign neoplasm arising from glandular epithelium, characterized by a tubular architectural pattern.','\0','','CL-NEOPLASM','DBX-NCIT-C4133'),('CL-NEOPLASM-T-4',NULL,'ADENOACANTHOMA, MALIGNANT','A malignant neoplasm arising from glandular cells that includes focal or extensive areas of squamous metaplasia.','\0','ADENOACANTHOMA','CL-NEOPLASM','DBX-NCIT-C4200'),('CL-NEOPLASM-T-40',NULL,'ADENOMA, TUBULOSTROMAL, BENIGN','A benign ovarian epithelial neoplasm characterized by the presence of tubular structures and interstitial stroma.','\0','','CL-NEOPLASM','DBX-NCIT-C79953'),('CL-NEOPLASM-T-41',NULL,'ADENOMA, ZYMBAL\'S GLAND, BENIGN','A benign neoplasm of the rodent Zymbal\'s gland with sebaceous and/or squamous differentiation.','\0','','CL-NEOPLASM','DBX-NCIT-C98800'),('CL-NEOPLASM-T-42',NULL,'ADENOMYOMA, BENIGN','A benign neoplasm characterized by the presence of a glandular and a mesenchymal component.','\0','','CL-NEOPLASM','DBX-NCIT-C3726'),('CL-NEOPLASM-T-43',NULL,'ADRENAL TUMOR, SUBCAPSULAR, BENIGN','A benign neoplasm located beneath the adrenal capsule.','\0','SUBCAPSULAR SINGLE CELL ADENOMA, ADRENAL','CL-NEOPLASM','DBX-NCIT-C83488'),('CL-NEOPLASM-T-44',NULL,'ADRENAL TUMOR, SUBCAPSULAR, MALIGNANT','A malignant neoplasm located beneath the adrenal capsule.','\0','SUBCAPSULAR SINGLE CELL CARCINOMA, ADRENAL','CL-NEOPLASM','DBX-NCIT-C83489'),('CL-NEOPLASM-T-45',NULL,'ADRENAL TUMOR, SUBCAPSULAR, UNDETERMINED','A neoplasm located beneath the adrenal capsule in which the malignancy status has not been established.','\0','SUBCAPSULAR CELL TUMOR, ADRENAL','CL-NEOPLASM','DBX-NCIT-C82973'),('CL-NEOPLASM-T-46',NULL,'ADRENOCORTICAL NEOPLASM, UNDETERMINED','A neoplasm of the adrenal cortex in which the malignancy status has not been established.','\0','ADRENAL CORTEX TUMOR; ADRENOCORTICAL NEOPLASM; ADRENOCORTICAL TUMOR','CL-NEOPLASM','DBX-NCIT-C2858'),('CL-NEOPLASM-T-47',NULL,'AMELOBLASTOMA, BENIGN','A benign odontogenic neoplasm arising from the epithelial component of the embryonic tooth.','\0','','CL-NEOPLASM','DBX-NCIT-C7111'),('CL-NEOPLASM-T-48',NULL,'AMELOBLASTOMA, MALIGNANT','A malignant odontogenic neoplasm arising from the epithelial component of the embryonic tooth.','\0','MALIGNANT AMELOBLASTOMA','CL-NEOPLASM','DBX-NCIT-C54297'),('CL-NEOPLASM-T-49',NULL,'AMELOBLASTOMA, UNDETERMINED','A odontogenic neoplasm arising from the epithelial component of the embryonic tooth of undetermined malignancy status.','\0','','CL-NEOPLASM','DBX-NCIT-C4313'),('CL-NEOPLASM-T-5',NULL,'ADENOCARCINOMA, CLEAR CELL, MALIGNANT','A malignant neoplasm comprising glandular epithelial clear cells.','\0','CLEAR CELL CARCINOMA; MESONEPHROID CLEAR CELL ADENOCARCINOMA; MESONEPHROID CLEAR CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3766'),('CL-NEOPLASM-T-50',NULL,'ANGIOFIBROMA, BENIGN','A benign, morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels.','\0','ANGIOFIBROMATOUS HYPERPLASIA; FIBROANGIOMA, BENIGN; FIBROUS PAPULE; TELANGIECTATIC FIBROMA','CL-NEOPLASM','DBX-NCIT-C3799'),('CL-NEOPLASM-T-51',NULL,'ANGIOLIPOMA, BENIGN','A lipoma characterized by prominent vascularization.','\0','ANGIOLIPOMA','CL-NEOPLASM','DBX-NCIT-C3733'),('CL-NEOPLASM-T-52',NULL,'ARRHENOBLASTOMA, BENIGN','A benign Sertoli-Leydig neoplasm of the ovary characterized by the presence of Sertoli cells in tubules without evidence of significant nuclear atypia or mitotic activity.','\0','ARRHENOBLASTOMA, BENIGN','CL-NEOPLASM','DBX-NCIT-C4209'),('CL-NEOPLASM-T-53',NULL,'ARRHENOBLASTOMA, MALIGNANT','A malignant Sertoli-Leydig neoplasm of the ovary characterized by the presence of a sarcomatoid stroma which contains primitive gonadal stromal cells.','\0','ARRHENOBLASTOMA, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C4210'),('CL-NEOPLASM-T-54',NULL,'ASTROCYTOMA, ANAPLASTIC, MALIGNANT','A malignant neoplasm of the brain or spinal cord originating from astrocytes, exhibiting poor differentiation (anaplasia).','\0','GRADE III ASTROCYTIC NEOPLASM; GRADE III ASTROCYTIC TUMOR; GRADE III ASTROCYTOMA; MALIGNANT ASTROCYTOMA','CL-NEOPLASM','DBX-NCIT-C9477'),('CL-NEOPLASM-T-55',NULL,'ASTROCYTOMA, DIFFUSE, MALIGNANT','A malignant astrocytic neoplasm characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures.','\0','ASTROCYTOMA, DIFFUSE','CL-NEOPLASM','DBX-NCIT-C7173'),('CL-NEOPLASM-T-56',NULL,'ASTROCYTOMA, PILOCYTIC, BENIGN','A benign neoplasm of the brain or spinal cord arising from astrocytes associated with single or multiple cysts.','\0','ASTROCYTOMA, BENIGN; GRADE I ASTROCYTIC NEOPLASM; GRADE I ASTROCYTIC TUMOR; GRADE I ASTROCYTOMA','CL-NEOPLASM','DBX-NCIT-C4047'),('CL-NEOPLASM-T-57',NULL,'ASTROCYTOMA, UNDETERMINED','A neoplasm of the brain or spinal cord exhibiting astrocytic differentiation, but in which the malignancy status has not been established.','\0','','CL-NEOPLASM','DBX-NCIT-C60781'),('CL-NEOPLASM-T-58',NULL,'BASALIOMA, BENIGN','A benign epithelial neoplasm arising from primary epithelial germ cells of the piliary complex.','\0','BASALIOMA','CL-NEOPLASM','DBX-NCIT-C103391'),('CL-NEOPLASM-T-59',NULL,'BASOSQUAMOUS TUMOR, BENIGN','A benign papillary neoplasm of the skin.','\0','CUTANEOUS PAPILLOMA; PAPILLOMA OF SKIN; PAPILLOMA OF THE SKIN','CL-NEOPLASM','DBX-NCIT-C4614'),('CL-NEOPLASM-T-6',NULL,'ADENOCARCINOMA, ENDOMETRIAL, MALIGNANT','A malignant glandular neoplasm of the uterine lining.','\0','ADENOCARCINOMA OF ENDOMETRIUM; ADENOCARCINOMA OF THE ENDOMETRIUM','CL-NEOPLASM','DBX-NCIT-C7359'),('CL-NEOPLASM-T-60',NULL,'BASOSQUAMOUS TUMOR, MALIGNANT','A basal cell carcinoma (skin neoplasm) which displays squamous differentiation.','\0','BASOSQUAMOUS CARCINOMA; BASOSQUAMOUS CELL CARCINOMA; SKIN MIXED BASAL AND SQUAMOUS CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C2922'),('CL-NEOPLASM-T-61',NULL,'CARCINOID TUMOR, MALIGNANT','A malignant neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) in the bronchi.','\0','MALIGNANT CARCINOID TUMOR','CL-NEOPLASM','DBX-NCIT-C72074'),('CL-NEOPLASM-T-62',NULL,'CARCINOID TUMOR, UNDETERMINED','A neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) the bronchi with undetermined malignancy status.','\0','CARCINOID; CARCINOID NEOPLASM; WELL-DIFFERENTIATED ENDOCRINE NEOPLASM','CL-NEOPLASM','DBX-NCIT-C2915'),('CL-NEOPLASM-T-63',NULL,'CARCINOMA, ACIDOPHIL, MALIGNANT','A malignant epithelial neoplasm of the anterior pituitary gland in which the neoplastic cells stain positive with acidic dyes.','\0','ACIDOPHIL ADENOCARCINOMA; ACIDOPHIL CARCINOMA; EOSINOPHIL ADENOCARCINOMA; EOSINOPHIL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C114109'),('CL-NEOPLASM-T-64',NULL,'CARCINOMA, ACINAR CELL, MALIGNANT','A malignant glandular epithelial neoplasm comprising secretory cells forming acinar patterns.','\0','ACINAR ADENOCARCINOMA; ACINAR CARCINOMA; ACINAR CELL ADENOCARCINOMA; ACINIC CELL ADENOCARCINOMA; ACINIC CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3768'),('CL-NEOPLASM-T-65',NULL,'CARCINOMA, ADENOSQUAMOUS, MALIGNANT','An epithelial neoplasm composed of malignant glandular and malignant squamous cells.','\0','MIXED ADENOCARCINOMA AND EPIDERMOID CARCINOMA; MIXED ADENOCARCINOMA AND EPIDERMOID CELL CARCINOMA; MIXED ADENOCARCINOMA AND SQUAMOUS CARCINOMA; MIXED ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3727'),('CL-NEOPLASM-T-66',NULL,'CARCINOMA, ADNEXAL, MALIGNANT','A malignant epithelial neoplasm arising from sebaceous or sweat glands or from hair follicles.','\0','CARCINOMA OF ADNEXA; CARCINOMA OF SKIN APPENDAGE; SKIN APPENDAGE CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3775'),('CL-NEOPLASM-T-67',NULL,'CARCINOMA, ADRENOCORTICAL, MALIGNANT','A malignant epithelial neoplasm arising from adrenal cortical cells.','\0','ADENOCARCINOMA, ADRENOCORTICAL, MALIGNANT; ADRENAL CORTEX ADENOCARCINOMA; ADRENAL CORTEX CANCER; ADRENAL CORTICAL ADENOCARCINOMA; ADRENAL CORTICAL CARCINOMA; ADRENOCORTICAL CARCINOMA; CORTICAL CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C9325'),('CL-NEOPLASM-T-68',NULL,'CARCINOMA, BASAL CELL, MALIGNANT','A malignant epithelial neoplasm arising from basal cells.','\0','BASAL CELL CANCER; BASAL CELL CARCINOMA; BASAL CELL EPITHELIOMA; BASAL CELL SKIN CARCINOMA; BCC','CL-NEOPLASM','DBX-NCIT-C111199'),('CL-NEOPLASM-T-69',NULL,'CARCINOMA, BRONCHIAL, MALIGNANT','A malignant neoplasia of the lung, arising from bronchial epithelium.','\0','','CL-NEOPLASM','DBX-NCIT-C35875'),('CL-NEOPLASM-T-7',NULL,'ADENOCARCINOMA, MALIGNANT','A malignant neoplasm arising from glandular cells.','\0','','CL-NEOPLASM','DBX-NCIT-C2852'),('CL-NEOPLASM-T-70',NULL,'CARCINOMA, BRONCHIOLOALVEOLAR, MALIGNANT','A malignant lung neoplasm originating from the alveolar/bronchiolar epithelium.','\0','BAC; BRONCHIOALVEOLAR ADENOCARCINOMA OF LUNG; BRONCHIOALVEOLAR ADENOCARCINOMA OF THE LUNG; BRONCHIOALVEOLAR LUNG CARCINOMA; BRONCHIOLO-ALVEOLAR CARCINOMA OF LUNG; BRONCHIOLO-ALVEOLAR CARCINOMA OF THE LUNG; BRONCHIOLO-ALVEOLAR LUNG CARCINOMA; BRONCHIOLOALV','CL-NEOPLASM','DBX-NCIT-C2923'),('CL-NEOPLASM-T-71',NULL,'CARCINOMA, C-CELL, MALIGNANT','A neuroendocrine malignant epithelial neoplasm arising from C-cells of the thyroid gland.','\0','C CELL CARCINOMA; MEDULLARY CARCINOMA; MEDULLARY CARCINOMA OF THE THYROID; MEDULLARY CARCINOMA OF THE THYROID GLAND; MEDULLARY CARCINOMA OF THYROID; MEDULLARY CARCINOMA OF THYROID GLAND; MEDULLARY THYROID CANCER; MEDULLARY THYROID CARCINOMA; MEDULLARY THY','CL-NEOPLASM','DBX-NCIT-C3879'),('CL-NEOPLASM-T-72',NULL,'CARCINOMA, CERUMINOUS GLAND, MALIGNANT','A malignant neoplasm derived from ceruminous glands in the external auditory canal.','\0','','CL-NEOPLASM','DBX-NCIT-C4176'),('CL-NEOPLASM-T-73',NULL,'CARCINOMA, CHOROID PLEXUS, MALIGNANT','A malignant neoplasm arising from the choroid plexus of the brain.','\0','ANAPLASTIC CHOROID PLEXUS PAPILLOMA; CANCER OF CHOROID PLEXUS; CANCER OF THE CHOROID PLEXUS; CARCINOMA OF CHOROID PLEXUS; CARCINOMA OF THE CHOROID PLEXUS; CHOROID PLEXUS CANCER','CL-NEOPLASM','DBX-NCIT-C4715'),('CL-NEOPLASM-T-74',NULL,'CARCINOMA, EMBRYONAL, MALIGNANT','A non-seminomatous malignant germ cell neoplasm of the testis or ovary.','\0','CARCINOMA, EMBRYONAL, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C3752'),('CL-NEOPLASM-T-75',NULL,'CARCINOMA, ENDOMETRIAL, MALIGNANT','A malignant epithelial neoplasm arising from the lining of the uterine body cavity.','\0','CARCINOMA OF ENDOMETRIUM; CARCINOMA OF THE ENDOMETRIUM','CL-NEOPLASM','DBX-NCIT-C7558'),('CL-NEOPLASM-T-76',NULL,'CARCINOMA, FOLLICULAR CELL, MALIGNANT','A malignant neoplasia arising from follicular cells of the thyroid gland.','\0','FOLLICULAR ADENOCARCINOMA; FOLLICULAR CANCER OF THE THYROID; FOLLICULAR CANCER OF THE THYROID GLAND; FOLLICULAR CANCER OF THYROID; FOLLICULAR CANCER OF THYROID GLAND; FOLLICULAR CARCINOMA; FOLLICULAR CARCINOMA OF THE THYROID; FOLLICULAR CARCINOMA OF THE T','CL-NEOPLASM','DBX-NCIT-C8054'),('CL-NEOPLASM-T-77',NULL,'CARCINOMA, HEPATOCELLULAR, MALIGNANT','A malignant neoplasm arising from hepatocytes.','\0','CARCINOMA OF LIVER CELLS; CARCINOMA OF THE LIVER CELLS; HCC; HEPATOMA; LIVER CELL CARCINOMA; PRIMARY CARCINOMA OF LIVER CELLS; PRIMARY CARCINOMA OF THE LIVER CELLS','CL-NEOPLASM','DBX-NCIT-C3099'),('CL-NEOPLASM-T-78',NULL,'CARCINOMA, HEPATOCHOLANGIOCELLULAR, MALIGNANT','A malignant mixed neoplasm of the liver comprising neoplastic hepatocytes and bile duct epithelial cells; both elements displaying evidence of malignancy.','\0','HEPATOCHOLANGIOCELLULAR CARCINOMA','CL-NEOPLASM','DBX-NCIT-C103393'),('CL-NEOPLASM-T-79',NULL,'CARCINOMA, IN SITU, MALIGNANT','A malignant epithelial neoplasm confined to the epithelial layer and without evidence of further tissue invasion.','\0','CIS; EPITHELIAL TUMOR, IN SITU, MALIGNANT; INTRAEPITHELIAL CARCINOMA; NON-INVASIVE CARCINOMA','CL-NEOPLASM','DBX-NCIT-C2917'),('CL-NEOPLASM-T-8',NULL,'ADENOCARCINOMA, MUCINOUS, MALIGNANT','An adenocarcinoma comprising neoplastic glandular cells containing intracytoplasmic mucin.','\0','COLLOID ADENOCARCINOMA; COLLOID CARCINOMA; GELATINOUS ADENOCARCINOMA; GELATINOUS CARCINOMA; MUCINOUS CARCINOMA; MUCOID ADENOCARCINOMA; MUCOID CARCINOMA; MUCOUS ADENOCARCINOMA; MUCOUS CARCINOMA','CL-NEOPLASM','DBX-NCIT-C26712'),('CL-NEOPLASM-T-80',NULL,'CARCINOMA, ISLET CELL, MALIGNANT','A malignant endocrine neoplasm arising from islets of Langerhans of the pancreas.','\0','ISLET CELL CANCER; ISLET CELL CARCINOMA; MALIGNANT ISLET CELL TUMOR; MALIGNANT PANCREATIC ENDOCRINE TUMOR; PANCREATIC NEUROENDOCRINE CARCINOMA','CL-NEOPLASM','DBX-NCIT-C3770'),('CL-NEOPLASM-T-81',NULL,'CARCINOMA, MALIGNANT','A malignant epithelial neoplasm.','\0','EPITHELIAL CARCINOMA; EPITHELIOMA MALIGNANT; MALIGNANT EPITHELIAL NEOPLASM; MALIGNANT EPITHELIAL TUMOR; MALIGNANT EPITHELIOMA','CL-NEOPLASM','DBX-NCIT-C2916'),('CL-NEOPLASM-T-82',NULL,'CARCINOMA, NEUROENDOCRINE CELL, MALIGNANT','A malignant neuroendocrine neoplasm comprising cells containing secretory granules.','\0','NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE CELL CARCINOMA; NEUROENDOCRINE TUMOR, MALIGNANT','CL-NEOPLASM','DBX-NCIT-C3773'),('CL-NEOPLASM-T-83',NULL,'CARCINOMA, PARS DISTALIS, MALIGNANT','A malignant epithelial neoplasm arising from the pars distalis of the pituitary gland.','\0','Rat Pars Distalis Carcinoma','CL-NEOPLASM','DBX-NCIT-C60491'),('CL-NEOPLASM-T-84',NULL,'CARCINOMA, PARS INTERMEDIA, MALIGNANT','A malignant epithelial neoplasm arising from the pars intermedia of the pituitary gland.','\0','Rat Pars Intermedia Carcinoma','CL-NEOPLASM','DBX-NCIT-C92183'),('CL-NEOPLASM-T-85',NULL,'CARCINOMA, RENAL CELL, MALIGNANT','A malignant neoplasm arising from renal parenchyma.','\0','ADENOCARCINOMA OF KIDNEY; ADENOCARCINOMA OF THE KIDNEY; KIDNEY ADENOCARCINOMA; RCC; RENAL CELL ADENOCARCINOMA; RENAL CELL CANCER; RENAL CELL CARCINOMA, STAGE UNSPECIFIED','CL-NEOPLASM','DBX-NCIT-C9385'),('CL-NEOPLASM-T-86',NULL,'CARCINOMA, RENAL, TUBULAR, MALIGNANT','A malignant neoplasm of the kidney, characterized by the presence of tubules.','\0','MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA OF THE KIDNEY','CL-NEOPLASM','DBX-NCIT-C39807'),('CL-NEOPLASM-T-87',NULL,'CARCINOMA, SPINDLE CELL, MALIGNANT','A malignant epithelial neoplasm characterized by the presence of spindle cells.','\0','PSEUDOSARCOMATOUS CARCINOMA; SPINDLE CELL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C27004'),('CL-NEOPLASM-T-88',NULL,'CARCINOMA, SQUAMOUS CELL, IN SITU, MALIGNANT','A malignant epithelial neoplasm confined to the squamous epithelium, without invasion of underlying tissues.','\0','EPIDERMOID CARCINOMA IN SITU; EPIDERMOID CELL CARCINOMA IN SITU; GRADE 3 SQUAMOUS INTRAEPITHELIAL NEOPLASIA; GRADE III SQUAMOUS INTRAEPITHELIAL NEOPLASIA; INTRAEPITHELIAL SQUAMOUS CELL CARCINOMA; SQUAMOUS CARCINOMA IN SITU; SQUAMOUS CELL CARCINOMA IN SITU','CL-NEOPLASM','DBX-NCIT-C27093'),('CL-NEOPLASM-T-89',NULL,'CARCINOMA, SQUAMOUS CELL, MALIGNANT','A malignant neoplasm arising from squamous epithelial cells.','\0','EPIDERMOID CARCINOMA; EPIDERMOID CELL CANCER; MALIGNANT EPIDERMOID CELL NEOPLASM; MALIGNANT EPIDERMOID CELL TUMOR; MALIGNANT SQUAMOUS CELL NEOPLASM; MALIGNANT SQUAMOUS CELL TUMOR; SQUAMOUS CARCINOMA; SQUAMOUS CELL CANCER; SQUAMOUS CELL EPITHELIOMA','CL-NEOPLASM','DBX-NCIT-C2929'),('CL-NEOPLASM-T-9',NULL,'ADENOCARCINOMA, PAPILLARY, MALIGNANT','An adenocarcinoma with papillary growth pattern.','\0','','CL-NEOPLASM','DBX-NCIT-C2853'),('CL-NEOPLASM-T-90',NULL,'CARCINOMA, SWEAT GLAND, MALIGNANT','A malignant neoplasm arising from sweat glands.','\0','CARCINOMA OF SWEAT GLAND; CARCINOMA OF THE SWEAT GLAND','CL-NEOPLASM','DBX-NCIT-C6938'),('CL-NEOPLASM-T-91',NULL,'CARCINOMA, TRANSITIONAL CELL, MALIGNANT','A malignant neoplasm arising from transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis.','\0','TRANSITIONAL CARCINOMA','CL-NEOPLASM','DBX-NCIT-C2930'),('CL-NEOPLASM-T-92',NULL,'CARCINOMA, TUBULAR CELL, MALIGNANT','A malignant glandular neoplasm exhibiting tubular structures.','\0','','CL-NEOPLASM','DBX-NCIT-C65192'),('CL-NEOPLASM-T-93',NULL,'CARCINOMA, TUBULOSTROMAL, MALIGNANT','A malignant epithelial neoplasm of the ovary with tubular and stromal neoplastic components.','\0','','CL-NEOPLASM','DBX-NCIT-C80356'),('CL-NEOPLASM-T-94',NULL,'CARCINOMA, UNDIFFERENTIATED, MALIGNANT','A malignant epithelial neoplasm exhibiting poor differentiation (anaplasia).','\0','ANAPLASTIC CARCINOMA; CARCINOMA, UNDIFFERENTIATED','CL-NEOPLASM','DBX-NCIT-C3692'),('CL-NEOPLASM-T-95',NULL,'CARCINOMA, ZYMBAL\'S GLAND','A malignant neoplasm of the rodent Zymbal\'s gland with sebaceous and/or squamous differentiation.','\0','','CL-NEOPLASM','DBX-NCIT-C98801'),('CL-NEOPLASM-T-96',NULL,'CARCINOSARCOMA, MALIGNANT','A malignant neoplasm comprising a mixture of carcinomatous and sarcomatous elements.','\0','','CL-NEOPLASM','DBX-NCIT-C34448'),('CL-NEOPLASM-T-97',NULL,'CARDIAC SCHWANNOMA, BENIGN','A benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart.','\0','SCHWANNOMA, ENDOCARDIAL, BENIGN','CL-NEOPLASM','DBX-NCIT-C5358'),('CL-NEOPLASM-T-98',NULL,'CHEMODECTOMA, BENIGN','A benign neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale).','\0','BENIGN CHEMODECTOMA','CL-NEOPLASM','DBX-NCIT-C79950'),('CL-NEOPLASM-T-99',NULL,'CHEMODECTOMA, MALIGNANT','A malignant neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale).','\0','MALIGNANT CAROTID BODY NEOPLASM; MALIGNANT CAROTID BODY TUMOR; MALIGNANT NEOPLASM OF CAROTID BODY; MALIGNANT NEOPLASM OF THE CAROTID BODY; MALIGNANT TUMOR OF CAROTID BODY; MALIGNANT TUMOR OF THE CAROTID BODY','CL-NEOPLASM','DBX-NCIT-C3574'),('CL-NORMABNM-T-1',NULL,'ABNORMAL','Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI)','\0','','CL-NORMABNM','DBX-NCIT-C25401'),('CL-NORMABNM-T-2',NULL,'INDETERMINATE','Cannot distinguish between two or more possible values in the current context. (NCI)','\0','Inconclusive','CL-NORMABNM','DBX-NCIT-C48658'),('CL-NORMABNM-T-3',NULL,'NORMAL','Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI)','\0','','CL-NORMABNM','DBX-NCIT-C14165'),('CL-NORMABNM-T-4',NULL,'NOT EVALUABLE','Unable to be evaluated. (NCI)','\0','Not Evaluable','CL-NORMABNM','DBX-NCIT-C62222'),('CL-NORMABNM-T-5',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-NORMABNM','DBX-NCIT-C17998'),('CL-NRIND-T-1',NULL,'ABNORMAL','Reported values outside the typical or expected range. (NCI)','\0','','CL-NRIND','DBX-NCIT-C78802'),('CL-NRIND-T-2',NULL,'HIGH','Reported values above the typical or expected range. (NCI)','\0','','CL-NRIND','DBX-NCIT-C78800'),('CL-NRIND-T-3',NULL,'LOW','Reported values below the typical or expected range. (NCI)','\0','','CL-NRIND','DBX-NCIT-C78801'),('CL-NRIND-T-4',NULL,'NORMAL','Reported values within the typical or expected range. (NCI)','\0','','CL-NRIND','DBX-NCIT-C78727'),('CL-NSYSPCID-T-1',NULL,'CARDIAC ARREST BEFORE PCI','Cardiac arrest which occurs before a percutaneous coronary intervention can take place.','\0','','CL-NSYSPCID','DBX-NCIT-C99920'),('CL-NSYSPCID-T-2',NULL,'DIFFICULT VASCULAR ACCESS','Access to the subject\'s vasculature is troublesome or formidable.','\0','','CL-NSYSPCID','DBX-NCIT-C99945'),('CL-NSYSPCID-T-3',NULL,'DIFFICULTY CROSSING THE CULPRIT LESION DURING THE PCI PROCEDURE','Placement of intracoronary devices across the coronary stenosis is troublesome or formidable.','\0','','CL-NSYSPCID','DBX-NCIT-C99946'),('CL-NSYSPCID-T-4',NULL,'ENDOTRACHEAL INTUBATION BEFORE PCI','Endotracheal intubation which occurs before a percutaneous coronary intervention can take place.','\0','Intubation before PCI','CL-NSYSPCID','DBX-NCIT-C99950'),('CL-NSYSPCID-T-5',NULL,'OTHER','Different than the one(s) previously specified or mentioned. (NCI)','\0','Other','CL-NSYSPCID','DBX-NCIT-C17649'),('CL-NSYSPCID-T-6',NULL,'SUBJECT DELAY IN PROVIDING CONSENT','The subject has not provided consent in a timely manner for the procedure to take place.','\0','Patient Delay in Providing Consent','CL-NSYSPCID','DBX-NCIT-C100016'),('CL-NVTEST-T-1',NULL,'N145 Latency','An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform.','\0','N145 Latency','CL-NVTEST','DBX-NCIT-C117886'),('CL-NVTEST-T-2',NULL,'P100 Amplitude','The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak.','\0','P100 Amplitude','CL-NVTEST','DBX-NCIT-C117887'),('CL-NVTEST-T-3',NULL,'P100 Latency','An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform.','\0','P100 Latency','CL-NVTEST','DBX-NCIT-C117888'),('CL-NVTEST-T-4',NULL,'Standard Uptake Value Ratio','The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region.','\0','Standard Uptake Value Ratio','CL-NVTEST','DBX-NCIT-C116141'),('CL-NVTESTCD-T-1',NULL,'N145LAT','An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform.','\0','N145 Latency','CL-NVTESTCD','DBX-NCIT-C117886'),('CL-NVTESTCD-T-2',NULL,'P100AMP','The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak.','\0','P100 Amplitude','CL-NVTESTCD','DBX-NCIT-C117887'),('CL-NVTESTCD-T-3',NULL,'P100LAT','An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform.','\0','P100 Latency','CL-NVTESTCD','DBX-NCIT-C117888'),('CL-NVTESTCD-T-4',NULL,'SUVR','The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region.','\0','Standard Uptake Value Ratio','CL-NVTESTCD','DBX-NCIT-C116141'),('CL-NY-T-1',NULL,'N','The non-affirmative response to a question. (NCI)','\0','No','CL-NY','DBX-NCIT-C49487'),('CL-NY-T-2',NULL,'NA','Determination of a value is not relevant in the current context. (NCI)','\0','NA; Not Applicable','CL-NY','DBX-NCIT-C48660'),('CL-NY-T-3',NULL,'U','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-NY','DBX-NCIT-C17998'),('CL-NY-T-4',NULL,'Y','The affirmative response to a question. (NCI)','\0','Yes','CL-NY','DBX-NCIT-C49488'),('CL-NYHAC-T-1',NULL,'NYHA CLASS I','Without limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea.','\0','New York Heart Association Class I','CL-NYHAC','DBX-NCIT-C66904'),('CL-NYHAC-T-2',NULL,'NYHA CLASS II','Slight limitation of physical activity. The patient is comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea.','\0','New York Heart Association Class II','CL-NYHAC','DBX-NCIT-C66905'),('CL-NYHAC-T-3',NULL,'NYHA CLASS III','Marked limitation of physical activity. The patient is comfortable at rest. Less than ordinary activity causes fatigue, palpitations, or dyspnea.','\0','New York Heart Association Class III','CL-NYHAC','DBX-NCIT-C66907'),('CL-NYHAC-T-4',NULL,'NYHA CLASS IV','Inability to carry on any physical activity without discomfort. Heart failure symptoms are present even at rest or with minimal exertion.','\0','New York Heart Association Class IV','CL-NYHAC','DBX-NCIT-C66908'),('CL-OETEST-T-1',NULL,'Astigmatism Axis','A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian.','\0','Astigmatism Axis','CL-OETEST','DBX-NCIT-C117889'),('CL-OETEST-T-2',NULL,'Cylindrical Refraction Error','A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI)','\0','Cylindrical Refraction Error','CL-OETEST','DBX-NCIT-C117892'),('CL-OETEST-T-3',NULL,'Log Score','A number or range of numeric values on the log scale that measures performance, function, quality, or ability.','\0','Log Score','CL-OETEST','DBX-NCIT-C117890'),('CL-OETEST-T-4',NULL,'Number of Letters Correct','The integer that describes the number of letters correctly identified by the subject during an eye chart assessment.','\0','Number of Letters Correct','CL-OETEST','DBX-NCIT-C117891'),('CL-OETEST-T-5',NULL,'Spherical Refractive Error','A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI)','\0','Spherical Refractive Error','CL-OETEST','DBX-NCIT-C117893'),('CL-OETESTCD-T-1',NULL,'ASTAXIS','A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian.','\0','Astigmatism Axis','CL-OETESTCD','DBX-NCIT-C117889'),('CL-OETESTCD-T-2',NULL,'LOGSCORE','A number or range of numeric values on the log scale that measures performance, function, quality, or ability.','\0','Log Score','CL-OETESTCD','DBX-NCIT-C117890'),('CL-OETESTCD-T-3',NULL,'NUMLCOR','The integer that describes the number of letters correctly identified by the subject during an eye chart assessment.','\0','Number of Letters Correct','CL-OETESTCD','DBX-NCIT-C117891'),('CL-OETESTCD-T-4',NULL,'RECYLDR','A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI)','\0','Cylindrical Refraction Error','CL-OETESTCD','DBX-NCIT-C117892'),('CL-OETESTCD-T-5',NULL,'RESPHERE','A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI)','\0','Spherical Refractive Error','CL-OETESTCD','DBX-NCIT-C117893'),('CL-OUT-T-1',NULL,'FATAL','The termination of life as a result of an adverse event. (NCI)','\0','5; FATAL; Grade 5','CL-OUT','DBX-NCIT-C48275'),('CL-OUT-T-2',NULL,'NOT RECOVERED/NOT RESOLVED','One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)','\0','','CL-OUT','DBX-NCIT-C49494'),('CL-OUT-T-3',NULL,'RECOVERED/RESOLVED','One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)','\0','','CL-OUT','DBX-NCIT-C49498'),('CL-OUT-T-4',NULL,'RECOVERED/RESOLVED WITH SEQUELAE','One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)','\0','','CL-OUT','DBX-NCIT-C49495'),('CL-OUT-T-5',NULL,'RECOVERING/RESOLVING','One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)','\0','','CL-OUT','DBX-NCIT-C49496'),('CL-OUT-T-6',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-OUT','DBX-NCIT-C17998'),('CL-PBSTMT-T-1',NULL,'NEGATIVE','A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.','\0','','CL-PBSTMT','DBX-NCIT-C38757'),('CL-PBSTMT-T-2',NULL,'POSITIVE','An observation confirming something, such as the presence of a disease, condition, or microorganism.','\0','','CL-PBSTMT','DBX-NCIT-C38758'),('CL-PBSTMT-T-3',NULL,'RESISTANT','The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mec','\0','Resistant','CL-PBSTMT','DBX-NCIT-C85562'),('CL-PBSTMT-T-4',NULL,'SUSCEPTIBLE','The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.','\0','Susceptible','CL-PBSTMT','DBX-NCIT-C85563'),('CL-PFTEST-T-1',NULL,'Allele','Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI)','\0','Allele','CL-PFTEST','DBX-NCIT-C16277'),('CL-PFTESTCD-T-1',NULL,'ALLELE','Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI)','\0','Allele','CL-PFTESTCD','DBX-NCIT-C16277'),('CL-PHSPRP-T-1',NULL,'Color','The appearance of objects (or light sources) described in terms of a person\'s perception of their hue and lightness (or brightness) and saturation. (NCI)','\0','Color','CL-PHSPRP','DBX-NCIT-C37927'),('CL-PHSPRP-T-10',NULL,'Width','The extent or measurement of something from side to side. (NCI)','\0','Width','CL-PHSPRP','DBX-NCIT-C25345'),('CL-PHSPRP-T-2',NULL,'Consistency','A description about the firmness or make-up of an entity.','\0','Consistency','CL-PHSPRP','DBX-NCIT-C95110'),('CL-PHSPRP-T-3',NULL,'Depth','The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)','\0','Depth','CL-PHSPRP','DBX-NCIT-C25333'),('CL-PHSPRP-T-4',NULL,'Description','A written or verbal account, representation, statement, or explanation of something. (NCI)','\0','Description','CL-PHSPRP','DBX-NCIT-C25365'),('CL-PHSPRP-T-5',NULL,'Diameter','The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)','\0','Diameter','CL-PHSPRP','DBX-NCIT-C25285'),('CL-PHSPRP-T-6',NULL,'Hair Cover','A description of the quantity or quality of the hair or fur covering a biological entity. (NCI)','\0','Hair Cover','CL-PHSPRP','DBX-NCIT-C95109'),('CL-PHSPRP-T-7',NULL,'Length','The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)','\0','Length','CL-PHSPRP','DBX-NCIT-C25334'),('CL-PHSPRP-T-8',NULL,'Shape','The spatial arrangement of something as distinct from its substance. (NCI)','\0','Shape','CL-PHSPRP','DBX-NCIT-C25677'),('CL-PHSPRP-T-9',NULL,'Ulceration','The formation or development of an ulcer. (NCI)','\0','Ulceration','CL-PHSPRP','DBX-NCIT-C25757'),('CL-PHSPRPCD-T-1',NULL,'COLOR','The appearance of objects (or light sources) described in terms of a person\'s perception of their hue and lightness (or brightness) and saturation. (NCI)','\0','Color','CL-PHSPRPCD','DBX-NCIT-C37927'),('CL-PHSPRPCD-T-10',NULL,'WIDTH','The extent or measurement of something from side to side. (NCI)','\0','Width','CL-PHSPRPCD','DBX-NCIT-C25345'),('CL-PHSPRPCD-T-2',NULL,'CONSIST','A description about the firmness or make-up of an entity.','\0','Consistency','CL-PHSPRPCD','DBX-NCIT-C95110'),('CL-PHSPRPCD-T-3',NULL,'DEPTH','The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)','\0','Depth','CL-PHSPRPCD','DBX-NCIT-C25333'),('CL-PHSPRPCD-T-4',NULL,'DESCR','A written or verbal account, representation, statement, or explanation of something. (NCI)','\0','Description','CL-PHSPRPCD','DBX-NCIT-C25365'),('CL-PHSPRPCD-T-5',NULL,'DIAMETER','The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)','\0','Diameter','CL-PHSPRPCD','DBX-NCIT-C25285'),('CL-PHSPRPCD-T-6',NULL,'HAIRCOV','A description of the quantity or quality of the hair or fur covering a biological entity. (NCI)','\0','Hair Cover','CL-PHSPRPCD','DBX-NCIT-C95109'),('CL-PHSPRPCD-T-7',NULL,'LENGTH','The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)','\0','Length','CL-PHSPRPCD','DBX-NCIT-C25334'),('CL-PHSPRPCD-T-8',NULL,'SHAPE','The spatial arrangement of something as distinct from its substance. (NCI)','\0','Shape','CL-PHSPRPCD','DBX-NCIT-C25677'),('CL-PHSPRPCD-T-9',NULL,'ULCER','The formation or development of an ulcer. (NCI)','\0','Ulceration','CL-PHSPRPCD','DBX-NCIT-C25757'),('CL-PKPARM-T-1',NULL,'Accumulation Index using Lambda z','Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data.','\0','Accumulation Index using Lambda z','CL-PKPARM','DBX-NCIT-C114234'),('CL-PKPARM-T-10',NULL,'Amt Rec Infinity Obs','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','Amt Rec Infinity Obs','CL-PKPARM','DBX-NCIT-C112032'),('CL-PKPARM-T-100',NULL,'AURC Infinity Pred Norm by BMI','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index.','\0','AURC Infinity Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C92358'),('CL-PKPARM-T-101',NULL,'AURC Infinity Pred Norm by Dose','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose.','\0','AURC Infinity Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C92359'),('CL-PKPARM-T-102',NULL,'AURC Infinity Pred Norm by SA','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area.','\0','AURC Infinity Pred Norm by SA','CL-PKPARM','DBX-NCIT-C92360'),('CL-PKPARM-T-103',NULL,'AURC Infinity Pred Norm by WT','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight.','\0','AURC Infinity Pred Norm by WT','CL-PKPARM','DBX-NCIT-C92361'),('CL-PKPARM-T-104',NULL,'AURC to Last Nonzero Rate','The area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration.','\0','AURC to Last Nonzero Rate','CL-PKPARM','DBX-NCIT-C85571'),('CL-PKPARM-T-105',NULL,'Average Conc','AUCTAU divided by TAU.','\0','Average Conc; Average Concentration','CL-PKPARM','DBX-NCIT-C85575'),('CL-PKPARM-T-106',NULL,'Average Conc Norm by BMI','AUCTAU divided by TAU and then divided by the body mass index.','\0','Average Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92367'),('CL-PKPARM-T-107',NULL,'Average Conc Norm by Dose','AUCTAU divided by TAU and then divided by the dose.','\0','Average Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92368'),('CL-PKPARM-T-108',NULL,'Average Conc Norm by SA','AUCTAU divided by TAU and then divided by the surface area.','\0','Average Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92369'),('CL-PKPARM-T-109',NULL,'Average Conc Norm by WT','AUCTAU divided by TAU and then divided by the weight.','\0','Average Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92370'),('CL-PKPARM-T-11',NULL,'Amt Rec Infinity Obs Norm by BMI','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Amt Rec Infinity Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C112223'),('CL-PKPARM-T-110',NULL,'Conc','The quantity of a specified substance in a unit volume or weight of another substance.','\0','Conc','CL-PKPARM','DBX-NCIT-C41185'),('CL-PKPARM-T-111',NULL,'Conc by BMI','The concentration divided by body mass index.','\0','Conc by BMI','CL-PKPARM','DBX-NCIT-C102367'),('CL-PKPARM-T-112',NULL,'Conc by Dose','The concentration divided by dose.','\0','Conc by Dose','CL-PKPARM','DBX-NCIT-C102368'),('CL-PKPARM-T-113',NULL,'Conc by SA','The concentration divided by surface area.','\0','Conc by SA','CL-PKPARM','DBX-NCIT-C102369'),('CL-PKPARM-T-114',NULL,'Conc by WT','The concentration divided by weight.','\0','Conc by WT','CL-PKPARM','DBX-NCIT-C102370'),('CL-PKPARM-T-115',NULL,'Conc Trough','Concentration at end of dosing interval.','\0','Conc Trough','CL-PKPARM','DBX-NCIT-C102394'),('CL-PKPARM-T-116',NULL,'Conc Trough by BMI','The trough concentration divided by body mass index.','\0','Conc Trough by BMI','CL-PKPARM','DBX-NCIT-C102395'),('CL-PKPARM-T-117',NULL,'Conc Trough by Dose','The trough concentration divided by dose.','\0','Conc Trough by Dose','CL-PKPARM','DBX-NCIT-C102396'),('CL-PKPARM-T-118',NULL,'Conc Trough by SA','The trough concentration divided by surface area.','\0','Conc Trough by SA','CL-PKPARM','DBX-NCIT-C102397'),('CL-PKPARM-T-119',NULL,'Conc Trough by WT','The trough concentration divided by weight.','\0','Conc Trough by WT','CL-PKPARM','DBX-NCIT-C102398'),('CL-PKPARM-T-12',NULL,'Amt Rec Infinity Obs Norm by SA','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Amt Rec Infinity Obs Norm by SA','CL-PKPARM','DBX-NCIT-C112224'),('CL-PKPARM-T-120',NULL,'Correlation Between TimeX and Log ConcY','The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z.','\0','Correlation Between TimeX and Log ConcY','CL-PKPARM','DBX-NCIT-C85821'),('CL-PKPARM-T-121',NULL,'Effective Half-Life','The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing.','\0','Effective Half-Life','CL-PKPARM','DBX-NCIT-C95007'),('CL-PKPARM-T-122',NULL,'Excret Rate from T1 to T2','The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2','CL-PKPARM','DBX-NCIT-C105449'),('CL-PKPARM-T-123',NULL,'Excret Rate from T1 to T2 Norm by BMI','The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by BMI','CL-PKPARM','DBX-NCIT-C105450'),('CL-PKPARM-T-124',NULL,'Excret Rate from T1 to T2 Norm by Dose','The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by Dose','CL-PKPARM','DBX-NCIT-C105451'),('CL-PKPARM-T-125',NULL,'Excret Rate from T1 to T2 Norm by SA','The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by SA','CL-PKPARM','DBX-NCIT-C105452'),('CL-PKPARM-T-126',NULL,'Excret Rate from T1 to T2 Norm by WT','The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by WT','CL-PKPARM','DBX-NCIT-C105453'),('CL-PKPARM-T-127',NULL,'Fluctuation%','The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau.','\0','Fluctuation%','CL-PKPARM','DBX-NCIT-C85581'),('CL-PKPARM-T-128',NULL,'Half-Life Lambda z','Terminal half-life.','\0','Half-Life Lambda z','CL-PKPARM','DBX-NCIT-C85818'),('CL-PKPARM-T-129',NULL,'Hemodialysis Clearance','The clearance of a substance from the blood during a hemodialysis session.','\0','Hemodialysis CL; Hemodialysis Clearance','CL-PKPARM','DBX-NCIT-C112287'),('CL-PKPARM-T-13',NULL,'Amt Rec Infinity Obs Norm by WT','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Amt Rec Infinity Obs Norm by WT','CL-PKPARM','DBX-NCIT-C112225'),('CL-PKPARM-T-130',NULL,'Hemodialysis Extraction Ratio','The fractional content of a substance removed from the blood during a hemodialysis session.','\0','Hemodialysis Extraction Ratio','CL-PKPARM','DBX-NCIT-C116213'),('CL-PKPARM-T-131',NULL,'Initial Conc','Initial concentration. Given only for bolus IV models.','\0','Initial Conc','CL-PKPARM','DBX-NCIT-C85644'),('CL-PKPARM-T-132',NULL,'Initial Conc Norm by BMI','Initial concentration divided by the body mass index. Given only for bolus IV models.','\0','Initial Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92383'),('CL-PKPARM-T-133',NULL,'Initial Conc Norm by Dose','Initial concentration divided by the dose. Given only for bolus IV models.','\0','Initial Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92384'),('CL-PKPARM-T-134',NULL,'Initial Conc Norm by SA','Initial concentration divided by the surface area. Given only for bolus IV models.','\0','Initial Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92385'),('CL-PKPARM-T-135',NULL,'Initial Conc Norm by WT','Initial concentration divided by the weight. Given only for bolus IV models.','\0','Initial Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92386'),('CL-PKPARM-T-136',NULL,'Lambda z','The first order rate constant associated with the terminal (log-linear) portion of the curve.','\0','Lambda z','CL-PKPARM','DBX-NCIT-C85652'),('CL-PKPARM-T-137',NULL,'Lambda z Lower Limit','The lower limit on time for values to be included in the calculation of Lambda z.','\0','Lambda z Lower Limit','CL-PKPARM','DBX-NCIT-C85653'),('CL-PKPARM-T-138',NULL,'Lambda z Upper Limit','The upper limit on time for values to be included in the calculation of Lambda z.','\0','Lambda z Upper Limit','CL-PKPARM','DBX-NCIT-C85654'),('CL-PKPARM-T-139',NULL,'Last Meas Excretion Rate','The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC.','\0','Last Meas Excretion Rate','CL-PKPARM','DBX-NCIT-C85656'),('CL-PKPARM-T-14',NULL,'Amt Rec Infinity Pred','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','Amt Rec Infinity Pred','CL-PKPARM','DBX-NCIT-C112033'),('CL-PKPARM-T-140',NULL,'Last Meas Excretion Rate Norm by BMI','The last measurable (positive) excretion rate divided by the body mass index.','\0','Last Meas Excretion Rate Norm by BMI','CL-PKPARM','DBX-NCIT-C92391'),('CL-PKPARM-T-141',NULL,'Last Meas Excretion Rate Norm by Dose','The last measurable (positive) excretion rate divided by the dose.','\0','Last Meas Excretion Rate Norm by Dose','CL-PKPARM','DBX-NCIT-C92392'),('CL-PKPARM-T-142',NULL,'Last Meas Excretion Rate Norm by SA','The last measurable (positive) excretion rate divided by the surface area.','\0','Last Meas Excretion Rate Norm by SA','CL-PKPARM','DBX-NCIT-C92393'),('CL-PKPARM-T-143',NULL,'Last Meas Excretion Rate Norm by WT','The last measurable (positive) excretion rate divided by the weight.','\0','Last Meas Excretion Rate Norm by WT','CL-PKPARM','DBX-NCIT-C92394'),('CL-PKPARM-T-144',NULL,'Last Nonzero Conc','The concentration corresponding to Tlast.','\0','Last Nonzero Conc','CL-PKPARM','DBX-NCIT-C85655'),('CL-PKPARM-T-145',NULL,'Last Nonzero Conc Norm by BMI','The concentration corresponding to Tlast divided by the body mass index.','\0','Last Nonzero Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92387'),('CL-PKPARM-T-146',NULL,'Last Nonzero Conc Norm by Dose','The concentration corresponding to Tlast divided by the dose.','\0','Last Nonzero Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92388'),('CL-PKPARM-T-147',NULL,'Last Nonzero Conc Norm by SA','The concentration corresponding to Tlast divided by the surface area.','\0','Last Nonzero Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92389'),('CL-PKPARM-T-148',NULL,'Last Nonzero Conc Norm by WT','The concentration corresponding to Tlast divided by the weight.','\0','Last Nonzero Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92390'),('CL-PKPARM-T-149',NULL,'Max Conc','The maximum concentration occurring at Tmax.','\0','Max Conc','CL-PKPARM','DBX-NCIT-C70918'),('CL-PKPARM-T-15',NULL,'Amt Rec Infinity Pred Norm by BMI','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Amt Rec Infinity Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C112226'),('CL-PKPARM-T-150',NULL,'Max Conc Norm by BMI','The maximum concentration occurring at Tmax, divided by the body mass index.','\0','Max Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92371'),('CL-PKPARM-T-151',NULL,'Max Conc Norm by Dose','The maximum concentration occurring at Tmax, divided by the dose.','\0','Max Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C85698'),('CL-PKPARM-T-152',NULL,'Max Conc Norm by SA','The maximum concentration occurring at Tmax, divided by the surface area.','\0','Max Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92372'),('CL-PKPARM-T-153',NULL,'Max Conc Norm by WT','The maximum concentration occurring at Tmax, divided by the weight.','\0','Max Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92373'),('CL-PKPARM-T-154',NULL,'Max Excretion Rate','The maximum excretion rate determined for the specimen type specified in PPSPEC.','\0','Max Excretion Rate','CL-PKPARM','DBX-NCIT-C85699'),('CL-PKPARM-T-155',NULL,'Max Excretion Rate Norm by BMI','The maximum excretion rate divided by the body mass index.','\0','Max Excretion Rate Norm by BMI','CL-PKPARM','DBX-NCIT-C92395'),('CL-PKPARM-T-156',NULL,'Max Excretion Rate Norm by Dose','The maximum excretion rate divided by the dose.','\0','Max Excretion Rate Norm by Dose','CL-PKPARM','DBX-NCIT-C92396'),('CL-PKPARM-T-157',NULL,'Max Excretion Rate Norm by SA','The maximum excretion rate divided by the surface area.','\0','Max Excretion Rate Norm by SA','CL-PKPARM','DBX-NCIT-C92397'),('CL-PKPARM-T-158',NULL,'Max Excretion Rate Norm by WT','The maximum excretion rate divided by the weight.','\0','Max Excretion Rate Norm by WT','CL-PKPARM','DBX-NCIT-C92398'),('CL-PKPARM-T-159',NULL,'Midpoint of Collection Interval','The midpoint of collection interval, which is associated with last Measurable rate.','\0','Midpoint of Collection Interval','CL-PKPARM','DBX-NCIT-C85580'),('CL-PKPARM-T-16',NULL,'Amt Rec Infinity Pred Norm by SA','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Amt Rec Infinity Pred Norm by SA','CL-PKPARM','DBX-NCIT-C112227'),('CL-PKPARM-T-160',NULL,'Min Conc','The minimum concentration between dose time and dose time plus Tau (at Tmin).','\0','Min Conc','CL-PKPARM','DBX-NCIT-C85579'),('CL-PKPARM-T-161',NULL,'Min Conc Norm by BMI','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index.','\0','Min Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92374'),('CL-PKPARM-T-162',NULL,'Min Conc Norm by Dose','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose.','\0','Min Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92375'),('CL-PKPARM-T-163',NULL,'Min Conc Norm by SA','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area.','\0','Min Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92376'),('CL-PKPARM-T-164',NULL,'Min Conc Norm by WT','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight.','\0','Min Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92377'),('CL-PKPARM-T-165',NULL,'MRT Infinity Obs','The mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','MRT Infinity Obs','CL-PKPARM','DBX-NCIT-C85769'),('CL-PKPARM-T-166',NULL,'MRT Infinity Pred','The mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','MRT Infinity Pred','CL-PKPARM','DBX-NCIT-C85793'),('CL-PKPARM-T-167',NULL,'MRT to Last Nonzero Conc','Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration.','\0','MRT to Last Nonzero Conc','CL-PKPARM','DBX-NCIT-C85700'),('CL-PKPARM-T-168',NULL,'Nonrenal CL','The total clearance of a substance from the blood less the renal clearance.','\0','Nonrenal CL','CL-PKPARM','DBX-NCIT-C102376'),('CL-PKPARM-T-169',NULL,'Nonrenal CL Norm by BMI','The total clearance of a substance from the blood minus the renal clearance divided by the body mass index.','\0','Nonrenal CL Norm by BMI','CL-PKPARM','DBX-NCIT-C105454'),('CL-PKPARM-T-17',NULL,'Amt Rec Infinity Pred Norm by WT','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Amt Rec Infinity Pred Norm by WT','CL-PKPARM','DBX-NCIT-C112228'),('CL-PKPARM-T-170',NULL,'Nonrenal CL Norm by Dose','The total clearance of a substance from the blood minus the renal clearance divided by the dose.','\0','Nonrenal CL Norm by Dose','CL-PKPARM','DBX-NCIT-C105455'),('CL-PKPARM-T-171',NULL,'Nonrenal CL Norm by SA','The total clearance of a substance from the blood minus the renal clearance divided by the surface area.','\0','Nonrenal CL Norm by SA','CL-PKPARM','DBX-NCIT-C105456'),('CL-PKPARM-T-172',NULL,'Nonrenal CL Norm by WT','The total clearance of a substance from the blood minus the renal clearance divided by the weight.','\0','Nonrenal CL Norm by WT','CL-PKPARM','DBX-NCIT-C105457'),('CL-PKPARM-T-173',NULL,'Number of Points for Lambda z','The number of time points used in computing Lambda z.','\0','Number of Points for Lambda z','CL-PKPARM','DBX-NCIT-C85816'),('CL-PKPARM-T-174',NULL,'Pct Rec from T1 to T2','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2.','\0','Pct Rec from T1 to T2','CL-PKPARM','DBX-NCIT-C102382'),('CL-PKPARM-T-175',NULL,'Pct Rec from T1 to T2 Norm by BMI','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index.','\0','Pct Rec from T1 to T2 Norm by BMI','CL-PKPARM','DBX-NCIT-C102383'),('CL-PKPARM-T-176',NULL,'Pct Rec from T1 to T2 Norm by SA','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area.','\0','Pct Rec from T1 to T2 Norm by SA','CL-PKPARM','DBX-NCIT-C102384'),('CL-PKPARM-T-177',NULL,'Pct Rec from T1 to T2 Norm by WT','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight.','\0','Pct Rec from T1 to T2 Norm by WT','CL-PKPARM','DBX-NCIT-C102385'),('CL-PKPARM-T-178',NULL,'Pct Rec Infinity Obs','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','Pct Rec Infinity Obs','CL-PKPARM','DBX-NCIT-C112034'),('CL-PKPARM-T-179',NULL,'Pct Rec Infinity Obs Norm by BMI','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Pct Rec Infinity Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C112389'),('CL-PKPARM-T-18',NULL,'Amt Rec Over Dosing Interval','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU).','\0','Amt Rec Over Dosing Interval','CL-PKPARM','DBX-NCIT-C102363'),('CL-PKPARM-T-180',NULL,'Pct Rec Infinity Obs Norm by SA','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Pct Rec Infinity Obs Norm by SA','CL-PKPARM','DBX-NCIT-C112390'),('CL-PKPARM-T-181',NULL,'Pct Rec Infinity Obs Norm by WT','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Pct Rec Infinity Obs Norm by WT','CL-PKPARM','DBX-NCIT-C112391'),('CL-PKPARM-T-182',NULL,'Pct Rec Infinity Pred','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','Pct Rec Infinity Pred','CL-PKPARM','DBX-NCIT-C112035'),('CL-PKPARM-T-183',NULL,'Pct Rec Infinity Pred Norm by BMI','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Pct Rec Infinity Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C112392'),('CL-PKPARM-T-184',NULL,'Pct Rec Infinity Pred Norm by SA','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Pct Rec Infinity Pred Norm by SA','CL-PKPARM','DBX-NCIT-C112393'),('CL-PKPARM-T-185',NULL,'Pct Rec Infinity Pred Norm by WT','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Pct Rec Infinity Pred Norm by WT','CL-PKPARM','DBX-NCIT-C112394'),('CL-PKPARM-T-186',NULL,'Pct Rec Over Dosing Interval','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU).','\0','Pct Rec Over Dosing Interval','CL-PKPARM','DBX-NCIT-C102386'),('CL-PKPARM-T-187',NULL,'Pct Rec Over Dosing Interval Norm by BMI','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index.','\0','Pct Rec Over Dosing Interval Norm by BMI','CL-PKPARM','DBX-NCIT-C102387'),('CL-PKPARM-T-188',NULL,'Pct Rec Over Dosing Interval Norm by SA','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area.','\0','Pct Rec Over Dosing Interval Norm by SA','CL-PKPARM','DBX-NCIT-C102388'),('CL-PKPARM-T-189',NULL,'Pct Rec Over Dosing Interval Norm by WT','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight.','\0','Pct Rec Over Dosing Interval Norm by WT','CL-PKPARM','DBX-NCIT-C102389'),('CL-PKPARM-T-19',NULL,'Amt Rec Over Dosing Interval Norm by BMI','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index.','\0','Amt Rec Over Dosing Interval Norm by BMI','CL-PKPARM','DBX-NCIT-C102364'),('CL-PKPARM-T-190',NULL,'Peak Trough Ratio','The ratio of Cmax to Ctrough during a dosing interval.','\0','Peak Trough Ratio','CL-PKPARM','DBX-NCIT-C102381'),('CL-PKPARM-T-191',NULL,'R Squared','The goodness of fit statistic for the terminal elimination phase.','\0','R Squared','CL-PKPARM','DBX-NCIT-C85542'),('CL-PKPARM-T-192',NULL,'R Squared Adjusted','The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z.','\0','R Squared Adjusted','CL-PKPARM','DBX-NCIT-C85553'),('CL-PKPARM-T-193',NULL,'Renal CL','The clearance of a substance from the blood by the kidneys.','\0','Renal CL','CL-PKPARM','DBX-NCIT-C75913'),('CL-PKPARM-T-194',NULL,'Renal CL Norm by BMI','The clearance of a substance from the blood by the kidneys divided by the body mass index.','\0','Renal CL Norm by BMI','CL-PKPARM','DBX-NCIT-C105458'),('CL-PKPARM-T-195',NULL,'Renal CL Norm by Dose','The clearance of a substance from the blood by the kidneys divided by the dose.','\0','Renal CL Norm by Dose','CL-PKPARM','DBX-NCIT-C105459'),('CL-PKPARM-T-196',NULL,'Renal CL Norm by SA','The clearance of a substance from the blood by the kidneys divided by the surface area.','\0','Renal CL Norm by SA','CL-PKPARM','DBX-NCIT-C105460'),('CL-PKPARM-T-197',NULL,'Renal CL Norm by WT','The clearance of a substance from the blood by the kidneys divided by the weight.','\0','Renal CL Norm by WT','CL-PKPARM','DBX-NCIT-C105461'),('CL-PKPARM-T-198',NULL,'Sum of Urine Vol','The sum of urine volumes that are used for PK parameters.','\0','Sum of Urine Vol','CL-PKPARM','DBX-NCIT-C85817'),('CL-PKPARM-T-199',NULL,'Time of CMAX','The time of maximum observed concentration sampled during a dosing interval.','\0','Time of CMAX','CL-PKPARM','DBX-NCIT-C70919'),('CL-PKPARM-T-2',NULL,'Accumulation Ratio AUC','The area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval.','\0','Accumulation Ratio AUC','CL-PKPARM','DBX-NCIT-C102356'),('CL-PKPARM-T-20',NULL,'Amt Rec Over Dosing Interval Norm by SA','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area.','\0','Amt Rec Over Dosing Interval Norm by SA','CL-PKPARM','DBX-NCIT-C102365'),('CL-PKPARM-T-200',NULL,'Time of CMIN Observation','The time of minimum concentration sampled during a dosing interval.','\0','Time of CMIN Observation','CL-PKPARM','DBX-NCIT-C85825'),('CL-PKPARM-T-201',NULL,'Time of Last Nonzero Conc','The time of the last measurable (positive) concentration.','\0','Time of Last Nonzero Conc','CL-PKPARM','DBX-NCIT-C85822'),('CL-PKPARM-T-202',NULL,'Time of Max Excretion Rate','The midpoint of collection interval associated with the maximum excretion rate.','\0','Time of Max Excretion Rate','CL-PKPARM','DBX-NCIT-C85823'),('CL-PKPARM-T-203',NULL,'Time Until First Nonzero Conc','The time prior to the first measurable (non-zero) concentration.','\0','Time Until First Nonzero Conc','CL-PKPARM','DBX-NCIT-C85824'),('CL-PKPARM-T-204',NULL,'Total CL by F for Dose Int','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.','\0','Total CL by F for Dose Int','CL-PKPARM','DBX-NCIT-C114121'),('CL-PKPARM-T-205',NULL,'Total CL by F for Dose Int Norm by BMI','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.','\0','Total CL by F for Dose Int Norm by BMI','CL-PKPARM','DBX-NCIT-C114227'),('CL-PKPARM-T-206',NULL,'Total CL by F for Dose Int Norm by Dose','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.','\0','Total CL by F for Dose Int Norm by Dose','CL-PKPARM','DBX-NCIT-C114226'),('CL-PKPARM-T-207',NULL,'Total CL by F for Dose Int Norm by SA','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.','\0','Total CL by F for Dose Int Norm by SA','CL-PKPARM','DBX-NCIT-C114228'),('CL-PKPARM-T-208',NULL,'Total CL by F for Dose Int Norm by WT','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.','\0','Total CL by F for Dose Int Norm by WT','CL-PKPARM','DBX-NCIT-C114229'),('CL-PKPARM-T-209',NULL,'Total CL for Dose Int','The total body clearance for intravascular administration, calculated using AUCTAU.','\0','Total CL for Dose Int','CL-PKPARM','DBX-NCIT-C114122'),('CL-PKPARM-T-21',NULL,'Amt Rec Over Dosing Interval Norm by WT','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight.','\0','Amt Rec Over Dosing Interval Norm by WT','CL-PKPARM','DBX-NCIT-C102366'),('CL-PKPARM-T-210',NULL,'Total CL for Dose Int Norm by BMI','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index.','\0','Total CL for Dose Int Norm by BMI','CL-PKPARM','DBX-NCIT-C114231'),('CL-PKPARM-T-211',NULL,'Total CL for Dose Int Norm by Dose','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose.','\0','Total CL for Dose Int Norm by Dose','CL-PKPARM','DBX-NCIT-C114230'),('CL-PKPARM-T-212',NULL,'Total CL for Dose Int Norm by SA','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area.','\0','Total CL for Dose Int Norm by SA','CL-PKPARM','DBX-NCIT-C114232'),('CL-PKPARM-T-213',NULL,'Total CL for Dose Int Norm by WT','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight.','\0','Total CL for Dose Int Norm by WT','CL-PKPARM','DBX-NCIT-C114233'),('CL-PKPARM-T-214',NULL,'Total CL Obs','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration.','\0','Total CL Obs','CL-PKPARM','DBX-NCIT-C85773'),('CL-PKPARM-T-215',NULL,'Total CL Obs by F','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.','\0','Total CL Obs by F','CL-PKPARM','DBX-NCIT-C85772'),('CL-PKPARM-T-216',NULL,'Total CL Obs by F Norm by BMI','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Obs by F Norm by BMI','CL-PKPARM','DBX-NCIT-C92399'),('CL-PKPARM-T-217',NULL,'Total CL Obs by F Norm by Dose','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Total CL Obs by F Norm by Dose','CL-PKPARM','DBX-NCIT-C92400'),('CL-PKPARM-T-218',NULL,'Total CL Obs by F Norm by SA','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Total CL Obs by F Norm by SA','CL-PKPARM','DBX-NCIT-C92401'),('CL-PKPARM-T-219',NULL,'Total CL Obs by F Norm by WT','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Total CL Obs by F Norm by WT','CL-PKPARM','DBX-NCIT-C92402'),('CL-PKPARM-T-22',NULL,'AUC %Back Extrapolation Obs','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Back Extrapolation Obs','CL-PKPARM','DBX-NCIT-C85763'),('CL-PKPARM-T-220',NULL,'Total CL Obs Norm by BMI','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C92403'),('CL-PKPARM-T-221',NULL,'Total CL Obs Norm by Dose','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Total CL Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C92404'),('CL-PKPARM-T-222',NULL,'Total CL Obs Norm by SA','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Total CL Obs Norm by SA','CL-PKPARM','DBX-NCIT-C92405'),('CL-PKPARM-T-223',NULL,'Total CL Obs Norm by WT','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Total CL Obs Norm by WT','CL-PKPARM','DBX-NCIT-C92406'),('CL-PKPARM-T-224',NULL,'Total CL Pred','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration.','\0','Total CL Pred','CL-PKPARM','DBX-NCIT-C85797'),('CL-PKPARM-T-225',NULL,'Total CL Pred by F','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.','\0','Total CL Pred by F','CL-PKPARM','DBX-NCIT-C85796'),('CL-PKPARM-T-226',NULL,'Total CL Pred by F Norm by BMI','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index.','\0','Total CL Pred by F Norm by BMI','CL-PKPARM','DBX-NCIT-C92417'),('CL-PKPARM-T-227',NULL,'Total CL Pred by F Norm by Dose','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Total CL Pred by F Norm by Dose','CL-PKPARM','DBX-NCIT-C92418'),('CL-PKPARM-T-228',NULL,'Total CL Pred by F Norm by SA','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Total CL Pred by F Norm by SA','CL-PKPARM','DBX-NCIT-C92419'),('CL-PKPARM-T-229',NULL,'Total CL Pred by F Norm by WT','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Total CL Pred by F Norm by WT','CL-PKPARM','DBX-NCIT-C92420'),('CL-PKPARM-T-23',NULL,'AUC %Back Extrapolation Pred','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Back Extrapolation Pred','CL-PKPARM','DBX-NCIT-C85787'),('CL-PKPARM-T-230',NULL,'Total CL Pred Norm by BMI','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C92421'),('CL-PKPARM-T-231',NULL,'Total CL Pred Norm by Dose','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Total CL Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C92422'),('CL-PKPARM-T-232',NULL,'Total CL Pred Norm by SA','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Total CL Pred Norm by SA','CL-PKPARM','DBX-NCIT-C92423'),('CL-PKPARM-T-233',NULL,'Total CL Pred Norm by WT','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Total CL Pred Norm by WT','CL-PKPARM','DBX-NCIT-C92424'),('CL-PKPARM-T-234',NULL,'Vol Dist Initial','The initial volume of distribution for a substance administered by bolus intravascular dosing.','\0','Vol Dist Initial','CL-PKPARM','DBX-NCIT-C102371'),('CL-PKPARM-T-235',NULL,'Vol Dist Initial Norm by BMI','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index.','\0','Vol Dist Initial Norm by BMI','CL-PKPARM','DBX-NCIT-C102372'),('CL-PKPARM-T-236',NULL,'Vol Dist Initial Norm by Dose','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose.','\0','Vol Dist Initial Norm by Dose','CL-PKPARM','DBX-NCIT-C102373'),('CL-PKPARM-T-237',NULL,'Vol Dist Initial Norm by SA','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area.','\0','Vol Dist Initial Norm by SA','CL-PKPARM','DBX-NCIT-C102374'),('CL-PKPARM-T-238',NULL,'Vol Dist Initial Norm by WT','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight.','\0','Vol Dist Initial Norm by WT','CL-PKPARM','DBX-NCIT-C102375'),('CL-PKPARM-T-239',NULL,'Vol Dist Steady State Obs','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing.','\0','Vol Dist Steady State Obs','CL-PKPARM','DBX-NCIT-C85770'),('CL-PKPARM-T-24',NULL,'AUC %Extrapolation Obs','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Extrapolation Obs','CL-PKPARM','DBX-NCIT-C85764'),('CL-PKPARM-T-240',NULL,'Vol Dist Steady State Obs Norm by BMI','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index.','\0','Vol Dist Steady State Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C102377'),('CL-PKPARM-T-241',NULL,'Vol Dist Steady State Obs Norm by Dose','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose.','\0','Vol Dist Steady State Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C102378'),('CL-PKPARM-T-242',NULL,'Vol Dist Steady State Obs Norm by SA','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area.','\0','Vol Dist Steady State Obs Norm by SA','CL-PKPARM','DBX-NCIT-C102379'),('CL-PKPARM-T-243',NULL,'Vol Dist Steady State Obs Norm by WT','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight.','\0','Vol Dist Steady State Obs Norm by WT','CL-PKPARM','DBX-NCIT-C102380'),('CL-PKPARM-T-244',NULL,'Vol Dist Steady State Pred','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing.','\0','Vol Dist Steady State Pred','CL-PKPARM','DBX-NCIT-C85794'),('CL-PKPARM-T-245',NULL,'Vol Dist Steady State Pred Norm by BMI','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index.','\0','Vol Dist Steady State Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C102390'),('CL-PKPARM-T-246',NULL,'Vol Dist Steady State Pred Norm by Dose','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose.','\0','Vol Dist Steady State Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C102391'),('CL-PKPARM-T-247',NULL,'Vol Dist Steady State Pred Norm by SA','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area.','\0','Vol Dist Steady State Pred Norm by SA','CL-PKPARM','DBX-NCIT-C102392'),('CL-PKPARM-T-248',NULL,'Vol Dist Steady State Pred Norm by WT','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight.','\0','Vol Dist Steady State Pred Norm by WT','CL-PKPARM','DBX-NCIT-C102393'),('CL-PKPARM-T-249',NULL,'Vz for Dose Int','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU.','\0','Vz for Dose Int','CL-PKPARM','DBX-NCIT-C111333'),('CL-PKPARM-T-25',NULL,'AUC %Extrapolation Pred','The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.','\0','AUC %Extrapolation Pred','CL-PKPARM','DBX-NCIT-C85788'),('CL-PKPARM-T-250',NULL,'Vz for Dose Int by F','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.','\0','Vz for Dose Int by F','CL-PKPARM','DBX-NCIT-C111364'),('CL-PKPARM-T-251',NULL,'Vz for Dose Int by F Norm by BMI','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.','\0','Vz for Dose Int by F Norm by BMI','CL-PKPARM','DBX-NCIT-C111365'),('CL-PKPARM-T-252',NULL,'Vz for Dose Int by F Norm by Dose','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.','\0','Vz for Dose Int by F Norm by Dose','CL-PKPARM','DBX-NCIT-C111366'),('CL-PKPARM-T-253',NULL,'Vz for Dose Int by F Norm by SA','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.','\0','Vz for Dose Int by F Norm by SA','CL-PKPARM','DBX-NCIT-C111367'),('CL-PKPARM-T-254',NULL,'Vz for Dose Int by F Norm by WT','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.','\0','Vz for Dose Int by F Norm by WT','CL-PKPARM','DBX-NCIT-C111368'),('CL-PKPARM-T-255',NULL,'Vz for Dose Int Norm by BMI','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index.','\0','Vz for Dose Int Norm by BMI','CL-PKPARM','DBX-NCIT-C111369'),('CL-PKPARM-T-256',NULL,'Vz for Dose Int Norm by Dose','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose.','\0','Vz for Dose Int Norm by Dose','CL-PKPARM','DBX-NCIT-C111370'),('CL-PKPARM-T-257',NULL,'Vz for Dose Int Norm by SA','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area.','\0','Vz for Dose Int Norm by SA','CL-PKPARM','DBX-NCIT-C111371'),('CL-PKPARM-T-258',NULL,'Vz for Dose Int Norm by WT','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight.','\0','Vz for Dose Int Norm by WT','CL-PKPARM','DBX-NCIT-C111372'),('CL-PKPARM-T-259',NULL,'Vz Obs','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration.','\0','Vz Obs','CL-PKPARM','DBX-NCIT-C85774'),('CL-PKPARM-T-26',NULL,'AUC All','The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not.','\0','AUC All','CL-PKPARM','DBX-NCIT-C85564'),('CL-PKPARM-T-260',NULL,'Vz Obs by F','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.','\0','Vz Obs by F','CL-PKPARM','DBX-NCIT-C85775'),('CL-PKPARM-T-261',NULL,'Vz Obs by F Norm by BMI','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Vz Obs by F Norm by BMI','CL-PKPARM','DBX-NCIT-C92410'),('CL-PKPARM-T-262',NULL,'Vz Obs by F Norm by Dose','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Vz Obs by F Norm by Dose','CL-PKPARM','DBX-NCIT-C102729'),('CL-PKPARM-T-263',NULL,'Vz Obs by F Norm by SA','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Vz Obs by F Norm by SA','CL-PKPARM','DBX-NCIT-C92411'),('CL-PKPARM-T-264',NULL,'Vz Obs by F Norm by WT','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Vz Obs by F Norm by WT','CL-PKPARM','DBX-NCIT-C92412'),('CL-PKPARM-T-265',NULL,'Vz Obs Norm by BMI','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Vz Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C92407'),('CL-PKPARM-T-266',NULL,'Vz Obs Norm by Dose','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Vz Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C102683'),('CL-PKPARM-T-267',NULL,'Vz Obs Norm by SA','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Vz Obs Norm by SA','CL-PKPARM','DBX-NCIT-C92408'),('CL-PKPARM-T-268',NULL,'Vz Obs Norm by WT','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Vz Obs Norm by WT','CL-PKPARM','DBX-NCIT-C92409'),('CL-PKPARM-T-269',NULL,'Vz Pred','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration.','\0','Vz Pred','CL-PKPARM','DBX-NCIT-C85798'),('CL-PKPARM-T-27',NULL,'AUC All Norm by BMI','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by BMI','CL-PKPARM','DBX-NCIT-C92362'),('CL-PKPARM-T-270',NULL,'Vz Pred by F','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.','\0','Vz Pred by F','CL-PKPARM','DBX-NCIT-C85799'),('CL-PKPARM-T-271',NULL,'Vz Pred by F Norm by BMI','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Vz Pred by F Norm by BMI','CL-PKPARM','DBX-NCIT-C92428'),('CL-PKPARM-T-272',NULL,'Vz Pred by F Norm by Dose','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Vz Pred by F Norm by Dose','CL-PKPARM','DBX-NCIT-C102730'),('CL-PKPARM-T-273',NULL,'Vz Pred by F Norm by SA','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Vz Pred by F Norm by SA','CL-PKPARM','DBX-NCIT-C92429'),('CL-PKPARM-T-274',NULL,'Vz Pred by F Norm by WT','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Vz Pred by F Norm by WT','CL-PKPARM','DBX-NCIT-C92430'),('CL-PKPARM-T-275',NULL,'Vz Pred Norm by BMI','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Vz Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C92425'),('CL-PKPARM-T-276',NULL,'Vz Pred Norm by Dose','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Vz Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C102696'),('CL-PKPARM-T-277',NULL,'Vz Pred Norm by SA','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Vz Pred Norm by SA','CL-PKPARM','DBX-NCIT-C92426'),('CL-PKPARM-T-278',NULL,'Vz Pred Norm by WT','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Vz Pred Norm by WT','CL-PKPARM','DBX-NCIT-C92427'),('CL-PKPARM-T-28',NULL,'AUC All Norm by Dose','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by Dose','CL-PKPARM','DBX-NCIT-C92306'),('CL-PKPARM-T-29',NULL,'AUC All Norm by SA','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by SA','CL-PKPARM','DBX-NCIT-C92307'),('CL-PKPARM-T-3',NULL,'Accumulation Ratio Cmax','The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval.','\0','Accumulation Ratio Cmax','CL-PKPARM','DBX-NCIT-C102357'),('CL-PKPARM-T-30',NULL,'AUC All Norm by WT','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by WT','CL-PKPARM','DBX-NCIT-C92308'),('CL-PKPARM-T-31',NULL,'AUC from T1 to T2','The area under the curve (AUC) over the interval from T1 to T2.','\0','AUC from T1 to T2','CL-PKPARM','DBX-NCIT-C85566'),('CL-PKPARM-T-32',NULL,'AUC from T1 to T2 Norm by BMI','The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index.','\0','AUC from T1 to T2 Norm by BMI','CL-PKPARM','DBX-NCIT-C92312'),('CL-PKPARM-T-33',NULL,'AUC from T1 to T2 Norm by Dose','The area under the curve (AUC) over the interval from T1 to T2 divided by the dose.','\0','AUC from T1 to T2 Norm by Dose','CL-PKPARM','DBX-NCIT-C92313'),('CL-PKPARM-T-34',NULL,'AUC from T1 to T2 Norm by SA','The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area.','\0','AUC from T1 to T2 Norm by SA','CL-PKPARM','DBX-NCIT-C92314'),('CL-PKPARM-T-35',NULL,'AUC from T1 to T2 Norm by WT','The area under the curve (AUC) over the interval from T1 to T2 divided by the weight.','\0','AUC from T1 to T2 Norm by WT','CL-PKPARM','DBX-NCIT-C92315'),('CL-PKPARM-T-36',NULL,'AUC Infinity Obs','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','AUC Infinity Obs','CL-PKPARM','DBX-NCIT-C85761'),('CL-PKPARM-T-37',NULL,'AUC Infinity Obs Norm by BMI','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','AUC Infinity Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C92316'),('CL-PKPARM-T-38',NULL,'AUC Infinity Obs Norm by Dose','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','AUC Infinity Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C96695'),('CL-PKPARM-T-39',NULL,'AUC Infinity Obs Norm by SA','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','AUC Infinity Obs Norm by SA','CL-PKPARM','DBX-NCIT-C92317'),('CL-PKPARM-T-4',NULL,'Accumulation Ratio Cmin','The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval.','\0','Accumulation Ratio Cmin','CL-PKPARM','DBX-NCIT-C102358'),('CL-PKPARM-T-40',NULL,'AUC Infinity Obs Norm by WT','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','AUC Infinity Obs Norm by WT','CL-PKPARM','DBX-NCIT-C92318'),('CL-PKPARM-T-41',NULL,'AUC Infinity Pred','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','AUC Infinity Pred','CL-PKPARM','DBX-NCIT-C85785'),('CL-PKPARM-T-42',NULL,'AUC Infinity Pred Norm by BMI','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','AUC Infinity Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C92319'),('CL-PKPARM-T-43',NULL,'AUC Infinity Pred Norm by Dose','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','AUC Infinity Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C85786'),('CL-PKPARM-T-44',NULL,'AUC Infinity Pred Norm by SA','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','AUC Infinity Pred Norm by SA','CL-PKPARM','DBX-NCIT-C92320'),('CL-PKPARM-T-45',NULL,'AUC Infinity Pred Norm by WT','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','AUC Infinity Pred Norm by WT','CL-PKPARM','DBX-NCIT-C92321'),('CL-PKPARM-T-46',NULL,'AUC Over Dosing Interval','The area under the curve (AUC) for the defined interval between doses (TAU).','\0','AUC Over Dosing Interval','CL-PKPARM','DBX-NCIT-C85567'),('CL-PKPARM-T-47',NULL,'AUC Over Dosing Interval Norm by BMI','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index.','\0','AUC Over Dosing Interval Norm by BMI','CL-PKPARM','DBX-NCIT-C92322'),('CL-PKPARM-T-48',NULL,'AUC Over Dosing Interval Norm by Dose','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose.','\0','AUC Over Dosing Interval Norm by Dose','CL-PKPARM','DBX-NCIT-C92323'),('CL-PKPARM-T-49',NULL,'AUC Over Dosing Interval Norm by SA','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area.','\0','AUC Over Dosing Interval Norm by SA','CL-PKPARM','DBX-NCIT-C92324'),('CL-PKPARM-T-5',NULL,'Accumulation Ratio Ctrough','The trough concentration at steady state divided by the trough concentration during the initial dosing interval.','\0','Accumulation Ratio Ctrough','CL-PKPARM','DBX-NCIT-C102426'),('CL-PKPARM-T-50',NULL,'AUC Over Dosing Interval Norm by WT','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight.','\0','AUC Over Dosing Interval Norm by WT','CL-PKPARM','DBX-NCIT-C92325'),('CL-PKPARM-T-51',NULL,'AUC to Last Nonzero Conc','The area under the curve (AUC) from the time of dosing to the last measurable concentration.','\0','AUC to Last Nonzero Conc','CL-PKPARM','DBX-NCIT-C85565'),('CL-PKPARM-T-52',NULL,'AUC to Last Nonzero Conc Norm by BMI','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index.','\0','AUC to Last Nonzero Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92309'),('CL-PKPARM-T-53',NULL,'AUC to Last Nonzero Conc Norm by Dose','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose.','\0','AUC to Last Nonzero Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92310'),('CL-PKPARM-T-54',NULL,'AUC to Last Nonzero Conc Norm by SA','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area.','\0','AUC to Last Nonzero Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92311'),('CL-PKPARM-T-55',NULL,'AUC to Last Nonzero Conc Norm by WT','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight.','\0','AUC to Last Nonzero Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92305'),('CL-PKPARM-T-56',NULL,'AUMC % Extrapolation Obs','The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.','\0','AUMC % Extrapolation Obs','CL-PKPARM','DBX-NCIT-C85766'),('CL-PKPARM-T-57',NULL,'AUMC % Extrapolation Pred','The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.','\0','AUMC % Extrapolation Pred','CL-PKPARM','DBX-NCIT-C85790'),('CL-PKPARM-T-58',NULL,'AUMC Infinity Obs','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','AUMC Infinity Obs','CL-PKPARM','DBX-NCIT-C85765'),('CL-PKPARM-T-59',NULL,'AUMC Infinity Obs Norm by BMI','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','AUMC Infinity Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C92330'),('CL-PKPARM-T-6',NULL,'Amt Rec from T1 to T2','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2.','\0','Amt Rec from T1 to T2','CL-PKPARM','DBX-NCIT-C102359'),('CL-PKPARM-T-60',NULL,'AUMC Infinity Obs Norm by Dose','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','AUMC Infinity Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C92331'),('CL-PKPARM-T-61',NULL,'AUMC Infinity Obs Norm by SA','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','AUMC Infinity Obs Norm by SA','CL-PKPARM','DBX-NCIT-C92332'),('CL-PKPARM-T-62',NULL,'AUMC Infinity Obs Norm by WT','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','AUMC Infinity Obs Norm by WT','CL-PKPARM','DBX-NCIT-C92333'),('CL-PKPARM-T-63',NULL,'AUMC Infinity Pred','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','AUMC Infinity Pred','CL-PKPARM','DBX-NCIT-C85789'),('CL-PKPARM-T-64',NULL,'AUMC Infinity Pred Norm by BMI','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','AUMC Infinity Pred Norm by BMI','CL-PKPARM','DBX-NCIT-C92334'),('CL-PKPARM-T-65',NULL,'AUMC Infinity Pred Norm by Dose','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','AUMC Infinity Pred Norm by Dose','CL-PKPARM','DBX-NCIT-C92335'),('CL-PKPARM-T-66',NULL,'AUMC Infinity Pred Norm by SA','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','AUMC Infinity Pred Norm by SA','CL-PKPARM','DBX-NCIT-C92336'),('CL-PKPARM-T-67',NULL,'AUMC Infinity Pred Norm by WT','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','AUMC Infinity Pred Norm by WT','CL-PKPARM','DBX-NCIT-C92337'),('CL-PKPARM-T-68',NULL,'AUMC Over Dosing Interval','The area under the first moment curve (AUMC) for the defined interval between doses (TAU).','\0','AUMC Over Dosing Interval','CL-PKPARM','DBX-NCIT-C85570'),('CL-PKPARM-T-69',NULL,'AUMC Over Dosing Interval Norm by BMI','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index.','\0','AUMC Over Dosing Interval Norm by BMI','CL-PKPARM','DBX-NCIT-C92338'),('CL-PKPARM-T-7',NULL,'Amt Rec from T1 to T2 Norm by BMI','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index.','\0','Amt Rec from T1 to T2 Norm by BMI','CL-PKPARM','DBX-NCIT-C102360'),('CL-PKPARM-T-70',NULL,'AUMC Over Dosing Interval Norm by Dose','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose.','\0','AUMC Over Dosing Interval Norm by Dose','CL-PKPARM','DBX-NCIT-C92339'),('CL-PKPARM-T-71',NULL,'AUMC Over Dosing Interval Norm by SA','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area.','\0','AUMC Over Dosing Interval Norm by SA','CL-PKPARM','DBX-NCIT-C92340'),('CL-PKPARM-T-72',NULL,'AUMC Over Dosing Interval Norm by WT','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight.','\0','AUMC Over Dosing Interval Norm by WT','CL-PKPARM','DBX-NCIT-C92341'),('CL-PKPARM-T-73',NULL,'AUMC to Last Nonzero Conc','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration.','\0','AUMC to Last Nonzero Conc','CL-PKPARM','DBX-NCIT-C85569'),('CL-PKPARM-T-74',NULL,'AUMC to Last Nonzero Conc Norm by BMI','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index.','\0','AUMC to Last Nonzero Conc Norm by BMI','CL-PKPARM','DBX-NCIT-C92326'),('CL-PKPARM-T-75',NULL,'AUMC to Last Nonzero Conc Norm by Dose','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose.','\0','AUMC to Last Nonzero Conc Norm by Dose','CL-PKPARM','DBX-NCIT-C92327'),('CL-PKPARM-T-76',NULL,'AUMC to Last Nonzero Conc Norm by SA','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area.','\0','AUMC to Last Nonzero Conc Norm by SA','CL-PKPARM','DBX-NCIT-C92328'),('CL-PKPARM-T-77',NULL,'AUMC to Last Nonzero Conc Norm by WT','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight.','\0','AUMC to Last Nonzero Conc Norm by WT','CL-PKPARM','DBX-NCIT-C92329'),('CL-PKPARM-T-78',NULL,'AURC % Extrapolation Obs','The area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.','\0','AURC % Extrapolation Obs','CL-PKPARM','DBX-NCIT-C85768'),('CL-PKPARM-T-79',NULL,'AURC % Extrapolation Pred','The area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.','\0','AURC % Extrapolation Pred','CL-PKPARM','DBX-NCIT-C85792'),('CL-PKPARM-T-8',NULL,'Amt Rec from T1 to T2 Norm by SA','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area.','\0','Amt Rec from T1 to T2 Norm by SA','CL-PKPARM','DBX-NCIT-C102361'),('CL-PKPARM-T-80',NULL,'AURC All','The area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not.','\0','AURC All','CL-PKPARM','DBX-NCIT-C85841'),('CL-PKPARM-T-81',NULL,'AURC All Norm by BMI','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index.','\0','AURC All Norm by BMI','CL-PKPARM','DBX-NCIT-C92342'),('CL-PKPARM-T-82',NULL,'AURC All Norm by Dose','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose.','\0','AURC All Norm by Dose','CL-PKPARM','DBX-NCIT-C92343'),('CL-PKPARM-T-83',NULL,'AURC All Norm by SA','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area.','\0','AURC All Norm by SA','CL-PKPARM','DBX-NCIT-C92344'),('CL-PKPARM-T-84',NULL,'AURC All Norm by WT','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight.','\0','AURC All Norm by WT','CL-PKPARM','DBX-NCIT-C92345'),('CL-PKPARM-T-85',NULL,'AURC Dosing to Last Conc Norm by BMI','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index.','\0','AURC to Last Nonzero Rate Norm by BMI','CL-PKPARM','DBX-NCIT-C92346'),('CL-PKPARM-T-86',NULL,'AURC Dosing to Last Conc Norm by Dose','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose.','\0','AURC to Last Nonzero Rate Norm by Dose','CL-PKPARM','DBX-NCIT-C92347'),('CL-PKPARM-T-87',NULL,'AURC Dosing to Last Conc Norm by SA','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area.','\0','AURC to Last Nonzero Rate Norm by SA','CL-PKPARM','DBX-NCIT-C92348'),('CL-PKPARM-T-88',NULL,'AURC Dosing to Last Conc Norm by WT','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight.','\0','AURC to Last Nonzero Rate Norm by WT','CL-PKPARM','DBX-NCIT-C92349'),('CL-PKPARM-T-89',NULL,'AURC from T1 to T2','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2.','\0','AURC from T1 to T2','CL-PKPARM','DBX-NCIT-C85572'),('CL-PKPARM-T-9',NULL,'Amt Rec from T1 to T2 Norm by WT','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight.','\0','Amt Rec from T1 to T2 Norm by WT','CL-PKPARM','DBX-NCIT-C102362'),('CL-PKPARM-T-90',NULL,'AURC from T1 to T2 Norm by BMI','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index.','\0','AURC from T1 to T2 Norm by BMI','CL-PKPARM','DBX-NCIT-C92350'),('CL-PKPARM-T-91',NULL,'AURC from T1 to T2 Norm by Dose','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose.','\0','AURC from T1 to T2 Norm by Dose','CL-PKPARM','DBX-NCIT-C92351'),('CL-PKPARM-T-92',NULL,'AURC from T1 to T2 Norm by SA','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area.','\0','AURC from T1 to T2 Norm by SA','CL-PKPARM','DBX-NCIT-C92352'),('CL-PKPARM-T-93',NULL,'AURC from T1 to T2 Norm by WT','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight.','\0','AURC from T1 to T2 Norm by WT','CL-PKPARM','DBX-NCIT-C92353'),('CL-PKPARM-T-94',NULL,'AURC Infinity Obs','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate.','\0','AURC Infinity Obs','CL-PKPARM','DBX-NCIT-C85767'),('CL-PKPARM-T-95',NULL,'AURC Infinity Obs Norm by BMI','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index.','\0','AURC Infinity Obs Norm by BMI','CL-PKPARM','DBX-NCIT-C92354'),('CL-PKPARM-T-96',NULL,'AURC Infinity Obs Norm by Dose','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose.','\0','AURC Infinity Obs Norm by Dose','CL-PKPARM','DBX-NCIT-C92355'),('CL-PKPARM-T-97',NULL,'AURC Infinity Obs Norm by SA','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area.','\0','AURC Infinity Obs Norm by SA','CL-PKPARM','DBX-NCIT-C92356'),('CL-PKPARM-T-98',NULL,'AURC Infinity Obs Norm by WT','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight.','\0','AURC Infinity Obs Norm by WT','CL-PKPARM','DBX-NCIT-C92357'),('CL-PKPARM-T-99',NULL,'AURC Infinity Pred','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate.','\0','AURC Infinity Pred','CL-PKPARM','DBX-NCIT-C85791'),('CL-PKPARMCD-T-1',NULL,'AILAMZ','Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data.','\0','Accumulation Index using Lambda z','CL-PKPARMCD','DBX-NCIT-C114234'),('CL-PKPARMCD-T-10',NULL,'AUCALLW','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by WT','CL-PKPARMCD','DBX-NCIT-C92308'),('CL-PKPARMCD-T-100',NULL,'CLFOB','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Obs by F Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92399'),('CL-PKPARMCD-T-101',NULL,'CLFOD','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Total CL Obs by F Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92400'),('CL-PKPARMCD-T-102',NULL,'CLFOS','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Total CL Obs by F Norm by SA','CL-PKPARMCD','DBX-NCIT-C92401'),('CL-PKPARMCD-T-103',NULL,'CLFOW','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Total CL Obs by F Norm by WT','CL-PKPARMCD','DBX-NCIT-C92402'),('CL-PKPARMCD-T-104',NULL,'CLFP','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.','\0','Total CL Pred by F','CL-PKPARMCD','DBX-NCIT-C85796'),('CL-PKPARMCD-T-105',NULL,'CLFPB','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index.','\0','Total CL Pred by F Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92417'),('CL-PKPARMCD-T-106',NULL,'CLFPD','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Total CL Pred by F Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92418'),('CL-PKPARMCD-T-107',NULL,'CLFPS','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Total CL Pred by F Norm by SA','CL-PKPARMCD','DBX-NCIT-C92419'),('CL-PKPARMCD-T-108',NULL,'CLFPW','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Total CL Pred by F Norm by WT','CL-PKPARMCD','DBX-NCIT-C92420'),('CL-PKPARMCD-T-109',NULL,'CLFTAU','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.','\0','Total CL by F for Dose Int','CL-PKPARMCD','DBX-NCIT-C114121'),('CL-PKPARMCD-T-11',NULL,'AUCIFO','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','AUC Infinity Obs','CL-PKPARMCD','DBX-NCIT-C85761'),('CL-PKPARMCD-T-110',NULL,'CLFTAUB','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.','\0','Total CL by F for Dose Int Norm by BMI','CL-PKPARMCD','DBX-NCIT-C114227'),('CL-PKPARMCD-T-111',NULL,'CLFTAUD','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.','\0','Total CL by F for Dose Int Norm by Dose','CL-PKPARMCD','DBX-NCIT-C114226'),('CL-PKPARMCD-T-112',NULL,'CLFTAUS','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.','\0','Total CL by F for Dose Int Norm by SA','CL-PKPARMCD','DBX-NCIT-C114228'),('CL-PKPARMCD-T-113',NULL,'CLFTAUW','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.','\0','Total CL by F for Dose Int Norm by WT','CL-PKPARMCD','DBX-NCIT-C114229'),('CL-PKPARMCD-T-114',NULL,'CLO','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration.','\0','Total CL Obs','CL-PKPARMCD','DBX-NCIT-C85773'),('CL-PKPARMCD-T-115',NULL,'CLOB','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92403'),('CL-PKPARMCD-T-116',NULL,'CLOD','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Total CL Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92404'),('CL-PKPARMCD-T-117',NULL,'CLOS','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Total CL Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C92405'),('CL-PKPARMCD-T-118',NULL,'CLOW','The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Total CL Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C92406'),('CL-PKPARMCD-T-119',NULL,'CLP','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration.','\0','Total CL Pred','CL-PKPARMCD','DBX-NCIT-C85797'),('CL-PKPARMCD-T-12',NULL,'AUCIFOB','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','AUC Infinity Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92316'),('CL-PKPARMCD-T-120',NULL,'CLPB','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Total CL Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92421'),('CL-PKPARMCD-T-121',NULL,'CLPD','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Total CL Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92422'),('CL-PKPARMCD-T-122',NULL,'CLPS','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Total CL Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C92423'),('CL-PKPARMCD-T-123',NULL,'CLPW','The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Total CL Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C92424'),('CL-PKPARMCD-T-124',NULL,'CLST','The concentration corresponding to Tlast.','\0','Last Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85655'),('CL-PKPARMCD-T-125',NULL,'CLSTB','The concentration corresponding to Tlast divided by the body mass index.','\0','Last Nonzero Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92387'),('CL-PKPARMCD-T-126',NULL,'CLSTD','The concentration corresponding to Tlast divided by the dose.','\0','Last Nonzero Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92388'),('CL-PKPARMCD-T-127',NULL,'CLSTS','The concentration corresponding to Tlast divided by the surface area.','\0','Last Nonzero Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92389'),('CL-PKPARMCD-T-128',NULL,'CLSTW','The concentration corresponding to Tlast divided by the weight.','\0','Last Nonzero Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92390'),('CL-PKPARMCD-T-129',NULL,'CLTAU','The total body clearance for intravascular administration, calculated using AUCTAU.','\0','Total CL for Dose Int','CL-PKPARMCD','DBX-NCIT-C114122'),('CL-PKPARMCD-T-13',NULL,'AUCIFOD','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','AUC Infinity Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C96695'),('CL-PKPARMCD-T-130',NULL,'CLTAUB','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index.','\0','Total CL for Dose Int Norm by BMI','CL-PKPARMCD','DBX-NCIT-C114231'),('CL-PKPARMCD-T-131',NULL,'CLTAUD','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose.','\0','Total CL for Dose Int Norm by Dose','CL-PKPARMCD','DBX-NCIT-C114230'),('CL-PKPARMCD-T-132',NULL,'CLTAUS','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area.','\0','Total CL for Dose Int Norm by SA','CL-PKPARMCD','DBX-NCIT-C114232'),('CL-PKPARMCD-T-133',NULL,'CLTAUW','The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight.','\0','Total CL for Dose Int Norm by WT','CL-PKPARMCD','DBX-NCIT-C114233'),('CL-PKPARMCD-T-134',NULL,'CMAX','The maximum concentration occurring at Tmax.','\0','Max Conc','CL-PKPARMCD','DBX-NCIT-C70918'),('CL-PKPARMCD-T-135',NULL,'CMAXB','The maximum concentration occurring at Tmax, divided by the body mass index.','\0','Max Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92371'),('CL-PKPARMCD-T-136',NULL,'CMAXD','The maximum concentration occurring at Tmax, divided by the dose.','\0','Max Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C85698'),('CL-PKPARMCD-T-137',NULL,'CMAXS','The maximum concentration occurring at Tmax, divided by the surface area.','\0','Max Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92372'),('CL-PKPARMCD-T-138',NULL,'CMAXW','The maximum concentration occurring at Tmax, divided by the weight.','\0','Max Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92373'),('CL-PKPARMCD-T-139',NULL,'CMIN','The minimum concentration between dose time and dose time plus Tau (at Tmin).','\0','Min Conc','CL-PKPARMCD','DBX-NCIT-C85579'),('CL-PKPARMCD-T-14',NULL,'AUCIFOS','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','AUC Infinity Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C92317'),('CL-PKPARMCD-T-140',NULL,'CMINB','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index.','\0','Min Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92374'),('CL-PKPARMCD-T-141',NULL,'CMIND','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose.','\0','Min Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92375'),('CL-PKPARMCD-T-142',NULL,'CMINS','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area.','\0','Min Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92376'),('CL-PKPARMCD-T-143',NULL,'CMINW','The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight.','\0','Min Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92377'),('CL-PKPARMCD-T-144',NULL,'CONC','The quantity of a specified substance in a unit volume or weight of another substance.','\0','Conc','CL-PKPARMCD','DBX-NCIT-C41185'),('CL-PKPARMCD-T-145',NULL,'CONCB','The concentration divided by body mass index.','\0','Conc by BMI','CL-PKPARMCD','DBX-NCIT-C102367'),('CL-PKPARMCD-T-146',NULL,'CONCD','The concentration divided by dose.','\0','Conc by Dose','CL-PKPARMCD','DBX-NCIT-C102368'),('CL-PKPARMCD-T-147',NULL,'CONCS','The concentration divided by surface area.','\0','Conc by SA','CL-PKPARMCD','DBX-NCIT-C102369'),('CL-PKPARMCD-T-148',NULL,'CONCW','The concentration divided by weight.','\0','Conc by WT','CL-PKPARMCD','DBX-NCIT-C102370'),('CL-PKPARMCD-T-149',NULL,'CORRXY','The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z.','\0','Correlation Between TimeX and Log ConcY','CL-PKPARMCD','DBX-NCIT-C85821'),('CL-PKPARMCD-T-15',NULL,'AUCIFOW','The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','AUC Infinity Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C92318'),('CL-PKPARMCD-T-150',NULL,'CTROUGH','Concentration at end of dosing interval.','\0','Conc Trough','CL-PKPARMCD','DBX-NCIT-C102394'),('CL-PKPARMCD-T-151',NULL,'CTROUGHB','The trough concentration divided by body mass index.','\0','Conc Trough by BMI','CL-PKPARMCD','DBX-NCIT-C102395'),('CL-PKPARMCD-T-152',NULL,'CTROUGHD','The trough concentration divided by dose.','\0','Conc Trough by Dose','CL-PKPARMCD','DBX-NCIT-C102396'),('CL-PKPARMCD-T-153',NULL,'CTROUGHS','The trough concentration divided by surface area.','\0','Conc Trough by SA','CL-PKPARMCD','DBX-NCIT-C102397'),('CL-PKPARMCD-T-154',NULL,'CTROUGHW','The trough concentration divided by weight.','\0','Conc Trough by WT','CL-PKPARMCD','DBX-NCIT-C102398'),('CL-PKPARMCD-T-155',NULL,'EFFHL','The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing.','\0','Effective Half-Life','CL-PKPARMCD','DBX-NCIT-C95007'),('CL-PKPARMCD-T-156',NULL,'ERINT','The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2','CL-PKPARMCD','DBX-NCIT-C105449'),('CL-PKPARMCD-T-157',NULL,'ERINTB','The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by BMI','CL-PKPARMCD','DBX-NCIT-C105450'),('CL-PKPARMCD-T-158',NULL,'ERINTD','The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by Dose','CL-PKPARMCD','DBX-NCIT-C105451'),('CL-PKPARMCD-T-159',NULL,'ERINTS','The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by SA','CL-PKPARMCD','DBX-NCIT-C105452'),('CL-PKPARMCD-T-16',NULL,'AUCIFP','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','AUC Infinity Pred','CL-PKPARMCD','DBX-NCIT-C85785'),('CL-PKPARMCD-T-160',NULL,'ERINTW','The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC.','\0','Excret Rate from T1 to T2 Norm by WT','CL-PKPARMCD','DBX-NCIT-C105453'),('CL-PKPARMCD-T-161',NULL,'ERLST','The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC.','\0','Last Meas Excretion Rate','CL-PKPARMCD','DBX-NCIT-C85656'),('CL-PKPARMCD-T-162',NULL,'ERLSTB','The last measurable (positive) excretion rate divided by the body mass index.','\0','Last Meas Excretion Rate Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92391'),('CL-PKPARMCD-T-163',NULL,'ERLSTD','The last measurable (positive) excretion rate divided by the dose.','\0','Last Meas Excretion Rate Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92392'),('CL-PKPARMCD-T-164',NULL,'ERLSTS','The last measurable (positive) excretion rate divided by the surface area.','\0','Last Meas Excretion Rate Norm by SA','CL-PKPARMCD','DBX-NCIT-C92393'),('CL-PKPARMCD-T-165',NULL,'ERLSTW','The last measurable (positive) excretion rate divided by the weight.','\0','Last Meas Excretion Rate Norm by WT','CL-PKPARMCD','DBX-NCIT-C92394'),('CL-PKPARMCD-T-166',NULL,'ERMAX','The maximum excretion rate determined for the specimen type specified in PPSPEC.','\0','Max Excretion Rate','CL-PKPARMCD','DBX-NCIT-C85699'),('CL-PKPARMCD-T-167',NULL,'ERMAXB','The maximum excretion rate divided by the body mass index.','\0','Max Excretion Rate Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92395'),('CL-PKPARMCD-T-168',NULL,'ERMAXD','The maximum excretion rate divided by the dose.','\0','Max Excretion Rate Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92396'),('CL-PKPARMCD-T-169',NULL,'ERMAXS','The maximum excretion rate divided by the surface area.','\0','Max Excretion Rate Norm by SA','CL-PKPARMCD','DBX-NCIT-C92397'),('CL-PKPARMCD-T-17',NULL,'AUCIFPB','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','AUC Infinity Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92319'),('CL-PKPARMCD-T-170',NULL,'ERMAXW','The maximum excretion rate divided by the weight.','\0','Max Excretion Rate Norm by WT','CL-PKPARMCD','DBX-NCIT-C92398'),('CL-PKPARMCD-T-171',NULL,'ERTMAX','The midpoint of collection interval associated with the maximum excretion rate.','\0','Time of Max Excretion Rate','CL-PKPARMCD','DBX-NCIT-C85823'),('CL-PKPARMCD-T-172',NULL,'FLUCP','The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau.','\0','Fluctuation%','CL-PKPARMCD','DBX-NCIT-C85581'),('CL-PKPARMCD-T-173',NULL,'HDCL','The clearance of a substance from the blood during a hemodialysis session.','\0','Hemodialysis CL; Hemodialysis Clearance','CL-PKPARMCD','DBX-NCIT-C112287'),('CL-PKPARMCD-T-174',NULL,'HDER','The fractional content of a substance removed from the blood during a hemodialysis session.','\0','Hemodialysis Extraction Ratio','CL-PKPARMCD','DBX-NCIT-C116213'),('CL-PKPARMCD-T-175',NULL,'LAMZ','The first order rate constant associated with the terminal (log-linear) portion of the curve.','\0','Lambda z','CL-PKPARMCD','DBX-NCIT-C85652'),('CL-PKPARMCD-T-176',NULL,'LAMZHL','Terminal half-life.','\0','Half-Life Lambda z','CL-PKPARMCD','DBX-NCIT-C85818'),('CL-PKPARMCD-T-177',NULL,'LAMZLL','The lower limit on time for values to be included in the calculation of Lambda z.','\0','Lambda z Lower Limit','CL-PKPARMCD','DBX-NCIT-C85653'),('CL-PKPARMCD-T-178',NULL,'LAMZNPT','The number of time points used in computing Lambda z.','\0','Number of Points for Lambda z','CL-PKPARMCD','DBX-NCIT-C85816'),('CL-PKPARMCD-T-179',NULL,'LAMZUL','The upper limit on time for values to be included in the calculation of Lambda z.','\0','Lambda z Upper Limit','CL-PKPARMCD','DBX-NCIT-C85654'),('CL-PKPARMCD-T-18',NULL,'AUCIFPD','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','AUC Infinity Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C85786'),('CL-PKPARMCD-T-180',NULL,'MIDPTLST','The midpoint of collection interval, which is associated with last Measurable rate.','\0','Midpoint of Collection Interval','CL-PKPARMCD','DBX-NCIT-C85580'),('CL-PKPARMCD-T-181',NULL,'MRTIFO','The mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','MRT Infinity Obs','CL-PKPARMCD','DBX-NCIT-C85769'),('CL-PKPARMCD-T-182',NULL,'MRTIFP','The mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','MRT Infinity Pred','CL-PKPARMCD','DBX-NCIT-C85793'),('CL-PKPARMCD-T-183',NULL,'MRTLST','Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration.','\0','MRT to Last Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85700'),('CL-PKPARMCD-T-184',NULL,'NRENALCL','The total clearance of a substance from the blood less the renal clearance.','\0','Nonrenal CL','CL-PKPARMCD','DBX-NCIT-C102376'),('CL-PKPARMCD-T-185',NULL,'NRENLCLB','The total clearance of a substance from the blood minus the renal clearance divided by the body mass index.','\0','Nonrenal CL Norm by BMI','CL-PKPARMCD','DBX-NCIT-C105454'),('CL-PKPARMCD-T-186',NULL,'NRENLCLD','The total clearance of a substance from the blood minus the renal clearance divided by the dose.','\0','Nonrenal CL Norm by Dose','CL-PKPARMCD','DBX-NCIT-C105455'),('CL-PKPARMCD-T-187',NULL,'NRENLCLS','The total clearance of a substance from the blood minus the renal clearance divided by the surface area.','\0','Nonrenal CL Norm by SA','CL-PKPARMCD','DBX-NCIT-C105456'),('CL-PKPARMCD-T-188',NULL,'NRENLCLW','The total clearance of a substance from the blood minus the renal clearance divided by the weight.','\0','Nonrenal CL Norm by WT','CL-PKPARMCD','DBX-NCIT-C105457'),('CL-PKPARMCD-T-189',NULL,'PTROUGHR','The ratio of Cmax to Ctrough during a dosing interval.','\0','Peak Trough Ratio','CL-PKPARMCD','DBX-NCIT-C102381'),('CL-PKPARMCD-T-19',NULL,'AUCIFPS','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','AUC Infinity Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C92320'),('CL-PKPARMCD-T-190',NULL,'R2','The goodness of fit statistic for the terminal elimination phase.','\0','R Squared','CL-PKPARMCD','DBX-NCIT-C85542'),('CL-PKPARMCD-T-191',NULL,'R2ADJ','The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z.','\0','R Squared Adjusted','CL-PKPARMCD','DBX-NCIT-C85553'),('CL-PKPARMCD-T-192',NULL,'RCAMIFO','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','Amt Rec Infinity Obs','CL-PKPARMCD','DBX-NCIT-C112032'),('CL-PKPARMCD-T-193',NULL,'RCAMIFOB','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Amt Rec Infinity Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C112223'),('CL-PKPARMCD-T-194',NULL,'RCAMIFOS','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Amt Rec Infinity Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C112224'),('CL-PKPARMCD-T-195',NULL,'RCAMIFOW','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Amt Rec Infinity Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C112225'),('CL-PKPARMCD-T-196',NULL,'RCAMIFP','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','Amt Rec Infinity Pred','CL-PKPARMCD','DBX-NCIT-C112033'),('CL-PKPARMCD-T-197',NULL,'RCAMIFPB','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Amt Rec Infinity Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C112226'),('CL-PKPARMCD-T-198',NULL,'RCAMIFPS','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Amt Rec Infinity Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C112227'),('CL-PKPARMCD-T-199',NULL,'RCAMIFPW','The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Amt Rec Infinity Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C112228'),('CL-PKPARMCD-T-2',NULL,'ARAUC','The area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval.','\0','Accumulation Ratio AUC','CL-PKPARMCD','DBX-NCIT-C102356'),('CL-PKPARMCD-T-20',NULL,'AUCIFPW','The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','AUC Infinity Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C92321'),('CL-PKPARMCD-T-200',NULL,'RCAMINT','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2.','\0','Amt Rec from T1 to T2','CL-PKPARMCD','DBX-NCIT-C102359'),('CL-PKPARMCD-T-201',NULL,'RCAMINTB','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index.','\0','Amt Rec from T1 to T2 Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102360'),('CL-PKPARMCD-T-202',NULL,'RCAMINTS','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area.','\0','Amt Rec from T1 to T2 Norm by SA','CL-PKPARMCD','DBX-NCIT-C102361'),('CL-PKPARMCD-T-203',NULL,'RCAMINTW','The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight.','\0','Amt Rec from T1 to T2 Norm by WT','CL-PKPARMCD','DBX-NCIT-C102362'),('CL-PKPARMCD-T-204',NULL,'RCAMTAU','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU).','\0','Amt Rec Over Dosing Interval','CL-PKPARMCD','DBX-NCIT-C102363'),('CL-PKPARMCD-T-205',NULL,'RCAMTAUB','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index.','\0','Amt Rec Over Dosing Interval Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102364'),('CL-PKPARMCD-T-206',NULL,'RCAMTAUS','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area.','\0','Amt Rec Over Dosing Interval Norm by SA','CL-PKPARMCD','DBX-NCIT-C102365'),('CL-PKPARMCD-T-207',NULL,'RCAMTAUW','The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight.','\0','Amt Rec Over Dosing Interval Norm by WT','CL-PKPARMCD','DBX-NCIT-C102366'),('CL-PKPARMCD-T-208',NULL,'RCPCIFO','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','Pct Rec Infinity Obs','CL-PKPARMCD','DBX-NCIT-C112034'),('CL-PKPARMCD-T-209',NULL,'RCPCIFOB','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Pct Rec Infinity Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C112389'),('CL-PKPARMCD-T-21',NULL,'AUCINT','The area under the curve (AUC) over the interval from T1 to T2.','\0','AUC from T1 to T2','CL-PKPARMCD','DBX-NCIT-C85566'),('CL-PKPARMCD-T-210',NULL,'RCPCIFOS','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Pct Rec Infinity Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C112390'),('CL-PKPARMCD-T-211',NULL,'RCPCIFOW','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Pct Rec Infinity Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C112391'),('CL-PKPARMCD-T-212',NULL,'RCPCIFP','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','Pct Rec Infinity Pred','CL-PKPARMCD','DBX-NCIT-C112035'),('CL-PKPARMCD-T-213',NULL,'RCPCIFPB','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Pct Rec Infinity Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C112392'),('CL-PKPARMCD-T-214',NULL,'RCPCIFPS','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Pct Rec Infinity Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C112393'),('CL-PKPARMCD-T-215',NULL,'RCPCIFPW','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Pct Rec Infinity Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C112394'),('CL-PKPARMCD-T-216',NULL,'RCPCINT','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2.','\0','Pct Rec from T1 to T2','CL-PKPARMCD','DBX-NCIT-C102382'),('CL-PKPARMCD-T-217',NULL,'RCPCINTB','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index.','\0','Pct Rec from T1 to T2 Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102383'),('CL-PKPARMCD-T-218',NULL,'RCPCINTS','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area.','\0','Pct Rec from T1 to T2 Norm by SA','CL-PKPARMCD','DBX-NCIT-C102384'),('CL-PKPARMCD-T-219',NULL,'RCPCINTW','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight.','\0','Pct Rec from T1 to T2 Norm by WT','CL-PKPARMCD','DBX-NCIT-C102385'),('CL-PKPARMCD-T-22',NULL,'AUCINTB','The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index.','\0','AUC from T1 to T2 Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92312'),('CL-PKPARMCD-T-220',NULL,'RCPCTAU','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU).','\0','Pct Rec Over Dosing Interval','CL-PKPARMCD','DBX-NCIT-C102386'),('CL-PKPARMCD-T-221',NULL,'RCPCTAUB','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index.','\0','Pct Rec Over Dosing Interval Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102387'),('CL-PKPARMCD-T-222',NULL,'RCPCTAUS','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area.','\0','Pct Rec Over Dosing Interval Norm by SA','CL-PKPARMCD','DBX-NCIT-C102388'),('CL-PKPARMCD-T-223',NULL,'RCPCTAUW','The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight.','\0','Pct Rec Over Dosing Interval Norm by WT','CL-PKPARMCD','DBX-NCIT-C102389'),('CL-PKPARMCD-T-224',NULL,'RENALCL','The clearance of a substance from the blood by the kidneys.','\0','Renal CL','CL-PKPARMCD','DBX-NCIT-C75913'),('CL-PKPARMCD-T-225',NULL,'RENALCLB','The clearance of a substance from the blood by the kidneys divided by the body mass index.','\0','Renal CL Norm by BMI','CL-PKPARMCD','DBX-NCIT-C105458'),('CL-PKPARMCD-T-226',NULL,'RENALCLD','The clearance of a substance from the blood by the kidneys divided by the dose.','\0','Renal CL Norm by Dose','CL-PKPARMCD','DBX-NCIT-C105459'),('CL-PKPARMCD-T-227',NULL,'RENALCLS','The clearance of a substance from the blood by the kidneys divided by the surface area.','\0','Renal CL Norm by SA','CL-PKPARMCD','DBX-NCIT-C105460'),('CL-PKPARMCD-T-228',NULL,'RENALCLW','The clearance of a substance from the blood by the kidneys divided by the weight.','\0','Renal CL Norm by WT','CL-PKPARMCD','DBX-NCIT-C105461'),('CL-PKPARMCD-T-229',NULL,'TLAG','The time prior to the first measurable (non-zero) concentration.','\0','Time Until First Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85824'),('CL-PKPARMCD-T-23',NULL,'AUCINTD','The area under the curve (AUC) over the interval from T1 to T2 divided by the dose.','\0','AUC from T1 to T2 Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92313'),('CL-PKPARMCD-T-230',NULL,'TLST','The time of the last measurable (positive) concentration.','\0','Time of Last Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85822'),('CL-PKPARMCD-T-231',NULL,'TMAX','The time of maximum observed concentration sampled during a dosing interval.','\0','Time of CMAX','CL-PKPARMCD','DBX-NCIT-C70919'),('CL-PKPARMCD-T-232',NULL,'TMIN','The time of minimum concentration sampled during a dosing interval.','\0','Time of CMIN Observation','CL-PKPARMCD','DBX-NCIT-C85825'),('CL-PKPARMCD-T-233',NULL,'V0','The initial volume of distribution for a substance administered by bolus intravascular dosing.','\0','Vol Dist Initial','CL-PKPARMCD','DBX-NCIT-C102371'),('CL-PKPARMCD-T-234',NULL,'V0B','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index.','\0','Vol Dist Initial Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102372'),('CL-PKPARMCD-T-235',NULL,'V0D','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose.','\0','Vol Dist Initial Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102373'),('CL-PKPARMCD-T-236',NULL,'V0S','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area.','\0','Vol Dist Initial Norm by SA','CL-PKPARMCD','DBX-NCIT-C102374'),('CL-PKPARMCD-T-237',NULL,'V0W','The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight.','\0','Vol Dist Initial Norm by WT','CL-PKPARMCD','DBX-NCIT-C102375'),('CL-PKPARMCD-T-238',NULL,'VOLPK','The sum of urine volumes that are used for PK parameters.','\0','Sum of Urine Vol','CL-PKPARMCD','DBX-NCIT-C85817'),('CL-PKPARMCD-T-239',NULL,'VSSO','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing.','\0','Vol Dist Steady State Obs','CL-PKPARMCD','DBX-NCIT-C85770'),('CL-PKPARMCD-T-24',NULL,'AUCINTS','The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area.','\0','AUC from T1 to T2 Norm by SA','CL-PKPARMCD','DBX-NCIT-C92314'),('CL-PKPARMCD-T-240',NULL,'VSSOB','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index.','\0','Vol Dist Steady State Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102377'),('CL-PKPARMCD-T-241',NULL,'VSSOD','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose.','\0','Vol Dist Steady State Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102378'),('CL-PKPARMCD-T-242',NULL,'VSSOS','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area.','\0','Vol Dist Steady State Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C102379'),('CL-PKPARMCD-T-243',NULL,'VSSOW','The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight.','\0','Vol Dist Steady State Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C102380'),('CL-PKPARMCD-T-244',NULL,'VSSP','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing.','\0','Vol Dist Steady State Pred','CL-PKPARMCD','DBX-NCIT-C85794'),('CL-PKPARMCD-T-245',NULL,'VSSPB','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index.','\0','Vol Dist Steady State Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C102390'),('CL-PKPARMCD-T-246',NULL,'VSSPD','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose.','\0','Vol Dist Steady State Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102391'),('CL-PKPARMCD-T-247',NULL,'VSSPS','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area.','\0','Vol Dist Steady State Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C102392'),('CL-PKPARMCD-T-248',NULL,'VSSPW','The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight.','\0','Vol Dist Steady State Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C102393'),('CL-PKPARMCD-T-249',NULL,'VZFO','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.','\0','Vz Obs by F','CL-PKPARMCD','DBX-NCIT-C85775'),('CL-PKPARMCD-T-25',NULL,'AUCINTW','The area under the curve (AUC) over the interval from T1 to T2 divided by the weight.','\0','AUC from T1 to T2 Norm by WT','CL-PKPARMCD','DBX-NCIT-C92315'),('CL-PKPARMCD-T-250',NULL,'VZFOB','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Vz Obs by F Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92410'),('CL-PKPARMCD-T-251',NULL,'VZFOD','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Vz Obs by F Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102729'),('CL-PKPARMCD-T-252',NULL,'VZFOS','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Vz Obs by F Norm by SA','CL-PKPARMCD','DBX-NCIT-C92411'),('CL-PKPARMCD-T-253',NULL,'VZFOW','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Vz Obs by F Norm by WT','CL-PKPARMCD','DBX-NCIT-C92412'),('CL-PKPARMCD-T-254',NULL,'VZFP','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.','\0','Vz Pred by F','CL-PKPARMCD','DBX-NCIT-C85799'),('CL-PKPARMCD-T-255',NULL,'VZFPB','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Vz Pred by F Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92428'),('CL-PKPARMCD-T-256',NULL,'VZFPD','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Vz Pred by F Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102730'),('CL-PKPARMCD-T-257',NULL,'VZFPS','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Vz Pred by F Norm by SA','CL-PKPARMCD','DBX-NCIT-C92429'),('CL-PKPARMCD-T-258',NULL,'VZFPW','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Vz Pred by F Norm by WT','CL-PKPARMCD','DBX-NCIT-C92430'),('CL-PKPARMCD-T-259',NULL,'VZFTAU','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.','\0','Vz for Dose Int by F','CL-PKPARMCD','DBX-NCIT-C111364'),('CL-PKPARMCD-T-26',NULL,'AUCLST','The area under the curve (AUC) from the time of dosing to the last measurable concentration.','\0','AUC to Last Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85565'),('CL-PKPARMCD-T-260',NULL,'VZFTAUB','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.','\0','Vz for Dose Int by F Norm by BMI','CL-PKPARMCD','DBX-NCIT-C111365'),('CL-PKPARMCD-T-261',NULL,'VZFTAUD','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.','\0','Vz for Dose Int by F Norm by Dose','CL-PKPARMCD','DBX-NCIT-C111366'),('CL-PKPARMCD-T-262',NULL,'VZFTAUS','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.','\0','Vz for Dose Int by F Norm by SA','CL-PKPARMCD','DBX-NCIT-C111367'),('CL-PKPARMCD-T-263',NULL,'VZFTAUW','The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.','\0','Vz for Dose Int by F Norm by WT','CL-PKPARMCD','DBX-NCIT-C111368'),('CL-PKPARMCD-T-264',NULL,'VZO','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration.','\0','Vz Obs','CL-PKPARMCD','DBX-NCIT-C85774'),('CL-PKPARMCD-T-265',NULL,'VZOB','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','Vz Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92407'),('CL-PKPARMCD-T-266',NULL,'VZOD','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','Vz Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102683'),('CL-PKPARMCD-T-267',NULL,'VZOS','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','Vz Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C92408'),('CL-PKPARMCD-T-268',NULL,'VZOW','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','Vz Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C92409'),('CL-PKPARMCD-T-269',NULL,'VZP','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration.','\0','Vz Pred','CL-PKPARMCD','DBX-NCIT-C85798'),('CL-PKPARMCD-T-27',NULL,'AUCLSTB','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index.','\0','AUC to Last Nonzero Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92309'),('CL-PKPARMCD-T-270',NULL,'VZPB','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','Vz Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92425'),('CL-PKPARMCD-T-271',NULL,'VZPD','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','Vz Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C102696'),('CL-PKPARMCD-T-272',NULL,'VZPS','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','Vz Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C92426'),('CL-PKPARMCD-T-273',NULL,'VZPW','The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','Vz Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C92427'),('CL-PKPARMCD-T-274',NULL,'VZTAU','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU.','\0','Vz for Dose Int','CL-PKPARMCD','DBX-NCIT-C111333'),('CL-PKPARMCD-T-275',NULL,'VZTAUB','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index.','\0','Vz for Dose Int Norm by BMI','CL-PKPARMCD','DBX-NCIT-C111369'),('CL-PKPARMCD-T-276',NULL,'VZTAUD','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose.','\0','Vz for Dose Int Norm by Dose','CL-PKPARMCD','DBX-NCIT-C111370'),('CL-PKPARMCD-T-277',NULL,'VZTAUS','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area.','\0','Vz for Dose Int Norm by SA','CL-PKPARMCD','DBX-NCIT-C111371'),('CL-PKPARMCD-T-278',NULL,'VZTAUW','The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight.','\0','Vz for Dose Int Norm by WT','CL-PKPARMCD','DBX-NCIT-C111372'),('CL-PKPARMCD-T-28',NULL,'AUCLSTD','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose.','\0','AUC to Last Nonzero Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92310'),('CL-PKPARMCD-T-29',NULL,'AUCLSTS','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area.','\0','AUC to Last Nonzero Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92311'),('CL-PKPARMCD-T-3',NULL,'ARCMAX','The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval.','\0','Accumulation Ratio Cmax','CL-PKPARMCD','DBX-NCIT-C102357'),('CL-PKPARMCD-T-30',NULL,'AUCLSTW','The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight.','\0','AUC to Last Nonzero Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92305'),('CL-PKPARMCD-T-31',NULL,'AUCPBEO','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Back Extrapolation Obs','CL-PKPARMCD','DBX-NCIT-C85763'),('CL-PKPARMCD-T-32',NULL,'AUCPBEP','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Back Extrapolation Pred','CL-PKPARMCD','DBX-NCIT-C85787'),('CL-PKPARMCD-T-33',NULL,'AUCPEO','Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using th','\0','AUC %Extrapolation Obs','CL-PKPARMCD','DBX-NCIT-C85764'),('CL-PKPARMCD-T-34',NULL,'AUCPEP','The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.','\0','AUC %Extrapolation Pred','CL-PKPARMCD','DBX-NCIT-C85788'),('CL-PKPARMCD-T-35',NULL,'AUCTAU','The area under the curve (AUC) for the defined interval between doses (TAU).','\0','AUC Over Dosing Interval','CL-PKPARMCD','DBX-NCIT-C85567'),('CL-PKPARMCD-T-36',NULL,'AUCTAUB','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index.','\0','AUC Over Dosing Interval Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92322'),('CL-PKPARMCD-T-37',NULL,'AUCTAUD','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose.','\0','AUC Over Dosing Interval Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92323'),('CL-PKPARMCD-T-38',NULL,'AUCTAUS','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area.','\0','AUC Over Dosing Interval Norm by SA','CL-PKPARMCD','DBX-NCIT-C92324'),('CL-PKPARMCD-T-39',NULL,'AUCTAUW','The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight.','\0','AUC Over Dosing Interval Norm by WT','CL-PKPARMCD','DBX-NCIT-C92325'),('CL-PKPARMCD-T-4',NULL,'ARCMIN','The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval.','\0','Accumulation Ratio Cmin','CL-PKPARMCD','DBX-NCIT-C102358'),('CL-PKPARMCD-T-40',NULL,'AUMCIFO','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.','\0','AUMC Infinity Obs','CL-PKPARMCD','DBX-NCIT-C85765'),('CL-PKPARMCD-T-41',NULL,'AUMCIFOB','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.','\0','AUMC Infinity Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92330'),('CL-PKPARMCD-T-42',NULL,'AUMCIFOD','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.','\0','AUMC Infinity Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92331'),('CL-PKPARMCD-T-43',NULL,'AUMCIFOS','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.','\0','AUMC Infinity Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C92332'),('CL-PKPARMCD-T-44',NULL,'AUMCIFOW','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.','\0','AUMC Infinity Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C92333'),('CL-PKPARMCD-T-45',NULL,'AUMCIFP','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.','\0','AUMC Infinity Pred','CL-PKPARMCD','DBX-NCIT-C85789'),('CL-PKPARMCD-T-46',NULL,'AUMCIFPB','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.','\0','AUMC Infinity Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92334'),('CL-PKPARMCD-T-47',NULL,'AUMCIFPD','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.','\0','AUMC Infinity Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92335'),('CL-PKPARMCD-T-48',NULL,'AUMCIFPS','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.','\0','AUMC Infinity Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C92336'),('CL-PKPARMCD-T-49',NULL,'AUMCIFPW','The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.','\0','AUMC Infinity Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C92337'),('CL-PKPARMCD-T-5',NULL,'ARCTROUG','The trough concentration at steady state divided by the trough concentration during the initial dosing interval.','\0','Accumulation Ratio Ctrough','CL-PKPARMCD','DBX-NCIT-C102426'),('CL-PKPARMCD-T-50',NULL,'AUMCLST','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration.','\0','AUMC to Last Nonzero Conc','CL-PKPARMCD','DBX-NCIT-C85569'),('CL-PKPARMCD-T-51',NULL,'AUMCLSTB','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index.','\0','AUMC to Last Nonzero Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92326'),('CL-PKPARMCD-T-52',NULL,'AUMCLSTD','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose.','\0','AUMC to Last Nonzero Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92327'),('CL-PKPARMCD-T-53',NULL,'AUMCLSTS','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area.','\0','AUMC to Last Nonzero Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92328'),('CL-PKPARMCD-T-54',NULL,'AUMCLSTW','The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight.','\0','AUMC to Last Nonzero Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92329'),('CL-PKPARMCD-T-55',NULL,'AUMCPEO','The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.','\0','AUMC % Extrapolation Obs','CL-PKPARMCD','DBX-NCIT-C85766'),('CL-PKPARMCD-T-56',NULL,'AUMCPEP','The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.','\0','AUMC % Extrapolation Pred','CL-PKPARMCD','DBX-NCIT-C85790'),('CL-PKPARMCD-T-57',NULL,'AUMCTAU','The area under the first moment curve (AUMC) for the defined interval between doses (TAU).','\0','AUMC Over Dosing Interval','CL-PKPARMCD','DBX-NCIT-C85570'),('CL-PKPARMCD-T-58',NULL,'AUMCTAUB','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index.','\0','AUMC Over Dosing Interval Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92338'),('CL-PKPARMCD-T-59',NULL,'AUMCTAUD','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose.','\0','AUMC Over Dosing Interval Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92339'),('CL-PKPARMCD-T-6',NULL,'AUCALL','The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not.','\0','AUC All','CL-PKPARMCD','DBX-NCIT-C85564'),('CL-PKPARMCD-T-60',NULL,'AUMCTAUS','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area.','\0','AUMC Over Dosing Interval Norm by SA','CL-PKPARMCD','DBX-NCIT-C92340'),('CL-PKPARMCD-T-61',NULL,'AUMCTAUW','The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight.','\0','AUMC Over Dosing Interval Norm by WT','CL-PKPARMCD','DBX-NCIT-C92341'),('CL-PKPARMCD-T-62',NULL,'AURCALL','The area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not.','\0','AURC All','CL-PKPARMCD','DBX-NCIT-C85841'),('CL-PKPARMCD-T-63',NULL,'AURCALLB','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index.','\0','AURC All Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92342'),('CL-PKPARMCD-T-64',NULL,'AURCALLD','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose.','\0','AURC All Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92343'),('CL-PKPARMCD-T-65',NULL,'AURCALLS','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area.','\0','AURC All Norm by SA','CL-PKPARMCD','DBX-NCIT-C92344'),('CL-PKPARMCD-T-66',NULL,'AURCALLW','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight.','\0','AURC All Norm by WT','CL-PKPARMCD','DBX-NCIT-C92345'),('CL-PKPARMCD-T-67',NULL,'AURCIFO','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate.','\0','AURC Infinity Obs','CL-PKPARMCD','DBX-NCIT-C85767'),('CL-PKPARMCD-T-68',NULL,'AURCIFOB','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index.','\0','AURC Infinity Obs Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92354'),('CL-PKPARMCD-T-69',NULL,'AURCIFOD','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose.','\0','AURC Infinity Obs Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92355'),('CL-PKPARMCD-T-7',NULL,'AUCALLB','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92362'),('CL-PKPARMCD-T-70',NULL,'AURCIFOS','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area.','\0','AURC Infinity Obs Norm by SA','CL-PKPARMCD','DBX-NCIT-C92356'),('CL-PKPARMCD-T-71',NULL,'AURCIFOW','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight.','\0','AURC Infinity Obs Norm by WT','CL-PKPARMCD','DBX-NCIT-C92357'),('CL-PKPARMCD-T-72',NULL,'AURCIFP','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate.','\0','AURC Infinity Pred','CL-PKPARMCD','DBX-NCIT-C85791'),('CL-PKPARMCD-T-73',NULL,'AURCIFPB','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index.','\0','AURC Infinity Pred Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92358'),('CL-PKPARMCD-T-74',NULL,'AURCIFPD','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose.','\0','AURC Infinity Pred Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92359'),('CL-PKPARMCD-T-75',NULL,'AURCIFPS','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area.','\0','AURC Infinity Pred Norm by SA','CL-PKPARMCD','DBX-NCIT-C92360'),('CL-PKPARMCD-T-76',NULL,'AURCIFPW','The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight.','\0','AURC Infinity Pred Norm by WT','CL-PKPARMCD','DBX-NCIT-C92361'),('CL-PKPARMCD-T-77',NULL,'AURCINT','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2.','\0','AURC from T1 to T2','CL-PKPARMCD','DBX-NCIT-C85572'),('CL-PKPARMCD-T-78',NULL,'AURCINTB','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index.','\0','AURC from T1 to T2 Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92350'),('CL-PKPARMCD-T-79',NULL,'AURCINTD','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose.','\0','AURC from T1 to T2 Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92351'),('CL-PKPARMCD-T-8',NULL,'AUCALLD','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92306'),('CL-PKPARMCD-T-80',NULL,'AURCINTS','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area.','\0','AURC from T1 to T2 Norm by SA','CL-PKPARMCD','DBX-NCIT-C92352'),('CL-PKPARMCD-T-81',NULL,'AURCINTW','The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight.','\0','AURC from T1 to T2 Norm by WT','CL-PKPARMCD','DBX-NCIT-C92353'),('CL-PKPARMCD-T-82',NULL,'AURCLST','The area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration.','\0','AURC to Last Nonzero Rate','CL-PKPARMCD','DBX-NCIT-C85571'),('CL-PKPARMCD-T-83',NULL,'AURCLSTB','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index.','\0','AURC to Last Nonzero Rate Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92346'),('CL-PKPARMCD-T-84',NULL,'AURCLSTD','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose.','\0','AURC to Last Nonzero Rate Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92347'),('CL-PKPARMCD-T-85',NULL,'AURCLSTS','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area.','\0','AURC to Last Nonzero Rate Norm by SA','CL-PKPARMCD','DBX-NCIT-C92348'),('CL-PKPARMCD-T-86',NULL,'AURCLSTW','The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight.','\0','AURC to Last Nonzero Rate Norm by WT','CL-PKPARMCD','DBX-NCIT-C92349'),('CL-PKPARMCD-T-87',NULL,'AURCPEO','The area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.','\0','AURC % Extrapolation Obs','CL-PKPARMCD','DBX-NCIT-C85768'),('CL-PKPARMCD-T-88',NULL,'AURCPEP','The area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.','\0','AURC % Extrapolation Pred','CL-PKPARMCD','DBX-NCIT-C85792'),('CL-PKPARMCD-T-89',NULL,'C0','Initial concentration. Given only for bolus IV models.','\0','Initial Conc','CL-PKPARMCD','DBX-NCIT-C85644'),('CL-PKPARMCD-T-9',NULL,'AUCALLS','The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not.','\0','AUC All Norm by SA','CL-PKPARMCD','DBX-NCIT-C92307'),('CL-PKPARMCD-T-90',NULL,'C0B','Initial concentration divided by the body mass index. Given only for bolus IV models.','\0','Initial Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92383'),('CL-PKPARMCD-T-91',NULL,'C0D','Initial concentration divided by the dose. Given only for bolus IV models.','\0','Initial Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92384'),('CL-PKPARMCD-T-92',NULL,'C0S','Initial concentration divided by the surface area. Given only for bolus IV models.','\0','Initial Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92385'),('CL-PKPARMCD-T-93',NULL,'C0W','Initial concentration divided by the weight. Given only for bolus IV models.','\0','Initial Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92386'),('CL-PKPARMCD-T-94',NULL,'CAVG','AUCTAU divided by TAU.','\0','Average Conc; Average Concentration','CL-PKPARMCD','DBX-NCIT-C85575'),('CL-PKPARMCD-T-95',NULL,'CAVGB','AUCTAU divided by TAU and then divided by the body mass index.','\0','Average Conc Norm by BMI','CL-PKPARMCD','DBX-NCIT-C92367'),('CL-PKPARMCD-T-96',NULL,'CAVGD','AUCTAU divided by TAU and then divided by the dose.','\0','Average Conc Norm by Dose','CL-PKPARMCD','DBX-NCIT-C92368'),('CL-PKPARMCD-T-97',NULL,'CAVGS','AUCTAU divided by TAU and then divided by the surface area.','\0','Average Conc Norm by SA','CL-PKPARMCD','DBX-NCIT-C92369'),('CL-PKPARMCD-T-98',NULL,'CAVGW','AUCTAU divided by TAU and then divided by the weight.','\0','Average Conc Norm by WT','CL-PKPARMCD','DBX-NCIT-C92370'),('CL-PKPARMCD-T-99',NULL,'CLFO','The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.','\0','Total CL Obs by F','CL-PKPARMCD','DBX-NCIT-C85772'),('CL-PKUNIT-T-1',NULL,'%','A fraction or ratio with 100 understood as the denominator. (NCI)','\0','Percentage','CL-PKUNIT','DBX-NCIT-C25613'),('CL-PKUNIT-T-10',NULL,'(L/min)/ug','Liters per minute (flow), divided by micrograms (dose).','\0','L/mcg/min; L/min/mcg; L/min/ug; mL/min/ng; mL/ng/min','CL-PKUNIT','DBX-NCIT-C85666'),('CL-PKUNIT-T-100',NULL,'h*fg/mL/(kg/m2)','Hours times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111210'),('CL-PKUNIT-T-101',NULL,'h*fg/mL/(mg/g)','Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117916'),('CL-PKUNIT-T-102',NULL,'h*fg/mL/(mg/g/day)','Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117917'),('CL-PKUNIT-T-103',NULL,'h*fg/mL/g','Hours times femtograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112298'),('CL-PKUNIT-T-104',NULL,'h*fg/mL/kg','Hours times femtograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112299'),('CL-PKUNIT-T-105',NULL,'h*fg/mL/m2','Hours times femtograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111211'),('CL-PKUNIT-T-106',NULL,'h*g/mL','Hours times grams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85613'),('CL-PKUNIT-T-107',NULL,'h*g/mL/(kg/m2)','Hours times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111212'),('CL-PKUNIT-T-108',NULL,'h*g/mL/(mg/g)','Hours times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117918'),('CL-PKUNIT-T-109',NULL,'h*g/mL/(mg/g/day)','Hours times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117919'),('CL-PKUNIT-T-11',NULL,'/h','A rate of occurrences of something within a period of time equal to sixty minutes.','\0','Per Hour','CL-PKUNIT','DBX-NCIT-C66966'),('CL-PKUNIT-T-110',NULL,'h*g/mL/(mg/kg)','Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).','\0','h*g/mL/(ug/g)','CL-PKUNIT','DBX-NCIT-C105464'),('CL-PKUNIT-T-111',NULL,'h*g/mL/(mg/kg/day)','Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','h*g/mL/(ug/g/day)','CL-PKUNIT','DBX-NCIT-C105465'),('CL-PKUNIT-T-112',NULL,'h*g/mL/g','Hours times grams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112300'),('CL-PKUNIT-T-113',NULL,'h*g/mL/kg','Hours times grams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112301'),('CL-PKUNIT-T-114',NULL,'h*g/mL/m2','Hours times grams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111213'),('CL-PKUNIT-T-115',NULL,'h*mg/mL','Hours times milligrams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85621'),('CL-PKUNIT-T-116',NULL,'h*mg/mL/(kg/m2)','Hours times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111218'),('CL-PKUNIT-T-117',NULL,'h*mg/mL/(mg/g)','Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117920'),('CL-PKUNIT-T-118',NULL,'h*mg/mL/(mg/g/day)','Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117921'),('CL-PKUNIT-T-119',NULL,'h*mg/mL/(mg/kg)','Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).','\0','h*mg/mL/(ug/g)','CL-PKUNIT','DBX-NCIT-C105468'),('CL-PKUNIT-T-12',NULL,'day','The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)','\0','Day','CL-PKUNIT','DBX-NCIT-C25301'),('CL-PKUNIT-T-120',NULL,'h*mg/mL/(mg/kg/day)','Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','h*mg/mL/(ug/g/day)','CL-PKUNIT','DBX-NCIT-C105469'),('CL-PKUNIT-T-121',NULL,'h*mg/mL/g','Hours times milligrams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112305'),('CL-PKUNIT-T-122',NULL,'h*mg/mL/kg','Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112306'),('CL-PKUNIT-T-123',NULL,'h*mg/mL/m2','Hours times milligrams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111219'),('CL-PKUNIT-T-124',NULL,'h*mmol/L','Hours times millimoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85618'),('CL-PKUNIT-T-125',NULL,'h*mmol/L/(kg/m2)','Hours times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111220'),('CL-PKUNIT-T-126',NULL,'h*mmol/L/(mg/g)','Hours times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117922'),('CL-PKUNIT-T-127',NULL,'h*mmol/L/(mg/g/day)','Hours times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117923'),('CL-PKUNIT-T-128',NULL,'h*mmol/L/g','Hours times millimoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C106530'),('CL-PKUNIT-T-129',NULL,'h*mmol/L/kg','Hours times millimoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112307'),('CL-PKUNIT-T-13',NULL,'day*fg/mL','Days times femtograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85583'),('CL-PKUNIT-T-130',NULL,'h*mmol/L/m2','Hours times millimoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111221'),('CL-PKUNIT-T-131',NULL,'h*mol/L','Hours times moles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85622'),('CL-PKUNIT-T-132',NULL,'h*mol/L/(kg/m2)','Hours times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111222'),('CL-PKUNIT-T-133',NULL,'h*mol/L/(mg/g)','Hours times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117924'),('CL-PKUNIT-T-134',NULL,'h*mol/L/(mg/g/day)','Hours times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117925'),('CL-PKUNIT-T-135',NULL,'h*mol/L/g','Hours times moles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C106531'),('CL-PKUNIT-T-136',NULL,'h*mol/L/kg','Hours times moles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112308'),('CL-PKUNIT-T-137',NULL,'h*mol/L/m2','Hours times moles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111223'),('CL-PKUNIT-T-138',NULL,'h*ng/mL','Hours times nanograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85624'),('CL-PKUNIT-T-139',NULL,'h*ng/mL/(kg/m2)','Hours times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111224'),('CL-PKUNIT-T-14',NULL,'day*fg/mL/(kg/m2)','Days times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111167'),('CL-PKUNIT-T-140',NULL,'h*ng/mL/(mg/g)','Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117926'),('CL-PKUNIT-T-141',NULL,'h*ng/mL/(mg/g/day)','Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117927'),('CL-PKUNIT-T-142',NULL,'h*ng/mL/(mg/kg)','Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).','\0','h*ng/mL/(ug/g)','CL-PKUNIT','DBX-NCIT-C85628'),('CL-PKUNIT-T-143',NULL,'h*ng/mL/(mg/kg/day)','Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','h*ng/mL/(ug/g/day)','CL-PKUNIT','DBX-NCIT-C105470'),('CL-PKUNIT-T-144',NULL,'h*ng/mL/(mg/m2)','Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area).','\0','','CL-PKUNIT','DBX-NCIT-C85629'),('CL-PKUNIT-T-145',NULL,'h*ng/mL/g','Hours times nanograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C85625'),('CL-PKUNIT-T-146',NULL,'h*ng/mL/kg','Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C85626'),('CL-PKUNIT-T-147',NULL,'h*ng/mL/m2','Hours times nanograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111225'),('CL-PKUNIT-T-148',NULL,'h*ng/mL/mg','Hours times nanograms per milliliter (area under the curve), divided by milligrams (dose).','\0','h*ng/mL/mg; h*ng/mg/mL; ng*h/mL/mg; ng*h/mg/mL','CL-PKUNIT','DBX-NCIT-C85627'),('CL-PKUNIT-T-149',NULL,'h*nmol/L','Hours times nanomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85640'),('CL-PKUNIT-T-15',NULL,'day*fg/mL/(mg/g)','Days times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117894'),('CL-PKUNIT-T-150',NULL,'h*nmol/L/(kg/m2)','Hours times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111226'),('CL-PKUNIT-T-151',NULL,'h*nmol/L/(mg/g)','Hours times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117928'),('CL-PKUNIT-T-152',NULL,'h*nmol/L/(mg/g/day)','Hours times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117929'),('CL-PKUNIT-T-153',NULL,'h*nmol/L/g','Hours times nanomoles per liter (area under the curve), divided by grams (dose or weight).','\0','','CL-PKUNIT','DBX-NCIT-C116062'),('CL-PKUNIT-T-154',NULL,'h*nmol/L/kg','Hours times nanomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112309'),('CL-PKUNIT-T-155',NULL,'h*nmol/L/m2','Hours times nanomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111227'),('CL-PKUNIT-T-156',NULL,'h*nmol/L/umol','Hours times nanomoles per liter per micromole.','\0','h*nmol/L/mcmol; h*nmol/umol/L; nmol*h/L/umol; nmol*h/umol/L','CL-PKUNIT','DBX-NCIT-C85631'),('CL-PKUNIT-T-157',NULL,'h*pg/mL','Hours times picograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85635'),('CL-PKUNIT-T-158',NULL,'h*pg/mL/(kg/m2)','Hours times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111228'),('CL-PKUNIT-T-159',NULL,'h*pg/mL/(mg/g)','Hours times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117930'),('CL-PKUNIT-T-16',NULL,'day*fg/mL/(mg/g/day)','Days times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117895'),('CL-PKUNIT-T-160',NULL,'h*pg/mL/(mg/g/day)','Hours times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117931'),('CL-PKUNIT-T-161',NULL,'h*pg/mL/(mg/kg)','Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).','\0','h*pg/mL/(ug/g)','CL-PKUNIT','DBX-NCIT-C105471'),('CL-PKUNIT-T-162',NULL,'h*pg/mL/(mg/kg/day)','Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','h*pg/mL/(ug/g/day)','CL-PKUNIT','DBX-NCIT-C105472'),('CL-PKUNIT-T-163',NULL,'h*pg/mL/g','Hours times picograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112310'),('CL-PKUNIT-T-164',NULL,'h*pg/mL/kg','Hours times picograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C85636'),('CL-PKUNIT-T-165',NULL,'h*pg/mL/m2','Hours times picograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111229'),('CL-PKUNIT-T-166',NULL,'h*pg/mL/mg','Hours times picograms per milliliter (area under the curve), divided by milligrams (dose).','\0','h*pg/mL/mg; h*pg/mg/mL; pg*h/mL/mg; pg*h/mg/mL','CL-PKUNIT','DBX-NCIT-C85638'),('CL-PKUNIT-T-167',NULL,'h*pmol/L','Hours times picomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85612'),('CL-PKUNIT-T-168',NULL,'h*pmol/L/(kg/m2)','Hours times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111230'),('CL-PKUNIT-T-169',NULL,'h*pmol/L/(mg/g)','Hours times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117932'),('CL-PKUNIT-T-17',NULL,'day*fg/mL/g','Days times femtograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112244'),('CL-PKUNIT-T-170',NULL,'h*pmol/L/(mg/g/day)','Hours times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117933'),('CL-PKUNIT-T-171',NULL,'h*pmol/L/g','Hours times picomoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C106532'),('CL-PKUNIT-T-172',NULL,'h*pmol/L/kg','Hours times picomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112311'),('CL-PKUNIT-T-173',NULL,'h*pmol/L/m2','Hours times picomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111231'),('CL-PKUNIT-T-174',NULL,'h*ug/mL','Hours times micrograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85615'),('CL-PKUNIT-T-175',NULL,'h*ug/mL/(kg/m2)','Hours times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111214'),('CL-PKUNIT-T-176',NULL,'h*ug/mL/(mg/g)','Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117934'),('CL-PKUNIT-T-177',NULL,'h*ug/mL/(mg/g/day)','Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117935'),('CL-PKUNIT-T-178',NULL,'h*ug/mL/(mg/kg)','Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).','\0','h*ug/mL/(ug/g)','CL-PKUNIT','DBX-NCIT-C105466'),('CL-PKUNIT-T-179',NULL,'h*ug/mL/(mg/kg/day)','Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','h*ug/mL/(ug/g/day)','CL-PKUNIT','DBX-NCIT-C105467'),('CL-PKUNIT-T-18',NULL,'day*fg/mL/kg','Days times femtograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112245'),('CL-PKUNIT-T-180',NULL,'h*ug/mL/g','Hours times micrograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112302'),('CL-PKUNIT-T-181',NULL,'h*ug/mL/kg','Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112303'),('CL-PKUNIT-T-182',NULL,'h*ug/mL/m2','Hours times micrograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111215'),('CL-PKUNIT-T-183',NULL,'h*ug/mL/mg','Hours times micrograms per milliliter (area under the curve), divided by milligrams (dose).','\0','h*mcg/mL/mg; h*ug/mg/mL; ug*h/mL/mg; ug*h/mg/mL','CL-PKUNIT','DBX-NCIT-C85617'),('CL-PKUNIT-T-184',NULL,'h*umol/L','Hours times micromoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85632'),('CL-PKUNIT-T-185',NULL,'h*umol/L/(kg/m2)','Hours times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111216'),('CL-PKUNIT-T-186',NULL,'h*umol/L/(mg/g)','Hours times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117936'),('CL-PKUNIT-T-187',NULL,'h*umol/L/(mg/g/day)','Hours times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117937'),('CL-PKUNIT-T-188',NULL,'h*umol/L/g','Hours times micromoles per liter (area under the curve), divided by grams (dose or weight).','\0','','CL-PKUNIT','DBX-NCIT-C116063'),('CL-PKUNIT-T-189',NULL,'h*umol/L/kg','Hours times micromoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112304'),('CL-PKUNIT-T-19',NULL,'day*fg/mL/m2','Days times femtograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111168'),('CL-PKUNIT-T-190',NULL,'h*umol/L/m2','Hours times micromoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111217'),('CL-PKUNIT-T-191',NULL,'h2*mg/mL','Hours squared times milligrams per milliliter.','\0','h*h*mg/mL; h2*g/L; h2*ug/uL; h^2*mg/mL; mg*h2/mL','CL-PKUNIT','DBX-NCIT-C85606'),('CL-PKUNIT-T-192',NULL,'h2*mmol/L','Hours squared times millimoles per liter (area under the moment curve).','\0','','CL-PKUNIT','DBX-NCIT-C85605'),('CL-PKUNIT-T-193',NULL,'h2*mol/L','Hours squared times moles per liter (area under the moment curve).','\0','','CL-PKUNIT','DBX-NCIT-C85607'),('CL-PKUNIT-T-194',NULL,'h2*ng/mL','Hours squared times nanograms per milliliter.','\0','h*h*ng/mL; h2*ug/L; h^2*ng/mL; ng*h2/mL','CL-PKUNIT','DBX-NCIT-C85608'),('CL-PKUNIT-T-195',NULL,'h2*nmol/L','Hours squared times nanomoles per liter (area under the moment curve).','\0','','CL-PKUNIT','DBX-NCIT-C85610'),('CL-PKUNIT-T-196',NULL,'h2*pg/mL','Hours squared times picogram per milliliter.','\0','h*h*pg/mL; h2*ng/L; h^2*pg/mL; pg*h2/mL','CL-PKUNIT','DBX-NCIT-C85609'),('CL-PKUNIT-T-197',NULL,'h2*pmol/L','Hours squared times picomoles per liter (area under the moment curve).','\0','','CL-PKUNIT','DBX-NCIT-C106529'),('CL-PKUNIT-T-198',NULL,'h2*ug/mL','Hours squared times micrograms per milliliter.','\0','h*h*ug/mL; h2*mcg/mL; h2*mg/L; h^2*ug/mL; ug*h2/mL','CL-PKUNIT','DBX-NCIT-C85604'),('CL-PKUNIT-T-199',NULL,'h2*umol/L','Hours squared times micromoles per liter (area under the moment curve).','\0','','CL-PKUNIT','DBX-NCIT-C106528'),('CL-PKUNIT-T-2',NULL,'(L/day)/g','Liters per day (flow), divided by grams (weight).','\0','L/g/d; mL/mg/day; uL/ug/day','CL-PKUNIT','DBX-NCIT-C85657'),('CL-PKUNIT-T-20',NULL,'day*g/mL','Days times grams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85584'),('CL-PKUNIT-T-200',NULL,'IU/day','International units per day.','\0','IU/d','CL-PKUNIT','DBX-NCIT-C85645'),('CL-PKUNIT-T-201',NULL,'IU/h','International units per hour.','\0','IU/h','CL-PKUNIT','DBX-NCIT-C85646'),('CL-PKUNIT-T-202',NULL,'IU/min','International units per minute.','\0','IU/min','CL-PKUNIT','DBX-NCIT-C85647'),('CL-PKUNIT-T-203',NULL,'L','A unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI)','\0','Liter','CL-PKUNIT','DBX-NCIT-C48505'),('CL-PKUNIT-T-204',NULL,'L/day','Liters per day.','\0','','CL-PKUNIT','DBX-NCIT-C69110'),('CL-PKUNIT-T-205',NULL,'L/h','Liters per hour.','\0','L/h','CL-PKUNIT','DBX-NCIT-C69160'),('CL-PKUNIT-T-206',NULL,'L/kg/day','Liters per kilogram per day.','\0','L/day/kg; L/kg/d; Milliliter per Gram per Day; mL/day/g; mL/g/day; uL/day/mg; uL/mg/day','CL-PKUNIT','DBX-NCIT-C73755'),('CL-PKUNIT-T-207',NULL,'L/kg/h','Milliliters per gram per hour.','\0','Milliliter per Gram per Hour','CL-PKUNIT','DBX-NCIT-C73756'),('CL-PKUNIT-T-208',NULL,'L/kg/min','Milliliters per gram per minute.','\0','Milliliter per Gram per Minute','CL-PKUNIT','DBX-NCIT-C73757'),('CL-PKUNIT-T-209',NULL,'L/min','A unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI)','\0','Liters per Minute','CL-PKUNIT','DBX-NCIT-C67388'),('CL-PKUNIT-T-21',NULL,'day*g/mL/(kg/m2)','Days times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111169'),('CL-PKUNIT-T-210',NULL,'L/mmol/day','Liters per millimole per day.','\0','L/day/mmol; L/mmol/d; mL/day/umol; mL/umol/day','CL-PKUNIT','DBX-NCIT-C85676'),('CL-PKUNIT-T-211',NULL,'L/mmol/h','Liters per millimole per hour.','\0','L/h/mmol; L/mmol/h; mL/h/umol; mL/umol/h','CL-PKUNIT','DBX-NCIT-C85677'),('CL-PKUNIT-T-212',NULL,'L/mmol/min','Liters per millimole per minute.','\0','L/min/mmol; L/mmol/min; mL/min/umol; mL/umol/min','CL-PKUNIT','DBX-NCIT-C85678'),('CL-PKUNIT-T-213',NULL,'L/mol','Liters per mole.','\0','L/mol; mL/mmol; uL/umol','CL-PKUNIT','DBX-NCIT-C85680'),('CL-PKUNIT-T-214',NULL,'L/mol/day','Liters per mole per day.','\0','L/day/mol; L/mol/d; mL/day/mmol; mL/mmol/day; uL/day/umol; uL/umol/day','CL-PKUNIT','DBX-NCIT-C85681'),('CL-PKUNIT-T-215',NULL,'L/mol/h','Liters per mole per hour.','\0','L/h/mol; L/mol/h; mL/h/mmol; mL/mmol/h; uL/h/umol; uL/umol/h','CL-PKUNIT','DBX-NCIT-C85682'),('CL-PKUNIT-T-216',NULL,'L/mol/min','Liters per mole per minute.','\0','L/min/mol; L/mol/min; mL/min/mmol; mL/mmol/min; uL/min/umol; uL/umol/min','CL-PKUNIT','DBX-NCIT-C85683'),('CL-PKUNIT-T-217',NULL,'L/ng/day','Liters per nanogram per day.','\0','L/day/ng; L/ng/d; mL/day/pg; mL/pg/day','CL-PKUNIT','DBX-NCIT-C85685'),('CL-PKUNIT-T-218',NULL,'L/ng/h','Liters per nanogram per hour.','\0','L/h/ng; L/ng/h; mL/h/pg; mL/pg/h','CL-PKUNIT','DBX-NCIT-C85686'),('CL-PKUNIT-T-219',NULL,'L/ng/min','Liters per nanogram per minute.','\0','L/min/ng; L/ng/min; mL/min/pg; mL/pg/min','CL-PKUNIT','DBX-NCIT-C85687'),('CL-PKUNIT-T-22',NULL,'day*g/mL/(mg/g)','Days times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117896'),('CL-PKUNIT-T-220',NULL,'L/nmol/day','Liters per nanomole per day.','\0','L/day/nmol; L/nmol/d; mL/day/pmol; mL/pmol/day','CL-PKUNIT','DBX-NCIT-C85689'),('CL-PKUNIT-T-221',NULL,'L/nmol/h','Liters per nanomole per hour.','\0','L/h/nmol; L/nmol/h; mL/h/pmol; mL/pmol/h','CL-PKUNIT','DBX-NCIT-C85690'),('CL-PKUNIT-T-222',NULL,'L/nmol/min','Liters per nanomole per minute.','\0','L/min/nmol; L/nmol/min; mL/min/pmol; mL/pmol/min','CL-PKUNIT','DBX-NCIT-C85691'),('CL-PKUNIT-T-223',NULL,'L/pg/day','Liters per picogram per day.','\0','L/day/pg; L/pg/d','CL-PKUNIT','DBX-NCIT-C85693'),('CL-PKUNIT-T-224',NULL,'L/pg/h','Liters per picogram per hour.','\0','L/h/pg; L/pg/h','CL-PKUNIT','DBX-NCIT-C85694'),('CL-PKUNIT-T-225',NULL,'L/pg/min','Liters per picogram per minute.','\0','L/min/pg; L/pg/min','CL-PKUNIT','DBX-NCIT-C85695'),('CL-PKUNIT-T-226',NULL,'L/umol/day','Liters per micromole per day.','\0','L/day/mcmol; L/day/umol; L/mcmol/day; L/umol/d','CL-PKUNIT','DBX-NCIT-C85668'),('CL-PKUNIT-T-227',NULL,'L/umol/h','Liters per micromole per hour.','\0','L/h/mcmol; L/h/umol; L/mcmol/h; L/umol/h','CL-PKUNIT','DBX-NCIT-C85669'),('CL-PKUNIT-T-228',NULL,'L/umol/min','Liters per micromole per minute.','\0','L/mcmol/min; L/min/mcmol; L/min/umol; L/umol/min','CL-PKUNIT','DBX-NCIT-C85670'),('CL-PKUNIT-T-229',NULL,'mg','The unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI)','\0','Milligram','CL-PKUNIT','DBX-NCIT-C28253'),('CL-PKUNIT-T-23',NULL,'day*g/mL/(mg/g/day)','Days times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117897'),('CL-PKUNIT-T-230',NULL,'mg/day','A unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI)','\0','Milligram per Day','CL-PKUNIT','DBX-NCIT-C67399'),('CL-PKUNIT-T-231',NULL,'mg/h','A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)','\0','Milligram per Hour','CL-PKUNIT','DBX-NCIT-C66969'),('CL-PKUNIT-T-232',NULL,'mg/min','Milligrams per minute.','\0','Milligram per Minute','CL-PKUNIT','DBX-NCIT-C73742'),('CL-PKUNIT-T-233',NULL,'mg/mL','A unit of mass concentration defined as the concentration of one kilogram of a substance per unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance per unit volume of the mixture equal to one milliliter, ','\0','Gram per Liter; Kilogram per Cubic Meter; Microgram per Microliter; Milligram per Milliliter; g/L; kg/m3; mg/mL; ug/uL','CL-PKUNIT','DBX-NCIT-C42576'),('CL-PKUNIT-T-234',NULL,'mg/mL/(mg/kg)','Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105475'),('CL-PKUNIT-T-235',NULL,'mg/mL/(mg/kg/day)','Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105476'),('CL-PKUNIT-T-236',NULL,'mg/mL/h','Milligrams per milliliter per hour.','\0','g/L/h; g/h/L; mg/h/mL; ug/h/uL; ug/uL/h','CL-PKUNIT','DBX-NCIT-C85711'),('CL-PKUNIT-T-237',NULL,'min','A unit measure of time equal to 60 seconds.(NCI)','\0','Minute Unit of Time','CL-PKUNIT','DBX-NCIT-C48154'),('CL-PKUNIT-T-238',NULL,'min*fg/mL','Minutes times femtograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85724'),('CL-PKUNIT-T-239',NULL,'min*fg/mL/(kg/m2)','Minutes times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111254'),('CL-PKUNIT-T-24',NULL,'day*g/mL/g','Days times grams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112246'),('CL-PKUNIT-T-240',NULL,'min*fg/mL/(mg/g)','Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117938'),('CL-PKUNIT-T-241',NULL,'min*fg/mL/(mg/g/day)','Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117939'),('CL-PKUNIT-T-242',NULL,'min*fg/mL/g','Minutes times femtograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112334'),('CL-PKUNIT-T-243',NULL,'min*fg/mL/kg','Minutes times femtograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112335'),('CL-PKUNIT-T-244',NULL,'min*fg/mL/m2','Minutes times femtograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111255'),('CL-PKUNIT-T-245',NULL,'min*g/mL','Minutes times grams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85725'),('CL-PKUNIT-T-246',NULL,'min*g/mL/(kg/m2)','Minutes times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111256'),('CL-PKUNIT-T-247',NULL,'min*g/mL/(mg/g)','Minutes times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117940'),('CL-PKUNIT-T-248',NULL,'min*g/mL/(mg/g/day)','Minutes times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117941'),('CL-PKUNIT-T-249',NULL,'min*g/mL/g','Minutes times grams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112336'),('CL-PKUNIT-T-25',NULL,'day*g/mL/kg','Days times grams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112247'),('CL-PKUNIT-T-250',NULL,'min*g/mL/kg','Minutes times grams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112337'),('CL-PKUNIT-T-251',NULL,'min*g/mL/m2','Minutes times grams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111257'),('CL-PKUNIT-T-252',NULL,'min*mg/mL','Minutes times milligrams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85729'),('CL-PKUNIT-T-253',NULL,'min*mg/mL/(kg/m2)','Minutes times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111262'),('CL-PKUNIT-T-254',NULL,'min*mg/mL/(mg/g)','Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117942'),('CL-PKUNIT-T-255',NULL,'min*mg/mL/(mg/g/day)','Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117943'),('CL-PKUNIT-T-256',NULL,'min*mg/mL/g','Minutes times milligrams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112342'),('CL-PKUNIT-T-257',NULL,'min*mg/mL/kg','Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112343'),('CL-PKUNIT-T-258',NULL,'min*mg/mL/m2','Minutes times milligrams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111263'),('CL-PKUNIT-T-259',NULL,'min*mmol/L','Minutes times millimoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85728'),('CL-PKUNIT-T-26',NULL,'day*g/mL/m2','Days times grams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111170'),('CL-PKUNIT-T-260',NULL,'min*mmol/L/(kg/m2)','Minutes times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111264'),('CL-PKUNIT-T-261',NULL,'min*mmol/L/(mg/g)','Minutes times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117944'),('CL-PKUNIT-T-262',NULL,'min*mmol/L/(mg/g/day)','Minutes times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117945'),('CL-PKUNIT-T-263',NULL,'min*mmol/L/g','Minutes times millimoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112344'),('CL-PKUNIT-T-264',NULL,'min*mmol/L/kg','Minutes times millimoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112345'),('CL-PKUNIT-T-265',NULL,'min*mmol/L/m2','Minutes times millimoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111265'),('CL-PKUNIT-T-266',NULL,'min*mol/L','Minutes times moles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85730'),('CL-PKUNIT-T-267',NULL,'min*mol/L/(kg/m2)','Minutes times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111266'),('CL-PKUNIT-T-268',NULL,'min*mol/L/(mg/g)','Minutes times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117946'),('CL-PKUNIT-T-269',NULL,'min*mol/L/(mg/g/day)','Minutes times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117947'),('CL-PKUNIT-T-27',NULL,'day*mg/mL','Days times milligrams per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85588'),('CL-PKUNIT-T-270',NULL,'min*mol/L/g','Minutes times moles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112346'),('CL-PKUNIT-T-271',NULL,'min*mol/L/kg','Minutes times moles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112347'),('CL-PKUNIT-T-272',NULL,'min*mol/L/m2','Minutes times moles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111267'),('CL-PKUNIT-T-273',NULL,'min*ng/mL','Minutes times nanograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85732'),('CL-PKUNIT-T-274',NULL,'min*ng/mL/(kg/m2)','Minutes times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111268'),('CL-PKUNIT-T-275',NULL,'min*ng/mL/(mg/g)','Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117948'),('CL-PKUNIT-T-276',NULL,'min*ng/mL/(mg/g/day)','Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117949'),('CL-PKUNIT-T-277',NULL,'min*ng/mL/g','Minutes times nanograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112348'),('CL-PKUNIT-T-278',NULL,'min*ng/mL/kg','Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112349'),('CL-PKUNIT-T-279',NULL,'min*ng/mL/m2','Minutes times nanograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111269'),('CL-PKUNIT-T-28',NULL,'day*mg/mL/(kg/m2)','Days times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111175'),('CL-PKUNIT-T-280',NULL,'min*nmol/L','Minutes times nanomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85735'),('CL-PKUNIT-T-281',NULL,'min*nmol/L/(kg/m2)','Minutes times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111270'),('CL-PKUNIT-T-282',NULL,'min*nmol/L/(mg/g)','Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117950'),('CL-PKUNIT-T-283',NULL,'min*nmol/L/(mg/g/day)','Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117951'),('CL-PKUNIT-T-284',NULL,'min*nmol/L/g','Minutes times nanomoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112350'),('CL-PKUNIT-T-285',NULL,'min*nmol/L/kg','Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112351'),('CL-PKUNIT-T-286',NULL,'min*nmol/L/m2','Minutes times nanomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111271'),('CL-PKUNIT-T-287',NULL,'min*pg/mL','Minutes times picograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85734'),('CL-PKUNIT-T-288',NULL,'min*pg/mL/(kg/m2)','Minutes times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111272'),('CL-PKUNIT-T-289',NULL,'min*pg/mL/(mg/g)','Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117952'),('CL-PKUNIT-T-29',NULL,'day*mg/mL/(mg/g)','Days times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117898'),('CL-PKUNIT-T-290',NULL,'min*pg/mL/(mg/g/day)','Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117953'),('CL-PKUNIT-T-291',NULL,'min*pg/mL/g','Minutes times picograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112352'),('CL-PKUNIT-T-292',NULL,'min*pg/mL/kg','Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112353'),('CL-PKUNIT-T-293',NULL,'min*pg/mL/m2','Minutes times picograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111273'),('CL-PKUNIT-T-294',NULL,'min*pmol/L','Minutes times picomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C106543'),('CL-PKUNIT-T-295',NULL,'min*pmol/L/(kg/m2)','Minutes times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111274'),('CL-PKUNIT-T-296',NULL,'min*pmol/L/(mg/g)','Minutes times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117954'),('CL-PKUNIT-T-297',NULL,'min*pmol/L/(mg/g/day)','Minutes times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117955'),('CL-PKUNIT-T-298',NULL,'min*pmol/L/g','Minutes times picomoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112354'),('CL-PKUNIT-T-299',NULL,'min*pmol/L/kg','Minutes times picomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112355'),('CL-PKUNIT-T-3',NULL,'(L/day)/mg','Liters per day (flow), divided by milligrams (dose).','\0','L/day/mg; L/mg/d; mL/day/ug; mL/ug/day','CL-PKUNIT','DBX-NCIT-C85672'),('CL-PKUNIT-T-30',NULL,'day*mg/mL/(mg/g/day)','Days times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117899'),('CL-PKUNIT-T-300',NULL,'min*pmol/L/m2','Minutes times picomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111275'),('CL-PKUNIT-T-301',NULL,'min*ug/mL','Minutes times micrograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85727'),('CL-PKUNIT-T-302',NULL,'min*ug/mL/(kg/m2)','Minutes times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111258'),('CL-PKUNIT-T-303',NULL,'min*ug/mL/(mg/g)','Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117956'),('CL-PKUNIT-T-304',NULL,'min*ug/mL/(mg/g/day)','Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117957'),('CL-PKUNIT-T-305',NULL,'min*ug/mL/g','Minutes times micrograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112338'),('CL-PKUNIT-T-306',NULL,'min*ug/mL/kg','Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112339'),('CL-PKUNIT-T-307',NULL,'min*ug/mL/m2','Minutes times micrograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111259'),('CL-PKUNIT-T-308',NULL,'min*umol/L','Minutes times micromoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85733'),('CL-PKUNIT-T-309',NULL,'min*umol/L/(kg/m2)','Minutes times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111260'),('CL-PKUNIT-T-31',NULL,'day*mg/mL/g','Days times milligrams per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112252'),('CL-PKUNIT-T-310',NULL,'min*umol/L/(mg/g)','Minutes times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117958'),('CL-PKUNIT-T-311',NULL,'min*umol/L/(mg/g/day)','Minutes times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117959'),('CL-PKUNIT-T-312',NULL,'min*umol/L/g','Minutes times micromoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112340'),('CL-PKUNIT-T-313',NULL,'min*umol/L/kg','Minutes times micromoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112341'),('CL-PKUNIT-T-314',NULL,'min*umol/L/m2','Minutes times micromoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111261'),('CL-PKUNIT-T-315',NULL,'mIU/mL','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of system volume.(NCI)','\0','IE/L; IU/L; International Unit per Liter; mIU/mL','CL-PKUNIT','DBX-NCIT-C67376'),('CL-PKUNIT-T-316',NULL,'mL','The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI)','\0','Milliliter; cm3','CL-PKUNIT','DBX-NCIT-C28254'),('CL-PKUNIT-T-317',NULL,'mL/day','Milliliters per day.','\0','Milliliter per Day','CL-PKUNIT','DBX-NCIT-C67410'),('CL-PKUNIT-T-318',NULL,'mL/h','A unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI)','\0','Milliliters per Hour','CL-PKUNIT','DBX-NCIT-C66962'),('CL-PKUNIT-T-319',NULL,'mL/kg/day','Milliliters per kilogram per day.','\0','Milliliter per Kilogram per Day','CL-PKUNIT','DBX-NCIT-C73758'),('CL-PKUNIT-T-32',NULL,'day*mg/mL/kg','Days times milligrams per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112253'),('CL-PKUNIT-T-320',NULL,'mL/kg/h','Milliliters per kilogram per hour.','\0','Milliliter per Kilogram per Hour','CL-PKUNIT','DBX-NCIT-C73759'),('CL-PKUNIT-T-321',NULL,'mL/kg/min','Milliliters per kilogram per minute.','\0','Milliliter per Kilogram per Minute; mL/kg/min; mL/min/kg; uL/g/min; uL/min/g','CL-PKUNIT','DBX-NCIT-C73760'),('CL-PKUNIT-T-322',NULL,'mL/min','A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI)','\0','Milliliters per Minute','CL-PKUNIT','DBX-NCIT-C64777'),('CL-PKUNIT-T-323',NULL,'mL/mol/day','Milliliters per mole per day.','\0','mL/day/mol; mL/mol/d; uL/day/mmol; uL/mmol/day','CL-PKUNIT','DBX-NCIT-C85716'),('CL-PKUNIT-T-324',NULL,'mL/mol/h','Milliliters per mole per hour.','\0','mL/h/mol; mL/mol/h; uL/h/mmol; uL/mmol/h','CL-PKUNIT','DBX-NCIT-C85717'),('CL-PKUNIT-T-325',NULL,'mL/mol/min','Milliliters per mole per minute.','\0','mL/min/mol; mL/mol/min; uL/min/mmol; uL/mmol/min','CL-PKUNIT','DBX-NCIT-C85718'),('CL-PKUNIT-T-326',NULL,'mmol','A unit of amount of substance equal to 0.001 mole.(NCI)','\0','Millimole','CL-PKUNIT','DBX-NCIT-C48513'),('CL-PKUNIT-T-327',NULL,'mmol/h','Millimoles per hour.','\0','','CL-PKUNIT','DBX-NCIT-C85720'),('CL-PKUNIT-T-328',NULL,'mmol/L','A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.(NCI)','\0','Micromole per Milliliter; Millimole per Liter; Mole per Cubic Meter; mcmol/mL; mmol/L; mol/m3; nmol/uL; umol/mL','CL-PKUNIT','DBX-NCIT-C64387'),('CL-PKUNIT-T-329',NULL,'mmol/min','Millimoles per minute.','\0','','CL-PKUNIT','DBX-NCIT-C85722'),('CL-PKUNIT-T-33',NULL,'day*mg/mL/m2','Days times milligrams per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111176'),('CL-PKUNIT-T-330',NULL,'mmol/mL/h','Millimoles per milliliter per hour.','\0','mmol/h/mL; mmol/mL/h; mol/L/h; mol/h/L; umol/h/uL; umol/uL/h','CL-PKUNIT','DBX-NCIT-C85721'),('CL-PKUNIT-T-331',NULL,'mol','A unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, o','\0','Mole','CL-PKUNIT','DBX-NCIT-C42539'),('CL-PKUNIT-T-332',NULL,'mol/day','Moles per day.','\0','mol/d','CL-PKUNIT','DBX-NCIT-C85737'),('CL-PKUNIT-T-333',NULL,'mol/h','Moles per hour.','\0','','CL-PKUNIT','DBX-NCIT-C85738'),('CL-PKUNIT-T-334',NULL,'mol/L','A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI)','\0','Mole per Liter; mmol/mL; mol/L','CL-PKUNIT','DBX-NCIT-C48555'),('CL-PKUNIT-T-335',NULL,'mol/min','Moles per minute.','\0','','CL-PKUNIT','DBX-NCIT-C85739'),('CL-PKUNIT-T-336',NULL,'ng','A unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI)','\0','Nanogram','CL-PKUNIT','DBX-NCIT-C48516'),('CL-PKUNIT-T-337',NULL,'ng/day','Nanograms per day.','\0','ng/d','CL-PKUNIT','DBX-NCIT-C85741'),('CL-PKUNIT-T-338',NULL,'ng/h','Nanograms per hour.','\0','','CL-PKUNIT','DBX-NCIT-C85742'),('CL-PKUNIT-T-339',NULL,'ng/kg/min','Nanograms per kilogram per minute.','\0','ng/kg/min; ng/min/kg; pg/g/min; pg/min/g','CL-PKUNIT','DBX-NCIT-C85743'),('CL-PKUNIT-T-34',NULL,'day*mmol/L','Days times millimoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85587'),('CL-PKUNIT-T-340',NULL,'ng/mg of Creatinine','Nanograms per milligram of creatinine.','\0','ng/mg of Creatinine; ug/g of Creatinine','CL-PKUNIT','DBX-NCIT-C85744'),('CL-PKUNIT-T-341',NULL,'ng/min','Nanograms per minute.','\0','','CL-PKUNIT','DBX-NCIT-C85749'),('CL-PKUNIT-T-342',NULL,'ng/mL','A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass ','\0','Microgram per Liter; Milligram per Cubic Meter; Nanogram per Milliliter; mcg/L; mg/m3; ng/mL; ug/L','CL-PKUNIT','DBX-NCIT-C67306'),('CL-PKUNIT-T-343',NULL,'ng/mL/(mg/kg)','Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105477'),('CL-PKUNIT-T-344',NULL,'ng/mL/(mg/kg/day)','Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105478'),('CL-PKUNIT-T-345',NULL,'ng/mL/h','Nanograms per milliliter per hour.','\0','ng/h/mL; ng/mL/h; ug/L/h','CL-PKUNIT','DBX-NCIT-C67430'),('CL-PKUNIT-T-346',NULL,'ng/mL/kg','Nanograms per milliliter per kilogram.','\0','ng/kg/mL; ng/mL/kg','CL-PKUNIT','DBX-NCIT-C85746'),('CL-PKUNIT-T-347',NULL,'ng/mL/mg','Nanograms per milliliter (concentration), divided by milligrams (dose).','\0','ng/mL/mg; ng/mg/mL','CL-PKUNIT','DBX-NCIT-C85747'),('CL-PKUNIT-T-348',NULL,'nL','A unit of volume equal to one billionth of a liter (10E-9 liter).(NCI)','\0','Nanoliter','CL-PKUNIT','DBX-NCIT-C69188'),('CL-PKUNIT-T-349',NULL,'nmol','A unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI)','\0','Nanomole','CL-PKUNIT','DBX-NCIT-C48517'),('CL-PKUNIT-T-35',NULL,'day*mmol/L/(kg/m2)','Days times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111177'),('CL-PKUNIT-T-350',NULL,'nmol/day','Nanomoles per day.','\0','nmol/d','CL-PKUNIT','DBX-NCIT-C85751'),('CL-PKUNIT-T-351',NULL,'nmol/g','Nanomoles per gram.','\0','nmol/g; pmol/mg; umol/kg','CL-PKUNIT','DBX-NCIT-C85752'),('CL-PKUNIT-T-352',NULL,'nmol/h','Nanomoles per hour.','\0','','CL-PKUNIT','DBX-NCIT-C85753'),('CL-PKUNIT-T-353',NULL,'nmol/kg','Nanomoles per kilogram.','\0','nmol/kg; pmol/g','CL-PKUNIT','DBX-NCIT-C85754'),('CL-PKUNIT-T-354',NULL,'nmol/L','A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.(NCI)','\0','Nanomole per Liter','CL-PKUNIT','DBX-NCIT-C67432'),('CL-PKUNIT-T-355',NULL,'nmol/L/umol','Nanomoles per liter per micromole.','\0','nmol/L/mcmol; nmol/L/umol; nmol/mcmol/L; nmol/umol/L','CL-PKUNIT','DBX-NCIT-C85755'),('CL-PKUNIT-T-356',NULL,'nmol/min','Nanomoles per minute.','\0','','CL-PKUNIT','DBX-NCIT-C85758'),('CL-PKUNIT-T-357',NULL,'nmol/mL/h','Nanomoles per milliliter per hour.','\0','nmol/h/mL; nmol/mL/h; umol/L/h','CL-PKUNIT','DBX-NCIT-C85757'),('CL-PKUNIT-T-358',NULL,'nU/mL','Nanounits per milliliter.','\0','mcU/L; nU/mL; uU/L','CL-PKUNIT','DBX-NCIT-C85760'),('CL-PKUNIT-T-359',NULL,'pg/day','Picograms per day.','\0','pg/d','CL-PKUNIT','DBX-NCIT-C85778'),('CL-PKUNIT-T-36',NULL,'day*mmol/L/(mg/g)','Days times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117900'),('CL-PKUNIT-T-360',NULL,'pg/dL','Picograms per deciliter.','\0','Picogram per Deciliter','CL-PKUNIT','DBX-NCIT-C67331'),('CL-PKUNIT-T-361',NULL,'pg/h','Picograms per hour.','\0','','CL-PKUNIT','DBX-NCIT-C85779'),('CL-PKUNIT-T-362',NULL,'pg/mg','A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)','\0','Microgram per Kilogram; mcg/kg; ng/g; ug/kg','CL-PKUNIT','DBX-NCIT-C67396'),('CL-PKUNIT-T-363',NULL,'pg/mg Creatinine','Picograms per milligram creatinine.','\0','ng/g of Creatinine; pg/mg of Creatinine','CL-PKUNIT','DBX-NCIT-C85780'),('CL-PKUNIT-T-364',NULL,'pg/min','Picograms per minute.','\0','','CL-PKUNIT','DBX-NCIT-C85782'),('CL-PKUNIT-T-365',NULL,'pg/mL','A unit of mass concentration defined as the concentration of one nanogram of a substance per one liter of the mixture, or one picogram of a substance in unit volume of the mixture equal to one milliliter, or one microgram of a substance per one cubic mete','\0','Microgram per Cubic Meter; ng/L; pg/mL; ug/m3','CL-PKUNIT','DBX-NCIT-C67327'),('CL-PKUNIT-T-366',NULL,'pg/mL/(mg/kg)','Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105479'),('CL-PKUNIT-T-367',NULL,'pg/mL/(mg/kg/day)','Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105480'),('CL-PKUNIT-T-368',NULL,'pg/mL/ug','Picograms per milliliter (concentration), divided by micrograms (dose).','\0','pg/mL/mcg; pg/mcg/mL; pg/ug/mL','CL-PKUNIT','DBX-NCIT-C85781'),('CL-PKUNIT-T-369',NULL,'pmol/L','A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.(NCI)','\0','Femtomole per Milliliter; Picomole per Liter; fmol/mL','CL-PKUNIT','DBX-NCIT-C67434'),('CL-PKUNIT-T-37',NULL,'day*mmol/L/(mg/g/day)','Days times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117901'),('CL-PKUNIT-T-370',NULL,'pmol/L/ug','Picomoles per liter (concentration), divided by micrograms (dose).','\0','pmol/L/mcg; pmol/mcg/L; pmol/ug/L','CL-PKUNIT','DBX-NCIT-C85784'),('CL-PKUNIT-T-371',NULL,'RATIO','A unit of measurement for the quotient of the amount of one entity to another.','\0','','CL-PKUNIT','DBX-NCIT-C44256'),('CL-PKUNIT-T-372',NULL,'ug','The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)','\0','Microgram; mcg','CL-PKUNIT','DBX-NCIT-C48152'),('CL-PKUNIT-T-373',NULL,'ug/day','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at ','\0','Microgram per Day; mcg/day','CL-PKUNIT','DBX-NCIT-C71205'),('CL-PKUNIT-T-374',NULL,'ug/h','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)','\0','Micrograms per Hour; mcg/h','CL-PKUNIT','DBX-NCIT-C67394'),('CL-PKUNIT-T-375',NULL,'ug/inh','Micrograms per inhalation.','\0','mcg/inh','CL-PKUNIT','DBX-NCIT-C85703'),('CL-PKUNIT-T-376',NULL,'ug/min','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at whic','\0','Micrograms per Minute; mcg/min','CL-PKUNIT','DBX-NCIT-C71211'),('CL-PKUNIT-T-377',NULL,'ug/mL','A unit of mass concentration equal to the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which','\0','Gram per Cubic Meter; Microgram per Milliliter; Milligram per Liter; g/m3; mcg/mL; mg/L; ng/uL; ug/mL','CL-PKUNIT','DBX-NCIT-C64572'),('CL-PKUNIT-T-378',NULL,'ug/mL/(mg/kg)','Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105473'),('CL-PKUNIT-T-379',NULL,'ug/mL/(mg/kg/day)','Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105474'),('CL-PKUNIT-T-38',NULL,'day*mmol/L/g','Days times millimoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112254'),('CL-PKUNIT-T-380',NULL,'ug/mL/mg','Micrograms per milliliter (concentration), divided by milligrams (dose).','\0','','CL-PKUNIT','DBX-NCIT-C85710'),('CL-PKUNIT-T-381',NULL,'ug/puff','Micrograms per puff.','\0','mcg/puff','CL-PKUNIT','DBX-NCIT-C85704'),('CL-PKUNIT-T-382',NULL,'uIU/mL','Microinternational units per milliliter.','\0','Micro-International Unit per milliliter; mIU/L; mcIU/mL; uIU/mL','CL-PKUNIT','DBX-NCIT-C67405'),('CL-PKUNIT-T-383',NULL,'uL','A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI)','\0','Microliter; mcL; mm3','CL-PKUNIT','DBX-NCIT-C48153'),('CL-PKUNIT-T-384',NULL,'umol','A unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI)','\0','Micromole; mcmol','CL-PKUNIT','DBX-NCIT-C48509'),('CL-PKUNIT-T-385',NULL,'umol/day','A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI)','\0','Micromoles per Day; mcmol/day','CL-PKUNIT','DBX-NCIT-C67406'),('CL-PKUNIT-T-386',NULL,'umol/h','Micromoles per hour.','\0','mcmol/h; umol/h','CL-PKUNIT','DBX-NCIT-C85707'),('CL-PKUNIT-T-387',NULL,'umol/L','A unit of concentration (molarity unit) equal to one micromole of solute per one liter of solution.','\0','','CL-PKUNIT','DBX-NCIT-C85756'),('CL-PKUNIT-T-388',NULL,'umol/min','Micromoles per minute.','\0','mcmol/min; umol/min','CL-PKUNIT','DBX-NCIT-C85708'),('CL-PKUNIT-T-39',NULL,'day*mmol/L/kg','Days times millimoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112255'),('CL-PKUNIT-T-4',NULL,'(L/day)/ug','Liters per day (flow), divided by micrograms (dose).','\0','L/day/mcg; L/day/ug; L/mcg/day; mL/day/ng; mL/ng/day','CL-PKUNIT','DBX-NCIT-C85665'),('CL-PKUNIT-T-40',NULL,'day*mmol/L/m2','Days times millimoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111178'),('CL-PKUNIT-T-41',NULL,'day*mol/L','Days times moles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85589'),('CL-PKUNIT-T-42',NULL,'day*mol/L/(kg/m2)','Days times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111179'),('CL-PKUNIT-T-43',NULL,'day*mol/L/(mg/g)','Days times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117902'),('CL-PKUNIT-T-44',NULL,'day*mol/L/(mg/g/day)','Days times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117903'),('CL-PKUNIT-T-45',NULL,'day*mol/L/g','Days times moles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112256'),('CL-PKUNIT-T-46',NULL,'day*mol/L/kg','Days times moles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112257'),('CL-PKUNIT-T-47',NULL,'day*mol/L/m2','Days times moles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111180'),('CL-PKUNIT-T-48',NULL,'day*ng/mL','Days times nanograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85591'),('CL-PKUNIT-T-49',NULL,'day*ng/mL/(kg/m2)','Days times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111181'),('CL-PKUNIT-T-5',NULL,'(L/h)/g','Liters per hour (flow), divided by grams (weight).','\0','L/g/h; L/h/g; mL/h/mg; mL/mg/h; uL/h/ug; uL/ug/h','CL-PKUNIT','DBX-NCIT-C85658'),('CL-PKUNIT-T-50',NULL,'day*ng/mL/(mg/g)','Days times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117904'),('CL-PKUNIT-T-51',NULL,'day*ng/mL/(mg/g/day)','Days times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117905'),('CL-PKUNIT-T-52',NULL,'day*ng/mL/g','Days times nanograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112258'),('CL-PKUNIT-T-53',NULL,'day*ng/mL/kg','Days times nanograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112259'),('CL-PKUNIT-T-54',NULL,'day*ng/mL/m2','Days times nanograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111182'),('CL-PKUNIT-T-55',NULL,'day*nmol/L','Days times nanomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85594'),('CL-PKUNIT-T-56',NULL,'day*nmol/L/(kg/m2)','Days times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111183'),('CL-PKUNIT-T-57',NULL,'day*nmol/L/(mg/g)','Days times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117906'),('CL-PKUNIT-T-58',NULL,'day*nmol/L/(mg/g/day)','Days times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117907'),('CL-PKUNIT-T-59',NULL,'day*nmol/L/g','Days times nanomoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112260'),('CL-PKUNIT-T-6',NULL,'(L/h)/mg','Liters per hour (flow), divided by milligrams (dose).','\0','L/h/mg; L/mg/h; mL/h/ug; mL/ug/h','CL-PKUNIT','DBX-NCIT-C85673'),('CL-PKUNIT-T-60',NULL,'day*nmol/L/kg','Days times nanomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112261'),('CL-PKUNIT-T-61',NULL,'day*nmol/L/m2','Days times nanomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111184'),('CL-PKUNIT-T-62',NULL,'day*pg/mL','Days times picograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85593'),('CL-PKUNIT-T-63',NULL,'day*pg/mL/(kg/m2)','Days times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111185'),('CL-PKUNIT-T-64',NULL,'day*pg/mL/(mg/g)','Days times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117908'),('CL-PKUNIT-T-65',NULL,'day*pg/mL/(mg/g/day)','Days times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117909'),('CL-PKUNIT-T-66',NULL,'day*pg/mL/g','Days times picograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112262'),('CL-PKUNIT-T-67',NULL,'day*pg/mL/kg','Days times picograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112263'),('CL-PKUNIT-T-68',NULL,'day*pg/mL/m2','Days times picograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111186'),('CL-PKUNIT-T-69',NULL,'day*pmol/L','Days times picomoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C111187'),('CL-PKUNIT-T-7',NULL,'(L/h)/ug','Liters per hour (flow), divided by micrograms (dose).','\0','L/h/mcg; L/h/ug; L/mcg/h; L/ug/h; mL/h/ng; mL/ng/h','CL-PKUNIT','DBX-NCIT-C85662'),('CL-PKUNIT-T-70',NULL,'day*pmol/L/(kg/m2)','Days times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111188'),('CL-PKUNIT-T-71',NULL,'day*pmol/L/(mg/g)','Days times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117910'),('CL-PKUNIT-T-72',NULL,'day*pmol/L/(mg/g/day)','Days times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117911'),('CL-PKUNIT-T-73',NULL,'day*pmol/L/g','Days times picomoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112264'),('CL-PKUNIT-T-74',NULL,'day*pmol/L/kg','Days times picomoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112265'),('CL-PKUNIT-T-75',NULL,'day*pmol/L/m2','Days times picomoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111189'),('CL-PKUNIT-T-76',NULL,'day*ug/mL','Days times micrograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85586'),('CL-PKUNIT-T-77',NULL,'day*ug/mL/(kg/m2)','Days times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111171'),('CL-PKUNIT-T-78',NULL,'day*ug/mL/(mg/g)','Days times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117912'),('CL-PKUNIT-T-79',NULL,'day*ug/mL/(mg/g/day)','Days times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117913'),('CL-PKUNIT-T-8',NULL,'(L/min)/g','Liters per minute (flow), divided by grams (weight).','\0','L/g/min; L/min/g; mL/mg/min; uL/ug/min','CL-PKUNIT','DBX-NCIT-C85659'),('CL-PKUNIT-T-80',NULL,'day*ug/mL/g','Days times micrograms per milliliter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112248'),('CL-PKUNIT-T-81',NULL,'day*ug/mL/kg','Days times micrograms per milliliter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112249'),('CL-PKUNIT-T-82',NULL,'day*ug/mL/m2','Days times micrograms per milliliter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111172'),('CL-PKUNIT-T-83',NULL,'day*umol/L','Days times micromoles per liter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85592'),('CL-PKUNIT-T-84',NULL,'day*umol/L/(kg/m2)','Days times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).','\0','','CL-PKUNIT','DBX-NCIT-C111173'),('CL-PKUNIT-T-85',NULL,'day*umol/L/(mg/g)','Days times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117914'),('CL-PKUNIT-T-86',NULL,'day*umol/L/(mg/g/day)','Days times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C117915'),('CL-PKUNIT-T-87',NULL,'day*umol/L/g','Days times micromoles per liter (area under the curve), divided by grams (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112250'),('CL-PKUNIT-T-88',NULL,'day*umol/L/kg','Days times micromoles per liter (area under the curve), divided by kilograms (weight).','\0','','CL-PKUNIT','DBX-NCIT-C112251'),('CL-PKUNIT-T-89',NULL,'day*umol/L/m2','Days times micromoles per liter (area under the curve), divided by meters squared (surface area).','\0','','CL-PKUNIT','DBX-NCIT-C111174'),('CL-PKUNIT-T-9',NULL,'(L/min)/mg','Liters per minute (flow), divided by milligrams (dose).','\0','L/mg/min; L/min/mg; mL/min/ug; mL/ug/min','CL-PKUNIT','DBX-NCIT-C85674'),('CL-PKUNIT-T-90',NULL,'fg/mL','Femtograms per milliliter.','\0','fg/mL; pg/L','CL-PKUNIT','DBX-NCIT-C85597'),('CL-PKUNIT-T-91',NULL,'g','A metric unit of mass equal to one one thousandth of a kilogram. (NCI)','\0','Gram','CL-PKUNIT','DBX-NCIT-C48155'),('CL-PKUNIT-T-92',NULL,'g/day','A dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours.','\0','Gram per Day; g/24h; g/d; gram/24 Hours; gram/day','CL-PKUNIT','DBX-NCIT-C67372'),('CL-PKUNIT-T-93',NULL,'g/h','Grams per hour.','\0','g/h; gram/h','CL-PKUNIT','DBX-NCIT-C85601'),('CL-PKUNIT-T-94',NULL,'g/min','Grams per minute.','\0','g/min; gram/min','CL-PKUNIT','DBX-NCIT-C85602'),('CL-PKUNIT-T-95',NULL,'g/mL','A unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass eq','\0','Gram per Milliliter; Kilogram per Liter; g/mL; gram/mL; kg/L; mg/uL','CL-PKUNIT','DBX-NCIT-C64566'),('CL-PKUNIT-T-96',NULL,'g/mL/(mg/kg)','Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105462'),('CL-PKUNIT-T-97',NULL,'g/mL/(mg/kg/day)','Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).','\0','','CL-PKUNIT','DBX-NCIT-C105463'),('CL-PKUNIT-T-98',NULL,'h','A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)','\0','Hour; hr','CL-PKUNIT','DBX-NCIT-C25529'),('CL-PKUNIT-T-99',NULL,'h*fg/mL','Hours times femtograms per milliliter (area under the curve).','\0','','CL-PKUNIT','DBX-NCIT-C85611'),('CL-PORTOT-T-1',NULL,'ALL','Being or representing the total number of individual entities.','\0','','CL-PORTOT','DBX-NCIT-C64916'),('CL-PORTOT-T-2',NULL,'ENTIRE','Being or representing the complete extent of a single entity.','\0','Whole','CL-PORTOT','DBX-NCIT-C25326'),('CL-PORTOT-T-3',NULL,'MULTIPLE','More than one. (NCI)','\0','Many; Several','CL-PORTOT','DBX-NCIT-C78728'),('CL-PORTOT-T-4',NULL,'PARTIAL','Being or representing an incomplete extent of a single entity.','\0','','CL-PORTOT','DBX-NCIT-C25378'),('CL-PORTOT-T-5',NULL,'SEGMENT','One of the parts into which something is divided.','\0','','CL-PORTOT','DBX-NCIT-C45312'),('CL-PORTOT-T-6',NULL,'SINGLE','One.','\0','','CL-PORTOT','DBX-NCIT-C48440'),('CL-POSITION-T-1',NULL,'DECUBITUS','Lying down. (NCI)','\0','Recumbent','CL-POSITION','DBX-NCIT-C77532'),('CL-POSITION-T-10',NULL,'SITTING','The state or act of one who sits; the posture of one who occupies a seat. (NCI)','\0','Sitting','CL-POSITION','DBX-NCIT-C62122'),('CL-POSITION-T-11',NULL,'SLING','A position in which the subject\'s body is supported by a sling.','\0','Sling','CL-POSITION','DBX-NCIT-C92604'),('CL-POSITION-T-12',NULL,'STANDING','The act of assuming or maintaining an erect upright position. (NCI)','\0','Standing','CL-POSITION','DBX-NCIT-C62166'),('CL-POSITION-T-13',NULL,'SUPINE','A posterior recumbent body position whereby the person lies on its back and faces upward. (NCI)','\0','Supine','CL-POSITION','DBX-NCIT-C62167'),('CL-POSITION-T-14',NULL,'TRENDELENBURG','A supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI)','\0','Trendelenburg','CL-POSITION','DBX-NCIT-C62168'),('CL-POSITION-T-15',NULL,'UNCONSTRAINED','The ability to move body parts and limbs without physical restriction. (NCI)','\0','Unconstrained','CL-POSITION','DBX-NCIT-C90480'),('CL-POSITION-T-2',NULL,'FOWLERS','A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI)','\0','Fowlers','CL-POSITION','DBX-NCIT-C62173'),('CL-POSITION-T-3',NULL,'LATERAL DECUBITUS','Lying down on one side.','\0','Lateral Decubitus','CL-POSITION','DBX-NCIT-C100758'),('CL-POSITION-T-4',NULL,'LEFT LATERAL DECUBITUS','A recumbent left lateral side position. (NCI)','\0','Left lateral decubitus','CL-POSITION','DBX-NCIT-C62172'),('CL-POSITION-T-5',NULL,'PRONE','An anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI)','\0','Prone','CL-POSITION','DBX-NCIT-C62165'),('CL-POSITION-T-6',NULL,'REVERSE TRENDELENBURG','A supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI)','\0','Reverse Trendelenburg','CL-POSITION','DBX-NCIT-C62169'),('CL-POSITION-T-7',NULL,'RIGHT LATERAL DECUBITUS','A recumbent right lateral side position. (NCI)','\0','Right lateral decubitus','CL-POSITION','DBX-NCIT-C62171'),('CL-POSITION-T-8',NULL,'SEMI-FOWLERS','A semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI)','\0','Semi-Fowlers','CL-POSITION','DBX-NCIT-C62174'),('CL-POSITION-T-9',NULL,'SEMI-RECUMBENT','A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI)','\0','','CL-POSITION','DBX-NCIT-C111310'),('CL-PRITBCON-T-1',NULL,'HIGH-PRIORITY TUBERCULOSIS CONTACT','An individual that has tested positive for pulmonary, laryngeal, or pleural tuberculosis and may or may not present with cavitary disease.','\0','','CL-PRITBCON','DBX-NCIT-C102644'),('CL-PRITBCON-T-2',NULL,'LOW-PRIORITY TUBERCULOSIS CONTACT','An individual that has had limited exposure to an individual with tuberculosis and has a low probability of having had a recent infection.','\0','','CL-PRITBCON','DBX-NCIT-C102662'),('CL-PRITBCON-T-3',NULL,'MEDIUM-PRIORITY TUBERCULOSIS CONTACT','An individual that has tested negative for pulmonary, laryngeal, or pleural tuberculosis but has had a non-cavitary chest x-ray that is consistent with tuberculosis.','\0','','CL-PRITBCON','DBX-NCIT-C102665'),('CL-PROCEDUR-T-1',NULL,'ABLATION','Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C20985'),('CL-PROCEDUR-T-10',NULL,'ATRIAL SEPTAL CLOSURE','Repair of atrial septum.','\0','','CL-PROCEDUR','DBX-NCIT-C99939'),('CL-PROCEDUR-T-11',NULL,'CARDIAC RESYNCHRONIZATION THERAPY','An invasive procedure that includes an electronic device that stimulates both right and left cardiac ventricles to improve coordination of ventricular contraction.','\0','','CL-PROCEDUR','DBX-NCIT-C80436'),('CL-PROCEDUR-T-12',NULL,'CARDIAC STENT PLACEMENT','A procedure performed during a percutaneous coronary intervention in which a device is deployed into the lumen of a coronary artery to expand and support the vessel wall such that the vessel remains patent and blood flow is uninhibited.','\0','','CL-PROCEDUR','DBX-NCIT-C100080'),('CL-PROCEDUR-T-13',NULL,'CARDIAC TRANSPLANT','A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor.','\0','Heart Transplant','CL-PROCEDUR','DBX-NCIT-C15246'),('CL-PROCEDUR-T-14',NULL,'CARDIOVERSION, CHEMICAL','The administration of pharmacologic agents to correct abnormal heart rhythm.','\0','CHEMICAL CARDIOVERSION','CL-PROCEDUR','DBX-NCIT-C99937'),('CL-PROCEDUR-T-15',NULL,'CARDIOVERSION, ELECTRICAL','The administration of electric current to correct abnormal heart rhythm.','\0','ELECTRICAL CARDIOVERSION','CL-PROCEDUR','DBX-NCIT-C99948'),('CL-PROCEDUR-T-16',NULL,'CORONARY ARTERY BYPASS GRAFT','A procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle).','\0','Aortocoronary Bypass; CAB; CABG; Coronary Artery Bypass; Coronary Artery Bypass Graft; Coronary Artery Bypass Graft Surgery; Coronary Artery Bypass Grafting; Heart Bypass','CL-PROCEDUR','DBX-NCIT-C51998'),('CL-PROCEDUR-T-17',NULL,'CRYOABLATION','Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by freezing. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C15215'),('CL-PROCEDUR-T-18',NULL,'CRYOTHERAPY','The therapeutic use of cold or refrigeration.','\0','','CL-PROCEDUR','DBX-NCIT-C40030'),('CL-PROCEDUR-T-19',NULL,'ELECTROCAUTERIZATION','A procedure for destroying tissue using an electrical current.','\0','','CL-PROCEDUR','DBX-NCIT-C111192'),('CL-PROCEDUR-T-2',NULL,'ABLATION, ACCESSORY PATHWAYS','An invasive therapeutic procedure to destroy tissue in an accessory pathways in the atrioventricular conduction system that contributes to arrhythmia.','\0','','CL-PROCEDUR','DBX-NCIT-C99907'),('CL-PROCEDUR-T-20',NULL,'ENDARTERECTOMY','Excision of an atheromatous plaque. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C52002'),('CL-PROCEDUR-T-21',NULL,'EXCISION','The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C15232'),('CL-PROCEDUR-T-22',NULL,'IMMUNOTHERAPY','A therapy designed to induce changes in a patient\'s immune status.','\0','','CL-PROCEDUR','DBX-NCIT-C15262'),('CL-PROCEDUR-T-23',NULL,'IMPLANTABLE CARDIOVERTER DEFIBRILLATOR','A procedure involving an electronic device implanted in the body that delivers electrical stimulation to the heart to treat tachycardia. It may also have the capability to treat bradycardia.','\0','Implantable Cardioverter Defibrillator Procedure','CL-PROCEDUR','DBX-NCIT-C80435'),('CL-PROCEDUR-T-24',NULL,'INFRARED PHOTO COAGULATION','The use of an intense beam of light, such as a laser, to seal off blood vessels or destroy tissue. (NCI)','\0','Infrared Coagulation','CL-PROCEDUR','DBX-NCIT-C62730'),('CL-PROCEDUR-T-25',NULL,'LEAD','A procedure involving one or more wires used for pacemaker or implantable defibrillator devices.','\0','Lead Procedure','CL-PROCEDUR','DBX-NCIT-C99934'),('CL-PROCEDUR-T-26',NULL,'LEFT ATRIAL APPENDAGE OCCLUSION','The therapeutic blockage of the muscular pouch in the left atrium.','\0','','CL-PROCEDUR','DBX-NCIT-C99965'),('CL-PROCEDUR-T-27',NULL,'LEFT VENTRICULAR ASSIST DEVICE','A procedure involving a mechanical cardiac pump which receives blood from the left ventricle and delivers it to the aorta.','\0','LVAD','CL-PROCEDUR','DBX-NCIT-C80473'),('CL-PROCEDUR-T-28',NULL,'LEFT VENTRICULAR SYSTOLIC DYSFUNCTION EVALUATION','An examination and assessment of the inability of the left ventricle to effectively pump blood to the body.','\0','','CL-PROCEDUR','DBX-NCIT-C99975'),('CL-PROCEDUR-T-29',NULL,'MITRAL BALLOON VALVOTOMY','Dilation of the valve between the left atrium and the left ventricle of the heart by inflating a balloon.','\0','','CL-PROCEDUR','DBX-NCIT-C99987'),('CL-PROCEDUR-T-3',NULL,'ABLATION, ATRIAL','An invasive therapeutic procedure to destroy tissue in the cardiac atria that is the source of an arrhythmia.','\0','','CL-PROCEDUR','DBX-NCIT-C80432'),('CL-PROCEDUR-T-30',NULL,'MITRAL COMMISSUROTOMY','Dilation of the valve between the left atrium and the left ventricle of the heart by use of a surgeon\'s finger or rigid instrument.','\0','','CL-PROCEDUR','DBX-NCIT-C99988'),('CL-PROCEDUR-T-31',NULL,'MITRAL VALVE REPAIR','Surgery performed for the purpose of reducing regurgitation of the mitral valve.','\0','','CL-PROCEDUR','DBX-NCIT-C80449'),('CL-PROCEDUR-T-32',NULL,'MITRAL VALVE REPLACEMENT','Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve.','\0','','CL-PROCEDUR','DBX-NCIT-C50825'),('CL-PROCEDUR-T-33',NULL,'NON-CARDIOVASCULAR SURGERY','An operative procedure that does not involve the heart or the blood vessels.','\0','','CL-PROCEDUR','DBX-NCIT-C99995'),('CL-PROCEDUR-T-34',NULL,'PACEMAKER','A procedure involving an electronic device that delivers electrical stimulation to the heart to treat bradycardia.','\0','Pacemaker Procedure','CL-PROCEDUR','DBX-NCIT-C99998'),('CL-PROCEDUR-T-35',NULL,'PERCUTANEOUS CORONARY INTERVENTION','A percutaneous coronary intervention (PCI) is the placement of an angioplasty guide wire, balloon, or other device (e.g. stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or coronary artery bypass graft for the pur','\0','PCI','CL-PROCEDUR','DBX-NCIT-C99521'),('CL-PROCEDUR-T-36',NULL,'PERCUTANEOUS MITRAL REPAIR','Invasive procedure through a puncture in the skin, performed for the purpose of reducing regurgitation of the mitral valve.','\0','','CL-PROCEDUR','DBX-NCIT-C100003'),('CL-PROCEDUR-T-37',NULL,'PERICARDIAL STRIPPING','Removal or resection of the pericardium.','\0','','CL-PROCEDUR','DBX-NCIT-C100004'),('CL-PROCEDUR-T-38',NULL,'PERICARDIAL WINDOW','A procedure in which an opening is made in the pericardium.','\0','','CL-PROCEDUR','DBX-NCIT-C51618'),('CL-PROCEDUR-T-39',NULL,'PERICARDIOCENTESIS','The aspiration of excess fluid between the pericardium and the heart.','\0','','CL-PROCEDUR','DBX-NCIT-C52010'),('CL-PROCEDUR-T-4',NULL,'ABLATION, AV NODE','An invasive therapeutic procedure to destroy tissue in the AV-node that contributes to arrhythmia.','\0','','CL-PROCEDUR','DBX-NCIT-C99908'),('CL-PROCEDUR-T-40',NULL,'PERIPHERAL VASCULAR INTERVENTION','A peripheral vascular intervention is a catheter-based or open surgical procedure designed to improve arterial or venous blood flow or otherwise modify or revise vascular conduits. In general, the intention to perform percutaneous vascular intervention is','\0','PVI','CL-PROCEDUR','DBX-NCIT-C116150'),('CL-PROCEDUR-T-41',NULL,'PULMONARY VALVE REPLACEMENT','Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. pulmonary valve with bioprosthetic, homograft or autograft valve.','\0','','CL-PROCEDUR','DBX-NCIT-C50817'),('CL-PROCEDUR-T-42',NULL,'PULMONIC VALVULOPLASTY','Dilation of the valve between the right ventricle and the pulmonary artery of the heart by inflating a balloon.','\0','','CL-PROCEDUR','DBX-NCIT-C100044'),('CL-PROCEDUR-T-43',NULL,'RIGHT VENTRICULAR ASSIST DEVICE','A procedure involving a mechanical pump which receives blood from the right ventricle and delivers it to the pulmonary artery.','\0','RVAD','CL-PROCEDUR','DBX-NCIT-C100010'),('CL-PROCEDUR-T-44',NULL,'SEPTAL ABLATION','A cardiac catheterization procedure to relieve symptoms in patients with severe obstructive hypertrophic cardiomyopathy. A catheter is used to inject alcohol into a septal artery supplying the heart muscle responsible for the obstruction, destroying the m','\0','','CL-PROCEDUR','DBX-NCIT-C80439'),('CL-PROCEDUR-T-45',NULL,'SURGICAL MAZE','A cardiac procedure intended to inhibit atrial fibrillation, in which a series of incisions are made in the atria to block abnormal electrical circuits that contribute to atrial fibrillation.','\0','Cox Maze','CL-PROCEDUR','DBX-NCIT-C100017'),('CL-PROCEDUR-T-46',NULL,'TRANSCATHETER AORTIC VALVE IMPLANT','Use of a thin tube to deliver an artificial valve apparatus between the left ventricle of the heart and the aorta.','\0','','CL-PROCEDUR','DBX-NCIT-C100022'),('CL-PROCEDUR-T-47',NULL,'TRICUSPID VALVE REPAIR','Surgery performed for the purpose of reducing regurgitation of the cardiac valve between the right atrium and right ventricle.','\0','','CL-PROCEDUR','DBX-NCIT-C99935'),('CL-PROCEDUR-T-48',NULL,'TRICUSPID VALVE REPLACEMENT','Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve.','\0','','CL-PROCEDUR','DBX-NCIT-C50816'),('CL-PROCEDUR-T-49',NULL,'VENTRICULAR ANEURYSM RESECTION','Cardiac surgical procedure performed for the removal of an aneurysm from the ventricular wall.','\0','','CL-PROCEDUR','DBX-NCIT-C80451'),('CL-PROCEDUR-T-5',NULL,'ABLATION, CHEMICAL','Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by chemical means. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C111157'),('CL-PROCEDUR-T-50',NULL,'VENTRICULAR SEPTAL CLOSURE','Repair of ventricular septum.','\0','','CL-PROCEDUR','DBX-NCIT-C99940'),('CL-PROCEDUR-T-6',NULL,'ABLATION, LASER','Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI)','\0','','CL-PROCEDUR','DBX-NCIT-C111241'),('CL-PROCEDUR-T-7',NULL,'ABLATION, VENTRICULAR','An invasive therapeutic procedure to destroy tissue in the cardiac ventricles that is the source of an arrhythmia.','\0','','CL-PROCEDUR','DBX-NCIT-C80433'),('CL-PROCEDUR-T-8',NULL,'AORTIC BALLOON VALVOTOMY','Dilation of the valve between the left ventricle of the heart and the aorta by inflating a balloon.','\0','','CL-PROCEDUR','DBX-NCIT-C99916'),('CL-PROCEDUR-T-9',NULL,'AORTIC VALVE REPLACEMENT','Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve.','\0','','CL-PROCEDUR','DBX-NCIT-C50815'),('CL-PROTMLST-T-1',NULL,'INFORMED CONSENT OBTAINED','Consent by a patient for participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.','\0','','CL-PROTMLST','DBX-NCIT-C16735'),('CL-PROTMLST-T-2',NULL,'RANDOMIZED','Participants are assigned to arms of a clinical trial by chance.','\0','','CL-PROTMLST','DBX-NCIT-C114209'),('CL-PRURGNCY-T-1',NULL,'ELECTIVE','Elective procedures can be deferred without increased risk of compromised outcome. Patient\'s clinical condition is currently stable and has been stable in the days/weeks prior. The clinical situation does not demand that the procedure take place at a spec','\0','','CL-PRURGNCY','DBX-NCIT-C51996'),('CL-PRURGNCY-T-2',NULL,'EMERGENCY','Emergency procedures must be performed as soon as possible because of substantial concerns that delay could lead to death. Clinical situation demands that procedure should be performed immediately or in next available room, even if it means another case m','\0','','CL-PRURGNCY','DBX-NCIT-C62648'),('CL-PRURGNCY-T-3',NULL,'SALVAGE','Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory','\0','','CL-PRURGNCY','DBX-NCIT-C15359'),('CL-PRURGNCY-T-4',NULL,'URGENT','Deferring an urgent procedure increases risk of adverse outcome or clinical deterioration. Clinical situation warrants performing urgent procedures during the current episode of care to avoid compromising patient safety.','\0','','CL-PRURGNCY','DBX-NCIT-C100031'),('CL-RACE-T-1',NULL,'AMERICAN INDIAN OR ALASKA NATIVE','A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA)','\0','','CL-RACE','DBX-NCIT-C41259'),('CL-RACE-T-2',NULL,'ASIAN','A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA)','\0','','CL-RACE','DBX-NCIT-C41260'),('CL-RACE-T-3',NULL,'BLACK OR AFRICAN AMERICAN','A person having origins in any of the black racial groups of Africa. Terms such as \"Haitian\" or \"Negro\" can be used in addition to \"Black or African American.\" (FDA)','\0','','CL-RACE','DBX-NCIT-C16352'),('CL-RACE-T-4',NULL,'NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER','Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu','\0','','CL-RACE','DBX-NCIT-C41219'),('CL-RACE-T-5',NULL,'WHITE','Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA)','\0','','CL-RACE','DBX-NCIT-C41261'),('CL-REASTINT-T-1',NULL,'FORGOT TO TAKE MEDICATION DOSE','A patient\'s failure to remember to take a dose of medication.','\0','','CL-REASTINT','DBX-NCIT-C102638'),('CL-REASTINT-T-2',NULL,'INTOLERANCE','An inability to absorb or metabolize certain substances in the normal way.','\0','','CL-REASTINT','DBX-NCIT-C71437'),('CL-REASTINT-T-3',NULL,'MEDICATION MISPLACED','Medications that were lost because they were put in the wrong place.','\0','','CL-REASTINT','DBX-NCIT-C102664'),('CL-REASTINT-T-4',NULL,'PATIENT NONCOMPLIANCE','Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.','\0','','CL-REASTINT','DBX-NCIT-C91752'),('CL-REASTINT-T-5',NULL,'TREATMENT FAILURE','The lack of expected or desired effect related to a therapy. (NCI)','\0','','CL-REASTINT','DBX-NCIT-C48226'),('CL-REASTINT-T-6',NULL,'VACATION','Leisure time away from work devoted to rest or pleasure.','\0','','CL-REASTINT','DBX-NCIT-C80227'),('CL-REASTRT-T-1',NULL,'FAILURE AFTER FIRST TREATMENT','A lack of response to the first cycle of therapy.','\0','','CL-REASTRT','DBX-NCIT-C102635'),('CL-REASTRT-T-2',NULL,'FAILURE AFTER MULTIPLE TREATMENTS','A lack of response to more than one cycle of therapy.','\0','','CL-REASTRT','DBX-NCIT-C102636'),('CL-REASTRT-T-3',NULL,'PREVIOUS PATIENT NONCOMPLIANCE','A previous episode of failure by a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.','\0','','CL-REASTRT','DBX-NCIT-C102698'),('CL-REASTRT-T-4',NULL,'RECURRENT DISEASE','The return of a disease after a period of remission.','\0','Recurrent Disease','CL-REASTRT','DBX-NCIT-C38155'),('CL-REASTRTF-T-1',NULL,'ANTIBIOTIC RESISTANCE','The mechanisms, functions, activities, or processes exhibited by microorganisms, especially bacteria, to resist or to become tolerant to antibiotics.','\0','','CL-REASTRTF','DBX-NCIT-C17449'),('CL-REASTRTF-T-2',NULL,'DRUG INTERRUPTED','An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)','\0','','CL-REASTRTF','DBX-NCIT-C49501'),('CL-REASTRTF-T-3',NULL,'PATIENT NONCOMPLIANCE','Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.','\0','','CL-REASTRTF','DBX-NCIT-C91752'),('CL-REASTRTF-T-4',NULL,'SUB-THERAPEUTIC DRUG LEVEL','A drug serum concentration below therapeutic levels.','\0','','CL-REASTRTF','DBX-NCIT-C102715'),('CL-RELSUB-T-1',NULL,'AUNT, BIOLOGICAL','A female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)','\0','Biological Aunt','CL-RELSUB','DBX-NCIT-C96569'),('CL-RELSUB-T-10',NULL,'CHILD, BIOLOGICAL','A son or daughter with genetic makeup inherited from the parent.','\0','Biological Child','CL-RELSUB','DBX-NCIT-C100807'),('CL-RELSUB-T-11',NULL,'CLINICIAN','An individual, such as a physician, nurse practitioner or other health care professional, who takes responsibility for a subject\'s care.','\0','Clinician','CL-RELSUB','DBX-NCIT-C85499'),('CL-RELSUB-T-12',NULL,'COUSIN, BIOLOGICAL','A relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor. (NCI)','\0','Biological Cousin','CL-RELSUB','DBX-NCIT-C96571'),('CL-RELSUB-T-13',NULL,'COUSIN, BIOLOGICAL MATERNAL','A relative who is the offspring of a sibling of the biological mother and share a common ancestor.','\0','Biological Maternal Cousin','CL-RELSUB','DBX-NCIT-C96576'),('CL-RELSUB-T-14',NULL,'COUSIN, BIOLOGICAL PATERNAL','A relative who is the offspring of a sibling of the biological father and share a common ancestor.','\0','Biological Paternal Cousin','CL-RELSUB','DBX-NCIT-C96582'),('CL-RELSUB-T-15',NULL,'DOMESTIC PARTNER','Person declares that a domestic partnership relationship exists. (HL7)','\0','Domestic Partner','CL-RELSUB','DBX-NCIT-C53262'),('CL-RELSUB-T-16',NULL,'DONOR','One that contributes something. (NCI)','\0','Donor','CL-RELSUB','DBX-NCIT-C48284'),('CL-RELSUB-T-17',NULL,'DONOR, ORGAN','Someone from whom an organ is removed for transplantation or other purpose.','\0','Organ Donor','CL-RELSUB','DBX-NCIT-C100810'),('CL-RELSUB-T-18',NULL,'DONOR, TISSUE','Someone from whom tissue is removed for transplantation or other purpose.','\0','Tissue Donor','CL-RELSUB','DBX-NCIT-C25168'),('CL-RELSUB-T-19',NULL,'FAMILY MEMBER','Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie.','\0','Family Member','CL-RELSUB','DBX-NCIT-C41256'),('CL-RELSUB-T-2',NULL,'AUNT, BIOLOGICAL MATERNAL','A female relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI)','\0','Biological Maternal Aunt','CL-RELSUB','DBX-NCIT-C96575'),('CL-RELSUB-T-20',NULL,'FATHER, BIOLOGICAL','A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm. (NCI)','\0','Biological Father','CL-RELSUB','DBX-NCIT-C96572'),('CL-RELSUB-T-21',NULL,'GRANDCHILD, BIOLOGICAL','A biological child of an individual\'s biological child.','\0','Biological Grandchild','CL-RELSUB','DBX-NCIT-C100805'),('CL-RELSUB-T-22',NULL,'GRANDFATHER, BIOLOGICAL','A male relative who is the biological father of either the biological mother or the biological father. (NCI)','\0','Biological Grandfather','CL-RELSUB','DBX-NCIT-C96573'),('CL-RELSUB-T-23',NULL,'GRANDFATHER, BIOLOGICAL MATERNAL','A male relative who is the biological father of the biological mother. (NCI)','\0','Biological Maternal Grandfather','CL-RELSUB','DBX-NCIT-C96577'),('CL-RELSUB-T-24',NULL,'GRANDFATHER, BIOLOGICAL PATERNAL','A male relative who is the biological father of the biological father. (NCI)','\0','Biological Paternal Grandfather','CL-RELSUB','DBX-NCIT-C96583'),('CL-RELSUB-T-25',NULL,'GRANDMOTHER, BIOLOGICAL','A female relative who is the biological mother of either the biological mother or the biological father. (NCI)','\0','Biological Grandmother','CL-RELSUB','DBX-NCIT-C96574'),('CL-RELSUB-T-26',NULL,'GRANDMOTHER, BIOLOGICAL MATERNAL','A female relative who is the biological mother of the biological mother. (NCI)','\0','Biological Maternal Grandmother','CL-RELSUB','DBX-NCIT-C96578'),('CL-RELSUB-T-27',NULL,'GRANDMOTHER, BIOLOGICAL PATERNAL','A female relative who is the biological mother of the biological father. (NCI)','\0','Biological Paternal Grandmother','CL-RELSUB','DBX-NCIT-C96584'),('CL-RELSUB-T-28',NULL,'GRANDPARENT, BIOLOGICAL','A biological parent of the biological father or biological mother.','\0','Biological Grandparent','CL-RELSUB','DBX-NCIT-C100806'),('CL-RELSUB-T-29',NULL,'GRANDPARENT, BIOLOGICAL MATERNAL','A relative who is the biological parent of the biological mother.','\0','','CL-RELSUB','DBX-NCIT-C111248'),('CL-RELSUB-T-3',NULL,'AUNT, BIOLOGICAL PATERNAL','A female relative who is a sibling of the biological father, and who both share a common ancestor. (NCI)','\0','Biological Paternal Aunt','CL-RELSUB','DBX-NCIT-C96581'),('CL-RELSUB-T-30',NULL,'GRANDPARENT, BIOLOGICAL PATERNAL','A relative who is the biological parent of the biological father.','\0','','CL-RELSUB','DBX-NCIT-C111286'),('CL-RELSUB-T-31',NULL,'MOTHER, BIOLOGICAL','A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum. (NCI)','\0','Biological Mother','CL-RELSUB','DBX-NCIT-C96580'),('CL-RELSUB-T-32',NULL,'NURSE','A professional healthcare provider who has graduated from a nursing program.','\0','Nurse','CL-RELSUB','DBX-NCIT-C20821'),('CL-RELSUB-T-33',NULL,'PREGNANCY PARTNER','An individual who provides support to a pregnant individual.','\0','Pregnancy Partner','CL-RELSUB','DBX-NCIT-C100811'),('CL-RELSUB-T-34',NULL,'RELATIVE, FIRST DEGREE','Any individual related biologically or legally to another individual and considered immediate family as in the case of a spouse, parent, sibling or child.','\0','First Degree Relative','CL-RELSUB','DBX-NCIT-C21481'),('CL-RELSUB-T-35',NULL,'RELATIVE, SECOND DEGREE','Any individual related biologically or legally to another individual and considered one degree removed from the immediate family as in the case of in-laws, grandparents, aunts and uncles.','\0','Second Degree Relative','CL-RELSUB','DBX-NCIT-C19811'),('CL-RELSUB-T-36',NULL,'RELATIVE, THIRD DEGREE','Any individual related biologically or legally to another individual and considered two degrees removed from the immediate family as in the case of cousins.','\0','Third Degree Relative','CL-RELSUB','DBX-NCIT-C100808'),('CL-RELSUB-T-37',NULL,'SEXUAL PARTNER','A person with whom one has had sexual relations.','\0','Sexual Partner','CL-RELSUB','DBX-NCIT-C100812'),('CL-RELSUB-T-38',NULL,'SIBLING, BIOLOGICAL','A person\'s brother or sister with whom they share a genetic makeup inherited from their shared biological parents.','\0','Biological Sibling','CL-RELSUB','DBX-NCIT-C100809'),('CL-RELSUB-T-39',NULL,'SIBLING, FULL','A person\'s brother or sister with whom they share a genetic makeup inherited from both of their shared biological parents.','\0','','CL-RELSUB','DBX-NCIT-C71390'),('CL-RELSUB-T-4',NULL,'BROTHER, BIOLOGICAL','A male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents.','\0','Biological Brother','CL-RELSUB','DBX-NCIT-C96570'),('CL-RELSUB-T-40',NULL,'SIBLING, HALF','A person\'s brother or sister with whom they share a genetic makeup inherited from one of their shared biological parents.','\0','','CL-RELSUB','DBX-NCIT-C71391'),('CL-RELSUB-T-41',NULL,'SISTER, BIOLOGICAL','A female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents.','\0','Biological Sister','CL-RELSUB','DBX-NCIT-C96586'),('CL-RELSUB-T-42',NULL,'SISTER, BIOLOGICAL MATERNAL HALF','A female who shares with her sibling the genetic makeup inherited from only the biological mother.','\0','Half-sister with Mother as Common Parent','CL-RELSUB','DBX-NCIT-C96658'),('CL-RELSUB-T-43',NULL,'SISTER, BIOLOGICAL PATERNAL HALF','A female who shares with her sibling the genetic makeup inherited from only the biological father.','\0','Half-sister with Father as Common Parent','CL-RELSUB','DBX-NCIT-C96657'),('CL-RELSUB-T-44',NULL,'SISTER, FULL','A female who shares with her sibling the genetic makeup inherited from both of the biological parents.','\0','','CL-RELSUB','DBX-NCIT-C111202'),('CL-RELSUB-T-45',NULL,'SISTER, HALF','A female who shares with her sibling the genetic makeup inherited from only one of the biological parents.','\0','Half Sister','CL-RELSUB','DBX-NCIT-C71403'),('CL-RELSUB-T-46',NULL,'SPOUSE','A person\'s partner in marriage. (NCI)','\0','Spouse','CL-RELSUB','DBX-NCIT-C62649'),('CL-RELSUB-T-47',NULL,'TECHNICIAN','A person skilled in the performance of the technical or procedural aspects of a profession. (NCI)','\0','Technician','CL-RELSUB','DBX-NCIT-C63861'),('CL-RELSUB-T-48',NULL,'TWIN','Either of two offspring born from the same pregnancy. (NCI)','\0','Twin','CL-RELSUB','DBX-NCIT-C73427'),('CL-RELSUB-T-49',NULL,'TWIN, DIZYGOTIC','Either of the two offspring resulting from two separately fertilized ovums during the same pregnancy.','\0','Dizygotic Twin','CL-RELSUB','DBX-NCIT-C73428'),('CL-RELSUB-T-5',NULL,'BROTHER, BIOLOGICAL MATERNAL HALF','A male who shares with his sibling the genetic makeup inherited from only the biological mother.','\0','Half-brother with Mother as Common Parent','CL-RELSUB','DBX-NCIT-C96656'),('CL-RELSUB-T-50',NULL,'TWIN, MONOZYGOTIC','Either of the two offspring resulting from a shared ovum. (NCI)','\0','Monozygotic Twin','CL-RELSUB','DBX-NCIT-C73429'),('CL-RELSUB-T-51',NULL,'UNCLE, BIOLOGICAL','A male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)','\0','Biological Uncle','CL-RELSUB','DBX-NCIT-C96587'),('CL-RELSUB-T-52',NULL,'UNCLE, BIOLOGICAL MATERNAL','A male relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI)','\0','Biological Maternal Uncle','CL-RELSUB','DBX-NCIT-C96579'),('CL-RELSUB-T-53',NULL,'UNCLE, BIOLOGICAL PATERNAL','A male relative who is a sibling of the biological father, and who both share a common ancestor. (NCI)','\0','Biological Paternal Uncle','CL-RELSUB','DBX-NCIT-C96585'),('CL-RELSUB-T-6',NULL,'BROTHER, BIOLOGICAL PATERNAL HALF','A male who shares with his sibling the genetic makeup inherited from only the biological father.','\0','Half-brother with Father as Common Parent','CL-RELSUB','DBX-NCIT-C96655'),('CL-RELSUB-T-7',NULL,'BROTHER, FULL','A male who shares with his sibling the genetic makeup inherited from both of the biological parents.','\0','','CL-RELSUB','DBX-NCIT-C111201'),('CL-RELSUB-T-8',NULL,'BROTHER, HALF','A male who shares with his sibling the genetic makeup inherited from only one of the biological parents.','\0','Half Brother','CL-RELSUB','DBX-NCIT-C71402'),('CL-RELSUB-T-9',NULL,'CAREGIVER','The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI)','\0','Caregiver','CL-RELSUB','DBX-NCIT-C17445'),('CL-RELTYPE-T-1',NULL,'MANY','More than one. (NCI)','\0','Many; Several','CL-RELTYPE','DBX-NCIT-C78728'),('CL-RELTYPE-T-2',NULL,'ONE','A textual representation of the numeral 1.','\0','','CL-RELTYPE','DBX-NCIT-C66832'),('CL-RETEST-T-1',NULL,'Expiratory Reserve Volume','The maximum volume of air a subject can exhale from the lungs after a tidal exhalation.','\0','Expiratory Reserve Volume','CL-RETEST','DBX-NCIT-C111200'),('CL-RETEST-T-10',NULL,'Inspiratory Reserve Volume','The maximum volume of air a subject can inhale into the lungs after a tidal inhalation.','\0','Inspiratory Reserve Volume','CL-RETEST','DBX-NCIT-C111237'),('CL-RETEST-T-11',NULL,'Maximum Forced Inspiratory Flow','Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled.','\0','Maximum Forced Inspiratory Flow','CL-RETEST','DBX-NCIT-C112333'),('CL-RETEST-T-12',NULL,'Peak Expiratory Flow','The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation.','\0','Peak Expiratory Flow','CL-RETEST','DBX-NCIT-C41372'),('CL-RETEST-T-13',NULL,'PEF Reversibility','The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value.','\0','PEF Reversibility','CL-RETEST','DBX-NCIT-C112368'),('CL-RETEST-T-14',NULL,'Percent Predicted ERV','The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value.','\0','Percent Predicted ERV','CL-RETEST','DBX-NCIT-C112375'),('CL-RETEST-T-15',NULL,'Percent Predicted FEV1','Forced expiratory volume in one second as a proportion of the predicted normal value.','\0','Percent Predicted FEV1','CL-RETEST','DBX-NCIT-C112376'),('CL-RETEST-T-16',NULL,'Percent Predicted FEV1/FVC','The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value.','\0','Percent Predicted FEV1/FVC','CL-RETEST','DBX-NCIT-C112377'),('CL-RETEST-T-17',NULL,'Percent Predicted FEV6','Forced expiratory volume in six seconds as a proportion of the predicted normal value.','\0','Percent Predicted FEV6','CL-RETEST','DBX-NCIT-C112378'),('CL-RETEST-T-18',NULL,'Percent Predicted FIFmax','Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value.','\0','Percent Predicted FIFmax','CL-RETEST','DBX-NCIT-C112379'),('CL-RETEST-T-19',NULL,'Percent Predicted FIV1','The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value.','\0','Percent Predicted FIV1','CL-RETEST','DBX-NCIT-C112380'),('CL-RETEST-T-2',NULL,'FEV1 Reversibility','The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value.','\0','FEV1 Reversibility','CL-RETEST','DBX-NCIT-C112285'),('CL-RETEST-T-20',NULL,'Percent Predicted Forced Vital Capacity','Forced vital capacity as a proportion of the predicted normal value.','\0','Percent Predicted Forced Vital Capacity','CL-RETEST','DBX-NCIT-C112381'),('CL-RETEST-T-21',NULL,'Percent Predicted Inspiratory Capacity','The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value.','\0','Percent Predicted Inspiratory Capacity','CL-RETEST','DBX-NCIT-C112382'),('CL-RETEST-T-22',NULL,'Percent Predicted IRV','The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value.','\0','Percent Predicted IRV','CL-RETEST','DBX-NCIT-C112383'),('CL-RETEST-T-23',NULL,'Percent Predicted Peak Expiratory Flow','The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Peak Expiratory Flow','CL-RETEST','DBX-NCIT-C112384'),('CL-RETEST-T-24',NULL,'Percent Predicted Residual Volume','The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value.','\0','Percent Predicted Residual Volume','CL-RETEST','DBX-NCIT-C112385'),('CL-RETEST-T-25',NULL,'Percent Predicted Slow Vital Capacity','The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Slow Vital Capacity','CL-RETEST','DBX-NCIT-C112386'),('CL-RETEST-T-26',NULL,'Percent Predicted Tidal Volume','The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value.','\0','Percent Predicted Tidal Volume','CL-RETEST','DBX-NCIT-C112387'),('CL-RETEST-T-27',NULL,'Percent Predicted Total Lung Capacity','The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Total Lung Capacity','CL-RETEST','DBX-NCIT-C112388'),('CL-RETEST-T-28',NULL,'Residual Volume','The volume of air remaining in the lungs after maximum exhalation.','\0','Residual Volume','CL-RETEST','DBX-NCIT-C89836'),('CL-RETEST-T-29',NULL,'Slow Vital Capacity','The maximum volume of air that can be exhaled after slow maximum inhalation.','\0','Slow Vital Capacity','CL-RETEST','DBX-NCIT-C111315'),('CL-RETEST-T-3',NULL,'FEV1/FVC','The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation.','\0','FEV1/FVC','CL-RETEST','DBX-NCIT-C111359'),('CL-RETEST-T-30',NULL,'Tidal Volume','The volume of air moved into and out of the lungs during breathing at rest.','\0','Tidal Volume','CL-RETEST','DBX-NCIT-C111324'),('CL-RETEST-T-31',NULL,'Total Lung Capacity','The total volume of air in the lungs after maximum inhalation.','\0','Total Lung Capacity','CL-RETEST','DBX-NCIT-C111325'),('CL-RETEST-T-4',NULL,'Forced Expiratory Volume in 1 Second','The volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation.','\0','Forced Expiratory Volume in 1 Second','CL-RETEST','DBX-NCIT-C38084'),('CL-RETEST-T-5',NULL,'Forced Expiratory Volume in 6 Seconds','The volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation.','\0','Forced Expiratory Volume in 6 Seconds','CL-RETEST','DBX-NCIT-C47843'),('CL-RETEST-T-6',NULL,'Forced Inspiratory Volume in 1 Second','The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation.','\0','Forced Inspiratory Volume in 1 Second','CL-RETEST','DBX-NCIT-C111360'),('CL-RETEST-T-7',NULL,'Forced Vital Capacity','The maximum volume of air that can be exhaled after forced maximum inhalation.','\0','Forced Vital Capacity','CL-RETEST','DBX-NCIT-C111361'),('CL-RETEST-T-8',NULL,'IC Reversibility','The change in IC following administration of a bronchodilator relative to the pre-treatment IC value.','\0','IC Reversibility','CL-RETEST','DBX-NCIT-C112321'),('CL-RETEST-T-9',NULL,'Inspiratory Capacity','The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV).','\0','Inspiratory Capacity','CL-RETEST','DBX-NCIT-C111362'),('CL-RETESTCD-T-1',NULL,'ERV','The maximum volume of air a subject can exhale from the lungs after a tidal exhalation.','\0','Expiratory Reserve Volume','CL-RETESTCD','DBX-NCIT-C111200'),('CL-RETESTCD-T-10',NULL,'FIFMAX','Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled.','\0','Maximum Forced Inspiratory Flow','CL-RETESTCD','DBX-NCIT-C112333'),('CL-RETESTCD-T-11',NULL,'FIFMAXPP','Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value.','\0','Percent Predicted FIFmax','CL-RETESTCD','DBX-NCIT-C112379'),('CL-RETESTCD-T-12',NULL,'FIV1','The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation.','\0','Forced Inspiratory Volume in 1 Second','CL-RETESTCD','DBX-NCIT-C111360'),('CL-RETESTCD-T-13',NULL,'FIV1PP','The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value.','\0','Percent Predicted FIV1','CL-RETESTCD','DBX-NCIT-C112380'),('CL-RETESTCD-T-14',NULL,'FVC','The maximum volume of air that can be exhaled after forced maximum inhalation.','\0','Forced Vital Capacity','CL-RETESTCD','DBX-NCIT-C111361'),('CL-RETESTCD-T-15',NULL,'FVCPP','Forced vital capacity as a proportion of the predicted normal value.','\0','Percent Predicted Forced Vital Capacity','CL-RETESTCD','DBX-NCIT-C112381'),('CL-RETESTCD-T-16',NULL,'IC','The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV).','\0','Inspiratory Capacity','CL-RETESTCD','DBX-NCIT-C111362'),('CL-RETESTCD-T-17',NULL,'ICPP','The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value.','\0','Percent Predicted Inspiratory Capacity','CL-RETESTCD','DBX-NCIT-C112382'),('CL-RETESTCD-T-18',NULL,'ICREV','The change in IC following administration of a bronchodilator relative to the pre-treatment IC value.','\0','IC Reversibility','CL-RETESTCD','DBX-NCIT-C112321'),('CL-RETESTCD-T-19',NULL,'IRV','The maximum volume of air a subject can inhale into the lungs after a tidal inhalation.','\0','Inspiratory Reserve Volume','CL-RETESTCD','DBX-NCIT-C111237'),('CL-RETESTCD-T-2',NULL,'ERVPP','The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value.','\0','Percent Predicted ERV','CL-RETESTCD','DBX-NCIT-C112375'),('CL-RETESTCD-T-20',NULL,'IRVPP','The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value.','\0','Percent Predicted IRV','CL-RETESTCD','DBX-NCIT-C112383'),('CL-RETESTCD-T-21',NULL,'PEF','The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation.','\0','Peak Expiratory Flow','CL-RETESTCD','DBX-NCIT-C41372'),('CL-RETESTCD-T-22',NULL,'PEFPP','The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Peak Expiratory Flow','CL-RETESTCD','DBX-NCIT-C112384'),('CL-RETESTCD-T-23',NULL,'PEFREV','The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value.','\0','PEF Reversibility','CL-RETESTCD','DBX-NCIT-C112368'),('CL-RETESTCD-T-24',NULL,'RV','The volume of air remaining in the lungs after maximum exhalation.','\0','Residual Volume','CL-RETESTCD','DBX-NCIT-C89836'),('CL-RETESTCD-T-25',NULL,'RVPP','The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value.','\0','Percent Predicted Residual Volume','CL-RETESTCD','DBX-NCIT-C112385'),('CL-RETESTCD-T-26',NULL,'SVC','The maximum volume of air that can be exhaled after slow maximum inhalation.','\0','Slow Vital Capacity','CL-RETESTCD','DBX-NCIT-C111315'),('CL-RETESTCD-T-27',NULL,'SVCPP','The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Slow Vital Capacity','CL-RETESTCD','DBX-NCIT-C112386'),('CL-RETESTCD-T-28',NULL,'TLC','The total volume of air in the lungs after maximum inhalation.','\0','Total Lung Capacity','CL-RETESTCD','DBX-NCIT-C111325'),('CL-RETESTCD-T-29',NULL,'TLCPP','The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value.','\0','Percent Predicted Total Lung Capacity','CL-RETESTCD','DBX-NCIT-C112388'),('CL-RETESTCD-T-3',NULL,'FEV1','The volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation.','\0','Forced Expiratory Volume in 1 Second','CL-RETESTCD','DBX-NCIT-C38084'),('CL-RETESTCD-T-30',NULL,'TV','The volume of air moved into and out of the lungs during breathing at rest.','\0','Tidal Volume','CL-RETESTCD','DBX-NCIT-C111324'),('CL-RETESTCD-T-31',NULL,'TVPP','The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value.','\0','Percent Predicted Tidal Volume','CL-RETESTCD','DBX-NCIT-C112387'),('CL-RETESTCD-T-4',NULL,'FEV1FVC','The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation.','\0','FEV1/FVC','CL-RETESTCD','DBX-NCIT-C111359'),('CL-RETESTCD-T-5',NULL,'FEV1FVCP','The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value.','\0','Percent Predicted FEV1/FVC','CL-RETESTCD','DBX-NCIT-C112377'),('CL-RETESTCD-T-6',NULL,'FEV1PP','Forced expiratory volume in one second as a proportion of the predicted normal value.','\0','Percent Predicted FEV1','CL-RETESTCD','DBX-NCIT-C112376'),('CL-RETESTCD-T-7',NULL,'FEV1REV','The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value.','\0','FEV1 Reversibility','CL-RETESTCD','DBX-NCIT-C112285'),('CL-RETESTCD-T-8',NULL,'FEV6','The volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation.','\0','Forced Expiratory Volume in 6 Seconds','CL-RETESTCD','DBX-NCIT-C47843'),('CL-RETESTCD-T-9',NULL,'FEV6PP','Forced expiratory volume in six seconds as a proportion of the predicted normal value.','\0','Percent Predicted FEV6','CL-RETESTCD','DBX-NCIT-C112378'),('CL-RISKSOC-T-1',NULL,'CONTACT WITH TUBERCULOSIS SOURCE','An individual that came into contact with a source of Tuberculosis.','\0','','CL-RISKSOC','DBX-NCIT-C102714'),('CL-RISKSOC-T-10',NULL,'MIGRATORY WORKER','An individual who moves from one location to another location within or outside of their homeland for work.','\0','','CL-RISKSOC','DBX-NCIT-C102670'),('CL-RISKSOC-T-11',NULL,'REFUGEE FROM HIGH TUBERCULOSIS PREVALENT AREA','An individual that has fled a country for their own safety which has a high occurrence of tuberculosis.','\0','','CL-RISKSOC','DBX-NCIT-C102705'),('CL-RISKSOC-T-12',NULL,'TRAVEL TO HIGH BURDEN COUNTRY','Entry into one or more of the 22 countries that have a relatively high prevalence of tuberculosis cases.','\0','','CL-RISKSOC','DBX-NCIT-C102719'),('CL-RISKSOC-T-13',NULL,'UNEMPLOYMENT','The state of not having a job.','\0','','CL-RISKSOC','DBX-NCIT-C75563'),('CL-RISKSOC-T-2',NULL,'CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN HOMELESS SHELTER','An individual who is presently or not long ago worked or offered to assist without pay at a temporary housing facility for persons without a stable or permanent residence.','\0','','CL-RISKSOC','DBX-NCIT-C102613'),('CL-RISKSOC-T-3',NULL,'CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN JAIL OR PRISON','An individual who is presently or not long ago worked or offered to assist without pay at an institution where persons are confined for punishment and to protect the public.','\0','','CL-RISKSOC','DBX-NCIT-C102614'),('CL-RISKSOC-T-4',NULL,'CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN NURSING HOME','An individual who is presently or not long ago worked or offered to assist without pay at a residential health care facility for persons with chronic illness or disability.','\0','','CL-RISKSOC','DBX-NCIT-C102615'),('CL-RISKSOC-T-5',NULL,'HOMELESS DURING PAST YEAR','An individual without a stable or permanent residence within the last 365 days.','\0','','CL-RISKSOC','DBX-NCIT-C102645'),('CL-RISKSOC-T-6',NULL,'IMMIGRANT FROM HIGH TUBERCULOSIS PREVALENT AREA','An individual that has migrated from a country with a high occurrence of tuberculosis.','\0','','CL-RISKSOC','DBX-NCIT-C102648'),('CL-RISKSOC-T-7',NULL,'INCARCERATION','The state of being confined to jail or prison.','\0','','CL-RISKSOC','DBX-NCIT-C85521'),('CL-RISKSOC-T-8',NULL,'LIVED IN REFUGEE CAMP','An individual that resided in a camp for those displaced from their homeland.','\0','','CL-RISKSOC','DBX-NCIT-C102657'),('CL-RISKSOC-T-9',NULL,'LONG-TERM FACILITY RESIDENT','An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living.','\0','','CL-RISKSOC','DBX-NCIT-C102660'),('CL-Role-T-1',NULL,'Identifier','Identifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-2',NULL,'Topic','Topic','\0',NULL,'CL-Role',NULL),('CL-Role-T-3',NULL,'RecordQualifier','RecordQualifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-4',NULL,'SynonymQualifier','SynonymQualifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-5',NULL,'VariableQualifier','VariableQualifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-6',NULL,'Timing','Timing','\0',NULL,'CL-Role',NULL),('CL-Role-T-7',NULL,'GroupingQualifier','GroupingQualifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-8',NULL,'ResultQualifier','ResultQualifier','\0',NULL,'CL-Role',NULL),('CL-Role-T-9',NULL,'Rule','Rule','\0',NULL,'CL-Role',NULL),('CL-ROUTE-T-1',NULL,'AURICULAR (OTIC)','Administration to or by way of the ear. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38192'),('CL-ROUTE-T-10',NULL,'ENDOTRACHEAL','Administration directly into the trachea. Synonymous with the term intratracheal. (FDA)','\0','Intratracheal Route of Administration','CL-ROUTE','DBX-NCIT-C38208'),('CL-ROUTE-T-100',NULL,'PERIVENOUS','Administration into the area surrounding a vein. (NCI)','\0','','CL-ROUTE','DBX-NCIT-C112396'),('CL-ROUTE-T-101',NULL,'RECTAL','Administration to the rectum. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38295'),('CL-ROUTE-T-102',NULL,'RESPIRATORY (INHALATION)','Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38216'),('CL-ROUTE-T-103',NULL,'RETROBULBAR','Administration behind the pons or behind the eyeball. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38296'),('CL-ROUTE-T-104',NULL,'SOFT TISSUE','Administration into any soft tissue. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38198'),('CL-ROUTE-T-105',NULL,'SUBARACHNOID','Administration beneath the arachnoid. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38297'),('CL-ROUTE-T-106',NULL,'SUBCONJUNCTIVAL','Administration beneath the conjunctiva. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38298'),('CL-ROUTE-T-107',NULL,'SUBCUTANEOUS','Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)','\0','SC; Subdermal Route of Administration','CL-ROUTE','DBX-NCIT-C38299'),('CL-ROUTE-T-108',NULL,'SUBLINGUAL','Administration beneath the tongue. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38300'),('CL-ROUTE-T-109',NULL,'SUBMUCOSAL','Administration beneath the mucous membrane. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38301'),('CL-ROUTE-T-11',NULL,'ENTERAL','Administration directly into the intestines. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38209'),('CL-ROUTE-T-110',NULL,'SUBTENON','Administration by injection through the membrane covering the muscles and nerves at the back of the eyeball.','\0','','CL-ROUTE','DBX-NCIT-C94636'),('CL-ROUTE-T-111',NULL,'TOPICAL','Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA)','\0','TOP','CL-ROUTE','DBX-NCIT-C38304'),('CL-ROUTE-T-112',NULL,'TRANSDERMAL','Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38305'),('CL-ROUTE-T-113',NULL,'TRANSMAMMARY','Administration by ingestion of colostrum or breast milk.','\0','','CL-ROUTE','DBX-NCIT-C111326'),('CL-ROUTE-T-114',NULL,'TRANSMUCOSAL','Administration across the mucosa. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38283'),('CL-ROUTE-T-115',NULL,'TRANSPLACENTAL','Administration through or across the placenta. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38307'),('CL-ROUTE-T-116',NULL,'TRANSTRACHEAL','Administration through the wall of the trachea. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38308'),('CL-ROUTE-T-117',NULL,'TRANSTYMPANIC','Administration across or through the tympanic cavity. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38309'),('CL-ROUTE-T-118',NULL,'UNASSIGNED','Route of administration has not yet been assigned. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38310'),('CL-ROUTE-T-119',NULL,'UNKNOWN','Route of administration is unknown. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38311'),('CL-ROUTE-T-12',NULL,'EPIDURAL','Administration upon or over the dura mater. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38210'),('CL-ROUTE-T-120',NULL,'URETERAL','Administration into the ureter. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38312'),('CL-ROUTE-T-121',NULL,'URETHRAL','Administration into the urethra. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38271'),('CL-ROUTE-T-122',NULL,'VAGINAL','Administration into the vagina. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38313'),('CL-ROUTE-T-13',NULL,'EXTRA-AMNIOTIC','Administration to the outside of the membrane enveloping the fetus. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38211'),('CL-ROUTE-T-14',NULL,'EXTRACORPOREAL','Administration outside of the body. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38212'),('CL-ROUTE-T-15',NULL,'HEMODIALYSIS','Administration through hemodialysate fluid. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38200'),('CL-ROUTE-T-16',NULL,'INFILTRATION','Administration that results in substances passing into tissue spaces or into cells. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38215'),('CL-ROUTE-T-17',NULL,'INTERSTITIAL','Administration to or in the interstices of a tissue. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38219'),('CL-ROUTE-T-18',NULL,'INTRA-ABDOMINAL','Administration within the abdomen. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38220'),('CL-ROUTE-T-19',NULL,'INTRA-AMNIOTIC','Administration within the amnion. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38221'),('CL-ROUTE-T-2',NULL,'BUCCAL','Administration directed toward the cheek, generally from within the mouth. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38193'),('CL-ROUTE-T-20',NULL,'INTRA-ARTERIAL','Administration within an artery or arteries. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38222'),('CL-ROUTE-T-21',NULL,'INTRA-ARTICULAR','Administration within a joint. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38223'),('CL-ROUTE-T-22',NULL,'INTRABILIARY','Administration within the bile, bile ducts or gallbladder. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38224'),('CL-ROUTE-T-23',NULL,'INTRABRONCHIAL','Administration within a bronchus. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38225'),('CL-ROUTE-T-24',NULL,'INTRABURSAL','Administration within a bursa. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38226'),('CL-ROUTE-T-25',NULL,'INTRACAMERAL','Administration by injection directly into the anterior chamber of the eye.','\0','','CL-ROUTE','DBX-NCIT-C64984'),('CL-ROUTE-T-26',NULL,'INTRACARDIAC','Administration within the heart. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38227'),('CL-ROUTE-T-27',NULL,'INTRACARTILAGINOUS','Administration within a cartilage; endochondral. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38228'),('CL-ROUTE-T-28',NULL,'INTRACAUDAL','Administration within the cauda equina. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38229'),('CL-ROUTE-T-29',NULL,'INTRACAVERNOUS','Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38230'),('CL-ROUTE-T-3',NULL,'CONJUNCTIVAL','Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38194'),('CL-ROUTE-T-30',NULL,'INTRACAVITARY','Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38231'),('CL-ROUTE-T-31',NULL,'INTRACEREBRAL','Administration within the cerebrum. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38232'),('CL-ROUTE-T-32',NULL,'INTRACISTERNAL','Administration within the cisterna magna cerebellomedularis. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38233'),('CL-ROUTE-T-33',NULL,'INTRACORNEAL','Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38234'),('CL-ROUTE-T-34',NULL,'INTRACORONAL, DENTAL','Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38217'),('CL-ROUTE-T-35',NULL,'INTRACORONARY','Administration within the coronary arteries. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38218'),('CL-ROUTE-T-36',NULL,'INTRACORPORUS CAVERNOSUM','Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38235'),('CL-ROUTE-T-37',NULL,'INTRADERMAL','Administration within the dermis. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38238'),('CL-ROUTE-T-38',NULL,'INTRADISCAL','Administration within a disc. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38239'),('CL-ROUTE-T-39',NULL,'INTRADUCTAL','Administration within the duct of a gland. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38240'),('CL-ROUTE-T-4',NULL,'CUTANEOUS','Administration to the skin. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38675'),('CL-ROUTE-T-40',NULL,'INTRADUODENAL','Administration within the duodenum. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38241'),('CL-ROUTE-T-41',NULL,'INTRADURAL','Administration within or beneath the dura. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38242'),('CL-ROUTE-T-42',NULL,'INTRAEPIDERMAL','Administration within the epidermis. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38243'),('CL-ROUTE-T-43',NULL,'INTRAESOPHAGEAL','Administration within the esophagus. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38245'),('CL-ROUTE-T-44',NULL,'INTRAGASTRIC','Administration within the stomach. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38246'),('CL-ROUTE-T-45',NULL,'INTRAGINGIVAL','Administration within the gingivae. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38247'),('CL-ROUTE-T-46',NULL,'INTRAHEPATIC','Administration into the liver.','\0','','CL-ROUTE','DBX-NCIT-C38248'),('CL-ROUTE-T-47',NULL,'INTRAILEAL','Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38249'),('CL-ROUTE-T-48',NULL,'INTRAJEJUNAL','Administration into the jejunum.','\0','','CL-ROUTE','DBX-NCIT-C102399'),('CL-ROUTE-T-49',NULL,'INTRALESIONAL','Administration within or introduced directly into a localized lesion. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38250'),('CL-ROUTE-T-5',NULL,'DENTAL','Administration to a tooth or teeth. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38197'),('CL-ROUTE-T-50',NULL,'INTRALUMINAL','Administration within the lumen of a tube. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38251'),('CL-ROUTE-T-51',NULL,'INTRALYMPHATIC','Administration within the lymph. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38252'),('CL-ROUTE-T-52',NULL,'INTRAMEDULLARY','Administration within the marrow cavity of a bone. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38253'),('CL-ROUTE-T-53',NULL,'INTRAMENINGEAL','Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38254'),('CL-ROUTE-T-54',NULL,'INTRAMUSCULAR','Administration within a muscle. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C28161'),('CL-ROUTE-T-55',NULL,'INTRAOCULAR','Administration within the eye. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38255'),('CL-ROUTE-T-56',NULL,'INTRAOVARIAN','Administration within the ovary. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38256'),('CL-ROUTE-T-57',NULL,'INTRAPALATAL','Administration into the palate.','\0','','CL-ROUTE','DBX-NCIT-C102400'),('CL-ROUTE-T-58',NULL,'INTRAPERICARDIAL','Administration within the pericardium. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38257'),('CL-ROUTE-T-59',NULL,'INTRAPERITONEAL','Administration within the peritoneal cavity. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38258'),('CL-ROUTE-T-6',NULL,'DIETARY','Administration by way of food stuff. (NCI)','\0','','CL-ROUTE','DBX-NCIT-C78373'),('CL-ROUTE-T-60',NULL,'INTRAPLEURAL','Administration within the pleura. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38259'),('CL-ROUTE-T-61',NULL,'INTRAPROSTATIC','Administration within the prostate gland. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38260'),('CL-ROUTE-T-62',NULL,'INTRAPULMONARY','Administration within the lungs or its bronchi. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38261'),('CL-ROUTE-T-63',NULL,'INTRASINAL','Administration within the nasal or periorbital sinuses. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38262'),('CL-ROUTE-T-64',NULL,'INTRASPINAL','Administration within the vertebral column. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38263'),('CL-ROUTE-T-65',NULL,'INTRASTOMAL','Administration into a stoma.','\0','','CL-ROUTE','DBX-NCIT-C65138'),('CL-ROUTE-T-66',NULL,'INTRASYNOVIAL','Administration within the synovial cavity of a joint. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38264'),('CL-ROUTE-T-67',NULL,'INTRATENDINOUS','Administration within a tendon. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38265'),('CL-ROUTE-T-68',NULL,'INTRATESTICULAR','Administration within the testicle. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38266'),('CL-ROUTE-T-69',NULL,'INTRATHECAL','Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38267'),('CL-ROUTE-T-7',NULL,'ELECTRO-OSMOSIS','Administration of through the diffusion of substance through a membrane in an electric field. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38633'),('CL-ROUTE-T-70',NULL,'INTRATHORACIC','Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38207'),('CL-ROUTE-T-71',NULL,'INTRATUBULAR','Administration within the tubules of an organ. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38268'),('CL-ROUTE-T-72',NULL,'INTRATUMOR','Administration within a tumor. (FDA)','\0','Intratumor Route of Administration','CL-ROUTE','DBX-NCIT-C38269'),('CL-ROUTE-T-73',NULL,'INTRATYMPANIC','Administration within the auris media. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38270'),('CL-ROUTE-T-74',NULL,'INTRAUTERINE','Administration within the uterus. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38272'),('CL-ROUTE-T-75',NULL,'INTRAVASCULAR','Administration within a vessel or vessels. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38273'),('CL-ROUTE-T-76',NULL,'INTRAVENOUS','Administration within or into a vein or veins. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38276'),('CL-ROUTE-T-77',NULL,'INTRAVENOUS BOLUS','Administration within or into a vein or veins all at once. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38274'),('CL-ROUTE-T-78',NULL,'INTRAVENOUS DRIP','Administration within or into a vein or veins over a sustained period of time. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38279'),('CL-ROUTE-T-79',NULL,'INTRAVENTRICULAR','Administration within a ventricle. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38277'),('CL-ROUTE-T-8',NULL,'ENDOCERVICAL','Administration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA)','\0','Intracervical Route of Administration','CL-ROUTE','DBX-NCIT-C38205'),('CL-ROUTE-T-80',NULL,'INTRAVESICAL','Administration within the bladder. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38278'),('CL-ROUTE-T-81',NULL,'INTRAVITREAL','Administration within the vitreous body of the eye. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38280'),('CL-ROUTE-T-82',NULL,'IONTOPHORESIS','Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38203'),('CL-ROUTE-T-83',NULL,'IRRIGATION','Administration to bathe or flush open wounds or body cavities. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38281'),('CL-ROUTE-T-84',NULL,'LARYNGEAL','Administration directly upon the larynx. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38282'),('CL-ROUTE-T-85',NULL,'NASAL','Administration to the nose; administered by way of the nose. (FDA)','\0','Intranasal Route of Administration','CL-ROUTE','DBX-NCIT-C38284'),('CL-ROUTE-T-86',NULL,'NASOGASTRIC','Administration through the nose and into the stomach, usually by means of a tube. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38285'),('CL-ROUTE-T-87',NULL,'NOT APPLICABLE','Routes of administration are not applicable. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C48623'),('CL-ROUTE-T-88',NULL,'OCCLUSIVE DRESSING TECHNIQUE','Administration by the topical route which is then covered by a dressing which occludes the area. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38286'),('CL-ROUTE-T-89',NULL,'OPHTHALMIC','Administration to the external eye. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38287'),('CL-ROUTE-T-9',NULL,'ENDOSINUSIAL','Administration within the nasal sinuses of the head. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38206'),('CL-ROUTE-T-90',NULL,'ORAL','Administration to or by way of the mouth. (FDA)','\0','Intraoral Route of Administration; PO','CL-ROUTE','DBX-NCIT-C38288'),('CL-ROUTE-T-91',NULL,'ORAL GAVAGE','Administration through the mouth and into the stomach, usually by means of a tube. (NCI)','\0','','CL-ROUTE','DBX-NCIT-C78374'),('CL-ROUTE-T-92',NULL,'OROMUCOSAL','Administration across the mucosa of the oral cavity.','\0','','CL-ROUTE','DBX-NCIT-C64906'),('CL-ROUTE-T-93',NULL,'OROPHARYNGEAL','Administration directly to the mouth and pharynx. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38289'),('CL-ROUTE-T-94',NULL,'PARENTERAL','Administration by injection, infusion, or implantation. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38291'),('CL-ROUTE-T-95',NULL,'PERCUTANEOUS','Administration through the skin. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38676'),('CL-ROUTE-T-96',NULL,'PERIARTICULAR','Administration around a joint. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38292'),('CL-ROUTE-T-97',NULL,'PERIDURAL','Administration to the outside of the dura mater of the spinal cord. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38677'),('CL-ROUTE-T-98',NULL,'PERINEURAL','Administration surrounding a nerve or nerves. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38293'),('CL-ROUTE-T-99',NULL,'PERIODONTAL','Administration around a tooth. (FDA)','\0','','CL-ROUTE','DBX-NCIT-C38294'),('CL-RPTEST-T-1',NULL,'Birth Control Method','The method by which conception or impregnation is prevented.','\0','Birth Control Method','CL-RPTEST','DBX-NCIT-C106501'),('CL-RPTEST-T-2',NULL,'Childbearing Potential','An indicator as to whether the female subject has the potential to become pregnant. (NCI)','\0','Childbearing Potential','CL-RPTEST','DBX-NCIT-C106508'),('CL-RPTEST-T-3',NULL,'Menarche Age','The age at which the first menstruation event occurred. (NCI)','\0','Menarche Age','CL-RPTEST','DBX-NCIT-C19666'),('CL-RPTEST-T-4',NULL,'Menopause Age','The age at which permanent cessation of menses occurred. (NCI)','\0','Menopause Age','CL-RPTEST','DBX-NCIT-C106497'),('CL-RPTEST-T-5',NULL,'Menopause Status','The status of a female with respect to menopause.','\0','Menopause Status','CL-RPTEST','DBX-NCIT-C106541'),('CL-RPTEST-T-6',NULL,'Number of Abortions','A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy.','\0','Number of Abortions','CL-RPTEST','DBX-NCIT-C106550'),('CL-RPTEST-T-7',NULL,'Number of Live Births','A measurement of the total number of live-born offspring a female has delivered.','\0','Number of Live Births','CL-RPTEST','DBX-NCIT-C16955'),('CL-RPTEST-T-8',NULL,'Number of Pregnancies','A measurement of the total number of pregnancy events experienced by a female.','\0','Number of Pregnancies','CL-RPTEST','DBX-NCIT-C106551'),('CL-RPTEST-T-9',NULL,'Pregnant During the Study','An indicator as to whether a female is pregnant during the study period. (NCI)','\0','Pregnant During the Study','CL-RPTEST','DBX-NCIT-C106561'),('CL-RPTESTCD-T-1',NULL,'ABORTN','A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy.','\0','Number of Abortions','CL-RPTESTCD','DBX-NCIT-C106550'),('CL-RPTESTCD-T-2',NULL,'BCMETHOD','The method by which conception or impregnation is prevented.','\0','Birth Control Method','CL-RPTESTCD','DBX-NCIT-C106501'),('CL-RPTESTCD-T-3',NULL,'BRTHLVN','A measurement of the total number of live-born offspring a female has delivered.','\0','Number of Live Births','CL-RPTESTCD','DBX-NCIT-C16955'),('CL-RPTESTCD-T-4',NULL,'CHILDPOT','An indicator as to whether the female subject has the potential to become pregnant. (NCI)','\0','Childbearing Potential','CL-RPTESTCD','DBX-NCIT-C106508'),('CL-RPTESTCD-T-5',NULL,'MENARAGE','The age at which the first menstruation event occurred. (NCI)','\0','Menarche Age','CL-RPTESTCD','DBX-NCIT-C19666'),('CL-RPTESTCD-T-6',NULL,'MENOAGE','The age at which permanent cessation of menses occurred. (NCI)','\0','Menopause Age','CL-RPTESTCD','DBX-NCIT-C106497'),('CL-RPTESTCD-T-7',NULL,'MENOSTAT','The status of a female with respect to menopause.','\0','Menopause Status','CL-RPTESTCD','DBX-NCIT-C106541'),('CL-RPTESTCD-T-8',NULL,'PREGNN','A measurement of the total number of pregnancy events experienced by a female.','\0','Number of Pregnancies','CL-RPTESTCD','DBX-NCIT-C106551'),('CL-RPTESTCD-T-9',NULL,'PREGST','An indicator as to whether a female is pregnant during the study period. (NCI)','\0','Pregnant During the Study','CL-RPTESTCD','DBX-NCIT-C106561'),('CL-RSKASMT-T-1',NULL,'HIGH RISK','The potential future harm that may arise from some present action or attribute or condition is almost certain.','\0','','CL-RSKASMT','DBX-NCIT-C102401'),('CL-RSKASMT-T-2',NULL,'INTERMEDIATE RISK','The potential future harm that may arise from some present action or attribute or condition is moderate.','\0','','CL-RSKASMT','DBX-NCIT-C102402'),('CL-RSKASMT-T-3',NULL,'LOW RISK','The potential future harm that may arise from some present action or attribute or condition is small.','\0','','CL-RSKASMT','DBX-NCIT-C102403'),('CL-RSKASMT-T-4',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-RSKASMT','DBX-NCIT-C17998'),('CL-RSSTRESC-T-1',NULL,'CR','The disappearance of all signs of cancer in response to treatment. (NCI)','\0','Complete Remission; Complete Response','CL-RSSTRESC','DBX-NCIT-C4870'),('CL-RSSTRESC-T-10',NULL,'SD','Cancer that is neither decreasing nor increasing in extent or severity. (NCI)','\0','Stable Disease','CL-RSSTRESC','DBX-NCIT-C18213'),('CL-RSSTRESC-T-11',NULL,'UPD','An overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or PR in target disease, the treating physician would feel it important to change therapy. (RECIST)','\0','Unequivocal Progression','CL-RSSTRESC','DBX-NCIT-C96644'),('CL-RSSTRESC-T-2',NULL,'CRi','The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.','\0','Complete Remission with Incomplete Blood Count Recovery; Complete Response with Incomplete Bone Marrow Recovery','CL-RSSTRESC','DBX-NCIT-C103385'),('CL-RSSTRESC-T-3',NULL,'EQUIVOCAL','Open to question.','\0','EQUIVOCAL','CL-RSSTRESC','DBX-NCIT-C86071'),('CL-RSSTRESC-T-4',NULL,'NE','Unable to be evaluated. (NCI)','\0','Not Evaluable','CL-RSSTRESC','DBX-NCIT-C62222'),('CL-RSSTRESC-T-5',NULL,'Non-CR/Non-PD','Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)','\0','Non Complete Response/Non Progressive Disease','CL-RSSTRESC','DBX-NCIT-C96700'),('CL-RSSTRESC-T-6',NULL,'NOT ALL EVALUATED','Not all target tumors were assessed. Or not all non-target tumors were assessed.','\0','Not All Evaluated','CL-RSSTRESC','DBX-NCIT-C103424'),('CL-RSSTRESC-T-7',NULL,'nPR','Remission with remaining lymphoid nodules reflecting residual disease.','\0','Nodular Partial Response','CL-RSSTRESC','DBX-NCIT-C103422'),('CL-RSSTRESC-T-8',NULL,'PD','A disease process that is increasing in scope or severity. (NCI)','\0','Progressive Disease','CL-RSSTRESC','DBX-NCIT-C35571'),('CL-RSSTRESC-T-9',NULL,'PR','A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient. (NCI)','\0','Partial Remission; Partial Response','CL-RSSTRESC','DBX-NCIT-C18058'),('CL-RSTEST-T-1',NULL,'Best Overall Response','An assessment of the most clinically favorable overall response of the disease to the therapy.','\0','Best Overall Response; Best Response','CL-RSTEST','DBX-NCIT-C94536'),('CL-RSTEST-T-2',NULL,'New Lesion Progression','An assessment of the equivocality of disease progression based on a newly identified lesion.','\0','New Lesion Progression','CL-RSTEST','DBX-NCIT-C103420'),('CL-RSTEST-T-3',NULL,'Non-Radiological Progression','A non-radiological determination of disease progression based on symptoms or other findings.','\0','Non-Radiological Progression','CL-RSTEST','DBX-NCIT-C96608'),('CL-RSTEST-T-4',NULL,'Non-target Response','An assessment of the response of a non-target tumor(s) to the therapy.','\0','Non-target Response','CL-RSTEST','DBX-NCIT-C94535'),('CL-RSTEST-T-5',NULL,'Overall Response','An assessment of the overall response of the disease to the therapy. (NCI)','\0','Overall Response','CL-RSTEST','DBX-NCIT-C96613'),('CL-RSTEST-T-6',NULL,'Target Response','An assessment of the response of a target tumor(s) to the therapy.','\0','Target Response','CL-RSTEST','DBX-NCIT-C94534'),('CL-RSTESTCD-T-1',NULL,'BESTRESP','An assessment of the most clinically favorable overall response of the disease to the therapy.','\0','Best Overall Response; Best Response','CL-RSTESTCD','DBX-NCIT-C94536'),('CL-RSTESTCD-T-2',NULL,'NEWLPROG','An assessment of the equivocality of disease progression based on a newly identified lesion.','\0','New Lesion Progression','CL-RSTESTCD','DBX-NCIT-C103420'),('CL-RSTESTCD-T-3',NULL,'NRADPROG','A non-radiological determination of disease progression based on symptoms or other findings.','\0','Non-Radiological Progression','CL-RSTESTCD','DBX-NCIT-C96608'),('CL-RSTESTCD-T-4',NULL,'NTRGRESP','An assessment of the response of a non-target tumor(s) to the therapy.','\0','Non-target Response','CL-RSTESTCD','DBX-NCIT-C94535'),('CL-RSTESTCD-T-5',NULL,'OVRLRESP','An assessment of the overall response of the disease to the therapy. (NCI)','\0','Overall Response','CL-RSTESTCD','DBX-NCIT-C96613'),('CL-RSTESTCD-T-6',NULL,'TRGRESP','An assessment of the response of a target tumor(s) to the therapy.','\0','Target Response','CL-RSTESTCD','DBX-NCIT-C94534'),('CL-RSTRTNA-T-1',NULL,'MEDICATION LOST','The medication is no longer held or possessed by the subject and is incapable of being recovered or regained.','\0','','CL-RSTRTNA','DBX-NCIT-C102663'),('CL-RSTRTNA-T-2',NULL,'NOT OFFERED','Is not an option.','\0','','CL-RSTRTNA','DBX-NCIT-C102682'),('CL-RSTRTNA-T-3',NULL,'REFUSE','To decline to do, accept, give, or allow something.','\0','','CL-RSTRTNA','DBX-NCIT-C49161'),('CL-RSTRTNA-T-4',NULL,'RELOCATION','The act of changing your residence or place of business.','\0','','CL-RSTRTNA','DBX-NCIT-C77951'),('CL-SCTEST-T-1',NULL,'Breast Fed Indicator','An indication as to whether the subject was breast fed (received mother\'s milk) as an infant.','\0','Breast Fed Indicator','CL-SCTEST','DBX-NCIT-C112233'),('CL-SCTEST-T-10',NULL,'Marital Status','A demographic parameter indicating a person\'s current conjugal status.','\0','Marital Status','CL-SCTEST','DBX-NCIT-C25188'),('CL-SCTEST-T-11',NULL,'Member of High Risk Population','An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder.','\0','Member of High Risk Population','CL-SCTEST','DBX-NCIT-C102666'),('CL-SCTEST-T-12',NULL,'National Origin','System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.','\0','National Origin','CL-SCTEST','DBX-NCIT-C28407'),('CL-SCTEST-T-13',NULL,'Premature Birth Indicator','An indication as to whether the subject was born prior to 38 weeks gestation.','\0','Premature Birth Indicator','CL-SCTEST','DBX-NCIT-C112400'),('CL-SCTEST-T-14',NULL,'Priority of Disease Contact','The categorization of individuals with or without the potential for having a particular disease.','\0','Priority of Disease Contact','CL-SCTEST','DBX-NCIT-C102699'),('CL-SCTEST-T-15',NULL,'Setting of Contact','The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier.','\0','Setting of Contact','CL-SCTEST','DBX-NCIT-C102708'),('CL-SCTEST-T-16',NULL,'Skin Classification','A classification system used to categorize the sensitivity of a subject\'s skin to sunlight.','\0','Skin Classification','CL-SCTEST','DBX-NCIT-C74563'),('CL-SCTEST-T-17',NULL,'Skin Type','A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.','\0','Skin Type','CL-SCTEST','DBX-NCIT-C74580'),('CL-SCTEST-T-18',NULL,'Social Risk Factor','Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.','\0','Social Risk Factor','CL-SCTEST','DBX-NCIT-C102711'),('CL-SCTEST-T-19',NULL,'Source Case Investigation','A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others.','\0','Source Case Investigation','CL-SCTEST','DBX-NCIT-C102713'),('CL-SCTEST-T-2',NULL,'Contact Investigation','A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic i','\0','Contact Investigation','CL-SCTEST','DBX-NCIT-C102625'),('CL-SCTEST-T-20',NULL,'Symptom','Subjective evidence of disease perceived by the patient.','\0','Symptom','CL-SCTEST','DBX-NCIT-C4876'),('CL-SCTEST-T-21',NULL,'Twin Type','The classification of the two offspring born from the same pregnancy.','\0','Twin Type','CL-SCTEST','DBX-NCIT-C112424'),('CL-SCTEST-T-22',NULL,'Type of Contact','Identification and clinical investigation of disease contacts.','\0','Type of Contact','CL-SCTEST','DBX-NCIT-C102723'),('CL-SCTEST-T-3',NULL,'Country of Potential Disease Exposure','System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides.','\0','Country of Potential Disease Exposure','CL-SCTEST','DBX-NCIT-C102612'),('CL-SCTEST-T-4',NULL,'Dominant Hand','The preferred hand of use for controlled and efficient performance of motor tasks.','\0','Dominant Hand','CL-SCTEST','DBX-NCIT-C114182'),('CL-SCTEST-T-5',NULL,'Education Level','Years of education that a person has completed.','\0','Education Level','CL-SCTEST','DBX-NCIT-C17953'),('CL-SCTEST-T-6',NULL,'Employee Job','A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc.','\0','Employee Job','CL-SCTEST','DBX-NCIT-C25193'),('CL-SCTEST-T-7',NULL,'Employee Job Class','A code qualifying the employment in various ways, such as, full-time vs. part time, etc.','\0','Employee Job Class','CL-SCTEST','DBX-NCIT-C74565'),('CL-SCTEST-T-8',NULL,'Employee Salary Type','A code specifying the method used by the employer to compute the employee\'s salary or wages. For example, hourly, annual, or commission.','\0','Employee Salary Type','CL-SCTEST','DBX-NCIT-C74566'),('CL-SCTEST-T-9',NULL,'Entry Date from Ptntl Cntry Disease Exp','The date on which the subject arrived in the reporting country from the country of potential disease exposure.','\0','Entry Date from Ptntl Cntry Disease Exp','CL-SCTEST','DBX-NCIT-C102631'),('CL-SCTESTCD-T-1',NULL,'BRFEDIND','An indication as to whether the subject was breast fed (received mother\'s milk) as an infant.','\0','Breast Fed Indicator','CL-SCTESTCD','DBX-NCIT-C112233'),('CL-SCTESTCD-T-10',NULL,'NATORIG','System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.','\0','National Origin','CL-SCTESTCD','DBX-NCIT-C28407'),('CL-SCTESTCD-T-11',NULL,'PREMBRTH','An indication as to whether the subject was born prior to 38 weeks gestation.','\0','Premature Birth Indicator','CL-SCTESTCD','DBX-NCIT-C112400'),('CL-SCTESTCD-T-12',NULL,'PRICON','The categorization of individuals with or without the potential for having a particular disease.','\0','Priority of Disease Contact','CL-SCTESTCD','DBX-NCIT-C102699'),('CL-SCTESTCD-T-13',NULL,'RISKPOP','An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder.','\0','Member of High Risk Population','CL-SCTESTCD','DBX-NCIT-C102666'),('CL-SCTESTCD-T-14',NULL,'RISKSOC','Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.','\0','Social Risk Factor','CL-SCTESTCD','DBX-NCIT-C102711'),('CL-SCTESTCD-T-15',NULL,'SALTYP','A code specifying the method used by the employer to compute the employee\'s salary or wages. For example, hourly, annual, or commission.','\0','Employee Salary Type','CL-SCTESTCD','DBX-NCIT-C74566'),('CL-SCTESTCD-T-16',NULL,'SETCON','The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier.','\0','Setting of Contact','CL-SCTESTCD','DBX-NCIT-C102708'),('CL-SCTESTCD-T-17',NULL,'SKINCLAS','A classification system used to categorize the sensitivity of a subject\'s skin to sunlight.','\0','Skin Classification','CL-SCTESTCD','DBX-NCIT-C74563'),('CL-SCTESTCD-T-18',NULL,'SKINTYP','A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.','\0','Skin Type','CL-SCTESTCD','DBX-NCIT-C74580'),('CL-SCTESTCD-T-19',NULL,'SRCCSINV','A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others.','\0','Source Case Investigation','CL-SCTESTCD','DBX-NCIT-C102713'),('CL-SCTESTCD-T-2',NULL,'CNTCINV','A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic i','\0','Contact Investigation','CL-SCTESTCD','DBX-NCIT-C102625'),('CL-SCTESTCD-T-20',NULL,'SYMPTOM','Subjective evidence of disease perceived by the patient.','\0','Symptom','CL-SCTESTCD','DBX-NCIT-C4876'),('CL-SCTESTCD-T-21',NULL,'TWINTYP','The classification of the two offspring born from the same pregnancy.','\0','Twin Type','CL-SCTESTCD','DBX-NCIT-C112424'),('CL-SCTESTCD-T-22',NULL,'TYPCON','Identification and clinical investigation of disease contacts.','\0','Type of Contact','CL-SCTESTCD','DBX-NCIT-C102723'),('CL-SCTESTCD-T-3',NULL,'CTRYDDTC','The date on which the subject arrived in the reporting country from the country of potential disease exposure.','\0','Entry Date from Ptntl Cntry Disease Exp','CL-SCTESTCD','DBX-NCIT-C102631'),('CL-SCTESTCD-T-4',NULL,'CTRYDEXP','System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides.','\0','Country of Potential Disease Exposure','CL-SCTESTCD','DBX-NCIT-C102612'),('CL-SCTESTCD-T-5',NULL,'EDLEVEL','Years of education that a person has completed.','\0','Education Level','CL-SCTESTCD','DBX-NCIT-C17953'),('CL-SCTESTCD-T-6',NULL,'EMPJOB','A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc.','\0','Employee Job','CL-SCTESTCD','DBX-NCIT-C25193'),('CL-SCTESTCD-T-7',NULL,'HANDDOM','The preferred hand of use for controlled and efficient performance of motor tasks.','\0','Dominant Hand','CL-SCTESTCD','DBX-NCIT-C114182'),('CL-SCTESTCD-T-8',NULL,'JOBCLAS','A code qualifying the employment in various ways, such as, full-time vs. part time, etc.','\0','Employee Job Class','CL-SCTESTCD','DBX-NCIT-C74565'),('CL-SCTESTCD-T-9',NULL,'MARISTAT','A demographic parameter indicating a person\'s current conjugal status.','\0','Marital Status','CL-SCTESTCD','DBX-NCIT-C25188'),('CL-SDTHSDTP-T-1',NULL,'BRUGADA SYNDROME','Polymorphic ventricular tachycardia in the absence of structural heart disease, associated with a baseline ECG pattern during sinus rhythm showing right bundle branch block with ST segment elevation in leads V1 through V3. It can also be characterized by ','\0','Ventricular arrhythmia associated with Brugada syndrome','CL-SDTHSDTP','DBX-NCIT-C71059'),('CL-SDTHSDTP-T-2',NULL,'CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA','Ventricular Tachycardia associated with syncope and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal.','\0','','CL-SDTHSDTP','DBX-NCIT-C99936'),('CL-SDTHSDTP-T-3',NULL,'IDIOPATHIC PRIMARY VENTRICULAR TACHYCARDIA/VENTRICULAR FLUTTER','Ventricular tachycardia or ventricular fibrillation whose cause is unknown.','\0','','CL-SDTHSDTP','DBX-NCIT-C100036'),('CL-SDTHSDTP-T-4',NULL,'LONG QT SYNDROME','Long QT Syndrome includes prolongation of the corrected QT interval beyond 440 ms for adult males, 460 ms for adult females and 50 ms in the presence of ventricular depolarization abnormalities (i.e., bundle branch blocks or IVCB more than 120 ms. A norma','\0','Ventricular arrhythmia associated with long QT syndrome','CL-SDTHSDTP','DBX-NCIT-C34786'),('CL-SDTHSDTP-T-5',NULL,'OTHER','Different than the one(s) previously specified or mentioned. (NCI)','\0','Other','CL-SDTHSDTP','DBX-NCIT-C17649'),('CL-SDTHSDTP-T-6',NULL,'SHORT QT SYNDROME','Short QT Syndrome is characterized by a QT interval of less than or equal to 300 ms.','\0','Ventricular arrhythmia associated with short QT syndrome','CL-SDTHSDTP','DBX-NCIT-C71060'),('CL-SETCON-T-1',NULL,'FARM','A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals.','\0','','CL-SETCON','DBX-NCIT-C48953'),('CL-SETCON-T-2',NULL,'HOUSEHOLD ENVIRONMENT','The area in which an individual lives.','\0','','CL-SETCON','DBX-NCIT-C102647'),('CL-SETCON-T-3',NULL,'NON-HOUSEHOLD ENVIRONMENT','An area outside of that in which an individual lives.','\0','','CL-SETCON','DBX-NCIT-C102679'),('CL-SETCON-T-4',NULL,'PRISON','An institution where persons are confined for punishment and to protect the public.','\0','','CL-SETCON','DBX-NCIT-C85862'),('CL-SETCON-T-5',NULL,'SCHOOL','An educational institution.','\0','','CL-SETCON','DBX-NCIT-C17118'),('CL-SETCON-T-6',NULL,'SOCIAL SETTING','The surroundings or environment in which social activities occur.','\0','','CL-SETCON','DBX-NCIT-C102712'),('CL-SETCON-T-7',NULL,'WORKSITE','Place or physical location of work or employment.','\0','','CL-SETCON','DBX-NCIT-C17556'),('CL-SEX-T-1',NULL,'F','A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)','\0','Female','CL-SEX','DBX-NCIT-C16576'),('CL-SEX-T-2',NULL,'M','A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)','\0','Male','CL-SEX','DBX-NCIT-C20197'),('CL-SEX-T-3',NULL,'U','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-SEX','DBX-NCIT-C17998'),('CL-SEX-T-4',NULL,'UNDIFFERENTIATED','A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)','\0','','CL-SEX','DBX-NCIT-C45908'),('CL-SEXPOP-T-1',NULL,'BOTH','One and the other; relating to or being two in conjunction. (NCI)','\0','','CL-SEXPOP','DBX-NCIT-C49636'),('CL-SEXPOP-T-2',NULL,'F','A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)','\0','Female','CL-SEXPOP','DBX-NCIT-C16576'),('CL-SEXPOP-T-3',NULL,'M','A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)','\0','Male','CL-SEXPOP','DBX-NCIT-C20197'),('CL-SIZE-T-1',NULL,'LARGE','Of considerable or relatively great size, extent, or capacity. (NCI)','\0','','CL-SIZE','DBX-NCIT-C49508'),('CL-SIZE-T-2',NULL,'MEDIUM','Mid-way between small and large in number, quantity, magnitude or extent. (NCI)','\0','','CL-SIZE','DBX-NCIT-C49507'),('CL-SIZE-T-3',NULL,'SMALL','Limited in number, quantity, magnitude or extent. (NCI)','\0','','CL-SIZE','DBX-NCIT-C25376'),('CL-SKINCLAS-T-1',NULL,'TYPEI','Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lightly complected blondes. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through ','\0','TYPE1','CL-SKINCLAS','DBX-NCIT-C74569'),('CL-SKINCLAS-T-2',NULL,'TYPEII','Individuals who frequently burn but are able to tan to a small degree after extended sun exposure. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)','\0','TYPE2','CL-SKINCLAS','DBX-NCIT-C74570'),('CL-SKINCLAS-T-3',NULL,'TYPEIII','Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)','\0','TYPE3','CL-SKINCLAS','DBX-NCIT-C74571'),('CL-SKINCLAS-T-4',NULL,'TYPEIV','Individuals who rarely burn and tan heavily with moderate sun exposures, especially individuals of Asian, American Indian, Mediterranean and Latin American descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I thr','\0','TYPE4','CL-SKINCLAS','DBX-NCIT-C74572'),('CL-SKINCLAS-T-5',NULL,'TYPEV','Individuals who have dark constitutive pigmentation but become noticeably darker with sun exposure, especially light complected black individuals, those of Indian descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin type','\0','TYPE5','CL-SKINCLAS','DBX-NCIT-C74573'),('CL-SKINCLAS-T-6',NULL,'TYPEVI','Individuals who have the heaviest constitutive pigmentation, especially dark skinned black individuals. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)','\0','TYPE6','CL-SKINCLAS','DBX-NCIT-C74574'),('CL-SKINTYP-T-1',NULL,'DRY','The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.','\0','','CL-SKINTYP','DBX-NCIT-C74592'),('CL-SKINTYP-T-2',NULL,'NORMAL','The pores are visible but not large. The texture is neither fine or thick and it neither feels dry or oily to the touch.','\0','','CL-SKINTYP','DBX-NCIT-C74593'),('CL-SKINTYP-T-3',NULL,'OILY','The pores of the skin are generally large and visible with a coarse or thick texture. It has a tendency to look dull and greasy and feels oily to the touch.','\0','','CL-SKINTYP','DBX-NCIT-C74591'),('CL-SPCIES-T-1',NULL,'ACINETOBACTER LWOFFII','Any bacterial organism that can be assigned to the species Acinetobacter lwoffii.','\0','ACINETOBACTER CALCOACETICUS SUBSP. LWOFFII','CL-SPCIES','DBX-NCIT-C86095'),('CL-SPCIES-T-10',NULL,'CLOSTRIDIUM GLYCOLICUM','Any bacterial organism that can be assigned to the species Clostridium glycolicum.','\0','','CL-SPCIES','DBX-NCIT-C86280'),('CL-SPCIES-T-100',NULL,'SARS CORONAVIRUS','Any viral organism that can be assigned to the species SARS coronavirus.','\0','HCoV-SARS; SARS; Severe Acute Respiratory Syndrome Coronavirus','CL-SPCIES','DBX-NCIT-C112432'),('CL-SPCIES-T-101',NULL,'SERRATIA PLYMUTHICA','Any bacterial organism that can be assigned to the species Serratia plymuthica.','\0','','CL-SPCIES','DBX-NCIT-C86740'),('CL-SPCIES-T-102',NULL,'STAPHYLOCOCCUS AUREUS','Any bacterial organism that can be assigned to the species Staphylococcus aureus.','\0','STAPH. AUREUS','CL-SPCIES','DBX-NCIT-C50921'),('CL-SPCIES-T-103',NULL,'STAPHYLOCOCCUS CAPITIS','Any bacterial organism that can be assigned to the species Staphylococcus capitis.','\0','','CL-SPCIES','DBX-NCIT-C86752'),('CL-SPCIES-T-104',NULL,'STAPHYLOCOCCUS COHNII','Any bacterial organism that can be assigned to the species Staphylococcus cohnii.','\0','','CL-SPCIES','DBX-NCIT-C86756'),('CL-SPCIES-T-105',NULL,'STREPTOCOCCUS PNEUMONIAE','Any bacterial organism that can be assigned to the species Streptococcus pneumoniae.','\0','DIPLOCOCCUS PNEUMONIAE','CL-SPCIES','DBX-NCIT-C76384'),('CL-SPCIES-T-106',NULL,'SUTTONELLA INDOLOGENES','Any bacterial organism that can be assigned to the species Suttonella indologenes.','\0','KINGELLA INDOLOGENES','CL-SPCIES','DBX-NCIT-C86816'),('CL-SPCIES-T-107',NULL,'TATLOCKIA MICDADEI','Any bacterial organism that can be assigned to the species Legionella micdadei.','\0','LEGIONELLA MICDADEI','CL-SPCIES','DBX-NCIT-C86817'),('CL-SPCIES-T-108',NULL,'TICK-BORNE ENCEPHALITIS VIRUS','Any viral organism that can be assigned to the species Tick-borne encephalitis virus.','\0','FSME virus; TBEV','CL-SPCIES','DBX-NCIT-C112422'),('CL-SPCIES-T-109',NULL,'VACCINIA VIRUS','Any viral organism that can be assigned to the species Vaccinia virus.','\0','VV','CL-SPCIES','DBX-NCIT-C14281'),('CL-SPCIES-T-11',NULL,'CLOSTRIDIUM HISTOLYTICUM','Any bacterial organism that can be assigned to the species Clostridium histolyticum.','\0','','CL-SPCIES','DBX-NCIT-C86282'),('CL-SPCIES-T-110',NULL,'VARIOLA VIRUS','Any viral organism that can be assigned to the species Variola virus.','\0','Smallpox Virus; Variola Virus VAR','CL-SPCIES','DBX-NCIT-C96527'),('CL-SPCIES-T-111',NULL,'VIBRIO ALGINOLYTICUS','Any bacterial organism that can be assigned to the species Vibrio alginolyticus.','\0','','CL-SPCIES','DBX-NCIT-C86840'),('CL-SPCIES-T-112',NULL,'VIBRIO PARAHAEMOLYTICUS','Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus.','\0','','CL-SPCIES','DBX-NCIT-C86846'),('CL-SPCIES-T-113',NULL,'VIBRIO VULNIFICUS','Any bacterial organism that can be assigned to the species Vibrio vulnificus.','\0','BENECKEA VULNIFICA','CL-SPCIES','DBX-NCIT-C86847'),('CL-SPCIES-T-114',NULL,'WEST NILE VIRUS','Any viral organism that can be assigned to the species West Nile virus.','\0','WNV','CL-SPCIES','DBX-NCIT-C71877'),('CL-SPCIES-T-115',NULL,'YELLOW FEVER VIRUS','Any viral organism that can be assigned to the species Yellow fever virus.','\0','Flavivirus febricis; YFV','CL-SPCIES','DBX-NCIT-C97156'),('CL-SPCIES-T-116',NULL,'YERSINIA PESTIS','Any bacterial organism that can be assigned to the species Yersinia pestis.','\0','PASTEURELLA PESTIS','CL-SPCIES','DBX-NCIT-C86860'),('CL-SPCIES-T-12',NULL,'CLOSTRIDIUM NOVYI','Any bacterial organism that can be assigned to the species Clostridium novyi.','\0','','CL-SPCIES','DBX-NCIT-C86285'),('CL-SPCIES-T-13',NULL,'CLOSTRIDIUM TERTIUM','Any bacterial organism that can be assigned to the species Clostridium tertium.','\0','','CL-SPCIES','DBX-NCIT-C86297'),('CL-SPCIES-T-14',NULL,'COLORADO TICK FEVER VIRUS','Any viral organism that can be assigned to the species Colorado tick fever virus.','\0','CTFV','CL-SPCIES','DBX-NCIT-C112240'),('CL-SPCIES-T-15',NULL,'CORYNEBACTERIUM AMYCOLATUM','Any bacterial organism that can be assigned to the species Corynebacterium amycolatum.','\0','','CL-SPCIES','DBX-NCIT-C86308'),('CL-SPCIES-T-16',NULL,'CORYNEBACTERIUM DIPHTHERIAE','Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae.','\0','','CL-SPCIES','DBX-NCIT-C86312'),('CL-SPCIES-T-17',NULL,'CORYNEBACTERIUM MACGINLEYI','Any bacterial organism that can be assigned to the species Corynebacterium macginleyi.','\0','','CL-SPCIES','DBX-NCIT-C86315'),('CL-SPCIES-T-18',NULL,'CORYNEBACTERIUM UREALYTICUM','Any bacterial organism that can be assigned to the species Corynebacterium urealyticum.','\0','CDC GROUP D2; CORYNEBACTERIUM GROUP D-2','CL-SPCIES','DBX-NCIT-C86325'),('CL-SPCIES-T-19',NULL,'CORYNEBACTERIUM XEROSIS','Any bacterial organism that can be assigned to the species Corynebacterium xerosis.','\0','','CL-SPCIES','DBX-NCIT-C86326'),('CL-SPCIES-T-2',NULL,'ACTINOBACILLUS PLEUROPNEUMONIAE','Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae.','\0','HAEMOPHILUS PLEUROPNEUMONIAE','CL-SPCIES','DBX-NCIT-C86101'),('CL-SPCIES-T-20',NULL,'COXIELLA BURNETII','Any bacterial organism that can be assigned to the species Coxiella burnetii.','\0','','CL-SPCIES','DBX-NCIT-C86328'),('CL-SPCIES-T-21',NULL,'DENGUE VIRUS','Any viral organism that can be assigned to the species Dengue virus.','\0','','CL-SPCIES','DBX-NCIT-C112036'),('CL-SPCIES-T-22',NULL,'ECHOVIRUS','Any viral organism that can be assigned to the species Echovirus.','\0','','CL-SPCIES','DBX-NCIT-C112272'),('CL-SPCIES-T-23',NULL,'ENTEROBACTER AEROGENES','Any bacterial organism that can be assigned to the species Enterobacter aerogenes.','\0','AEROBACTER AEROGENES','CL-SPCIES','DBX-NCIT-C86356'),('CL-SPCIES-T-24',NULL,'ENTEROBACTER ASBURIAE','Any bacterial organism that can be assigned to the species Enterobacter asburiae.','\0','CDC ENTERIC GROUP 17','CL-SPCIES','DBX-NCIT-C86358'),('CL-SPCIES-T-25',NULL,'ESCHERICHIA COLI','Any bacterial organism that can be assigned to the species Escherichia coli.','\0','E. COLI','CL-SPCIES','DBX-NCIT-C14206'),('CL-SPCIES-T-26',NULL,'ESCHERICHIA FERGUSONII','Any bacterial organism that can be assigned to the species Escherichia fergusonii.','\0','CDC ENTERIC GROUP 10','CL-SPCIES','DBX-NCIT-C86380'),('CL-SPCIES-T-27',NULL,'ESCHERICHIA VULNERIS','Any bacterial organism that can be assigned to the species Escherichia vulneris.','\0','CDC ENTERIC GROUP 1','CL-SPCIES','DBX-NCIT-C86382'),('CL-SPCIES-T-28',NULL,'EWINGELLA AMERICANA','Any bacterial organism that can be assigned to the species Ewingella americana.','\0','CDC ENTERIC GROUP 40','CL-SPCIES','DBX-NCIT-C86391'),('CL-SPCIES-T-29',NULL,'EXIGUOBACTERIUM ACETYLICUM','Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum.','\0','BREVIBACTERIUM ACETYLICUM','CL-SPCIES','DBX-NCIT-C86886'),('CL-SPCIES-T-3',NULL,'BACILLUS ANTHRACIS','Any bacterial organism that can be assigned to the species Bacillus anthracis.','\0','','CL-SPCIES','DBX-NCIT-C86160'),('CL-SPCIES-T-30',NULL,'GORDONIA BRONCHIALIS','Any bacterial organism that can be assigned to the species Gordonia bronchialis.','\0','GORDONA BRONCHIALIS; RHODOCOCCUS BRONCHIALIS','CL-SPCIES','DBX-NCIT-C86416'),('CL-SPCIES-T-31',NULL,'GORDONIA SPUTI','Any bacterial organism that can be assigned to the species Gordonia sputi.','\0','GORDONA SPUTI','CL-SPCIES','DBX-NCIT-C86418'),('CL-SPCIES-T-32',NULL,'HAEMOPHILUS AEGYPTIUS','Any bacterial organism that can be assigned to the species Haemophilus aegyptius.','\0','','CL-SPCIES','DBX-NCIT-C86428'),('CL-SPCIES-T-33',NULL,'HAEMOPHILUS INFLUENZAE','Any bacterial organism that can be assigned to the species Haemophilus influenzae.','\0','H-FLU','CL-SPCIES','DBX-NCIT-C86431'),('CL-SPCIES-T-34',NULL,'HENDRA VIRUS','Any viral organism that can be assigned to the species Hendra virus.','\0','','CL-SPCIES','DBX-NCIT-C112289'),('CL-SPCIES-T-35',NULL,'HEPATITIS A VIRUS','Any viral organism that can be assigned to the species Hepatitis A virus.','\0','HAV','CL-SPCIES','DBX-NCIT-C14325'),('CL-SPCIES-T-36',NULL,'HEPATITIS B VIRUS','Any viral organism that can be assigned to the species Hepatitis B virus.','\0','HBV','CL-SPCIES','DBX-NCIT-C14215'),('CL-SPCIES-T-37',NULL,'HEPATITIS C VIRUS','Any viral organism that can be assigned to the species Hepatitis C virus.','\0','HCV','CL-SPCIES','DBX-NCIT-C14312'),('CL-SPCIES-T-38',NULL,'HEPATITIS D VIRUS','Any viral organism that can be assigned to the species Hepatitis D virus.','\0','HDV','CL-SPCIES','DBX-NCIT-C93324'),('CL-SPCIES-T-39',NULL,'HEPATITIS E VIRUS','Any viral organism that can be assigned to the species Hepatitis E virus.','\0','HEV','CL-SPCIES','DBX-NCIT-C14295'),('CL-SPCIES-T-4',NULL,'BARMAH FOREST VIRUS','Any viral organism that can be assigned to the species Barmah Forest virus.','\0','','CL-SPCIES','DBX-NCIT-C112232'),('CL-SPCIES-T-40',NULL,'HUMAN HERPESVIRUS 1','Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus.','\0','HHV-1; HSV-1; Herpes Simplex Virus type 1','CL-SPCIES','DBX-NCIT-C14311'),('CL-SPCIES-T-41',NULL,'HUMAN HERPESVIRUS 2','Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus.','\0','HHV-2; HSV-2; Herpes Simplex Virus type 2','CL-SPCIES','DBX-NCIT-C112313'),('CL-SPCIES-T-42',NULL,'HUMAN HERPESVIRUS 3','Any viral organism that can be assigned to the species Human Herpesvirus 3.','\0','HHV-3; VZV; Varicella Zoster Virus','CL-SPCIES','DBX-NCIT-C71091'),('CL-SPCIES-T-43',NULL,'HUMAN HERPESVIRUS 4','Any viral organism that can be assigned to the species Human Herpesvirus 4.','\0','EBV; Epstein-Barr Virus; HHV-4','CL-SPCIES','DBX-NCIT-C14204'),('CL-SPCIES-T-44',NULL,'HUMAN HERPESVIRUS 5','Any viral organism that can be assigned to the species Human Herpesvirus 5.','\0','HCMV; HHV-5; Human Cytomegalovirus','CL-SPCIES','DBX-NCIT-C112314'),('CL-SPCIES-T-45',NULL,'HUMAN HERPESVIRUS 6','Any viral organism that can be assigned to the species Human Herpesvirus 6.','\0','HHV-6','CL-SPCIES','DBX-NCIT-C14218'),('CL-SPCIES-T-46',NULL,'HUMAN HERPESVIRUS 7','Any viral organism that can be assigned to the species Human Herpesvirus 7.','\0','HHV-7','CL-SPCIES','DBX-NCIT-C112315'),('CL-SPCIES-T-47',NULL,'HUMAN HERPESVIRUS 8','Any viral organism that can be assigned to the species Human herpesvirus 8.','\0','HHV-8; KSHV; Kaposi\'s sarcoma-associated herpesvirus','CL-SPCIES','DBX-NCIT-C14327'),('CL-SPCIES-T-48',NULL,'HUMAN IMMUNODEFICIENCY VIRUS 1','Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.','\0','HIV-1; LAV-1','CL-SPCIES','DBX-NCIT-C14220'),('CL-SPCIES-T-49',NULL,'HUMAN IMMUNODEFICIENCY VIRUS 2','Any viral organism that can be assigned to the species Human Immunodeficiency virus 2.','\0','HIV-2; LAV-2','CL-SPCIES','DBX-NCIT-C14221'),('CL-SPCIES-T-5',NULL,'BK POLYOMAVIRUS','Any viral organism that can be assigned to the species BK polyomavirus.','\0','BK Virus','CL-SPCIES','DBX-NCIT-C89820'),('CL-SPCIES-T-50',NULL,'HUMAN PARVOVIRUS B19','Any viral organism that can be assigned to the species Human Parvovirus B19.','\0','B19 Virus; Human Erythrovirus B19; Parvovirus B19','CL-SPCIES','DBX-NCIT-C89772'),('CL-SPCIES-T-51',NULL,'HUMAN RESPIRATORY SYNCYTIAL VIRUS','Any viral organism that can be assigned to the species Human Respiratory Syncitial virus.','\0','Human RSV; RSV; hRSV','CL-SPCIES','DBX-NCIT-C14267'),('CL-SPCIES-T-52',NULL,'INFLUENZA A VIRUS','Any viral organism that can be assigned to the species Influenza A virus.','\0','FLUAV; Influenza Virus Type A','CL-SPCIES','DBX-NCIT-C53454'),('CL-SPCIES-T-53',NULL,'INFLUENZA B VIRUS','Any viral organism that can be assigned to the species Influenza B virus.','\0','FLUBV; Influenza Virus Type B','CL-SPCIES','DBX-NCIT-C53468'),('CL-SPCIES-T-54',NULL,'INFLUENZA C VIRUS','Any viral organism that can be assigned to the species Influenza C virus.','\0','FLUCV; Influenza Virus Type C','CL-SPCIES','DBX-NCIT-C97157'),('CL-SPCIES-T-55',NULL,'JC VIRUS','Any viral organism that can be assigned to the species JC polyomavirus.','\0','Human polyomavirus (type JC); Polyomavirus hominis 2; polyomavirus JC','CL-SPCIES','DBX-NCIT-C14229'),('CL-SPCIES-T-56',NULL,'KLEBSIELLA OZAENAE','Any bacterial organism that can be assigned to the species Klebsiella ozaenae.','\0','KLEBSIELLA PNEUMONIAE SUBSP. OZAENAE','CL-SPCIES','DBX-NCIT-C86456'),('CL-SPCIES-T-57',NULL,'KLEBSIELLA PNEUMONIAE','Any bacterial organism that can be assigned to the species Klebsiella pneumoniae.','\0','K. PNEUMONIAE','CL-SPCIES','DBX-NCIT-C86457'),('CL-SPCIES-T-58',NULL,'KLEBSIELLA RHINOSCLEROMATIS','Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis.','\0','KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATIS','CL-SPCIES','DBX-NCIT-C86458'),('CL-SPCIES-T-59',NULL,'KLEBSIELLA SINGAPORENSIS','Any bacterial organism that can be assigned to the species Klebsiella singaporensis.','\0','','CL-SPCIES','DBX-NCIT-C86459'),('CL-SPCIES-T-6',NULL,'BORDETELLA PERTUSSIS','Any bacterial organism that can be assigned to the species Bordetella pertussis.','\0','','CL-SPCIES','DBX-NCIT-C76205'),('CL-SPCIES-T-60',NULL,'KLEBSIELLA VARIICOLA','Any bacterial organism that can be assigned to the species Klebsiella variicola.','\0','','CL-SPCIES','DBX-NCIT-C86460'),('CL-SPCIES-T-61',NULL,'KLUYVERA ASCORBATA','Any bacterial organism that can be assigned to the species Kluyvera ascorbata.','\0','CDC ENTERIC GROUP 8','CL-SPCIES','DBX-NCIT-C86462'),('CL-SPCIES-T-62',NULL,'KLUYVERA CRYOCRESCENS','Any bacterial organism that can be assigned to the species Kluyvera cryocrescens.','\0','','CL-SPCIES','DBX-NCIT-C86463'),('CL-SPCIES-T-63',NULL,'KOCURIA KRISTINAE','Any bacterial organism that can be assigned to the species Kocuria kristinae.','\0','MICROCOCCUS KRISTINAE','CL-SPCIES','DBX-NCIT-C86468'),('CL-SPCIES-T-64',NULL,'KOCURIA RHIZOPHILA','Any bacterial organism that can be assigned to the species Kocuria rhizophila.','\0','MICROCOCCUS LUTEUS; SARCINA LUTEA','CL-SPCIES','DBX-NCIT-C86513'),('CL-SPCIES-T-65',NULL,'KOCURIA ROSEA','Any bacterial organism that can be assigned to the species Kocuria rosea.','\0','','CL-SPCIES','DBX-NCIT-C86469'),('CL-SPCIES-T-66',NULL,'KOCURIA VARIANS','Any bacterial organism that can be assigned to the species Kocuria varians.','\0','','CL-SPCIES','DBX-NCIT-C86470'),('CL-SPCIES-T-67',NULL,'LEGIONELLA PNEUMOPHILA','Any bacterial organism that can be assigned to the species Legionella pneumophila.','\0','','CL-SPCIES','DBX-NCIT-C86489'),('CL-SPCIES-T-68',NULL,'MANNHEIMIA HAEMOLYTICA','Any bacterial organism that can be assigned to the species Mannheimia haemolytica.','\0','PASTEURELLA HAEMOLYTICA','CL-SPCIES','DBX-NCIT-C86508'),('CL-SPCIES-T-69',NULL,'MEASLES VIRUS','Any viral organism that can be assigned to the species Measles virus.','\0','Rubeola Virus; SSPEV; rougeole virus; subacute sclerosing panencephalitis virus','CL-SPCIES','DBX-NCIT-C14237'),('CL-SPCIES-T-7',NULL,'BUTTIAUXELLA AGRESTIS','Any bacterial organism that can be assigned to the species Buttiauxella agrestis.','\0','','CL-SPCIES','DBX-NCIT-C86229'),('CL-SPCIES-T-70',NULL,'MEGASPHAERA ELSDENII','Any bacterial organism that can be assigned to the species Megasphaera elsdenii.','\0','PEPTOSTREPTOCOCCUS ELSDENII','CL-SPCIES','DBX-NCIT-C86896'),('CL-SPCIES-T-71',NULL,'METHYLOBACTERIUM MESOPHILICUM','Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum.','\0','PSEUDOMONAS MESOPHILICA','CL-SPCIES','DBX-NCIT-C86510'),('CL-SPCIES-T-72',NULL,'MICROBACTERIUM PARAOXYDANS','Any bacterial organism that can be assigned to the species Microbacterium paraoxydans.','\0','','CL-SPCIES','DBX-NCIT-C86512'),('CL-SPCIES-T-73',NULL,'MICROCOCCUS LYLAE','Any bacterial organism that can be assigned to the species Micrococcus lylae.','\0','','CL-SPCIES','DBX-NCIT-C86514'),('CL-SPCIES-T-74',NULL,'MITSUOKELLA MULTACIDA','Any bacterial organism that can be assigned to the species Mitsuokella multacida.','\0','','CL-SPCIES','DBX-NCIT-C86516'),('CL-SPCIES-T-75',NULL,'MOLLUSCUM CONTAGIOSUM VIRUS','Any viral organism that can be assigned to the species Molluscum contagiosum virus.','\0','MCV; MOCV','CL-SPCIES','DBX-NCIT-C112357'),('CL-SPCIES-T-76',NULL,'MORAXELLA BOVIS','Any bacterial organism that can be assigned to the species Moraxella bovis.','\0','','CL-SPCIES','DBX-NCIT-C86524'),('CL-SPCIES-T-77',NULL,'MORAXELLA CATARRHALIS','Any bacterial organism that can be assigned to the species Moraxella catarrhalis.','\0','BRANHAMELLA CATARRHALIS','CL-SPCIES','DBX-NCIT-C76210'),('CL-SPCIES-T-78',NULL,'MORAXELLA LACUNATA','Any bacterial organism that can be assigned to the species Moraxella lacunata.','\0','MORAXELLA LIQUEFACIENS','CL-SPCIES','DBX-NCIT-C86526'),('CL-SPCIES-T-79',NULL,'MYCOBACTERIUM FORTUITUM','Any bacterial organism that can be assigned to the species Mycobacterium fortuitum.','\0','','CL-SPCIES','DBX-NCIT-C86538'),('CL-SPCIES-T-8',NULL,'CHLAMYDIA TRACHOMATIS','Any bacterial organism that can be assigned to the species Chlamydia trachomatis.','\0','','CL-SPCIES','DBX-NCIT-C86253'),('CL-SPCIES-T-80',NULL,'MYCOBACTERIUM PEREGRINUM','Any bacterial organism that can be assigned to the species Mycobacterium peregrinum.','\0','','CL-SPCIES','DBX-NCIT-C86546'),('CL-SPCIES-T-81',NULL,'MYCOBACTERIUM SMEGMATIS','Any bacterial organism that can be assigned to the species Mycobacterium smegmatis.','\0','','CL-SPCIES','DBX-NCIT-C86590'),('CL-SPCIES-T-82',NULL,'MYCOPLASMA PNEUMONIAE','Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae.','\0','','CL-SPCIES','DBX-NCIT-C86599'),('CL-SPCIES-T-83',NULL,'MYROIDES ODORATUS','Any bacterial organism that can be assigned to the species Myroides odoratus.','\0','FLAVOBACTERIUM ODORATUM','CL-SPCIES','DBX-NCIT-C86954'),('CL-SPCIES-T-84',NULL,'NEISSERIA GONORRHOEAE','Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae.','\0','','CL-SPCIES','DBX-NCIT-C86603'),('CL-SPCIES-T-85',NULL,'NEWCASTLE DISEASE VIRUS','Any viral organism that can be assigned to the species Newcastle disease virus.','\0','Avian Paramyxovirus Type 1; NDV','CL-SPCIES','DBX-NCIT-C93023'),('CL-SPCIES-T-86',NULL,'NIPAH VIRUS','Any viral organism that can be assigned to the species Nipah virus.','\0','NiV','CL-SPCIES','DBX-NCIT-C112359'),('CL-SPCIES-T-87',NULL,'NORWALK VIRUS','Any viral organism that can be assigned to the species Norwalk virus.','\0','NV; Norwalk calicivirus','CL-SPCIES','DBX-NCIT-C112363'),('CL-SPCIES-T-88',NULL,'POLIOVIRUS','Any viral organism that can be assigned to the species Poliovirus.','\0','Enterovirus C; Human enterovirus C','CL-SPCIES','DBX-NCIT-C14259'),('CL-SPCIES-T-89',NULL,'PROTEUS MIRABILIS','Any bacterial organism that can be assigned to the species Proteus mirabilis.','\0','','CL-SPCIES','DBX-NCIT-C86019'),('CL-SPCIES-T-9',NULL,'CHLAMYDOPHILA PNEUMONIAE','Any bacterial organism that can be assigned to the species Chlamydophila pneumoniae.','\0','CHLAMYDIA PNEUMONIAE','CL-SPCIES','DBX-NCIT-C76272'),('CL-SPCIES-T-90',NULL,'PROTEUS PENNERI','Any bacterial organism that can be assigned to the species Proteus penneri.','\0','INDOLE NEGATIVE PROTEUS VULGARIS','CL-SPCIES','DBX-NCIT-C86688'),('CL-SPCIES-T-91',NULL,'PSEUDOCOWPOX VIRUS','Any viral organism that can be assigned to the species Pseudocowpox virus.','\0','Paravaccinia virus; Pseudocowpoxvirus','CL-SPCIES','DBX-NCIT-C112401'),('CL-SPCIES-T-92',NULL,'PSEUDOMONAS AERUGINOSA','Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa.','\0','','CL-SPCIES','DBX-NCIT-C86696'),('CL-SPCIES-T-93',NULL,'RABIES VIRUS','Any viral organism that can be assigned to the species Rabies virus.','\0','','CL-SPCIES','DBX-NCIT-C112405'),('CL-SPCIES-T-94',NULL,'RHINOVIRUS A','Any viral organism that can be assigned to the species Rhinovirus A.','\0','Human Rhinovirus A','CL-SPCIES','DBX-NCIT-C112407'),('CL-SPCIES-T-95',NULL,'RHINOVIRUS B','Any viral organism that can be assigned to the species Rhinovirus B.','\0','Human Rhinovirus B','CL-SPCIES','DBX-NCIT-C112408'),('CL-SPCIES-T-96',NULL,'RHINOVIRUS C','Any viral organism that can be assigned to the species Rhinovirus C.','\0','Human Rhinovirus C','CL-SPCIES','DBX-NCIT-C112409'),('CL-SPCIES-T-97',NULL,'ROSS RIVER VIRUS','Any viral organism that can be assigned to the species Ross River virus.','\0','RRV','CL-SPCIES','DBX-NCIT-C112411'),('CL-SPCIES-T-98',NULL,'RUBELLA VIRUS','Any viral organism that can be assigned to the species Rubella virus.','\0','German Measles Virus','CL-SPCIES','DBX-NCIT-C77198'),('CL-SPCIES-T-99',NULL,'SAPPORO VIRUS','Any viral organism that can be assigned to the species Sapporo virus.','\0','Human calicivirus SLV; Human calicivirus Sapporo-like Virus','CL-SPCIES','DBX-NCIT-C112415'),('CL-SPECCOND-T-1',NULL,'AUTOLIZED','A specimen that has undergone autolysis, or self-digestion by the specimen\'s own digestive enzymes. (NCI)','\0','Autolized Specimen','CL-SPECCOND','DBX-NCIT-C78725'),('CL-SPECCOND-T-10',NULL,'LIPEMIC','A specimen that consists of or contains excessive amounts of fat and fatty substances. (NCI)','\0','Lipemic Specimen','CL-SPECCOND','DBX-NCIT-C70715'),('CL-SPECCOND-T-11',NULL,'PARAFFIN-EMBEDDED','A specimen that has been fixed and preserved in paraffin.','\0','Paraffin Block; Paraffin-Embedded Specimen','CL-SPECCOND','DBX-NCIT-C19597'),('CL-SPECCOND-T-12',NULL,'REFRIGERATED','A specimen that has been kept or preserved at a low temperature in a refrigerator. (NCI)','\0','Refrigerated Specimen','CL-SPECCOND','DBX-NCIT-C70718'),('CL-SPECCOND-T-13',NULL,'ROOM TEMPERATURE','A specimen that has been subjected to and adjusted to the average ambient temperature of a room, usually considered to be around 20 degrees C (68 degrees F). (NCI)','\0','Ambient Temperature; Specimen at Room Temperature','CL-SPECCOND','DBX-NCIT-C70719'),('CL-SPECCOND-T-2',NULL,'CALCIFIED','A specimen that has undergone calcification. (NCI)','\0','Calcified Specimen','CL-SPECCOND','DBX-NCIT-C78723'),('CL-SPECCOND-T-3',NULL,'CLOTTED','A specimen that has become coagulated. (NCI)','\0','Clotted Specimen','CL-SPECCOND','DBX-NCIT-C78724'),('CL-SPECCOND-T-4',NULL,'CONTAMINATED','The presence of any substance or organism that makes a preparation impure. (NCI)','\0','','CL-SPECCOND','DBX-NCIT-C68768'),('CL-SPECCOND-T-5',NULL,'DRIED','A specimen that has become dessicated or dehydrated.','\0','Dried Specimen','CL-SPECCOND','DBX-NCIT-C84516'),('CL-SPECCOND-T-6',NULL,'FRESH','A specimen that is analyzed in the state that it was collected.','\0','Fresh Specimen','CL-SPECCOND','DBX-NCIT-C84517'),('CL-SPECCOND-T-7',NULL,'FROZEN','A specimen that has been subjected to and immobilized by severe cold. (NCI)','\0','Frozen Specimen','CL-SPECCOND','DBX-NCIT-C70717'),('CL-SPECCOND-T-8',NULL,'HEMOLYZED','A specimen that has undergone the destruction of red blood cells followed by the release of the hemoglobin. (NCI)','\0','Hemolysis in Specimen','CL-SPECCOND','DBX-NCIT-C70720'),('CL-SPECCOND-T-9',NULL,'ICTERIC','A specimen that exhibits a yellowish pigmentation due to jaundice. (NCI)','\0','Icteric Specimen','CL-SPECCOND','DBX-NCIT-C98744'),('CL-SPECTYPE-T-1',NULL,'ADIPOSE TISSUE','A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)','\0','Adipose Tissue; Body Fat; Fat Tissue','CL-SPECTYPE','DBX-NCIT-C12472'),('CL-SPECTYPE-T-10',NULL,'BREAST MILK','Milk produced by females for the purpose of feeding their young. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13257'),('CL-SPECTYPE-T-11',NULL,'BUFFY COAT','The middle fraction of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets.','\0','','CL-SPECTYPE','DBX-NCIT-C84507'),('CL-SPECTYPE-T-12',NULL,'CALCULUS','Accumulated material from the secretions of an organ. It is solid and representative examples include gallbladder stones, kidney stones, and salivary gland stones. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C35708'),('CL-SPECTYPE-T-13',NULL,'CAPILLARY BLOOD','A mixture of arterial blood, venous blood and interstitial fluid, which is found in the capillaries.','\0','','CL-SPECTYPE','DBX-NCIT-C112235'),('CL-SPECTYPE-T-14',NULL,'CARDIAC MUSCLE TISSUE','The striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI)','\0','Myocardium','CL-SPECTYPE','DBX-NCIT-C12371'),('CL-SPECTYPE-T-15',NULL,'CEREBROSPINAL FLUID','The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (NCI)','\0','CSF','CL-SPECTYPE','DBX-NCIT-C12692'),('CL-SPECTYPE-T-16',NULL,'CERUMEN','A wax secreted by glands in the ear canal.','\0','','CL-SPECTYPE','DBX-NCIT-C32293'),('CL-SPECTYPE-T-17',NULL,'CIRCULATING TUMOR CELL','A metastatic cancer cell found in the peripheral blood. (NCI)','\0','CTC','CL-SPECTYPE','DBX-NCIT-C63797'),('CL-SPECTYPE-T-18',NULL,'COLOSTRUM','A thick, protein-rich substance secreted by the breasts during the second half of pregnancy and for a few days after birth before the breast milk comes in.','\0','','CL-SPECTYPE','DBX-NCIT-C32348'),('CL-SPECTYPE-T-19',NULL,'DIALYSIS FLUID','The fluid which runs through a dialysis machine and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI)','\0','Dialysate','CL-SPECTYPE','DBX-NCIT-C106515'),('CL-SPECTYPE-T-2',NULL,'AMNIOTIC FLUID','The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI)','\0','Aqua Amnii','CL-SPECTYPE','DBX-NCIT-C13188'),('CL-SPECTYPE-T-20',NULL,'EMESIS','Stomach contents that have returned to the mouth or are ejected beyond the mouth. (NCI)','\0','Emesis; Vomit','CL-SPECTYPE','DBX-NCIT-C77666'),('CL-SPECTYPE-T-21',NULL,'ERYTHROCYTES','Cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals.','\0','RBC; Red Blood Cells','CL-SPECTYPE','DBX-NCIT-C12521'),('CL-SPECTYPE-T-22',NULL,'EXPIRED AIR','The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78741'),('CL-SPECTYPE-T-23',NULL,'EXUDATE','Fluid, cells or cellular debris that escapes from the blood vessels and accumulates in nearby tissues. It is the result of inflammation and is rich in proteins.','\0','','CL-SPECTYPE','DBX-NCIT-C13233'),('CL-SPECTYPE-T-24',NULL,'FLUID','Liquid substances produced by the body.','\0','','CL-SPECTYPE','DBX-NCIT-C13236'),('CL-SPECTYPE-T-25',NULL,'HAIR','The filamentous outgrowth of the epidermis. (NCI)','\0','Hair','CL-SPECTYPE','DBX-NCIT-C32705'),('CL-SPECTYPE-T-26',NULL,'HAIR FOLLICLE','A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from t','\0','','CL-SPECTYPE','DBX-NCIT-C13317'),('CL-SPECTYPE-T-27',NULL,'INFRANATANT, PLASMA','The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106554'),('CL-SPECTYPE-T-28',NULL,'INFRANATANT, PLEURAL FLUID','The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106558'),('CL-SPECTYPE-T-29',NULL,'INFRANATANT, SERUM','The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106565'),('CL-SPECTYPE-T-3',NULL,'AQUEOUS HUMOR','The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI)','\0','Aqueous Humour','CL-SPECTYPE','DBX-NCIT-C13190'),('CL-SPECTYPE-T-30',NULL,'ISOLATE','A specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system.','\0','Microbial Isolate','CL-SPECTYPE','DBX-NCIT-C53471'),('CL-SPECTYPE-T-31',NULL,'LAVAGE FLUID','Fluid introduced into, and collected from, a body cavity by lavage procedure. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C103411'),('CL-SPECTYPE-T-32',NULL,'LOCHIA','Vaginal discharge occurring during the post-partum period. It consists of a mixture of blood, mucus, and placental remnants. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78742'),('CL-SPECTYPE-T-33',NULL,'LUNG SURFACTANT','Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alve','\0','Surfactant','CL-SPECTYPE','DBX-NCIT-C13273'),('CL-SPECTYPE-T-34',NULL,'LYMPH','A clear, transparent, sometimes faintly yellow and slightly opalescent fluid that is collected from the tissues throughout the body, flows in the lymphatic vessels (through the lymph nodes), and is eventually added to the venous blood circulation. Lymph c','\0','','CL-SPECTYPE','DBX-NCIT-C13252'),('CL-SPECTYPE-T-35',NULL,'LYSATE','The cellular debris and fluid produced by lysis of cells.','\0','','CL-SPECTYPE','DBX-NCIT-C62004'),('CL-SPECTYPE-T-36',NULL,'MECONIUM','The newborn\'s first intestinal discharge. It is a dark-green, thick substance composed of mucus, intestinal secretions, hair, and intestinal mucosa cells. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78743'),('CL-SPECTYPE-T-37',NULL,'MENSTRUAL BLOOD','The discharged blood from the uterus during the reproductive years. The discharge occurs approximately once a month. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78740'),('CL-SPECTYPE-T-38',NULL,'MUCUS','The thick fluid secreted by the mucus glands in the aerodigestive tract and the vagina. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13259'),('CL-SPECTYPE-T-39',NULL,'NAIL','The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI)','\0','Nail','CL-SPECTYPE','DBX-NCIT-C33156'),('CL-SPECTYPE-T-4',NULL,'ARTERIAL BLOOD','Oxygenated blood which is transported with nutrients to body tissues through the arterial system. The exception is blood within the pulmonary artery which carries deoxygenated blood to the lungs. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78729'),('CL-SPECTYPE-T-40',NULL,'PERIPHERAL BLOOD MONONUCLEAR CELL','A peripheral blood cell with a single nucleus, for example lymphocytes and monocytes.','\0','PBMC','CL-SPECTYPE','DBX-NCIT-C12954'),('CL-SPECTYPE-T-41',NULL,'PERSPIRATION','The liquid secreted by the sweat glands. (NCI)','\0','Sweat','CL-SPECTYPE','DBX-NCIT-C13280'),('CL-SPECTYPE-T-42',NULL,'PLASMA','Plasma is the fluid (acellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.','\0','','CL-SPECTYPE','DBX-NCIT-C13356'),('CL-SPECTYPE-T-43',NULL,'PLATELET','An irregular, disc-shaped structure in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes. (NCI)','\0','Thrombocyte','CL-SPECTYPE','DBX-NCIT-C12520'),('CL-SPECTYPE-T-44',NULL,'PLATELET POOR PLASMA','A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to decrease the amount of platelets. (NCI)','\0','PPP','CL-SPECTYPE','DBX-NCIT-C106556'),('CL-SPECTYPE-T-45',NULL,'PLATELET RICH PLASMA','A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to concentrate the amount of platelets. (NCI)','\0','PRP','CL-SPECTYPE','DBX-NCIT-C106557'),('CL-SPECTYPE-T-46',NULL,'PLEURAL FLUID','The fluid that is abnormally collected in the pleural cavity. (NCI)','\0','Pleural Fluid','CL-SPECTYPE','DBX-NCIT-C77613'),('CL-SPECTYPE-T-47',NULL,'PROSTATIC FLUID','A slightly alkaline, white fluid secreted from the prostate and is a constituent of semen.','\0','','CL-SPECTYPE','DBX-NCIT-C100896'),('CL-SPECTYPE-T-48',NULL,'PUS','A yellowish substance produced during bacterial inflammation. It contains necrotic cells and cells fighting the infection. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C50718'),('CL-SPECTYPE-T-49',NULL,'SALIVA','A clear liquid secreted into the mouth by the salivary glands and mucous glands of the mouth; moistens the mouth and starts the digestion of starches. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13275'),('CL-SPECTYPE-T-5',NULL,'ATHEROSCLEROTIC PLAQUE','Fatty tissue which is deposited in the inner lining of the arterial wall. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78739'),('CL-SPECTYPE-T-50',NULL,'SEBUM','A thick, oily substance produced by the sebaceous glands located in the dermis. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13276'),('CL-SPECTYPE-T-51',NULL,'SEMEN','The thick, whitish secretion of the male reproductive organs. It is composed of spermatozoa in their nutrient plasma, secretions from the prostate, seminal vesicles, and various other glands, epithelial cells, and minor constituents. (NCI)','\0','Seminal Plasma','CL-SPECTYPE','DBX-NCIT-C13277'),('CL-SPECTYPE-T-52',NULL,'SEMINAL FLUID','Part of the ejaculated fluid. It contains secretions from the seminal vesicles, Cowper gland, and prostate gland.','\0','','CL-SPECTYPE','DBX-NCIT-C33529'),('CL-SPECTYPE-T-53',NULL,'SERUM','The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI)','\0','Sera','CL-SPECTYPE','DBX-NCIT-C13325'),('CL-SPECTYPE-T-54',NULL,'SKELETAL MUSCLE TISSUE','Striated muscles that are under voluntary control of the organism. They are connected at either or both ends to a bone and are utilized for locomotion and other movements. (NCI)','\0','Skeletal Muscle Tissue','CL-SPECTYPE','DBX-NCIT-C13050'),('CL-SPECTYPE-T-55',NULL,'SMEGMA','A white secretion of the sebaceous glands of the foreskin. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C33574'),('CL-SPECTYPE-T-56',NULL,'SMOOTH MUSCLE TISSUE','Involuntary muscle tissue of the internal organs. It is composed of elongated muscle cells or fibers that are not arranged in a striated pattern and form layers of muscle tissue. The smooth muscle cells contain a contractile apparatus composed of thin and','\0','','CL-SPECTYPE','DBX-NCIT-C12437'),('CL-SPECTYPE-T-57',NULL,'SOFT TISSUE','Refers to muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.','\0','Soft Tissue','CL-SPECTYPE','DBX-NCIT-C12471'),('CL-SPECTYPE-T-58',NULL,'SPUTUM','Material containing mucus, cellular debris, microorganisms and sometimes blood or pus. It is ejected through the mouth from the lungs, bronchi, and trachea. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13278'),('CL-SPECTYPE-T-59',NULL,'STOOL','The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria. (NCI)','\0','Feces','CL-SPECTYPE','DBX-NCIT-C13234'),('CL-SPECTYPE-T-6',NULL,'BILE','Fluid composed of waste products, bile acids, salts, cholesterol, and electrolytes. It is secreted by the liver parenchyma and stored in the gallbladder. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13192'),('CL-SPECTYPE-T-60',NULL,'STRIATED MUSCLE TISSUE','Striated muscles are appendicular and axial muscles typically connected at either or both ends to the bony skeleton of the body. Striated muscle fibers contain a highly organized, contractile cytoskeletal apparatus with a striated microscopic appearance; ','\0','','CL-SPECTYPE','DBX-NCIT-C12436'),('CL-SPECTYPE-T-61',NULL,'SUPERNATANT, PLASMA','The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106555'),('CL-SPECTYPE-T-62',NULL,'SUPERNATANT, PLEURAL FLUID','The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106559'),('CL-SPECTYPE-T-63',NULL,'SUPERNATANT, SERUM','The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C106566'),('CL-SPECTYPE-T-64',NULL,'SYNOVIAL FLUID','A viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI)','\0','Synovia; Synovial Fluid','CL-SPECTYPE','DBX-NCIT-C33718'),('CL-SPECTYPE-T-65',NULL,'TISSUE','An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C12801'),('CL-SPECTYPE-T-66',NULL,'TRANSUDATE','The fluid that passes through the wall of the veins and capillaries to the surrounding tissues because of increased intravascular pressure. It has low protein content. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C78744'),('CL-SPECTYPE-T-67',NULL,'TUMOR TISSUE','A tumor sample, or entire tumor that is removed for examination.','\0','','CL-SPECTYPE','DBX-NCIT-C18009'),('CL-SPECTYPE-T-68',NULL,'URINE','The fluid that is excreted by the kidneys. It is stored in the bladder and discharged through the urethra. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13283'),('CL-SPECTYPE-T-69',NULL,'VENOUS BLOOD','Deoxygenated blood containing urea and other waste products which is transported through the venous system to the heart and lungs. The exception is blood within the pulmonary vein which is oxygenated and travels from the lungs to the left atrium of the he','\0','','CL-SPECTYPE','DBX-NCIT-C78730'),('CL-SPECTYPE-T-7',NULL,'BLOOD','A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.','\0','Blood; Peripheral Blood','CL-SPECTYPE','DBX-NCIT-C12434'),('CL-SPECTYPE-T-70',NULL,'VITREOUS HUMOR','The clear colorless transparent jelly that fills the posterior chamber of the eyeball. (NCI)','\0','','CL-SPECTYPE','DBX-NCIT-C13323'),('CL-SPECTYPE-T-8',NULL,'BONE','Calcified connective tissue that forms the skeletal components of the body. (NCI)','\0','Bone','CL-SPECTYPE','DBX-NCIT-C12366'),('CL-SPECTYPE-T-9',NULL,'BONE MARROW','The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI)','\0','Bone Marrow','CL-SPECTYPE','DBX-NCIT-C12431'),('CL-SRTEST-T-1',NULL,'Allergen Skin Response Index','A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test.','\0','Allergen Skin Response Index','CL-SRTEST','DBX-NCIT-C112221'),('CL-SRTEST-T-2',NULL,'Allergen Skin Response Intensity','A semi-quantitative assessment of the intensity of the wheal and flare reaction.','\0','Allergen Skin Response Intensity','CL-SRTEST','DBX-NCIT-C112222'),('CL-SRTEST-T-3',NULL,'Flare Longest Diameter','The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Longest Diameter','CL-SRTEST','DBX-NCIT-C112281'),('CL-SRTEST-T-4',NULL,'Flare Mean Diameter','The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Mean Diameter','CL-SRTEST','DBX-NCIT-C112282'),('CL-SRTEST-T-5',NULL,'Flare Size','The size of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Size','CL-SRTEST','DBX-NCIT-C112283'),('CL-SRTEST-T-6',NULL,'Wheal Longest Diameter','The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Longest Diameter','CL-SRTEST','DBX-NCIT-C112427'),('CL-SRTEST-T-7',NULL,'Wheal Mean Diameter','The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Mean Diameter','CL-SRTEST','DBX-NCIT-C112428'),('CL-SRTEST-T-8',NULL,'Wheal Size','A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Size','CL-SRTEST','DBX-NCIT-C112429'),('CL-SRTESTCD-T-1',NULL,'ASRINDEX','A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test.','\0','Allergen Skin Response Index','CL-SRTESTCD','DBX-NCIT-C112221'),('CL-SRTESTCD-T-2',NULL,'ASRINT','A semi-quantitative assessment of the intensity of the wheal and flare reaction.','\0','Allergen Skin Response Intensity','CL-SRTESTCD','DBX-NCIT-C112222'),('CL-SRTESTCD-T-3',NULL,'FLARESZ','The size of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Size','CL-SRTESTCD','DBX-NCIT-C112283'),('CL-SRTESTCD-T-4',NULL,'FLRLDIAM','The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Longest Diameter','CL-SRTESTCD','DBX-NCIT-C112281'),('CL-SRTESTCD-T-5',NULL,'FLRMDIAM','The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin.','\0','Flare Mean Diameter','CL-SRTESTCD','DBX-NCIT-C112282'),('CL-SRTESTCD-T-6',NULL,'WHEALSZ','A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Size','CL-SRTESTCD','DBX-NCIT-C112429'),('CL-SRTESTCD-T-7',NULL,'WHLLDIAM','The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Longest Diameter','CL-SRTESTCD','DBX-NCIT-C112427'),('CL-SRTESTCD-T-8',NULL,'WHLMDIAM','The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.','\0','Wheal Mean Diameter','CL-SRTESTCD','DBX-NCIT-C112428'),('CL-STENRF-T-1',NULL,'AFTER','The time period following a point or another period of time. (NCI)','\0','','CL-STENRF','DBX-NCIT-C38008'),('CL-STENRF-T-2',NULL,'BEFORE','Earlier in time or order. (NCI)','\0','','CL-STENRF','DBX-NCIT-C25629'),('CL-STENRF-T-3',NULL,'COINCIDENT','Occurring or operating at the same time.','\0','','CL-STENRF','DBX-NCIT-C25456'),('CL-STENRF-T-4',NULL,'DURING','At some point in a given period of time. (NCI)','\0','','CL-STENRF','DBX-NCIT-C25490'),('CL-STENRF-T-5',NULL,'DURING/AFTER','Within a certain period of time or after a certain point or period in time. (NCI)','\0','','CL-STENRF','DBX-NCIT-C49640'),('CL-STENRF-T-6',NULL,'ONGOING','Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)','\0','Continuous','CL-STENRF','DBX-NCIT-C53279'),('CL-STENRF-T-7',NULL,'UNKNOWN','Not known, not observed, not recorded, or refused. (NCI)','\0','U; Unknown','CL-STENRF','DBX-NCIT-C17998'),('CL-STYPE-T-1',NULL,'EXPANDED ACCESS','Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clini','\0','','CL-STYPE','DBX-NCIT-C98722'),('CL-STYPE-T-2',NULL,'INTERVENTIONAL','Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. ','\0','','CL-STYPE','DBX-NCIT-C98388'),('CL-STYPE-T-3',NULL,'OBSERVATIONAL','Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the sub','\0','','CL-STYPE','DBX-NCIT-C16084'),('CL-TBLIND-T-1',NULL,'DOUBLE BLIND','A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)','\0','','CL-TBLIND','DBX-NCIT-C15228'),('CL-TBLIND-T-2',NULL,'OPEN LABEL','A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)','\0','','CL-TBLIND','DBX-NCIT-C49659'),('CL-TBLIND-T-3',NULL,'SINGLE BLIND','A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)','\0','','CL-TBLIND','DBX-NCIT-C28233'),('CL-TCNTRL-T-1',NULL,'ACTIVE','A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].','\0','','CL-TCNTRL','DBX-NCIT-C49649'),('CL-TCNTRL-T-2',NULL,'NONE','No person or thing, nobody, not any. (NCI)','\0','','CL-TCNTRL','DBX-NCIT-C41132'),('CL-TCNTRL-T-3',NULL,'PLACEBO','Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the dru','\0','','CL-TCNTRL','DBX-NCIT-C49648'),('CL-TDIGRP-T-1',NULL,'HEALTHY SUBJECTS','An individual who is or becomes a participant in a research study and has no significant health-related issues. (NCI)','\0','','CL-TDIGRP','DBX-NCIT-C49651'),('CL-TIMIFLOW-T-1',NULL,'GRADE 0','No perfusion. There is no antegrade flow beyond the point of occlusion. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenou','\0','Thrombolysis in Myocardial Infarction Flow - 0','CL-TIMIFLOW','DBX-NCIT-C100040'),('CL-TIMIFLOW-T-2',NULL,'GRADE 1','Penetration without perfusion. Contrast material passes beyond the area of obstruction but \"hangs up\" and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cineangiographic filming sequence. (Chesebro JH, Knatterud','\0','Thrombolysis in Myocardial Infarction Flow - 1','CL-TIMIFLOW','DBX-NCIT-C100041'),('CL-TIMIFLOW-T-3',NULL,'GRADE 2','Partial perfusion. The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. However, the rate of entry of contrast material into the vessel distal to the obstruction or its rate of clearance from the di','\0','Thrombolysis in Myocardial Infarction Flow - 2','CL-TIMIFLOW','DBX-NCIT-C100042'),('CL-TIMIFLOW-T-4',NULL,'GRADE 3','Complete perfusion. Antegrade flow into the bed distal to the obstruction occurs as promptly as into the bed from the involved bed and is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery. (Chesebro JH, Knatterud GL, R','\0','Thrombolysis in Myocardial Infarction Flow - 3','CL-TIMIFLOW','DBX-NCIT-C100043'),('CL-TINDTP-T-1',NULL,'CURE','A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition. (NCI)','\0','','CL-TINDTP','DBX-NCIT-C49654'),('CL-TINDTP-T-2',NULL,'DIAGNOSIS','A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition. (NCI)','\0','','CL-TINDTP','DBX-NCIT-C49653'),('CL-TINDTP-T-3',NULL,'MITIGATION','A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI)','\0','','CL-TINDTP','DBX-NCIT-C49655'),('CL-TINDTP-T-4',NULL,'PREVENTION','A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.','\0','','CL-TINDTP','DBX-NCIT-C49657'),('CL-TINDTP-T-5',NULL,'TREATMENT','A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.','\0','','CL-TINDTP','DBX-NCIT-C49656'),('CL-TOXGRV3-T-1',NULL,'1','A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.','\0','1; Grade 1','CL-TOXGRV3','DBX-NCIT-C41338'),('CL-TOXGRV3-T-2',NULL,'2','A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research partici','\0','2; Grade 2','CL-TOXGRV3','DBX-NCIT-C41339'),('CL-TOXGRV3-T-3',NULL,'3','A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.','\0','3; Grade 3','CL-TOXGRV3','DBX-NCIT-C41340'),('CL-TOXGRV3-T-4',NULL,'4','An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, amb','\0','4; Grade 4; LIFE THREATENING','CL-TOXGRV3','DBX-NCIT-C41337'),('CL-TOXGRV3-T-5',NULL,'5','The termination of life as a result of an adverse event. (NCI)','\0','5; FATAL; Grade 5','CL-TOXGRV3','DBX-NCIT-C48275'),('CL-TOXGRV4-T-1',NULL,'0','Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.','\0','0; ABSENT; Grade 0','CL-TOXGRV4','DBX-NCIT-C75533'),('CL-TOXGRV4-T-2',NULL,'1','An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription inter','\0','1; Grade 1; MILD','CL-TOXGRV4','DBX-NCIT-C84263'),('CL-TOXGRV4-T-3',NULL,'2','An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).','\0','2; Grade 2; MODERATE','CL-TOXGRV4','DBX-NCIT-C84264'),('CL-TOXGRV4-T-4',NULL,'3','An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the pa','\0','3; Grade 3; SEVERE','CL-TOXGRV4','DBX-NCIT-C84265'),('CL-TOXGRV4-T-5',NULL,'4','An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken; or that causes blindness or deafness.','\0','4; Grade 4; LIFE THREATENING','CL-TOXGRV4','DBX-NCIT-C84266'),('CL-TOXGRV4-T-6',NULL,'5','The termination of life as a result of an adverse event. (NCI)','\0','5; FATAL; Grade 5','CL-TOXGRV4','DBX-NCIT-C48275'),('CL-TPHASE-T-1',NULL,'NOT APPLICABLE','Determination of a value is not relevant in the current context. (NCI)','\0','NA; Not Applicable','CL-TPHASE','DBX-NCIT-C48660'),('CL-TPHASE-T-10',NULL,'Phase IIIb Trial','A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approva','\0','3B; Trial Phase 3B','CL-TPHASE','DBX-NCIT-C49689'),('CL-TPHASE-T-11',NULL,'Phase IV Trial','Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug\'s risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but w','\0','4; Trial Phase 4','CL-TPHASE','DBX-NCIT-C15603'),('CL-TPHASE-T-12',NULL,'Phase V Trial','Postmarketing surveillance is sometimes referred to as Phase V.','\0','5; Trial Phase 5','CL-TPHASE','DBX-NCIT-C47865'),('CL-TPHASE-T-2',NULL,'Phase I Trial','The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacolo','\0','1; Trial Phase 1','CL-TPHASE','DBX-NCIT-C15600'),('CL-TPHASE-T-3',NULL,'Phase I/II Trial','A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.','\0','1-2; Trial Phase 1-2','CL-TPHASE','DBX-NCIT-C15693'),('CL-TPHASE-T-4',NULL,'Phase II Trial','Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associa','\0','2; Trial Phase 2','CL-TPHASE','DBX-NCIT-C15601'),('CL-TPHASE-T-5',NULL,'Phase II/III Trial','A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.','\0','2-3; Trial Phase 2-3','CL-TPHASE','DBX-NCIT-C15694'),('CL-TPHASE-T-6',NULL,'Phase IIa Trial','A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)','\0','2A; Trial Phase 2A','CL-TPHASE','DBX-NCIT-C49686'),('CL-TPHASE-T-7',NULL,'Phase IIb Trial','A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and ','\0','2B; Trial Phase 2B','CL-TPHASE','DBX-NCIT-C49688'),('CL-TPHASE-T-8',NULL,'Phase III Trial','Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety th','\0','3; Trial Phase 3','CL-TPHASE','DBX-NCIT-C15602'),('CL-TPHASE-T-9',NULL,'Phase IIIa Trial','A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI)','\0','3A; Trial Phase 3A','CL-TPHASE','DBX-NCIT-C49687'),('CL-TRTEPSD-T-1',NULL,'NEW','Having no previous example or precedent or parallel; of a kind not seen before.','\0','','CL-TRTEPSD','DBX-NCIT-C25586'),('CL-TRTEPSD-T-2',NULL,'RETREATMENT','The repeated act of the dispensing, applying, or tendering of something to another after an initial treatment.','\0','','CL-TRTEPSD','DBX-NCIT-C54055'),('CL-TRTEST-T-1',NULL,'Absolute Change From Nadir','The current value minus the lowest value previously recorded.','\0','Absolute Change From Nadir','CL-TRTEST','DBX-NCIT-C103347'),('CL-TRTEST-T-10',NULL,'Percent Change Baseline in Sum of Diam','The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100.','\0','Percent Change Baseline in Sum of Diam','CL-TRTEST','DBX-NCIT-C112370'),('CL-TRTEST-T-11',NULL,'Percent Change Baseline in Sum of Volume','The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100.','\0','Percent Change Baseline in Sum of Volume','CL-TRTEST','DBX-NCIT-C112372'),('CL-TRTEST-T-12',NULL,'Percent Change Baseline Sum Longest Diam','The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100.','\0','Percent Change Baseline Sum Longest Diam','CL-TRTEST','DBX-NCIT-C112371'),('CL-TRTEST-T-13',NULL,'Percent Change From Baseline','The (current value minus the baseline value) divided by the baseline value, multiplied by 100.','\0','Percent Change From Baseline','CL-TRTEST','DBX-NCIT-C96621'),('CL-TRTEST-T-14',NULL,'Percent Change From Nadir','The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100.','\0','Percent Change From Nadir','CL-TRTEST','DBX-NCIT-C96622'),('CL-TRTEST-T-15',NULL,'Percent Change Nadir in Sum Longest Diam','The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100.','\0','Percent Change Nadir in Sum Longest Diam','CL-TRTEST','DBX-NCIT-C112374'),('CL-TRTEST-T-16',NULL,'Percent Change Nadir in Sum of Diam','The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100.','\0','Percent Change Nadir in Sum of Diam','CL-TRTEST','DBX-NCIT-C112373'),('CL-TRTEST-T-17',NULL,'Radiodensity','The transparency of a material to the passage of X-rays and other forms of radiation.','\0','Radiodensity','CL-TRTEST','DBX-NCIT-C96627'),('CL-TRTEST-T-18',NULL,'Short Axis','The plane through a body or figure that is at the shortest width of that body or figure.','\0','Short Axis','CL-TRTEST','DBX-NCIT-C94982'),('CL-TRTEST-T-19',NULL,'Sum Diameters of Non Lymph Node Tumors','A calculation of the aggregated diameter values for tumors other than the lymph nodes.','\0','Sum Diameters of Non Lymph Node Tumors','CL-TRTEST','DBX-NCIT-C103441'),('CL-TRTEST-T-2',NULL,'Absolute Change Nadir in Sum of Diam','The current sum of diameters minus the lowest sum of diameters previously recorded.','\0','Absolute Change Nadir in Sum of Diam','CL-TRTEST','DBX-NCIT-C112218'),('CL-TRTEST-T-20',NULL,'Sum of Area','A calculation of the aggregated area values.','\0','Sum of Area; Sum of Products of Perpendicular Diameters','CL-TRTEST','DBX-NCIT-C96630'),('CL-TRTEST-T-21',NULL,'Sum of Diameter','A calculation of the aggregated diameter values.','\0','Sum of Diameter','CL-TRTEST','DBX-NCIT-C96631'),('CL-TRTEST-T-22',NULL,'Sum of Longest Diameter','A calculation of the aggregated longest diameter values.','\0','Sum of Longest Diameter','CL-TRTEST','DBX-NCIT-C96632'),('CL-TRTEST-T-23',NULL,'Sum of Longest Perpendicular','A calculation of the aggregated longest perpendicular values.','\0','Sum of Longest Perpendicular','CL-TRTEST','DBX-NCIT-C96633'),('CL-TRTEST-T-24',NULL,'Sum of Viable Diameter','A calculation of the aggregated diameter values taken from the viable portion of the tumor mass.','\0','Sum of Viable Diameter','CL-TRTEST','DBX-NCIT-C96634'),('CL-TRTEST-T-25',NULL,'Sum of Volume','A calculation of the aggregated volume values.','\0','Sum of Volume','CL-TRTEST','DBX-NCIT-C96635'),('CL-TRTEST-T-26',NULL,'Tumor State','A condition or state of a tumor at a particular time.','\0','Tumor State','CL-TRTEST','DBX-NCIT-C96643'),('CL-TRTEST-T-27',NULL,'Viable Diameter','The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis.','\0','Viable Diameter','CL-TRTEST','DBX-NCIT-C96646'),('CL-TRTEST-T-28',NULL,'Volume','The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)','\0','Volume','CL-TRTEST','DBX-NCIT-C25335'),('CL-TRTEST-T-3',NULL,'Area','The extent of a 2-dimensional surface enclosed within a boundary. (NCI)','\0','Area','CL-TRTEST','DBX-NCIT-C25244'),('CL-TRTEST-T-4',NULL,'Average Metabolic Standard Uptake Value','A semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte.','\0','Average Metabolic Standard Uptake Value','CL-TRTEST','DBX-NCIT-C96566'),('CL-TRTEST-T-5',NULL,'Diameter','The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)','\0','Diameter','CL-TRTEST','DBX-NCIT-C25285'),('CL-TRTEST-T-6',NULL,'Longest Diameter','The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference.','\0','Longest Diameter','CL-TRTEST','DBX-NCIT-C96684'),('CL-TRTEST-T-7',NULL,'Longest Perpendicular','The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane.','\0','Longest Perpendicular','CL-TRTEST','DBX-NCIT-C96685'),('CL-TRTEST-T-8',NULL,'New Tumor Confirmed','The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject.','\0','New Tumor Confirmed','CL-TRTEST','DBX-NCIT-C103421'),('CL-TRTEST-T-9',NULL,'Percent Change Baseline in Sum of Area','The (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100.','\0','Percent Change Baseline in Sum of Area','CL-TRTEST','DBX-NCIT-C112369'),('CL-TRTESTCD-T-1',NULL,'ACHNAD','The current value minus the lowest value previously recorded.','\0','Absolute Change From Nadir','CL-TRTESTCD','DBX-NCIT-C103347'),('CL-TRTESTCD-T-10',NULL,'PCBSD','The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100.','\0','Percent Change Baseline in Sum of Diam','CL-TRTESTCD','DBX-NCIT-C112370'),('CL-TRTESTCD-T-11',NULL,'PCBSLD','The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100.','\0','Percent Change Baseline Sum Longest Diam','CL-TRTESTCD','DBX-NCIT-C112371'),('CL-TRTESTCD-T-12',NULL,'PCBSV','The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100.','\0','Percent Change Baseline in Sum of Volume','CL-TRTESTCD','DBX-NCIT-C112372'),('CL-TRTESTCD-T-13',NULL,'PCHGBL','The (current value minus the baseline value) divided by the baseline value, multiplied by 100.','\0','Percent Change From Baseline','CL-TRTESTCD','DBX-NCIT-C96621'),('CL-TRTESTCD-T-14',NULL,'PCHGNAD','The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100.','\0','Percent Change From Nadir','CL-TRTESTCD','DBX-NCIT-C96622'),('CL-TRTESTCD-T-15',NULL,'PCNSD','The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100.','\0','Percent Change Nadir in Sum of Diam','CL-TRTESTCD','DBX-NCIT-C112373'),('CL-TRTESTCD-T-16',NULL,'PCNSLD','The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100.','\0','Percent Change Nadir in Sum Longest Diam','CL-TRTESTCD','DBX-NCIT-C112374'),('CL-TRTESTCD-T-17',NULL,'RADIODEN','The transparency of a material to the passage of X-rays and other forms of radiation.','\0','Radiodensity','CL-TRTESTCD','DBX-NCIT-C96627'),('CL-TRTESTCD-T-18',NULL,'SAXIS','The plane through a body or figure that is at the shortest width of that body or figure.','\0','Short Axis','CL-TRTESTCD','DBX-NCIT-C94982'),('CL-TRTESTCD-T-19',NULL,'SUMAREA','A calculation of the aggregated area values.','\0','Sum of Area; Sum of Products of Perpendicular Diameters','CL-TRTESTCD','DBX-NCIT-C96630'),('CL-TRTESTCD-T-2',NULL,'ACNSD','The current sum of diameters minus the lowest sum of diameters previously recorded.','\0','Absolute Change Nadir in Sum of Diam','CL-TRTESTCD','DBX-NCIT-C112218'),('CL-TRTESTCD-T-20',NULL,'SUMDIAM','A calculation of the aggregated diameter values.','\0','Sum of Diameter','CL-TRTESTCD','DBX-NCIT-C96631'),('CL-TRTESTCD-T-21',NULL,'SUMLDIAM','A calculation of the aggregated longest diameter values.','\0','Sum of Longest Diameter','CL-TRTESTCD','DBX-NCIT-C96632'),('CL-TRTESTCD-T-22',NULL,'SUMLPERP','A calculation of the aggregated longest perpendicular values.','\0','Sum of Longest Perpendicular','CL-TRTESTCD','DBX-NCIT-C96633'),('CL-TRTESTCD-T-23',NULL,'SUMNLNLD','A calculation of the aggregated diameter values for tumors other than the lymph nodes.','\0','Sum Diameters of Non Lymph Node Tumors','CL-TRTESTCD','DBX-NCIT-C103441'),('CL-TRTESTCD-T-24',NULL,'SUMVDIAM','A calculation of the aggregated diameter values taken from the viable portion of the tumor mass.','\0','Sum of Viable Diameter','CL-TRTESTCD','DBX-NCIT-C96634'),('CL-TRTESTCD-T-25',NULL,'SUMVOL','A calculation of the aggregated volume values.','\0','Sum of Volume','CL-TRTESTCD','DBX-NCIT-C96635'),('CL-TRTESTCD-T-26',NULL,'TUMSTATE','A condition or state of a tumor at a particular time.','\0','Tumor State','CL-TRTESTCD','DBX-NCIT-C96643'),('CL-TRTESTCD-T-27',NULL,'VDIAM','The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis.','\0','Viable Diameter','CL-TRTESTCD','DBX-NCIT-C96646'),('CL-TRTESTCD-T-28',NULL,'VOLUME','The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)','\0','Volume','CL-TRTESTCD','DBX-NCIT-C25335'),('CL-TRTESTCD-T-3',NULL,'AREA','The extent of a 2-dimensional surface enclosed within a boundary. (NCI)','\0','Area','CL-TRTESTCD','DBX-NCIT-C25244'),('CL-TRTESTCD-T-4',NULL,'AVMETSUV','A semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte.','\0','Average Metabolic Standard Uptake Value','CL-TRTESTCD','DBX-NCIT-C96566'),('CL-TRTESTCD-T-5',NULL,'DIAMETER','The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)','\0','Diameter','CL-TRTESTCD','DBX-NCIT-C25285'),('CL-TRTESTCD-T-6',NULL,'LDIAM','The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference.','\0','Longest Diameter','CL-TRTESTCD','DBX-NCIT-C96684'),('CL-TRTESTCD-T-7',NULL,'LPERP','The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane.','\0','Longest Perpendicular','CL-TRTESTCD','DBX-NCIT-C96685'),('CL-TRTESTCD-T-8',NULL,'NEWCONF','The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject.','\0','New Tumor Confirmed','CL-TRTESTCD','DBX-NCIT-C103421'),('CL-TRTESTCD-T-9',NULL,'PCBSA','The (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100.','\0','Percent Change Baseline in Sum of Area','CL-TRTESTCD','DBX-NCIT-C112369'),('CL-TSPARM-T-1',NULL,'Actual Number of Subjects','Actual number of subjects enrolled; may include subjects who were not randomized.','\0','Actual Number of Subjects','CL-TSPARM','DBX-NCIT-C98703'),('CL-TSPARM-T-10',NULL,'Data Cutoff Description','Text that describes the cutoff date.','\0','Data Cutoff Description','CL-TSPARM','DBX-NCIT-C98718'),('CL-TSPARM-T-11',NULL,'Diagnosis Group','A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a ','\0','Diagnosis Group','CL-TSPARM','DBX-NCIT-C49650'),('CL-TSPARM-T-12',NULL,'Diagnostic Criteria','A standard from which a judgment concerning a medical diagnosis can be established.','\0','Diagnostic Criteria','CL-TSPARM','DBX-NCIT-C117960'),('CL-TSPARM-T-13',NULL,'Dose per Administration','The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)','\0','Dose Level; Dose per Administration','CL-TSPARM','DBX-NCIT-C25488'),('CL-TSPARM-T-14',NULL,'Dose Units','The unit of measure for the dosage form.','\0','Dose Units','CL-TSPARM','DBX-NCIT-C73558'),('CL-TSPARM-T-15',NULL,'Dosing Frequency','The number of doses administered per a specific interval.','\0','Dosing Frequency','CL-TSPARM','DBX-NCIT-C89081'),('CL-TSPARM-T-16',NULL,'Exploratory Outcome Measure','Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.','\0','Exploratory Outcome Measure','CL-TSPARM','DBX-NCIT-C98724'),('CL-TSPARM-T-17',NULL,'Healthy Subject Indicator','Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.','\0','Healthy Subject Indicator','CL-TSPARM','DBX-NCIT-C98737'),('CL-TSPARM-T-18',NULL,'Intervention Model','The trial design developed to compare treatment groups.','\0','Intervention Model','CL-TSPARM','DBX-NCIT-C98746'),('CL-TSPARM-T-19',NULL,'Intervention Type','The kind of product or procedure studied in a trial.','\0','Intervention Type','CL-TSPARM','DBX-NCIT-C98747'),('CL-TSPARM-T-2',NULL,'Adaptive Design','Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.','\0','Adaptive Design','CL-TSPARM','DBX-NCIT-C98704'),('CL-TSPARM-T-20',NULL,'Investigational Therapy or Treatment','The investigational product under study.','\0','Investigational Therapy or Treatment','CL-TSPARM','DBX-NCIT-C41161'),('CL-TSPARM-T-21',NULL,'Pharmacological Class of Invest. Therapy','The pharmacological class of the investigational product.','\0','Pharmacological Class of Invest. Therapy','CL-TSPARM','DBX-NCIT-C98768'),('CL-TSPARM-T-22',NULL,'Planned Country of Investigational Sites','The country name of planned study facility which has received IRB approval.','\0','Planned Country of Investigational Sites','CL-TSPARM','DBX-NCIT-C98770'),('CL-TSPARM-T-23',NULL,'Planned Maximum Age of Subjects','The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)','\0','Planned Maximum Age of Subjects','CL-TSPARM','DBX-NCIT-C49694'),('CL-TSPARM-T-24',NULL,'Planned Minimum Age of Subjects','The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)','\0','Planned Minimum Age of Subjects','CL-TSPARM','DBX-NCIT-C49693'),('CL-TSPARM-T-25',NULL,'Planned Number of Arms','The planned number of intervention groups.','\0','Planned Number of Arms','CL-TSPARM','DBX-NCIT-C98771'),('CL-TSPARM-T-26',NULL,'Planned Number of Subjects','The planned number of subjects to be entered in a clinical trial. (NCI)','\0','Anticipated Enrollment; Planned Enrollment; Planned Number of Subjects; Target Enrollment','CL-TSPARM','DBX-NCIT-C49692'),('CL-TSPARM-T-27',NULL,'Primary Outcome Measure','The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the','\0','Primary Outcome Measure','CL-TSPARM','DBX-NCIT-C98772'),('CL-TSPARM-T-28',NULL,'Randomization Quotient','The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.','\0','Randomization Quotient','CL-TSPARM','DBX-NCIT-C98775'),('CL-TSPARM-T-29',NULL,'Registry Identifier','Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.','\0','Registry Identifier','CL-TSPARM','DBX-NCIT-C98714'),('CL-TSPARM-T-3',NULL,'Added on to Existing Treatments','The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.','\0','Added on to Existing Treatments','CL-TSPARM','DBX-NCIT-C49703'),('CL-TSPARM-T-30',NULL,'Relapse Criteria','A standard from which a judgment concerning a disease relapse can be established.','\0','Relapse Criteria','CL-TSPARM','DBX-NCIT-C117961'),('CL-TSPARM-T-31',NULL,'Route of Administration','The course by which a substance was administered in order to reach the site of action in the body.','\0','Route of Administration','CL-TSPARM','DBX-NCIT-C38114'),('CL-TSPARM-T-32',NULL,'Secondary Outcome Measure','Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).','\0','Secondary Outcome Measure','CL-TSPARM','DBX-NCIT-C98781'),('CL-TSPARM-T-33',NULL,'Severity Criteria','A standard from which a judgment concerning the severity of an event, disease or condition can be established.','\0','Severity Criteria','CL-TSPARM','DBX-NCIT-C117962'),('CL-TSPARM-T-34',NULL,'Sex of Participants','The specific sex, either male, female, or mixed of the subject group being studied. (NCI)','\0','Sex Of Participants; Sex of Participants','CL-TSPARM','DBX-NCIT-C49696'),('CL-TSPARM-T-35',NULL,'Stable Disease Minimum Duration','The protocol specified minimum amount of time needed to meet the definition of stable disease.','\0','Stable Disease Minimum Duration','CL-TSPARM','DBX-NCIT-C98783'),('CL-TSPARM-T-36',NULL,'Stratification Factor','Selected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol.','\0','Stratification Factor','CL-TSPARM','DBX-NCIT-C16153'),('CL-TSPARM-T-37',NULL,'Study End Date','Final date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.','\0','Study End Date','CL-TSPARM','DBX-NCIT-C90462'),('CL-TSPARM-T-38',NULL,'Study Start Date','The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen f','\0','Study Start Date','CL-TSPARM','DBX-NCIT-C69208'),('CL-TSPARM-T-39',NULL,'Study Stop Rules','The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)','\0','Study Stop Rules','CL-TSPARM','DBX-NCIT-C49698'),('CL-TSPARM-T-4',NULL,'Clinical Study Sponsor','An entity that is responsible for the initiation, management, and/or financing of a clinical study.','\0','Clinical Study Sponsor; Sponsor; Study Sponsor','CL-TSPARM','DBX-NCIT-C70793'),('CL-TSPARM-T-40',NULL,'Study Type','Describes the role the study plays in determining the interventions a subject receives.','\0','Study Type','CL-TSPARM','DBX-NCIT-C15320'),('CL-TSPARM-T-41',NULL,'Trial Blinding Schema','The name of a code list that contains terms to define the type of blinding for the trial. (NCI)','\0','Trial Blinding Schema','CL-TSPARM','DBX-NCIT-C49658'),('CL-TSPARM-T-42',NULL,'Trial Indication','The condition, disease or disorder that the clinical trial is intended to investigate or address.','\0','Trial Indication','CL-TSPARM','DBX-NCIT-C112038'),('CL-TSPARM-T-43',NULL,'Trial Indication Type','The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)','\0','Trial Indication Type','CL-TSPARM','DBX-NCIT-C49652'),('CL-TSPARM-T-44',NULL,'Trial is Randomized','The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for exampl','\0','Trial is Randomized','CL-TSPARM','DBX-NCIT-C25196'),('CL-TSPARM-T-45',NULL,'Trial Length','Planned length of observation for a single subject.','\0','Trial Length','CL-TSPARM','DBX-NCIT-C49697'),('CL-TSPARM-T-46',NULL,'Trial Phase Classification','Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure wheth','\0','Trial Phase Classification','CL-TSPARM','DBX-NCIT-C48281'),('CL-TSPARM-T-47',NULL,'Trial Primary Objective','The principal purpose of the trial.','\0','Trial Primary Objective','CL-TSPARM','DBX-NCIT-C85826'),('CL-TSPARM-T-48',NULL,'Trial Secondary Objective','The auxiliary purpose of the trial.','\0','Trial Secondary Objective','CL-TSPARM','DBX-NCIT-C85827'),('CL-TSPARM-T-49',NULL,'Trial Title','The name of a clinical trial. (NCI)','\0','Trial Title','CL-TSPARM','DBX-NCIT-C49802'),('CL-TSPARM-T-5',NULL,'Comparative Treatment Name','A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.','\0','Comparative Treatment Name','CL-TSPARM','DBX-NCIT-C68612'),('CL-TSPARM-T-50',NULL,'Trial Type','The type of clinical trial performed e.g. efficacy, safety. (NCI)','\0','Trial Type','CL-TSPARM','DBX-NCIT-C49660'),('CL-TSPARM-T-6',NULL,'Confirmed Response Minimum Duration','The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.','\0','Confirmed Response Minimum Duration','CL-TSPARM','DBX-NCIT-C98715'),('CL-TSPARM-T-7',NULL,'Control Type','Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).','\0','Control Type','CL-TSPARM','DBX-NCIT-C49647'),('CL-TSPARM-T-8',NULL,'Current Therapy or Treatment','The literal identifier of the therapy or medication that is currently being given per protocol.','\0','Current Therapy or Treatment','CL-TSPARM','DBX-NCIT-C85582'),('CL-TSPARM-T-9',NULL,'Data Cutoff Date','A date which indicates any data collected by this date will be used for analysis.','\0','Data Cutoff Date','CL-TSPARM','DBX-NCIT-C98717'),('CL-TSPARMCD-T-1',NULL,'ACTSUB','Actual number of subjects enrolled; may include subjects who were not randomized.','\0','Actual Number of Subjects','CL-TSPARMCD','DBX-NCIT-C98703'),('CL-TSPARMCD-T-10',NULL,'DCUTDTC','A date which indicates any data collected by this date will be used for analysis.','\0','Data Cutoff Date','CL-TSPARMCD','DBX-NCIT-C98717'),('CL-TSPARMCD-T-11',NULL,'DOSE','The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)','\0','Dose Level; Dose per Administration','CL-TSPARMCD','DBX-NCIT-C25488'),('CL-TSPARMCD-T-12',NULL,'DOSFRQ','The number of doses administered per a specific interval.','\0','Dosing Frequency','CL-TSPARMCD','DBX-NCIT-C89081'),('CL-TSPARMCD-T-13',NULL,'DOSU','The unit of measure for the dosage form.','\0','Dose Units','CL-TSPARMCD','DBX-NCIT-C73558'),('CL-TSPARMCD-T-14',NULL,'DXCRIT','A standard from which a judgment concerning a medical diagnosis can be established.','\0','Diagnostic Criteria','CL-TSPARMCD','DBX-NCIT-C117960'),('CL-TSPARMCD-T-15',NULL,'FCNTRY','The country name of planned study facility which has received IRB approval.','\0','Planned Country of Investigational Sites','CL-TSPARMCD','DBX-NCIT-C98770'),('CL-TSPARMCD-T-16',NULL,'HLTSUBJI','Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.','\0','Healthy Subject Indicator','CL-TSPARMCD','DBX-NCIT-C98737'),('CL-TSPARMCD-T-17',NULL,'INDIC','The condition, disease or disorder that the clinical trial is intended to investigate or address.','\0','Trial Indication','CL-TSPARMCD','DBX-NCIT-C112038'),('CL-TSPARMCD-T-18',NULL,'INTMODEL','The trial design developed to compare treatment groups.','\0','Intervention Model','CL-TSPARMCD','DBX-NCIT-C98746'),('CL-TSPARMCD-T-19',NULL,'INTTYPE','The kind of product or procedure studied in a trial.','\0','Intervention Type','CL-TSPARMCD','DBX-NCIT-C98747'),('CL-TSPARMCD-T-2',NULL,'ADAPT','Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.','\0','Adaptive Design','CL-TSPARMCD','DBX-NCIT-C98704'),('CL-TSPARMCD-T-20',NULL,'LENGTH','Planned length of observation for a single subject.','\0','Trial Length','CL-TSPARMCD','DBX-NCIT-C49697'),('CL-TSPARMCD-T-21',NULL,'NARMS','The planned number of intervention groups.','\0','Planned Number of Arms','CL-TSPARMCD','DBX-NCIT-C98771'),('CL-TSPARMCD-T-22',NULL,'OBJPRIM','The principal purpose of the trial.','\0','Trial Primary Objective','CL-TSPARMCD','DBX-NCIT-C85826'),('CL-TSPARMCD-T-23',NULL,'OBJSEC','The auxiliary purpose of the trial.','\0','Trial Secondary Objective','CL-TSPARMCD','DBX-NCIT-C85827'),('CL-TSPARMCD-T-24',NULL,'OUTMSEXP','Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.','\0','Exploratory Outcome Measure','CL-TSPARMCD','DBX-NCIT-C98724'),('CL-TSPARMCD-T-25',NULL,'OUTMSPRI','The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the','\0','Primary Outcome Measure','CL-TSPARMCD','DBX-NCIT-C98772'),('CL-TSPARMCD-T-26',NULL,'OUTMSSEC','Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).','\0','Secondary Outcome Measure','CL-TSPARMCD','DBX-NCIT-C98781'),('CL-TSPARMCD-T-27',NULL,'PCLAS','The pharmacological class of the investigational product.','\0','Pharmacological Class of Invest. Therapy','CL-TSPARMCD','DBX-NCIT-C98768'),('CL-TSPARMCD-T-28',NULL,'PLANSUB','The planned number of subjects to be entered in a clinical trial. (NCI)','\0','Anticipated Enrollment; Planned Enrollment; Planned Number of Subjects; Target Enrollment','CL-TSPARMCD','DBX-NCIT-C49692'),('CL-TSPARMCD-T-29',NULL,'RANDOM','The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for exampl','\0','Trial is Randomized','CL-TSPARMCD','DBX-NCIT-C25196'),('CL-TSPARMCD-T-3',NULL,'ADDON','The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.','\0','Added on to Existing Treatments','CL-TSPARMCD','DBX-NCIT-C49703'),('CL-TSPARMCD-T-30',NULL,'RANDQT','The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.','\0','Randomization Quotient','CL-TSPARMCD','DBX-NCIT-C98775'),('CL-TSPARMCD-T-31',NULL,'REGID','Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.','\0','Registry Identifier','CL-TSPARMCD','DBX-NCIT-C98714'),('CL-TSPARMCD-T-32',NULL,'RLPSCRIT','A standard from which a judgment concerning a disease relapse can be established.','\0','Relapse Criteria','CL-TSPARMCD','DBX-NCIT-C117961'),('CL-TSPARMCD-T-33',NULL,'ROUTE','The course by which a substance was administered in order to reach the site of action in the body.','\0','Route of Administration','CL-TSPARMCD','DBX-NCIT-C38114'),('CL-TSPARMCD-T-34',NULL,'SDMDUR','The protocol specified minimum amount of time needed to meet the definition of stable disease.','\0','Stable Disease Minimum Duration','CL-TSPARMCD','DBX-NCIT-C98783'),('CL-TSPARMCD-T-35',NULL,'SENDTC','Final date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.','\0','Study End Date','CL-TSPARMCD','DBX-NCIT-C90462'),('CL-TSPARMCD-T-36',NULL,'SEVCRIT','A standard from which a judgment concerning the severity of an event, disease or condition can be established.','\0','Severity Criteria','CL-TSPARMCD','DBX-NCIT-C117962'),('CL-TSPARMCD-T-37',NULL,'SEXPOP','The specific sex, either male, female, or mixed of the subject group being studied. (NCI)','\0','Sex Of Participants; Sex of Participants','CL-TSPARMCD','DBX-NCIT-C49696'),('CL-TSPARMCD-T-38',NULL,'SPONSOR','An entity that is responsible for the initiation, management, and/or financing of a clinical study.','\0','Clinical Study Sponsor; Sponsor; Study Sponsor','CL-TSPARMCD','DBX-NCIT-C70793'),('CL-TSPARMCD-T-39',NULL,'SSTDTC','The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen f','\0','Study Start Date','CL-TSPARMCD','DBX-NCIT-C69208'),('CL-TSPARMCD-T-4',NULL,'AGEMAX','The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)','\0','Planned Maximum Age of Subjects','CL-TSPARMCD','DBX-NCIT-C49694'),('CL-TSPARMCD-T-40',NULL,'STOPRULE','The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)','\0','Study Stop Rules','CL-TSPARMCD','DBX-NCIT-C49698'),('CL-TSPARMCD-T-41',NULL,'STRATFCT','Selected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol.','\0','Stratification Factor','CL-TSPARMCD','DBX-NCIT-C16153'),('CL-TSPARMCD-T-42',NULL,'STYPE','Describes the role the study plays in determining the interventions a subject receives.','\0','Study Type','CL-TSPARMCD','DBX-NCIT-C15320'),('CL-TSPARMCD-T-43',NULL,'TBLIND','The name of a code list that contains terms to define the type of blinding for the trial. (NCI)','\0','Trial Blinding Schema','CL-TSPARMCD','DBX-NCIT-C49658'),('CL-TSPARMCD-T-44',NULL,'TCNTRL','Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).','\0','Control Type','CL-TSPARMCD','DBX-NCIT-C49647'),('CL-TSPARMCD-T-45',NULL,'TDIGRP','A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a ','\0','Diagnosis Group','CL-TSPARMCD','DBX-NCIT-C49650'),('CL-TSPARMCD-T-46',NULL,'TINDTP','The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)','\0','Trial Indication Type','CL-TSPARMCD','DBX-NCIT-C49652'),('CL-TSPARMCD-T-47',NULL,'TITLE','The name of a clinical trial. (NCI)','\0','Trial Title','CL-TSPARMCD','DBX-NCIT-C49802'),('CL-TSPARMCD-T-48',NULL,'TPHASE','Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure wheth','\0','Trial Phase Classification','CL-TSPARMCD','DBX-NCIT-C48281'),('CL-TSPARMCD-T-49',NULL,'TRT','The investigational product under study.','\0','Investigational Therapy or Treatment','CL-TSPARMCD','DBX-NCIT-C41161'),('CL-TSPARMCD-T-5',NULL,'AGEMIN','The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)','\0','Planned Minimum Age of Subjects','CL-TSPARMCD','DBX-NCIT-C49693'),('CL-TSPARMCD-T-50',NULL,'TTYPE','The type of clinical trial performed e.g. efficacy, safety. (NCI)','\0','Trial Type','CL-TSPARMCD','DBX-NCIT-C49660'),('CL-TSPARMCD-T-6',NULL,'COMPTRT','A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.','\0','Comparative Treatment Name','CL-TSPARMCD','DBX-NCIT-C68612'),('CL-TSPARMCD-T-7',NULL,'CRMDUR','The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.','\0','Confirmed Response Minimum Duration','CL-TSPARMCD','DBX-NCIT-C98715'),('CL-TSPARMCD-T-8',NULL,'CURTRT','The literal identifier of the therapy or medication that is currently being given per protocol.','\0','Current Therapy or Treatment','CL-TSPARMCD','DBX-NCIT-C85582'),('CL-TSPARMCD-T-9',NULL,'DCUTDESC','Text that describes the cutoff date.','\0','Data Cutoff Description','CL-TSPARMCD','DBX-NCIT-C98718'),('CL-TTYPE-T-1',NULL,'BIO-AVAILABILITY','A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)','\0','','CL-TTYPE','DBX-NCIT-C49664'),('CL-TTYPE-T-10',NULL,'TOLERABILITY','A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject.','\0','','CL-TTYPE','DBX-NCIT-C98791'),('CL-TTYPE-T-2',NULL,'BIO-EQUIVALENCE','A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)','\0','','CL-TTYPE','DBX-NCIT-C49665'),('CL-TTYPE-T-3',NULL,'EFFICACY','A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)','\0','','CL-TTYPE','DBX-NCIT-C49666'),('CL-TTYPE-T-4',NULL,'FOOD EFFECT','Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug.','\0','','CL-TTYPE','DBX-NCIT-C98729'),('CL-TTYPE-T-5',NULL,'PHARMACODYNAMIC','A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)','\0','','CL-TTYPE','DBX-NCIT-C49662'),('CL-TTYPE-T-6',NULL,'PHARMACOECONOMIC','A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indi','\0','','CL-TTYPE','DBX-NCIT-C39493'),('CL-TTYPE-T-7',NULL,'PHARMACOGENOMIC','A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual\'s drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may','\0','','CL-TTYPE','DBX-NCIT-C49661'),('CL-TTYPE-T-8',NULL,'PHARMACOKINETIC','A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)','\0','','CL-TTYPE','DBX-NCIT-C49663'),('CL-TTYPE-T-9',NULL,'SAFETY','A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests.','\0','','CL-TTYPE','DBX-NCIT-C49667'),('CL-TUMIDENT-T-1',NULL,'BENIGN','For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For ','\0','Benign','CL-TUMIDENT','DBX-NCIT-C14172'),('CL-TUMIDENT-T-10',NULL,'TARGET NODULE','The identification of a nodule that is the target of the therapeutic intervention.','\0','','CL-TUMIDENT','DBX-NCIT-C103444'),('CL-TUMIDENT-T-2',NULL,'MEASURED','The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured.','\0','','CL-TUMIDENT','DBX-NCIT-C103416'),('CL-TUMIDENT-T-3',NULL,'NEW','The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized.','\0','','CL-TUMIDENT','DBX-NCIT-C94522'),('CL-TUMIDENT-T-4',NULL,'NON-MEASURABLE','The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline.','\0','','CL-TUMIDENT','DBX-NCIT-C103423'),('CL-TUMIDENT-T-5',NULL,'NON-TARGET','The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention.','\0','','CL-TUMIDENT','DBX-NCIT-C94521'),('CL-TUMIDENT-T-6',NULL,'NOT MEASURED','The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured.','\0','','CL-TUMIDENT','DBX-NCIT-C103425'),('CL-TUMIDENT-T-7',NULL,'TARGET','The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention.','\0','','CL-TUMIDENT','DBX-NCIT-C94520'),('CL-TUMIDENT-T-8',NULL,'TARGET EXTRA NODAL','The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention.','\0','','CL-TUMIDENT','DBX-NCIT-C103442'),('CL-TUMIDENT-T-9',NULL,'TARGET NODAL','The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention.','\0','','CL-TUMIDENT','DBX-NCIT-C103443'),('CL-TUTEST-T-1',NULL,'Tumor Identification','An indication that a tumor has been located and characterized.','\0','Tumor Identification','CL-TUTEST','DBX-NCIT-C94523'),('CL-TUTEST-T-2',NULL,'Tumor Merged','An indication that multiple tumors have coalesced into one tumor.','\0','Tumor Merged','CL-TUTEST','DBX-NCIT-C94525'),('CL-TUTEST-T-3',NULL,'Tumor Split','An indication that a single tumor has divided into two or more tumors.','\0','Tumor Split','CL-TUTEST','DBX-NCIT-C96642'),('CL-TUTESTCD-T-1',NULL,'TUMERGE','An indication that multiple tumors have coalesced into one tumor.','\0','Tumor Merged','CL-TUTESTCD','DBX-NCIT-C94525'),('CL-TUTESTCD-T-2',NULL,'TUMIDENT','An indication that a tumor has been located and characterized.','\0','Tumor Identification','CL-TUTESTCD','DBX-NCIT-C94523'),('CL-TUTESTCD-T-3',NULL,'TUSPLIT','An indication that a single tumor has divided into two or more tumors.','\0','Tumor Split','CL-TUTESTCD','DBX-NCIT-C96642'),('CL-UNIT-T-1',NULL,'%','A fraction or ratio with 100 understood as the denominator. (NCI)','\0','Percentage','CL-UNIT','DBX-NCIT-C25613'),('CL-UNIT-T-10',NULL,'/day','Occurring or done each day. (NCI)','\0','Daily; Per Day','CL-UNIT','DBX-NCIT-C25473'),('CL-UNIT-T-100',NULL,'Bq/mg','A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI)','\0','Becquerel per Milligram; Kilobecquerel per Gram; kBq/g','CL-UNIT','DBX-NCIT-C70524'),('CL-UNIT-T-101',NULL,'Bq/mL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI)','\0','Becquerel per Milliliter; Kilobecquerel per Liter; kBq/L','CL-UNIT','DBX-NCIT-C71167'),('CL-UNIT-T-102',NULL,'Bq/ug','A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram.(NCI)','\0','Becquerel per Microgram; Bq/mcg; Kilobecquerel per Milligram; MBq/g; Megabecquerel per Gram; kBq/mg','CL-UNIT','DBX-NCIT-C70523'),('CL-UNIT-T-103',NULL,'Bq/uL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI)','\0','Becquerel per Microliter; Kilobecquerel per Milliliter; MBq/L; Megabecquerel per Liter; kBq/mL','CL-UNIT','DBX-NCIT-C71166'),('CL-UNIT-T-104',NULL,'BREATHS/MIN','The number of breaths (inhalation and exhalation) taken per minute time. (NCI)','\0','Breaths per Minute','CL-UNIT','DBX-NCIT-C49674'),('CL-UNIT-T-105',NULL,'BU','A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period.','\0','Bethesda Unit','CL-UNIT','DBX-NCIT-C117966'),('CL-UNIT-T-106',NULL,'BU/mL','A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter. (NCI)','\0','Bethesda Unit per Milliliter','CL-UNIT','DBX-NCIT-C117967'),('CL-UNIT-T-107',NULL,'C','A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple ','\0','Degree Celsius','CL-UNIT','DBX-NCIT-C42559'),('CL-UNIT-T-108',NULL,'cal','A measurement of nutritional energy. The quantity of thermal energy required to raise one gram of water one degree Centigrade under standard conditions. 1 calorie equals 4.186 joules. (NCI)','\0','Calorie','CL-UNIT','DBX-NCIT-C67193'),('CL-UNIT-T-109',NULL,'CAN','A dosing measurement based on the can unit.(NCI)','\0','Can Dosing Unit','CL-UNIT','DBX-NCIT-C48479'),('CL-UNIT-T-11',NULL,'/dL','A volume unit equal to one deciliter used as a denominator to build a derived unit expressed as a ratio. (NCI)','\0','Per Deciliter','CL-UNIT','DBX-NCIT-C105514'),('CL-UNIT-T-110',NULL,'CAPFUL','A unit of measure equal to the amount that the cap on the bottle can contain.','\0','Capful Dosing Unit','CL-UNIT','DBX-NCIT-C102405'),('CL-UNIT-T-111',NULL,'CAPLET','A dosing measurement based on the caplet unit.','\0','Caplet Dosing Unit','CL-UNIT','DBX-NCIT-C64696'),('CL-UNIT-T-112',NULL,'CAPSULE','A dosing measurement based on the capsule unit.(NCI)','\0','Capsule Dosing Unit; cap','CL-UNIT','DBX-NCIT-C48480'),('CL-UNIT-T-113',NULL,'CARTRIDGE','A dosing measurement based on the cartridge unit.(NCI)','\0','Cartridge Dosing Unit','CL-UNIT','DBX-NCIT-C48481'),('CL-UNIT-T-114',NULL,'CCID 50','A potency unit defined as a minimal dose of infectious material at which preparation causes cytopathic effects (changes in the morphology and metabolism of cell culture cells, indicating cell death, due to suspected infection) in the 50% of the cell cultu','\0','50 Percent Cell Culture Infective Dose','CL-UNIT','DBX-NCIT-C70534'),('CL-UNIT-T-115',NULL,'CCID 50/dose','A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.(NCI)','\0','50 Percent Cell Culture Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70535'),('CL-UNIT-T-116',NULL,'cd','The candela is the basic unit of luminous intensity. It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of th','\0','Candela','CL-UNIT','DBX-NCIT-C42538'),('CL-UNIT-T-117',NULL,'cells/kg','A unit of cell concentration expressed in cells per unit of mass equal to one kilogram.','\0','','CL-UNIT','DBX-NCIT-C116239'),('CL-UNIT-T-118',NULL,'cells/uL','A unit of cell concentration expressed in cells per unit of area equal to one cubic millimeter.','\0','cells/mm3','CL-UNIT','DBX-NCIT-C67242'),('CL-UNIT-T-119',NULL,'CFU/g','A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of colony forming units in one gram of substance.(NCI)','\0','Colony Forming Unit per Gram','CL-UNIT','DBX-NCIT-C68898'),('CL-UNIT-T-12',NULL,'/h','A rate of occurrences of something within a period of time equal to sixty minutes.','\0','Per Hour','CL-UNIT','DBX-NCIT-C66966'),('CL-UNIT-T-120',NULL,'CFU/mL','A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of colony forming units in one milliliter of substance.(NCI)','\0','Colony Forming Unit per Milliliter','CL-UNIT','DBX-NCIT-C68902'),('CL-UNIT-T-121',NULL,'cg','A unit of mass equal to one hundredth of a gram.(NCI)','\0','Centigram','CL-UNIT','DBX-NCIT-C64554'),('CL-UNIT-T-122',NULL,'cGy','The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter.','\0','Centigray','CL-UNIT','DBX-NCIT-C64693'),('CL-UNIT-T-123',NULL,'Ci','A unit of radioactivity defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One Curie is equal to 37 gigabecquerels.(NCI)','\0','Curie','CL-UNIT','DBX-NCIT-C48466'),('CL-UNIT-T-124',NULL,'Ci/g','A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.(NCI)','\0','Curie per Gram; Microcurie per Microgram; Millicurie per Milligram; mCi/mg; uCi/ug','CL-UNIT','DBX-NCIT-C70528'),('CL-UNIT-T-125',NULL,'Ci/kg','A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.(NCI)','\0','Curie per Kilogram; Microcurie per Milligram; Millicurie per Gram; mCi/g; uCi/mg','CL-UNIT','DBX-NCIT-C70529'),('CL-UNIT-T-126',NULL,'Ci/L','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI)','\0','Curie per Liter; Microcurie per Microliter; uCi/uL','CL-UNIT','DBX-NCIT-C71170'),('CL-UNIT-T-127',NULL,'Ci/mg','A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.(NCI)','\0','Curie per Milligram; Millicurie per Microgram; mCi/ug','CL-UNIT','DBX-NCIT-C70531'),('CL-UNIT-T-128',NULL,'Ci/mL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one milliliter.(NCI)','\0','Curie per Milliliter','CL-UNIT','DBX-NCIT-C71172'),('CL-UNIT-T-129',NULL,'Ci/ug','A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.(NCI)','\0','Ci/mcg; Curie per Microgram','CL-UNIT','DBX-NCIT-C70530'),('CL-UNIT-T-13',NULL,'/HPF','A unit of measure equal to the instances of an entity per visual field of a microscope set to its maximum magnification power.','\0','per High Powered Field','CL-UNIT','DBX-NCIT-C96619'),('CL-UNIT-T-130',NULL,'Ci/uL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one millionth of a liter.(NCI)','\0','Ci/mcL; Curie per Microliter','CL-UNIT','DBX-NCIT-C71171'),('CL-UNIT-T-131',NULL,'CIGAR','A dosing measurement based on the cigar unit.','\0','Cigar Dosing Unit','CL-UNIT','DBX-NCIT-C116244'),('CL-UNIT-T-132',NULL,'CIGARETTE','A dosing measurement based on the cigarette unit.','\0','Cigarette Dosing Unit','CL-UNIT','DBX-NCIT-C116245'),('CL-UNIT-T-133',NULL,'cL','The unit of volume equal to one hundredth of a liter or 10 milliliters or 10 cubic centimeters or 0.6102 cubic inch.','\0','Centiliter','CL-UNIT','DBX-NCIT-C69087'),('CL-UNIT-T-134',NULL,'cm','A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.','\0','Centimeter','CL-UNIT','DBX-NCIT-C49668'),('CL-UNIT-T-135',NULL,'cm H2O','A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.','\0','','CL-UNIT','DBX-NCIT-C91060'),('CL-UNIT-T-136',NULL,'cm/min','A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one minute. (NCI)','\0','Centimeters per Minute','CL-UNIT','DBX-NCIT-C105481'),('CL-UNIT-T-137',NULL,'cm/s','A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI)','\0','cm/sec','CL-UNIT','DBX-NCIT-C102406'),('CL-UNIT-T-138',NULL,'cm2','A unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.(NCI)','\0','Square Centimeter','CL-UNIT','DBX-NCIT-C48460'),('CL-UNIT-T-139',NULL,'cmol','A unit of amount of substance equal to one hundredth of a mole (10E-2 mole).(NCI)','\0','Centimole','CL-UNIT','DBX-NCIT-C68687'),('CL-UNIT-T-14',NULL,'/L','A volume unit equal to one liter used as a denominator to build a derived unit expressed as a ratio. (NCI)','\0','Per Liter','CL-UNIT','DBX-NCIT-C105515'),('CL-UNIT-T-140',NULL,'cmol/L','A unit of concentration (molarity unit) equal to one centimole of solute in one liter of solution. (NCI)','\0','Millimoles per Deciliter; mmol/dL','CL-UNIT','DBX-NCIT-C68886'),('CL-UNIT-T-141',NULL,'COAT','A dosing measurement based on the coat unit.(NCI)','\0','Coat Dosing Unit','CL-UNIT','DBX-NCIT-C48483'),('CL-UNIT-T-142',NULL,'CONTAINER','A dosing measurement based on the container unit.(NCI)','\0','Container Dosing Unit','CL-UNIT','DBX-NCIT-C48484'),('CL-UNIT-T-143',NULL,'copies/mL','A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C100900'),('CL-UNIT-T-144',NULL,'copies/uL','A unit of concentration expressed as a number of copies per unit volume equal to one microliter.','\0','','CL-UNIT','DBX-NCIT-C116237'),('CL-UNIT-T-145',NULL,'Coulomb','A unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one Ampere.(NCI)','\0','Coulomb','CL-UNIT','DBX-NCIT-C42550'),('CL-UNIT-T-146',NULL,'cpm','A unit of frequency expressed as the detection rate of ionization events per minute.','\0','Counts per Minute','CL-UNIT','DBX-NCIT-C73688'),('CL-UNIT-T-147',NULL,'cs','A unit of time equal to one hundredth of a second (10E-2 seconds). (NCI)','\0','10^-2 sec; Centisecond; csec','CL-UNIT','DBX-NCIT-C105482'),('CL-UNIT-T-148',NULL,'CUP','A dosing measurement based on the cup unit.(NCI)','\0','Cup Dosing Unit','CL-UNIT','DBX-NCIT-C54703'),('CL-UNIT-T-149',NULL,'cy/cm','A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card.','\0','Grating Cycles per Centimeter; cpcm','CL-UNIT','DBX-NCIT-C114242'),('CL-UNIT-T-15',NULL,'/LPF','A unit of measure equal to the instances of an entity per visual field of a microscope set to its minimum magnification power.','\0','per Low Powered Field','CL-UNIT','DBX-NCIT-C96620'),('CL-UNIT-T-150',NULL,'cycle/min','A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.(NCI)','\0','Cycle per Minute','CL-UNIT','DBX-NCIT-C71176'),('CL-UNIT-T-151',NULL,'cycle/sec','A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one second.(NCI)','\0','Cycle per Second','CL-UNIT','DBX-NCIT-C71480'),('CL-UNIT-T-152',NULL,'CYLINDER','A dosing measurement based on the cylinder unit.(NCI)','\0','Cylinder Dosing Unit','CL-UNIT','DBX-NCIT-C48489'),('CL-UNIT-T-153',NULL,'DAgU','A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.(NCI)','\0','D Antigen Unit','CL-UNIT','DBX-NCIT-C70501'),('CL-UNIT-T-154',NULL,'DAgU/mL','A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.(NCI)','\0','D Antigen Unit per Milliliter','CL-UNIT','DBX-NCIT-C70502'),('CL-UNIT-T-155',NULL,'damol/L','A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution. (NCI)','\0','Decamole per Liter; Moles per Deciliter; mol/dL','CL-UNIT','DBX-NCIT-C105483'),('CL-UNIT-T-156',NULL,'DAYS','The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)','\0','Day','CL-UNIT','DBX-NCIT-C25301'),('CL-UNIT-T-157',NULL,'dB','A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals.','\0','Decibel','CL-UNIT','DBX-NCIT-C102407'),('CL-UNIT-T-158',NULL,'deg','A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree i','\0','Degree Unit of Plane Angle','CL-UNIT','DBX-NCIT-C68667'),('CL-UNIT-T-159',NULL,'DIOPTER','A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters.','\0','Diopter','CL-UNIT','DBX-NCIT-C100899'),('CL-UNIT-T-16',NULL,'/mL','A volume unit equal to one milliliter used as a denominator to build a derived unit expressed as a ratio. (NCI)','\0','Per Milliliter','CL-UNIT','DBX-NCIT-C103452'),('CL-UNIT-T-160',NULL,'DISK','A dosing measurement based on the disk unit.(NCI)','\0','Disk Dosing Unit','CL-UNIT','DBX-NCIT-C48490'),('CL-UNIT-T-161',NULL,'dL','The unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI)','\0','Deciliter','CL-UNIT','DBX-NCIT-C64697'),('CL-UNIT-T-162',NULL,'dmol','A unit of amount of substance equal to one tenth of a mole (10E-1 mole).(NCI)','\0','Decimole','CL-UNIT','DBX-NCIT-C68685'),('CL-UNIT-T-163',NULL,'DNA copies/mL','The unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter.','\0','DNA Copies per Milliliter','CL-UNIT','DBX-NCIT-C98719'),('CL-UNIT-T-164',NULL,'DPM','A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds. (NCI)','\0','Disintegrations per Minute','CL-UNIT','DBX-NCIT-C73710'),('CL-UNIT-T-165',NULL,'dpm/100mg','A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one hundred milligrams.','\0','Disintegrations per Minute per 100 milligrams; dpm/cg','CL-UNIT','DBX-NCIT-C117968'),('CL-UNIT-T-166',NULL,'dpm/mg','A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram.','\0','Disintegrations per Minute per Milligram','CL-UNIT','DBX-NCIT-C117969'),('CL-UNIT-T-167',NULL,'dpm/mL','A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter.','\0','Disintegrations per Minute per Milliliter','CL-UNIT','DBX-NCIT-C117970'),('CL-UNIT-T-168',NULL,'dram','A unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.(NCI)','\0','Dram','CL-UNIT','DBX-NCIT-C64564'),('CL-UNIT-T-169',NULL,'DRUM','A dosing measurement based on the drum unit.(NCI)','\0','Drum Dosing Unit','CL-UNIT','DBX-NCIT-C48492'),('CL-UNIT-T-17',NULL,'/month','Every month. (NCI)','\0','Every Month; Per Month','CL-UNIT','DBX-NCIT-C64498'),('CL-UNIT-T-170',NULL,'dyn','A unit of force defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 10E-5 Newton and 2.248E-6 pounds of force.(NCI)','\0','Dyne','CL-UNIT','DBX-NCIT-C70470'),('CL-UNIT-T-171',NULL,'EID 50','Amount of infectious agent or biological product that causes infection in the 50% of embryos such as chicken embryos used in the product potency assay or pathogen activity assay.(NCI)','\0','50 Percent Embryo Infective Dose','CL-UNIT','DBX-NCIT-C70532'),('CL-UNIT-T-172',NULL,'EID 50/dose','A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)','\0','50 Percent Embryo Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70533'),('CL-UNIT-T-173',NULL,'ELISA unit','A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immun','\0','Enzyme-Linked Immunosorbent Assay Unit','CL-UNIT','DBX-NCIT-C68875'),('CL-UNIT-T-174',NULL,'ELISA unit/dose','A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI)','\0','Enzyme-Linked Immunosorbent Assay Unit per Dose','CL-UNIT','DBX-NCIT-C68876'),('CL-UNIT-T-175',NULL,'ELISA unit/mL','A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.(NCI)','\0','Enzyme-Linked Immunosorbent Assay Unit per Milliliter','CL-UNIT','DBX-NCIT-C68877'),('CL-UNIT-T-176',NULL,'Enzyme U','A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system.','\0','Enzyme Unit','CL-UNIT','DBX-NCIT-C64778'),('CL-UNIT-T-177',NULL,'eq','A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox rea','\0','Equivalent Weight','CL-UNIT','DBX-NCIT-C67273'),('CL-UNIT-T-178',NULL,'EU','A unit of measure equal to one milligram of urobilinogen per deciliter.','\0','EU/dL; Ehrlich Units','CL-UNIT','DBX-NCIT-C96599'),('CL-UNIT-T-179',NULL,'F','The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and','\0','Degree Fahrenheit','CL-UNIT','DBX-NCIT-C44277'),('CL-UNIT-T-18',NULL,'/nL','A volume unit equal to one nanoliter used as a denominator and a unitless measure used as the numerator.','\0','Per Nanoliter','CL-UNIT','DBX-NCIT-C116243'),('CL-UNIT-T-180',NULL,'Farad','A unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.(NCI)','\0','Farad','CL-UNIT','DBX-NCIT-C42552'),('CL-UNIT-T-181',NULL,'FEU','A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.','\0','Fibrinogen Equivalent Units','CL-UNIT','DBX-NCIT-C96649'),('CL-UNIT-T-182',NULL,'fg','A unit of mass equal to one quadrillionth of a gram (10E-15 gram).(NCI)','\0','Femtogram','CL-UNIT','DBX-NCIT-C64552'),('CL-UNIT-T-183',NULL,'FINGERTIP UNIT','An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult\'s ','\0','Fingertip Unit','CL-UNIT','DBX-NCIT-C71321'),('CL-UNIT-T-184',NULL,'fL','The unit of volume equal 10E-15 liter.','\0','Cubic Micrometer; Cubic Micron; Femtoliter; um3','CL-UNIT','DBX-NCIT-C64780'),('CL-UNIT-T-185',NULL,'fmol','A unit of amount of substance equal to one quadrillionth of a mole (10E-15 mole).(NCI)','\0','Femtomole','CL-UNIT','DBX-NCIT-C68854'),('CL-UNIT-T-186',NULL,'fmol/g','A molality unit that describes the amount of substance, expressed in femtomole(s) per gram. (NCI)','\0','Femtomole per Gram','CL-UNIT','DBX-NCIT-C73711'),('CL-UNIT-T-187',NULL,'fmol/L','A unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution. (NCI)','\0','Femtomole per Liter','CL-UNIT','DBX-NCIT-C68887'),('CL-UNIT-T-188',NULL,'foz_br','A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733871 cubic inches or 28.413063 milliliters.','\0','Fluid Ounce Imperial','CL-UNIT','DBX-NCIT-C48577'),('CL-UNIT-T-189',NULL,'foz_us','A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804687 cubic inches or 29.573531 milliliters.','\0','Fluid Ounce US','CL-UNIT','DBX-NCIT-C48494'),('CL-UNIT-T-19',NULL,'/pL','A volume unit equal to one picoliter used as a denominator to build a derived unit expressed as a ratio.','\0','Per Picoliter','CL-UNIT','DBX-NCIT-C117964'),('CL-UNIT-T-190',NULL,'fraction of 1','A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1.','\0','','CL-UNIT','DBX-NCIT-C105484'),('CL-UNIT-T-191',NULL,'Frames/s','A unit of measure equal to the number of visual frames per unit of time equal to one second. (NCI)','\0','F/s; FPS; Frames per Second; Frames/sec','CL-UNIT','DBX-NCIT-C106524'),('CL-UNIT-T-192',NULL,'ft','A unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI)','\0','Foot','CL-UNIT','DBX-NCIT-C71253'),('CL-UNIT-T-193',NULL,'ft2','A unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.(NCI)','\0','Square Foot','CL-UNIT','DBX-NCIT-C48461'),('CL-UNIT-T-194',NULL,'ft3','A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.(NCI)','\0','Standard Cubic Foot','CL-UNIT','DBX-NCIT-C68859'),('CL-UNIT-T-195',NULL,'g','A metric unit of mass equal to one one thousandth of a kilogram. (NCI)','\0','Gram','CL-UNIT','DBX-NCIT-C48155'),('CL-UNIT-T-196',NULL,'g/animal','A unit of measure expressed in gram(s) per animal.','\0','Gram per Animal','CL-UNIT','DBX-NCIT-C73713'),('CL-UNIT-T-197',NULL,'g/animal/day','A unit of measure expressed in gram(s) per animal per period of time equal to twenty-four hours.','\0','Gram per Animal per Day','CL-UNIT','DBX-NCIT-C73714'),('CL-UNIT-T-198',NULL,'g/animal/wk','A unit of measure expressed in gram(s) per animal per period of time equal to seven days.','\0','Gram per Animal per Week','CL-UNIT','DBX-NCIT-C73715'),('CL-UNIT-T-199',NULL,'g/cage','A unit of measure expressed in gram(s) per cage.','\0','Gram per Cage','CL-UNIT','DBX-NCIT-C73716'),('CL-UNIT-T-2',NULL,'% INHIBITION','The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage.','\0','Percent Inhibition','CL-UNIT','DBX-NCIT-C117963'),('CL-UNIT-T-20',NULL,'/uL','A volume unit equal to one microliter used as a denominator to build a derived unit expressed as a ratio. (NCI)','\0','Per Microliter','CL-UNIT','DBX-NCIT-C67254'),('CL-UNIT-T-200',NULL,'g/cage/day','A unit of measure expressed in gram(s) per cage per period of time equal to twenty-four hours.','\0','Gram per Cage per Day','CL-UNIT','DBX-NCIT-C73717'),('CL-UNIT-T-201',NULL,'g/cage/wk','A unit of measure expressed in gram(s) per cage per period of time equal to seven days.','\0','Gram per Cage per Week','CL-UNIT','DBX-NCIT-C73718'),('CL-UNIT-T-202',NULL,'g/cm2','A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.(NCI)','\0','Gram per Square Centimeter','CL-UNIT','DBX-NCIT-C71201'),('CL-UNIT-T-203',NULL,'g/day','A dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours.','\0','Gram per Day; g/24h; g/d; gram/24 Hours; gram/day','CL-UNIT','DBX-NCIT-C67372'),('CL-UNIT-T-204',NULL,'g/dL','A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density ','\0','Gram per Deciliter; g%','CL-UNIT','DBX-NCIT-C64783'),('CL-UNIT-T-205',NULL,'g/g','A unit of a mass fraction expressed as a number of grams of substance per gram of mixture.','\0','Gram per Gram','CL-UNIT','DBX-NCIT-C70453'),('CL-UNIT-T-206',NULL,'g/g Creatinine','A unit of substance concentration defined as the number of grams per gram of creatinine.','\0','mg/mg Creatinine','CL-UNIT','DBX-NCIT-C105485'),('CL-UNIT-T-207',NULL,'g/g/day','A unit of measure expressed in gram(s) per gram per period of time equal to twenty-four hours.','\0','Gram per Gram per Day','CL-UNIT','DBX-NCIT-C73720'),('CL-UNIT-T-208',NULL,'g/kg','A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)','\0','Gram per Kilogram; Milligram per Gram; mg/g','CL-UNIT','DBX-NCIT-C69104'),('CL-UNIT-T-209',NULL,'g/kg/day','A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day. (NCI)','\0','Gram per Kilogram per Day; Milligram per Gram per Day; mg/g/day','CL-UNIT','DBX-NCIT-C66975'),('CL-UNIT-T-21',NULL,'/VF','A unit of measure equal to the instances of an entity per visual field of a microscope. (NCI)','\0','per Visual Field','CL-UNIT','DBX-NCIT-C105516'),('CL-UNIT-T-210',NULL,'g/L','A unit of mass concentration defined as the concentration of one kilogram of a substance per unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance per unit volume of the mixture equal to one milliliter, ','\0','Gram per Liter; Kilogram per Cubic Meter; Microgram per Microliter; Milligram per Milliliter; g/L; kg/m3; mg/mL; ug/uL','CL-UNIT','DBX-NCIT-C42576'),('CL-UNIT-T-211',NULL,'g/m2','A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit.(NCI)','\0','Gram per Square Meter','CL-UNIT','DBX-NCIT-C67282'),('CL-UNIT-T-212',NULL,'g/m2/day','A dose calculation unit expressed in gram(s) per square meter per period of time equal to twenty-four hours.','\0','Gram per Square Meter per Day','CL-UNIT','DBX-NCIT-C73722'),('CL-UNIT-T-213',NULL,'g/mol','A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole. (NCI)','\0','Gram per Mole','CL-UNIT','DBX-NCIT-C73721'),('CL-UNIT-T-214',NULL,'g/mol Creatinine','A unit of substance concentration defined as the number of grams per mole of creatinine.','\0','mg/mmol Creatinine','CL-UNIT','DBX-NCIT-C105486'),('CL-UNIT-T-215',NULL,'Gauss','The unit of magnetic flux density. A field of one Gauss exerts a force on a conductor, placed in the field of 0.1 dyne per Ampere of current per centimeter of conductor. One Gauss represents a magnetic flux of one Maxwell per square centimeter of cross-se','\0','Gauss','CL-UNIT','DBX-NCIT-C68915'),('CL-UNIT-T-216',NULL,'GBq','A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 10E9 Becquerels.(NCI)','\0','Gigabecquerel','CL-UNIT','DBX-NCIT-C70513'),('CL-UNIT-T-217',NULL,'GBq/g','A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram.(NCI)','\0','Gigabecquerel per Gram; Kilobecquerel per Microgram; kBq/ug','CL-UNIT','DBX-NCIT-C70525'),('CL-UNIT-T-218',NULL,'GBq/mg','A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI)','\0','Gigabecquerel per Milligram; MBq/mcg; MBq/ug; Megabecquerel per Microgram','CL-UNIT','DBX-NCIT-C70527'),('CL-UNIT-T-219',NULL,'GBq/ug','A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI)','\0','GBq/mcg; Gigabecquerel per Microgram; MBq/ng; Megabecquerel per nanogram','CL-UNIT','DBX-NCIT-C70526'),('CL-UNIT-T-22',NULL,'/wk','Every week. (NCI)','\0','Every week; Per Week; QS','CL-UNIT','DBX-NCIT-C67069'),('CL-UNIT-T-220',NULL,'GPL U/mL','A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.','\0','Immunoglobin G Phospholipid Units per Milliliter','CL-UNIT','DBX-NCIT-C117971'),('CL-UNIT-T-221',NULL,'grain','A unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain un','\0','Grain','CL-UNIT','DBX-NCIT-C48497'),('CL-UNIT-T-222',NULL,'gtt','A unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI)','\0','Drop','CL-UNIT','DBX-NCIT-C69442'),('CL-UNIT-T-223',NULL,'Gy','A unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.(NCI)','\0','Gray','CL-UNIT','DBX-NCIT-C18063'),('CL-UNIT-T-224',NULL,'Henry','A unit of electric inductance. A coil with an inductance of one Henry requires a flux of one Weber for each Ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the ','\0','Henry','CL-UNIT','DBX-NCIT-C42558'),('CL-UNIT-T-225',NULL,'HEP','Unit of measure of potency of allergenic product expressed as a number of histamine equivalent prick units.','\0','Histamine Equivalent Prick Unit','CL-UNIT','DBX-NCIT-C116232'),('CL-UNIT-T-226',NULL,'HOMEOPATHIC DILUTION','A dosing measurement based on the homeopathic dilution unit.(NCI)','\0','Homeopathic Dilution Unit','CL-UNIT','DBX-NCIT-C48498'),('CL-UNIT-T-227',NULL,'Hounsfield Unit','The unit of measure for the radiodensity of a substance. The radiodensity of distilled water at standard temperature and pressure is zero on the Hounsfield scale.','\0','HU','CL-UNIT','DBX-NCIT-C94908'),('CL-UNIT-T-228',NULL,'HOURS','A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)','\0','Hour; hr','CL-UNIT','DBX-NCIT-C25529'),('CL-UNIT-T-229',NULL,'hPa','A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch.','\0','Hectopascal','CL-UNIT','DBX-NCIT-C105487'),('CL-UNIT-T-23',NULL,'100 IU/mL','A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.(NCI)','\0','100 International units/Milliliter','CL-UNIT','DBX-NCIT-C71185'),('CL-UNIT-T-230',NULL,'HPF','The area visible under the maximum magnification power of the objective being used in microscopy.(NCI)','\0','High Power Field','CL-UNIT','DBX-NCIT-C67274'),('CL-UNIT-T-231',NULL,'Hz','A unit of frequency equal to one cycle per second.(NCI)','\0','Hertz','CL-UNIT','DBX-NCIT-C42545'),('CL-UNIT-T-232',NULL,'IMPLANT','A dosing measurement based on the implant unit.(NCI)','\0','Implant Dosing Unit','CL-UNIT','DBX-NCIT-C48499'),('CL-UNIT-T-233',NULL,'IN','A traditional unit of length equal to 2.54 centimeters. (NCI)','\0','Inch','CL-UNIT','DBX-NCIT-C48500'),('CL-UNIT-T-234',NULL,'in2','A unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.(NCI)','\0','Square Inch','CL-UNIT','DBX-NCIT-C68871'),('CL-UNIT-T-235',NULL,'INHALATION','A dosing measurement based on the inhalation unit.(NCI)','\0','Inhalation Dosing Unit','CL-UNIT','DBX-NCIT-C48501'),('CL-UNIT-T-236',NULL,'IU','The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biolog','\0','IE; International Unit','CL-UNIT','DBX-NCIT-C48579'),('CL-UNIT-T-237',NULL,'IU/g','A unit of measure of quantity of substance per unit mass, expressed in terms of the International Unit per grams.(NCI)','\0','International Unit per Gram','CL-UNIT','DBX-NCIT-C70493'),('CL-UNIT-T-238',NULL,'IU/kg','An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of b','\0','International Unit per Kilogram','CL-UNIT','DBX-NCIT-C67379'),('CL-UNIT-T-239',NULL,'IU/kg/h','A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.(NCI)','\0','International units per Kilogram per Hour','CL-UNIT','DBX-NCIT-C71209'),('CL-UNIT-T-24',NULL,'10^10/L','A unit of measurement equal to 10 to the tenth power of entities per unit of volume equal to one liter. (NCI)','\0','10^4/mm3; 10^4/uL; 10^7/mL','CL-UNIT','DBX-NCIT-C105517'),('CL-UNIT-T-240',NULL,'IU/L','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of system volume.(NCI)','\0','IE/L; IU/L; International Unit per Liter; mIU/mL','CL-UNIT','DBX-NCIT-C67376'),('CL-UNIT-T-241',NULL,'IU/mg','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milligram of substance.(NCI)','\0','International Unit per Milligram','CL-UNIT','DBX-NCIT-C67380'),('CL-UNIT-T-242',NULL,'IU/mL','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.(NCI)','\0','IE/mL; International Unit per Milliliter; Kilo International Unit per Liter; kIU/L','CL-UNIT','DBX-NCIT-C67377'),('CL-UNIT-T-243',NULL,'JAR','A dosing measurement based on the jar unit.(NCI)','\0','Jar Dosing Unit','CL-UNIT','DBX-NCIT-C48502'),('CL-UNIT-T-244',NULL,'Joule','A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat), equal to the work done when the point of application of a force of one Newton is displaced through a distance of one meter in the direction of the force or the wo','\0','Joule','CL-UNIT','DBX-NCIT-C42548'),('CL-UNIT-T-245',NULL,'KALLIKREIN INHIBITOR UNIT','A dosing measurement based on the Kallikrein inhibitor unit.(NCI)','\0','Kallikrein Inhibitor Unit','CL-UNIT','DBX-NCIT-C48503'),('CL-UNIT-T-246',NULL,'kat','A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the','\0','Katal','CL-UNIT','DBX-NCIT-C42566'),('CL-UNIT-T-247',NULL,'kBq','A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 10E3 Becquerels.(NCI)','\0','Kilobecquerel','CL-UNIT','DBX-NCIT-C70511'),('CL-UNIT-T-248',NULL,'kBq/uL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI)','\0','GBq/L; Gigabecquerel per Liter; Kilobecquerel per Microliter; MBq/mL; Megabecquerel per Milliliter','CL-UNIT','DBX-NCIT-C71168'),('CL-UNIT-T-249',NULL,'kcal','A unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 ki','\0','Kilogram-Calorie','CL-UNIT','DBX-NCIT-C67194'),('CL-UNIT-T-25',NULL,'10^11/L','A unit of measurement equal to 10 to the eleventh power of entities per unit of volume equal to one liter.','\0','10^5/mm3; 10^5/uL; 10^8/mL','CL-UNIT','DBX-NCIT-C105488'),('CL-UNIT-T-250',NULL,'kDa','A mass unit equal to one thousand daltons.','\0','Kilodalton; Kilounified Atomic Mass Unit; ku','CL-UNIT','DBX-NCIT-C105491'),('CL-UNIT-T-251',NULL,'kg','The basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a pre','\0','Kilogram','CL-UNIT','DBX-NCIT-C28252'),('CL-UNIT-T-252',NULL,'kg/cm2','A unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.(NCI)','\0','Kilogram per Square Centimeter','CL-UNIT','DBX-NCIT-C69094'),('CL-UNIT-T-253',NULL,'kg/L','A unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass eq','\0','Gram per Milliliter; Kilogram per Liter; g/mL; gram/mL; kg/L; mg/uL','CL-UNIT','DBX-NCIT-C64566'),('CL-UNIT-T-254',NULL,'kg/m2','A unit expressed as kilogram of mass per square meter of area.(NCI)','\0','Kilogram per Square Meter','CL-UNIT','DBX-NCIT-C49671'),('CL-UNIT-T-255',NULL,'kHz','A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second. (NCI)','\0','kilohertz','CL-UNIT','DBX-NCIT-C67279'),('CL-UNIT-T-256',NULL,'KIT','A dosing measurement based on the kit unit.(NCI)','\0','Kit Dosing Unit','CL-UNIT','DBX-NCIT-C48504'),('CL-UNIT-T-257',NULL,'kIU','A unit equal to one thousand international units.(NCI)','\0','Kilo International Unit','CL-UNIT','DBX-NCIT-C70492'),('CL-UNIT-T-258',NULL,'km','A unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.(NCI)','\0','Kilometer','CL-UNIT','DBX-NCIT-C71177'),('CL-UNIT-T-259',NULL,'km/h','A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.(NCI)','\0','Kilometer Per Hour','CL-UNIT','DBX-NCIT-C71203'),('CL-UNIT-T-26',NULL,'10^12 IU/L','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.(NCI)','\0','TIU/L; Tera International Unit per Liter','CL-UNIT','DBX-NCIT-C105518'),('CL-UNIT-T-260',NULL,'kN/cm2','The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive ','\0','Kilonewton per Centimeter Squared; kdyn/cm2','CL-UNIT','DBX-NCIT-C92615'),('CL-UNIT-T-261',NULL,'kPa','A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch. (NCI)','\0','Kilopascal','CL-UNIT','DBX-NCIT-C67284'),('CL-UNIT-T-262',NULL,'kPa/L/sec','A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second. (NCI)','\0','Pa/mL/sec','CL-UNIT','DBX-NCIT-C105492'),('CL-UNIT-T-263',NULL,'ks','A unit of time equal to one thousand seconds (10E3 seconds). (NCI)','\0','10^3 sec; Kilosecond; ksec','CL-UNIT','DBX-NCIT-C105493'),('CL-UNIT-T-264',NULL,'kUSP','A unit of potency equal to one thousand US Pharmacopoeia Units.(NCI)','\0','Kilo United States Pharmacopoeia Unit','CL-UNIT','DBX-NCIT-C71202'),('CL-UNIT-T-265',NULL,'L','A unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI)','\0','Liter','CL-UNIT','DBX-NCIT-C48505'),('CL-UNIT-T-266',NULL,'L/h','Liters per hour.','\0','L/h','CL-UNIT','DBX-NCIT-C69160'),('CL-UNIT-T-267',NULL,'L/h/m2','A unit expressed as one liter of volume per unit of time equal to one hour per square meter of area. (NCI)','\0','Liters per Hour per Square Meter','CL-UNIT','DBX-NCIT-C105494'),('CL-UNIT-T-268',NULL,'L/kg','A dose calculation unit expressed in liter(s) per kilogram. (NCI)','\0','Liter per Kilogram','CL-UNIT','DBX-NCIT-C73725'),('CL-UNIT-T-269',NULL,'L/L','A unit of volume concentration equal to the number of liters per unit of volume equal to one liter.','\0','Liter per Liter; dL/dL; mL/mL; uL/uL','CL-UNIT','DBX-NCIT-C105495'),('CL-UNIT-T-27',NULL,'10^12/L','A unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter.','\0','10^6/mm3; 10^6/uL; T/L; Tera/L','CL-UNIT','DBX-NCIT-C67308'),('CL-UNIT-T-270',NULL,'L/min','A unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI)','\0','Liters per Minute','CL-UNIT','DBX-NCIT-C67388'),('CL-UNIT-T-271',NULL,'L/min/m2','A unit expressed as one liter of volume per unit of time equal to one minute per square meter of area. (NCI)','\0','Liters per Minute per Square Meter','CL-UNIT','DBX-NCIT-C105496'),('CL-UNIT-T-272',NULL,'L/s','Liters per second.','\0','L/sec','CL-UNIT','DBX-NCIT-C67390'),('CL-UNIT-T-273',NULL,'LB','A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)','\0','Pound','CL-UNIT','DBX-NCIT-C48531'),('CL-UNIT-T-274',NULL,'lm','A unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.(NCI)','\0','Lumen','CL-UNIT','DBX-NCIT-C42560'),('CL-UNIT-T-275',NULL,'log EID 50/dose','A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)','\0','Log10 50 Percent Embryo Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70480'),('CL-UNIT-T-276',NULL,'log10 CCID 50','A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the cell culture-containing vessels inoculate','\0','Log10 50 Percent Cell Culture Infective Dose','CL-UNIT','DBX-NCIT-C70484'),('CL-UNIT-T-277',NULL,'log10 CCID 50/dose','A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.(NCI)','\0','Log10 50 Percent Cell Culture Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70485'),('CL-UNIT-T-278',NULL,'log10 CFU/g','A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram.','\0','','CL-UNIT','DBX-NCIT-C102658'),('CL-UNIT-T-279',NULL,'log10 CFU/mL','A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C102659'),('CL-UNIT-T-28',NULL,'10^3 CFU','A unit of measurement of viable bacterial numbers equal to 10 to the third power colony forming units.','\0','Thousand CFU; Thousand Colony Forming Units','CL-UNIT','DBX-NCIT-C68895'),('CL-UNIT-T-280',NULL,'log10 copies/mL','A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C117972'),('CL-UNIT-T-281',NULL,'log10 EID 50','A potency unit for measuring infectious activity of a biologic product or infectious agent equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of embryos (such as chicken embryos) used in the product pot','\0','Log10 50 Percent Embryo Infective Dose','CL-UNIT','DBX-NCIT-C70479'),('CL-UNIT-T-282',NULL,'Log10 ELISA unit','A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.(NCI)','\0','Log10 Enzyme-Linked Immunosorbent Assay Unit','CL-UNIT','DBX-NCIT-C68878'),('CL-UNIT-T-283',NULL,'Log10 ELISA unit/dose','A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single ','\0','Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose','CL-UNIT','DBX-NCIT-C68879'),('CL-UNIT-T-284',NULL,'log10 IU/mL','A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C116238'),('CL-UNIT-T-285',NULL,'log10 TCID 50','A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the tissue culture-containing flasks inoculat','\0','Log10 50 Percent Tissue Culture Infective Dose','CL-UNIT','DBX-NCIT-C70488'),('CL-UNIT-T-286',NULL,'log10 TCID 50/dose','A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.(NCI)','\0','Log10 50 Percent Tissue Culture Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70489'),('CL-UNIT-T-287',NULL,'LOZENGE','A dosing measurement based on the lozenge unit.(NCI)','\0','Lozenge Dosing Unit','CL-UNIT','DBX-NCIT-C48506'),('CL-UNIT-T-288',NULL,'LPF','The area visible in one view field of the microscope under the low magnification of the objective being used in microscopy.(NCI)','\0','Low Power Field','CL-UNIT','DBX-NCIT-C67307'),('CL-UNIT-T-289',NULL,'lx','A unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.(NCI)','\0','Lux','CL-UNIT','DBX-NCIT-C42561'),('CL-UNIT-T-29',NULL,'10^3 CFU/g','A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the third power colony forming units in one gram of substance.','\0','Thousand CFU/g; Thousand Colony Forming Units per Gram','CL-UNIT','DBX-NCIT-C68899'),('CL-UNIT-T-290',NULL,'m','A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI)','\0','Meter','CL-UNIT','DBX-NCIT-C41139'),('CL-UNIT-T-291',NULL,'m/sec','A unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.(NCI)','\0','Meter Per Second','CL-UNIT','DBX-NCIT-C42571'),('CL-UNIT-T-292',NULL,'m2','The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)','\0','Square Meter','CL-UNIT','DBX-NCIT-C42569'),('CL-UNIT-T-293',NULL,'m3','A unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.(NCI)','\0','Cubic Meter','CL-UNIT','DBX-NCIT-C42570'),('CL-UNIT-T-294',NULL,'MBq','A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 10E6 Becquerels.(NCI)','\0','Megabecquerel','CL-UNIT','DBX-NCIT-C70512'),('CL-UNIT-T-295',NULL,'MBq/uL','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter.(NCI)','\0','GBq/mL; Gigabecquerel per Milliliter; Megabecquerel per Microliter','CL-UNIT','DBX-NCIT-C71169'),('CL-UNIT-T-296',NULL,'mCi','A unit of radioactivity equal to one thousandth of a Curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.(NCI)','\0','Millicurie','CL-UNIT','DBX-NCIT-C48511'),('CL-UNIT-T-297',NULL,'mCi/kg','A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.(NCI)','\0','Microcurie per Gram; Millicurie per Kilogram; uCi/g','CL-UNIT','DBX-NCIT-C70570'),('CL-UNIT-T-298',NULL,'mCi/L','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a Curie per unit volume equal to one liter.(NCI)','\0','Microcurie per Milliliter; Millicurie per Liter; uCi/mL','CL-UNIT','DBX-NCIT-C71174'),('CL-UNIT-T-299',NULL,'mEq','A unit of relative amount of a substance equal to one thousandth of an equivalent weight.(NCI)','\0','Milliequivalent','CL-UNIT','DBX-NCIT-C48512'),('CL-UNIT-T-3',NULL,'%(v/v)','A percent ratio of volume to volume, defined by the equation: [volume of solute (in ml)/ volume of solution (in ml)](100), typically used for admixtures of solutions.(NCI)','\0','Percent Volume per Volume; vol%','CL-UNIT','DBX-NCIT-C48571'),('CL-UNIT-T-30',NULL,'10^3 CFU/mL','A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the third power colony forming units in one milliliter of substance.','\0','Thousand CFU/mL; Thousand Colony Forming Units per Milliliter','CL-UNIT','DBX-NCIT-C68903'),('CL-UNIT-T-300',NULL,'mEq/day','A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to twenty four hours.(NCI)','\0','Milliequivalents per Day','CL-UNIT','DBX-NCIT-C67471'),('CL-UNIT-T-301',NULL,'mEq/dL','A concentration unit measured as a number of milliequivalents of solute per deciliter of solution. (NCI)','\0','Milliequivalent per Deciliter','CL-UNIT','DBX-NCIT-C67473'),('CL-UNIT-T-302',NULL,'mEq/g','A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)','\0','Milliequivalent Per Gram','CL-UNIT','DBX-NCIT-C70580'),('CL-UNIT-T-303',NULL,'mEq/g Creatinine','A unit of relative amount of substance concentration defined as the concentration of milliequivalents per gram of creatinine.','\0','','CL-UNIT','DBX-NCIT-C105501'),('CL-UNIT-T-304',NULL,'mEq/kg','A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)','\0','Milliequivalent Per Kilogram','CL-UNIT','DBX-NCIT-C67475'),('CL-UNIT-T-305',NULL,'mEq/L','A concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI)','\0','Milliequivalent Per Liter; Millivalent per Liter; mval/L','CL-UNIT','DBX-NCIT-C67474'),('CL-UNIT-T-306',NULL,'mEq/mL','A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution. (NCI)','\0','Milliequivalent per Milliliter','CL-UNIT','DBX-NCIT-C73737'),('CL-UNIT-T-307',NULL,'mEq/mmol','A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance. (NCI)','\0','Milliequivalent per Millimole','CL-UNIT','DBX-NCIT-C92616'),('CL-UNIT-T-308',NULL,'mEq/ug','A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)','\0','Milliequivalent Per Microgram; mEq/mcg','CL-UNIT','DBX-NCIT-C70581'),('CL-UNIT-T-309',NULL,'mEq/uL','A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI)','\0','Milliequivalent Per Microliter','CL-UNIT','DBX-NCIT-C70578'),('CL-UNIT-T-31',NULL,'10^3 copies/mL','The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter. (NCI)','\0','','CL-UNIT','DBX-NCIT-C100897'),('CL-UNIT-T-310',NULL,'MESF','A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental c','\0','Molecules of Equivalent Soluble Fluorochromes','CL-UNIT','DBX-NCIT-C96691'),('CL-UNIT-T-311',NULL,'MFI','A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.','\0','Median Fluorescence Intensity','CL-UNIT','DBX-NCIT-C96687'),('CL-UNIT-T-312',NULL,'mg','The unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI)','\0','Milligram','CL-UNIT','DBX-NCIT-C28253'),('CL-UNIT-T-313',NULL,'mg/animal','A unit of measure expressed in milligram(s) per animal.','\0','Milligram per Animal','CL-UNIT','DBX-NCIT-C73738'),('CL-UNIT-T-314',NULL,'mg/day','A unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI)','\0','Milligram per Day','CL-UNIT','DBX-NCIT-C67399'),('CL-UNIT-T-315',NULL,'mg/dL','A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of subst','\0','Milligram per Deciliter; mg%','CL-UNIT','DBX-NCIT-C67015'),('CL-UNIT-T-316',NULL,'mg/g Creatinine','A unit of substance concentration defined as the number of milligrams per gram of creatinine.','\0','','CL-UNIT','DBX-NCIT-C105502'),('CL-UNIT-T-317',NULL,'mg/g/h','A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes. (NCI)','\0','Milligram per Gram per Hour','CL-UNIT','DBX-NCIT-C73740'),('CL-UNIT-T-318',NULL,'mg/g/min','A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds. (NCI)','\0','Milligram per Gram per Minute','CL-UNIT','DBX-NCIT-C73741'),('CL-UNIT-T-319',NULL,'mg/h','A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)','\0','Milligram per Hour','CL-UNIT','DBX-NCIT-C66969'),('CL-UNIT-T-32',NULL,'10^3 DNA copies/mL','A unit of measurement equal to 10 to the third power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C98788'),('CL-UNIT-T-320',NULL,'mg/kg','A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)','\0','Milligram per Kilogram','CL-UNIT','DBX-NCIT-C67401'),('CL-UNIT-T-321',NULL,'mg/kg/day','A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI)','\0','Milligram per Kilogram per Day','CL-UNIT','DBX-NCIT-C66976'),('CL-UNIT-T-322',NULL,'mg/kg/h','A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.(NCI)','\0','Milligram per Kilogram per Hour','CL-UNIT','DBX-NCIT-C71362'),('CL-UNIT-T-323',NULL,'mg/kg/min','A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI)','\0','Milligram per Kilogram per Minute','CL-UNIT','DBX-NCIT-C71207'),('CL-UNIT-T-324',NULL,'mg/L','A unit of mass concentration equal to the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which','\0','Gram per Cubic Meter; Microgram per Milliliter; Milligram per Liter; g/m3; mcg/mL; mg/L; ng/uL; ug/mL','CL-UNIT','DBX-NCIT-C64572'),('CL-UNIT-T-325',NULL,'mg/m2','A unit of area density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.(NCI)','\0','Milligram per Square Meter','CL-UNIT','DBX-NCIT-C67402'),('CL-UNIT-T-326',NULL,'mg/m2/day','A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours. (NCI)','\0','Milligram per Square Meter per Day','CL-UNIT','DBX-NCIT-C66974'),('CL-UNIT-T-327',NULL,'mg/m2/h','A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes. (NCI)','\0','Milligram per Square Meter per Hour','CL-UNIT','DBX-NCIT-C73743'),('CL-UNIT-T-328',NULL,'mg/m2/min','A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds. (NCI)','\0','Milligram per Square Meter per Minute','CL-UNIT','DBX-NCIT-C73744'),('CL-UNIT-T-329',NULL,'mg/min','Milligrams per minute.','\0','Milligram per Minute','CL-UNIT','DBX-NCIT-C73742'),('CL-UNIT-T-33',NULL,'10^3 organisms','A unit of measure of quantity of organisms expressed in 10 to the third power of organisms.','\0','Thousand Organisms','CL-UNIT','DBX-NCIT-C71187'),('CL-UNIT-T-330',NULL,'mg/mL/min','A unit expressed in milligrams per milliliter per period of time equal to sixty seconds.','\0','Milligram per Milliliter per Minute','CL-UNIT','DBX-NCIT-C67403'),('CL-UNIT-T-331',NULL,'MHz','The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz. (NCI)','\0','Megahertz','CL-UNIT','DBX-NCIT-C67314'),('CL-UNIT-T-332',NULL,'Mile','A unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.(NCI)','\0','International Mile','CL-UNIT','DBX-NCIT-C71183'),('CL-UNIT-T-333',NULL,'min','A unit measure of time equal to 60 seconds.(NCI)','\0','Minute Unit of Time','CL-UNIT','DBX-NCIT-C48154'),('CL-UNIT-T-334',NULL,'mJoule/cm2','A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter.','\0','','CL-UNIT','DBX-NCIT-C116241'),('CL-UNIT-T-335',NULL,'mkat','A unit of catalytic activity measurement equal to one thousandth of one katal (10E-3 katal).(NCI)','\0','Millikatal','CL-UNIT','DBX-NCIT-C70507'),('CL-UNIT-T-336',NULL,'mL','The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI)','\0','Milliliter; cm3','CL-UNIT','DBX-NCIT-C28254'),('CL-UNIT-T-337',NULL,'mL/animal','A unit of measure expressed in milliliter(s) per animal.','\0','Milliliter per Animal','CL-UNIT','DBX-NCIT-C73746'),('CL-UNIT-T-338',NULL,'mL/animal/day','A unit of measure expressed in milliliter(s) per animal per period of time equal to twenty-four hours.','\0','Milliliter per Animal per Day','CL-UNIT','DBX-NCIT-C73747'),('CL-UNIT-T-339',NULL,'mL/animal/wk','A unit of measure expressed in milliliter(s) per animal per period of time equal to seven days.','\0','Milliliter per Animal per Week','CL-UNIT','DBX-NCIT-C73748'),('CL-UNIT-T-34',NULL,'10^3 organisms/g','A unit of measure of organism content expressed in 10 to the third power of organisms per unit of mass equal to one gram.','\0','Thousand Organisms per Gram; Thousand Organisms/g','CL-UNIT','DBX-NCIT-C71190'),('CL-UNIT-T-340',NULL,'mL/breath','A unit of measure expressed in milliliter(s) per inspiration or expiration of breath.','\0','Milliliter per Breath','CL-UNIT','DBX-NCIT-C73749'),('CL-UNIT-T-341',NULL,'mL/cage','A unit of measure expressed in milliliter(s) per cage.','\0','Milliliter per Cage','CL-UNIT','DBX-NCIT-C73750'),('CL-UNIT-T-342',NULL,'mL/cage/day','A unit of measure expressed in milliliter(s) per cage per period of time equal to twenty-four hours.','\0','Milliliter per Cage per Day','CL-UNIT','DBX-NCIT-C73751'),('CL-UNIT-T-343',NULL,'mL/cage/wk','A unit of measure expressed in milliliter(s) per cage expressed per period of time equal to seven days.','\0','Milliliter per Cage per Week','CL-UNIT','DBX-NCIT-C73752'),('CL-UNIT-T-344',NULL,'mL/cm','A unit of measure equal to the number of milliliters per unit of length equal to one centimeter. (NCI)','\0','Milliliter per Centimeter; dL/m','CL-UNIT','DBX-NCIT-C105503'),('CL-UNIT-T-345',NULL,'mL/cm H2O','A unit of pressure expressed in milliliter(s) per centimeter of water. (NCI)','\0','','CL-UNIT','DBX-NCIT-C98755'),('CL-UNIT-T-346',NULL,'mL/day','Milliliters per day.','\0','Milliliter per Day','CL-UNIT','DBX-NCIT-C67410'),('CL-UNIT-T-347',NULL,'mL/dL','A unit of volume concentration equal to the number of milliliters per unit of volume equal to one deciliter.','\0','Milliliters per Deciliter','CL-UNIT','DBX-NCIT-C105504'),('CL-UNIT-T-348',NULL,'mL/g','A unit of measure expressed in milliliter(s) per gram.','\0','Milliliter per Gram','CL-UNIT','DBX-NCIT-C73754'),('CL-UNIT-T-349',NULL,'mL/g/day','Liters per kilogram per day.','\0','L/day/kg; L/kg/d; Milliliter per Gram per Day; mL/day/g; mL/g/day; uL/day/mg; uL/mg/day','CL-UNIT','DBX-NCIT-C73755'),('CL-UNIT-T-35',NULL,'10^3 organisms/mL','A unit of measure of organism concentration expressed in 10 to the third power of organisms per unit of volume equal to one milliliter.','\0','Thousand Organisms per Milliliter; Thousand Organisms/mL','CL-UNIT','DBX-NCIT-C71195'),('CL-UNIT-T-350',NULL,'mL/g/h','Milliliters per gram per hour.','\0','Milliliter per Gram per Hour','CL-UNIT','DBX-NCIT-C73756'),('CL-UNIT-T-351',NULL,'mL/g/min','Milliliters per gram per minute.','\0','Milliliter per Gram per Minute','CL-UNIT','DBX-NCIT-C73757'),('CL-UNIT-T-352',NULL,'mL/h','A unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI)','\0','Milliliters per Hour','CL-UNIT','DBX-NCIT-C66962'),('CL-UNIT-T-353',NULL,'mL/kg','A dose calculation unit equal to one milliliter of preparation per one kilogram of body mass. (NCI)','\0','Milliliter per Kilogram','CL-UNIT','DBX-NCIT-C67411'),('CL-UNIT-T-354',NULL,'mL/kg/day','Milliliters per kilogram per day.','\0','Milliliter per Kilogram per Day','CL-UNIT','DBX-NCIT-C73758'),('CL-UNIT-T-355',NULL,'mL/kg/h','Milliliters per kilogram per hour.','\0','Milliliter per Kilogram per Hour','CL-UNIT','DBX-NCIT-C73759'),('CL-UNIT-T-356',NULL,'mL/kg/min','Milliliters per kilogram per minute.','\0','Milliliter per Kilogram per Minute; mL/kg/min; mL/min/kg; uL/g/min; uL/min/g','CL-UNIT','DBX-NCIT-C73760'),('CL-UNIT-T-357',NULL,'mL/m2','A unit of measure expressed in milliliter(s) per square meter.','\0','Milliliter per Square Meter','CL-UNIT','DBX-NCIT-C73761'),('CL-UNIT-T-358',NULL,'mL/m2/day','A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours. (NCI)','\0','Milliliter per Square Meter per Day','CL-UNIT','DBX-NCIT-C66977'),('CL-UNIT-T-359',NULL,'mL/m2/h','A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes. (NCI)','\0','Milliliter per Square Meter per Hour','CL-UNIT','DBX-NCIT-C73762'),('CL-UNIT-T-36',NULL,'10^3 RNA copies/mL','A unit of measurement equal to 10 to the third power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C98790'),('CL-UNIT-T-360',NULL,'mL/m2/min','A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds. (NCI)','\0','Milliliter per Square Meter per Minute','CL-UNIT','DBX-NCIT-C73763'),('CL-UNIT-T-361',NULL,'mL/min','A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI)','\0','Milliliters per Minute','CL-UNIT','DBX-NCIT-C64777'),('CL-UNIT-T-362',NULL,'mL/min/1.73m2','A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute per 1.73 meters squared of body surface area.','\0','','CL-UNIT','DBX-NCIT-C67412'),('CL-UNIT-T-363',NULL,'mL/min/mmHg','A unit of measure equal to the number of milliliters per unit of time equal to one minute per unit of pressure equal to one milliter of mercury (mmHg).','\0','Milliliter per Minute per Torr','CL-UNIT','DBX-NCIT-C67417'),('CL-UNIT-T-364',NULL,'mL/mmHg','A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth\'s surface. (NCI)','\0','Milliliters per Millimeter of Mercury','CL-UNIT','DBX-NCIT-C106542'),('CL-UNIT-T-365',NULL,'mL/mmHg/min/L','A unit of gas diffusion capacity equal to one milliliter per millimeter of mercury per minute per liter of volume.','\0','','CL-UNIT','DBX-NCIT-C67418'),('CL-UNIT-T-366',NULL,'mL/s','Milliliters per second.','\0','mL/sec','CL-UNIT','DBX-NCIT-C69073'),('CL-UNIT-T-367',NULL,'mL/sec/1.73m2','A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area.','\0','','CL-UNIT','DBX-NCIT-C105505'),('CL-UNIT-T-368',NULL,'mm','A unit of measure equal to one thousandth of a meter. (NCI)','\0','Millimeter','CL-UNIT','DBX-NCIT-C28251'),('CL-UNIT-T-369',NULL,'mm/2h','A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to two hours. (NCI)','\0','Millimeters per Two Hours','CL-UNIT','DBX-NCIT-C105509'),('CL-UNIT-T-37',NULL,'10^3/hpf','A unit of measurement equal to 10 to the third power of the number of entities per unit of area equal to one high powered field.','\0','','CL-UNIT','DBX-NCIT-C98789'),('CL-UNIT-T-370',NULL,'mm/h','A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travels per unit time equal to one hour.(NCI)','\0','Millimeter per Hour','CL-UNIT','DBX-NCIT-C67419'),('CL-UNIT-T-371',NULL,'mm/min','A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one minute. (NCI)','\0','Millimeters per Minute','CL-UNIT','DBX-NCIT-C105507'),('CL-UNIT-T-372',NULL,'mm/sec','A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one second. (NCI)','\0','Millimeters per Second','CL-UNIT','DBX-NCIT-C105508'),('CL-UNIT-T-373',NULL,'mm2','A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.(NCI)','\0','Square Millimeter','CL-UNIT','DBX-NCIT-C65104'),('CL-UNIT-T-374',NULL,'mmHg','A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth\'s surface. (NCI)','\0','Millimeter of Mercury','CL-UNIT','DBX-NCIT-C49670'),('CL-UNIT-T-375',NULL,'mmHg/L/min','A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute.','\0','','CL-UNIT','DBX-NCIT-C105506'),('CL-UNIT-T-376',NULL,'mmHg/sec','A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute. (NCI)','\0','Millimeter of Mercury per Second','CL-UNIT','DBX-NCIT-C73764'),('CL-UNIT-T-377',NULL,'mmol','A unit of amount of substance equal to 0.001 mole.(NCI)','\0','Millimole','CL-UNIT','DBX-NCIT-C48513'),('CL-UNIT-T-378',NULL,'mmol/day','A unit of amount of substance flow rate equivalent to the rate at which one thousandth of a mole of substance travels or is delivered to a given object or space over a period of time equal to 24 hours.(NCI)','\0','Millimole per 24 Hours','CL-UNIT','DBX-NCIT-C67420'),('CL-UNIT-T-379',NULL,'mmol/g','A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.(NCI)','\0','Millimole per Gram','CL-UNIT','DBX-NCIT-C68740'),('CL-UNIT-T-38',NULL,'10^3/L','A unit of measurement equal to 10 to the third power of entities per unit of volume equal to one liter.','\0','','CL-UNIT','DBX-NCIT-C105519'),('CL-UNIT-T-380',NULL,'mmol/g Creatinine','A unit of substance concentration defined as the concentration of millimoles of solute per gram of creatinine.','\0','','CL-UNIT','DBX-NCIT-C105510'),('CL-UNIT-T-381',NULL,'mmol/kg','A unit of amount of substance content (molality unit) defined as one thousandth of mole (10E-3 mole) of solute per one kilogram of solvent.(NCI)','\0','Millimole per Kilogram','CL-UNIT','DBX-NCIT-C68892'),('CL-UNIT-T-382',NULL,'mmol/L','A unit of concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution.(NCI)','\0','Micromole per Milliliter; Millimole per Liter; Mole per Cubic Meter; mcmol/mL; mmol/L; mol/m3; nmol/uL; umol/mL','CL-UNIT','DBX-NCIT-C64387'),('CL-UNIT-T-383',NULL,'mmol/min/kPa','A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.','\0','','CL-UNIT','DBX-NCIT-C116242'),('CL-UNIT-T-384',NULL,'mmol/min/kPa/L','A unit of gas diffusion capacity equal to one millimole per minute per kilopascal per liter of volume.','\0','','CL-UNIT','DBX-NCIT-C67423'),('CL-UNIT-T-385',NULL,'mmol/mol','A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles.','\0','','CL-UNIT','DBX-NCIT-C111253'),('CL-UNIT-T-386',NULL,'mmol/mol Creatinine','A unit of substance concentration defined as the concentration of millimoles of solute per mole of creatinine.','\0','','CL-UNIT','DBX-NCIT-C105511'),('CL-UNIT-T-387',NULL,'mol','A unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, o','\0','Mole','CL-UNIT','DBX-NCIT-C42539'),('CL-UNIT-T-388',NULL,'mol/g','A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.(NCI)','\0','Mole per Gram','CL-UNIT','DBX-NCIT-C68893'),('CL-UNIT-T-389',NULL,'mol/L','A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI)','\0','Mole per Liter; mmol/mL; mol/L','CL-UNIT','DBX-NCIT-C48555'),('CL-UNIT-T-39',NULL,'10^4/hpf','A unit of measurement equal to 10 to the fourth power of the number of entities per unit of area equal to one high powered field.','\0','','CL-UNIT','DBX-NCIT-C98787'),('CL-UNIT-T-390',NULL,'mol/mg','A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.(NCI)','\0','Mole per Milligram','CL-UNIT','DBX-NCIT-C68894'),('CL-UNIT-T-391',NULL,'mol/mL','A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.(NCI)','\0','Mole per Milliliter','CL-UNIT','DBX-NCIT-C68891'),('CL-UNIT-T-392',NULL,'mol/mol','A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.(NCI)','\0','Mole per Mole; mmol/mmol','CL-UNIT','DBX-NCIT-C70455'),('CL-UNIT-T-393',NULL,'MONTHS','One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon\'s phases, about 30 days or 4 weeks. (NCI)','\0','Month','CL-UNIT','DBX-NCIT-C29846'),('CL-UNIT-T-394',NULL,'mOsm','A unit of osmotic pressure equal to one thousandth of an osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate. (NCI)','\0','Milliosmole','CL-UNIT','DBX-NCIT-C67318'),('CL-UNIT-T-395',NULL,'mOsm/kg','A unit of osmotic pressure equal to one thousandth of an osmole per kilogram substance.','\0','Milliosmole per Kilogram','CL-UNIT','DBX-NCIT-C67427'),('CL-UNIT-T-396',NULL,'mPa','A SI derived unit of pressure equivalent to one thousandth of one pascal. (NCI)','\0','Millipascal','CL-UNIT','DBX-NCIT-C73765'),('CL-UNIT-T-397',NULL,'mph','A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile travelled per unit time equal to one hour. (NCI)','\0','Miles per Hour','CL-UNIT','DBX-NCIT-C105500'),('CL-UNIT-T-398',NULL,'MPL U/mL','A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.','\0','Immunoglobin M Phospholipid Units per Milliliter','CL-UNIT','DBX-NCIT-C117973'),('CL-UNIT-T-399',NULL,'msec','A unit of time, which is equal to one thousandth of a second.(NCI)','\0','Millisecond','CL-UNIT','DBX-NCIT-C41140'),('CL-UNIT-T-4',NULL,'%(w/v)','A percent ratio of weight to volume, defined by the equation: [weight of solute (in gm)/volume of solution (in dl)](100). Since the numerator and denominator of this ratio have different units, it is not a true percentage. A 1% w/v solution is defined as ','\0','Percent Weight per Volume','CL-UNIT','DBX-NCIT-C48527'),('CL-UNIT-T-40',NULL,'10^4/L','A unit of measurement equal to 10 to the fourth power of entities per unit of volume equal to one liter.','\0','','CL-UNIT','DBX-NCIT-C73771'),('CL-UNIT-T-400',NULL,'mU/L','An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one thousandth of a unit of a substance.','\0','','CL-UNIT','DBX-NCIT-C67408'),('CL-UNIT-T-401',NULL,'mV','A unit of electric potential and electromotive force equal to one thousandth of a volt.(NCI)','\0','Millivolt','CL-UNIT','DBX-NCIT-C67324'),('CL-UNIT-T-402',NULL,'mV*min','A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute. (NCI)','\0','Millivolt * Minutes','CL-UNIT','DBX-NCIT-C105512'),('CL-UNIT-T-403',NULL,'mV2/Hz','A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz.','\0','Millivolt Squared per Hertz; Millivolt^2/Hertz','CL-UNIT','DBX-NCIT-C114241'),('CL-UNIT-T-404',NULL,'nCi','A unit of radioactivity equal to one billionth of Curie or 37 Becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second.(NCI)','\0','Nanocurie','CL-UNIT','DBX-NCIT-C67352'),('CL-UNIT-T-405',NULL,'NEBULE','A unit of measurement based on the nebule dosing unit.(NCI)','\0','Nebule','CL-UNIT','DBX-NCIT-C71204'),('CL-UNIT-T-406',NULL,'NEEDLE GAUGE','A number representing the outer diameter of a needle. (NCI)','\0','','CL-UNIT','DBX-NCIT-C101687'),('CL-UNIT-T-407',NULL,'Newton','A unit of force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 10E5 dynes.(NCI)','\0','Newton','CL-UNIT','DBX-NCIT-C42546'),('CL-UNIT-T-408',NULL,'ng','A unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI)','\0','Nanogram','CL-UNIT','DBX-NCIT-C48516'),('CL-UNIT-T-409',NULL,'ng/dL','A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mas','\0','Nanogram per Deciliter','CL-UNIT','DBX-NCIT-C67326'),('CL-UNIT-T-41',NULL,'10^5/hpf','A unit of measurement equal to 10 to the fifth power of the number of entities per unit of area equal to one high powered field.','\0','','CL-UNIT','DBX-NCIT-C98743'),('CL-UNIT-T-410',NULL,'ng/L','A unit of mass concentration defined as the concentration of one nanogram of a substance per one liter of the mixture, or one picogram of a substance in unit volume of the mixture equal to one milliliter, or one microgram of a substance per one cubic mete','\0','Microgram per Cubic Meter; ng/L; pg/mL; ug/m3','CL-UNIT','DBX-NCIT-C67327'),('CL-UNIT-T-411',NULL,'NIU','A unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard. (NCI)','\0','Normalized Fluorescence Intensity Unit; Normalized Intensity Unit; Relative Fluorescence Intensity Unit; Relative Intensity Unit','CL-UNIT','DBX-NCIT-C77535'),('CL-UNIT-T-412',NULL,'nkat','A unit of catalytic activity measurement equal to one billionth of one katal (10E-9 katal).(NCI)','\0','Nanokatal','CL-UNIT','DBX-NCIT-C70508'),('CL-UNIT-T-413',NULL,'nkat/L','A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of one katal (10E-9 katal) in the unit volume of the system equal to one liter.(NCI)','\0','Nanokatal per Liter','CL-UNIT','DBX-NCIT-C70510'),('CL-UNIT-T-414',NULL,'nL','A unit of volume equal to one billionth of a liter (10E-9 liter).(NCI)','\0','Nanoliter','CL-UNIT','DBX-NCIT-C69188'),('CL-UNIT-T-415',NULL,'nm','A unit of length equal to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement.(NCI)','\0','Nanometer','CL-UNIT','DBX-NCIT-C67328'),('CL-UNIT-T-416',NULL,'nmol','A unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI)','\0','Nanomole','CL-UNIT','DBX-NCIT-C48517'),('CL-UNIT-T-417',NULL,'nmol BCE/L','A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter.','\0','Nanomoles Bone Collagen Equivalents per Liter','CL-UNIT','DBX-NCIT-C117974'),('CL-UNIT-T-418',NULL,'nmol BCE/mmol','A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole.','\0','Nanomoles Bone Collagen Equivalents per Millimole','CL-UNIT','DBX-NCIT-C118137'),('CL-UNIT-T-419',NULL,'nmol/L','A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.(NCI)','\0','Nanomole per Liter','CL-UNIT','DBX-NCIT-C67432'),('CL-UNIT-T-42',NULL,'10^5/L','A unit of measurement equal to 10 to the fifth power of entities per unit of volume equal to one liter.','\0','10^2/mL','CL-UNIT','DBX-NCIT-C105490'),('CL-UNIT-T-420',NULL,'nmol/mL/min','A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one milliliter of solution to be administered per minute of time.','\0','Nanomole per Milliliter per Minute','CL-UNIT','DBX-NCIT-C92613'),('CL-UNIT-T-421',NULL,'nsec','A unit of time equal to one billionth of a second. (NCI)','\0','Nanosecond','CL-UNIT','DBX-NCIT-C73767'),('CL-UNIT-T-422',NULL,'nU/cL','An arbitrary unit of substance content expressed in nanounit(s) per centiliter. (NCI)','\0','Nanounit per Centiliter','CL-UNIT','DBX-NCIT-C105513'),('CL-UNIT-T-423',NULL,'ohm','A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A ','\0','Ohm','CL-UNIT','DBX-NCIT-C42554'),('CL-UNIT-T-424',NULL,'osm','A unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.(NCI)','\0','Osmole','CL-UNIT','DBX-NCIT-C67330'),('CL-UNIT-T-425',NULL,'oz','A unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI)','\0','Ounce','CL-UNIT','DBX-NCIT-C48519'),('CL-UNIT-T-426',NULL,'PA','A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.','\0','/Year; Every Year; Per Annum; Per Year','CL-UNIT','DBX-NCIT-C74924'),('CL-UNIT-T-427',NULL,'Pa','A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI)','\0','Pascal','CL-UNIT','DBX-NCIT-C42547'),('CL-UNIT-T-428',NULL,'PACK','A number of individual items packaged as a unit.','\0','','CL-UNIT','DBX-NCIT-C62653'),('CL-UNIT-T-429',NULL,'Pack Year','A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year.','\0','','CL-UNIT','DBX-NCIT-C73993'),('CL-UNIT-T-43',NULL,'10^6 CFU','A unit of measurement of viable bacterial numbers equal to 10 to the sixth power colony forming units.','\0','Million CFU; Million Colony Forming Units','CL-UNIT','DBX-NCIT-C68896'),('CL-UNIT-T-430',NULL,'PACKAGE','A dosing measurement based on the package unit.(NCI)','\0','Pack Dosing Unit; Package Dosing Unit','CL-UNIT','DBX-NCIT-C48520'),('CL-UNIT-T-431',NULL,'PACKET','A dosing measurement based on the packet unit.(NCI)','\0','Packet Dosing Unit','CL-UNIT','DBX-NCIT-C48521'),('CL-UNIT-T-432',NULL,'PATCH','A dosing measurement based on the patch unit.(NCI)','\0','Patch Dosing Unit','CL-UNIT','DBX-NCIT-C48524'),('CL-UNIT-T-433',NULL,'PELLET','A dosing measurement based on the pellet unit.(NCI)','\0','Pellet Dosing Unit','CL-UNIT','DBX-NCIT-C48525'),('CL-UNIT-T-434',NULL,'per min','The number of occurrences of something within a minute of time.(NCI)','\0','Per Minute','CL-UNIT','DBX-NCIT-C66967'),('CL-UNIT-T-435',NULL,'per sec','The number of occurrences of something within a second of time.(NCI)','\0','Per Second','CL-UNIT','DBX-NCIT-C66965'),('CL-UNIT-T-436',NULL,'PFU','A measure of viable infectious entities (e.g. viral particle or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible und','\0','Plaque Forming Unit','CL-UNIT','DBX-NCIT-C67264'),('CL-UNIT-T-437',NULL,'PFU/dose','A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per a single dose of the preparation.(NCI)','\0','Plaque Forming Unit per Dose','CL-UNIT','DBX-NCIT-C71198'),('CL-UNIT-T-438',NULL,'PFU/mL','A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per one milliliter of the preparation.(NCI)','\0','Plaque Forming Unit per Milliliter','CL-UNIT','DBX-NCIT-C71199'),('CL-UNIT-T-439',NULL,'pg','A unit of mass equal to one trillionth of a gram (10E-12 gram).(NCI)','\0','Picogram','CL-UNIT','DBX-NCIT-C64551'),('CL-UNIT-T-44',NULL,'10^6 CFU/g','A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the sixth power colony forming units in one gram of substance.','\0','Million CFU/g; Million Colony Forming Units per Gram','CL-UNIT','DBX-NCIT-C68900'),('CL-UNIT-T-440',NULL,'pg/dL','Picograms per deciliter.','\0','Picogram per Deciliter','CL-UNIT','DBX-NCIT-C67331'),('CL-UNIT-T-441',NULL,'PIPE','A dosing measurement based on the pipe unit.','\0','Pipe Dosing Unit','CL-UNIT','DBX-NCIT-C116246'),('CL-UNIT-T-442',NULL,'PIXEL','The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (NCI)','\0','','CL-UNIT','DBX-NCIT-C48367'),('CL-UNIT-T-443',NULL,'PIXELS/cm','A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction.','\0','PPCM; Pixels per Centimeter','CL-UNIT','DBX-NCIT-C114238'),('CL-UNIT-T-444',NULL,'PIXELS/in','A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction.','\0','PPI; Pixels per Inch','CL-UNIT','DBX-NCIT-C114239'),('CL-UNIT-T-445',NULL,'pkat','A unit of catalytic activity measurement equal to trillionth of one katal (10E-12 katal).(NCI)','\0','Picokatal','CL-UNIT','DBX-NCIT-C70509'),('CL-UNIT-T-446',NULL,'pL','A unit of volume equal to one trillionth of a liter (10E-12 liter). (NCI)','\0','Picoliter','CL-UNIT','DBX-NCIT-C69189'),('CL-UNIT-T-447',NULL,'pm','A unit of length equal to one trillionth of a meter (10E-12 meter).(NCI)','\0','Picometer','CL-UNIT','DBX-NCIT-C69148'),('CL-UNIT-T-448',NULL,'pmol','A unit of amount of substance equal to a trillionth (10E-12) of a mole.(NCI)','\0','Picomole','CL-UNIT','DBX-NCIT-C65045'),('CL-UNIT-T-449',NULL,'pmol/L','A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.(NCI)','\0','Femtomole per Milliliter; Picomole per Liter; fmol/mL','CL-UNIT','DBX-NCIT-C67434'),('CL-UNIT-T-45',NULL,'10^6 CFU/mL','A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the sixth power colony forming units in one milliliter of substance.','\0','Million CFU/mL; Million Colony Forming Units per Milliliter','CL-UNIT','DBX-NCIT-C68904'),('CL-UNIT-T-450',NULL,'PNU/mL','Unit of measure of potency of an allergenic product expressed as a number of protein nitrogen units per one milliliter of formulation.','\0','Protein Nitrogen Unit per Milliliter','CL-UNIT','DBX-NCIT-C116236'),('CL-UNIT-T-451',NULL,'POUCH','A dosing measurement based on the pouch unit.(NCI)','\0','Pouch Dosing Unit','CL-UNIT','DBX-NCIT-C48530'),('CL-UNIT-T-452',NULL,'ppb','A unit of measure referring to one entity counted per one billion entities.(NCI)','\0','Part per Billion','CL-UNIT','DBX-NCIT-C70565'),('CL-UNIT-T-453',NULL,'ppm','A unit of measurement referring to one entity counted per one million entities.(NCI)','\0','Part per Million','CL-UNIT','DBX-NCIT-C48523'),('CL-UNIT-T-454',NULL,'ppth','A unit of proportion equal to 10E-3.(NCI)','\0','Part per Thousand','CL-UNIT','DBX-NCIT-C69112'),('CL-UNIT-T-455',NULL,'pptr','A unit of measure referring to one entity counted per one trillion entities.(NCI)','\0','Parts per Trillion','CL-UNIT','DBX-NCIT-C70566'),('CL-UNIT-T-456',NULL,'PRESSOR UNITS','A dosing measurement based on the pressor unit.(NCI)','\0','Pressor Unit','CL-UNIT','DBX-NCIT-C48532'),('CL-UNIT-T-457',NULL,'psec','A unit of time equal to one trillionth of a second. (NCI)','\0','Picosecond','CL-UNIT','DBX-NCIT-C73768'),('CL-UNIT-T-458',NULL,'psi','A unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.(NCI)','\0','Pounds per Square Inch','CL-UNIT','DBX-NCIT-C67334'),('CL-UNIT-T-459',NULL,'pt_br','A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters.','\0','British Pint; Imperial Pint','CL-UNIT','DBX-NCIT-C69114'),('CL-UNIT-T-46',NULL,'10^6 copies/mL','The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter. (NCI)','\0','','CL-UNIT','DBX-NCIT-C100898'),('CL-UNIT-T-460',NULL,'pt_us','A United States liquid unit equal to 16 US fluid ounces or 28.875 cubic inches or approximately 473.177 milliliters.','\0','US Pint','CL-UNIT','DBX-NCIT-C48529'),('CL-UNIT-T-461',NULL,'PUFF','A means of delivering a defined dose of a therapeutic aerolized solution into either the upper or lower respiratory tract. Metered-dose inhalers or spray pumps are devices that provide a puff dose for delivery into either the oral or the nasal cavity.(NCI','\0','Puff','CL-UNIT','DBX-NCIT-C65060'),('CL-UNIT-T-462',NULL,'QUANTITY SUFFICIENT','A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amoun','\0','Quantity Sufficient','CL-UNIT','DBX-NCIT-C48590'),('CL-UNIT-T-463',NULL,'Rad','The special unit for absorbed radiation dose, which is the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 er','\0','Rad','CL-UNIT','DBX-NCIT-C18064'),('CL-UNIT-T-464',NULL,'RATIO','A unit of measurement for the quotient of the amount of one entity to another.','\0','','CL-UNIT','DBX-NCIT-C44256'),('CL-UNIT-T-465',NULL,'RING','A dosing measurement based on the ring unit.(NCI)','\0','Ring Dosing Unit','CL-UNIT','DBX-NCIT-C62609'),('CL-UNIT-T-466',NULL,'RNA copies/mL','The unit of concentration of Ribonucleic Acid (RNA) copies expressed as a number of copies in unit volume equal to one milliliter.(NCI)','\0','RNA Copies per Milliliter','CL-UNIT','DBX-NCIT-C67441'),('CL-UNIT-T-467',NULL,'Roentgen','A unit of exposure to ionizing radiation. One Roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 Coulombs/kilogram of air under standard conditions.(NCI)','\0','Roentgen','CL-UNIT','DBX-NCIT-C70575'),('CL-UNIT-T-468',NULL,'rpm','A unit of frequency equal to one revolution per unit of time equal to one minute.(NCI)','\0','Revolution per Minute','CL-UNIT','DBX-NCIT-C70469'),('CL-UNIT-T-469',NULL,'SACHET','A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.(NCI)','\0','Sachet dosing unit','CL-UNIT','DBX-NCIT-C71324'),('CL-UNIT-T-47',NULL,'10^6 DNA copies/mL','A unit of measurement equal to 10 to the sixth power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C98756'),('CL-UNIT-T-470',NULL,'SBE/mL','Unit of measure of potency of allergenic product expressed as a number of standardized biological units per one milliliter of formulation.','\0','Standardized Biological Unit per Milliliter','CL-UNIT','DBX-NCIT-C116233'),('CL-UNIT-T-471',NULL,'scm','A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kilopascals).(NCI)','\0','Standard Cubic Meter','CL-UNIT','DBX-NCIT-C68858'),('CL-UNIT-T-472',NULL,'SCOOPFUL','A dosing measurement based on the scoopful unit.(NCI)','\0','Scoopful Dosing Unit','CL-UNIT','DBX-NCIT-C48536'),('CL-UNIT-T-473',NULL,'sec','The second is a unit of time with a duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. According to the convention, 60 seco','\0','Second','CL-UNIT','DBX-NCIT-C42535'),('CL-UNIT-T-474',NULL,'Shock Wave','A dosing measurement based on the shock wave unit.','\0','Shock Wave','CL-UNIT','DBX-NCIT-C112433'),('CL-UNIT-T-475',NULL,'Siemens','A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one Siemens if an electrical potential difference of one volt produces a one Ampere current in it. The conductance in Siemens is the reciprocal of its resistan','\0','Siemens','CL-UNIT','DBX-NCIT-C42555'),('CL-UNIT-T-476',NULL,'SPRAY','A dosing measurement based on the spray unit.(NCI)','\0','Spray Dosing Unit','CL-UNIT','DBX-NCIT-C48537'),('CL-UNIT-T-477',NULL,'SQU/mL','Unit of measure of potency of allergenic product expressed as a number of standardized quality units per one milliliter of formulation.','\0','Standardized Quality Unit per Milliliter','CL-UNIT','DBX-NCIT-C116234'),('CL-UNIT-T-478',NULL,'STEPS','A unit of measure to quantify the number of strides taken during a normal walking gait.','\0','','CL-UNIT','DBX-NCIT-C111318'),('CL-UNIT-T-479',NULL,'STRIP','A dosing measurement based on the strip unit.(NCI)','\0','Strip Dosing Unit','CL-UNIT','DBX-NCIT-C48538'),('CL-UNIT-T-48',NULL,'10^6 IU','A unit of biological activity equal to 10 to the sixth power international units.','\0','Million IU; Million International Units','CL-UNIT','DBX-NCIT-C67335'),('CL-UNIT-T-480',NULL,'SUPPOSITORY','A dosing measurement based on the suppository unit.(NCI)','\0','Suppository Dosing Unit','CL-UNIT','DBX-NCIT-C48539'),('CL-UNIT-T-481',NULL,'Sv','A unit of equivalent radiation dose. One Sv is received when the actual absorbed dose of ionizing radiation, after being multiplied by the dimensionless factors Q (the relative biological efficiency or quality factor) and N (the product of any other multi','\0','Sievert','CL-UNIT','DBX-NCIT-C42553'),('CL-UNIT-T-482',NULL,'SYRINGE','A dosing measurement based on the syringe unit.(NCI)','\0','Syringe Dosing Unit','CL-UNIT','DBX-NCIT-C48540'),('CL-UNIT-T-483',NULL,'TABLET','A dosing measurement based on the tablet unit.(NCI)','\0','Tablet Dosing Unit; tab','CL-UNIT','DBX-NCIT-C48542'),('CL-UNIT-T-484',NULL,'TAMPON','A dosing measurement based on the tampon unit.(NCI)','\0','Tampon Dosing Unit','CL-UNIT','DBX-NCIT-C48543'),('CL-UNIT-T-485',NULL,'Tbsp','A unit of volume informally used in pharmacy. The tablespoon has been standardized at 15 milliliters in US, Britain, Canada, and New Zealand, and at 20 milliliters in Australia and some European countries.(NCI)','\0','Tablespoon Dosing Unit','CL-UNIT','DBX-NCIT-C48541'),('CL-UNIT-T-486',NULL,'TCID 50/dose','A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.(NCI)','\0','50 Percent Tissue Culture Infective Dose per Dose','CL-UNIT','DBX-NCIT-C70537'),('CL-UNIT-T-487',NULL,'Tesla','A unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one Newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per s','\0','Tesla','CL-UNIT','DBX-NCIT-C42557'),('CL-UNIT-T-488',NULL,'titer','Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.','\0','','CL-UNIT','DBX-NCIT-C67454'),('CL-UNIT-T-489',NULL,'Torr','A non-SI manometric unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101325 pascals). One Torr is equal to 133.3223684 pascals.','\0','Torr','CL-UNIT','DBX-NCIT-C112423'),('CL-UNIT-T-49',NULL,'10^6 IU/mL','A unit of measurement equal to 10 to the sixth power of the number of international units of an entity per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C98757'),('CL-UNIT-T-490',NULL,'TRACE','An extremely small amount.(NCI)','\0','Trace Dosing Unit','CL-UNIT','DBX-NCIT-C48547'),('CL-UNIT-T-491',NULL,'TROCHE','A dosing measurement based on the troche unit.(NCI)','\0','Troche Dosing Unit','CL-UNIT','DBX-NCIT-C48548'),('CL-UNIT-T-492',NULL,'tsp','A unit of volume used in pharmacy equal to 5 milliliters.(NCI)','\0','Teaspoon Dosing Unit','CL-UNIT','DBX-NCIT-C48544'),('CL-UNIT-T-493',NULL,'TUBE','A dosing measurement based on the tube unit.(NCI)','\0','Tube Dosing Unit','CL-UNIT','DBX-NCIT-C48549'),('CL-UNIT-T-494',NULL,'tuberculin unit','An arbitrary unit of tuberculin dosage defined by comparison of clinical response with a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.(NCI)','\0','Tuberculin Unit','CL-UNIT','DBX-NCIT-C65132'),('CL-UNIT-T-495',NULL,'tuberculin unit/mL','A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.(NCI)','\0','Tuberculin Unit per Milliliter','CL-UNIT','DBX-NCIT-C70506'),('CL-UNIT-T-496',NULL,'U','A single undivided thing occurring in the composition of something else.','\0','Unit','CL-UNIT','DBX-NCIT-C44278'),('CL-UNIT-T-497',NULL,'U/animal','An arbitrary dosing unit expressed in unit(s) per animal. (NCI)','\0','Unit per Animal','CL-UNIT','DBX-NCIT-C73773'),('CL-UNIT-T-498',NULL,'U/cL','An arbitrary unit of substance content expressed in unit(s) per centiliter.','\0','Unit per Centiliter','CL-UNIT','DBX-NCIT-C105520'),('CL-UNIT-T-499',NULL,'U/dL','An arbitrary unit of substance content expressed in unit(s) per deciliter.','\0','Unit per Deciliter','CL-UNIT','DBX-NCIT-C105521'),('CL-UNIT-T-5',NULL,'%(w/w)','A percent ratio of weight to weight, defined by the equation: [weight of solute (in gm)/weight of solution (in gm)](100).(NCI)','\0','Percent Weight per Weight','CL-UNIT','DBX-NCIT-C48528'),('CL-UNIT-T-50',NULL,'10^6 organisms','A unit of measure of quantity of organisms expressed in 10 to the sixth power of organisms.','\0','Million Organisms','CL-UNIT','DBX-NCIT-C71188'),('CL-UNIT-T-500',NULL,'U/g','An arbitrary unit of substance content expressed in unit(s) per gram. (NCI)','\0','Unit per Gram','CL-UNIT','DBX-NCIT-C77606'),('CL-UNIT-T-501',NULL,'U/g Creatinine','A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of creatinine.','\0','','CL-UNIT','DBX-NCIT-C105523'),('CL-UNIT-T-502',NULL,'U/g HGB','Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of hemoglobin. (NCI)','\0','Units per Gram Hemoglobin','CL-UNIT','DBX-NCIT-C105522'),('CL-UNIT-T-503',NULL,'U/g/day','An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours. (NCI)','\0','Unit per Gram per Day','CL-UNIT','DBX-NCIT-C73774'),('CL-UNIT-T-504',NULL,'U/g/h','An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes. (NCI)','\0','Unit per Gram per Hour','CL-UNIT','DBX-NCIT-C73775'),('CL-UNIT-T-505',NULL,'U/g/min','An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds. (NCI)','\0','Unit per Gram per Minute','CL-UNIT','DBX-NCIT-C73776'),('CL-UNIT-T-506',NULL,'U/kg','An arbitrary unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass. (NCI)','\0','Unit per Kilogram','CL-UNIT','DBX-NCIT-C67465'),('CL-UNIT-T-507',NULL,'U/kg/day','An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours. (NCI)','\0','Unit per kilogram per Day','CL-UNIT','DBX-NCIT-C73777'),('CL-UNIT-T-508',NULL,'U/kg/h','An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes. (NCI)','\0','Unit per Kilogram per Hour','CL-UNIT','DBX-NCIT-C73778'),('CL-UNIT-T-509',NULL,'U/kg/min','An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds. (NCI)','\0','Unit per Kilogram per Minute','CL-UNIT','DBX-NCIT-C73779'),('CL-UNIT-T-51',NULL,'10^6 organisms/g','A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one gram.','\0','Million Organisms per Gram; Million Organisms/g','CL-UNIT','DBX-NCIT-C71191'),('CL-UNIT-T-510',NULL,'U/L','An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. (NCI)','\0','Unit per Liter; mU/mL','CL-UNIT','DBX-NCIT-C67456'),('CL-UNIT-T-511',NULL,'U/m2','A unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.','\0','Unit per Square Meter','CL-UNIT','DBX-NCIT-C67467'),('CL-UNIT-T-512',NULL,'U/m2/day','An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours. (NCI)','\0','Unit per Square Meter per Day','CL-UNIT','DBX-NCIT-C73783'),('CL-UNIT-T-513',NULL,'U/m2/h','An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes. (NCI)','\0','Unit per Square Meter per Hour','CL-UNIT','DBX-NCIT-C73784'),('CL-UNIT-T-514',NULL,'U/m2/min','An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds. (NCI)','\0','Unit per Square Meter per Minute','CL-UNIT','DBX-NCIT-C73785'),('CL-UNIT-T-515',NULL,'U/mg','An arbitrary unit of substance content expressed in unit(s) per milligram. (NCI)','\0','Unit per Milligram','CL-UNIT','DBX-NCIT-C73780'),('CL-UNIT-T-516',NULL,'U/mL','An arbitrary unit of substance content expressed in unit(s) per milliliter. (NCI)','\0','Unit per Milliliter','CL-UNIT','DBX-NCIT-C77607'),('CL-UNIT-T-517',NULL,'U/mmol','An arbitrary unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance. (NCI)','\0','Unit per Millimole','CL-UNIT','DBX-NCIT-C92618'),('CL-UNIT-T-518',NULL,'uCi','A unit of radioactivity equal to one millionth of a Curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.(NCI)','\0','Microcurie; mcCi','CL-UNIT','DBX-NCIT-C48507'),('CL-UNIT-T-519',NULL,'uCi/kg','A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.(NCI)','\0','Microcurie per Kilogram; mcCi/kg','CL-UNIT','DBX-NCIT-C70571'),('CL-UNIT-T-52',NULL,'10^6 organisms/mg','A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one milligram.','\0','Million Organisms per Milligram; Million Organisms/mg','CL-UNIT','DBX-NCIT-C71193'),('CL-UNIT-T-520',NULL,'uCi/L','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a Curie per unit volume equal to one liter.(NCI)','\0','Microcurie per Liter; mcCi/L','CL-UNIT','DBX-NCIT-C71173'),('CL-UNIT-T-521',NULL,'uEq','A unit of relative amount of a substance equal to one millionth of an equivalent weight.(NCI)','\0','Microequivalent','CL-UNIT','DBX-NCIT-C73726'),('CL-UNIT-T-522',NULL,'uEq/L','A concentration unit measured as a number of microequivalents of solute per liter of solution.','\0','Microequivalent per Liter; Nanoequivalent per Milliliter; nEq/mL','CL-UNIT','DBX-NCIT-C117975'),('CL-UNIT-T-523',NULL,'ug','The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)','\0','Microgram; mcg','CL-UNIT','DBX-NCIT-C48152'),('CL-UNIT-T-524',NULL,'ug/animal','A unit of measure expressed in microgram(s) per animal.','\0','Microgram per Animal','CL-UNIT','DBX-NCIT-C73728'),('CL-UNIT-T-525',NULL,'ug/day','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at ','\0','Microgram per Day; mcg/day','CL-UNIT','DBX-NCIT-C71205'),('CL-UNIT-T-526',NULL,'ug/dL','A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which m','\0','Microgram per Deciliter','CL-UNIT','DBX-NCIT-C67305'),('CL-UNIT-T-527',NULL,'ug/g Creatinine','Nanograms per milligram of creatinine.','\0','ng/mg of Creatinine; ug/g of Creatinine','CL-UNIT','DBX-NCIT-C85744'),('CL-UNIT-T-528',NULL,'ug/g/day','A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours. (NCI)','\0','Microgram per Gram per Day','CL-UNIT','DBX-NCIT-C74921'),('CL-UNIT-T-529',NULL,'ug/g/h','A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes. (NCI)','\0','Microgram per Gram per Hour','CL-UNIT','DBX-NCIT-C74922'),('CL-UNIT-T-53',NULL,'10^6 organisms/mL','A unit of measure of organism concentration expressed in 10 to the sixth power of organisms per unit of volume equal to one milliliter.','\0','Million Organisms per Milliliter; Million Organisms/mL','CL-UNIT','DBX-NCIT-C71196'),('CL-UNIT-T-530',NULL,'ug/g/min','A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds. (NCI)','\0','Microgram per Gram per Minute','CL-UNIT','DBX-NCIT-C74923'),('CL-UNIT-T-531',NULL,'ug/h','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)','\0','Micrograms per Hour; mcg/h','CL-UNIT','DBX-NCIT-C67394'),('CL-UNIT-T-532',NULL,'ug/kg','A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)','\0','Microgram per Kilogram; mcg/kg; ng/g; ug/kg','CL-UNIT','DBX-NCIT-C67396'),('CL-UNIT-T-533',NULL,'ug/kg/day','A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours. (NCI)','\0','Microgram per Kilogram per Day','CL-UNIT','DBX-NCIT-C73729'),('CL-UNIT-T-534',NULL,'ug/kg/h','A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes. (NCI)','\0','Microgram per Kilogram per Hour','CL-UNIT','DBX-NCIT-C73730'),('CL-UNIT-T-535',NULL,'ug/kg/min','A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI)','\0','Gamma per Kilogram per Minute; Microgram per Kilogram per Minute; gamma/kg/min; mcg/kg/min','CL-UNIT','DBX-NCIT-C71210'),('CL-UNIT-T-536',NULL,'ug/L','A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass ','\0','Microgram per Liter; Milligram per Cubic Meter; Nanogram per Milliliter; mcg/L; mg/m3; ng/mL; ug/L','CL-UNIT','DBX-NCIT-C67306'),('CL-UNIT-T-537',NULL,'ug/m2','A dose calculation unit expressed in microgram(s) per square meter.','\0','Microgram per Square Meter','CL-UNIT','DBX-NCIT-C67312'),('CL-UNIT-T-538',NULL,'ug/m2/day','A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours. (NCI)','\0','Microgram per Square Meter per Day','CL-UNIT','DBX-NCIT-C73787'),('CL-UNIT-T-539',NULL,'ug/m2/h','A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes. (NCI)','\0','Microgram per Square Meter per Hour','CL-UNIT','DBX-NCIT-C73727'),('CL-UNIT-T-54',NULL,'10^6 RNA copies/mL','A unit of measurement equal to 10 to the sixth power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.','\0','','CL-UNIT','DBX-NCIT-C98760'),('CL-UNIT-T-540',NULL,'ug/m2/min','A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds. (NCI)','\0','Microgram per Square Meter per Minute','CL-UNIT','DBX-NCIT-C73733'),('CL-UNIT-T-541',NULL,'ug/min','A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at whic','\0','Micrograms per Minute; mcg/min','CL-UNIT','DBX-NCIT-C71211'),('CL-UNIT-T-542',NULL,'ug/mL/h','A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes. (NCI)','\0','Microgram per Milliliter per Hour','CL-UNIT','DBX-NCIT-C75905'),('CL-UNIT-T-543',NULL,'ugEq','A unit of relative amount of substance concentration equal to one millionth of a gram of an equivalent weight. (NCI)','\0','Microgram Equivalent','CL-UNIT','DBX-NCIT-C105497'),('CL-UNIT-T-544',NULL,'uIU/mL','Microinternational units per milliliter.','\0','Micro-International Unit per milliliter; mIU/L; mcIU/mL; uIU/mL','CL-UNIT','DBX-NCIT-C67405'),('CL-UNIT-T-545',NULL,'ukat','A unit of catalytic activity measurement equal to one millionth of katal (10E-6 katal).(NCI)','\0','Microkatal; mckat','CL-UNIT','DBX-NCIT-C70562'),('CL-UNIT-T-546',NULL,'ukat/L','Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.(NCI)','\0','Microkatal per Liter; mckat/L','CL-UNIT','DBX-NCIT-C67397'),('CL-UNIT-T-547',NULL,'uL','A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI)','\0','Microliter; mcL; mm3','CL-UNIT','DBX-NCIT-C48153'),('CL-UNIT-T-548',NULL,'uL/mL','A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.(NCI)','\0','Microliter per Milliliter; mcL/mL','CL-UNIT','DBX-NCIT-C69175'),('CL-UNIT-T-549',NULL,'um','A unit of length in metric system equal to 10E-6 meter, or micrometer.(NCI)','\0','Micron; mcm','CL-UNIT','DBX-NCIT-C48510'),('CL-UNIT-T-55',NULL,'10^6/g','A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one gram.','\0','','CL-UNIT','DBX-NCIT-C98758'),('CL-UNIT-T-550',NULL,'um2','A SI unit of area measurement equal to a square whose sides are one micrometer long. (NCI)','\0','MicroSquare Meter','CL-UNIT','DBX-NCIT-C73770'),('CL-UNIT-T-551',NULL,'umol','A unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI)','\0','Micromole; mcmol','CL-UNIT','DBX-NCIT-C48509'),('CL-UNIT-T-552',NULL,'umol/day','A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI)','\0','Micromoles per Day; mcmol/day','CL-UNIT','DBX-NCIT-C67406'),('CL-UNIT-T-553',NULL,'umol/L','A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution. (NCI)','\0','Micromole per Liter','CL-UNIT','DBX-NCIT-C48508'),('CL-UNIT-T-554',NULL,'umol/L/sec','A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second. (NCI)','\0','Micromoles per Liter per Second','CL-UNIT','DBX-NCIT-C105498'),('CL-UNIT-T-555',NULL,'umol/mg/min','A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per milligram of a substance per period of time equal to sixty seconds. (NCI)','\0','Micromole per Milligram per Minute','CL-UNIT','DBX-NCIT-C73735'),('CL-UNIT-T-556',NULL,'umol/min','Micromoles per minute.','\0','mcmol/min; umol/min','CL-UNIT','DBX-NCIT-C85708'),('CL-UNIT-T-557',NULL,'uOsM','A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 10E-6 molar solution of a substance that does not dissociate. (NCI)','\0','Microosmole','CL-UNIT','DBX-NCIT-C73736'),('CL-UNIT-T-558',NULL,'usec','A unit of time equal to one millionth of a second. (NCI)','\0','Microsecond','CL-UNIT','DBX-NCIT-C69149'),('CL-UNIT-T-559',NULL,'uV','A unit of an electric potential and electromotive force equal to one millionth of a volt.(NCI)','\0','Microvolt; mcV','CL-UNIT','DBX-NCIT-C71175'),('CL-UNIT-T-56',NULL,'10^6/hpf','A unit of measurement equal to 10 to the sixth power of the number of entities per unit of area equal to one high powered field.','\0','','CL-UNIT','DBX-NCIT-C98759'),('CL-UNIT-T-560',NULL,'uV*sec','A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second. (NCI)','\0','Microvolt * Seconds','CL-UNIT','DBX-NCIT-C105499'),('CL-UNIT-T-561',NULL,'V','A unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one Ampere when the power dissipated between the points is one watt. This is equival','\0','Volt','CL-UNIT','DBX-NCIT-C42551'),('CL-UNIT-T-562',NULL,'V/sec','A SI derived rate unit equal to one volt per unit of time equal to one second.','\0','V/s; Volt per Second','CL-UNIT','DBX-NCIT-C105524'),('CL-UNIT-T-563',NULL,'v/v','Quotient of the volume of a substance and the total volume of the sample containing the substance.','\0','volume fraction','CL-UNIT','DBX-NCIT-C67469'),('CL-UNIT-T-564',NULL,'VIAL','A dosing measurement based on the vial unit.(NCI)','\0','Vial Dosing Unit','CL-UNIT','DBX-NCIT-C48551'),('CL-UNIT-T-565',NULL,'VIRTUAL PIXEL','A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye.','\0','','CL-UNIT','DBX-NCIT-C114237'),('CL-UNIT-T-566',NULL,'WAFER','A dosing measurement based on the wafer unit.(NCI)','\0','Wafer Dosing Unit','CL-UNIT','DBX-NCIT-C48552'),('CL-UNIT-T-567',NULL,'Watt','A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal ','\0','Watt','CL-UNIT','DBX-NCIT-C42549'),('CL-UNIT-T-568',NULL,'Weber','A unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.(NCI)','\0','V*sec; Volt Second; Volt-second; Weber','CL-UNIT','DBX-NCIT-C42556'),('CL-UNIT-T-569',NULL,'WEEKS','Any period of seven consecutive days. (NCI)','\0','Week','CL-UNIT','DBX-NCIT-C29844'),('CL-UNIT-T-57',NULL,'10^6/L','A unit of measurement equal to 10 to the sixth power of the number of entities per unit of volume equal to one liter.','\0','10^3/mL; M/L; Mega/L','CL-UNIT','DBX-NCIT-C67452'),('CL-UNIT-T-570',NULL,'yd','A unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.(NCI)','\0','Yard','CL-UNIT','DBX-NCIT-C48553'),('CL-UNIT-T-571',NULL,'YEARS','The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)','\0','Year','CL-UNIT','DBX-NCIT-C29848'),('CL-UNIT-T-58',NULL,'10^7/L','A unit of measurement equal to 10 to the seventh power of the number of entities per unit of volume equal to one liter.','\0','10^6/dL','CL-UNIT','DBX-NCIT-C98786'),('CL-UNIT-T-59',NULL,'10^8/L','A unit of measurement equal to 10 to the eighth power of entities per unit of volume equal to one liter.','\0','10^2/mm3; 10^2/uL; 10^5/mL','CL-UNIT','DBX-NCIT-C105489'),('CL-UNIT-T-6',NULL,'%/min','A unit of frequency expressed as the percentage of entities or events per minute.','\0','Percent per Minute','CL-UNIT','DBX-NCIT-C114240'),('CL-UNIT-T-60',NULL,'10^9 CFU','A unit of measurement of viable bacterial numbers equal to 10 to the ninth power colony forming units.','\0','Billion CFU; Billion Colony Forming Units','CL-UNIT','DBX-NCIT-C68897'),('CL-UNIT-T-61',NULL,'10^9 CFU/g','A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the ninth power colony forming units in one gram of substance.','\0','Billion CFU/g; Billion Colony Forming Units per Gram','CL-UNIT','DBX-NCIT-C68901'),('CL-UNIT-T-62',NULL,'10^9 CFU/mL','A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the ninth power colony forming units in one milliliter of substance.','\0','Billion CFU/mL; Billion Colony Forming Units per Milliliter','CL-UNIT','DBX-NCIT-C68905'),('CL-UNIT-T-63',NULL,'10^9 organisms','A unit of measure of quantity of organisms expressed in 10 to the ninth power of organisms.','\0','Billion Organisms','CL-UNIT','DBX-NCIT-C71189'),('CL-UNIT-T-64',NULL,'10^9 organisms/g','A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one gram.','\0','Billion Organisms per Gram; Billion Organisms/g','CL-UNIT','DBX-NCIT-C71192'),('CL-UNIT-T-65',NULL,'10^9 organisms/mg','A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one milligram.','\0','Billion Organisms per Milligram; Billion Organisms/mg','CL-UNIT','DBX-NCIT-C71194'),('CL-UNIT-T-66',NULL,'10^9 organisms/mL','A unit of measure of organism concentration expressed in 10 to the ninth power of organisms per unit of volume equal to one milliliter.','\0','Billion Organisms per Milliliter; Billion Organisms/mL','CL-UNIT','DBX-NCIT-C71197'),('CL-UNIT-T-67',NULL,'10^9/L','A unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter.','\0','10^3/mm3; 10^3/uL; 10^6/mL; G/L; Giga per Liter','CL-UNIT','DBX-NCIT-C67255'),('CL-UNIT-T-68',NULL,'AFU','Arbitrary unit(s) of fluorescent luminescence. (NCI)','\0','Arbitrary Fluorescence Unit','CL-UNIT','DBX-NCIT-C77534'),('CL-UNIT-T-69',NULL,'ag','A unit of mass equal to one quintillionth of a gram (10E-18 gram).(NCI)','\0','Attogram','CL-UNIT','DBX-NCIT-C64553'),('CL-UNIT-T-7',NULL,'/100 HPFs','A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields.','\0','per 100 High Powered Fields','CL-UNIT','DBX-NCIT-C102695'),('CL-UNIT-T-70',NULL,'AgU/mL','A measure of an antigen potency defined as a number of antigen units per one milliliter of product.(NCI)','\0','Antigen Unit per Milliliter','CL-UNIT','DBX-NCIT-C70500'),('CL-UNIT-T-71',NULL,'amol','A unit of amount of substance equal to one quintillionth of a mole (10E-18 mole).(NCI)','\0','Attomole','CL-UNIT','DBX-NCIT-C68855'),('CL-UNIT-T-72',NULL,'amp','A unit of electric current, named after the French physicist Andre Ampere. It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between ','\0','Ampere','CL-UNIT','DBX-NCIT-C42536'),('CL-UNIT-T-73',NULL,'AMPULE','A dosing measurement based on the ampule unit.(NCI)','\0','Ampule Dosing Unit','CL-UNIT','DBX-NCIT-C48473'),('CL-UNIT-T-74',NULL,'amu','A small unit of mass used to express atomic and molecular masses. (NCI)','\0','Atomic Mass Unit','CL-UNIT','DBX-NCIT-C64559'),('CL-UNIT-T-75',NULL,'anti-Xa IU','A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO (World Health Organization) Fir','\0','Anti-Xa Activity International Unit','CL-UNIT','DBX-NCIT-C70497'),('CL-UNIT-T-76',NULL,'anti-Xa IU/mL','A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.(NCI)','\0','Anti-Xa Activity International Unit per Milliliter','CL-UNIT','DBX-NCIT-C70498'),('CL-UNIT-T-77',NULL,'Antibody Unit','A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen.','\0','','CL-UNIT','DBX-NCIT-C111129'),('CL-UNIT-T-78',NULL,'APL U/mL','A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.','\0','Immunoglobin A Phospholipid Units per Milliliter','CL-UNIT','DBX-NCIT-C117965'),('CL-UNIT-T-79',NULL,'APPLICATION','A dosing measurement based on the amount of substance applied.','\0','Application Dosing Unit','CL-UNIT','DBX-NCIT-C25397'),('CL-UNIT-T-8',NULL,'/100 WBC','Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 100 white blood cells.','\0','Per 100 White Blood Cells','CL-UNIT','DBX-NCIT-C67219'),('CL-UNIT-T-80',NULL,'atm','A unit of pressure, equal to a barometer reading of 760 mm Hg. 1 atmosphere is 101325 Pascals and 1.01325 bar. This unit of pressure is roughly equal to the average atmospheric pressure at sea level on the earth.(NCI)','\0','Atmosphere','CL-UNIT','DBX-NCIT-C54711'),('CL-UNIT-T-81',NULL,'AU','A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale. (NCI)','\0','Absorbance Unit','CL-UNIT','DBX-NCIT-C73686'),('CL-UNIT-T-82',NULL,'AU/min','A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute. (NCI)','\0','Absorbance Unit per Minute','CL-UNIT','DBX-NCIT-C73687'),('CL-UNIT-T-83',NULL,'AU/mL','Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.(NCI)','\0','Allergy Unit per Milliliter','CL-UNIT','DBX-NCIT-C70504'),('CL-UNIT-T-84',NULL,'BAG','A dosing measurement based on the bag unit.(NCI)','\0','Bag Dosing Unit','CL-UNIT','DBX-NCIT-C48474'),('CL-UNIT-T-85',NULL,'BAR','A dosing measurement based on the bar unit.(NCI)','\0','Bar Dosing Unit','CL-UNIT','DBX-NCIT-C48475'),('CL-UNIT-T-86',NULL,'BAU','A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.(NCI)','\0','Bioequivalent Allergy Unit','CL-UNIT','DBX-NCIT-C70505'),('CL-UNIT-T-87',NULL,'BAU/mL','Unit of measure of potency of allergenic product expressed as a number of bioequivalent allergy units per one milliliter of formulation.','\0','Bioequivalent Allergy Unit per Milliliter','CL-UNIT','DBX-NCIT-C116235'),('CL-UNIT-T-88',NULL,'BE/mL','Unit of measure of potency of allergenic product expressed as a number of biological units per one milliliter of formulation.','\0','Biological Unit per Milliliter','CL-UNIT','DBX-NCIT-C116231'),('CL-UNIT-T-89',NULL,'BEATS/MIN','The number of heartbeats measured per minute time. (NCI)','\0','Beats per Minute','CL-UNIT','DBX-NCIT-C49673'),('CL-UNIT-T-9',NULL,'/10^3 cells','A unit of measure equal to the instances of an entity per 1000 cells.','\0','','CL-UNIT','DBX-NCIT-C116240'),('CL-UNIT-T-90',NULL,'bel','A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity','\0','Bel','CL-UNIT','DBX-NCIT-C71200'),('CL-UNIT-T-91',NULL,'BISCUIT','A measurement based on the biscuit unit.','\0','','CL-UNIT','DBX-NCIT-C111139'),('CL-UNIT-T-92',NULL,'BLOCKS','A unit of measure to quantify the number of rectangular areas in a city surrounded by streets.','\0','','CL-UNIT','DBX-NCIT-C111140'),('CL-UNIT-T-93',NULL,'BOLUS','A dosing measurement based on the bolus unit.(NCI)','\0','Bolus Dosing Unit','CL-UNIT','DBX-NCIT-C48476'),('CL-UNIT-T-94',NULL,'BOTTLE','A dosing measurement based on the bottle unit.(NCI)','\0','Bottle Dosing Unit','CL-UNIT','DBX-NCIT-C48477'),('CL-UNIT-T-95',NULL,'BOX','A dosing measurement based on the box unit.(NCI)','\0','Box Dosing Unit','CL-UNIT','DBX-NCIT-C48478'),('CL-UNIT-T-96',NULL,'Bq','A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI)','\0','Becquerel','CL-UNIT','DBX-NCIT-C42562'),('CL-UNIT-T-97',NULL,'Bq/g','A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI)','\0','Becquerel per Gram','CL-UNIT','DBX-NCIT-C70522'),('CL-UNIT-T-98',NULL,'Bq/kg','A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI)','\0','Becquerel per Kilogram','CL-UNIT','DBX-NCIT-C70521'),('CL-UNIT-T-99',NULL,'Bq/L','A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI)','\0','Becquerel per Liter','CL-UNIT','DBX-NCIT-C71165'),('CL-VCNEVD-T-1',NULL,'SCAR','A mark left (usually on the skin) by the healing of injured tissue.','\0','','CL-VCNEVD','DBX-NCIT-C34483'),('CL-VCNEVD-T-2',NULL,'SELF-REPORT','An individual\'s perspective or subjective interpretation of an event or information.','\0','','CL-VCNEVD','DBX-NCIT-C74528'),('CL-VCNEVD-T-3',NULL,'WRITTEN DOCUMENTATION','The collecting, abstracting, and coding of printed or written information for future reference.','\0','','CL-VCNEVD','DBX-NCIT-C86042'),('CL-VRTEST-T-1',NULL,'IC50 Fold Change from Baseline','A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the ','\0','IC50 Fold Change from Baseline','CL-VRTEST','DBX-NCIT-C116250'),('CL-VRTEST-T-2',NULL,'IC50 Fold Change from Reference','A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Ref','\0','IC50 Fold Change from Reference','CL-VRTEST','DBX-NCIT-C116249'),('CL-VRTEST-T-3',NULL,'IC50 Reference Control Result','A reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.','\0','IC50 Reference Control Result','CL-VRTEST','DBX-NCIT-C116248'),('CL-VRTEST-T-4',NULL,'IC50 Treatment Result','A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction.','\0','IC50 Treatment Result','CL-VRTEST','DBX-NCIT-C116247'),('CL-VRTEST-T-5',NULL,'IC95 Fold Change from Baseline','A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the ','\0','IC95 Fold Change from Baseline','CL-VRTEST','DBX-NCIT-C116254'),('CL-VRTEST-T-6',NULL,'IC95 Fold Change from Reference','A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Ref','\0','IC95 Fold Change from Reference','CL-VRTEST','DBX-NCIT-C116253'),('CL-VRTEST-T-7',NULL,'IC95 Reference Control Result','A reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.','\0','IC95 Reference Control Result','CL-VRTEST','DBX-NCIT-C116252'),('CL-VRTEST-T-8',NULL,'IC95 Treatment Result','A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction.','\0','IC95 Treatment Result','CL-VRTEST','DBX-NCIT-C116251'),('CL-VRTEST-T-9',NULL,'Inhibitory Concentration Net Assessment','An indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug.','\0','Inhibitory Concentration Net Assessment','CL-VRTEST','DBX-NCIT-C116255'),('CL-VRTESTCD-T-1',NULL,'IC50FCB','A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the ','\0','IC50 Fold Change from Baseline','CL-VRTESTCD','DBX-NCIT-C116250'),('CL-VRTESTCD-T-2',NULL,'IC50FCR','A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Ref','\0','IC50 Fold Change from Reference','CL-VRTESTCD','DBX-NCIT-C116249'),('CL-VRTESTCD-T-3',NULL,'IC50R','A reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.','\0','IC50 Reference Control Result','CL-VRTESTCD','DBX-NCIT-C116248'),('CL-VRTESTCD-T-4',NULL,'IC50T','A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction.','\0','IC50 Treatment Result','CL-VRTESTCD','DBX-NCIT-C116247'),('CL-VRTESTCD-T-5',NULL,'IC95FCB','A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the ','\0','IC95 Fold Change from Baseline','CL-VRTESTCD','DBX-NCIT-C116254'),('CL-VRTESTCD-T-6',NULL,'IC95FCR','A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Ref','\0','IC95 Fold Change from Reference','CL-VRTESTCD','DBX-NCIT-C116253'),('CL-VRTESTCD-T-7',NULL,'IC95R','A reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.','\0','IC95 Reference Control Result','CL-VRTESTCD','DBX-NCIT-C116252'),('CL-VRTESTCD-T-8',NULL,'IC95T','A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction.','\0','IC95 Treatment Result','CL-VRTESTCD','DBX-NCIT-C116251'),('CL-VRTESTCD-T-9',NULL,'ICNETAS','An indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug.','\0','Inhibitory Concentration Net Assessment','CL-VRTESTCD','DBX-NCIT-C116255'),('CL-VSRESU-T-1',NULL,'%','A fraction or ratio with 100 understood as the denominator. (NCI)','\0','Percentage','CL-VSRESU','DBX-NCIT-C25613'),('CL-VSRESU-T-10',NULL,'kg/m2','A unit expressed as kilogram of mass per square meter of area.(NCI)','\0','Kilogram per Square Meter','CL-VSRESU','DBX-NCIT-C49671'),('CL-VSRESU-T-11',NULL,'LB','A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)','\0','Pound','CL-VSRESU','DBX-NCIT-C48531'),('CL-VSRESU-T-12',NULL,'m2','The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)','\0','Square Meter','CL-VSRESU','DBX-NCIT-C42569'),('CL-VSRESU-T-13',NULL,'mm','A unit of measure equal to one thousandth of a meter. (NCI)','\0','Millimeter','CL-VSRESU','DBX-NCIT-C28251'),('CL-VSRESU-T-14',NULL,'mmHg','A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth\'s surface. (NCI)','\0','Millimeter of Mercury','CL-VSRESU','DBX-NCIT-C49670'),('CL-VSRESU-T-15',NULL,'ohm','A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A ','\0','Ohm','CL-VSRESU','DBX-NCIT-C42554'),('CL-VSRESU-T-2',NULL,'BEATS/MIN','The number of heartbeats measured per minute time. (NCI)','\0','Beats per Minute','CL-VSRESU','DBX-NCIT-C49673'),('CL-VSRESU-T-3',NULL,'BREATHS/MIN','The number of breaths (inhalation and exhalation) taken per minute time. (NCI)','\0','Breaths per Minute','CL-VSRESU','DBX-NCIT-C49674'),('CL-VSRESU-T-4',NULL,'C','A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple ','\0','Degree Celsius','CL-VSRESU','DBX-NCIT-C42559'),('CL-VSRESU-T-5',NULL,'cm','A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.','\0','Centimeter','CL-VSRESU','DBX-NCIT-C49668'),('CL-VSRESU-T-6',NULL,'F','The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and','\0','Degree Fahrenheit','CL-VSRESU','DBX-NCIT-C44277'),('CL-VSRESU-T-7',NULL,'g','A metric unit of mass equal to one one thousandth of a kilogram. (NCI)','\0','Gram','CL-VSRESU','DBX-NCIT-C48155'),('CL-VSRESU-T-8',NULL,'IN','A traditional unit of length equal to 2.54 centimeters. (NCI)','\0','Inch','CL-VSRESU','DBX-NCIT-C48500'),('CL-VSRESU-T-9',NULL,'kg','The basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a pre','\0','Kilogram','CL-VSRESU','DBX-NCIT-C28252'),('CL-VSTEST-T-1',NULL,'Abdominal Skinfold Thickness','A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI)','\0','Abdominal Skinfold Thickness','CL-VSTEST','DBX-NCIT-C103346'),('CL-VSTEST-T-10',NULL,'Heart Rate','The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)','\0','Heart Rate','CL-VSTEST','DBX-NCIT-C49677'),('CL-VSTEST-T-11',NULL,'Height','The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)','\0','Height','CL-VSTEST','DBX-NCIT-C25347'),('CL-VSTEST-T-12',NULL,'Hip Circumference','The distance around an individual\'s pelvic area or hips.','\0','Hip Circumference','CL-VSTEST','DBX-NCIT-C100947'),('CL-VSTEST-T-13',NULL,'Ideal Body Weight','A person\'s optimum weight as calculated by a standard methodology.','\0','Ideal Body Weight','CL-VSTEST','DBX-NCIT-C117976'),('CL-VSTEST-T-14',NULL,'Knee to Heel Length','A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)','\0','Knee to Heel Length; Lower Leg Length','CL-VSTEST','DBX-NCIT-C84372'),('CL-VSTEST-T-15',NULL,'Lean Body Mass','The weight of all organs and tissue in an individual less the weight of the individual\'s body fat.','\0','Lean Body Mass','CL-VSTEST','DBX-NCIT-C71258'),('CL-VSTEST-T-16',NULL,'Mean Arterial Pressure','The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis ','\0','Mean Arterial Pressure','CL-VSTEST','DBX-NCIT-C49679'),('CL-VSTEST-T-17',NULL,'Oxygen Saturation','A measurement of the oxygen-hemoglobin saturation of a volume of blood.','\0','Oxygen Saturation','CL-VSTEST','DBX-NCIT-C60832'),('CL-VSTEST-T-18',NULL,'Pulse Pressure','The change in systolic to diastolic pressure which produces a pulse.','\0','Pulse Pressure','CL-VSTEST','DBX-NCIT-C100945'),('CL-VSTEST-T-19',NULL,'Pulse Rate','The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)','\0','Pulse Rate','CL-VSTEST','DBX-NCIT-C49676'),('CL-VSTEST-T-2',NULL,'Adipose Tissue','A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)','\0','Adipose Tissue; Body Fat; Fat Tissue','CL-VSTEST','DBX-NCIT-C12472'),('CL-VSTEST-T-20',NULL,'Respiratory Rate','The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)','\0','Respiratory Rate','CL-VSTEST','DBX-NCIT-C49678'),('CL-VSTEST-T-21',NULL,'Sagittal Abdominal Diameter','A standard measure of visceral obesity, or abdominal fat, which is measured from the patient\'s back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supin','\0','Sagittal Abdominal Diameter','CL-VSTEST','DBX-NCIT-C87054'),('CL-VSTEST-T-22',NULL,'Subscapular Skinfold Thickness','A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)','\0','Subscapular Skinfold Thickness','CL-VSTEST','DBX-NCIT-C98785'),('CL-VSTEST-T-23',NULL,'Systolic Blood Pressure','The blood pressure during the contraction of the left ventricle of the heart. (NCI)','\0','Systolic Blood Pressure','CL-VSTEST','DBX-NCIT-C25298'),('CL-VSTEST-T-24',NULL,'Temperature','The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somati','\0','Temperature','CL-VSTEST','DBX-NCIT-C25206'),('CL-VSTEST-T-25',NULL,'Total Body Water','A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments.','\0','Total Body Water','CL-VSTEST','DBX-NCIT-C104622'),('CL-VSTEST-T-26',NULL,'Triceps Skinfold Thickness','A measurement of the thickness of a pinch of skin on the triceps. (NCI)','\0','Triceps Skinfold Thickness','CL-VSTEST','DBX-NCIT-C98793'),('CL-VSTEST-T-27',NULL,'Waist Circumference','The distance around an individual\'s midsection or waist.','\0','Waist Circumference','CL-VSTEST','DBX-NCIT-C100948'),('CL-VSTEST-T-28',NULL,'Weight','The vertical force exerted by a mass as a result of gravity. (NCI)','\0','Weight','CL-VSTEST','DBX-NCIT-C25208'),('CL-VSTEST-T-3',NULL,'Body Frame Size','The categorization of a person\'s body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)','\0','Body Frame Size','CL-VSTEST','DBX-NCIT-C49680'),('CL-VSTEST-T-4',NULL,'Body Length','The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end.','\0','Body Length','CL-VSTEST','DBX-NCIT-C81298'),('CL-VSTEST-T-5',NULL,'Body Mass Index','A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)','\0','Body Mass Index','CL-VSTEST','DBX-NCIT-C16358'),('CL-VSTEST-T-6',NULL,'Body Surface Area','A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)','\0','Body Surface Area','CL-VSTEST','DBX-NCIT-C25157'),('CL-VSTEST-T-7',NULL,'Diastolic Blood Pressure','The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)','\0','Diastolic Blood Pressure','CL-VSTEST','DBX-NCIT-C25299'),('CL-VSTEST-T-8',NULL,'Forearm Circumference','The distance around an individual\'s forearm.','\0','Forearm Circumference','CL-VSTEST','DBX-NCIT-C100946'),('CL-VSTEST-T-9',NULL,'Head Circumference','A circumferential measurement of the head at the widest point.','\0','Head Circumference','CL-VSTEST','DBX-NCIT-C81255'),('CL-VSTESTCD-T-1',NULL,'ABSKNF','A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI)','\0','Abdominal Skinfold Thickness','CL-VSTESTCD','DBX-NCIT-C103346'),('CL-VSTESTCD-T-10',NULL,'HEIGHT','The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)','\0','Height','CL-VSTESTCD','DBX-NCIT-C25347'),('CL-VSTESTCD-T-11',NULL,'HIPCIR','The distance around an individual\'s pelvic area or hips.','\0','Hip Circumference','CL-VSTESTCD','DBX-NCIT-C100947'),('CL-VSTESTCD-T-12',NULL,'HR','The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)','\0','Heart Rate','CL-VSTESTCD','DBX-NCIT-C49677'),('CL-VSTESTCD-T-13',NULL,'IDEALWT','A person\'s optimum weight as calculated by a standard methodology.','\0','Ideal Body Weight','CL-VSTESTCD','DBX-NCIT-C117976'),('CL-VSTESTCD-T-14',NULL,'KNEEHEEL','A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)','\0','Knee to Heel Length; Lower Leg Length','CL-VSTESTCD','DBX-NCIT-C84372'),('CL-VSTESTCD-T-15',NULL,'LBM','The weight of all organs and tissue in an individual less the weight of the individual\'s body fat.','\0','Lean Body Mass','CL-VSTESTCD','DBX-NCIT-C71258'),('CL-VSTESTCD-T-16',NULL,'MAP','The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis ','\0','Mean Arterial Pressure','CL-VSTESTCD','DBX-NCIT-C49679'),('CL-VSTESTCD-T-17',NULL,'OXYSAT','A measurement of the oxygen-hemoglobin saturation of a volume of blood.','\0','Oxygen Saturation','CL-VSTESTCD','DBX-NCIT-C60832'),('CL-VSTESTCD-T-18',NULL,'PULSE','The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)','\0','Pulse Rate','CL-VSTESTCD','DBX-NCIT-C49676'),('CL-VSTESTCD-T-19',NULL,'PULSEPR','The change in systolic to diastolic pressure which produces a pulse.','\0','Pulse Pressure','CL-VSTESTCD','DBX-NCIT-C100945'),('CL-VSTESTCD-T-2',NULL,'BMI','A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)','\0','Body Mass Index','CL-VSTESTCD','DBX-NCIT-C16358'),('CL-VSTESTCD-T-20',NULL,'RESP','The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)','\0','Respiratory Rate','CL-VSTESTCD','DBX-NCIT-C49678'),('CL-VSTESTCD-T-21',NULL,'SAD','A standard measure of visceral obesity, or abdominal fat, which is measured from the patient\'s back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supin','\0','Sagittal Abdominal Diameter','CL-VSTESTCD','DBX-NCIT-C87054'),('CL-VSTESTCD-T-22',NULL,'SSSKNF','A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)','\0','Subscapular Skinfold Thickness','CL-VSTESTCD','DBX-NCIT-C98785'),('CL-VSTESTCD-T-23',NULL,'SYSBP','The blood pressure during the contraction of the left ventricle of the heart. (NCI)','\0','Systolic Blood Pressure','CL-VSTESTCD','DBX-NCIT-C25298'),('CL-VSTESTCD-T-24',NULL,'TBW','A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments.','\0','Total Body Water','CL-VSTESTCD','DBX-NCIT-C104622'),('CL-VSTESTCD-T-25',NULL,'TEMP','The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somati','\0','Temperature','CL-VSTESTCD','DBX-NCIT-C25206'),('CL-VSTESTCD-T-26',NULL,'TRSKNF','A measurement of the thickness of a pinch of skin on the triceps. (NCI)','\0','Triceps Skinfold Thickness','CL-VSTESTCD','DBX-NCIT-C98793'),('CL-VSTESTCD-T-27',NULL,'WEIGHT','The vertical force exerted by a mass as a result of gravity. (NCI)','\0','Weight','CL-VSTESTCD','DBX-NCIT-C25208'),('CL-VSTESTCD-T-28',NULL,'WSTCIR','The distance around an individual\'s midsection or waist.','\0','Waist Circumference','CL-VSTESTCD','DBX-NCIT-C100948'),('CL-VSTESTCD-T-3',NULL,'BODLNGTH','The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end.','\0','Body Length','CL-VSTESTCD','DBX-NCIT-C81298'),('CL-VSTESTCD-T-4',NULL,'BODYFAT','A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)','\0','Adipose Tissue; Body Fat; Fat Tissue','CL-VSTESTCD','DBX-NCIT-C12472'),('CL-VSTESTCD-T-5',NULL,'BSA','A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)','\0','Body Surface Area','CL-VSTESTCD','DBX-NCIT-C25157'),('CL-VSTESTCD-T-6',NULL,'DIABP','The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)','\0','Diastolic Blood Pressure','CL-VSTESTCD','DBX-NCIT-C25299'),('CL-VSTESTCD-T-7',NULL,'FARMCIR','The distance around an individual\'s forearm.','\0','Forearm Circumference','CL-VSTESTCD','DBX-NCIT-C100946'),('CL-VSTESTCD-T-8',NULL,'FRMSIZE','The categorization of a person\'s body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)','\0','Body Frame Size','CL-VSTESTCD','DBX-NCIT-C49680'),('CL-VSTESTCD-T-9',NULL,'HDCIRC','A circumferential measurement of the head at the widest point.','\0','Head Circumference','CL-VSTESTCD','DBX-NCIT-C81255');
/*!40000 ALTER TABLE `CVterms` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping data for table `DomainTemplates`
--

LOCK TABLES `DomainTemplates` WRITE;
/*!40000 ALTER TABLE `DomainTemplates` DISABLE KEYS */;
INSERT INTO `DomainTemplates` VALUES ('D-CUST-CY','Cytometry Data','Assay Observations','A custom domain for collecting processed cytometry data, which is primarily about collecting observations about cells and populations of cells and their expression of certain markers','CY','One record per measured prameter per cell population (group) per biospecimen identifier','\0'),('D-CUST-HD','High dimensional assay data','Assay Observations','A custom domain for collecting processed high dimensional assay data, which is primarily about collecting observations about samples and their expression of certain markers','HD','One record per measured prameter per biospecimen identifier','\0'),('D-CUST-MX','Assay data matrix','Assay Observations','A simple template for a two dimensional data matrix used for array data or any other assay data that is represented in a matrix structure, where columns/rows are sample or feature identifiers and cells are single measurement values  (e.g. log intensity)','MX','A two dimensional data matrix with a single measurement for each feature/sample combination','\0'),('D-MAGE-ADF','Microarray Feature Annotation','Assay Feature Annotations','An ADF file describes the design of an array, e.g., what sequence is located at each position on an array and what the annotation of this sequence is. If the investigation uses arrays for which a description has been previously provided, such as a standard commercial array, cross-references to entries in a public repository (e.g., an Array Express accession number) can be included instead of explicit array descriptions.','ADF','An optional header section providing some top-level information about the array design. 2- Main section with one row per feature on the array describing what sequence is located at each position on an',''),('D-SDTM-AE','Adverse Events','Events','Adverse events may be captured either as free text or a pre-specified list of terms.','AE','One record per adverse event per subject','\0'),('D-SDTM-BS','Biospecimen Findings','Sample Annotations','A findings domain that contains the details regarding the characteristics of biospecimens and extracted samples (e.g., RNA, DNA) such as specimen volume, quantity of extracted sample, specimen condition and the integrity of the DNA or RNA samples.','BS','One record per measurement per biospecimen identifier per subject ','\0'),('D-SDTM-CE','Clinical Events','Events','A dataset used to capture clinical events of interest that would not be classified as adverse events','CE','One record per event per subject','\0'),('D-SDTM-CM','Concomitant Medications','Interventions','Case report form CRF data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.','CM','One record per recorded medication occurrence or constant-dosing interval per subject','\0'),('D-SDTM-CO','Comments','SpecialPurpose','The Comments dataset accommodates two sources of comments: 1- those collected alongside other data on topical case report form CRF pages such as Adverse Events and 2- those collected on a separate page specifically dedicated to comments.','CO','One record per comment per subject','\0'),('D-SDTM-DA','Drug Accountability','Findings','Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.','DA','One record per drug accountability finding per subject','\0'),('D-SDTM-DD','Death Details','Findings','The domain is designed to hold supplemental data that are typically collected when a death occurs, such as the official cause of death. It does not replace existing data such as the SAE details in AE. Furthermore, it does not introduce a new requirement to collect information that is not already indicated as Good Clinical Practice or defined in regulatory guidelines. Instead, it provides a consistent place within SDTM to hold information that previously did not have a clearly defined home.','DD','One record per finding per subject','\0'),('D-SDTM-DM','Demographics','SpecialPurpose','The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects.','DM','One record per subject','\0'),('D-SDTM-DS','Disposition','Events','A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)','DS','One record per disposition status or protocol milestone per subject','\0'),('D-SDTM-DV','Protocol Deviations','Events','The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.','DV','One record per protocol deviation per subject','\0'),('D-SDTM-EG','ECG Test Results','Findings','Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.','EG','One record per ECG observation per time point per visit per subject','\0'),('D-SDTM-EX','Exposure','Interventions','The Exposure domain model records the details of a subject\'s exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.','EX','One record per constant dosing interval per subject','\0'),('D-SDTM-FA','Findings About Events or Interventions','FindingsAbout','A dataset used to capture the findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier.','FA','One record per finding per object per time point per time point reference per visit per subject','\0'),('D-SDTM-HO','Health Encounters','Events','The Healthcare Encounters dataset includes inpatient and outpatient healthcare events (e.g., hospitalizations, nursing home stay, rehabilitation facility stays, ambulatory surgery).','HO','One record per healthcare encounter per subject','\0'),('D-SDTM-IE','Inclusion/ Exclusion Criteria Not Met','Findings','The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.','IE','One record per inclusion/exclusion criterion not met per subject','\0'),('D-SDTM-IS','The Immunogenicity Specimen Assessments','Findings','It is intended to be used only for data collected regarding the immunogenic potential of materials under study.','IS','One record per test per visit per subject','\0'),('D-SDTM-LB','Laboratory Test Results','Findings','Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.','LB','One record per analyte per planned time point number per time point reference per visit per subject','\0'),('D-SDTM-MB','Microbiology Specimen','Findings','Microbiology specimen findings, including gram stain results, and organisms found.','MB','One record per microbiology specimen finding per time point per visit per subject','\0'),('D-SDTM-MH','Medical History','Events','The medical history dataset includes the subject\'s prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.','MH','One record per medical history event per subject','\0'),('D-SDTM-MI','Microscopic Findings','Findings','Microbiology specimen findings, including gram stain results, and organisms found..','MI','One record per finding per specimen per subject','\0'),('D-SDTM-MO','Morphology','Findings','Macroscopic results (e.g. size, shape, color, and abnormalities of body parts or specimens) that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies. Many morphology results are obtained from a procedure, although information about the procedure may or may not be collected','MO','One record per Morphology finding per location per time point per visit per subject','\0'),('D-SDTM-MS','Microbiology Susceptibility','Findings','This includes microbiology susceptibility test results, plus results of any other organism-related tests','MS','One record per microbiology susceptibility test (or other organism-related finding) per organism found in MB','\0'),('D-SDTM-PC','Pharmacokinetic Concentrations','Findings','Concentrations of drugs/metabolites in fluids or tissues as a function of time.','PC','One record per analyte per planned time point number per time point reference per visit per subject','\0'),('D-SDTM-PE','Physical Examination','Findings','Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.','PE','One record per body system or abnormality per visit per subject','\0'),('D-SDTM-PP','Pharmacokinetic Parameters','Findings','Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.','PP','One record per PK parameter per time-concentration profile per modeling method per subject','\0'),('D-SDTM-QS','Questionnaire','Findings','Questionnaires are named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis.','QS','One record per questionnaire per question per time point per visit per subject','\0'),('D-SDTM-RE','Respiratory System Findings','Findings','A domain for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs','RE','One record per finding or result per time point per visit per subject.','\0'),('D-SDTM-RELREC','Related Records','Relationship','','RELREC','One record per related record, group of records or datasets','\0'),('D-SDTM-RP','Reproductive System Findings','Findings','The Reproductive System Findings domain captures all Reproductive information related to a subject','RP','One record per Reproductive System Finding per time point per visit per subject','\0'),('D-SDTM-RS','Disease Response','Findings','A domain represents the response evaluation(s) determined from the data in TR. Data from other sources (in other SDTM domains) might also be used in an assessment of response.','RS','One record per response assessment per visit per subject per assessor','\0'),('D-SDTM-SC','Subject Characteristics','Findings','The subject characteristics domain is for data not collected in other domains that is subject-related.','SC','One record per characteristic per subject','\0'),('D-SDTM-SE','Subject Elements','SpecialPurpose','The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.','SE','One record per actual Element per subject','\0'),('D-SDTM-SR','Skin Response','FindingsAbout','The Skin Response (SR) is the first implementation of the Findings About concept that is Findings About an Intervention and uses a different domain code instead of FA','SR','One record per test per visit per subject','\0'),('D-SDTM-SS','Subjec Status','Findings','Subject Status is for data relating to general subject characteristics that are evaluated periodically to determine if they have changed.','SS','One record per finding per visit per subject','\0'),('D-SDTM-SU','Substance Use','Interventions','The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.','SU','One record per substance type per reported occurrence per subject','\0'),('D-SDTM-SUPPQUAL','Supplemental Qualifiers','Relationship','','SUPP','One record per IDVAR, IDVARVAL, and QNAM value per subject','\0'),('D-SDTM-SV','Subject Visits','SpecialPurpose','The subject visits table describes the actual start and end data/time for each visit of each individual subject.','SV','One record per actual visit per subject','\0'),('D-SDTM-TA','Trial Arms','TrialDesignModel','The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.','TA','One record per planned Element per Arm','\0'),('D-SDTM-TE','Trial Elements','TrialDesignModel','The Trial Elements (TE) dataset contains the definitions of the elements that appear in the Trial Arms (TA) dataset. An Element may appear multiple times in the Trial Arms table because it appears either 1) in multiple Arms, 2) multiple times within an Arm, or 3) both. However, an Element will appear only once in the Trial Elements table.','TE','One record per planned Element','\0'),('D-SDTM-TI','Trial Inclusion/ Exclusion Criteria','TrialDesignModel','The Trial Inclusion Exclusion (TI) dataset is not subject oriented. It contains all the inclusion and exclusion criteria for the trial, and thus provides information that may not be present in the subject-level data on inclusion and exclusion criteria.','TI','One record per I/E criterion','\0'),('D-SDTM-TR','Tumor Results','Findings','Represents quantitative measurements and/or qualitative assessments of the tumors identified in the TU domain. These measurements are usually taken at baseline and then at each subsequent assessment to support response evaluations.','TR','One record per tumor measurement/assessment per visit per subject per assessor','\0'),('D-SDTM-TS','Trial Summary','TrialDesignModel','The Trial Summary (TS) dataset allows the sponsor to submit a summary of the trial in a structured format. Each record in the Trial Summary dataset contains the value of a parameter, a characteristic of the trial. For example, Trial Summary is used to record basic information about the study such as trial phase, protocol title, and trial objectives. The Trial Summary dataset contains information about the planned and actual trial characteristics.','TS','One record per trial summary parameter value','\0'),('D-SDTM-TU','Tumor Identification','Findings','domain represents data that uniquely identifies tumors. The tumors are identified by an investigator and/or independent assessor and classified according to the disease assessment criteria.','TU','One record per identified tumor per subject per assessor','\0'),('D-SDTM-TV','Trial Visits','TrialDesignModel','The Trial Visits (TV) dataset describes the planned Visits in a trial. Visits are defined as \"clinical encounters\" and are described using the timing variables VISIT, VISITNUM, and VISITDY. Protocols define Visits in order to describe assessments and procedures that are to be performed at the Visits.','TV','One record per planned Visit per Arm','\0'),('D-SDTM-VS','Vital Signs','Findings','Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.','VS','One record per vital sign measurement per time point per visit per subject','\0');
/*!40000 ALTER TABLE `DomainTemplates` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Dumping data for table `DomainTemplateVariables`
--

LOCK TABLES `DomainTemplateVariables` WRITE;
/*!40000 ALTER TABLE `DomainTemplateVariables` DISABLE KEYS */;
INSERT INTO `DomainTemplateVariables` VALUES ('V-CUST-CY-COUNT','COUNT','The number of cells in each node','decimal','The number of cells in each node','D-CUST-CY','CL-Role-T-8','CL-Compliance-T-2',NULL,4,'\0','\0','COLUMN',NULL),('V-CUST-CY-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-CUST-CY','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-CUST-CY-FEAT','FEAT','The molecular feature, biomarker that is being measured for this group of cells (e.g. CD14, TNFR1 ?)','string','Feature','D-CUST-CY','CL-Role-T-3','CL-Compliance-T-2',NULL,6,'\0','\0','COLUMN',NULL),('V-CUST-CY-OBSMEA','OBSMEA','The measruement observed for each feature (e.g. Median Intensity, CVS ?) ','string','Observed measure','D-CUST-CY','CL-Role-T-3','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-CUST-CY-OBSVALUE','OBSVALUE','The Observed value for the measure specified in OBSMEA','decimal','Observed Value','D-CUST-CY','CL-Role-T-3','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-CUST-CY-PERTOT','PERTOT','Percentage of cells in each population (group) as proportion of the total number of cells in each sample','decimal','Percent of total','D-CUST-CY','CL-Role-T-8','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-CUST-CY-POP','POP','A description of the group / population that a number of cells have been classified into','string','Name of population','D-CUST-CY','CL-Role-T-2','CL-Compliance-T-2',NULL,3,'\0','\0','COLUMN',NULL),('V-CUST-CY-SAMPLEID','SAMPLEID','Unique identifier for a sample','string','Sample Identifier','D-CUST-CY','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-CUST-HD-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-CUST-HD','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-CUST-HD-FEAT','FEAT','The molecular feature, biomarker that is being measured for this group of cells (e.g. CD14, TNFR1 ?)','string','Feature','D-CUST-HD','CL-Role-T-2','CL-Compliance-T-2',NULL,3,'\0','\0','COLUMN',NULL),('V-CUST-HD-OBSMEA','OBSMEA','The measruement observed for each feature (e.g. Median Intensity, CVS ?) ','string','Observed measure','D-CUST-HD','CL-Role-T-3','CL-Compliance-T-2',NULL,4,'\0','\0','COLUMN',NULL),('V-CUST-HD-OBSVALUE','OBSVALUE','The Observed value for the measure specified in OBSMEA','decimal','Observed Value','D-CUST-HD','CL-Role-T-8','CL-Compliance-T-2',NULL,5,'\0','\0','COLUMN',NULL),('V-CUST-HD-SAMPLEID','SAMPLEID','Unique identifier for a sample','string','Sample Identifier','D-CUST-HD','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-CUST-MX-VAL','VALUE','Measured observation value','decimal','Measured Value','D-CUST-MX','CL-Role-T-8','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-CUST-MX-X','X','Identifiers for columns of the matrix','decimal','Column Identifier','D-CUST-MX','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-CUST-MX-Y','Y','Identifiers for rows of the matrix','decimal','Row Identifier','D-CUST-MX','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-MAGE-ADF-BCOL','Block Column','Block Column position for a spot on the array','positive integer','Block Column','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-3',NULL,13,'','','COLUMN',NULL),('V-MAGE-ADF-BROW','Block Row','Block row position for a spot on the array','positive integer','Block Row','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-3',NULL,14,'','','COLUMN',NULL),('V-MAGE-ADF-COL','Column','Column position for a spot on the array','positive integer','Column','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,15,'','','COLUMN',NULL),('V-MAGE-ADF-COMM','Comment[<NAME>]','The Comment columns are included as a basic extensibility mechanism for local implementations, analogous to the use of NameValueTypes in MAGEv1. The name associated with the comment is included in square brackets in the column heading, and the value(s) entered in the body of the column.','string','Comment[<NAME>]','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-3',NULL,12,'','','HEADER',NULL),('V-MAGE-ADF-COMPANN','Composite Element Database Entry[<REFSRC>]','Annotation for Composite Element. Cross-reference accession in external database. You can enter multiple accessions from the same database by separating them with semicolons, e.g. AJ12345;BX45678','string','Composite Element Database Entry[<REFSRC>]','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,23,'','','COLUMN','CL-FEATDBS'),('V-MAGE-ADF-COPNAM','Composite Element Name','Composite Element unique name. In case of different reporters that are designed from two exons of a gene, you can indicate that the reporters belong to the same \"composite element\"\"\"','string','Composite Element Name','D-MAGE-ADF','CL-Role-T-1','CL-Compliance-T-2',NULL,22,'','','COLUMN',NULL),('V-MAGE-ADF-NAME','Array Design Name','An informative title of the array design. Should include the name of the manufacturer (e.g. Agilent) or the lab which designed it, the species, version number, purpose of the array (e.g. genotyping), the number of probes/features (e.g 450k)','string','Array Design Name','D-MAGE-ADF','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'','','HEADER',NULL),('V-MAGE-ADF-PROT','Printing Protocol','How the probes were printed on the array. Include URLs to stable online resources if possible. Especially important if you are submitting a custom array printed with non-propreitary methods.','string','Printing Protocol','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-3',NULL,4,'','','HEADER',NULL),('V-MAGE-ADF-PROV','Provider','Name and contact email address of the array design\'s submitter.','string','Provider','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-1',NULL,3,'','','HEADER',NULL),('V-MAGE-ADF-REF','Term Source Name','In the ADF table, for each cross-reference provided, e.g.Reporter Database Entry [uniprot], the cross-referenced resource\'s name needs to be entered here, so the resource can be looked up via the URL in Term Source File.','string','Term Source Name','D-MAGE-ADF','CL-Role-T-5','CL-Compliance-T-3',NULL,9,'','','HEADER',NULL),('V-MAGE-ADF-REFURI','Term Source File','The URL where an external database resource mentioned in Term Source Name  is hosted.','string','Term Source File','D-MAGE-ADF','CL-Role-T-5','CL-Compliance-T-3',NULL,10,'','','HEADER',NULL),('V-MAGE-ADF-REFVER','Term Source Version','The version of the external database resource mentioned in Term Source Name  is hosted.','string','Term Source Version','D-MAGE-ADF','CL-Role-T-5','CL-Compliance-T-3',NULL,11,'','','HEADER',NULL),('V-MAGE-ADF-REPANN','Reporter Database Entry[<REFSRC>]','Annotation for Reporter. Cross-reference accession in external database. You can enter multiple accessions from the same database by separating them with semicolons, e.g. AJ12345;BX45678','string','Reporter Database Entry[<REFSRC>]','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,21,'','','COLUMN','CL-FEATDBS'),('V-MAGE-ADF-REPCRL','Control Type','Type of Control the reporter represents','string','Control Type','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,20,'','','COLUMN',NULL),('V-MAGE-ADF-REPGRP','Reporter Group[<Role>]','Defined role of the probe at this location. Can be experimental or control','string','Reporter Group[role]','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'','','COLUMN',NULL),('V-MAGE-ADF-REPNAM','Reporter Name','Unique probe or probset name','string','Reporter Name','D-MAGE-ADF','CL-Role-T-1','CL-Compliance-T-1',NULL,17,'','','COLUMN',NULL),('V-MAGE-ADF-ROW','Row','Row position for a spot on the array','positive integer','Row','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,16,'','','COLUMN',NULL),('V-MAGE-ADF-SEQPLOY','Sequence Polymer Type','The polymer that makes up the probes.','string','Sequence Polymer Type','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,8,'','','HEADER',NULL),('V-MAGE-ADF-SUBS','Substrate Type','The material/substrate of the microarray.','string','Substrate Type','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,7,'','','HEADER',NULL),('V-MAGE-ADF-SURF','Surface Type','The chemical coating on the surface of the substrate see below. Probes are immobilised by the coating.','string','Surface Type','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,6,'','','HEADER',NULL),('V-MAGE-ADF-TECH','Technology Type','Printing/synthesis technology used when creating the microarray.','string','Technology Type','D-MAGE-ADF','CL-Role-T-3','CL-Compliance-T-2',NULL,5,'','','HEADER',NULL),('V-MAGE-ADF-VER','Version','Version (or revision) number of the array design.','string','Version','D-MAGE-ADF','CL-Role-T-1','CL-Compliance-T-3',NULL,2,'','','HEADER',NULL),('V-SDTM-AE-AEACN','AEACN','Describes changes to the study treatment as a result of the event. AEACN is specifically for the relationship to study treatment. AEACNOTH is for actions unrelated to dose adjustments of study treatment. Examples of AEACN values include ICH E2B values: DRUG WITHDRAWN, DOSE REDUCED, DOSE INCREASED, DOSE NOT CHANGED, UNKNOWN or NOT APPLICABLE.','string','Action Taken with Study Treatment','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-2','CL-ACN',28,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEACNOTH','AEACNOTH','Describes other actions taken as a result of the event that are unrelated to dose adjustments of study treatment. Usually reported as free text. Example: \"TREATMENT UNBLINDED. PRIMARY CARE PHYSICIAN NOTIFIED.\"','string','Other Action Taken','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEBDSYCD','AEBDSYCD','Dictionary derived. Code for the body system or organ class used by the sponsor. When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for the sponsor\'s analyses and summary tables, which may not necessarily be the primary SOC.','decimal','Body System or Organ Class Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEBODSYS','AEBODSYS','Dictionary derived. Body system or organ class used by the sponsor from the coding dictionary (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for the sponsor\'s analyses and summary tables which may not necessarily be the primary SOC.','string','Body System or Organ Class','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-2',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AECAT','AECAT','Used to define a category of related records. Example: BLEEDING, NEUROPSYCHIATRIC.','string','Category for Adverse Event','D-SDTM-AE','CL-Role-T-7','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AECONTRT','AECONTRT','Was another treatment given because of the occurrence of the event?','string','Concomitant or Additional Trtmnt Given','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',42,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEDECOD','AEDECOD','Dictionary-derived text description of AETERM or AEMODIFY. Equivalent to the Preferred Term (PT in MedDRA). The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','Dictionary-Derived Term','D-SDTM-AE','CL-Role-T-4','CL-Compliance-T-1',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEDUR','AEDUR','Collected duration and unit of an adverse event. Used only if collected on the CRF and not derived from start and end date/times. Example: P1DT2H (for 1 day, 2 hours).','duration','Duration of Adverse Event','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3',NULL,48,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEENDTC','AEENDTC','','dateTime','End Date/Time of Adverse Event','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-2',NULL,45,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEENDY','AEENDY','Study day of end of event relative to the sponsor-defined RFSTDTC.','integer','Study Day of End of Adverse Event','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3',NULL,47,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEENRF','AEENRF','Describes the end of the event relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point (RFSTDTC) and a discrete ending point (RFENDTC) of the trial.','string','End Relative to Reference Period','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',49,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEENRTPT','AEENRTPT','Identifies the end of the event as being before or after the reference time point defined by variable AEENTPT.','string','End Relative to Reference Time Point','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3',NULL,50,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEENTPT','AEENTPT','Description of date/time in ISO 8601 character format of the reference point referred to by AEENRTPT. Examples: \"2003-12-25\" or \"VISIT 2\".','string','End Reference Time Point','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3',NULL,51,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEGRPID','AEGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEHLGT','AEHLGT','Dictionary-derived text description of the High Level Group Term for the primary System Organ Class.','string','High Level Group Term','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEHLGTCD','AEHLGTCD','Dictionary-derived code for the High Level Group Term for the primary System Organ Class.','decimal','High Level Group Term Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEHLT','AEHLT','Dictionary-derived text description of the High Level Term for the primary System Organ Class.','string','High Level Term','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEHLTCD','AEHLTCD','Dictionary-derived code for the High Level Term for the primary System Organ Class.','decimal','High Level Term Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AELLT','AELLT','Dictionary-derived text description of the Lowest Level Term.','string','Lowest Level Term','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AELLTCD','AELLTCD','Dictionary-derived code for the Lowest Level Term.','decimal','Lowest Level Term Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AELOC','AELOC','Describes anatomical location relevant for the event (e.g., LEFT ARM for skin rash).','string','Location of Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',25,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEMODIFY','AEMODIFY','If AETERM is modified to facilitate coding, then AEMODIFY will contain the modified text.','string','Modified Reported Term','D-SDTM-AE','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEOUT','AEOUT','Description of the outcome of an event.','string','Outcome of Adverse Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-OUT',33,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEPATT','AEPATT','Used to indicate the pattern of the event over time. Examples: INTERMITTENT, CONTINUOUS, SINGLE EVENT.','string','Pattern of Adverse Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEPRESP','AEPRESP','A value of \"Y\" indicates that this adverse event was pre-specified on the CRF. Values are null for spontaneously reported events (i.e., those collected as free-text verbatim terms).','string','Pre-Specified Adverse Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',20,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEPTCD','AEPTCD','Dictionary-derived code for the Preferred Term.','decimal','Preferred Term Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEREFID','AEREFID','Internal or external identifier such as a serial number on an SAE reporting form.','string','Reference ID','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AEREL','AEREL','Records the investigator\'s opinion as to the causality of the event to the treatment. ICH E2A and E2B examples include NOT RELATED, UNLIKELY RELATED, POSSIBLY RELATED, RELATED. Controlled Terminology may be defined in the future. Check with regulatory authority for population of this variable.','string','Causality','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-2',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AERELNST','AERELNST','Records the investigator\'s opinion as to whether the event may have been due to a treatment other than study drug. May be reported as free text. Example: \"MORE LIKELY RELATED TO ASPIRIN USE.\"','string','Relationship to Non-Study Treatment','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESCAN','AESCAN','Was the serious event associated with the development of cancer?','string','Involves Cancer','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',34,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESCAT','AESCAT','A further categorization of adverse event. Example: NEUROLOGIC.','string','Subcategory for Adverse Event','D-SDTM-AE','CL-Role-T-7','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESCONG','AESCONG','Was the serious event associated with congenital anomaly or birth defect?','string','Congenital Anomaly or Birth Defect','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',35,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESDISAB','AESDISAB','Did the serious event result in persistent or significant disability/incapacity?','string','Persist or Signif Disability/Incapacity','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',36,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESDTH','AESDTH','Did the serious event result in death?','string','Results in Death','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',37,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESEQ','AESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESER','AESER','Is this a serious event?','string','Serious Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-2','CL-NY',27,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESEV','AESEV','The severity or intensity of the event. Examples: MILD, MODERATE, SEVERE.','string','Severity/Intensity','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-AESEV',26,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESHOSP','AESHOSP','Did the serious event sdtm-1-3:Classifier.RequiredVariableuire or prolong hospitalization?','string','sdtm-1-3:Classifier.RequiredVariableuires or Prolongs Hospitalization','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',38,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESLIFE','AESLIFE','Was the serious event life threatening?','string','Is Life Threatening','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',39,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESMIE','AESMIE','Do additional categories for seriousness apply?','string','Other Medically Important Serious Event','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',41,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESOC','AESOC','Dictionary-derived text description of the primary System Organ Class. Will be the same as AEBODSYS if the primary SOC was used for analysis.','string','Primary System Organ Class','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESOCCD','AESOCCD','Dictionary-derived code for the primary System Organ Class. Will be the same as AEBDSYCD if the primary SOC was used for analysis.','decimal','Primary System Organ Class Code','D-SDTM-AE','CL-Role-T-5','CL-Compliance-T-2',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESOD','AESOD','Did the serious event occur with an overdose?','string','Occurred with Overdose','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',40,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESPID','AESPID','Sponsor-defined identifier. It may be pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on an Adverse Events page.','string','Sponsor-Defined Identifier','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESTDTC','AESTDTC','','dateTime','Start Date/Time of Adverse Event','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-2',NULL,44,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AESTDY','AESTDY','Study day of start of adverse event relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Adverse Event','D-SDTM-AE','CL-Role-T-6','CL-Compliance-T-3',NULL,46,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AETERM','AETERM','Verbatim name of the event.','string','Reported Term for the Adverse Event','D-SDTM-AE','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-AE-AETOXGR','AETOXGR','Toxicity grade according to a standard toxicity scale such as Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Sponsor should specify name of the scale and version used in the metadata (see 6.2.1.1, Assumption 6c). If value is from a numeric scale, represent only the number (e.g., \"2\" and not \"Grade 2\").','string','Standard Toxicity Grade','D-SDTM-AE','CL-Role-T-3','CL-Compliance-T-3',NULL,43,'\0','\0','COLUMN',NULL),('V-SDTM-AE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-AE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-AE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-AE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSANTREG','BSANTREG ','Defines the specific anatomical or biological region of a tissue, organ specimen or the region from which the specimen is obtained, as defined in the protocol, such as a section or part of what is described in the BSSPEC variable. Examples: CORTEX, MEDULLA, MUCOSA.','string','Anatomical Region of Specimen','D-SDTM-BS','CL-Role-T-5','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSBLFL','BSBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSCAT','BSCAT','Used to define a category of topic-variable values. Example: MEASUREMENT, QUALITY','string','Category for Biospecimen Test','D-SDTM-BS','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSDTC','BSDTC','Date and time of specimen collection','dateTime','Date/Time of Specimen Collection','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-2',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSDY','BSDY','Study day of specimen collection relative to the sponsor-defined RFSTDTC. ','integer','Study Day of Specimen Collection','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSELTM','BSELTM','Elapsed time relative to a planned fixed reference (BSTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable, but an interval, represented as ISO duration. ','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSGRPID','BSGRPID','Optional group identifier, used to link together a block of related records within a subject in a domain. ','string','Group ID','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSMETHOD','BSMETHOD ','Method of the test or examination. Examples: SPECTROPHOTOMETRY, ELECTROPHORESIS.','string','Method of Test or Examination ','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSNAM','BSNAM','Name or identifier of the vendor (e.g., laboratory) that provided the test results. ','string','Vendor Name','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSORRES','BSORRES','Result of the vital signs measurement as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-BS','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSORRESU','BSORRESU','Unit for BSORRES. Examples: mg, mL','string','Original Units','D-SDTM-BS','CL-Role-T-5','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSREASND','BSREASND','Reason not done. Used in conjunction with BSSTAT when value is NOT DONE. ','string','Reason Not Done','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSREFID','BSREFID','Internal or external identifier such as lab specimen ID. ','string','Reference ID','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSRFTDTC','BSRFTDTC','Date/time for a fixed reference time point defined by PFTPTREF. ','dateTime','Date/Time of Reference Time Point','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSCAT','BSSCAT','Used to define a further categorization of BSCAT values.','string','Subcategory for Biospecimen Test','D-SDTM-BS','CL-Role-T-7','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSEQ','BSSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSPCCND','BSSPCCND ','Defines the condition of the specimen. Examples: HEMOLYZED, ICTERIC, LIPEMIC. ','string','Specimen Condition','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSPEC','BSSPEC','Defines the type of specimen used for a measurement. Examples: SERUM, PLASMA, URINE, SOFT TISSUE.','string','Specimen Type','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSPID','BSSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database.','string','Sponsor-Defined Identifier','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSTAT','BSSTAT','Used to indicate that a test was not done, or was attempted but did not generate a result. Should be null or have a value of NOT DONE.','string','Completion Status','D-SDTM-BS','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSTRESC','BSSTRESC','Contains the result value for all findings, copied or derived from BSORRES in a standard format or standard units. BSSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in BSSTRESN ','string','Character Result/Finding in Std Format','D-SDTM-BS','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSTRESN','BSSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from BSSTRESC. BSSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-BS','CL-Role-T-8','CL-Compliance-T-2',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSSTRESU','BSSTRESU','Standardized unit used for BSSTRESC and BSSTRESN.','string','Standard Units','D-SDTM-BS','CL-Role-T-5','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSTEST','BSTEST','Long name for BSTESTCD. Examples: Volume, RNA Integrity Number','string','Biospecimen Test Name','D-SDTM-BS','CL-Role-T-4','CL-Compliance-T-1',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSTESTCD','BSTESTCD','Short character value for BSTEST used as a column name when converting a dataset from a vertical format to a horizontal format. The short value can be up to 8 characters. Examples: VOLUME, RIN ','string','Biospecimen Test Short Name','D-SDTM-BS','CL-Role-T-2','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSTPT','BSTPT','Text description of time when a measurement or observation should be taken as defined in the protocol. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See BSTPTNUM and BSTPTREF. ','string','Planned Time Point Name','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSTPTNUM','BSTPTNUM','Numerical version of BSTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-BS-BSTPTREF','BSTPTREF','Name of the fixed reference point referred to by BSELTM, BSTPTNUM, and BSTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-BS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-BS-SPDEVID','SPDEVID','Sponsor-defined identifier for a device. ','string','Sponsor Device Identifier ','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-3',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-BS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-BS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-BS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-BS-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\r2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-BS-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-BS-VISITNUM','VISITNUM','1. Clinical encounter number.\r2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-BS','CL-Role-T-6','CL-Compliance-T-2',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEBODSYS','CEBODSYS','Dictionary-derived. Body system or organ class that is involved in an event or measurement from a standard hierarchy (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for the sponsor\'s analyses and summary tables which may not necessarily be the primary SOC.','string','Body System or Organ Class','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CECAT','CECAT','Used to define a category of related records.','string','Category for Clinical Event','D-SDTM-CE','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEDECOD','CEDECOD','Controlled terminology for the name of the clinical event. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','Dictionary-Derived Term','D-SDTM-CE','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEDTC','CEDTC','','dateTime','Date/Time of Event Collection','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEDY','CEDY','1. Study day of clinical event collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of Event Collection','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEENDTC','CEENDTC','','dateTime','End Date/Time of Clinical Event','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEENRF','CEENRF','Describes the end of the event relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics).','string','End Relative to Reference Period','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',23,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEENRTPT','CEENRTPT','Identifies the end of the event as being before or after the reference time point defined by variable CEENTPT.','string','End Relative to Reference Time Point','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEENTPT','CEENTPT','Description or date/time in ISO 8601 character format of the reference point referred to by CEENRTPT. Examples: \"2003-12-25\" or \"VISIT 2\".','string','End Reference Time Point','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEGRPID','CEGRPID','Used to tie together a block of related records for a subject within a domain.','string','Group ID','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEOCCUR','CEOCCUR','Used when the occurrence of specific events is solicited to indicate whether or not a clinical event occurred. Values are null for spontaneously reported events.','string','Clinical Event Occurrence','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',13,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEPRESP','CEPRESP','Used to indicate whether the Event in CETERM was pre-specified. Value is Y for pre-specified events, null for spontaneously reported events.','string','Clinical Event Pre-Specified','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3','CL-NY',12,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEREASND','CEREASND','Describes the reason clinical event data was not collected. Used in conjunction with CESTAT when value is NOT DONE.','string','Reason Clinical Event Not Collected','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CEREFID','CEREFID','Internal or external identifier.','string','Reference ID','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESCAT','CESCAT','A further categorization of the condition or event.','string','Subcategory for Clinical Event','D-SDTM-CE','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESEQ','CESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESEV','CESEV','The severity or intensity of the event. Examples: MILD, MODERATE, SEVERE.','string','Severity/Intensity','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESPID','CESPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a CRF page.','string','Sponsor-Defined Identifier','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESTAT','CESTAT','The status indicates that a question from a pre-specified list was not answered.','string','Completion Status','D-SDTM-CE','CL-Role-T-3','CL-Compliance-T-3','CL-ND',14,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESTDTC','CESTDTC','','dateTime','Start Date/Time of Clinical Event','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESTRF','CESTRF','Describes the start of the clinical event relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics).','string','Start Relative to Reference Period','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',22,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESTRTPT','CESTRTPT','Identifies the start of the observation as being before or after the reference time point defined by variable CESTTPT.','string','Start Relative to Reference Time Point','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CESTTPT','CESTTPT','Description or date/time in ISO 8601 character format of the sponsor-defined reference point referred to by --STRTPT. Examples: \"2003-12-15\" or \"VISIT 1\".','string','Start Reference Time Point','D-SDTM-CE','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-CE-CETERM','CETERM','Term for the medical condition or event. Most likely pre-printed on CRF.','string','Reported Term for the Clinical Event','D-SDTM-CE','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-CE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-CE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-CE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-CE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMCAT','CMCAT','Used to define a category of medications/treatments. Examples: PRIOR, CONCOMITANT, ANTI-CANCER MEDICATION, or GENERAL CONMED.','string','Category for Medication','D-SDTM-CM','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMCLAS','CMCLAS','Drug class. May be obtained from coding. When coding to a single class, populate with class value. If using a dictionary and coding to multiple classes, then follow assumption 4.1.2.8.3 or omit CMCLAS.','string','Medication Class','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMCLASCD','CMCLASCD','Class code corresponding to CMCLAS. Drug class. May be obtained from coding. When coding to a single class, populate with class code. If using a dictionary and coding to multiple classes, then follow assumption 4.1.2.8.3 or omit CMCLASCD.','string','Medication Class Code','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDECOD','CMDECOD','Standardized or dictionary-derived text description of CMTRT or CMMODIFY. Equivalent to the generic medication name in WHO Drug. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes. If an intervention term does not have a decode value in the dictionary then CMDECOD will be left blank.','string','Standardized Medication Name','D-SDTM-CM','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSE','CMDOSE','Amount of CMTRT taken.','decimal','Dose per Administration','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSFRM','CMDOSFRM','Dose form for CMTRT. Examples: TABLET, LOTION.','string','Dose Form','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3','CL-FRM',22,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSFRQ','CMDOSFRQ','Usually sdtm-1-3:Classifier.ExpecedVariableressed as the number of repeated administrations of CMDOSE within a specific time period. Examples: BID (twice daily), Q12H (every 12 hours).','string','Dosing Fsdtm-1-3:Classifier.RequiredVariableuency per Interval','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSRGM','CMDOSRGM','Text description of the (intended) schedule or regimen for the Intervention. Examples: TWO WEEKS ON, TWO WEEKS OFF.','string','Intended Dose Regimen','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSTOT','CMDOSTOT','Total daily dose of CMTRT using the units in CMDOSU. Total dose over a period other than day could be recorded in a separate Supplemental Qualifier variable. CMDOSTOT should be used in addition to CMDOSE, and not in place of it.','decimal','Total Daily Dose','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSTXT','CMDOSTXT','Dosing amounts or a range of dosing information collected in text form. Units may be stored in CMDOSU. Example: 200-400, 15-20.','string','Dose Description','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDOSU','CMDOSU','Units for CMDOSE, CMDOSTXT, and CMDOSTOT. Examples: ng, mg, or mg/kg.','string','Dose Units','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',21,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMDUR','CMDUR','Collected duration for a treatment episode. Used only if collected on the CRF and not derived from start and end date/times.','duration','Duration of Medication','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMENDTC','CMENDTC','','dateTime','End Date/Time of Medication','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMENDY','CMENDY','Study day of end of medication relative to the sponsor-defined RFSTDTC.','integer','Study Day of End of Medication','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMENRF','CMENRF','Describes the end of the medication relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into CMENRF.','string','End Relative to Reference Period','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',33,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMENRTPT','CMENRTPT','Identifies the end of the medication as being before or after the reference time point defined by variable CMENTPT.','string','End Relative to Reference Time Point','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMENTPT','CMENTPT','Description or date/time in ISO 8601 character format of the reference point referred to by CMENRTPT. Examples: \"2003-12-25\" or \"VISIT 2\".','string','End Reference Time Point','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,37,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMGRPID','CMGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMINDC','CMINDC','Denotes why a medication was taken or administered. Examples: NAUSEA, HYPERTENSION.','string','Indication','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMMODIFY','CMMODIFY','If CMTRT is modified to facilitate coding, then CMMODIFY will contain the modified text.','string','Modified Reported Name','D-SDTM-CM','CL-Role-T-4','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMOCCUR','CMOCCUR','When the use of specific medications is solicited, CMOCCUR is used to indicate whether or not (Y/N) use of the medication occurred. Values are null for medications not specifically solicited.','string','CM Occurrence','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3','CL-NY',13,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMPRESP','CMPRESP','Used to indicate whether (Y/null) information about the use of a specific medication was solicited on the CRF.','string','CM Pre-Specified','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3','CL-NY',12,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMREASND','CMREASND','Describes the reason concomitant medication was not collected. Used in conjunction with CMSTAT when value is NOT DONE.','string','Reason Medication Not Collected','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMROUTE','CMROUTE','Route of administration for CMTRT. Examples: ORAL, INTRAVENOUS.','string','Route of Administration','D-SDTM-CM','CL-Role-T-5','CL-Compliance-T-3','CL-ROUTE',26,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSCAT','CMSCAT','A further categorization of medications/ treatment. Examples: CHEMOTHERAPY, HORMONAL THERAPY, ALTERNATIVE THERAPY.','string','Subcategory for Medication','D-SDTM-CM','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSEQ','CMSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSPID','CMSPID','Sponsor-defined reference number. Examples: a number pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or record identifier defined in the sponsor\'s operational database. Example: line number on a concomitant medication page.','string','Sponsor-Defined Identifier','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTAT','CMSTAT','Used to indicate that a question about a pre-specified medication was not answered. Should be null or have a value of NOT DONE.','string','Completion Status','D-SDTM-CM','CL-Role-T-3','CL-Compliance-T-3','CL-ND',14,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTDTC','CMSTDTC','','dateTime','Start Date/Time of Medication','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTDY','CMSTDY','Study day of start of medication relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Medication','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTRF','CMSTRF','Describes the start of the medication relative to sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into CMSTRF.','string','Start Relative to Reference Period','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',32,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTRTPT','CMSTRTPT','Identifies the start of the medication as being before or after the reference time point defined by variable CMSTTPT.','string','Start Relative to Reference Time Point','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMSTTPT','CMSTTPT','Description or date/time in ISO 8601 character format of the reference point referred to by CMSTRTPT. Examples: \"2003-12-15\" or \"VISIT 1\".','string','Start Reference Time Point','D-SDTM-CM','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-CM-CMTRT','CMTRT','Verbatim medication name that is either pre-printed or collected on a CRF.','string','Reported Name of Drug, Med, or Therapy','D-SDTM-CM','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-CM-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-CM-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-CM-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-CM','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-CO-CODTC','CODTC','Date/time of comment on dedicated comment form. Should be null if this is a child record of another domain or if comment date was not collected.','dateTime','Date/Time of Comment','D-SDTM-CO','CL-Role-T-6','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-CO-COEVAL','COEVAL','Used to describe the originator of the comment. Examples: CENTRAL, REVIEWER, ADJUDICATION COMMITTEE, PRINCIPAL INVESTIGATOR.','string','Evaluator','D-SDTM-CO','CL-Role-T-3','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-CO-COREF','COREF','Sponsor-defined reference associated with the comment. May be the CRF page number (e.g. 650), or a module name (e.g. DEMOG), or a combination of information that identifies the reference (e.g. 650-VITALS-VISIT 2).','string','Comment Reference','D-SDTM-CO','CL-Role-T-3','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-CO-COSEQ','COSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-CO','CL-Role-T-1','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-CO-COVAL','COVAL','The text of the comment. Text over 200 characters can be added to additional columns COVAL1-COVALn. See assumption 5.2.1.1.3.','string','Comment','D-SDTM-CO','CL-Role-T-2','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-CO-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-CO','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-CO-IDVAR','IDVAR','Identifying variable in the parent dataset that identifies the record(s) to which the comment applies. Examples AESEQ or CMGRPID. Used only when individual comments are related to domain records. Null for comments collected on separate CRFs.','string','Identifying Variable','D-SDTM-CO','CL-Role-T-3','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-CO-IDVARVAL','IDVARVAL','Value of identifying variable of the parent record(s). Used only when individual comments are related to domain records. Null for comments collected on separate CRFs.','string','Identifying Variable Value','D-SDTM-CO','CL-Role-T-3','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-CO-RDOMAIN','RDOMAIN','Two-character abbreviation for the domain of the parent record(s). Null for comments collected on a general comments or additional information CRF page.','string','Related Domain Abbreviation','D-SDTM-CO','CL-Role-T-3','CL-Compliance-T-3',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-CO-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-CO','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-CO-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-CO','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DACAT','DACAT','Used to define a category of related records. Examples: STUDY MEDICATION, RESCUE MEDICATION.','string','Category of Assessment','D-SDTM-DA','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DADTC','DADTC','','dateTime','Date/Time of Accountability Assessment','D-SDTM-DA','CL-Role-T-6','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DADY','DADY','1. Study day of drug accountability assessment, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Accountability Assessment','D-SDTM-DA','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DAGRPID','DAGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DAORRES','DAORRES','Result of the Drug Accountability assessment as originally received or collected.','string','Assessment Result in Original Units','D-SDTM-DA','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DAORRESU','DAORRESU','Unit for DAORRES.','string','Original Units','D-SDTM-DA','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DAREASND','DAREASND','Reason not done. Used in conjunction with DASTAT when value is NOT DONE.','string','Reason Not Performed','D-SDTM-DA','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DAREFID','DAREFID','Internal or external identifier such as label number.','string','Reference ID','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASCAT','DASCAT','Used to define a further categorization level for a group of related records.','string','Subcategory of Assessment','D-SDTM-DA','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASEQ','DASEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASPID','DASPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Examples: Line number on the Drug Accountability page, drug label code.','string','Sponsor-Defined Identifier','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASTAT','DASTAT','Used to indicate that a drug accountability assessment was not done. Should be null or have a value of NOT DONE.','string','Completion Status','D-SDTM-DA','CL-Role-T-3','CL-Compliance-T-3','CL-ND',17,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASTRESC','DASTRESC','Contains the result value for all Drug Accountability assessments, copied or derived from DAORRES in a standard format or in standard units. DASTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in DASTRESN.','string','Assessment Result in Std Format','D-SDTM-DA','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASTRESN','DASTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from DASTRESC. DASTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-DA','CL-Role-T-8','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DASTRESU','DASTRESU','Standardized units used for DASTRESC and DASTRESN.','string','Assessment Standard Units','D-SDTM-DA','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DATEST','DATEST','Verbatim name, corresponding to the topic variable, of the test or examination used to obtain the drug accountability assessment. The value in DATEST cannot be longer than 40 characters. Example: Dispensed Amount, Returned Amount.','string','Name of Accountability Assessment','D-SDTM-DA','CL-Role-T-4','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DATESTCD','DATESTCD','Short character value for DATEST used as a column name when converting a dataset from a vertical format to a horizontal format. The short value can be up to 8 characters and cannot begin with a number or contain characters other than letters, numbers or underscores. Example: DISPAMT, RETAMT.','string','Short Name of Accountability Assessment','D-SDTM-DA','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-DA-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-DA-STUDYID','STUDYID','Unique identifier for a study within the submission.','string','Study Identifier','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-DA-USUBJID','USUBJID','Unique subject identifier within the submission.','string','Unique Subject Identifier','D-SDTM-DA','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-DA-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-DA','CL-Role-T-6','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-DA-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-DA','CL-Role-T-6','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-DA-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-DA','CL-Role-T-6','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-DM-ACTARM','ACTARM','Description of actual Arm. When an Arm is not planned (not in Trial Arms), ACTARM will be \"Unplanned Treatment\". Randomized subjects who were not treated will be given a value of \"Not Treated\". Values should be \"Screen Failure\" for screen failures and \"Not Assigned\" for subjects not assigned to treatment. Restricted to values in Trial Arms in all other cases.','string','Description of Actual Arm','D-SDTM-DM','CL-Role-T-4','CL-Compliance-T-1',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-DM-ACTARMCD','ACTARMCD','Code of actual Arm. When an Arm is not planned (not in Trial Arms), ACTARMCD will be UNPLAN. Randomized subjects who were not treated will be given a value of NOTTRT. Values should be \"SCRNFAIL\" for screen failures and \"NOTASSGN\" for subjects not assigned to treatment. Restricted to values in Trial Arms in all other cases. ACTARMCD is limited to 20 characters and does not have special character restrictions. The maximum length of ACTARMCD is longer than for other short variables to accommodate the kind of values that are likely to be needed for crossover trials.','string','Actual Arm Code','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-1',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-DM-AGE','AGE','Age expressed in AGEU. May be derived from RFSTDTC and BRTHDTC, but BRTHDTC may not be available in all cases (due to subject privacy concerns).','positiveInteger','Age','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-DM-AGEU','AGEU','Units associated with AGE.','string','Age Units','D-SDTM-DM','CL-Role-T-5','CL-Compliance-T-2','CL-AGEU',18,'\0','\0','COLUMN',NULL),('V-SDTM-DM-ARM','ARM','Name of the Arm to which the subject was assigned.','string','Description of Planned Arm','D-SDTM-DM','CL-Role-T-4','CL-Compliance-T-1',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-DM-ARMCD','ARMCD','ARMCD is limited to 20 characters and does not have special character restrictions. The maximum length of ARMCD is longer than for other \"short\" variables to accommodate the kind of values that are likely to be needed for crossover trials. For example, if ARMCD values for a seven-period crossover were constructed using two-character abbreviations for each treatment and separating hyphens, the length of ARMCD values would be 20.','string','Planned Arm Code','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-1',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-DM-BRTHDTC','BRTHDTC','Date/time of birth of the subject.','dateTime','Date/Time of Birth','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-DM-COUNTRY','COUNTRY','Country of the investigational site in which the subject participated in the trial.','string','Country','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-1','CL-COUNTRY',26,'\0','\0','COLUMN',NULL),('V-SDTM-DM-DMDTC','DMDTC','Date/time of demographic data collection.','dateTime','Date/Time of Collection','D-SDTM-DM','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-DM-DMDY','DMDY','Study day of collection measured as integer days.','integer','Study Day of Collection','D-SDTM-DM','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-DM-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-DM','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-DM-DTHDTC','DTHDTC','Date/time of death for any subject who died, in ISO 8601 format. Should represent the date/time that is captured in the clinical-trial database.','dateTime','Date/Time of Death','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-DM-DTHFL','DTHFL','Indicates the subject died. Should be Y or null. Should be populated even when the death date is unknown.','string','Subject Death Flag','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2','CL-NY',12,'\0','\0','COLUMN',NULL),('V-SDTM-DM-ETHNIC','ETHNIC','The ethnicity of the subject. Sponsors should refer to \"Collection of Race and Ethnicity Data in Clinical Trials\" (FDA, September 2005) for guidance regarding the collection of ethnicity (http://www.fda.gov/cder/guidance/5656fnl.htm).','string','Ethnicity','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-3','CL-ETHNIC',21,'\0','\0','COLUMN',NULL),('V-SDTM-DM-INVID','INVID','An identifier to describe the Investigator for the study. May be used in addition to SITEID. Not needed if SITEID is equivalent to INVID.','string','Investigator Identifier','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-3',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-DM-INVNAM','INVNAM','Name of the investigator for a site.','string','Investigator Name','D-SDTM-DM','CL-Role-T-4','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RACE','RACE','Race of the subject. Sponsors should refer to \"Collection of Race and Ethnicity Data in Clinical Trials\" (FDA, September 2005) for guidance regarding the collection of race (http://www.fda.gov/cder/guidance/5656fnl.htm) See Assumption below regarding RACE.','string','Race','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2','CL-RACE',20,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFENDTC','RFENDTC','Reference End Date/time for the subject in ISO 8601 character format. Usually equivalent to the date/time when subject was determined to have ended the trial, and often equivalent to date/time of last sdtm-1-3:Classifier.ExpecedVariableosure to study treatment. sdtm-1-3:Classifier.RequiredVariableuired for all randomized subjects; null for screen failures or unassigned subjects.','dateTime','Subject Reference End Date/Time','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFICDTC','RFICDTC','Date/time of informed consent in ISO 8601 character format. This will be the same as the date of informed consent in the Disposition domain, if that protocol milestone is documented. Would be null only in studies not collecting the date of informed consent.','dateTime','Date/Time of Informed Consent','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFPENDTC','RFPENDTC','Date/time when subject ended participation or follow-up in a trial, as defined in the protocol, in ISO 8601 character format. Should correspond to the last known date of contact. Examples include completion date, withdrawal date, last follow-up, date recorded for lost to follow up, or death date.','dateTime','Date/Time of End of Participation','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFSTDTC','RFSTDTC','Reference Start Date/time for the subject in ISO 8601 character format. Usually equivalent to date/time when subject was first sdtm-1-3:Classifier.ExpecedVariableosed to study treatment. sdtm-1-3:Classifier.RequiredVariableuired for all randomized subjects; will be null for all subjects who did not meet the milestone the date sdtm-1-3:Classifier.RequiredVariableuires, such as screen failures or unassigned subjects.','dateTime','Subject Reference Start Date/Time','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFXENDTC','RFXENDTC','Last date of sdtm-1-3:Classifier.ExpecedVariableosure to any protocol-specified treatment or therapy, equal to the latest value of EXENDTC (or the latest value of EXSTDTC if EXENDTC was not collected or is missing).','dateTime','Date/Time of Last Study Treatment','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-DM-RFXSTDTC','RFXSTDTC','First date of sdtm-1-3:Classifier.ExpecedVariableosure to any protocol-specified treatment or therapy, equal to the earliest value of EXSTDTC.','dateTime','Date/Time of First Study Treatment','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-DM-SEX','SEX','Sex of the subject.','string','Sex','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-1','CL-SEX',19,'\0','\0','COLUMN',NULL),('V-SDTM-DM-SITEID','SITEID','Unique identifier for a site within a study.','string','Study Site Identifier','D-SDTM-DM','CL-Role-T-3','CL-Compliance-T-1',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-DM-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-DM','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-DM-SUBJID','SUBJID','Subject identifier, which must be unique within the study. Often the ID of the subject as recorded on a CRF.','string','Subject Identifier for the Study','D-SDTM-DM','CL-Role-T-2','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-DM-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. This must be a unique number, and could be a compound identifier formed by concatenating STUDYID-SITEID-SUBJID.','string','Unique Subject Identifier','D-SDTM-DM','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSCAT','DSCAT','Used to define a category of related records. DSCAT is now an \"sdtm-1-3:Classifier.ExpecedVariableected\" variable. DSCAT was sdtm-1-3:Classifier.PermissibleVariableissible in SDTMIG 3.1.1 and earlier versions. The change from \"sdtm-1-3:Classifier.PermissibleVariableissible\" to \"sdtm-1-3:Classifier.ExpecedVariableected\" is based on the sdtm-1-3:Classifier.RequiredVariableuirement to distinguish protocol milestones and/or other events from disposition events. DSCAT may be null if there are only \"disposition events\"; however, it is recommended that DSCAT always be populated.','string','Category for Disposition Event','D-SDTM-DS','CL-Role-T-7','CL-Compliance-T-2','CL-DSCAT',10,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSDECOD','DSDECOD','Controlled terminology for the name of disposition event or protocol milestone. Examples of protocol milestones: INFORMED CONSENT OBTAINED, RANDOMIZED.','string','Standardized Disposition Term','D-SDTM-DS','CL-Role-T-4','CL-Compliance-T-1','CL-NCOMPLT',9,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSDTC','DSDTC','','dateTime','Date/Time of Collection','D-SDTM-DS','CL-Role-T-6','CL-Compliance-T-3',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSGRPID','DSGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSREFID','DSREFID','Internal or external identifier.','string','Reference ID','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSSCAT','DSSCAT','A further categorization of disposition event.','string','Subcategory for Disposition Event','D-SDTM-DS','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSSEQ','DSSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSSPID','DSSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a Disposition page.','string','Sponsor-Defined Identifier','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSSTDTC','DSSTDTC','','dateTime','Start Date/Time of Disposition Event','D-SDTM-DS','CL-Role-T-6','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSSTDY','DSSTDY','Study day of start of event relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Disposition Event','D-SDTM-DS','CL-Role-T-6','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-DS-DSTERM','DSTERM','Verbatim name of the event or protocol milestone. Some terms in DSTERM will match DSDECOD, but others, such as \"Subject moved\" will map to controlled terminology in DSDECOD, such as \"LOST TO FOLLOW-UP.\"','string','Reported Term for the Disposition Event','D-SDTM-DS','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-DS-EPOCH','EPOCH','EPOCH may be used when DSCAT = \"DISPOSITION EVENT\". Examples: SCREENING, TREATMENT PHASE, FOLLOW-UP.','string','Epoch','D-SDTM-DS','CL-Role-T-6','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-DS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-DS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-DS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVCAT','DVCAT','Category of the protocol deviation criterion.','string','Category for Protocol Deviation','D-SDTM-DV','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVDECOD','DVDECOD','Controlled terminology for the name of the protocol deviation. Examples:\nSUBJECT NOT WITHDRAWN AS PER PROTOCOL, SELECTION CRITERIA NOT MET, EXCLUDED CONCOMITANT MEDICATION, TREATMENT DEVIATION.','string','Protocol Deviation Coded Term','D-SDTM-DV','CL-Role-T-4','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVENDTC','DVENDTC','End date/time of deviation represented in ISO 8601 character format.','dateTime','End Date/Time of Deviation','D-SDTM-DV','CL-Role-T-6','CL-Compliance-T-3',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVREFID','DVREFID','Internal or external identifier.','string','Reference ID','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVSCAT','DVSCAT','A further categorization of the protocol deviation.','string','Subcategory for Protocol Deviation','D-SDTM-DV','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVSEQ','DVSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVSPID','DVSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a CRF page.','string','Sponsor-Defined Identifier','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVSTDTC','DVSTDTC','Start date/time of deviation represented in ISO 8601 character format.','dateTime','Start Date/Time of Deviation','D-SDTM-DV','CL-Role-T-6','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-DV-DVTERM','DVTERM','Verbatim name of the protocol deviation criterion. Example: IVRS PROCESS DEVIATION - NO DOSE CALL PERFORMED. The DVTERM values will map to the controlled terminology in DVDECOD, such as TREATMENT DEVIATION.','string','Protocol Deviation Term','D-SDTM-DV','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-DV-EPOCH','EPOCH','Epoch associated with the start date/time of the deviation. Examples: TREATMENT PHASE, SCREENING, and FOLLOW-UP.','string','Epoch','D-SDTM-DV','CL-Role-T-6','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-DV-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-DV-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-DV','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-EG-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGBLFL','EGBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-2','CL-NY',24,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGCAT','EGCAT','Used to categorize ECG observations across subjects. Examples: MEASUREMENT, FINDING, INTERVAL.','string','Category for ECG','D-SDTM-EG','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGDRVFL','EGDRVFL','Used to indicate a derived record. The value should be Y or null. Records which represent the average of other records, or that do not come from the CRF, or are not as originally collected or received are examples of records that would be derived for the submission datasets. If EGDRVFL=Y, then EGORRES could be null, with EGSTRESC, and (if numeric) EGSTRESN having the derived value.','string','Derived Flag','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3','CL-NY',25,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGDTC','EGDTC','Date of ECG.','dateTime','Date/Time of ECG','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-2',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGDY','EGDY','1. Study day of the ECG, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of ECG','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGELTM','EGELTM','Planned elapsed time (in ISO 8601) relative to a fixed time point reference (EGTPTREF). Not a clock time or a date time variable. Represented as an ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by EGTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point indicated by EGTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGEVAL','EGEVAL','Role of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a person or a group). Should be null for records that contain collected or derived data. Examples: INVESTIGATOR, ADJUDICATION COMMITTEE, VENDOR.','string','Evaluator','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGGRPID','EGGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGLOC','EGLOC','The lead used for the measurement, examples, V1, V6, aVR, I, II, III.','string','Lead Location Used for Measurement','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',22,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGMETHOD','EGMETHOD','Method of the ECG test. Examples: 12 LEAD STANDARD.','string','Method of ECG Test','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3','CL-EGMETHOD',23,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGNAM','EGNAM','Name or identifier of the laboratory or vendor who provided the test results.','string','Vendor Name','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGORRES','EGORRES','Result of the ECG measurement or finding as originally received or collected. Examples of sdtm-1-3:Classifier.ExpecedVariableected values are 62 or 0.151 when the result is an interval or measurement, or \"ATRIAL FIBRILLATION\" or \"QT PROLONGATION\" when the result is a finding.','string','Result or Finding in Original Units','D-SDTM-EG','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGORRESU','EGORRESU','Original units in which the data were collected. The unit for EGORRES. Examples: sec or msec.','string','Original Units','D-SDTM-EG','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',14,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGPOS','EGPOS','Position of the subject during a measurement or examination. Examples: SUPINE, STANDING, SITTING.','string','ECG Position of Subject','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3','CL-POSITION',12,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGREASND','EGREASND','Describes why a measurement or test was not performed. Examples: BROKEN EQUIPMENT or SUBJECT REFUSED. Used in conjunction with EGSTAT when value is NOT DONE.','string','Reason ECG Not Performed','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGREFID','EGREFID','Internal or external ECG identifier. Example: UUID.','string','ECG Reference ID','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGRFTDTC','EGRFTDTC','Date/time of the reference time point, EGTPTREF.','dateTime','Date/Time of Reference Time Point','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSCAT','EGSCAT','A further categorization of the ECG.','string','Subcategory for ECG','D-SDTM-EG','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSEQ','EGSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSPID','EGSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number from the ECG page.','string','Sponsor-Defined Identifier','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSTAT','EGSTAT','Used to indicate an ECG was not done, or an ECG measurement was not taken. Should be null if a result exists in EGORRES.','string','Completion Status','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3','CL-ND',18,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSTRESC','EGSTRESC','Contains the result value for all findings, copied or derived from EGORRES in a standard format or standard units. EGSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in EGSTRESN. For example, if a test has results of \"NONE\", \"NEG\", and \"NEGATIVE\" in EGORRES and these results effectively have the same meaning, they could be represented in standard format in EGSTRESC as \"NEGATIVE\". For other examples, see general assumptions. Additional examples of result data: SINUS BRADYCARDIA, ATRIAL FLUTTER, ATRIAL FIBRILLATION.','string','Character Result/Finding in Std Format','D-SDTM-EG','CL-Role-T-8','CL-Compliance-T-2','CL-EGSTRESC',15,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSTRESN','EGSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from EGSTRESC. EGSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-EG','CL-Role-T-8','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGSTRESU','EGSTRESU','Standardized unit used for EGSTRESC or EGSTRESN.','string','Standard Units','D-SDTM-EG','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',17,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGTEST','EGTEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in EGTEST cannot be longer than 40 characters. Examples: Summary (Mean) PR Duration, Summary (Mean) QT Duration.','string','ECG Test or Examination Name','D-SDTM-EG','CL-Role-T-4','CL-Compliance-T-1','CL-EGTEST',9,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGTESTCD','EGTESTCD','Short name of the measurement, test, or examination described in EGTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in EGTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). EGTESTCD cannot contain characters other than letters, numbers, or underscores. Examples :PRMEAN, QTMEAN.','string','ECG Test or Examination Short Name','D-SDTM-EG','CL-Role-T-2','CL-Compliance-T-1','CL-EGTESTCD',8,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGTPT','EGTPT','1. Text Description of time when measurement should be taken.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See EGTPTNUM and EGTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGTPTNUM','EGTPTNUM','Numerical version of EGTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGTPTREF','EGTPTREF','Name of the fixed reference point referred to by EGELTM, EGTPTNUM, and EGTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-EG-EGXFN','EGXFN','File name and path for the external ECG Waveform file.','string','ECG External File Path','D-SDTM-EG','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-EG-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-EG-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-EG','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-EG-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-EG-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-EG-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-EG','CL-Role-T-6','CL-Compliance-T-2',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-EX-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EPOCH','EPOCH','Trial Epoch of the sdtm-1-3:Classifier.ExpecedVariableosure record. Examples: SCREENING, TREATMENT PHASE, FOLLOW-UP.','string','Epoch','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXADJ','EXADJ','Describes reason or sdtm-1-3:Classifier.ExpecedVariablelanation of why a dose is adjusted - used only when an adjustment is represented in EX.','string','Reason for Dose Adjustment','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXCAT','EXCAT','Used to define a category of related records. Example: COMPARATOR CLASS.','string','Category for Treatment','D-SDTM-EX','CL-Role-T-7','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSE','EXDOSE','Amount of EXTRT administered or given.','decimal','Dose per Administration','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSFRM','EXDOSFRM','Dose form for EXTRT. Examples: TABLET, LOTION.','string','Dose Form','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-2','CL-FRM',13,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSFRQ','EXDOSFRQ','Usually sdtm-1-3:Classifier.ExpecedVariableressed as the number of repeated administrations of EXDOSE within a specific time period. Examples: BID (twice daily), Q4S (once every four weeks), BIS (twice a week).','string','Dosing Fsdtm-1-3:Classifier.RequiredVariableuency per Interval','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-3',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSRGM','EXDOSRGM','Text description of the (intended) schedule or regimen for the Intervention. Examples: TWO WEEKS ON, TWO WEEKS OFF.','string','Intended Dose Regimen','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSTOT','EXDOSTOT','Total daily dose of EXTRT using the units in EXDOSU. Total dose over a period other than day could be recorded in a separate Supplemental Qualifier variable.','decimal','Total Daily Dose','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSTXT','EXDOSTXT','Dosing amounts or a range of dosing information collected in text form. Example: 200-400.','string','Dose Description','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDOSU','EXDOSU','Units for EXDOSE and EXDOSTOT. Examples: ng, mg, or mg/kg.','string','Dose Units','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',12,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXDUR','EXDUR','Collected duration and unit of a treatment. Used only if collected on the CRF and not derived from start and end date/times.','duration','Duration of Treatment','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXELTM','EXELTM','Planned elapsed time (in ISO 8601 format) relative to the planned fixed reference (EXTPTREF). This variable is useful where there are repetitive measures. Not a clock time. Represented as an ISO duration.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXENDTC','EXENDTC','The time when administration of the treatment indicated by EXTRT and EXDOSE ended.','dateTime','End Date/Time of Treatment','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXENDY','EXENDY','Study day of end of treatment relative to the sponsor-defined RFSTDTC.','integer','Study Day of End of Treatment','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXGRPID','EXGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXLOC','EXLOC','Specifies location of administration. Example: LEFT ARM for a topical application.','string','Location of Dose Administration','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',19,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXLOT','EXLOT','Lot Number of the EXTRT product.','string','Lot Number','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXROUTE','EXROUTE','Route of administration for EXTRT. Examples: ORAL, INTRAVENOUS.','string','Route of Administration','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-3','CL-ROUTE',17,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXSCAT','EXSCAT','A further categorization of treatment.','string','Subcategory for Treatment','D-SDTM-EX','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXSEQ','EXSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXSPID','EXSPID','Sponsor-defined identifier. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a CRF Page.','string','Sponsor-Defined Identifier','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXSTDTC','EXSTDTC','The time when administration of the treatment indicated by EXTRT and EXDOSE began.','dateTime','Start Date/Time of Treatment','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-2',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXSTDY','EXSTDY','Study day of start of treatment relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Treatment','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXTPT','EXTPT','1. Text Description of time when a dose should be given.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See EXTPTNUM and EXTPTREF. Examples: Start or 5 min post.','string','Planned Time Point Name','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXTPTNUM','EXTPTNUM','Numerical version of EXTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXTPTREF','EXTPTREF','Name of the fixed reference point referred to by EXELTM, EXTPTNUM, and EXTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXTRT','EXTRT','Name of the intervention treatment - usually the verbatim name of the investigational treatment given during the dosing period for the observation.','string','Name of Actual Treatment','D-SDTM-EX','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXTRTV','EXTRTV','Describes vehicle used for treatment. Example: SALINE.','string','Treatment Vehicle','D-SDTM-EX','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXVAMT','EXVAMT','Amount administered of the treatment vehicle indicated by EXTRTV.','decimal','Treatment Vehicle Amount','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-EX-EXVAMTU','EXVAMTU','Units of the treatment vehicle amount indicated by EXVAMT.','string','Treatment Vehicle Amount Units','D-SDTM-EX','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',22,'\0','\0','COLUMN',NULL),('V-SDTM-EX-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-EX-TAETORD','TAETORD','Number that gives the order of the Element within the Arm.','decimal','Planned Order of Element within Arm','D-SDTM-EX','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-EX-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-EX','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-FA-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FABLFL','FABLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-FA','CL-Role-T-3','CL-Compliance-T-3','CL-NY',20,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FACAT','FACAT','Used to define a category of related records. Examples: GERD, PRE-SPECIFIED AE.','string','Category for Findings About','D-SDTM-FA','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FADTC','FADTC','','dateTime','Date/Time of Collection','D-SDTM-FA','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FADY','FADY','1. Study day of collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of Collection','D-SDTM-FA','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAEVAL','FAEVAL','Role of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a person or a group). Should be null for records that contain collected or derived data. Examples: INVESTIGATOR, ADJUDICATION COMMITTEE, VENDOR.','string','Evaluator','D-SDTM-FA','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAGRPID','FAGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FALOC','FALOC','Used to specify the location of the clinical evaluation. Example: LEFT ARM.','string','Location of the Finding About','D-SDTM-FA','CL-Role-T-5','CL-Compliance-T-3','CL-LOC',19,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAOBJ','FAOBJ','Used to describe the object or focal point of the findings observation that is represented by --TEST. Examples: the term (such as Acne) describing a clinical sign or symptom that is being measured by a Severity test, or an event such as VOMIT where the volume of Vomit is being measured by a VOLUME test.','string','Object of the Observation','D-SDTM-FA','CL-Role-T-3','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAORRES','FAORRES','Result of the test as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-FA','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAORRESU','FAORRESU','Original units in which the data were collected. The unit for FAORRES.','string','Original Units','D-SDTM-FA','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FAREASND','FAREASND','Describes why a question was not answered. Example: subject refused. Used in conjunction with FASTAT when value is NOT DONE.','string','Reason Not Performed','D-SDTM-FA','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASCAT','FASCAT','A further categorization of FACAT.','string','Subcategory for Findings About','D-SDTM-FA','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASEQ','FASEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASPID','FASPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a CRF.','string','Sponsor-Defined Identifier','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASTAT','FASTAT','Used to indicate that the measurement was not done. Should be null if a result exists in FAORRES.','string','Completion Status','D-SDTM-FA','CL-Role-T-3','CL-Compliance-T-3','CL-ND',17,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASTRESC','FASTRESC','Contains the result value for all findings, copied or derived from FAORRES in a standard format or standard units. FASTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in FASTRESN. For example, if a test has results \"NONE\", \"NEG\", and \"NEGATIVE\" in FAORRES and these results effectively have the same meaning; they could be represented in standard format in FASTRESC as \"NEGATIVE\".','string','Character Result/Finding in Std Format','D-SDTM-FA','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASTRESN','FASTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from FASTRESC. FASTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-FA','CL-Role-T-8','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FASTRESU','FASTRESU','Standardized unit used for FASTRESC and FASTRESN.','string','Standard Units','D-SDTM-FA','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FATEST','FATEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in FATEST cannot be longer than 40 characters. Examples: Severity/Intensity, Occurrence.','string','Findings About Test Name','D-SDTM-FA','CL-Role-T-4','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-FA-FATESTCD','FATESTCD','Short name of the measurement, test, or examination described in FATEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in FATESTCD cannot be longer than 8 characters, nor can it start with a number (e.g. \"1TEST\"). FATESTCD cannot contain characters other than letters, numbers, or underscores. Example: SEV, OCCUR.','string','Findings About Test Short Name','D-SDTM-FA','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-FA-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-FA-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-FA','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-FA-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-FA','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-FA-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-FA','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-FA-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-FA','CL-Role-T-6','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-IE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-IE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IECAT','IECAT','Used to define a category of related records across subjects.','string','Inclusion/Exclusion Category','D-SDTM-IE','CL-Role-T-7','CL-Compliance-T-1','CL-IECAT',8,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IEDTC','IEDTC','','dateTime','Date/Time of Collection','D-SDTM-IE','CL-Role-T-6','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IEDY','IEDY','1. Study day of collection of the inclusion/exclusion exceptions, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of Collection','D-SDTM-IE','CL-Role-T-6','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IEORRES','IEORRES','Original response to Inclusion/Exclusion Criterion question. Inclusion or Exclusion criterion met?','string','I/E Criterion Original Result','D-SDTM-IE','CL-Role-T-8','CL-Compliance-T-1','CL-NY',10,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IESCAT','IESCAT','A further categorization of the exception criterion. Can be used to distinguish criteria for a sub-study or for to categorize as a major or minor exceptions. Examples: MAJOR, MINOR.','string','Inclusion/Exclusion Subcategory','D-SDTM-IE','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IESEQ','IESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-IE','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IESPID','IESPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Inclusion or Exclusion criteria number from CRF.','string','Sponsor-Defined Identifier','D-SDTM-IE','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IESTRESC','IESTRESC','Response to Inclusion/Exclusion criterion result in standard format.','string','I/E Criterion Result in Std Format','D-SDTM-IE','CL-Role-T-8','CL-Compliance-T-1','CL-NY',11,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IETEST','IETEST','Verbatim description of the inclusion or exclusion criterion that was the exception for the subject within the study. IETEST cannot be longer than 200 characters.','string','Inclusion/Exclusion Criterion','D-SDTM-IE','CL-Role-T-4','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-IE-IETESTCD','IETESTCD','Short name of the criterion described in IETEST. The value in IETESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.”1TEST”). IETESTCD cannot contain characters other than letters, numbers, or underscores. Examples: IN01, EX01.','string','Inclusion/Exclusion Criterion Short Name','D-SDTM-IE','CL-Role-T-2','CL-Compliance-T-1',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-IE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-IE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-IE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-IE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-IE-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-IE','CL-Role-T-6','CL-Compliance-T-3',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-IE-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-IE','CL-Role-T-6','CL-Compliance-T-3',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-IE-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-IE','CL-Role-T-6','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-LB-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBBLFL','LBBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-2','CL-NY',30,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBCAT','LBCAT','Used to define a category of related records across subjects. Examples: such as HEMATOLOGY, URINALYSIS, CHEMISTRY.','string','Category for Lab Test','D-SDTM-LB','CL-Role-T-7','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBDRVFL','LBDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records, or do not come from the CRF, or are not as originally received or collected are examples of records that might be derived for the submission datasets. If LBDRVFL=Y, then LBORRES may be null, with LBSTRESC, and (if numeric) LBSTRESN having the derived value.','string','Derived Flag','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3','CL-NY',32,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBDTC','LBDTC','','dateTime','Date/Time of Specimen Collection','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-2',NULL,38,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBDY','LBDY','1. Study day of specimen collection, measured as integer days. \n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of Specimen Collection','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,40,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBELTM','LBELTM','Planned Elapsed time (in ISO 8601) relative to a planned fixed reference (LBTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable. Represented as an ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by LBTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point indicated by LBTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,43,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBENDTC','LBENDTC','','dateTime','End Date/Time of Specimen Collection','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,39,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBFAST','LBFAST','Indicator used to identify fasting status such as Y, N, U, or null if not relevant.','string','Fasting Status','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3','CL-NY',31,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBGRPID','LBGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBLOINC','LBLOINC','1. Dictionary-derived LOINC Code for LBTEST.\n2. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','LOINC Code','D-SDTM-LB','CL-Role-T-4','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBMETHOD','LBMETHOD','Method of the test or examination. Examples: EIA (Enzyme Immunoassay), ELECTROPHORESIS, DIPSTICK.','string','Method of Test or Examination','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBNAM','LBNAM','The name or identifier of the laboratory that performed the test.','string','Vendor Name','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBNRIND','LBNRIND','1. Indicates where the value falls with respect to reference range defined by LBORNRLO and LBORNRHI, LBSTNRLO and LBSTNRHI, or by LBSTNRC. Examples: NORMAL, ABNORMAL, HIGH, LOW.\n2. Sponsors should specify in the study metadata (Comments column in the define.xml) whether LBNRIND refers to the original or standard reference ranges and results.\n3. Should not be used to indicate clinical significance.','string','Reference Range Indicator','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBORNRHI','LBORNRHI','Upper end of reference range for continuous measurements in original units. Should be populated only for continuous results.','string','Reference Range Upper Limit in Orig Unit','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBORNRLO','LBORNRLO','Lower end of reference range for continuous measurements in original units. Should be populated only for continuous results.','string','Reference Range Lower Limit in Orig Unit','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBORRES','LBORRES','Result of the measurement or finding as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-LB','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBORRESU','LBORRESU','Original units in which the data were collected. The unit for LBORRES. Example: g/L.','string','Original Units','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBREASND','LBREASND','Describes why a measurement or test was not performed such as BROKEN EQUIPMENT, SUBJECT REFUSED, or SPECIMEN LOST. Used in conjunction with LBSTAT when value is NOT DONE.','string','Reason Test Not Done','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBREFID','LBREFID','Internal or external specimen identifier. Example: Specimen ID.','string','Specimen ID','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBRFTDTC','LBRFTDTC','Date/time of the reference time point, LBTPTREF.','dateTime','Date/Time of Reference Time Point','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,45,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSCAT','LBSCAT','A further categorization of a test category such as DIFFERENTIAL, COAGULATON, LIVER FUNCTION, ELECTROLYTES.','string','Subcategory for Lab Test','D-SDTM-LB','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSEQ','LBSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSPCCND','LBSPCCND','Free or standardized text describing the condition of the specimen e.g. HEMOLYZED, ICTERIC, LIPEMIC etc.','string','Specimen Condition','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSPEC','LBSPEC','Defines the type of specimen used for a measurement. Examples: SERUM, PLASMA, URINE.','string','Specimen Type','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSPID','LBSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on the Lab page.','string','Sponsor-Defined Identifier','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTAT','LBSTAT','Used to indicate exam not done. Should be null if a result exists in LBORRES.','string','Completion Status','D-SDTM-LB','CL-Role-T-3','CL-Compliance-T-3','CL-ND',23,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTNRC','LBSTNRC','For normal range values that are character in ordinal scale or if categorical ranges were supplied (e.g., \"-1 to +1\", \"NEGATIVE TO TRACE\").','string','Reference Range for Char Rslt-Std Units','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTNRHI','LBSTNRHI','Upper end of reference range for continuous measurements in standardized units. Should be populated only for continuous results.','decimal','Reference Range Upper Limit-Std Units','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTNRLO','LBSTNRLO','Lower end of reference range for continuous measurements for LBSTRESC/LBSTRESN in standardized units. Should be populated only for continuous results.','decimal','Reference Range Lower Limit-Std Units','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTRESC','LBSTRESC','Contains the result value for all findings, copied or derived from LBORRES in a standard format or standard units. LBSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in LBSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \"NEGATIVE\" in LBORRES and these results effectively have the same meaning, they could be represented in standard format in LBSTRESC as \"NEGATIVE\". For other examples, see general assumptions.','string','Character Result/Finding in Std Format','D-SDTM-LB','CL-Role-T-8','CL-Compliance-T-2',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTRESN','LBSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from LBSTRESC. LBSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-LB','CL-Role-T-8','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBSTRESU','LBSTRESU','Standardized unit used for LBSTRESC or LBSTRESN.','string','Standard Units','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',18,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTEST','LBTEST','Verbatim name of the test or examination used to obtain the measurement or finding. Note any test normally performed by a clinical laboratory is considered a lab test. The value in LBTEST cannot be longer than 40 characters. Examples: Alanine Aminotransferase, Lactate Dehydrogenase.','string','Lab Test or Examination Name','D-SDTM-LB','CL-Role-T-4','CL-Compliance-T-1','CL-LBTEST',9,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTESTCD','LBTESTCD','Short name of the measurement, test, or examination described in LBTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in LBTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). LBTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: ALT, LDH.','string','Lab Test or Examination Short Name','D-SDTM-LB','CL-Role-T-2','CL-Compliance-T-1','CL-LBTESTCD',8,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTOX','LBTOX','Description of toxicity quantified by LBTOXGR. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the name of the scale and version used to map the terms, utilizing the define.xml external codelist attributes.','string','Toxicity','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTOXGR','LBTOXGR','Records toxicity grade value using a standard toxicity scale (such as the NCI CTCAE). If value is from a numeric scale, represent only the number (e.g., \"2\" and not \"Grade 2\"). The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the name of the scale and version used to map the terms, utilizing the define.xml external codelist attributes.','string','Standard Toxicity Grade','D-SDTM-LB','CL-Role-T-5','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTPT','LBTPT','1. Text Description of time when specimen should be taken.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See LBTPTNUM and LBTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,41,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTPTNUM','LBTPTNUM','Numerical version of LBTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,42,'\0','\0','COLUMN',NULL),('V-SDTM-LB-LBTPTREF','LBTPTREF','Name of the fixed reference point referred to by LBELTM, LBTPTNUM, and LBTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,44,'\0','\0','COLUMN',NULL),('V-SDTM-LB-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-LB-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-LB','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-LB-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-LB-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-3',NULL,37,'\0','\0','COLUMN',NULL),('V-SDTM-LB-VISITNUM','VISITNUM','1. Clinical encounter number. \n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-LB','CL-Role-T-6','CL-Compliance-T-2',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-MB-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBBLFL','MBBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3','CL-NY',26,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBCAT','MBCAT','Used to define a category of related records.','string','Category for Microbiology Finding','D-SDTM-MB','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBDRVFL','MBDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records or some other derivation, and those that do not come from the CRF, are examples of records that would be derived for the submission datasets. If MBDRVFL=Y, then MBORRES may be null with MBSTRESC and (if numeric) MBSTRESN having the derived value.','string','Derived Flag','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3','CL-NY',27,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBDTC','MBDTC','','dateTime','Date/Time of Specimen Collection','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-2',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBDY','MBDY','1. Study day of the specimen collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of MB Specimen Collection','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBELTM','MBELTM','Planned elapsed time (in ISO 8601) relative to a planned fixed reference (MBTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable. Represented as an ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by MBTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point indicated by MBTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBGRPID','MBGRPID','Used to tie together a block of related records in a single domain to support relationships within the domain and between domains. In MB, used to link to findings about organisms which are stored in MS.','string','Group ID','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-2',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBLOC','MBLOC','Location relevant to the collection of the measurement. Examples: LUNG, VEIN, LEFT KNEE WOUND, ARM ULCER 1, RIGHT THIGH LATERAL.','string','Specimen Collection Location','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',24,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBLOINC','MBLOINC','1. Dictionary-derived LOINC Code for MBTEST.\n2. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','LOINC Code','D-SDTM-MB','CL-Role-T-4','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBMETHOD','MBMETHOD','Method of the test or examination. Examples: GRAM STAIN, CULTURE PLATE, BROTH.','string','Method of Test or Examination','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBNAM','MBNAM','Name or identifier of the laboratory or vendor who provides the test results.','string','Vendor Name','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBORRES','MBORRES','Result of the Microbiology measurement or finding as originally received or collected. Examples for GRAM STAIN findings: +3 MODERATE, +2 FEW, <10. Examples for CULTURE PLATE (ORGANISM) findings: KLEBSIELLA PNEUMONIAE, STREPTOCOCCUS PNEUMONIAE PENICILLIN RESISTANT.','string','Result or Finding in Original Units','D-SDTM-MB','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBORRESU','MBORRESU','Original unit for MBORRES. Example: mcg/mL.','string','Original Units','D-SDTM-MB','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBREASND','MBREASND','Reason not done. Used in conjunction with MBSTAT when value is NOT DONE. Examples: BROKEN EQUIPMENT or SUBJECT REFUSED.','string','Reason Microbiology Not Performed','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBREFID','MBREFID','Internal or external specimen identifier. Example: Specimen ID.','string','Reference ID','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBRESCAT','MBRESCAT','Used to categorize the result of a finding in a standard format. Example for ORGANISM finding: INFECTING, COLONIZER, CONTAMINANT, or NORMAL FLORA.','string','Result Category','D-SDTM-MB','CL-Role-T-5','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBRFTDTC','MBRFTDTC','Date/time of the reference time point, MBTPTREF.','dateTime','Date/Time of Reference Time Point','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,37,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSCAT','MBSCAT','Used to define a further categorization of MBCAT.','string','Subcategory for Microbiology Finding','D-SDTM-MB','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSEQ','MBSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSPCCND','MBSPCCND','Free or standardized text describing the condition of the specimen. Example: CONTAMINATED.','string','Specimen Condition','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSPEC','MBSPEC','Defines the type of specimen used for a measurement. Examples: SPUTUM, BLOOD, PUS.','string','Specimen Type','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSPID','MBSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: ORGANISM IDENTIFIER. For organism identification, MBSPID would remain the same each time the same organism is identified in a new specimen.','string','Sponsor-Defined Identifier','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSTAT','MBSTAT','Used to indicate Microbiology was not done, or a test was not done. Should be null or have a value of NOT DONE.','string','Completion Status','D-SDTM-MB','CL-Role-T-3','CL-Compliance-T-3','CL-ND',18,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSTRESC','MBSTRESC','Contains the result value for all findings, copied or derived from MBORRES in a standard format or standard units. MBSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in MBSTRESN. For example, if a test has results \"+3 MODERATE\", \"MOD\", and \"MODERATE\" in MBORRES and these results effectively have the same meaning, they could be represented in standard format in MBSTRESC as \"MODERATE\".','string','Character Result/Finding in Std Format','D-SDTM-MB','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSTRESN','MBSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from MBSTRESC. MBSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-MB','CL-Role-T-8','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBSTRESU','MBSTRESU','Standardized unit used for MBSTRESC and MBSTRESN.','string','Standard Units','D-SDTM-MB','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBTEST','MBTEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in MBTEST cannot be longer than 40 characters. Examples: GRAM NEGATIVE RODS, GRAM NEGATIVE COCCI, SQUAMOUS EPITHELIAL CELLS, PMN PER FIELD LOW, ORGANISM PRESENT.','string','Microbiology Test or Finding Name','D-SDTM-MB','CL-Role-T-4','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBTESTCD','MBTESTCD','Short name of the measurement, test, or finding described in MBTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in MBTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). MBTESTCD cannot contain characters other than letters, numbers, or underscores. Examples for GRAM STAIN findings: GMNROD, GMNCOC, GMSQEPCE, GMPMNLOW. Examples for CULTURE PLATE findings: ORGANISM.','string','Microbiology Test or Finding Short Name','D-SDTM-MB','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBTPT','MBTPT','1. Text Description of time when specimen should be taken.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See MBTPTNUM and MBTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBTPTNUM','MBTPTNUM','Numerical version of MBTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-MB-MBTPTREF','MBTPTREF','Name of the fixed reference point referred to by MBELTM, MBTPTNUM, and MBTPT. Example: PREVIOUS DOSE.','string','Time Point Reference','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-MB-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-MB-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-MB','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-MB-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-MB-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-MB-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-MB','CL-Role-T-6','CL-Compliance-T-2',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-MH-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHBODSYS','MHBODSYS','Dictionary-derived. Body system or organ class that is involved in an event or measurement from a standard hierarchy (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for the sponsor\'s analyses and summary tables which may not necessarily be the primary SOC.','string','Body System or Organ Class','D-SDTM-MH','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHCAT','MHCAT','Used to define a category of related records. Examples: CARDIAC or GENERAL.','string','Category for Medical History','D-SDTM-MH','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHDECOD','MHDECOD','Dictionary-derived text description of MHTERM or MHMODIFY. Equivalent to the Preferred Term (PT in MedDRA). The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','Dictionary-Derived Term','D-SDTM-MH','CL-Role-T-4','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHDTC','MHDTC','','dateTime','Date/Time of History Collection','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHDY','MHDY','1. Study day of medical history collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of History Collection','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHENDTC','MHENDTC','','dateTime','End Date/Time of Medical History Event','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHENRF','MHENRF','Describes the end of the event relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics).','string','End Relative to Reference Period','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',22,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHENRTPT','MHENRTPT','Identifies the end of the event as being before or after the reference time point defined by variable MHENTPT.','string','End Relative to Reference Time Point','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHENTPT','MHENTPT','Description or date/time in ISO 8601 character format of the reference point referred to by MHENRTPT. Examples: \"2003-12-25\" or \"VISIT 2\".','string','End Reference Time Point','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHGRPID','MHGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHMODIFY','MHMODIFY','If MHTERM is modified to facilitate coding, then MHMODIFY will contain the modified text.','string','Modified Reported Term','D-SDTM-MH','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHOCCUR','MHOCCUR','Used when the occurrence of specific medical history conditions is solicited to indicate whether or not (Y/N) a medical condition (MHTERM) had ever occurred. Values are null for spontaneously reported events.','string','Medical History Occurrence','D-SDTM-MH','CL-Role-T-3','CL-Compliance-T-3','CL-NY',14,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHPRESP','MHPRESP','A value of \"Y\" indicates that this medical history event was pre-specified on the CRF. Values are null for spontaneously reported events (i.e., those collected as free-text verbatim terms).','string','Medical History Event Pre-Specified','D-SDTM-MH','CL-Role-T-3','CL-Compliance-T-3','CL-NY',13,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHREASND','MHREASND','Describes the reason data for a pre-specified condition was not collected. Used in conjunction with MHSTAT when value is NOT DONE.','string','Reason Medical History Not Collected','D-SDTM-MH','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHREFID','MHREFID','Internal or external medical history identifier.','string','Reference ID','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHSCAT','MHSCAT','A further categorization of the condition or event.','string','Subcategory for Medical History','D-SDTM-MH','CL-Role-T-7','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHSEQ','MHSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHSPID','MHSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a Medical History page.','string','Sponsor-Defined Identifier','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHSTAT','MHSTAT','The status indicates that the pre-specified question was not answered.','string','Completion Status','D-SDTM-MH','CL-Role-T-3','CL-Compliance-T-3','CL-ND',15,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHSTDTC','MHSTDTC','','dateTime','Start Date/Time of Medical History Event','D-SDTM-MH','CL-Role-T-6','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-MH-MHTERM','MHTERM','Verbatim or preprinted CRF term for the medical condition or event.','string','Reported Term for the Medical History','D-SDTM-MH','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-MH-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-MH-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-MH','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-MS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSBLFL','MSBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-3','CL-NY',23,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSCAT','MSCAT','Used to define a category of related records. Examples: GROWTH, SUSCEPTIBILITY.','string','Category for Organism Findings','D-SDTM-MS','CL-Role-T-7','CL-Compliance-T-1',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSDRVFL','MSDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records or some other derivation, and those that do not come from the CRF, are examples of records that would be derived for the submission datasets. If MSDRVFL=Y, then MSORRES may be null, with MSSTRESC and (if numeric) MSSTRESN having the derived value.','string','Derived Flag','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-3','CL-NY',24,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSDTC','MSDTC','','dateTime','Date/Time of Test','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSDY','MSDY','1. Study day of the test, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission.','integer','Study Day of Test','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSELTM','MSELTM','Elapsed time (in ISO 8601) relative to a planned fixed reference (MSTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by MSTPTREF, or \"P8H\" to represent the period of 8 hours after the reference point indicated by MSTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSGRPID','MSGRPID','Used to tie together a block of related records in a single domain to support relationships within the domain and between domains. In MS, used to link to organism in MB.','string','Group ID','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSLOINC','MSLOINC','1. Dictionary-derived LOINC Code for MSTEST.\n2. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','LOINC Code','D-SDTM-MS','CL-Role-T-4','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSMETHOD','MSMETHOD','Method of the test or examination. Example for SUSCEPTIBILITY: ETEST, BROTH DILUTION.','string','Method of Test or Examination','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSNAM','MSNAM','Name or identifier of the laboratory or vendor that provided the test results.','string','Vendor Name','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSORRES','MSORRES','Result of the Microbiology Organism measurement or finding as originally received or collected. Examples for GROWTH findings: GROWTH INTO 3RD QUADRANT. Examples for SUSCEPTIBLITY findings:.0080,.0023.','string','Result or Finding in Original Units','D-SDTM-MS','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSORRESU','MSORRESU','Original units in which the data were collected. The unit for MSORRES. Example: mcg/mL.','string','Original Units','D-SDTM-MS','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSREASND','MSREASND','Reason not done. Describes why a measurement or test was not performed. Used in conjunction with MSSTAT when value is NOT DONE. Example: SAMPLE LOST.','string','Reason Test Not Done','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSREFID','MSREFID','Internal or external specimen identifier. Example: Specimen ID.','string','Reference ID','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSRESCAT','MSRESCAT','Used to categorize the result of a finding in a standard format. Example for SUSCEPTIBILITY finding: SUSCEPTIBLE, INTERMEDIATE, RESISTANT, or UNKNOWN.','string','Result Category','D-SDTM-MS','CL-Role-T-5','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSCAT','MSSCAT','A further categorization of a test category. Examples: CULTURE, ISOLATE.','string','Subcategory for Organism Findings','D-SDTM-MS','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSEQ','MSSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSPID','MSSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database.','string','Sponsor-Defined Identifier','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSTAT','MSSTAT','Used to indicate a test on an organism was not done, or a test was not performed. Should be null if a result exists in MSORRES or have a value of NOT DONE.','string','Completion Status','D-SDTM-MS','CL-Role-T-3','CL-Compliance-T-3','CL-ND',18,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSTRESC','MSSTRESC','Contains the result value for all findings, copied or derived from MSORRES in a standard format or standard units. MSSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in MSSTRESN. For example, if a test has results \"+3 MODERATE\", \"MOD\", and \"MODERATE\", and in MSORRES and these results effectively have the same meaning, they could be represented in standard format in MSSTRESC as \"MODERATE\".','string','Character Result/Finding in Std Format','D-SDTM-MS','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSTRESN','MSSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from MSSTRESC. MSSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-MS','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSSTRESU','MSSTRESU','Standardized unit used for MSSTRESC and MSSTRESN.','string','Standard Units','D-SDTM-MS','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSTEST','MSTEST','Verbatim name of the test or examination used to obtain the measurement or finding. Examples for GROWTH findings: Extent of Growth, Colony Count. Examples for SUSCEPTIBILITY findings: Amoxicillin Susceptibility, Penicillin Susceptibility.','string','Organism Test or Finding Name','D-SDTM-MS','CL-Role-T-4','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSTESTCD','MSTESTCD','Short name of the measurement, test, or finding described in MSTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in MSTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). MSTESTCD cannot contain characters other than letters, numbers, or underscores. Examples for GROWTH findings: EXTGROW, COLCOUNT. For SUSCEPTIBILITY findings, the test is the drug the organism was tested with, i.e. PENICLLN, AMOXCLLN.','string','Microbiology Organism Finding Short Name','D-SDTM-MS','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSTPT','MSTPT','1. Text Description of time when test should be done. \n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See MSTPTNUM and MSTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSTPTNUM','MSTPTNUM','Numerical version of MSTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-MS-MSTPTREF','MSTPTREF','Name of the fixed reference point referred to by MSELTM, MSTPTNUM, and MSTPT. Example: PREVIOUS DOSE.','string','Time Point Reference','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-MS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-MS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-MS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-MS-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-MS-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-MS-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-MS','CL-Role-T-6','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-PC-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCCAT','PCCAT','Used to define a category of related records. Examples: ANALYTE, SPECIMEN PROPERTY.','decimal','Test Category','D-SDTM-PC','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCDRVFL','PCDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records, which do not come from the CRF, are examples of records that would be derived for the submission datasets. If PCDRVFL=Y, then PCORRES should be null with PCSTRESC, and (if numeric) PCSTRESN having the derived value.','string','Derived Flag','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3','CL-NY',24,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCDTC','PCDTC','Date/time of specimen collection represented in ISO 8601 character format. If there is no end time, then this will be the collection time.','dateTime','Date/Time of Specimen Collection','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-2',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCDY','PCDY','1. Study day of specimen collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Actual Study Day of Specimen Collection','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCELTM','PCELTM','Planned elapsed time (in ISO 8601) relative to a planned fixed reference (PCTPTREF) such as \"PREVIOUS DOSE\" or \"PREVIOUS MEAL\". This variable is useful where there are repetitive measures. Not a clock time or a date time variable.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCENDTC','PCENDTC','End date/time of specimen collection represented in ISO 8601 character format. If there is no end time, the collection time should be stored in PCDTC, and PCENDTC should be null.','dateTime','End Date/Time of Specimen Collection','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCEVLINT','PCEVLINT','Evaluation Interval associated with a PCTEST record represented in ISO 8601 character format. Example: \"-P2H\" to represent an interval of 2 hours prior to a PCTPT.','duration','Evaluation Interval','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,37,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCFAST','PCFAST','Indicator used to identify fasting status.','string','Fasting Status','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3','CL-NY',23,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCGRPID','PCGRPID','Used to tie together a block of related records in a single domain to support relationships within the domain and between domains.','string','Group ID','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCLLOQ','PCLLOQ','Indicates the lower limit of quantitation for an assay. Units should be those used in PCSTRESU.','decimal','Lower Limit of Quantitation','D-SDTM-PC','CL-Role-T-5','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCMETHOD','PCMETHOD','Method of the test or examination. Examples include HPLC/MS, ELISA. This should contain sufficient information and granularity to allow differentiation of various methods that might have been used within a study.','string','Method of Test or Examination','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCNAM','PCNAM','Name or identifier of the laboratory or vendor who provides the test results.','string','Vendor Name','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCORRES','PCORRES','Result of the measurement or finding as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-PC','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCORRESU','PCORRESU','Original units in which the data were collected. The unit for PCORRES. Example: mg/L.','string','Original Units','D-SDTM-PC','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCREASND','PCREASND','Describes why a result was not obtained such as SPECIMEN LOST. Used in conjunction with PCSTAT when value is NOT DONE.','string','Reason Test Not Done','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCREFID','PCREFID','Internal or external specimen identifier. Example: Specimen ID.','string','Reference ID','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCRFTDTC','PCRFTDTC','Date/time of the reference time point described by PCTPTREF.','dateTime','Date/Time of Reference Point','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSCAT','PCSCAT','A further categorization of a test category.','decimal','Test Subcategory','D-SDTM-PC','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSEQ','PCSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSPCCND','PCSPCCND','Free or standardized text describing the condition of the specimen e.g. HEMOLYZED, ICTERIC, LIPEMIC etc.','string','Specimen Condition','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSPEC','PCSPEC','Defines the type of specimen used for a measurement. Examples: SERUM, PLASMA, URINE.','string','Specimen Material Type','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-1',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSPID','PCSPID','Sponsor-defined reference number.','string','Sponsor-Defined Identifier','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSTAT','PCSTAT','Used to indicate a result was not obtained. Should be null if a result exists in PCORRES.','string','Completion Status','D-SDTM-PC','CL-Role-T-3','CL-Compliance-T-3','CL-ND',17,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSTRESC','PCSTRESC','Contains the result value for all findings, copied or derived from PCORRES in a standard format or standard units. PCSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in PCSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \"NEGATIVE\" in PCORRES and these results effectively have the same meaning, they could be represented in standard format in PCSTRESC as \"NEGATIVE\". For other examples, see general assumptions.','string','Character Result/Finding in Std Format','D-SDTM-PC','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSTRESN','PCSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from PCSTRESC. PCSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-PC','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCSTRESU','PCSTRESU','Standardized unit used for PCSTRESC and PCSTRESN.','string','Standard Units','D-SDTM-PC','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCTEST','PCTEST','Name of the analyte or specimen characteristic. Note any test normally performed by a clinical laboratory is considered a lab test. The value in PCTEST cannot be longer than 40 characters. Examples: Acetylsalicylic Acid, Volume, Specific Gravity.','decimal','Pharmacokinetic Test Name','D-SDTM-PC','CL-Role-T-4','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCTESTCD','PCTESTCD','Short name of the analyte or specimen characteristic. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in PCTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). PCTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: ASA, VOL, SPG.','decimal','Pharmacokinetic Test Short Name','D-SDTM-PC','CL-Role-T-2','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCTPT','PCTPT','1. Text Description of time when specimen should be taken.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See PCTPTNUM and PCTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCTPTNUM','PCTPTNUM','Numerical version of PCTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-PC-PCTPTREF','PCTPTREF','Name of the fixed reference point used as a basis for PCTPT, PCTPTNUM, and PCELTM. Example: Most Recent Dose.','string','Time Point Reference','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-PC-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-PC-USUBJID','USUBJID','Unique subject identifier within the submission.','string','Unique Subject Identifier','D-SDTM-PC','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-PC-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-PC-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-PC-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-PC','CL-Role-T-6','CL-Compliance-T-2',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-PE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEBODSYS','PEBODSYS','Body system or organ class ( MedDRA SOC) that is involved in a measurement from the standard hierarchy (e.g., MedDRA).','string','Body System or Organ Class','D-SDTM-PE','CL-Role-T-8','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PECAT','PECAT','Used to define a category of examination. Examples: GENERAL, NEUROLOGICAL.','string','Category for Examination','D-SDTM-PE','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEDTC','PEDTC','','dateTime','Date/Time of Examination','D-SDTM-PE','CL-Role-T-6','CL-Compliance-T-2',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEDY','PEDY','1. Study day of physical exam, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Examination','D-SDTM-PE','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEEVAL','PEEVAL','Role of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a person or a group). Should be null for records that contain collected or derived data. Examples: INVESTIGATOR, ADJUDICATION COMMITTEE, VENDOR.','string','Evaluator','D-SDTM-PE','CL-Role-T-3','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEGRPID','PEGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PELOC','PELOC','Can be used to specify where a physical exam finding occurred. Example: LEFT ARM for skin rash.','string','Location of Physical Exam Finding','D-SDTM-PE','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',18,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEMETHOD','PEMETHOD','Method of the test or examination. Examples: XRAY, MRI.','string','Method of Test or Examination','D-SDTM-PE','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEMODIFY','PEMODIFY','If PEORRES is modified as part of a defined procedure, then PEMODIFY will contain the modified text.','string','Modified Reported Term','D-SDTM-PE','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEORRES','PEORRES','Text description of any abnormal findings. If the examination was completed and there were no abnormal findings, the value should be NORMAL. If the examination was not performed on a particular body system, or at the subject level, then the value should be null, and NOT DONE should appear in PESTAT.','string','Verbatim Examination Finding','D-SDTM-PE','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEORRESU','PEORRESU','Original units in which the data were collected. The unit for PEORRES.','string','Original Units','D-SDTM-PE','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',14,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PEREASND','PEREASND','Describes why an examination was not performed or why a body system was not examined. Example: SUBJECT REFUSED. Used in conjunction with STAT when value is NOT DONE.','string','Reason Not Examined','D-SDTM-PE','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PESCAT','PESCAT','A further categorization of the examination. Used if needed to add further detail to PECAT.','string','Subcategory for Examination','D-SDTM-PE','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PESEQ','PESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PESPID','PESPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a CRF.','string','Sponsor-Defined Identifier','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PESTAT','PESTAT','Used to indicate exam not done. Should be null if a result exists in PEORRES.','string','Completion Status','D-SDTM-PE','CL-Role-T-3','CL-Compliance-T-3','CL-ND',16,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PESTRESC','PESTRESC','If there are findings for a body system, then either the dictionary preferred term (if findings are coded using a dictionary) or PEORRES (if findings are not coded) should appear here. If PEORRES is null, PESTRESC should be null.','string','Character Result/Finding in Std Format','D-SDTM-PE','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PETEST','PETEST','Verbatim term part of the body examined. The value in PETEST cannot be longer than 40 characters. Examples: Cardiovascular and Respiratory. For subject-level exam, value should be \"Physical Examination\".','string','Body System Examined','D-SDTM-PE','CL-Role-T-4','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-PE-PETESTCD','PETESTCD','Short name of the measurement, test, or examination described in PETEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in PETESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). PETESTCD cannot contain characters other than letters, numbers, or underscores.','string','Body System Examined Short Name','D-SDTM-PE','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-PE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-PE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-PE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-PE-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-PE','CL-Role-T-6','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-PE-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-PE','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-PE-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-PE','CL-Role-T-6','CL-Compliance-T-2',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-PP-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-PP','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPCAT','PPCAT','Used to define a category of related records. For PP, this should be the name of the analyte in PCTEST whose profile the parameter is associated with.','decimal','Parameter Category','D-SDTM-PP','CL-Role-T-7','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPDTC','PPDTC','Nominal date/time of parameter calculations.','dateTime','Date/Time of Parameter Calculations','D-SDTM-PP','CL-Role-T-6','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPGRPID','PPGRPID','Used to tie together a block of related records in a single domain to support relationships within the domain and between domains.','string','Group ID','D-SDTM-PP','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPORRES','PPORRES','Result of the measurement or finding as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-PP','CL-Role-T-8','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPORRESU','PPORRESU','Original units in which the data were collected. The unit for PPORRES. Example: ng/L.','string','Original Units','D-SDTM-PP','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',11,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPREASND','PPREASND','Describes why a parameter was not calculated, such as INSUFFICIENT DATA. Used in conjunction with PPSTAT when value is NOT DONE.','string','Reason Parameter Not Calculated','D-SDTM-PP','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPRFTDTC','PPRFTDTC','Date/time of the reference time point from the PC records used to calculate a parameter record. The values in PPRFTDTC should be the same as that in PCRFTDTC for related records.','dateTime','Date/Time of Reference Point','D-SDTM-PP','CL-Role-T-6','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSCAT','PPSCAT','Categorization of the model type used to calculate the PK parameters. Examples include COMPARTMENTAL, NON-COMPARTMENTAL.','decimal','Parameter Subcategory','D-SDTM-PP','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSEQ','PPSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-PP','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSPEC','PPSPEC','Defines the type of specimen used for a measurement. If multiple specimen types are used for a calculation (e.g., serum and urine for renal clearance), then this field should be left blank. Examples: SERUM, PLASMA, URINE.','string','Specimen Material Type','D-SDTM-PP','CL-Role-T-3','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSTAT','PPSTAT','Used to indicate that a parameter was not calculated. Should be null if a result exists in PPORRES.','string','Completion Status','D-SDTM-PP','CL-Role-T-3','CL-Compliance-T-3','CL-ND',15,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSTRESC','PPSTRESC','Contains the result value for all findings, copied or derived from PPORRES in a standard format or standard units. PPSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in PPSTRESN.','string','Character Result/Finding in Std Format','D-SDTM-PP','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSTRESN','PPSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from PPSTRESC. PPSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-PP','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPSTRESU','PPSTRESU','Standardized unit used for PPSTRESC and PPSTRESN.','string','Standard Units','D-SDTM-PP','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',14,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPTEST','PPTEST','Name of the pharmacokinetic parameter. The value in PPTEST cannot be longer than 40 characters. Examples: AUC, Tmax, Cmax.','decimal','Parameter Name','D-SDTM-PP','CL-Role-T-4','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-PP-PPTESTCD','PPTESTCD','Short name of the pharmacokinetic parameter. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in PPTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). PPTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: AUC, TMAX, CMAX.','decimal','Parameter Short Name','D-SDTM-PP','CL-Role-T-2','CL-Compliance-T-1',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-PP-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-PP','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-PP-USUBJID','USUBJID','Unique subject identifier within the submission.','string','Unique Subject Identifier','D-SDTM-PP','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-QS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSBLFL','QSBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-QS','CL-Role-T-3','CL-Compliance-T-2','CL-NY',18,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSCAT','QSCAT','Used to define a category of related records that will be meaningful to the Reviewer. Examples: HAMILTON DEPRESSION SCALE, SF36, ADAS.','string','Category of Question','D-SDTM-QS','CL-Role-T-7','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSDRVFL','QSDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records or questionnaire sub-scores that do not come from the CRF are examples of records that would be derived for the submission datasets. If QSDRVFL=Y, then QSORRES may be null with QSSTRESC and (if numeric) QSSTRESN having the derived value.','string','Derived Flag','D-SDTM-QS','CL-Role-T-3','CL-Compliance-T-3','CL-NY',19,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSDTC','QSDTC','Date of questionnaire.','dateTime','Date/Time of Finding','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-2',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSDY','QSDY','1. Study day of finding collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Finding','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSELTM','QSELTM','Planned Elapsed time (in ISO 8601) relative to a planned fixed reference (QSTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable. Represented as an ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by QSTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point indicated by QSTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSEVLINT','QSEVLINT','Evaluation Interval associated with a QSTEST question represented in ISO 8601 character format. Example: \"-P2Y\" to represent an interval of 2 years in the question \"Have you sdtm-1-3:Classifier.ExpecedVariableerienced any episodes in the past 2 years?\"','duration','Evaluation Interval','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSGRPID','QSGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSORRES','QSORRES','Finding as originally received or collected (e.g. RARELY, SOMETIMES). When sponsors apply codelist to indicate the code values are statistically meaningful standardized scores, which are defined by sponsors or by valid methodologies such as SF36 questionnaires, QSORRES will contain the decode format, and QSSTRESC and QSSTRESN may contain the standardized code values or scores.','string','Finding in Original Units','D-SDTM-QS','CL-Role-T-8','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSORRESU','QSORRESU','Original units in which the data were collected. The unit for QSORRES, such as minutes or seconds or the units associated with a visual analog scale.','string','Original Units','D-SDTM-QS','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',12,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSREASND','QSREASND','Describes why a question was not answered. Used in conjunction with QSSTAT when value is NOT DONE. Example: SUBJECT REFUSED.','string','Reason Not Performed','D-SDTM-QS','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSRFTDTC','QSRFTDTC','Date/time of the reference time point, LBTPTREF.','dateTime','Date/Time of Reference Time Point','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSCAT','QSSCAT','A further categorization of the questions within the category. Examples: MENTAL HEALTH DOMAIN, DEPRESSION DOMAIN, WORD RECALL.','string','Subcategory for Question','D-SDTM-QS','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSEQ','QSSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSPID','QSSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Question number on a questionnaire.','string','Sponsor-Defined Identifier','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSTAT','QSSTAT','Used to indicate a questionnaire or response to a questionnaire was not done. Should be null if a result exists in QSORRES.','string','Completion Status','D-SDTM-QS','CL-Role-T-3','CL-Compliance-T-3','CL-ND',16,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSTRESC','QSSTRESC','Contains the finding for all questions or sub-scores, copied or derived from QSORRES in a standard format or standard units. QSSTRESC should store all findings in character format; if findings are numeric, they should also be stored in numeric format in QSSTRESN. If question scores are derived from the original finding, then the standard format is the score. Examples: 0, 1. When sponsors apply codelist to indicate the code values are statistically meaningful standardized scores, which are defined by sponsors or by valid methodologies such as SF36 questionnaires, QSORRES will contain the decode format, and QSSTRESC and QSSTRESN may contain the standardized code values or scores.','string','Character Result/Finding in Std Format','D-SDTM-QS','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSTRESN','QSSTRESN','Used for continuous or numeric findings in standard format; copied in numeric format from QSSTRESC. QSSTRESN should store all numeric results or findings.','decimal','Numeric Finding in Standard Units','D-SDTM-QS','CL-Role-T-8','CL-Compliance-T-3',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSSTRESU','QSSTRESU','Standardized unit used for QSSTRESC or QSSTRESN.','string','Standard Units','D-SDTM-QS','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',15,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSTEST','QSTEST','Verbatim name of the question or group of questions used to obtain the measurement or finding. The value in QSTEST cannot be longer than 40 characters. Example: In General, How is Your Health?','string','Question Name','D-SDTM-QS','CL-Role-T-4','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSTESTCD','QSTESTCD','Topic variable for QS. Short name for the value in QSTEST, which can be used as a column name when converting the dataset from a vertical format to a horizontal format. The value in QSTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). QSTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: COG01, GH1, PF1.','string','Question Short Name','D-SDTM-QS','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSTPT','QSTPT','1. Text Description of time when questionnaire should be administered.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See QSTPTNUM and QSTPTREF.','string','Planned Time Point Name','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSTPTNUM','QSTPTNUM','Numerical version of QSTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-QS-QSTPTREF','QSTPTREF','Name of the fixed reference point referred to by QSELTM, QSTPTNUM, and QSTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-QS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-QS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-QS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-QS-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-QS-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-QS-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-QS','CL-Role-T-6','CL-Compliance-T-2',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-RE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REBLFL','REBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-2',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RECAT','RECAT','Used to define a category of topic-variable values. Example: MEASUREMENT, QUALITY','string','Category for Test','D-SDTM-RE','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REDIR','REDIR','Directionality to indicate where on the body the collection was taken. Examples: PROXIMAL, DISTAL, ANTERIOR','string','Directionality','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REDRVFL','REDRVFL','Used to indicate a derived record. The value should be Y or null. Records that represent the average of other records, or that do not come from the CRF, or are not as originally collected or received are examples of records that would be derived for the submission datasets. If REDRVFL=Y, then REORRES could be null, with RESTRESC, and (if numeric) RESTRESN having the derived value','string','Derived Flag','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REDTC','REDTC','Date and time of specimen collection','dateTime','Date/Time of Test','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-2',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REDY','REDY','Study day of specimen collection relative to the sponsor-defined RFSTDTC. ','integer','Study Day of Test','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REELTM','REELTM','Elapsed time relative to a planned fixed reference (RETPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable, but an interval, represented as ISO duration. ','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,38,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REEVAL','REEVAL','Role of the person who provided the evaluation. Used only for results that are subjective.','string','Evaluator','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REGRPID','REGRPID','Optional group identifier, used to link together a block of related records within a subject in a domain. ','string','Group ID','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REIRESFL','REIRESFL','Used to indicated that a result is not considered acceptable/adequate according to the assessment protocol. The value should be Y or null.','string','Inadequate Results Flag','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RELAT','RELAT','Side of the body used to collect measurement. Examples: RIGHT, LEFT, BILATERAL, UNILATERAL','string','Laterality','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RELOC','RELOC','Location relevant to the collection of the measurement. Example: ?LUNG?, ?BRONCHUS?','string','Location Used for Measurement','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REMETHOD','REMETHOD ','Method of the test or examination. Examples: SPECTROPHOTOMETRY, ELECTROPHORESIS.','string','Method of Test or Examination ','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REORREF','REORREF','Reference result for continuous measurements in original units. Should be populated only for continuous results.','string','Reference Result in Original Units','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REORRES','REORRES','Result of the measurement as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-RE','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REORRESU','REORRESU','Original units in which the data were collected. The unit for REORRES and REORREF','string','Original Units','D-SDTM-RE','CL-Role-T-5','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REPOS','REPOS','Position of the subject during measurement or examination. Examples: SUPINE, STANDING, SITTING','string','Position of Subject','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REREASND','REREASND','Reason not done. Used in conjunction with RESTAT when value is NOT DONE. ','string','Reason Not Done','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-RE-REREFID','REREFID ','Internal or external identifier such as lab specimen ID. ','string','Reference ID','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RERFTDTC','RERFTDTC','Date/time for a fixed reference time point defined by PFTPTREF. ','dateTime','Date/Time of Reference Time Point','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,40,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESCAT','RESCAT','Used to define a further categorization of RECAT values.','string','Subcategory for Test','D-SDTM-RE','CL-Role-T-7','CL-Compliance-T-3',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESEQ','RESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESPID','RESPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database.','string','Sponsor-Defined Identifier','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESTAT','RESTAT','Used to indicate that a test was not done, or was attempted but did not generate a result. Should be null or have a value of NOT DONE.','string','Completion Status','D-SDTM-RE','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESTREFN','RESTREFN','','decimal','Reference Result in Standard Units','D-SDTM-RE','CL-Role-T-5','CL-Compliance-T-3',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESTRESC','RESTRESC','Contains the result value for all findings, copied or derived from REORRES in a standard format or standard units. RESTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in RESTRESN ','string','Character Result/Finding in Std Format','D-SDTM-RE','CL-Role-T-8','CL-Compliance-T-2',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESTRESN','RESTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from RESTRESC. RESTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-RE','CL-Role-T-8','CL-Compliance-T-2',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RESTRESU','RESTRESU','Standardized unit used for RESTRESC and RESTRESN.','string','Standard Units','D-SDTM-RE','CL-Role-T-5','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RETEST','RETEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in RETEST cannot be longer than 40 characters. Examples: Forced Expiratory Volume in 1 Second, Forced Vital Capacity','string','Test or Examination Name','D-SDTM-RE','CL-Role-T-4','CL-Compliance-T-1',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RETESTCD','RETESTCD','Short name of the measurement, test, or examination described in RETEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in RETESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., ?1TEST?). RETESTCD cannot contain characters other than letters, numbers, or underscores. Examples: FEV1','string','Test or Examination Short Name','D-SDTM-RE','CL-Role-T-2','CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RETPT','RETPT','Text description of time when a measurement or oREervation should be taken as defined in the protocol. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See RETPTNUM and RETPTREF. ','string','Planned Time Point Name','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,36,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RETPTNUM','RETPTNUM','Numerical version of RETPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,37,'\0','\0','COLUMN',NULL),('V-SDTM-RE-RETPTREF','RETPTREF','Name of the fixed reference point referred to by REELTM, RETPTNUM, and RETPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,39,'\0','\0','COLUMN',NULL),('V-SDTM-RE-SPDEVID','SPDEVID','Sponsor-defined identifier for a device. ','string','Sponsor Device Identifier ','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-3',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-RE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-RE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-RE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-RE-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\r2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-RE-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-RE-VISITNUM','VISITNUM','1. Clinical encounter number.\r2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-RE','CL-Role-T-6','CL-Compliance-T-2',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-IDVAR','IDVAR','Name of the identifying variable in the general-observation-class dataset that identifies the related record(s). Examples include --SEQ and --GRPID.','string','Identifying Variable','D-SDTM-RELREC',NULL,'CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-IDVARVAL','IDVARVAL','Value of identifying variable described in IDVAR. If --SEQ is the variable being used to describe this record, then the value of --SEQ would be entered here.','string','Identifying Variable Value','D-SDTM-RELREC',NULL,'CL-Compliance-T-2',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-RDOMAIN','RDOMAIN','Two-character abbreviation for the domain of the parent record(s).','string','Related Domain Abbreviation','D-SDTM-RELREC',NULL,'CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-RELID','RELID','Unique value within USUBJID that identifies the relationship. All records for the same USUBJID that have the same RELID are considered \"related/associated.\" RELID can be any value the sponsor chooses, and is only meaningful within the RELREC dataset to identify the related/associated Domain records.','string','Relationship Identifier','D-SDTM-RELREC',NULL,'CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-RELTYPE','RELTYPE','Identifies the hierarchical level of the records in the relationship. Values should be either ONE or MANY. Used only when identifying a relationship between datasets (as described in Section 8.3).','string','Relationship Type','D-SDTM-RELREC',NULL,'CL-Compliance-T-2',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-RELREC',NULL,'CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-RELREC-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-RELREC',NULL,'CL-Compliance-T-2',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-RS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-RS-EPOCH','EPOCH','Epoch associated with the Element in the planned sequence of Elements for the ARM to which the subject was assigned.','string','Epoch','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSACPTFL','RSACPTFL','In cases where more than one independent assessor (e.g. RADIOLOGIST 1, RADIOLOGIST 2, ADJUDICATOR) provides an evaluation of response this flag identifies the record that is considered to be the accepted evaluation.','string','Accepted Record Flag','D-SDTM-RS','CL-Role-T-3','CL-Compliance-T-3','CL-NY',20,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSCAT','RSCAT','RSCAT is used to identify the criteria used in the assessment of response and a version number if appropriate.','string','Category for Response Assessment','D-SDTM-RS','CL-Role-T-7','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSDTC','RSDTC','RSDTC may be derived from the dates of scans/images/physical exams which may be performed on different dates. However, if all assessments are performed on the same date, RSDTC may be consistent with the TUDTC and TRDTC.  Note the physical exam date may correspond to the visit date.','dateTime','Date/Time of Response Assessment','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSDY','RSDY','1. Study day of the response assessment, measured as integer days.  2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Response Assessment','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSEVAL','RSEVAL','Role of the person who provided the evaluation. Examples: INVESTIGATOR, INDEPENDENT ASSESSOR.  This column can be left Null when the Investigator provides the complete set of data in the domain. However the column should contain no Null values when data from one or more independent assessors is included meaning that the rows attributed to the Investigator should contain a value of INVESTIGATOR.','string','Evaluator','D-SDTM-RS','CL-Role-T-3','CL-Compliance-T-2','CL-EVAL',18,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSEVALID','RSEVALID','The Evaluator Specified variable is used in conjunction with RSEVAL to provide an additional level of detail. When multiple assessors play the role identified in RSEVAL, values of RSEVALID will attribute a row of data to a particular assessor. RSEVALID should not contain the names of the assessors, or a code identifier for a specific assessor. The RSEVALID variable is subject to CDISC Controlled Terminology. Examples: RADIOLOGIST, RADIOLOGIST 1 or RADIOLOGIST 2.  See Assumption 4.','string','Evaluator Identifier','D-SDTM-RS','CL-Role-T-5','CL-Compliance-T-3','CL-MEDEVAL',19,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSGRPID','RSGRPID','Used to link together a block of related records within a subject in a domain.','string','Group ID','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSLNKGRP','RSLNKGRP','Used to link the response assessment to the all of the measurement/assessment records in the TR domain which were used in the assessment of the response.','string','Link Group','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSLNKID','RSLNKID','Used to link the response assessment to the appropriate measurement records (in TR) for same tumor that was used to determine the response result.','string','Link ID','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSNAM','RSNAM','The name or identifier of the vendor that performed the response assessment.  This column can be left Null when the Investigator provides the complete set of data in the domain.','string','Vendor Name','D-SDTM-RS','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSORRES','RSORRES','Result of the Response assessment as originally received, collected, or calculated.','string','Response Assessment Original Result','D-SDTM-RS','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSREASND','RSREASND','Describes why a response assessment was not performed.  Examples: All target tumors not evaluated, Subject does not have non-target tumors. Used in conjunction with RSSTAT when value is NOT DONE.','string','Reason Response Assessment Not Performed','D-SDTM-RS','CL-Role-T-3','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSREFID','RSREFID','Internal or external identifier.','string','Reference ID','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSSEQ','RSSEQ','Sequence number given to ensure uniqueness within a dataset for a subject. May be any valid number.','decimal','Sequence Number','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSSPID','RSSPID','Sponsor-defined identifier.','string','Sponsor-Defined Identifier','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSSTAT','RSSTAT','Used to indicate the response assessment was not performed. Should be Null if a result exists in RSORRES.','string','Completion Status','D-SDTM-RS','CL-Role-T-8','CL-Compliance-T-3','CL-ND',15,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSSTRESC','RSSTRESC','Contains the result value for the response assessment, copied or derived from RSORRES in a standard format or standard units. RSSTRESC should store all results or findings in character format.','string','Response Assessment Result in Std Format','D-SDTM-RS','CL-Role-T-3','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSTEST','RSTEST','Verbatim name of the response assessment.  The value in RSTEST cannot be longer than 40 characters. Examples: Target Response, Non-target Response, Overall Response, Best Overall Response, Non-radiological progression (i.e. Symptomatic deterioration).','string','Response  Assessment Name','D-SDTM-RS','CL-Role-T-4','CL-Compliance-T-1','CL-RSTEST',11,'\0','\0','COLUMN',NULL),('V-SDTM-RS-RSTESTCD','RSTESTCD','Short name of the TEST in RSTEST. RSTESTCD cannot contain characters other than letters, numbers, or underscores.  Examples: TRGRESP, NTRGRESP, OVRRESP, BESTRESP, NRADPROG.','string','Response  Assessment Short Name','D-SDTM-RS','CL-Role-T-2','CL-Compliance-T-1','CL-RSTESTCD',10,'\0','\0','COLUMN',NULL),('V-SDTM-RS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-RS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-RS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-RS-VISIT','VISIT','1. Protocol-defined description of clinical encounter.   2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-RS-VISITDY','VISITDY','','integer','Planned Study Day of Visit','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-RS-VISITNUM','VISITNUM','1. Clinical encounter number.  2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-RS','CL-Role-T-6','CL-Compliance-T-2',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-SC-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCCAT','SCCAT','Used to define a category of related records.','string','Category for Subject Characteristic','D-SDTM-SC','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCDTC','SCDTC','','dateTime','Date/Time of Collection','D-SDTM-SC','CL-Role-T-6','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCDY','SCDY','1. Study day of collection, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Examination','D-SDTM-SC','CL-Role-T-6','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCGRPID','SCGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCORRES','SCORRES','Result of the subject characteristic as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-SC','CL-Role-T-8','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCORRESU','SCORRESU','Original Unit in which the data were collected. The unit for SCORRES.','string','Original Units','D-SDTM-SC','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',12,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCREASND','SCREASND','Describes why the observation has no result. Example: subject refused. Used in conjunction with SCSTAT when value is NOT DONE.','string','Reason Not Performed','D-SDTM-SC','CL-Role-T-3','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSCAT','SCSCAT','A further categorization of the subject characteristic.','string','Subcategory for Subject Characteristic','D-SDTM-SC','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSEQ','SCSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSPID','SCSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor’s operational database.','string','Sponsor-Defined Identifier','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSTAT','SCSTAT','Used to indicate that the measurement was not done. Should be null if a result exists in SCORRES.','string','Completion Status','D-SDTM-SC','CL-Role-T-3','CL-Compliance-T-3','CL-ND',16,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSTRESC','SCSTRESC','Contains the result value for all findings, copied or derived from SCORRES in a standard format or standard units. SCSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in SCSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \"NEGATIVE\" in SCORRES and these results effectively have the same meaning, they could be represented in standard format in SCSTRESC as \"NEGATIVE\".','string','Character Result/Finding in Std Format','D-SDTM-SC','CL-Role-T-8','CL-Compliance-T-2',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSTRESN','SCSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from SCSTRESC. SCSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-SC','CL-Role-T-8','CL-Compliance-T-3',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCSTRESU','SCSTRESU','Standardized unit used for SCSTRESC or SCSTRESN.','string','Standard Units','D-SDTM-SC','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',15,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCTEST','SCTEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in SCTEST cannot be longer than 40 characters. Examples: Subject Initials, Eye Color.','string','Subject Characteristic','D-SDTM-SC','CL-Role-T-4','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-SC-SCTESTCD','SCTESTCD','Short name of the measurement, test, or examination described in SCTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in SCTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). SCTESTCD cannot contain characters other than letters, numbers, or underscores. Example: SUBJINIT, EYECD.','string','Subject Characteristic Short Name','D-SDTM-SC','CL-Role-T-2','CL-Compliance-T-1','CL-SCTESTCD',7,'\0','\0','COLUMN',NULL),('V-SDTM-SC-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-SC-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-SC','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-SE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-SE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-SE-ELEMENT','ELEMENT','The name of the Element. If ETCD has a value of \"UNPLAN\" then ELEMENT should be Null.','string','Description of Element','D-SDTM-SE','CL-Role-T-4','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-SE-EPOCH','EPOCH','Epoch associated with the Element in the planned sequence of Elements for the ARM to which the subject was assigned.','string','Epoch','D-SDTM-SE','CL-Role-T-6','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-SE-ETCD','ETCD','1. ETCD (the companion to ELEMENT) is limited to 8 characters and does not have special character restrictions. These values should be short for ease of use in programming, but it is not sdtm-1-3:Classifier.ExpecedVariableected that ETCD will need to serve as a variable name.\n2. If an encountered Element differs from the planned Element to the point that it is considered a new Element, then use \"UNPLAN\" as the value for ETCD to represent this Element.','string','Element Code','D-SDTM-SE','CL-Role-T-2','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-SE-SEENDTC','SEENDTC','End date/time for an Element for each subject.','dateTime','End Date/Time of Element','D-SDTM-SE','CL-Role-T-6','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-SE-SESEQ','SESEQ','Sequence Number given to ensure uniqueness of subject records within a domain. Should be assigned to be consistent chronological order.','decimal','Sequence Number','D-SDTM-SE','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-SE-SESTDTC','SESTDTC','Start date/time for an Element for each subject.','dateTime','Start Date/Time of Element','D-SDTM-SE','CL-Role-T-6','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-SE-SEUPDES','SEUPDES','Description of what happened to the subject during this unplanned Element. Used only if ETCD has the value of \"UNPLAN\".','string','Description of Unplanned Element','D-SDTM-SE','CL-Role-T-4','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-SE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-SE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-SE-TAETORD','TAETORD','Number that gives the planned order of the Element within the subject\'s assigned ARM.','decimal','Planned Order of Element within Arm','D-SDTM-SE','CL-Role-T-6','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-SE-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-SE','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-SU-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-SU-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUCAT','SUCAT','Used to define a category of related records. Examples: TOBACCO, ALCOHOL, or CAFFEINE.','string','Category for Substance Use','D-SDTM-SU','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUCLAS','SUCLAS','Substance use class. May be obtained from coding. When coding to a single class, populate with class value. If using a dictionary and coding to multiple classes, then follow assumption 4.1.3.5 or omit SUCLAS.','string','Substance Use Class','D-SDTM-SU','CL-Role-T-5','CL-Compliance-T-3',NULL,16,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUCLASCD','SUCLASCD','Code corresponding to SUCLAS. May be obtained from coding.','string','Substance Use Class Code','D-SDTM-SU','CL-Role-T-5','CL-Compliance-T-3',NULL,17,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDECOD','SUDECOD','Standardized or dictionary-derived text description of SUTRT or SUMODIFY if the sponsor chooses to code the substance use. The sponsor is sdtm-1-3:Classifier.ExpecedVariableected to provide the dictionary name and version used to map the terms utilizing the define.xml external codelist attributes.','string','Standardized Substance Name','D-SDTM-SU','CL-Role-T-4','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSE','SUDOSE','Amount of SUTRT consumed.','decimal','Substance Use Consumption','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSFRM','SUDOSFRM','Dose form for SUTRT. Examples: INJECTABLE, LIQUID, or POWDER.','string','Dose Form','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3',NULL,21,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSFRQ','SUDOSFRQ','Usually sdtm-1-3:Classifier.ExpecedVariableressed as the number of repeated administrations of SUDOSE within a specific time period. Example: Q24H (every day).','string','Use Fsdtm-1-3:Classifier.RequiredVariableuency Per Interval','D-SDTM-SU','CL-Role-T-5','CL-Compliance-T-3',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSTOT','SUDOSTOT','Total daily use of SUTRT using the units in SUDOSU. If sponsor needs to aggregate the data over a period other than daily, then the aggregated total could be recorded in a Supplemental Qualifier variable.','decimal','Total Daily Consumption','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSTXT','SUDOSTXT','Substance use consumption amounts or a range of consumption information collected in text form.','string','Substance Use Consumption Text','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDOSU','SUDOSU','Units for SUDOSE, SUDOSTXT, and SUDOSTOT. Examples: OUNCES, CIGARETTE EQUIVALENTS, or GRAMS.','string','Consumption Units','D-SDTM-SU','CL-Role-T-5','CL-Compliance-T-3','CL-UNIT',20,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUDUR','SUDUR','Collected duration of substance use in ISO 8601 format. Used only if collected on the CRF and not derived from start and end date/times.','duration','Duration of Substance Use','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUENDTC','SUENDTC','','dateTime','End Date/Time of Substance Use','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUENDY','SUENDY','Study day of end of substance use relative to the sponsor-defined RFSTDTC.','integer','Study Day of End of Substance Use','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUENRF','SUENRF','Describes the end of the substance use with relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into SUENRF.','string','End Relative to Reference Period','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',31,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUENRTPT','SUENRTPT','Identifies the end of the medication as being before or after the reference time point defined by variable SUENTPT.','string','End Relative to Reference Time Point','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,34,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUENTPT','SUENTPT','Description or date/time in ISO 8601 character format of the reference point referred to by SUENRTPT. Examples: \"2003-12-25\" or \"VISIT 2\".','string','End Reference Time Point','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,35,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUGRPID','SUGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUMODIFY','SUMODIFY','If SUTRT is modified, then the modified text is placed here.','string','Modified Substance Name','D-SDTM-SU','CL-Role-T-4','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUOCCUR','SUOCCUR','When the use of specific substances is solicited, SUOCCUR is used to indicate whether or not (Y/N) a particular pre-specified substance was used. Values are null for substances not specifically solicited.','string','SU Occurrence','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3','CL-NY',13,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUPRESP','SUPRESP','Used to indicate whether (Y/null) information about the use of a specific substance was solicited on the CRF.','string','SU Pre-Specified','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3','CL-NY',12,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUREASND','SUREASND','Describes the reason substance use was not collected. Used in conjunction with SUSTAT when value of SUSTAT is NOT DONE.','string','Reason Substance Use Not Collected','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUROUTE','SUROUTE','Route of administration for SUTRT. Examples: ORAL, INTRAVENOUS.','string','Route of Administration','D-SDTM-SU','CL-Role-T-5','CL-Compliance-T-3','CL-ROUTE',24,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSCAT','SUSCAT','A further categorization of substance use. Examples: CIGARS, CIGARETTES, BEER, WINE.','string','Subcategory for Substance Use','D-SDTM-SU','CL-Role-T-7','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSEQ','SUSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSPID','SUSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database. Example: Line number on a Tobacco & Alcohol use CRF page.','string','Sponsor-Defined Identifier','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTAT','SUSTAT','When the use of pre-specified substances is solicited, the completion status indicates that there was no response to the question about the pre-specified substance. When there is no pre-specified list on the CRF, then the completion status indicates that substance use was not assessed for the subject.','string','Completion Status','D-SDTM-SU','CL-Role-T-3','CL-Compliance-T-3','CL-ND',14,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTDTC','SUSTDTC','','dateTime','Start Date/Time of Substance Use','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTDY','SUSTDY','Study day of start of substance use relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Substance Use','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTRF','SUSTRF','Describes the start of the substance use relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into SUSTRF.','string','Start Relative to Reference Period','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3','CL-STENRF',30,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTRTPT','SUSTRTPT','Identifies the start of the medication as being before or after the reference time point defined by variable SUSTTPT.','string','Start Relative to Reference Time Point','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,32,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUSTTPT','SUSTTPT','Description or date/time in ISO 8601 character format of the reference point referred to by SUSTRTPT. Examples: \"2003-12-15\" or \"VISIT 1\".','string','Start Reference Time Point','D-SDTM-SU','CL-Role-T-6','CL-Compliance-T-3',NULL,33,'\0','\0','COLUMN',NULL),('V-SDTM-SU-SUTRT','SUTRT','Substance name. Examples: Cigarettes, Coffee.','string','Reported Name of Substance','D-SDTM-SU','CL-Role-T-2','CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-SU-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-SU','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-IDVAR','IDVAR','Identifying variable in the dataset that identifies the related record(s). Examples: --SEQ, --GRPID.','string','Identifying Variable','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-2',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-IDVARVAL','IDVARVAL','Value of identifying variable of the parent record(s).','string','Identifying Variable Value','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-2',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-QEVAL','QEVAL','Used only for results that are subjective (e.g., assigned by a person or a group). Should be null for records that contain objectively collected or derived data. Some examples include ADJUDICATION COMMITTEE, STATISTICIAN, DATABASE ADMINISTRATOR, CLINICAL COORDINATOR, etc.','string','Evaluator','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-QLABEL','QLABEL','This is the long name or label associated with QNAM. The value in QLABEL cannot be longer than 40 characters. This will often be the column label in the sponsor\'s original dataset.','string','Qualifier Variable Label','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-QNAM','QNAM','The short name of the Qualifier variable, which is used as a column name in a domain view with data from the parent domain. The value in QNAM cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). QNAM cannot contain characters other than letters, numbers, or underscores. This will often be the column name in the sponsor\'s operational dataset.','string','Qualifier Variable Name','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-QORIG','QORIG','Since QVAL can represent a mixture of collected (on a CRF), derived, or assigned items, QORIG is used to indicate the origin of this data. Examples include CRF, ASSIGNED, or DERIVED. See Section 4.1.1.8.','string','Origin','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-QVAL','QVAL','Result of, response to, or value associated with QNAM. A value for this column is sdtm-1-3:Classifier.RequiredVariableuired; no records can be in SUPP-- with a null value for QVAL.','string','Data Value','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-RDOMAIN','RDOMAIN','Two-character abbreviation for the domain of the parent record(s).','string','Related Domain Abbreviation','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-STUDYID','STUDYID','Study Identifier of the Parent record(s).','string','Study Identifier','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-SUPPQUAL-USUBJID','USUBJID','Unique Subject Identifier of the Parent record(s).','string','Unique Subject Identifier','D-SDTM-SUPPQUAL',NULL,'CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-SV-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-SV','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-SV-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-SV','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-SV-SVENDTC','SVENDTC','End date/time of a Visit.','dateTime','End Date/Time of Visit','D-SDTM-SV','CL-Role-T-6','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-SV-SVENDY','SVENDY','Study day of end of visit relative to the sponsor-defined RFSTDTC.','integer','Study Day of End of Visit','D-SDTM-SV','CL-Role-T-6','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-SV-SVSTDTC','SVSTDTC','Start date/time for a Visit.','dateTime','Start Date/Time of Visit','D-SDTM-SV','CL-Role-T-6','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-SV-SVSTDY','SVSTDY','Study day of start of visit relative to the sponsor-defined RFSTDTC.','integer','Study Day of Start of Visit','D-SDTM-SV','CL-Role-T-6','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-SV-SVUPDES','SVUPDES','Description of what happened to the subject during an unplanned visit.','string','Description of Unplanned Visit','D-SDTM-SV','CL-Role-T-4','CL-Compliance-T-3',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-SV-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-SV','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-SV-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY as a text description of the clinical encounter.','string','Visit Name','D-SDTM-SV','CL-Role-T-4','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-SV-VISITDY','VISITDY','Planned study day of the start of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-SV','CL-Role-T-6','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-SV-VISITNUM','VISITNUM','1. Clinical encounter number. (Decimal numbering may be useful for inserting unplanned visits.)\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-SV','CL-Role-T-2','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TA-ARM','ARM','Name given to an Arm or treatment group.','string','Description of Planned Arm','D-SDTM-TA','CL-Role-T-4','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TA-ARMCD','ARMCD','ARMCD is limited to 20 characters and does not have special character restrictions. The maximum length of ARMCD is longer than that for other \"short\" variables to accommodate the kind of values that are likely to be needed for crossover trials. For example, if ARMCD values for a seven-period crossover were constructed using two-character abbreviations for each treatment and separating hyphens, the length of ARMCD values would be 20.','string','Planned Arm Code','D-SDTM-TA','CL-Role-T-2','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TA-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TA','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TA-ELEMENT','ELEMENT','The name of the Element. The same Element may occur more than once within an Arm.','string','Description of Element','D-SDTM-TA','CL-Role-T-4','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TA-EPOCH','EPOCH','Name of the Trial Epoch with which this Element of the Arm is associated.','string','Epoch','D-SDTM-TA','CL-Role-T-6','CL-Compliance-T-1',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-TA-ETCD','ETCD','ETCD (the companion to ELEMENT) is limited to 8 characters and does not have special character restrictions. These values should be short for ease of use in programming, but it is not sdtm-1-3:Classifier.ExpecedVariableected that ETCD will need to serve as a variable name.','string','Element Code','D-SDTM-TA','CL-Role-T-3','CL-Compliance-T-1',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TA-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TA','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TA-TABRANCH','TABRANCH','Condition subject met, at a \"branch\" in the trial design at the end of this Element, to be included in this Arm; (e.g., randomization to DRUG X).','string','Branch','D-SDTM-TA','CL-Role-T-9','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TA-TAETORD','TAETORD','Number that gives the order of the Element within the Arm.','decimal','Order of Element within Arm','D-SDTM-TA','CL-Role-T-6','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TA-TATRANS','TATRANS','If the trial design allows a subject to transition to an Element other than the next Element in sequence, then the conditions for transitioning to those other Elements, and the alternative Element sequences, are specified in this rule (e.g., Responders go to washout).','string','Transition Rule','D-SDTM-TA','CL-Role-T-9','CL-Compliance-T-2',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-TE-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TE','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TE-ELEMENT','ELEMENT','The name of the Element.','string','Description of Element','D-SDTM-TE','CL-Role-T-4','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TE-ETCD','ETCD','ETCD (the companion to ELEMENT) is limited to 8 characters and does not have special character restrictions. These values should be short for ease of use in programming, but it is not sdtm-1-3:Classifier.ExpecedVariableected that ETCD will need to serve as a variable name.','string','Element Code','D-SDTM-TE','CL-Role-T-2','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TE-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TE','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TE-TEDUR','TEDUR','Planned Duration of Element in ISO 8601 format. Used when the rule for ending the Element is applied after a fixed duration.','duration','Planned Duration of Element','D-SDTM-TE','CL-Role-T-6','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TE-TEENRL','TEENRL','sdtm-1-3:Classifier.ExpecedVariableresses rule for ending Element. Either TEENRL or TEDUR must be present for each Element.','string','Rule for End of Element','D-SDTM-TE','CL-Role-T-9','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TE-TESTRL','TESTRL','sdtm-1-3:Classifier.ExpecedVariableresses rule for beginning Element.','string','Rule for Start of Element','D-SDTM-TE','CL-Role-T-9','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TI-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TI','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TI-IECAT','IECAT','Used for categorization of the inclusion or exclusion criteria.','string','Inclusion/Exclusion Category','D-SDTM-TI','CL-Role-T-7','CL-Compliance-T-1','CL-IECAT',5,'\0','\0','COLUMN',NULL),('V-SDTM-TI-IESCAT','IESCAT','A further categorization of the exception criterion. Can be used to distinguish criteria for a sub-study or for to categorize as a major or minor exceptions. Examples: MAJOR, MINOR.','string','Inclusion/Exclusion Subcategory','D-SDTM-TI','CL-Role-T-7','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TI-IETEST','IETEST','Full text of the inclusion or exclusion criterion. The prefix \"IE\" is used to ensure consistency with the IE domain.','string','Inclusion/Exclusion Criterion','D-SDTM-TI','CL-Role-T-4','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TI-IETESTCD','IETESTCD','Short name IETEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in IETESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\"). IETESTCD cannot contain characters other than letters, numbers, or underscores. The prefix \"IE\" is used to ensure consistency with the IE domain.','string','Incl/Excl Criterion Short Name','D-SDTM-TI','CL-Role-T-2','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TI-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TI','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TI-TIRL','TIRL','Rule that sdtm-1-3:Classifier.ExpecedVariableresses the criterion in computer-executable form (see assumption 4 below).','string','Inclusion/Exclusion Criterion Rule','D-SDTM-TI','CL-Role-T-9','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TI-TIVERS','TIVERS','The number of this version of the Inclusion/Exclusion criteria. May be omitted if there is only one version.','string','Protocol Criteria Versions','D-SDTM-TI','CL-Role-T-3','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TR-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TR-EPOCH','EPOCH','Epoch associated with the Element in the planned sequence of Elements for the ARM to which the subject was assigned.','string','Epoch','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-TR-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRACPTFL','TRACPTFL','In cases where more than one independent assessor (e.g. RADIOLOGIST 1, RADIOLOGIST 2, ADJUDICATOR) provide independent assessments at the same timepoint this flag identifies the record that is considered to be the accepted assessment.','string','Accepted Record Flag','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-3','CL-NY',23,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRDTC','TRDTC','TRDTC variable represents the date of the scan/image/physical exam not the date that the image was read to identify tumors.  TRDTC variable does not represent the VISIT date.','dateTime','Date/Time of Tumor Measurement','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-2',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRDY','TRDY','1. Study day of the scan/image/physical exam, measured as integer days.   2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Tumor Measurement','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TREVAL','TREVAL','Role of the person who provided the evaluation. Examples: INVESTIGATOR, INDEPENDENT ASSESSOR.  This column can be left Null when the Investigator provides the complete set of data in the domain. However the column should contain no Null values when data from one or more independent assessors is included meaning that the rows attributed to the Investigator should contain a value of INVESTIGATOR.','string','Evaluator','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-2','CL-EVAL',21,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TREVALID','TREVALID','The Evaluator Specified variable is used in conjunction with TREVAL to provide an additional level of detail. When multiple assessors play the role identified in TREVAL, values of TREVALID will attribute a row of data to a particular assessor. TREVALID should not contain the names of the assessors, or a code identifier for a specific assessor,  but should contain values such as RADIOLOGIST, RADIOLOGIST 1 or RADIOLOGIST 2. The TREVALID variable is subject to CDISC Controlled Terminology. Note TREVAL must also be populated when TREVALID is populated.  See Assumption 7.','string','Evaluator Identifier','D-SDTM-TR','CL-Role-T-5','CL-Compliance-T-3','CL-MEDEVAL',22,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRGRPID','TRGRPID','Used to link together a block of related records within a subject in a domain.','string','Group ID','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRLNKGRP','TRLNKGRP','Used to group and link all of the measurement/assessment records used in the assessment of the response record in the RS domain.','string','Link Group','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRLNKID','TRLNKID','Identifier used to link the assessment result records to the individual tumor identification record in TU domain.','string','Link ID','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRMETHOD','TRMETHOD','Method used to measure the tumor. Examples: MRI, CT SCAN.','decimal','Method used to identify the Tumor','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-2','CL-METHOD',20,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRNAM','TRNAM','The name or identifier of the vendor that performed the Tumor measurement or assessment.  This column can be left Null when the Investigator provides the complete set of data in the domain.','string','Vendor Name','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-3',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRORRES','TRORRES','Result of the Tumor measurement/assessment as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-TR','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRORRESU','TRORRESU','Original units in which the data were collected. The unit for TRORRES. Example: mm.','string','Original Units','D-SDTM-TR','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',13,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRREASND','TRREASND','Describes why a scan/image/physical exam was not performed or a tumor measurement was not taken.  Examples: SCAN NOT PERFORMED, NOT ASSESSABLE: Image obscured, TUMOR. Used in conjunction with TRSTAT when value is NOT DONE.','string','Reason Tumor Measurement Not Performed','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRREFID','TRREFID','Internal or external identifier.','string','Reference ID','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSEQ','TRSEQ','Sequence number given to ensure uniqueness within a dataset for a subject. May be any valid number.','decimal','Sequence Number','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSPID','TRSPID','Sponsor-defined identifier.','string','Sponsor-Defined  Identifier','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSTAT','TRSTAT','Used to indicate a scan/image/physical exam was not performed or a tumor measurement was not taken. Should be Null if a result exists in TRORRES.','string','Completion Status','D-SDTM-TR','CL-Role-T-8','CL-Compliance-T-3','CL-ND',17,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSTRESC','TRSTRESC','Contains the result value for all findings, copied or derived from TRORRES in a standard format or standard units. TRSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in TRSTRESN.','string','Character Result/Finding in Std Format','D-SDTM-TR','CL-Role-T-3','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSTRESN','TRSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from TRSTRESC. TRSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-TR','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRSTRESU','TRSTRESU','Standardized unit used for TRSTRESN.','string','Standard Units','D-SDTM-TR','CL-Role-T-5','CL-Compliance-T-2','CL-UNIT',16,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRTEST','TRTEST','Verbatim name of the test or examination used to obtain the measurement or finding.   The value in TRTEST cannot be longer than 40 characters. Examples: Tumor State, Diameter, Longest Perpendicular diameter, Volume, Area. See Assumption 2.','string','Tumor Assessment Test Name','D-SDTM-TR','CL-Role-T-4','CL-Compliance-T-1','CL-TRTEST',11,'\0','\0','COLUMN',NULL),('V-SDTM-TR-TRTESTCD','TRTESTCD','Short name of the TEST in TRTEST.  TRTESTCD cannot contain characters other than letters, numbers, or underscores.  Examples: TUMSTATE, DIAMETER. See Assumption 2.','string','Tumor Assessment Short Name','D-SDTM-TR','CL-Role-T-2','CL-Compliance-T-1','CL-TRTESTCD',10,'\0','\0','COLUMN',NULL),('V-SDTM-TR-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-TR','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TR-VISIT','VISIT','1. Protocol-defined description of clinical encounter.   2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-TR-VISITDY','VISITDY','','integer','Planned Study Day of Visit','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-TR-VISITNUM','VISITNUM','1. Clinical encounter number.   2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-TR','CL-Role-T-6','CL-Compliance-T-2',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-TS-DOMAIN','DOMAIN','Two-character abbreviation for the domain, which must be TS.','string','Domain Abbreviation','D-SDTM-TS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSGRPID','TSGRPID','Used to tie together a group of related records.','string','Group ID','D-SDTM-TS','CL-Role-T-1','CL-Compliance-T-3',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSPARM','TSPARM','Term for the Trial Summary Parameter. The value in TSPARM cannot be longer than 40 characters. Examples Planned Minimum Age of Subjects, Planned Maximum Age of Subjects.','string','Trial Summary Parameter','D-SDTM-TS','CL-Role-T-4','CL-Compliance-T-1',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSPARMCD','TSPARMCD','TSPARMCD (the companion to TSPARM) is limited to 8 characters and does not have special character restrictions. These values should be short for ease of use in programming, but it is not sdtm-1-3:Classifier.ExpecedVariableected that TSPARMCD will need to serve as variable names. Examples: AGEMIN, AGEMAX.','string','Trial Summary Parameter Short Name','D-SDTM-TS','CL-Role-T-2','CL-Compliance-T-1',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSSEQ','TSSEQ','Sequence number given to ensure uniqueness within a dataset.  Allows inclusion of multiple records for the same TSPARMCD, and can be used to join related records.','decimal','Sequence Number','D-SDTM-TS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSVAL','TSVAL','Value of TSPARM. Example: \"ASTHMA\" when TSPARM value is \"Trial Indication\". TSVAL can only be null when TSVALNF is populated. Text over 200 characters can be added to additional columns TSVAL1-TSVALn.','string','Parameter Value','D-SDTM-TS','CL-Role-T-8','CL-Compliance-T-2',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSVALCD','TSVALCD','This is the code of the term in TSVAL. For example; 6CW7F3G59X is the code for Gabapentin, C49488 is the code for Y. The length of this variable can be longer than 8 to accommodate the length of the external terminology.','string','Parameter Value Code','D-SDTM-TS','CL-Role-T-8','CL-Compliance-T-2',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSVALNF','TSVALNF','Null flavor for the value of TSPARM, to be populated if and only if TSVAL is null.','string','Parameter Null Flavor','D-SDTM-TS','CL-Role-T-8','CL-Compliance-T-3',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSVCDREF','TSVCDREF','The name of the Reference Terminology from which TSVALCD is taken. For example; CDISC, SNOMED, ISO 8601.','string','Name of the Reference Terminology','D-SDTM-TS','CL-Role-T-8','CL-Compliance-T-2',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-TS-TSVCDVER','TSVCDVER','The version number of the Reference Terminology, if applicable.','string','Version of the Reference Terminology','D-SDTM-TS','CL-Role-T-8','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-TU-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TU-EPOCH','EPOCH','Epoch associated with the Element in the planned sequence of Elements for the ARM to which the subject was assigned.','string','Epoch','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-3',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-TU-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUACPTFL','TUACPTFL','In cases where more than one independent assessor (e.g. RADIOLOGIST 1, RADIOLOGIST 2, ADJUDICATOR) provide independent assessments at the same time point this flag identifies the record that is considered to be the accepted assessment.','string','Accepted Record Flag','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-3','CL-NY',21,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUDIR','TUDIR','Qualifier for anatomical location or specimen further detailing directionality, for example, UPPER, INTERIOR.','string','Directionality','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-3','CL-DIR',16,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUDTC','TUDTC','TUDTC variable represents the date of the scan/image/physical exam not the date that the image was read to identify tumors.  TUDTC variable does not represent the VISIT date.','dateTime','Date/Time of Tumor Identification','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-2',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUDY','TUDY','1. Study day of the scan/image/physical exam, measured as integer days.  2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Tumor Identification','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUEVAL','TUEVAL','Role of the person who provided the evaluation. Examples: INVESTIGATOR, INDEPENDNT ASSESSOR  This column can be left Null when the Investigator provides the complete set of data in the domain. However the column should contain no Null values when data from one or more independent assessors is included meaning that the rows attributed to the Investigator should contain a value of INVESTIGATOR.','string','Evaluator','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-2','CL-EVAL',19,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUEVALID','TUEVALID','The Evaluator Specified variable is used in conjunction with TUEVAL to provide an additional level of detail. When multiple assessors play the role identified in TUEVAL, values of TUEVALID will attribute a row of data to a particular assessor. TUEVALID should not contain the names of the assessors, or a code identifier for a specific assessor, but should contain values such as RADIOLOGIST, RADIOLOGIST 1 or RADIOLOGIST 2. The TUEVALID is subject to CDISC Controlled Terminology. See Assumption 7.','string','Evaluator Identifier','D-SDTM-TU','CL-Role-T-5','CL-Compliance-T-3','CL-MEDEVAL',20,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUGRPID','TUGRPID','Used to link together a block of related records within a subject in a domain.  Can be used to group split or merged tumors which have been identified.','string','Group ID','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TULAT','TULAT','Qualifier for anatomical location or specimen further detailing laterality, for example, LEFT, RIGHT, BILATERAL.','string','Laterality','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-3','CL-LAT',15,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TULNKID','TULNKID','Identifier used to link identified tumors to the assessment results (in TR domain) over the course of the study.','string','Link ID','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-2',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TULOC','TULOC','Used to specify the anatomical location of the identified tumor. Example: LIVER  Note: When anatomical location is broken down and collected as distinct pieces of data that when combined provide the overall location information (e.g. laterality /directionality / distribution) then the additional anatomical location qualifiers should be used. See Assumption 3.','string','Location of the Tumor','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-2','CL-LOC',14,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUMETHOD','TUMETHOD','Method used to identify the tumor. Examples:  MRI, CT SCAN.','string','Method of Identification','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-2','CL-METHOD',18,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUNAM','TUNAM','The name or identifier of the vendor that performed the Tumor Identification.  This column can be left Null when the Investigator provides the complete set of data in the domain.','string','Vendor Name','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-3',NULL,13,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUORRES','TUORRES','Result of the Tumor identification.  The result of tumor identification is a classification of identified tumor.  Examples: When TUTESTCD=TUMIDENT (Tumor Identification), values of TUORRES might be: TARGET, NON-TARGET, or NEW, or BENIGN ABNORMALITY.','string','Tumor Identification Result','D-SDTM-TU','CL-Role-T-8','CL-Compliance-T-2',NULL,11,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUPORTOT','TUPORTOT','Qualifier for anatomical location or specimen further detailing the distribution which means arrangement of, or apportioning of, for example, ENTIRE, SINGLE, SEGMENT, MANY.','string','Portion or Totality','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-3','CL-PORTOT',17,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUREFID','TUREFID','Internal or external identifier. Example: Medical image ID number.','string','Reference ID','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUSEQ','TUSEQ','Sequence number given to ensure uniqueness within a dataset for a subject. May be any valid number.','decimal','Sequence Number','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUSPID','TUSPID','Sponsor-defined identifier.','string','Sponsor-Defined Identifier','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUSTRESC','TUSTRESC','Contains the result value for all findings copied from TUORRES.','string','Tumor Identification Result Std. Format','D-SDTM-TU','CL-Role-T-3','CL-Compliance-T-2','CL-TUMIDENT',12,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUTEST','TUTEST','Verbatim name of the test for the tumor identification. The value in TUTEST cannot be longer than 40 characters. Example: Tumor Identification. See Assumption 2.','string','Tumor Identification Test Name','D-SDTM-TU','CL-Role-T-4','CL-Compliance-T-1','CL-TUTEST',10,'\0','\0','COLUMN',NULL),('V-SDTM-TU-TUTESTCD','TUTESTCD','Short name of the TEST in TUTEST. TUTESTCD cannot be longer than 8 characters nor can start with a number. TUTESTCD contain characters other than letters, numbers, or underscores.  Example: TUMIDENT (Tumor Identification). See Assumption 2.','string','Tumor Identification Short Name','D-SDTM-TU','CL-Role-T-2','CL-Compliance-T-1','CL-TUTESTCD',9,'\0','\0','COLUMN',NULL),('V-SDTM-TU-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-TU','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-TU-VISIT','VISIT','1. Protocol-defined description of clinical encounter.  2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-TU-VISITDY','VISITDY','','integer','Planned Study Day of Visit','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-TU-VISITNUM','VISITNUM','1. Clinical encounter number.  2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-TU','CL-Role-T-6','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-TV-ARM','ARM','1. Name given to an Arm or Treatment Group.\n2. If the timing of Visits for a trial does not depend on which Arm a subject is in, then Arm should be left blank.','string','Description of Planned Arm','D-SDTM-TV','CL-Role-T-4','CL-Compliance-T-3',NULL,7,'\0','\0','COLUMN',NULL),('V-SDTM-TV-ARMCD','ARMCD','1.ARMCD is limited to 20 characters and does not have special character restrictions. The maximum length of ARMCD is longer than for other \"short\" variables to accommodate the kind of values that are likely to be needed for crossover trials. For example, if ARMCD values for a seven-period crossover were constructed using two-character abbreviations for each treatment and separating hyphens, the length of ARMCD values would be 20.\n2. If the timing of Visits for a trial does not depend on which ARM a subject is in, then ARMCD should be null.','string','Planned Arm Code','D-SDTM-TV','CL-Role-T-3','CL-Compliance-T-2',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-TV-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-TV','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-TV-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-TV','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-TV-TVENRL','TVENRL','Rule describing when the Visit ends, in relation to the sequence of Elements.','string','Visit End Rule','D-SDTM-TV','CL-Role-T-9','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-TV-TVSTRL','TVSTRL','Rule describing when the Visit starts, in relation to the sequence of Elements.','string','Visit Start Rule','D-SDTM-TV','CL-Role-T-9','CL-Compliance-T-1',NULL,8,'\0','\0','COLUMN',NULL),('V-SDTM-TV-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY as a text description of the clinical encounter.','string','Visit Name','D-SDTM-TV','CL-Role-T-4','CL-Compliance-T-3',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-TV-VISITDY','VISITDY','1. Planned study day of VISIT.\n2. Due to its sequential nature, used for sorting.','integer','Planned Study Day of Visit','D-SDTM-TV','CL-Role-T-6','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-TV-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-TV','CL-Role-T-2','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-VS-DOMAIN','DOMAIN','Two-character abbreviation for the domain.','string','Domain Abbreviation','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-1',NULL,2,'\0','\0','COLUMN',NULL),('V-SDTM-VS-STUDYID','STUDYID','Unique identifier for a study.','string','Study Identifier','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-1',NULL,1,'\0','\0','COLUMN',NULL),('V-SDTM-VS-USUBJID','USUBJID','Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product.','string','Unique Subject Identifier','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-1',NULL,3,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VISIT','VISIT','1. Protocol-defined description of clinical encounter.\n2. May be used in addition to VISITNUM and/or VISITDY.','string','Visit Name','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,23,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VISITDY','VISITDY','Planned study day of the visit based upon RFSTDTC in Demographics.','integer','Planned Study Day of Visit','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,24,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VISITNUM','VISITNUM','1. Clinical encounter number.\n2. Numeric version of VISIT, used for sorting.','decimal','Visit Number','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSBLFL','VSBLFL','Indicator used to identify a baseline value. The value should be \"Y\" or null.','string','Baseline Flag','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-2','CL-NY',20,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSCAT','VSCAT','Used to define a category of related records.','string','Category for Vital Signs','D-SDTM-VS','CL-Role-T-7','CL-Compliance-T-3',NULL,9,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSDRVFL','VSDRVFL','Used to indicate a derived record. The value should be Y or null. Records which represent the average of other records or which do not come from the CRF are examples of records that would be derived for the submission datasets. If VSDRVFL=Y, then VSORRES may be null, with VSSTRESC and (if numeric) VSSTRESN having the derived value.','string','Derived Flag','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-3','CL-NY',21,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSDTC','VSDTC','','dateTime','Date/Time of Measurements','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-2',NULL,25,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSDY','VSDY','1. Study day of vital signs measurements, measured as integer days.\n2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics.','integer','Study Day of Vital Signs','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,26,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSELTM','VSELTM','Planned Elapsed time (in ISO 8601) relative to a planned fixed reference (VSTPTREF). This variable is useful where there are repetitive measures. Not a clock time or a date time variable. Represented as an ISO 8601 Duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by VSTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point indicated by VSTPTREF.','duration','Planned Elapsed Time from Time Point Ref','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,29,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSGRPID','VSGRPID','Used to tie together a block of related records in a single domain for a subject.','string','Group ID','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-3',NULL,5,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSLOC','VSLOC','Location relevant to the collection of Vital Signs measurement. Example: LEFT ARM for blood pressure.','string','Location of Vital Signs Measurement','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-3','CL-LOC',19,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSNRIND','VSNRIND','1. Indicates where the value falls with respect to reference range defined by VSORNRLO and VSORNRHI, VSSTNRLO and VSSTNRHI, or by VSSTNRC. Examples: NORMAL, ABNORMAL, HIGH, LOW.\r 2. Sponsors should specify in the study metadata (Comments column in the define.xml) whether VSNRIND refers to the original or standard reference ranges and results.\r 3. Should not be used to indicate clinical significance.','string','Reference Range Indicator','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2',NULL,22,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSORNRHI','VSORNRHI','Upper end of reference range for continuous measurements in original units. Should be populated only for continuous results.','string','Reference Range Upper Limit in Orig Unit','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSORNRLO','VSORNRLO','Lower end of reference range for continuous measurements in original units. Should be populated only for continuous results.','string','Reference Range Lower Limit in Orig Unit','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSORRES','VSORRES','Result of the vital signs measurement as originally received or collected.','string','Result or Finding in Original Units','D-SDTM-VS','CL-Role-T-8','CL-Compliance-T-2',NULL,12,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSORRESU','VSORRESU','Original units in which the data were collected. The unit for VSORRES. Examples: IN, LB, BEATS/MIN.','string','Original Units','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2','CL-VSRESU',13,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSPOS','VSPOS','Position of the subject during a measurement or examination. Examples: SUPINE, STANDING, SITTING.','string','Vital Signs Position of Subject','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-3','CL-POSITION',11,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSREASND','VSREASND','Describes why a measurement or test was not performed. Examples: BROKEN EQUIPMENT or SUBJECT REFUSED. Used in conjunction with VSSTAT when value is NOT DONE.','string','Reason Not Performed','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-3',NULL,18,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSRFTDTC','VSRFTDTC','Date/time of the reference time point, LBTPTREF.','dateTime','Date/Time of Reference Time Point','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,31,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSCAT','VSSCAT','A further categorization of a measurement or examination.','string','Subcategory for Vital Signs','D-SDTM-VS','CL-Role-T-7','CL-Compliance-T-3',NULL,10,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSEQ','VSSEQ','Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number.','decimal','Sequence Number','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-1',NULL,4,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSPID','VSSPID','Sponsor-defined reference number. Perhaps pre-printed on the CRF as an sdtm-1-3:Classifier.ExpecedVariablelicit line identifier or defined in the sponsor\'s operational database.','string','Sponsor-Defined Identifier','D-SDTM-VS','CL-Role-T-1','CL-Compliance-T-3',NULL,6,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTAT','VSSTAT','Used to indicate that a vital sign measurement was not done. Should be null if a result exists in VSORRES.','string','Completion Status','D-SDTM-VS','CL-Role-T-3','CL-Compliance-T-3','CL-ND',17,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTNRHI','VSSTNRHI','Upper end of reference range for continuous measurements in standardized units. Should be populated only for continuous results.','decimal','Reference Range Upper Limit-Std Units','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2',NULL,20,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTNRLO','VSSTNRLO','Lower end of reference range for continuous measurements for VSSTRESC/VSSTRESN in standardized units. Should be populated only for continuous results.','decimal','Reference Range Lower Limit-Std Units','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2',NULL,19,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTRESC','VSSTRESC','Contains the result value for all findings, copied or derived from VSORRES in a standard format or standard units. VSSTRESC should store all results or findings in character format; if results are numeric, they should also be stored in numeric format in VSSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \"NEGATIVE\" in VSORRES and these results effectively have the same meaning, they could be represented in standard format in VSSTRESC as \"NEGATIVE\".','string','Character Result/Finding in Std Format','D-SDTM-VS','CL-Role-T-8','CL-Compliance-T-2',NULL,14,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTRESN','VSSTRESN','Used for continuous or numeric results or findings in standard format; copied in numeric format from VSSTRESC. VSSTRESN should store all numeric test results or findings.','decimal','Numeric Result/Finding in Standard Units','D-SDTM-VS','CL-Role-T-8','CL-Compliance-T-2',NULL,15,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSSTRESU','VSSTRESU','Standardized unit used for VSSTRESC and VSSTRESN.','string','Standard Units','D-SDTM-VS','CL-Role-T-5','CL-Compliance-T-2','CL-VSRESU',16,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSTEST','VSTEST','Verbatim name of the test or examination used to obtain the measurement or finding. The value in VSTEST cannot be longer than 40 characters. Examples: Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index.','string','Vital Signs Test Name','D-SDTM-VS','CL-Role-T-4','CL-Compliance-T-1','CL-VSTEST',8,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSTESTCD','VSTESTCD','Short name of the measurement, test, or examination described in VSTEST. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in VSTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g.\"1TEST\"). VSTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: SYSBP, DIABP, BMI.','string','Vital Signs Test Short Name','D-SDTM-VS','CL-Role-T-2','CL-Compliance-T-1','CL-VSTESTCD',7,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSTPT','VSTPT','1. Text Description of time when measurement should be taken.\n2. This may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. See VSTPTNUM and VSTPTREF. Examples: Start, 5 min post.','string','Planned Time Point Name','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,27,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSTPTNUM','VSTPTNUM','Numerical version of VSTPT to aid in sorting.','decimal','Planned Time Point Number','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,28,'\0','\0','COLUMN',NULL),('V-SDTM-VS-VSTPTREF','VSTPTREF','Name of the fixed reference point referred to by VSELTM, VSTPTNUM, and VSTPT. Examples: PREVIOUS DOSE, PREVIOUS MEAL.','string','Time Point Reference','D-SDTM-VS','CL-Role-T-6','CL-Compliance-T-3',NULL,30,'\0','\0','COLUMN',NULL);
/*!40000 ALTER TABLE `DomainTemplateVariables` ENABLE KEYS */;
UNLOCK TABLES;


/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2017-04-24 19:05:06
